
PMID- 35926767
OWN - NLM
STAT- Publisher
LR  - 20220804
IS  - 1873-0442 (Electronic)
IS  - 1477-8939 (Linking)
DP  - 2022 Aug 1
TI  - Monkeypox virus neurological manifestations in comparison to otherorthopoxviruses.
PG  - 102414
LID - S1477-8939(22)00160-0 [pii]
LID - 10.1016/j.tmaid.2022.102414 [doi]
AB  - Viral infectious diseases have various neurological manifestations, whether they are epidemic or pandemic in nature. Nonspecific encephalopathy is the most commoncentral nervous system (CNS) manifestation. The spectrum of nervous evidencevaries for viral pathogens. Some infectious viruses, such as the Ebola virus,exhibit direct neurotropism. Others, such as the Rift Valley fever virus, havethe potential for neurotropism. Direct neurotropism is unknown in monkeypoxvirus, SARS-CoV-2, MERS-CoV, and even smallpox. As seen in the COVID-19, theremay be evidence of para-infectious neurological syndrome. There have only been a few reports of neurological diseases caused by monkeypox infection. Futureefforts to prevent the spread of infectious disease surges can reduce mortalitycomplications, the therapeutic burden on the health-care system, and preventfurther spread. This study describes the clinical and neurological complications of monkeypox infection, particularly encephalitis, as well as the laboratorydiagnosis of these cases.
CI  - Copyright (c) 2022. Published by Elsevier Ltd.
FAU - Shafaati, Maryam
AU  - Shafaati M
AD  - Department of Microbiology, Faculty Science, Jahrom Branch, Islamic AzadUniversity, Jahrom, Iran.
FAU - Zandi, Milad
AU  - Zandi M
AD  - Department of Virology, School of Public Health, Tehran University of MedicalSciences, Tehran, Iran. Electronic address: Miladzandi416@gmail.com.
LA  - eng
PT  - Journal Article
DEP - 20220801
PL  - Netherlands
TA  - Travel Med Infect Dis
JT  - Travel medicine and infectious disease
JID - 101230758
SB  - IM
OTO - NOTNLM
OT  - Monkeypox virus
OT  - Nervous system
OT  - Neurology
COIS- Declaration of competing interest The authors declare that there are no conflictsof interest.
EDAT- 2022/08/05 06:00
MHDA- 2022/08/05 06:00
CRDT- 2022/08/04 19:26
PHST- 2022/06/24 00:00 [received]
PHST- 2022/07/27 00:00 [revised]
PHST- 2022/07/29 00:00 [accepted]
PHST- 2022/08/04 19:26 [entrez]
PHST- 2022/08/05 06:00 [pubmed]
PHST- 2022/08/05 06:00 [medline]
AID - S1477-8939(22)00160-0 [pii]
AID - 10.1016/j.tmaid.2022.102414 [doi]
PST - aheadofprint
SO  - Travel Med Infect Dis. 2022 Aug 1:102414. doi: 10.1016/j.tmaid.2022.102414.

PMID- 35926551
OWN - NLM
STAT- Publisher
LR  - 20220804
IS  - 1474-547X (Electronic)
IS  - 0140-6736 (Linking)
DP  - 2022 Aug 1
TI  - Monkeypox as a PHEIC: implications for global health governance.
LID - S0140-6736(22)01437-4 [pii]
LID - 10.1016/S0140-6736(22)01437-4 [doi]
FAU - Wenham, Clare
AU  - Wenham C
AD  - Department of Health Policy, London School of Economics and Political Science,London WC2A 2AE, UK. Electronic address: c.wenham@lse.ac.uk.
FAU - Eccleston-Turner, Mark
AU  - Eccleston-Turner M
AD  - Department of Global Health and Social Medicine, King's College London, London,UK.
LA  - eng
PT  - Journal Article
DEP - 20220801
PL  - England
TA  - Lancet
JT  - Lancet (London, England)
JID - 2985213R
SB  - IM
EDAT- 2022/08/05 06:00
MHDA- 2022/08/05 06:00
CRDT- 2022/08/04 19:03
PHST- 2022/07/26 00:00 [received]
PHST- 2022/07/28 00:00 [accepted]
PHST- 2022/08/04 19:03 [entrez]
PHST- 2022/08/05 06:00 [pubmed]
PHST- 2022/08/05 06:00 [medline]
AID - S0140-6736(22)01437-4 [pii]
AID - 10.1016/S0140-6736(22)01437-4 [doi]
PST - aheadofprint
SO  - Lancet. 2022 Aug 1. pii: S0140-6736(22)01437-4. doi:10.1016/S0140-6736(22)01437-4.

PMID- 35926522
OWN - NLM
STAT- Publisher
LR  - 20220804
IS  - 2352-4650 (Electronic)
IS  - 2352-4642 (Linking)
DP  - 2022 Aug 1
TI  - The monkeypox outbreak: risks to children and pregnant women.
LID - S2352-4642(22)00223-1 [pii]
LID - 10.1016/S2352-4642(22)00223-1 [doi]
FAU - Vouga, Manon
AU  - Vouga M
AD  - Materno-fetal and Obstetrics Research Unit, Department Woman-Mother-Child,Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
FAU - Nielsen-Saines, Karin
AU  - Nielsen-Saines K
AD  - Division of Pediatric Infectious Diseases, Department of Pediatrics, David GeffenSchool of Medicine, University of California, Los Angeles CA, USA.
FAU - Dashraath, Pradip
AU  - Dashraath P
AD  - Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology,National University Hospital, Singapore; Yong Loo Lin School of Medicine,National University of Singapore, Singapore.
FAU - Baud, David
AU  - Baud D
AD  - Materno-fetal and Obstetrics Research Unit, Department Woman-Mother-Child,Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.Electronic address: david.baud@chuv.ch.
LA  - eng
PT  - Journal Article
DEP - 20220801
PL  - England
TA  - Lancet Child Adolesc Health
JT  - The Lancet. Child & adolescent health
JID - 101712925
SB  - IM
COIS- We declare no competing interests.
EDAT- 2022/08/05 06:00
MHDA- 2022/08/05 06:00
CRDT- 2022/08/04 19:02
PHST- 2022/07/14 00:00 [received]
PHST- 2022/07/22 00:00 [accepted]
PHST- 2022/08/04 19:02 [entrez]
PHST- 2022/08/05 06:00 [pubmed]
PHST- 2022/08/05 06:00 [medline]
AID - S2352-4642(22)00223-1 [pii]
AID - 10.1016/S2352-4642(22)00223-1 [doi]
PST - aheadofprint
SO  - Lancet Child Adolesc Health. 2022 Aug 1. pii: S2352-4642(22)00223-1. doi:10.1016/S2352-4642(22)00223-1.

PMID- 35924973
OWN - NLM
STAT- Publisher
LR  - 20220804
IS  - 1601-0825 (Electronic)
IS  - 1354-523X (Linking)
DP  - 2022 Aug 4
TI  - Monkeypox infection: Relevance of oral health screening.
LID - 10.1111/odi.14339 [doi]
FAU - Pandey, Aishwarya
AU  - Pandey A
AUID- ORCID: https://orcid.org/0000-0001-5626-293X
AD  - Department of Periodontology, Faculty of Dental Science, Institute of MedicalSciences, Banaras Hindu University, 221005, Varanasi, Uttar Pradesh, India.
FAU - Reddy, Gowtham N
AU  - Reddy GN
AD  - Department of Medicine, ABVIMS & Dr RML Hospital, 110001, New Delhi, India.
LA  - eng
PT  - Letter
DEP - 20220804
PL  - Denmark
TA  - Oral Dis
JT  - Oral diseases
JID - 9508565
OTO - NOTNLM
OT  - Monkeypox virus
OT  - Oral health screening
OT  - Oral manifestations
OT  - Public health emergency of international concern
OT  - Rapid Containment
EDAT- 2022/08/05 06:00
MHDA- 2022/08/05 06:00
CRDT- 2022/08/04 09:52
PHST- 2022/07/29 00:00 [received]
PHST- 2022/08/02 00:00 [accepted]
PHST- 2022/08/04 09:52 [entrez]
PHST- 2022/08/05 06:00 [pubmed]
PHST- 2022/08/05 06:00 [medline]
AID - 10.1111/odi.14339 [doi]
PST - aheadofprint
SO  - Oral Dis. 2022 Aug 4. doi: 10.1111/odi.14339.

PMID- 35924712
OWN - NLM
STAT- Publisher
LR  - 20220804
IS  - 1945-1938 (Electronic)
IS  - 1049-023X (Linking)
DP  - 2022 Aug 4
TI  - Monkeypox 2022: A Primer and Identify-Isolate-Inform (3I) Tool for EmergencyMedical Services Professionals.
PG  - 1-6
LID - 10.1017/S1049023X22001121 [doi]
AB  - Monkeypox 2022 exhibits unprecedented human-to-human transmission and presentswith different clinical features than those observed in prior outbreaks.Previously endemic only to West and Central Africa, the monkeypox virus spreadrapidly world-wide following confirmation of a case in the United Kingdom on May 7, 2022 of an individual that had traveled to Nigeria. Detection of cases with notravel history confirms on-going community spread. Emergency Medical Services(EMS) professionals will likely encounter patients suspected or confirmed to havemonkeypox, previously a rare disease and therefore unfamiliar to most clinicians.Consequently, it is critical for EMS medical directors to immediately implementpolicies and procedures for EMS teams - including emergency medical dispatchers -to identify potential monkeypox cases. These must include direction on actionsEMS professionals should take to protect themselves and others from virustransmission. Monkeypox 2022 may manifest more subtly than it has historically.Presentations include a subclinical prodrome and less dramatic skin lesions -potentially limited to genital or anal body regions - which can be easilyconfused with dermatologic manifestations of common sexually transmittedinfections (STIs). While most readily spread by close contact with infectiousskin lesions on a patient, it is also transmissible from fomites, such as bedsheets. Additionally, droplet transmission can occur, and the virus can be spreadby aerosolization under certain conditions. The long incubation period could haveprofound negative consequences on EMS staffing if clinicians are exposed tomonkeypox. This report summarizes crucial information needed for EMSprofessionals to understand and manage the monkeypox 2022 outbreak. It presentsan innovative Identify-Isolate-Inform (3I) Tool for use by EMS policymakers,educators, and clinicians on the frontlines who may encounter monkeypox patients.Patients are identified as potentially exposed or infected after an initialassessment of risk factors with associated signs and symptoms. Prehospitalworkers must immediately don personal protective equipment (PPE) and isolateinfectious patients. Also, EMS professionals must report exposures to theiragency infection control officer and alert health authorities for non-transportedpatients. Prehospital professionals play a crucial role in emerging andre-emerging infectious disease mitigation. The monkeypox 2022 3I Tool includesknowledge essential for all clinicians, plus specific information to guidecritical actions in the prehospital environment.
FAU - Koenig, Kristi L
AU  - Koenig KL
AUID- ORCID: https://orcid.org/0000-0002-9626-0442
AD  - County of San Diego, Emergency Medical Services Office, Public Safety Group - SanDiego County Fire, San Diego, California, USA.
AD  - Department of Emergency Medicine and Public Health, University of CaliforniaIrvine, Orange, California, USA.
FAU - Bey, Christian K
AU  - Bey CK
AD  - County of San Diego, Emergency Medical Services Office, Public Safety Group - SanDiego County Fire, San Diego, California, USA.
FAU - Marty, Aileen M
AU  - Marty AM
AD  - College of Arts, Sciences, and Education and Department of TranslationalMedicine, Herbert Wertheim College of Medicine, Florida International University,Miami, Florida, USA.
LA  - eng
PT  - Journal Article
DEP - 20220804
PL  - United States
TA  - Prehosp Disaster Med
JT  - Prehospital and disaster medicine
JID - 8918173
OTO - NOTNLM
OT  - Emergency Medical Services
OT  - emergency medical dispatch
OT  - infectious disease outbreak
OT  - monkeypox
OT  - patient isolation
EDAT- 2022/08/05 06:00
MHDA- 2022/08/05 06:00
CRDT- 2022/08/04 06:22
PHST- 2022/08/04 06:22 [entrez]
PHST- 2022/08/05 06:00 [pubmed]
PHST- 2022/08/05 06:00 [medline]
AID - S1049023X22001121 [pii]
AID - 10.1017/S1049023X22001121 [doi]
PST - aheadofprint
SO  - Prehosp Disaster Med. 2022 Aug 4:1-6. doi: 10.1017/S1049023X22001121.

PMID- 35924502
OWN - NLM
STAT- In-Process
LR  - 20220804
IS  - 0370-629X (Print)
IS  - 0370-629X (Linking)
VI  - 77
IP  - 7-8
DP  - 2022 Jul
TI  - [Monkeypox].
PG  - 452-455
AB  - Monkeypox (MPX), is a rare endemic zoonotic disease of certain areas of Centraland West Africa. Nevertheless, in recent years, several outbreaks have occurredoutside the African continent. Monkeypox usually presents with a flu-likeprodromal period (fever, headache, chills, sweating) associated or followed bythe appearance of lymphadenopathy and a typical skin rash. Transmission issuspected to be direct or indirect via contact with saliva, respiratory droplets or skin lesions of infected animals or more rarely of humans. The gold standardfor diagnosis is the detection of MPX virus (MPXV) by PCR on skin lesion fluid.The evolution is usually favourable in 2 to 5 weeks but severe complications and sequelae are possible. In the absence of a specific treatment, the management is essentially supportive: appropriate local care, rehydration, analgesia andmanagement of eventual complications.
FAU - Absil, G
AU  - Absil G
AD  - Service de Dermatologie, CHU Liege, Belgique.
FAU - Sougne, L
AU  - Sougne L
AD  - Service des Urgences, CHU Liege, Belgique.
FAU - Lahrichi, D
AU  - Lahrichi D
AD  - Service de Dermatologie, CHU Liege, Belgique.
FAU - Collins, P
AU  - Collins P
AD  - Service de Dermatopathologie, CHU Liege, Belgique.
FAU - Meuris, C
AU  - Meuris C
AD  - Service des Maladies infectieuses, CHU Liege, Belgique.
FAU - Moutschen, M
AU  - Moutschen M
AD  - Service des Maladies infectieuses, CHU Liege, Belgique.
FAU - Nikkels, A F
AU  - Nikkels AF
AD  - Service de Dermatologie, CHU Liege, Belgique.
FAU - Orban, C
AU  - Orban C
AD  - Service des Maladies infectieuses, CHU Liege, Belgique.
LA  - fre
PT  - Case Reports
PT  - English Abstract
TT  - Variole du singe.
PL  - Belgium
TA  - Rev Med Liege
JT  - Revue medicale de Liege
JID - 0404317
SB  - IM
OTO - NOTNLM
OT  - Infection
OT  - Orthopoxvirus
OT  - Outbreak
OT  - Zoonotic disease
OT  - Monkeypox
EDAT- 2022/08/05 06:00
MHDA- 2022/08/05 06:00
CRDT- 2022/08/04 04:43
PHST- 2022/08/04 04:43 [entrez]
PHST- 2022/08/05 06:00 [pubmed]
PHST- 2022/08/05 06:00 [medline]
PST - ppublish
SO  - Rev Med Liege. 2022 Jul;77(7-8):452-455.

PMID- 35922921
OWN - NLM
STAT- Publisher
LR  - 20220804
IS  - 1881-7823 (Electronic)
IS  - 1881-7815 (Linking)
DP  - 2022 Aug 2
TI  - Monkeypox - A danger approaching Asia.
LID - 10.5582/bst.2022.01343 [doi]
AB  - Since the end of June 2022, there has been a dramatic increase in the number ofmonkeypox cases worldwide. Given the potential spread of this epidemic, WHO hasdeclared the monkeypox epidemic a global public health emergency. In the face of the changing epidemiology during this monkeypox outbreak, vaccines and preventivemeasures are being researched around the world in response to this emergingdisease. Recently, confirmed cases were reported in South Korea and Japan; asconnections between countries around the world resume, imported cases may beinevitable. China is also concerned and prepared for the danger approaching Asia.In response to this risk, China issued the "Monkeypox Diagnosis and TreatmentGuidelines" and the General Administration of Customs of China announced thattravelers from countries reporting monkeypox cases and with suspected symptomsshould be identified to customs upon entry. Chinese researchers have recentlygenerated two pseudovirus reference materials for the monkeypox viral wild-typeB6R gene and mutant F3L gene. Moreover, monkeypox as a communicable disease canbe added to the current COVID-19 tracking system for better surveillance andmanagement.
FAU - Liu, Xiaoning
AU  - Liu X
AD  - Department of Infectious Diseases and Nursing research institution, NationalClinical Research Center for Infectious Diseases, The Third People's Hospital of Shenzhen , Shenzhen, Guangdong, China.
AD  - National Heart & Lung Institute, Faculty of Medicine, Imperial College London,London, United Kingdom.
FAU - Zhu, Zheng
AU  - Zhu Z
AD  - School of Nursing, Fudan University, Shanghai, China.
AD  - NYU Rory Meyers College of Nursing, New York University, NY, USA.
FAU - Miao, Qiqi
AU  - Miao Q
AD  - Department of Infectious Diseases and Nursing research institution, NationalClinical Research Center for Infectious Diseases, The Third People's Hospital of Shenzhen , Shenzhen, Guangdong, China.
FAU - Lim, Jia Wen
AU  - Lim JW
AD  - National Heart & Lung Institute, Faculty of Medicine, Imperial College London,London, United Kingdom.
FAU - Lu, Hongzhou
AU  - Lu H
AD  - Department of Infectious Diseases and Nursing research institution, NationalClinical Research Center for Infectious Diseases, The Third People's Hospital of Shenzhen , Shenzhen, Guangdong, China.
LA  - eng
PT  - Journal Article
DEP - 20220802
PL  - Japan
TA  - Biosci Trends
JT  - Bioscience trends
JID - 101502754
SB  - IM
OTO - NOTNLM
OT  - Asia
OT  - monkeypox
OT  - preventive measures
OT  - vaccine
EDAT- 2022/08/05 06:00
MHDA- 2022/08/05 06:00
CRDT- 2022/08/04 00:33
PHST- 2022/08/04 00:33 [entrez]
PHST- 2022/08/05 06:00 [pubmed]
PHST- 2022/08/05 06:00 [medline]
AID - 10.5582/bst.2022.01343 [doi]
PST - aheadofprint
SO  - Biosci Trends. 2022 Aug 2. doi: 10.5582/bst.2022.01343.

PMID- 35922201
OWN - NLM
STAT- In-Process
LR  - 20220803
IS  - 0578-1310 (Print)
IS  - 0578-1310 (Linking)
VI  - 60
IP  - 8
DP  - 2022 Aug 2
TI  - [History of epidemiological changes of human monkeypox].
PG  - 836-839
LID - 10.3760/cma.j.cn112140-20220607-00520 [doi]
FAU - Chang, Y N
AU  - Chang YN
AD  - Department of Infectious Disease, Children's Hospital of Chongqing MedicalUniversity, National Clinical Research Center for Child Health and Disorders,Ministry of Education Key Laboratory of Child Developmental Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing 401122, China.
FAU - Shang, T T
AU  - Shang TT
AD  - Department of Infectious Disease, Children's Hospital of Chongqing MedicalUniversity, National Clinical Research Center for Child Health and Disorders,Ministry of Education Key Laboratory of Child Developmental Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing 401122, China.
FAU - Tang, Q Q
AU  - Tang QQ
AD  - Department of Infectious Disease, Children's Hospital of Chongqing MedicalUniversity, National Clinical Research Center for Child Health and Disorders,Ministry of Education Key Laboratory of Child Developmental Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing 401122, China.
FAU - Long, X R
AU  - Long XR
AD  - Department of Infectious Disease, Children's Hospital of Chongqing MedicalUniversity, National Clinical Research Center for Child Health and Disorders,Ministry of Education Key Laboratory of Child Developmental Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing 401122, China.
FAU - Zhao, R Q
AU  - Zhao RQ
AD  - Department of Infectious Disease, Children's Hospital of Chongqing MedicalUniversity, National Clinical Research Center for Child Health and Disorders,Ministry of Education Key Laboratory of Child Developmental Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing 401122, China.
FAU - Xu, H M
AU  - Xu HM
AD  - Department of Infectious Disease, Children's Hospital of Chongqing MedicalUniversity, National Clinical Research Center for Child Health and Disorders,Ministry of Education Key Laboratory of Child Developmental Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing 401122, China.
LA  - chi
PT  - Journal Article
PL  - China
TA  - Zhonghua Er Ke Za Zhi
JT  - Zhonghua er ke za zhi = Chinese journal of pediatrics
JID - 0417427
SB  - IM
EDAT- 2022/08/04 06:00
MHDA- 2022/08/04 06:00
CRDT- 2022/08/03 21:44
PHST- 2022/08/03 21:44 [entrez]
PHST- 2022/08/04 06:00 [pubmed]
PHST- 2022/08/04 06:00 [medline]
AID - 10.3760/cma.j.cn112140-20220607-00520 [doi]
PST - ppublish
SO  - Zhonghua Er Ke Za Zhi. 2022 Aug 2;60(8):836-839. doi:10.3760/cma.j.cn112140-20220607-00520.

PMID- 35921981
OWN - NLM
STAT- Publisher
LR  - 20220803
IS  - 1873-0442 (Electronic)
IS  - 1477-8939 (Linking)
DP  - 2022 Jul 31
TI  - What concerns the general public the most about monkeypox virus? - A textanalytics study based on Natural Language Processing (NLP).
PG  - 102404
LID - S1477-8939(22)00150-8 [pii]
LID - 10.1016/j.tmaid.2022.102404 [doi]
FAU - Sv, Praveen
AU  - Sv P
AD  - Department of Management Studies, National Institute of Technology, Trichy,India. Electronic address: praveenscissci@gmail.com.
FAU - Ittamalla, Rajesh
AU  - Ittamalla R
AD  - Department of Management Studies, National Institute of Technology, Trichy,India.
LA  - eng
PT  - Journal Article
DEP - 20220731
PL  - Netherlands
TA  - Travel Med Infect Dis
JT  - Travel medicine and infectious disease
JID - 101230758
SB  - IM
EDAT- 2022/08/04 06:00
MHDA- 2022/08/04 06:00
CRDT- 2022/08/03 19:14
PHST- 2022/07/04 00:00 [received]
PHST- 2022/07/11 00:00 [revised]
PHST- 2022/07/17 00:00 [accepted]
PHST- 2022/08/03 19:14 [entrez]
PHST- 2022/08/04 06:00 [pubmed]
PHST- 2022/08/04 06:00 [medline]
AID - S1477-8939(22)00150-8 [pii]
AID - 10.1016/j.tmaid.2022.102404 [doi]
PST - aheadofprint
SO  - Travel Med Infect Dis. 2022 Jul 31:102404. doi: 10.1016/j.tmaid.2022.102404.

PMID- 35921681
OWN - NLM
STAT- In-Process
LR  - 20220803
IS  - 0189-160X (Print)
IS  - 0189-160X (Linking)
VI  - 39
IP  - 7
DP  - 2022 Jul 31
TI  - The Rise of Monkeypox Virus Infection and Global Epidemics.
PG  - 653-654
LID - West Afr J Med. [pii]
FAU - Erhabor, G E
AU  - Erhabor GE
AD  - Department of Medicine, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria.
AD  - Editor-in-Chief, West African Journal of Medicine, Yaba, Lagos, Nigeria.
LA  - eng
PT  - Editorial
PL  - Nigeria
TA  - West Afr J Med
JT  - West African journal of medicine
JID - 8301891
SB  - IM
COIS- The Authors declare that no competing interest exists.
EDAT- 2022/08/04 06:00
MHDA- 2022/08/04 06:00
CRDT- 2022/08/03 17:32
PHST- 2022/08/03 17:32 [entrez]
PHST- 2022/08/04 06:00 [pubmed]
PHST- 2022/08/04 06:00 [medline]
AID - West Afr J Med. 2022 July; 39 (7): 653-654 [pii]
PST - ppublish
SO  - West Afr J Med. 2022 Jul 31;39(7):653-654.

PMID- 35921460
OWN - NLM
STAT- In-Process
LR  - 20220803
IS  - 1533-4406 (Electronic)
IS  - 0028-4793 (Linking)
VI  - 387
IP  - 5
DP  - 2022 Aug 4
TI  - Audio Interview: Updated Covid-19 Vaccines and a Look at Monkeypox.
PG  - e16
LID - 10.1056/NEJMe2210394 [doi]
FAU - Rubin, Eric J
AU  - Rubin EJ
FAU - Baden, Lindsey R
AU  - Baden LR
FAU - Morrissey, Stephen
AU  - Morrissey S
LA  - eng
PT  - Editorial
PL  - United States
TA  - N Engl J Med
JT  - The New England journal of medicine
JID - 0255562
SB  - IM
EDAT- 2022/08/04 06:00
MHDA- 2022/08/04 06:00
CRDT- 2022/08/03 14:04
PHST- 2022/08/03 14:04 [entrez]
PHST- 2022/08/04 06:00 [pubmed]
PHST- 2022/08/04 06:00 [medline]
AID - 10.1056/NEJMe2210394 [doi]
PST - ppublish
SO  - N Engl J Med. 2022 Aug 4;387(5):e16. doi: 10.1056/NEJMe2210394.

PMID- 35921403
OWN - NLM
STAT- Publisher
LR  - 20220803
IS  - 1533-4406 (Electronic)
IS  - 0028-4793 (Linking)
DP  - 2022 Aug 3
TI  - Tecovirimat and the Treatment of Monkeypox - Past, Present, and FutureConsiderations.
LID - 10.1056/NEJMp2210125 [doi]
FAU - Sherwat, Adam
AU  - Sherwat A
AD  - From the Office of Infectious Diseases, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring (A.S., D.B.), and the NationalInstitute of Allergy and Infectious Diseases, Bethesda (P.K.) - both in Maryland;and the Multinational Monkeypox Outbreak Response, Centers for Disease Controland Prevention, Atlanta (J.T.B.).
FAU - Brooks, John T
AU  - Brooks JT
AUID- ORCID: 0000-0002-2399-3389
AD  - From the Office of Infectious Diseases, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring (A.S., D.B.), and the NationalInstitute of Allergy and Infectious Diseases, Bethesda (P.K.) - both in Maryland;and the Multinational Monkeypox Outbreak Response, Centers for Disease Controland Prevention, Atlanta (J.T.B.).
FAU - Birnkrant, Debra
AU  - Birnkrant D
AD  - From the Office of Infectious Diseases, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring (A.S., D.B.), and the NationalInstitute of Allergy and Infectious Diseases, Bethesda (P.K.) - both in Maryland;and the Multinational Monkeypox Outbreak Response, Centers for Disease Controland Prevention, Atlanta (J.T.B.).
FAU - Kim, Peter
AU  - Kim P
AD  - From the Office of Infectious Diseases, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring (A.S., D.B.), and the NationalInstitute of Allergy and Infectious Diseases, Bethesda (P.K.) - both in Maryland;and the Multinational Monkeypox Outbreak Response, Centers for Disease Controland Prevention, Atlanta (J.T.B.).
LA  - eng
PT  - Journal Article
DEP - 20220803
PL  - United States
TA  - N Engl J Med
JT  - The New England journal of medicine
JID - 0255562
SB  - IM
EDAT- 2022/08/04 06:00
MHDA- 2022/08/04 06:00
CRDT- 2022/08/03 14:03
PHST- 2022/08/03 14:03 [entrez]
PHST- 2022/08/04 06:00 [pubmed]
PHST- 2022/08/04 06:00 [medline]
AID - 10.1056/NEJMp2210125 [doi]
PST - aheadofprint
SO  - N Engl J Med. 2022 Aug 3. doi: 10.1056/NEJMp2210125.

PMID- 35920493
OWN - NLM
STAT- MEDLINE
DCOM- 20220804
LR  - 20220804
IS  - 1984-0446 (Electronic)
IS  - 0034-7167 (Linking)
VI  - 75
IP  - 5
DP  - 2022 Aug 1
TI  - Monkeypox: between precision public health and stigma risk.
PG  - e750501
LID - S0034-71672022000600100 [pii]
LID - 10.1590/0034-7167.2022750501 [doi]
FAU - Sousa, Alvaro Francisco Lopes de
AU  - Sousa AFL
AUID- ORCID: http://orcid.org/0000-0003-2710-2122
AD  - Universidade Nova de Lisboa, Instituto de Higiene e Medicina Tropical, GlobalHealth and Tropical Medicine. Lisbon, Portugal.
AD  - Associacao Brasileira de Enfermagem, Scientific Editor at Revista Brasileira deEnfermagem. Brasilia, Federal District, Brazil.
FAU - Sousa, Anderson Reis de
AU  - Sousa AR
AUID- ORCID: http://orcid.org/0000-0001-8534-1960
AD  - Universidade Federal da Bahia. Associacao Brasileira de Enfermagem, Director ofDevelopment of Professional Practice and Work in Nursing. Salvador, Bahia,Brazil.
FAU - Fronteira, Ines
AU  - Fronteira I
AUID- ORCID: http://orcid.org/0000-0003-1406-4585
AD  - Universidade Nova de Lisboa, Instituto de Higiene e Medicina Tropical, GlobalHealth and Tropical Medicine. Lisbon, Portugal.
AD  - Associacao Brasileira de Enfermagem, Board Member at Revista Brasileira deEnfermagem. Brasilia, Federal District, Brasil.
LA  - eng
LA  - spa
LA  - por
PT  - Editorial
DEP - 20220801
PL  - Brazil
TA  - Rev Bras Enferm
JT  - Revista brasileira de enfermagem
JID - 7910105
MH  - Animals
MH  - Data Collection
MH  - Humans
MH  - *Monkeypox
MH  - Public Health
MH  - Social Stigma
EDAT- 2022/08/04 06:00
MHDA- 2022/08/05 06:00
CRDT- 2022/08/03 07:53
PHST- 2022/08/03 07:53 [entrez]
PHST- 2022/08/04 06:00 [pubmed]
PHST- 2022/08/05 06:00 [medline]
AID - S0034-71672022000600100 [pii]
AID - 10.1590/0034-7167.2022750501 [doi]
PST - epublish
SO  - Rev Bras Enferm. 2022 Aug 1;75(5):e750501. doi: 10.1590/0034-7167.2022750501.

PMID- 35920269
OWN - NLM
STAT- Publisher
LR  - 20220803
IS  - 2093-2340 (Print)
IS  - 1598-8112 (Linking)
DP  - 2022 Jul 22
TI  - Monkeypox in HIV Infected Cases: A Summary on Clinical Presentation of 27 Cases.
LID - 10.3947/ic.2022.0104 [doi]
FAU - Mungmunpuntipantip, Rujittika
AU  - Mungmunpuntipantip R
AUID- ORCID: https://orcid.org/0000-0003-0078-7897
AD  - Private Academic Consultant, Bangkok, Thailand. rujittika@gmail.com.
FAU - Wiwanitkit, Viroj
AU  - Wiwanitkit V
AUID- ORCID: https://orcid.org/0000-0003-1039-3728
AD  - Joseph Ayobaalola University, Ikeji-Arakeji, Nigeria.
AD  - Dr DY Patil University, Pune, India.
AD  - Faculty of Medicine, University of Nis, Serbia.
AD  - Parasitic Disease Research Center, Suranaree University of Technology, NakhonRatchasima, Thailand.
LA  - eng
PT  - Journal Article
DEP - 20220722
PL  - Korea (South)
TA  - Infect Chemother
JT  - Infection & chemotherapy
JID - 101531537
EDAT- 2022/08/04 06:00
MHDA- 2022/08/04 06:00
CRDT- 2022/08/03 06:12
PHST- 2022/06/27 00:00 [received]
PHST- 2022/07/03 00:00 [accepted]
PHST- 2022/08/03 06:12 [entrez]
PHST- 2022/08/04 06:00 [pubmed]
PHST- 2022/08/04 06:00 [medline]
AID - 54.e53 [pii]
AID - 10.3947/ic.2022.0104 [doi]
PST - aheadofprint
SO  - Infect Chemother. 2022 Jul 22. pii: 54.e53. doi: 10.3947/ic.2022.0104.

PMID- 35920152
OWN - NLM
STAT- MEDLINE
DCOM- 20220804
LR  - 20220804
IS  - 1440-1754 (Electronic)
IS  - 1034-4810 (Linking)
VI  - 58
IP  - 8
DP  - 2022 Aug
TI  - Monkeypox.
PG  - 1290-1292
LID - 10.1111/jpc.16121 [doi]
FAU - Isaacs, David
AU  - Isaacs D
AUID- ORCID: https://orcid.org/0000-0002-9593-7378
AD  - Clinical Ethics, Children's Hospital at Westmead, Sydney, New South Wales,Australia.
LA  - eng
PT  - Editorial
PL  - Australia
TA  - J Paediatr Child Health
JT  - Journal of paediatrics and child health
JID - 9005421
SB  - IM
MH  - Animals
MH  - Disease Outbreaks
MH  - Humans
MH  - *Monkeypox/diagnosis/epidemiology
EDAT- 2022/08/04 06:00
MHDA- 2022/08/05 06:00
CRDT- 2022/08/03 05:03
PHST- 2022/06/29 00:00 [received]
PHST- 2022/07/01 00:00 [accepted]
PHST- 2022/08/03 05:03 [entrez]
PHST- 2022/08/04 06:00 [pubmed]
PHST- 2022/08/05 06:00 [medline]
AID - 10.1111/jpc.16121 [doi]
PST - ppublish
SO  - J Paediatr Child Health. 2022 Aug;58(8):1290-1292. doi: 10.1111/jpc.16121.

PMID- 35919078
OWN - NLM
STAT- MEDLINE
DCOM- 20220804
LR  - 20220804
IS  - 1735-3688 (Electronic)
IS  - 0253-0716 (Linking)
VI  - 47
IP  - 4
DP  - 2022 Jul
TI  - Human Monkeypox.
PG  - 289-290
LID - 10.30476/ijms.2022.48507 [doi]
FAU - Tabarsi, Payam
AU  - Tabarsi P
AD  - Clinical TB and Epidemiology Research Center, Shahid Beheshti University ofMedical Sciences, Tehran, Iran.
LA  - eng
PT  - Editorial
PL  - Iran
TA  - Iran J Med Sci
JT  - Iranian journal of medical sciences
JID - 8104374
SB  - IM
MH  - Animals
MH  - Disease Outbreaks
MH  - Humans
MH  - *Monkeypox/diagnosis/epidemiology
MH  - Monkeypox virus
PMC - PMC9339110
EDAT- 2022/08/04 06:00
MHDA- 2022/08/05 06:00
CRDT- 2022/08/03 02:04
PHST- 2022/08/03 02:04 [entrez]
PHST- 2022/08/04 06:00 [pubmed]
PHST- 2022/08/05 06:00 [medline]
AID - 10.30476/ijms.2022.48507 [doi]
AID - IJMS-47-4 [pii]
PST - ppublish
SO  - Iran J Med Sci. 2022 Jul;47(4):289-290. doi: 10.30476/ijms.2022.48507.

PMID- 35918005
OWN - NLM
STAT- Publisher
LR  - 20220802
IS  - 1743-9159 (Electronic)
IS  - 1743-9159 (Linking)
DP  - 2022 Jul 31
TI  - Clinical characteristics of human monkeypox laboratory confirmed cases: Lessonsfrom observational studies.
PG  - 106795
LID - S1743-9191(22)00572-6 [pii]
LID - 10.1016/j.ijsu.2022.106795 [doi]
FAU - Sahebi, Saeed
AU  - Sahebi S
AD  - Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
FAU - Keikha, Masoud
AU  - Keikha M
AD  - Antimicrobial Resistance Research Center, Mashhad University of Medical Sciences,Mashhad, Iran; Department of Microbiology and Virology, Faculty of Medicine,Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address:masoud.keykha90@gmail.com.
LA  - eng
PT  - Letter
DEP - 20220731
PL  - England
TA  - Int J Surg
JT  - International journal of surgery (London, England)
JID - 101228232
SB  - IM
COIS- Declaration of competing interest There is no conflict of interest.
EDAT- 2022/08/03 06:00
MHDA- 2022/08/03 06:00
CRDT- 2022/08/02 19:24
PHST- 2022/07/12 00:00 [received]
PHST- 2022/07/20 00:00 [accepted]
PHST- 2022/08/02 19:24 [entrez]
PHST- 2022/08/03 06:00 [pubmed]
PHST- 2022/08/03 06:00 [medline]
AID - S1743-9191(22)00572-6 [pii]
AID - 10.1016/j.ijsu.2022.106795 [doi]
PST - aheadofprint
SO  - Int J Surg. 2022 Jul 31:106795. doi: 10.1016/j.ijsu.2022.106795.

PMID- 35918003
OWN - NLM
STAT- Publisher
LR  - 20220802
IS  - 1743-9159 (Electronic)
IS  - 1743-9159 (Linking)
DP  - 2022 Jul 30
TI  - The global human monkeypox outbreak in 2022: An overview.
PG  - 106794
LID - S1743-9191(22)00571-4 [pii]
LID - 10.1016/j.ijsu.2022.106794 [doi]
FAU - Ahmed, Sirwan Khalid
AU  - Ahmed SK
AD  - Department of Emergency, Ranya Teaching Hospital, Ranya, Sulaimani,Kurdistan-region, Iraq. Electronic address: sirwan.ahmed1989@gmail.com.
FAU - Ahmed Rashad, Eman Abdelaziz
AU  - Ahmed Rashad EA
AD  - Department of Adult Nursing, RAK Medical and Health Sciences University, Ras AlKhaimah, United Arab Emirates.
FAU - Mohamed, Mona Gamal
AU  - Mohamed MG
AD  - Department of Adult Nursing, RAK Medical and Health Sciences University, Ras AlKhaimah, United Arab Emirates.
FAU - Ravi, Ramya Kundayi
AU  - Ravi RK
AD  - Department of Adult Nursing, RAK Medical and Health Sciences University, Ras AlKhaimah, United Arab Emirates.
FAU - Essa, Rawand Abdulrahman
AU  - Essa RA
AD  - Department of Emergency, Ranya Teaching Hospital, Ranya, Sulaimani,Kurdistan-region, Iraq.
FAU - Abdulqadir, Salar Omar
AU  - Abdulqadir SO
AD  - Department of Psychiatric, College of Nursing, University of Raparin, Ranya,Sulaimani, Kurdistan-region, Iraq.
FAU - Khdir, Awat Alla
AU  - Khdir AA
AD  - Department of Emergency, Ranya Teaching Hospital, Ranya, Sulaimani,Kurdistan-region, Iraq.
LA  - eng
PT  - Letter
DEP - 20220730
PL  - England
TA  - Int J Surg
JT  - International journal of surgery (London, England)
JID - 101228232
SB  - IM
EDAT- 2022/08/03 06:00
MHDA- 2022/08/03 06:00
CRDT- 2022/08/02 19:24
PHST- 2022/07/04 00:00 [received]
PHST- 2022/07/08 00:00 [revised]
PHST- 2022/07/12 00:00 [accepted]
PHST- 2022/08/02 19:24 [entrez]
PHST- 2022/08/03 06:00 [pubmed]
PHST- 2022/08/03 06:00 [medline]
AID - S1743-9191(22)00571-4 [pii]
AID - 10.1016/j.ijsu.2022.106794 [doi]
PST - aheadofprint
SO  - Int J Surg. 2022 Jul 30:106794. doi: 10.1016/j.ijsu.2022.106794.

PMID- 35917191
OWN - NLM
STAT- Publisher
LR  - 20220802
IS  - 1365-2133 (Electronic)
IS  - 0007-0963 (Linking)
DP  - 2022 Aug 2
TI  - Monkeypox outbreak in Spain: clinical and epidemiological findings in aprospective cross-sectional study of 185 cases.
LID - 10.1111/bjd.21790 [doi]
AB  - BACKGROUND: Since May 2022, a new outbreak of monkeypox has been reported inseveral countries, including Spain. The clinical and epidemiologicalcharacteristics of the cases in this outbreak may differ form earlier reports.METHODS: We conducted a prospective cross-sectional study in multiple medicalfacilities in Spain to describe the cases of monkeypox in the 2022 outbreak.RESULTS: In total, 185 patients were included. Most cases started with primarily localised homogeneous papules, not pustules, in the probable area of inoculation,whichcould be cutaneous or mucous, including single lesions. Generalised smallpustules appeared later in some of them. Heterogeneous lesions occurred duringthis generalised phase. All patients had systemic symptoms. Less common lesionsincluded mucosal ulcers (including pharyngeal ulcers and proctitis) and monkeypoxwhitlows. Four patients were hospitalised, none died. Smallpox vaccination andwell-controlled HIV disease were not associated with markers of severity. Contactduring sex is the most likely mechanism of transmission. In this outbreak, cases have been described in males having sex with males and are strongly associatedwith high-risk sexual behaviours. Seventy-six percent of the patients had othersexually transmitted diseases upon screening. CONCLUSIONS: The clinical findings in this outbreak differ from previous findings and highly suggest contacttransmission and initiation at the entry site. The characterisation of theepidemiology of this outbreak has implications for control.
CI  - This article is protected by copyright. All rights reserved.
FAU - Catala, Alba
AU  - Catala A
AD  - Sexually Transmitted Diseases Clinic. Dermatology Department. Hospital Clinic.Barcelona, Spain.
FAU - Clavo Escribano, Petunia
AU  - Clavo Escribano P
AD  - Centro Sandoval. Dermatology Department. Hospital Clinico San Carlos. Madrid,Spain.
FAU - Riera, Josep
AU  - Riera J
AD  - Sexually Transmitted Diseases Clinic. Dermatology Department. Hospital Clinic.Barcelona, Spain.
FAU - Martin-Ezquerra, Gemma
AU  - Martin-Ezquerra G
AD  - Sexually Transmitted Diseases Clinic. Dermatology Department. Hospital Clinic.Barcelona, Spain.
FAU - Fernandez-Gonzalez, Pablo
AU  - Fernandez-Gonzalez P
AD  - Dermatology Department. Hospital Ramon y Cajal. Madrid, Spain.
FAU - Revelles Penas, Leonor
AU  - Revelles Penas L
AD  - Centro Sandoval. Dermatology Department. Hospital Clinico San Carlos. Madrid,Spain.
AD  - Dermatology Department. Complejo Asistencial Universitario de Salamanca.Salamanca, Spain.
FAU - Simon Gozalbo, Ana
AU  - Simon Gozalbo A
AUID- ORCID: https://orcid.org/0000-0003-1310-3538
AD  - Dermatology department. Hospital Universitario Infanta Leonor. Madrid, Spain.
FAU - Rodriguez-Cuadrado, Francisco Jose
AU  - Rodriguez-Cuadrado FJ
AUID- ORCID: https://orcid.org/0000-0001-9168-4038
AD  - Dermatology Department. Hospital Universitario Puerta de Hierro Majadahonda.Madrid, Spain.
FAU - Guilera Castells, Vanessa
AU  - Guilera Castells V
AD  - STDs Program. Hospital Clinic Barcelona., Spain.
FAU - De la Torre Gomar, Francisco Javier
AU  - De la Torre Gomar FJ
AUID- ORCID: https://orcid.org/0000-0002-4400-7859
AD  - Dermatology Department. Hospital Universitario San Cecilio. Granada, Spain.
FAU - Comunion Artieda, Alicia
AU  - Comunion Artieda A
AD  - Centro de diagnostico Montesa. Madrid, Spain.
FAU - Fuertes de Vega, Laura
AU  - Fuertes de Vega L
AD  - Dermatology Department. Hospital Universitario Fundacion Jimenez Diaz. Madrid,Spain.
FAU - Blanco, Jose Luis
AU  - Blanco JL
AD  - Infectious Diseases & AIDS Unit. Hospital Clinic Barcelona., Spain.
FAU - Puig, Susana
AU  - Puig S
AD  - Dermatology Department. Hospital Clinic. Barcelona, Spain.
FAU - Garcia Minarro, Angela Maria
AU  - Garcia Minarro AM
AD  - Hospital Universitario De Gran Canaria Dr. Negrin. Las Palmas de Gran Canaria,Spain.
FAU - Fiz Benito, Esther
AU  - Fiz Benito E
AD  - Dermatology Department. Hospital La Paz. Madrid, Spain.
FAU - Munoz-Santos, Carlos
AU  - Munoz-Santos C
AUID- ORCID: https://orcid.org/0000-0003-3721-8030
AD  - Dermatology Department. Hospital General de Granollers. Granollers, Barcelona,Spain.
FAU - Repiso-Jimenez, Juan Bosco
AU  - Repiso-Jimenez JB
AD  - Dermatology Department. Hospital Costa del Sol. Marbella, Spain.
FAU - Ceballos-Rodriguez, Carmen
AU  - Ceballos-Rodriguez C
AD  - Dermatology Department. Hospital Universitario Fundacion Jimenez Diaz. Madrid,Spain.
FAU - Garcia Rodriguez, Victor
AU  - Garcia Rodriguez V
AD  - Dermatology Department. Hospital Universitari Sagrat Cor, Grupo Quironsalud.Barcelona, Spain.
FAU - Castano Fernandez, Juan Luis
AU  - Castano Fernandez JL
AD  - Dermatology Department. Hospital Universitario Puerta de Hierro Majadahonda.Madrid, Spain.
FAU - Sanchez-Gutierrez, Irene
AU  - Sanchez-Gutierrez I
AD  - Dermatology Department. Hospital Universitario Puerta de Hierro Majadahonda.Madrid, Spain.
FAU - Calvo Lopez, Ricardo
AU  - Calvo Lopez R
AD  - Emergency Department. Hospital Universitario A Coruna. A Coruna, Spain.
FAU - Berna-Rico, Emilio
AU  - Berna-Rico E
AUID- ORCID: https://orcid.org/0000-0003-0348-5421
AD  - Dermatology Department. Hospital Ramon y Cajal. Madrid, Spain.
FAU - de Nicolas-Ruanes, Belen
AU  - de Nicolas-Ruanes B
AD  - Dermatology Department. Hospital Ramon y Cajal. Madrid, Spain.
FAU - Corella Vicente, Francesca
AU  - Corella Vicente F
AD  - Dermatology Department. Hospital Universitari Mutua de Terrassa. Barcelona,Spain.
FAU - Tarin Vicente, Eloy Jose
AU  - Tarin Vicente EJ
AD  - Dermatology Department. Hospital 12 de octubre. Madrid, Spain.
FAU - Fernandez de la Fuente, Laura
AU  - Fernandez de la Fuente L
AD  - Dermatology Department. Hospital Universitario de Fuenlabrada. Madrid, Spain.
FAU - Riera-Marti, Nuria
AU  - Riera-Marti N
AD  - Dermatology Department. Hospital Universitari Parc Tauli. Barcelona, Spain.
FAU - Descalzo-Gallego, Miguel Angel
AU  - Descalzo-Gallego MA
AD  - Research Unit. Fundacion Piel Sana AEDV. Madrid, Spain.
FAU - Grau-Perez, Merce
AU  - Grau-Perez M
AD  - Research Unit. Fundacion Piel Sana AEDV. Madrid, Spain. Dermatology Department.Hospital Universitario Puerta de Hierro Majadahonda. Madrid, Spain.
FAU - Garcia-Doval, Ignacio
AU  - Garcia-Doval I
AUID- ORCID: https://orcid.org/0000-0002-6881-5260
AD  - Research Unit. Fundacion Piel Sana AEDV. Madrid, Spain. Dermatology Department.Complexo Hospitalario Universitario de Vigo, Vigo, Spain.
FAU - Fuertes, Irene
AU  - Fuertes I
AD  - Sexually Transmitted Diseases Clinic. Dermatology Department. Hospital Clinic.Barcelona, Spain.
LA  - eng
PT  - Journal Article
DEP - 20220802
PL  - England
TA  - Br J Dermatol
JT  - The British journal of dermatology
JID - 0004041
SB  - IM
OTO - NOTNLM
OT  - Monkeypox
OT  - epidemiology
EDAT- 2022/08/03 06:00
MHDA- 2022/08/03 06:00
CRDT- 2022/08/02 12:03
PHST- 2022/07/22 00:00 [revised]
PHST- 2022/07/14 00:00 [received]
PHST- 2022/07/22 00:00 [accepted]
PHST- 2022/08/02 12:03 [entrez]
PHST- 2022/08/03 06:00 [pubmed]
PHST- 2022/08/03 06:00 [medline]
AID - 10.1111/bjd.21790 [doi]
PST - aheadofprint
SO  - Br J Dermatol. 2022 Aug 2. doi: 10.1111/bjd.21790.

PMID- 35916973
OWN - NLM
STAT- Publisher
LR  - 20220802
IS  - 1468-2869 (Electronic)
IS  - 1099-3460 (Linking)
DP  - 2022 Aug 2
TI  - Deja vu All Over Again? Emergent Monkeypox, Delayed Responses, and StigmatizedPopulations.
LID - 10.1007/s11524-022-00671-1 [doi]
FAU - Gonsalves, Gregg S
AU  - Gonsalves GS
AD  - Department of Epidemiology of Microbial Diseases, Yale School of Public Health,New Haven, CT, USA. gregg.gonsalves@yale.edu.
AD  - Public Health Modeling Unit, Yale School of Public Health, New Haven, CT, 06511, USA. gregg.gonsalves@yale.edu.
FAU - Mayer, Kenneth
AU  - Mayer K
AD  - Fenway Health, Boston, MA, USA.
AD  - Harvard Medical School, Boston, MA, USA.
AD  - Harvard T.C. Chan School of Public Health, Boston, MA, USA.
FAU - Beyrer, Chris
AU  - Beyrer C
AD  - Duke Global Health Institute, Duke University, Durham, NC, USA.
LA  - eng
PT  - Editorial
DEP - 20220802
PL  - United States
TA  - J Urban Health
JT  - Journal of urban health : bulletin of the New York Academy of Medicine
JID - 9809909
SB  - IM
EDAT- 2022/08/03 06:00
MHDA- 2022/08/03 06:00
CRDT- 2022/08/02 11:16
PHST- 2022/07/07 00:00 [accepted]
PHST- 2022/08/02 11:16 [entrez]
PHST- 2022/08/03 06:00 [pubmed]
PHST- 2022/08/03 06:00 [medline]
AID - 10.1007/s11524-022-00671-1 [doi]
AID - 10.1007/s11524-022-00671-1 [pii]
PST - aheadofprint
SO  - J Urban Health. 2022 Aug 2. pii: 10.1007/s11524-022-00671-1. doi:10.1007/s11524-022-00671-1.

PMID- 35914609
OWN - NLM
STAT- Publisher
LR  - 20220801
IS  - 1532-2742 (Electronic)
IS  - 0163-4453 (Linking)
DP  - 2022 Jul 29
TI  - Monkeypox infection among men who have sex with men: PCR testing on seminalfluids.
LID - S0163-4453(22)00449-2 [pii]
LID - 10.1016/j.jinf.2022.07.022 [doi]
FAU - Raccagni, Angelo Roberto
AU  - Raccagni AR
AD  - Vita-Salute San Raffaele University, Milan, Italy. Electronic address:raccagni.angelo@hsr.it.
FAU - Candela, Caterina
AU  - Candela C
AD  - Vita-Salute San Raffaele University, Milan, Italy.
FAU - DavideMileto
AU  - DavideMileto
AD  - Laboratory of Clinical Microbiology, Virology and Bioemergencies, Ospedale Sacco,Milan, Italy.
FAU - Canetti, Diana
AU  - Canetti D
AD  - Infectious Diseases Unit, San Raffaele Scientific Institute, Milan, Italy.
FAU - Bruzzesi, Elena
AU  - Bruzzesi E
AD  - Vita-Salute San Raffaele University, Milan, Italy.
FAU - Rizzo, Alberto
AU  - Rizzo A
AD  - Laboratory of Clinical Microbiology, Virology and Bioemergencies, Ospedale Sacco,Milan, Italy; University of Milan, Milan, Italy.
FAU - Castagna, Antonella
AU  - Castagna A
AD  - Vita-Salute San Raffaele University, Milan, Italy; Infectious Diseases Unit, San Raffaele Scientific Institute, Milan, Italy.
FAU - Nozza, Silvia
AU  - Nozza S
AD  - Infectious Diseases Unit, San Raffaele Scientific Institute, Milan, Italy.
LA  - eng
PT  - Letter
DEP - 20220729
PL  - England
TA  - J Infect
JT  - The Journal of infection
JID - 7908424
SB  - IM
OTO - NOTNLM
OT  - Men who have Sex with Men
OT  - Monkeypox
OT  - Seminal Fluids
OT  - Sexual Transmission
COIS- Declaration of Competing Interest None.
EDAT- 2022/08/02 06:00
MHDA- 2022/08/02 06:00
CRDT- 2022/08/01 19:13
PHST- 2022/07/25 00:00 [received]
PHST- 2022/07/26 00:00 [accepted]
PHST- 2022/08/01 19:13 [entrez]
PHST- 2022/08/02 06:00 [pubmed]
PHST- 2022/08/02 06:00 [medline]
AID - S0163-4453(22)00449-2 [pii]
AID - 10.1016/j.jinf.2022.07.022 [doi]
PST - aheadofprint
SO  - J Infect. 2022 Jul 29. pii: S0163-4453(22)00449-2. doi:10.1016/j.jinf.2022.07.022.

PMID- 35914540
OWN - NLM
STAT- Publisher
LR  - 20220801
IS  - 2666-5247 (Electronic)
IS  - 2666-5247 (Linking)
DP  - 2022 Jul 29
TI  - Evolutionary implications of human transmission of monkeypox: the importance ofsequencing multiple lesions.
LID - S2666-5247(22)00194-X [pii]
LID - 10.1016/S2666-5247(22)00194-X [doi]
FAU - Ulaeto, David O
AU  - Ulaeto DO
AD  - CBR Division, Defence Science and Technology Laboratory, Salisbury SP4 0JQ, UK.Electronic address: dulaeto@dstl.gov.uk.
FAU - Dunning, Jake
AU  - Dunning J
AD  - Pandemic Sciences Institute, Nuffield Department of Medicine, University ofOxford, Oxford, UK.
FAU - Carroll, Miles W
AU  - Carroll MW
AD  - High Consequence Emerging Viruses Group, Wellcome Centre for Human Genetics,Nuffield Department of Medicine, University of Oxford, Oxford, UK; PandemicSciences Institute, Nuffield Department of Medicine, University of Oxford,Oxford, UK.
LA  - eng
PT  - Journal Article
DEP - 20220729
PL  - England
TA  - Lancet Microbe
JT  - The Lancet. Microbe
JID - 101769019
SB  - IM
EDAT- 2022/08/02 06:00
MHDA- 2022/08/02 06:00
CRDT- 2022/08/01 19:03
PHST- 2022/07/01 00:00 [received]
PHST- 2022/07/01 00:00 [accepted]
PHST- 2022/08/01 19:03 [entrez]
PHST- 2022/08/02 06:00 [pubmed]
PHST- 2022/08/02 06:00 [medline]
AID - S2666-5247(22)00194-X [pii]
AID - 10.1016/S2666-5247(22)00194-X [doi]
PST - aheadofprint
SO  - Lancet Microbe. 2022 Jul 29. pii: S2666-5247(22)00194-X. doi:10.1016/S2666-5247(22)00194-X.

PMID- 35914539
OWN - NLM
STAT- Publisher
LR  - 20220801
IS  - 1474-4457 (Electronic)
IS  - 1473-3099 (Linking)
DP  - 2022 Jul 29
TI  - Ophthalmic manifestation of monkeypox infection.
LID - S1473-3099(22)00504-7 [pii]
LID - 10.1016/S1473-3099(22)00504-7 [doi]
FAU - Benatti, Simone Vasilij
AU  - Benatti SV
AD  - Infectious Diseases Unit, ASST "Papa Giovanni XXIII", Bergamo, Italy. Electronic address: sbenatti@asst-pg23.it.
FAU - Venturelli, Serena
AU  - Venturelli S
AD  - Infectious Diseases Unit, ASST "Papa Giovanni XXIII", Bergamo, Italy.
FAU - Comi, Natalia
AU  - Comi N
AD  - Ophtalmology Unit, ASST "Papa Giovanni XXIII", Bergamo, Italy.
FAU - Borghi, Federica
AU  - Borghi F
AD  - Infectious Diseases Unit, ASST "Papa Giovanni XXIII", Bergamo, Italy.
FAU - Paolucci, Stefania
AU  - Paolucci S
AD  - Department of Clinical, Surgical, Diagnostics, and Pediatric Sciences, Universityof Pavia, Pavia, Italy; Microbiology and Virology Unit, Fondazione IRCCSPoliclinico San Matteo, Pavia, Italy.
FAU - Baldanti, Fausto
AU  - Baldanti F
AD  - Department of Clinical, Surgical, Diagnostics, and Pediatric Sciences, Universityof Pavia, Pavia, Italy; Microbiology and Virology Unit, Fondazione IRCCSPoliclinico San Matteo, Pavia, Italy.
LA  - eng
PT  - Journal Article
DEP - 20220729
PL  - United States
TA  - Lancet Infect Dis
JT  - The Lancet. Infectious diseases
JID - 101130150
SB  - IM
COIS- Declaration of interests We declare no competing interests.
EDAT- 2022/08/02 06:00
MHDA- 2022/08/02 06:00
CRDT- 2022/08/01 19:02
PHST- 2022/07/04 00:00 [received]
PHST- 2022/07/13 00:00 [accepted]
PHST- 2022/08/01 19:02 [entrez]
PHST- 2022/08/02 06:00 [pubmed]
PHST- 2022/08/02 06:00 [medline]
AID - S1473-3099(22)00504-7 [pii]
AID - 10.1016/S1473-3099(22)00504-7 [doi]
PST - aheadofprint
SO  - Lancet Infect Dis. 2022 Jul 29. pii: S1473-3099(22)00504-7. doi:10.1016/S1473-3099(22)00504-7.

PMID- 35912913
OWN - NLM
STAT- Publisher
LR  - 20220801
IS  - 1897-9483 (Electronic)
IS  - 0032-3772 (Linking)
DP  - 2022 Jul 29
TI  - Monkeypox present with genital ulcers-challenging clinical problem.
LID - 16304 [pii]
LID - 10.20452/pamw.16304 [doi]
FAU - Bociaga-Jasik, Monika
AU  - Bociaga-Jasik M
FAU - Raczynska, Aleksandra
AU  - Raczynska A
FAU - Lara, Martyna
AU  - Lara M
FAU - Kalinowska-Nowak, Anna
AU  - Kalinowska-Nowak A
FAU - Garlicki, Aleksander
AU  - Garlicki A
LA  - eng
PT  - Journal Article
DEP - 20220729
PL  - Poland
TA  - Pol Arch Intern Med
JT  - Polish archives of internal medicine
JID - 101700960
SB  - IM
EDAT- 2022/08/02 06:00
MHDA- 2022/08/02 06:00
CRDT- 2022/08/01 06:24
PHST- 2022/08/01 06:24 [entrez]
PHST- 2022/08/02 06:00 [pubmed]
PHST- 2022/08/02 06:00 [medline]
AID - 10.20452/pamw.16304 [doi]
PST - aheadofprint
SO  - Pol Arch Intern Med. 2022 Jul 29. doi: 10.20452/pamw.16304.

PMID- 35912445
OWN - NLM
STAT- Publisher
LR  - 20220801
IS  - 1866-0452 (Electronic)
IS  - 1866-0452 (Linking)
IP  - Forthcoming
DP  - 2022 Aug 12
TI  - Monkeypox in Germany-Initial Clinical Observations.
LID - 10.3238/arztebl.m2022.0287 [doi]
LID - arztebl.m2022.0287 [pii]
AB  - BACKGROUND: Many cases of monkeypox have been reported across Europe from earlyMay 2022 onward. Initial publications suggest that nearly all of the affectedpersons to date have been men who have sex with men (MSM). METHODS: Tocharacterize the German cases, an anonymous questionnaire was sent via themailing lists of the German AIDS Society (Deutsche AIDS-Gesellschaft, DAIG) andthe German Association of Outpatient Physicians for Infectious Diseases and HIVMedicine (Deutsche Arbeitsgemeinschaft ambulant tatiger Arztinnen und Arzte furInfektionskrankheiten und HIV-Medizin e.V., DAGNAE). RESULTS: 301 PCR-verifiedcases had been registered as of 23 June 2022. All of the affected persons wereMSM, including 141 (46.7%) with HIV infection and 135 (44.7%) with preexposureprophylaxis (PrEP). The great majority of skin lesions were in the anal andgenital areas. The most common general symptoms were fever, headache, limb pain, and, often, painfully swollen lymph nodes. Most infections to date have taken arelatively mild course: 5.0% of the patients were hospitalized, and none died. A high frequency of sexually transmitted infections (STI) was noted: only 41.0% of the patients had not been given a diagnosis of an STI in the six months beforetheir monkeypox infection. CONCLUSION: Monkeypox seems to be establishing itself as a new type of STI among MSM. In view of the rising case numbers, there is aneed for a rapid information and vaccination campaign in the population at risk. Heightened alertness among physicians is needed as well.
FAU - Hoffmann, Christian
AU  - Hoffmann C
FAU - Jessen, Heiko
AU  - Jessen H
FAU - Boesecke, Christoph
AU  - Boesecke C
LA  - eng
PT  - Journal Article
DEP - 20220812
PL  - Germany
TA  - Dtsch Arztebl Int
JT  - Deutsches Arzteblatt international
JID - 101475967
SB  - IM
EDAT- 2022/08/02 06:00
MHDA- 2022/08/02 06:00
CRDT- 2022/08/01 04:04
PHST- 2022/08/01 04:04 [entrez]
PHST- 2022/08/02 06:00 [pubmed]
PHST- 2022/08/02 06:00 [medline]
AID - arztebl.m2022.0287 [pii]
AID - 10.3238/arztebl.m2022.0287 [doi]
PST - aheadofprint
SO  - Dtsch Arztebl Int. 2022 Aug 12;(Forthcoming). pii: arztebl.m2022.0287. doi:10.3238/arztebl.m2022.0287.

PMID- 35910829
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220802
IS  - 0974-777X (Print)
IS  - 0974-777X (Linking)
VI  - 14
IP  - 2
DP  - 2022 Apr-Jun
TI  - Why Should RNA Viruses Have All the Fun - Monkeypox, a Close Relative of Smallpoxand a DNA Virus.
PG  - 47-49
LID - 10.4103/jgid.jgid_104_22 [doi]
FAU - Thakur, Suman
AU  - Thakur S
AD  - Department of Microbiology, IGMC, Shimla, Himachal Pradesh, India.
FAU - Kelkar, Dhanashree
AU  - Kelkar D
AD  - Department of Emergency Medicine, University of Florida, Jacksonville, Florida,USA.
FAU - Garg, Suneela
AU  - Garg S
AD  - Department of Community Medicine, MAMC, New Delhi, India.
FAU - Raina, Sunil Kumar
AU  - Raina SK
AD  - Department of Community Medicine, Dr. RPGMC, Kangra, Himachal Pradesh, India.
FAU - Lateef, Fatimah
AU  - Lateef F
AD  - Department of Emergency Medicine, Singapore General Hospital, Singapore.
FAU - Gilada, Ishwar
AU  - Gilada I
AD  - Unison Medicare and Research Centre, Mumbai, Maharashtra, India.
FAU - Kumar, Vivek
AU  - Kumar V
AD  - Department of Critical Care Medicine, Reliance Foundation Hospital, Mumbai,Maharashtra, India.
FAU - Bhoi, Sanjeev
AU  - Bhoi S
AD  - Department of Emergency Medicine, JPNATC, AIIMS, New Delhi, India.
FAU - Galwankar, Sagar
AU  - Galwankar S
AD  - Department of Emergency Medicine, University of Florida, Jacksonville, Florida,USA.
FAU - Chauhan, Vivek
AU  - Chauhan V
AD  - Department of Medicine, IGMC, Shimla, Himachal Pradesh, India.
LA  - eng
PT  - Journal Article
DEP - 20220629
PL  - India
TA  - J Glob Infect Dis
JT  - Journal of global infectious diseases
JID - 101521436
PMC - PMC9336599
EDAT- 2022/08/02 06:00
MHDA- 2022/08/02 06:01
CRDT- 2022/08/01 03:38
PHST- 2022/06/03 00:00 [received]
PHST- 2022/06/16 00:00 [revised]
PHST- 2022/06/06 00:00 [accepted]
PHST- 2022/08/01 03:38 [entrez]
PHST- 2022/08/02 06:00 [pubmed]
PHST- 2022/08/02 06:01 [medline]
AID - 10.4103/jgid.jgid_104_22 [doi]
AID - JGID-14-47 [pii]
PST - epublish
SO  - J Glob Infect Dis. 2022 Jun 29;14(2):47-49. doi: 10.4103/jgid.jgid_104_22.eCollection 2022 Apr-Jun.

PMID- 35910429
OWN - NLM
STAT- MEDLINE
DCOM- 20220802
LR  - 20220802
IS  - 1661-8564 (Electronic)
IS  - 1661-8556 (Linking)
VI  - 67
DP  - 2022
TI  - Monkeypox Outbreaks in 2022: Battling Another "Pandemic" of Misinformation.
PG  - 1605149
LID - 10.3389/ijph.2022.1605149 [doi]
FAU - Ennab, Farah
AU  - Ennab F
AD  - College of Medicine, Mohammed Bin Rashid University of Medicine and HealthSciences, Dubai, United Arab Emirates.
FAU - Nawaz, Faisal A
AU  - Nawaz FA
AD  - College of Medicine, Mohammed Bin Rashid University of Medicine and HealthSciences, Dubai, United Arab Emirates.
FAU - Narain, Kapil
AU  - Narain K
AD  - Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
FAU - Nchasi, Goodluck
AU  - Nchasi G
AD  - Department of Medicine, Catholic University of Health and Allied Sciences,Mwanza, Tanzania.
FAU - Essar, Mohammad Yasir
AU  - Essar MY
AD  - Kabul University of Medical Sciences, Kabul, Afghanistan.
FAU - Head, Michael G
AU  - Head MG
AD  - Clinical Informatics Research Unit, Faculty of Medicine, University ofSouthampton, Southampton, United Kingdom.
FAU - Singla, Rajeev K
AU  - Singla RK
AD  - Institutes for Systems Genetics, Frontiers Science Center for Disease-RelatedMolecular Network, West China Hospital, Sichuan University, Chengdu, China.
AD  - iGlobal Research and Publishing Foundation, New Delhi, India.
FAU - Atanasov, Atanas G
AU  - Atanasov AG
AD  - Ludwig Boltzmann Institute for Digital Health and Patient Safety, MedicalUniversity of Vienna, Vienna, Austria.
AD  - Institute of Genetics and Animal Biotechnology of the Polish Academy of Sciences,Jastrzebiec, Poland.
FAU - Shen, Bairong
AU  - Shen B
AD  - Institutes for Systems Genetics, Frontiers Science Center for Disease-RelatedMolecular Network, West China Hospital, Sichuan University, Chengdu, China.
LA  - eng
PT  - Journal Article
DEP - 20220714
PL  - Switzerland
TA  - Int J Public Health
JT  - International journal of public health
JID - 101304551
SB  - IM
MH  - Animals
MH  - Communication
MH  - Disease Outbreaks
MH  - Humans
MH  - *Monkeypox/epidemiology
MH  - Pandemics
PMC - PMC9329665
OTO - NOTNLM
OT  - Monkeypox
OT  - infection
OT  - infection control
OT  - infodemic
OT  - outbreak
OT  - pandemic
COIS- RS has an honorary-based association with the iGlobal Research and PublishingFoundation (iGRPF), New Delhi, India. The remaining authors declare that theresearch was conducted in the absence of any commercial or financialrelationships that could be construed as a potential conflict of interest.
EDAT- 2022/08/02 06:00
MHDA- 2022/08/03 06:00
CRDT- 2022/08/01 03:31
PHST- 2022/06/18 00:00 [received]
PHST- 2022/06/24 00:00 [accepted]
PHST- 2022/08/01 03:31 [entrez]
PHST- 2022/08/02 06:00 [pubmed]
PHST- 2022/08/03 06:00 [medline]
AID - 10.3389/ijph.2022.1605149 [doi]
AID - 1605149 [pii]
PST - epublish
SO  - Int J Public Health. 2022 Jul 14;67:1605149. doi: 10.3389/ijph.2022.1605149.eCollection 2022.

PMID- 35910397
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220802
IS  - 2049-9361 (Print)
IS  - 2049-9361 (Linking)
VI  - 9
DP  - 2022 Jan-Dec
TI  - Monkeypox - a description of the clinical progression of skin lesions: a casereport from Colorado, USA.
PG  - 20499361221117726
LID - 10.1177/20499361221117726 [doi]
AB  - A rapidly emerging global outbreak of monkeypox virus infection (MPXV) in over 50non-endemic countries was identified in May 2022. We report the case and imagesof a patient with MPXV presenting with genital lesions later complicated bysuperimposed cellulitis in Colorado, USA. MPXV lesions are susceptible tobacterial superinfection, and with the advent of new cases, the earlyidentification of skin lesions and their evolution during MPXV are imperative fortreating clinicians. Clinicians should consider MPXV in differential diagnoses ofsexually transmitted diseases presenting with genital lesions.
CI  - (c) The Author(s), 2022.
FAU - Ortiz-Martinez, Yeimer
AU  - Ortiz-Martinez Y
AD  - Department of Internal Medicine, Universidad Industrial de Santander,Bucaramanga, Colombia.
FAU - Rodriguez-Morales, Alfonso J
AU  - Rodriguez-Morales AJ
AUID- ORCID: https://orcid.org/0000-0001-9773-2192
AD  - Grupo de Investigacion Biomedicina, Faculty of Medicine, Fundacion Universitaria Autonoma de las Americas, Pereira, Colombia.
FAU - Franco-Paredes, Carlos
AU  - Franco-Paredes C
AD  - Hospital Infantil de Mexico, Federico Gomez, Mexico City, Mexico.
FAU - Chastain, Daniel B
AU  - Chastain DB
AUID- ORCID: https://orcid.org/0000-0002-4018-0195
AD  - Department of Clinical and Administrative Pharmacy, College of Pharmacy,University of Georgia, Albany, GA, USA.
FAU - Gharamti, Amal A
AU  - Gharamti AA
AD  - Department of Internal Medicine, Yale University, Waterbury, CT, USA.
FAU - Vargas Barahona, Lilian
AU  - Vargas Barahona L
AD  - Division of Infectious Diseases, School of Medicine, University of Colorado,Anschutz Medical Campus, Aurora, CO, USA.
FAU - Henao-Martinez, Andres F
AU  - Henao-Martinez AF
AUID- ORCID: https://orcid.org/0000-0001-7363-8652
AD  - Division of Infectious Diseases, School of Medicine, University of Colorado,Anschutz Medical Campus, 12700 E. 19th Avenue, Mail Stop B168, Aurora, CO 80045, USA.
LA  - eng
PT  - Case Reports
DEP - 20220727
PL  - England
TA  - Ther Adv Infect Dis
JT  - Therapeutic advances in infectious disease
JID - 101606715
PMC - PMC9335484
OTO - NOTNLM
OT  - Orthopoxvirus
OT  - bacterial cellulitis
OT  - imported viral diseases
OT  - monkeypox
OT  - travel medicine
COIS- Competing interests: The authors declare that there is no conflict of interest.The Editor in Chief and Associate Editor of Therapeutic Advances in InfectiousDisease are authors of this paper. Therefore, the peer review process was managedby alternative members of the Editorial Board and the submitting Editors had noinvolvement in the decision-making process.
EDAT- 2022/08/02 06:00
MHDA- 2022/08/02 06:01
CRDT- 2022/08/01 03:30
PHST- 2022/07/08 00:00 [received]
PHST- 2022/07/19 00:00 [accepted]
PHST- 2022/08/01 03:30 [entrez]
PHST- 2022/08/02 06:00 [pubmed]
PHST- 2022/08/02 06:01 [medline]
AID - 10.1177/20499361221117726 [doi]
AID - 10.1177_20499361221117726 [pii]
PST - epublish
SO  - Ther Adv Infect Dis. 2022 Jul 27;9:20499361221117726. doi:10.1177/20499361221117726. eCollection 2022 Jan-Dec.

PMID- 35910060
OWN - NLM
STAT- MEDLINE
DCOM- 20220802
LR  - 20220802
IS  - 1937-8688 (Electronic)
VI  - 42
DP  - 2022
TI  - First confirmed case of monkeypox in Adamawa State, Nigeria: aclinico-epidemiological case report.
PG  - 38
LID - 10.11604/pamj.2022.42.38.34715 [doi]
AB  - Monkeypox is a rare zoonotic infection caused by monkeypox virus. It is anemerging disease which has become the most prevalent orthopoxvirus since theglobal eradication of smallpox in 1980. It is a mild illness which is mostlycharacterized by a prodromal of fever, malaise and progressive appearance ofvesiculo-papular skin lesions. We report a case of a 30-year-old militarypersonnel who was referred from 23 Brigade Medical Centre (BMC) to FederalMedical Centre (FMC) Yola on account of fever and progressive eruption ofwidespread skin rashes. Following isolation from suspicion of monkeypox, he wasconfirmed by PCR and managed symptomatically and fully recovered within two weeksof onset. His five close contacts did not develop any symptoms during the period of follow-up. This is the first confirmed case of monkey pox in the state. Thiscase will trigger an awareness, amongst clinicians and surveillance officers inAdamawa State, of the existence of monkeypox and heighten the suspicion topromptly detect, isolate and treat more cases to halt transmission.
CI  - Copyright: Emmanuel Pembi et al.
FAU - Pembi, Emmanuel
AU  - Pembi E
AD  - State Ministry of Health and Human Services, Yola, Adamawa State, Nigeria.
FAU - Awang, Sati
AU  - Awang S
AD  - Department of Internal Medicine, Federal Medical Centre, Yola., Adamawa State,Nigeria.
FAU - Salaudeen, Saheed Olalekan
AU  - Salaudeen SO
AD  - 23 Brigade Medical Centre, Yola, Adamawa State, Nigeria.
FAU - Agaba, Innocent Adoyi
AU  - Agaba IA
AD  - 23 Brigade Medical Centre, Yola, Adamawa State, Nigeria.
FAU - Omoleke, Semeeh
AU  - Omoleke S
AD  - Doctoral Programme in International Public Health, Euclid University, Bangui,Central African Republic.
LA  - eng
PT  - Case Reports
DEP - 20220516
PL  - Uganda
TA  - Pan Afr Med J
JT  - The Pan African medical journal
JID - 101517926
SB  - IM
MH  - Animals
MH  - *Exanthema
MH  - Fever
MH  - Male
MH  - *Monkeypox/diagnosis/epidemiology
MH  - Monkeypox virus
MH  - Nigeria/epidemiology
MH  - *Smallpox
MH  - Zoonoses
PMC - PMC9288116
OTO - NOTNLM
OT  - Adamawa State
OT  - Monkeypox
OT  - Nigeria
OT  - case report
OT  - surveillance
COIS- The authors declare no competing interests.
EDAT- 2022/08/02 06:00
MHDA- 2022/08/03 06:00
CRDT- 2022/08/01 03:24
PHST- 2022/04/06 00:00 [received]
PHST- 2022/04/10 00:00 [accepted]
PHST- 2022/08/01 03:24 [entrez]
PHST- 2022/08/02 06:00 [pubmed]
PHST- 2022/08/03 06:00 [medline]
AID - 10.11604/pamj.2022.42.38.34715 [doi]
AID - PAMJ-42-38 [pii]
PST - epublish
SO  - Pan Afr Med J. 2022 May 16;42:38. doi: 10.11604/pamj.2022.42.38.34715.eCollection 2022.

PMID- 35908851
OWN - NLM
STAT- Publisher
LR  - 20220731
IS  - 1881-7823 (Electronic)
IS  - 1881-7815 (Linking)
DP  - 2022 Jul 31
TI  - Marburg virus disease: A deadly rare virus is coming.
LID - 10.5582/bst.2022.01333 [doi]
AB  - Two cases of the deadly Marburgvirus were reported in Ghana, which might be a newglobal virus alert following COVID-19 and novel monkeypox. Thus far, there is no vaccine or treatment for Marburg virus disease, which is a disease with amortality rate as high as that of Ebola. Although now human infections withMarburgvirus occurred mainly in Africa, outbreaks were twice reported in Europeover the past 55 years. A concern is that globalization might promote its global viral transmission, just like what happened with COVID-19. The current study has briefly summarized the etiology, epidemiology, and clinical symptoms of theMarburgvirus as well as vaccine development and experimental treatments in order to prevent and control this virus.
FAU - Zhao, Fang
AU  - Zhao F
AD  - National Clinical Research Centre for Infectious Diseases, The Third People'sHospital of Shenzhen and the Second Hospital Affiliated to Southern University ofScience and Technology, Shenzhen, Guangdong, China.
FAU - He, Yun
AU  - He Y
AD  - National Clinical Research Centre for Infectious Diseases, The Third People'sHospital of Shenzhen and the Second Hospital Affiliated to Southern University ofScience and Technology, Shenzhen, Guangdong, China.
FAU - Lu, Hongzhou
AU  - Lu H
AD  - National Clinical Research Centre for Infectious Diseases, The Third People'sHospital of Shenzhen and the Second Hospital Affiliated to Southern University ofScience and Technology, Shenzhen, Guangdong, China.
LA  - eng
PT  - Journal Article
DEP - 20220731
PL  - Japan
TA  - Biosci Trends
JT  - Bioscience trends
JID - 101502754
SB  - IM
OTO - NOTNLM
OT  - Marburg virus disease (MVD)
OT  - Marburgvirus (MARV)
OT  - emerging infectious disease
OT  - public health
EDAT- 2022/08/01 06:00
MHDA- 2022/08/01 06:00
CRDT- 2022/07/31 21:42
PHST- 2022/07/31 21:42 [entrez]
PHST- 2022/08/01 06:00 [pubmed]
PHST- 2022/08/01 06:00 [medline]
AID - 10.5582/bst.2022.01333 [doi]
PST - aheadofprint
SO  - Biosci Trends. 2022 Jul 31. doi: 10.5582/bst.2022.01333.

PMID- 35908563
OWN - NLM
STAT- MEDLINE
DCOM- 20220802
LR  - 20220802
IS  - 1474-547X (Electronic)
IS  - 0140-6736 (Linking)
VI  - 400
IP  - 10349
DP  - 2022 Jul 30
TI  - Monkeypox PHEIC decision hoped to spur the world to act.
PG  - 347
LID - S0140-6736(22)01419-2 [pii]
LID - 10.1016/S0140-6736(22)01419-2 [doi]
FAU - Zarocostas, John
AU  - Zarocostas J
LA  - eng
PT  - Journal Article
PL  - England
TA  - Lancet
JT  - Lancet (London, England)
JID - 2985213R
SB  - IM
MH  - Animals
MH  - Disease Outbreaks
MH  - Humans
MH  - *Monkeypox/epidemiology
EDAT- 2022/08/01 06:00
MHDA- 2022/08/03 06:00
CRDT- 2022/07/31 19:02
PHST- 2022/07/31 19:02 [entrez]
PHST- 2022/08/01 06:00 [pubmed]
PHST- 2022/08/03 06:00 [medline]
AID - S0140-6736(22)01419-2 [pii]
AID - 10.1016/S0140-6736(22)01419-2 [doi]
PST - ppublish
SO  - Lancet. 2022 Jul 30;400(10349):347. doi: 10.1016/S0140-6736(22)01419-2.

PMID- 35908560
OWN - NLM
STAT- MEDLINE
DCOM- 20220802
LR  - 20220802
IS  - 1474-547X (Electronic)
IS  - 0140-6736 (Linking)
VI  - 400
IP  - 10349
DP  - 2022 Jul 30
TI  - Monkeypox: a global wake-up call.
PG  - 337
LID - S0140-6736(22)01422-2 [pii]
LID - 10.1016/S0140-6736(22)01422-2 [doi]
FAU - The Lancet
AU  - The Lancet
LA  - eng
PT  - Editorial
PL  - England
TA  - Lancet
JT  - Lancet (London, England)
JID - 2985213R
SB  - IM
MH  - Animals
MH  - Disease Outbreaks
MH  - Humans
MH  - *Monkeypox/epidemiology/prevention & control
EDAT- 2022/08/01 06:00
MHDA- 2022/08/03 06:00
CRDT- 2022/07/31 19:02
PHST- 2022/07/31 19:02 [entrez]
PHST- 2022/08/01 06:00 [pubmed]
PHST- 2022/08/03 06:00 [medline]
AID - S0140-6736(22)01422-2 [pii]
AID - 10.1016/S0140-6736(22)01422-2 [doi]
PST - ppublish
SO  - Lancet. 2022 Jul 30;400(10349):337. doi: 10.1016/S0140-6736(22)01422-2.

PMID- 35906185
OWN - NLM
STAT- Publisher
LR  - 20220729
IS  - 1096-9071 (Electronic)
IS  - 0146-6615 (Linking)
DP  - 2022 Jul 29
TI  - Genomic Annotation and Molecular Evolution of Monkeypox Virus Outbreak in 2022.
LID - 10.1002/jmv.28036 [doi]
AB  - Monkeypox virus (MPXV) has generally circulated in West and Central Africa since its emergence. Recently, sporadic MPXV infections in several non-endemiccountries have attracted widespread attention. Here, we conducted a systematicanalysis of the recent outbreak of MPXV-2022, including its genomic annotationand molecular evolution. The phylogenetic analysis indicated that the MPXV-2022strains belong to the same lineage of the MPXV strain isolated in 2018. However, compared with the MPXV strain in 2018, in total 46 new consensus mutations wereobserved in the MPXV-2022 strains, including 24 non-synonymous mutations. Byassigning mutations to 187 proteins encoded by the MPXV genome, we found that tenproteins in the monkeypox virus are more prone to mutation, including D2L-like,OPG023, OPG047, OPG071, OPG105, OPG109, A27L-like, OPG153, OPG188, and OPG210proteins. In the MPXV-2022 strains, 4 and 3 nucleotide substitutions are observedin OPG105 and OPG210, respectively. Overall, our studies illustrated the genomeevolution of the ongoing MPXV outbreak and pointed out novel mutations as areference for further studies. This article is protected by copyright. All rightsreserved.
CI  - This article is protected by copyright. All rights reserved.
FAU - Wang, Lulan
AU  - Wang L
AD  - Department of Microbiology, Immunology and Molecular Genetics, University ofCalifornia, Los Angeles, Los Angeles, 90095, USA.
FAU - Shang, Jingzhe
AU  - Shang J
AD  - Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking UnionMedical College, Beijing, 100005, China.
AD  - Suzhou Institute of Systems Medicine, Suzhou, Jiangsu, 215123, China.
FAU - Weng, Shenghui
AU  - Weng S
AD  - Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking UnionMedical College, Beijing, 100005, China.
AD  - Suzhou Institute of Systems Medicine, Suzhou, Jiangsu, 215123, China.
FAU - Aliyari, Saba R
AU  - Aliyari SR
AD  - Department of Microbiology, Immunology and Molecular Genetics, University ofCalifornia, Los Angeles, Los Angeles, 90095, USA.
FAU - Ji, Chengyang
AU  - Ji C
AD  - Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking UnionMedical College, Beijing, 100005, China.
AD  - Suzhou Institute of Systems Medicine, Suzhou, Jiangsu, 215123, China.
FAU - Cheng, Genhong
AU  - Cheng G
AUID- ORCID: http://orcid.org/0000-0002-6713-2783
AD  - Department of Microbiology, Immunology and Molecular Genetics, University ofCalifornia, Los Angeles, Los Angeles, 90095, USA.
FAU - Wu, Aiping
AU  - Wu A
AD  - Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking UnionMedical College, Beijing, 100005, China.
AD  - Suzhou Institute of Systems Medicine, Suzhou, Jiangsu, 215123, China.
LA  - eng
PT  - Journal Article
DEP - 20220729
PL  - United States
TA  - J Med Virol
JT  - Journal of medical virology
JID - 7705876
SB  - IM
OTO - NOTNLM
OT  - MPXV Endemic
OT  - Molecular evolution
OT  - Monkeypox
OT  - Orthopoxvirus
EDAT- 2022/07/30 06:00
MHDA- 2022/07/30 06:00
CRDT- 2022/07/29 22:42
PHST- 2022/07/29 22:42 [entrez]
PHST- 2022/07/30 06:00 [pubmed]
PHST- 2022/07/30 06:00 [medline]
AID - 10.1002/jmv.28036 [doi]
PST - aheadofprint
SO  - J Med Virol. 2022 Jul 29. doi: 10.1002/jmv.28036.

PMID- 35905991
OWN - NLM
STAT- MEDLINE
DCOM- 20220802
LR  - 20220802
IS  - 1756-1833 (Electronic)
IS  - 0959-8138 (Linking)
VI  - 378
DP  - 2022 Jul 29
TI  - What poo tells us: wastewater surveillance comes of age amid covid, monkeypox,and polio.
PG  - o1869
LID - 10.1136/bmj.o1869 [doi]
FAU - Nelson, Bryn
AU  - Nelson B
AD  - Seattle, USA.
LA  - eng
PT  - Journal Article
DEP - 20220729
PL  - England
TA  - BMJ
JT  - BMJ (Clinical research ed.)
JID - 8900488
RN  - 0 (Waste Water)
SB  - IM
MH  - Animals
MH  - *COVID-19/epidemiology
MH  - Humans
MH  - *Monkeypox/epidemiology
MH  - *Poliomyelitis/prevention & control
MH  - Waste Water
MH  - Wastewater-Based Epidemiological Monitoring
COIS- Competing interests: Bryn Nelson is author of the forthcoming book Flush: TheRemarkable Science of an Unlikely Treasure.
EDAT- 2022/07/30 06:00
MHDA- 2022/08/03 06:00
CRDT- 2022/07/29 20:33
PHST- 2022/07/29 20:33 [entrez]
PHST- 2022/07/30 06:00 [pubmed]
PHST- 2022/08/03 06:00 [medline]
AID - 10.1136/bmj.o1869 [doi]
PST - epublish
SO  - BMJ. 2022 Jul 29;378:o1869. doi: 10.1136/bmj.o1869.

PMID- 35905463
OWN - NLM
STAT- Publisher
LR  - 20220729
IS  - 1080-6059 (Electronic)
IS  - 1080-6040 (Linking)
VI  - 28
IP  - 9
DP  - 2022 Jul 29
TI  - Rapid Adaptation of Established High-Throughput Molecular Testing Infrastructure for Monkeypox Virus Detection.
LID - 10.3201/eid2809.220917 [doi]
AB  - Beginning in May 2022, a rising number of monkeypox cases were reported innon-monkeypox-endemic countries in the Northern Hemisphere. We adapted 2published quantitative PCRs for use as a dual-target monkeypox virus test onwidely used automated high-throughput PCR systems. We determined analyticperformance by serial dilutions of monkeypox virus reference material, which wequantified by digital PCR. We found the lower limit of detection for the combinedassays was 4.795 (95% CI 3.6-8.6) copies/mL. We compared clinical performanceagainst a commercial manual orthopoxvirus research use only PCR kit by usingclinical remnant swab samples. Our assay showed 100% positive (n = 11) and 100%negative (n = 56) agreement. Timely and scalable PCR tests are crucial forlimiting further spread of monkeypox. The assay we provide streamlineshigh-throughput molecular testing for monkeypox virus on existing broadlyestablished platforms used for SARS-CoV-2 diagnostic testing.
FAU - Norz, Dominik
AU  - Norz D
FAU - Tang, Hui Ting
AU  - Tang HT
FAU - Emmerich, Petra
AU  - Emmerich P
FAU - Giersch, Katja
AU  - Giersch K
FAU - Fischer, Nicole
AU  - Fischer N
FAU - Schmiedel, Stephan
AU  - Schmiedel S
FAU - Addo, Marylyn M
AU  - Addo MM
FAU - Aepfelbacher, Martin
AU  - Aepfelbacher M
FAU - Pfefferle, Susanne
AU  - Pfefferle S
FAU - Lutgehetmann, Marc
AU  - Lutgehetmann M
LA  - eng
PT  - Journal Article
DEP - 20220729
PL  - United States
TA  - Emerg Infect Dis
JT  - Emerging infectious diseases
JID - 9508155
SB  - IM
OTO - NOTNLM
OT  - Germany
OT  - SARS-CoV-2
OT  - cobas
OT  - high-throughput PCR testing
OT  - molecular diagnostics
OT  - monkeypox virus
OT  - viruses
OT  - zoonoses
EDAT- 2022/07/30 06:00
MHDA- 2022/07/30 06:00
CRDT- 2022/07/29 16:22
PHST- 2022/07/29 16:22 [entrez]
PHST- 2022/07/30 06:00 [pubmed]
PHST- 2022/07/30 06:00 [medline]
AID - 10.3201/eid2809.220917 [doi]
PST - aheadofprint
SO  - Emerg Infect Dis. 2022 Jul 29;28(9). doi: 10.3201/eid2809.220917.

PMID- 35905027
OWN - NLM
STAT- MEDLINE
DCOM- 20220802
LR  - 20220802
IS  - 1972-2680 (Electronic)
IS  - 1972-2680 (Linking)
VI  - 16
IP  - 7
DP  - 2022 Jul 28
TI  - Monkeypox goes viral: measuring the misinformation outbreak on Twitter.
PG  - 1218-1220
LID - 10.3855/jidc.16907 [doi]
FAU - Ortiz-Martinez, Yeimer
AU  - Ortiz-Martinez Y
AD  - Department of Internal Medicine, 469618 Universidad Industrial de Santander,Bucaramanga, Colombia.
FAU - Sarmiento, Jheinner
AU  - Sarmiento J
AD  - Faculty of Health Sciences, 28000 Universidad de Sucre, Sincelejo, Sucre,Colombia.
FAU - Bonilla-Aldana, D Katterine
AU  - Bonilla-Aldana DK
AD  - Latin American Network on Monkeypox Virus research (LAMOVI), Pereira, Risaralda, Colombia.
FAU - Rodriguez-Morales, Alfonso J
AU  - Rodriguez-Morales AJ
AD  - Grupo de Investigacion Biomedicina, Faculty of Medicine, Fundacion Universitaria Autonoma de las Americas, Pereira, Risaralda, Colombia. arodriguez@jidc.org.
LA  - eng
PT  - Journal Article
DEP - 20220728
PL  - Italy
TA  - J Infect Dev Ctries
JT  - Journal of infection in developing countries
JID - 101305410
SB  - IM
MH  - Animals
MH  - Communication
MH  - Disease Outbreaks
MH  - Humans
MH  - *Monkeypox/epidemiology
MH  - *Social Media
OTO - NOTNLM
OT  - Monkeypox
OT  - concern
OT  - global
OT  - reemerging
OT  - zoonosis
COIS- No Conflict of Interest is declared
EDAT- 2022/07/30 06:00
MHDA- 2022/08/03 06:00
CRDT- 2022/07/29 13:13
PHST- 2022/05/26 00:00 [received]
PHST- 2022/06/11 00:00 [accepted]
PHST- 2022/07/29 13:13 [entrez]
PHST- 2022/07/30 06:00 [pubmed]
PHST- 2022/08/03 06:00 [medline]
AID - 10.3855/jidc.16907 [doi]
PST - epublish
SO  - J Infect Dev Ctries. 2022 Jul 28;16(7):1218-1220. doi: 10.3855/jidc.16907.

PMID- 35904894
OWN - NLM
STAT- Publisher
LR  - 20220729
IS  - 1365-2230 (Electronic)
IS  - 0307-6938 (Linking)
DP  - 2022 Jul 29
TI  - The return of monkeypox: key pointers for dermatologists.
LID - 10.1111/ced.15357 [doi]
FAU - Kawsar, Anusuya
AU  - Kawsar A
AUID- ORCID: https://orcid.org/0000-0002-7065-1779
AD  - Department of Dermatology, Chelsea and Westminster Hospital NHS Foundation Trust.
FAU - Hussain, Khawar
AU  - Hussain K
AUID- ORCID: https://orcid.org/0000-0003-2116-7718
AD  - Department of Dermatology, Chelsea and Westminster Hospital NHS Foundation Trust.
FAU - Roberts, Nerys
AU  - Roberts N
AD  - Department of Dermatology, Chelsea and Westminster Hospital NHS Foundation Trust.
LA  - eng
PT  - Letter
DEP - 20220729
PL  - England
TA  - Clin Exp Dermatol
JT  - Clinical and experimental dermatology
JID - 7606847
SB  - IM
EDAT- 2022/07/30 06:00
MHDA- 2022/07/30 06:00
CRDT- 2022/07/29 12:13
PHST- 2022/07/25 00:00 [accepted]
PHST- 2022/07/29 12:13 [entrez]
PHST- 2022/07/30 06:00 [pubmed]
PHST- 2022/07/30 06:00 [medline]
AID - 10.1111/ced.15357 [doi]
PST - aheadofprint
SO  - Clin Exp Dermatol. 2022 Jul 29. doi: 10.1111/ced.15357.

PMID- 35904001
OWN - NLM
STAT- Publisher
LR  - 20220729
IS  - 1537-6591 (Electronic)
IS  - 1058-4838 (Linking)
DP  - 2022 Jul 29
TI  - Antivirals with Activity Against Monkeypox: A Clinically Oriented Review.
LID - ciac622 [pii]
LID - 10.1093/cid/ciac622 [doi]
AB  - Monkeypox virus is an emergent human pathogen. While it is less lethal thansmallpox, it can still cause significant morbidity and mortality. In this review,we explore three antiviral agents with activity against monkeypox and otherorthopoxviruses: cidofovir, brincidofovir, and tecovirimat. Cidofovir, and itsprodrug brincidofovir, are inhibitors of DNA replication with a broad spectrum ofactivity against multiple families of double-stranded DNA viruses. Tecovirimathas more specific activity against orthopoxviruses, and inhibits the formation ofthe extracellular enveloped virus necessary for cell-to-cell transmission. Foreach agent, we review basic pharmacology, data from animal models and reportedexperience in human patients.
CI  - (c) The Author(s) 2022. Published by Oxford University Press on behalf ofInfectious Diseases Society of America.
FAU - Siegrist, Emily A
AU  - Siegrist EA
AD  - Department of Pharmacy, OUHealth, Oklahoma City, OK, USA.
FAU - Sassine, Joseph
AU  - Sassine J
AUID- ORCID: 0000-0001-8730-8929
AD  - Infectious Diseases Section, Department of Medicine, University of OklahomaHealth Sciences Center, Oklahoma City, OK, USA.
LA  - eng
PT  - Journal Article
DEP - 20220729
PL  - United States
TA  - Clin Infect Dis
JT  - Clinical infectious diseases : an official publication of the Infectious DiseasesSociety of America
JID - 9203213
SB  - IM
OTO - NOTNLM
OT  - Monkeypox
OT  - brincidofovir
OT  - cidofovir
OT  - tecovirimat
EDAT- 2022/07/30 06:00
MHDA- 2022/07/30 06:00
CRDT- 2022/07/29 04:52
PHST- 2022/06/21 00:00 [received]
PHST- 2022/07/19 00:00 [revised]
PHST- 2022/07/26 00:00 [accepted]
PHST- 2022/07/29 04:52 [entrez]
PHST- 2022/07/30 06:00 [pubmed]
PHST- 2022/07/30 06:00 [medline]
AID - 6651596 [pii]
AID - 10.1093/cid/ciac622 [doi]
PST - aheadofprint
SO  - Clin Infect Dis. 2022 Jul 29. pii: 6651596. doi: 10.1093/cid/ciac622.

PMID- 35903306
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220729
IS  - 2500-0462 (Print)
IS  - 2500-3259 (Linking)
VI  - 26
IP  - 4
DP  - 2022 Jul
TI  - Genome stability of the vaccine strain VACDelta6.
PG  - 394-401
LID - 10.18699/VJGB-22-48 [doi]
AB  - Due to cessation of mass smallpox vaccination in 1980, the collective immunity ofhumans against orthopoxvirus infections has virtually been lost. Therefore, therisk of spreading zoonotic human orthopoxvirus infections caused by monkeypox andcowpox viruses has increased in the world. First-generation smallpox vaccinesbased on Vaccinia virus (VAC) are reactogenic and therefore not suitable for massvaccination under current conditions. This necessitates the development of modernsafe live vaccines based on VAC using genetic engineering. We created theVACDelta6 strain by transient dominant selection. In the VACDelta6 genome, f ive virulence genes were intentionally deleted, and one gene was inactivated byinserting a synthetic DNA fragment. The virus was passaged 71 times in CV-1 cellsto obtain the VACDelta6 strain from the VAC LIVP clonal variant. Such a longpassage history might have led to additional off-target mutations in VACDelta6compared to the original LIVP variant. To prevent this, we performed agenome-wide sequencing of VAC LIVP, VACDelta6, and f ive intermediate viralstrains to assess possible off-target mutations. A comparative analysis ofcomplete viral genomes showed that, in addition to target mutations, only twonucleotide substitutions occurred spontaneously when obtaining VACDelta4 from theVACDelta3 strain; the mutations persisting in the VACDelta5 and VACDelta6genomes. Both nucleotide substitutions are located in intergenic regions(positions 1431 and 189738 relative to LIVP), which indicates an extremely rareoccurrence of off-target mutations when using transient dominant selection toobtain recombinant VAC variants with multiple insertions/deletions. To assess thegenome stability of the resulting attenuated vaccine strain, 15 consecutivecycles of cultivation of the industrial VACDelta6 strain were performed in 4647cells certif ied for vaccine production in accordance with the "Guidelines forClinical Trials of Medicinal Products". PCR and sequencing analysis of six DNAfragments corresponding to the regions of disrupted genes in VACDelta6 showedthat all viral DNA sequences remained unchanged after 15 passages in 4647 cells.
CI  - Copyright (c) AUTHORS.
FAU - Maksyutov, R A
AU  - Maksyutov RA
AD  - State Research Center of Virology and Biotechnology "Vector", Rospotrebnadzor,Koltsovo, Novosibirsk region, Russia.
FAU - Yakubitskiy, S N
AU  - Yakubitskiy SN
AD  - State Research Center of Virology and Biotechnology "Vector", Rospotrebnadzor,Koltsovo, Novosibirsk region, Russia.
FAU - Kolosova, I V
AU  - Kolosova IV
AD  - State Research Center of Virology and Biotechnology "Vector", Rospotrebnadzor,Koltsovo, Novosibirsk region, Russia.
FAU - Tregubchak, T V
AU  - Tregubchak TV
AD  - State Research Center of Virology and Biotechnology "Vector", Rospotrebnadzor,Koltsovo, Novosibirsk region, Russia.
FAU - Shvalov, A N
AU  - Shvalov AN
AD  - State Research Center of Virology and Biotechnology "Vector", Rospotrebnadzor,Koltsovo, Novosibirsk region, Russia.
FAU - Gavrilova, E V
AU  - Gavrilova EV
AD  - State Research Center of Virology and Biotechnology "Vector", Rospotrebnadzor,Koltsovo, Novosibirsk region, Russia.
FAU - Shchelkunov, S N
AU  - Shchelkunov SN
AD  - State Research Center of Virology and Biotechnology "Vector", Rospotrebnadzor,Koltsovo, Novosibirsk region, Russia.
LA  - eng
PT  - Journal Article
PL  - Russia (Federation)
TA  - Vavilovskii Zhurnal Genet Selektsii
JT  - Vavilovskii zhurnal genetiki i selektsii
JID - 101583566
PMC - PMC9284249
OTO - NOTNLM
OT  - genome stability
OT  - targeted gene inactivation
OT  - transient dominant selection
OT  - vaccinia virus
EDAT- 2022/07/30 06:00
MHDA- 2022/07/30 06:01
CRDT- 2022/07/29 01:58
PHST- 2021/12/24 00:00 [received]
PHST- 2022/03/09 00:00 [revised]
PHST- 2022/03/14 00:00 [accepted]
PHST- 2022/07/29 01:58 [entrez]
PHST- 2022/07/30 06:00 [pubmed]
PHST- 2022/07/30 06:01 [medline]
AID - 10.18699/VJGB-22-48 [doi]
PST - ppublish
SO  - Vavilovskii Zhurnal Genet Selektsii. 2022 Jul;26(4):394-401. doi:10.18699/VJGB-22-48.

PMID- 35902115
OWN - NLM
STAT- MEDLINE
DCOM- 20220801
LR  - 20220801
IS  - 1756-1833 (Electronic)
IS  - 0959-8138 (Linking)
VI  - 378
DP  - 2022 Jul 28
TI  - Clinical features and novel presentations of human monkeypox in a central London centre during the 2022 outbreak: descriptive case series.
PG  - e072410
LID - 10.1136/bmj-2022-072410 [doi]
AB  - OBJECTIVE: To characterise the clinical features of monkeypox infection inhumans. DESIGN: Descriptive case series. SETTING: A regional high consequencesinfectious disease centre with associated primary and secondary care referrals,and affiliated sexual health centres in south London between May and July 2022.PARTICIPANTS: 197 patients with polymerase chain reaction confirmed monkeypoxinfection. RESULTS: The median age of participants was 38 years. All 197participants were men, and 196 identified as gay, bisexual, or other men who havesex with men. All presented with mucocutaneous lesions, most commonly on thegenitals (n=111 participants, 56.3%) or in the perianal area (n=82, 41.6%). 170(86.3%) participants reported systemic illness. The most common systemic symptomswere fever (n=122, 61.9%), lymphadenopathy (114, 57.9%), and myalgia (n=62,31.5%). 102/166 (61.5%) developed systemic features before the onset ofmucocutaneous manifestations and 64 (38.5%) after (n=4 unknown). 27 (13.7%)presented exclusively with mucocutaneous manifestations without systemicfeatures. 71 (36.0%) reported rectal pain, 33 (16.8%) sore throat, and 31 (15.7%)penile oedema. 27 (13.7%) had oral lesions and 9 (4.6%) had tonsillar signs.70/195 (35.9%) participants had concomitant HIV infection. 56 (31.5%) of thosescreened for sexually transmitted infections had a concomitant sexuallytransmitted infection. Overall, 20 (10.2%) participants were admitted to hospitalfor the management of symptoms, most commonly rectal pain and penile swelling.CONCLUSIONS: These findings confirm the ongoing unprecedented communitytransmission of monkeypox virus among gay, bisexual, and other men who have sexwith men seen in the UK and many other non-endemic countries. A variable temporalassociation was observed between mucocutaneous and systemic features, suggesting a new clinical course to the disease. New clinical presentations of monkeypoxinfection were identified, including rectal pain and penile oedema. Thesepresentations should be included in public health messaging to aid earlydiagnosis and reduce onward transmission.
CI  - (c) Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. Nocommercial re-use. See rights and permissions. Published by BMJ.
FAU - Patel, Aatish
AU  - Patel A
AUID- ORCID: 0000-0002-2503-2602
AD  - Guys and St Thomas' NHS Foundation Trust, London, SE1 7EH, UKAatish.patel@gstt.nhs.uk.
FAU - Bilinska, Julia
AU  - Bilinska J
AD  - Guys and St Thomas' NHS Foundation Trust, London, SE1 7EH, UK.
FAU - Tam, Jerry C H
AU  - Tam JCH
AD  - Guys and St Thomas' NHS Foundation Trust, London, SE1 7EH, UK.
FAU - Da Silva Fontoura, Dayana
AU  - Da Silva Fontoura D
AD  - Guys and St Thomas' NHS Foundation Trust, London, SE1 7EH, UK.
FAU - Mason, Claire Y
AU  - Mason CY
AD  - Guys and St Thomas' NHS Foundation Trust, London, SE1 7EH, UK.
FAU - Daunt, Anna
AU  - Daunt A
AD  - Guys and St Thomas' NHS Foundation Trust, London, SE1 7EH, UK.
FAU - Snell, Luke B
AU  - Snell LB
AD  - Guys and St Thomas' NHS Foundation Trust, London, SE1 7EH, UK.
FAU - Murphy, Jamie
AU  - Murphy J
AD  - Guys and St Thomas' NHS Foundation Trust, London, SE1 7EH, UK.
FAU - Potter, Jack
AU  - Potter J
AD  - Guys and St Thomas' NHS Foundation Trust, London, SE1 7EH, UK.
FAU - Tuudah, Cecilia
AU  - Tuudah C
AD  - Guys and St Thomas' NHS Foundation Trust, London, SE1 7EH, UK.
FAU - Sundramoorthi, Rohan
AU  - Sundramoorthi R
AD  - Guys and St Thomas' NHS Foundation Trust, London, SE1 7EH, UK.
FAU - Abeywickrema, Movin
AU  - Abeywickrema M
AD  - Guys and St Thomas' NHS Foundation Trust, London, SE1 7EH, UK.
FAU - Pley, Caitlin
AU  - Pley C
AD  - Guys and St Thomas' NHS Foundation Trust, London, SE1 7EH, UK.
FAU - Naidu, Vasanth
AU  - Naidu V
AD  - Guys and St Thomas' NHS Foundation Trust, London, SE1 7EH, UK.
FAU - Nebbia, Gaia
AU  - Nebbia G
AD  - Guys and St Thomas' NHS Foundation Trust, London, SE1 7EH, UK.
FAU - Aarons, Emma
AU  - Aarons E
AD  - Guys and St Thomas' NHS Foundation Trust, London, SE1 7EH, UK.
FAU - Botgros, Alina
AU  - Botgros A
AD  - Guys and St Thomas' NHS Foundation Trust, London, SE1 7EH, UK.
FAU - Douthwaite, Sam T
AU  - Douthwaite ST
AD  - Guys and St Thomas' NHS Foundation Trust, London, SE1 7EH, UK.
FAU - van Nispen Tot Pannerden, Claire
AU  - van Nispen Tot Pannerden C
AD  - Guys and St Thomas' NHS Foundation Trust, London, SE1 7EH, UK.
FAU - Winslow, Helen
AU  - Winslow H
AD  - Guys and St Thomas' NHS Foundation Trust, London, SE1 7EH, UK.
FAU - Brown, Aisling
AU  - Brown A
AD  - Guys and St Thomas' NHS Foundation Trust, London, SE1 7EH, UK.
FAU - Chilton, Daniella
AU  - Chilton D
AD  - Guys and St Thomas' NHS Foundation Trust, London, SE1 7EH, UK.
FAU - Nori, Achyuta
AU  - Nori A
AD  - Guys and St Thomas' NHS Foundation Trust, London, SE1 7EH, UK.
LA  - eng
PT  - Case Reports
PT  - Journal Article
DEP - 20220728
PL  - England
TA  - BMJ
JT  - BMJ (Clinical research ed.)
JID - 8900488
SB  - IM
MH  - Adult
MH  - Animals
MH  - Disease Outbreaks
MH  - Female
MH  - *HIV Infections/complications/diagnosis/epidemiology
MH  - Homosexuality, Male
MH  - Humans
MH  - London/epidemiology
MH  - Male
MH  - *Monkeypox/complications
MH  - Pain/complications
MH  - *Sexual and Gender Minorities
MH  - *Sexually Transmitted Diseases/diagnosis/epidemiology
COIS- Competing interests: All authors have completed the ICMJE uniform disclosure format https://www.icmje.org/disclosure-of-interest/ and declare: no support from anyorganisation for the submitted work; no financial relationships with anyorganisations that might have an interest in the submitted work in the previousthree years; no other relationships or activities that could appear to haveinfluenced the submitted work.
EDAT- 2022/07/29 06:00
MHDA- 2022/08/02 06:00
CRDT- 2022/07/28 20:43
PHST- 2022/07/28 20:43 [entrez]
PHST- 2022/07/29 06:00 [pubmed]
PHST- 2022/08/02 06:00 [medline]
AID - 10.1136/bmj-2022-072410 [doi]
PST - epublish
SO  - BMJ. 2022 Jul 28;378:e072410. doi: 10.1136/bmj-2022-072410.

PMID- 35902024
OWN - NLM
STAT- Publisher
LR  - 20220728
IS  - 1878-3511 (Electronic)
IS  - 1201-9712 (Linking)
DP  - 2022 Jul 25
TI  - The first monkeypox virus infection detected in Taiwan-the awareness andpreparation.
LID - S1201-9712(22)00445-3 [pii]
LID - 10.1016/j.ijid.2022.07.051 [doi]
AB  - OBJECTIVE: Monkeypox has recently been detected outside African countries. Thisstudy aims to report and analyze the first monkeypox virus infection case inTaiwan. METHODS: The global epidemiological information was collected from theworld health organization (WHO) and US CDC. The data from first confirmedTaiwanese monkeypox case was obtained from Taiwan CDC. Monkeypox diagnosis andprevention strategies were obtained from WHO monkeypox guidelines. Phylogenetictree analysis and sequence alignment and comparison were used to identify thephylogeny and single nucleotide polymorphisms (SNPs) characterization. RESULTS:Epidemiological data indicated that monkeypox has caused outbreaks outsideAfrican countries via contact with infected animals and international travelssince 2013. Recently, two confirmed monkeypox cases were reported in Singaporeand South Korea. In June 24(th) 2022, Taiwan CDC reported the first confirmedcase of monkeypox virus infection from a 20-year-old young man that returned formstudying in Germany, during January to June 2022. This is the third monkeypoximported infection confirmed cases in Asia. Phylogenetic analysis demonstratedthat this imported monkeypox virus belonged to the West African clade and isclustered with the 2022 European outbreak monkeypox isolates. Full lengthsequence analysis indicates that this virus contained 51 SNPs, which has 5variant SNPs compared to the recent outbreak strains. CONCLUSION: This studysuggests that active surveillance, enhancing border control and development ofvaccine and antiviral drugs are urgently demanded to prevent and control theburden by monkeypox disease.
CI  - Copyright (c) 2022. Published by Elsevier Ltd.
FAU - Yang, Zih-Syuan
AU  - Yang ZS
AD  - Center for Tropical Medicine and Infectious Disease, Kaohsiung MedicalUniversity, Kaohsiung, 80708, Taiwan; Department of Medical Laboratory Scienceand Biotechnology, Kaohsiung Medical University, Kaohsiung, 80708, Taiwan.
FAU - Lin, Chih-Yen
AU  - Lin CY
AD  - Center for Tropical Medicine and Infectious Disease, Kaohsiung MedicalUniversity, Kaohsiung, 80708, Taiwan; Department of Medical Laboratory Scienceand Biotechnology, Kaohsiung Medical University, Kaohsiung, 80708, Taiwan.
FAU - Urbina, Aspiro Nayim
AU  - Urbina AN
AD  - Center for Tropical Medicine and Infectious Disease, Kaohsiung MedicalUniversity, Kaohsiung, 80708, Taiwan.
FAU - Wang, Wen-Hung
AU  - Wang WH
AD  - Center for Tropical Medicine and Infectious Disease, Kaohsiung MedicalUniversity, Kaohsiung, 80708, Taiwan; Division of Infectious Disease, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung MedicalUniversity, Kaohsiung, 80708, Taiwan.
FAU - Assavalapsakul, Wanchai
AU  - Assavalapsakul W
AD  - Department of Microbiology, Faculty of Science, Chulalongkorn University, Bangkok10330, Thailand.
FAU - Tseng, Sung-Pin
AU  - Tseng SP
AD  - Department of Medical Laboratory Science and Biotechnology, Kaohsiung MedicalUniversity, Kaohsiung, 80708, Taiwan.
FAU - Lu, Po-Liang
AU  - Lu PL
AD  - Center for Tropical Medicine and Infectious Disease, Kaohsiung MedicalUniversity, Kaohsiung, 80708, Taiwan; Division of Infectious Disease, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung MedicalUniversity, Kaohsiung, 80708, Taiwan.
FAU - Chen, Yen-Hsu
AU  - Chen YH
AD  - Center for Tropical Medicine and Infectious Disease, Kaohsiung MedicalUniversity, Kaohsiung, 80708, Taiwan; Division of Infectious Disease, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung MedicalUniversity, Kaohsiung, 80708, Taiwan.
FAU - Yu, Ming-Lung
AU  - Yu ML
AD  - Hepatobiliary Section, Department of Internal Medicine, and Hepatitis Center,Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung,80708, Taiwan.
FAU - Wang, Sheng-Fan
AU  - Wang SF
AD  - Center for Tropical Medicine and Infectious Disease, Kaohsiung MedicalUniversity, Kaohsiung, 80708, Taiwan; Department of Medical Laboratory Scienceand Biotechnology, Kaohsiung Medical University, Kaohsiung, 80708, Taiwan;Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, 80708, Taiwan. Electronic address:wasf1234@kmu.edu.tw.
LA  - eng
PT  - Journal Article
DEP - 20220725
PL  - Canada
TA  - Int J Infect Dis
JT  - International journal of infectious diseases : IJID : official publication of theInternational Society for Infectious Diseases
JID - 9610933
SB  - IM
OTO - NOTNLM
OT  - Monkeypox
OT  - Single-nucleotide polymorphism
OT  - Taiwan
OT  - first case
OT  - imported infection
EDAT- 2022/07/29 06:00
MHDA- 2022/07/29 06:00
CRDT- 2022/07/28 19:23
PHST- 2022/06/28 00:00 [received]
PHST- 2022/07/19 00:00 [revised]
PHST- 2022/07/20 00:00 [accepted]
PHST- 2022/07/28 19:23 [entrez]
PHST- 2022/07/29 06:00 [pubmed]
PHST- 2022/07/29 06:00 [medline]
AID - S1201-9712(22)00445-3 [pii]
AID - 10.1016/j.ijid.2022.07.051 [doi]
PST - aheadofprint
SO  - Int J Infect Dis. 2022 Jul 25. pii: S1201-9712(22)00445-3. doi:10.1016/j.ijid.2022.07.051.

PMID- 35899428
OWN - NLM
STAT- Publisher
LR  - 20220728
IS  - 1708-8305 (Electronic)
IS  - 1195-1982 (Linking)
DP  - 2022 Jul 28
TI  - Monkeypox Virus Containment: The Application of Ring Vaccination and PossibleChallenges.
LID - taac085 [pii]
LID - 10.1093/jtm/taac085 [doi]
AB  - Due to the pandemic potential of monkeypox, the application of ring vaccinationwould be of great value in breaking the chain of transmission as well as inpreventing the occurrence of severe disease. Accompanying challenges should beovercome to properly contain the disease before it is declared pandemic.
CI  - (c) The Author(s) 2022. Published by Oxford University Press on behalf ofInternational Society of Travel Medicine. All rights reserved. For permissions,please e-mail: journals.permissions@oup.com.
FAU - Sah, Ranjit
AU  - Sah R
AUID- ORCID: 0000-0002-2695-8714
AD  - Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal.
AD  - Research Scholar, Harvard Medical School, Boston, MA 02115, USA.
FAU - Abdelaal, Abdelaziz
AU  - Abdelaal A
AD  - Research Scholar, Harvard Medical School, Boston, MA 02115, USA.
AD  - MSc Candidate in Clinical Research, Boston University, MA 02215, USA.
AD  - General Practitioner, Tanta University Hospitals, 31516 Egypt.
FAU - Asija, Ankush
AU  - Asija A
AD  - Hospitalist, West Virginia University, School of Medicine, WV, USA.
FAU - Basnyat, Soney
AU  - Basnyat S
AD  - Hospitalist, Virginia Commonwealth University Health System, VA, USA.
FAU - Sedhai, Yub Raj
AU  - Sedhai YR
AD  - University of Kentucky, Bowling Green, KY, USA.
FAU - Ghimire, Sadikshya
AU  - Ghimire S
AD  - Shree Birendra Sainik Hospital, Kathmandu, Nepal.
FAU - Sah, Sanjit
AU  - Sah S
AD  - SR Sanjeevani Hospital, Kalyanpur, Siraha, Nepal.
FAU - Bonilla-Aldana, D Katterine
AU  - Bonilla-Aldana DK
AD  - Faculty of Medicine, Fundacion Universitaria Autonoma de las Americas, Pereira,Risaralda, Colombia.
AD  - Latin American network on Monkeypox Virus research (LAMOVI), Pereira, Risaralda, Colombia.
AD  - Institucion Universitaria Vision de las Americas, Pereira, Risaralda, Colombia.
AD  - Grupo de Investigacion Biomedicina, Faculty of Medicine, Fundacion Universitaria Autonoma de las Americas, 660003, Pereira, Risaralda, Colombia.
FAU - Rodriguez-Morales, Alfonso J
AU  - Rodriguez-Morales AJ
AD  - Faculty of Medicine, Fundacion Universitaria Autonoma de las Americas, Pereira,Risaralda, Colombia.
AD  - Latin American network on Monkeypox Virus research (LAMOVI), Pereira, Risaralda, Colombia.
AD  - Institucion Universitaria Vision de las Americas, Pereira, Risaralda, Colombia.
AD  - Grupo de Investigacion Biomedicina, Faculty of Medicine, Fundacion Universitaria Autonoma de las Americas, 660003, Pereira, Risaralda, Colombia.
AD  - Master of Clinical Epidemiology and Biostatistics, Universidad Cientifica delSur, Lima, 4861, Peru.
LA  - eng
PT  - Journal Article
DEP - 20220728
PL  - England
TA  - J Travel Med
JT  - Journal of travel medicine
JID - 9434456
SB  - IM
OTO - NOTNLM
OT  - Monkeypox
OT  - Ring Vaccination
EDAT- 2022/07/29 06:00
MHDA- 2022/07/29 06:00
CRDT- 2022/07/28 03:53
PHST- 2022/07/01 00:00 [received]
PHST- 2022/07/08 00:00 [revised]
PHST- 2022/07/25 00:00 [accepted]
PHST- 2022/07/28 03:53 [entrez]
PHST- 2022/07/29 06:00 [pubmed]
PHST- 2022/07/29 06:00 [medline]
AID - 6650947 [pii]
AID - 10.1093/jtm/taac085 [doi]
PST - aheadofprint
SO  - J Travel Med. 2022 Jul 28. pii: 6650947. doi: 10.1093/jtm/taac085.

PMID- 35896700
OWN - NLM
STAT- Publisher
LR  - 20220727
IS  - 1476-5454 (Electronic)
IS  - 0950-222X (Linking)
DP  - 2022 Jul 27
TI  - Ophthalmic manifestations of monkeypox virus.
LID - 10.1038/s41433-022-02195-z [doi]
FAU - Abdelaal, Abdelaziz
AU  - Abdelaal A
AUID- ORCID: http://orcid.org/0000-0003-3787-5970
AD  - Tanta Research Team (TRT), Tanta, El-Gharbia, Egypt. drabdoseliem@gmail.com.
AD  - Research Scholar, Harvard Medical School, Boston, MA, 02155, USA.drabdoseliem@gmail.com.
AD  - Boston University, School of Medicine, Boston, MA, USA. drabdoseliem@gmail.com.
AD  - Faculty of Medicine, Tanta University, Tanta, El-Gharbia Governorate, Egypt.drabdoseliem@gmail.com.
FAU - Serhan, Hashem Abu
AU  - Serhan HA
AD  - Tanta Research Team (TRT), Tanta, El-Gharbia, Egypt.
AD  - Department of Ophthalmology, Hamad Medical Corporations, Doha, Qatar.
FAU - Mahmoud, Mariam Abdelmageed
AU  - Mahmoud MA
AD  - Tanta Research Team (TRT), Tanta, El-Gharbia, Egypt.
AD  - Department of Ophthalmology, Tanta University Hospital, Tanta, Egypt.
FAU - Rodriguez-Morales, Alfonso J
AU  - Rodriguez-Morales AJ
AD  - Grupo de Investigacion Biomedicina, Faculty of Medicine, Fundacion Universitaria Autonoma de las Americas, 660003, Pereira, Risaralda, Colombia.
AD  - Latin American network on Monkeypox Virus research (LAMOVI), Pereira, Risaralda, Colombia.
AD  - Institucion Universitaria Vision de las Americas, Pereira, Risaralda, Colombia.
AD  - Master of Clinical Epidemiology and Biostatistics, Universidad Cientifica delSur, Lima, 4861, Peru.
FAU - Sah, Ranjit
AU  - Sah R
AUID- ORCID: http://orcid.org/0000-0002-2695-8714
AD  - Research Scholar, Harvard Medical School, Boston, MA, 02155, USA.
AD  - Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal.
LA  - eng
PT  - Editorial
DEP - 20220727
PL  - England
TA  - Eye (Lond)
JT  - Eye (London, England)
JID - 8703986
SB  - IM
EDAT- 2022/07/28 06:00
MHDA- 2022/07/28 06:00
CRDT- 2022/07/27 23:28
PHST- 2022/07/06 00:00 [received]
PHST- 2022/07/19 00:00 [accepted]
PHST- 2022/07/07 00:00 [revised]
PHST- 2022/07/27 23:28 [entrez]
PHST- 2022/07/28 06:00 [pubmed]
PHST- 2022/07/28 06:00 [medline]
AID - 10.1038/s41433-022-02195-z [doi]
AID - 10.1038/s41433-022-02195-z [pii]
PST - aheadofprint
SO  - Eye (Lond). 2022 Jul 27. pii: 10.1038/s41433-022-02195-z. doi:10.1038/s41433-022-02195-z.

PMID- 35895041
OWN - NLM
STAT- Publisher
LR  - 20220727
IS  - 1538-3598 (Electronic)
IS  - 0098-7484 (Linking)
DP  - 2022 Jul 27
TI  - The WHO Declaration of Monkeypox as a Global Public Health Emergency.
LID - 10.1001/jama.2022.12513 [doi]
FAU - Nuzzo, Jennifer B
AU  - Nuzzo JB
AD  - Brown University School of Public Health, Providence, Rhode Island.
FAU - Borio, Luciana L
AU  - Borio LL
AD  - Council on Foreign Relations, New York, New York.
FAU - Gostin, Lawrence O
AU  - Gostin LO
AD  - O'Neill Institute for National and Global Health Law, Georgetown University,Washington, DC.
LA  - eng
PT  - Journal Article
DEP - 20220727
PL  - United States
TA  - JAMA
JT  - JAMA
JID - 7501160
SB  - IM
EDAT- 2022/07/28 06:00
MHDA- 2022/07/28 06:00
CRDT- 2022/07/27 11:33
PHST- 2022/07/27 11:33 [entrez]
PHST- 2022/07/28 06:00 [pubmed]
PHST- 2022/07/28 06:00 [medline]
AID - 2794922 [pii]
AID - 10.1001/jama.2022.12513 [doi]
PST - aheadofprint
SO  - JAMA. 2022 Jul 27. pii: 2794922. doi: 10.1001/jama.2022.12513.

PMID- 35894704
OWN - NLM
STAT- Publisher
LR  - 20220727
IS  - 1365-2141 (Electronic)
IS  - 0007-1048 (Linking)
DP  - 2022 Jul 27
TI  - The potential impact of monkeypox infection and vaccination on blood donordeferrals and the blood supply.
LID - 10.1111/bjh.18388 [doi]
FAU - Jacobs, Jeremy W
AU  - Jacobs JW
AUID- ORCID: https://orcid.org/0000-0002-5719-9685
AD  - Department of Laboratory Medicine, Yale School of Medicine, New Haven,Connecticut, USA.
FAU - Filkins, Laura
AU  - Filkins L
AUID- ORCID: https://orcid.org/0000-0002-0406-4947
AD  - Department of Pathology, University of Texas Southwestern, Dallas, Texas, USA.
FAU - Booth, Garrett S
AU  - Booth GS
AUID- ORCID: https://orcid.org/0000-0002-8422-9480
AD  - Department of Pathology, Microbiology and Immunology, Vanderbilt UniversityMedical Center, Nashville, Tennessee, USA.
FAU - Adkins, Brian D
AU  - Adkins BD
AUID- ORCID: https://orcid.org/0000-0002-9480-2762
AD  - Department of Pathology, University of Texas Southwestern, Dallas, Texas, USA.
LA  - eng
PT  - Letter
DEP - 20220727
PL  - England
TA  - Br J Haematol
JT  - British journal of haematology
JID - 0372544
SB  - IM
EDAT- 2022/07/28 06:00
MHDA- 2022/07/28 06:00
CRDT- 2022/07/27 09:43
PHST- 2022/07/17 00:00 [revised]
PHST- 2022/06/27 00:00 [received]
PHST- 2022/07/18 00:00 [accepted]
PHST- 2022/07/27 09:43 [entrez]
PHST- 2022/07/28 06:00 [pubmed]
PHST- 2022/07/28 06:00 [medline]
AID - 10.1111/bjh.18388 [doi]
PST - aheadofprint
SO  - Br J Haematol. 2022 Jul 27. doi: 10.1111/bjh.18388.

PMID- 35894184
OWN - NLM
STAT- MEDLINE
DCOM- 20220728
LR  - 20220801
IS  - 1008-8830 (Print)
IS  - 1008-8830 (Linking)
VI  - 24
IP  - 7
DP  - 2022 Jul 15
TI  - [Learning from the past: the history of human monkeypox and the atypicalmulti-country outbreak in 2022].
PG  - 717-727
LID - 1008-8830(2022)07-0717-11 [pii]
LID - 10.7499/j.issn.1008-8830.2206019 [doi]
AB  - In 2022, the outbreak of human monkeypox (HMPX) occurred in many non-endemiccountries. World Health Organization (WHO) assesses that this outbreak is"atypical". The history of monkeypox and HMPX must be reviewed to clearlyrecognize the "typical" outbreaks to fully understand this comment. Therefore,this paper reviews the epidemiological history of monkeypox, especially HMPX, anddiscusses and analyzes the atypical manifestations and the possible causes of thepresent outbreak based on the recent views of WHO, otherorganizations/institutions, and experts. The text describes the thought-provokinghistory of the interaction between the monkeypox virus and the human being in thepast 64 years, and provides various information and views on the outbreak ofHMPX, which is helpful to understand risk assessment and the potential impact of this outbreak on clinical and public health in future.
FAU - Yao, Kai-Hu
AU  - Yao KH
AD  - National Center for Children's Health/Beijing Children's Hospital, CapitalMedical University/Laboratory of Dermatology, Beijing Pediatric ResearchInstitute/National Key Discipline of Pediatrics (Capital Medical University)/Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing 100045, China.
LA  - chi
PT  - Journal Article
PT  - Review
TT  - 2022.
PL  - China
TA  - Zhongguo Dang Dai Er Ke Za Zhi
JT  - Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
JID - 100909956
SB  - IM
MH  - Animals
MH  - Disease Outbreaks
MH  - Humans
MH  - *Monkeypox/epidemiology
MH  - Monkeypox virus
PMC - PMC9336622
OTO - NOTNLM
OT  - History
OT  - Human monkeypox
OT  - Monkeypox
OT  - Outbreak
EDAT- 2022/07/28 06:00
MHDA- 2022/07/29 06:00
CRDT- 2022/07/27 06:43
PHST- 2022/07/27 06:43 [entrez]
PHST- 2022/07/28 06:00 [pubmed]
PHST- 2022/07/29 06:00 [medline]
AID - 1008-8830(2022)07-0717-11 [pii]
AID - 10.7499/j.issn.1008-8830.2206019 [doi]
PST - ppublish
SO  - Zhongguo Dang Dai Er Ke Za Zhi. 2022 Jul 15;24(7):717-727. doi:10.7499/j.issn.1008-8830.2206019.

PMID- 35892265
OWN - NLM
STAT- Publisher
LR  - 20220727
IS  - 2576-2095 (Electronic)
IS  - 2576-2095 (Linking)
DP  - 2022 Jul 27
TI  - Is China ready for monkeypox?
LID - 10.1002/ame2.12259 [doi]
FAU - Wei, Qiang
AU  - Wei Q
AD  - Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing, China.
AD  - NHC Key Laboratory of Human Disease Comparative Medicine.
AD  - Beijing Engineering Research Center for Experimental Animal Models of HumanCritical Diseases.
LA  - eng
PT  - Journal Article
DEP - 20220727
PL  - United States
TA  - Animal Model Exp Med
JT  - Animal models and experimental medicine
JID - 101726292
SB  - IM
EDAT- 2022/07/28 06:00
MHDA- 2022/07/28 06:00
CRDT- 2022/07/27 03:54
PHST- 2022/06/06 00:00 [received]
PHST- 2022/06/21 00:00 [accepted]
PHST- 2022/07/28 06:00 [pubmed]
PHST- 2022/07/28 06:00 [medline]
PHST- 2022/07/27 03:54 [entrez]
AID - 10.1002/ame2.12259 [doi]
PST - aheadofprint
SO  - Animal Model Exp Med. 2022 Jul 27. doi: 10.1002/ame2.12259.

PMID- 35891689
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220729
IS  - 2328-8957 (Print)
IS  - 2328-8957 (Linking)
VI  - 9
IP  - 7
DP  - 2022 Jul
TI  - Monkeypox: A Contemporary Review for Healthcare Professionals.
PG  - ofac310
LID - 10.1093/ofid/ofac310 [doi]
AB  - The ongoing 2022 multicountry outbreak of monkeypox is the largest in history to occur outside of Africa. Monkeypox is an emerging zoonotic disease that fordecades has been viewed as an infectious disease with significant epidemicpotential because of the increasing occurrence of human outbreaks in recentyears. As public health entities work to contain the current outbreak, healthcareprofessionals globally are aiming to become familiar with the various clinicalpresentations and management of this infection. We present in this review anupdated overview of monkeypox for healthcare professionals in the context of the ongoing outbreaks around the world.
CI  - (c) The Author(s) 2022. Published by Oxford University Press on behalf ofInfectious Diseases Society of America.
FAU - Titanji, Boghuma K
AU  - Titanji BK
AUID- ORCID: https://orcid.org/0000-0002-6881-2764
AD  - Division of Infectious Diseases, Emory University School of Medicine, Atlanta,Georgia, USA.
FAU - Tegomoh, Bryan
AU  - Tegomoh B
AD  - Nebraska Department of Health and Human Services, Lincoln, Nebraska, USA.
FAU - Nematollahi, Saman
AU  - Nematollahi S
AD  - Department of Medicine, University of Arizona College of Medicine, Tucson,Arizona, USA.
FAU - Konomos, Michael
AU  - Konomos M
AD  - Visual Medical Education, Emory University School of Medicine, Atlanta, Georgia, USA.
FAU - Kulkarni, Prathit A
AU  - Kulkarni PA
AD  - Infectious Diseases Section, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20220623
PL  - United States
TA  - Open Forum Infect Dis
JT  - Open forum infectious diseases
JID - 101637045
PMC - PMC9307103
OTO - NOTNLM
OT  - emerging infectious diseases
OT  - monkeypox
OT  - outbreak
EDAT- 2022/07/28 06:00
MHDA- 2022/07/28 06:01
CRDT- 2022/07/27 02:13
PHST- 2022/06/01 00:00 [received]
PHST- 2022/06/21 00:00 [accepted]
PHST- 2022/07/27 02:13 [entrez]
PHST- 2022/07/28 06:00 [pubmed]
PHST- 2022/07/28 06:01 [medline]
AID - 10.1093/ofid/ofac310 [doi]
AID - ofac310 [pii]
PST - epublish
SO  - Open Forum Infect Dis. 2022 Jun 23;9(7):ofac310. doi: 10.1093/ofid/ofac310.eCollection 2022 Jul.

PMID- 35891248
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220731
IS  - 2076-393X (Print)
IS  - 2076-393X (Linking)
VI  - 10
IP  - 7
DP  - 2022 Jul 6
TI  - Protective Human Anti-Poxvirus Monoclonal Antibodies Are Generated from RareMemory B Cells Isolated by Multicolor Antigen Tetramers.
LID - 1084 [pii]
LID - 10.3390/vaccines10071084 [doi]
AB  - Smallpox, an epidemic disease caused by Orthopoxvirus variola, was eradicatedworldwide through immunization. The immunization against smallpox wasdiscontinued in 1980. However, incidences of monkeypox virus infection in humans have occurred sporadically, and there is also great fear that engineered forms ofpoxvirus could be used as biological weapons. Therefore, monoclonal antibodiesagainst poxvirus are urgently needed for the detection and treatment of poxvirus infection. The vaccinia virus' extracellular envelope protein A33 is a potential candidate for a subunit vaccine. We used multi-fluorescence-labeled tetramericA33 antigen to identify rare poxvirus-specific memory B cells from the PBMC ofvolunteers with vaccinia virus immunization more than 40 years ago. Despiteextremely low frequencies of the poxvirus-specific memory B cells, wesuccessfully sorted A33 tetramer-labeled single memory B cells and reconstructed the antibodies with the single-cell RT-PCR of the B-cell receptor. Among themonoclonal antibodies, one clone H2 exhibited high specificity and affinity with A33. H2 efficiently inhibited viral infection and spread in cells. Passiveimmunotherapy of H2 in mice protected mice from lethal infection whenadministered either prophylactically or therapeutically. These results suggestthe potential of anti-A33 human-antibody-based detection and therapeutics forpoxvirus infection.
FAU - Gu, Xiuling
AU  - Gu X
AD  - CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute ofMicrobiology, Chinese Academy of Sciences, Beijing 100101, China.
AD  - University of Chinese Academy of Sciences, Beijing 101408, China.
FAU - Zhang, Yufan
AU  - Zhang Y
AD  - CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute ofMicrobiology, Chinese Academy of Sciences, Beijing 100101, China.
AD  - University of Chinese Academy of Sciences, Beijing 101408, China.
FAU - Jiang, Wei
AU  - Jiang W
AUID- ORCID: 0000-0001-5488-7303
AD  - CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute ofMicrobiology, Chinese Academy of Sciences, Beijing 100101, China.
FAU - Wang, Dongfang
AU  - Wang D
AD  - CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute ofMicrobiology, Chinese Academy of Sciences, Beijing 100101, China.
AD  - University of Chinese Academy of Sciences, Beijing 101408, China.
FAU - Lu, Jiao
AU  - Lu J
AD  - CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute ofMicrobiology, Chinese Academy of Sciences, Beijing 100101, China.
FAU - Gu, Guanglei
AU  - Gu G
AD  - CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute ofMicrobiology, Chinese Academy of Sciences, Beijing 100101, China.
AD  - University of Chinese Academy of Sciences, Beijing 101408, China.
FAU - Qin, Chengfeng
AU  - Qin C
AUID- ORCID: 0000-0002-0632-2807
AD  - State Key Laboratory of Pathogen and Biosecurity, Beijing Institute ofMicrobiology and Epidemiology, Academy of Military Medical Sciences, Beijing100071, China.
FAU - Fang, Min
AU  - Fang M
AUID- ORCID: 0000-0002-5278-1430
AD  - CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute ofMicrobiology, Chinese Academy of Sciences, Beijing 100101, China.
AD  - International College, University of Chinese Academy of Sciences, Beijing 101408,China.
LA  - eng
GR  - 31970164/National Natural Science Foundation of China
PT  - Journal Article
DEP - 20220706
PL  - Switzerland
TA  - Vaccines (Basel)
JT  - Vaccines
JID - 101629355
PMC - PMC9319751
OTO - NOTNLM
OT  - A33
OT  - Orthopoxvirus
OT  - human antibody
OT  - subunit vaccine
OT  - tetramer
EDAT- 2022/07/28 06:00
MHDA- 2022/07/28 06:01
CRDT- 2022/07/27 01:43
PHST- 2022/06/08 00:00 [received]
PHST- 2022/07/02 00:00 [revised]
PHST- 2022/07/04 00:00 [accepted]
PHST- 2022/07/27 01:43 [entrez]
PHST- 2022/07/28 06:00 [pubmed]
PHST- 2022/07/28 06:01 [medline]
AID - vaccines10071084 [pii]
AID - 10.3390/vaccines10071084 [doi]
PST - epublish
SO  - Vaccines (Basel). 2022 Jul 6;10(7). pii: vaccines10071084. doi:10.3390/vaccines10071084.

PMID- 35889960
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220731
IS  - 2076-0817 (Print)
IS  - 2076-0817 (Linking)
VI  - 11
IP  - 7
DP  - 2022 Jun 21
TI  - Monkeypox: Another Sexually Transmitted Infection?
LID - 713 [pii]
LID - 10.3390/pathogens11070713 [doi]
AB  - Monkeypox virus is a zoonotic DNA virus (Poxviridae family), identified in 1958in Asian monkeys (mostly Macaca fascicularis) in a polio vaccine research animal facility in Copenhagen, Denmark [...].
FAU - Rodriguez-Morales, Alfonso J
AU  - Rodriguez-Morales AJ
AUID- ORCID: 0000-0001-9773-2192
AD  - Grupo de Investigacion Biomedicina, Faculty of Medicine, Fundacion Universitaria Autonoma de las Americas, Pereira 660003, Colombia.
AD  - Clinical Epidemiology and Biostatistics, Universidad Cientifica del Sur, Lima15067, Peru.
FAU - Lopardo, Gustavo
AU  - Lopardo G
AD  - Faculty of Medicine, Universidad de Buenos Aires, Buenos Aires C1120AAQ,Argentina.
LA  - eng
PT  - Editorial
DEP - 20220621
PL  - Switzerland
TA  - Pathogens
JT  - Pathogens (Basel, Switzerland)
JID - 101596317
PMC - PMC9318491
EDAT- 2022/07/28 06:00
MHDA- 2022/07/28 06:01
CRDT- 2022/07/27 01:37
PHST- 2022/06/16 00:00 [received]
PHST- 2022/06/20 00:00 [accepted]
PHST- 2022/07/27 01:37 [entrez]
PHST- 2022/07/28 06:00 [pubmed]
PHST- 2022/07/28 06:01 [medline]
AID - pathogens11070713 [pii]
AID - 10.3390/pathogens11070713 [doi]
PST - epublish
SO  - Pathogens. 2022 Jun 21;11(7). pii: pathogens11070713. doi:10.3390/pathogens11070713.

PMID- 35888642
OWN - NLM
STAT- MEDLINE
DCOM- 20220728
LR  - 20220731
IS  - 1648-9144 (Electronic)
IS  - 1010-660X (Linking)
VI  - 58
IP  - 7
DP  - 2022 Jul 11
TI  - Knowledge of Human Monkeypox and Its Relation to Conspiracy Beliefs amongStudents in Jordanian Health Schools: Filling the Knowledge Gap on EmergingZoonotic Viruses.
LID - 924 [pii]
LID - 10.3390/medicina58070924 [doi]
AB  - Background and Objective: The recent multi-country outbreak of human monkeypox(HMPX) in non-endemic regions poses an emerging public health concern. Universitystudents in health schools/faculties represent a core knowledgeable group thatcan be helpful to study from a public health point of view. As future healthcare workers, assessment of their knowledge and attitude towards emerging zoonoticviral infections can be helpful to assess their taught material and courses with potential improvement if gaps in knowledge were identified. Therefore, we aimedto evaluate the level of HMPX knowledge, conspiracy beliefs regarding emergingvirus infections, as well as their associated determinants among universitystudents studying Medicine, Nursing, Dentistry, Pharmacy, Medical LaboratorySciences, and Rehabilitation in Jordanian health schools/faculties. In addition, we sought to evaluate the correlation between HMPX knowledge and the extent ofholding conspiracy beliefs regarding emerging viral infection. Materials andMethods: A convenient sample of university students was obtained through anelectronic survey distributed in late May 2022 using the chain-referral approach.Assessment of HMPX knowledge and general attitude towards emerging virusinfections was based on survey items adopted from previously publishedliterature. Results: The study sample comprised 615 students with a mean age of20 years and a majority of females (432, 70.2%) and medical students (n = 351,57.1%). Out of eleven monkeypox knowledge items, three were identified correctly by &gt;70% of the respondents. Only 26.2% of the respondents (n = 161) knew that vaccination to prevent monkeypox is available. Age was significantly associatedwith better HMPX knowledge for a majority of items. Older age, females, andaffiliation to non-medical schools/faculties were associated with harboringhigher levels of conspiracy beliefs regarding emerging virus infections. Our dataalso indicate that lower levels of HMPX knowledge were associated with higherlevels of conspiracy beliefs. Conclusion: The current study pointed to generally unsatisfactory levels of knowledge regarding the emerging HMPX among universitystudents in Jordanian health schools/faculties. Conspiracy beliefs regardingemerging virus infections were widely prevalent, and its potential detrimentalimpact on health behavior should be evaluated in future studies.
FAU - Sallam, Malik
AU  - Sallam M
AUID- ORCID: 0000-0002-0165-9670
AD  - Department of Pathology, Microbiology and Forensic Medicine, School of Medicine, The University of Jordan, Amman 11942, Jordan.
AD  - Department of Clinical Laboratories and Forensic Medicine, Jordan UniversityHospital, Amman 11942, Jordan.
AD  - Department of Translational Medicine, Faculty of Medicine, Lund University, 22184Malmo, Sweden.
FAU - Al-Mahzoum, Kholoud
AU  - Al-Mahzoum K
AD  - School of Medicine, The University of Jordan, Amman 11942, Jordan.
FAU - Dardas, Latefa Ali
AU  - Dardas LA
AUID- ORCID: 0000-0001-5437-4778
AD  - School of Nursing, The University of Jordan, Amman 11942, Jordan.
FAU - Al-Tammemi, Ala'a B
AU  - Al-Tammemi AB
AUID- ORCID: 0000-0003-0862-0186
AD  - Migration Health Division, International Organization for Migration (IOM), The UNMigration Agency, Amman 11953, Jordan.
FAU - Al-Majali, Laith
AU  - Al-Majali L
AD  - School of Medicine, The University of Jordan, Amman 11942, Jordan.
FAU - Al-Naimat, Hala
AU  - Al-Naimat H
AD  - School of Medicine, The University of Jordan, Amman 11942, Jordan.
FAU - Jardaneh, Laila
AU  - Jardaneh L
AD  - School of Dentistry, The University of Jordan, Amman 11942, Jordan.
FAU - AlHadidi, Farah
AU  - AlHadidi F
AD  - School of Medicine, The University of Jordan, Amman 11942, Jordan.
FAU - Al-Salahat, Khaled
AU  - Al-Salahat K
AD  - Department of Pathology, Microbiology and Forensic Medicine, School of Medicine, The University of Jordan, Amman 11942, Jordan.
AD  - Department of Clinical Laboratories and Forensic Medicine, Jordan UniversityHospital, Amman 11942, Jordan.
FAU - Al-Ajlouni, Eyad
AU  - Al-Ajlouni E
AD  - Department of Pathology, Microbiology and Forensic Medicine, School of Medicine, The University of Jordan, Amman 11942, Jordan.
AD  - Department of Clinical Laboratories and Forensic Medicine, Jordan UniversityHospital, Amman 11942, Jordan.
FAU - AlHadidi, Nadin Mohammad
AU  - AlHadidi NM
AD  - Department of Clinical Laboratories and Forensic Medicine, Jordan UniversityHospital, Amman 11942, Jordan.
FAU - Bakri, Faris G
AU  - Bakri FG
AD  - Department of Internal Medicine, School of Medicine, The University of Jordan,Amman 11942, Jordan.
AD  - Infectious Diseases and Vaccine Center, The University of Jordan, Amman 11942,Jordan.
FAU - Mahafzah, Azmi
AU  - Mahafzah A
AD  - Department of Pathology, Microbiology and Forensic Medicine, School of Medicine, The University of Jordan, Amman 11942, Jordan.
AD  - Department of Clinical Laboratories and Forensic Medicine, Jordan UniversityHospital, Amman 11942, Jordan.
FAU - Harapan, Harapan
AU  - Harapan H
AUID- ORCID: 0000-0001-7630-8413
AD  - Medical Research Unit, School of Medicine, Universitas Syiah Kuala, Banda Aceh23111, Indonesia.
AD  - Tropical Disease Centre, School of Medicine, Universitas Syiah Kuala, Banda Aceh 23111, Indonesia.
AD  - Department of Microbiology, School of Medicine, Universitas Syiah Kuala, BandaAceh 23111, Indonesia.
LA  - eng
PT  - Journal Article
DEP - 20220711
PL  - Switzerland
TA  - Medicina (Kaunas)
JT  - Medicina (Kaunas, Lithuania)
JID - 9425208
SB  - IM
MH  - Adult
MH  - Animals
MH  - Female
MH  - Health Knowledge, Attitudes, Practice
MH  - Humans
MH  - Jordan
MH  - *Monkeypox
MH  - *Students, Medical
MH  - *Virus Diseases
MH  - *Viruses
MH  - Young Adult
PMC - PMC9317638
OTO - NOTNLM
OT  - Orthopoxviruses
OT  - attitude
OT  - biological warfare
OT  - conspiracy theory
OT  - lockdown
OT  - preventive behavior
OT  - rumors
EDAT- 2022/07/28 06:00
MHDA- 2022/07/29 06:00
CRDT- 2022/07/27 01:31
PHST- 2022/06/02 00:00 [received]
PHST- 2022/06/19 00:00 [revised]
PHST- 2022/07/05 00:00 [accepted]
PHST- 2022/07/27 01:31 [entrez]
PHST- 2022/07/28 06:00 [pubmed]
PHST- 2022/07/29 06:00 [medline]
AID - medicina58070924 [pii]
AID - 10.3390/medicina58070924 [doi]
PST - epublish
SO  - Medicina (Kaunas). 2022 Jul 11;58(7). pii: medicina58070924. doi:10.3390/medicina58070924.

PMID- 35887214
OWN - NLM
STAT- MEDLINE
DCOM- 20220728
LR  - 20220731
IS  - 1422-0067 (Electronic)
IS  - 1422-0067 (Linking)
VI  - 23
IP  - 14
DP  - 2022 Jul 17
TI  - Monkeypox: A New Threat?
LID - 7866 [pii]
LID - 10.3390/ijms23147866 [doi]
AB  - The global vaccination programme against smallpox led to its successfuleradication and averted millions of deaths. Monkeypox virus (MPXV) is a closerelative of the Variola (smallpox) virus. Due to antigenic similarity, smallpoxvaccines cross-protect against MPXV. However, over 70% of people living todaywere never vaccinated against smallpox. Symptoms of monkeypox (MPX) includefever, head- and muscle ache, lymphadenopathy and a characteristic rash thatdevelops into papules, vesicles and pustules which eventually scab over and heal.MPX is less often fatal (case fatality rates range from &lt;1% to up to 11%) thansmallpox (up to 30%). MPXV is endemic in sub-Saharan Africa, infecting wildanimals and causing zoonotic outbreaks. Exotic animal trade and internationaltravel, combined with the increasing susceptibility of the human population dueto halted vaccination, facilitated the spread of MPXV to new areas. The ongoingoutbreak, with &gt;10,000 cases in &gt;50 countries between May and July 2022,shows that MPXV can significantly spread between people and may thus become aserious threat to public health with global consequences. Here, we summarize the current knowledge about this re-emerging virus, discuss available strategies tolimit its spread and pathogenicity and evaluate its risk to the human population.
FAU - Kmiec, Dorota
AU  - Kmiec D
AUID- ORCID: 0000-0001-7302-6015
AD  - Institute of Molecular Virology, Ulm University Medical Center, 89081 Ulm,Germany.
FAU - Kirchhoff, Frank
AU  - Kirchhoff F
AUID- ORCID: 0000-0002-7052-2360
AD  - Institute of Molecular Virology, Ulm University Medical Center, 89081 Ulm,Germany.
LA  - eng
GR  - CRC 1279/Deutsche Forschungsgemeinschaft
GR  - SP1600/Deutsche Forschungsgemeinschaft
GR  - Restrict SARS-CoV-2/Federal Ministry of Education and Research
GR  - Intramural funding/Universitatsklikum ulm
PT  - Journal Article
PT  - Review
DEP - 20220717
PL  - Switzerland
TA  - Int J Mol Sci
JT  - International journal of molecular sciences
JID - 101092791
SB  - IM
MH  - Animals
MH  - Humans
MH  - *Monkeypox/epidemiology/prevention & control
MH  - Monkeypox virus
MH  - *Smallpox/epidemiology/prevention & control
PMC - PMC9321130
OTO - NOTNLM
OT  - 2022 MPXV outbreak
OT  - MPXV
OT  - emerging viruses
OT  - monkeypox
OT  - zoonosis
EDAT- 2022/07/28 06:00
MHDA- 2022/07/29 06:00
CRDT- 2022/07/27 01:24
PHST- 2022/07/03 00:00 [received]
PHST- 2022/07/13 00:00 [revised]
PHST- 2022/07/16 00:00 [accepted]
PHST- 2022/07/27 01:24 [entrez]
PHST- 2022/07/28 06:00 [pubmed]
PHST- 2022/07/29 06:00 [medline]
AID - ijms23147866 [pii]
AID - 10.3390/ijms23147866 [doi]
PST - epublish
SO  - Int J Mol Sci. 2022 Jul 17;23(14). pii: ijms23147866. doi: 10.3390/ijms23147866.

PMID- 35882992
OWN - NLM
STAT- MEDLINE
DCOM- 20220728
LR  - 20220731
IS  - 1476-4687 (Electronic)
IS  - 0028-0836 (Linking)
VI  - 607
IP  - 7920
DP  - 2022 Jul
TI  - Monkeypox: wealthy countries must avoid their COVID-19 mistakes.
PG  - 635-636
LID - 10.1038/d41586-022-02036-9 [doi]
LA  - eng
PT  - Editorial
PT  - Comment
PL  - England
TA  - Nature
JT  - Nature
JID - 0410462
SB  - IM
CON - Nat Rev Microbiol. 2022 Jul 20;:null. PMID: 35859005
MH  - *COVID-19/epidemiology/prevention & control
MH  - *Developed Countries
MH  - Humans
MH  - *Monkeypox/epidemiology/prevention & control
OTO - NOTNLM
OT  - *Diseases
OT  - *Public health
OT  - *Virology
EDAT- 2022/07/27 06:00
MHDA- 2022/07/29 06:00
CRDT- 2022/07/26 23:38
PHST- 2022/07/26 23:38 [entrez]
PHST- 2022/07/27 06:00 [pubmed]
PHST- 2022/07/29 06:00 [medline]
AID - 10.1038/d41586-022-02036-9 [doi]
AID - 10.1038/d41586-022-02036-9 [pii]
PST - ppublish
SO  - Nature. 2022 Jul;607(7920):635-636. doi: 10.1038/d41586-022-02036-9.

PMID- 35882402
OWN - NLM
STAT- MEDLINE
DCOM- 20220728
LR  - 20220729
IS  - 1756-1833 (Electronic)
IS  - 0959-8138 (Linking)
VI  - 378
DP  - 2022 Jul 26
TI  - Monkeypox: WHO declares a public health emergency of international concern.
PG  - o1874
LID - 10.1136/bmj.o1874 [doi]
FAU - Taylor, Luke
AU  - Taylor L
AD  - Portsmouth.
LA  - eng
PT  - Journal Article
DEP - 20220726
PL  - England
TA  - BMJ
JT  - BMJ (Clinical research ed.)
JID - 8900488
SB  - IM
MH  - Animals
MH  - Disease Outbreaks
MH  - Humans
MH  - *Monkeypox/epidemiology
MH  - Public Health
MH  - World Health Organization
EDAT- 2022/07/27 06:00
MHDA- 2022/07/29 06:00
CRDT- 2022/07/26 20:43
PHST- 2022/07/26 20:43 [entrez]
PHST- 2022/07/27 06:00 [pubmed]
PHST- 2022/07/29 06:00 [medline]
AID - 10.1136/bmj.o1874 [doi]
PST - epublish
SO  - BMJ. 2022 Jul 26;378:o1874. doi: 10.1136/bmj.o1874.

PMID- 35881138
OWN - NLM
STAT- MEDLINE
DCOM- 20220728
LR  - 20220801
IS  - 1538-3598 (Electronic)
IS  - 0098-7484 (Linking)
VI  - 328
IP  - 4
DP  - 2022 Jul 26
TI  - Expanding Monkeypox Testing.
PG  - 321
LID - 10.1001/jama.2022.11839 [doi]
FAU - Suran, Melissa
AU  - Suran M
LA  - eng
PT  - Journal Article
PL  - United States
TA  - JAMA
JT  - JAMA
JID - 7501160
SB  - IM
MH  - Animals
MH  - Diagnostic Techniques and Procedures
MH  - *Disease Outbreaks
MH  - *Health Services Accessibility
MH  - Humans
MH  - *Monkeypox/diagnosis/epidemiology
MH  - Zoonoses/diagnosis/epidemiology
EDAT- 2022/07/27 06:00
MHDA- 2022/07/29 06:00
CRDT- 2022/07/26 11:03
PHST- 2022/07/26 11:03 [entrez]
PHST- 2022/07/27 06:00 [pubmed]
PHST- 2022/07/29 06:00 [medline]
AID - 2794584 [pii]
AID - 10.1001/jama.2022.11839 [doi]
PST - ppublish
SO  - JAMA. 2022 Jul 26;328(4):321. doi: 10.1001/jama.2022.11839.

PMID- 35880509
OWN - NLM
STAT- MEDLINE
DCOM- 20220727
LR  - 20220731
IS  - 1598-6357 (Electronic)
IS  - 1011-8934 (Linking)
VI  - 37
IP  - 29
DP  - 2022 Jul 25
TI  - Monkeypox Vaccination in the Republic of Korea: Identifying the High-Risk Target Group.
PG  - e239
LID - 10.3346/jkms.2022.37.e239 [doi]
AB  - In June 2022, the first monkeypox case was reported as imported into Korea. Thegeneral public asked whether they should get vaccinated against monkeypox becauseof the recent COVID-19 vaccination experience. As of the current monkeypoxoutbreak situation, a ring vaccination strategy for the high-risk group is moreappropriate than the mass population vaccination with smallpox vaccines.Therefore, identifying the proper target group by available vaccines based on therisk and benefit analysis is a key issue of the vaccination program. In addition,the target group should be reviewed by the epidemiological situation of thejurisdiction along with the updated evidence of the monkeypox virus ontransmission dynamics, severity, and fatality.
CI  - (c) 2022 The Korean Academy of Medical Sciences.
FAU - Kwon, Seunghyun Lewis
AU  - Kwon SL
AUID- ORCID: https://orcid.org/0000-0002-0113-0179
AD  - Division of Immunization, Bureau of Healthcare Safety and Immunization, KoreaDisease Control and Prevention Agency, Cheongju, Korea.
AD  - Central Disease Control Headquarters of Monkeypox, Korea Disease Control andPrevention Agency, Cheongju, Korea. haramkwon83@gmail.com.
FAU - Ban, Seonhwa
AU  - Ban S
AUID- ORCID: https://orcid.org/0000-0003-1701-2529
AD  - Division of Immunization, Bureau of Healthcare Safety and Immunization, KoreaDisease Control and Prevention Agency, Cheongju, Korea.
AD  - Central Disease Control Headquarters of Monkeypox, Korea Disease Control andPrevention Agency, Cheongju, Korea.
FAU - Shin, Jeeyeon
AU  - Shin J
AUID- ORCID: https://orcid.org/0000-0001-7960-1535
AD  - Division of Immunization, Bureau of Healthcare Safety and Immunization, KoreaDisease Control and Prevention Agency, Cheongju, Korea.
AD  - Central Disease Control Headquarters of Monkeypox, Korea Disease Control andPrevention Agency, Cheongju, Korea.
FAU - Bae, Hyuna
AU  - Bae H
AUID- ORCID: https://orcid.org/0000-0001-6602-2817
AD  - Division of Immunization, Bureau of Healthcare Safety and Immunization, KoreaDisease Control and Prevention Agency, Cheongju, Korea.
AD  - Central Disease Control Headquarters of Monkeypox, Korea Disease Control andPrevention Agency, Cheongju, Korea.
FAU - Park, Heeyoun
AU  - Park H
AUID- ORCID: https://orcid.org/0000-0001-8315-8898
AD  - Division of Immunization, Bureau of Healthcare Safety and Immunization, KoreaDisease Control and Prevention Agency, Cheongju, Korea.
AD  - Central Disease Control Headquarters of Monkeypox, Korea Disease Control andPrevention Agency, Cheongju, Korea.
FAU - Kwon, Geun-Yong
AU  - Kwon GY
AUID- ORCID: https://orcid.org/0000-0003-2385-1847
AD  - Division of Immunization, Bureau of Healthcare Safety and Immunization, KoreaDisease Control and Prevention Agency, Cheongju, Korea.
AD  - Central Disease Control Headquarters of Monkeypox, Korea Disease Control andPrevention Agency, Cheongju, Korea.
LA  - eng
PT  - Journal Article
DEP - 20220725
PL  - Korea (South)
TA  - J Korean Med Sci
JT  - Journal of Korean medical science
JID - 8703518
RN  - 0 (COVID-19 Vaccines)
SB  - IM
MH  - Animals
MH  - *COVID-19/epidemiology/prevention & control
MH  - COVID-19 Vaccines
MH  - Humans
MH  - *Monkeypox/epidemiology/prevention & control
MH  - Monkeypox virus
MH  - Vaccination
PMC - PMC9313979
OTO - NOTNLM
OT  - Korea
OT  - Monkeypox
OT  - Risk Assessment
OT  - Smallpox Vaccine
OT  - Vaccination
COIS- All authors have no potential conflicts of interest to disclose.
EDAT- 2022/07/27 06:00
MHDA- 2022/07/28 06:00
CRDT- 2022/07/26 04:53
PHST- 2022/07/14 00:00 [received]
PHST- 2022/07/15 00:00 [accepted]
PHST- 2022/07/26 04:53 [entrez]
PHST- 2022/07/27 06:00 [pubmed]
PHST- 2022/07/28 06:00 [medline]
AID - 37.e239 [pii]
AID - 10.3346/jkms.2022.37.e239 [doi]
PST - epublish
SO  - J Korean Med Sci. 2022 Jul 25;37(29):e239. doi: 10.3346/jkms.2022.37.e239.

PMID- 35877947
STAT- Publisher
DA  - 20220726
PB  - National Library of Medicine (US)
DP  - 2006
TI  - Monkeypox Vaccine
BTI - Drugs and Lactation Database (LactMed)
AB  - No information is available on the clinical use of monkeypox vaccine duringbreastfeeding. Monkeypox vaccine does not replicate and behaves like a non-livevaccine. The US Centers of Disease Control and Prevention states that ifmonkeypox vaccine is required by the mother, it is not a reason to discontinuebreastfeeding.[1]
LA  - eng
PT  - Review
PT  - Book Chapter
PL  - Bethesda (MD)
OTO - NLM
OT  - Monkeypox Vaccine
OT  - Jynneos
OT  - Imvanex
OT  - Smallpox and Monkeypox Vaccine, Live, Non-replicating
OT  - vaccinia virus modified strain ankara-bavarian nordic nonreplicating antigen
EDAT- 2022/07/26 06:01
MHDA- 2022/07/26 06:01
CDAT- 2022/07/26 06:01
AID - NBK582099 [bookaccession]

PMID- 35879614
OWN - NLM
STAT- Publisher
LR  - 20220726
IS  - 1476-4687 (Electronic)
IS  - 0028-0836 (Linking)
DP  - 2022 Jul 25
TI  - Monkeypox declared a global emergency: will it help contain the outbreak?
LID - 10.1038/d41586-022-02054-7 [doi]
FAU - Kozlov, Max
AU  - Kozlov M
LA  - eng
PT  - News
DEP - 20220725
PL  - England
TA  - Nature
JT  - Nature
JID - 0410462
SB  - IM
OTO - NOTNLM
OT  - Government
OT  - Public health
OT  - Vaccines
EDAT- 2022/07/26 06:00
MHDA- 2022/07/26 06:00
CRDT- 2022/07/25 23:39
PHST- 2022/07/26 06:00 [pubmed]
PHST- 2022/07/26 06:00 [medline]
PHST- 2022/07/25 23:39 [entrez]
AID - 10.1038/d41586-022-02054-7 [doi]
AID - 10.1038/d41586-022-02054-7 [pii]
PST - aheadofprint
SO  - Nature. 2022 Jul 25. pii: 10.1038/d41586-022-02054-7. doi:10.1038/d41586-022-02054-7.

PMID- 35878146
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220728
IS  - 2414-6366 (Electronic)
IS  - 2414-6366 (Linking)
VI  - 7
IP  - 7
DP  - 2022 Jul 14
TI  - When a Neglected Tropical Disease Goes Global: Knowledge, Attitudes and Practicesof Italian Physicians towards Monkeypox, Preliminary Results.
LID - 135 [pii]
LID - 10.3390/tropicalmed7070135 [doi]
AB  - Monkeypox (MPX) has been regarded as a neglected tropic disease of Western andCentral Africa since the early 70s. However, during May 2022, an unprecedentoutbreak of MPX has involved most of European Countries, as well as North andSouth America. While the actual extent of this outbreak is being assessed byhealth authorities, we performed a pilot study on specific knowledge, attitudes, and practices (KAP) in a sample of Italian medical professionals (24-30 May 2022;10,293 potential recipients), focusing on Occupational Physicians (OP), PublicHealth Professionals (PH), and General Practitioners (GP), i.e., medicalprofessionals more likely involved in the early management of incident cases.More specifically, we inquired into their attitude on the use of variola vaccine in order to prevent MPX infection. From a total of 566 questionnaire (responserate of 5.5%), 163 participants were included in the final analyses. Knowledgestatus was quite unsatisfying, with substantial knowledge gaps on all aspect ofMPX. In turn, analysis of risk perception suggested a substantial overlooking of MPX as a pathogen, particularly when compared to SARS-CoV-2, TB, HIV, and HBV.Overall, 58.6% of respondents were somehow favorable to implement variolavaccination in order to prevent MPX, and the main effectors of this attitude wereidentified in having been previously vaccinated against seasonal influenza(adjusted Odds Ratio [aOR] 6.443, 95% Confidence Interval [95%CI] 1.798-23.093), and being favorable to receive variola vaccine (aOR 21.416; 95%CI 7.290-62.914). In summary, the significant extent of knowledge gaps and the erratic riskperception, associated collectively stress the importance of appropriateinformation campaigns among first-line medical professionals.
FAU - Ricco, Matteo
AU  - Ricco M
AUID- ORCID: 0000-0002-6525-2159
AD  - Servizio di Prevenzione e Sicurezza Negli Ambienti di Lavoro (SPSAL), AUSL-IRCCS di Reggio Emilia, Via Amendola n.2, I-42122 Reggio Emilia, Italy.
FAU - Ferraro, Pietro
AU  - Ferraro P
AUID- ORCID: 0000-0002-9149-1647
AD  - Occupational Medicine Unit, Direzione Sanita, Italian Railways' InfrastructureDivision, RFI SpA, I-00161 Rome, Italy.
FAU - Camisa, Vincenzo
AU  - Camisa V
AD  - Health Directorate, Occupational Medicine Unit, Bambino Gesu Children's Hospital IRCCS, I-00146 Rome, Italy.
FAU - Satta, Elia
AU  - Satta E
AD  - Department of Medicine and Surgery, University of Parma, Via Gramsci, 14, I-43126Parma, Italy.
FAU - Zaniboni, Alessandro
AU  - Zaniboni A
AD  - Department of Medicine and Surgery, University of Parma, Via Gramsci, 14, I-43126Parma, Italy.
FAU - Ranzieri, Silvia
AU  - Ranzieri S
AUID- ORCID: 0000-0002-9607-8624
AD  - Department of Medicine and Surgery, University of Parma, Via Gramsci, 14, I-43126Parma, Italy.
FAU - Baldassarre, Antonio
AU  - Baldassarre A
AUID- ORCID: 0000-0002-6124-3570
AD  - Occupational Medicine Unit, Careggi University Hospital, I-50134 Florence, Italy.
FAU - Zaffina, Salvatore
AU  - Zaffina S
AUID- ORCID: 0000-0002-8858-5423
AD  - Health Directorate, Occupational Medicine Unit, Bambino Gesu Children's Hospital IRCCS, I-00146 Rome, Italy.
FAU - Marchesi, Federico
AU  - Marchesi F
AD  - Department of Medicine and Surgery, University of Parma, Via Gramsci, 14, I-43126Parma, Italy.
LA  - eng
PT  - Journal Article
DEP - 20220714
PL  - Switzerland
TA  - Trop Med Infect Dis
JT  - Tropical medicine and infectious disease
JID - 101709042
PMC - PMC9316880
OTO - NOTNLM
OT  - attitudes
OT  - knowledge
OT  - monkeypox virus
OT  - practices
OT  - smallpox
OT  - vaccine hesitancy
OT  - variola
EDAT- 2022/07/26 06:00
MHDA- 2022/07/26 06:01
CRDT- 2022/07/25 16:12
PHST- 2022/06/02 00:00 [received]
PHST- 2022/07/09 00:00 [revised]
PHST- 2022/07/12 00:00 [accepted]
PHST- 2022/07/25 16:12 [entrez]
PHST- 2022/07/26 06:00 [pubmed]
PHST- 2022/07/26 06:01 [medline]
AID - tropicalmed7070135 [pii]
AID - 10.3390/tropicalmed7070135 [doi]
PST - epublish
SO  - Trop Med Infect Dis. 2022 Jul 14;7(7). pii: tropicalmed7070135. doi:10.3390/tropicalmed7070135.

PMID- 35876271
OWN - NLM
STAT- Publisher
LR  - 20220725
IS  - 1708-8305 (Electronic)
IS  - 1195-1982 (Linking)
DP  - 2022 Jul 24
TI  - Monkeypox outbreak 2022: an unusual case of peritonsillar abscess in a personpreviously vaccinated against smallpox.
LID - taac082 [pii]
LID - 10.1093/jtm/taac082 [doi]
AB  - Descriptions of monkeypox 2022 outbreak have been increasingly reported withunusual presentations and therefore a risk of misdiagnosis. Diagnosis isprimarily based on risk factors, including men having sex with men and high-risk contact, with the presence of cutaneous lesions and/or rashes including thegenitals in a context of fever.
CI  - (c) The Author(s) 2022. Published by Oxford University Press on behalf ofInternational Society of Travel Medicine. All rights reserved. For permissions,please e-mail: journals.permissions@oup.com.
FAU - Davido, Benjamin
AU  - Davido B
AUID- ORCID: 0000-0002-2859-8417
AD  - Maladies Infectieuses, Hopital Universitaire Raymond-Poincare, AP-HP, 92380Garches, France.
AD  - Universite Paris Saclay, 78000 Versailles, France.
FAU - D'Anglejan, Emma
AU  - D'Anglejan E
AD  - Maladies Infectieuses, Hopital Universitaire Raymond-Poincare, AP-HP, 92380Garches, France.
FAU - Baudoin, Robin
AU  - Baudoin R
AD  - Universite Paris Saclay, 78000 Versailles, France.
AD  - Service d'ORL, Hopital Foch, 92150 Suresnes, France.
FAU - Dahmane, Lotfi
AU  - Dahmane L
AD  - Maladies Infectieuses, Hopital Universitaire Raymond-Poincare, AP-HP, 92380Garches, France.
AD  - Universite Paris Saclay, 78000 Versailles, France.
FAU - Chaud, Adrien
AU  - Chaud A
AD  - AP-HP Nord, Service des Maladies Infectieuses, Hopital UniversitaireBichat-Claude Bernard, Paris, France.
FAU - Cortier, Marie
AU  - Cortier M
AD  - AP-HP Nord, Service des Maladies Infectieuses, Hopital UniversitaireBichat-Claude Bernard, Paris, France.
FAU - Fellous, Christelle Vauloup
AU  - Fellous CV
AD  - Unite de Virologie, Hopital Universitaire Paul-Brousse, AP-HP, 94808 Villejuif,France.
FAU - De Truchis, Pierre
AU  - De Truchis P
AD  - Maladies Infectieuses, Hopital Universitaire Raymond-Poincare, AP-HP, 92380Garches, France.
FAU - Ghosn, Jade
AU  - Ghosn J
AD  - AP-HP Nord, Service des Maladies Infectieuses, Hopital UniversitaireBichat-Claude Bernard, Paris, France.
AD  - Universite Paris Cite, INSERM UMRS 1137 IAME, Paris, France.
LA  - eng
PT  - Journal Article
DEP - 20220724
PL  - England
TA  - J Travel Med
JT  - Journal of travel medicine
JID - 9434456
SB  - IM
OTO - NOTNLM
OT  - Monkeypoxcervical lymphadenopathyatypicalperitonsillar abscess
EDAT- 2022/07/26 06:00
MHDA- 2022/07/26 06:00
CRDT- 2022/07/25 07:03
PHST- 2022/07/01 00:00 [received]
PHST- 2022/07/06 00:00 [revised]
PHST- 2022/07/19 00:00 [accepted]
PHST- 2022/07/25 07:03 [entrez]
PHST- 2022/07/26 06:00 [pubmed]
PHST- 2022/07/26 06:00 [medline]
AID - 6649389 [pii]
AID - 10.1093/jtm/taac082 [doi]
PST - aheadofprint
SO  - J Travel Med. 2022 Jul 24. pii: 6649389. doi: 10.1093/jtm/taac082.

PMID- 35872578
OWN - NLM
STAT- MEDLINE
DCOM- 20220726
LR  - 20220726
IS  - 0376-2491 (Print)
IS  - 0376-2491 (Linking)
VI  - 102
IP  - 28
DP  - 2022 Jul 26
TI  - [Perspectives on recent monkeypox outbreak in non-endemic areas].
PG  - 2148-2152
LID - 10.3760/cma.j.cn112137-20220526-01162 [doi]
AB  - Monkeypox is a rare infectious disease caused by the monkeypox virus, which used to occur endemically in central and western Africa. As of 25th May, a total of219 recently confirmed cases of monkeypox have been reported from 19 non-endemic countries. This outbreak unusually takes place in non-endemic areas for monkeypoxvirus and has exhibited features of high risk of human-to-human transmission.Onset of multiple human monkeypox cases may be related to the decreased level of herd cross-immunity after the cessation of smallpox vaccination. Moreover,behavioral patterns in specific populations may account for the human-to-humantransmission in this outbreak. Currently, possibility of global epidemic ofmonkeypox is extremely low, but China should be cautious about risks ofimportation of monkeypox cases. The key to prevention and control is to establisha surveillance system to identify suspicious cases and close contacts as soon as possible.
FAU - Li, X D
AU  - Li XD
AD  - Department of Infectious Diseases, State Key Laboratory of Complex Severe andRare Disease, Peking Union Medical College hospital, Chinese Academy of MedicalScience and Peking Union Medical College, Beijing 100730, China.
FAU - Cao, W
AU  - Cao W
AD  - Department of Infectious Diseases, State Key Laboratory of Complex Severe andRare Disease, Peking Union Medical College hospital, Chinese Academy of MedicalScience and Peking Union Medical College, Beijing 100730, China.
FAU - Li, T S
AU  - Li TS
AD  - Department of Infectious Diseases, State Key Laboratory of Complex Severe andRare Disease, Peking Union Medical College hospital, Chinese Academy of MedicalScience and Peking Union Medical College, Beijing 100730, China.
LA  - chi
GR  - Key Clinical Specialties Program of Beijing
PT  - Journal Article
PL  - China
TA  - Zhonghua Yi Xue Za Zhi
JT  - Zhonghua yi xue za zhi
JID - 7511141
SB  - IM
MH  - Animals
MH  - China
MH  - Disease Outbreaks
MH  - Humans
MH  - *Monkeypox/epidemiology/prevention & control
MH  - Monkeypox virus
MH  - Vaccination
EDAT- 2022/07/26 06:00
MHDA- 2022/07/27 06:00
CRDT- 2022/07/25 02:39
PHST- 2022/07/25 02:39 [entrez]
PHST- 2022/07/26 06:00 [pubmed]
PHST- 2022/07/27 06:00 [medline]
AID - 10.3760/cma.j.cn112137-20220526-01162 [doi]
PST - ppublish
SO  - Zhonghua Yi Xue Za Zhi. 2022 Jul 26;102(28):2148-2152. doi:10.3760/cma.j.cn112137-20220526-01162.

PMID- 35872096
OWN - NLM
STAT- Publisher
LR  - 20220725
IS  - 1878-3511 (Electronic)
IS  - 1201-9712 (Linking)
DP  - 2022 Jul 21
TI  - Emergence potential of Monkeypox in the Western Pacific Region, July 2022.
LID - S1201-9712(22)00441-6 [pii]
LID - 10.1016/j.ijid.2022.07.044 [doi]
AB  - Although new cases of monkeypox have been expected in the Western Pacific Region (WPR) since the virus emerged in Europe earlier this year, there have been only afew reported cases across the WPR (New Zealand 2, Singapore 6, South Korea 1,Taiwan 2), other than a limited number of cases (compared to numbers of casesseen elsewhere in the world) in Australia (33) as of 15 July 2022. In ourcommunication, we highlight two key reasons for this: i) international travel hasstill not fully resumed in the WPR following the COVID-19 pandemic, and ii) localpublic health measures to counter the spread of COVID-19 have not been completelyrelaxed. We provide supporting evidence for both of these reasons.
CI  - Copyright (c) 2022. Published by Elsevier Ltd.
FAU - Akhmetzhanov, Andrei R
AU  - Akhmetzhanov AR
AD  - College of Public Health, National Taiwan University, 17 Xu-Zhou Road, ZhongzhengDistrict, Taipei, 10055, Taiwan. Electronic address: akhmetzhanov@ntu.edu.tw.
FAU - Ponce, Luis
AU  - Ponce L
AD  - College of Public Health, National Taiwan University, 17 Xu-Zhou Road, ZhongzhengDistrict, Taipei, 10055, Taiwan. Electronic address: luis41397@gmail.com.
FAU - Thompson, Robin N
AU  - Thompson RN
AD  - Mathematics Institute, University of Warwick, Coventry, CV4 7AL, U.K.; ZeemanInstitute for Systems Biology and Infectious Disease Epidemiology Research,University of Warwick, Coventry, CV4 7AL, U.K.. Electronic address:robin.n.thompson@warwick.ac.uk.
LA  - eng
PT  - Journal Article
DEP - 20220721
PL  - Canada
TA  - Int J Infect Dis
JT  - International journal of infectious diseases : IJID : official publication of theInternational Society for Infectious Diseases
JID - 9610933
SB  - IM
OTO - NOTNLM
OT  - COVID-19
OT  - Monkeypox
OT  - international travel
EDAT- 2022/07/26 06:00
MHDA- 2022/07/26 06:00
CRDT- 2022/07/25 01:48
PHST- 2022/06/20 00:00 [received]
PHST- 2022/07/17 00:00 [revised]
PHST- 2022/07/18 00:00 [accepted]
PHST- 2022/07/25 01:48 [entrez]
PHST- 2022/07/26 06:00 [pubmed]
PHST- 2022/07/26 06:00 [medline]
AID - S1201-9712(22)00441-6 [pii]
AID - 10.1016/j.ijid.2022.07.044 [doi]
PST - aheadofprint
SO  - Int J Infect Dis. 2022 Jul 21. pii: S1201-9712(22)00441-6. doi:10.1016/j.ijid.2022.07.044.

PMID- 35871003
OWN - NLM
STAT- MEDLINE
DCOM- 20220726
LR  - 20220729
IS  - 2049-9957 (Electronic)
IS  - 2049-9957 (Linking)
VI  - 11
IP  - 1
DP  - 2022 Jul 23
TI  - Monkeypox claims new victims: the outbreak in men who have sex with men.
PG  - 84
LID - 10.1186/s40249-022-01007-6 [doi]
AB  - Monkeypox has a very prominent regional epidemic. It has been confined to Westernand Central African countries. Sporadic cases found in countries outside Africagenerally have a history of sojourn in endemic areas. However, the recentmultinational outbreak of monkeypox cases in Europe in early May 2022 hasrevealed a changing epidemiological trend, those confirmed cases had no sojournhistory in endemic areas and with a high proportion of cases involving men whohave sex with men (MSM). Among the MSM cases, many of them presented atypicalclinical manifestations of monkeypox and with other sexually transmitted diseasesco-infection. Combined with the high social interactivity in this community,there is likely a higher risk of monkeypox transmission in this population.Establishing an infectious disease surveillance system, maintaining highlyvigilant regarding the transmission of monkeypox in MSM, and responding promptly are necessary and effective measures to contain the outbreak.
CI  - (c) 2022. The Author(s).
FAU - Liu, Xiaoning
AU  - Liu X
AD  - Department of Infectious Diseases, National Clinical Research Center forInfectious Diseases, The Third People's Hospital of Shenzhen, Shenzhen, 518112,Guangdong, China.
AD  - National Heart & Lung Institute, Faculty of Medicine, Imperial College London,London, UK.
FAU - Zhu, Zheng
AU  - Zhu Z
AD  - School of Nursing, Fudan University, Shanghai, China.
AD  - Fudan University Centre for Evidence-Based Nursing: A Joanna Briggs InstituteCentre of Excellence, Shanghai, China.
AD  - NYU Rory Meyers College of Nursing, New York University, New York, NY, USA.
FAU - He, Yun
AU  - He Y
AD  - Department of Infectious Diseases, National Clinical Research Center forInfectious Diseases, The Third People's Hospital of Shenzhen, Shenzhen, 518112,Guangdong, China.
FAU - Lim, Jia Wen
AU  - Lim JW
AD  - National Heart & Lung Institute, Faculty of Medicine, Imperial College London,London, UK.
FAU - Lane, Bethany
AU  - Lane B
AD  - National Heart & Lung Institute, Faculty of Medicine, Imperial College London,London, UK.
AD  - St Bartholomew's Hospital, London, UK.
FAU - Wang, Hui
AU  - Wang H
AD  - Department of Infectious Diseases, National Clinical Research Center forInfectious Diseases, The Third People's Hospital of Shenzhen, Shenzhen, 518112,Guangdong, China.
FAU - Peng, Qiaoli
AU  - Peng Q
AD  - Department of Infectious Diseases, National Clinical Research Center forInfectious Diseases, The Third People's Hospital of Shenzhen, Shenzhen, 518112,Guangdong, China.
FAU - Sun, Liqin
AU  - Sun L
AD  - Department of Infectious Diseases, National Clinical Research Center forInfectious Diseases, The Third People's Hospital of Shenzhen, Shenzhen, 518112,Guangdong, China.
FAU - Lu, Hongzhou
AU  - Lu H
AD  - Department of Infectious Diseases, National Clinical Research Center forInfectious Diseases, The Third People's Hospital of Shenzhen, Shenzhen, 518112,Guangdong, China. luhongzhou@szsy.sustech.edu.cn.
LA  - eng
GR  - [2021] No. 255/Shenzhen Science and Technology Innovation committee project
PT  - Letter
DEP - 20220723
PL  - England
TA  - Infect Dis Poverty
JT  - Infectious diseases of poverty
JID - 101606645
SB  - IM
MH  - Animals
MH  - Disease Outbreaks
MH  - Europe/epidemiology
MH  - Homosexuality, Male
MH  - Humans
MH  - Male
MH  - *Monkeypox/epidemiology
MH  - *Sexual and Gender Minorities
PMC - PMC9308177
OTO - NOTNLM
OT  - Infectious diseases
OT  - Men have sex with men
OT  - Monkeypox
OT  - Public health
EDAT- 2022/07/24 06:00
MHDA- 2022/07/27 06:00
CRDT- 2022/07/23 23:38
PHST- 2022/06/20 00:00 [received]
PHST- 2022/07/07 00:00 [accepted]
PHST- 2022/07/23 23:38 [entrez]
PHST- 2022/07/24 06:00 [pubmed]
PHST- 2022/07/27 06:00 [medline]
AID - 10.1186/s40249-022-01007-6 [doi]
AID - 10.1186/s40249-022-01007-6 [pii]
PST - epublish
SO  - Infect Dis Poverty. 2022 Jul 23;11(1):84. doi: 10.1186/s40249-022-01007-6.

PMID- 35868644
OWN - NLM
STAT- MEDLINE
DCOM- 20220726
LR  - 20220726
IS  - 1756-1833 (Electronic)
IS  - 0959-8138 (Linking)
VI  - 378
DP  - 2022 Jul 22
TI  - Monkeypox: New clinical symptoms are identified in confirmed cases.
PG  - o1845
LID - 10.1136/bmj.o1845 [doi]
FAU - Wise, Jacqui
AU  - Wise J
AD  - Kent.
LA  - eng
PT  - Journal Article
DEP - 20220722
PL  - England
TA  - BMJ
JT  - BMJ (Clinical research ed.)
JID - 8900488
SB  - IM
MH  - Animals
MH  - Disease Outbreaks
MH  - Humans
MH  - *Monkeypox/diagnosis/epidemiology
EDAT- 2022/07/23 06:00
MHDA- 2022/07/27 06:00
CRDT- 2022/07/22 20:43
PHST- 2022/07/22 20:43 [entrez]
PHST- 2022/07/23 06:00 [pubmed]
PHST- 2022/07/27 06:00 [medline]
AID - 10.1136/bmj.o1845 [doi]
PST - epublish
SO  - BMJ. 2022 Jul 22;378:o1845. doi: 10.1136/bmj.o1845.

PMID- 35866746
OWN - NLM
STAT- Publisher
LR  - 20220722
IS  - 1533-4406 (Electronic)
IS  - 0028-4793 (Linking)
DP  - 2022 Jul 21
TI  - Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022.
LID - 10.1056/NEJMoa2207323 [doi]
AB  - BACKGROUND: Before April 2022, monkeypox virus infection in humans was seldomreported outside African regions where it is endemic. Currently, cases areoccurring worldwide. Transmission, risk factors, clinical presentation, andoutcomes of infection are poorly defined. METHODS: We formed an internationalcollaborative group of clinicians who contributed to an international case seriesto describe the presentation, clinical course, and outcomes ofpolymerase-chain-reaction-confirmed monkeypox virus infections. RESULTS: Wereport 528 infections diagnosed between April 27 and June 24, 2022, at 43 sitesin 16 countries. Overall, 98% of the persons with infection were gay or bisexual men, 75% were White, and 41% had human immunodeficiency virus infection; themedian age was 38 years. Transmission was suspected to have occurred throughsexual activity in 95% of the persons with infection. In this case series, 95% ofthe persons presented with a rash (with 64% having <10 lesions), 73% hadanogenital lesions, and 41% had mucosal lesions (with 54 having a single genital lesion). Common systemic features preceding the rash included fever (62%),lethargy (41%), myalgia (31%), and headache (27%); lymphadenopathy was alsocommon (reported in 56%). Concomitant sexually transmitted infections werereported in 109 of 377 persons (29%) who were tested. Among the 23 persons with aclear exposure history, the median incubation period was 7 days (range, 3 to 20).Monkeypox virus DNA was detected in 29 of the 32 persons in whom seminal fluidwas analyzed. Antiviral treatment was given to 5% of the persons overall, and 70 (13%) were hospitalized; the reasons for hospitalization were pain management,mostly for severe anorectal pain (21 persons); soft-tissue superinfection (18);pharyngitis limiting oral intake (5); eye lesions (2); acute kidney injury (2);myocarditis (2); and infection-control purposes (13). No deaths were reported.CONCLUSIONS: In this case series, monkeypox manifested with a variety ofdermatologic and systemic clinical findings. The simultaneous identification ofcases outside areas where monkeypox has traditionally been endemic highlights theneed for rapid identification and diagnosis of cases to contain further communityspread.
CI  - Copyright (c) 2022 Massachusetts Medical Society.
FAU - Thornhill, John P
AU  - Thornhill JP
AD  - From the Blizard Institute and the SHARE Collaborative, Queen Mary University of London, and the Department of Infection and Immunity, Barts Health NHS Trust(J.P.T., V.A., C.M.O.), the Department of Genitourinary Medicine and InfectiousDisease, Guys and St. Thomas' NHS Trust (A.N.), the Department of Sexual Health, Homerton University Hospital (I.R.), and the Clinical Infection Unit, St.George's University Hospitals NHS Foundation Trust (M.S.H.) - all in London; the Department of Medicine, Division of Infectious Diseases (S.B., L.B.H., M.B.K.),the J.D. MacLean Centre for Tropical Diseases (S.B.), the Research Institute ofthe McGill University Health Centre (S.B., M.B.K.), and the Chronic Viral IllnessService, Department of Medicine (M.B.K.), McGill University Health Centre,Montreal, and the Department of Medicine, University Health Network, Universityof Toronto (S.W.), the Division of Infectious Diseases and the MAP Centre forUrban Health Solutions, St. Michael's Hospital (D.T.), and the Department ofMedicine, University of Toronto (D.T.), Toronto - all in Canada; UniversityHospital Bonn, Department of Medicine I, Bonn (J.R., C.B.), the Department ofInfectious Diseases, St. Joseph Hospital, Berlin (P.M.), MedizinischesVersorgungszentrum (MVZ) Munchen am Goetheplatz, Munich (S. Noe), and theInfektionsmedizinisches Centrum Hamburg (ICH) Study Center, Hamburg MVZ ICHStadmitte, Hamburg (C.H.) - all in Germany; the National Institute for InfectiousDiseases Lazzaro Spallanzani IRCCS, Rome (A.A., F.M.), the Division of InfectiousDisease, Luigi Sacco Hospital, Azienda Socio-Sanitaria TerritorialeFatebenefratelli Sacco (D.M.), and the Department of Infectious and TropicalDiseases, IRCCS-Ospedale San Raffaele (S. Nozza), Milan, the Clinic of InfectiousDiseases, University of Modena, Modena (C.M.), and the Infectious DiseasesDivision, Department of Medical Sciences, Azienda Ospedale Universita, Padua(A.C.) - all in Italy; the Department of Infectious Diseases, SorbonneUniversity, Assistance Publique-Hopitaux de Paris (AP-HP), Pitie-SalpetriereHospital (R.P., V.P.), and the Department of Infectious Diseases, Saint LouisLariboisiere Hospital, AP-HP, University of Paris Cite (C.P.), Paris, and theDepartment of Prevention and Community Health, Creteil Intercommunal Hospital,Creteil (C.P.) - all in France; the HIV Cure Research Center, Department ofInternal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent (L.V.), and the HIV/STI Clinic,Institute of Tropical Medicine, Antwerp (E.F.) - both in Belgium; the SacklerFaculty of Medicine, Tel Aviv University, and the Israel Department of InfectiousDiseases and Infection Control, Tel Aviv Sourasky Medical Center, Tel Aviv,Israel (M.Y.); the Department of Dermatology, University Hospital La Paz, Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC),Instituto de Investigacion Hospital Universitario La Paz (E.S.), and CIBERINFEC, Instituto de Salud Carlos III (J.L.B.), Madrid, and the Infectious DiseasesService, Hospital Clinic-IDIBAPS (Instituto de Investigaciones Biomedicas August Pi i Sunyer), University of Barcelona, Barcelona (J.L.B.) - all in Spain;Hospital de Curry Cabral-Centro Hospitalar Universitario de Lisboa Central,Lisbon, Portugal (F.M.M.); Amsterdam University Medical Centers, University ofAmsterdam, Amsterdam (A.G.); the Department of Infectious Diseases, UniversityHospital of Copenhagen, Hvidovre, Denmark (A.-B.E.H.); the Condesa SpecializedClinic, Mexico City (J.I.L.); the Francois-Xavier Bagnoud Center for Health andHuman Rights at Harvard University, Boston (K.M.); and the Department ofInfectious Diseases and Hospital Epidemiology, University Hospital Zurich,Zurich, Switzerland (J.N.).
FAU - Barkati, Sapha
AU  - Barkati S
AD  - From the Blizard Institute and the SHARE Collaborative, Queen Mary University of London, and the Department of Infection and Immunity, Barts Health NHS Trust(J.P.T., V.A., C.M.O.), the Department of Genitourinary Medicine and InfectiousDisease, Guys and St. Thomas' NHS Trust (A.N.), the Department of Sexual Health, Homerton University Hospital (I.R.), and the Clinical Infection Unit, St.George's University Hospitals NHS Foundation Trust (M.S.H.) - all in London; the Department of Medicine, Division of Infectious Diseases (S.B., L.B.H., M.B.K.),the J.D. MacLean Centre for Tropical Diseases (S.B.), the Research Institute ofthe McGill University Health Centre (S.B., M.B.K.), and the Chronic Viral IllnessService, Department of Medicine (M.B.K.), McGill University Health Centre,Montreal, and the Department of Medicine, University Health Network, Universityof Toronto (S.W.), the Division of Infectious Diseases and the MAP Centre forUrban Health Solutions, St. Michael's Hospital (D.T.), and the Department ofMedicine, University of Toronto (D.T.), Toronto - all in Canada; UniversityHospital Bonn, Department of Medicine I, Bonn (J.R., C.B.), the Department ofInfectious Diseases, St. Joseph Hospital, Berlin (P.M.), MedizinischesVersorgungszentrum (MVZ) Munchen am Goetheplatz, Munich (S. Noe), and theInfektionsmedizinisches Centrum Hamburg (ICH) Study Center, Hamburg MVZ ICHStadmitte, Hamburg (C.H.) - all in Germany; the National Institute for InfectiousDiseases Lazzaro Spallanzani IRCCS, Rome (A.A., F.M.), the Division of InfectiousDisease, Luigi Sacco Hospital, Azienda Socio-Sanitaria TerritorialeFatebenefratelli Sacco (D.M.), and the Department of Infectious and TropicalDiseases, IRCCS-Ospedale San Raffaele (S. Nozza), Milan, the Clinic of InfectiousDiseases, University of Modena, Modena (C.M.), and the Infectious DiseasesDivision, Department of Medical Sciences, Azienda Ospedale Universita, Padua(A.C.) - all in Italy; the Department of Infectious Diseases, SorbonneUniversity, Assistance Publique-Hopitaux de Paris (AP-HP), Pitie-SalpetriereHospital (R.P., V.P.), and the Department of Infectious Diseases, Saint LouisLariboisiere Hospital, AP-HP, University of Paris Cite (C.P.), Paris, and theDepartment of Prevention and Community Health, Creteil Intercommunal Hospital,Creteil (C.P.) - all in France; the HIV Cure Research Center, Department ofInternal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent (L.V.), and the HIV/STI Clinic,Institute of Tropical Medicine, Antwerp (E.F.) - both in Belgium; the SacklerFaculty of Medicine, Tel Aviv University, and the Israel Department of InfectiousDiseases and Infection Control, Tel Aviv Sourasky Medical Center, Tel Aviv,Israel (M.Y.); the Department of Dermatology, University Hospital La Paz, Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC),Instituto de Investigacion Hospital Universitario La Paz (E.S.), and CIBERINFEC, Instituto de Salud Carlos III (J.L.B.), Madrid, and the Infectious DiseasesService, Hospital Clinic-IDIBAPS (Instituto de Investigaciones Biomedicas August Pi i Sunyer), University of Barcelona, Barcelona (J.L.B.) - all in Spain;Hospital de Curry Cabral-Centro Hospitalar Universitario de Lisboa Central,Lisbon, Portugal (F.M.M.); Amsterdam University Medical Centers, University ofAmsterdam, Amsterdam (A.G.); the Department of Infectious Diseases, UniversityHospital of Copenhagen, Hvidovre, Denmark (A.-B.E.H.); the Condesa SpecializedClinic, Mexico City (J.I.L.); the Francois-Xavier Bagnoud Center for Health andHuman Rights at Harvard University, Boston (K.M.); and the Department ofInfectious Diseases and Hospital Epidemiology, University Hospital Zurich,Zurich, Switzerland (J.N.).
FAU - Walmsley, Sharon
AU  - Walmsley S
AD  - From the Blizard Institute and the SHARE Collaborative, Queen Mary University of London, and the Department of Infection and Immunity, Barts Health NHS Trust(J.P.T., V.A., C.M.O.), the Department of Genitourinary Medicine and InfectiousDisease, Guys and St. Thomas' NHS Trust (A.N.), the Department of Sexual Health, Homerton University Hospital (I.R.), and the Clinical Infection Unit, St.George's University Hospitals NHS Foundation Trust (M.S.H.) - all in London; the Department of Medicine, Division of Infectious Diseases (S.B., L.B.H., M.B.K.),the J.D. MacLean Centre for Tropical Diseases (S.B.), the Research Institute ofthe McGill University Health Centre (S.B., M.B.K.), and the Chronic Viral IllnessService, Department of Medicine (M.B.K.), McGill University Health Centre,Montreal, and the Department of Medicine, University Health Network, Universityof Toronto (S.W.), the Division of Infectious Diseases and the MAP Centre forUrban Health Solutions, St. Michael's Hospital (D.T.), and the Department ofMedicine, University of Toronto (D.T.), Toronto - all in Canada; UniversityHospital Bonn, Department of Medicine I, Bonn (J.R., C.B.), the Department ofInfectious Diseases, St. Joseph Hospital, Berlin (P.M.), MedizinischesVersorgungszentrum (MVZ) Munchen am Goetheplatz, Munich (S. Noe), and theInfektionsmedizinisches Centrum Hamburg (ICH) Study Center, Hamburg MVZ ICHStadmitte, Hamburg (C.H.) - all in Germany; the National Institute for InfectiousDiseases Lazzaro Spallanzani IRCCS, Rome (A.A., F.M.), the Division of InfectiousDisease, Luigi Sacco Hospital, Azienda Socio-Sanitaria TerritorialeFatebenefratelli Sacco (D.M.), and the Department of Infectious and TropicalDiseases, IRCCS-Ospedale San Raffaele (S. Nozza), Milan, the Clinic of InfectiousDiseases, University of Modena, Modena (C.M.), and the Infectious DiseasesDivision, Department of Medical Sciences, Azienda Ospedale Universita, Padua(A.C.) - all in Italy; the Department of Infectious Diseases, SorbonneUniversity, Assistance Publique-Hopitaux de Paris (AP-HP), Pitie-SalpetriereHospital (R.P., V.P.), and the Department of Infectious Diseases, Saint LouisLariboisiere Hospital, AP-HP, University of Paris Cite (C.P.), Paris, and theDepartment of Prevention and Community Health, Creteil Intercommunal Hospital,Creteil (C.P.) - all in France; the HIV Cure Research Center, Department ofInternal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent (L.V.), and the HIV/STI Clinic,Institute of Tropical Medicine, Antwerp (E.F.) - both in Belgium; the SacklerFaculty of Medicine, Tel Aviv University, and the Israel Department of InfectiousDiseases and Infection Control, Tel Aviv Sourasky Medical Center, Tel Aviv,Israel (M.Y.); the Department of Dermatology, University Hospital La Paz, Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC),Instituto de Investigacion Hospital Universitario La Paz (E.S.), and CIBERINFEC, Instituto de Salud Carlos III (J.L.B.), Madrid, and the Infectious DiseasesService, Hospital Clinic-IDIBAPS (Instituto de Investigaciones Biomedicas August Pi i Sunyer), University of Barcelona, Barcelona (J.L.B.) - all in Spain;Hospital de Curry Cabral-Centro Hospitalar Universitario de Lisboa Central,Lisbon, Portugal (F.M.M.); Amsterdam University Medical Centers, University ofAmsterdam, Amsterdam (A.G.); the Department of Infectious Diseases, UniversityHospital of Copenhagen, Hvidovre, Denmark (A.-B.E.H.); the Condesa SpecializedClinic, Mexico City (J.I.L.); the Francois-Xavier Bagnoud Center for Health andHuman Rights at Harvard University, Boston (K.M.); and the Department ofInfectious Diseases and Hospital Epidemiology, University Hospital Zurich,Zurich, Switzerland (J.N.).
FAU - Rockstroh, Juergen
AU  - Rockstroh J
AD  - From the Blizard Institute and the SHARE Collaborative, Queen Mary University of London, and the Department of Infection and Immunity, Barts Health NHS Trust(J.P.T., V.A., C.M.O.), the Department of Genitourinary Medicine and InfectiousDisease, Guys and St. Thomas' NHS Trust (A.N.), the Department of Sexual Health, Homerton University Hospital (I.R.), and the Clinical Infection Unit, St.George's University Hospitals NHS Foundation Trust (M.S.H.) - all in London; the Department of Medicine, Division of Infectious Diseases (S.B., L.B.H., M.B.K.),the J.D. MacLean Centre for Tropical Diseases (S.B.), the Research Institute ofthe McGill University Health Centre (S.B., M.B.K.), and the Chronic Viral IllnessService, Department of Medicine (M.B.K.), McGill University Health Centre,Montreal, and the Department of Medicine, University Health Network, Universityof Toronto (S.W.), the Division of Infectious Diseases and the MAP Centre forUrban Health Solutions, St. Michael's Hospital (D.T.), and the Department ofMedicine, University of Toronto (D.T.), Toronto - all in Canada; UniversityHospital Bonn, Department of Medicine I, Bonn (J.R., C.B.), the Department ofInfectious Diseases, St. Joseph Hospital, Berlin (P.M.), MedizinischesVersorgungszentrum (MVZ) Munchen am Goetheplatz, Munich (S. Noe), and theInfektionsmedizinisches Centrum Hamburg (ICH) Study Center, Hamburg MVZ ICHStadmitte, Hamburg (C.H.) - all in Germany; the National Institute for InfectiousDiseases Lazzaro Spallanzani IRCCS, Rome (A.A., F.M.), the Division of InfectiousDisease, Luigi Sacco Hospital, Azienda Socio-Sanitaria TerritorialeFatebenefratelli Sacco (D.M.), and the Department of Infectious and TropicalDiseases, IRCCS-Ospedale San Raffaele (S. Nozza), Milan, the Clinic of InfectiousDiseases, University of Modena, Modena (C.M.), and the Infectious DiseasesDivision, Department of Medical Sciences, Azienda Ospedale Universita, Padua(A.C.) - all in Italy; the Department of Infectious Diseases, SorbonneUniversity, Assistance Publique-Hopitaux de Paris (AP-HP), Pitie-SalpetriereHospital (R.P., V.P.), and the Department of Infectious Diseases, Saint LouisLariboisiere Hospital, AP-HP, University of Paris Cite (C.P.), Paris, and theDepartment of Prevention and Community Health, Creteil Intercommunal Hospital,Creteil (C.P.) - all in France; the HIV Cure Research Center, Department ofInternal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent (L.V.), and the HIV/STI Clinic,Institute of Tropical Medicine, Antwerp (E.F.) - both in Belgium; the SacklerFaculty of Medicine, Tel Aviv University, and the Israel Department of InfectiousDiseases and Infection Control, Tel Aviv Sourasky Medical Center, Tel Aviv,Israel (M.Y.); the Department of Dermatology, University Hospital La Paz, Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC),Instituto de Investigacion Hospital Universitario La Paz (E.S.), and CIBERINFEC, Instituto de Salud Carlos III (J.L.B.), Madrid, and the Infectious DiseasesService, Hospital Clinic-IDIBAPS (Instituto de Investigaciones Biomedicas August Pi i Sunyer), University of Barcelona, Barcelona (J.L.B.) - all in Spain;Hospital de Curry Cabral-Centro Hospitalar Universitario de Lisboa Central,Lisbon, Portugal (F.M.M.); Amsterdam University Medical Centers, University ofAmsterdam, Amsterdam (A.G.); the Department of Infectious Diseases, UniversityHospital of Copenhagen, Hvidovre, Denmark (A.-B.E.H.); the Condesa SpecializedClinic, Mexico City (J.I.L.); the Francois-Xavier Bagnoud Center for Health andHuman Rights at Harvard University, Boston (K.M.); and the Department ofInfectious Diseases and Hospital Epidemiology, University Hospital Zurich,Zurich, Switzerland (J.N.).
FAU - Antinori, Andrea
AU  - Antinori A
AD  - From the Blizard Institute and the SHARE Collaborative, Queen Mary University of London, and the Department of Infection and Immunity, Barts Health NHS Trust(J.P.T., V.A., C.M.O.), the Department of Genitourinary Medicine and InfectiousDisease, Guys and St. Thomas' NHS Trust (A.N.), the Department of Sexual Health, Homerton University Hospital (I.R.), and the Clinical Infection Unit, St.George's University Hospitals NHS Foundation Trust (M.S.H.) - all in London; the Department of Medicine, Division of Infectious Diseases (S.B., L.B.H., M.B.K.),the J.D. MacLean Centre for Tropical Diseases (S.B.), the Research Institute ofthe McGill University Health Centre (S.B., M.B.K.), and the Chronic Viral IllnessService, Department of Medicine (M.B.K.), McGill University Health Centre,Montreal, and the Department of Medicine, University Health Network, Universityof Toronto (S.W.), the Division of Infectious Diseases and the MAP Centre forUrban Health Solutions, St. Michael's Hospital (D.T.), and the Department ofMedicine, University of Toronto (D.T.), Toronto - all in Canada; UniversityHospital Bonn, Department of Medicine I, Bonn (J.R., C.B.), the Department ofInfectious Diseases, St. Joseph Hospital, Berlin (P.M.), MedizinischesVersorgungszentrum (MVZ) Munchen am Goetheplatz, Munich (S. Noe), and theInfektionsmedizinisches Centrum Hamburg (ICH) Study Center, Hamburg MVZ ICHStadmitte, Hamburg (C.H.) - all in Germany; the National Institute for InfectiousDiseases Lazzaro Spallanzani IRCCS, Rome (A.A., F.M.), the Division of InfectiousDisease, Luigi Sacco Hospital, Azienda Socio-Sanitaria TerritorialeFatebenefratelli Sacco (D.M.), and the Department of Infectious and TropicalDiseases, IRCCS-Ospedale San Raffaele (S. Nozza), Milan, the Clinic of InfectiousDiseases, University of Modena, Modena (C.M.), and the Infectious DiseasesDivision, Department of Medical Sciences, Azienda Ospedale Universita, Padua(A.C.) - all in Italy; the Department of Infectious Diseases, SorbonneUniversity, Assistance Publique-Hopitaux de Paris (AP-HP), Pitie-SalpetriereHospital (R.P., V.P.), and the Department of Infectious Diseases, Saint LouisLariboisiere Hospital, AP-HP, University of Paris Cite (C.P.), Paris, and theDepartment of Prevention and Community Health, Creteil Intercommunal Hospital,Creteil (C.P.) - all in France; the HIV Cure Research Center, Department ofInternal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent (L.V.), and the HIV/STI Clinic,Institute of Tropical Medicine, Antwerp (E.F.) - both in Belgium; the SacklerFaculty of Medicine, Tel Aviv University, and the Israel Department of InfectiousDiseases and Infection Control, Tel Aviv Sourasky Medical Center, Tel Aviv,Israel (M.Y.); the Department of Dermatology, University Hospital La Paz, Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC),Instituto de Investigacion Hospital Universitario La Paz (E.S.), and CIBERINFEC, Instituto de Salud Carlos III (J.L.B.), Madrid, and the Infectious DiseasesService, Hospital Clinic-IDIBAPS (Instituto de Investigaciones Biomedicas August Pi i Sunyer), University of Barcelona, Barcelona (J.L.B.) - all in Spain;Hospital de Curry Cabral-Centro Hospitalar Universitario de Lisboa Central,Lisbon, Portugal (F.M.M.); Amsterdam University Medical Centers, University ofAmsterdam, Amsterdam (A.G.); the Department of Infectious Diseases, UniversityHospital of Copenhagen, Hvidovre, Denmark (A.-B.E.H.); the Condesa SpecializedClinic, Mexico City (J.I.L.); the Francois-Xavier Bagnoud Center for Health andHuman Rights at Harvard University, Boston (K.M.); and the Department ofInfectious Diseases and Hospital Epidemiology, University Hospital Zurich,Zurich, Switzerland (J.N.).
FAU - Harrison, Luke B
AU  - Harrison LB
AD  - From the Blizard Institute and the SHARE Collaborative, Queen Mary University of London, and the Department of Infection and Immunity, Barts Health NHS Trust(J.P.T., V.A., C.M.O.), the Department of Genitourinary Medicine and InfectiousDisease, Guys and St. Thomas' NHS Trust (A.N.), the Department of Sexual Health, Homerton University Hospital (I.R.), and the Clinical Infection Unit, St.George's University Hospitals NHS Foundation Trust (M.S.H.) - all in London; the Department of Medicine, Division of Infectious Diseases (S.B., L.B.H., M.B.K.),the J.D. MacLean Centre for Tropical Diseases (S.B.), the Research Institute ofthe McGill University Health Centre (S.B., M.B.K.), and the Chronic Viral IllnessService, Department of Medicine (M.B.K.), McGill University Health Centre,Montreal, and the Department of Medicine, University Health Network, Universityof Toronto (S.W.), the Division of Infectious Diseases and the MAP Centre forUrban Health Solutions, St. Michael's Hospital (D.T.), and the Department ofMedicine, University of Toronto (D.T.), Toronto - all in Canada; UniversityHospital Bonn, Department of Medicine I, Bonn (J.R., C.B.), the Department ofInfectious Diseases, St. Joseph Hospital, Berlin (P.M.), MedizinischesVersorgungszentrum (MVZ) Munchen am Goetheplatz, Munich (S. Noe), and theInfektionsmedizinisches Centrum Hamburg (ICH) Study Center, Hamburg MVZ ICHStadmitte, Hamburg (C.H.) - all in Germany; the National Institute for InfectiousDiseases Lazzaro Spallanzani IRCCS, Rome (A.A., F.M.), the Division of InfectiousDisease, Luigi Sacco Hospital, Azienda Socio-Sanitaria TerritorialeFatebenefratelli Sacco (D.M.), and the Department of Infectious and TropicalDiseases, IRCCS-Ospedale San Raffaele (S. Nozza), Milan, the Clinic of InfectiousDiseases, University of Modena, Modena (C.M.), and the Infectious DiseasesDivision, Department of Medical Sciences, Azienda Ospedale Universita, Padua(A.C.) - all in Italy; the Department of Infectious Diseases, SorbonneUniversity, Assistance Publique-Hopitaux de Paris (AP-HP), Pitie-SalpetriereHospital (R.P., V.P.), and the Department of Infectious Diseases, Saint LouisLariboisiere Hospital, AP-HP, University of Paris Cite (C.P.), Paris, and theDepartment of Prevention and Community Health, Creteil Intercommunal Hospital,Creteil (C.P.) - all in France; the HIV Cure Research Center, Department ofInternal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent (L.V.), and the HIV/STI Clinic,Institute of Tropical Medicine, Antwerp (E.F.) - both in Belgium; the SacklerFaculty of Medicine, Tel Aviv University, and the Israel Department of InfectiousDiseases and Infection Control, Tel Aviv Sourasky Medical Center, Tel Aviv,Israel (M.Y.); the Department of Dermatology, University Hospital La Paz, Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC),Instituto de Investigacion Hospital Universitario La Paz (E.S.), and CIBERINFEC, Instituto de Salud Carlos III (J.L.B.), Madrid, and the Infectious DiseasesService, Hospital Clinic-IDIBAPS (Instituto de Investigaciones Biomedicas August Pi i Sunyer), University of Barcelona, Barcelona (J.L.B.) - all in Spain;Hospital de Curry Cabral-Centro Hospitalar Universitario de Lisboa Central,Lisbon, Portugal (F.M.M.); Amsterdam University Medical Centers, University ofAmsterdam, Amsterdam (A.G.); the Department of Infectious Diseases, UniversityHospital of Copenhagen, Hvidovre, Denmark (A.-B.E.H.); the Condesa SpecializedClinic, Mexico City (J.I.L.); the Francois-Xavier Bagnoud Center for Health andHuman Rights at Harvard University, Boston (K.M.); and the Department ofInfectious Diseases and Hospital Epidemiology, University Hospital Zurich,Zurich, Switzerland (J.N.).
FAU - Palich, Romain
AU  - Palich R
AUID- ORCID: 0000-0003-0047-0101
AD  - From the Blizard Institute and the SHARE Collaborative, Queen Mary University of London, and the Department of Infection and Immunity, Barts Health NHS Trust(J.P.T., V.A., C.M.O.), the Department of Genitourinary Medicine and InfectiousDisease, Guys and St. Thomas' NHS Trust (A.N.), the Department of Sexual Health, Homerton University Hospital (I.R.), and the Clinical Infection Unit, St.George's University Hospitals NHS Foundation Trust (M.S.H.) - all in London; the Department of Medicine, Division of Infectious Diseases (S.B., L.B.H., M.B.K.),the J.D. MacLean Centre for Tropical Diseases (S.B.), the Research Institute ofthe McGill University Health Centre (S.B., M.B.K.), and the Chronic Viral IllnessService, Department of Medicine (M.B.K.), McGill University Health Centre,Montreal, and the Department of Medicine, University Health Network, Universityof Toronto (S.W.), the Division of Infectious Diseases and the MAP Centre forUrban Health Solutions, St. Michael's Hospital (D.T.), and the Department ofMedicine, University of Toronto (D.T.), Toronto - all in Canada; UniversityHospital Bonn, Department of Medicine I, Bonn (J.R., C.B.), the Department ofInfectious Diseases, St. Joseph Hospital, Berlin (P.M.), MedizinischesVersorgungszentrum (MVZ) Munchen am Goetheplatz, Munich (S. Noe), and theInfektionsmedizinisches Centrum Hamburg (ICH) Study Center, Hamburg MVZ ICHStadmitte, Hamburg (C.H.) - all in Germany; the National Institute for InfectiousDiseases Lazzaro Spallanzani IRCCS, Rome (A.A., F.M.), the Division of InfectiousDisease, Luigi Sacco Hospital, Azienda Socio-Sanitaria TerritorialeFatebenefratelli Sacco (D.M.), and the Department of Infectious and TropicalDiseases, IRCCS-Ospedale San Raffaele (S. Nozza), Milan, the Clinic of InfectiousDiseases, University of Modena, Modena (C.M.), and the Infectious DiseasesDivision, Department of Medical Sciences, Azienda Ospedale Universita, Padua(A.C.) - all in Italy; the Department of Infectious Diseases, SorbonneUniversity, Assistance Publique-Hopitaux de Paris (AP-HP), Pitie-SalpetriereHospital (R.P., V.P.), and the Department of Infectious Diseases, Saint LouisLariboisiere Hospital, AP-HP, University of Paris Cite (C.P.), Paris, and theDepartment of Prevention and Community Health, Creteil Intercommunal Hospital,Creteil (C.P.) - all in France; the HIV Cure Research Center, Department ofInternal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent (L.V.), and the HIV/STI Clinic,Institute of Tropical Medicine, Antwerp (E.F.) - both in Belgium; the SacklerFaculty of Medicine, Tel Aviv University, and the Israel Department of InfectiousDiseases and Infection Control, Tel Aviv Sourasky Medical Center, Tel Aviv,Israel (M.Y.); the Department of Dermatology, University Hospital La Paz, Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC),Instituto de Investigacion Hospital Universitario La Paz (E.S.), and CIBERINFEC, Instituto de Salud Carlos III (J.L.B.), Madrid, and the Infectious DiseasesService, Hospital Clinic-IDIBAPS (Instituto de Investigaciones Biomedicas August Pi i Sunyer), University of Barcelona, Barcelona (J.L.B.) - all in Spain;Hospital de Curry Cabral-Centro Hospitalar Universitario de Lisboa Central,Lisbon, Portugal (F.M.M.); Amsterdam University Medical Centers, University ofAmsterdam, Amsterdam (A.G.); the Department of Infectious Diseases, UniversityHospital of Copenhagen, Hvidovre, Denmark (A.-B.E.H.); the Condesa SpecializedClinic, Mexico City (J.I.L.); the Francois-Xavier Bagnoud Center for Health andHuman Rights at Harvard University, Boston (K.M.); and the Department ofInfectious Diseases and Hospital Epidemiology, University Hospital Zurich,Zurich, Switzerland (J.N.).
FAU - Nori, Achyuta
AU  - Nori A
AD  - From the Blizard Institute and the SHARE Collaborative, Queen Mary University of London, and the Department of Infection and Immunity, Barts Health NHS Trust(J.P.T., V.A., C.M.O.), the Department of Genitourinary Medicine and InfectiousDisease, Guys and St. Thomas' NHS Trust (A.N.), the Department of Sexual Health, Homerton University Hospital (I.R.), and the Clinical Infection Unit, St.George's University Hospitals NHS Foundation Trust (M.S.H.) - all in London; the Department of Medicine, Division of Infectious Diseases (S.B., L.B.H., M.B.K.),the J.D. MacLean Centre for Tropical Diseases (S.B.), the Research Institute ofthe McGill University Health Centre (S.B., M.B.K.), and the Chronic Viral IllnessService, Department of Medicine (M.B.K.), McGill University Health Centre,Montreal, and the Department of Medicine, University Health Network, Universityof Toronto (S.W.), the Division of Infectious Diseases and the MAP Centre forUrban Health Solutions, St. Michael's Hospital (D.T.), and the Department ofMedicine, University of Toronto (D.T.), Toronto - all in Canada; UniversityHospital Bonn, Department of Medicine I, Bonn (J.R., C.B.), the Department ofInfectious Diseases, St. Joseph Hospital, Berlin (P.M.), MedizinischesVersorgungszentrum (MVZ) Munchen am Goetheplatz, Munich (S. Noe), and theInfektionsmedizinisches Centrum Hamburg (ICH) Study Center, Hamburg MVZ ICHStadmitte, Hamburg (C.H.) - all in Germany; the National Institute for InfectiousDiseases Lazzaro Spallanzani IRCCS, Rome (A.A., F.M.), the Division of InfectiousDisease, Luigi Sacco Hospital, Azienda Socio-Sanitaria TerritorialeFatebenefratelli Sacco (D.M.), and the Department of Infectious and TropicalDiseases, IRCCS-Ospedale San Raffaele (S. Nozza), Milan, the Clinic of InfectiousDiseases, University of Modena, Modena (C.M.), and the Infectious DiseasesDivision, Department of Medical Sciences, Azienda Ospedale Universita, Padua(A.C.) - all in Italy; the Department of Infectious Diseases, SorbonneUniversity, Assistance Publique-Hopitaux de Paris (AP-HP), Pitie-SalpetriereHospital (R.P., V.P.), and the Department of Infectious Diseases, Saint LouisLariboisiere Hospital, AP-HP, University of Paris Cite (C.P.), Paris, and theDepartment of Prevention and Community Health, Creteil Intercommunal Hospital,Creteil (C.P.) - all in France; the HIV Cure Research Center, Department ofInternal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent (L.V.), and the HIV/STI Clinic,Institute of Tropical Medicine, Antwerp (E.F.) - both in Belgium; the SacklerFaculty of Medicine, Tel Aviv University, and the Israel Department of InfectiousDiseases and Infection Control, Tel Aviv Sourasky Medical Center, Tel Aviv,Israel (M.Y.); the Department of Dermatology, University Hospital La Paz, Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC),Instituto de Investigacion Hospital Universitario La Paz (E.S.), and CIBERINFEC, Instituto de Salud Carlos III (J.L.B.), Madrid, and the Infectious DiseasesService, Hospital Clinic-IDIBAPS (Instituto de Investigaciones Biomedicas August Pi i Sunyer), University of Barcelona, Barcelona (J.L.B.) - all in Spain;Hospital de Curry Cabral-Centro Hospitalar Universitario de Lisboa Central,Lisbon, Portugal (F.M.M.); Amsterdam University Medical Centers, University ofAmsterdam, Amsterdam (A.G.); the Department of Infectious Diseases, UniversityHospital of Copenhagen, Hvidovre, Denmark (A.-B.E.H.); the Condesa SpecializedClinic, Mexico City (J.I.L.); the Francois-Xavier Bagnoud Center for Health andHuman Rights at Harvard University, Boston (K.M.); and the Department ofInfectious Diseases and Hospital Epidemiology, University Hospital Zurich,Zurich, Switzerland (J.N.).
FAU - Reeves, Iain
AU  - Reeves I
AD  - From the Blizard Institute and the SHARE Collaborative, Queen Mary University of London, and the Department of Infection and Immunity, Barts Health NHS Trust(J.P.T., V.A., C.M.O.), the Department of Genitourinary Medicine and InfectiousDisease, Guys and St. Thomas' NHS Trust (A.N.), the Department of Sexual Health, Homerton University Hospital (I.R.), and the Clinical Infection Unit, St.George's University Hospitals NHS Foundation Trust (M.S.H.) - all in London; the Department of Medicine, Division of Infectious Diseases (S.B., L.B.H., M.B.K.),the J.D. MacLean Centre for Tropical Diseases (S.B.), the Research Institute ofthe McGill University Health Centre (S.B., M.B.K.), and the Chronic Viral IllnessService, Department of Medicine (M.B.K.), McGill University Health Centre,Montreal, and the Department of Medicine, University Health Network, Universityof Toronto (S.W.), the Division of Infectious Diseases and the MAP Centre forUrban Health Solutions, St. Michael's Hospital (D.T.), and the Department ofMedicine, University of Toronto (D.T.), Toronto - all in Canada; UniversityHospital Bonn, Department of Medicine I, Bonn (J.R., C.B.), the Department ofInfectious Diseases, St. Joseph Hospital, Berlin (P.M.), MedizinischesVersorgungszentrum (MVZ) Munchen am Goetheplatz, Munich (S. Noe), and theInfektionsmedizinisches Centrum Hamburg (ICH) Study Center, Hamburg MVZ ICHStadmitte, Hamburg (C.H.) - all in Germany; the National Institute for InfectiousDiseases Lazzaro Spallanzani IRCCS, Rome (A.A., F.M.), the Division of InfectiousDisease, Luigi Sacco Hospital, Azienda Socio-Sanitaria TerritorialeFatebenefratelli Sacco (D.M.), and the Department of Infectious and TropicalDiseases, IRCCS-Ospedale San Raffaele (S. Nozza), Milan, the Clinic of InfectiousDiseases, University of Modena, Modena (C.M.), and the Infectious DiseasesDivision, Department of Medical Sciences, Azienda Ospedale Universita, Padua(A.C.) - all in Italy; the Department of Infectious Diseases, SorbonneUniversity, Assistance Publique-Hopitaux de Paris (AP-HP), Pitie-SalpetriereHospital (R.P., V.P.), and the Department of Infectious Diseases, Saint LouisLariboisiere Hospital, AP-HP, University of Paris Cite (C.P.), Paris, and theDepartment of Prevention and Community Health, Creteil Intercommunal Hospital,Creteil (C.P.) - all in France; the HIV Cure Research Center, Department ofInternal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent (L.V.), and the HIV/STI Clinic,Institute of Tropical Medicine, Antwerp (E.F.) - both in Belgium; the SacklerFaculty of Medicine, Tel Aviv University, and the Israel Department of InfectiousDiseases and Infection Control, Tel Aviv Sourasky Medical Center, Tel Aviv,Israel (M.Y.); the Department of Dermatology, University Hospital La Paz, Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC),Instituto de Investigacion Hospital Universitario La Paz (E.S.), and CIBERINFEC, Instituto de Salud Carlos III (J.L.B.), Madrid, and the Infectious DiseasesService, Hospital Clinic-IDIBAPS (Instituto de Investigaciones Biomedicas August Pi i Sunyer), University of Barcelona, Barcelona (J.L.B.) - all in Spain;Hospital de Curry Cabral-Centro Hospitalar Universitario de Lisboa Central,Lisbon, Portugal (F.M.M.); Amsterdam University Medical Centers, University ofAmsterdam, Amsterdam (A.G.); the Department of Infectious Diseases, UniversityHospital of Copenhagen, Hvidovre, Denmark (A.-B.E.H.); the Condesa SpecializedClinic, Mexico City (J.I.L.); the Francois-Xavier Bagnoud Center for Health andHuman Rights at Harvard University, Boston (K.M.); and the Department ofInfectious Diseases and Hospital Epidemiology, University Hospital Zurich,Zurich, Switzerland (J.N.).
FAU - Habibi, Maximillian S
AU  - Habibi MS
AD  - From the Blizard Institute and the SHARE Collaborative, Queen Mary University of London, and the Department of Infection and Immunity, Barts Health NHS Trust(J.P.T., V.A., C.M.O.), the Department of Genitourinary Medicine and InfectiousDisease, Guys and St. Thomas' NHS Trust (A.N.), the Department of Sexual Health, Homerton University Hospital (I.R.), and the Clinical Infection Unit, St.George's University Hospitals NHS Foundation Trust (M.S.H.) - all in London; the Department of Medicine, Division of Infectious Diseases (S.B., L.B.H., M.B.K.),the J.D. MacLean Centre for Tropical Diseases (S.B.), the Research Institute ofthe McGill University Health Centre (S.B., M.B.K.), and the Chronic Viral IllnessService, Department of Medicine (M.B.K.), McGill University Health Centre,Montreal, and the Department of Medicine, University Health Network, Universityof Toronto (S.W.), the Division of Infectious Diseases and the MAP Centre forUrban Health Solutions, St. Michael's Hospital (D.T.), and the Department ofMedicine, University of Toronto (D.T.), Toronto - all in Canada; UniversityHospital Bonn, Department of Medicine I, Bonn (J.R., C.B.), the Department ofInfectious Diseases, St. Joseph Hospital, Berlin (P.M.), MedizinischesVersorgungszentrum (MVZ) Munchen am Goetheplatz, Munich (S. Noe), and theInfektionsmedizinisches Centrum Hamburg (ICH) Study Center, Hamburg MVZ ICHStadmitte, Hamburg (C.H.) - all in Germany; the National Institute for InfectiousDiseases Lazzaro Spallanzani IRCCS, Rome (A.A., F.M.), the Division of InfectiousDisease, Luigi Sacco Hospital, Azienda Socio-Sanitaria TerritorialeFatebenefratelli Sacco (D.M.), and the Department of Infectious and TropicalDiseases, IRCCS-Ospedale San Raffaele (S. Nozza), Milan, the Clinic of InfectiousDiseases, University of Modena, Modena (C.M.), and the Infectious DiseasesDivision, Department of Medical Sciences, Azienda Ospedale Universita, Padua(A.C.) - all in Italy; the Department of Infectious Diseases, SorbonneUniversity, Assistance Publique-Hopitaux de Paris (AP-HP), Pitie-SalpetriereHospital (R.P., V.P.), and the Department of Infectious Diseases, Saint LouisLariboisiere Hospital, AP-HP, University of Paris Cite (C.P.), Paris, and theDepartment of Prevention and Community Health, Creteil Intercommunal Hospital,Creteil (C.P.) - all in France; the HIV Cure Research Center, Department ofInternal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent (L.V.), and the HIV/STI Clinic,Institute of Tropical Medicine, Antwerp (E.F.) - both in Belgium; the SacklerFaculty of Medicine, Tel Aviv University, and the Israel Department of InfectiousDiseases and Infection Control, Tel Aviv Sourasky Medical Center, Tel Aviv,Israel (M.Y.); the Department of Dermatology, University Hospital La Paz, Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC),Instituto de Investigacion Hospital Universitario La Paz (E.S.), and CIBERINFEC, Instituto de Salud Carlos III (J.L.B.), Madrid, and the Infectious DiseasesService, Hospital Clinic-IDIBAPS (Instituto de Investigaciones Biomedicas August Pi i Sunyer), University of Barcelona, Barcelona (J.L.B.) - all in Spain;Hospital de Curry Cabral-Centro Hospitalar Universitario de Lisboa Central,Lisbon, Portugal (F.M.M.); Amsterdam University Medical Centers, University ofAmsterdam, Amsterdam (A.G.); the Department of Infectious Diseases, UniversityHospital of Copenhagen, Hvidovre, Denmark (A.-B.E.H.); the Condesa SpecializedClinic, Mexico City (J.I.L.); the Francois-Xavier Bagnoud Center for Health andHuman Rights at Harvard University, Boston (K.M.); and the Department ofInfectious Diseases and Hospital Epidemiology, University Hospital Zurich,Zurich, Switzerland (J.N.).
FAU - Apea, Vanessa
AU  - Apea V
AD  - From the Blizard Institute and the SHARE Collaborative, Queen Mary University of London, and the Department of Infection and Immunity, Barts Health NHS Trust(J.P.T., V.A., C.M.O.), the Department of Genitourinary Medicine and InfectiousDisease, Guys and St. Thomas' NHS Trust (A.N.), the Department of Sexual Health, Homerton University Hospital (I.R.), and the Clinical Infection Unit, St.George's University Hospitals NHS Foundation Trust (M.S.H.) - all in London; the Department of Medicine, Division of Infectious Diseases (S.B., L.B.H., M.B.K.),the J.D. MacLean Centre for Tropical Diseases (S.B.), the Research Institute ofthe McGill University Health Centre (S.B., M.B.K.), and the Chronic Viral IllnessService, Department of Medicine (M.B.K.), McGill University Health Centre,Montreal, and the Department of Medicine, University Health Network, Universityof Toronto (S.W.), the Division of Infectious Diseases and the MAP Centre forUrban Health Solutions, St. Michael's Hospital (D.T.), and the Department ofMedicine, University of Toronto (D.T.), Toronto - all in Canada; UniversityHospital Bonn, Department of Medicine I, Bonn (J.R., C.B.), the Department ofInfectious Diseases, St. Joseph Hospital, Berlin (P.M.), MedizinischesVersorgungszentrum (MVZ) Munchen am Goetheplatz, Munich (S. Noe), and theInfektionsmedizinisches Centrum Hamburg (ICH) Study Center, Hamburg MVZ ICHStadmitte, Hamburg (C.H.) - all in Germany; the National Institute for InfectiousDiseases Lazzaro Spallanzani IRCCS, Rome (A.A., F.M.), the Division of InfectiousDisease, Luigi Sacco Hospital, Azienda Socio-Sanitaria TerritorialeFatebenefratelli Sacco (D.M.), and the Department of Infectious and TropicalDiseases, IRCCS-Ospedale San Raffaele (S. Nozza), Milan, the Clinic of InfectiousDiseases, University of Modena, Modena (C.M.), and the Infectious DiseasesDivision, Department of Medical Sciences, Azienda Ospedale Universita, Padua(A.C.) - all in Italy; the Department of Infectious Diseases, SorbonneUniversity, Assistance Publique-Hopitaux de Paris (AP-HP), Pitie-SalpetriereHospital (R.P., V.P.), and the Department of Infectious Diseases, Saint LouisLariboisiere Hospital, AP-HP, University of Paris Cite (C.P.), Paris, and theDepartment of Prevention and Community Health, Creteil Intercommunal Hospital,Creteil (C.P.) - all in France; the HIV Cure Research Center, Department ofInternal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent (L.V.), and the HIV/STI Clinic,Institute of Tropical Medicine, Antwerp (E.F.) - both in Belgium; the SacklerFaculty of Medicine, Tel Aviv University, and the Israel Department of InfectiousDiseases and Infection Control, Tel Aviv Sourasky Medical Center, Tel Aviv,Israel (M.Y.); the Department of Dermatology, University Hospital La Paz, Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC),Instituto de Investigacion Hospital Universitario La Paz (E.S.), and CIBERINFEC, Instituto de Salud Carlos III (J.L.B.), Madrid, and the Infectious DiseasesService, Hospital Clinic-IDIBAPS (Instituto de Investigaciones Biomedicas August Pi i Sunyer), University of Barcelona, Barcelona (J.L.B.) - all in Spain;Hospital de Curry Cabral-Centro Hospitalar Universitario de Lisboa Central,Lisbon, Portugal (F.M.M.); Amsterdam University Medical Centers, University ofAmsterdam, Amsterdam (A.G.); the Department of Infectious Diseases, UniversityHospital of Copenhagen, Hvidovre, Denmark (A.-B.E.H.); the Condesa SpecializedClinic, Mexico City (J.I.L.); the Francois-Xavier Bagnoud Center for Health andHuman Rights at Harvard University, Boston (K.M.); and the Department ofInfectious Diseases and Hospital Epidemiology, University Hospital Zurich,Zurich, Switzerland (J.N.).
FAU - Boesecke, Christoph
AU  - Boesecke C
AD  - From the Blizard Institute and the SHARE Collaborative, Queen Mary University of London, and the Department of Infection and Immunity, Barts Health NHS Trust(J.P.T., V.A., C.M.O.), the Department of Genitourinary Medicine and InfectiousDisease, Guys and St. Thomas' NHS Trust (A.N.), the Department of Sexual Health, Homerton University Hospital (I.R.), and the Clinical Infection Unit, St.George's University Hospitals NHS Foundation Trust (M.S.H.) - all in London; the Department of Medicine, Division of Infectious Diseases (S.B., L.B.H., M.B.K.),the J.D. MacLean Centre for Tropical Diseases (S.B.), the Research Institute ofthe McGill University Health Centre (S.B., M.B.K.), and the Chronic Viral IllnessService, Department of Medicine (M.B.K.), McGill University Health Centre,Montreal, and the Department of Medicine, University Health Network, Universityof Toronto (S.W.), the Division of Infectious Diseases and the MAP Centre forUrban Health Solutions, St. Michael's Hospital (D.T.), and the Department ofMedicine, University of Toronto (D.T.), Toronto - all in Canada; UniversityHospital Bonn, Department of Medicine I, Bonn (J.R., C.B.), the Department ofInfectious Diseases, St. Joseph Hospital, Berlin (P.M.), MedizinischesVersorgungszentrum (MVZ) Munchen am Goetheplatz, Munich (S. Noe), and theInfektionsmedizinisches Centrum Hamburg (ICH) Study Center, Hamburg MVZ ICHStadmitte, Hamburg (C.H.) - all in Germany; the National Institute for InfectiousDiseases Lazzaro Spallanzani IRCCS, Rome (A.A., F.M.), the Division of InfectiousDisease, Luigi Sacco Hospital, Azienda Socio-Sanitaria TerritorialeFatebenefratelli Sacco (D.M.), and the Department of Infectious and TropicalDiseases, IRCCS-Ospedale San Raffaele (S. Nozza), Milan, the Clinic of InfectiousDiseases, University of Modena, Modena (C.M.), and the Infectious DiseasesDivision, Department of Medical Sciences, Azienda Ospedale Universita, Padua(A.C.) - all in Italy; the Department of Infectious Diseases, SorbonneUniversity, Assistance Publique-Hopitaux de Paris (AP-HP), Pitie-SalpetriereHospital (R.P., V.P.), and the Department of Infectious Diseases, Saint LouisLariboisiere Hospital, AP-HP, University of Paris Cite (C.P.), Paris, and theDepartment of Prevention and Community Health, Creteil Intercommunal Hospital,Creteil (C.P.) - all in France; the HIV Cure Research Center, Department ofInternal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent (L.V.), and the HIV/STI Clinic,Institute of Tropical Medicine, Antwerp (E.F.) - both in Belgium; the SacklerFaculty of Medicine, Tel Aviv University, and the Israel Department of InfectiousDiseases and Infection Control, Tel Aviv Sourasky Medical Center, Tel Aviv,Israel (M.Y.); the Department of Dermatology, University Hospital La Paz, Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC),Instituto de Investigacion Hospital Universitario La Paz (E.S.), and CIBERINFEC, Instituto de Salud Carlos III (J.L.B.), Madrid, and the Infectious DiseasesService, Hospital Clinic-IDIBAPS (Instituto de Investigaciones Biomedicas August Pi i Sunyer), University of Barcelona, Barcelona (J.L.B.) - all in Spain;Hospital de Curry Cabral-Centro Hospitalar Universitario de Lisboa Central,Lisbon, Portugal (F.M.M.); Amsterdam University Medical Centers, University ofAmsterdam, Amsterdam (A.G.); the Department of Infectious Diseases, UniversityHospital of Copenhagen, Hvidovre, Denmark (A.-B.E.H.); the Condesa SpecializedClinic, Mexico City (J.I.L.); the Francois-Xavier Bagnoud Center for Health andHuman Rights at Harvard University, Boston (K.M.); and the Department ofInfectious Diseases and Hospital Epidemiology, University Hospital Zurich,Zurich, Switzerland (J.N.).
FAU - Vandekerckhove, Linos
AU  - Vandekerckhove L
AD  - From the Blizard Institute and the SHARE Collaborative, Queen Mary University of London, and the Department of Infection and Immunity, Barts Health NHS Trust(J.P.T., V.A., C.M.O.), the Department of Genitourinary Medicine and InfectiousDisease, Guys and St. Thomas' NHS Trust (A.N.), the Department of Sexual Health, Homerton University Hospital (I.R.), and the Clinical Infection Unit, St.George's University Hospitals NHS Foundation Trust (M.S.H.) - all in London; the Department of Medicine, Division of Infectious Diseases (S.B., L.B.H., M.B.K.),the J.D. MacLean Centre for Tropical Diseases (S.B.), the Research Institute ofthe McGill University Health Centre (S.B., M.B.K.), and the Chronic Viral IllnessService, Department of Medicine (M.B.K.), McGill University Health Centre,Montreal, and the Department of Medicine, University Health Network, Universityof Toronto (S.W.), the Division of Infectious Diseases and the MAP Centre forUrban Health Solutions, St. Michael's Hospital (D.T.), and the Department ofMedicine, University of Toronto (D.T.), Toronto - all in Canada; UniversityHospital Bonn, Department of Medicine I, Bonn (J.R., C.B.), the Department ofInfectious Diseases, St. Joseph Hospital, Berlin (P.M.), MedizinischesVersorgungszentrum (MVZ) Munchen am Goetheplatz, Munich (S. Noe), and theInfektionsmedizinisches Centrum Hamburg (ICH) Study Center, Hamburg MVZ ICHStadmitte, Hamburg (C.H.) - all in Germany; the National Institute for InfectiousDiseases Lazzaro Spallanzani IRCCS, Rome (A.A., F.M.), the Division of InfectiousDisease, Luigi Sacco Hospital, Azienda Socio-Sanitaria TerritorialeFatebenefratelli Sacco (D.M.), and the Department of Infectious and TropicalDiseases, IRCCS-Ospedale San Raffaele (S. Nozza), Milan, the Clinic of InfectiousDiseases, University of Modena, Modena (C.M.), and the Infectious DiseasesDivision, Department of Medical Sciences, Azienda Ospedale Universita, Padua(A.C.) - all in Italy; the Department of Infectious Diseases, SorbonneUniversity, Assistance Publique-Hopitaux de Paris (AP-HP), Pitie-SalpetriereHospital (R.P., V.P.), and the Department of Infectious Diseases, Saint LouisLariboisiere Hospital, AP-HP, University of Paris Cite (C.P.), Paris, and theDepartment of Prevention and Community Health, Creteil Intercommunal Hospital,Creteil (C.P.) - all in France; the HIV Cure Research Center, Department ofInternal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent (L.V.), and the HIV/STI Clinic,Institute of Tropical Medicine, Antwerp (E.F.) - both in Belgium; the SacklerFaculty of Medicine, Tel Aviv University, and the Israel Department of InfectiousDiseases and Infection Control, Tel Aviv Sourasky Medical Center, Tel Aviv,Israel (M.Y.); the Department of Dermatology, University Hospital La Paz, Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC),Instituto de Investigacion Hospital Universitario La Paz (E.S.), and CIBERINFEC, Instituto de Salud Carlos III (J.L.B.), Madrid, and the Infectious DiseasesService, Hospital Clinic-IDIBAPS (Instituto de Investigaciones Biomedicas August Pi i Sunyer), University of Barcelona, Barcelona (J.L.B.) - all in Spain;Hospital de Curry Cabral-Centro Hospitalar Universitario de Lisboa Central,Lisbon, Portugal (F.M.M.); Amsterdam University Medical Centers, University ofAmsterdam, Amsterdam (A.G.); the Department of Infectious Diseases, UniversityHospital of Copenhagen, Hvidovre, Denmark (A.-B.E.H.); the Condesa SpecializedClinic, Mexico City (J.I.L.); the Francois-Xavier Bagnoud Center for Health andHuman Rights at Harvard University, Boston (K.M.); and the Department ofInfectious Diseases and Hospital Epidemiology, University Hospital Zurich,Zurich, Switzerland (J.N.).
FAU - Yakubovsky, Michal
AU  - Yakubovsky M
AD  - From the Blizard Institute and the SHARE Collaborative, Queen Mary University of London, and the Department of Infection and Immunity, Barts Health NHS Trust(J.P.T., V.A., C.M.O.), the Department of Genitourinary Medicine and InfectiousDisease, Guys and St. Thomas' NHS Trust (A.N.), the Department of Sexual Health, Homerton University Hospital (I.R.), and the Clinical Infection Unit, St.George's University Hospitals NHS Foundation Trust (M.S.H.) - all in London; the Department of Medicine, Division of Infectious Diseases (S.B., L.B.H., M.B.K.),the J.D. MacLean Centre for Tropical Diseases (S.B.), the Research Institute ofthe McGill University Health Centre (S.B., M.B.K.), and the Chronic Viral IllnessService, Department of Medicine (M.B.K.), McGill University Health Centre,Montreal, and the Department of Medicine, University Health Network, Universityof Toronto (S.W.), the Division of Infectious Diseases and the MAP Centre forUrban Health Solutions, St. Michael's Hospital (D.T.), and the Department ofMedicine, University of Toronto (D.T.), Toronto - all in Canada; UniversityHospital Bonn, Department of Medicine I, Bonn (J.R., C.B.), the Department ofInfectious Diseases, St. Joseph Hospital, Berlin (P.M.), MedizinischesVersorgungszentrum (MVZ) Munchen am Goetheplatz, Munich (S. Noe), and theInfektionsmedizinisches Centrum Hamburg (ICH) Study Center, Hamburg MVZ ICHStadmitte, Hamburg (C.H.) - all in Germany; the National Institute for InfectiousDiseases Lazzaro Spallanzani IRCCS, Rome (A.A., F.M.), the Division of InfectiousDisease, Luigi Sacco Hospital, Azienda Socio-Sanitaria TerritorialeFatebenefratelli Sacco (D.M.), and the Department of Infectious and TropicalDiseases, IRCCS-Ospedale San Raffaele (S. Nozza), Milan, the Clinic of InfectiousDiseases, University of Modena, Modena (C.M.), and the Infectious DiseasesDivision, Department of Medical Sciences, Azienda Ospedale Universita, Padua(A.C.) - all in Italy; the Department of Infectious Diseases, SorbonneUniversity, Assistance Publique-Hopitaux de Paris (AP-HP), Pitie-SalpetriereHospital (R.P., V.P.), and the Department of Infectious Diseases, Saint LouisLariboisiere Hospital, AP-HP, University of Paris Cite (C.P.), Paris, and theDepartment of Prevention and Community Health, Creteil Intercommunal Hospital,Creteil (C.P.) - all in France; the HIV Cure Research Center, Department ofInternal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent (L.V.), and the HIV/STI Clinic,Institute of Tropical Medicine, Antwerp (E.F.) - both in Belgium; the SacklerFaculty of Medicine, Tel Aviv University, and the Israel Department of InfectiousDiseases and Infection Control, Tel Aviv Sourasky Medical Center, Tel Aviv,Israel (M.Y.); the Department of Dermatology, University Hospital La Paz, Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC),Instituto de Investigacion Hospital Universitario La Paz (E.S.), and CIBERINFEC, Instituto de Salud Carlos III (J.L.B.), Madrid, and the Infectious DiseasesService, Hospital Clinic-IDIBAPS (Instituto de Investigaciones Biomedicas August Pi i Sunyer), University of Barcelona, Barcelona (J.L.B.) - all in Spain;Hospital de Curry Cabral-Centro Hospitalar Universitario de Lisboa Central,Lisbon, Portugal (F.M.M.); Amsterdam University Medical Centers, University ofAmsterdam, Amsterdam (A.G.); the Department of Infectious Diseases, UniversityHospital of Copenhagen, Hvidovre, Denmark (A.-B.E.H.); the Condesa SpecializedClinic, Mexico City (J.I.L.); the Francois-Xavier Bagnoud Center for Health andHuman Rights at Harvard University, Boston (K.M.); and the Department ofInfectious Diseases and Hospital Epidemiology, University Hospital Zurich,Zurich, Switzerland (J.N.).
FAU - Sendagorta, Elena
AU  - Sendagorta E
AD  - From the Blizard Institute and the SHARE Collaborative, Queen Mary University of London, and the Department of Infection and Immunity, Barts Health NHS Trust(J.P.T., V.A., C.M.O.), the Department of Genitourinary Medicine and InfectiousDisease, Guys and St. Thomas' NHS Trust (A.N.), the Department of Sexual Health, Homerton University Hospital (I.R.), and the Clinical Infection Unit, St.George's University Hospitals NHS Foundation Trust (M.S.H.) - all in London; the Department of Medicine, Division of Infectious Diseases (S.B., L.B.H., M.B.K.),the J.D. MacLean Centre for Tropical Diseases (S.B.), the Research Institute ofthe McGill University Health Centre (S.B., M.B.K.), and the Chronic Viral IllnessService, Department of Medicine (M.B.K.), McGill University Health Centre,Montreal, and the Department of Medicine, University Health Network, Universityof Toronto (S.W.), the Division of Infectious Diseases and the MAP Centre forUrban Health Solutions, St. Michael's Hospital (D.T.), and the Department ofMedicine, University of Toronto (D.T.), Toronto - all in Canada; UniversityHospital Bonn, Department of Medicine I, Bonn (J.R., C.B.), the Department ofInfectious Diseases, St. Joseph Hospital, Berlin (P.M.), MedizinischesVersorgungszentrum (MVZ) Munchen am Goetheplatz, Munich (S. Noe), and theInfektionsmedizinisches Centrum Hamburg (ICH) Study Center, Hamburg MVZ ICHStadmitte, Hamburg (C.H.) - all in Germany; the National Institute for InfectiousDiseases Lazzaro Spallanzani IRCCS, Rome (A.A., F.M.), the Division of InfectiousDisease, Luigi Sacco Hospital, Azienda Socio-Sanitaria TerritorialeFatebenefratelli Sacco (D.M.), and the Department of Infectious and TropicalDiseases, IRCCS-Ospedale San Raffaele (S. Nozza), Milan, the Clinic of InfectiousDiseases, University of Modena, Modena (C.M.), and the Infectious DiseasesDivision, Department of Medical Sciences, Azienda Ospedale Universita, Padua(A.C.) - all in Italy; the Department of Infectious Diseases, SorbonneUniversity, Assistance Publique-Hopitaux de Paris (AP-HP), Pitie-SalpetriereHospital (R.P., V.P.), and the Department of Infectious Diseases, Saint LouisLariboisiere Hospital, AP-HP, University of Paris Cite (C.P.), Paris, and theDepartment of Prevention and Community Health, Creteil Intercommunal Hospital,Creteil (C.P.) - all in France; the HIV Cure Research Center, Department ofInternal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent (L.V.), and the HIV/STI Clinic,Institute of Tropical Medicine, Antwerp (E.F.) - both in Belgium; the SacklerFaculty of Medicine, Tel Aviv University, and the Israel Department of InfectiousDiseases and Infection Control, Tel Aviv Sourasky Medical Center, Tel Aviv,Israel (M.Y.); the Department of Dermatology, University Hospital La Paz, Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC),Instituto de Investigacion Hospital Universitario La Paz (E.S.), and CIBERINFEC, Instituto de Salud Carlos III (J.L.B.), Madrid, and the Infectious DiseasesService, Hospital Clinic-IDIBAPS (Instituto de Investigaciones Biomedicas August Pi i Sunyer), University of Barcelona, Barcelona (J.L.B.) - all in Spain;Hospital de Curry Cabral-Centro Hospitalar Universitario de Lisboa Central,Lisbon, Portugal (F.M.M.); Amsterdam University Medical Centers, University ofAmsterdam, Amsterdam (A.G.); the Department of Infectious Diseases, UniversityHospital of Copenhagen, Hvidovre, Denmark (A.-B.E.H.); the Condesa SpecializedClinic, Mexico City (J.I.L.); the Francois-Xavier Bagnoud Center for Health andHuman Rights at Harvard University, Boston (K.M.); and the Department ofInfectious Diseases and Hospital Epidemiology, University Hospital Zurich,Zurich, Switzerland (J.N.).
FAU - Blanco, Jose L
AU  - Blanco JL
AD  - From the Blizard Institute and the SHARE Collaborative, Queen Mary University of London, and the Department of Infection and Immunity, Barts Health NHS Trust(J.P.T., V.A., C.M.O.), the Department of Genitourinary Medicine and InfectiousDisease, Guys and St. Thomas' NHS Trust (A.N.), the Department of Sexual Health, Homerton University Hospital (I.R.), and the Clinical Infection Unit, St.George's University Hospitals NHS Foundation Trust (M.S.H.) - all in London; the Department of Medicine, Division of Infectious Diseases (S.B., L.B.H., M.B.K.),the J.D. MacLean Centre for Tropical Diseases (S.B.), the Research Institute ofthe McGill University Health Centre (S.B., M.B.K.), and the Chronic Viral IllnessService, Department of Medicine (M.B.K.), McGill University Health Centre,Montreal, and the Department of Medicine, University Health Network, Universityof Toronto (S.W.), the Division of Infectious Diseases and the MAP Centre forUrban Health Solutions, St. Michael's Hospital (D.T.), and the Department ofMedicine, University of Toronto (D.T.), Toronto - all in Canada; UniversityHospital Bonn, Department of Medicine I, Bonn (J.R., C.B.), the Department ofInfectious Diseases, St. Joseph Hospital, Berlin (P.M.), MedizinischesVersorgungszentrum (MVZ) Munchen am Goetheplatz, Munich (S. Noe), and theInfektionsmedizinisches Centrum Hamburg (ICH) Study Center, Hamburg MVZ ICHStadmitte, Hamburg (C.H.) - all in Germany; the National Institute for InfectiousDiseases Lazzaro Spallanzani IRCCS, Rome (A.A., F.M.), the Division of InfectiousDisease, Luigi Sacco Hospital, Azienda Socio-Sanitaria TerritorialeFatebenefratelli Sacco (D.M.), and the Department of Infectious and TropicalDiseases, IRCCS-Ospedale San Raffaele (S. Nozza), Milan, the Clinic of InfectiousDiseases, University of Modena, Modena (C.M.), and the Infectious DiseasesDivision, Department of Medical Sciences, Azienda Ospedale Universita, Padua(A.C.) - all in Italy; the Department of Infectious Diseases, SorbonneUniversity, Assistance Publique-Hopitaux de Paris (AP-HP), Pitie-SalpetriereHospital (R.P., V.P.), and the Department of Infectious Diseases, Saint LouisLariboisiere Hospital, AP-HP, University of Paris Cite (C.P.), Paris, and theDepartment of Prevention and Community Health, Creteil Intercommunal Hospital,Creteil (C.P.) - all in France; the HIV Cure Research Center, Department ofInternal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent (L.V.), and the HIV/STI Clinic,Institute of Tropical Medicine, Antwerp (E.F.) - both in Belgium; the SacklerFaculty of Medicine, Tel Aviv University, and the Israel Department of InfectiousDiseases and Infection Control, Tel Aviv Sourasky Medical Center, Tel Aviv,Israel (M.Y.); the Department of Dermatology, University Hospital La Paz, Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC),Instituto de Investigacion Hospital Universitario La Paz (E.S.), and CIBERINFEC, Instituto de Salud Carlos III (J.L.B.), Madrid, and the Infectious DiseasesService, Hospital Clinic-IDIBAPS (Instituto de Investigaciones Biomedicas August Pi i Sunyer), University of Barcelona, Barcelona (J.L.B.) - all in Spain;Hospital de Curry Cabral-Centro Hospitalar Universitario de Lisboa Central,Lisbon, Portugal (F.M.M.); Amsterdam University Medical Centers, University ofAmsterdam, Amsterdam (A.G.); the Department of Infectious Diseases, UniversityHospital of Copenhagen, Hvidovre, Denmark (A.-B.E.H.); the Condesa SpecializedClinic, Mexico City (J.I.L.); the Francois-Xavier Bagnoud Center for Health andHuman Rights at Harvard University, Boston (K.M.); and the Department ofInfectious Diseases and Hospital Epidemiology, University Hospital Zurich,Zurich, Switzerland (J.N.).
FAU - Florence, Eric
AU  - Florence E
AD  - From the Blizard Institute and the SHARE Collaborative, Queen Mary University of London, and the Department of Infection and Immunity, Barts Health NHS Trust(J.P.T., V.A., C.M.O.), the Department of Genitourinary Medicine and InfectiousDisease, Guys and St. Thomas' NHS Trust (A.N.), the Department of Sexual Health, Homerton University Hospital (I.R.), and the Clinical Infection Unit, St.George's University Hospitals NHS Foundation Trust (M.S.H.) - all in London; the Department of Medicine, Division of Infectious Diseases (S.B., L.B.H., M.B.K.),the J.D. MacLean Centre for Tropical Diseases (S.B.), the Research Institute ofthe McGill University Health Centre (S.B., M.B.K.), and the Chronic Viral IllnessService, Department of Medicine (M.B.K.), McGill University Health Centre,Montreal, and the Department of Medicine, University Health Network, Universityof Toronto (S.W.), the Division of Infectious Diseases and the MAP Centre forUrban Health Solutions, St. Michael's Hospital (D.T.), and the Department ofMedicine, University of Toronto (D.T.), Toronto - all in Canada; UniversityHospital Bonn, Department of Medicine I, Bonn (J.R., C.B.), the Department ofInfectious Diseases, St. Joseph Hospital, Berlin (P.M.), MedizinischesVersorgungszentrum (MVZ) Munchen am Goetheplatz, Munich (S. Noe), and theInfektionsmedizinisches Centrum Hamburg (ICH) Study Center, Hamburg MVZ ICHStadmitte, Hamburg (C.H.) - all in Germany; the National Institute for InfectiousDiseases Lazzaro Spallanzani IRCCS, Rome (A.A., F.M.), the Division of InfectiousDisease, Luigi Sacco Hospital, Azienda Socio-Sanitaria TerritorialeFatebenefratelli Sacco (D.M.), and the Department of Infectious and TropicalDiseases, IRCCS-Ospedale San Raffaele (S. Nozza), Milan, the Clinic of InfectiousDiseases, University of Modena, Modena (C.M.), and the Infectious DiseasesDivision, Department of Medical Sciences, Azienda Ospedale Universita, Padua(A.C.) - all in Italy; the Department of Infectious Diseases, SorbonneUniversity, Assistance Publique-Hopitaux de Paris (AP-HP), Pitie-SalpetriereHospital (R.P., V.P.), and the Department of Infectious Diseases, Saint LouisLariboisiere Hospital, AP-HP, University of Paris Cite (C.P.), Paris, and theDepartment of Prevention and Community Health, Creteil Intercommunal Hospital,Creteil (C.P.) - all in France; the HIV Cure Research Center, Department ofInternal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent (L.V.), and the HIV/STI Clinic,Institute of Tropical Medicine, Antwerp (E.F.) - both in Belgium; the SacklerFaculty of Medicine, Tel Aviv University, and the Israel Department of InfectiousDiseases and Infection Control, Tel Aviv Sourasky Medical Center, Tel Aviv,Israel (M.Y.); the Department of Dermatology, University Hospital La Paz, Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC),Instituto de Investigacion Hospital Universitario La Paz (E.S.), and CIBERINFEC, Instituto de Salud Carlos III (J.L.B.), Madrid, and the Infectious DiseasesService, Hospital Clinic-IDIBAPS (Instituto de Investigaciones Biomedicas August Pi i Sunyer), University of Barcelona, Barcelona (J.L.B.) - all in Spain;Hospital de Curry Cabral-Centro Hospitalar Universitario de Lisboa Central,Lisbon, Portugal (F.M.M.); Amsterdam University Medical Centers, University ofAmsterdam, Amsterdam (A.G.); the Department of Infectious Diseases, UniversityHospital of Copenhagen, Hvidovre, Denmark (A.-B.E.H.); the Condesa SpecializedClinic, Mexico City (J.I.L.); the Francois-Xavier Bagnoud Center for Health andHuman Rights at Harvard University, Boston (K.M.); and the Department ofInfectious Diseases and Hospital Epidemiology, University Hospital Zurich,Zurich, Switzerland (J.N.).
FAU - Moschese, Davide
AU  - Moschese D
AD  - From the Blizard Institute and the SHARE Collaborative, Queen Mary University of London, and the Department of Infection and Immunity, Barts Health NHS Trust(J.P.T., V.A., C.M.O.), the Department of Genitourinary Medicine and InfectiousDisease, Guys and St. Thomas' NHS Trust (A.N.), the Department of Sexual Health, Homerton University Hospital (I.R.), and the Clinical Infection Unit, St.George's University Hospitals NHS Foundation Trust (M.S.H.) - all in London; the Department of Medicine, Division of Infectious Diseases (S.B., L.B.H., M.B.K.),the J.D. MacLean Centre for Tropical Diseases (S.B.), the Research Institute ofthe McGill University Health Centre (S.B., M.B.K.), and the Chronic Viral IllnessService, Department of Medicine (M.B.K.), McGill University Health Centre,Montreal, and the Department of Medicine, University Health Network, Universityof Toronto (S.W.), the Division of Infectious Diseases and the MAP Centre forUrban Health Solutions, St. Michael's Hospital (D.T.), and the Department ofMedicine, University of Toronto (D.T.), Toronto - all in Canada; UniversityHospital Bonn, Department of Medicine I, Bonn (J.R., C.B.), the Department ofInfectious Diseases, St. Joseph Hospital, Berlin (P.M.), MedizinischesVersorgungszentrum (MVZ) Munchen am Goetheplatz, Munich (S. Noe), and theInfektionsmedizinisches Centrum Hamburg (ICH) Study Center, Hamburg MVZ ICHStadmitte, Hamburg (C.H.) - all in Germany; the National Institute for InfectiousDiseases Lazzaro Spallanzani IRCCS, Rome (A.A., F.M.), the Division of InfectiousDisease, Luigi Sacco Hospital, Azienda Socio-Sanitaria TerritorialeFatebenefratelli Sacco (D.M.), and the Department of Infectious and TropicalDiseases, IRCCS-Ospedale San Raffaele (S. Nozza), Milan, the Clinic of InfectiousDiseases, University of Modena, Modena (C.M.), and the Infectious DiseasesDivision, Department of Medical Sciences, Azienda Ospedale Universita, Padua(A.C.) - all in Italy; the Department of Infectious Diseases, SorbonneUniversity, Assistance Publique-Hopitaux de Paris (AP-HP), Pitie-SalpetriereHospital (R.P., V.P.), and the Department of Infectious Diseases, Saint LouisLariboisiere Hospital, AP-HP, University of Paris Cite (C.P.), Paris, and theDepartment of Prevention and Community Health, Creteil Intercommunal Hospital,Creteil (C.P.) - all in France; the HIV Cure Research Center, Department ofInternal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent (L.V.), and the HIV/STI Clinic,Institute of Tropical Medicine, Antwerp (E.F.) - both in Belgium; the SacklerFaculty of Medicine, Tel Aviv University, and the Israel Department of InfectiousDiseases and Infection Control, Tel Aviv Sourasky Medical Center, Tel Aviv,Israel (M.Y.); the Department of Dermatology, University Hospital La Paz, Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC),Instituto de Investigacion Hospital Universitario La Paz (E.S.), and CIBERINFEC, Instituto de Salud Carlos III (J.L.B.), Madrid, and the Infectious DiseasesService, Hospital Clinic-IDIBAPS (Instituto de Investigaciones Biomedicas August Pi i Sunyer), University of Barcelona, Barcelona (J.L.B.) - all in Spain;Hospital de Curry Cabral-Centro Hospitalar Universitario de Lisboa Central,Lisbon, Portugal (F.M.M.); Amsterdam University Medical Centers, University ofAmsterdam, Amsterdam (A.G.); the Department of Infectious Diseases, UniversityHospital of Copenhagen, Hvidovre, Denmark (A.-B.E.H.); the Condesa SpecializedClinic, Mexico City (J.I.L.); the Francois-Xavier Bagnoud Center for Health andHuman Rights at Harvard University, Boston (K.M.); and the Department ofInfectious Diseases and Hospital Epidemiology, University Hospital Zurich,Zurich, Switzerland (J.N.).
FAU - Maltez, Fernando M
AU  - Maltez FM
AD  - From the Blizard Institute and the SHARE Collaborative, Queen Mary University of London, and the Department of Infection and Immunity, Barts Health NHS Trust(J.P.T., V.A., C.M.O.), the Department of Genitourinary Medicine and InfectiousDisease, Guys and St. Thomas' NHS Trust (A.N.), the Department of Sexual Health, Homerton University Hospital (I.R.), and the Clinical Infection Unit, St.George's University Hospitals NHS Foundation Trust (M.S.H.) - all in London; the Department of Medicine, Division of Infectious Diseases (S.B., L.B.H., M.B.K.),the J.D. MacLean Centre for Tropical Diseases (S.B.), the Research Institute ofthe McGill University Health Centre (S.B., M.B.K.), and the Chronic Viral IllnessService, Department of Medicine (M.B.K.), McGill University Health Centre,Montreal, and the Department of Medicine, University Health Network, Universityof Toronto (S.W.), the Division of Infectious Diseases and the MAP Centre forUrban Health Solutions, St. Michael's Hospital (D.T.), and the Department ofMedicine, University of Toronto (D.T.), Toronto - all in Canada; UniversityHospital Bonn, Department of Medicine I, Bonn (J.R., C.B.), the Department ofInfectious Diseases, St. Joseph Hospital, Berlin (P.M.), MedizinischesVersorgungszentrum (MVZ) Munchen am Goetheplatz, Munich (S. Noe), and theInfektionsmedizinisches Centrum Hamburg (ICH) Study Center, Hamburg MVZ ICHStadmitte, Hamburg (C.H.) - all in Germany; the National Institute for InfectiousDiseases Lazzaro Spallanzani IRCCS, Rome (A.A., F.M.), the Division of InfectiousDisease, Luigi Sacco Hospital, Azienda Socio-Sanitaria TerritorialeFatebenefratelli Sacco (D.M.), and the Department of Infectious and TropicalDiseases, IRCCS-Ospedale San Raffaele (S. Nozza), Milan, the Clinic of InfectiousDiseases, University of Modena, Modena (C.M.), and the Infectious DiseasesDivision, Department of Medical Sciences, Azienda Ospedale Universita, Padua(A.C.) - all in Italy; the Department of Infectious Diseases, SorbonneUniversity, Assistance Publique-Hopitaux de Paris (AP-HP), Pitie-SalpetriereHospital (R.P., V.P.), and the Department of Infectious Diseases, Saint LouisLariboisiere Hospital, AP-HP, University of Paris Cite (C.P.), Paris, and theDepartment of Prevention and Community Health, Creteil Intercommunal Hospital,Creteil (C.P.) - all in France; the HIV Cure Research Center, Department ofInternal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent (L.V.), and the HIV/STI Clinic,Institute of Tropical Medicine, Antwerp (E.F.) - both in Belgium; the SacklerFaculty of Medicine, Tel Aviv University, and the Israel Department of InfectiousDiseases and Infection Control, Tel Aviv Sourasky Medical Center, Tel Aviv,Israel (M.Y.); the Department of Dermatology, University Hospital La Paz, Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC),Instituto de Investigacion Hospital Universitario La Paz (E.S.), and CIBERINFEC, Instituto de Salud Carlos III (J.L.B.), Madrid, and the Infectious DiseasesService, Hospital Clinic-IDIBAPS (Instituto de Investigaciones Biomedicas August Pi i Sunyer), University of Barcelona, Barcelona (J.L.B.) - all in Spain;Hospital de Curry Cabral-Centro Hospitalar Universitario de Lisboa Central,Lisbon, Portugal (F.M.M.); Amsterdam University Medical Centers, University ofAmsterdam, Amsterdam (A.G.); the Department of Infectious Diseases, UniversityHospital of Copenhagen, Hvidovre, Denmark (A.-B.E.H.); the Condesa SpecializedClinic, Mexico City (J.I.L.); the Francois-Xavier Bagnoud Center for Health andHuman Rights at Harvard University, Boston (K.M.); and the Department ofInfectious Diseases and Hospital Epidemiology, University Hospital Zurich,Zurich, Switzerland (J.N.).
FAU - Goorhuis, Abraham
AU  - Goorhuis A
AD  - From the Blizard Institute and the SHARE Collaborative, Queen Mary University of London, and the Department of Infection and Immunity, Barts Health NHS Trust(J.P.T., V.A., C.M.O.), the Department of Genitourinary Medicine and InfectiousDisease, Guys and St. Thomas' NHS Trust (A.N.), the Department of Sexual Health, Homerton University Hospital (I.R.), and the Clinical Infection Unit, St.George's University Hospitals NHS Foundation Trust (M.S.H.) - all in London; the Department of Medicine, Division of Infectious Diseases (S.B., L.B.H., M.B.K.),the J.D. MacLean Centre for Tropical Diseases (S.B.), the Research Institute ofthe McGill University Health Centre (S.B., M.B.K.), and the Chronic Viral IllnessService, Department of Medicine (M.B.K.), McGill University Health Centre,Montreal, and the Department of Medicine, University Health Network, Universityof Toronto (S.W.), the Division of Infectious Diseases and the MAP Centre forUrban Health Solutions, St. Michael's Hospital (D.T.), and the Department ofMedicine, University of Toronto (D.T.), Toronto - all in Canada; UniversityHospital Bonn, Department of Medicine I, Bonn (J.R., C.B.), the Department ofInfectious Diseases, St. Joseph Hospital, Berlin (P.M.), MedizinischesVersorgungszentrum (MVZ) Munchen am Goetheplatz, Munich (S. Noe), and theInfektionsmedizinisches Centrum Hamburg (ICH) Study Center, Hamburg MVZ ICHStadmitte, Hamburg (C.H.) - all in Germany; the National Institute for InfectiousDiseases Lazzaro Spallanzani IRCCS, Rome (A.A., F.M.), the Division of InfectiousDisease, Luigi Sacco Hospital, Azienda Socio-Sanitaria TerritorialeFatebenefratelli Sacco (D.M.), and the Department of Infectious and TropicalDiseases, IRCCS-Ospedale San Raffaele (S. Nozza), Milan, the Clinic of InfectiousDiseases, University of Modena, Modena (C.M.), and the Infectious DiseasesDivision, Department of Medical Sciences, Azienda Ospedale Universita, Padua(A.C.) - all in Italy; the Department of Infectious Diseases, SorbonneUniversity, Assistance Publique-Hopitaux de Paris (AP-HP), Pitie-SalpetriereHospital (R.P., V.P.), and the Department of Infectious Diseases, Saint LouisLariboisiere Hospital, AP-HP, University of Paris Cite (C.P.), Paris, and theDepartment of Prevention and Community Health, Creteil Intercommunal Hospital,Creteil (C.P.) - all in France; the HIV Cure Research Center, Department ofInternal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent (L.V.), and the HIV/STI Clinic,Institute of Tropical Medicine, Antwerp (E.F.) - both in Belgium; the SacklerFaculty of Medicine, Tel Aviv University, and the Israel Department of InfectiousDiseases and Infection Control, Tel Aviv Sourasky Medical Center, Tel Aviv,Israel (M.Y.); the Department of Dermatology, University Hospital La Paz, Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC),Instituto de Investigacion Hospital Universitario La Paz (E.S.), and CIBERINFEC, Instituto de Salud Carlos III (J.L.B.), Madrid, and the Infectious DiseasesService, Hospital Clinic-IDIBAPS (Instituto de Investigaciones Biomedicas August Pi i Sunyer), University of Barcelona, Barcelona (J.L.B.) - all in Spain;Hospital de Curry Cabral-Centro Hospitalar Universitario de Lisboa Central,Lisbon, Portugal (F.M.M.); Amsterdam University Medical Centers, University ofAmsterdam, Amsterdam (A.G.); the Department of Infectious Diseases, UniversityHospital of Copenhagen, Hvidovre, Denmark (A.-B.E.H.); the Condesa SpecializedClinic, Mexico City (J.I.L.); the Francois-Xavier Bagnoud Center for Health andHuman Rights at Harvard University, Boston (K.M.); and the Department ofInfectious Diseases and Hospital Epidemiology, University Hospital Zurich,Zurich, Switzerland (J.N.).
FAU - Pourcher, Valerie
AU  - Pourcher V
AUID- ORCID: 0000-0001-7378-2179
AD  - From the Blizard Institute and the SHARE Collaborative, Queen Mary University of London, and the Department of Infection and Immunity, Barts Health NHS Trust(J.P.T., V.A., C.M.O.), the Department of Genitourinary Medicine and InfectiousDisease, Guys and St. Thomas' NHS Trust (A.N.), the Department of Sexual Health, Homerton University Hospital (I.R.), and the Clinical Infection Unit, St.George's University Hospitals NHS Foundation Trust (M.S.H.) - all in London; the Department of Medicine, Division of Infectious Diseases (S.B., L.B.H., M.B.K.),the J.D. MacLean Centre for Tropical Diseases (S.B.), the Research Institute ofthe McGill University Health Centre (S.B., M.B.K.), and the Chronic Viral IllnessService, Department of Medicine (M.B.K.), McGill University Health Centre,Montreal, and the Department of Medicine, University Health Network, Universityof Toronto (S.W.), the Division of Infectious Diseases and the MAP Centre forUrban Health Solutions, St. Michael's Hospital (D.T.), and the Department ofMedicine, University of Toronto (D.T.), Toronto - all in Canada; UniversityHospital Bonn, Department of Medicine I, Bonn (J.R., C.B.), the Department ofInfectious Diseases, St. Joseph Hospital, Berlin (P.M.), MedizinischesVersorgungszentrum (MVZ) Munchen am Goetheplatz, Munich (S. Noe), and theInfektionsmedizinisches Centrum Hamburg (ICH) Study Center, Hamburg MVZ ICHStadmitte, Hamburg (C.H.) - all in Germany; the National Institute for InfectiousDiseases Lazzaro Spallanzani IRCCS, Rome (A.A., F.M.), the Division of InfectiousDisease, Luigi Sacco Hospital, Azienda Socio-Sanitaria TerritorialeFatebenefratelli Sacco (D.M.), and the Department of Infectious and TropicalDiseases, IRCCS-Ospedale San Raffaele (S. Nozza), Milan, the Clinic of InfectiousDiseases, University of Modena, Modena (C.M.), and the Infectious DiseasesDivision, Department of Medical Sciences, Azienda Ospedale Universita, Padua(A.C.) - all in Italy; the Department of Infectious Diseases, SorbonneUniversity, Assistance Publique-Hopitaux de Paris (AP-HP), Pitie-SalpetriereHospital (R.P., V.P.), and the Department of Infectious Diseases, Saint LouisLariboisiere Hospital, AP-HP, University of Paris Cite (C.P.), Paris, and theDepartment of Prevention and Community Health, Creteil Intercommunal Hospital,Creteil (C.P.) - all in France; the HIV Cure Research Center, Department ofInternal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent (L.V.), and the HIV/STI Clinic,Institute of Tropical Medicine, Antwerp (E.F.) - both in Belgium; the SacklerFaculty of Medicine, Tel Aviv University, and the Israel Department of InfectiousDiseases and Infection Control, Tel Aviv Sourasky Medical Center, Tel Aviv,Israel (M.Y.); the Department of Dermatology, University Hospital La Paz, Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC),Instituto de Investigacion Hospital Universitario La Paz (E.S.), and CIBERINFEC, Instituto de Salud Carlos III (J.L.B.), Madrid, and the Infectious DiseasesService, Hospital Clinic-IDIBAPS (Instituto de Investigaciones Biomedicas August Pi i Sunyer), University of Barcelona, Barcelona (J.L.B.) - all in Spain;Hospital de Curry Cabral-Centro Hospitalar Universitario de Lisboa Central,Lisbon, Portugal (F.M.M.); Amsterdam University Medical Centers, University ofAmsterdam, Amsterdam (A.G.); the Department of Infectious Diseases, UniversityHospital of Copenhagen, Hvidovre, Denmark (A.-B.E.H.); the Condesa SpecializedClinic, Mexico City (J.I.L.); the Francois-Xavier Bagnoud Center for Health andHuman Rights at Harvard University, Boston (K.M.); and the Department ofInfectious Diseases and Hospital Epidemiology, University Hospital Zurich,Zurich, Switzerland (J.N.).
FAU - Migaud, Pascal
AU  - Migaud P
AD  - From the Blizard Institute and the SHARE Collaborative, Queen Mary University of London, and the Department of Infection and Immunity, Barts Health NHS Trust(J.P.T., V.A., C.M.O.), the Department of Genitourinary Medicine and InfectiousDisease, Guys and St. Thomas' NHS Trust (A.N.), the Department of Sexual Health, Homerton University Hospital (I.R.), and the Clinical Infection Unit, St.George's University Hospitals NHS Foundation Trust (M.S.H.) - all in London; the Department of Medicine, Division of Infectious Diseases (S.B., L.B.H., M.B.K.),the J.D. MacLean Centre for Tropical Diseases (S.B.), the Research Institute ofthe McGill University Health Centre (S.B., M.B.K.), and the Chronic Viral IllnessService, Department of Medicine (M.B.K.), McGill University Health Centre,Montreal, and the Department of Medicine, University Health Network, Universityof Toronto (S.W.), the Division of Infectious Diseases and the MAP Centre forUrban Health Solutions, St. Michael's Hospital (D.T.), and the Department ofMedicine, University of Toronto (D.T.), Toronto - all in Canada; UniversityHospital Bonn, Department of Medicine I, Bonn (J.R., C.B.), the Department ofInfectious Diseases, St. Joseph Hospital, Berlin (P.M.), MedizinischesVersorgungszentrum (MVZ) Munchen am Goetheplatz, Munich (S. Noe), and theInfektionsmedizinisches Centrum Hamburg (ICH) Study Center, Hamburg MVZ ICHStadmitte, Hamburg (C.H.) - all in Germany; the National Institute for InfectiousDiseases Lazzaro Spallanzani IRCCS, Rome (A.A., F.M.), the Division of InfectiousDisease, Luigi Sacco Hospital, Azienda Socio-Sanitaria TerritorialeFatebenefratelli Sacco (D.M.), and the Department of Infectious and TropicalDiseases, IRCCS-Ospedale San Raffaele (S. Nozza), Milan, the Clinic of InfectiousDiseases, University of Modena, Modena (C.M.), and the Infectious DiseasesDivision, Department of Medical Sciences, Azienda Ospedale Universita, Padua(A.C.) - all in Italy; the Department of Infectious Diseases, SorbonneUniversity, Assistance Publique-Hopitaux de Paris (AP-HP), Pitie-SalpetriereHospital (R.P., V.P.), and the Department of Infectious Diseases, Saint LouisLariboisiere Hospital, AP-HP, University of Paris Cite (C.P.), Paris, and theDepartment of Prevention and Community Health, Creteil Intercommunal Hospital,Creteil (C.P.) - all in France; the HIV Cure Research Center, Department ofInternal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent (L.V.), and the HIV/STI Clinic,Institute of Tropical Medicine, Antwerp (E.F.) - both in Belgium; the SacklerFaculty of Medicine, Tel Aviv University, and the Israel Department of InfectiousDiseases and Infection Control, Tel Aviv Sourasky Medical Center, Tel Aviv,Israel (M.Y.); the Department of Dermatology, University Hospital La Paz, Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC),Instituto de Investigacion Hospital Universitario La Paz (E.S.), and CIBERINFEC, Instituto de Salud Carlos III (J.L.B.), Madrid, and the Infectious DiseasesService, Hospital Clinic-IDIBAPS (Instituto de Investigaciones Biomedicas August Pi i Sunyer), University of Barcelona, Barcelona (J.L.B.) - all in Spain;Hospital de Curry Cabral-Centro Hospitalar Universitario de Lisboa Central,Lisbon, Portugal (F.M.M.); Amsterdam University Medical Centers, University ofAmsterdam, Amsterdam (A.G.); the Department of Infectious Diseases, UniversityHospital of Copenhagen, Hvidovre, Denmark (A.-B.E.H.); the Condesa SpecializedClinic, Mexico City (J.I.L.); the Francois-Xavier Bagnoud Center for Health andHuman Rights at Harvard University, Boston (K.M.); and the Department ofInfectious Diseases and Hospital Epidemiology, University Hospital Zurich,Zurich, Switzerland (J.N.).
FAU - Noe, Sebastian
AU  - Noe S
AD  - From the Blizard Institute and the SHARE Collaborative, Queen Mary University of London, and the Department of Infection and Immunity, Barts Health NHS Trust(J.P.T., V.A., C.M.O.), the Department of Genitourinary Medicine and InfectiousDisease, Guys and St. Thomas' NHS Trust (A.N.), the Department of Sexual Health, Homerton University Hospital (I.R.), and the Clinical Infection Unit, St.George's University Hospitals NHS Foundation Trust (M.S.H.) - all in London; the Department of Medicine, Division of Infectious Diseases (S.B., L.B.H., M.B.K.),the J.D. MacLean Centre for Tropical Diseases (S.B.), the Research Institute ofthe McGill University Health Centre (S.B., M.B.K.), and the Chronic Viral IllnessService, Department of Medicine (M.B.K.), McGill University Health Centre,Montreal, and the Department of Medicine, University Health Network, Universityof Toronto (S.W.), the Division of Infectious Diseases and the MAP Centre forUrban Health Solutions, St. Michael's Hospital (D.T.), and the Department ofMedicine, University of Toronto (D.T.), Toronto - all in Canada; UniversityHospital Bonn, Department of Medicine I, Bonn (J.R., C.B.), the Department ofInfectious Diseases, St. Joseph Hospital, Berlin (P.M.), MedizinischesVersorgungszentrum (MVZ) Munchen am Goetheplatz, Munich (S. Noe), and theInfektionsmedizinisches Centrum Hamburg (ICH) Study Center, Hamburg MVZ ICHStadmitte, Hamburg (C.H.) - all in Germany; the National Institute for InfectiousDiseases Lazzaro Spallanzani IRCCS, Rome (A.A., F.M.), the Division of InfectiousDisease, Luigi Sacco Hospital, Azienda Socio-Sanitaria TerritorialeFatebenefratelli Sacco (D.M.), and the Department of Infectious and TropicalDiseases, IRCCS-Ospedale San Raffaele (S. Nozza), Milan, the Clinic of InfectiousDiseases, University of Modena, Modena (C.M.), and the Infectious DiseasesDivision, Department of Medical Sciences, Azienda Ospedale Universita, Padua(A.C.) - all in Italy; the Department of Infectious Diseases, SorbonneUniversity, Assistance Publique-Hopitaux de Paris (AP-HP), Pitie-SalpetriereHospital (R.P., V.P.), and the Department of Infectious Diseases, Saint LouisLariboisiere Hospital, AP-HP, University of Paris Cite (C.P.), Paris, and theDepartment of Prevention and Community Health, Creteil Intercommunal Hospital,Creteil (C.P.) - all in France; the HIV Cure Research Center, Department ofInternal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent (L.V.), and the HIV/STI Clinic,Institute of Tropical Medicine, Antwerp (E.F.) - both in Belgium; the SacklerFaculty of Medicine, Tel Aviv University, and the Israel Department of InfectiousDiseases and Infection Control, Tel Aviv Sourasky Medical Center, Tel Aviv,Israel (M.Y.); the Department of Dermatology, University Hospital La Paz, Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC),Instituto de Investigacion Hospital Universitario La Paz (E.S.), and CIBERINFEC, Instituto de Salud Carlos III (J.L.B.), Madrid, and the Infectious DiseasesService, Hospital Clinic-IDIBAPS (Instituto de Investigaciones Biomedicas August Pi i Sunyer), University of Barcelona, Barcelona (J.L.B.) - all in Spain;Hospital de Curry Cabral-Centro Hospitalar Universitario de Lisboa Central,Lisbon, Portugal (F.M.M.); Amsterdam University Medical Centers, University ofAmsterdam, Amsterdam (A.G.); the Department of Infectious Diseases, UniversityHospital of Copenhagen, Hvidovre, Denmark (A.-B.E.H.); the Condesa SpecializedClinic, Mexico City (J.I.L.); the Francois-Xavier Bagnoud Center for Health andHuman Rights at Harvard University, Boston (K.M.); and the Department ofInfectious Diseases and Hospital Epidemiology, University Hospital Zurich,Zurich, Switzerland (J.N.).
FAU - Pintado, Claire
AU  - Pintado C
AD  - From the Blizard Institute and the SHARE Collaborative, Queen Mary University of London, and the Department of Infection and Immunity, Barts Health NHS Trust(J.P.T., V.A., C.M.O.), the Department of Genitourinary Medicine and InfectiousDisease, Guys and St. Thomas' NHS Trust (A.N.), the Department of Sexual Health, Homerton University Hospital (I.R.), and the Clinical Infection Unit, St.George's University Hospitals NHS Foundation Trust (M.S.H.) - all in London; the Department of Medicine, Division of Infectious Diseases (S.B., L.B.H., M.B.K.),the J.D. MacLean Centre for Tropical Diseases (S.B.), the Research Institute ofthe McGill University Health Centre (S.B., M.B.K.), and the Chronic Viral IllnessService, Department of Medicine (M.B.K.), McGill University Health Centre,Montreal, and the Department of Medicine, University Health Network, Universityof Toronto (S.W.), the Division of Infectious Diseases and the MAP Centre forUrban Health Solutions, St. Michael's Hospital (D.T.), and the Department ofMedicine, University of Toronto (D.T.), Toronto - all in Canada; UniversityHospital Bonn, Department of Medicine I, Bonn (J.R., C.B.), the Department ofInfectious Diseases, St. Joseph Hospital, Berlin (P.M.), MedizinischesVersorgungszentrum (MVZ) Munchen am Goetheplatz, Munich (S. Noe), and theInfektionsmedizinisches Centrum Hamburg (ICH) Study Center, Hamburg MVZ ICHStadmitte, Hamburg (C.H.) - all in Germany; the National Institute for InfectiousDiseases Lazzaro Spallanzani IRCCS, Rome (A.A., F.M.), the Division of InfectiousDisease, Luigi Sacco Hospital, Azienda Socio-Sanitaria TerritorialeFatebenefratelli Sacco (D.M.), and the Department of Infectious and TropicalDiseases, IRCCS-Ospedale San Raffaele (S. Nozza), Milan, the Clinic of InfectiousDiseases, University of Modena, Modena (C.M.), and the Infectious DiseasesDivision, Department of Medical Sciences, Azienda Ospedale Universita, Padua(A.C.) - all in Italy; the Department of Infectious Diseases, SorbonneUniversity, Assistance Publique-Hopitaux de Paris (AP-HP), Pitie-SalpetriereHospital (R.P., V.P.), and the Department of Infectious Diseases, Saint LouisLariboisiere Hospital, AP-HP, University of Paris Cite (C.P.), Paris, and theDepartment of Prevention and Community Health, Creteil Intercommunal Hospital,Creteil (C.P.) - all in France; the HIV Cure Research Center, Department ofInternal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent (L.V.), and the HIV/STI Clinic,Institute of Tropical Medicine, Antwerp (E.F.) - both in Belgium; the SacklerFaculty of Medicine, Tel Aviv University, and the Israel Department of InfectiousDiseases and Infection Control, Tel Aviv Sourasky Medical Center, Tel Aviv,Israel (M.Y.); the Department of Dermatology, University Hospital La Paz, Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC),Instituto de Investigacion Hospital Universitario La Paz (E.S.), and CIBERINFEC, Instituto de Salud Carlos III (J.L.B.), Madrid, and the Infectious DiseasesService, Hospital Clinic-IDIBAPS (Instituto de Investigaciones Biomedicas August Pi i Sunyer), University of Barcelona, Barcelona (J.L.B.) - all in Spain;Hospital de Curry Cabral-Centro Hospitalar Universitario de Lisboa Central,Lisbon, Portugal (F.M.M.); Amsterdam University Medical Centers, University ofAmsterdam, Amsterdam (A.G.); the Department of Infectious Diseases, UniversityHospital of Copenhagen, Hvidovre, Denmark (A.-B.E.H.); the Condesa SpecializedClinic, Mexico City (J.I.L.); the Francois-Xavier Bagnoud Center for Health andHuman Rights at Harvard University, Boston (K.M.); and the Department ofInfectious Diseases and Hospital Epidemiology, University Hospital Zurich,Zurich, Switzerland (J.N.).
FAU - Maggi, Fabrizio
AU  - Maggi F
AD  - From the Blizard Institute and the SHARE Collaborative, Queen Mary University of London, and the Department of Infection and Immunity, Barts Health NHS Trust(J.P.T., V.A., C.M.O.), the Department of Genitourinary Medicine and InfectiousDisease, Guys and St. Thomas' NHS Trust (A.N.), the Department of Sexual Health, Homerton University Hospital (I.R.), and the Clinical Infection Unit, St.George's University Hospitals NHS Foundation Trust (M.S.H.) - all in London; the Department of Medicine, Division of Infectious Diseases (S.B., L.B.H., M.B.K.),the J.D. MacLean Centre for Tropical Diseases (S.B.), the Research Institute ofthe McGill University Health Centre (S.B., M.B.K.), and the Chronic Viral IllnessService, Department of Medicine (M.B.K.), McGill University Health Centre,Montreal, and the Department of Medicine, University Health Network, Universityof Toronto (S.W.), the Division of Infectious Diseases and the MAP Centre forUrban Health Solutions, St. Michael's Hospital (D.T.), and the Department ofMedicine, University of Toronto (D.T.), Toronto - all in Canada; UniversityHospital Bonn, Department of Medicine I, Bonn (J.R., C.B.), the Department ofInfectious Diseases, St. Joseph Hospital, Berlin (P.M.), MedizinischesVersorgungszentrum (MVZ) Munchen am Goetheplatz, Munich (S. Noe), and theInfektionsmedizinisches Centrum Hamburg (ICH) Study Center, Hamburg MVZ ICHStadmitte, Hamburg (C.H.) - all in Germany; the National Institute for InfectiousDiseases Lazzaro Spallanzani IRCCS, Rome (A.A., F.M.), the Division of InfectiousDisease, Luigi Sacco Hospital, Azienda Socio-Sanitaria TerritorialeFatebenefratelli Sacco (D.M.), and the Department of Infectious and TropicalDiseases, IRCCS-Ospedale San Raffaele (S. Nozza), Milan, the Clinic of InfectiousDiseases, University of Modena, Modena (C.M.), and the Infectious DiseasesDivision, Department of Medical Sciences, Azienda Ospedale Universita, Padua(A.C.) - all in Italy; the Department of Infectious Diseases, SorbonneUniversity, Assistance Publique-Hopitaux de Paris (AP-HP), Pitie-SalpetriereHospital (R.P., V.P.), and the Department of Infectious Diseases, Saint LouisLariboisiere Hospital, AP-HP, University of Paris Cite (C.P.), Paris, and theDepartment of Prevention and Community Health, Creteil Intercommunal Hospital,Creteil (C.P.) - all in France; the HIV Cure Research Center, Department ofInternal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent (L.V.), and the HIV/STI Clinic,Institute of Tropical Medicine, Antwerp (E.F.) - both in Belgium; the SacklerFaculty of Medicine, Tel Aviv University, and the Israel Department of InfectiousDiseases and Infection Control, Tel Aviv Sourasky Medical Center, Tel Aviv,Israel (M.Y.); the Department of Dermatology, University Hospital La Paz, Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC),Instituto de Investigacion Hospital Universitario La Paz (E.S.), and CIBERINFEC, Instituto de Salud Carlos III (J.L.B.), Madrid, and the Infectious DiseasesService, Hospital Clinic-IDIBAPS (Instituto de Investigaciones Biomedicas August Pi i Sunyer), University of Barcelona, Barcelona (J.L.B.) - all in Spain;Hospital de Curry Cabral-Centro Hospitalar Universitario de Lisboa Central,Lisbon, Portugal (F.M.M.); Amsterdam University Medical Centers, University ofAmsterdam, Amsterdam (A.G.); the Department of Infectious Diseases, UniversityHospital of Copenhagen, Hvidovre, Denmark (A.-B.E.H.); the Condesa SpecializedClinic, Mexico City (J.I.L.); the Francois-Xavier Bagnoud Center for Health andHuman Rights at Harvard University, Boston (K.M.); and the Department ofInfectious Diseases and Hospital Epidemiology, University Hospital Zurich,Zurich, Switzerland (J.N.).
FAU - Hansen, Ann-Brit E
AU  - Hansen AE
AD  - From the Blizard Institute and the SHARE Collaborative, Queen Mary University of London, and the Department of Infection and Immunity, Barts Health NHS Trust(J.P.T., V.A., C.M.O.), the Department of Genitourinary Medicine and InfectiousDisease, Guys and St. Thomas' NHS Trust (A.N.), the Department of Sexual Health, Homerton University Hospital (I.R.), and the Clinical Infection Unit, St.George's University Hospitals NHS Foundation Trust (M.S.H.) - all in London; the Department of Medicine, Division of Infectious Diseases (S.B., L.B.H., M.B.K.),the J.D. MacLean Centre for Tropical Diseases (S.B.), the Research Institute ofthe McGill University Health Centre (S.B., M.B.K.), and the Chronic Viral IllnessService, Department of Medicine (M.B.K.), McGill University Health Centre,Montreal, and the Department of Medicine, University Health Network, Universityof Toronto (S.W.), the Division of Infectious Diseases and the MAP Centre forUrban Health Solutions, St. Michael's Hospital (D.T.), and the Department ofMedicine, University of Toronto (D.T.), Toronto - all in Canada; UniversityHospital Bonn, Department of Medicine I, Bonn (J.R., C.B.), the Department ofInfectious Diseases, St. Joseph Hospital, Berlin (P.M.), MedizinischesVersorgungszentrum (MVZ) Munchen am Goetheplatz, Munich (S. Noe), and theInfektionsmedizinisches Centrum Hamburg (ICH) Study Center, Hamburg MVZ ICHStadmitte, Hamburg (C.H.) - all in Germany; the National Institute for InfectiousDiseases Lazzaro Spallanzani IRCCS, Rome (A.A., F.M.), the Division of InfectiousDisease, Luigi Sacco Hospital, Azienda Socio-Sanitaria TerritorialeFatebenefratelli Sacco (D.M.), and the Department of Infectious and TropicalDiseases, IRCCS-Ospedale San Raffaele (S. Nozza), Milan, the Clinic of InfectiousDiseases, University of Modena, Modena (C.M.), and the Infectious DiseasesDivision, Department of Medical Sciences, Azienda Ospedale Universita, Padua(A.C.) - all in Italy; the Department of Infectious Diseases, SorbonneUniversity, Assistance Publique-Hopitaux de Paris (AP-HP), Pitie-SalpetriereHospital (R.P., V.P.), and the Department of Infectious Diseases, Saint LouisLariboisiere Hospital, AP-HP, University of Paris Cite (C.P.), Paris, and theDepartment of Prevention and Community Health, Creteil Intercommunal Hospital,Creteil (C.P.) - all in France; the HIV Cure Research Center, Department ofInternal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent (L.V.), and the HIV/STI Clinic,Institute of Tropical Medicine, Antwerp (E.F.) - both in Belgium; the SacklerFaculty of Medicine, Tel Aviv University, and the Israel Department of InfectiousDiseases and Infection Control, Tel Aviv Sourasky Medical Center, Tel Aviv,Israel (M.Y.); the Department of Dermatology, University Hospital La Paz, Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC),Instituto de Investigacion Hospital Universitario La Paz (E.S.), and CIBERINFEC, Instituto de Salud Carlos III (J.L.B.), Madrid, and the Infectious DiseasesService, Hospital Clinic-IDIBAPS (Instituto de Investigaciones Biomedicas August Pi i Sunyer), University of Barcelona, Barcelona (J.L.B.) - all in Spain;Hospital de Curry Cabral-Centro Hospitalar Universitario de Lisboa Central,Lisbon, Portugal (F.M.M.); Amsterdam University Medical Centers, University ofAmsterdam, Amsterdam (A.G.); the Department of Infectious Diseases, UniversityHospital of Copenhagen, Hvidovre, Denmark (A.-B.E.H.); the Condesa SpecializedClinic, Mexico City (J.I.L.); the Francois-Xavier Bagnoud Center for Health andHuman Rights at Harvard University, Boston (K.M.); and the Department ofInfectious Diseases and Hospital Epidemiology, University Hospital Zurich,Zurich, Switzerland (J.N.).
FAU - Hoffmann, Christian
AU  - Hoffmann C
AD  - From the Blizard Institute and the SHARE Collaborative, Queen Mary University of London, and the Department of Infection and Immunity, Barts Health NHS Trust(J.P.T., V.A., C.M.O.), the Department of Genitourinary Medicine and InfectiousDisease, Guys and St. Thomas' NHS Trust (A.N.), the Department of Sexual Health, Homerton University Hospital (I.R.), and the Clinical Infection Unit, St.George's University Hospitals NHS Foundation Trust (M.S.H.) - all in London; the Department of Medicine, Division of Infectious Diseases (S.B., L.B.H., M.B.K.),the J.D. MacLean Centre for Tropical Diseases (S.B.), the Research Institute ofthe McGill University Health Centre (S.B., M.B.K.), and the Chronic Viral IllnessService, Department of Medicine (M.B.K.), McGill University Health Centre,Montreal, and the Department of Medicine, University Health Network, Universityof Toronto (S.W.), the Division of Infectious Diseases and the MAP Centre forUrban Health Solutions, St. Michael's Hospital (D.T.), and the Department ofMedicine, University of Toronto (D.T.), Toronto - all in Canada; UniversityHospital Bonn, Department of Medicine I, Bonn (J.R., C.B.), the Department ofInfectious Diseases, St. Joseph Hospital, Berlin (P.M.), MedizinischesVersorgungszentrum (MVZ) Munchen am Goetheplatz, Munich (S. Noe), and theInfektionsmedizinisches Centrum Hamburg (ICH) Study Center, Hamburg MVZ ICHStadmitte, Hamburg (C.H.) - all in Germany; the National Institute for InfectiousDiseases Lazzaro Spallanzani IRCCS, Rome (A.A., F.M.), the Division of InfectiousDisease, Luigi Sacco Hospital, Azienda Socio-Sanitaria TerritorialeFatebenefratelli Sacco (D.M.), and the Department of Infectious and TropicalDiseases, IRCCS-Ospedale San Raffaele (S. Nozza), Milan, the Clinic of InfectiousDiseases, University of Modena, Modena (C.M.), and the Infectious DiseasesDivision, Department of Medical Sciences, Azienda Ospedale Universita, Padua(A.C.) - all in Italy; the Department of Infectious Diseases, SorbonneUniversity, Assistance Publique-Hopitaux de Paris (AP-HP), Pitie-SalpetriereHospital (R.P., V.P.), and the Department of Infectious Diseases, Saint LouisLariboisiere Hospital, AP-HP, University of Paris Cite (C.P.), Paris, and theDepartment of Prevention and Community Health, Creteil Intercommunal Hospital,Creteil (C.P.) - all in France; the HIV Cure Research Center, Department ofInternal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent (L.V.), and the HIV/STI Clinic,Institute of Tropical Medicine, Antwerp (E.F.) - both in Belgium; the SacklerFaculty of Medicine, Tel Aviv University, and the Israel Department of InfectiousDiseases and Infection Control, Tel Aviv Sourasky Medical Center, Tel Aviv,Israel (M.Y.); the Department of Dermatology, University Hospital La Paz, Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC),Instituto de Investigacion Hospital Universitario La Paz (E.S.), and CIBERINFEC, Instituto de Salud Carlos III (J.L.B.), Madrid, and the Infectious DiseasesService, Hospital Clinic-IDIBAPS (Instituto de Investigaciones Biomedicas August Pi i Sunyer), University of Barcelona, Barcelona (J.L.B.) - all in Spain;Hospital de Curry Cabral-Centro Hospitalar Universitario de Lisboa Central,Lisbon, Portugal (F.M.M.); Amsterdam University Medical Centers, University ofAmsterdam, Amsterdam (A.G.); the Department of Infectious Diseases, UniversityHospital of Copenhagen, Hvidovre, Denmark (A.-B.E.H.); the Condesa SpecializedClinic, Mexico City (J.I.L.); the Francois-Xavier Bagnoud Center for Health andHuman Rights at Harvard University, Boston (K.M.); and the Department ofInfectious Diseases and Hospital Epidemiology, University Hospital Zurich,Zurich, Switzerland (J.N.).
FAU - Lezama, Jezer I
AU  - Lezama JI
AD  - From the Blizard Institute and the SHARE Collaborative, Queen Mary University of London, and the Department of Infection and Immunity, Barts Health NHS Trust(J.P.T., V.A., C.M.O.), the Department of Genitourinary Medicine and InfectiousDisease, Guys and St. Thomas' NHS Trust (A.N.), the Department of Sexual Health, Homerton University Hospital (I.R.), and the Clinical Infection Unit, St.George's University Hospitals NHS Foundation Trust (M.S.H.) - all in London; the Department of Medicine, Division of Infectious Diseases (S.B., L.B.H., M.B.K.),the J.D. MacLean Centre for Tropical Diseases (S.B.), the Research Institute ofthe McGill University Health Centre (S.B., M.B.K.), and the Chronic Viral IllnessService, Department of Medicine (M.B.K.), McGill University Health Centre,Montreal, and the Department of Medicine, University Health Network, Universityof Toronto (S.W.), the Division of Infectious Diseases and the MAP Centre forUrban Health Solutions, St. Michael's Hospital (D.T.), and the Department ofMedicine, University of Toronto (D.T.), Toronto - all in Canada; UniversityHospital Bonn, Department of Medicine I, Bonn (J.R., C.B.), the Department ofInfectious Diseases, St. Joseph Hospital, Berlin (P.M.), MedizinischesVersorgungszentrum (MVZ) Munchen am Goetheplatz, Munich (S. Noe), and theInfektionsmedizinisches Centrum Hamburg (ICH) Study Center, Hamburg MVZ ICHStadmitte, Hamburg (C.H.) - all in Germany; the National Institute for InfectiousDiseases Lazzaro Spallanzani IRCCS, Rome (A.A., F.M.), the Division of InfectiousDisease, Luigi Sacco Hospital, Azienda Socio-Sanitaria TerritorialeFatebenefratelli Sacco (D.M.), and the Department of Infectious and TropicalDiseases, IRCCS-Ospedale San Raffaele (S. Nozza), Milan, the Clinic of InfectiousDiseases, University of Modena, Modena (C.M.), and the Infectious DiseasesDivision, Department of Medical Sciences, Azienda Ospedale Universita, Padua(A.C.) - all in Italy; the Department of Infectious Diseases, SorbonneUniversity, Assistance Publique-Hopitaux de Paris (AP-HP), Pitie-SalpetriereHospital (R.P., V.P.), and the Department of Infectious Diseases, Saint LouisLariboisiere Hospital, AP-HP, University of Paris Cite (C.P.), Paris, and theDepartment of Prevention and Community Health, Creteil Intercommunal Hospital,Creteil (C.P.) - all in France; the HIV Cure Research Center, Department ofInternal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent (L.V.), and the HIV/STI Clinic,Institute of Tropical Medicine, Antwerp (E.F.) - both in Belgium; the SacklerFaculty of Medicine, Tel Aviv University, and the Israel Department of InfectiousDiseases and Infection Control, Tel Aviv Sourasky Medical Center, Tel Aviv,Israel (M.Y.); the Department of Dermatology, University Hospital La Paz, Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC),Instituto de Investigacion Hospital Universitario La Paz (E.S.), and CIBERINFEC, Instituto de Salud Carlos III (J.L.B.), Madrid, and the Infectious DiseasesService, Hospital Clinic-IDIBAPS (Instituto de Investigaciones Biomedicas August Pi i Sunyer), University of Barcelona, Barcelona (J.L.B.) - all in Spain;Hospital de Curry Cabral-Centro Hospitalar Universitario de Lisboa Central,Lisbon, Portugal (F.M.M.); Amsterdam University Medical Centers, University ofAmsterdam, Amsterdam (A.G.); the Department of Infectious Diseases, UniversityHospital of Copenhagen, Hvidovre, Denmark (A.-B.E.H.); the Condesa SpecializedClinic, Mexico City (J.I.L.); the Francois-Xavier Bagnoud Center for Health andHuman Rights at Harvard University, Boston (K.M.); and the Department ofInfectious Diseases and Hospital Epidemiology, University Hospital Zurich,Zurich, Switzerland (J.N.).
FAU - Mussini, Cristina
AU  - Mussini C
AD  - From the Blizard Institute and the SHARE Collaborative, Queen Mary University of London, and the Department of Infection and Immunity, Barts Health NHS Trust(J.P.T., V.A., C.M.O.), the Department of Genitourinary Medicine and InfectiousDisease, Guys and St. Thomas' NHS Trust (A.N.), the Department of Sexual Health, Homerton University Hospital (I.R.), and the Clinical Infection Unit, St.George's University Hospitals NHS Foundation Trust (M.S.H.) - all in London; the Department of Medicine, Division of Infectious Diseases (S.B., L.B.H., M.B.K.),the J.D. MacLean Centre for Tropical Diseases (S.B.), the Research Institute ofthe McGill University Health Centre (S.B., M.B.K.), and the Chronic Viral IllnessService, Department of Medicine (M.B.K.), McGill University Health Centre,Montreal, and the Department of Medicine, University Health Network, Universityof Toronto (S.W.), the Division of Infectious Diseases and the MAP Centre forUrban Health Solutions, St. Michael's Hospital (D.T.), and the Department ofMedicine, University of Toronto (D.T.), Toronto - all in Canada; UniversityHospital Bonn, Department of Medicine I, Bonn (J.R., C.B.), the Department ofInfectious Diseases, St. Joseph Hospital, Berlin (P.M.), MedizinischesVersorgungszentrum (MVZ) Munchen am Goetheplatz, Munich (S. Noe), and theInfektionsmedizinisches Centrum Hamburg (ICH) Study Center, Hamburg MVZ ICHStadmitte, Hamburg (C.H.) - all in Germany; the National Institute for InfectiousDiseases Lazzaro Spallanzani IRCCS, Rome (A.A., F.M.), the Division of InfectiousDisease, Luigi Sacco Hospital, Azienda Socio-Sanitaria TerritorialeFatebenefratelli Sacco (D.M.), and the Department of Infectious and TropicalDiseases, IRCCS-Ospedale San Raffaele (S. Nozza), Milan, the Clinic of InfectiousDiseases, University of Modena, Modena (C.M.), and the Infectious DiseasesDivision, Department of Medical Sciences, Azienda Ospedale Universita, Padua(A.C.) - all in Italy; the Department of Infectious Diseases, SorbonneUniversity, Assistance Publique-Hopitaux de Paris (AP-HP), Pitie-SalpetriereHospital (R.P., V.P.), and the Department of Infectious Diseases, Saint LouisLariboisiere Hospital, AP-HP, University of Paris Cite (C.P.), Paris, and theDepartment of Prevention and Community Health, Creteil Intercommunal Hospital,Creteil (C.P.) - all in France; the HIV Cure Research Center, Department ofInternal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent (L.V.), and the HIV/STI Clinic,Institute of Tropical Medicine, Antwerp (E.F.) - both in Belgium; the SacklerFaculty of Medicine, Tel Aviv University, and the Israel Department of InfectiousDiseases and Infection Control, Tel Aviv Sourasky Medical Center, Tel Aviv,Israel (M.Y.); the Department of Dermatology, University Hospital La Paz, Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC),Instituto de Investigacion Hospital Universitario La Paz (E.S.), and CIBERINFEC, Instituto de Salud Carlos III (J.L.B.), Madrid, and the Infectious DiseasesService, Hospital Clinic-IDIBAPS (Instituto de Investigaciones Biomedicas August Pi i Sunyer), University of Barcelona, Barcelona (J.L.B.) - all in Spain;Hospital de Curry Cabral-Centro Hospitalar Universitario de Lisboa Central,Lisbon, Portugal (F.M.M.); Amsterdam University Medical Centers, University ofAmsterdam, Amsterdam (A.G.); the Department of Infectious Diseases, UniversityHospital of Copenhagen, Hvidovre, Denmark (A.-B.E.H.); the Condesa SpecializedClinic, Mexico City (J.I.L.); the Francois-Xavier Bagnoud Center for Health andHuman Rights at Harvard University, Boston (K.M.); and the Department ofInfectious Diseases and Hospital Epidemiology, University Hospital Zurich,Zurich, Switzerland (J.N.).
FAU - Cattelan, AnnaMaria
AU  - Cattelan A
AD  - From the Blizard Institute and the SHARE Collaborative, Queen Mary University of London, and the Department of Infection and Immunity, Barts Health NHS Trust(J.P.T., V.A., C.M.O.), the Department of Genitourinary Medicine and InfectiousDisease, Guys and St. Thomas' NHS Trust (A.N.), the Department of Sexual Health, Homerton University Hospital (I.R.), and the Clinical Infection Unit, St.George's University Hospitals NHS Foundation Trust (M.S.H.) - all in London; the Department of Medicine, Division of Infectious Diseases (S.B., L.B.H., M.B.K.),the J.D. MacLean Centre for Tropical Diseases (S.B.), the Research Institute ofthe McGill University Health Centre (S.B., M.B.K.), and the Chronic Viral IllnessService, Department of Medicine (M.B.K.), McGill University Health Centre,Montreal, and the Department of Medicine, University Health Network, Universityof Toronto (S.W.), the Division of Infectious Diseases and the MAP Centre forUrban Health Solutions, St. Michael's Hospital (D.T.), and the Department ofMedicine, University of Toronto (D.T.), Toronto - all in Canada; UniversityHospital Bonn, Department of Medicine I, Bonn (J.R., C.B.), the Department ofInfectious Diseases, St. Joseph Hospital, Berlin (P.M.), MedizinischesVersorgungszentrum (MVZ) Munchen am Goetheplatz, Munich (S. Noe), and theInfektionsmedizinisches Centrum Hamburg (ICH) Study Center, Hamburg MVZ ICHStadmitte, Hamburg (C.H.) - all in Germany; the National Institute for InfectiousDiseases Lazzaro Spallanzani IRCCS, Rome (A.A., F.M.), the Division of InfectiousDisease, Luigi Sacco Hospital, Azienda Socio-Sanitaria TerritorialeFatebenefratelli Sacco (D.M.), and the Department of Infectious and TropicalDiseases, IRCCS-Ospedale San Raffaele (S. Nozza), Milan, the Clinic of InfectiousDiseases, University of Modena, Modena (C.M.), and the Infectious DiseasesDivision, Department of Medical Sciences, Azienda Ospedale Universita, Padua(A.C.) - all in Italy; the Department of Infectious Diseases, SorbonneUniversity, Assistance Publique-Hopitaux de Paris (AP-HP), Pitie-SalpetriereHospital (R.P., V.P.), and the Department of Infectious Diseases, Saint LouisLariboisiere Hospital, AP-HP, University of Paris Cite (C.P.), Paris, and theDepartment of Prevention and Community Health, Creteil Intercommunal Hospital,Creteil (C.P.) - all in France; the HIV Cure Research Center, Department ofInternal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent (L.V.), and the HIV/STI Clinic,Institute of Tropical Medicine, Antwerp (E.F.) - both in Belgium; the SacklerFaculty of Medicine, Tel Aviv University, and the Israel Department of InfectiousDiseases and Infection Control, Tel Aviv Sourasky Medical Center, Tel Aviv,Israel (M.Y.); the Department of Dermatology, University Hospital La Paz, Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC),Instituto de Investigacion Hospital Universitario La Paz (E.S.), and CIBERINFEC, Instituto de Salud Carlos III (J.L.B.), Madrid, and the Infectious DiseasesService, Hospital Clinic-IDIBAPS (Instituto de Investigaciones Biomedicas August Pi i Sunyer), University of Barcelona, Barcelona (J.L.B.) - all in Spain;Hospital de Curry Cabral-Centro Hospitalar Universitario de Lisboa Central,Lisbon, Portugal (F.M.M.); Amsterdam University Medical Centers, University ofAmsterdam, Amsterdam (A.G.); the Department of Infectious Diseases, UniversityHospital of Copenhagen, Hvidovre, Denmark (A.-B.E.H.); the Condesa SpecializedClinic, Mexico City (J.I.L.); the Francois-Xavier Bagnoud Center for Health andHuman Rights at Harvard University, Boston (K.M.); and the Department ofInfectious Diseases and Hospital Epidemiology, University Hospital Zurich,Zurich, Switzerland (J.N.).
FAU - Makofane, Keletso
AU  - Makofane K
AD  - From the Blizard Institute and the SHARE Collaborative, Queen Mary University of London, and the Department of Infection and Immunity, Barts Health NHS Trust(J.P.T., V.A., C.M.O.), the Department of Genitourinary Medicine and InfectiousDisease, Guys and St. Thomas' NHS Trust (A.N.), the Department of Sexual Health, Homerton University Hospital (I.R.), and the Clinical Infection Unit, St.George's University Hospitals NHS Foundation Trust (M.S.H.) - all in London; the Department of Medicine, Division of Infectious Diseases (S.B., L.B.H., M.B.K.),the J.D. MacLean Centre for Tropical Diseases (S.B.), the Research Institute ofthe McGill University Health Centre (S.B., M.B.K.), and the Chronic Viral IllnessService, Department of Medicine (M.B.K.), McGill University Health Centre,Montreal, and the Department of Medicine, University Health Network, Universityof Toronto (S.W.), the Division of Infectious Diseases and the MAP Centre forUrban Health Solutions, St. Michael's Hospital (D.T.), and the Department ofMedicine, University of Toronto (D.T.), Toronto - all in Canada; UniversityHospital Bonn, Department of Medicine I, Bonn (J.R., C.B.), the Department ofInfectious Diseases, St. Joseph Hospital, Berlin (P.M.), MedizinischesVersorgungszentrum (MVZ) Munchen am Goetheplatz, Munich (S. Noe), and theInfektionsmedizinisches Centrum Hamburg (ICH) Study Center, Hamburg MVZ ICHStadmitte, Hamburg (C.H.) - all in Germany; the National Institute for InfectiousDiseases Lazzaro Spallanzani IRCCS, Rome (A.A., F.M.), the Division of InfectiousDisease, Luigi Sacco Hospital, Azienda Socio-Sanitaria TerritorialeFatebenefratelli Sacco (D.M.), and the Department of Infectious and TropicalDiseases, IRCCS-Ospedale San Raffaele (S. Nozza), Milan, the Clinic of InfectiousDiseases, University of Modena, Modena (C.M.), and the Infectious DiseasesDivision, Department of Medical Sciences, Azienda Ospedale Universita, Padua(A.C.) - all in Italy; the Department of Infectious Diseases, SorbonneUniversity, Assistance Publique-Hopitaux de Paris (AP-HP), Pitie-SalpetriereHospital (R.P., V.P.), and the Department of Infectious Diseases, Saint LouisLariboisiere Hospital, AP-HP, University of Paris Cite (C.P.), Paris, and theDepartment of Prevention and Community Health, Creteil Intercommunal Hospital,Creteil (C.P.) - all in France; the HIV Cure Research Center, Department ofInternal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent (L.V.), and the HIV/STI Clinic,Institute of Tropical Medicine, Antwerp (E.F.) - both in Belgium; the SacklerFaculty of Medicine, Tel Aviv University, and the Israel Department of InfectiousDiseases and Infection Control, Tel Aviv Sourasky Medical Center, Tel Aviv,Israel (M.Y.); the Department of Dermatology, University Hospital La Paz, Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC),Instituto de Investigacion Hospital Universitario La Paz (E.S.), and CIBERINFEC, Instituto de Salud Carlos III (J.L.B.), Madrid, and the Infectious DiseasesService, Hospital Clinic-IDIBAPS (Instituto de Investigaciones Biomedicas August Pi i Sunyer), University of Barcelona, Barcelona (J.L.B.) - all in Spain;Hospital de Curry Cabral-Centro Hospitalar Universitario de Lisboa Central,Lisbon, Portugal (F.M.M.); Amsterdam University Medical Centers, University ofAmsterdam, Amsterdam (A.G.); the Department of Infectious Diseases, UniversityHospital of Copenhagen, Hvidovre, Denmark (A.-B.E.H.); the Condesa SpecializedClinic, Mexico City (J.I.L.); the Francois-Xavier Bagnoud Center for Health andHuman Rights at Harvard University, Boston (K.M.); and the Department ofInfectious Diseases and Hospital Epidemiology, University Hospital Zurich,Zurich, Switzerland (J.N.).
FAU - Tan, Darrell
AU  - Tan D
AD  - From the Blizard Institute and the SHARE Collaborative, Queen Mary University of London, and the Department of Infection and Immunity, Barts Health NHS Trust(J.P.T., V.A., C.M.O.), the Department of Genitourinary Medicine and InfectiousDisease, Guys and St. Thomas' NHS Trust (A.N.), the Department of Sexual Health, Homerton University Hospital (I.R.), and the Clinical Infection Unit, St.George's University Hospitals NHS Foundation Trust (M.S.H.) - all in London; the Department of Medicine, Division of Infectious Diseases (S.B., L.B.H., M.B.K.),the J.D. MacLean Centre for Tropical Diseases (S.B.), the Research Institute ofthe McGill University Health Centre (S.B., M.B.K.), and the Chronic Viral IllnessService, Department of Medicine (M.B.K.), McGill University Health Centre,Montreal, and the Department of Medicine, University Health Network, Universityof Toronto (S.W.), the Division of Infectious Diseases and the MAP Centre forUrban Health Solutions, St. Michael's Hospital (D.T.), and the Department ofMedicine, University of Toronto (D.T.), Toronto - all in Canada; UniversityHospital Bonn, Department of Medicine I, Bonn (J.R., C.B.), the Department ofInfectious Diseases, St. Joseph Hospital, Berlin (P.M.), MedizinischesVersorgungszentrum (MVZ) Munchen am Goetheplatz, Munich (S. Noe), and theInfektionsmedizinisches Centrum Hamburg (ICH) Study Center, Hamburg MVZ ICHStadmitte, Hamburg (C.H.) - all in Germany; the National Institute for InfectiousDiseases Lazzaro Spallanzani IRCCS, Rome (A.A., F.M.), the Division of InfectiousDisease, Luigi Sacco Hospital, Azienda Socio-Sanitaria TerritorialeFatebenefratelli Sacco (D.M.), and the Department of Infectious and TropicalDiseases, IRCCS-Ospedale San Raffaele (S. Nozza), Milan, the Clinic of InfectiousDiseases, University of Modena, Modena (C.M.), and the Infectious DiseasesDivision, Department of Medical Sciences, Azienda Ospedale Universita, Padua(A.C.) - all in Italy; the Department of Infectious Diseases, SorbonneUniversity, Assistance Publique-Hopitaux de Paris (AP-HP), Pitie-SalpetriereHospital (R.P., V.P.), and the Department of Infectious Diseases, Saint LouisLariboisiere Hospital, AP-HP, University of Paris Cite (C.P.), Paris, and theDepartment of Prevention and Community Health, Creteil Intercommunal Hospital,Creteil (C.P.) - all in France; the HIV Cure Research Center, Department ofInternal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent (L.V.), and the HIV/STI Clinic,Institute of Tropical Medicine, Antwerp (E.F.) - both in Belgium; the SacklerFaculty of Medicine, Tel Aviv University, and the Israel Department of InfectiousDiseases and Infection Control, Tel Aviv Sourasky Medical Center, Tel Aviv,Israel (M.Y.); the Department of Dermatology, University Hospital La Paz, Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC),Instituto de Investigacion Hospital Universitario La Paz (E.S.), and CIBERINFEC, Instituto de Salud Carlos III (J.L.B.), Madrid, and the Infectious DiseasesService, Hospital Clinic-IDIBAPS (Instituto de Investigaciones Biomedicas August Pi i Sunyer), University of Barcelona, Barcelona (J.L.B.) - all in Spain;Hospital de Curry Cabral-Centro Hospitalar Universitario de Lisboa Central,Lisbon, Portugal (F.M.M.); Amsterdam University Medical Centers, University ofAmsterdam, Amsterdam (A.G.); the Department of Infectious Diseases, UniversityHospital of Copenhagen, Hvidovre, Denmark (A.-B.E.H.); the Condesa SpecializedClinic, Mexico City (J.I.L.); the Francois-Xavier Bagnoud Center for Health andHuman Rights at Harvard University, Boston (K.M.); and the Department ofInfectious Diseases and Hospital Epidemiology, University Hospital Zurich,Zurich, Switzerland (J.N.).
FAU - Nozza, Silvia
AU  - Nozza S
AD  - From the Blizard Institute and the SHARE Collaborative, Queen Mary University of London, and the Department of Infection and Immunity, Barts Health NHS Trust(J.P.T., V.A., C.M.O.), the Department of Genitourinary Medicine and InfectiousDisease, Guys and St. Thomas' NHS Trust (A.N.), the Department of Sexual Health, Homerton University Hospital (I.R.), and the Clinical Infection Unit, St.George's University Hospitals NHS Foundation Trust (M.S.H.) - all in London; the Department of Medicine, Division of Infectious Diseases (S.B., L.B.H., M.B.K.),the J.D. MacLean Centre for Tropical Diseases (S.B.), the Research Institute ofthe McGill University Health Centre (S.B., M.B.K.), and the Chronic Viral IllnessService, Department of Medicine (M.B.K.), McGill University Health Centre,Montreal, and the Department of Medicine, University Health Network, Universityof Toronto (S.W.), the Division of Infectious Diseases and the MAP Centre forUrban Health Solutions, St. Michael's Hospital (D.T.), and the Department ofMedicine, University of Toronto (D.T.), Toronto - all in Canada; UniversityHospital Bonn, Department of Medicine I, Bonn (J.R., C.B.), the Department ofInfectious Diseases, St. Joseph Hospital, Berlin (P.M.), MedizinischesVersorgungszentrum (MVZ) Munchen am Goetheplatz, Munich (S. Noe), and theInfektionsmedizinisches Centrum Hamburg (ICH) Study Center, Hamburg MVZ ICHStadmitte, Hamburg (C.H.) - all in Germany; the National Institute for InfectiousDiseases Lazzaro Spallanzani IRCCS, Rome (A.A., F.M.), the Division of InfectiousDisease, Luigi Sacco Hospital, Azienda Socio-Sanitaria TerritorialeFatebenefratelli Sacco (D.M.), and the Department of Infectious and TropicalDiseases, IRCCS-Ospedale San Raffaele (S. Nozza), Milan, the Clinic of InfectiousDiseases, University of Modena, Modena (C.M.), and the Infectious DiseasesDivision, Department of Medical Sciences, Azienda Ospedale Universita, Padua(A.C.) - all in Italy; the Department of Infectious Diseases, SorbonneUniversity, Assistance Publique-Hopitaux de Paris (AP-HP), Pitie-SalpetriereHospital (R.P., V.P.), and the Department of Infectious Diseases, Saint LouisLariboisiere Hospital, AP-HP, University of Paris Cite (C.P.), Paris, and theDepartment of Prevention and Community Health, Creteil Intercommunal Hospital,Creteil (C.P.) - all in France; the HIV Cure Research Center, Department ofInternal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent (L.V.), and the HIV/STI Clinic,Institute of Tropical Medicine, Antwerp (E.F.) - both in Belgium; the SacklerFaculty of Medicine, Tel Aviv University, and the Israel Department of InfectiousDiseases and Infection Control, Tel Aviv Sourasky Medical Center, Tel Aviv,Israel (M.Y.); the Department of Dermatology, University Hospital La Paz, Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC),Instituto de Investigacion Hospital Universitario La Paz (E.S.), and CIBERINFEC, Instituto de Salud Carlos III (J.L.B.), Madrid, and the Infectious DiseasesService, Hospital Clinic-IDIBAPS (Instituto de Investigaciones Biomedicas August Pi i Sunyer), University of Barcelona, Barcelona (J.L.B.) - all in Spain;Hospital de Curry Cabral-Centro Hospitalar Universitario de Lisboa Central,Lisbon, Portugal (F.M.M.); Amsterdam University Medical Centers, University ofAmsterdam, Amsterdam (A.G.); the Department of Infectious Diseases, UniversityHospital of Copenhagen, Hvidovre, Denmark (A.-B.E.H.); the Condesa SpecializedClinic, Mexico City (J.I.L.); the Francois-Xavier Bagnoud Center for Health andHuman Rights at Harvard University, Boston (K.M.); and the Department ofInfectious Diseases and Hospital Epidemiology, University Hospital Zurich,Zurich, Switzerland (J.N.).
FAU - Nemeth, Johannes
AU  - Nemeth J
AD  - From the Blizard Institute and the SHARE Collaborative, Queen Mary University of London, and the Department of Infection and Immunity, Barts Health NHS Trust(J.P.T., V.A., C.M.O.), the Department of Genitourinary Medicine and InfectiousDisease, Guys and St. Thomas' NHS Trust (A.N.), the Department of Sexual Health, Homerton University Hospital (I.R.), and the Clinical Infection Unit, St.George's University Hospitals NHS Foundation Trust (M.S.H.) - all in London; the Department of Medicine, Division of Infectious Diseases (S.B., L.B.H., M.B.K.),the J.D. MacLean Centre for Tropical Diseases (S.B.), the Research Institute ofthe McGill University Health Centre (S.B., M.B.K.), and the Chronic Viral IllnessService, Department of Medicine (M.B.K.), McGill University Health Centre,Montreal, and the Department of Medicine, University Health Network, Universityof Toronto (S.W.), the Division of Infectious Diseases and the MAP Centre forUrban Health Solutions, St. Michael's Hospital (D.T.), and the Department ofMedicine, University of Toronto (D.T.), Toronto - all in Canada; UniversityHospital Bonn, Department of Medicine I, Bonn (J.R., C.B.), the Department ofInfectious Diseases, St. Joseph Hospital, Berlin (P.M.), MedizinischesVersorgungszentrum (MVZ) Munchen am Goetheplatz, Munich (S. Noe), and theInfektionsmedizinisches Centrum Hamburg (ICH) Study Center, Hamburg MVZ ICHStadmitte, Hamburg (C.H.) - all in Germany; the National Institute for InfectiousDiseases Lazzaro Spallanzani IRCCS, Rome (A.A., F.M.), the Division of InfectiousDisease, Luigi Sacco Hospital, Azienda Socio-Sanitaria TerritorialeFatebenefratelli Sacco (D.M.), and the Department of Infectious and TropicalDiseases, IRCCS-Ospedale San Raffaele (S. Nozza), Milan, the Clinic of InfectiousDiseases, University of Modena, Modena (C.M.), and the Infectious DiseasesDivision, Department of Medical Sciences, Azienda Ospedale Universita, Padua(A.C.) - all in Italy; the Department of Infectious Diseases, SorbonneUniversity, Assistance Publique-Hopitaux de Paris (AP-HP), Pitie-SalpetriereHospital (R.P., V.P.), and the Department of Infectious Diseases, Saint LouisLariboisiere Hospital, AP-HP, University of Paris Cite (C.P.), Paris, and theDepartment of Prevention and Community Health, Creteil Intercommunal Hospital,Creteil (C.P.) - all in France; the HIV Cure Research Center, Department ofInternal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent (L.V.), and the HIV/STI Clinic,Institute of Tropical Medicine, Antwerp (E.F.) - both in Belgium; the SacklerFaculty of Medicine, Tel Aviv University, and the Israel Department of InfectiousDiseases and Infection Control, Tel Aviv Sourasky Medical Center, Tel Aviv,Israel (M.Y.); the Department of Dermatology, University Hospital La Paz, Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC),Instituto de Investigacion Hospital Universitario La Paz (E.S.), and CIBERINFEC, Instituto de Salud Carlos III (J.L.B.), Madrid, and the Infectious DiseasesService, Hospital Clinic-IDIBAPS (Instituto de Investigaciones Biomedicas August Pi i Sunyer), University of Barcelona, Barcelona (J.L.B.) - all in Spain;Hospital de Curry Cabral-Centro Hospitalar Universitario de Lisboa Central,Lisbon, Portugal (F.M.M.); Amsterdam University Medical Centers, University ofAmsterdam, Amsterdam (A.G.); the Department of Infectious Diseases, UniversityHospital of Copenhagen, Hvidovre, Denmark (A.-B.E.H.); the Condesa SpecializedClinic, Mexico City (J.I.L.); the Francois-Xavier Bagnoud Center for Health andHuman Rights at Harvard University, Boston (K.M.); and the Department ofInfectious Diseases and Hospital Epidemiology, University Hospital Zurich,Zurich, Switzerland (J.N.).
FAU - Klein, Marina B
AU  - Klein MB
AD  - From the Blizard Institute and the SHARE Collaborative, Queen Mary University of London, and the Department of Infection and Immunity, Barts Health NHS Trust(J.P.T., V.A., C.M.O.), the Department of Genitourinary Medicine and InfectiousDisease, Guys and St. Thomas' NHS Trust (A.N.), the Department of Sexual Health, Homerton University Hospital (I.R.), and the Clinical Infection Unit, St.George's University Hospitals NHS Foundation Trust (M.S.H.) - all in London; the Department of Medicine, Division of Infectious Diseases (S.B., L.B.H., M.B.K.),the J.D. MacLean Centre for Tropical Diseases (S.B.), the Research Institute ofthe McGill University Health Centre (S.B., M.B.K.), and the Chronic Viral IllnessService, Department of Medicine (M.B.K.), McGill University Health Centre,Montreal, and the Department of Medicine, University Health Network, Universityof Toronto (S.W.), the Division of Infectious Diseases and the MAP Centre forUrban Health Solutions, St. Michael's Hospital (D.T.), and the Department ofMedicine, University of Toronto (D.T.), Toronto - all in Canada; UniversityHospital Bonn, Department of Medicine I, Bonn (J.R., C.B.), the Department ofInfectious Diseases, St. Joseph Hospital, Berlin (P.M.), MedizinischesVersorgungszentrum (MVZ) Munchen am Goetheplatz, Munich (S. Noe), and theInfektionsmedizinisches Centrum Hamburg (ICH) Study Center, Hamburg MVZ ICHStadmitte, Hamburg (C.H.) - all in Germany; the National Institute for InfectiousDiseases Lazzaro Spallanzani IRCCS, Rome (A.A., F.M.), the Division of InfectiousDisease, Luigi Sacco Hospital, Azienda Socio-Sanitaria TerritorialeFatebenefratelli Sacco (D.M.), and the Department of Infectious and TropicalDiseases, IRCCS-Ospedale San Raffaele (S. Nozza), Milan, the Clinic of InfectiousDiseases, University of Modena, Modena (C.M.), and the Infectious DiseasesDivision, Department of Medical Sciences, Azienda Ospedale Universita, Padua(A.C.) - all in Italy; the Department of Infectious Diseases, SorbonneUniversity, Assistance Publique-Hopitaux de Paris (AP-HP), Pitie-SalpetriereHospital (R.P., V.P.), and the Department of Infectious Diseases, Saint LouisLariboisiere Hospital, AP-HP, University of Paris Cite (C.P.), Paris, and theDepartment of Prevention and Community Health, Creteil Intercommunal Hospital,Creteil (C.P.) - all in France; the HIV Cure Research Center, Department ofInternal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent (L.V.), and the HIV/STI Clinic,Institute of Tropical Medicine, Antwerp (E.F.) - both in Belgium; the SacklerFaculty of Medicine, Tel Aviv University, and the Israel Department of InfectiousDiseases and Infection Control, Tel Aviv Sourasky Medical Center, Tel Aviv,Israel (M.Y.); the Department of Dermatology, University Hospital La Paz, Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC),Instituto de Investigacion Hospital Universitario La Paz (E.S.), and CIBERINFEC, Instituto de Salud Carlos III (J.L.B.), Madrid, and the Infectious DiseasesService, Hospital Clinic-IDIBAPS (Instituto de Investigaciones Biomedicas August Pi i Sunyer), University of Barcelona, Barcelona (J.L.B.) - all in Spain;Hospital de Curry Cabral-Centro Hospitalar Universitario de Lisboa Central,Lisbon, Portugal (F.M.M.); Amsterdam University Medical Centers, University ofAmsterdam, Amsterdam (A.G.); the Department of Infectious Diseases, UniversityHospital of Copenhagen, Hvidovre, Denmark (A.-B.E.H.); the Condesa SpecializedClinic, Mexico City (J.I.L.); the Francois-Xavier Bagnoud Center for Health andHuman Rights at Harvard University, Boston (K.M.); and the Department ofInfectious Diseases and Hospital Epidemiology, University Hospital Zurich,Zurich, Switzerland (J.N.).
FAU - Orkin, Chloe M
AU  - Orkin CM
AUID- ORCID: 0000-0001-6168-6745
AD  - From the Blizard Institute and the SHARE Collaborative, Queen Mary University of London, and the Department of Infection and Immunity, Barts Health NHS Trust(J.P.T., V.A., C.M.O.), the Department of Genitourinary Medicine and InfectiousDisease, Guys and St. Thomas' NHS Trust (A.N.), the Department of Sexual Health, Homerton University Hospital (I.R.), and the Clinical Infection Unit, St.George's University Hospitals NHS Foundation Trust (M.S.H.) - all in London; the Department of Medicine, Division of Infectious Diseases (S.B., L.B.H., M.B.K.),the J.D. MacLean Centre for Tropical Diseases (S.B.), the Research Institute ofthe McGill University Health Centre (S.B., M.B.K.), and the Chronic Viral IllnessService, Department of Medicine (M.B.K.), McGill University Health Centre,Montreal, and the Department of Medicine, University Health Network, Universityof Toronto (S.W.), the Division of Infectious Diseases and the MAP Centre forUrban Health Solutions, St. Michael's Hospital (D.T.), and the Department ofMedicine, University of Toronto (D.T.), Toronto - all in Canada; UniversityHospital Bonn, Department of Medicine I, Bonn (J.R., C.B.), the Department ofInfectious Diseases, St. Joseph Hospital, Berlin (P.M.), MedizinischesVersorgungszentrum (MVZ) Munchen am Goetheplatz, Munich (S. Noe), and theInfektionsmedizinisches Centrum Hamburg (ICH) Study Center, Hamburg MVZ ICHStadmitte, Hamburg (C.H.) - all in Germany; the National Institute for InfectiousDiseases Lazzaro Spallanzani IRCCS, Rome (A.A., F.M.), the Division of InfectiousDisease, Luigi Sacco Hospital, Azienda Socio-Sanitaria TerritorialeFatebenefratelli Sacco (D.M.), and the Department of Infectious and TropicalDiseases, IRCCS-Ospedale San Raffaele (S. Nozza), Milan, the Clinic of InfectiousDiseases, University of Modena, Modena (C.M.), and the Infectious DiseasesDivision, Department of Medical Sciences, Azienda Ospedale Universita, Padua(A.C.) - all in Italy; the Department of Infectious Diseases, SorbonneUniversity, Assistance Publique-Hopitaux de Paris (AP-HP), Pitie-SalpetriereHospital (R.P., V.P.), and the Department of Infectious Diseases, Saint LouisLariboisiere Hospital, AP-HP, University of Paris Cite (C.P.), Paris, and theDepartment of Prevention and Community Health, Creteil Intercommunal Hospital,Creteil (C.P.) - all in France; the HIV Cure Research Center, Department ofInternal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent (L.V.), and the HIV/STI Clinic,Institute of Tropical Medicine, Antwerp (E.F.) - both in Belgium; the SacklerFaculty of Medicine, Tel Aviv University, and the Israel Department of InfectiousDiseases and Infection Control, Tel Aviv Sourasky Medical Center, Tel Aviv,Israel (M.Y.); the Department of Dermatology, University Hospital La Paz, Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC),Instituto de Investigacion Hospital Universitario La Paz (E.S.), and CIBERINFEC, Instituto de Salud Carlos III (J.L.B.), Madrid, and the Infectious DiseasesService, Hospital Clinic-IDIBAPS (Instituto de Investigaciones Biomedicas August Pi i Sunyer), University of Barcelona, Barcelona (J.L.B.) - all in Spain;Hospital de Curry Cabral-Centro Hospitalar Universitario de Lisboa Central,Lisbon, Portugal (F.M.M.); Amsterdam University Medical Centers, University ofAmsterdam, Amsterdam (A.G.); the Department of Infectious Diseases, UniversityHospital of Copenhagen, Hvidovre, Denmark (A.-B.E.H.); the Condesa SpecializedClinic, Mexico City (J.I.L.); the Francois-Xavier Bagnoud Center for Health andHuman Rights at Harvard University, Boston (K.M.); and the Department ofInfectious Diseases and Hospital Epidemiology, University Hospital Zurich,Zurich, Switzerland (J.N.).
CN  - SHARE-net Clinical Group
LA  - eng
PT  - Journal Article
DEP - 20220721
PL  - United States
TA  - N Engl J Med
JT  - The New England journal of medicine
JID - 0255562
SB  - IM
EDAT- 2022/07/23 06:00
MHDA- 2022/07/23 06:00
CRDT- 2022/07/22 09:23
PHST- 2022/07/22 09:23 [entrez]
PHST- 2022/07/23 06:00 [pubmed]
PHST- 2022/07/23 06:00 [medline]
AID - 10.1056/NEJMoa2207323 [doi]
PST - aheadofprint
SO  - N Engl J Med. 2022 Jul 21. doi: 10.1056/NEJMoa2207323.

PMID- 35866435
OWN - NLM
STAT- MEDLINE
DCOM- 20220725
LR  - 20220802
IS  - 1560-7917 (Electronic)
IS  - 1025-496X (Linking)
VI  - 27
IP  - 29
DP  - 2022 Jul
TI  - Paediatric monkeypox patient with unknown source of infection, the Netherlands,June 2022.
LID - 10.2807/1560-7917.ES.2022.27.29.2200552 [doi]
AB  - Since May 2022, an international monkeypox (MPX) outbreak has been ongoing inmore than 50 countries. While most cases are men who have sex with men,transmission is not restricted to this population. In this report, we describethe case of a male child younger than 10 years with MPX in the Netherlands.Despite thorough source tracing, a likely source of infection has not beenidentified. No secondary cases were identified in close contacts.
FAU - Tutu van Furth, A Marceline
AU  - Tutu van Furth AM
AD  - Amsterdam Institute for Infection and Immunity, Infectious diseases, Amsterdam,The Netherlands.
AD  - Amsterdam UMC location Vrije Universiteit Amsterdam, Emma Children's Hospital,Department of Paediatric Infectious Diseases and Immunology, Amsterdam, TheNetherlands.
FAU - van der Kuip, Martijn
AU  - van der Kuip M
AD  - Amsterdam Institute for Infection and Immunity, Infectious diseases, Amsterdam,The Netherlands.
AD  - Amsterdam UMC location Vrije Universiteit Amsterdam, Emma Children's Hospital,Department of Paediatric Infectious Diseases and Immunology, Amsterdam, TheNetherlands.
FAU - van Els, Anne L
AU  - van Els AL
AD  - Amsterdam Institute for Infection and Immunity, Infectious diseases, Amsterdam,The Netherlands.
AD  - Amsterdam UMC location Vrije Universiteit Amsterdam, Emma Children's Hospital,Department of Paediatric Infectious Diseases and Immunology, Amsterdam, TheNetherlands.
FAU - Fievez, Lydia Cr
AU  - Fievez LC
AD  - Public Health Service Amsterdam, Dept. of Infectious Diseases, Amsterdam, TheNetherlands.
FAU - van Rijckevorsel, Gini Gc
AU  - van Rijckevorsel GG
AD  - Centre for Infectious Disease Control, National Institute for Public Health andthe Environment (RIVM), Bilthoven, The Netherlands.
AD  - Public Health Service Amsterdam, Dept. of Infectious Diseases, Amsterdam, TheNetherlands.
FAU - van den Ouden, Anton
AU  - van den Ouden A
AD  - Molecular Biology Systems BV, Goes, The Netherlands.
FAU - Jonges, Marcel
AU  - Jonges M
AD  - Amsterdam UMC location AMC, University of Amsterdam, Department of MedicalMicrobiology and Infection Prevention, Amsterdam, The Netherlands.
FAU - Welkers, Matthijs Ra
AU  - Welkers MR
AD  - Public Health Service Amsterdam, Public Health Laboratory, Amsterdam, TheNetherlands.
AD  - Amsterdam UMC location AMC, University of Amsterdam, Department of MedicalMicrobiology and Infection Prevention, Amsterdam, The Netherlands.
LA  - eng
PT  - Case Reports
PT  - Journal Article
PL  - Sweden
TA  - Euro Surveill
JT  - Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
JID - 100887452
SB  - IM
MH  - Animals
MH  - Child
MH  - Female
MH  - Homosexuality, Male
MH  - Humans
MH  - Male
MH  - *Monkeypox/diagnosis/epidemiology
MH  - Monkeypox virus
MH  - Netherlands/epidemiology
MH  - *Sexual and Gender Minorities
PMC - PMC9306258
OTO - NOTNLM
OT  - Monkeypox
OT  - Netherlands
OT  - child
OT  - whole genome sequencing
EDAT- 2022/07/23 06:00
MHDA- 2022/07/26 06:00
CRDT- 2022/07/22 05:12
PHST- 2022/07/22 05:12 [entrez]
PHST- 2022/07/23 06:00 [pubmed]
PHST- 2022/07/26 06:00 [medline]
AID - 10.2807/1560-7917.ES.2022.27.29.2200552 [doi]
PST - ppublish
SO  - Euro Surveill. 2022 Jul;27(29). doi: 10.2807/1560-7917.ES.2022.27.29.2200552.

PMID- 35863624
OWN - NLM
STAT- Publisher
LR  - 20220804
IS  - 1743-9159 (Electronic)
IS  - 1743-9159 (Linking)
VI  - 104
DP  - 2022 Jul 19
TI  - Monkeypox: Prioritizing public health through early intervention and treatment.
PG  - 106774
LID - S1743-9191(22)00551-9 [pii]
LID - 10.1016/j.ijsu.2022.106774 [doi]
FAU - Fahrni, Mathumalar Loganathan
AU  - Fahrni ML
AD  - Faculty of Pharmacy, Universiti Teknologi MARA (UiTM) Puncak Alam Campus,Selangor Branch, 42300 Bandar Puncak Alam, Selangor Darul Ehsan, Malaysia.
FAU - Priyanka
AU  - Priyanka
AD  - Department of Veterinary Microbiology, College of Veterinary Science, Guru Angad Dev Veterinary and Animal Sciences University (GADVASU), Rampura Phul, Bathinda, 151103, Punjab, India.
FAU - Sharma, Amit
AU  - Sharma A
AD  - Veterinary Officer, State Dissease Diagnostic Center, Panch Batti, Jaipur,302001, Rajasthan, India.
FAU - Choudhary, Om Prakash
AU  - Choudhary OP
AD  - Department of Veterinary Anatomy and Histology, College of Veterinary Sciencesand Animal Husbandry, Central Agricultural University (I), Selesih, Aizawl,796015, Mizoram, India. Electronic address: dr.om.choudhary@gmail.com.
LA  - eng
PT  - Letter
DEP - 20220719
PL  - England
TA  - Int J Surg
JT  - International journal of surgery (London, England)
JID - 101228232
SB  - IM
PMC - PMC9293389
OTO - NOTNLM
OT  - Antiviral
OT  - COVID-19
OT  - Control
OT  - Monkeypox
OT  - Public health
OT  - Transmission
OT  - Treatment
EDAT- 2022/07/22 06:00
MHDA- 2022/07/22 06:00
CRDT- 2022/07/21 19:36
PHST- 2022/06/29 00:00 [received]
PHST- 2022/07/08 00:00 [accepted]
PHST- 2022/07/22 06:00 [pubmed]
PHST- 2022/07/22 06:00 [medline]
PHST- 2022/07/21 19:36 [entrez]
AID - S1743-9191(22)00551-9 [pii]
AID - 10.1016/j.ijsu.2022.106774 [doi]
PST - aheadofprint
SO  - Int J Surg. 2022 Jul 19;104:106774. doi: 10.1016/j.ijsu.2022.106774.

PMID- 35860158
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220722
IS  - 2049-0801 (Print)
IS  - 2049-0801 (Linking)
VI  - 79
DP  - 2022 Jul
TI  - Monkeypox- a menacing challenge or an endemic?
PG  - 103979
LID - 10.1016/j.amsu.2022.103979 [doi]
FAU - Fatima, Nabeela
AU  - Fatima N
AD  - Department of Pharmacy Practice, St Pauls College of Pharmacy, Turkayamjal,Hyderabad, India.
FAU - Mandava, Kiranmai
AU  - Mandava K
AD  - Department of Pharmacy Practice, St Pauls College of Pharmacy, Turkayamjal,Hyderabad, India.
LA  - eng
PT  - Journal Article
DEP - 20220613
PL  - England
TA  - Ann Med Surg (Lond)
JT  - Annals of medicine and surgery (2012)
JID - 101616869
PMC - PMC9289337
COIS- None.
EDAT- 2022/07/22 06:00
MHDA- 2022/07/22 06:01
CRDT- 2022/07/21 02:25
PHST- 2022/06/04 00:00 [received]
PHST- 2022/06/06 00:00 [accepted]
PHST- 2022/07/21 02:25 [entrez]
PHST- 2022/07/22 06:00 [pubmed]
PHST- 2022/07/22 06:01 [medline]
AID - 10.1016/j.amsu.2022.103979 [doi]
AID - S2049-0801(22)00739-7 [pii]
PST - epublish
SO  - Ann Med Surg (Lond). 2022 Jun 13;79:103979. doi: 10.1016/j.amsu.2022.103979.eCollection 2022 Jul.

PMID- 35860147
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220722
IS  - 2049-0801 (Print)
IS  - 2049-0801 (Linking)
VI  - 79
DP  - 2022 Jul
TI  - Monkeypox virus: A spreading threat for Pakistan?
PG  - 103977
LID - 10.1016/j.amsu.2022.103977 [doi]
FAU - Najeeb, Hala
AU  - Najeeb H
AD  - Department of Internal Medicine, Dow University of Health Sciences, Karachi,Pakistan.
FAU - Huda, Zunera
AU  - Huda Z
AD  - Department of Internal Medicine, Dow University of Health Sciences, Karachi,Pakistan.
LA  - eng
PT  - Journal Article
DEP - 20220611
PL  - England
TA  - Ann Med Surg (Lond)
JT  - Annals of medicine and surgery (2012)
JID - 101616869
PMC - PMC9289342
OTO - NOTNLM
OT  - Monkeypox virus
OT  - Orthopoxviral
OT  - Smallpox vaccines
COIS- The authors declare that there is no conflict of interest.
EDAT- 2022/07/22 06:00
MHDA- 2022/07/22 06:01
CRDT- 2022/07/21 02:25
PHST- 2022/06/03 00:00 [received]
PHST- 2022/06/06 00:00 [accepted]
PHST- 2022/07/21 02:25 [entrez]
PHST- 2022/07/22 06:00 [pubmed]
PHST- 2022/07/22 06:01 [medline]
AID - 10.1016/j.amsu.2022.103977 [doi]
AID - S2049-0801(22)00737-3 [pii]
PST - epublish
SO  - Ann Med Surg (Lond). 2022 Jun 11;79:103977. doi: 10.1016/j.amsu.2022.103977.eCollection 2022 Jul.

PMID- 35860140
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220722
IS  - 2049-0801 (Print)
IS  - 2049-0801 (Linking)
VI  - 79
DP  - 2022 Jul
TI  - The outbreak of monkeypox 2022: An overview.
PG  - 104069
LID - 10.1016/j.amsu.2022.104069 [doi]
AB  - On May 6, 2022 an outbreak of monkeypox (MPX) was confirmed in the UnitedKingdom, originating from a British resident who had travelled to Nigeria. As of May 21, 2022, 92 cases have been confirmed worldwide, from 13 countries wheremonkeypox virus (MPXV) is not endemic. Reported cases thus far have mainly butnot exclusively been identified among gay and bisexual men aged 20-50. MPXV is a viral zoonosis transmitted to humans via contacting or eating an infected animal,and direct connect with natural host's blood and body fluids. In addition tocontacting with a patient's respiratory droplets, lesions, body fluids andpolluted personal objects. Symptoms including shivers, headaches, fainting,backaches, and myodynia do not have any specific characteristics making itdifficult to establish a proper diagnosis. Nevertheless, lymphatic hyperplasia,one of the most common symptoms of monkeypox, can be useful for diagnosing thedisease. Clinical symptoms help establish the suspicion of monkeypox. However, inthe absence of confirmed diagnostic tests it is very difficult to verify thedisease and determine its cause based on clinical symptoms alone. There arenumerous methods for detecting MPX, involving genetic, phenotypic, immunological methods, and electron microscopy. These tests require modern equipment and experthands, which may not be available in developing countries where this disease isprevalent. Currently, there is no definite treatment for MPX. CDC recommendsadministering the smallpox vaccine within 4 days of exposure which may preventthe disease from happening, and within 2 weeks to reduce symptoms severity. Topromptly identify patients and prevent further spreading, physicians should beaware of the travel or contact history of the patient with compatible symptoms.
CI  - (c) 2022 The Authors.
FAU - Hraib, Munawar
AU  - Hraib M
AD  - Faculty of Medicine, Tishreen University, Latakia, Syria.
FAU - Jouni, Sarah
AU  - Jouni S
AD  - Faculty of Medicine, Tishreen University, Latakia, Syria.
FAU - Albitar, Mhd Mustafa
AU  - Albitar MM
AD  - Faculty of Medicine, Damascus University, Damascus, Syria.
FAU - Alaidi, Sara
AU  - Alaidi S
AD  - Faculty of Medicine, Tishreen University, Latakia, Syria.
FAU - Alshehabi, Zuheir
AU  - Alshehabi Z
AD  - Department of Pathology, Tishreen University Hospital, Latakia, Syria.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20220624
PL  - England
TA  - Ann Med Surg (Lond)
JT  - Annals of medicine and surgery (2012)
JID - 101616869
PMC - PMC9289401
OTO - NOTNLM
OT  - Monkeypox
OT  - Outbreak
OT  - Smallpox
OT  - Zoonosis
COIS- The Authors declare that there is no conflict of interest.
EDAT- 2022/07/22 06:00
MHDA- 2022/07/22 06:01
CRDT- 2022/07/21 02:25
PHST- 2022/05/25 00:00 [received]
PHST- 2022/06/22 00:00 [accepted]
PHST- 2022/07/21 02:25 [entrez]
PHST- 2022/07/22 06:00 [pubmed]
PHST- 2022/07/22 06:01 [medline]
AID - 10.1016/j.amsu.2022.104069 [doi]
AID - S2049-0801(22)00829-9 [pii]
PST - epublish
SO  - Ann Med Surg (Lond). 2022 Jun 24;79:104069. doi: 10.1016/j.amsu.2022.104069.eCollection 2022 Jul.

PMID- 35860124
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220722
IS  - 2049-0801 (Print)
IS  - 2049-0801 (Linking)
VI  - 79
DP  - 2022 Jul
TI  - Human monkeypox expansion from the endemic to non-endemic regions: Controlmeasures.
PG  - 104048
LID - 10.1016/j.amsu.2022.104048 [doi]
AB  - The recent monkeypox outbreak in non-endemic countries is a rare event. It is azoonosis with clinical features similar to smallpox, transmitting from animal to human and human to human. Since 2000, the number of monkeypox cases in humans hadincreased in African countries, resulting in its spread to the other parts of theworld. On May 26, 2022 World Health Organization has confirmed 120 cases ofmonkeypox in 23 non-endemic countries. The decreased immunity to theOrthopoxviruses, human migration from endemic to non-endemic regions, geneticmutations in the viral genome, and reduced surveillance may contribute to therecent outbreaks. A multi-pronged approach comprising health education, tracking human migration, developing diagnostic facilities, and an effective vaccine couldprevent transmission and pathogenicity.
CI  - (c) 2022 The Author(s).
FAU - Jamil, Hashaam
AU  - Jamil H
AD  - Lahore General Hospital, Lahore, 54000, Pakistan.
FAU - Tariq, Waleed
AU  - Tariq W
AD  - Lahore General Hospital, Lahore, 54000, Pakistan.
FAU - Tahir, Muhammad Junaid
AU  - Tahir MJ
AD  - Lahore General Hospital, Lahore, 54000, Pakistan.
FAU - Mahfooz, Rabia Salman
AU  - Mahfooz RS
AD  - Shalamar Institute of Health Sciences, Lahore, Pakistan.
FAU - Asghar, Muhammad Sohaib
AU  - Asghar MS
AD  - Dow University of Health Sciences-Ojha Campus, Karachi, Pakistan.
FAU - Ahmed, Ali
AU  - Ahmed A
AD  - School of Pharmacy, Monash University, Jalan Lagoon Selatan, Bandar Sunway,47500, Subang Jaya, Selangor, Malaysia.
LA  - eng
PT  - Journal Article
DEP - 20220623
PL  - England
TA  - Ann Med Surg (Lond)
JT  - Annals of medicine and surgery (2012)
JID - 101616869
PMC - PMC9289418
OTO - NOTNLM
OT  - Epidemic
OT  - Infection
OT  - Public health
OT  - Vaccination
OT  - Virology
OT  - Zoonosis
COIS- None.
EDAT- 2022/07/22 06:00
MHDA- 2022/07/22 06:01
CRDT- 2022/07/21 02:25
PHST- 2022/06/15 00:00 [received]
PHST- 2022/06/18 00:00 [accepted]
PHST- 2022/07/21 02:25 [entrez]
PHST- 2022/07/22 06:00 [pubmed]
PHST- 2022/07/22 06:01 [medline]
AID - 10.1016/j.amsu.2022.104048 [doi]
AID - S2049-0801(22)00808-1 [pii]
PST - epublish
SO  - Ann Med Surg (Lond). 2022 Jun 23;79:104048. doi: 10.1016/j.amsu.2022.104048.eCollection 2022 Jul.

PMID- 35860122
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220722
IS  - 2049-0801 (Print)
IS  - 2049-0801 (Linking)
VI  - 79
DP  - 2022 Jul
TI  - Monkeypox has devastated the world; should we prepare for the outbreak of a newpandemic?
PG  - 104051
LID - 10.1016/j.amsu.2022.104051 [doi]
AB  - The monkeypox virus, which belongs to the orthopoxy virus family, causes fever,lethargy, headache, lymphadenopathy, myalgia, and rash, as well as variouscomplications such as superimposed infections, sepsis, keratitis, encephalitis,and bronchopneumonia. Following replication at the site of injection, the virusoften enters by the oropharynx, nasopharynx, or intradermal pathway, spreading tolymph nodes before viremia, promoting viral dissemination to other organ systems.Monkeypox cases have recently been brought to WHO's notice from 12 presentlynon-endemic member nations spread over three WHO regions, with 92laboratory-confirmed cases and 28 cases of suspicion as of May 21, 2022.Monkeypox is presently endemic in the Central African Republic, the DemocraticRepublic of the Congo, Benin, Cameroon, Gabon, Sierra Leone, and South Sudan.Monkeypox cases have been detected all across the world, posing a challenge tohealthcare infrastructure that is still recovering from the COVID-19 outbreak.Close monitoring and exact data collecting, the implementation of successfulprograms across the world, and public support of preventative measures are someof the strategies being used to cope with the increasing incidence of monkeypox.
CI  - (c) 2022 The Authors.
FAU - Awan, Malik Ali Ehtsham
AU  - Awan MAE
AD  - Dow University of Health Sciences, Karachi, Pakistan.
FAU - Waseem, Maria
AU  - Waseem M
AD  - Dow University of Health Sciences, Karachi, Pakistan.
FAU - Sahito, Areesh Fatima
AU  - Sahito AF
AD  - Peoples University of Medical and Health Sciences for Women (PUMHSW), Nawabshah, Pakistan.
FAU - Sahito, Abdul Moiz
AU  - Sahito AM
AD  - Dow University of Health Sciences, Karachi, Pakistan.
FAU - Khatri, Govinda
AU  - Khatri G
AD  - Dow University of Health Sciences, Karachi, Pakistan.
FAU - Butt, Masood Ahmed
AU  - Butt MA
AD  - Pir Abdul Qadir Shah Jeelani Institute of Medical Sciences, Gambat, Pakistan.
FAU - Ramproshad, Sarker
AU  - Ramproshad S
AD  - Department of Pharmacy, Ranada Prasad Shaha University, Narayanganj, Bangladesh.
FAU - Mondal, Banani
AU  - Mondal B
AD  - Department of Pharmacy, Ranada Prasad Shaha University, Narayanganj, Bangladesh.
FAU - Hasan, Mohammad Mehedi
AU  - Hasan MM
AD  - Department of Biochemistry and Molecular Biology, Faculty of Life Science,Mawlana Bhashani Science and Technology University, Tangail, Bangladesh.
LA  - eng
PT  - Journal Article
DEP - 20220623
PL  - England
TA  - Ann Med Surg (Lond)
JT  - Annals of medicine and surgery (2012)
JID - 101616869
PMC - PMC9289421
OTO - NOTNLM
OT  - COVID-19
OT  - Healthcare system
OT  - Monkeypox
OT  - Outbreak
OT  - Prevention
COIS- No conflict of interest to be declared.
EDAT- 2022/07/22 06:00
MHDA- 2022/07/22 06:01
CRDT- 2022/07/21 02:25
PHST- 2022/06/14 00:00 [received]
PHST- 2022/06/18 00:00 [accepted]
PHST- 2022/07/21 02:25 [entrez]
PHST- 2022/07/22 06:00 [pubmed]
PHST- 2022/07/22 06:01 [medline]
AID - 10.1016/j.amsu.2022.104051 [doi]
AID - S2049-0801(22)00811-1 [pii]
PST - epublish
SO  - Ann Med Surg (Lond). 2022 Jun 23;79:104051. doi: 10.1016/j.amsu.2022.104051.eCollection 2022 Jul.

PMID- 35859005
OWN - NLM
STAT- Publisher
LR  - 20220731
IS  - 1740-1534 (Electronic)
IS  - 1740-1526 (Linking)
DP  - 2022 Jul 20
TI  - Monkeypox virus: a neglected zoonotic pathogen spreads globally.
LID - 10.1038/s41579-022-00776-z [doi]
FAU - Alakunle, Emmanuel F
AU  - Alakunle EF
AUID- ORCID: http://orcid.org/0000-0003-1960-6152
AD  - Department of Natural and Environmental Sciences, American University of Nigeria,Yola, Adamawa, Nigeria.
FAU - Okeke, Malachy I
AU  - Okeke MI
AUID- ORCID: http://orcid.org/0000-0002-7137-9551
AD  - Department of Natural and Environmental Sciences, American University of Nigeria,Yola, Adamawa, Nigeria. malachy.okeke@aun.edu.ng.
LA  - eng
PT  - Journal Article
DEP - 20220720
PL  - England
TA  - Nat Rev Microbiol
JT  - Nature reviews. Microbiology
JID - 101190261
SB  - IM
CIN - Nature. 2022 Jul;607(7920):635-636. PMID: 35882992
PMC - PMC9297671
EDAT- 2022/07/21 06:00
MHDA- 2022/07/21 06:00
CRDT- 2022/07/20 23:47
PHST- 2022/07/20 23:47 [entrez]
PHST- 2022/07/21 06:00 [pubmed]
PHST- 2022/07/21 06:00 [medline]
AID - 10.1038/s41579-022-00776-z [doi]
AID - 10.1038/s41579-022-00776-z [pii]
PST - aheadofprint
SO  - Nat Rev Microbiol. 2022 Jul 20. pii: 10.1038/s41579-022-00776-z. doi:10.1038/s41579-022-00776-z.

PMID- 35857487
OWN - NLM
STAT- Publisher
LR  - 20220720
IS  - 1095-9203 (Electronic)
IS  - 0036-8075 (Linking)
DP  - 2022 Jul 19
TI  - Confronting 21st-century monkeypox.
PG  - eadd9651
LID - 10.1126/science.add9651 [doi]
FAU - Osterholm, Michael T
AU  - Osterholm MT
AD  - Michael T. Osterholm is director of the Center for Infectious Disease Researchand Policy at the University of Minnesota, Minneapolis, MN, USA. mto@umn.edu.
AD  - Bruce Gellin is chief of global public health strategy at The RockefellerFoundation, Washington, DC, USA. bgellin@rockfound.org.
FAU - Gellin, Bruce
AU  - Gellin B
AD  - Michael T. Osterholm is director of the Center for Infectious Disease Researchand Policy at the University of Minnesota, Minneapolis, MN, USA. mto@umn.edu.
AD  - Bruce Gellin is chief of global public health strategy at The RockefellerFoundation, Washington, DC, USA. bgellin@rockfound.org.
LA  - eng
PT  - Editorial
DEP - 20220719
PL  - United States
TA  - Science
JT  - Science (New York, N.Y.)
JID - 0404511
SB  - IM
EDAT- 2022/07/21 06:00
MHDA- 2022/07/21 06:00
CRDT- 2022/07/20 12:43
PHST- 2022/07/20 12:43 [entrez]
PHST- 2022/07/21 06:00 [pubmed]
PHST- 2022/07/21 06:00 [medline]
AID - 10.1126/science.add9651 [doi]
PST - aheadofprint
SO  - Science. 2022 Jul 19:eadd9651. doi: 10.1126/science.add9651.

PMID- 35855877
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220720
IS  - 2049-0801 (Print)
IS  - 2049-0801 (Linking)
VI  - 80
DP  - 2022 Aug
TI  - Is MonkeyPox the next pandemic to be dealt with?
PG  - 104131
LID - 10.1016/j.amsu.2022.104131 [doi]
FAU - Pokhrel, Amrit
AU  - Pokhrel A
AD  - Medical Officer, Department of Emergency, Metrocity Hospital, Nepal.
LA  - eng
PT  - Journal Article
DEP - 20220714
PL  - England
TA  - Ann Med Surg (Lond)
JT  - Annals of medicine and surgery (2012)
JID - 101616869
PMC - PMC9280142
COIS- None.
EDAT- 2022/07/21 06:00
MHDA- 2022/07/21 06:01
CRDT- 2022/07/20 04:08
PHST- 2022/07/04 00:00 [received]
PHST- 2022/07/06 00:00 [accepted]
PHST- 2022/07/20 04:08 [entrez]
PHST- 2022/07/21 06:00 [pubmed]
PHST- 2022/07/21 06:01 [medline]
AID - 10.1016/j.amsu.2022.104131 [doi]
AID - S2049-0801(22)00891-3 [pii]
PST - ppublish
SO  - Ann Med Surg (Lond). 2022 Aug;80:104131. doi: 10.1016/j.amsu.2022.104131. Epub2022 Jul 14.

PMID- 35855873
OWN - NLM
STAT- Publisher
LR  - 20220721
IS  - 2049-0801 (Print)
IS  - 2049-0801 (Linking)
DP  - 2022 Jul 14
TI  - The burden of monkeypox virus amidst the Covid-19 pandemic in Africa: A doublebattle for Africa.
PG  - 104197
LID - 10.1016/j.amsu.2022.104197 [doi]
AB  - The Coronavirus Disease - 19 (COVID-19) pandemic has put additional strain onAfrica's fragile healthcare systems and has impacted the rise of emerging andre-emerging infectious diseases. Currently, there is a rise in cases of MonkeypoxDisease, a zoonotic viral disease caused by the Monkeypox virus, which was first documented in 1970 in the Democratic Republic of the Congo. Most of the clinical symptoms of Monkeypox resemble that of smallpox, whose virus also belongs to the same genus. Initial symptoms include headache, fever, and fatigue, followed bylymphadenopathy and a rash. This study aims to provide more insight intoMonkeypox by exposing its current burden and efforts to combat it amidst COVID-19in Africa. Since Monkeypox disease is re-emerging and is less contagious thanCOVID-19, prevention and treatment are much more manageable. Still, Africancountries face several crucial challenges in responding to the Monkeypox in timesof the covid-19 pandemic. These include lack of a well-functioning surveillancesystem for early detection of the disease, lack of awareness and knowledge of themonkeypox disease across the general population, lack of healthcare facilitiesalready burdened by COVID-19 cases, and shortage of trained healthcareprofessionals. On the other hand, one significant factor contributing to theminimized risk in Africa was the smallpox vaccination done before 1980. However, a declining cross-protective immunity is seen in those inoculated with thesmallpox vaccine and the ever-increasing risk to the unvaccinated population.Thus, focusing on vaccination and disease surveillance operations and diligentmonitoring, as well as cross-border collaborations with international sectors,including One Health, FOA, OIE, and WHO is critical to achieving the ultimateeradication of monkeypox in Africa.
CI  - (c) 2022 Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.
FAU - Uwishema, Olivier
AU  - Uwishema O
AD  - Oli Health Magazine Organization, Research and Education, Kigali, Rwanda.
AD  - Clinton Global Initiative University, New York, USA.
AD  - Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey.
FAU - Adekunbi, Oluyemisi
AU  - Adekunbi O
AD  - Oli Health Magazine Organization, Research and Education, Kigali, Rwanda.
AD  - Babcock University, Ilishan-Remo, Ogun State, Nigeria.
FAU - Penamante, Criselle Angeline
AU  - Penamante CA
AD  - Oli Health Magazine Organization, Research and Education, Kigali, Rwanda.
AD  - Department of Psychology, College of Science, University of Santo Tomas, Manila, Philippines.
AD  - Faculty of Medicine and Surgery, University of Santo Tomas, Manila, Philippines.
FAU - Bekele, Bezawit Kassahun
AU  - Bekele BK
AD  - Oli Health Magazine Organization, Research and Education, Kigali, Rwanda.
AD  - Faculty of Medicine, Addis Ababa University, Addis Ababa, Ethiopia.
FAU - Khoury, Carlo
AU  - Khoury C
AD  - Oli Health Magazine Organization, Research and Education, Kigali, Rwanda.
AD  - Faculty of Medicine, University of Saint Joseph of Beirut, Beirut, Lebanon.
FAU - Mhanna, Melissa
AU  - Mhanna M
AD  - Oli Health Magazine Organization, Research and Education, Kigali, Rwanda.
AD  - Faculty of Medicine, University of Saint Joseph of Beirut, Beirut, Lebanon.
FAU - Nicholas, Aderinto
AU  - Nicholas A
AD  - Oli Health Magazine Organization, Research and Education, Kigali, Rwanda.
AD  - Department of Medicine and Surgery, Ladoke Akintola University of Technology,Ogbomoso, Nigeria.
FAU - Adanur, Irem
AU  - Adanur I
AD  - Oli Health Magazine Organization, Research and Education, Kigali, Rwanda.
AD  - Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey.
FAU - Dost, Burhan
AU  - Dost B
AD  - Department of Anaesthesiology and Reanimation, Ondokuz Mayis University Facultyof Medicine, Samsun, Turkey.
FAU - Onyeaka, Helen
AU  - Onyeaka H
AD  - School of Chemical Engineering, University of Birmingham, Edgbaston, Birmingham, B152TT, UK.
LA  - eng
PT  - Journal Article
DEP - 20220714
PL  - England
TA  - Ann Med Surg (Lond)
JT  - Annals of medicine and surgery (2012)
JID - 101616869
PMC - PMC9279180
OTO - NOTNLM
OT  - Africa2
OT  - COVID-19
OT  - Monkeypox virus
OT  - Pandemic
EDAT- 2022/07/21 06:00
MHDA- 2022/07/21 06:00
CRDT- 2022/07/20 04:08
PHST- 2022/06/10 00:00 [received]
PHST- 2022/07/11 00:00 [revised]
PHST- 2022/07/11 00:00 [accepted]
PHST- 2022/07/20 04:08 [entrez]
PHST- 2022/07/21 06:00 [pubmed]
PHST- 2022/07/21 06:00 [medline]
AID - 10.1016/j.amsu.2022.104197 [doi]
AID - S2049-0801(22)00957-8 [pii]
PST - aheadofprint
SO  - Ann Med Surg (Lond). 2022 Jul 14:104197. doi: 10.1016/j.amsu.2022.104197.

PMID- 35848685
OWN - NLM
STAT- MEDLINE
DCOM- 20220719
LR  - 20220719
IS  - 1998-3751 (Electronic)
IS  - 0253-7613 (Linking)
VI  - 54
IP  - 3
DP  - 2022 May-Jun
TI  - Monkeypox infection: A quick glance.
PG  - 161-164
LID - 10.4103/ijp.ijp_400_22 [doi]
FAU - Choudhary, Gajendra
AU  - Choudhary G
AD  - Department of Pharmacology, Postgraduate Institute of Medical Education andResearch, Chandigarh, India.
FAU - Prabha, Praisy K
AU  - Prabha PK
AD  - Department of Pharmacology, Postgraduate Institute of Medical Education andResearch, Chandigarh, India.
FAU - Gupta, Shreya
AU  - Gupta S
AD  - Department of Pharmacology, Postgraduate Institute of Medical Education andResearch, Chandigarh, India.
FAU - Prakash, Ajay
AU  - Prakash A
AD  - Department of Pharmacology, Postgraduate Institute of Medical Education andResearch, Chandigarh, India.
FAU - Medhi, Bikash
AU  - Medhi B
AD  - Department of Pharmacology, Postgraduate Institute of Medical Education andResearch, Chandigarh, India.
LA  - eng
PT  - Editorial
PL  - India
TA  - Indian J Pharmacol
JT  - Indian journal of pharmacology
JID - 7902477
SB  - IM
MH  - Animals
MH  - Humans
MH  - *Monkeypox/diagnosis
COIS- None
EDAT- 2022/07/19 06:00
MHDA- 2022/07/20 06:00
CRDT- 2022/07/18 07:33
PHST- 2022/07/18 07:33 [entrez]
PHST- 2022/07/19 06:00 [pubmed]
PHST- 2022/07/20 06:00 [medline]
AID - Indian J Pharmacol_2022_54_3_161_350704 [pii]
AID - 10.4103/ijp.ijp_400_22 [doi]
PST - ppublish
SO  - Indian J Pharmacol. 2022 May-Jun;54(3):161-164. doi: 10.4103/ijp.ijp_400_22.

PMID- 35847384
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220719
IS  - 2590-0889 (Electronic)
IS  - 2590-0889 (Linking)
VI  - 4
IP  - 3
DP  - 2022 Sep
TI  - Monkeypox: An old foe, with new challenges.
PG  - 100229
LID - 10.1016/j.infpip.2022.100229 [doi]
AB  - At first glance, a multi-country outbreak of monkeypox in 2022 seems unusual.However, the re-emergence and expansion of this viral disease beyond itsendemicity in West and Central Africa had previously been predicted as a possibleconsequence of a decline in population immunity following smallpox eradication.Since the 13th of May 2022, cases of monkeypox have been reported in at least 28 WHO member states from within 4 regions (the Americans, European, EasternMediterranean and Western Pacific regions). This summary describes themulti-country outbreak to date, with an emphasis on patient demographics, common symptoms and signs, clinical management (including infection prevention measures)and clinical outcomes of the cases in the United Kingdom, which has so farreported the largest number of laboratory confirmed cases. The futureimplications of this outbreak, including preventative measures to curb thecurrent outbreak, prevent future outbreaks and the likelihood of the diseasebecoming endemic in the UK are also discussed.
CI  - Crown Copyright (c) 2022 Published by Elsevier Ltd on behalf of The HealthcareInfection Society.
FAU - Bosworth, Andrew
AU  - Bosworth A
AD  - Infection Service, Clinical Laboratory Services, Queen Elizabeth Hospital,University Hospitals Birmingham NHS Foundation Trust, B15 2GW, UK.
FAU - Wakerley, Dominic
AU  - Wakerley D
AD  - Rare and Imported Pathogens Laboratory, UK Health Security Agency, Porton Down,Manor Farm Road, Salisbury, SP4 0JG, UK.
AD  - Department of Pathology, University College London Hospital, UK.
FAU - Houlihan, Catherine F
AU  - Houlihan CF
AD  - Rare and Imported Pathogens Laboratory, UK Health Security Agency, Porton Down,Manor Farm Road, Salisbury, SP4 0JG, UK.
AD  - Department of Pathology, University College London Hospital, UK.
AD  - Department of Infection and Immunity, University College London, UK.
FAU - Atabani, Sowsan F
AU  - Atabani SF
AD  - Infection Service, Clinical Laboratory Services, Queen Elizabeth Hospital,University Hospitals Birmingham NHS Foundation Trust, B15 2GW, UK.
AD  - Regional Public Health Laboratory Birmingham, UK Health Security Agency,Birmingham, B9 5SS, UK.
LA  - eng
PT  - Journal Article
DEP - 20220630
PL  - England
TA  - Infect Prev Pract
JT  - Infection prevention in practice
JID - 101777928
PMC - PMC9283547
EDAT- 2022/07/19 06:00
MHDA- 2022/07/19 06:01
CRDT- 2022/07/18 04:15
PHST- 2022/06/21 00:00 [received]
PHST- 2022/06/23 00:00 [accepted]
PHST- 2022/07/18 04:15 [entrez]
PHST- 2022/07/19 06:00 [pubmed]
PHST- 2022/07/19 06:01 [medline]
AID - 10.1016/j.infpip.2022.100229 [doi]
AID - S2590-0889(22)00030-0 [pii]
PST - epublish
SO  - Infect Prev Pract. 2022 Jun 30;4(3):100229. doi: 10.1016/j.infpip.2022.100229.eCollection 2022 Sep.

PMID- 35843593
OWN - NLM
STAT- Publisher
LR  - 20220804
IS  - 1743-9159 (Electronic)
IS  - 1743-9159 (Linking)
DP  - 2022 Jul 16
TI  - A commentary on "The 2022 monkeypox outbreak: Lessons from the 640 cases in 36countries" (Int J Surg 2022;104:106712).
PG  - 106769
LID - S1743-9191(22)00546-5 [pii]
LID - 10.1016/j.ijsu.2022.106769 [doi]
FAU - Sookaromdee, Pathum
AU  - Sookaromdee P
AD  - Private Academic Consultant, Bangkok, Thailand. Electronic address:pathumsook@gmail.com.
FAU - Wiwanitkti, Viroj
AU  - Wiwanitkti V
AD  - Dr DY Patil University, Pune, India.
LA  - eng
PT  - Letter
DEP - 20220716
PL  - England
TA  - Int J Surg
JT  - International journal of surgery (London, England)
JID - 101228232
SB  - IM
EDAT- 2022/07/18 06:00
MHDA- 2022/07/18 06:00
CRDT- 2022/07/17 19:29
PHST- 2022/06/17 00:00 [received]
PHST- 2022/07/05 00:00 [accepted]
PHST- 2022/07/18 06:00 [pubmed]
PHST- 2022/07/18 06:00 [medline]
PHST- 2022/07/17 19:29 [entrez]
AID - S1743-9191(22)00546-5 [pii]
AID - 10.1016/j.ijsu.2022.106769 [doi]
PST - aheadofprint
SO  - Int J Surg. 2022 Jul 16:106769. doi: 10.1016/j.ijsu.2022.106769.

PMID- 35842889
OWN - NLM
STAT- Publisher
LR  - 20220717
IS  - 1326-5377 (Electronic)
IS  - 0025-729X (Linking)
DP  - 2022 Jul 17
TI  - Is Australia ready for monkeypox?
LID - 10.5694/mja2.51647 [doi]
FAU - MacIntyre, C Raina
AU  - MacIntyre CR
AUID- ORCID: https://orcid.org/0000-0002-3060-0555
AD  - Kirby Institute, UNSW Sydney, Sydney, NSW.
FAU - Grulich, Andrew E
AU  - Grulich AE
AD  - Kirby Institute, UNSW Sydney, Sydney, NSW.
LA  - eng
PT  - Editorial
DEP - 20220717
PL  - Australia
TA  - Med J Aust
JT  - The Medical journal of Australia
JID - 0400714
SB  - IM
OTO - NOTNLM
OT  - Infectious diseases
OT  - Poxviridae infections
EDAT- 2022/07/18 06:00
MHDA- 2022/07/18 06:00
CRDT- 2022/07/17 14:10
PHST- 2022/06/16 00:00 [revised]
PHST- 2022/06/06 00:00 [received]
PHST- 2022/06/21 00:00 [accepted]
PHST- 2022/07/17 14:10 [entrez]
PHST- 2022/07/18 06:00 [pubmed]
PHST- 2022/07/18 06:00 [medline]
AID - 10.5694/mja2.51647 [doi]
PST - aheadofprint
SO  - Med J Aust. 2022 Jul 17. doi: 10.5694/mja2.51647.

PMID- 35841292
OWN - NLM
STAT- Publisher
LR  - 20220721
IS  - 1468-3083 (Electronic)
IS  - 0926-9959 (Linking)
DP  - 2022 Jul 16
TI  - Monkeypox: a new (sexually transmissible) epidemic?
LID - 10.1111/jdv.18424 [doi]
FAU - Alpalhao, M
AU  - Alpalhao M
AUID- ORCID: https://orcid.org/0000-0001-7672-0395
AD  - Dermatology Research Unit (PFilipe Lab), Instituto de Medicina Molecular JoaoLobo Antunes, University of Lisbon, Lisbon, Portugal.
AD  - Dermatology Department, Centro Hospitalar Universitario Lisboa Norte EPE, Lisbon,Portugal.
AD  - Dermatology University Clinic, Faculty of Medicine, University of Lisbon, Lisbon,Portugal.
FAU - Frade, J V
AU  - Frade JV
AD  - Dermatology Department, Centro Hospitalar Universitario Lisboa Norte EPE, Lisbon,Portugal.
FAU - Sousa, D
AU  - Sousa D
AUID- ORCID: https://orcid.org/0000-0002-5415-887X
AD  - Dermatology Department, Centro Hospitalar Universitario Lisboa Norte EPE, Lisbon,Portugal.
FAU - Patrocinio, J
AU  - Patrocinio J
AD  - Dermatology Department, Centro Hospitalar Universitario Lisboa Norte EPE, Lisbon,Portugal.
FAU - Garrido, P M
AU  - Garrido PM
AD  - Dermatology Department, Centro Hospitalar Universitario Lisboa Norte EPE, Lisbon,Portugal.
FAU - Correia, C
AU  - Correia C
AD  - Dermatology Department, Centro Hospitalar Universitario Lisboa Norte EPE, Lisbon,Portugal.
FAU - Brazao, C
AU  - Brazao C
AD  - Dermatology Department, Centro Hospitalar Universitario Lisboa Norte EPE, Lisbon,Portugal.
FAU - Mancha, D
AU  - Mancha D
AD  - Dermatology Department, Centro Hospitalar Universitario Lisboa Norte EPE, Lisbon,Portugal.
FAU - Borrego, M J
AU  - Borrego MJ
AD  - Unidade de Investigacao e Desenvolvimento do Departamento de Doencas Infecciosas do Instituto Nacional de Saude Dr. Ricardo Jorge, Lisbon, Portugal.
FAU - Filipe, P
AU  - Filipe P
AD  - Dermatology Research Unit (PFilipe Lab), Instituto de Medicina Molecular JoaoLobo Antunes, University of Lisbon, Lisbon, Portugal.
AD  - Dermatology Department, Centro Hospitalar Universitario Lisboa Norte EPE, Lisbon,Portugal.
AD  - Dermatology University Clinic, Faculty of Medicine, University of Lisbon, Lisbon,Portugal.
LA  - eng
PT  - Letter
DEP - 20220716
PL  - England
TA  - J Eur Acad Dermatol Venereol
JT  - Journal of the European Academy of Dermatology and Venereology : JEADV
JID - 9216037
SB  - IM
EDAT- 2022/07/17 06:00
MHDA- 2022/07/17 06:00
CRDT- 2022/07/16 06:32
PHST- 2022/07/17 06:00 [pubmed]
PHST- 2022/07/17 06:00 [medline]
PHST- 2022/07/16 06:32 [entrez]
AID - 10.1111/jdv.18424 [doi]
PST - aheadofprint
SO  - J Eur Acad Dermatol Venereol. 2022 Jul 16. doi: 10.1111/jdv.18424.

PMID- 35840078
OWN - NLM
STAT- Publisher
LR  - 20220804
IS  - 1873-0442 (Electronic)
IS  - 1477-8939 (Linking)
VI  - 49
DP  - 2022 Jul 13
TI  - Phylogenomic analysis of the monkeypox virus (MPXV) 2022 outbreak: Emergence of anovel viral lineage?
PG  - 102402
LID - S1477-8939(22)00148-X [pii]
LID - 10.1016/j.tmaid.2022.102402 [doi]
AB  - Monkeypox is a zoonotic disease with clinical manifestations similar to smallpox in humans. Since May 13, 2022, an increasing number of suspected and confirmedcases have been reported, affecting non-endemic regions across the globe. Morestrikingly, reports from the current outbreak reveal unique aspects regardingtransmission dynamics and an unprecedented, rapidly expanding and sustainedcommunity transmission. As demonstrated through the still-ongoing COVID-19pandemic, genomic surveillance has been an essential resource for monitoring and tracking the evolution of pathogens of public health relevance. Herein, weperformed a phylogenomic analysis of available Monkeypox virus (MPXV) genomes to determine their evolution and diversity. Our analysis revealed that all MPXVgenomes grouped into three monophyletic clades: two previously characterizedclades and a newly emerging clade harboring genomes from the ongoing 2022multi-country outbreak with 286 genomes comprising the hMPXV-1A clade and thenewly classified lineages: A.1 (n = 6), A.1.1 (n = 1), A.2 (n = 3) and B.1 (n =262), where lineage B.1 includes all MPXV genomes from the 2022 outbreak.Finally, it was estimated that B.1 lineage of this clade emerged in Europe on03/02/2022 [95%CI = 11/13/2021 to 05/10/2022]. The exceptional surge of cases andthe broader geographical expansion suggest multifactorial factors as drivers ofthe current outbreak dynamics. Such factors may include the cessation of smallpoxvaccination and its potential spread across particular networks. Integratingpertinent epidemiological information with genomic surveillance information will help generate real-time data to help implement adequate preventive and controlmeasures by optimizing public health decisions to mitigate this outbreak.
CI  - Copyright (c) 2022 Elsevier Ltd. All rights reserved.
FAU - Luna, Nicolas
AU  - Luna N
AD  - Centro de Investigaciones en Microbiologia y Biotecnologia - UR (CIMBIUR),Facultad de Ciencias Naturales, Universidad del Rosario, Bogota, Colombia.
FAU - Ramirez, Angie L
AU  - Ramirez AL
AD  - Centro de Investigaciones en Microbiologia y Biotecnologia - UR (CIMBIUR),Facultad de Ciencias Naturales, Universidad del Rosario, Bogota, Colombia.
FAU - Munoz, Marina
AU  - Munoz M
AD  - Centro de Investigaciones en Microbiologia y Biotecnologia - UR (CIMBIUR),Facultad de Ciencias Naturales, Universidad del Rosario, Bogota, Colombia.
FAU - Ballesteros, Nathalia
AU  - Ballesteros N
AD  - Centro de Investigaciones en Microbiologia y Biotecnologia - UR (CIMBIUR),Facultad de Ciencias Naturales, Universidad del Rosario, Bogota, Colombia.
FAU - Patino, Luz H
AU  - Patino LH
AD  - Centro de Investigaciones en Microbiologia y Biotecnologia - UR (CIMBIUR),Facultad de Ciencias Naturales, Universidad del Rosario, Bogota, Colombia.
FAU - Castaneda, Sergio Andres
AU  - Castaneda SA
AD  - Centro de Investigaciones en Microbiologia y Biotecnologia - UR (CIMBIUR),Facultad de Ciencias Naturales, Universidad del Rosario, Bogota, Colombia.
FAU - Bonilla-Aldana, D Katterine
AU  - Bonilla-Aldana DK
AD  - Grupo de Investigacion Biomedicina, Faculty of Medicine, InstitucionUniversitaria Vision de las Americas, Pereira, Risaralda, Colombia; LatinAmerican network of Monkeypox Virus research (LAMOVI), Pereira, Risaralda,Colombia.
FAU - Paniz-Mondolfi, Alberto
AU  - Paniz-Mondolfi A
AD  - Molecular Microbiology Laboratory, Department of Pathology, Molecular andCell-based Medicine, Icahn School of Medicine at Mount Sinai, New York city, NY, USA.
FAU - Ramirez, Juan David
AU  - Ramirez JD
AD  - Centro de Investigaciones en Microbiologia y Biotecnologia - UR (CIMBIUR),Facultad de Ciencias Naturales, Universidad del Rosario, Bogota, Colombia;Molecular Microbiology Laboratory, Department of Pathology, Molecular andCell-based Medicine, Icahn School of Medicine at Mount Sinai, New York city, NY, USA. Electronic address: juand.ramirez@urosario.edu.co.
LA  - eng
PT  - Journal Article
DEP - 20220713
PL  - Netherlands
TA  - Travel Med Infect Dis
JT  - Travel medicine and infectious disease
JID - 101230758
SB  - IM
OTO - NOTNLM
OT  - B.1 lineage
OT  - Monkeypox virus
OT  - Outbreak
OT  - Phylogenomic analysis
EDAT- 2022/07/16 06:00
MHDA- 2022/07/16 06:00
CRDT- 2022/07/15 19:27
PHST- 2022/07/04 00:00 [received]
PHST- 2022/07/10 00:00 [revised]
PHST- 2022/07/11 00:00 [accepted]
PHST- 2022/07/16 06:00 [pubmed]
PHST- 2022/07/16 06:00 [medline]
PHST- 2022/07/15 19:27 [entrez]
AID - S1477-8939(22)00148-X [pii]
AID - 10.1016/j.tmaid.2022.102402 [doi]
PST - aheadofprint
SO  - Travel Med Infect Dis. 2022 Jul 13;49:102402. doi: 10.1016/j.tmaid.2022.102402.

PMID- 35837964
OWN - NLM
STAT- MEDLINE
DCOM- 20220718
LR  - 20220729
IS  - 1560-7917 (Electronic)
IS  - 1025-496X (Linking)
VI  - 27
IP  - 28
DP  - 2022 Jul
TI  - Frequent detection of monkeypox virus DNA in saliva, semen, and other clinicalsamples from 12 patients, Barcelona, Spain, May to June 2022.
LID - 10.2807/1560-7917.ES.2022.27.28.2200503 [doi]
AB  - A monkeypox (MPX) outbreak has expanded worldwide since May 2022. We tested 147clinical samples collected at different time points from 12 patients by real-timePCR. MPX DNA was detected in saliva from all cases, sometimes with high viralloads. Other samples were frequently positive: rectal swab (11/12 cases),nasopharyngeal swab (10/12 cases), semen (7/9 cases), urine (9/12 cases) andfaeces (8/12 cases). These results improve knowledge on virus shedding and thepossible role of bodily fluids in disease transmission.
FAU - Peiro-Mestres, Aida
AU  - Peiro-Mestres A
AD  - Barcelona Institute for Global Health (ISGlobal), Hospital Clinic-Universitat de Barcelona, Barcelona, Spain.
FAU - Fuertes, Irene
AU  - Fuertes I
AD  - Dermatology Department, Hospital Clinic-Universitat de Barcelona, Barcelona,Spain.
FAU - Camprubi-Ferrer, Daniel
AU  - Camprubi-Ferrer D
AD  - Barcelona Institute for Global Health (ISGlobal), Hospital Clinic-Universitat de Barcelona, Barcelona, Spain.
FAU - Marcos, Maria Angeles
AU  - Marcos MA
AD  - Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas(CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
AD  - Microbiology Department, Hospital Clinic-Universitat de Barcelona, Barcelona,Spain.
AD  - Barcelona Institute for Global Health (ISGlobal), Hospital Clinic-Universitat de Barcelona, Barcelona, Spain.
FAU - Vilella, Anna
AU  - Vilella A
AD  - Preventive Medicine and Epidemiology Department, Hospital Clinic-Universitat deBarcelona, Barcelona, Spain.
AD  - Barcelona Institute for Global Health (ISGlobal), Hospital Clinic-Universitat de Barcelona, Barcelona, Spain.
FAU - Navarro, Mireia
AU  - Navarro M
AD  - Microbiology Department, Hospital Clinic-Universitat de Barcelona, Barcelona,Spain.
FAU - Rodriguez-Elena, Laura
AU  - Rodriguez-Elena L
AD  - Microbiology Department, Hospital Clinic-Universitat de Barcelona, Barcelona,Spain.
FAU - Riera, Josep
AU  - Riera J
AD  - Dermatology Department, Hospital Clinic-Universitat de Barcelona, Barcelona,Spain.
FAU - Catala, Alba
AU  - Catala A
AD  - Dermatology Department, Hospital Clinic-Universitat de Barcelona, Barcelona,Spain.
FAU - Martinez, Miguel J
AU  - Martinez MJ
AD  - Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas(CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
AD  - Microbiology Department, Hospital Clinic-Universitat de Barcelona, Barcelona,Spain.
AD  - Barcelona Institute for Global Health (ISGlobal), Hospital Clinic-Universitat de Barcelona, Barcelona, Spain.
FAU - Blanco, Jose L
AU  - Blanco JL
AD  - Infectious Diseases Department, Hospital Clinic-IDIBAPS, Universitat deBarcelona, Barcelona, Spain.
AD  - Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas(CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
CN  - Hospital Clinic de Barcelona Monkeypox Study Group
AD  - Additional members of the Hospital Clinic de Barcelona Monkeypox Study Group are listed under Acknowledgements.
LA  - eng
PT  - Journal Article
PL  - Sweden
TA  - Euro Surveill
JT  - Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
JID - 100887452
RN  - 0 (DNA, Viral)
SB  - IM
MH  - Animals
MH  - DNA, Viral/genetics
MH  - Humans
MH  - *Monkeypox/diagnosis
MH  - Monkeypox virus
MH  - Saliva
MH  - Semen
MH  - Spain/epidemiology
PMC - PMC9284919
OTO - NOTNLM
OT  - PCR
OT  - monkeypox
OT  - outbreak
OT  - saliva
OT  - semen
OT  - shedding
EDAT- 2022/07/16 06:00
MHDA- 2022/07/19 06:00
CRDT- 2022/07/15 05:12
PHST- 2022/07/15 05:12 [entrez]
PHST- 2022/07/16 06:00 [pubmed]
PHST- 2022/07/19 06:00 [medline]
AID - 10.2807/1560-7917.ES.2022.27.28.2200503 [doi]
PST - ppublish
SO  - Euro Surveill. 2022 Jul;27(28). doi: 10.2807/1560-7917.ES.2022.27.28.2200503.

PMID- 35837859
OWN - NLM
STAT- Publisher
LR  - 20220721
IS  - 1462-2920 (Electronic)
IS  - 1462-2912 (Linking)
DP  - 2022 Jul 15
TI  - Infection-competent monkeypox virus contamination identified in domestic settingsfollowing an imported case of monkeypox into the UK.
LID - 10.1111/1462-2920.16129 [doi]
AB  - An imported case of monkeypox was diagnosed in December 2019 in a travellerreturning from Nigeria to the UK. Subsequently, environmental sampling wasperformed at two adjoining single-room residences occupied by the patient andtheir sibling. Monkeypox virus DNA was identified in multiple locationsthroughout both properties, and monkeypox virus was isolated from several samples3 days after the patient was last in these locations. Positive samples wereidentified following the use of both vacuum and surface sampling techniques;these methodologies allowed for environmental analysis of potentiallycontaminated porous and non-porous surfaces via real-time quantitative reversetranscriptase PCR analysis in addition to viral isolation to confirm the presenceof infection-competent virus. This report confirms the potential forinfection-competent monkeypox virus to be recovered in environmental settingsassociated with known positive cases and the necessity for rapid environmentalassessment to reduce potential exposure to close contacts and the general public.The methods adopted in this investigation may be used for future confirmed cases of monkeypox in order to establish levels of contamination, confirm the presence of infection-competent material and to identify locations requiring additionalcleaning.
CI  - (c) 2022 Crown copyright. Environmental Microbiology published by Society forApplied Microbiology and John Wiley & Sons Ltd. This article is published withthe permission of the Controller of HMSO and the Queen's Printer for Scotland.
FAU - Atkinson, Barry
AU  - Atkinson B
AUID- ORCID: https://orcid.org/0000-0002-1348-7204
AD  - Research and Evaluation, UK Health Security Agency, Porton Down, Salisbury, UK.
FAU - Burton, Christopher
AU  - Burton C
AD  - High Containment Microbiology, UK Health Security Agency, Porton Down, Salisbury,UK.
FAU - Pottage, Thomas
AU  - Pottage T
AD  - Research and Evaluation, UK Health Security Agency, Porton Down, Salisbury, UK.
FAU - Thompson, Katy-Anne
AU  - Thompson KA
AD  - Research and Evaluation, UK Health Security Agency, Porton Down, Salisbury, UK.
FAU - Ngabo, Didier
AU  - Ngabo D
AD  - Research and Evaluation, UK Health Security Agency, Porton Down, Salisbury, UK.
FAU - Crook, Ant
AU  - Crook A
AD  - Research and Evaluation, UK Health Security Agency, Porton Down, Salisbury, UK.
FAU - Pitman, James
AU  - Pitman J
AD  - High Containment Microbiology, UK Health Security Agency, Porton Down, Salisbury,UK.
FAU - Summers, Sian
AU  - Summers S
AD  - High Containment Microbiology, UK Health Security Agency, Porton Down, Salisbury,UK.
FAU - Lewandowski, Kuiama
AU  - Lewandowski K
AD  - Research and Evaluation, UK Health Security Agency, Porton Down, Salisbury, UK.
FAU - Furneaux, Jenna
AU  - Furneaux J
AD  - Rare and Imported Pathogens Laboratory, UK Health Security Agency, Porton Down,Salisbury, UK.
FAU - Davies, Katherine
AU  - Davies K
AD  - Research and Evaluation, UK Health Security Agency, Porton Down, Salisbury, UK.
FAU - Brooks, Timothy
AU  - Brooks T
AD  - Rare and Imported Pathogens Laboratory, UK Health Security Agency, Porton Down,Salisbury, UK.
AD  - National Institute for Health Research, Health Protection Research Unit inEmerging and Zoonotic Infections, Liverpool, UK.
FAU - Bennett, Allan M
AU  - Bennett AM
AD  - Research and Evaluation, UK Health Security Agency, Porton Down, Salisbury, UK.
FAU - Richards, Kevin S
AU  - Richards KS
AD  - High Containment Microbiology, UK Health Security Agency, Porton Down, Salisbury,UK.
AD  - Oxford Brookes University, Headington Campus, Oxford, UK.
LA  - eng
GR  - UK Health Security Agency
PT  - Journal Article
DEP - 20220715
PL  - England
TA  - Environ Microbiol
JT  - Environmental microbiology
JID - 100883692
SB  - IM
EDAT- 2022/07/16 06:00
MHDA- 2022/07/16 06:00
CRDT- 2022/07/15 04:23
PHST- 2022/07/06 00:00 [revised]
PHST- 2022/06/15 00:00 [received]
PHST- 2022/07/06 00:00 [accepted]
PHST- 2022/07/16 06:00 [pubmed]
PHST- 2022/07/16 06:00 [medline]
PHST- 2022/07/15 04:23 [entrez]
AID - 10.1111/1462-2920.16129 [doi]
PST - aheadofprint
SO  - Environ Microbiol. 2022 Jul 15. doi: 10.1111/1462-2920.16129.

PMID- 35835284
OWN - NLM
STAT- Publisher
LR  - 20220714
IS  - 1532-2939 (Electronic)
IS  - 0195-6701 (Linking)
DP  - 2022 Jul 11
TI  - YouTube and 2022 Monkeypox outbreak: opportunities for awareness and infectioncontrol.
LID - S0195-6701(22)00226-2 [pii]
LID - 10.1016/j.jhin.2022.07.007 [doi]
FAU - Ortiz-Martinez, Yeimer
AU  - Ortiz-Martinez Y
AD  - Department of Internal Medicine, Universidad Industrial de Santander,Bucaramanga, Colombia; Faculty of Health Sciences, Universidad de Sucre,Sincelejo, Colombia. Electronic address: yeimer10@hotmail.com.
FAU - Galvis-Catano, Lina M
AU  - Galvis-Catano LM
AD  - Faculty of Health Sciences, Universidad de Sucre, Sincelejo, Colombia.
FAU - Arias-Rodriguez, Daniela
AU  - Arias-Rodriguez D
AD  - Faculty of Health Sciences, Universidad de Sucre, Sincelejo, Colombia.
FAU - Romero-Dager, Cristhian
AU  - Romero-Dager C
AD  - Faculty of Health Sciences, Universidad de Sucre, Sincelejo, Colombia.
FAU - Bonilla-Aldana, D Katterine
AU  - Bonilla-Aldana DK
AD  - Faculty of Medicine, Institucion Universitaria Vision de las Americas, Pereira,Risaralda, Colombia; Master of Clinical Epidemiology and Biostatistics,Universidad Cientifica del Sur, Lima, Peru; School of Medicine, UniversidadPrivada Franz Tamayo, Cochabamba, Bolivia.
FAU - Rodriguez-Morales, Alfonso J
AU  - Rodriguez-Morales AJ
AD  - Faculty of Medicine, Institucion Universitaria Vision de las Americas, Pereira,Risaralda, Colombia; Grupo de Investigacion Biomedicina, Faculty of Medicine,Fundacion Universitaria Autonoma de las Americas, Pereira, Risaralda, Colombia;Master of Clinical Epidemiology and Biostatistics, Universidad Cientifica delSur, Lima, Peru; School of Medicine, Universidad Privada Franz Tamayo,Cochabamba, Bolivia.
LA  - eng
PT  - Letter
DEP - 20220711
PL  - England
TA  - J Hosp Infect
JT  - The Journal of hospital infection
JID - 8007166
SB  - IM
COIS- Declaration of Competing Interest The authors declare no potential conflict ofinterest with respect to the authorship and/or publication of this article.
EDAT- 2022/07/15 06:00
MHDA- 2022/07/15 06:00
CRDT- 2022/07/14 19:34
PHST- 2022/07/05 00:00 [received]
PHST- 2022/07/06 00:00 [accepted]
PHST- 2022/07/14 19:34 [entrez]
PHST- 2022/07/15 06:00 [pubmed]
PHST- 2022/07/15 06:00 [medline]
AID - S0195-6701(22)00226-2 [pii]
AID - 10.1016/j.jhin.2022.07.007 [doi]
PST - aheadofprint
SO  - J Hosp Infect. 2022 Jul 11. pii: S0195-6701(22)00226-2. doi:10.1016/j.jhin.2022.07.007.

PMID- 35834423
OWN - NLM
STAT- MEDLINE
DCOM- 20220718
LR  - 20220731
IS  - 1545-861X (Electronic)
IS  - 0149-2195 (Linking)
VI  - 71
IP  - 28
DP  - 2022 Jul 15
TI  - Rapid Diagnostic Testing for Response to the Monkeypox Outbreak - LaboratoryResponse Network, United States, May 17-June 30, 2022.
PG  - 904-907
LID - 10.15585/mmwr.mm7128e1 [doi]
AB  - As part of public health preparedness for infectious disease threats, CDCcollaborates with other U.S. public health officials to ensure that theLaboratory Response Network (LRN) has diagnostic tools to detect Orthopoxviruses,the genus that includes Variola virus, the causative agent of smallpox. LRN is a network of state and local public health, federal, U.S. Department of Defense(DOD), veterinary, food, and environmental testing laboratories. CDC developed,and the Food and Drug Administration (FDA) granted 510(k) clearance* for theNon-variola Orthopoxvirus Real-time PCR Primer and Probe Set (non-variolaOrthopoxvirus [NVO] assay), a polymerase chain reaction (PCR) diagnostic test to detect NVO. On May 17, 2022, CDC was contacted by the Massachusetts Department ofPublic Health (DPH) regarding a suspected case of monkeypox, a disease caused by the Orthopoxvirus Monkeypox virus. Specimens were collected and tested by theMassachusetts DPH public health laboratory with LRN testing capability using the NVO assay. Nationwide, 68 LRN laboratories had capacity to test approximately8,000 NVO tests per week during June. During May 17-June 30, LRN laboratoriestested 2,009 specimens from suspected monkeypox cases. Among those, 730 (36.3%)specimens from 395 patients were positive for NVO. NVO-positive specimens from159 persons were confirmed by CDC to be monkeypox; final characterization ispending for 236. Prompt identification of persons with infection allowed rapidresponse to the outbreak, including isolation and treatment of patients,administration of vaccines, and other public health action. To further facilitateaccess to testing and increase convenience for providers and patients by usingexisting provider-laboratory relationships, CDC and LRN are supporting five largecommercial laboratories with a national footprint (Aegis Science, LabCorp, MayoClinic Laboratories, Quest Diagnostics, and Sonic Healthcare) to establish NVOtesting capacity of 10,000 specimens per week per laboratory. On July 6, 2022,the first commercial laboratory began accepting specimens for NVO testing basedon clinician orders.
FAU - Aden, Tricia A
AU  - Aden TA
FAU - Blevins, Patricia
AU  - Blevins P
FAU - York, Shannon Whitman
AU  - York SW
FAU - Rager, Stacy
AU  - Rager S
FAU - Balachandran, Devika
AU  - Balachandran D
FAU - Hutson, Christina L
AU  - Hutson CL
FAU - Lowe, David
AU  - Lowe D
FAU - Mangal, Chris N
AU  - Mangal CN
FAU - Wolford, Tyler
AU  - Wolford T
FAU - Matheny, Audrey
AU  - Matheny A
FAU - Davidson, Whitni
AU  - Davidson W
FAU - Wilkins, Kimberly
AU  - Wilkins K
FAU - Cook, Rachael
AU  - Cook R
FAU - Roulo, Rebecca M
AU  - Roulo RM
FAU - White, Michael K
AU  - White MK
FAU - Berman, LaShondra
AU  - Berman L
FAU - Murray, Janna
AU  - Murray J
FAU - Laurance, John
AU  - Laurance J
FAU - Francis, Drew
AU  - Francis D
FAU - Green, Nicole M
AU  - Green NM
FAU - Berumen, Ricardo A 3rd
AU  - Berumen RA 3rd
FAU - Gonzalez, Anthony
AU  - Gonzalez A
FAU - Evans, Stacy
AU  - Evans S
FAU - Hudziec, Meghan
AU  - Hudziec M
FAU - Noel, Diane
AU  - Noel D
FAU - Adjei, Michael
AU  - Adjei M
FAU - Hovan, Gregory
AU  - Hovan G
FAU - Lee, Phil
AU  - Lee P
FAU - Tate, Lisa
AU  - Tate L
FAU - Gose, Remedios B
AU  - Gose RB
FAU - Voermans, Robert
AU  - Voermans R
FAU - Crew, Jennifer
AU  - Crew J
FAU - Adam, Phillip R
AU  - Adam PR
FAU - Haydel, Danielle
AU  - Haydel D
FAU - Lukula, Salimatu
AU  - Lukula S
FAU - Matluk, Nick
AU  - Matluk N
FAU - Shah, Sandip
AU  - Shah S
FAU - Featherston, Joshua
AU  - Featherston J
FAU - Ware, Daphne
AU  - Ware D
FAU - Pettit, Denise
AU  - Pettit D
FAU - McCutchen, Emily
AU  - McCutchen E
FAU - Acheampong, Edward
AU  - Acheampong E
FAU - Buttery, Erin
AU  - Buttery E
FAU - Gorzalski, Andrew
AU  - Gorzalski A
FAU - Perry, Michael
AU  - Perry M
FAU - Fowler, Randal
AU  - Fowler R
FAU - Lee, Robert B
AU  - Lee RB
FAU - Nickla, Robert
AU  - Nickla R
FAU - Huard, Richard
AU  - Huard R
FAU - Moore, Amanda
AU  - Moore A
FAU - Jones, Katie
AU  - Jones K
FAU - Johnson, Renee
AU  - Johnson R
FAU - Swaney, Erin
AU  - Swaney E
FAU - Jaramillo, Juan
AU  - Jaramillo J
FAU - Reinoso Webb, Cynthia
AU  - Reinoso Webb C
FAU - Guin, Brandon
AU  - Guin B
FAU - Yost, Janine
AU  - Yost J
FAU - Atkinson, Annette
AU  - Atkinson A
FAU - Griffin-Thomas, Latoya
AU  - Griffin-Thomas L
FAU - Chenette, Jessica
AU  - Chenette J
FAU - Gant, Jessica
AU  - Gant J
FAU - Sterkel, Alana
AU  - Sterkel A
FAU - Ghuman, Harjinder K
AU  - Ghuman HK
FAU - Lute, James
AU  - Lute J
FAU - Smole, Sandra C
AU  - Smole SC
FAU - Arora, Vaneet
AU  - Arora V
FAU - Demontigny, Courtney K
AU  - Demontigny CK
FAU - Bielby, Meilan
AU  - Bielby M
FAU - Geeter, Evelyn
AU  - Geeter E
FAU - Newman, Kimberly A M
AU  - Newman KAM
FAU - Glazier, Mark
AU  - Glazier M
FAU - Lutkemeier, Whitney
AU  - Lutkemeier W
FAU - Nelson, Megan
AU  - Nelson M
FAU - Martinez, Raymond
AU  - Martinez R
FAU - Chaitram, Jasmine
AU  - Chaitram J
FAU - Honein, Margaret A
AU  - Honein MA
FAU - Villanueva, Julie M
AU  - Villanueva JM
LA  - eng
PT  - Journal Article
DEP - 20220715
PL  - United States
TA  - MMWR Morb Mortal Wkly Rep
JT  - MMWR. Morbidity and mortality weekly report
JID - 7802429
SB  - IM
MH  - Animals
MH  - Diagnostic Techniques and Procedures
MH  - Disease Outbreaks/prevention & control
MH  - Humans
MH  - Laboratories
MH  - *Monkeypox/diagnosis/epidemiology
MH  - *Orthopoxvirus
MH  - United States/epidemiology
MH  - *Variola virus
PMC - PMC9290387
COIS- All authors have completed and submitted the International Committee of MedicalJournal Editors form for disclosure of potential conflicts of interest RemediosB. Gose reports membership on the APHL LRN Operational Work Group. DanielleHaydel reports support from APHL to attend the APHL Conference. Robert B. Leereports receipt of general revenue funds from the state of Ohio. Robert Nicklareports providing contracted subject matter expert review and development ofonline lab training courses for MediaLab, receipt of past travel awards throughAPHL to attend meetings, unpaid volunteer membership on the APHL Public HealthPreparedness and Response Committee, and chair of the APHL Sentinel LaboratoryPartnerships and Outreach Subcommittee. Nicole M. Green reports support forattending the Southern California American Society for Microbiology meeting,leadership or fiduciary roles in the Southern California American Society forMicrobiology, the California Association of Public Health Laboratory Directors,and APHL. Erin Swaney reports support from the Texas Department of State HealthServices to travel to the 2020 Texas LRN Conference. Jessica Chenette reportssupport from the Vermont Department of Health Laboratory for purchase ofreagents, supplies, equipment, and salary. Jessica Gant reports institutionalsupport from APHL. Cynthia Reinoso Webb reports payment for a 2019 lecture fromthe Southwestern Association of Clinical Microbiology and a diverse portfolio in growth mutual funds and individual holdings in Apple, Amazon, Disney, and Fordcorporations. No other potential conflicts of interest were disclosed.
EDAT- 2022/07/15 06:00
MHDA- 2022/07/19 06:00
CRDT- 2022/07/14 13:13
PHST- 2022/07/14 13:13 [entrez]
PHST- 2022/07/15 06:00 [pubmed]
PHST- 2022/07/19 06:00 [medline]
AID - 10.15585/mmwr.mm7128e1 [doi]
PST - epublish
SO  - MMWR Morb Mortal Wkly Rep. 2022 Jul 15;71(28):904-907. doi:10.15585/mmwr.mm7128e1.

PMID- 35833402
OWN - NLM
STAT- MEDLINE
DCOM- 20220715
LR  - 20220715
IS  - 0004-5772 (Print)
IS  - 0004-5772 (Linking)
VI  - 70
IP  - 7
DP  - 2022 Jul
TI  - Monkeypox: What do we know so far? A short narrative review of literature.
PG  - 11-12
LID - 10.5005/japi-11001-0071 [doi]
AB  - Monkeypox was a zoonotic infection, first detected in parts of northern Africa inthe 1970s. Monkeypoxvirus, the causative agent of monkeypox, is a species ofgenus Orthopoxvirus and is closely related to long-eradicated smallpox caused by variola virus. Outbreaks in the West (in USA, UK, and Ireland) along withperiodic re-emergence of the disease in parts of Africa have generated concernamong global health bodies due to the existent deficiency of guidelines formanagement of the disease. Genetic variations and altered mechanisms favoringbetter survival of the virus have made early identification of the disease duringscreening difficult, particularly in resource-limited settings like rural areasof Africa. Through evidences gathered from experimental studies conducted afterthese outbreaks, the virus is known to be transmitted from several animalreservoirs along with human-to-human contact of blood, body fluids, or aerosol.Early diagnosis through immunoassays and polymerase chain reaction (PCR) tests,although not very specific, allows early treatment and subsequently betterpatient survival and recovery. Presence of lymphadenopathy along with fever, sorethroat, and a vesiculopustular rash is diagnostic. The virus affects thegastrointestinal, hematological, ocular, and respiratory systems, in like manner producing afflictions of the specific system. Treatment, through experimentaldata, has been preferred to be symptomatic, with the aim to preventsuperinfections. Antivirals like cidofovir and tecovirimat have been studied uponand used in clinical trials with favorable outcomes. Antiviral immunoglobulinshave also been used with success in certain patients for postexposureprophylaxis.
CI  - (c) Journal of the Association of Physicians of India 2011.
FAU - Deshmukh, Paulami
AU  - Deshmukh P
AD  - MBBS Student, Smt. Kashibai Navale Medical College and General Hospital, Pune;Corresponding Author.
FAU - Vora, Agam
AU  - Vora A
AD  - Chest Physician, Vora Clinic.
FAU - Tiwaskar, Mangesh
AU  - Tiwaskar M
AD  - Consultant Physician and Diabetologist, Shilpa Medical Research Centre.
FAU - Joshi, Shashank
AU  - Joshi S
AD  - Consultant Endocrinologist, Joshi Clinic and Lilavati Hospital and ResearchCentre, Mumbai, Maharashtra, India.
LA  - eng
PT  - Journal Article
PT  - Review
PL  - India
TA  - J Assoc Physicians India
JT  - The Journal of the Association of Physicians of India
JID - 7505585
RN  - JIL713Q00N (Cidofovir)
SB  - IM
MH  - Animals
MH  - Cidofovir
MH  - Disease Outbreaks
MH  - Humans
MH  - *Monkeypox/diagnosis/drug therapy/epidemiology
MH  - Monkeypox virus/genetics
MH  - Zoonoses/epidemiology
EDAT- 2022/07/15 06:00
MHDA- 2022/07/16 06:00
CRDT- 2022/07/14 04:56
PHST- 2022/07/14 04:56 [entrez]
PHST- 2022/07/15 06:00 [pubmed]
PHST- 2022/07/16 06:00 [medline]
AID - 10.5005/japi-11001-0071 [doi]
PST - ppublish
SO  - J Assoc Physicians India. 2022 Jul;70(7):11-12. doi: 10.5005/japi-11001-0071.

PMID- 35831941
OWN - NLM
STAT- Publisher
LR  - 20220714
IS  - 1537-6613 (Electronic)
IS  - 0022-1899 (Linking)
DP  - 2022 Jul 14
TI  - Geographic structuring and divergence time frame of monkeypox virus in theendemic region.
LID - jiac298 [pii]
LID - 10.1093/infdis/jiac298 [doi]
AB  - Monkeypox is an emerging zoonosis endemic to Central and West Africa. Monkeypoxvirus (MPXV) is genetically structured in two major clades (clades 1 and 2/3),but its evolution is poorly explored. We show that the population transmitted in West Africa (clades 2/3) experienced limited drift. Conversely, clade 1(transmitted in the Congo Basin) possibly underwent a bottleneck or foundereffect. Depending on the model used, we estimated that the two clades separatedapproximately 560-860 (HPD: 450-960) years ago, a period characterized byexpansions and contractions of rainforest areas, possibly creating the ecologicalconditions for the MPXV reservoir(s) to migrate. In the Congo Basin, MPXVdiversity is characterized by four subpopulations that show no geographicstructuring. Conversely, clades 2/3 are spatially structured with two populationslocated West and East of the Dahomey Gap. The distinct histories of the twoclades may derive from differences in MPXV ecology in West and Central Africa.
CI  - (c) The Author(s) 2022. Published by Oxford University Press on behalf ofInfectious Diseases Society of America. All rights reserved. For permissions,please e-mail: journals.permissions@oup.com.
FAU - Forni, Diego
AU  - Forni D
AUID- ORCID: 0000-0001-9291-5352
AD  - Scientific Institute IRCCS E. MEDEA, Bioinformatics, 23842 Bosisio Parini, Italy.
FAU - Molteni, Cristian
AU  - Molteni C
AD  - Scientific Institute IRCCS E. MEDEA, Bioinformatics, 23842 Bosisio Parini, Italy.
FAU - Cagliani, Rachele
AU  - Cagliani R
AD  - Scientific Institute IRCCS E. MEDEA, Bioinformatics, 23842 Bosisio Parini, Italy.
FAU - Sironi, Manuela
AU  - Sironi M
AD  - Scientific Institute IRCCS E. MEDEA, Bioinformatics, 23842 Bosisio Parini, Italy.
LA  - eng
PT  - Journal Article
DEP - 20220714
PL  - United States
TA  - J Infect Dis
JT  - The Journal of infectious diseases
JID - 0413675
SB  - IM
OTO - NOTNLM
OT  - Monkeypox virus
OT  - Orthopoxvirus
OT  - molecular dating
OT  - population structure
EDAT- 2022/07/15 06:00
MHDA- 2022/07/15 06:00
CRDT- 2022/07/14 00:33
PHST- 2022/03/09 00:00 [received]
PHST- 2022/07/08 00:00 [revised]
PHST- 2022/07/11 00:00 [accepted]
PHST- 2022/07/14 00:33 [entrez]
PHST- 2022/07/15 06:00 [pubmed]
PHST- 2022/07/15 06:00 [medline]
AID - 6643513 [pii]
AID - 10.1093/infdis/jiac298 [doi]
PST - aheadofprint
SO  - J Infect Dis. 2022 Jul 14. pii: 6643513. doi: 10.1093/infdis/jiac298.

PMID- 35831633
OWN - NLM
STAT- Publisher
LR  - 20220713
IS  - 1546-170X (Electronic)
IS  - 1078-8956 (Linking)
DP  - 2022 Jul 13
TI  - A prospective national cohort evaluating ring MVA vaccination as post-exposureprophylaxis for monkeypox.
LID - 10.1038/d41591-022-00077-1 [doi]
FAU - Luong Nguyen, Liem Binh
AU  - Luong Nguyen LB
FAU - Ghosn, Jade
AU  - Ghosn J
FAU - Durier, Christine
AU  - Durier C
FAU - Tachot, Carla
AU  - Tachot C
FAU - Tartour, Eric
AU  - Tartour E
FAU - Touati, Amel
AU  - Touati A
FAU - Simon, Tabassome
AU  - Simon T
FAU - Autran, Brigitte
AU  - Autran B
FAU - Ortega Perez, Inmaculata
AU  - Ortega Perez I
FAU - Telford, Erica
AU  - Telford E
FAU - Ward, Jeremy K
AU  - Ward JK
FAU - Michels, David
AU  - Michels D
FAU - Meyer, Laurence
AU  - Meyer L
FAU - Rousseau, Alexandra
AU  - Rousseau A
FAU - Berard, Laurence
AU  - Berard L
FAU - de Lamballerie, Xavier
AU  - de Lamballerie X
FAU - Launay, Odile
AU  - Launay O
LA  - eng
PT  - News
DEP - 20220713
PL  - United States
TA  - Nat Med
JT  - Nature medicine
JID - 9502015
SB  - IM
OTO - NOTNLM
OT  - Clinical trials
OT  - Public health
OT  - Vaccines
OT  - Virology
EDAT- 2022/07/14 06:00
MHDA- 2022/07/14 06:00
CRDT- 2022/07/13 23:39
PHST- 2022/07/13 23:39 [entrez]
PHST- 2022/07/14 06:00 [pubmed]
PHST- 2022/07/14 06:00 [medline]
AID - 10.1038/d41591-022-00077-1 [doi]
AID - 10.1038/d41591-022-00077-1 [pii]
PST - aheadofprint
SO  - Nat Med. 2022 Jul 13. pii: 10.1038/d41591-022-00077-1. doi:10.1038/d41591-022-00077-1.

PMID- 35831136
OWN - NLM
STAT- Publisher
LR  - 20220720
IS  - 1096-9071 (Electronic)
IS  - 0146-6615 (Linking)
DP  - 2022 Jul 13
TI  - Monkeypox in a 71-year-old woman.
LID - 10.1002/jmv.27993 [doi]
FAU - Bruno, Giuseppe
AU  - Bruno G
AUID- ORCID: http://orcid.org/0000-0003-0285-9524
AD  - Infectious Diseases Unit, San Giuseppe Moscati Hospital, Taranto, Italy.
FAU - Fabrizio, Claudia
AU  - Fabrizio C
AD  - Infectious Diseases Unit, San Giuseppe Moscati Hospital, Taranto, Italy.
FAU - Rodano, Leonardo
AU  - Rodano L
AD  - Infectious Diseases Unit, San Giuseppe Moscati Hospital, Taranto, Italy.
FAU - Buccoliero, Giovanni Battista
AU  - Buccoliero GB
AD  - Infectious Diseases Unit, San Giuseppe Moscati Hospital, Taranto, Italy.
LA  - eng
PT  - Letter
DEP - 20220713
PL  - United States
TA  - J Med Virol
JT  - Journal of medical virology
JID - 7705876
SB  - IM
EDAT- 2022/07/14 06:00
MHDA- 2022/07/14 06:00
CRDT- 2022/07/13 21:23
PHST- 2022/07/07 00:00 [revised]
PHST- 2022/07/01 00:00 [received]
PHST- 2022/07/08 00:00 [accepted]
PHST- 2022/07/14 06:00 [pubmed]
PHST- 2022/07/14 06:00 [medline]
PHST- 2022/07/13 21:23 [entrez]
AID - 10.1002/jmv.27993 [doi]
PST - aheadofprint
SO  - J Med Virol. 2022 Jul 13. doi: 10.1002/jmv.27993.

PMID- 35830990
OWN - NLM
STAT- MEDLINE
DCOM- 20220715
LR  - 20220715
IS  - 0379-5284 (Print)
IS  - 0379-5284 (Linking)
VI  - 43
IP  - 7
DP  - 2022 Jul
TI  - WHO consultation sets research priorities for monkeypox.
PG  - 767
LA  - eng
PT  - Journal Article
PL  - Saudi Arabia
TA  - Saudi Med J
JT  - Saudi medical journal
JID - 7909441
SB  - IM
MH  - Animals
MH  - Disease Outbreaks
MH  - Humans
MH  - *Monkeypox/epidemiology
MH  - Referral and Consultation
MH  - Research
MH  - World Health Organization
EDAT- 2022/07/14 06:00
MHDA- 2022/07/16 06:00
CRDT- 2022/07/13 20:43
PHST- 2022/07/13 20:43 [entrez]
PHST- 2022/07/14 06:00 [pubmed]
PHST- 2022/07/16 06:00 [medline]
AID - 43/7/767 [pii]
PST - ppublish
SO  - Saudi Med J. 2022 Jul;43(7):767.

PMID- 35830908
OWN - NLM
STAT- Publisher
LR  - 20220726
IS  - 1532-2742 (Electronic)
IS  - 0163-4453 (Linking)
DP  - 2022 Jul 10
TI  - Monkeypox outbreak in Madrid (Spain): Clinical and virological aspects.
LID - S0163-4453(22)00415-7 [pii]
LID - 10.1016/j.jinf.2022.07.005 [doi]
AB  - BACKGROUND: Monkeypox is the most prevalent Orthopoxvirus zoonosis infectionsince the eradication of smallpox. The current multi-country outbreak involvesfive WHO regions affecting mainly Europe. Accurate clinical and virologicalaspects of the disease outside endemic areas are needed. METHODS: We performed anobservational study of cases diagnosed in Madrid (Spain) (May/June 2022).Confirmation from vesicular lesions swabs, Orthopoxvirus real-time PCR,sequencing, phylogenetic analysis, and direct detection by Electron microscopywas performed. In addition, a structured epidemiological questionnaire wascompleted systematically to gather sociodemographic, clinical, and behavioraldata from all confirmed cases. FINDINGS: We extracted data from 48 patients, all cisgender men. The median age was 35 years (IQR 29 - 44), and 87.5% were MSM. Themost prevalent symptoms were the presence of vesicular-umbilicated andpseudo-pustular skin lesions (93.8%), asthenia (66.6%), and fever (52.1%). Inaddition, the location of the lesions in the genital or perianal area was relatedto the role in sexual intercourse (p<0.001). Sequencing analysis indicated thevirus circulating in Spain belongs to the western African clade. Like the otherEuropean cases in the outbreak, the Spanish isolates are a direct descendant ofviruses previously detected in Nigeria, the UK, Singapore, and Israel in2017-2018. CONCLUSIONS: Monkeypox is an emerging infectious disease in Europewhere community transmission is reported, mainly in MSM. The first symptom wasskin lesions instead of classical fever and rash. The disease follows aself-limited course, and there have been no cases with a serious presentation or severe complications.
CI  - Copyright (c) 2022 The British Infection Association. Published by Elsevier Ltd. All rights reserved.
FAU - Orviz, Eva
AU  - Orviz E
AD  - Centro Sandoval/Hospital Clinico San Carlos, IdISSC.
FAU - Negredo, Anabel
AU  - Negredo A
AD  - Laboratorio de Arbovirus y Enfermedades Viricas importadas, Centro Nacional deMicrobiologia. Instituto de Salud Carlos III; CIBERINFEC.
FAU - Ayerdi, Oskar
AU  - Ayerdi O
AD  - Centro Sandoval/Hospital Clinico San Carlos, IdISSC.
FAU - Vazquez, Ana
AU  - Vazquez A
AD  - Laboratorio de Arbovirus y Enfermedades Viricas importadas, Centro Nacional deMicrobiologia. Instituto de Salud Carlos III; CIBERINFEC.
FAU - Munoz-Gomez, Ana
AU  - Munoz-Gomez A
AD  - Centro Sandoval/Hospital Clinico San Carlos, IdISSC.
FAU - Monzon, Sara
AU  - Monzon S
AD  - Unidad de Bioinformatica, Instituto de Salud Carlos III.
FAU - Clavo, Petunia
AU  - Clavo P
AD  - Centro Sandoval/Hospital Clinico San Carlos, IdISSC.
FAU - Zaballos, Angel
AU  - Zaballos A
AD  - Unidad de Genomica, Instituto de Salud Carlos III.
FAU - Vera, Mar
AU  - Vera M
AD  - Centro Sandoval/Hospital Clinico San Carlos, IdISSC.
FAU - Sanchez, Patricia
AU  - Sanchez P
AD  - Laboratorio de Arbovirus y Enfermedades Viricas importadas, Centro Nacional deMicrobiologia. Instituto de Salud Carlos III; CIBERINFEC.
FAU - Cabello, Noemi
AU  - Cabello N
AD  - Centro Sandoval/Hospital Clinico San Carlos, IdISSC; CIBERINFEC.
FAU - Jimenez, Pilar
AU  - Jimenez P
AD  - Unidad de Genomica, Instituto de Salud Carlos III.
FAU - Perez-Garcia, Jorge A
AU  - Perez-Garcia JA
AD  - Centro Sandoval/Hospital Clinico San Carlos, IdISSC.
FAU - Varona, Sarai
AU  - Varona S
AD  - Unidad de Bioinformatica, Instituto de Salud Carlos III.
FAU - Del Romero, Jorge
AU  - Del Romero J
AD  - Centro Sandoval/Hospital Clinico San Carlos, IdISSC.
FAU - Cuesta, Isabel
AU  - Cuesta I
AD  - Unidad de Bioinformatica, Instituto de Salud Carlos III.
FAU - Delgado-Iribarren, Alberto
AU  - Delgado-Iribarren A
AD  - Centro Sandoval/Hospital Clinico San Carlos, IdISSC.
FAU - Torres, Montse
AU  - Torres M
AD  - Centro Nacional de Microbiologia, Instituto de Salud Carlos III.
FAU - Sagastagoitia, Inigo
AU  - Sagastagoitia I
AD  - Centro Sandoval/Hospital Clinico San Carlos, IdISSC; CIBERINFEC.
FAU - Palacios, Gustavo
AU  - Palacios G
AD  - Icahn School of Medicine at Mount Sinai, New York, USA.
FAU - Estrada, Vicente
AU  - Estrada V
AD  - Centro Sandoval/Hospital Clinico San Carlos, IdISSC; CIBERINFEC. Electronicaddress: vicente.estrada@salud.madrid.org.
FAU - Sanchez-Seco, Maria Paz
AU  - Sanchez-Seco MP
AD  - Laboratorio de Arbovirus y Enfermedades Viricas importadas, Centro Nacional deMicrobiologia. Instituto de Salud Carlos III; CIBERINFEC.
CN  - Grupo Viruela del Simio Madrid CNM/ISCIII/HCSC/Sandoval
LA  - eng
PT  - Journal Article
DEP - 20220710
PL  - England
TA  - J Infect
JT  - The Journal of infection
JID - 7908424
SB  - IM
OTO - NOTNLM
OT  - Communicable diseases
OT  - Emerging
OT  - Monkeypox
COIS- Declaration of Competing Interest The authors declare no conflict of interests.
IR  - Ballesteros J
FIR - Ballesteros, Juan
IR  - Baza B
FIR - Baza, Begona
IR  - Carrio JC
FIR - Carrio, Juan Carlos
IR  - Chocron C
FIR - Chocron, Cynthia
IR  - Fedele G
FIR - Fedele, Giovanni
IR  - Garcia-Amil C
FIR - Garcia-Amil, Cristina
IR  - Herrero L
FIR - Herrero, Laura
IR  - Homen R
FIR - Homen, Reynaldo
IR  - Mariano A
FIR - Mariano, Alberto
IR  - Martinez-Burgoa T
FIR - Martinez-Burgoa, Teresa
IR  - Molero F
FIR - Molero, Francisca
IR  - Navarro ML
FIR - Navarro, Maria Luisa
IR  - Nunez MJ
FIR - Nunez, Maria Jose
IR  - Perez-Somarriba J
FIR - Perez-Somarriba, Juncal
IR  - Puerta T
FIR - Puerta, Teresa
IR  - Rodriguez-Anover J
FIR - Rodriguez-Anover, Javier
IR  - Pastrana EP
FIR - Pastrana, Esperanza Perez
IR  - Jimenez M
FIR - Jimenez, Mercedes
IR  - de la Vega L
FIR - de la Vega, Leticia
IR  - Vergas J
FIR - Vergas, Jorge
IR  - Zarza I
FIR - Zarza, Isabel
EDAT- 2022/07/14 06:00
MHDA- 2022/07/14 06:00
CRDT- 2022/07/13 19:23
PHST- 2022/07/03 00:00 [received]
PHST- 2022/07/05 00:00 [accepted]
PHST- 2022/07/14 06:00 [pubmed]
PHST- 2022/07/14 06:00 [medline]
PHST- 2022/07/13 19:23 [entrez]
AID - S0163-4453(22)00415-7 [pii]
AID - 10.1016/j.jinf.2022.07.005 [doi]
PST - aheadofprint
SO  - J Infect. 2022 Jul 10. pii: S0163-4453(22)00415-7. doi:10.1016/j.jinf.2022.07.005.

PMID- 35822910
OWN - NLM
STAT- Publisher
LR  - 20220713
IS  - 1758-1052 (Electronic)
IS  - 0956-4624 (Linking)
DP  - 2022 Jul 13
TI  - Human monkeypox coinfection with acute HIV: an exuberant presentation.
PG  - 9564624221114998
LID - 10.1177/09564624221114998 [doi]
AB  - Human monkeypox (MPX) is a zoonotic endemic disease in regions of Africa causedby the monkeypox virus, with a recent outbreak in several non-African countries. We report a case of a 24-year-old male patient with a concurrent diagnosis of MPXand acute HIV infection who presented to our Emergency Care Dermatology Clinicwith disseminated papules throughout the trunk, face and genital area. On theperianal area, several grouped umbilicated whitish papules in a kissing lesionconfiguration could be seen. Laboratory workups were consistent with recent HIVinfection, and swab samples from the lesion surfaces were positive for monkeypox virus. We provide novel information on the clinical presentation of MPX,expanding the data pool of the clinical manifestations of which health workersshould be aware.
FAU - de Sousa, Diogo
AU  - de Sousa D
AUID- ORCID: https://orcid.org/0000-0002-5415-887X
AD  - Department of Dermatology, 218728Centro Hospitalar Universitario Lisboa Norte,Lisbon, Portugal.
FAU - Patrocinio, Joao
AU  - Patrocinio J
AD  - Department of Dermatology, 218728Centro Hospitalar Universitario Lisboa Norte,Lisbon, Portugal.
FAU - Frade, Joana
AU  - Frade J
AD  - Department of Dermatology, 218728Centro Hospitalar Universitario Lisboa Norte,Lisbon, Portugal.
FAU - Correia, Catarina
AU  - Correia C
AD  - Department of Dermatology, 218728Centro Hospitalar Universitario Lisboa Norte,Lisbon, Portugal.
FAU - Borges-Costa, Joao
AU  - Borges-Costa J
AD  - Department of Dermatology, 218728Centro Hospitalar Universitario Lisboa Norte,Lisbon, Portugal.
AD  - Dermatology University Clinic, Faculty of Medicine, University of Lisbon, Lisbon,Portugal.
AD  - Instituto de Higiene e Medicina Tropical, Nova University of Lisbon, Lisbon,Portugal.
FAU - Filipe, Paulo
AU  - Filipe P
AD  - Department of Dermatology, 218728Centro Hospitalar Universitario Lisboa Norte,Lisbon, Portugal.
AD  - Dermatology University Clinic, Faculty of Medicine, University of Lisbon, Lisbon,Portugal.
AD  - Dermatology Research Unit, Instituto de Medicina Molecular, University of Lisbon,Lisbon, Portugal.
LA  - eng
PT  - Journal Article
DEP - 20220713
PL  - England
TA  - Int J STD AIDS
JT  - International journal of STD & AIDS
JID - 9007917
SB  - IM
OTO - NOTNLM
OT  - HIV
OT  - Monkeypox
OT  - disease outbreak
EDAT- 2022/07/14 06:00
MHDA- 2022/07/14 06:00
CRDT- 2022/07/13 09:04
PHST- 2022/07/13 09:04 [entrez]
PHST- 2022/07/14 06:00 [pubmed]
PHST- 2022/07/14 06:00 [medline]
AID - 10.1177/09564624221114998 [doi]
PST - aheadofprint
SO  - Int J STD AIDS. 2022 Jul 13:9564624221114998. doi: 10.1177/09564624221114998.

PMID- 35822876
OWN - NLM
STAT- Publisher
LR  - 20220713
IS  - 1758-1052 (Electronic)
IS  - 0956-4624 (Linking)
DP  - 2022 Jul 13
TI  - Monkeypox and HIV/AIDS: When the outbreak faces the epidemic.
PG  - 9564624221114191
LID - 10.1177/09564624221114191 [doi]
FAU - Ortiz-Martinez, Yeimer
AU  - Ortiz-Martinez Y
AUID- ORCID: https://orcid.org/0000-0001-9035-5654
AD  - Department of Internal Medicine, 469618Universidad Industrial de Santander,Bucaramanga, Colombia.
AD  - Faculty of Health Sciences, Universidad de Sucre, Sincelejo, Colombia.
FAU - Zambrano-Sanchez, Gabriela
AU  - Zambrano-Sanchez G
AD  - School of Medicine of the International University of Ecuador, Quito, Ecuador.
FAU - Rodriguez-Morales, Alfonso J
AU  - Rodriguez-Morales AJ
AD  - Grupo de Investigacion Biomedicina, Faculty of Medicine, Fundacion Universitaria Autonoma de las Americas, Pereira, Risaralda, Colombia.
AD  - Committe on Tropical Medicine, Zoonoses and Travel Medicine, ColombianAssociation of Infectious Diseases (ACIN), Bogota, Colombia.
AD  - Faculty of Medicine, Fundacion Universitaria de las Americas, Sede Pereira,Pereira, Risaralda, Colombia.
AD  - Institucion Universitaria Vision de las Americas, Pereira, Risaralda, Colombia.
AD  - Master of Clinical Epidemiology and Biostatistics, Universidad Cientifica delSur, Lima, Peru.
LA  - eng
PT  - Letter
DEP - 20220713
PL  - England
TA  - Int J STD AIDS
JT  - International journal of STD & AIDS
JID - 9007917
SB  - IM
EDAT- 2022/07/14 06:00
MHDA- 2022/07/14 06:00
CRDT- 2022/07/13 08:52
PHST- 2022/07/13 08:52 [entrez]
PHST- 2022/07/14 06:00 [pubmed]
PHST- 2022/07/14 06:00 [medline]
AID - 10.1177/09564624221114191 [doi]
PST - aheadofprint
SO  - Int J STD AIDS. 2022 Jul 13:9564624221114191. doi: 10.1177/09564624221114191.

PMID- 35822390
OWN - NLM
STAT- Publisher
LR  - 20220713
IS  - 1365-2133 (Electronic)
IS  - 0007-0963 (Linking)
DP  - 2022 Jul 13
TI  - Clinical, dermoscopic and histopathological findings in localized humanmonkeypox: a case from northern Italy.
LID - 10.1111/bjd.21773 [doi]
FAU - Maronese, Carlo A
AU  - Maronese CA
AUID- ORCID: https://orcid.org/0000-0002-9449-849X
AD  - Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico,Milan, Italy.
AD  - Department of Pathophysiology and Transplantation, Universita degli Studi diMilano, Milan, Italy.
FAU - Beretta, Andrea
AU  - Beretta A
AD  - Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico,Milan, Italy.
AD  - Department of Pathophysiology and Transplantation, Universita degli Studi diMilano, Milan, Italy.
FAU - Avallone, Gianluca
AU  - Avallone G
AUID- ORCID: https://orcid.org/0000-0001-7253-2370
AD  - Department of Medical Sciences, University of Turin, Dermatology Clinic, Turin,Italy.
FAU - Boggio, Francesca L
AU  - Boggio FL
AD  - Pathology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan,Italy.
FAU - Marletta, Dario A
AU  - Marletta DA
AUID- ORCID: https://orcid.org/0000-0002-9329-0531
AD  - Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico,Milan, Italy.
AD  - Department of Pathophysiology and Transplantation, Universita degli Studi diMilano, Milan, Italy.
FAU - Murgia, Giulia
AU  - Murgia G
AD  - Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico,Milan, Italy.
AD  - Department of Pathophysiology and Transplantation, Universita degli Studi diMilano, Milan, Italy.
FAU - Cusini, Marco
AU  - Cusini M
AD  - Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico,Milan, Italy.
FAU - Gori, Andrea
AU  - Gori A
AD  - Department of Pathophysiology and Transplantation, Universita degli Studi diMilano, Milan, Italy.
AD  - Infectious Diseases Unit, Fondazione IRCCS Ca' Granda Ospedale MaggiorePoliclinico, Milan, Italy.
FAU - Carrera, Carlo G
AU  - Carrera CG
AD  - Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico,Milan, Italy.
FAU - Di Benedetto, Alessandra
AU  - Di Benedetto A
AD  - Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico,Milan, Italy.
FAU - Ramoni, Stefano
AU  - Ramoni S
AD  - Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico,Milan, Italy.
FAU - Marzano, Angelo V
AU  - Marzano AV
AUID- ORCID: https://orcid.org/0000-0002-8160-4169
AD  - Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico,Milan, Italy.
AD  - Department of Pathophysiology and Transplantation, Universita degli Studi diMilano, Milan, Italy.
LA  - eng
PT  - Letter
DEP - 20220713
PL  - England
TA  - Br J Dermatol
JT  - The British journal of dermatology
JID - 0004041
SB  - IM
EDAT- 2022/07/14 06:00
MHDA- 2022/07/14 06:00
CRDT- 2022/07/13 04:02
PHST- 2022/07/10 00:00 [revised]
PHST- 2022/06/15 00:00 [received]
PHST- 2022/07/12 00:00 [accepted]
PHST- 2022/07/13 04:02 [entrez]
PHST- 2022/07/14 06:00 [pubmed]
PHST- 2022/07/14 06:00 [medline]
AID - 10.1111/bjd.21773 [doi]
PST - aheadofprint
SO  - Br J Dermatol. 2022 Jul 13. doi: 10.1111/bjd.21773.

PMID- 35820590
OWN - NLM
STAT- Publisher
LR  - 20220712
IS  - 1995-820X (Electronic)
IS  - 1995-820X (Linking)
DP  - 2022 Jul 9
TI  - Monkeypox virus: a re-emergent threat to humans.
LID - S1995-820X(22)00120-1 [pii]
LID - 10.1016/j.virs.2022.07.006 [doi]
AB  - Human monkeypox (MPX) is a rare zoonotic infection characterized by smallpox-likesigns and symptoms. It is caused by monkeypox virus (MPXV), a double stranded DNAvirus belonging to the genus Orthopoxvirus. MPX was first identified in 1970 and mostly prevailed in the rural rainforests of Central and West Africa in the past.Outside Africa, MPX was reported in the United Kingdom, the USA, Israel, andSingapore. In 2022, the resurgence of MPX in Europe and elsewhere posed apotential threat to humans. MPXV was transmitted by the animals-human orhuman-human pathway, and the symptoms of MPXV infection are similar to that ofsmallpox, but in a milder form and with lower mortality (1% to 10%). Although thesmallpox vaccination has been shown to provide 85% protection against MPXVinfection, and two anti-smallpox virus drugs have been approved to treat MPXV,there are still no specific vaccines and drugs against MPXV infection. Therefore it is urgent to take active measures including the adoption of novel anti-MPXVstrategies to control the spread of MPXV and prevent MPX epidemic. In thisreview, we summarize the biological features, epidemiology, pathogenicity,laboratory diagnosis, and prevention and treatment strategies on MPXV. Thisreview provides the basic knowledge for prevention and control of futureoutbreaks of this emerging infection.
CI  - Copyright (c) 2022 The Authors. Publishing services by Elsevier B.V. All rightsreserved.
FAU - Gong, Qizan
AU  - Gong Q
AD  - Division of Life Sciences and Medicine, University of Science and Technology ofChina, Hefei, 230026, China.
FAU - Wang, Changle
AU  - Wang C
AD  - Department of Pathogenic Biology, Hebei Medical University, Shijiazhuang, Hebei, 050017, China.
FAU - Chuai, Xia
AU  - Chuai X
AD  - Department of Pathogenic Biology, Hebei Medical University, Shijiazhuang, Hebei, 050017, China. Electronic address: chuaixiahb@126.com.
FAU - Chiu, Sandra
AU  - Chiu S
AD  - Division of Life Sciences and Medicine, University of Science and Technology ofChina, Hefei, 230026, China. Electronic address: qiux@ustc.edu.cn.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20220709
PL  - Netherlands
TA  - Virol Sin
JT  - Virologica Sinica
JID - 101514185
SB  - IM
OTO - NOTNLM
OT  - Antiviral drugs
OT  - Monkeypox virus (MPXV)
OT  - Orthopoxvirus
OT  - Smallpox vaccine
EDAT- 2022/07/13 06:00
MHDA- 2022/07/13 06:00
CRDT- 2022/07/12 19:25
PHST- 2022/06/07 00:00 [received]
PHST- 2022/07/05 00:00 [accepted]
PHST- 2022/07/12 19:25 [entrez]
PHST- 2022/07/13 06:00 [pubmed]
PHST- 2022/07/13 06:00 [medline]
AID - S1995-820X(22)00120-1 [pii]
AID - 10.1016/j.virs.2022.07.006 [doi]
PST - aheadofprint
SO  - Virol Sin. 2022 Jul 9. pii: S1995-820X(22)00120-1. doi:10.1016/j.virs.2022.07.006.

PMID- 35820165
OWN - NLM
STAT- Publisher
LR  - 20220712
IS  - 1080-6059 (Electronic)
IS  - 1080-6040 (Linking)
VI  - 28
IP  - 9
DP  - 2022 Jul 12
TI  - Epidemiologic Features and Control Measures during Monkeypox Outbreak, Spain,June 2022.
LID - 10.3201/eid2809.221051 [doi]
AB  - During June 2022, Spain was one of the countries most affected worldwide by amulticountry monkeypox outbreak with chains of transmission and withoutidentified links to disease-endemic countries. We provide epidemiologic features of cases reported in Spain and the coordinated measures taken to respond to this outbreak.
FAU - Rodriguez, Berta Suarez
AU  - Rodriguez BS
FAU - Herrador, Bernardo R Guzman
AU  - Herrador BRG
FAU - Franco, Asuncion Diaz
AU  - Franco AD
FAU - Farinas, Maria Paz Sanchez-Seco
AU  - Farinas MPS
FAU - Del Amo Valero, Julia
AU  - Del Amo Valero J
FAU - Llorente, Adrian Hugo Aginagalde
AU  - Llorente AHA
FAU - de Agreda, Juan Pablo Alonso Perez
AU  - de Agreda JPAP
FAU - Malonda, Rosa Carbo
AU  - Malonda RC
FAU - Castrillejo, Daniel
AU  - Castrillejo D
FAU - Chirlaque Lopez, Maria Dolores
AU  - Chirlaque Lopez MD
FAU - Chong, Eduardo Javier
AU  - Chong EJ
FAU - Balbuena, Sonia Fernandez
AU  - Balbuena SF
FAU - Garcia, Virtudes Gallardo
AU  - Garcia VG
FAU - Garcia-Cenoz, Manuel
AU  - Garcia-Cenoz M
FAU - Hernandez, Laura Garcia
AU  - Hernandez LG
FAU - Montalban, Elisa Gil
AU  - Montalban EG
FAU - Carril, Fernando Gonzalez
AU  - Carril FG
FAU - Cortijo, Teresa Gonzalez
AU  - Cortijo TG
FAU - Bueno, Susana Jimenez
AU  - Bueno SJ
FAU - Sanchez, Aurora Limia
AU  - Sanchez AL
FAU - Linares Dopido, Juan Antonio
AU  - Linares Dopido JA
FAU - Lorusso, Nicola
AU  - Lorusso N
FAU - Martins, Mario Margolles
AU  - Martins MM
FAU - Martinez Ochoa, Eva Maria
AU  - Martinez Ochoa EM
FAU - Mateo, Ana Martinez
AU  - Mateo AM
FAU - Pena, Jacobo Mendioroz
AU  - Pena JM
FAU - Anton, Ana Isabel Negredo
AU  - Anton AIN
FAU - Otero Barros, Maria Teresa
AU  - Otero Barros MT
FAU - Martinez, Maria Del Carmen Pacheco
AU  - Martinez MDCP
FAU - Jimenez, Pilar Peces
AU  - Jimenez PP
FAU - Martin, Oscar-Guillermo Perez
AU  - Martin OP
FAU - Rivas Perez, Ana Isabel
AU  - Rivas Perez AI
FAU - Garcia, Maria Sastre
AU  - Garcia MS
CN  - National Monkeypox Response Group,2
FAU - Soria, Fernando Simon
AU  - Soria FS
FAU - Sierra Moros, Maria Jose
AU  - Sierra Moros MJ
LA  - eng
PT  - Journal Article
DEP - 20220712
PL  - United States
TA  - Emerg Infect Dis
JT  - Emerging infectious diseases
JID - 9508155
SB  - IM
OTO - NOTNLM
OT  - MSM
OT  - Spain
OT  - bioterrorism and preparedness
OT  - control measures
OT  - epidemiologic features
OT  - men who have had sex with men
OT  - monkeypox
OT  - monkeypox viruses
OT  - multicountry
OT  - outbreak
OT  - response
OT  - viruses
OT  - zoonoses
EDAT- 2022/07/13 06:00
MHDA- 2022/07/13 06:00
CRDT- 2022/07/12 17:12
PHST- 2022/07/12 17:12 [entrez]
PHST- 2022/07/13 06:00 [pubmed]
PHST- 2022/07/13 06:00 [medline]
AID - 10.3201/eid2809.221051 [doi]
PST - aheadofprint
SO  - Emerg Infect Dis. 2022 Jul 12;28(9). doi: 10.3201/eid2809.221051.

PMID- 35819906
OWN - NLM
STAT- Publisher
LR  - 20220712
IS  - 1537-4521 (Electronic)
IS  - 0148-5717 (Linking)
DP  - 2022 Jul 13
TI  - Cutaneous lesions from monkeypox infection.
LID - 10.1097/OLQ.0000000000001674 [doi]
FAU - Caldeira, Margarida Brito
AU  - Caldeira MB
AD  - Centro Hospitalar de Lisboa Central EPE, Lisbon, Lisbon, Portugal.
FAU - Fernandes, Candida
AU  - Fernandes C
LA  - eng
PT  - Journal Article
DEP - 20220713
PL  - United States
TA  - Sex Transm Dis
JT  - Sexually transmitted diseases
JID - 7705941
SB  - IM
EDAT- 2022/07/13 06:00
MHDA- 2022/07/13 06:00
CRDT- 2022/07/12 13:02
PHST- 2022/07/12 13:02 [entrez]
PHST- 2022/07/13 06:00 [pubmed]
PHST- 2022/07/13 06:00 [medline]
AID - 10.1097/OLQ.0000000000001674 [doi]
AID - 00007435-990000000-00054 [pii]
PST - aheadofprint
SO  - Sex Transm Dis. 2022 Jul 13. pii: 00007435-990000000-00054. doi:10.1097/OLQ.0000000000001674.

PMID- 35818706
OWN - NLM
STAT- MEDLINE
DCOM- 20220713
LR  - 20220722
IS  - 1598-6357 (Electronic)
IS  - 1011-8934 (Linking)
VI  - 37
IP  - 27
DP  - 2022 Jul 11
TI  - The First Case of Monkeypox in the Republic of Korea.
PG  - e224
LID - 10.3346/jkms.2022.37.e224 [doi]
AB  - A rapid outbreak of monkeypox is ongoing in non-endemic countries since May 2022.We report the first case of monkeypox in the Republic of Korea. This occurred in a 34-year-old male patient who traveled to Europe in June 2022. On the day of hisreturn to the Republic of Korea (June 21, 2022), the patient presented with agenital lesion. The results of the monkeypox real-time polymerase chain reaction tests were positive in the penile ulcer, oropharyngeal and nasopharyngealspecimens. The patient subsequently developed fever and skin rash after hospital admission. Careful history taking along physical examination should be conducted in the patients who have epidemiologic risk factors for monkeypox. Moreover,appropriate specimens should be obtained from lesions and tested for themonkeypox virus.
CI  - (c) 2022 The Korean Academy of Medical Sciences.
FAU - Jang, Young Rock
AU  - Jang YR
AUID- ORCID: https://orcid.org/0000-0003-1080-7839
AD  - Division of Infectious Disease, Department of Internal Medicine, Incheon Medical Center, Incheon, Korea.
AD  - Infection Control Office, Incheon Medical Center, Incheon, Korea.
AD  - Designated Isolation Unit, Incheon Medical Center, Incheon, Korea.
FAU - Lee, Minji
AU  - Lee M
AUID- ORCID: https://orcid.org/0000-0003-4356-0051
AD  - Division of High-Risk Pathogens, Bureau of Infectious Disease Diagnosis Control, Korea Disease Control and Prevention Agency, Cheongju, Korea.
FAU - Shin, Hwachul
AU  - Shin H
AUID- ORCID: https://orcid.org/0000-0003-4380-0908
AD  - Division of High-Risk Pathogens, Bureau of Infectious Disease Diagnosis Control, Korea Disease Control and Prevention Agency, Cheongju, Korea.
FAU - Kim, Jin-Won
AU  - Kim JW
AUID- ORCID: https://orcid.org/0000-0002-2374-1077
AD  - Division of High-Risk Pathogens, Bureau of Infectious Disease Diagnosis Control, Korea Disease Control and Prevention Agency, Cheongju, Korea.
FAU - Choi, Myung-Min
AU  - Choi MM
AUID- ORCID: https://orcid.org/0000-0002-7242-297X
AD  - Division of High-Risk Pathogens, Bureau of Infectious Disease Diagnosis Control, Korea Disease Control and Prevention Agency, Cheongju, Korea.
FAU - Kim, Young Mi
AU  - Kim YM
AUID- ORCID: https://orcid.org/0000-0003-3346-0567
AD  - Division of Bacterial Diseases, Bureau of Infectious Disease Diagnosis Control,Korea Disease Control and Prevention Agency, Cheongju, Korea.
FAU - Lee, Min Ji
AU  - Lee MJ
AUID- ORCID: https://orcid.org/0000-0001-8818-2694
AD  - Division of Bacterial Diseases, Bureau of Infectious Disease Diagnosis Control,Korea Disease Control and Prevention Agency, Cheongju, Korea.
FAU - Kim, Jinsil
AU  - Kim J
AUID- ORCID: https://orcid.org/0000-0002-7936-0572
AD  - Infection Control Office, Incheon Medical Center, Incheon, Korea.
FAU - Na, Hye Kyoung
AU  - Na HK
AUID- ORCID: https://orcid.org/0000-0002-3524-9581
AD  - Designated Isolation Unit, Incheon Medical Center, Incheon, Korea.
FAU - Kim, Jin Yong
AU  - Kim JY
AUID- ORCID: https://orcid.org/0000-0002-4306-1597
AD  - Division of Infectious Disease, Department of Internal Medicine, Incheon Medical Center, Incheon, Korea.
AD  - Infection Control Office, Incheon Medical Center, Incheon, Korea.
AD  - Designated Isolation Unit, Incheon Medical Center, Incheon, Korea.kjykey@gmail.com.
LA  - eng
PT  - Case Reports
PT  - Journal Article
DEP - 20220711
PL  - Korea (South)
TA  - J Korean Med Sci
JT  - Journal of Korean medical science
JID - 8703518
SB  - IM
MH  - Adult
MH  - Animals
MH  - Disease Outbreaks
MH  - *Exanthema
MH  - Fever/etiology
MH  - Humans
MH  - Male
MH  - *Monkeypox/diagnosis/epidemiology
MH  - Monkeypox virus
PMC - PMC9274108
OTO - NOTNLM
OT  - Diagnosis
OT  - Monkeypox
OT  - Republic of Korea
COIS- The authors have no potential conflicts of interest to disclose.
EDAT- 2022/07/13 06:00
MHDA- 2022/07/14 06:00
CRDT- 2022/07/12 02:44
PHST- 2022/06/29 00:00 [received]
PHST- 2022/06/30 00:00 [accepted]
PHST- 2022/07/12 02:44 [entrez]
PHST- 2022/07/13 06:00 [pubmed]
PHST- 2022/07/14 06:00 [medline]
AID - 37.e224 [pii]
AID - 10.3346/jkms.2022.37.e224 [doi]
PST - epublish
SO  - J Korean Med Sci. 2022 Jul 11;37(27):e224. doi: 10.3346/jkms.2022.37.e224.

PMID- 35817337
OWN - NLM
STAT- Publisher
LR  - 20220804
IS  - 1873-0442 (Electronic)
IS  - 1477-8939 (Linking)
VI  - 49
DP  - 2022 Jul 8
TI  - What has been researched on monkeypox in Latin America? A brief bibliometricanalysis.
PG  - 102399
LID - S1477-8939(22)00145-4 [pii]
LID - 10.1016/j.tmaid.2022.102399 [doi]
FAU - Lozada-Martinez, Ivan David
AU  - Lozada-Martinez ID
AD  - Medical and Surgical Research Center, Future Surgeons Chapter, Colombian Surgery Association, Bogota, Colombia; International Coalition on Surgical Research,Universidad Nacional Autonoma de Nicaragua, Managua, Nicaragua; Grupo Prometheus y Biomedicina Aplicada a las Ciencias Clinicas, School of Medicine, Universidadde Cartagena, Cartagena, Colombia. Electronic address:ilozadam@unicartagena.edu.co.
FAU - Fernandez-Gomez, Maria Paula
AU  - Fernandez-Gomez MP
AD  - School of Medicine, Universidad de la Sabana, Chia, Colombia.
FAU - Acevedo-Lopez, Domenica
AU  - Acevedo-Lopez D
AD  - Semillero de Investigacion en Infecciones Emergentes y Medicina Tropical, Grupode Investigacion Biomedicina, School of Medicine, Institucion UniversitariaVision de las Americas, Pereira, Colombia.
FAU - Bolano-Romero, Maria Paz
AU  - Bolano-Romero MP
AD  - Grupo Prometheus y Biomedicina Aplicada a las Ciencias Clinicas, School ofMedicine, Universidad de Cartagena, Cartagena, Colombia.
FAU - Picon-Jaimes, Yelson Alejandro
AU  - Picon-Jaimes YA
AD  - Medical and Surgical Research Center, Future Surgeons Chapter, Colombian Surgery Association, Bogota, Colombia; Department of Epidemiology and Public Health,Valencian International University, Valencia, Spain.
FAU - Moscote-Salazar, Luis Rafael
AU  - Moscote-Salazar LR
AD  - Colombian Clinical Research Group in Neurocritical Care, Latin American Councilof Neurocritical Care, Ontario, Canada.
LA  - eng
PT  - Letter
DEP - 20220708
PL  - Netherlands
TA  - Travel Med Infect Dis
JT  - Travel medicine and infectious disease
JID - 101230758
SB  - IM
PMC - PMC9264804
EDAT- 2022/07/12 06:00
MHDA- 2022/07/12 06:00
CRDT- 2022/07/11 19:27
PHST- 2022/07/05 00:00 [received]
PHST- 2022/07/07 00:00 [accepted]
PHST- 2022/07/12 06:00 [pubmed]
PHST- 2022/07/12 06:00 [medline]
PHST- 2022/07/11 19:27 [entrez]
AID - S1477-8939(22)00145-4 [pii]
AID - 10.1016/j.tmaid.2022.102399 [doi]
PST - aheadofprint
SO  - Travel Med Infect Dis. 2022 Jul 8;49:102399. doi: 10.1016/j.tmaid.2022.102399.

PMID- 35817333
OWN - NLM
STAT- Publisher
LR  - 20220711
IS  - 1097-6787 (Electronic)
IS  - 0190-9622 (Linking)
DP  - 2022 Jul 8
TI  - Monkeypox emerges on a global scale: a historical review and dermatologicalprimer.
LID - S0190-9622(22)02261-7 [pii]
LID - 10.1016/j.jaad.2022.07.007 [doi]
AB  - The current monkeypox outbreak reawakens the concern that poxviridae have highpotential of zoonotic spillover and for causing pandemic.(1) Much fieldwork andresearch has been done by healthcare and public health workers in Africa duringprevious human outbreaks, and their knowledge should inform our global responseto the current outbreak. However, unusual clinical presentations now havepotential implications in recognizing disease. Infections from poxviridae such asmonkeypox have common cutaneous signs that occur early, may be related to periodsof transmissibility, and can leave scarring. Therefore, dermatologists will play a key role in recognizing and diagnosing infections, and in educating andpreparing front-line healthcare workers for early detection of new cases andclusters of monkeypox.
CI  - Copyright (c) 2022. Published by Elsevier Inc.
FAU - Bryer, J S
AU  - Bryer JS
AD  - Department of Dermatology, University of Pennsylvania, Philadelphia, PA.
FAU - Freeman, E E
AU  - Freeman EE
AD  - Department of Dermatology, Massachusetts General Hospital, Boston, MA.
FAU - Rosenbach, M
AU  - Rosenbach M
AD  - Department of Dermatology, University of Pennsylvania, Philadelphia, PA.Electronic address: Misha.Rosenbach@pennmedicine.upenn.edu.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20220708
PL  - United States
TA  - J Am Acad Dermatol
JT  - Journal of the American Academy of Dermatology
JID - 7907132
SB  - IM
OTO - NOTNLM
OT  - complex medical dermatology
OT  - dermatology
OT  - infectious disease
OT  - monkeypox
OT  - poxviridae
EDAT- 2022/07/12 06:00
MHDA- 2022/07/12 06:00
CRDT- 2022/07/11 19:27
PHST- 2022/06/15 00:00 [received]
PHST- 2022/07/01 00:00 [revised]
PHST- 2022/07/05 00:00 [accepted]
PHST- 2022/07/11 19:27 [entrez]
PHST- 2022/07/12 06:00 [pubmed]
PHST- 2022/07/12 06:00 [medline]
AID - S0190-9622(22)02261-7 [pii]
AID - 10.1016/j.jaad.2022.07.007 [doi]
PST - aheadofprint
SO  - J Am Acad Dermatol. 2022 Jul 8. pii: S0190-9622(22)02261-7. doi:10.1016/j.jaad.2022.07.007.

PMID- 35817231
OWN - NLM
STAT- Publisher
LR  - 20220711
IS  - 1469-0691 (Electronic)
IS  - 1198-743X (Linking)
DP  - 2022 Jul 8
TI  - Estimation of local transmissibility in the early phase of monkeypox epidemic in 2022.
LID - S1198-743X(22)00340-8 [pii]
LID - 10.1016/j.cmi.2022.06.025 [doi]
AB  - OBJECTIVES: To estimate the basic reproductive number (Ro) to help us understand and control the spread of monkeypox in immunologically-naive populations.METHODS: Using three highest incidence populations including England, Portugaland Spain as examples as of 18 June 2022, we employed the branching process with a Poisson likelihood and gamma-distributed serial interval to fit daily reported case data of monkeypox to estimate Ro. Sensitivity analyses were performed byvarying mean serial interval from 6.8 to 12.8 days. RESULTS: The median posteriorestimates of Ro for monkeypox in three study populations were statisticallygreater than 1 (England: Ro=1.60 (95% Credible Interval: (CI) 1.50, 1.70);Portugal: Ro=1.40 (1.20, 1.60); Spain: Ro=1.80 (1.70, 2.00)). Ro estimates variedover 1.30- 2.10, depending on the serial interval. CONCLUSIONS: Updated Roestimates across different populations informs policy makers plan for publichealth control measures. Currently, monkeypox has a sustainable outbreakpotential and may challenge healthcare systems, mainly due to declines in thepopulation level immunity to Orthopoxviruses since the cessation of routinesmallpox vaccination. Smallpox vaccination has been shown to be effective inprotecting (up to 85% effectiveness) against monkeypox infection in earliertimes. So early post-exposure vaccination is currently being offered in anattempt to control its spread.
CI  - Copyright (c) 2022 European Society of Clinical Microbiology and InfectiousDiseases. Published by Elsevier Ltd. All rights reserved.
FAU - Kwok, Kin On
AU  - Kwok KO
AD  - JC School of Public Health and Primary Care, The Chinese University of Hong Kong,Hong Kong Special Administrative Region, China; Stanley Ho Centre for EmergingInfectious Diseases, The Chinese University of Hong Kong, Hong Kong SpecialAdministrative Region, China; Hong Kong Institute of Asia-Pacific Studies, TheChinese University of Hong Kong, Hong Kong Special Administrative Region, China; Shenzhen Research Institute of the Chinese University of Hong Kong, Shenzhen,China. Electronic address: kkokwok@cuhk.edu.hk.
FAU - Wei, Wan In
AU  - Wei WI
AD  - JC School of Public Health and Primary Care, The Chinese University of Hong Kong,Hong Kong Special Administrative Region, China.
FAU - Tang, Arthur
AU  - Tang A
AD  - College of Computing and Informatics, Sungkyunkwan University, Seoul, Republic ofKorea.
FAU - Shan Wong, Samuel Yeung
AU  - Shan Wong SY
AD  - JC School of Public Health and Primary Care, The Chinese University of Hong Kong,Hong Kong Special Administrative Region, China.
FAU - Tang, Julian W
AU  - Tang JW
AD  - Respiratory Sciences, University of Leicester, Leicester, UK; ClinicalMicrobiology, Leicester Royal Infirmary, Leicester, UK. Electronic address:jwtang49@hotmail.com.
LA  - eng
PT  - Journal Article
DEP - 20220708
PL  - England
TA  - Clin Microbiol Infect
JT  - Clinical microbiology and infection : the official publication of the EuropeanSociety of Clinical Microbiology and Infectious Diseases
JID - 9516420
SB  - IM
OTO - NOTNLM
OT  - Monkeypox
OT  - basic reproductive number
OT  - branching process
OT  - epidemic
OT  - outbreak
EDAT- 2022/07/12 06:00
MHDA- 2022/07/12 06:00
CRDT- 2022/07/11 19:25
PHST- 2022/05/25 00:00 [received]
PHST- 2022/06/21 00:00 [revised]
PHST- 2022/06/23 00:00 [accepted]
PHST- 2022/07/11 19:25 [entrez]
PHST- 2022/07/12 06:00 [pubmed]
PHST- 2022/07/12 06:00 [medline]
AID - S1198-743X(22)00340-8 [pii]
AID - 10.1016/j.cmi.2022.06.025 [doi]
PST - aheadofprint
SO  - Clin Microbiol Infect. 2022 Jul 8. pii: S1198-743X(22)00340-8. doi:10.1016/j.cmi.2022.06.025.

PMID- 35816222
OWN - NLM
STAT- Publisher
LR  - 20220716
IS  - 1439-0973 (Electronic)
IS  - 0300-8126 (Linking)
DP  - 2022 Jul 11
TI  - Clinical and virological features of first human monkeypox cases in Germany.
LID - 10.1007/s15010-022-01874-z [doi]
AB  - BACKGROUND: Monkeypox is a zoonotic orthopoxvirus infection endemic in centraland western Africa. In May 2022, human monkeypox infections includinghuman-to-human transmission were reported in a multi-country outbreak in Europeand North America. CASE PRESENTATIONS: Here we present the first two cases ofmonkeypox infection in humans diagnosed in Germany. We present clinical andvirological findings, including the detection of monkeypox virus DNA in blood andsemen. The clinical presentation and medical history of our patients suggestclose physical contact during sexual interactions as the route of infection.CONCLUSION: Monkeypox requires rapid diagnosis and prompt public health response.The disease should be considered in the current situation especially thedifferential diagnosis of vesicular or pustular rash, particularly in patientswith frequent sexual contacts. Most importantly, it is essential to raiseawareness among all health professionals for the rapid and correct recognitionand diagnosis of this disease, which is probably still underreported in Europe(Adler et al. in Lancet Infect Dis https://doi.org/10.1016/s1473-3099(22)00228-6 , 2022).
CI  - (c) 2022. The Author(s).
FAU - Noe, Sebastian
AU  - Noe S
AD  - MVZ Munchen am Goetheplatz, Munich, Germany.
FAU - Zange, Sabine
AU  - Zange S
AD  - Bundeswehr Institute of Microbiology, Munich, Germany.
AD  - German Center for Infection Research (DZIF), Munich Partner Site, Munich,Germany.
FAU - Seilmaier, Michael
AU  - Seilmaier M
AD  - Munich Clinic Schwabing, Academic Teaching Hospital, Ludwig-Maximilian University(LMU), Munich, Germany.
FAU - Antwerpen, Markus H
AU  - Antwerpen MH
AD  - Bundeswehr Institute of Microbiology, Munich, Germany.
AD  - German Center for Infection Research (DZIF), Munich Partner Site, Munich,Germany.
FAU - Fenzl, Thomas
AU  - Fenzl T
AD  - Munich Clinic Schwabing, Academic Teaching Hospital, Ludwig-Maximilian University(LMU), Munich, Germany.
FAU - Schneider, Jochen
AU  - Schneider J
AD  - School of Medicine, University Hospital Rechts der Isar, Technical University of Munich , Munich, Germany.
AD  - German Center for Infection Research (DZIF), Munich Partner Site, Munich,Germany.
FAU - Spinner, Christoph D
AU  - Spinner CD
AD  - School of Medicine, University Hospital Rechts der Isar, Technical University of Munich , Munich, Germany.
AD  - German Center for Infection Research (DZIF), Munich Partner Site, Munich,Germany.
FAU - Bugert, Joachim J
AU  - Bugert JJ
AD  - Bundeswehr Institute of Microbiology, Munich, Germany.
AD  - German Center for Infection Research (DZIF), Munich Partner Site, Munich,Germany.
FAU - Wendtner, Clemens-Martin
AU  - Wendtner CM
AD  - Munich Clinic Schwabing, Academic Teaching Hospital, Ludwig-Maximilian University(LMU), Munich, Germany.
FAU - Wolfel, Roman
AU  - Wolfel R
AUID- ORCID: http://orcid.org/0000-0002-8756-7821
AD  - Bundeswehr Institute of Microbiology, Munich, Germany.romanwoelfel@bundeswehr.org.
AD  - German Center for Infection Research (DZIF), Munich Partner Site, Munich,Germany. romanwoelfel@bundeswehr.org.
LA  - eng
PT  - Journal Article
DEP - 20220711
PL  - Germany
TA  - Infection
JT  - Infection
JID - 0365307
SB  - IM
PMC - PMC9272654
OTO - NOTNLM
OT  - Blood
OT  - Efflorescence
OT  - Germany
OT  - HIV
OT  - Monkeypox
OT  - Semen
OT  - Skin lesion
EDAT- 2022/07/12 06:00
MHDA- 2022/07/12 06:00
CRDT- 2022/07/11 11:14
PHST- 2022/06/03 00:00 [received]
PHST- 2022/06/09 00:00 [accepted]
PHST- 2022/07/11 11:14 [entrez]
PHST- 2022/07/12 06:00 [pubmed]
PHST- 2022/07/12 06:00 [medline]
AID - 10.1007/s15010-022-01874-z [doi]
AID - 10.1007/s15010-022-01874-z [pii]
PST - aheadofprint
SO  - Infection. 2022 Jul 11. pii: 10.1007/s15010-022-01874-z. doi:10.1007/s15010-022-01874-z.

PMID- 35815416
OWN - NLM
STAT- MEDLINE
DCOM- 20220803
LR  - 20220803
IS  - 1559-6834 (Electronic)
IS  - 0899-823X (Linking)
VI  - 43
IP  - 8
DP  - 2022 Aug
TI  - Development and deployment of tools for rapid response notification of Monkeypox exposure, exposure risk assessment and stratification, and symptom monitoring.
PG  - 963-967
LID - 10.1017/ice.2022.167 [doi]
AB  - OBJECTIVES: Public health authorities recommend symptom monitoring of healthcare personnel (HCP) after defined exposures to monkeypox. We report on the rapiddevelopment and implementation of mobile responsive survey solutions fornotification of possible exposure, exposure risk assessment and stratification,and symptom monitoring. SETTING: An academic health center in Boston,Massachusetts, after admission of first diagnosed case of monkeypox in the UnitedStates during the current global outbreak. PARTICIPANTS: Research Electronic DataCapture (REDCap) design and programmers, infection control, occupational health, and emergency preparedness specialists, and HCP with possible exposure tomonkeypox. INTERVENTIONS: Design and deployment of REDCap tools to identify HCPwith possible exposure to monkeypox, to perform exposure risk assessment andstratification for postexposure prophylaxis (PEP), and to conduct symptommonitoring during the exposure window. Project enhancements included dashboardsfor HCP tracking and short message service (SMS text) reminders for symptommonitoring. RESULTS: Tools to support the contact tracing and exposureinvestigation were deployed within 24 hours of identification of a patient withsuspected monkeypox, with the full suite in production within 4 days ofconfirmation of the monkeypox diagnosis. Clinical follow-up of HCP was integratedinto the design, and real-time versioning allowed for improvements in HCP symptommonitoring compliance and enhanced tracking. CONCLUSIONS: During the currentmonkeypox outbreak, timely and comprehensive evaluation of potential HCPexposures is necessary but presents logistical challenges. Rapid development ofmonkeypox-specific solutions using REDCap facilitated flexibility in design andapproach, and integration of targeted clinical support enhanced functionality.
FAU - Simpson, Lynn A
AU  - Simpson LA
AUID- ORCID: https://orcid.org/0000-0002-4487-7547
AD  - Harvard Catalyst, The Harvard Clinical and Translational Science Center, Boston, Massachusetts.
AD  - Mass General Brigham Research Information Science & Computing, Boston,Massachusetts.
FAU - Macdonald, Kaitlin
AU  - Macdonald K
AD  - Mass General Brigham Occupational Health Services, Boston, Massachusetts.
FAU - Searle, Eileen F
AU  - Searle EF
AD  - Center for Disaster Medicine, Massachusetts General Hospital, Boston,Massachusetts.
AD  - Regional Emerging Special Pathogens Treatment Center, Massachusetts GeneralHospital, Boston, Massachusetts.
FAU - Shearer, Jennifer A
AU  - Shearer JA
AD  - Center for Disaster Medicine, Massachusetts General Hospital, Boston,Massachusetts.
AD  - Department of Emergency Preparedness and Business Continuity, Mass GeneralBrigham, Boston, Massachusetts.
FAU - Dimitrov, Dimitar
AU  - Dimitrov D
AUID- ORCID: https://orcid.org/0000-0002-9073-1653
AD  - Mass General Brigham Research Information Science & Computing, Boston,Massachusetts.
FAU - Foley, Daniel
AU  - Foley D
AD  - Mass General Brigham Research Information Science & Computing, Boston,Massachusetts.
FAU - Morales, Eduardo
AU  - Morales E
AD  - Mass General Brigham Research Information Science & Computing, Boston,Massachusetts.
FAU - Shenoy, Erica S
AU  - Shenoy ES
AUID- ORCID: https://orcid.org/0000-0001-8086-1123
AD  - Regional Emerging Special Pathogens Treatment Center, Massachusetts GeneralHospital, Boston, Massachusetts.
AD  - Infection Control Unit, Massachusetts General Hospital, Boston, Massachusetts.
AD  - Division of Infectious Diseases, Department of Medicine, Massachusetts GeneralHospital, Boston, Massachusetts.
AD  - Harvard Medical School, Boston, Massachusetts.
LA  - eng
PT  - Journal Article
DEP - 20220711
PL  - United States
TA  - Infect Control Hosp Epidemiol
JT  - Infection control and hospital epidemiology
JID - 8804099
SB  - IM
MH  - Animals
MH  - Humans
MH  - Infectious Disease Transmission, Patient-to-Professional/prevention & control
MH  - *Monkeypox/diagnosis/epidemiology
MH  - *Occupational Exposure/prevention & control
MH  - Post-Exposure Prophylaxis
MH  - Risk Assessment
MH  - United States
EDAT- 2022/07/12 06:00
MHDA- 2022/08/04 06:00
CRDT- 2022/07/11 04:36
PHST- 2022/07/12 06:00 [pubmed]
PHST- 2022/08/04 06:00 [medline]
PHST- 2022/07/11 04:36 [entrez]
AID - S0899823X22001672 [pii]
AID - 10.1017/ice.2022.167 [doi]
PST - ppublish
SO  - Infect Control Hosp Epidemiol. 2022 Aug;43(8):963-967. doi: 10.1017/ice.2022.167.Epub 2022 Jul 11.

PMID- 35813461
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220716
IS  - 2667-193X (Electronic)
IS  - 2667-193X (Linking)
VI  - 13
DP  - 2022 Sep
TI  - Latin America: Situation and preparedness facing the multi-country humanmonkeypox outbreak.
PG  - 100318
LID - 10.1016/j.lana.2022.100318 [doi]
FAU - Rodriguez-Morales, Alfonso J
AU  - Rodriguez-Morales AJ
AD  - Grupo de Investigacion Biomedicina, Faculty of Medicine, Fundacion Universitaria Autonoma de las Americas, Pereira, Risaralda, Colombia.
AD  - Master of Clinical Epidemiology and Biostatistics, Universidad Cientifica delSur, Lima, Peru.
AD  - Latin American network of MOnkeypox VIrus research (LAMOVI), Pereira, Risaralda, Colombia.
FAU - Lopardo, Gustavo
AU  - Lopardo G
AD  - Catedra de Enfermedades Infecciosas, University of Buenos Aires, Buenos Aires,Argentina.
FAU - Verbanaz, Sergio
AU  - Verbanaz S
AD  - Servicio de Infectologia, Hospital Britanico de Buenos Aires. Buenos Aires,Argentina.
FAU - Orduna, Tomas
AU  - Orduna T
AD  - Catedra de Enfermedades Infecciosas, University of Buenos Aires, Buenos Aires,Argentina.
AD  - Hospital de Enfermedades Infecciosas F. J. Muniz, Buenos Aires, Argentina.
FAU - Lloveras, Susana
AU  - Lloveras S
AD  - Catedra de Enfermedades Infecciosas, University of Buenos Aires, Buenos Aires,Argentina.
AD  - Hospital de Enfermedades Infecciosas F. J. Muniz, Buenos Aires, Argentina.
FAU - Azenas-Burgoa, Jose Maria
AU  - Azenas-Burgoa JM
AD  - Hospital Clinico Viedma, Cochabamba, Bolivia.
FAU - Escalera-Antezana, Juan Pablo
AU  - Escalera-Antezana JP
AD  - Direction, Centros de Salud de Primer Nivel, Secretaria de Salud, GobiernoAutonomo Municipal de Cochabamba, Cochabamba, Bolivia.
FAU - Alvarado-Arnez, Lucia Elena
AU  - Alvarado-Arnez LE
AD  - National Research Coordination, Franz Tamayo University (UNIFRANZ), La Paz,Bolivia.
FAU - Barbosa, Alexandre Naime
AU  - Barbosa AN
AD  - Infectious Diseases Department, Botucatu Medical School, UNESP; Brazilian Societyfor Infectious Diseases, Sao Paulo, SP, Brazil.
FAU - Diaz-Quijano, Fredi
AU  - Diaz-Quijano F
AD  - Departamento de Epidemiologia, Faculdade de Saude Publica da Universidade de Sao Paulo, Sao Paulo, SP, Brazil. Beneficiary of a fellowship for researchproductivity from the National Council for Scientific and TechnologicalDevelopment - CNPq, process/contract identification: 312656/2019-0, Brazil.
FAU - Cimerman, Sergio
AU  - Cimerman S
AD  - Institute of Infectious Diseases Emilio Ribas, Sao Paulo, Brazil.
FAU - Chaves, Tania do Socorro Souza
AU  - Chaves TDSS
AD  - Evandro Chagas Institute, Health of Ministry of Brazil, Belem, Para, Brazil;Faculdade de Medicina da Universidade Federal do Para, Brazil.
FAU - Rodriguez-Morales, Andrea G
AU  - Rodriguez-Morales AG
AD  - Unidad Procedimientos, Policlinico Neurologia, Centro de Referencia de Salud Dr. Salvador Allende Gossens, Santiago de Chile, Chile.
FAU - Perret, Cecilia
AU  - Perret C
AD  - Department of Pediatric Infectious Diseases and Immunology, School of Medicine,Pontificia Universidad Catolica de Chile, Santiago de Chile, Chile.
FAU - Mendez, Claudio A
AU  - Mendez CA
AD  - Instituto de Salud Publica, Facultad de Medicina, Universidad Austral de Chile,Valdivia, Chile.
FAU - Riera, Jorge A
AU  - Riera JA
AD  - Hospital de San Fernando, Ministerio de Salud, San Fernando, VI Region, Chile.
FAU - Bonilla-Aldana, D Katterine
AU  - Bonilla-Aldana DK
AD  - Grupo de Investigacion Biomedicina, Faculty of Medicine, Fundacion Universitaria Autonoma de las Americas, Pereira, Risaralda, Colombia.
FAU - Camacho-Moreno, German
AU  - Camacho-Moreno G
AD  - Department of Pediatrics, Universidad Nacional de Colombia, Bogota, DC, Colombia.Division of Infectious Diseases, HOMI, Hospital Pediatrico La Misericordia,Bogota, DC, Colombia.
FAU - Mendoza, Henry
AU  - Mendoza H
AD  - Hemera Unidad de Infectologia IPS SAS, Bogota, Colombia.
FAU - Rodriguez-Sabogal, Ivan Arturo
AU  - Rodriguez-Sabogal IA
AD  - Hospital San Vicente Fundacion, Rionegro, Antioquia, Colombia.
FAU - Onate, Jose
AU  - Onate J
AD  - Clinica Imbanaco Grupo Quironsalud, Cali, Colombia. Universidad Santiago de Cali,Cali, Colombia. Clinica de Occidente, Cali, Colombia. Clinica Sebastian deBelalcazar, Valle del Cauca, Colombia.
FAU - Escobedo, Angel A
AU  - Escobedo AA
AD  - Epidemiology Unit, National Institute of Gastroenterology, La Habana, Cuba.
FAU - Thormann, Monica
AU  - Thormann M
AD  - Hospital Salvador Bienvenido Gautier, Santo Domingo, Dominican Republic.
FAU - Roque, Yori
AU  - Roque Y
AD  - Pontificia Universidad Catolica Madre y Maestra (PUCMM), Santiago, DominicanRepublic.
FAU - Zambrano, Patricia Gabriela
AU  - Zambrano PG
AD  - School of Medicine of the International University of Ecuador, Quito, Ecuador.
FAU - Carrero, Yenddy
AU  - Carrero Y
AD  - Universidad Tecnica de Ambato, Ambato, Ecuador.
FAU - Sandoval, Nancy
AU  - Sandoval N
AD  - Hospital Roosevelt, Guatemala City, Guatemala.
FAU - Zambrano, Lysien
AU  - Zambrano L
AD  - Unit of Scientific Research, School of Medical, Faculty of Medical Sciences,Universidad Nacional Autonoma de Honduras (UNAH), Tegucigalpa, Honduras.
FAU - Franco-Paredes, Carlos
AU  - Franco-Paredes C
AD  - Hospital Infantil de Mexico, Federico Gomez, Mexico City, Mexico.
FAU - Chacon-Cruz, Enrique
AU  - Chacon-Cruz E
AD  - Departamento de Infectologia, Hospital General de Tijuana, Tijuana, Mexico.
FAU - Lopez-Delgado, Ivan
AU  - Lopez-Delgado I
AD  - Departamento de Infectologia, Hospital General de Tijuana, Tijuana, Mexico.
FAU - Cuadra-Sanchez, Cesar
AU  - Cuadra-Sanchez C
AD  - Asociacion de Microbiologos y Quimicos Clinicos de Nicaragua, Managua, Nicaragua.
FAU - Pachar-Flores, Monica
AU  - Pachar-Flores M
AD  - Medicine Department-Infectious Diseases Service, Hospital Santo Tomas, PanamaCity, Panama. Instituto Oncologico Nacional, Panama city, Panama.
FAU - Correa, Ricardo
AU  - Correa R
AD  - University of Arizona College of Medicine-Phoenix, Division of Endocrinology,Department of Medicine.650 E Indian School Rd, suite 117B, Phoenix, AZ 85022,USA.
FAU - Rodriguez-Enciso, Hernan D
AU  - Rodriguez-Enciso HD
AD  - Direccion de Investigacion, Direccion Nacional de Vigilancia Sanitaria, Asuncion,Paraguay.
FAU - Rotela-Fisch, Veronica
AU  - Rotela-Fisch V
AD  - Division of Dermatology, Faculty of Medical Sciences, Universidad Nacional deAsuncion, Asuncion, Paraguay.
FAU - Maquera-Afaray, Julio
AU  - Maquera-Afaray J
AD  - Infectious Diseases Division, Instituto Nacional de Salud del Nino San Borja,Lima, Peru. Facultad de Ciencias de la Salud, Universidad Privada de Tacna,Tacna, Peru.
FAU - Herrera-Anazco, Percy
AU  - Herrera-Anazco P
AD  - Universidad San Juan Bautista, Lima, Peru.
FAU - Benites-Zapata, Vicente
AU  - Benites-Zapata V
AD  - Unidad de Investigacion para la Generacion y Sintesis de Evidencias en Salud,Vicerrectorado de Investigacion, Universidad San Ignacio de Loyola, Lima, Peru.
FAU - Savio-Larriera, Eduardo
AU  - Savio-Larriera E
AD  - Hospital Evangelico de Montevideo, Montevideo, Uruguay.
FAU - Ramirez, Juan David
AU  - Ramirez JD
AD  - Molecular Microbiology Laboratory, Department of Pathology, Molecular andCell-based Medicine, Icahn School of Medicine at Mount Sinai, New York, USA.
AD  - Centro de Investigaciones en Microbiologia y Biotecnologia-UR (CIMBIUR), Facultadde Ciencias Naturales, Universidad del Rosario, Bogota, Colombia.
FAU - Paniz-Mondolfi, Alberto
AU  - Paniz-Mondolfi A
AD  - Hospital Evangelico de Montevideo, Montevideo, Uruguay.
AD  - Infectious Diseases Research Branch, Venezuelan Science Incubator and theZoonosis and Emerging Pathogens Regional Collaborative Network, Cabudare, 3023,Lara, Venezuela.
FAU - Risquez, Alejandro
AU  - Risquez A
AD  - Faculty of Medicine, Universidad Central de Venezuela, Caracas, Venezuela.
FAU - Forero-Pena, David A
AU  - Forero-Pena DA
AD  - Faculty of Medicine, Universidad Central de Venezuela, Caracas, Venezuela.
AD  - Biomedical Research and Therapeutic Vaccines Institute, Ciudad Bolivar,Venezuela.
FAU - Torres, Jaime R
AU  - Torres JR
AD  - Tropical Medicine Institute, Infectious Diseases Section, Universidad Central de Venezuela, Caracas 1053, Venezuela.
FAU - Suarez, Jose Antonio
AU  - Suarez JA
AD  - Investigador SNI Senacyt Panama, Clinical Research Deparment, InstitutoConmemorativo Gorgas de Estudios de la Salud, Panama City, Panama.
LA  - eng
PT  - Journal Article
DEP - 20220706
PL  - England
TA  - Lancet Reg Health Am
JT  - Lancet Regional Health. Americas
JID - 9918232503006676
PMC - PMC9257677
COIS- All authors declare no competing of interest. GC-M has received an independentgrant from Pfizer through the Asociacion Colombiana de Infectologia ACIN-capitulo central; speaker fees from Pfizer, Sanofi Pasteur and Biomerieux; andparticipated in Advisory Boards for MSD and Sanofi Pasteur.
EDAT- 2022/07/12 06:00
MHDA- 2022/07/12 06:01
CRDT- 2022/07/11 04:02
PHST- 2022/07/11 04:02 [entrez]
PHST- 2022/07/12 06:00 [pubmed]
PHST- 2022/07/12 06:01 [medline]
AID - 10.1016/j.lana.2022.100318 [doi]
AID - S2667-193X(22)00135-1 [pii]
PST - ppublish
SO  - Lancet Reg Health Am. 2022 Sep;13:100318. doi: 10.1016/j.lana.2022.100318. Epub2022 Jul 6.

PMID- 35811294
OWN - NLM
STAT- MEDLINE
DCOM- 20220726
LR  - 20220726
IS  - 2589-7500 (Electronic)
IS  - 2589-7500 (Linking)
VI  - 4
IP  - 8
DP  - 2022 Aug
TI  - Early human judgment forecasts of human monkeypox, May 2022.
PG  - e569-e571
LID - S2589-7500(22)00127-3 [pii]
LID - 10.1016/S2589-7500(22)00127-3 [doi]
FAU - McAndrew, Thomas
AU  - McAndrew T
AD  - Department of Community and Population Health, College of Health, LehighUniversity, Bethlehem, PA 18015, USA. Electronic address: mcandrew@lehigh.edu.
FAU - Majumder, Maimuna S
AU  - Majumder MS
AD  - Boston Children's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
FAU - Lover, Andrew A
AU  - Lover AA
AD  - Department of Biostatistics and Epidemiology, School of Public Health and Health Sciences, University of Massachusetts Amherst, Amherst, MA, USA.
FAU - Venkatramanan, Srini
AU  - Venkatramanan S
AD  - Biocomplexity Institute and Initiative, University of Virginia, Charlottesville, VA, USA.
FAU - Bocchini, Paolo
AU  - Bocchini P
AD  - Department of Civil and Environmental Engineering, P C Rossin College ofEngineering and Applied Science, Lehigh University, Bethlehem, PA 18015, USA.
FAU - Besiroglu, Tamay
AU  - Besiroglu T
AD  - MIT Computer Science and Artificial Intelligence Laboratory, Cambridge, MA, USA; Metaculus, Santa Cruz, CA, USA.
FAU - Codi, Allison
AU  - Codi A
AD  - Department of Community and Population Health, College of Health, LehighUniversity, Bethlehem, PA 18015, USA.
FAU - Braun, David
AU  - Braun D
AD  - Department of Psychology, College of Arts and Sciences, Lehigh University,Bethlehem, PA 18015, USA.
FAU - Dempsey, Gaia
AU  - Dempsey G
AD  - Metaculus, Santa Cruz, CA, USA.
FAU - Abbott, Sam
AU  - Abbott S
AD  - Centre for Mathematical Modelling of Infectious Diseases, London School ofHygiene & Tropical Medicine, London, UK.
FAU - Chevalier, Sylvain
AU  - Chevalier S
AD  - Metaculus, Santa Cruz, CA, USA.
FAU - Bosse, Nikos I
AU  - Bosse NI
AD  - Metaculus, Santa Cruz, CA, USA; Centre for Mathematical Modelling of InfectiousDiseases, London School of Hygiene & Tropical Medicine, London, UK.
FAU - Cambeiro, Juan
AU  - Cambeiro J
AD  - Metaculus, Santa Cruz, CA, USA; Department of Epidemiology, Mailman School ofPublic Health, Columbia University, New York, NY, USA.
LA  - eng
PT  - Journal Article
DEP - 20220707
PL  - England
TA  - Lancet Digit Health
JT  - The Lancet. Digital health
JID - 101751302
SB  - IM
MH  - Animals
MH  - Forecasting
MH  - Humans
MH  - Judgment
MH  - *Monkeypox
COIS- MSM has been awarded funds from the National Science Foundation and BostonChildren's Hospital. TB is an advisor to Metaculus and holds stock options withMetaculus. SV has been awarded funds from Centers for Disease Control andPrevention, Council for State and Territorial Epidemiologists, VirginiaDepartment of Health, National Science Foundation, Defense Threat ReductionAgency, and the University of Pittsburgh. GD holds leadership and board roles at Metaculus, which is the public benefit corporation that develops the forecasting platform used to elicit forecasts in this Comment. All other authors declare nocompeting interests. We would like to thank all individuals who dedicated theirtime and energy to submitting probabilistic forecasts of the transmission andburden of the monkeypox virus. The forecasting data used to generate figures inthis Comment are available on GitHub. Real time forecasts are available on theMetaculus website. Because no personal information about forecasters wascollected for this work, we determined, in consultation with an internationalreview board analyst, that this study should not be considered Human SubjectsResearch.
EDAT- 2022/07/11 06:00
MHDA- 2022/07/27 06:00
CRDT- 2022/07/10 22:08
PHST- 2022/06/02 00:00 [received]
PHST- 2022/06/20 00:00 [revised]
PHST- 2022/06/27 00:00 [accepted]
PHST- 2022/07/11 06:00 [pubmed]
PHST- 2022/07/27 06:00 [medline]
PHST- 2022/07/10 22:08 [entrez]
AID - S2589-7500(22)00127-3 [pii]
AID - 10.1016/S2589-7500(22)00127-3 [doi]
PST - ppublish
SO  - Lancet Digit Health. 2022 Aug;4(8):e569-e571. doi: 10.1016/S2589-7500(22)00127-3.Epub 2022 Jul 7.

PMID- 35811013
OWN - NLM
STAT- Publisher
LR  - 20220804
IS  - 1743-9159 (Electronic)
IS  - 1743-9159 (Linking)
VI  - 104
DP  - 2022 Jul 7
TI  - Monkeypox virus under COVID-19: Caution for sexual transmission - Correspondence.
PG  - 106768
LID - S1743-9191(22)00545-3 [pii]
LID - 10.1016/j.ijsu.2022.106768 [doi]
FAU - Zhu, Fengya
AU  - Zhu F
AD  - Academy of Medical Sciences, Zigong First People's Hospital, Zigong, China.
FAU - Li, Liuying
AU  - Li L
AD  - Academy of Medical Sciences, Zigong First People's Hospital, Zigong, China.
FAU - Che, Deya
AU  - Che D
AD  - Academy of Medical Sciences, Zigong First People's Hospital, Zigong, China.Electronic address: dyche0820@163.com.
LA  - eng
PT  - Letter
DEP - 20220707
PL  - England
TA  - Int J Surg
JT  - International journal of surgery (London, England)
JID - 101228232
SB  - IM
PMC - PMC9259512
EDAT- 2022/07/11 06:00
MHDA- 2022/07/11 06:00
CRDT- 2022/07/10 19:26
PHST- 2022/06/03 00:00 [received]
PHST- 2022/06/23 00:00 [revised]
PHST- 2022/06/27 00:00 [accepted]
PHST- 2022/07/11 06:00 [pubmed]
PHST- 2022/07/11 06:00 [medline]
PHST- 2022/07/10 19:26 [entrez]
AID - S1743-9191(22)00545-3 [pii]
AID - 10.1016/j.ijsu.2022.106768 [doi]
PST - aheadofprint
SO  - Int J Surg. 2022 Jul 7;104:106768. doi: 10.1016/j.ijsu.2022.106768.

PMID- 35810941
OWN - NLM
STAT- Publisher
LR  - 20220717
IS  - 1532-2742 (Electronic)
IS  - 0163-4453 (Linking)
DP  - 2022 Jul 8
TI  - Targeting F13 from monkeypox virus and variola virus by tecovirimat: Molecularsimulation analysis.
LID - S0163-4453(22)00410-8 [pii]
LID - 10.1016/j.jinf.2022.07.001 [doi]
FAU - Li, Daoqun
AU  - Li D
AD  - Shandong Provincial Hospital Affiliated to Shandong First Medical University,Jinan, Shandong, China; Department of Pathogen Biology, School of Clinical andBasic Medical Sciences, Shandong First Medical University and Shandong Academy ofMedical Sciences, Jinan, Shandong, China; Medical Science and TechnologyInnovation Center, Shandong First Medical University & Shandong Academy ofMedical Sciences, Jinan, Shandong, China.
FAU - Liu, Yuwen
AU  - Liu Y
AD  - Department of Pathogen Biology, School of Clinical and Basic Medical Sciences,Shandong First Medical University and Shandong Academy of Medical Sciences,Jinan, Shandong, China; Medical Science and Technology Innovation Center,Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China.
FAU - Li, Kangxin
AU  - Li K
AD  - Department of Pathogen Biology, School of Clinical and Basic Medical Sciences,Shandong First Medical University and Shandong Academy of Medical Sciences,Jinan, Shandong, China; Medical Science and Technology Innovation Center,Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China.
FAU - Zhang, Leiliang
AU  - Zhang L
AD  - Shandong Provincial Hospital Affiliated to Shandong First Medical University,Jinan, Shandong, China; Department of Pathogen Biology, School of Clinical andBasic Medical Sciences, Shandong First Medical University and Shandong Academy ofMedical Sciences, Jinan, Shandong, China; Medical Science and TechnologyInnovation Center, Shandong First Medical University & Shandong Academy ofMedical Sciences, Jinan, Shandong, China. Electronic address:armzhang@hotmail.com.
LA  - eng
PT  - Letter
DEP - 20220708
PL  - England
TA  - J Infect
JT  - The Journal of infection
JID - 7908424
SB  - IM
COIS- Declaration of Competing Interest The authors declare that there are no conflictsof interest.
EDAT- 2022/07/11 06:00
MHDA- 2022/07/11 06:00
CRDT- 2022/07/10 19:25
PHST- 2022/06/28 00:00 [received]
PHST- 2022/07/02 00:00 [accepted]
PHST- 2022/07/11 06:00 [pubmed]
PHST- 2022/07/11 06:00 [medline]
PHST- 2022/07/10 19:25 [entrez]
AID - S0163-4453(22)00410-8 [pii]
AID - 10.1016/j.jinf.2022.07.001 [doi]
PST - aheadofprint
SO  - J Infect. 2022 Jul 8. pii: S0163-4453(22)00410-8. doi:10.1016/j.jinf.2022.07.001.

PMID- 35809857
OWN - NLM
STAT- Publisher
LR  - 20220726
IS  - 1878-3511 (Electronic)
IS  - 1201-9712 (Linking)
VI  - 122
DP  - 2022 Jul 7
TI  - Enhanced surveillance of monkeypox in Bas-Uele, Democratic Republic of Congo: thelimitations of symptom-based case definitions.
PG  - 647-655
LID - S1201-9712(22)00390-3 [pii]
LID - 10.1016/j.ijid.2022.06.060 [doi]
AB  - BACKGROUND: Following an outbreak of cases of vesicular-pustular rash with fever,evocative of human monkeypox, in Bas-Uele province, Democratic Republic of Congo,surveillance was strengthened. METHODS: Households with at least one activegeneralized vesicular-pustular rash case were visited, and contact and clinicalhistory information were collected from all household members. Whenever possible,skin lesions were screened by polymerase chain reaction for the monkeypox virus, followed by the varicella-zoster virus, when negative for the former. RESULTS:Polymerase chain reaction results were obtained for 77 suspected cases,distributed in 138 households, of which 27.3% were positive for monkeypox, 58.4% positive for chickenpox, and 14.3% negative for both. Confirmed monkeypox casespresented more often with monomorphic skin lesions on the palms of the hands and on the soles of the feet. Integrating these three features into the casedefinition raised the specificity to 85% but would miss 50% of true monkeypoxcases. A predictive model fit on patient demographics and symptoms had 97%specificity and 80% sensitivity but only 80% and 33% in predicting out-of-sample cases. CONCLUSION: Few discriminating features were identified and theperformance of clinical case definitions was suboptimal. Rapid field diagnostics are needed to optimize worldwide early detection and surveillance of monkeypox.
CI  - Published by Elsevier Ltd.
FAU - Mande, Gaspard
AU  - Mande G
AD  - University of Kisangani, Faculty of Medicine and Pharmacy, BP 2012, Kisangani,Democratic Republic of Congo. Electronic address: gaspard.mande@unikis.ac.cd.
FAU - Akonda, Innocent
AU  - Akonda I
AD  - Ministry of Health, Buta, Democratic Republic of Congo. Electronic address:boseluc@gmail.com.
FAU - De Weggheleire, Anja
AU  - De Weggheleire A
AD  - Outbreak research team, Department of Clinical Sciences, Institute of TropicalMedicine, Nationalestraat 155, 2000 Antwerp, Belgium. Electronic address:Adeweggheleire@ext.itg.be.
FAU - Brosius, Isabel
AU  - Brosius I
AD  - Outbreak research team, Department of Clinical Sciences, Institute of TropicalMedicine, Nationalestraat 155, 2000 Antwerp, Belgium. Electronic address:ibrosius@itg.be.
FAU - Liesenborghs, Laurens
AU  - Liesenborghs L
AD  - Outbreak research team, Department of Clinical Sciences, Institute of TropicalMedicine, Nationalestraat 155, 2000 Antwerp, Belgium. Electronic address:lliesenborghs@itg.be.
FAU - Bottieau, Emmanuel
AU  - Bottieau E
AD  - Outbreak research team, Department of Clinical Sciences, Institute of TropicalMedicine, Nationalestraat 155, 2000 Antwerp, Belgium. Electronic address:EBottieau@itg.be.
FAU - Ross, Noam
AU  - Ross N
AD  - Ecohealth Alliance, 520 8(th) Avenue, 10018 New York, NY, United States ofAmerica. Electronic address: ross@ecohealthalliance.org.
FAU - Gembu, Guy-Crispin
AU  - Gembu GC
AD  - University of Kisangani, Faculty of Science and Center for BiodiversityMonitoring, BP2012, Kisangani, Democratic Republic of Congo. Electronic address: guycrispin.gembu@unikis.ac.cd.
FAU - Colebunders, Robert
AU  - Colebunders R
AD  - Global Health Institute, University of Antwerp, Campus drie Eiken, GouverneurKinsbergen Centrum, Doornstraat 331, 2610 Wilrijk, Belgium. Electronic address:robert.colebunders@uantwerpen.be.
FAU - Verheyen, Erik
AU  - Verheyen E
AD  - Royal Belgian Institute of Natural Sciences, Rue Vautier 29, 1000 Brussels,Belgium; Evolutionary Ecology Group, University of Antwerp, Campus Drie Eiken.Electronic address: erik.verheyen@uantwerpen.be.
FAU - Ngonda, Dauly
AU  - Ngonda D
AD  - University of Kisangani, Faculty of Medicine and Pharmacy, BP 2012, Kisangani,Democratic Republic of Congo. Electronic address: dauly_ngbonda@yahoo.com.
FAU - Leirs, Herwig
AU  - Leirs H
AD  - Evolutionary Ecology Group, University of Antwerp, Campus Drie Eiken. Electronic address: herwig.leirs@uantwerpen.be.
FAU - Laudisoit, Anne
AU  - Laudisoit A
AD  - Ecohealth Alliance, 520 8(th) Avenue, 10018 New York, NY, United States ofAmerica; Evolutionary Ecology Group, University of Antwerp, Campus Drie Eiken.Electronic address: laudisoit@ecohealthalliance.org.
LA  - eng
PT  - Journal Article
DEP - 20220707
PL  - Canada
TA  - Int J Infect Dis
JT  - International journal of infectious diseases : IJID : official publication of theInternational Society for Infectious Diseases
JID - 9610933
SB  - IM
OTO - NOTNLM
OT  - Chickenpox
OT  - Democratic Republic of Congo
OT  - Diagnostic
OT  - Monkeypox
OT  - Orthopoxvirus
EDAT- 2022/07/10 06:00
MHDA- 2022/07/10 06:00
CRDT- 2022/07/09 19:28
PHST- 2022/05/25 00:00 [received]
PHST- 2022/06/22 00:00 [revised]
PHST- 2022/06/30 00:00 [accepted]
PHST- 2022/07/10 06:00 [pubmed]
PHST- 2022/07/10 06:00 [medline]
PHST- 2022/07/09 19:28 [entrez]
AID - S1201-9712(22)00390-3 [pii]
AID - 10.1016/j.ijid.2022.06.060 [doi]
PST - aheadofprint
SO  - Int J Infect Dis. 2022 Jul 7;122:647-655. doi: 10.1016/j.ijid.2022.06.060.

PMID- 35809556
OWN - NLM
STAT- MEDLINE
DCOM- 20220712
LR  - 20220716
IS  - 2666-6340 (Electronic)
IS  - 2666-6340 (Linking)
VI  - 3
IP  - 7
DP  - 2022 Jul 8
TI  - Neglecting emerging diseases - monkeypox is the latest price of a costly default.
PG  - 433-434
LID - S2666-6340(22)00233-1 [pii]
LID - 10.1016/j.medj.2022.06.002 [doi]
FAU - Titanji, Boghuma K
AU  - Titanji BK
AD  - Department of Infectious Diseases, Emory University School of Medicine, 100Woodruff Circle, Atlanta, GA 30322, USA. Electronic address: btitanj@emory.edu.
LA  - eng
PT  - Letter
DEP - 20220610
PL  - United States
TA  - Med (N Y)
JT  - Med (New York, N.Y.)
JID - 101769215
SB  - IM
MH  - Animals
MH  - *Communicable Diseases, Emerging/prevention & control
MH  - *Monkeypox
MH  - Monkeypox virus
PMC - PMC9185854
COIS- Declaration of interests The author has no interests to declare.
EDAT- 2022/07/10 06:00
MHDA- 2022/07/14 06:00
CRDT- 2022/07/09 18:31
PHST- 2022/07/09 18:31 [entrez]
PHST- 2022/07/10 06:00 [pubmed]
PHST- 2022/07/14 06:00 [medline]
AID - S2666-6340(22)00233-1 [pii]
AID - 10.1016/j.medj.2022.06.002 [doi]
PST - ppublish
SO  - Med (N Y). 2022 Jul 8;3(7):433-434. doi: 10.1016/j.medj.2022.06.002. Epub 2022Jun 10.

PMID- 35809242
OWN - NLM
STAT- Publisher
LR  - 20220709
IS  - 1469-0705 (Electronic)
IS  - 0960-7692 (Linking)
DP  - 2022 Jul 9
TI  - Monkeypox infection during pregnancy: European registry to quantify maternal and fetal risks.
LID - 10.1002/uog.26031 [doi]
FAU - Pomar, L
AU  - Pomar L
AUID- ORCID: https://orcid.org/0000-0002-3021-8129
AD  - Department Woman-mother-child, Lausanne University Hospital and LausanneUniversity, 1011, Lausanne, Switzerland.
AD  - School of Health Sciences (HESAV), HES-SO University of Applied Sciences and ArtsWestern Switzerland, 1011, Lausanne, Switzerland.
FAU - Favre, G
AU  - Favre G
AD  - Department Woman-mother-child, Lausanne University Hospital and LausanneUniversity, 1011, Lausanne, Switzerland.
FAU - Baud, D
AU  - Baud D
AUID- ORCID: https://orcid.org/0000-0001-9914-6496
AD  - Department Woman-mother-child, Lausanne University Hospital and LausanneUniversity, 1011, Lausanne, Switzerland.
LA  - eng
PT  - Letter
DEP - 20220709
PL  - England
TA  - Ultrasound Obstet Gynecol
JT  - Ultrasound in obstetrics & gynecology : the official journal of the InternationalSociety of Ultrasound in Obstetrics and Gynecology
JID - 9108340
SB  - IM
EDAT- 2022/07/10 06:00
MHDA- 2022/07/10 06:00
CRDT- 2022/07/09 13:22
PHST- 2022/06/30 00:00 [revised]
PHST- 2022/06/07 00:00 [received]
PHST- 2022/07/05 00:00 [accepted]
PHST- 2022/07/09 13:22 [entrez]
PHST- 2022/07/10 06:00 [pubmed]
PHST- 2022/07/10 06:00 [medline]
AID - 10.1002/uog.26031 [doi]
PST - aheadofprint
SO  - Ultrasound Obstet Gynecol. 2022 Jul 9. doi: 10.1002/uog.26031.

PMID- 35806320
OWN - NLM
STAT- MEDLINE
DCOM- 20220712
LR  - 20220716
IS  - 1422-0067 (Electronic)
IS  - 1422-0067 (Linking)
VI  - 23
IP  - 13
DP  - 2022 Jun 30
TI  - Omicron BA.2 Lineage, the "Stealth" Variant: Is It Truly a Silent Epidemic? ALiterature Review.
LID - 7315 [pii]
LID - 10.3390/ijms23137315 [doi]
AB  - The epidemic curve of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) is silently rising again. Worldwide, the dominant SARS-CoV-2 variantof concern (VOC) is Omicron, and its virological characteristics, such astransmissibility, pathogenicity, and resistance to both vaccine- andinfection-induced immunity as well as antiviral drugs, are an urgent publichealth concern. The Omicron variant has five major sub-lineages; as of February2022, the BA.2 lineage has been detected in several European and Asian countries,becoming the predominant variant and the real antagonist of the ongoing surge.Hence, although global attention is currently focused on dramatic, historicallysignificant events and the multi-country monkeypox outbreak, this new epidemic isunlikely to fade away in silence. Many aspects of this lineage are still unclear and controversial, but its apparent replication advantage and highertransmissibility, as well as its ability to escape neutralizing antibodiesinduced by vaccination and previous infection, are rising global concerns.Herein, we review the latest publications and the most recent availableliterature on the BA.2 lineage of the Omicron variant.
FAU - Tiecco, Giorgio
AU  - Tiecco G
AD  - Unit of Infectious and Tropical Diseases, Department of Clinical and ExperimentalSciences, ASST Spedali Civili di Brescia, University of Brescia, 25123 Brescia,Italy.
FAU - Storti, Samuele
AU  - Storti S
AD  - Unit of Infectious and Tropical Diseases, Department of Clinical and ExperimentalSciences, ASST Spedali Civili di Brescia, University of Brescia, 25123 Brescia,Italy.
FAU - Arsuffi, Stefania
AU  - Arsuffi S
AD  - Unit of Infectious and Tropical Diseases, Department of Clinical and ExperimentalSciences, ASST Spedali Civili di Brescia, University of Brescia, 25123 Brescia,Italy.
FAU - Degli Antoni, Melania
AU  - Degli Antoni M
AD  - Unit of Infectious and Tropical Diseases, Department of Clinical and ExperimentalSciences, ASST Spedali Civili di Brescia, University of Brescia, 25123 Brescia,Italy.
FAU - Foca, Emanuele
AU  - Foca E
AUID- ORCID: 0000-0003-4395-5379
AD  - Unit of Infectious and Tropical Diseases, Department of Clinical and ExperimentalSciences, ASST Spedali Civili di Brescia, University of Brescia, 25123 Brescia,Italy.
FAU - Castelli, Francesco
AU  - Castelli F
AD  - Unit of Infectious and Tropical Diseases, Department of Clinical and ExperimentalSciences, ASST Spedali Civili di Brescia, University of Brescia, 25123 Brescia,Italy.
FAU - Quiros-Roldan, Eugenia
AU  - Quiros-Roldan E
AUID- ORCID: 0000-0003-1452-9100
AD  - Unit of Infectious and Tropical Diseases, Department of Clinical and ExperimentalSciences, ASST Spedali Civili di Brescia, University of Brescia, 25123 Brescia,Italy.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20220630
PL  - Switzerland
TA  - Int J Mol Sci
JT  - International journal of molecular sciences
JID - 101092791
RN  - SARS-CoV-2 variants
SB  - IM
MH  - *COVID-19/epidemiology
MH  - Disease Outbreaks
MH  - *Epidemics
MH  - Humans
MH  - SARS-CoV-2
PMC - PMC9266794
OTO - NOTNLM
OT  - BA.2
OT  - Omicron
OT  - XE
OT  - lineage
OT  - recombinant variant
OT  - stealth variant
EDAT- 2022/07/10 06:00
MHDA- 2022/07/14 06:00
CRDT- 2022/07/09 01:12
PHST- 2022/05/01 00:00 [received]
PHST- 2022/06/10 00:00 [revised]
PHST- 2022/06/27 00:00 [accepted]
PHST- 2022/07/09 01:12 [entrez]
PHST- 2022/07/10 06:00 [pubmed]
PHST- 2022/07/14 06:00 [medline]
AID - ijms23137315 [pii]
AID - 10.3390/ijms23137315 [doi]
PST - epublish
SO  - Int J Mol Sci. 2022 Jun 30;23(13). pii: ijms23137315. doi: 10.3390/ijms23137315.

PMID- 35803753
OWN - NLM
STAT- Publisher
LR  - 20220708
IS  - 1471-6771 (Electronic)
IS  - 0007-0912 (Linking)
DP  - 2022 Jul 5
TI  - Monkeypox and its pandemic potential: what the anaesthetist should know.
LID - S0007-0912(22)00305-1 [pii]
LID - 10.1016/j.bja.2022.06.007 [doi]
FAU - Chowdhury, Sumit R
AU  - Chowdhury SR
AD  - Department of Anaesthesiology, Pain Medicine and Critical Care, All IndiaInstitute of Medical Sciences, New Delhi, India. Electronic address:sumitroychowdhury94@gmail.com.
FAU - Datta, Priyankar K
AU  - Datta PK
AD  - Department of Anaesthesiology, Pain Medicine and Critical Care, All IndiaInstitute of Medical Sciences, New Delhi, India.
FAU - Maitra, Souvik
AU  - Maitra S
AD  - Department of Anaesthesiology, Pain Medicine and Critical Care, All IndiaInstitute of Medical Sciences, New Delhi, India.
LA  - eng
PT  - Letter
DEP - 20220705
PL  - England
TA  - Br J Anaesth
JT  - British journal of anaesthesia
JID - 0372541
SB  - IM
OTO - NOTNLM
OT  - brincidofovir
OT  - human monkeypox
OT  - infection prevention and control
OT  - intensive care unit
OT  - monkeypox virus
OT  - tecovirimat
EDAT- 2022/07/09 06:00
MHDA- 2022/07/09 06:00
CRDT- 2022/07/08 22:02
PHST- 2022/06/02 00:00 [received]
PHST- 2022/06/08 00:00 [revised]
PHST- 2022/06/08 00:00 [accepted]
PHST- 2022/07/08 22:02 [entrez]
PHST- 2022/07/09 06:00 [pubmed]
PHST- 2022/07/09 06:00 [medline]
AID - S0007-0912(22)00305-1 [pii]
AID - 10.1016/j.bja.2022.06.007 [doi]
PST - aheadofprint
SO  - Br J Anaesth. 2022 Jul 5. pii: S0007-0912(22)00305-1. doi:10.1016/j.bja.2022.06.007.

PMID- 35803574
OWN - NLM
STAT- Publisher
LR  - 20220708
IS  - 2352-5568 (Electronic)
IS  - 2352-5568 (Linking)
DP  - 2022 Jul 5
TI  - Monkeypox-infected patients in the perioperative context: Recommendations from anexpert centre.
PG  - 101122
LID - S2352-5568(22)00103-5 [pii]
LID - 10.1016/j.accpm.2022.101122 [doi]
FAU - Gouel-Cheron, Aurelie
AU  - Gouel-Cheron A
AD  - Departement d'Anesthesie-Reanimation, CHU Bichat-Claude Bernard, DMU PARABOL,AP-HP, Nord, Paris, France; Institut Pasteur, Antibodies in Therapy andPathology, Inserm UMR 1222, Paris, France; National Institute of Allergy andInfectious Diseases, National Institutes of Health, Biostatistics ResearchBranch, Division of Clinical Research, Bethesda, MD, USA. Electronic address:aurelie.gouel@aphp.fr.
FAU - Kantor, Elie
AU  - Kantor E
AD  - Departement d'Anesthesie-Reanimation, CHU Bichat-Claude Bernard, DMU PARABOL,AP-HP, Nord, Paris, France.
FAU - Rioux, Christophe
AU  - Rioux C
AD  - Service de Maladies Infectieuses et Tropicales, Hopital Bichat Claude Bernard,AP-HP, Paris, France.
FAU - Kerneis, Solen
AU  - Kerneis S
AD  - Universite Paris Cite, INSERM, IAME, F-75018 Paris, France; Equipe de Prevention du Risque Infectieux (EPRI), AP-HP, Hopital Bichat, F-75018 Paris, France.
FAU - Montravers, Philippe
AU  - Montravers P
AD  - Departement d'Anesthesie-Reanimation, CHU Bichat-Claude Bernard, DMU PARABOL,AP-HP, Nord, Paris, France; Universite Paris Cite, INSERM, IAME, F-75018 Paris,France; INSERM UMR 1152, Universite de Paris, Paris, France.
LA  - eng
PT  - Letter
DEP - 20220705
PL  - France
TA  - Anaesth Crit Care Pain Med
JT  - Anaesthesia, critical care & pain medicine
JID - 101652401
SB  - IM
OTO - NOTNLM
OT  - Monkeypox virus
OT  - anaesthesia
OT  - infectious agent
OT  - perioperative care
OT  - prevention
EDAT- 2022/07/09 06:00
MHDA- 2022/07/09 06:00
CRDT- 2022/07/08 19:28
PHST- 2022/06/24 00:00 [received]
PHST- 2022/06/30 00:00 [revised]
PHST- 2022/06/30 00:00 [accepted]
PHST- 2022/07/08 19:28 [entrez]
PHST- 2022/07/09 06:00 [pubmed]
PHST- 2022/07/09 06:00 [medline]
AID - S2352-5568(22)00103-5 [pii]
AID - 10.1016/j.accpm.2022.101122 [doi]
PST - aheadofprint
SO  - Anaesth Crit Care Pain Med. 2022 Jul 5:101122. doi: 10.1016/j.accpm.2022.101122.

PMID- 35801519
OWN - NLM
STAT- MEDLINE
DCOM- 20220711
LR  - 20220723
IS  - 1560-7917 (Electronic)
IS  - 1025-496X (Linking)
VI  - 27
IP  - 27
DP  - 2022 Jul
TI  - Monkeypox outbreak predominantly affecting men who have sex with men, Madrid,Spain, 26 April to 16 June 2022.
LID - 10.2807/1560-7917.ES.2022.27.27.2200471 [doi]
AB  - Up to 22 June 2022, 508 confirmed cases of monkeypox (MPX) have been reported in the Madrid region of Spain, 99% are men (n=503) with a median age of 35 years(range: 18-67). In this ongoing outbreak, 427 cases (84.1%) reported condomlesssex or sex with multiple partners within the 21 days before onset of symptoms,who were predominantly men who have sex with men (MSM) (n=397; 93%). Both thelocation of the rash, mainly in the anogenital and perineal area, as well as the presence of inguinal lymphadenopathy suggest that close physical contact duringsexual activity played a key role in transmission. Several cases reported beingat a sauna in the city of Madrid (n=34) or a mass event held on the Spanishisland of Gran Canaria (n=27), activities which may represent a conduciveenvironment for MPX virus spread, with many private parties also playing animportant role. Because of the rapid implementation of MPX surveillance inMadrid, one of the largest outbreaks reported outside Africa was identified. Tominimise transmission, we continue to actively work with LGBTIQ+ groups andassociations, with the aim of raising awareness among people at risk andencouraging them to adopt preventive measures.
FAU - Inigo Martinez, Jesus
AU  - Inigo Martinez J
AD  - Directorate General of Public Health, Regional Ministry of Health of Madrid,Madrid, Spain.
FAU - Gil Montalban, Elisa
AU  - Gil Montalban E
AD  - Directorate General of Public Health, Regional Ministry of Health of Madrid,Madrid, Spain.
FAU - Jimenez Bueno, Susana
AU  - Jimenez Bueno S
AD  - Directorate General of Public Health, Regional Ministry of Health of Madrid,Madrid, Spain.
FAU - Martin Martinez, Fernando
AU  - Martin Martinez F
AD  - Directorate General of Public Health, Regional Ministry of Health of Madrid,Madrid, Spain.
FAU - Nieto Julia, Alba
AU  - Nieto Julia A
AD  - Directorate General of Public Health, Regional Ministry of Health of Madrid,Madrid, Spain.
FAU - Sanchez Diaz, Jesus
AU  - Sanchez Diaz J
AD  - Directorate General of Public Health, Regional Ministry of Health of Madrid,Madrid, Spain.
FAU - Garcia Marin, Natividad
AU  - Garcia Marin N
AD  - Directorate General of Public Health, Regional Ministry of Health of Madrid,Madrid, Spain.
FAU - Cordoba Deorador, Esther
AU  - Cordoba Deorador E
AD  - Directorate General of Public Health, Regional Ministry of Health of Madrid,Madrid, Spain.
FAU - Nunziata Forte, Antonio
AU  - Nunziata Forte A
AD  - Directorate General of Public Health, Regional Ministry of Health of Madrid,Madrid, Spain.
FAU - Alonso Garcia, Marcos
AU  - Alonso Garcia M
AD  - Directorate General of Public Health, Regional Ministry of Health of Madrid,Madrid, Spain.
FAU - Humanes Navarro, Ana Maria
AU  - Humanes Navarro AM
AD  - Directorate General of Public Health, Regional Ministry of Health of Madrid,Madrid, Spain.
FAU - Montero Morales, Laura
AU  - Montero Morales L
AD  - Directorate General of Public Health, Regional Ministry of Health of Madrid,Madrid, Spain.
FAU - Dominguez Rodriguez, Maria Jose
AU  - Dominguez Rodriguez MJ
AD  - Directorate General of Public Health, Regional Ministry of Health of Madrid,Madrid, Spain.
FAU - Carbajo Ariza, Manuel
AU  - Carbajo Ariza M
AD  - Directorate General of Public Health, Regional Ministry of Health of Madrid,Madrid, Spain.
FAU - Diaz Garcia, Luis Miguel
AU  - Diaz Garcia LM
AD  - Directorate General of Public Health, Regional Ministry of Health of Madrid,Madrid, Spain.
FAU - Mata Pariente, Nelva
AU  - Mata Pariente N
AD  - Directorate General of Public Health, Regional Ministry of Health of Madrid,Madrid, Spain.
FAU - Rumayor Zarzuelo, Mercedes
AU  - Rumayor Zarzuelo M
AD  - Directorate General of Public Health, Regional Ministry of Health of Madrid,Madrid, Spain.
FAU - Velasco Rodriguez, Manuel Jose
AU  - Velasco Rodriguez MJ
AD  - Directorate General of Public Health, Regional Ministry of Health of Madrid,Madrid, Spain.
FAU - Aragon Pena, Andres
AU  - Aragon Pena A
AD  - Directorate General of Public Health, Regional Ministry of Health of Madrid,Madrid, Spain.
FAU - Rodriguez Baena, Elena
AU  - Rodriguez Baena E
AD  - Directorate General of Public Health, Regional Ministry of Health of Madrid,Madrid, Spain.
FAU - Miguel Benito, Angel
AU  - Miguel Benito A
AD  - Directorate General of Public Health, Regional Ministry of Health of Madrid,Madrid, Spain.
FAU - Perez Meixeira, Ana
AU  - Perez Meixeira A
AD  - Directorate General of Public Health, Regional Ministry of Health of Madrid,Madrid, Spain.
FAU - Ordobas Gavin, Maria
AU  - Ordobas Gavin M
AD  - Directorate General of Public Health, Regional Ministry of Health of Madrid,Madrid, Spain.
FAU - Lopaz Perez, Maria Angeles
AU  - Lopaz Perez MA
AD  - Directorate General of Public Health, Regional Ministry of Health of Madrid,Madrid, Spain.
FAU - Arce Arnaez, Araceli
AU  - Arce Arnaez A
AD  - Directorate General of Public Health, Regional Ministry of Health of Madrid,Madrid, Spain.
LA  - eng
PT  - Journal Article
PL  - Sweden
TA  - Euro Surveill
JT  - Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
JID - 100887452
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Animals
MH  - Disease Outbreaks
MH  - Female
MH  - Homosexuality, Male
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - *Monkeypox/diagnosis
MH  - Sexual Behavior
MH  - *Sexual and Gender Minorities
MH  - Spain/epidemiology
MH  - Young Adult
PMC - PMC9264731
OTO - NOTNLM
OT  - Outbreak
OT  - men who have sex with men
OT  - monkeypox
OT  - public health
OT  - surveillance
EDAT- 2022/07/09 06:00
MHDA- 2022/07/12 06:00
CRDT- 2022/07/08 05:12
PHST- 2022/07/08 05:12 [entrez]
PHST- 2022/07/09 06:00 [pubmed]
PHST- 2022/07/12 06:00 [medline]
AID - 10.2807/1560-7917.ES.2022.27.27.2200471 [doi]
PST - ppublish
SO  - Euro Surveill. 2022 Jul;27(27). doi: 10.2807/1560-7917.ES.2022.27.27.2200471.

PMID- 35801518
OWN - NLM
STAT- MEDLINE
DCOM- 20220711
LR  - 20220723
IS  - 1560-7917 (Electronic)
IS  - 1025-496X (Linking)
VI  - 27
IP  - 27
DP  - 2022 Jul
TI  - A shift from travel-associated cases to autochthonous transmission with Berlin asepicentre of the monkeypox outbreak in Germany, May to June 2022.
LID - 10.2807/1560-7917.ES.2022.27.27.2200499 [doi]
AB  - By 22 June 2022, 521 cases of monkeypox were notified in Germany. The median age was 38 years (IQR: 32-44); all cases were men. In Berlin, where 69% of all cases occurred, almost all were men who have sex with men. Monkeypox virus likelycirculated unrecognised in Berlin before early May. Since mid-May, we observed a shift from travel-associated infections to mainly autochthonous transmission thatpredominantly took place in Berlin, often in association with visits to clubs andparties.
FAU - Selb, Regina
AU  - Selb R
AD  - Unit 'HIV/AIDS, STI and Blood-borne Infections', Department of Infectious DiseaseEpidemiology, Robert Koch Institute, Berlin, Germany.
FAU - Werber, Dirk
AU  - Werber D
AD  - State Office for Health and Social Affairs (SOHSA), Unit for Surveillance andEpidemiology of Infectious Diseases, Berlin, Germany.
FAU - Falkenhorst, Gerhard
AU  - Falkenhorst G
AD  - Unit 'Gastrointestinal Infections, Zoonoses and Tropical Infections', Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
FAU - Steffen, Gyde
AU  - Steffen G
AD  - Unit 'HIV/AIDS, STI and Blood-borne Infections', Department of Infectious DiseaseEpidemiology, Robert Koch Institute, Berlin, Germany.
FAU - Lachmann, Raskit
AU  - Lachmann R
AD  - Unit 'Gastrointestinal Infections, Zoonoses and Tropical Infections', Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
FAU - Ruscher, Claudia
AU  - Ruscher C
AD  - State Office for Health and Social Affairs (SOHSA), Unit for Surveillance andEpidemiology of Infectious Diseases, Berlin, Germany.
FAU - McFarland, Sarah
AU  - McFarland S
AD  - State Office for Health and Social Affairs (SOHSA), Unit for Surveillance andEpidemiology of Infectious Diseases, Berlin, Germany.
FAU - Bartel, Alexander
AU  - Bartel A
AD  - State Office for Health and Social Affairs (SOHSA), Unit for Surveillance andEpidemiology of Infectious Diseases, Berlin, Germany.
FAU - Hemmers, Lukas
AU  - Hemmers L
AD  - European Programme for Intervention Epidemiology Training (EPIET), EuropeanCentre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
AD  - Postgraduate Training in Applied Epidemiology (PAE) Unit 'Infectious DiseaseEpidemiology, Crisis Management, Outbreak Investigations and Training Programmes,Focal Point for the Public Health Service', Department of Infectious DiseaseEpidemiology, Robert Koch Institute, Berlin, Germany.
AD  - State Office for Health and Social Affairs (SOHSA), Unit for Surveillance andEpidemiology of Infectious Diseases, Berlin, Germany.
FAU - Koppe, Uwe
AU  - Koppe U
AD  - Unit 'HIV/AIDS, STI and Blood-borne Infections', Department of Infectious DiseaseEpidemiology, Robert Koch Institute, Berlin, Germany.
FAU - Stark, Klaus
AU  - Stark K
AD  - Unit 'Gastrointestinal Infections, Zoonoses and Tropical Infections', Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
FAU - Bremer, Viviane
AU  - Bremer V
AD  - Unit 'HIV/AIDS, STI and Blood-borne Infections', Department of Infectious DiseaseEpidemiology, Robert Koch Institute, Berlin, Germany.
FAU - Jansen, Klaus
AU  - Jansen K
AD  - Unit 'HIV/AIDS, STI and Blood-borne Infections', Department of Infectious DiseaseEpidemiology, Robert Koch Institute, Berlin, Germany.
CN  - Berlin MPX study group
AD  - Members of the Berlin MPX study group are listed under Acknowledgements.
LA  - eng
PT  - Journal Article
PL  - Sweden
TA  - Euro Surveill
JT  - Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
JID - 100887452
SB  - IM
MH  - Adult
MH  - Berlin/epidemiology
MH  - *Disease Outbreaks
MH  - Disease Transmission, Infectious/statistics & numerical data
MH  - Germany/epidemiology
MH  - Homosexuality, Male
MH  - Humans
MH  - Male
MH  - Monkeypox/diagnosis/*epidemiology/etiology/*transmission
MH  - *Sexual and Gender Minorities
MH  - Travel
PMC - PMC9264732
OTO - NOTNLM
OT  - MPX
OT  - MSM
OT  - men who have sex with men
OT  - monkeypox
OT  - outbreak
EDAT- 2022/07/09 06:00
MHDA- 2022/07/12 06:00
CRDT- 2022/07/08 05:12
PHST- 2022/07/08 05:12 [entrez]
PHST- 2022/07/09 06:00 [pubmed]
PHST- 2022/07/12 06:00 [medline]
AID - 10.2807/1560-7917.ES.2022.27.27.2200499 [doi]
PST - ppublish
SO  - Euro Surveill. 2022 Jul;27(27). doi: 10.2807/1560-7917.ES.2022.27.27.2200499.

PMID- 35798203
OWN - NLM
STAT- Publisher
LR  - 20220804
IS  - 1743-9159 (Electronic)
IS  - 1743-9159 (Linking)
VI  - 104
DP  - 2022 Jul 5
TI  - Should not airborne transmission be ignored in the 2022 monkeypox outbreak?
PG  - 106762
LID - S1743-9191(22)00539-8 [pii]
LID - 10.1016/j.ijsu.2022.106762 [doi]
FAU - Saied, AbdulRahman A
AU  - Saied AA
AD  - National Food Safety Authority (NFSA), Aswan Branch, Aswan, 81511, Egypt;Ministry of Tourism and Antiquities, Aswan Office, Aswan, 81511, Egypt.Electronic address: saied_abdelrahman@yahoo.com.
LA  - eng
PT  - Letter
DEP - 20220705
PL  - England
TA  - Int J Surg
JT  - International journal of surgery (London, England)
JID - 101228232
SB  - IM
EDAT- 2022/07/08 06:00
MHDA- 2022/07/08 06:00
CRDT- 2022/07/07 19:25
PHST- 2022/06/16 00:00 [received]
PHST- 2022/07/02 00:00 [accepted]
PHST- 2022/07/08 06:00 [pubmed]
PHST- 2022/07/08 06:00 [medline]
PHST- 2022/07/07 19:25 [entrez]
AID - S1743-9191(22)00539-8 [pii]
AID - 10.1016/j.ijsu.2022.106762 [doi]
PST - aheadofprint
SO  - Int J Surg. 2022 Jul 5;104:106762. doi: 10.1016/j.ijsu.2022.106762.

PMID- 35798023
OWN - NLM
STAT- Publisher
LR  - 20220707
IS  - 1474-4457 (Electronic)
IS  - 1473-3099 (Linking)
DP  - 2022 Jul 4
TI  - A prototype lateral flow assay for detection of orthopoxviruses.
LID - S1473-3099(22)00440-6 [pii]
LID - 10.1016/S1473-3099(22)00440-6 [doi]
FAU - Ulaeto, David O
AU  - Ulaeto DO
AD  - Chemical, Biological and Radiological Division, Defence Science and TechnologyLaboratory, Salisbury, UK.
FAU - Lonsdale, Steve G
AU  - Lonsdale SG
AD  - Pandemic Sciences Institute, Nuffield Department of Medicine, Oxford University, Oxford OX3 7BN, UK.
FAU - Laidlaw, Stephen M
AU  - Laidlaw SM
AD  - Chemical, Biological and Radiological Division, Defence Science and TechnologyLaboratory, Salisbury, UK.
FAU - Clark, Graeme C
AU  - Clark GC
AD  - Chemical, Biological and Radiological Division, Defence Science and TechnologyLaboratory, Salisbury, UK.
FAU - Horby, Peter
AU  - Horby P
AD  - Pandemic Sciences Institute, Nuffield Department of Medicine, Oxford University, Oxford OX3 7BN, UK.
FAU - Carroll, Miles W
AU  - Carroll MW
AD  - Pandemic Sciences Institute, Nuffield Department of Medicine, Oxford University, Oxford OX3 7BN, UK. Electronic address: miles.carroll@ndm.ox.ac.uk.
LA  - eng
PT  - Letter
DEP - 20220704
PL  - United States
TA  - Lancet Infect Dis
JT  - The Lancet. Infectious diseases
JID - 101130150
SB  - IM
COIS- MWC received funding from the US FDA to provide materials for this research. PHreceived the tecoviramat drug from Siga Technologies for an expanded accessprotocol for monkeypox treatment in Central African Republic. All other authorsdeclare no competing interests.
EDAT- 2022/07/08 06:00
MHDA- 2022/07/08 06:00
CRDT- 2022/07/07 19:03
PHST- 2022/06/10 00:00 [received]
PHST- 2022/06/23 00:00 [revised]
PHST- 2022/06/24 00:00 [accepted]
PHST- 2022/07/07 19:03 [entrez]
PHST- 2022/07/08 06:00 [pubmed]
PHST- 2022/07/08 06:00 [medline]
AID - S1473-3099(22)00440-6 [pii]
AID - 10.1016/S1473-3099(22)00440-6 [doi]
PST - aheadofprint
SO  - Lancet Infect Dis. 2022 Jul 4. pii: S1473-3099(22)00440-6. doi:10.1016/S1473-3099(22)00440-6.

PMID- 35798003
OWN - NLM
STAT- MEDLINE
DCOM- 20220722
LR  - 20220722
IS  - 1080-6059 (Electronic)
IS  - 1080-6040 (Linking)
VI  - 28
IP  - 8
DP  - 2022 Aug
TI  - Imported Monkeypox from International Traveler, Maryland, USA, 2021 (Response).
PG  - 1739
LID - 10.3201/eid2808.220830 [doi]
FAU - Costello, Varea
AU  - Costello V
FAU - Sowash, Madeleine
AU  - Sowash M
FAU - Gaur, Aahana
AU  - Gaur A
FAU - Cardis, Michael
AU  - Cardis M
FAU - Pasieka, Helena
AU  - Pasieka H
FAU - Wortmann, Glenn
AU  - Wortmann G
FAU - Ramdeen, Sheena
AU  - Ramdeen S
LA  - eng
PT  - Letter
DEP - 20220707
PL  - United States
TA  - Emerg Infect Dis
JT  - Emerging infectious diseases
JID - 9508155
SB  - IM
MH  - Animals
MH  - Humans
MH  - Maryland
MH  - *Monkeypox/diagnosis/epidemiology
MH  - Monkeypox virus
MH  - Zoonoses
OTO - NOTNLM
OT  - Monkeypox
OT  - Orthopoxvirus
OT  - United States
OT  - global health
OT  - travel medicine
OT  - viruses
OT  - zoonoses
EDAT- 2022/07/08 06:00
MHDA- 2022/07/23 06:00
CRDT- 2022/07/07 18:53
PHST- 2022/07/08 06:00 [pubmed]
PHST- 2022/07/23 06:00 [medline]
PHST- 2022/07/07 18:53 [entrez]
AID - 10.3201/eid2808.220830 [doi]
PST - ppublish
SO  - Emerg Infect Dis. 2022 Aug;28(8):1739. doi: 10.3201/eid2808.220830. Epub 2022 Jul7.

PMID- 35798002
OWN - NLM
STAT- MEDLINE
DCOM- 20220722
LR  - 20220722
IS  - 1080-6059 (Electronic)
IS  - 1080-6040 (Linking)
VI  - 28
IP  - 8
DP  - 2022 Aug
TI  - Imported Monkeypox from International Traveler, Maryland, USA, 2021.
PG  - 1738
LID - 10.3201/eid2808.220726 [doi]
FAU - Minhaj, Faisal S
AU  - Minhaj FS
FAU - Rao, Agam K
AU  - Rao AK
FAU - McCollum, Andrea M
AU  - McCollum AM
LA  - eng
PT  - Letter
DEP - 20220707
PL  - United States
TA  - Emerg Infect Dis
JT  - Emerging infectious diseases
JID - 9508155
SB  - IM
MH  - Animals
MH  - Disease Outbreaks
MH  - Humans
MH  - Maryland
MH  - *Monkeypox/diagnosis/epidemiology
MH  - Monkeypox virus
OTO - NOTNLM
OT  - Monkeypox
OT  - Orthopoxvirus
OT  - United States
OT  - poxvirus
OT  - public health
OT  - viruses
EDAT- 2022/07/08 06:00
MHDA- 2022/07/23 06:00
CRDT- 2022/07/07 18:52
PHST- 2022/07/08 06:00 [pubmed]
PHST- 2022/07/23 06:00 [medline]
PHST- 2022/07/07 18:52 [entrez]
AID - 10.3201/eid2808.220726 [doi]
PST - ppublish
SO  - Emerg Infect Dis. 2022 Aug;28(8):1738. doi: 10.3201/eid2808.220726. Epub 2022 Jul7.

PMID- 35797206
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20220711
LR  - 20220731
IS  - 1545-861X (Electronic)
IS  - 0149-2195 (Linking)
VI  - 71
IP  - 27
DP  - 2022 Jul 8
TI  - Erratum: Vol. 71, No. 22: Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live,Nonreplicating) for Preexposure Vaccination of Persons at Risk for OccupationalExposure to Orthopoxviruses: Recommendations of the Advisory Committee onImmunization Practices - United States, 2022.
PG  - 886
LID - 10.15585/mmwr.mm7127a5 [doi]
LA  - eng
PT  - Published Erratum
DEP - 20220708
PL  - United States
TA  - MMWR Morb Mortal Wkly Rep
JT  - MMWR. Morbidity and mortality weekly report
JID - 7802429
SB  - IM
EFR - MMWR Morb Mortal Wkly Rep. 2022 Jun 03;71(22):734-742. PMID: 35653347
PMC - PMC9290383
EDAT- 2022/07/08 06:00
MHDA- 2022/07/08 06:01
CRDT- 2022/07/07 12:53
PHST- 2022/07/07 12:53 [entrez]
PHST- 2022/07/08 06:00 [pubmed]
PHST- 2022/07/08 06:01 [medline]
AID - 10.15585/mmwr.mm7127a5 [doi]
PST - epublish
SO  - MMWR Morb Mortal Wkly Rep. 2022 Jul 8;71(27):886. doi: 10.15585/mmwr.mm7127a5.

PMID- 35794644
OWN - NLM
STAT- MEDLINE
DCOM- 20220708
LR  - 20220716
IS  - 2049-9957 (Electronic)
IS  - 2049-9957 (Linking)
VI  - 11
IP  - 1
DP  - 2022 Jul 7
TI  - Combating the global spread of poverty-related Monkeypox outbreaks and beyond.
PG  - 80
LID - 10.1186/s40249-022-01004-9 [doi]
AB  - The current unprecedented Monkeypox outbreaks emergence and spread on non-endemiccountries has led to over 3413 laboratory confirmed cases and one death, and yet,does not constitute a public health emergency of international concern as June23th 2022. We urgently call for collective regional and global partnership,leadership commitment and investment to rapidly strengthen and implementMonkeypox World Health Organization outbreak Preparedness and emergency response actions plans implementation against Monkeypox outbreak. Given the importance of human-animal-environment interface and transmission dynamics, fostering globaland regional One Health approach partnership and multisectoral collaborationprograms have timely and robust sustained investment benefits on poverty-linkedMonkeypox and other emerging epidemics population-based programs, whileleveraging from lessons learnt. Moving forward requires addressing priorityresearch questions listed and closing the knowledge gaps for Monkeypox and othersneglected tropical diseases roadmap implementation in vulnerable and at riskcountries.
CI  - (c) 2022. The Author(s).
FAU - Tambo, Ernest
AU  - Tambo E
AD  - Africa Disease Intelligence, Preparedness and Response, Yaounde, Cameroon.tambo0711@gmail.com.
AD  - Depatment Public Health, Faculty of Medicine, Universite des Montagnes,Bangangte, Cameroon. tambo0711@gmail.com.
FAU - Al-Nazawi, Ashwaq M
AU  - Al-Nazawi AM
AD  - Vector-Borne and Zoonotic Diseases Department, Public Health Directorate,Ministry of Health, Jeddah, 22246, Saudi Arabia. ash_gg@hotmail.com.
LA  - eng
PT  - Editorial
DEP - 20220707
PL  - England
TA  - Infect Dis Poverty
JT  - Infectious diseases of poverty
JID - 101606645
SB  - IM
MH  - Disease Outbreaks/prevention & control
MH  - Humans
MH  - *Monkeypox/epidemiology/prevention & control
MH  - Poverty
MH  - Public Health
MH  - World Health Organization
PMC - PMC9261034
OTO - NOTNLM
OT  - Emergency response
OT  - Monkeypox
OT  - Neglected tropical diseases
OT  - One Health
OT  - Outbreak
OT  - Poverty
OT  - Preparedness
OT  - Research
OT  - Vaccination
EDAT- 2022/07/07 06:00
MHDA- 2022/07/09 06:00
CRDT- 2022/07/06 23:49
PHST- 2022/07/06 23:49 [entrez]
PHST- 2022/07/07 06:00 [pubmed]
PHST- 2022/07/09 06:00 [medline]
AID - 10.1186/s40249-022-01004-9 [doi]
AID - 10.1186/s40249-022-01004-9 [pii]
PST - epublish
SO  - Infect Dis Poverty. 2022 Jul 7;11(1):80. doi: 10.1186/s40249-022-01004-9.

PMID- 35793837
OWN - NLM
STAT- MEDLINE
DCOM- 20220804
LR  - 20220804
IS  - 1488-2329 (Electronic)
IS  - 0820-3946 (Linking)
VI  - 194
IP  - 29
DP  - 2022 Aug 2
TI  - A case of human monkeypox in Canada.
PG  - E1031-E1035
LID - 10.1503/cmaj.220886 [doi]
FAU - Sukhdeo, Sharon S
AU  - Sukhdeo SS
AD  - Department of Medicine, University of Toronto, Toronto, Ont.
FAU - Aldhaheri, Khuloud
AU  - Aldhaheri K
AD  - Department of Medicine, University of Toronto, Toronto, Ont.
FAU - Lam, Philip W
AU  - Lam PW
AD  - Department of Medicine, University of Toronto, Toronto, Ont.
FAU - Walmsley, Sharon
AU  - Walmsley S
AD  - Department of Medicine, University of Toronto, Toronto, Ont.sharon.sukhdeo@uhn.ca.
LA  - eng
PT  - Case Reports
PT  - Journal Article
DEP - 20220706
PL  - Canada
TA  - CMAJ
JT  - CMAJ : Canadian Medical Association journal = journal de l'Association medicalecanadienne
JID - 9711805
SB  - IM
MH  - Animals
MH  - Canada
MH  - Disease Outbreaks
MH  - Humans
MH  - *Monkeypox/diagnosis/epidemiology
MH  - Zoonoses
COIS- Competing interests: Sharon Walmsley reports grants from Merck, ViiV Healthcare, GSK, Gilead and Janssen. She also reports consulting fees, honoraria andparticipation on advisory boards with Merck, ViiV Healthcare, GSK and Gilead. No other competing interests were declared.
EDAT- 2022/07/07 06:00
MHDA- 2022/08/05 06:00
CRDT- 2022/07/06 20:52
PHST- 2022/07/07 06:00 [pubmed]
PHST- 2022/08/05 06:00 [medline]
PHST- 2022/07/06 20:52 [entrez]
AID - cmaj.220886 [pii]
AID - 10.1503/cmaj.220886 [doi]
PST - ppublish
SO  - CMAJ. 2022 Aug 2;194(29):E1031-E1035. doi: 10.1503/cmaj.220886. Epub 2022 Jul 6.

PMID- 35792844
OWN - NLM
STAT- MEDLINE
DCOM- 20220708
LR  - 20220708
IS  - 1267-8694 (Print)
IS  - 1267-8694 (Linking)
VI  - 26
IP  - 3
DP  - 2022 May 1
TI  - What are we talking about? When Monkeypox virus infection inadvertently resultsin smallpox in French
PG  - 219-221
LID - 10.1684/vir.2022.0958 [doi]
FAU - Tournier, Jean-Nicolas
AU  - Tournier JN
LA  - fre
PT  - Journal Article
TT  - De quoi parlons-nous ? Quand l'infection par le virus Monkeypox se traduitmalencontreusement par variole en francais
PL  - France
TA  - Virologie (Montrouge)
JT  - Virologie (Montrouge, France)
JID - 9802575
SB  - IM
MH  - Animals
MH  - *Monkeypox/epidemiology
MH  - Monkeypox virus
MH  - *Smallpox/epidemiology/prevention & control
MH  - Vaccinia virus
MH  - *Variola virus
EDAT- 2022/07/07 06:00
MHDA- 2022/07/09 06:00
CRDT- 2022/07/06 10:35
PHST- 2022/07/06 10:35 [entrez]
PHST- 2022/07/07 06:00 [pubmed]
PHST- 2022/07/09 06:00 [medline]
AID - 10.1684/vir.2022.0958 [doi]
PST - ppublish
SO  - Virologie (Montrouge). 2022 May 1;26(3):219-221. doi: 10.1684/vir.2022.0958.

PMID- 35791639
OWN - NLM
STAT- Publisher
LR  - 20220706
IS  - 1099-1751 (Electronic)
IS  - 0749-6753 (Linking)
DP  - 2022 Jul 6
TI  - Monkeypox outbreak - No panic and stigma; Only awareness and preventive measures can halt the pandemic turn of this epidemic infection.
LID - 10.1002/hpm.3539 [doi]
FAU - Rabiul Islam, Md
AU  - Rabiul Islam M
AUID- ORCID: https://orcid.org/0000-0003-2820-3144
AD  - Department of Pharmacy, University of Asia Pacific, Dhaka, Bangladesh.
FAU - Hasan, Moynul
AU  - Hasan M
AD  - Department of Pharmacy, Jagannath University, Dhaka, Bangladesh.
FAU - Rahman, Mohammad Saydur
AU  - Rahman MS
AD  - Department of Pharmacy, Jagannath University, Dhaka, Bangladesh.
FAU - Rahman, Md Ashrafur
AU  - Rahman MA
AD  - Department of Pharmaceutical Sciences, Jerry H. Hodge School of Pharmacy, TexasTech University Health Sciences Center (TTUHSC), Amarillo, Texas, USA.
LA  - eng
PT  - Letter
DEP - 20220706
PL  - England
TA  - Int J Health Plann Manage
JT  - The International journal of health planning and management
JID - 8605825
OTO - NOTNLM
OT  - disease outbreaks
OT  - monkeypox
OT  - monkeypox virus
OT  - poxviridae
OT  - poxviridae infections
OT  - public health
OT  - viral zoonoses
EDAT- 2022/07/07 06:00
MHDA- 2022/07/07 06:00
CRDT- 2022/07/06 03:14
PHST- 2022/07/06 03:14 [entrez]
PHST- 2022/07/07 06:00 [pubmed]
PHST- 2022/07/07 06:00 [medline]
AID - 10.1002/hpm.3539 [doi]
PST - aheadofprint
SO  - Int J Health Plann Manage. 2022 Jul 6. doi: 10.1002/hpm.3539.

PMID- 35791347
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220707
IS  - 2666-7762 (Electronic)
IS  - 2666-7762 (Linking)
VI  - 18
DP  - 2022 Jul
TI  - Lessons from COVID-19 are shaping the response to monkeypox outbreak.
PG  - 100463
LID - 10.1016/j.lanepe.2022.100463 [doi]
FAU - The Lancet Regional Health-Europe
AU  - The Lancet Regional Health-Europe
LA  - eng
PT  - Editorial
DEP - 20220701
PL  - England
TA  - Lancet Reg Health Eur
JT  - The Lancet regional health. Europe
JID - 101777707
PMC - PMC9247622
EDAT- 2022/07/07 06:00
MHDA- 2022/07/07 06:01
CRDT- 2022/07/06 01:54
PHST- 2022/07/06 01:54 [entrez]
PHST- 2022/07/07 06:00 [pubmed]
PHST- 2022/07/07 06:01 [medline]
AID - 10.1016/j.lanepe.2022.100463 [doi]
AID - S2666-7762(22)00159-4 [pii]
PST - ppublish
SO  - Lancet Reg Health Eur. 2022 Jul;18:100463. doi: 10.1016/j.lanepe.2022.100463.Epub 2022 Jul 1.

PMID- 35790223
OWN - NLM
STAT- MEDLINE
DCOM- 20220706
LR  - 20220711
IS  - 1756-1833 (Electronic)
IS  - 0959-8138 (Linking)
VI  - 378
DP  - 2022 Jul 5
TI  - Monkeypox: Symptoms seen in London sexual health clinics differ from previousoutbreaks, study finds.
PG  - o1659
LID - 10.1136/bmj.o1659 [doi]
FAU - Zachariou, Melina
AU  - Zachariou M
AD  - The BMJ.
LA  - eng
PT  - Journal Article
DEP - 20220705
PL  - England
TA  - BMJ
JT  - BMJ (Clinical research ed.)
JID - 8900488
SB  - IM
MH  - Ambulatory Care Facilities
MH  - Disease Outbreaks
MH  - Humans
MH  - London/epidemiology
MH  - *Monkeypox/epidemiology
MH  - *Sexual Health
EDAT- 2022/07/06 06:00
MHDA- 2022/07/07 06:00
CRDT- 2022/07/05 20:31
PHST- 2022/07/05 20:31 [entrez]
PHST- 2022/07/06 06:00 [pubmed]
PHST- 2022/07/07 06:00 [medline]
AID - 10.1136/bmj.o1659 [doi]
PST - epublish
SO  - BMJ. 2022 Jul 5;378:o1659. doi: 10.1136/bmj.o1659.

PMID- 35789125
OWN - NLM
STAT- Publisher
LR  - 20220713
IS  - 1865-1682 (Electronic)
IS  - 1865-1674 (Linking)
DP  - 2022 Jul 5
TI  - Is monkeypox virus older than we think?
LID - 10.1111/tbed.14651 [doi]
FAU - Saied, AbdulRahman A
AU  - Saied AA
AUID- ORCID: https://orcid.org/0000-0001-8616-5874
AD  - National Food Safety Authority, Aswan Branch, Aswan, Egypt.
AD  - Ministry of Tourism and Antiquities, Aswan Office, Aswan, Egypt.
LA  - eng
PT  - Letter
DEP - 20220705
PL  - Germany
TA  - Transbound Emerg Dis
JT  - Transboundary and emerging diseases
JID - 101319538
SB  - IM
EDAT- 2022/07/06 06:00
MHDA- 2022/07/06 06:00
CRDT- 2022/07/05 19:12
PHST- 2022/06/28 00:00 [revised]
PHST- 2022/06/17 00:00 [received]
PHST- 2022/06/30 00:00 [accepted]
PHST- 2022/07/06 06:00 [pubmed]
PHST- 2022/07/06 06:00 [medline]
PHST- 2022/07/05 19:12 [entrez]
AID - 10.1111/tbed.14651 [doi]
PST - aheadofprint
SO  - Transbound Emerg Dis. 2022 Jul 5. doi: 10.1111/tbed.14651.

PMID- 35788415
OWN - NLM
STAT- Publisher
LR  - 20220726
IS  - 1878-3511 (Electronic)
IS  - 1201-9712 (Linking)
VI  - 122
DP  - 2022 Jul 2
TI  - Vaccination for monkeypox prevention in persons with high-risk sexual behaviours to control on-going outbreak of monkeypox virus clade 3.
PG  - 569-571
LID - S1201-9712(22)00378-2 [pii]
LID - 10.1016/j.ijid.2022.06.047 [doi]
FAU - Petersen, E
AU  - Petersen E
AD  - Institute for Clinical Medicine, Faculty of Health Sciences, University ofAarhus, Denmark; European Society for Clinical Microbiology and InfectiousDiseases [ESCMID] Task Force for Emerging Infections, Basel, Switzerland.Electronic address: eskild.petersen@gmail.com.
FAU - Zumla, A
AU  - Zumla A
AD  - Centre for Clinical Microbiology, Division of Infection and Immunity, University College London; NIHR Biomedical Research Centre, UCL Hospitals NHS FoundationTrust, London, United Kingdom.
FAU - Hui, D S
AU  - Hui DS
AD  - Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince ofWales Hospital, Shatin, New Territories, Hong Kong, China.
FAU - Blumberg, L
AU  - Blumberg L
AD  - Division of Public Health Surveillance and Response, National Institute forCommunicable Diseases, Johannesburg, South Africa; Faculty of Veterinary Science,University of Pretoria, South Africa.
FAU - Valdoleiros, S R
AU  - Valdoleiros SR
AD  - European Society for Clinical Microbiology and Infectious Diseases [ESCMID] Task Force for Emerging Infections, Basel, Switzerland; Infectious DiseasesDepartment, Centro Hospitalar Universitario de Sao Joao, Porto, Portugal.
FAU - Amao, L
AU  - Amao L
AD  - Nigeria Centre for Disease Control, Abuja, Nigeria.
FAU - Ntoumi, F
AU  - Ntoumi F
AD  - Congolese Foundation for Medical Research, Brazzaville, Republic of Congo;Institute of Tropical Medicine, University of Tubingen, Germany.
FAU - Asogun, D
AU  - Asogun D
AD  - Irrua Specialized Teaching Hospital, Irrua, Nigeria.
FAU - Simonsen, L
AU  - Simonsen L
AD  - PandemiX Center, Department of Science and Environment, Roskilde University,Denmark.
FAU - Haider, N
AU  - Haider N
AD  - The Royal Veterinary College, University of London, Hatfield, Hertfordshire,United Kingdom.
FAU - Traore, T
AU  - Traore T
AD  - Emergency Preparedness and Response Programme, WHO Regional Office for Africa,Dakar Hub, Dakar, Senegal.
FAU - Kapata, N
AU  - Kapata N
AD  - National Public Health Institute, Ministry of Health, Lusaka, Zambia.
FAU - Dar, O
AU  - Dar O
AD  - Chatham House and UK Public health security agency, London, UK.
FAU - Nachega, J
AU  - Nachega J
AD  - Department of Medicine and Center for Infectious Diseases, StellenboschUniversity, Cape Town, South Africa; University of Pittsburgh Graduate School of Public Health, Pittsburgh, USA; Departments of Epidemiology and InternationalHealth, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA.
FAU - Abbara, A
AU  - Abbara A
AD  - UK Syria Public Health Network, and Department of Infection, Faculty of Medicine,Imperial College, London, UK.
FAU - Al Balushi, A
AU  - Al Balushi A
AD  - Infectious Diseases Unit, Department of Medicine, Sultan Qaboos UniversityHospital, Muscat, Oman.
FAU - Kock, R
AU  - Kock R
AD  - The Royal Veterinary College, University of London, Hatfield, Hertfordshire, UK.
FAU - Maeurer, M
AU  - Maeurer M
AD  - ImmunoSurgery Unit, Champalimaud Centre for the Unknown, Lisbon, Portugal;Medizinische Klinik, Johannes Gutenberg University Mainz, Germany.
FAU - Lee, S S
AU  - Lee SS
AD  - Stanley Ho Centre for Emerging Infectious Diseases, The Chinese University ofHong Kong, 206 Postgraduate Education Centre, Prince of Wales Hospital, HongKong, China.
FAU - Lucey, D R
AU  - Lucey DR
AD  - Daniel R. Lucey, Geisel School of Medicine at Dartmouth, Hanover, NH, USA.Electronic address: daniel.lucey8@gmail.com.
FAU - Ippolito, G
AU  - Ippolito G
AD  - Guiseppe Ippolito: Ministry of Health, Rome, Italy. Electronic address:g.ippolito@sanita.it.
FAU - Koopmans, Mpg
AU  - Koopmans M
AD  - Viroscience Department, Erasmus Medical Center, Rotterdam, Netherlands; Pandemic and Disaster Preparedness Centre, Rotterdam, Netherlands.
LA  - eng
PT  - Editorial
DEP - 20220702
PL  - Canada
TA  - Int J Infect Dis
JT  - International journal of infectious diseases : IJID : official publication of theInternational Society for Infectious Diseases
JID - 9610933
SB  - IM
EDAT- 2022/07/06 06:00
MHDA- 2022/07/06 06:00
CRDT- 2022/07/05 18:26
PHST- 2022/06/23 00:00 [received]
PHST- 2022/06/27 00:00 [accepted]
PHST- 2022/07/06 06:00 [pubmed]
PHST- 2022/07/06 06:00 [medline]
PHST- 2022/07/05 18:26 [entrez]
AID - S1201-9712(22)00378-2 [pii]
AID - 10.1016/j.ijid.2022.06.047 [doi]
PST - aheadofprint
SO  - Int J Infect Dis. 2022 Jul 2;122:569-571. doi: 10.1016/j.ijid.2022.06.047.

PMID- 35788011
OWN - NLM
STAT- Publisher
LR  - 20220711
IS  - 1532-2742 (Electronic)
IS  - 0163-4453 (Linking)
DP  - 2022 Jul 3
TI  - Monkeypox and pan-resistant Campylobacter spp infection in Entamoeba histolytica and Chlamydia trachomatis re-infection in a man who have sex with men.
LID - S0163-4453(22)00382-6 [pii]
LID - 10.1016/j.jinf.2022.06.028 [doi]
FAU - Raccagni, Angelo Roberto
AU  - Raccagni AR
AD  - Vita-Salute San Raffele University, Via Stamira D'Ancona 20, Milan 20127, Italy. Electronic address: raccagni.angelo@hsr.it.
FAU - Mileto, Davide
AU  - Mileto D
AD  - Laboratory of Clinical Microbiology, Virology and Bioemergencies, Ospedale Sacco,Milan, Italy.
FAU - Canetti, Diana
AU  - Canetti D
AD  - Infectious Diseases Unit, San Raffaele Scientific Institute, Milan, Italy.
FAU - Tamburini, Andrea Marco
AU  - Tamburini AM
AD  - Vita-Salute San Raffele University, Via Stamira D'Ancona 20, Milan 20127, Italy; Gastrointestinal Surgery Unit, San Raffaele Scientific Institute, Milan, Italy.
FAU - Rizzo, Alberto
AU  - Rizzo A
AD  - Laboratory of Clinical Microbiology, Virology and Bioemergencies, Ospedale Sacco,Milan, Italy; University of Milan, Milan, Italy.
FAU - Bruzzesi, Elena
AU  - Bruzzesi E
AD  - Vita-Salute San Raffele University, Via Stamira D'Ancona 20, Milan 20127, Italy.
FAU - Castagna, Antonella
AU  - Castagna A
AD  - Vita-Salute San Raffele University, Via Stamira D'Ancona 20, Milan 20127, Italy; Infectious Diseases Unit, San Raffaele Scientific Institute, Milan, Italy.
FAU - Nozza, Silvia
AU  - Nozza S
AD  - Infectious Diseases Unit, San Raffaele Scientific Institute, Milan, Italy.
LA  - eng
PT  - Letter
DEP - 20220703
PL  - England
TA  - J Infect
JT  - The Journal of infection
JID - 7908424
SB  - IM
OTO - NOTNLM
OT  - Antimicrobial resistance
OT  - Campylobacter
OT  - Men who have sex with men
OT  - Monkeypox
OT  - Sexually transmitted enteric infections
OT  - Sexually transmitted infections
EDAT- 2022/07/06 06:00
MHDA- 2022/07/06 06:00
CRDT- 2022/07/05 17:58
PHST- 2022/06/24 00:00 [received]
PHST- 2022/06/27 00:00 [accepted]
PHST- 2022/07/06 06:00 [pubmed]
PHST- 2022/07/06 06:00 [medline]
PHST- 2022/07/05 17:58 [entrez]
AID - S0163-4453(22)00382-6 [pii]
AID - 10.1016/j.jinf.2022.06.028 [doi]
PST - aheadofprint
SO  - J Infect. 2022 Jul 3. pii: S0163-4453(22)00382-6. doi:10.1016/j.jinf.2022.06.028.

PMID- 35785957
OWN - NLM
STAT- Publisher
LR  - 20220705
IS  - 1988-9518 (Electronic)
IS  - 0214-3429 (Linking)
DP  - 2022 Jul 6
TI  - Monkeypox in humans: a new outbreak.
LID - martin06jul2022 [pii]
LID - 10.37201/req/059.2022 [doi]
AB  - Infection caused by Monkeypox Virus (MPVX) has small rodents as its naturalreservoir and both monkeys and humans are occasional hosts. The causative agentis an Orthopoxvirus (MPVX) that was isolated in monkeys in 1958 and provedcapable of passing to humans in 1970. It remained contained in Africa, causingisolated episodes of infection, until 2003 when an outbreak occurred in theUnited States following importation of animals from that continent. Since then,anecdotal cases have continued to be reported outside Africa, usually veryclearly linked to travelers to those countries, but in May 2022, a broad outbreakof this disease has begun, now affecting several continents, with the emergenceof human cases of MPVX (H-MPVX) infection mainly among Men that have Sex with Men(MSM). The disease has an incubation time ranging from 5 to 15 days and ischaracterized by the presence of pustules, fever, malaise and headache. Thepresence of significant regional lymphadenopathy is a differential feature withepisodes of classical smallpox. Proctitis and pharyngitis, with minimal skinlesions, may be another form of presentation. Diagnosis can be confirmed by PCRtesting of lesions or by demonstration of MPVX in other body fluids or tissues,although in the appropriate epidemiologic setting the clinical picture is highly suggestive of the disease. Effective drug treatment has been developed as part ofprograms to protect against potential bioterrorist agents and smallpox vaccinees are known to have high protection against monkeypox. New vaccines are available, but neither the drugs nor the vaccines are yet freely available on the market.The prognosis of the disease appears, at least in adults in developed countries, to be good, with very low mortality figures and much less aggressive behaviorthan that described in classical smallpox. Isolation measures, essential for the control of the outbreak, have been published by the health authorities.
CI  - (c)The Author 2022. Published by Sociedad Espanola de Quimioterapia. This articleis distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC4.0)(https://creativecommons.org/licenses/by-nc/4.0/).
FAU - Martin-Delgado, M C
AU  - Martin-Delgado MC
FAU - Martin Sanchez, F J
AU  - Martin Sanchez FJ
FAU - Martinez-Selles, M
AU  - Martinez-Selles M
FAU - Molero Garcia, J M
AU  - Molero Garcia JM
FAU - Moreno Guillen, S
AU  - Moreno Guillen S
FAU - Rodriguez-Artalejo, F J
AU  - Rodriguez-Artalejo FJ
FAU - Ruiz-Galiana, J
AU  - Ruiz-Galiana J
FAU - Canton, R
AU  - Canton R
FAU - De Lucas Ramos, P
AU  - De Lucas Ramos P
FAU - Garcia-Botella, A
AU  - Garcia-Botella A
FAU - Garcia-Lledo, A
AU  - Garcia-Lledo A
FAU - Hernandez-Sampelayo, T
AU  - Hernandez-Sampelayo T
FAU - Gomez-Pavon, J
AU  - Gomez-Pavon J
FAU - Gonzalez Del Castillo, J
AU  - Gonzalez Del Castillo J
FAU - Munoz, P
AU  - Munoz P
FAU - Valerio, M
AU  - Valerio M
FAU - Catalan, P
AU  - Catalan P
FAU - Burillo, A
AU  - Burillo A
FAU - Cobo, A
AU  - Cobo A
FAU - Alcami, A
AU  - Alcami A
FAU - Bouza, E
AU  - Bouza E
AD  - Servicio de Microbiologia Clinica y Enfermedades Infecciosas del Hospital GeneralUniversitario Gregorio Maranon, Universidad Complutense. CIBERES. Ciber deEnfermedades Respiratorias. Madrid, Spain. emilio.bouza@gmail.com.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20220706
PL  - Spain
TA  - Rev Esp Quimioter
JT  - Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanolade Quimioterapia
JID - 9108821
SB  - IM
OTO - NOTNLM
OT  - MPVX
OT  - Monkeypox
OT  - Poxvirus
OT  - outbreaks
OT  - sexually transmitted infections
OT  - smallpox
OT  - vaccines
EDAT- 2022/07/06 06:00
MHDA- 2022/07/06 06:00
CRDT- 2022/07/05 11:23
PHST- 2022/07/05 11:23 [entrez]
PHST- 2022/07/06 06:00 [pubmed]
PHST- 2022/07/06 06:00 [medline]
AID - 10.37201/req/059.2022 [doi]
PST - aheadofprint
SO  - Rev Esp Quimioter. 2022 Jul 6. doi: 10.37201/req/059.2022.

PMID- 35785793
OWN - NLM
STAT- Publisher
LR  - 20220705
IS  - 1474-4457 (Electronic)
IS  - 1473-3099 (Linking)
DP  - 2022 Jul 1
TI  - Demographic and clinical characteristics of confirmed human monkeypox virus casesin individuals attending a sexual health centre in London, UK: an observationalanalysis.
LID - S1473-3099(22)00411-X [pii]
LID - 10.1016/S1473-3099(22)00411-X [doi]
AB  - BACKGROUND: Historically, human monkeypox virus cases in the UK have been limitedto imported infections from west Africa. Currently, the UK and several othercountries are reporting a rapid increase in monkeypox cases among individualsattending sexual health clinics, with no apparent epidemiological links toendemic areas. We describe demographic and clinical characteristics of patientsdiagnosed with human monkeypox virus attending a sexual health centre. METHODS:In this observational analysis, we considered patients with confirmed monkeypoxvirus infection via PCR detection attending open-access sexual health clinics in London, UK, between May 14 and May 25, 2022. We report hospital admissions andconcurrent sexually transmitted infection (STI) proportions, and describe ourlocal response within the first 2 weeks of the outbreak. FINDINGS: Monkeypoxvirus infection was confirmed in 54 individuals, all identifying as men who have sex with men (MSM), with a median age of 41 years (IQR 34-45). 38 (70%) of 54individuals were White, 26 (48%) were born in the UK, and 13 (24%) were livingwith HIV. 36 (67%) of 54 individuals reported fatigue or lethargy, 31 (57%)reported fever, and ten (18%) had no prodromal symptoms. All patients presentedwith skin lesions, of which 51 (94%) were anogenital. 37 (89%) of 54 individuals had skin lesions affecting more than one anatomical site and four (7%) hadoropharyngeal lesions. 30 (55%) of 54 individuals had lymphadenopathy. One infour patients had a concurrent STI. Five (9%) of 54 individuals requiredadmission to hospital, mainly due to pain or localised bacterial cellulitisrequiring antibiotic intervention or analgesia. We recorded no fatal outcomes.INTERPRETATION: Autochthonous community monkeypox virus transmission is currentlyobserved among MSM in the UK. We found a high proportion of concomitant STIs and frequent anogenital symptoms, suggesting transmissibility through localinoculation during close skin-to-skin or mucosal contact, during sexual activity.Additional resources are required to support sexual health and other specialistservices in managing this condition. A review of the case definition and betterunderstanding of viral transmission routes are needed to shape infection control policies, education and prevention strategies, and contact tracing. FUNDING:None.
CI  - Copyright (c) 2022 Elsevier Ltd. All rights reserved.
FAU - Girometti, Nicolo
AU  - Girometti N
AD  - Department of HIV/GUM, Chelsea and Westminster Hospital NHS Foundation Trust,London, UK. Electronic address: n.girometti@nhs.net.
FAU - Byrne, Ruth
AU  - Byrne R
AD  - Department of HIV/GUM, Chelsea and Westminster Hospital NHS Foundation Trust,London, UK.
FAU - Bracchi, Margherita
AU  - Bracchi M
AD  - Department of HIV/GUM, Chelsea and Westminster Hospital NHS Foundation Trust,London, UK.
FAU - Heskin, Joseph
AU  - Heskin J
AD  - Department of HIV/GUM, Chelsea and Westminster Hospital NHS Foundation Trust,London, UK.
FAU - McOwan, Alan
AU  - McOwan A
AD  - Department of HIV/GUM, Chelsea and Westminster Hospital NHS Foundation Trust,London, UK.
FAU - Tittle, Victoria
AU  - Tittle V
AD  - Department of HIV/GUM, Chelsea and Westminster Hospital NHS Foundation Trust,London, UK.
FAU - Gedela, Keerti
AU  - Gedela K
AD  - Department of HIV/GUM, Chelsea and Westminster Hospital NHS Foundation Trust,London, UK.
FAU - Scott, Christopher
AU  - Scott C
AD  - Department of HIV/GUM, Chelsea and Westminster Hospital NHS Foundation Trust,London, UK.
FAU - Patel, Sheel
AU  - Patel S
AD  - Department of HIV/GUM, Chelsea and Westminster Hospital NHS Foundation Trust,London, UK.
FAU - Gohil, Jesal
AU  - Gohil J
AD  - Department of HIV/GUM, Chelsea and Westminster Hospital NHS Foundation Trust,London, UK.
FAU - Nugent, Diarmuid
AU  - Nugent D
AD  - Department of HIV/GUM, Chelsea and Westminster Hospital NHS Foundation Trust,London, UK.
FAU - Suchak, Tara
AU  - Suchak T
AD  - Department of HIV/GUM, Chelsea and Westminster Hospital NHS Foundation Trust,London, UK.
FAU - Dickinson, Molly
AU  - Dickinson M
AD  - Department of HIV/GUM, Chelsea and Westminster Hospital NHS Foundation Trust,London, UK.
FAU - Feeney, Margaret
AU  - Feeney M
AD  - Department of HIV/GUM, Chelsea and Westminster Hospital NHS Foundation Trust,London, UK.
FAU - Mora-Peris, Borja
AU  - Mora-Peris B
AD  - Department of HIV/GUM, Chelsea and Westminster Hospital NHS Foundation Trust,London, UK; Imperial College Healthcare NHS Trust, London, UK.
FAU - Stegmann, Katrina
AU  - Stegmann K
AD  - Department of HIV/GUM, Chelsea and Westminster Hospital NHS Foundation Trust,London, UK; Falcon Road Clinic (Wandsworth), Central London Community Healthcare NHS Trust, London, UK.
FAU - Plaha, Komal
AU  - Plaha K
AD  - Department of HIV/GUM, Chelsea and Westminster Hospital NHS Foundation Trust,London, UK; Falcon Road Clinic (Wandsworth), Central London Community Healthcare NHS Trust, London, UK.
FAU - Davies, Gary
AU  - Davies G
AD  - Department of HIV/GUM, Chelsea and Westminster Hospital NHS Foundation Trust,London, UK.
FAU - Moore, Luke S P
AU  - Moore LSP
AD  - Department of HIV/GUM, Chelsea and Westminster Hospital NHS Foundation Trust,London, UK; Imperial College Healthcare NHS Trust, London, UK; Department ofInfectious Diseases, Imperial College London, London, UK.
FAU - Mughal, Nabeela
AU  - Mughal N
AD  - Department of HIV/GUM, Chelsea and Westminster Hospital NHS Foundation Trust,London, UK; Imperial College Healthcare NHS Trust, London, UK; Department ofInfectious Diseases, Imperial College London, London, UK.
FAU - Asboe, David
AU  - Asboe D
AD  - Department of HIV/GUM, Chelsea and Westminster Hospital NHS Foundation Trust,London, UK.
FAU - Boffito, Marta
AU  - Boffito M
AD  - Department of HIV/GUM, Chelsea and Westminster Hospital NHS Foundation Trust,London, UK; Department of Infectious Diseases, Imperial College London, London,UK.
FAU - Jones, Rachael
AU  - Jones R
AD  - Department of HIV/GUM, Chelsea and Westminster Hospital NHS Foundation Trust,London, UK.
FAU - Whitlock, Gary
AU  - Whitlock G
AD  - Department of HIV/GUM, Chelsea and Westminster Hospital NHS Foundation Trust,London, UK.
LA  - eng
PT  - Journal Article
DEP - 20220701
PL  - United States
TA  - Lancet Infect Dis
JT  - The Lancet. Infectious diseases
JID - 101130150
SB  - IM
COIS- Declaration of interests LSPM has consulted for or received speaker fees frombioMerieux, DNAelectronics, Eumedica, Dairy Crest, Pfizer, Profile Pharma, UmovisLab, Kent Pharma, Pulmocide, Sumiovant, and Shionogi, and received researchgrants from the National Institute for Health Research, CW+ charity, and LifeArc.NG has consulted for or received speaker fees from Viiv Healthcare. JH hasreceived a research grant from the CW+ charity. DA has consulted for or received speaker fees from Viiv Healthcare and Theratechnologies. BM-P has consulted foror received speaker fees from MSD. NM has consulted for or received speaker fees from Pfizer and Shionogi. MBo has consulted for or received speaker fees fromViiv Healthcare, Gilead, GlaxoSmithKline, Pfizer, Cypla, Mylan, and Janssen. MBo has also received research grants from Gilead, Viiv Healthcare, Mylan, Novavax,Janssen, Valneva, Moderna, and Roche. RJ has consulted for or received speakerfees from Viiv Healthcare and Gilead. GW has consulted for or received speakerfees from Viiv Healthcare and Gilead. All other authors declare no competinginterests.
EDAT- 2022/07/06 06:00
MHDA- 2022/07/06 06:00
CRDT- 2022/07/05 11:15
PHST- 2022/05/31 00:00 [received]
PHST- 2022/06/14 00:00 [revised]
PHST- 2022/06/14 00:00 [accepted]
PHST- 2022/07/05 11:15 [entrez]
PHST- 2022/07/06 06:00 [pubmed]
PHST- 2022/07/06 06:00 [medline]
AID - S1473-3099(22)00411-X [pii]
AID - 10.1016/S1473-3099(22)00411-X [doi]
PST - aheadofprint
SO  - Lancet Infect Dis. 2022 Jul 1. pii: S1473-3099(22)00411-X. doi:10.1016/S1473-3099(22)00411-X.

PMID- 35784677
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220716
IS  - 2055-6640 (Print)
IS  - 2055-6640 (Linking)
VI  - 8
IP  - 2
DP  - 2022 Jun
TI  - A viewpoint: The 2022 monkeypox outbreak.
PG  - 100078
LID - 10.1016/j.jve.2022.100078 [doi]
FAU - Simoes, Pedro
AU  - Simoes P
AD  - Department of Infectious Diseases/HIV Medicine, The Royal Free Hospital, London, NW3 2QG, United Kingdom.
FAU - Bhagani, Sanjay
AU  - Bhagani S
AD  - Department of Infectious Diseases/HIV Medicine, The Royal Free Hospital, London, NW3 2QG, United Kingdom.
LA  - eng
PT  - Journal Article
DEP - 20220618
PL  - England
TA  - J Virus Erad
JT  - Journal of virus eradication
JID - 101654142
PMC - PMC9241087
OTO - NOTNLM
OT  - Monkeypox
OT  - Orthopox virus
OT  - Vesicular rash
OT  - West Africa
COIS- The authors declare that they have no known competing financial interests orpersonal relationships that could have appeared to influence the work reported inthis paper.
EDAT- 2022/07/06 06:00
MHDA- 2022/07/06 06:01
CRDT- 2022/07/05 10:28
PHST- 2022/07/05 10:28 [entrez]
PHST- 2022/07/06 06:00 [pubmed]
PHST- 2022/07/06 06:01 [medline]
AID - 10.1016/j.jve.2022.100078 [doi]
AID - S2055-6640(22)00016-4 [pii]
PST - epublish
SO  - J Virus Erad. 2022 Jun 18;8(2):100078. doi: 10.1016/j.jve.2022.100078.eCollection 2022 Jun.

PMID- 35782632
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220716
IS  - 2052-2975 (Print)
IS  - 2052-2975 (Linking)
VI  - 47
DP  - 2022 Apr-May
TI  - What has been researched about monkeypox? a bibliometric analysis of an oldzoonotic virus causing global concern.
PG  - 100993
LID - 10.1016/j.nmni.2022.100993 [doi]
FAU - Rodriguez-Morales, Alfonso J
AU  - Rodriguez-Morales AJ
AD  - Grupo de Investigacion Biomedicina, Faculty of Medicine, Fundacion Universitaria Autonoma de las Americas, Pereira, Risaralda, Colombia.
AD  - Committe on Tropical Medicine, Zoonoses and Travel Medicine, ColombianAssociation of Infectious Diseases (ACIN), Bogota, Colombia.
AD  - Faculty of Medicine, Fundacion Universitaria de las Americas, Sede Pereira,Pereira, Risaralda, Colombia.
AD  - Institucion Universitaria Vision de las Americas, Pereira, Risaralda, Colombia.
AD  - Master of Clinical Epidemiology and Biostatistics, Universidad Cientifica delSur, Lima, Peru.
FAU - Ortiz-Martinez, Yeimer
AU  - Ortiz-Martinez Y
AD  - Department of Internal Medicine, 469618 Universidad Industrial de Santander,Bucaramanga, Colombia.
AD  - Faculty of Health Sciences, 28000 Universidad de Sucre, Sincelejo, Colombia.
FAU - Bonilla-Aldana, D Katterine
AU  - Bonilla-Aldana DK
AD  - Grupo de Investigacion Biomedicina, Faculty of Medicine, Fundacion Universitaria Autonoma de las Americas, Pereira, Risaralda, Colombia.
AD  - Committe on Tropical Medicine, Zoonoses and Travel Medicine, ColombianAssociation of Infectious Diseases (ACIN), Bogota, Colombia.
AD  - Faculty of Medicine, Fundacion Universitaria de las Americas, Sede Pereira,Pereira, Risaralda, Colombia.
AD  - Institucion Universitaria Vision de las Americas, Pereira, Risaralda, Colombia.
LA  - eng
PT  - Journal Article
DEP - 20220531
PL  - England
TA  - New Microbes New Infect
JT  - New microbes and new infections
JID - 101624750
PMC - PMC9243150
OTO - NOTNLM
OT  - Monkeypox
OT  - orthopoxvirus
OT  - outbreak
OT  - poxviridae
OT  - zoonotic
EDAT- 2022/07/06 06:00
MHDA- 2022/07/06 06:01
CRDT- 2022/07/05 09:54
PHST- 2022/05/24 00:00 [received]
PHST- 2022/05/25 00:00 [accepted]
PHST- 2022/07/05 09:54 [entrez]
PHST- 2022/07/06 06:00 [pubmed]
PHST- 2022/07/06 06:01 [medline]
AID - 10.1016/j.nmni.2022.100993 [doi]
AID - S2052-2975(22)00045-2 [pii]
PST - epublish
SO  - New Microbes New Infect. 2022 May 31;47:100993. doi: 10.1016/j.nmni.2022.100993. eCollection 2022 Apr-May.

PMID- 35780819
OWN - NLM
STAT- Publisher
LR  - 20220705
IS  - 1578-2190 (Electronic)
IS  - 0001-7310 (Linking)
DP  - 2022 Jun 30
TI  - Monkeypox Virus Infection: A Case Report.
LID - S0001-7310(22)00602-0 [pii]
LID - 10.1016/j.ad.2022.06.014 [doi]
FAU - Moreno, David Mateos
AU  - Moreno DM
AD  - Hospital Universitario de Toledo, Departamento de Dermatologia, Toledo, Spain.Electronic address: davmatmor@gmail.com.
FAU - Escribano, Petunia Clavo
AU  - Escribano PC
AD  - Centro Sanitario Sandoval, Departamento de Dermatologia, Madrid, Spain.Electronic address: petuniaclavo@yahoo.es.
LA  - eng
LA  - spa
PT  - Case Reports
TT  - Infeccion por virus de la viruela del mono. Caso clinico.
DEP - 20220630
PL  - Spain
TA  - Actas Dermosifiliogr
JT  - Actas dermo-sifiliograficas
JID - 0373062
SB  - IM
EDAT- 2022/07/06 06:00
MHDA- 2022/07/06 06:00
CRDT- 2022/07/05 08:43
PHST- 2022/05/26 00:00 [received]
PHST- 2022/06/16 00:00 [revised]
PHST- 2022/06/20 00:00 [accepted]
PHST- 2022/07/05 08:43 [entrez]
PHST- 2022/07/06 06:00 [pubmed]
PHST- 2022/07/06 06:00 [medline]
AID - S0001-7310(22)00602-0 [pii]
AID - 10.1016/j.ad.2022.06.014 [doi]
PST - aheadofprint
SO  - Actas Dermosifiliogr. 2022 Jun 30. pii: S0001-7310(22)00602-0. doi:10.1016/j.ad.2022.06.014.

PMID- 35780787
OWN - NLM
STAT- MEDLINE
DCOM- 20220707
LR  - 20220716
IS  - 1474-547X (Electronic)
IS  - 0140-6736 (Linking)
VI  - 400
IP  - 10345
DP  - 2022 Jul 2
TI  - The monkeypox outbreak is amplifying hidden voices in the global discourse.
PG  - 23
LID - S0140-6736(22)01187-4 [pii]
LID - 10.1016/S0140-6736(22)01187-4 [doi]
FAU - Abbara, Aula
AU  - Abbara A
AD  - Manson Unit, Medecins Sans Frontieres UK, London EC4A 1AB, UK; Department ofInfection, Imperial College London, London, UK. Electronic address:a.abbara15@ic.ac.uk.
FAU - Rao, Bhargavi
AU  - Rao B
AD  - Manson Unit, Medecins Sans Frontieres UK, London EC4A 1AB, UK; Department ofGlobal Health, London School of Hygiene & Tropical Medicine, London, UK.
FAU - Titanji, Boghuma K
AU  - Titanji BK
AD  - Department of Medicine, Emory University School of Medicine, Emory University,Atlanta, GA, USA.
FAU - Boum, Yap
AU  - Boum Y
AD  - Epicentre, Medecins Sans Frontieres, Yaounde, Cameroon; Public Health EmergencyOperation Centre, Ministry of Public Health, Yaounde, Cameroon.
FAU - Zumla, Alimuddin
AU  - Zumla A
AD  - Department of Infection, Division of Infection and Immunity, University CollegeLondon, London, UK; National Institute for Health and Care Research BiomedicalResearch Centre, University College London, London, UK.
LA  - eng
PT  - Letter
PT  - Comment
PL  - England
TA  - Lancet
JT  - Lancet (London, England)
JID - 2985213R
SB  - IM
CON - Lancet. 2022 Jun 18;399(10343):2249-2250. PMID: 35644165
EIN - Lancet. 2022 Jul 16;400(10347):160. PMID: 35817076
MH  - Disease Outbreaks
MH  - Humans
MH  - *Monkeypox/epidemiology
PMC - PMC9270035
EDAT- 2022/07/06 06:00
MHDA- 2022/07/08 06:00
CRDT- 2022/07/05 08:42
PHST- 2022/06/08 00:00 [received]
PHST- 2022/06/12 00:00 [accepted]
PHST- 2022/07/05 08:42 [entrez]
PHST- 2022/07/06 06:00 [pubmed]
PHST- 2022/07/08 06:00 [medline]
AID - S0140-6736(22)01187-4 [pii]
AID - 10.1016/S0140-6736(22)01187-4 [doi]
PST - ppublish
SO  - Lancet. 2022 Jul 2;400(10345):23. doi: 10.1016/S0140-6736(22)01187-4.

PMID- 35780786
OWN - NLM
STAT- MEDLINE
DCOM- 20220707
LR  - 20220716
IS  - 1474-547X (Electronic)
IS  - 0140-6736 (Linking)
VI  - 400
IP  - 10345
DP  - 2022 Jul 2
TI  - Monkeypox genomic surveillance will challenge lessons learned from SARS-CoV-2.
PG  - 22-23
LID - S0140-6736(22)01106-0 [pii]
LID - 10.1016/S0140-6736(22)01106-0 [doi]
FAU - Pfaff, Florian
AU  - Pfaff F
AD  - Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Insel Riems,Greifswald, 17498, Germany.
FAU - Hoffmann, Donata
AU  - Hoffmann D
AD  - Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Insel Riems,Greifswald, 17498, Germany.
FAU - Beer, Martin
AU  - Beer M
AD  - Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Insel Riems,Greifswald, 17498, Germany. Electronic address: martin.beer@fli.de.
LA  - eng
PT  - Letter
PL  - England
TA  - Lancet
JT  - Lancet (London, England)
JID - 2985213R
SB  - IM
MH  - *COVID-19
MH  - Genomics
MH  - Humans
MH  - *Monkeypox
MH  - SARS-CoV-2/genetics
PMC - PMC9246459
EDAT- 2022/07/06 06:00
MHDA- 2022/07/08 06:00
CRDT- 2022/07/05 08:42
PHST- 2022/06/09 00:00 [received]
PHST- 2022/06/12 00:00 [accepted]
PHST- 2022/07/05 08:42 [entrez]
PHST- 2022/07/06 06:00 [pubmed]
PHST- 2022/07/08 06:00 [medline]
AID - S0140-6736(22)01106-0 [pii]
AID - 10.1016/S0140-6736(22)01106-0 [doi]
PST - ppublish
SO  - Lancet. 2022 Jul 2;400(10345):22-23. doi: 10.1016/S0140-6736(22)01106-0.

PMID- 35779853
OWN - NLM
STAT- Publisher
LR  - 20220804
IS  - 1873-0442 (Electronic)
IS  - 1477-8939 (Linking)
VI  - 49
DP  - 2022 Jun 29
TI  - Recently spreading human monkeypox virus infection and its transmission duringCOVID-19 pandemic period: A travelers' prospective.
PG  - 102398
LID - S1477-8939(22)00144-2 [pii]
LID - 10.1016/j.tmaid.2022.102398 [doi]
AB  - Presently, monkeypox has emerged in multiple countries with many confirmed cases,posing a global public health threat. A link has been found between air traveland the international spread of infectious diseases including the previous spreadof monkeypox. This article highlights the spread of COVID-19 through air travel, and then monkeypox spread from one country to another. Scientists are trying toestablish the air travel and monkeypox spread. Any travel link from an endemiccountry has not been proven yet to describe the rising number of currentmonkeypox cases in non-endemic countries. Due to the quantification method, thedirect link of the diseases with air travel might be difficult to establish.However, we have also developed different statistical models of the confirmedcases and the number of air travelers per year (noted in countries wheremonkeypox has spread). As there is no direct link, these models might show aprobability of an indirect association of air travel. However, more strongevidence is needed in this direction. Although, the sudden appearance ofmonkeypox cases in multiple countries in a few days demands comprehensiveepidemiological investigations, genome sequencing, and phylogenetic analysis ofviral isolates to prove the travel link from an endemic country. At the sametime, it is also necessary to know the real cause while also exploring any directand/or indirect travel links between different countries. Similarly, thepossibility of any zoonotic event should find out to understand the more aboutnatural animal reservoir(s) for the monkeypox virus, which is unknown until now. However, this report will help researchers for conducting further explorativeresearch and investigations for understanding transmission patterns and guidepolicymakers to make proactive policies to limit the spread of monkeypox.
CI  - Copyright (c) 2022 Elsevier Ltd. All rights reserved.
FAU - Bhattacharya, Manojit
AU  - Bhattacharya M
AD  - Department of Zoology, Fakir Mohan University, Vyasa Vihar, Balasore, 756020,Odisha, India.
FAU - Dhama, Kuldeep
AU  - Dhama K
AD  - Division of Pathology, ICAR-Indian Veterinary Research Institute, Izatnagar,Bareilly, 243122, Uttar Pradesh, India.
FAU - Chakraborty, Chiranjib
AU  - Chakraborty C
AD  - Department of Biotechnology, School of Life Science and Biotechnology, AdamasUniversity, Kolkata, West Bengal, 700126, India. Electronic address:drchiranjib@yahoo.com.
LA  - eng
PT  - Journal Article
DEP - 20220629
PL  - Netherlands
TA  - Travel Med Infect Dis
JT  - Travel medicine and infectious disease
JID - 101230758
SB  - IM
PMC - PMC9239924
OTO - NOTNLM
OT  - Country-wise transmission
OT  - International travel
OT  - Monkeypox virus
OT  - SARS-CoV-2 virus
EDAT- 2022/07/03 06:00
MHDA- 2022/07/03 06:00
CRDT- 2022/07/02 19:28
PHST- 2022/05/26 00:00 [received]
PHST- 2022/06/24 00:00 [revised]
PHST- 2022/06/25 00:00 [accepted]
PHST- 2022/07/03 06:00 [pubmed]
PHST- 2022/07/03 06:00 [medline]
PHST- 2022/07/02 19:28 [entrez]
AID - S1477-8939(22)00144-2 [pii]
AID - 10.1016/j.tmaid.2022.102398 [doi]
PST - aheadofprint
SO  - Travel Med Infect Dis. 2022 Jun 29;49:102398. doi: 10.1016/j.tmaid.2022.102398.

PMID- 35779571
OWN - NLM
STAT- Publisher
LR  - 20220725
IS  - 1578-2190 (Electronic)
IS  - 0001-7310 (Linking)
DP  - 2022 Jun 30
TI  - RF - Potential Treatments for Monkeypox.
LID - S0001-7310(22)00601-9 [pii]
LID - 10.1016/j.ad.2022.06.013 [doi]
FAU - Rodriguez-Cuadrado, F J
AU  - Rodriguez-Cuadrado FJ
AD  - Servicio de Dermatologia, Hospital Universitario Puerta de Hierro Majadahonda,Madrid, Espana. Electronic address: franciscojose.rodriguezcuadrado@gmail.com.
FAU - Pinto-Pulido, E L
AU  - Pinto-Pulido EL
AD  - Servicio de Dermatologia, Hospital Universitario Principe de Asturias, Madrid,Espana.
FAU - Fernandez-Parrado, M
AU  - Fernandez-Parrado M
AD  - Servicio de Dermatologia, Hospital Universitario de Navarra, Pamplona, Espana.
LA  - eng
LA  - spa
PT  - Journal Article
TT  - FR - Potenciales tratamientos en viruela simica (monkeypox).
DEP - 20220630
PL  - Spain
TA  - Actas Dermosifiliogr
JT  - Actas dermo-sifiliograficas
JID - 0373062
SB  - IM
OTO - NOTNLM
OT  - Monkeypox
OT  - Smallpox
OT  - Tecovirimat
OT  - Tratamiento
OT  - Treatment
OT  - Viruela
EDAT- 2022/07/03 06:00
MHDA- 2022/07/03 06:00
CRDT- 2022/07/02 19:22
PHST- 2022/05/27 00:00 [received]
PHST- 2022/06/20 00:00 [accepted]
PHST- 2022/07/03 06:00 [pubmed]
PHST- 2022/07/03 06:00 [medline]
PHST- 2022/07/02 19:22 [entrez]
AID - S0001-7310(22)00601-9 [pii]
AID - 10.1016/j.ad.2022.06.013 [doi]
PST - aheadofprint
SO  - Actas Dermosifiliogr. 2022 Jun 30. pii: S0001-7310(22)00601-9. doi:10.1016/j.ad.2022.06.013.

PMID- 35779015
OWN - NLM
STAT- Publisher
LR  - 20220710
IS  - 1365-3156 (Electronic)
IS  - 1360-2276 (Linking)
DP  - 2022 Jul 2
TI  - Monkeypox outbreak: Preventing another episode of stigmatisation.
LID - 10.1111/tmi.13798 [doi]
FAU - Chang, Chee Tao
AU  - Chang CT
AUID- ORCID: https://orcid.org/0000-0002-9263-446X
AD  - Clinical Research Centre, Hospital Raja Permaisuri Bainun, Ministry of HealthMalaysia, Ipoh, Malaysia.
FAU - Thum, Chern Choong
AU  - Thum CC
AUID- ORCID: https://orcid.org/0000-0002-5032-0980
AD  - Department of Psychiatry, Universiti Putra Malaysia Teaching Hospital, Serdang,Malaysia.
FAU - Lim, Xin Jie
AU  - Lim XJ
AUID- ORCID: https://orcid.org/0000-0003-0676-2113
AD  - Clinical Research Centre, Hospital Raja Permaisuri Bainun, Ministry of HealthMalaysia, Ipoh, Malaysia.
FAU - Chew, Chii Chii
AU  - Chew CC
AUID- ORCID: https://orcid.org/0000-0002-9316-3671
AD  - Clinical Research Centre, Hospital Raja Permaisuri Bainun, Ministry of HealthMalaysia, Ipoh, Malaysia.
FAU - Rajan, Philip
AU  - Rajan P
AUID- ORCID: https://orcid.org/0000-0002-5407-2427
AD  - Clinical Research Centre, Hospital Raja Permaisuri Bainun, Ministry of HealthMalaysia, Ipoh, Malaysia.
LA  - eng
PT  - Journal Article
DEP - 20220702
PL  - England
TA  - Trop Med Int Health
JT  - Tropical medicine & international health : TM & IH
JID - 9610576
SB  - IM
EDAT- 2022/07/03 06:00
MHDA- 2022/07/03 06:00
CRDT- 2022/07/02 09:32
PHST- 2022/07/03 06:00 [pubmed]
PHST- 2022/07/03 06:00 [medline]
PHST- 2022/07/02 09:32 [entrez]
AID - 10.1111/tmi.13798 [doi]
PST - aheadofprint
SO  - Trop Med Int Health. 2022 Jul 2. doi: 10.1111/tmi.13798.

PMID- 35777781
OWN - NLM
STAT- MEDLINE
DCOM- 20220707
LR  - 20220711
IS  - 1756-1833 (Electronic)
IS  - 0959-8138 (Linking)
VI  - 378
DP  - 2022 Jul 1
TI  - Monkeypox-not doing enough is not an option.
PG  - o1631
LID - 10.1136/bmj.o1631 [doi]
FAU - Titanji, Boghuma K
AU  - Titanji BK
AD  - Emory University, Atlanta, USA.
LA  - eng
PT  - Editorial
DEP - 20220701
PL  - England
TA  - BMJ
JT  - BMJ (Clinical research ed.)
JID - 8900488
SB  - IM
MH  - Humans
MH  - *Monkeypox
COIS- Competing interests: I have read and understood The BMJ policy on declaration of interests and declare the following: none.
EDAT- 2022/07/02 06:00
MHDA- 2022/07/08 06:00
CRDT- 2022/07/01 20:43
PHST- 2022/07/01 20:43 [entrez]
PHST- 2022/07/02 06:00 [pubmed]
PHST- 2022/07/08 06:00 [medline]
AID - 10.1136/bmj.o1631 [doi]
PST - epublish
SO  - BMJ. 2022 Jul 1;378:o1631. doi: 10.1136/bmj.o1631.

PMID- 35777702
OWN - NLM
STAT- Publisher
LR  - 20220722
IS  - 1532-2939 (Electronic)
IS  - 0195-6701 (Linking)
VI  - 127
DP  - 2022 Jun 28
TI  - Efficacy of biocidal agents and disinfectants against the monkeypox virus andother orthopoxviruses.
PG  - 101-110
LID - S0195-6701(22)00200-6 [pii]
LID - 10.1016/j.jhin.2022.06.012 [doi]
AB  - The number of human monkeypox virus infections is increasing in many countries.The typical mode of transmission is by direct contact. As orthopoxviruses maystay infectious on inanimate surfaces under laboratory conditions for up to 42days, disinfection may be relevant in the surroundings of confirmed cases. Theaim of this review was to evaluate published data on the antiviral efficacy ofbiocidal agents and disinfectants against the monkeypox virus and otherorthopoxviruses. A Medline search was carried out on 5(th) June 2022. The terms'monkeypox virus', 'poxvirus' and 'orthopoxvirus' were used in combination with'disinfection'. Publications were included and results were extracted where they provided original data on any orthopoxvirus regarding its inactivation bydisinfectants. Vaccinia viruses could be inactivated by at least 4 log10 insuspension tests and on artificially contaminated surfaces by 70% ethanol (</=1min), 0.2% peracetic acid (</=10 min) and 1-10% of a probiotic cleaner (1 h),mostly shown with different types of organic load. Hydrogen peroxide (14.4%) and iodine (0.04-1%) were effective in suspension tests, sodium hypochlorite(0.25-2.5%; 1 min), 2% glutaraldehyde (10 min) and 0.55% orthophthalaldehyde (5min) were effective on artificially contaminated surfaces. Copper (99.9%) wasequally effective against vaccinia virus and monkeypox virus in 3 min.Disinfectants with efficacy data obtained in suspension tests and under practicalconditions with different types of organic load resembling compounds of theblood, the respiratory tract and skin lesions are preferred for the inactivation of the monkeypox virus.
CI  - Copyright (c) 2022 The Healthcare Infection Society. Published by Elsevier Ltd.All rights reserved.
FAU - Kampf, G
AU  - Kampf G
AD  - University Medicine Greifswald, Greifswald, Germany. Electronic address:guenter.kampf@uni-greifswald.de.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20220628
PL  - England
TA  - J Hosp Infect
JT  - The Journal of hospital infection
JID - 8007166
SB  - IM
OTO - NOTNLM
OT  - Biocidal agent
OT  - Disinfectant
OT  - Efficacy
OT  - Monkeypox virus
OT  - Orthopoxvirus
OT  - Vaccinia virus
EDAT- 2022/07/02 06:00
MHDA- 2022/07/02 06:00
CRDT- 2022/07/01 19:28
PHST- 2022/06/08 00:00 [received]
PHST- 2022/06/22 00:00 [revised]
PHST- 2022/06/22 00:00 [accepted]
PHST- 2022/07/02 06:00 [pubmed]
PHST- 2022/07/02 06:00 [medline]
PHST- 2022/07/01 19:28 [entrez]
AID - S0195-6701(22)00200-6 [pii]
AID - 10.1016/j.jhin.2022.06.012 [doi]
PST - aheadofprint
SO  - J Hosp Infect. 2022 Jun 28;127:101-110. doi: 10.1016/j.jhin.2022.06.012.

PMID- 35777695
OWN - NLM
STAT- Publisher
LR  - 20220804
IS  - 1743-9159 (Electronic)
IS  - 1743-9159 (Linking)
VI  - 104
DP  - 2022 Jun 28
TI  - Monkeypox: An extra burden on global health.
PG  - 106745
LID - S1743-9191(22)00522-2 [pii]
LID - 10.1016/j.ijsu.2022.106745 [doi]
FAU - Saied, AbdulRahman A
AU  - Saied AA
AD  - National Food Safety Authority (NFSA), Aswan Branch, Aswan, 81511, Egypt;Ministry of Tourism and Antiquities, Aswan Office, Aswan, 81511, Egypt.Electronic address: saied_abdelrahman@yahoo.com.
FAU - Priyanka
AU  - Priyanka
AD  - Department of Veterinary Microbiology, College of Veterinary Science, Guru Angad Dev Veterinary and Animal Sciences University (GADVASU), Rampura Phul, Bathinda, 151103, Punjab, India.
FAU - Metwally, Asmaa A
AU  - Metwally AA
AD  - Department of Surgery, Anesthesiology, and Radiology, Aswan University, Aswan,81528, Egypt.
FAU - Choudhary, Om Prakash
AU  - Choudhary OP
AD  - Department of Veterinary Anatomy and Histology, College of Veterinary Sciencesand Animal Husbandry, Central Agricultural University (I), Selesih, Aizawl,796015, Mizoram, India.
LA  - eng
PT  - Letter
DEP - 20220628
PL  - England
TA  - Int J Surg
JT  - International journal of surgery (London, England)
JID - 101228232
SB  - IM
PMC - PMC9238059
OTO - NOTNLM
OT  - COVID-19
OT  - Economy
OT  - Global health
OT  - Monkeypox
OT  - Russo-Ukraine war
EDAT- 2022/07/02 06:00
MHDA- 2022/07/02 06:00
CRDT- 2022/07/01 19:28
PHST- 2022/06/10 00:00 [received]
PHST- 2022/06/24 00:00 [accepted]
PHST- 2022/07/02 06:00 [pubmed]
PHST- 2022/07/02 06:00 [medline]
PHST- 2022/07/01 19:28 [entrez]
AID - S1743-9191(22)00522-2 [pii]
AID - 10.1016/j.ijsu.2022.106745 [doi]
PST - aheadofprint
SO  - Int J Surg. 2022 Jun 28;104:106745. doi: 10.1016/j.ijsu.2022.106745.

PMID- 35777659
OWN - NLM
STAT- Publisher
LR  - 20220804
IS  - 1873-0442 (Electronic)
IS  - 1477-8939 (Linking)
VI  - 49
DP  - 2022 Jun 28
TI  - Monkeypox virus: A novel sexually transmitted disease? A case report from France.
PG  - 102394
LID - S1477-8939(22)00140-5 [pii]
LID - 10.1016/j.tmaid.2022.102394 [doi]
FAU - Vallee, Alexandre
AU  - Vallee A
AD  - Department of Epidemiology - Data - Biostatistics, Delegation of ClinicalResearch and Innovation (DRCI), Foch Hospital, 92150, Suresnes, France.Electronic address: al.vallee@hopital-foch.com.
FAU - Farfour, Eric
AU  - Farfour E
AD  - Biology Department, Foch Hospital, 92150, Suresnes, France.
FAU - Zucman, David
AU  - Zucman D
AD  - Reseau Ville-Hopital, Service de Medecine Interne, Hopital Foch, 92150, Suresnes,France.
LA  - eng
PT  - Letter
DEP - 20220628
PL  - Netherlands
TA  - Travel Med Infect Dis
JT  - Travel medicine and infectious disease
JID - 101230758
SB  - IM
OTO - NOTNLM
OT  - Epidemic
OT  - Human monkeypox virus
OT  - Monkeypox
OT  - Orthopoxvirus
OT  - Sexually transmitted disease
OT  - Virus
EDAT- 2022/07/02 06:00
MHDA- 2022/07/02 06:00
CRDT- 2022/07/01 19:27
PHST- 2022/06/18 00:00 [received]
PHST- 2022/06/21 00:00 [revised]
PHST- 2022/06/22 00:00 [accepted]
PHST- 2022/07/02 06:00 [pubmed]
PHST- 2022/07/02 06:00 [medline]
PHST- 2022/07/01 19:27 [entrez]
AID - S1477-8939(22)00140-5 [pii]
AID - 10.1016/j.tmaid.2022.102394 [doi]
PST - aheadofprint
SO  - Travel Med Infect Dis. 2022 Jun 28;49:102394. doi: 10.1016/j.tmaid.2022.102394.

PMID- 35777458
OWN - NLM
STAT- Publisher
LR  - 20220725
IS  - 1578-2190 (Electronic)
IS  - 0001-7310 (Linking)
DP  - 2022 Jun 28
TI  - RF - Monkeypox: Key Concepts.
LID - S0001-7310(22)00600-7 [pii]
LID - 10.1016/j.ad.2022.05.024 [doi]
FAU - Pinto-Pulido, E L
AU  - Pinto-Pulido EL
AD  - Servicio de Dermatologia, Hospital Universitario Principe de Asturias,Universidad de Alcala, Madrid, Espana. Electronic address:elucia.pinto95@gmail.com.
FAU - Fernandez-Parrado, M
AU  - Fernandez-Parrado M
AD  - Servicio de Dermatologia, Hospital Universitario de Navarra, Pamplona, Espana.
FAU - Rodriguez-Cuadrado, F J
AU  - Rodriguez-Cuadrado FJ
AD  - Servicio de Dermatologia, Hospital Universitario Puerta de Hierro, Madrid,Espana.
LA  - eng
LA  - spa
PT  - Journal Article
TT  - FR - Viruela simica: conceptos clave.
DEP - 20220628
PL  - Spain
TA  - Actas Dermosifiliogr
JT  - Actas dermo-sifiliograficas
JID - 0373062
SB  - IM
OTO - NOTNLM
OT  - Cutaneous manifestations
OT  - Infecciones virales
OT  - Manifestaciones cutaneas
OT  - Monkeypox
OT  - Vaccination
OT  - Vacunacion
OT  - Viral infections
OT  - Viruela simica
EDAT- 2022/07/02 06:00
MHDA- 2022/07/02 06:00
CRDT- 2022/07/01 19:23
PHST- 2022/05/23 00:00 [received]
PHST- 2022/05/24 00:00 [accepted]
PHST- 2022/07/02 06:00 [pubmed]
PHST- 2022/07/02 06:00 [medline]
PHST- 2022/07/01 19:23 [entrez]
AID - S0001-7310(22)00600-7 [pii]
AID - 10.1016/j.ad.2022.05.024 [doi]
PST - aheadofprint
SO  - Actas Dermosifiliogr. 2022 Jun 28. pii: S0001-7310(22)00600-7. doi:10.1016/j.ad.2022.05.024.

PMID- 35777384
OWN - NLM
STAT- Publisher
LR  - 20220701
IS  - 1474-4457 (Electronic)
IS  - 1473-3099 (Linking)
DP  - 2022 Jun 28
TI  - Does it matter who is spreading monkeypox?
LID - S1473-3099(22)00431-5 [pii]
LID - 10.1016/S1473-3099(22)00431-5 [doi]
FAU - Schneider, Kristan A
AU  - Schneider KA
AD  - Department of Applied Computer Sciences and Biosciences, Hochschule Mittweida,Mittweida 09648, Germany. Electronic address: kristan.schneider@hs-mittweida.de.
FAU - Eichner, Martin
AU  - Eichner M
AD  - Institute for Clinical Epidemiology and Applied Biometrics, University ofTubingen, Tubingen, Germany; Epimos, Bischofsheim in der Rhon, Germany.
LA  - eng
PT  - Journal Article
DEP - 20220628
PL  - United States
TA  - Lancet Infect Dis
JT  - The Lancet. Infectious diseases
JID - 101130150
SB  - IM
COIS- We declare no competing interests.
EDAT- 2022/07/02 06:00
MHDA- 2022/07/02 06:00
CRDT- 2022/07/01 19:02
PHST- 2022/06/01 00:00 [received]
PHST- 2022/06/20 00:00 [revised]
PHST- 2022/06/21 00:00 [accepted]
PHST- 2022/07/01 19:02 [entrez]
PHST- 2022/07/02 06:00 [pubmed]
PHST- 2022/07/02 06:00 [medline]
AID - S1473-3099(22)00431-5 [pii]
AID - 10.1016/S1473-3099(22)00431-5 [doi]
PST - aheadofprint
SO  - Lancet Infect Dis. 2022 Jun 28. pii: S1473-3099(22)00431-5. doi:10.1016/S1473-3099(22)00431-5.

PMID- 35775427
OWN - NLM
STAT- MEDLINE
DCOM- 20220704
LR  - 20220711
IS  - 1560-7917 (Electronic)
IS  - 1025-496X (Linking)
VI  - 27
IP  - 26
DP  - 2022 Jun
TI  - Evidence of surface contamination in hospital rooms occupied by patients infectedwith monkeypox, Germany, June 2022.
LID - 10.2807/1560-7917.ES.2022.27.26.2200477 [doi]
AB  - The extent of monkeypox virus environmental contamination of surfaces is unclear.We examined surfaces in rooms occupied by two monkeypox patients on their fourth hospitalisation day. Contamination with up to 105 viral copies/cm2 on inanimatesurfaces was estimated by PCR and the virus was successfully isolated fromsurfaces with more than 106 copies. These data highlight the importance of strictadherence of hospital staff to recommended protective measures. If appropriate,pre-exposure or early post-exposure vaccination should be considered forindividuals at risk.
FAU - Norz, Dominik
AU  - Norz D
AD  - University Medical Center Hamburg-Eppendorf (UKE), Institute of MedicalMicrobiology, Virology and Hygiene, Hamburg, Germany.
FAU - Pfefferle, Susanne
AU  - Pfefferle S
AD  - University Medical Center Hamburg-Eppendorf (UKE), Institute of MedicalMicrobiology, Virology and Hygiene, Hamburg, Germany.
AD  - Bernhard-Nocht Institute for Tropical Medicine (BNITM), Virology Department,Hamburg, Germany.
FAU - Brehm, Thomas T
AU  - Brehm TT
AD  - University Medical Center Hamburg-Eppendorf (UKE), 1. Department of Medicine,Hamburg, Germany.
AD  - German Center for Infection Research, Partner site Hamburg-Lubeck-Borstel-Riems, Germany.
FAU - Franke, Gefion
AU  - Franke G
AD  - University Medical Center Hamburg-Eppendorf (UKE), Institute of MedicalMicrobiology, Virology and Hygiene, Department for Infection Prevention andControl, Hamburg, Germany.
FAU - Grewe, Ilka
AU  - Grewe I
AD  - University Medical Center Hamburg-Eppendorf (UKE), 1. Department of Medicine,Hamburg, Germany.
FAU - Knobling, Birte
AU  - Knobling B
AD  - University Medical Center Hamburg-Eppendorf (UKE), Institute of MedicalMicrobiology, Virology and Hygiene, Department for Infection Prevention andControl, Hamburg, Germany.
FAU - Aepfelbacher, Martin
AU  - Aepfelbacher M
AD  - University Medical Center Hamburg-Eppendorf (UKE), Institute of MedicalMicrobiology, Virology and Hygiene, Hamburg, Germany.
FAU - Huber, Samuel
AU  - Huber S
AD  - University Medical Center Hamburg-Eppendorf (UKE), 1. Department of Medicine,Hamburg, Germany.
FAU - Klupp, Eva M
AU  - Klupp EM
AD  - University Medical Center Hamburg-Eppendorf (UKE), Institute of MedicalMicrobiology, Virology and Hygiene, Department for Infection Prevention andControl, Hamburg, Germany.
FAU - Jordan, Sabine
AU  - Jordan S
AD  - University Medical Center Hamburg-Eppendorf (UKE), 1. Department of Medicine,Hamburg, Germany.
FAU - Addo, Marylyn M
AU  - Addo MM
AD  - German Center for Infection Research, Partner site Hamburg-Lubeck-Borstel-Riems, Germany.
AD  - University Medical Center Hamburg-Eppendorf (UKE), Institute for InfectionResearch and Vaccine Development (IIRVD), Hamburg, Germany.
AD  - Bernhard-Nocht Institute for Tropical Medicine (BNI), Department of ClinicalImmunology of Infectious Diseases, Hamburg, Germany.
FAU - Schulze Zur Wiesch, Julian
AU  - Schulze Zur Wiesch J
AD  - University Medical Center Hamburg-Eppendorf (UKE), 1. Department of Medicine,Hamburg, Germany.
AD  - German Center for Infection Research, Partner site Hamburg-Lubeck-Borstel-Riems, Germany.
FAU - Schmiedel, Stefan
AU  - Schmiedel S
AD  - University Medical Center Hamburg-Eppendorf (UKE), 1. Department of Medicine,Hamburg, Germany.
FAU - Lutgehetmann, Marc
AU  - Lutgehetmann M
AD  - University Medical Center Hamburg-Eppendorf (UKE), Institute of MedicalMicrobiology, Virology and Hygiene, Hamburg, Germany.
AD  - German Center for Infection Research, Partner site Hamburg-Lubeck-Borstel-Riems, Germany.
FAU - Knobloch, Johannes K
AU  - Knobloch JK
AD  - German Center for Infection Research, Partner site Hamburg-Lubeck-Borstel-Riems, Germany.
AD  - University Medical Center Hamburg-Eppendorf (UKE), Institute of MedicalMicrobiology, Virology and Hygiene, Department for Infection Prevention andControl, Hamburg, Germany.
LA  - eng
PT  - Journal Article
PL  - Sweden
TA  - Euro Surveill
JT  - Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
JID - 100887452
SB  - IM
MH  - Germany
MH  - Hospitals
MH  - Humans
MH  - *Monkeypox/transmission
MH  - *Monkeypox virus
OTO - NOTNLM
OT  - environmental contamination
OT  - monkeypox virus
OT  - personal protective equipment
OT  - transmission
OT  - vaccination
EDAT- 2022/07/02 06:00
MHDA- 2022/07/06 06:00
CRDT- 2022/07/01 05:12
PHST- 2022/07/01 05:12 [entrez]
PHST- 2022/07/02 06:00 [pubmed]
PHST- 2022/07/06 06:00 [medline]
AID - 10.2807/1560-7917.ES.2022.27.26.2200477 [doi]
PST - ppublish
SO  - Euro Surveill. 2022 Jun;27(26). doi: 10.2807/1560-7917.ES.2022.27.26.2200477.

PMID- 35774117
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220716
IS  - 2049-0801 (Print)
IS  - 2049-0801 (Linking)
VI  - 79
DP  - 2022 Jul
TI  - Monkeypox as an emerging global health threat during the COVID- 19 time.
PG  - 104075
LID - 10.1016/j.amsu.2022.104075 [doi]
FAU - Mukherjee, Dattatreya
AU  - Mukherjee D
AD  - Jinan University, PR China.
FAU - Roy, Shubhajeet
AU  - Roy S
AD  - King George's Medical University, Lucknow, India.
FAU - Singh, Vaishali
AU  - Singh V
AD  - King George's Medical University, Lucknow, India.
FAU - Gopinath, Shilpa
AU  - Gopinath S
AD  - The John Hopkins University School of Medicine, Maryland, USA.
FAU - Pokhrel, Nishan Babu
AU  - Pokhrel NB
AD  - Tribhuvan University Institute of Medicine, Kathmandu, Nepal.
FAU - Jaiswal, Vikash
AU  - Jaiswal V
AD  - AMA School of Medicine, Philippines.
LA  - eng
PT  - Journal Article
DEP - 20220624
PL  - England
TA  - Ann Med Surg (Lond)
JT  - Annals of medicine and surgery (2012)
JID - 101616869
PMC - PMC9225920
COIS- None
EDAT- 2022/07/02 06:00
MHDA- 2022/07/02 06:01
CRDT- 2022/07/01 02:27
PHST- 2022/06/15 00:00 [received]
PHST- 2022/06/22 00:00 [accepted]
PHST- 2022/07/01 02:27 [entrez]
PHST- 2022/07/02 06:00 [pubmed]
PHST- 2022/07/02 06:01 [medline]
AID - 10.1016/j.amsu.2022.104075 [doi]
AID - S2049-0801(22)00835-4 [pii]
PST - ppublish
SO  - Ann Med Surg (Lond). 2022 Jul;79:104075. doi: 10.1016/j.amsu.2022.104075. Epub2022 Jun 24.

PMID- 35773978
OWN - NLM
STAT- Publisher
LR  - 20220712
IS  - 1096-9071 (Electronic)
IS  - 0146-6615 (Linking)
DP  - 2022 Jun 30
TI  - Multicounty outbreak of monkeypox virus-Challenges and recommendations.
LID - 10.1002/jmv.27966 [doi]
FAU - Siddiqui, Muhammad Osama
AU  - Siddiqui MO
AD  - Department of Community Medicine, Liaquat National Hospital and Medical College, Karachi, Sindh, Pakistan.
FAU - Syed, Mohammad Ali
AU  - Syed MA
AD  - Department of Community Medicine, Liaquat National Hospital and Medical College, Karachi, Sindh, Pakistan.
FAU - Tariq, Rabeet
AU  - Tariq R
AUID- ORCID: http://orcid.org/0000-0002-4281-7436
AD  - Department of Community Medicine, Liaquat National Hospital and Medical College, Karachi, Sindh, Pakistan.
FAU - Mansoor, Saira
AU  - Mansoor S
AD  - Department of Community Medicine, Liaquat National Hospital and Medical College, Karachi, Sindh, Pakistan.
LA  - eng
PT  - Letter
DEP - 20220630
PL  - United States
TA  - J Med Virol
JT  - Journal of medical virology
JID - 7705876
SB  - IM
EDAT- 2022/07/02 06:00
MHDA- 2022/07/02 06:00
CRDT- 2022/07/01 01:42
PHST- 2022/06/21 00:00 [revised]
PHST- 2022/05/27 00:00 [received]
PHST- 2022/06/22 00:00 [accepted]
PHST- 2022/07/02 06:00 [pubmed]
PHST- 2022/07/02 06:00 [medline]
PHST- 2022/07/01 01:42 [entrez]
AID - 10.1002/jmv.27966 [doi]
PST - aheadofprint
SO  - J Med Virol. 2022 Jun 30. doi: 10.1002/jmv.27966.

PMID- 35772413
OWN - NLM
STAT- Publisher
LR  - 20220716
IS  - 2214-109X (Electronic)
IS  - 2214-109X (Linking)
DP  - 2022 Jun 27
TI  - Monkeypox vaccines in pregnancy: lessons must be learned from COVID-19.
LID - S2214-109X(22)00284-4 [pii]
LID - 10.1016/S2214-109X(22)00284-4 [doi]
FAU - Khalil, Asma
AU  - Khalil A
AD  - Fetal Medicine Unit, St George's Hospital, St George's University of London,London, UK; Vascular Biology Research Centre, Molecular and Clinical SciencesResearch Institute, St George's University of London, London, UK. Electronicaddress: akhalil@sgul.ac.uk.
FAU - Samara, Athina
AU  - Samara A
AD  - Department of Women's and Children's Health, Karolinska Institutet, Stockholm,Sweden; Astrid Lindgren Children's Hospital, Karolinska University Hospital,Stockholm, Sweden.
FAU - O'Brien, Pat
AU  - O'Brien P
AD  - The Royal College of Obstetricians and Gynaecologists, London, UK; Department of Women's Health, University College London Hospitals NHS Foundation Trust, London,UK.
FAU - Morris, Edward
AU  - Morris E
AD  - The Royal College of Obstetricians and Gynaecologists, London, UK; Department of Women's Health, Norfolk and Norwich University Hospitals NHS Foundation Trust,Norwich, Norfolk, UK.
FAU - Draycott, Tim
AU  - Draycott T
AD  - The Royal College of Obstetricians and Gynaecologists, London, UK; North Bristol NHS Trust Department of Women's Health, Westbury on Trym, UK.
FAU - Lees, Christoph
AU  - Lees C
AD  - Department of Women's Health, Imperial College, London, UK.
FAU - Ladhani, Shamez
AU  - Ladhani S
AD  - Paediatric Infectious Diseases Research Group and Vaccine Institute, Institute ofInfection and Immunity, St George's University of London, London, UK;Immunisation and Countermeasures Division, Public Health England, London, UK;British Paediatric Surveillance Unit, Royal College of Paediatrics and ChildHealth, London, UK.
LA  - eng
PT  - Journal Article
DEP - 20220627
PL  - England
TA  - Lancet Glob Health
JT  - The Lancet. Global health
JID - 101613665
SB  - IM
PMC - PMC9236565
COIS- EM is President of the Royal College of Obstetricians and Gynaecologists (RCOG). PO is Vice President of the RCOG and co-chair of the RCOG Vaccine Committee. TDis Vice President of the RCOG. We declare no competing interests.
EDAT- 2022/07/01 06:00
MHDA- 2022/07/01 06:00
CRDT- 2022/06/30 19:02
PHST- 2022/05/26 00:00 [received]
PHST- 2022/05/31 00:00 [accepted]
PHST- 2022/06/30 19:02 [entrez]
PHST- 2022/07/01 06:00 [pubmed]
PHST- 2022/07/01 06:00 [medline]
AID - S2214-109X(22)00284-4 [pii]
AID - 10.1016/S2214-109X(22)00284-4 [doi]
PST - aheadofprint
SO  - Lancet Glob Health. 2022 Jun 27. pii: S2214-109X(22)00284-4. doi:10.1016/S2214-109X(22)00284-4.

PMID- 35771933
OWN - NLM
STAT- MEDLINE
DCOM- 20220704
LR  - 20220711
IS  - 1095-9203 (Electronic)
IS  - 0036-8075 (Linking)
VI  - 377
IP  - 6601
DP  - 2022 Jul
TI  - WHO holds off on global alarm for monkeypox.
PG  - 17
LID - 10.1126/science.add6994 [doi]
AB  - Critics blast agency for not declaring a Public Health Emergency of InternationalConcern.
FAU - Kupferschmidt, Kai
AU  - Kupferschmidt K
LA  - eng
PT  - News
DEP - 20220630
PL  - United States
TA  - Science
JT  - Science (New York, N.Y.)
JID - 0404511
SB  - IM
MH  - Humans
MH  - *Monkeypox/epidemiology/prevention & control
MH  - *Public Health
MH  - World Health Organization
EDAT- 2022/07/01 06:00
MHDA- 2022/07/06 06:00
CRDT- 2022/06/30 14:03
PHST- 2022/06/30 14:03 [entrez]
PHST- 2022/07/01 06:00 [pubmed]
PHST- 2022/07/06 06:00 [medline]
AID - 10.1126/science.add6994 [doi]
PST - ppublish
SO  - Science. 2022 Jul;377(6601):17. doi: 10.1126/science.add6994. Epub 2022 Jun 30.

PMID- 35770346
OWN - NLM
STAT- Publisher
LR  - 20220705
IS  - 1096-9071 (Electronic)
IS  - 0146-6615 (Linking)
DP  - 2022 Jun 29
TI  - Monkeypox virus: A zoonosis of concern.
LID - 10.1002/jmv.27968 [doi]
AB  - An outbreak of Monkeypox detected in nonendemic regions outside Africa hasreceived much attention around the globe. In this letter, we highlightepidemiology, pathogenesis, diagnosis, and recommendations to mitigate the spreadof monkeypox.
CI  - (c) 2022 Wiley Periodicals LLC.
FAU - Mahmoud, Ashraf
AU  - Mahmoud A
AUID- ORCID: http://orcid.org/0000-0001-8642-6712
AD  - Faculty of Medicine, Kilimanjaro Christian Medical University College,Kilimanjaro, Tanzania.
FAU - Nchasi, Goodluck
AU  - Nchasi G
AUID- ORCID: http://orcid.org/0000-0002-1002-0596
AD  - Catholic University of Health and Allied Sciences, Mwanza, Tanzania.
LA  - eng
PT  - Letter
DEP - 20220629
PL  - United States
TA  - J Med Virol
JT  - Journal of medical virology
JID - 7705876
SB  - IM
EDAT- 2022/07/01 06:00
MHDA- 2022/07/01 06:00
CRDT- 2022/06/30 03:02
PHST- 2022/06/26 00:00 [revised]
PHST- 2022/05/28 00:00 [received]
PHST- 2022/06/27 00:00 [accepted]
PHST- 2022/07/01 06:00 [pubmed]
PHST- 2022/07/01 06:00 [medline]
PHST- 2022/06/30 03:02 [entrez]
AID - 10.1002/jmv.27968 [doi]
PST - aheadofprint
SO  - J Med Virol. 2022 Jun 29. doi: 10.1002/jmv.27968.

PMID- 35768135
OWN - NLM
STAT- MEDLINE
DCOM- 20220701
LR  - 20220711
IS  - 1756-1833 (Electronic)
IS  - 0959-8138 (Linking)
VI  - 377
DP  - 2022 Jun 29
TI  - Monkeypox: What's behind WHO's decision not to declare a public health emergency?
PG  - o1604
LID - 10.1136/bmj.o1604 [doi]
FAU - Taylor, Luke
AU  - Taylor L
AD  - Bogota.
LA  - eng
PT  - Journal Article
DEP - 20220629
PL  - England
TA  - BMJ
JT  - BMJ (Clinical research ed.)
JID - 8900488
SB  - IM
MH  - Humans
MH  - *Monkeypox
MH  - *Public Health
MH  - World Health Organization
EDAT- 2022/06/30 06:00
MHDA- 2022/07/02 06:00
CRDT- 2022/06/29 20:33
PHST- 2022/06/29 20:33 [entrez]
PHST- 2022/06/30 06:00 [pubmed]
PHST- 2022/07/02 06:00 [medline]
AID - 10.1136/bmj.o1604 [doi]
PST - epublish
SO  - BMJ. 2022 Jun 29;377:o1604. doi: 10.1136/bmj.o1604.

PMID- 35767293
OWN - NLM
STAT- MEDLINE
DCOM- 20220721
LR  - 20220725
IS  - 1538-3598 (Electronic)
IS  - 0098-7484 (Linking)
VI  - 328
IP  - 3
DP  - 2022 Jul 19
TI  - Global Monkeypox Outbreaks Spur Drug Research for the Neglected Disease.
PG  - 231-233
LID - 10.1001/jama.2022.11224 [doi]
FAU - Harris, Emily
AU  - Harris E
LA  - eng
PT  - Journal Article
PL  - United States
TA  - JAMA
JT  - JAMA
JID - 7501160
SB  - IM
MH  - Animals
MH  - *Disease Outbreaks
MH  - Global Health/statistics & numerical data
MH  - Humans
MH  - Internationality
MH  - *Monkeypox/epidemiology
MH  - *Neglected Diseases/drug therapy/epidemiology
MH  - *Pharmaceutical Research
EDAT- 2022/06/30 06:00
MHDA- 2022/07/22 06:00
CRDT- 2022/06/29 11:42
PHST- 2022/06/30 06:00 [pubmed]
PHST- 2022/07/22 06:00 [medline]
PHST- 2022/06/29 11:42 [entrez]
AID - 2793925 [pii]
AID - 10.1001/jama.2022.11224 [doi]
PST - ppublish
SO  - JAMA. 2022 Jul 19;328(3):231-233. doi: 10.1001/jama.2022.11224.

PMID- 35763853
OWN - NLM
STAT- MEDLINE
DCOM- 20220630
LR  - 20220801
IS  - 0807-7096 (Electronic)
IS  - 0029-2001 (Linking)
VI  - 142
IP  - 10
DP  - 2022 Jun 28
TI  - Monkeypox in Norway.
LID - 10.4045/tidsskr.22.0412 [doi]
FAU - Morch, Kristine
AU  - Morch K
FAU - Pettersen, Frank O
AU  - Pettersen FO
LA  - nor
PT  - Journal Article
TT  - Apekopper i Norge.
DEP - 20220617
PL  - Norway
TA  - Tidsskr Nor Laegeforen
JT  - Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, nyraekke
JID - 0413423
SB  - IM
MH  - Animals
MH  - *Arthroplasty, Replacement, Hip
MH  - Haplorhini
MH  - Norway
EDAT- 2022/06/29 06:00
MHDA- 2022/07/01 06:00
CRDT- 2022/06/28 18:00
PHST- 2022/06/29 06:00 [pubmed]
PHST- 2022/07/01 06:00 [medline]
PHST- 2022/06/28 18:00 [entrez]
AID - 22-0412 [pii]
AID - 10.4045/tidsskr.22.0412 [doi]
PST - epublish
SO  - Tidsskr Nor Laegeforen. 2022 Jun 17;142(10). pii: 22-0412. doi:10.4045/tidsskr.22.0412. Print 2022 Jun 28.

PMID- 35763248
OWN - NLM
STAT- MEDLINE
DCOM- 20220714
LR  - 20220716
IS  - 1179-1950 (Electronic)
IS  - 0012-6667 (Linking)
VI  - 82
IP  - 9
DP  - 2022 Jun
TI  - Prevention and Treatment of Monkeypox.
PG  - 957-963
LID - 10.1007/s40265-022-01742-y [doi]
AB  - Human monkeypox is a zoonotic orthopoxvirus with presentation similar tosmallpox. Monkeypox is transmitted incidentally to humans when they encounterinfected animals. Reports have shown that the virus can also be transmittedthrough direct contact (sexual or skin-to-skin), respiratory droplets, and viafomites such as towels and bedding. Multiple medical countermeasures arestockpiled for orthopoxviruses such as monkeypox. Two vaccines are currentlyavailable, JYNNEOS(TM) (live, replication incompetent vaccinia virus) andACAM2000((R)) (live, replication competent vaccinia virus). While most cases ofmonkeypox will have mild and self-limited disease, with supportive care beingtypically sufficient, antivirals (e.g. tecovirimat, brincidofovir, cidofovir) andvaccinia immune globulin intravenous (VIGIV) are available as treatments.Antivirals can be considered in severe disease, immunocompromised patients,pediatrics, pregnant and breastfeeding women, complicated lesions, and whenlesions appear near the mouth, eyes, and genitals. The purpose of this shortreview is to describe each of these countermeasures.
CI  - (c) 2022. The Author(s), under exclusive licence to Springer Nature SwitzerlandAG.
FAU - Rizk, John G
AU  - Rizk JG
AUID- ORCID: http://orcid.org/0000-0002-5216-8695
AD  - Department of Pharmaceutical Health Services Research, University of Maryland,Baltimore, School of Pharmacy, 220 Arch Street, 12th Floor, Room 01-409-E,Baltimore, MD, 21201, USA. john.rizk@umaryland.edu.
FAU - Lippi, Giuseppe
AU  - Lippi G
AD  - Section of Clinical Biochemistry, University of Verona, Verona, Italy.
FAU - Henry, Brandon M
AU  - Henry BM
AD  - The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati,OH, USA.
FAU - Forthal, Donald N
AU  - Forthal DN
AD  - Division of Infectious Diseases, Department of Medicine, University ofCalifornia, Irvine, School of Medicine, Irvine, CA, USA.
AD  - Department of Molecular Biology and Biochemistry, University of California,Irvine, School of Medicine, Irvine, CA, USA.
FAU - Rizk, Youssef
AU  - Rizk Y
AD  - Division of Family Medicine, Department of Internal Medicine, Lebanese AmericanUniversity School of Medicine, Beirut, Lebanon.
LA  - eng
PT  - Journal Article
DEP - 20220628
PL  - New Zealand
TA  - Drugs
JT  - Drugs
JID - 7600076
RN  - 0 (Antiviral Agents)
RN  - JIL713Q00N (Cidofovir)
SB  - IM
MH  - Animals
MH  - Antiviral Agents/pharmacology/therapeutic use
MH  - Child
MH  - Cidofovir
MH  - Female
MH  - Humans
MH  - *Monkeypox/drug therapy/prevention & control
MH  - Pregnancy
MH  - *Smallpox/drug therapy
MH  - Vaccinia virus
PMC - PMC9244487
EDAT- 2022/06/29 06:00
MHDA- 2022/07/15 06:00
CRDT- 2022/06/28 11:22
PHST- 2022/06/17 00:00 [accepted]
PHST- 2022/06/29 06:00 [pubmed]
PHST- 2022/07/15 06:00 [medline]
PHST- 2022/06/28 11:22 [entrez]
AID - 10.1007/s40265-022-01742-y [doi]
AID - 10.1007/s40265-022-01742-y [pii]
PST - ppublish
SO  - Drugs. 2022 Jun;82(9):957-963. doi: 10.1007/s40265-022-01742-y. Epub 2022 Jun 28.

PMID- 35762024
OWN - NLM
STAT- Publisher
LR  - 20220628
IS  - 0974-7559 (Electronic)
IS  - 0019-6061 (Linking)
DP  - 2022 Jun 27
TI  - Monkeypox Disease Outbreak (2022): Epidemiology, Challenges, and the Way Forward.
LID - S097475591600438 [pii]
AB  - The biggest-ever outbreak of monkeypox disease in non-endemic countries startedin May, 2022. Though no monkeypox case has been reported from India, tillmid-June, 2022, yet, considering the rate of spread to the non-endemic countries,there is an urgent need of better understanding of the monkeypox virus anddisease epidemiology to help clinicians, public health specialists, andpolicymakers to be prepared for any eventuality. This review summarises themonkeypox disease epidemiology, clinical features, therapies, vaccines andoutlines the measures for preparedness and response for a possible outbreak. The disease is known to cause severe outcome in children, pregnant women, andimmunocompromised hosts and this group need to be given special attention. TheMonkeypox disease outbreak (2022) in non-endemic countries should be used as anopportunity by India and other low and middle income countries to strengthenpublic health surveillance and health system capacity for outbreak and epidemicpreparedness and response.
FAU - Lahariya, Chandrakant
AU  - Lahariya C
AD  - Foundation for People-Centric Health Systems, New Delhi, India. Correspondenceto: Dr Chandrakant Lahariya, B-2/173, First Floor, Safdarjung Enclave, New Delhi 110 029, India. c.lahariya@gmail.com.
FAU - Thakur, Archana
AU  - Thakur A
AD  - Foundation for People-Centric Health Systems, New Delhi, India.
FAU - Dudeja, Nonita
AU  - Dudeja N
AD  - Human Capital Lighthouse (Consulting) Pvt. Ltd., New Delhi, India.
LA  - eng
PT  - Journal Article
DEP - 20220627
PL  - India
TA  - Indian Pediatr
JT  - Indian pediatrics
JID - 2985062R
SB  - IM
EDAT- 2022/06/29 06:00
MHDA- 2022/06/29 06:00
CRDT- 2022/06/28 02:07
PHST- 2022/06/28 02:07 [entrez]
PHST- 2022/06/29 06:00 [pubmed]
PHST- 2022/06/29 06:00 [medline]
AID - S097475591600438 [pii]
PST - aheadofprint
SO  - Indian Pediatr. 2022 Jun 27. pii: S097475591600438.

PMID- 35760647
OWN - NLM
STAT- MEDLINE
DCOM- 20220726
LR  - 20220726
IS  - 1095-9157 (Electronic)
IS  - 0896-8411 (Linking)
VI  - 131
DP  - 2022 Jul
TI  - The 2022 outbreak and the pathobiology of the monkeypox virus.
PG  - 102855
LID - S0896-8411(22)00063-4 [pii]
LID - 10.1016/j.jaut.2022.102855 [doi]
AB  - Following two reports of monkeypox virus infection in individuals who returnedfrom Nigeria to the USA, one who returned to Texas (July 2021) and the other tothe Washington, DC area (November 2021), the number of monkeypox infection havedramatically increased. This sounded an alarm of potential for spreading of thevirus throughout the USA. During 2022, there was a report of monkeypox virusinfection (May 6, 2022) in a British national following a visit to Nigeria whodeveloped readily recognizable signs and symptoms of monkeypox virus infection.Soon following this report, case numbers climbed. By June 10, 2022, more than1,500 cases were reported in 43 countries, including Europe and North America.While the prevalence of the monkeypox virus is well known in central and western Africa, its presence in the developed world has raised disturbing signs forworldwide spread. While infection was reported during the past half-century,starting in the Democratic Republic of Congo in 1970, in the United States, only sporadic monkeypox cases have been reported. All cases have been linked tointernational travel or through African animal imports. The monkeypox virus istransmitted through contact with infected skin, body fluids, or respiratorydroplets. The virus spreads from oral and nasopharyngeal fluid exchanges or byintradermal injection; then rapidly replicates at the inoculation site withspreads to adjacent lymph nodes. Monkeypox disease begins with constitutionalsymptoms that include fever, chills, headache, muscle aches, backache, andfatigue. Phylogenetically the virus has two clades. One clade emerged from WestAfrica and the other in the Congo Basin of Central Africa. During the most recentoutbreak, the identity of the reservoir host or the primary carriage remainsunknown. African rodents are the suspected intermediate hosts. At the same time, the Centers for Disease Control (CDC) affirmed that there are no specifictreatments for the 2022 monkeypox virus infection; existing antivirals shown tobe effective against smallpox may slow monkeypox spread. A smallpox vaccineJYNNEOS (Imvamune or Imvanex) may also be used to prevent infection. The WorldHealth Organization (WHO), has warned that the world could be facing a formidableinfectious disease challenge in light of the current status of worldwide affairs.These affairs include the SARS-COVID-19 pandemic and the Ukraine-Russia war. Inaddition, the recent rise in case of numbers worldwide could continue to pose an international threat. With this in mind, strategies to mitigate the spread ofmonkeypox virus are warranted.
CI  - Copyright (c) 2022 Elsevier Ltd. All rights reserved.
FAU - Kumar, Narendra
AU  - Kumar N
AD  - Department of Pharmacology and Experimental Neuroscience, College of Medicine,University of Nebraska Medical Center, Omaha, NE, USA.
FAU - Acharya, Arpan
AU  - Acharya A
AD  - Department of Pharmacology and Experimental Neuroscience, College of Medicine,University of Nebraska Medical Center, Omaha, NE, USA.
FAU - Gendelman, Howard E
AU  - Gendelman HE
AD  - Department of Pharmacology and Experimental Neuroscience, College of Medicine,University of Nebraska Medical Center, Omaha, NE, USA; Department of Pathologyand Microbiology, College of Medicine, University of Nebraska Medical Center,Omaha, NE, USA; Department of Pharmaceutical Sciences, College of Pharmacy,University of Nebraska Medical Center, Omaha, NE, USA.
FAU - Byrareddy, Siddappa N
AU  - Byrareddy SN
AD  - Department of Pharmacology and Experimental Neuroscience, College of Medicine,University of Nebraska Medical Center, Omaha, NE, USA; Department of Genetics,Cell Biology and Anatomy, College of Medicine, University of Nebraska MedicalCenter, Omaha, NE, USA; Department of Biochemistry and Molecular Biology, Collegeof Medicine, University of Nebraska Medical Center, Omaha, NE, USA. Electronicaddress: sid.byrareddy@unmc.edu.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20220625
PL  - England
TA  - J Autoimmun
JT  - Journal of autoimmunity
JID - 8812164
SB  - IM
MH  - Animals
MH  - *COVID-19
MH  - Disease Outbreaks
MH  - Humans
MH  - *Monkeypox/epidemiology
MH  - Monkeypox virus
MH  - Pandemics
OTO - NOTNLM
OT  - Antiviral therapies
OT  - Monkeypox outbreak 2022
OT  - Prevention
OT  - Transmission
OT  - Viral pathogenesis
EDAT- 2022/06/28 06:00
MHDA- 2022/07/27 06:00
CRDT- 2022/06/27 22:04
PHST- 2022/06/05 00:00 [received]
PHST- 2022/06/11 00:00 [revised]
PHST- 2022/06/11 00:00 [accepted]
PHST- 2022/06/28 06:00 [pubmed]
PHST- 2022/07/27 06:00 [medline]
PHST- 2022/06/27 22:04 [entrez]
AID - S0896-8411(22)00063-4 [pii]
AID - 10.1016/j.jaut.2022.102855 [doi]
PST - ppublish
SO  - J Autoimmun. 2022 Jul;131:102855. doi: 10.1016/j.jaut.2022.102855. Epub 2022 Jun 25.

PMID- 35760344
OWN - NLM
STAT- Publisher
LR  - 20220804
IS  - 1743-9159 (Electronic)
IS  - 1743-9159 (Linking)
VI  - 104
DP  - 2022 Jun 24
TI  - Human monkeypox coinfections; lessons from available cases - Correspondence.
PG  - 106734
LID - S1743-9191(22)00511-8 [pii]
LID - 10.1016/j.ijsu.2022.106734 [doi]
FAU - Karbalaei, Mohsen
AU  - Karbalaei M
AD  - Department of Microbiology and Virology, School of Medicine, Jiroft University ofMedical Sciences, Jiroft, Iran.
FAU - Keikha, Masoud
AU  - Keikha M
AD  - Antimicrobial Resistance Research Center, Mashhad University of Medical Sciences,Mashhad, Iran; Department of Microbiology and Virology, Faculty of Medicine,Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address:keikham971@mums.ac.ir.
LA  - eng
PT  - Letter
DEP - 20220624
PL  - England
TA  - Int J Surg
JT  - International journal of surgery (London, England)
JID - 101228232
SB  - IM
EDAT- 2022/06/28 06:00
MHDA- 2022/06/28 06:00
CRDT- 2022/06/27 19:28
PHST- 2022/06/18 00:00 [received]
PHST- 2022/06/22 00:00 [accepted]
PHST- 2022/06/28 06:00 [pubmed]
PHST- 2022/06/28 06:00 [medline]
PHST- 2022/06/27 19:28 [entrez]
AID - S1743-9191(22)00511-8 [pii]
AID - 10.1016/j.ijsu.2022.106734 [doi]
PST - aheadofprint
SO  - Int J Surg. 2022 Jun 24;104:106734. doi: 10.1016/j.ijsu.2022.106734.

PMID- 35760342
OWN - NLM
STAT- Publisher
LR  - 20220804
IS  - 1743-9159 (Electronic)
IS  - 1743-9159 (Linking)
VI  - 104
DP  - 2022 Jun 26
TI  - Immediate countermeasures against the monkeypox outbreak.
PG  - 106733
LID - S1743-9191(22)00510-6 [pii]
LID - 10.1016/j.ijsu.2022.106733 [doi]
FAU - Rahimi, Farid
AU  - Rahimi F
AD  - Research School of Biology, The Australian National University, Ngunnawal andNgambri Country, Canberra, Australia.
FAU - Talebi Bezmin Abadi, Amin
AU  - Talebi Bezmin Abadi A
AD  - Department of Bacteriology, Faculty of Medical Sciences, Tarbiat ModaresUniversity, Tehran, Iran. Electronic address: Amin.talebi@modares.ac.ir.
FAU - Kamali, Negin
AU  - Kamali N
AD  - Department of Bacteriology, Faculty of Medical Sciences, Tarbiat ModaresUniversity, Tehran, Iran.
LA  - eng
PT  - Letter
DEP - 20220626
PL  - England
TA  - Int J Surg
JT  - International journal of surgery (London, England)
JID - 101228232
SB  - IM
EDAT- 2022/06/28 06:00
MHDA- 2022/06/28 06:00
CRDT- 2022/06/27 19:28
PHST- 2022/06/13 00:00 [received]
PHST- 2022/06/22 00:00 [accepted]
PHST- 2022/06/28 06:00 [pubmed]
PHST- 2022/06/28 06:00 [medline]
PHST- 2022/06/27 19:28 [entrez]
AID - S1743-9191(22)00510-6 [pii]
AID - 10.1016/j.ijsu.2022.106733 [doi]
PST - aheadofprint
SO  - Int J Surg. 2022 Jun 26;104:106733. doi: 10.1016/j.ijsu.2022.106733.

PMID- 35760308
OWN - NLM
STAT- Publisher
LR  - 20220702
IS  - 2468-7855 (Electronic)
IS  - 2468-7855 (Linking)
DP  - 2022 Jun 24
TI  - Mouth sores and monkeypox: A consideration.
LID - S2468-7855(22)00180-X [pii]
LID - 10.1016/j.jormas.2022.06.020 [doi]
FAU - Sookaromdee, Pathum
AU  - Sookaromdee P
AD  - Private Academic Consultant, Bangkok, Thailand. Electronic address:pathumsook@gmail.com.
FAU - Wiwanitkit, Viroj
AU  - Wiwanitkit V
AD  - Adjunct professor, Joseph Ayobaalola University, Ikeji-Arakeji, Nigeria; Honoraryprofessor, Dr DY Patil University, Pune, India; visiting professor, Faculty ofMedicine, University of Nis, Serbia.
LA  - eng
PT  - Letter
DEP - 20220624
PL  - France
TA  - J Stomatol Oral Maxillofac Surg
JT  - Journal of stomatology, oral and maxillofacial surgery
JID - 101701089
SB  - IM
OTO - NOTNLM
OT  - Monkey pox
OT  - Monkeypox
OT  - Sore throat
COIS- Declaration of Competing Interest None.
EDAT- 2022/06/28 06:00
MHDA- 2022/06/28 06:00
CRDT- 2022/06/27 19:27
PHST- 2022/05/25 00:00 [received]
PHST- 2022/06/08 00:00 [revised]
PHST- 2022/06/23 00:00 [accepted]
PHST- 2022/06/28 06:00 [pubmed]
PHST- 2022/06/28 06:00 [medline]
PHST- 2022/06/27 19:27 [entrez]
AID - S2468-7855(22)00180-X [pii]
AID - 10.1016/j.jormas.2022.06.020 [doi]
PST - aheadofprint
SO  - J Stomatol Oral Maxillofac Surg. 2022 Jun 24. pii: S2468-7855(22)00180-X. doi:10.1016/j.jormas.2022.06.020.

PMID- 35758536
OWN - NLM
STAT- MEDLINE
DCOM- 20220628
LR  - 20220801
IS  - 2095-8137 (Print)
IS  - 2095-8137 (Linking)
VI  - 43
IP  - 4
DP  - 2022 Jul 18
TI  - Monkeypox, wild animals, and potential big problem.
PG  - 612-614
LID - 2095-8137(2022)04-0612-03 [pii]
LID - 10.24272/j.issn.2095-8137.2022.217 [doi]
FAU - Song, Tian-Zhang
AU  - Song TZ
AD  - Key Laboratory of Animal Models and Human Disease Mechanisms of the ChineseAcademy of Sciences, KIZ-CUHK Joint Laboratory of Bioresources and MolecularResearch in Common Diseases, Kunming Institute of Zoology, Chinese Academy ofSciences, Kunming, Yunnan 650223, China.
AD  - National Resource Center for Non-Human Primates, National Research Facility forPhenotypic & Genetic Analysis of Model Animals (Primate Facility), KunmingInstitute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan 650107, China.
FAU - Zheng, Yong-Tang
AU  - Zheng YT
AD  - Key Laboratory of Animal Models and Human Disease Mechanisms of the ChineseAcademy of Sciences, KIZ-CUHK Joint Laboratory of Bioresources and MolecularResearch in Common Diseases, Kunming Institute of Zoology, Chinese Academy ofSciences, Kunming, Yunnan 650223, China.
AD  - National Resource Center for Non-Human Primates, National Research Facility forPhenotypic & Genetic Analysis of Model Animals (Primate Facility), KunmingInstitute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan 650107, China.E-mail: zhengyt@mail.kiz.ac.cn.
LA  - eng
PT  - Journal Article
PL  - China
TA  - Zool Res
JT  - Zoological research
JID - 101697192
SB  - IM
MH  - Animals
MH  - Animals, Wild
MH  - *Monkeypox/veterinary
PMC - PMC9336448
EDAT- 2022/06/28 06:00
MHDA- 2022/06/29 06:00
CRDT- 2022/06/27 08:13
PHST- 2022/06/27 08:13 [entrez]
PHST- 2022/06/28 06:00 [pubmed]
PHST- 2022/06/29 06:00 [medline]
AID - 10.24272/j.issn.2095-8137.2022.217 [doi]
PST - ppublish
SO  - Zool Res. 2022 Jul 18;43(4):612-614. doi: 10.24272/j.issn.2095-8137.2022.217.

PMID- 35758210
OWN - NLM
STAT- Publisher
LR  - 20220627
IS  - 1757-4684 (Electronic)
IS  - 1757-4676 (Linking)
DP  - 2022 Jun 27
TI  - Strengthening vaccines and medicines manufacturing capabilities in Africa:challenges and perspectives.
PG  - e16287
LID - 10.15252/emmm.202216287 [doi]
AB  - Africa carries a high burden of infectious diseases. Every year, millions ofAfricans contract tuberculosis, malaria, and many other diseases. Malaria killshundreds of thousands of children under the age of five years annually. More than11,000 people died during the 2014-2016 Ebola outbreak in West Africa; still,occasional cases of Ebola, as well as monkeypox, periodically appear in theDemocratic Republic of Congo. Since most of the African countries gained theirindependence during the 1960s, the continent has relied heavily on the outsideworld for diagnostics, medicines, vaccines, personal protective equipment, andother medical supplies. Africa consumes nearly 25% of the globally producedvaccines but imports 99% and 95% of its vaccines and medicines, respectively. The55 African countries were not able to ensure the health of 1.3 billion Africansduring the COVID-19 pandemic but had to rely on other global initiatives andother countries for help and support. However, the pandemic and the shortage ofvaccines may have been the much-needed trigger for this situation to change."When misfortunes increase, they erase each other." Naguib Mahfouz (1911-2006).
CI  - (c) 2022 The Authors. Published under the terms of the CC BY 4.0 license.
FAU - Saied, AbdulRahman A
AU  - Saied AA
AUID- ORCID: https://orcid.org/0000-0001-8616-5874
AD  - National Food Safety Authority (NFSA), Aswan, Egypt.
AD  - Ministry of Tourism and Antiquities, Aswan, Egypt.
FAU - Metwally, Asmaa A
AU  - Metwally AA
AUID- ORCID: https://orcid.org/0000-0001-8565-8220
AD  - Department of Surgery, Anesthesiology, and Radiology, Faculty of VeterinaryMedicine, Aswan University, Aswan, Egypt.
FAU - Dhawan, Manish
AU  - Dhawan M
AUID- ORCID: https://orcid.org/0000-0002-7783-7138
AD  - Department of Microbiology, Punjab Agricultural University, Ludhiana, Punjab,India.
AD  - Trafford College, Altrincham, Manchester, UK.
FAU - Choudhary, Om Prakash
AU  - Choudhary OP
AUID- ORCID: https://orcid.org/0000-0001-6929-675X
AD  - Department of Veterinary Anatomy and Histology, College of Veterinary Sciencesand Animal Husbandry, Central Agricultural University (I), Selesih, Aizawl,Mizoram, India.
FAU - Aiash, Hani
AU  - Aiash H
AUID- ORCID: https://orcid.org/0000-0001-9191-7479
AD  - Department of Family Medicine, Suez Canal University, Ismailia, Egypt.
AD  - Department of Cardiovascular Perfusion, SUNY Upstate Medical University,Syracuse, NY, USA.
AD  - Department of Medicine, SUNY Upstate Medical University, Syracuse, NY, USA.
AD  - Department of Surgery, SUNY Upstate Medical University, Syracuse, NY, USA.
LA  - eng
PT  - Journal Article
DEP - 20220627
PL  - England
TA  - EMBO Mol Med
JT  - EMBO molecular medicine
JID - 101487380
SB  - IM
OTO - NOTNLM
OT  - Africa
OT  - COVID-19
OT  - mRNA vaccine
OT  - manufacturing
OT  - vaccines
EDAT- 2022/06/28 06:00
MHDA- 2022/06/28 06:00
CRDT- 2022/06/27 06:24
PHST- 2022/06/09 00:00 [revised]
PHST- 2022/05/10 00:00 [received]
PHST- 2022/06/10 00:00 [accepted]
PHST- 2022/06/27 06:24 [entrez]
PHST- 2022/06/28 06:00 [pubmed]
PHST- 2022/06/28 06:00 [medline]
AID - 10.15252/emmm.202216287 [doi]
PST - aheadofprint
SO  - EMBO Mol Med. 2022 Jun 27:e16287. doi: 10.15252/emmm.202216287.

PMID- 35757887
OWN - NLM
STAT- Publisher
LR  - 20220627
IS  - 1938-744X (Electronic)
IS  - 1935-7893 (Linking)
DP  - 2022 Jun 27
TI  - Re-emergence of monkeypox virus and public health preparedness in Pakistan.
PG  - 1-4
LID - 10.1017/dmp.2022.164 [doi]
FAU - Saif, Arifa
AU  - Saif A
AUID- ORCID: https://orcid.org/0000-0002-6020-1037
AD  - Institute of Pharmaceutical Sciences, University of Veterinary and AnimalSciences, Lahore, Pakistan.
FAU - Yaseen, Muhammad Osama
AU  - Yaseen MO
AUID- ORCID: https://orcid.org/0000-0003-2698-8830
AD  - Institute of Pharmaceutical Sciences, University of Veterinary and AnimalSciences, Lahore, Pakistan.
LA  - eng
PT  - Journal Article
DEP - 20220627
PL  - United States
TA  - Disaster Med Public Health Prep
JT  - Disaster medicine and public health preparedness
JID - 101297401
SB  - IM
OTO - NOTNLM
OT  - Healthcare
OT  - Infectious disease
OT  - Monkeypox
OT  - Pakistan
OT  - Public health
EDAT- 2022/06/28 06:00
MHDA- 2022/06/28 06:00
CRDT- 2022/06/27 04:35
PHST- 2022/06/27 04:35 [entrez]
PHST- 2022/06/28 06:00 [pubmed]
PHST- 2022/06/28 06:00 [medline]
AID - S1935789322001641 [pii]
AID - 10.1017/dmp.2022.164 [doi]
PST - aheadofprint
SO  - Disaster Med Public Health Prep. 2022 Jun 27:1-4. doi: 10.1017/dmp.2022.164.

PMID- 35757311
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220716
IS  - 2049-0801 (Print)
IS  - 2049-0801 (Linking)
VI  - 79
DP  - 2022 Jul
TI  - Rise of monkeypox: Lessons from COVID-19 pandemic to mitigate global healthcrises.
PG  - 104049
LID - 10.1016/j.amsu.2022.104049 [doi]
FAU - Ennab, Farah
AU  - Ennab F
AD  - College of Medicine, Mohammed Bin Rashid University of Medicine and HealthSciences, Dubai, United Arab Emirates.
FAU - Nawaz, Faisal A
AU  - Nawaz FA
AD  - College of Medicine, Mohammed Bin Rashid University of Medicine and HealthSciences, Dubai, United Arab Emirates.
FAU - Narain, Kapil
AU  - Narain K
AD  - Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
FAU - Nchasi, Goodluck
AU  - Nchasi G
AD  - The Catholic University of Health and Allied Sciences, Mwanza, Tanzania.
FAU - Essar, Mohammad Yasir
AU  - Essar MY
AD  - Kabul University of Medical Sciences, Kabul, Afghanistan.
LA  - eng
PT  - Journal Article
DEP - 20220622
PL  - England
TA  - Ann Med Surg (Lond)
JT  - Annals of medicine and surgery (2012)
JID - 101616869
PMC - PMC9217059
COIS- None declared.
EDAT- 2022/06/28 06:00
MHDA- 2022/06/28 06:01
CRDT- 2022/06/27 04:22
PHST- 2022/06/14 00:00 [received]
PHST- 2022/06/18 00:00 [accepted]
PHST- 2022/06/27 04:22 [entrez]
PHST- 2022/06/28 06:00 [pubmed]
PHST- 2022/06/28 06:01 [medline]
AID - 10.1016/j.amsu.2022.104049 [doi]
AID - S2049-0801(22)00809-3 [pii]
PST - ppublish
SO  - Ann Med Surg (Lond). 2022 Jul;79:104049. doi: 10.1016/j.amsu.2022.104049. Epub2022 Jun 22.

PMID- 35755463
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220716
IS  - 2772-7076 (Electronic)
IS  - 2772-7076 (Linking)
VI  - 3
DP  - 2022 Jun
TI  - A case of suicide during the 2017 monkeypox outbreak in Nigeria.
PG  - 226-227
LID - 10.1016/j.ijregi.2022.04.004 [doi]
AB  - We report a case of suicide in a 34-year-old businessman who was admitted to anisolation facility in a tertiary hospital during the 2017/2018 monkeypox outbreakin Nigeria. We describe the possible psychosocial factors associated with suicideand highlight the challenges faced and lessons learnt in the management of thecase. To our knowledge, this is the first reported case of suicide linked tohuman monkeypox.
CI  - (c) 2022 The Author(s).
FAU - Ogoina, Dimie
AU  - Ogoina D
AD  - Niger Delta University/Niger Delta University Teaching Hospital, Yenagoa,Bayelsa, Nigeria.
FAU - Mohammed, Abdulaziz
AU  - Mohammed A
AD  - Africa Centers for Disease Control and Prevention, Addis Ababa, Ethiopia.
FAU - Yinka-Ogunleye, Adesola
AU  - Yinka-Ogunleye A
AD  - Nigeria Centre for Disease Control, Abuja, Nigeria.
FAU - Ihekweazu, Chikwe
AU  - Ihekweazu C
AD  - Nigeria Centre for Disease Control, Abuja, Nigeria.
LA  - eng
PT  - Case Reports
DEP - 20220425
PL  - England
TA  - IJID Reg
JT  - IJID Regions (Online)
JID - 9918418183106676
PMC - PMC9216383
OTO - NOTNLM
OT  - epidemics
OT  - mental health
OT  - monkeypox
OT  - psychological
OT  - suicide
COIS- The authors declare that they have no known competing financial interests orpersonal relationships that could have appeared to influence the work reported inthis paper.
EDAT- 2022/06/28 06:00
MHDA- 2022/06/28 06:01
CRDT- 2022/06/27 03:51
PHST- 2022/03/16 00:00 [received]
PHST- 2022/04/15 00:00 [revised]
PHST- 2022/04/20 00:00 [accepted]
PHST- 2022/06/27 03:51 [entrez]
PHST- 2022/06/28 06:00 [pubmed]
PHST- 2022/06/28 06:01 [medline]
AID - 10.1016/j.ijregi.2022.04.004 [doi]
AID - S2772-7076(22)00057-1 [pii]
PST - epublish
SO  - IJID Reg. 2022 Apr 25;3:226-227. doi: 10.1016/j.ijregi.2022.04.004. eCollection2022 Jun.

PMID- 35753658
OWN - NLM
STAT- Publisher
LR  - 20220804
IS  - 1873-0442 (Electronic)
IS  - 1477-8939 (Linking)
VI  - 49
DP  - 2022 Jun 24
TI  - First report of monkeypox in a patient living with HIV from Romania.
PG  - 102395
LID - S1477-8939(22)00141-7 [pii]
LID - 10.1016/j.tmaid.2022.102395 [doi]
FAU - Oprea, Cristiana
AU  - Oprea C
AD  - Carol Davila University of Medicine and Pharmacy, Bucharest, Romania; Dr VictorBabes Clinical Hospital for Infectious and Tropical Diseases, Bucharest, Romania.
FAU - Ianache, Irina
AU  - Ianache I
AD  - Dr Victor Babes Clinical Hospital for Infectious and Tropical Diseases,Bucharest, Romania.
FAU - Piscu, Sebastian
AU  - Piscu S
AD  - Dr Victor Babes Clinical Hospital for Infectious and Tropical Diseases,Bucharest, Romania.
FAU - Tardei, Gratiela
AU  - Tardei G
AD  - Dr Victor Babes Clinical Hospital for Infectious and Tropical Diseases,Bucharest, Romania.
FAU - Nica, Maria
AU  - Nica M
AD  - Carol Davila University of Medicine and Pharmacy, Bucharest, Romania; Dr VictorBabes Clinical Hospital for Infectious and Tropical Diseases, Bucharest, Romania.
FAU - Ceausu, Emanoil
AU  - Ceausu E
AD  - Dr Victor Babes Clinical Hospital for Infectious and Tropical Diseases,Bucharest, Romania; Academia de Stiinte Medicale, Romania.
FAU - Popescu, Corneliu Petru
AU  - Popescu CP
AD  - Carol Davila University of Medicine and Pharmacy, Bucharest, Romania; Dr VictorBabes Clinical Hospital for Infectious and Tropical Diseases, Bucharest, Romania.Electronic address: cornel160@yahoo.com.
FAU - Florescu, Simin Aysel
AU  - Florescu SA
AD  - Carol Davila University of Medicine and Pharmacy, Bucharest, Romania; Dr VictorBabes Clinical Hospital for Infectious and Tropical Diseases, Bucharest, Romania.
LA  - eng
PT  - Journal Article
DEP - 20220624
PL  - Netherlands
TA  - Travel Med Infect Dis
JT  - Travel medicine and infectious disease
JID - 101230758
SB  - IM
OTO - NOTNLM
OT  - HIV
OT  - Men having sex with men (MSM)
OT  - Monkeypox virus
EDAT- 2022/06/27 06:00
MHDA- 2022/06/27 06:00
CRDT- 2022/06/26 19:28
PHST- 2022/06/20 00:00 [received]
PHST- 2022/06/22 00:00 [accepted]
PHST- 2022/06/27 06:00 [pubmed]
PHST- 2022/06/27 06:00 [medline]
PHST- 2022/06/26 19:28 [entrez]
AID - S1477-8939(22)00141-7 [pii]
AID - 10.1016/j.tmaid.2022.102395 [doi]
PST - aheadofprint
SO  - Travel Med Infect Dis. 2022 Jun 24;49:102395. doi: 10.1016/j.tmaid.2022.102395.

PMID- 35753629
OWN - NLM
STAT- MEDLINE
DCOM- 20220803
LR  - 20220803
IS  - 2666-9919 (Electronic)
IS  - 2666-9919 (Linking)
VI  - 52
IP  - 5
DP  - 2022 Aug
TI  - The presumed receptivity and susceptibility to monkeypox of European animalspecies.
PG  - 294-298
LID - S2666-9919(22)00122-1 [pii]
LID - 10.1016/j.idnow.2022.06.006 [doi]
AB  - The Monkeypox virus belongs to the Orthopoxvius genus, as does the specificallyhuman smallpox virus. It is zoonotic and had never previously been considered as capable of human-to-human transmission over more than nine viral generationcycles. While relevant animal reservoirs have yet to be identified, non-humanprimates (NHP) are only accidental hosts. The potentially high number of current human shedders during the clinical phase (3 weeks maximum) raises the question ofa risk in our countries of animals being contaminated by infected humans (reversezoonosis). Cats as well as cows are susceptible to the Cowpox virus, anotherzoonotic Orthopoxvirus, which they transmit to humans. Dogs are much lesssusceptible to this virus and seem only receptive to Vaccinia virus (alsobelonging to the Orthopoxvirus genus). On the other hand, one study hasdemonstrated the pronounced susceptibility of the adult albino rabbit and ofyoung animals of several rodent species to Monkeypox virus (MPXV). Given thesusceptibility to MPXV of prairie dogs, which are American Sciuridae, thepotential for infection of European squirrels cannot be ruled out.
CI  - Copyright (c) 2022 Elsevier Masson SAS. All rights reserved.
FAU - Haddad, Nadia
AU  - Haddad N
AD  - Anses, INRAe, Ecole Nationale Veterinaire d'Alfort, UMR BIPAR, Laboratoire deSante Animale, Maisons-Alfort 94700, France. Electronic address:nadiahaddad@vet-alfort.fr.
LA  - eng
PT  - Journal Article
DEP - 20220623
PL  - France
TA  - Infect Dis Now
JT  - Infectious diseases now
JID - 101775152
SB  - IM
MH  - Adult
MH  - Animals
MH  - Cattle
MH  - Female
MH  - Humans
MH  - *Monkeypox/epidemiology/veterinary
MH  - Monkeypox virus
MH  - Rabbits
MH  - Sciuridae
MH  - United States
OTO - NOTNLM
OT  - Animal reservoir
OT  - Monkeypox
OT  - Reverse zoonosis
EDAT- 2022/06/27 06:00
MHDA- 2022/08/04 06:00
CRDT- 2022/06/26 19:27
PHST- 2022/06/22 00:00 [received]
PHST- 2022/06/22 00:00 [accepted]
PHST- 2022/06/27 06:00 [pubmed]
PHST- 2022/08/04 06:00 [medline]
PHST- 2022/06/26 19:27 [entrez]
AID - S2666-9919(22)00122-1 [pii]
AID - 10.1016/j.idnow.2022.06.006 [doi]
PST - ppublish
SO  - Infect Dis Now. 2022 Aug;52(5):294-298. doi: 10.1016/j.idnow.2022.06.006. Epub2022 Jun 23.

PMID- 35753551
OWN - NLM
STAT- Publisher
LR  - 20220626
IS  - 1097-6787 (Electronic)
IS  - 0190-9622 (Linking)
DP  - 2022 Jun 23
TI  - Current Outbreak of Monkeypox- Essentials for the Dermatologist.
LID - S0190-9622(22)02218-6 [pii]
LID - 10.1016/j.jaad.2022.06.1170 [doi]
FAU - Khanna, Urmi
AU  - Khanna U
AD  - Division of Dermatology, Department of Medicine, Albert Einstein College ofMedicine, Bronx, New York.
FAU - Bishnoi, Anuradha
AU  - Bishnoi A
AD  - Department of Dermatology, Venereology and Leprology Postgraduate Institute ofMedical Education and Research Chandigarh, India.
FAU - Vinay, Keshavamurthy
AU  - Vinay K
AD  - Department of Dermatology, Venereology and Leprology Postgraduate Institute ofMedical Education and Research Chandigarh, India.
LA  - eng
PT  - Letter
DEP - 20220623
PL  - United States
TA  - J Am Acad Dermatol
JT  - Journal of the American Academy of Dermatology
JID - 7907132
SB  - IM
OTO - NOTNLM
OT  - Monkeypox
OT  - fever
OT  - outbreak
OT  - rash
OT  - vesiculopustular
EDAT- 2022/06/27 06:00
MHDA- 2022/06/27 06:00
CRDT- 2022/06/26 19:26
PHST- 2022/05/27 00:00 [received]
PHST- 2022/06/04 00:00 [revised]
PHST- 2022/06/18 00:00 [accepted]
PHST- 2022/06/26 19:26 [entrez]
PHST- 2022/06/27 06:00 [pubmed]
PHST- 2022/06/27 06:00 [medline]
AID - S0190-9622(22)02218-6 [pii]
AID - 10.1016/j.jaad.2022.06.1170 [doi]
PST - aheadofprint
SO  - J Am Acad Dermatol. 2022 Jun 23. pii: S0190-9622(22)02218-6. doi:10.1016/j.jaad.2022.06.1170.

PMID- 35753315
OWN - NLM
STAT- Publisher
LR  - 20220716
IS  - 2666-5247 (Electronic)
IS  - 2666-5247 (Linking)
DP  - 2022 Jun 23
TI  - Projected burden and duration of the 2022 Monkeypox outbreaks in non-endemiccountries.
LID - S2666-5247(22)00183-5 [pii]
LID - 10.1016/S2666-5247(22)00183-5 [doi]
FAU - Bisanzio, Donal
AU  - Bisanzio D
AD  - Research Triangle Institute International, Washington DC 20005-3967, USA.Electronic address: dbisanzio@rti.org.
FAU - Reithinger, Richard
AU  - Reithinger R
AD  - Research Triangle Institute International, Washington DC 20005-3967, USA.
LA  - eng
PT  - Letter
DEP - 20220623
PL  - England
TA  - Lancet Microbe
JT  - The Lancet. Microbe
JID - 101769019
SB  - IM
PMC - PMC9225111
COIS- We declare no competing interests.
EDAT- 2022/06/27 06:00
MHDA- 2022/06/27 06:00
CRDT- 2022/06/26 19:02
PHST- 2022/06/14 00:00 [received]
PHST- 2022/06/15 00:00 [revised]
PHST- 2022/06/15 00:00 [accepted]
PHST- 2022/06/26 19:02 [entrez]
PHST- 2022/06/27 06:00 [pubmed]
PHST- 2022/06/27 06:00 [medline]
AID - S2666-5247(22)00183-5 [pii]
AID - 10.1016/S2666-5247(22)00183-5 [doi]
PST - aheadofprint
SO  - Lancet Microbe. 2022 Jun 23. pii: S2666-5247(22)00183-5. doi:10.1016/S2666-5247(22)00183-5.

PMID- 35752293
OWN - NLM
STAT- Publisher
LR  - 20220804
IS  - 1873-0442 (Electronic)
IS  - 1477-8939 (Linking)
VI  - 49
DP  - 2022 Jun 22
TI  - Emergence of monkeypox: Risk assessment and containment measures.
PG  - 102392
LID - S1477-8939(22)00138-7 [pii]
LID - 10.1016/j.tmaid.2022.102392 [doi]
FAU - Dhawan, Manish
AU  - Dhawan M
AD  - Department of Microbiology, Punjab Agricultural University, Ludhiana, 141004,Punjab, India; Trafford College, Altrincham, Manchester, WA14 5PQ, UK.
FAU - Priyanka
AU  - Priyanka
AD  - Department of Veterinary Microbiology, College of Veterinary Science, Guru Angad Dev Veterinary and Animal Sciences University (GADVASU), Rampura Phul, Bathinda, 151103, Punjab, India. Electronic address: priyanka7malik@gmail.com.
FAU - Choudhary, Om Prakash
AU  - Choudhary OP
AD  - Department of Veterinary Anatomy and Histology, College of Veterinary Sciencesand Animal Husbandry, Central Agricultural University (I), Selesih, Aizawl,796015, Mizoram, India. Electronic address: dr.om.choudhary@gmail.com.
LA  - eng
PT  - Letter
DEP - 20220622
PL  - Netherlands
TA  - Travel Med Infect Dis
JT  - Travel medicine and infectious disease
JID - 101230758
SB  - IM
PMC - PMC9217686
OTO - NOTNLM
OT  - COVID-19
OT  - Control
OT  - Epidemiology
OT  - Monkeypox
OT  - Pandemic
OT  - Prevention
OT  - Zoonotic
EDAT- 2022/06/26 06:00
MHDA- 2022/06/26 06:00
CRDT- 2022/06/25 19:14
PHST- 2022/05/25 00:00 [received]
PHST- 2022/06/17 00:00 [revised]
PHST- 2022/06/20 00:00 [accepted]
PHST- 2022/06/26 06:00 [pubmed]
PHST- 2022/06/26 06:00 [medline]
PHST- 2022/06/25 19:14 [entrez]
AID - S1477-8939(22)00138-7 [pii]
AID - 10.1016/j.tmaid.2022.102392 [doi]
PST - aheadofprint
SO  - Travel Med Infect Dis. 2022 Jun 22;49:102392. doi: 10.1016/j.tmaid.2022.102392.

PMID- 35752185
OWN - NLM
STAT- MEDLINE
LR  - 20220707
IS  - 1474-4457 (Electronic)
IS  - 1473-3099 (Linking)
VI  - 22
IP  - 7
DP  - 2022 Jul
TI  - Global monkeypox outbreak.
PG  - 950
LID - S1473-3099(22)00379-6 [pii]
LID - 10.1016/S1473-3099(22)00379-6 [doi]
FAU - Venkatesan, Priya
AU  - Venkatesan P
LA  - eng
PT  - News
PL  - United States
TA  - Lancet Infect Dis
JT  - The Lancet. Infectious diseases
JID - 101130150
SB  - IM
MH  - Animals
MH  - Disease Outbreaks
MH  - Humans
MH  - *Monkeypox/epidemiology
MH  - Monkeypox virus
EDAT- 2022/06/26 06:00
MHDA- 2022/06/29 06:00
CRDT- 2022/06/25 19:06
PHST- 2022/06/25 19:06 [entrez]
PHST- 2022/06/26 06:00 [pubmed]
PHST- 2022/06/29 06:00 [medline]
AID - S1473-3099(22)00379-6 [pii]
AID - 10.1016/S1473-3099(22)00379-6 [doi]
PST - ppublish
SO  - Lancet Infect Dis. 2022 Jul;22(7):950. doi: 10.1016/S1473-3099(22)00379-6.

PMID- 35751634
OWN - NLM
STAT- In-Process
LR  - 20220804
IS  - 1943-7722 (Electronic)
IS  - 0002-9173 (Linking)
VI  - 158
IP  - 2
DP  - 2022 Aug 4
TI  - Monkeypox in 2022.
PG  - 160-161
LID - 10.1093/ajcp/aqac091 [doi]
FAU - Guarner, Jeannette
AU  - Guarner J
AUID- ORCID: 0000-0001-5610-3541
AD  - Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA,USA.
LA  - eng
PT  - Journal Article
PL  - England
TA  - Am J Clin Pathol
JT  - American journal of clinical pathology
JID - 0370470
SB  - IM
OTO - NOTNLM
OT  - Monkeypox
OT  - Pathology
OT  - Testing
EDAT- 2022/06/26 06:00
MHDA- 2022/06/26 06:00
CRDT- 2022/06/25 10:02
PHST- 2022/06/26 06:00 [pubmed]
PHST- 2022/06/26 06:00 [medline]
PHST- 2022/06/25 10:02 [entrez]
AID - 6617956 [pii]
AID - 10.1093/ajcp/aqac091 [doi]
PST - ppublish
SO  - Am J Clin Pathol. 2022 Aug 4;158(2):160-161. doi: 10.1093/ajcp/aqac091.

PMID- 35751396
OWN - NLM
STAT- MEDLINE
DCOM- 20220713
LR  - 20220716
IS  - 2222-1751 (Electronic)
IS  - 2222-1751 (Linking)
VI  - 11
IP  - 1
DP  - 2022 Dec
TI  - Monkeypox virus emerges from the shadow of its more infamous cousin: familybiology matters.
PG  - 1768-1777
LID - 10.1080/22221751.2022.2095309 [doi]
AB  - Monkeypox virus (MPXV) is closely related to the infamous variola (smallpox)virus, causing a febrile rash illness in humans similar to but milder thansmallpox. In the twentieth century, human monkeypox had been mostly a rarezoonotic disease confined to forested areas in West and Central Africa. However, the case number and geographic range have increased significantly in thiscentury, coincided with the waning of the smallpox vaccine-induced immunity inthe global population. The outbreak of human monkeypox in multiple countriessince May 2022 has been unusual in its large case number and the absence ofdirect links to endemic countries, raising concerns for a possible change inmonkeypox transmission pattern that could pose a greater global threat. Here, we review aspects of MPXV biology that are relevant for risk assessment andpreparedness for a monkeypox epidemic, with an emphasis on recent progress inunderstanding of the virus host range, evolutionary potential, and neutralizationtargets.
FAU - Xiang, Yan
AU  - Xiang Y
AD  - Department of Microbiology, Immunology and Molecular Genetics, University ofTexas Health Science Center, San Antonio, TX, USA.
FAU - White, Addison
AU  - White A
AD  - Department of Microbiology, Immunology and Molecular Genetics, University ofTexas Health Science Center, San Antonio, TX, USA.
LA  - eng
GR  - R01 AI151638/AI/NIAID NIH HHS/United States
PT  - Journal Article
PT  - Review
PL  - United States
TA  - Emerg Microbes Infect
JT  - Emerging microbes & infections
JID - 101594885
SB  - IM
MH  - Animals
MH  - Biology
MH  - Disease Outbreaks
MH  - Humans
MH  - *Monkeypox/epidemiology
MH  - Monkeypox virus/genetics
MH  - *Smallpox
PMC - PMC9278444
OTO - NOTNLM
OT  - Poxvirus
OT  - antibodies
OT  - evolution
OT  - host range
OT  - monkeypox
EDAT- 2022/06/26 06:00
MHDA- 2022/07/14 06:00
CRDT- 2022/06/25 02:13
PHST- 2022/06/26 06:00 [pubmed]
PHST- 2022/07/14 06:00 [medline]
PHST- 2022/06/25 02:13 [entrez]
AID - 10.1080/22221751.2022.2095309 [doi]
PST - ppublish
SO  - Emerg Microbes Infect. 2022 Dec;11(1):1768-1777. doi:10.1080/22221751.2022.2095309.

PMID- 35750759
OWN - NLM
STAT- MEDLINE
DCOM- 20220628
LR  - 20220716
IS  - 2045-2322 (Electronic)
IS  - 2045-2322 (Linking)
VI  - 12
IP  - 1
DP  - 2022 Jun 24
TI  - Nanopore sequencing of a monkeypox virus strain isolated from a pustular lesionin the Central African Republic.
PG  - 10768
LID - 10.1038/s41598-022-15073-1 [doi]
AB  - Monkeypox is an emerging and neglected zoonotic disease whose number of reported cases has been gradually increasing in Central Africa since 1980. This disease iscaused by the monkeypox virus (MPXV), which belongs to the genus Orthopoxvirus inthe family Poxviridae. Obtaining molecular data is particularly useful forestablishing the relationships between the viral strains involved in outbreaks incountries affected by this disease. In this study, we evaluated the use of theMinION real-time sequencer as well as different polishing tools onMinION-sequenced genome for sequencing the MPXV genome originating from apustular lesion in the context of an epidemic in a remote area of the CentralAfrican Republic. The reads corresponding to the MPXV genome were identifiedusing two taxonomic classifiers, Kraken2 and Kaiju. Assembly of these reads ledto a complete sequence of 196,956 bases, which is 6322 bases longer than thesequence previously obtained with Illumina sequencing from the same sample. Thecomparison of the two sequences showed mainly indels at the homopolymericregions. However, the combined use of Canu with specific polishing tools such as Medaka and Homopolish was the best combination that reduced their numbers withoutadding mismatches. Although MinION sequencing is known to introduce a number ofcharacteristic errors compared to Illumina sequencing, the new polishing toolsallow a better-quality MinION-sequenced genome, thus to be used to help determinestrain origin through phylogenetic analysis.
CI  - (c) 2022. The Author(s).
FAU - Vandenbogaert, Mathias
AU  - Vandenbogaert M
AD  - Unite Environnement et Risque Infectieux, Cellule d'Intervention Biologiqued'Urgence, Institut Pasteur, Paris, France.
FAU - Kwasiborski, Aurelia
AU  - Kwasiborski A
AD  - Unite Environnement et Risque Infectieux, Cellule d'Intervention Biologiqued'Urgence, Institut Pasteur, Paris, France.
FAU - Gonofio, Ella
AU  - Gonofio E
AD  - Institut Pasteur de Bangui, Bangui, Central African Republic.
FAU - Descorps-Declere, Stephane
AU  - Descorps-Declere S
AD  - Centre of Bioinformatics, Biostatistics and Integrative Biology (C3BI), Institut Pasteur, Paris, France.
FAU - Selekon, Benjamin
AU  - Selekon B
AD  - Institut Pasteur de Bangui, Bangui, Central African Republic.
FAU - Nkili Meyong, Andriniaina Andy
AU  - Nkili Meyong AA
AD  - Centre Interdisciplinaire de Recherches Medicales de Franceville (CIRMF),Franceville, Gabon.
FAU - Ouilibona, Rita Sem
AU  - Ouilibona RS
AD  - Institut Pasteur de Bangui, Bangui, Central African Republic.
FAU - Gessain, Antoine
AU  - Gessain A
AD  - Unite d'Epidemiologie et Physiopathologie des Virus Oncogenes, Departement deVirologie, UMR3569, Institut Pasteur, Centre National de la RechercheScientifique (CNRS, Paris, France.
FAU - Manuguerra, Jean-Claude
AU  - Manuguerra JC
AD  - Unite Environnement et Risque Infectieux, Cellule d'Intervention Biologiqued'Urgence, Institut Pasteur, Paris, France.
FAU - Caro, Valerie
AU  - Caro V
AD  - Unite Environnement et Risque Infectieux, Cellule d'Intervention Biologiqued'Urgence, Institut Pasteur, Paris, France.
FAU - Nakoune, Emmanuel
AU  - Nakoune E
AD  - Institut Pasteur de Bangui, Bangui, Central African Republic.
FAU - Berthet, Nicolas
AU  - Berthet N
AD  - Unite Environnement et Risque Infectieux, Cellule d'Intervention Biologiqued'Urgence, Institut Pasteur, Paris, France. nicolas.berthet@pasteur.fr.
AD  - The Center for Microbes, Development and Health, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai-Chinese Academy ofSciences, Discovery and Molecular Characterization of Pathogens, No. 320 Yueyang Road, XuHui District, Shanghai, 200031, China. nicolas.berthet@pasteur.fr.
LA  - eng
GR  - 2019SHZDZX02/Shanghai Municipal Science and Technology Major Project
GR  - 153211KYSB20160001/External Cooperation Program of Chinese Academy of Sciences
PT  - Journal Article
DEP - 20220624
PL  - England
TA  - Sci Rep
JT  - Scientific reports
JID - 101563288
SB  - IM
MH  - Central African Republic
MH  - High-Throughput Nucleotide Sequencing
MH  - Humans
MH  - *Monkeypox/epidemiology
MH  - Monkeypox virus/genetics
MH  - *Nanopore Sequencing
MH  - Phylogeny
PMC - PMC9232561
EDAT- 2022/06/25 06:00
MHDA- 2022/06/29 06:00
CRDT- 2022/06/24 23:21
PHST- 2021/01/08 00:00 [received]
PHST- 2022/06/17 00:00 [accepted]
PHST- 2022/06/25 06:00 [pubmed]
PHST- 2022/06/29 06:00 [medline]
PHST- 2022/06/24 23:21 [entrez]
AID - 10.1038/s41598-022-15073-1 [doi]
AID - 10.1038/s41598-022-15073-1 [pii]
PST - epublish
SO  - Sci Rep. 2022 Jun 24;12(1):10768. doi: 10.1038/s41598-022-15073-1.

PMID- 35750596
OWN - NLM
STAT- Publisher
LR  - 20220624
IS  - 2254-8874 (Electronic)
IS  - 2254-8874 (Linking)
DP  - 2022 Jun 21
TI  - Monkeypox: A poxvirus emerges once again.
LID - S2254-8874(22)00047-9 [pii]
LID - 10.1016/j.rceng.2022.05.001 [doi]
FAU - Ena, J
AU  - Ena J
AD  - Departmento de Medicina Interna, Hospital Marina Baixa, Alicante, Spain.Electronic address: ena_jav@gva.es.
FAU - Wenzel, R P
AU  - Wenzel RP
AD  - Departamento de Medicina Interna, Virginia Commonwealth University Health,Richmond, VA, USA.
LA  - eng
PT  - Editorial
DEP - 20220621
PL  - Spain
TA  - Rev Clin Esp (Barc)
JT  - Revista clinica espanola
JID - 101632437
SB  - IM
EDAT- 2022/06/25 06:00
MHDA- 2022/06/25 06:00
CRDT- 2022/06/24 22:07
PHST- 2022/05/24 00:00 [received]
PHST- 2022/05/24 00:00 [accepted]
PHST- 2022/06/24 22:07 [entrez]
PHST- 2022/06/25 06:00 [pubmed]
PHST- 2022/06/25 06:00 [medline]
AID - S2254-8874(22)00047-9 [pii]
AID - 10.1016/j.rceng.2022.05.001 [doi]
PST - aheadofprint
SO  - Rev Clin Esp (Barc). 2022 Jun 21. pii: S2254-8874(22)00047-9. doi:10.1016/j.rceng.2022.05.001.

PMID- 35750272
OWN - NLM
STAT- Publisher
LR  - 20220804
IS  - 1873-0442 (Electronic)
IS  - 1477-8939 (Linking)
VI  - 49
DP  - 2022 Jun 21
TI  - Monkeypox and human transmission: Are we on the verge of another pandemic?
PG  - 102387
LID - S1477-8939(22)00133-8 [pii]
LID - 10.1016/j.tmaid.2022.102387 [doi]
FAU - Farahat, Ramadan Abdelmoez
AU  - Farahat RA
AD  - Faculty of Medicine, Kafrelsheikh University, Kafrelsheikh, 33511, Egypt.Electronic address: ramadan.med_2587@med.kfs.edu.eg.
FAU - Ali, Iftikhar
AU  - Ali I
AD  - Department of Pharmacy, Paraplegic Center, Peshawar, Pakistan. Electronicaddress: iftikharalijan@gmail.com.
FAU - Al-Ahdal, Tareq
AU  - Al-Ahdal T
AD  - Institute of Global Health, Heidelberg University, Heidelberg, Germany.Electronic address: talahda1@asu.edu.
FAU - Benmelouka, Amira Yasmine
AU  - Benmelouka AY
AD  - Faculty of Medicine, University of Algiers, Algiers, 16000, Algeria. Electronicaddress: amira.yasmine.benmelouka@gmail.com.
FAU - Albakri, Khaled
AU  - Albakri K
AD  - Faculty of Medicine, The Hashemite University, Zarqa, Jordan. Electronic address:Khaledalbakri1999@gmail.com.
FAU - El-Sakka, Amro A
AU  - El-Sakka AA
AD  - Faculty of Medicine, Suez Canal University, Ismailia, 41511, Egypt. Electronicaddress: amroelsakka@gmail.com.
FAU - Abdelaal, Abdelaziz
AU  - Abdelaal A
AD  - Harvard Medical School, Boston, MA, 02115, USA; Boston University, MA, 02215,USA; Tanta University Hospitals, 31516, Egypt. Electronic address:abdelaziz30839407@med.tanta.edu.eg.
FAU - Abdelazeem, Basel
AU  - Abdelazeem B
AD  - Department of Internal Medicine, McLaren Health Care, Flint, 48532, Michigan,USA; Department of Internal Medicine, Michigan State University, East Lansing,48823, Michigan, USA. Electronic address: baselelramly@gmail.com.
FAU - Anwar, Mohammed Moustapha
AU  - Anwar MM
AD  - Department of Biotechnology, Institute of Graduate Studies and Research (IGSR),Alexandria University, Alexandria, Egypt. Electronic address:igsr.dr.mohamedanwar@alexu.edu.eg.
FAU - Mehta, Rachana
AU  - Mehta R
AD  - National Public Health Laboratory (NPHL), Kathmandu, Nepal. Electronic address:mehtarachana89@gmail.com.
FAU - Sah, Ranjana
AU  - Sah R
AD  - Kirtipur Hospital, Kathmandu, Nepal. Electronic address: shahranu22@gmail.com.
FAU - Rouniyar, Ramhari
AU  - Rouniyar R
AD  - Nepalese Army Institute of Health Science-college of Medicine, Kathmandu, Nepal. Electronic address: ramharirouniyar@gmail.com.
FAU - Sah, Ranjit
AU  - Sah R
AD  - Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal. Electronic address: ranjitsah@iom.edu.np.
LA  - eng
PT  - Journal Article
DEP - 20220621
PL  - Netherlands
TA  - Travel Med Infect Dis
JT  - Travel medicine and infectious disease
JID - 101230758
SB  - IM
EDAT- 2022/06/25 06:00
MHDA- 2022/06/25 06:00
CRDT- 2022/06/24 19:24
PHST- 2022/06/13 00:00 [received]
PHST- 2022/06/16 00:00 [accepted]
PHST- 2022/06/25 06:00 [pubmed]
PHST- 2022/06/25 06:00 [medline]
PHST- 2022/06/24 19:24 [entrez]
AID - S1477-8939(22)00133-8 [pii]
AID - 10.1016/j.tmaid.2022.102387 [doi]
PST - aheadofprint
SO  - Travel Med Infect Dis. 2022 Jun 21;49:102387. doi: 10.1016/j.tmaid.2022.102387.

PMID- 35750157
OWN - NLM
STAT- Publisher
LR  - 20220719
IS  - 1546-170X (Electronic)
IS  - 1078-8956 (Linking)
DP  - 2022 Jun 24
TI  - Phylogenomic characterization and signs of microevolution in the 2022multi-country outbreak of monkeypox virus.
LID - 10.1038/s41591-022-01907-y [doi]
AB  - The largest monkeypox virus (MPXV) outbreak described so far in non-endemiccountries was identified in May 2022 (refs. (1-6)). In this study, shotgunmetagenomics allowed the rapid reconstruction and phylogenomic characterizationof the first MPXV outbreak genome sequences, showing that this MPXV belongs toclade 3 and that the outbreak most likely has a single origin. Although 2022 MPXV(lineage B.1) clustered with 2018-2019 cases linked to an endemic country, itsegregates in a divergent phylogenetic branch, likely reflecting continuousaccelerated evolution. An in-depth mutational analysis suggests the action ofhost APOBEC3 in viral evolution as well as signs of potential MPXV humanadaptation in ongoing microevolution. Our findings also indicate that genomesequencing may provide resolution to track the spread and transmission of thispresumably slow-evolving double-stranded DNA virus.
CI  - (c) 2022. The Author(s).
FAU - Isidro, Joana
AU  - Isidro J
AD  - Genomics and Bioinformatics Unit, Department of Infectious Diseases, NationalInstitute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
FAU - Borges, Vitor
AU  - Borges V
AD  - Genomics and Bioinformatics Unit, Department of Infectious Diseases, NationalInstitute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
FAU - Pinto, Miguel
AU  - Pinto M
AD  - Genomics and Bioinformatics Unit, Department of Infectious Diseases, NationalInstitute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
FAU - Sobral, Daniel
AU  - Sobral D
AUID- ORCID: http://orcid.org/0000-0003-3955-0117
AD  - Genomics and Bioinformatics Unit, Department of Infectious Diseases, NationalInstitute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
FAU - Santos, Joao Dourado
AU  - Santos JD
AD  - Genomics and Bioinformatics Unit, Department of Infectious Diseases, NationalInstitute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
FAU - Nunes, Alexandra
AU  - Nunes A
AUID- ORCID: http://orcid.org/0000-0001-6449-8053
AD  - Genomics and Bioinformatics Unit, Department of Infectious Diseases, NationalInstitute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
FAU - Mixao, Veronica
AU  - Mixao V
AD  - Genomics and Bioinformatics Unit, Department of Infectious Diseases, NationalInstitute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
FAU - Ferreira, Rita
AU  - Ferreira R
AD  - Genomics and Bioinformatics Unit, Department of Infectious Diseases, NationalInstitute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
FAU - Santos, Daniela
AU  - Santos D
AD  - Technology and Innovation Unit, Department of Human Genetics, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
FAU - Duarte, Silvia
AU  - Duarte S
AD  - Technology and Innovation Unit, Department of Human Genetics, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
FAU - Vieira, Luis
AU  - Vieira L
AD  - Technology and Innovation Unit, Department of Human Genetics, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
FAU - Borrego, Maria Jose
AU  - Borrego MJ
AD  - National Reference Laboratory of Sexually Transmitted Infections, Department ofInfectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA),Lisbon, Portugal.
FAU - Nuncio, Sofia
AU  - Nuncio S
AD  - Emergency Response and Biopreparedness Unit, Department of Infectious Diseases,National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
FAU - de Carvalho, Isabel Lopes
AU  - de Carvalho IL
AD  - Emergency Response and Biopreparedness Unit, Department of Infectious Diseases,National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
FAU - Pelerito, Ana
AU  - Pelerito A
AD  - Emergency Response and Biopreparedness Unit, Department of Infectious Diseases,National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
FAU - Cordeiro, Rita
AU  - Cordeiro R
AD  - Emergency Response and Biopreparedness Unit, Department of Infectious Diseases,National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.
FAU - Gomes, Joao Paulo
AU  - Gomes JP
AUID- ORCID: http://orcid.org/0000-0002-2697-2399
AD  - Genomics and Bioinformatics Unit, Department of Infectious Diseases, NationalInstitute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.j.paulo.gomes@insa.min-saude.pt.
AD  - Faculty of Veterinary Medicine, Lusofona University, Lisbon, Portugal.j.paulo.gomes@insa.min-saude.pt.
LA  - eng
PT  - Journal Article
DEP - 20220624
PL  - United States
TA  - Nat Med
JT  - Nature medicine
JID - 9502015
SB  - IM
EDAT- 2022/06/25 06:00
MHDA- 2022/06/25 06:00
CRDT- 2022/06/24 19:14
PHST- 2022/05/27 00:00 [received]
PHST- 2022/06/20 00:00 [accepted]
PHST- 2022/06/25 06:00 [pubmed]
PHST- 2022/06/25 06:00 [medline]
PHST- 2022/06/24 19:14 [entrez]
AID - 10.1038/s41591-022-01907-y [doi]
AID - 10.1038/s41591-022-01907-y [pii]
PST - aheadofprint
SO  - Nat Med. 2022 Jun 24. pii: 10.1038/s41591-022-01907-y. doi:10.1038/s41591-022-01907-y.

PMID- 35750071
OWN - NLM
STAT- MEDLINE
LR  - 20220707
IS  - 1474-547X (Electronic)
IS  - 0140-6736 (Linking)
VI  - 400
IP  - 10345
DP  - 2022 Jul 2
TI  - Guidelines for pregnant individuals with monkeypox virus exposure.
PG  - 21-22
LID - S0140-6736(22)01063-7 [pii]
LID - 10.1016/S0140-6736(22)01063-7 [doi]
FAU - Dashraath, Pradip
AU  - Dashraath P
AD  - Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology,National University Hospital, Singapore; Yong Loo Lin School of Medicine,National University of Singapore, Singapore.
FAU - Nielsen-Saines, Karin
AU  - Nielsen-Saines K
AD  - Division of Pediatric Infectious Diseases, Department of Pediatrics, David GeffenSchool of Medicine, UCLA, Los Angeles, CA, USA.
FAU - Mattar, Citra
AU  - Mattar C
AD  - Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology,National University Hospital, Singapore; Yong Loo Lin School of Medicine,National University of Singapore, Singapore.
FAU - Musso, Didier
AU  - Musso D
AD  - Aix Marseille Universite, IRD, AP-HM, SSA, VITROME, IHU - Mediterranee infection,Marseille, France; Laboratoire Eurofins Labazur Guyane, French Guiana.
FAU - Tambyah, Paul
AU  - Tambyah P
AD  - Yong Loo Lin School of Medicine, National University of Singapore, Singapore;Division of Infectious Diseases, Department of Medicine, National UniversityHospital, Singapore.
FAU - Baud, David
AU  - Baud D
AD  - Materno-fetal and Obstetrics Research Unit, Department Woman-Mother-Child,Lausanne University Hospital (CHUV), 1011 Lausanne, Switzerland. Electronicaddress: david.baud@chuv.ch.
LA  - eng
PT  - Journal Article
DEP - 20220621
PL  - England
TA  - Lancet
JT  - Lancet (London, England)
JID - 2985213R
SB  - IM
MH  - Animals
MH  - Female
MH  - Humans
MH  - *Monkeypox/epidemiology/prevention & control
MH  - *Monkeypox virus
MH  - Pregnancy
EDAT- 2022/06/25 06:00
MHDA- 2022/07/08 06:00
CRDT- 2022/06/24 19:03
PHST- 2022/05/24 00:00 [received]
PHST- 2022/06/01 00:00 [revised]
PHST- 2022/06/06 00:00 [accepted]
PHST- 2022/06/25 06:00 [pubmed]
PHST- 2022/07/08 06:00 [medline]
PHST- 2022/06/24 19:03 [entrez]
AID - S0140-6736(22)01063-7 [pii]
AID - 10.1016/S0140-6736(22)01063-7 [doi]
PST - ppublish
SO  - Lancet. 2022 Jul 2;400(10345):21-22. doi: 10.1016/S0140-6736(22)01063-7. Epub2022 Jun 21.

PMID- 35749419
OWN - NLM
STAT- MEDLINE
DCOM- 20220628
LR  - 20220716
IS  - 1678-9946 (Electronic)
IS  - 0036-4665 (Linking)
VI  - 64
DP  - 2022
TI  - Shotgun metagenomic sequencing of the first case of monkeypox virus in Brazil,2022.
PG  - e48
LID - S0036-46652022000100224 [pii]
LID - 10.1590/S1678-9946202264048 [doi]
AB  - Monkeypox virus (MPXV), a zoonotic virus endemic to the African continent, hasbeen reported in 33 non-endemic countries since May 2022. We report an almostcomplete genome of the first confirmed case of MPXV in Brazil. Shotgunmetagenomic sequencing was completed in 18 hours, from DNA extraction toconsensus sequence generation.
FAU - Claro, Ingra Morales
AU  - Claro IM
AUID- ORCID: http://orcid.org/0000-0001-8637-2910
AD  - Universidade de Sao Paulo, Faculdade de Medicina, Instituto de Medicina Tropical de Sao Paulo, Sao Paulo, Sao Paulo, Brazil.
AD  - Imperial College London, MRC Centre for Global Infectious Disease Analysis,London, United Kingdom.
FAU - Romano, Camila Malta
AU  - Romano CM
AUID- ORCID: http://orcid.org/0000-0003-4550-1987
AD  - Universidade de Sao Paulo, Faculdade de Medicina, Instituto de Medicina Tropical de Sao Paulo, Sao Paulo, Sao Paulo, Brazil.
FAU - Candido, Darlan da Silva
AU  - Candido DDS
AD  - Universidade de Sao Paulo, Faculdade de Medicina, Instituto de Medicina Tropical de Sao Paulo, Sao Paulo, Sao Paulo, Brazil.
AD  - Imperial College London, MRC Centre for Global Infectious Disease Analysis,London, United Kingdom.
AD  - University of Oxford, Department of Zoology, Oxford, United Kingdom.
FAU - Lima, Evelyn Lepka de
AU  - Lima EL
AD  - Instituto de Infectologia Emilio Ribas, Sao Paulo, Sao Paulo, Brazil.
FAU - Lindoso, Jose Angelo Lauletta
AU  - Lindoso JAL
AUID- ORCID: http://orcid.org/0000-0002-4405-4401
AD  - Universidade de Sao Paulo, Faculdade de Medicina, Instituto de Medicina Tropical de Sao Paulo, Sao Paulo, Sao Paulo, Brazil.
AD  - Instituto de Infectologia Emilio Ribas, Sao Paulo, Sao Paulo, Brazil.
AD  - Universidade de Sao Paulo, Faculdade de Medicina, Departamento de MolestiasInfecciosas e Parasitarias, Sao Paulo, Sao Paulo, Brazil.
FAU - Ramundo, Mariana Severo
AU  - Ramundo MS
AD  - Universidade de Sao Paulo, Faculdade de Medicina, Instituto de Medicina Tropical de Sao Paulo, Sao Paulo, Sao Paulo, Brazil.
FAU - Moreira, Filipe Romero Rebello
AU  - Moreira FRR
AD  - Imperial College London, MRC Centre for Global Infectious Disease Analysis,London, United Kingdom.
AD  - Universidade Federal do Rio de Janeiro, Instituto de Biologia, Departamento deGenetica, Rio de Janeiro, Rio de Janeiro, Brazil.
FAU - Barra, Luiz Alberto Costa
AU  - Barra LAC
AD  - Instituto de Infectologia Emilio Ribas, Sao Paulo, Sao Paulo, Brazil.
FAU - Borges, Luciana Marques Sansao
AU  - Borges LMS
AD  - Instituto de Infectologia Emilio Ribas, Sao Paulo, Sao Paulo, Brazil.
FAU - Medeiros, Lucas Alberto
AU  - Medeiros LA
AD  - Instituto de Infectologia Emilio Ribas, Sao Paulo, Sao Paulo, Brazil.
FAU - Tomishige, Marcia Y S
AU  - Tomishige MYS
AD  - Instituto de Infectologia Emilio Ribas, Sao Paulo, Sao Paulo, Brazil.
FAU - Moutinho, Tomas
AU  - Moutinho T
AUID- ORCID: http://orcid.org/0000-0002-0375-1366
AD  - Universidade de Sao Paulo, Faculdade de Medicina, Departamento de MolestiasInfecciosas e Parasitarias, Sao Paulo, Sao Paulo, Brazil.
FAU - Silva, Anderson Jose Dias da
AU  - Silva AJDD
AD  - Instituto de Infectologia Emilio Ribas, Sao Paulo, Sao Paulo, Brazil.
FAU - Rodrigues, Camila Cristina Martini
AU  - Rodrigues CCM
AD  - Instituto de Infectologia Emilio Ribas, Sao Paulo, Sao Paulo, Brazil.
FAU - Azevedo, Luiz Cesar Fernandes de
AU  - Azevedo LCF
AD  - Instituto de Infectologia Emilio Ribas, Sao Paulo, Sao Paulo, Brazil.
FAU - Villas-Boas, Lucy Santos
AU  - Villas-Boas LS
AD  - Universidade de Sao Paulo, Faculdade de Medicina, Instituto de Medicina Tropical de Sao Paulo, Sao Paulo, Sao Paulo, Brazil.
FAU - Silva, Camila Alves Maia da
AU  - Silva CAMD
AUID- ORCID: http://orcid.org/0000-0002-4298-6782
AD  - Universidade de Sao Paulo, Faculdade de Medicina, Instituto de Medicina Tropical de Sao Paulo, Sao Paulo, Sao Paulo, Brazil.
FAU - Coletti, Thais Moura
AU  - Coletti TM
AD  - Universidade de Sao Paulo, Faculdade de Medicina, Instituto de Medicina Tropical de Sao Paulo, Sao Paulo, Sao Paulo, Brazil.
FAU - Manuli, Erika R
AU  - Manuli ER
AUID- ORCID: http://orcid.org/0000-0003-2376-8488
AD  - Universidade de Sao Paulo, Faculdade de Medicina, Instituto de Medicina Tropical de Sao Paulo, Sao Paulo, Sao Paulo, Brazil.
FAU - O'Toole, Aine
AU  - O'Toole A
AD  - University of Edinburgh, Institute of Ecology and Evolution, Edinburgh, UnitedKingdom.
FAU - Quick, Joshua
AU  - Quick J
AD  - University of Birmingham, School of Biosciences, Birmingham, United Kingdom.
FAU - Loman, Nicholas
AU  - Loman N
AD  - University of Birmingham, School of Biosciences, Birmingham, United Kingdom.
FAU - Rambaut, Andrew
AU  - Rambaut A
AD  - University of Edinburgh, Institute of Ecology and Evolution, Edinburgh, UnitedKingdom.
FAU - Faria, Nuno R
AU  - Faria NR
AD  - Universidade de Sao Paulo, Faculdade de Medicina, Instituto de Medicina Tropical de Sao Paulo, Sao Paulo, Sao Paulo, Brazil.
AD  - Imperial College London, MRC Centre for Global Infectious Disease Analysis,London, United Kingdom.
AD  - University of Oxford, Department of Zoology, Oxford, United Kingdom.
FAU - Figueiredo-Mello, Claudia
AU  - Figueiredo-Mello C
AD  - Instituto de Infectologia Emilio Ribas, Sao Paulo, Sao Paulo, Brazil.
FAU - Sabino, Ester Cerdeira
AU  - Sabino EC
AUID- ORCID: http://orcid.org/0000-0003-2623-5126
AD  - Universidade de Sao Paulo, Faculdade de Medicina, Instituto de Medicina Tropical de Sao Paulo, Sao Paulo, Sao Paulo, Brazil.
LA  - eng
GR  - WT_/Wellcome Trust/United Kingdom
PT  - Case Reports
PT  - Journal Article
DEP - 20220624
PL  - Brazil
TA  - Rev Inst Med Trop Sao Paulo
JT  - Revista do Instituto de Medicina Tropical de Sao Paulo
JID - 7507484
SB  - IM
MH  - Brazil
MH  - Humans
MH  - Metagenomics
MH  - *Monkeypox/diagnosis/epidemiology
MH  - *Monkeypox virus/genetics
PMC - PMC9217064
EDAT- 2022/06/25 06:00
MHDA- 2022/06/29 06:00
CRDT- 2022/06/24 13:44
PHST- 2022/06/16 00:00 [received]
PHST- 2022/06/20 00:00 [accepted]
PHST- 2022/06/24 13:44 [entrez]
PHST- 2022/06/25 06:00 [pubmed]
PHST- 2022/06/29 06:00 [medline]
AID - S0036-46652022000100224 [pii]
AID - 10.1590/S1678-9946202264048 [doi]
PST - epublish
SO  - Rev Inst Med Trop Sao Paulo. 2022 Jun 24;64:e48. doi:10.1590/S1678-9946202264048. eCollection 2022.

PMID- 35748084
OWN - NLM
STAT- Publisher
LR  - 20220624
IS  - 1399-3062 (Electronic)
IS  - 1398-2273 (Linking)
DP  - 2022 Jun 24
TI  - Monkey pox and transplant recipient: Current issue in transplantation medicine.
LID - 10.1111/tid.13884 [doi]
FAU - Mungmunpuntipantip, Rujittika
AU  - Mungmunpuntipantip R
AUID- ORCID: https://orcid.org/0000-0003-0078-7897
AD  - Private Academic Consultant, Bangkok, Thailand.
FAU - Wiwanitkit, Viroj
AU  - Wiwanitkit V
AUID- ORCID: https://orcid.org/0000-0003-1039-3728
AD  - Adjunct professor, Joseph Ayobaalola University, Ikeji-Arakeji, Nigeria.
AD  - Honorary professor, Dr DY Patil University, Pune, India.
AD  - visiting professor, Faculty of Medicine, University of Nis, Serbia.
LA  - eng
PT  - Letter
DEP - 20220624
PL  - Denmark
TA  - Transpl Infect Dis
JT  - Transplant infectious disease : an official journal of the TransplantationSociety
JID - 100883688
SB  - IM
OTO - NOTNLM
OT  - liver
OT  - monkey pox
OT  - presentation
OT  - transaminase
EDAT- 2022/06/25 06:00
MHDA- 2022/06/25 06:00
CRDT- 2022/06/24 03:33
PHST- 2022/05/31 00:00 [received]
PHST- 2022/06/02 00:00 [accepted]
PHST- 2022/06/24 03:33 [entrez]
PHST- 2022/06/25 06:00 [pubmed]
PHST- 2022/06/25 06:00 [medline]
AID - 10.1111/tid.13884 [doi]
PST - aheadofprint
SO  - Transpl Infect Dis. 2022 Jun 24. doi: 10.1111/tid.13884.

PMID- 35746754
OWN - NLM
STAT- MEDLINE
DCOM- 20220627
LR  - 20220721
IS  - 1999-4915 (Electronic)
IS  - 1999-4915 (Linking)
VI  - 14
IP  - 6
DP  - 2022 Jun 13
TI  - Travel-Related Monkeypox Outbreaks in the Era of COVID-19 Pandemic: Are WePrepared?
LID - 1283 [pii]
LID - 10.3390/v14061283 [doi]
AB  - Several neglected infectious pathogens, such as the monkeypox virus (MPXV), have re-emerged in the last few decades, becoming a global health burden. Despite the incipient vaccine against MPXV infection, the global incidence of travel-related outbreaks continues to rise. About 472 confirmed cases have been reported in 27countries as of 31 May 2022, the largest recorded number of cases outside Africa since the disease was discovered in the early 1970s.
FAU - Adegboye, Oyelola A
AU  - Adegboye OA
AUID- ORCID: 0000-0002-9793-8024
AD  - Public Health & Tropical Medicine, College of Public Health, Medical andVeterinary Sciences, James Cook University, Townsville, QLD 4811, Australia.
AD  - World Health Organization Collaborating Center for Vector-Borne and NeglectedTropical Diseases, College of Public Health, Medical and Veterinary Sciences,James Cook University, Townsville, QLD 4811, Australia.
AD  - Australian Institute of Tropical Health and Medicine, James Cook University,Townsville, QLD 4811, Australia.
FAU - Eugenia Castellanos, Maria
AU  - Eugenia Castellanos M
AUID- ORCID: 0000-0002-8181-6321
AD  - Public Health & Tropical Medicine, College of Public Health, Medical andVeterinary Sciences, James Cook University, Townsville, QLD 4811, Australia.
AD  - World Health Organization Collaborating Center for Vector-Borne and NeglectedTropical Diseases, College of Public Health, Medical and Veterinary Sciences,James Cook University, Townsville, QLD 4811, Australia.
AD  - Australian Institute of Tropical Health and Medicine, James Cook University,Townsville, QLD 4811, Australia.
FAU - Alele, Faith O
AU  - Alele FO
AUID- ORCID: 0000-0001-5570-3641
AD  - Public Health & Tropical Medicine, College of Public Health, Medical andVeterinary Sciences, James Cook University, Townsville, QLD 4811, Australia.
AD  - Australian Institute of Tropical Health and Medicine, James Cook University,Townsville, QLD 4811, Australia.
FAU - Pak, Anton
AU  - Pak A
AUID- ORCID: 0000-0002-1813-5873
AD  - Centre for the Business and Economics of Health, The University of Queensland,Brisbane, QLD 4067, Australia.
FAU - Ezechukwu, Henry C
AU  - Ezechukwu HC
AUID- ORCID: 0000-0001-6198-120X
AD  - Department of Medical Biochemistry, Eko University of Medicine and HealthSciences, Ijanikin 102004, Lagos State, Nigeria.
FAU - Hou, Kay
AU  - Hou K
AUID- ORCID: 0000-0002-5997-3830
AD  - College of Medicine and Dentistry, James Cook University, Townsville, QLD 4811,Australia.
FAU - Emeto, Theophilus I
AU  - Emeto TI
AUID- ORCID: 0000-0002-3282-1861
AD  - Public Health & Tropical Medicine, College of Public Health, Medical andVeterinary Sciences, James Cook University, Townsville, QLD 4811, Australia.
AD  - World Health Organization Collaborating Center for Vector-Borne and NeglectedTropical Diseases, College of Public Health, Medical and Veterinary Sciences,James Cook University, Townsville, QLD 4811, Australia.
AD  - Australian Institute of Tropical Health and Medicine, James Cook University,Townsville, QLD 4811, Australia.
LA  - eng
PT  - Journal Article
DEP - 20220613
PL  - Switzerland
TA  - Viruses
JT  - Viruses
JID - 101509722
SB  - IM
MH  - Animals
MH  - *COVID-19/epidemiology
MH  - Disease Outbreaks
MH  - Humans
MH  - *Monkeypox/epidemiology
MH  - Monkeypox virus
MH  - Pandemics/prevention & control
MH  - Travel
MH  - Travel-Related Illness
PMC - PMC9228578
OTO - NOTNLM
OT  - *COVID-19
OT  - *communicable disease control
OT  - *monkeypox
OT  - *orthopoxvirus
OT  - *travel medicine
EDAT- 2022/06/25 06:00
MHDA- 2022/06/28 06:00
CRDT- 2022/06/24 01:43
PHST- 2022/05/21 00:00 [received]
PHST- 2022/06/02 00:00 [revised]
PHST- 2022/06/10 00:00 [accepted]
PHST- 2022/06/24 01:43 [entrez]
PHST- 2022/06/25 06:00 [pubmed]
PHST- 2022/06/28 06:00 [medline]
AID - v14061283 [pii]
AID - 10.3390/v14061283 [doi]
PST - epublish
SO  - Viruses. 2022 Jun 13;14(6). pii: v14061283. doi: 10.3390/v14061283.

PMID- 35739391
OWN - NLM
STAT- MEDLINE
DCOM- 20220707
LR  - 20220708
IS  - 1476-4687 (Electronic)
IS  - 0028-0836 (Linking)
VI  - 607
IP  - 7917
DP  - 2022 Jul
TI  - Monkeypox in Africa: the science the world ignored.
PG  - 17-18
LID - 10.1038/d41586-022-01686-z [doi]
FAU - Kozlov, Max
AU  - Kozlov M
LA  - eng
PT  - News
PT  - Comment
PL  - England
TA  - Nature
JT  - Nature
JID - 0410462
SB  - IM
CON - Lancet Infect Dis. 2019 Aug;19(8):872-879. PMID: 31285143
MH  - Africa/epidemiology
MH  - Animals
MH  - *Biomedical Research
MH  - Humans
MH  - *Monkeypox/epidemiology/prevention & control
OTO - NOTNLM
OT  - *Diseases
OT  - *Public health
OT  - *Virology
EDAT- 2022/06/24 06:00
MHDA- 2022/07/08 06:00
CRDT- 2022/06/23 23:34
PHST- 2022/06/24 06:00 [pubmed]
PHST- 2022/07/08 06:00 [medline]
PHST- 2022/06/23 23:34 [entrez]
AID - 10.1038/d41586-022-01686-z [doi]
AID - 10.1038/d41586-022-01686-z [pii]
PST - ppublish
SO  - Nature. 2022 Jul;607(7917):17-18. doi: 10.1038/d41586-022-01686-z.

PMID- 35738529
OWN - NLM
STAT- Publisher
LR  - 20220804
IS  - 1873-0442 (Electronic)
IS  - 1477-8939 (Linking)
VI  - 49
DP  - 2022 Jun 20
TI  - New challenges in human monkeypox outside Africa: A review and case report fromItaly.
PG  - 102386
LID - S1477-8939(22)00132-6 [pii]
LID - 10.1016/j.tmaid.2022.102386 [doi]
AB  - BACKGROUND: Human monkeypox (MPX) is a neglected zoonotic disease caused by theMPX virus a double-stranded DNA virus which belongs to the Poxviridae familygenus Orthopoxvirus. It is endemic in the rural rainforests of Central andWestern Africa where it is responsible of human sporadic cases and outbreakssince 1970. Outside Africa MPXV caused an outbreak in 2003 in the United Stateslinked to importation of infected rodents from Ghana and a few travel-relatedcases in the USA, United Kingdom, Israel and Singapore. Actually, a worldwideoutbreak with more than 1200 confirmed cases mainly concentrated among men whohave sex with men is ongoing. CASE REPORT: We present the case of an Italian man living in Portugal that was diagnosed with MPX at our clinic in Milan, Italy.Monkeypox virus infection was confirmed by a specific homemade Real-Time PCR.Samples obtained from different sites (pharynx, skin lesions, anal ulcer, seminalfluid) turned all positive with different viral load. CONCLUSIONS: Our reportillustrates the challenge of a disease that seems to present in a different wayfrom classic description with possible human-to-human transmission through sexualcontact.
CI  - Copyright (c) 2022 Elsevier Ltd. All rights reserved.
FAU - Mileto, Davide
AU  - Mileto D
AD  - Clinical Microbiology, Virology and Bioemergency Diagnostics, ASSTFatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy.
FAU - Riva, Agostino
AU  - Riva A
AD  - Department of Biomedical and Clinical Sciences, Universita Degli Studi di Milano,Italy; III Division of Infectious Diseases, ASST Fatebenefratelli Sacco, LuigiSacco Hospital, Milan, Italy.
FAU - Cutrera, Miriam
AU  - Cutrera M
AD  - Clinical Microbiology, Virology and Bioemergency Diagnostics, ASSTFatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy.
FAU - Moschese, Davide
AU  - Moschese D
AD  - I Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Luigi SaccoHospital, Milan, Italy.
FAU - Mancon, Alessandro
AU  - Mancon A
AD  - Clinical Microbiology, Virology and Bioemergency Diagnostics, ASSTFatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy.
FAU - Meroni, Luca
AU  - Meroni L
AD  - III Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Luigi SaccoHospital, Milan, Italy.
FAU - Giacomelli, Andrea
AU  - Giacomelli A
AD  - III Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Luigi SaccoHospital, Milan, Italy.
FAU - Bestetti, Giovanna
AU  - Bestetti G
AD  - III Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Luigi SaccoHospital, Milan, Italy.
FAU - Rizzardini, Giuliano
AU  - Rizzardini G
AD  - I Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Luigi SaccoHospital, Milan, Italy.
FAU - Gismondo, Maria Rita
AU  - Gismondo MR
AD  - Clinical Microbiology, Virology and Bioemergency Diagnostics, ASSTFatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy; Department ofBiomedical and Clinical Sciences, Universita Degli Studi di Milano, Italy.
FAU - Antinori, Spinello
AU  - Antinori S
AD  - Department of Biomedical and Clinical Sciences, Universita Degli Studi di Milano,Italy; III Division of Infectious Diseases, ASST Fatebenefratelli Sacco, LuigiSacco Hospital, Milan, Italy. Electronic address: spinello.antinori@unimi.it.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20220620
PL  - Netherlands
TA  - Travel Med Infect Dis
JT  - Travel medicine and infectious disease
JID - 101230758
SB  - IM
OTO - NOTNLM
OT  - Diagnosis
OT  - HIV
OT  - Italy
OT  - Monkeypox
OT  - Outbreak
EDAT- 2022/06/24 06:00
MHDA- 2022/06/24 06:00
CRDT- 2022/06/23 19:26
PHST- 2022/06/09 00:00 [received]
PHST- 2022/06/13 00:00 [revised]
PHST- 2022/06/16 00:00 [accepted]
PHST- 2022/06/24 06:00 [pubmed]
PHST- 2022/06/24 06:00 [medline]
PHST- 2022/06/23 19:26 [entrez]
AID - S1477-8939(22)00132-6 [pii]
AID - 10.1016/j.tmaid.2022.102386 [doi]
PST - aheadofprint
SO  - Travel Med Infect Dis. 2022 Jun 20;49:102386. doi: 10.1016/j.tmaid.2022.102386.

PMID- 35737802
OWN - NLM
STAT- MEDLINE
DCOM- 20220627
LR  - 20220629
IS  - 1095-9203 (Electronic)
IS  - 0036-8075 (Linking)
VI  - 376
IP  - 6600
DP  - 2022 Jun 24
TI  - Why monkeypox is mostly hitting men who have sex with men.
PG  - 1364-1365
LID - 10.1126/science.add5966 [doi]
AB  - The once slow spreading virus may have found a new niche in tightly connectedsexual networks.
FAU - Kupferschmidt, Kai
AU  - Kupferschmidt K
LA  - eng
PT  - News
DEP - 20220623
PL  - United States
TA  - Science
JT  - Science (New York, N.Y.)
JID - 0404511
SB  - IM
MH  - *Homosexuality, Male
MH  - Humans
MH  - Male
MH  - *Monkeypox/epidemiology/prevention & control/transmission
MH  - *Monkeypox virus
MH  - Risk
MH  - Sex Factors
MH  - *Sexual and Gender Minorities
EDAT- 2022/06/24 06:00
MHDA- 2022/06/28 06:00
CRDT- 2022/06/23 14:04
PHST- 2022/06/23 14:04 [entrez]
PHST- 2022/06/24 06:00 [pubmed]
PHST- 2022/06/28 06:00 [medline]
AID - 10.1126/science.add5966 [doi]
PST - ppublish
SO  - Science. 2022 Jun 24;376(6600):1364-1365. doi: 10.1126/science.add5966. Epub 2022Jun 23.

PMID- 35736852
OWN - NLM
STAT- MEDLINE
DCOM- 20220627
LR  - 20220711
IS  - 0966-0461 (Print)
IS  - 0966-0461 (Linking)
VI  - 31
IP  - 12
DP  - 2022 Jun 23
TI  - The 2022 multinational monkeypox outbreak in non-endemic countries.
PG  - 664-665
LID - 10.12968/bjon.2022.31.12.664 [doi]
FAU - Hill, Barry
AU  - Hill B
AD  - Director of Education (Employability), Nursing, Midwifery and Health, NorthumbriaUniverity, Newcastle upon Tyne.
LA  - eng
PT  - Journal Article
PL  - England
TA  - Br J Nurs
JT  - British journal of nursing (Mark Allen Publishing)
JID - 9212059
MH  - Disease Outbreaks
MH  - Humans
MH  - *Monkeypox/epidemiology
EDAT- 2022/06/24 06:00
MHDA- 2022/06/28 06:00
CRDT- 2022/06/23 11:03
PHST- 2022/06/23 11:03 [entrez]
PHST- 2022/06/24 06:00 [pubmed]
PHST- 2022/06/28 06:00 [medline]
AID - 10.12968/bjon.2022.31.12.664 [doi]
PST - ppublish
SO  - Br J Nurs. 2022 Jun 23;31(12):664-665. doi: 10.12968/bjon.2022.31.12.664.

PMID- 35734647
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220716
IS  - 2049-0801 (Print)
IS  - 2049-0801 (Linking)
VI  - 78
DP  - 2022 Jun
TI  - Monkeypox in 2022: A new threat in developing.
PG  - 103975
LID - 10.1016/j.amsu.2022.103975 [doi]
AB  - Monkeypox that started spreading from central and western Africa has recentlybeen detected in various countries including Spain, Canada, Australia, and UAE.Though it has a very low incidence rate, it is still a significant threat thatmust be dealt with as quickly as possible and the probability of it spreading to many other countries is still very high. It is caused the by Monkeypox virus thatbelongs to the genus Orthopox that also include smallpox virus, which has quitesimilar clinical presentation as that of Monkeypox. With fading immunity against Smallpox, it is important to counter this threat with newly developed vaccines.
CI  - (c) 2022 The Authors. Published by Elsevier Ltd on behalf of IJS Publishing GroupLtd.
FAU - Ahmed, Mansoor
AU  - Ahmed M
AD  - Holy Family Hospital, Rawalpindi Medical University, New Teaching Block, RMU,Satellite Town, Rawalpindi, Punjab, 46000 , Pakistan.
FAU - Naseer, Haseena
AU  - Naseer H
AD  - Fauji Foundation Hospital, Foundation University Medical College, Defence Ave,DHA Phase-I Islamabad, Rawalpindi, Punjab, 44000 , Pakistan.
FAU - Arshad, Mateen
AU  - Arshad M
AD  - Holy Family Hospital, Rawalpindi Medical University, New Teaching Block, RMU,Satellite Town, Rawalpindi, Punjab, 46000 , Pakistan.
FAU - Ahmad, Afnan
AU  - Ahmad A
AD  - Holy Family Hospital, Rawalpindi Medical University, New Teaching Block, RMU,Satellite Town, Rawalpindi, Punjab, 46000 , Pakistan.
LA  - eng
PT  - Journal Article
DEP - 20220607
PL  - England
TA  - Ann Med Surg (Lond)
JT  - Annals of medicine and surgery (2012)
JID - 101616869
PMC - PMC9207131
OTO - NOTNLM
OT  - Monkey pox
OT  - Viral
OT  - Viral Zoonose
OT  - Zoonotic diseases
COIS- None to declare.
EDAT- 2022/06/24 06:00
MHDA- 2022/06/24 06:01
CRDT- 2022/06/23 02:46
PHST- 2022/05/31 00:00 [received]
PHST- 2022/06/05 00:00 [revised]
PHST- 2022/06/06 00:00 [accepted]
PHST- 2022/06/23 02:46 [entrez]
PHST- 2022/06/24 06:00 [pubmed]
PHST- 2022/06/24 06:01 [medline]
AID - 10.1016/j.amsu.2022.103975 [doi]
AID - S2049-0801(22)00735-X [pii]
PST - epublish
SO  - Ann Med Surg (Lond). 2022 Jun 7;78:103975. doi: 10.1016/j.amsu.2022.103975.eCollection 2022 Jun.

PMID- 35732718
OWN - NLM
STAT- Publisher
LR  - 20220627
IS  - 1476-4687 (Electronic)
IS  - 0028-0836 (Linking)
DP  - 2022 Jun 21
TI  - Daily briefing: How monkeypox might be spreading in sexual networks.
LID - 10.1038/d41586-022-01726-8 [doi]
FAU - Graham, Flora
AU  - Graham F
LA  - eng
PT  - News
DEP - 20220621
PL  - England
TA  - Nature
JT  - Nature
JID - 0410462
SB  - IM
EDAT- 2022/06/23 06:00
MHDA- 2022/06/23 06:00
CRDT- 2022/06/22 23:20
PHST- 2022/06/23 06:00 [pubmed]
PHST- 2022/06/23 06:00 [medline]
PHST- 2022/06/22 23:20 [entrez]
AID - 10.1038/d41586-022-01726-8 [doi]
AID - 10.1038/d41586-022-01726-8 [pii]
PST - aheadofprint
SO  - Nature. 2022 Jun 21. pii: 10.1038/d41586-022-01726-8. doi:10.1038/d41586-022-01726-8.

PMID- 35732317
OWN - NLM
STAT- MEDLINE
DCOM- 20220624
LR  - 20220711
IS  - 1756-1833 (Electronic)
IS  - 0959-8138 (Linking)
VI  - 377
DP  - 2022 Jun 22
TI  - Monkeypox: Gay and bisexual men with high exposure risk will be offered vaccinein England.
PG  - o1542
LID - 10.1136/bmj.o1542 [doi]
FAU - Mahase, Elisabeth
AU  - Mahase E
AD  - The BMJ.
LA  - eng
PT  - Journal Article
DEP - 20220622
PL  - England
TA  - BMJ
JT  - BMJ (Clinical research ed.)
JID - 8900488
RN  - 0 (Vaccines)
SB  - IM
MH  - Bisexuality
MH  - *HIV Infections
MH  - Homosexuality, Male
MH  - Humans
MH  - Male
MH  - *Monkeypox
MH  - Sexual Behavior
MH  - *Sexual and Gender Minorities
MH  - *Vaccines
EDAT- 2022/06/23 06:00
MHDA- 2022/06/25 06:00
CRDT- 2022/06/22 20:33
PHST- 2022/06/22 20:33 [entrez]
PHST- 2022/06/23 06:00 [pubmed]
PHST- 2022/06/25 06:00 [medline]
AID - 10.1136/bmj.o1542 [doi]
PST - epublish
SO  - BMJ. 2022 Jun 22;377:o1542. doi: 10.1136/bmj.o1542.

PMID- 35732260
OWN - NLM
STAT- Publisher
LR  - 20220804
IS  - 1743-9159 (Electronic)
IS  - 1743-9159 (Linking)
VI  - 104
DP  - 2022 Jun 19
TI  - Monkeypox virus (MPX) in humans a concern: Trespassing the global boundaries -Correspondence.
PG  - 106703
LID - S1743-9191(22)00480-0 [pii]
LID - 10.1016/j.ijsu.2022.106703 [doi]
FAU - Thakur, Vikram
AU  - Thakur V
AD  - Department of Virology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh 160012, India. Electronic address: vik5atif@gmail.com.
FAU - Thakur, Pryanka
AU  - Thakur P
AD  - Department of Virology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, 160012, India.
FAU - Srivastava, Sonakshi
AU  - Srivastava S
AD  - Department of Microbiology, All India Institute of Medical Sciences (AIIMS),Kalyani, West Bengal, 741245, India.
FAU - Kumar, Pradeep
AU  - Kumar P
AD  - Faculty of Applied Sciences and Biotechnology, Shoolini University ofBiotechnology and Management Sciences, Solan, 173229, India. Electronic address: pradeep.kumar@shooliniuniversity.com.
LA  - eng
PT  - Letter
DEP - 20220619
PL  - England
TA  - Int J Surg
JT  - International journal of surgery (London, England)
JID - 101228232
SB  - IM
EDAT- 2022/06/23 06:00
MHDA- 2022/06/23 06:00
CRDT- 2022/06/22 19:14
PHST- 2022/05/22 00:00 [received]
PHST- 2022/06/05 00:00 [accepted]
PHST- 2022/06/23 06:00 [pubmed]
PHST- 2022/06/23 06:00 [medline]
PHST- 2022/06/22 19:14 [entrez]
AID - S1743-9191(22)00480-0 [pii]
AID - 10.1016/j.ijsu.2022.106703 [doi]
PST - aheadofprint
SO  - Int J Surg. 2022 Jun 19;104:106703. doi: 10.1016/j.ijsu.2022.106703.

PMID- 35731477
OWN - NLM
STAT- MEDLINE
DCOM- 20220624
LR  - 20220714
IS  - 1613-3560 (Electronic)
IS  - 1438-3276 (Linking)
VI  - 164
IP  - Suppl 2
DP  - 2022 Jun
PG  - 10-11
LID - 10.1007/s15006-022-1252-x [doi]
FAU - Oberhofer, Elke
AU  - Oberhofer E
AD  - Springer Medizin Verlag GmbH, Aschauer Str. 30, 81549, Munchen, Germany.
LA  - ger
PT  - News
TT  - "Verdacht auf Affenpocken? Machen Sie eine Sexualanamnese!"
PL  - Germany
TA  - MMW Fortschr Med
JT  - MMW Fortschritte der Medizin
JID - 100893959
SB  - IM
MH  - Animals
MH  - Disease Outbreaks
MH  - Humans
MH  - *Monkeypox/epidemiology
MH  - Sexual Behavior
EDAT- 2022/06/23 06:00
MHDA- 2022/06/25 06:00
CRDT- 2022/06/22 11:32
PHST- 2022/06/22 11:32 [entrez]
PHST- 2022/06/23 06:00 [pubmed]
PHST- 2022/06/25 06:00 [medline]
AID - 10.1007/s15006-022-1252-x [doi]
AID - 10.1007/s15006-022-1252-x [pii]
PST - ppublish
SO  - MMW Fortschr Med. 2022 Jun;164(Suppl 2):10-11. doi: 10.1007/s15006-022-1252-x.

PMID- 35731398
OWN - NLM
STAT- MEDLINE
DCOM- 20220624
LR  - 20220715
IS  - 1613-3560 (Electronic)
IS  - 1438-3276 (Linking)
VI  - 164
IP  - 12
DP  - 2022 Jun
PG  - 31
LID - 10.1007/s15006-022-1255-7 [doi]
FAU - Zimmermann, Gerd W
AU  - Zimmermann GW
AD  - Facharzt fur Allgemeinmedizin, Kapellenstr. 9, 65719, Hofheim, Deutschland.
LA  - ger
PT  - Journal Article
TT  - Jetzt auf Affenpocken vorbereiten.
PL  - Germany
TA  - MMW Fortschr Med
JT  - MMW Fortschritte der Medizin
JID - 100893959
SB  - IM
MH  - Animals
MH  - Humans
MH  - *Monkeypox
EDAT- 2022/06/23 06:00
MHDA- 2022/06/25 06:00
CRDT- 2022/06/22 11:30
PHST- 2022/06/22 11:30 [entrez]
PHST- 2022/06/23 06:00 [pubmed]
PHST- 2022/06/25 06:00 [medline]
AID - 10.1007/s15006-022-1255-7 [doi]
AID - 10.1007/s15006-022-1255-7 [pii]
PST - ppublish
SO  - MMW Fortschr Med. 2022 Jun;164(12):31. doi: 10.1007/s15006-022-1255-7.

PMID- 35731176
OWN - NLM
STAT- MEDLINE
DCOM- 20220719
LR  - 20220719
IS  - 1468-3083 (Electronic)
IS  - 0926-9959 (Linking)
VI  - 36
IP  - 8
DP  - 2022 Aug
TI  - As monkeypox goes sexual: a public health perspective.
PG  - 1164-1166
LID - 10.1111/jdv.18301 [doi]
FAU - Brockmeyer, N H
AU  - Brockmeyer NH
AUID- ORCID: 0000-0002-0729-6006
AD  - WIR - Walk In Ruhr, Center for Sexual Health and Medicine, Bochum, Germany.
AD  - Interdisciplinary Immunological Outpatient Clinic, Center for Sexual Health andMedicine, Department of Dermatology, Venereology and Allergology, RuhrUniversitat Bochum, Bochum, Germany.
LA  - eng
PT  - Journal Article
DEP - 20220622
PL  - England
TA  - J Eur Acad Dermatol Venereol
JT  - Journal of the European Academy of Dermatology and Venereology : JEADV
JID - 9216037
SB  - IM
MH  - Animals
MH  - Disease Outbreaks
MH  - Humans
MH  - *Monkeypox/epidemiology
MH  - Public Health
MH  - Zoonoses
EDAT- 2022/06/23 06:00
MHDA- 2022/07/20 06:00
CRDT- 2022/06/22 10:23
PHST- 2022/05/30 00:00 [received]
PHST- 2022/06/03 00:00 [accepted]
PHST- 2022/06/23 06:00 [pubmed]
PHST- 2022/07/20 06:00 [medline]
PHST- 2022/06/22 10:23 [entrez]
AID - 10.1111/jdv.18301 [doi]
PST - ppublish
SO  - J Eur Acad Dermatol Venereol. 2022 Aug;36(8):1164-1166. doi: 10.1111/jdv.18301.Epub 2022 Jun 22.

PMID- 35730397
OWN - NLM
STAT- Publisher
LR  - 20220627
IS  - 1096-9071 (Electronic)
IS  - 0146-6615 (Linking)
DP  - 2022 Jun 22
TI  - Post-pandemic world at the mercy of monkeypox virus outbreak: Time to worry ornot?
LID - 10.1002/jmv.27948 [doi]
FAU - Taseen, Shafaq
AU  - Taseen S
AUID- ORCID: http://orcid.org/0000-0001-6253-3679
AD  - Department of medicine, Karachi Medical and Dental College, Karachi, Pakistan.
FAU - Nasir, Filza
AU  - Nasir F
AUID- ORCID: http://orcid.org/0000-0003-4553-8077
AD  - Department of medicine, Shaheed Mohtarma Benazir Bhutto Medical College, Karachi,Pakistan.
FAU - Abbas, Munib
AU  - Abbas M
AUID- ORCID: http://orcid.org/0000-0002-1057-7036
AD  - Department of medicine, Karachi Medical and Dental College, Karachi, Pakistan.
FAU - Altaf, Mahran
AU  - Altaf M
AD  - Department of medicine, Lahore General Hospital, Lahore, Pakistan.
FAU - Asghar, Muhammad Sohaib
AU  - Asghar MS
AUID- ORCID: https://orcid.org/0000-0001-6705-2030
AD  - Department of medicine, Dow University of Health Sciences-Ojha Campus, Karachi,Pakistan.
FAU - Tahir, Muhammad Junaid
AU  - Tahir MJ
AUID- ORCID: https://orcid.org/0000-0002-0335-6681
AD  - Department of medicine, Lahore General Hospital, Lahore, Pakistan.
LA  - eng
PT  - Journal Article
DEP - 20220622
PL  - United States
TA  - J Med Virol
JT  - Journal of medical virology
JID - 7705876
SB  - IM
OTO - NOTNLM
OT  - SARS-CoV-2
OT  - awareness
OT  - infection
OT  - monkeypox virus
OT  - outbreak
OT  - public health
EDAT- 2022/06/23 06:00
MHDA- 2022/06/23 06:00
CRDT- 2022/06/22 04:43
PHST- 2022/06/18 00:00 [revised]
PHST- 2022/05/29 00:00 [received]
PHST- 2022/06/20 00:00 [accepted]
PHST- 2022/06/23 06:00 [pubmed]
PHST- 2022/06/23 06:00 [medline]
PHST- 2022/06/22 04:43 [entrez]
AID - 10.1002/jmv.27948 [doi]
PST - aheadofprint
SO  - J Med Virol. 2022 Jun 22. doi: 10.1002/jmv.27948.

PMID- 35728695
OWN - NLM
STAT- Publisher
LR  - 20220716
IS  - 1532-2939 (Electronic)
IS  - 0195-6701 (Linking)
DP  - 2022 Jun 18
TI  - Efficacy of heat against the vaccinia virus, variola virus and monkeypox virus.
LID - S0195-6701(22)00196-7 [pii]
LID - 10.1016/j.jhin.2022.06.008 [doi]
FAU - Kampf, G
AU  - Kampf G
AD  - University Medicine Greifswald, Ferdinand-Sauerbruch-Strasse, 17475 Greifswald,Germany. Electronic address: guenter.kampf@uni-greifswald.de.
LA  - eng
PT  - Letter
DEP - 20220618
PL  - England
TA  - J Hosp Infect
JT  - The Journal of hospital infection
JID - 8007166
SB  - IM
EDAT- 2022/06/22 06:00
MHDA- 2022/06/22 06:00
CRDT- 2022/06/21 19:24
PHST- 2022/06/14 00:00 [received]
PHST- 2022/06/14 00:00 [accepted]
PHST- 2022/06/22 06:00 [pubmed]
PHST- 2022/06/22 06:00 [medline]
PHST- 2022/06/21 19:24 [entrez]
AID - S0195-6701(22)00196-7 [pii]
AID - 10.1016/j.jhin.2022.06.008 [doi]
PST - aheadofprint
SO  - J Hosp Infect. 2022 Jun 18. pii: S0195-6701(22)00196-7. doi:10.1016/j.jhin.2022.06.008.

PMID- 35726117
OWN - NLM
STAT- Publisher
LR  - 20220716
IS  - 2509-2723 (Electronic)
IS  - 2509-2723 (Linking)
DP  - 2022 Jun 20
TI  - Monkeypox: considerations for the understanding and containment of the currentoutbreak in non-endemic countries.
LID - 10.1007/s11357-022-00611-6 [doi]
AB  - The neglected and rare zoonotic disease caused by monkeypox virus (MPV) hasrecently spread widely, resulting in the largest known monkeypox outbreak outsideof Africa, where it is endemic. MPV belongs to the Poxviridae family, genusOrthopoxvirus. At least two different clades have been identified, each havingdifferent fatality rates but recent cases are all phylogenetically related to theWest African clade. MPV is transmitted directly by either person-to-person,-animal, or virus-contaminated fomite contact. The disease is often self-limited,and clinical symptoms include fever, skin lesions, and lymphadenopathies. Atpresent, no deaths have been associated with the current outbreak. MPV DNAdetection using molecular techniques is recommended for diagnosis. At least twoapproved drugs for antiviral therapy are available in the USA. Two differentvaccines, including the vaccine used in the past for smallpox eradication and anew formulation more recently approved based on a live but non-replicating virus,are available that provide immunity to MPV. These and other clinical and publichealth considerations pertaining to the recent monkeypox outbreaks together with aspects of MPV biology are discussed in this article.
CI  - (c) 2022. The Author(s), under exclusive licence to American Aging Association.
FAU - Quarleri, Jorge
AU  - Quarleri J
AUID- ORCID: http://orcid.org/0000-0001-5110-8773
AD  - Instituto de Investigaciones Biomedicas en Retrovirus Y Sida (INBIRS), Facultadde Medicina, Consejo de Investigaciones Cientificas Y Tecnicas (CONICET),Universidad de Buenos Aires, Buenos Aires, Argentina. quarleri@fmed.uba.ar.
FAU - Delpino, M Victoria
AU  - Delpino MV
AD  - Instituto de Investigaciones Biomedicas en Retrovirus Y Sida (INBIRS), Facultadde Medicina, Consejo de Investigaciones Cientificas Y Tecnicas (CONICET),Universidad de Buenos Aires, Buenos Aires, Argentina.
FAU - Galvan, Veronica
AU  - Galvan V
AD  - Department of Biochemistry and Molecular Biology, University of Oklahoma HealthSciences Center, Oklahoma City, OK, USA.
AD  - Center for Geroscience and Healthy Brain Aging, University of Oklahoma HealthSciences Center, Oklahoma City, OK, USA.
AD  - Research Health Scientist, US Department of Veterans Affairs, Oklahoma City VAHealth Care System, Oklahoma City, OK, USA.
LA  - eng
PT  - Journal Article
DEP - 20220620
PL  - Switzerland
TA  - Geroscience
JT  - GeroScience
JID - 101686284
SB  - IM
PMC - PMC9208705
OTO - NOTNLM
OT  - Antiviral therapy
OT  - Clinical presentation
OT  - Diagnosis
OT  - Epidemiology
OT  - Monkeypox
OT  - Orthopoxvirus
OT  - Outbreak
OT  - Prophylaxis
EDAT- 2022/06/22 06:00
MHDA- 2022/06/22 06:00
CRDT- 2022/06/21 00:17
PHST- 2022/06/05 00:00 [received]
PHST- 2022/06/15 00:00 [accepted]
PHST- 2022/06/21 00:17 [entrez]
PHST- 2022/06/22 06:00 [pubmed]
PHST- 2022/06/22 06:00 [medline]
AID - 10.1007/s11357-022-00611-6 [doi]
AID - 10.1007/s11357-022-00611-6 [pii]
PST - aheadofprint
SO  - Geroscience. 2022 Jun 20. pii: 10.1007/s11357-022-00611-6. doi:10.1007/s11357-022-00611-6.

PMID- 35723740
OWN - NLM
STAT- Publisher
LR  - 20220620
IS  - 1432-0460 (Electronic)
IS  - 0179-051X (Linking)
DP  - 2022 Jun 20
TI  - Dysphagia and Monkeypox: A Consideration.
LID - 10.1007/s00455-022-10481-x [doi]
FAU - Mungmunpuntipantip, Rujittika
AU  - Mungmunpuntipantip R
AD  - Private Academic Consultant, Bangkok, Thailand. rujittika@gmail.com.
FAU - Wiwanitkit, Viroj
AU  - Wiwanitkit V
AD  - Joseph Ayobaalola University, Ikeji-Arakeji, Nigeria.
AD  - Dr DY Patil University, Pune, India.
AD  - Faculty of Medicine, University of Nis, Nis, Serbia.
LA  - eng
PT  - Letter
DEP - 20220620
PL  - United States
TA  - Dysphagia
JT  - Dysphagia
JID - 8610856
SB  - IM
EDAT- 2022/06/21 06:00
MHDA- 2022/06/21 06:00
CRDT- 2022/06/20 11:15
PHST- 2022/06/02 00:00 [received]
PHST- 2022/06/10 00:00 [accepted]
PHST- 2022/06/20 11:15 [entrez]
PHST- 2022/06/21 06:00 [pubmed]
PHST- 2022/06/21 06:00 [medline]
AID - 10.1007/s00455-022-10481-x [doi]
AID - 10.1007/s00455-022-10481-x [pii]
PST - aheadofprint
SO  - Dysphagia. 2022 Jun 20. pii: 10.1007/s00455-022-10481-x. doi:10.1007/s00455-022-10481-x.

PMID- 35720796
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220716
IS  - 2038-9922 (Print)
IS  - 2038-9922 (Linking)
VI  - 13
IP  - 1
DP  - 2022 May 24
TI  - Trend and enhanced surveillance of Monkeypox during COVID-19 pandemic in Nigeria.
PG  - 2184
LID - 10.4081/jphia.2022.2184 [doi]
AB  - Monkeypox (MPX) is a viral zoonosis with lesions like smallpox. Though rare inNigeria, sporadic outbreaks have been reported in 17 states since September 2017.Unfortunately, the COVID-19 pandemic has further reduced surveillance andreporting of MPX disease. This study seeks to assess the effect of an enhancedsurveillance approach to detect MPX cases and measure the cumulative incidence ofMPX in priority states in Nigeria. We identified three priority states (Rivers,Delta and Bayelsa) and their Local Government Areas (LGAs) based on previousdisease incidence. We also identified, trained, and incentivized communityvolunteers to conduct active case searches over three months (January to March2021). We supported case investigation of suspected cases and followed up oncases in addition to routine active surveillance for MPX in health facilities andcommunities. Weekly and monthly follow-up was carried out during the same period.Out of the three states, 30 hotspots LGAs out of the 56 LGAs (54%) were engagedfor enhanced surveillance. We trained three state supervisors, 30 LGAsurveillance facilitators and 600 Community informants across the three priority states. Overall, twenty-five (25) suspected cases of MPX were identified. Out of these, three (12%) were confirmed as positive. Enhanced surveillance improvedreporting of MPX diseases in hotspots LGAs across the priority states. Extension of this surveillance approach alongside tailored technical support is criticalintra and post-pandemic.
CI  - (c)Copyright: the Author(s).
FAU - Amao, Lateefat Kikelomo
AU  - Amao LK
AD  - Nigeria Centre for Disease Control, Abuja.
FAU - Olatunji, David Idowu
AU  - Olatunji DI
AD  - Nigeria Centre for Disease Control, Abuja.
FAU - Igbodo, Gordon
AU  - Igbodo G
AD  - Nigeria Centre for Disease Control, Abuja.
FAU - Okoli, Solomon Chieloka
AU  - Okoli SC
AD  - Federal Ministry of Agriculture and Rural Development, Abuja.
FAU - Amaechi, Ifeanyichukwu
AU  - Amaechi I
AD  - Nigeria Centre for Disease Control, Abuja.
FAU - Goni, Muhammad Isa
AU  - Goni MI
AD  - Nigeria Centre for Disease Control, Abuja.
FAU - Ehiakhamen, Odianosen
AU  - Ehiakhamen O
AD  - Nigeria Centre for Disease Control, Abuja.
FAU - Aderinola, Olaolu
AU  - Aderinola O
AD  - Nigeria Centre for Disease Control, Abuja.
FAU - Ogunleye, Adesola
AU  - Ogunleye A
AD  - Nigeria Centre for Disease Control, Abuja.
FAU - Ogunbode, Oladipo
AU  - Ogunbode O
AD  - Nigeria Centre for Disease Control, Abuja.
FAU - Adeleye, Adesola
AU  - Adeleye A
AD  - Nigeria Centre for Disease Control, Abuja.
FAU - Arowolo, Tajudeen
AU  - Arowolo T
AD  - Nigeria Centre for Disease Control, Abuja.
FAU - Suleman, Kabiru
AU  - Suleman K
AD  - Nigeria Centre for Disease Control, Abuja.
FAU - Hassan, Abubakar
AU  - Hassan A
AD  - Nigeria Centre for Disease Control, Abuja.
FAU - Yelwa, Mohammed Usman
AU  - Yelwa MU
AD  - Nigeria Centre for Disease Control, Abuja.
FAU - Inam, Nsikak
AU  - Inam N
AD  - Nigeria Centre for Disease Control, Abuja.
FAU - Akinpelu, Afolabi
AU  - Akinpelu A
AD  - Nigeria Centre for Disease Control, Abuja.
FAU - Muhammad, Fahad
AU  - Muhammad F
AD  - Nigeria Centre for Disease Control, Abuja.
FAU - Jinadu, Kola
AU  - Jinadu K
AD  - Nigeria Centre for Disease Control, Abuja.
FAU - Onoh, Ikenna
AU  - Onoh I
AD  - Nigeria Centre for Disease Control, Abuja.
FAU - Akinrogbe, Jessica
AU  - Akinrogbe J
AD  - Nigeria Centre for Disease Control, Abuja.
FAU - Ilori, Elsie
AU  - Ilori E
AD  - Nigeria Centre for Disease Control, Abuja.
FAU - Biobelu, Abaye
AU  - Biobelu A
AD  - Bayelsa State Ministry of Health, Yenegoa.
FAU - Richard, Ikwuogu
AU  - Richard I
AD  - Delta State Ministry of Health, Asaba.
FAU - Nwadiuto, Ifeoma
AU  - Nwadiuto I
AD  - Rivers State Ministry of Health, Port Harcourt, Nigeria.
FAU - Demebons, Oyaba
AU  - Demebons O
AD  - Bayelsa State Ministry of Health, Yenegoa.
FAU - Nwakaego, Ogbue
AU  - Nwakaego O
AD  - Delta State Ministry of Health, Asaba.
FAU - Owhodar, Emmanuel
AU  - Owhodar E
AD  - Rivers State Ministry of Health, Port Harcourt, Nigeria.
FAU - Oladejo, John
AU  - Oladejo J
AD  - Nigeria Centre for Disease Control, Abuja.
FAU - Okpokoro, Evaezi
AU  - Okpokoro E
AD  - International Research Center of Excellence, Institute of Human Virology.
FAU - Ihekweazu, Chikwe
AU  - Ihekweazu C
AD  - Nigeria Centre for Disease Control, Abuja.
LA  - eng
PT  - Journal Article
DEP - 20220525
PL  - Italy
TA  - J Public Health Afr
JT  - Journal of public health in Africa
JID - 101586943
PMC - PMC9202462
OTO - NOTNLM
OT  - COVID-19
OT  - Enhanced Surveillance
OT  - Monkeypox
OT  - Nigeria
OT  - Zoonosis
COIS- Conflict of interest: The authors declare no potential conflict of interest.
EDAT- 2022/06/21 06:00
MHDA- 2022/06/21 06:01
CRDT- 2022/06/20 03:46
PHST- 2022/03/15 00:00 [received]
PHST- 2022/04/21 00:00 [accepted]
PHST- 2022/06/20 03:46 [entrez]
PHST- 2022/06/21 06:00 [pubmed]
PHST- 2022/06/21 06:01 [medline]
AID - 10.4081/jphia.2022.2184 [doi]
PST - epublish
SO  - J Public Health Afr. 2022 May 25;13(1):2184. doi: 10.4081/jphia.2022.2184.eCollection 2022 May 24.

PMID- 35719410
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220716
IS  - 2049-0801 (Print)
IS  - 2049-0801 (Linking)
VI  - 79
DP  - 2022 Jul
TI  - Monkeypox virus: A future scourge to the Pakistani Healthcare system.
PG  - 103978
LID - 10.1016/j.amsu.2022.103978 [doi]
AB  - Monkeypox is a rare viral infection that is mostly concentrated in the regions ofCentral and West Africa. During the last couple of weeks, reports of confirmedmonkeypox cases in non-endemic countries such as the United Kingdom have alerted health authorities in Pakistan as well. Keeping in mind the devastating effectsof the recent COVID-19 pandemic on the healthcare system of Pakistan, asubsequent monkeypox outbreak can be catastrophic. During the COVID-19 outbreak, the lack of financial resources and manpower exposed the vulnerability of thecountry's healthcare system. Therefore, it is imperative that relevant healthauthorities proactively work towards educating the public regarding effectiveprecautionary measures that can keep them safe in the event of a monkeypoxoutbreak.
CI  - (c) 2022 The Authors.
FAU - Mansoor, Hussain
AU  - Mansoor H
AD  - Dow University of Health Sciences, Karachi, Pakistan.
FAU - Abbas, Samina
AU  - Abbas S
AD  - Dow University of Health Sciences, Karachi, Pakistan.
FAU - Rehan, Syeda Tayyaba
AU  - Rehan ST
AD  - Dow University of Health Sciences, Karachi, Pakistan.
FAU - Hasan, Mohammad Mehedi
AU  - Hasan MM
AD  - Department of Biochemistry and Molecular Biology, Faculty of Life Science,Mawlana Bhashani Science and Technology University, Tangail, Bangladesh.
LA  - eng
PT  - Journal Article
DEP - 20220611
PL  - England
TA  - Ann Med Surg (Lond)
JT  - Annals of medicine and surgery (2012)
JID - 101616869
PMC - PMC9187879
OTO - NOTNLM
OT  - Healthcare system
OT  - Monkeypox
OT  - Outbreak
OT  - Pakistan
OT  - Public health
COIS- The authors declare that there is no conflict of interests.
EDAT- 2022/06/21 06:00
MHDA- 2022/06/21 06:01
CRDT- 2022/06/20 03:29
PHST- 2022/06/03 00:00 [received]
PHST- 2022/06/06 00:00 [accepted]
PHST- 2022/06/20 03:29 [entrez]
PHST- 2022/06/21 06:00 [pubmed]
PHST- 2022/06/21 06:01 [medline]
AID - 10.1016/j.amsu.2022.103978 [doi]
AID - S2049-0801(22)00738-5 [pii]
PST - ppublish
SO  - Ann Med Surg (Lond). 2022 Jul;79:103978. doi: 10.1016/j.amsu.2022.103978. Epub2022 Jun 11.

PMID- 35717977
OWN - NLM
STAT- MEDLINE
DCOM- 20220621
LR  - 20220711
IS  - 1474-547X (Electronic)
IS  - 0140-6736 (Linking)
VI  - 399
IP  - 10343
DP  - 2022 Jun 18
TI  - Investigating monkeypox.
PG  - 2254-2255
LID - S0140-6736(22)01096-0 [pii]
LID - 10.1016/S0140-6736(22)01096-0 [doi]
FAU - Burki, Talha
AU  - Burki T
LA  - eng
PT  - Journal Article
PL  - England
TA  - Lancet
JT  - Lancet (London, England)
JID - 2985213R
SB  - IM
MH  - Disease Outbreaks
MH  - Humans
MH  - *Monkeypox/diagnosis/epidemiology
EDAT- 2022/06/20 06:00
MHDA- 2022/06/22 06:00
CRDT- 2022/06/19 19:02
PHST- 2022/06/19 19:02 [entrez]
PHST- 2022/06/20 06:00 [pubmed]
PHST- 2022/06/22 06:00 [medline]
AID - S0140-6736(22)01096-0 [pii]
AID - 10.1016/S0140-6736(22)01096-0 [doi]
PST - ppublish
SO  - Lancet. 2022 Jun 18;399(10343):2254-2255. doi: 10.1016/S0140-6736(22)01096-0.

PMID- 35716671
OWN - NLM
STAT- MEDLINE
DCOM- 20220628
LR  - 20220711
IS  - 1474-547X (Electronic)
IS  - 0140-6736 (Linking)
VI  - 399
IP  - 10344
DP  - 2022 Jun 25
TI  - Monkeypox in the UK: arguments for a broader case definition.
PG  - 2345-2346
LID - S0140-6736(22)01101-1 [pii]
LID - 10.1016/S0140-6736(22)01101-1 [doi]
FAU - Pan, Daniel
AU  - Pan D
AD  - Department of Respiratory Sciences, University of Leicester, Leicester LE1 9HN,UK; Department of Infectious Diseases and HIV Medicine, University Hospitals ofLeicester NHS Trust, Leicester, UK.
FAU - Sze, Shirley
AU  - Sze S
AD  - Department of Life Sciences, University of Leicester, Leicester LE1 9HN, UK.
FAU - Nazareth, Joshua
AU  - Nazareth J
AD  - Department of Respiratory Sciences, University of Leicester, Leicester LE1 9HN,UK; Department of Infectious Diseases and HIV Medicine, University Hospitals ofLeicester NHS Trust, Leicester, UK.
FAU - Martin, Christopher A
AU  - Martin CA
AD  - Department of Respiratory Sciences, University of Leicester, Leicester LE1 9HN,UK; Department of Infectious Diseases and HIV Medicine, University Hospitals ofLeicester NHS Trust, Leicester, UK.
FAU - Al-Oraibi, Amani
AU  - Al-Oraibi A
AD  - Department of Respiratory Sciences, University of Leicester, Leicester LE1 9HN,UK; Lifespan and Population Health, School of Medicine, University of Nottingham,Nottingham, UK.
FAU - Baggaley, Rebecca F
AU  - Baggaley RF
AD  - Department of Respiratory Sciences, University of Leicester, Leicester LE1 9HN,UK; Department of Life Sciences, University of Leicester, Leicester LE1 9HN, UK.
FAU - Nellums, Laura B
AU  - Nellums LB
AD  - Lifespan and Population Health, School of Medicine, University of Nottingham,Nottingham, UK.
FAU - Hollingsworth, T Deirdre
AU  - Hollingsworth TD
AD  - Oxford Big Data Institute, Oxford, UK.
FAU - Tang, Julian W
AU  - Tang JW
AD  - Department of Respiratory Sciences, University of Leicester, Leicester LE1 9HN,UK; Department of Virology, University Hospitals of Leicester NHS Trust,Leicester, UK.
FAU - Pareek, Manish
AU  - Pareek M
AD  - Department of Respiratory Sciences, University of Leicester, Leicester LE1 9HN,UK; Department of Infectious Diseases and HIV Medicine, University Hospitals ofLeicester NHS Trust, Leicester, UK. Electronic address:manish.pareek@leicester.ac.uk.
LA  - eng
PT  - Letter
DEP - 20220615
PL  - England
TA  - Lancet
JT  - Lancet (London, England)
JID - 2985213R
SB  - IM
MH  - Disease Outbreaks
MH  - Dissent and Disputes
MH  - Humans
MH  - *Monkeypox/epidemiology
MH  - United Kingdom
EDAT- 2022/06/19 06:00
MHDA- 2022/06/29 06:00
CRDT- 2022/06/18 19:06
PHST- 2022/05/25 00:00 [received]
PHST- 2022/06/12 00:00 [accepted]
PHST- 2022/06/19 06:00 [pubmed]
PHST- 2022/06/29 06:00 [medline]
PHST- 2022/06/18 19:06 [entrez]
AID - S0140-6736(22)01101-1 [pii]
AID - 10.1016/S0140-6736(22)01101-1 [doi]
PST - ppublish
SO  - Lancet. 2022 Jun 25;399(10344):2345-2346. doi: 10.1016/S0140-6736(22)01101-1.Epub 2022 Jun 15.

PMID- 35714856
OWN - NLM
STAT- Publisher
LR  - 20220804
IS  - 1873-0442 (Electronic)
IS  - 1477-8939 (Linking)
VI  - 49
DP  - 2022 Jun 14
TI  - Sexually or intimately transmitted infections: A look at the current outbreak of monkeypox in 2022.
PG  - 102383
LID - S1477-8939(22)00129-6 [pii]
LID - 10.1016/j.tmaid.2022.102383 [doi]
FAU - Zambrano, Patricia Gabriela
AU  - Zambrano PG
AD  - School of Medicine of the International University of Ecuador, Quito, Ecuador.Electronic address: dra.gzambrano@gmail.com.
FAU - Acosta-Espana, Jaime David
AU  - Acosta-Espana JD
AD  - Institute for Natural Product Research and Infection Biology Friedrich-SchillerUniversity Jena, Jena, Germany; Leibniz Institute for Natural Product Researchand Infection Biology, Germany.
FAU - Mosquera Moyano, Felipe
AU  - Mosquera Moyano F
AD  - Faculty of Medicine of the Pontifical Catholic University of Ecuador, Quito,Ecuador.
FAU - Altamirano Jara, Jenny Belen
AU  - Altamirano Jara JB
AD  - Medical Graduate of the Faculty of Medicine of the Evandro Chagas University Rio de Janeiro, Rio de Janeiro, Brazil.
LA  - eng
PT  - Letter
DEP - 20220614
PL  - Netherlands
TA  - Travel Med Infect Dis
JT  - Travel medicine and infectious disease
JID - 101230758
SB  - IM
EDAT- 2022/06/18 06:00
MHDA- 2022/06/18 06:00
CRDT- 2022/06/17 19:27
PHST- 2022/06/02 00:00 [received]
PHST- 2022/06/06 00:00 [revised]
PHST- 2022/06/07 00:00 [accepted]
PHST- 2022/06/18 06:00 [pubmed]
PHST- 2022/06/18 06:00 [medline]
PHST- 2022/06/17 19:27 [entrez]
AID - S1477-8939(22)00129-6 [pii]
AID - 10.1016/j.tmaid.2022.102383 [doi]
PST - aheadofprint
SO  - Travel Med Infect Dis. 2022 Jun 14;49:102383. doi: 10.1016/j.tmaid.2022.102383.

PMID- 35713026
OWN - NLM
STAT- MEDLINE
DCOM- 20220620
LR  - 20220716
IS  - 1560-7917 (Electronic)
IS  - 1025-496X (Linking)
VI  - 27
IP  - 24
DP  - 2022 Jun
TI  - Estimated incubation period for monkeypox cases confirmed in the Netherlands, May2022.
LID - 10.2807/1560-7917.ES.2022.27.24.2200448 [doi]
AB  - In May 2022, monkeypox outbreaks have been reported in countries not endemic for monkeypox. We estimated the monkeypox incubation period, using reported exposure and symptom-onset times for 18 cases detected and confirmed in the Netherlands upto 31 May 2022. Mean incubation period was 8.5 days (5th-95th percentiles:4.2-17.3), underpinning the current recommendation to monitor orisolate/quarantine case contacts for 21 days. However, as the incubation periodmay differ between different transmission routes, further epidemiologicalinvestigations are needed.
FAU - Miura, Fuminari
AU  - Miura F
AD  - Center for Marine Environmental Studies (CMES), Ehime University, Ehime, Japan.
AD  - Centre for Infectious Disease Control, National Institute for Public Health andthe Environment (RIVM), Bilthoven, the Netherlands.
FAU - van Ewijk, Catharina Else
AU  - van Ewijk CE
AD  - European Programme for Intervention Epidemiology Training (EPIET), EuropeanCentre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
AD  - Centre for Infectious Disease Control, National Institute for Public Health andthe Environment (RIVM), Bilthoven, the Netherlands.
FAU - Backer, Jantien A
AU  - Backer JA
AD  - Centre for Infectious Disease Control, National Institute for Public Health andthe Environment (RIVM), Bilthoven, the Netherlands.
FAU - Xiridou, Maria
AU  - Xiridou M
AD  - Centre for Infectious Disease Control, National Institute for Public Health andthe Environment (RIVM), Bilthoven, the Netherlands.
FAU - Franz, Eelco
AU  - Franz E
AD  - Centre for Infectious Disease Control, National Institute for Public Health andthe Environment (RIVM), Bilthoven, the Netherlands.
FAU - Op de Coul, Eline
AU  - Op de Coul E
AD  - Centre for Infectious Disease Control, National Institute for Public Health andthe Environment (RIVM), Bilthoven, the Netherlands.
FAU - Brandwagt, Diederik
AU  - Brandwagt D
AD  - Centre for Infectious Disease Control, National Institute for Public Health andthe Environment (RIVM), Bilthoven, the Netherlands.
FAU - van Cleef, Brigitte
AU  - van Cleef B
AD  - Centre for Infectious Disease Control, National Institute for Public Health andthe Environment (RIVM), Bilthoven, the Netherlands.
FAU - van Rijckevorsel, Gini
AU  - van Rijckevorsel G
AD  - Department of Infectious Diseases, Public Health Service Amsterdam, Amsterdam,the Netherlands.
AD  - Centre for Infectious Disease Control, National Institute for Public Health andthe Environment (RIVM), Bilthoven, the Netherlands.
FAU - Swaan, Corien
AU  - Swaan C
AD  - Centre for Infectious Disease Control, National Institute for Public Health andthe Environment (RIVM), Bilthoven, the Netherlands.
FAU - van den Hof, Susan
AU  - van den Hof S
AD  - Centre for Infectious Disease Control, National Institute for Public Health andthe Environment (RIVM), Bilthoven, the Netherlands.
FAU - Wallinga, Jacco
AU  - Wallinga J
AD  - Department of Biomedical Data Sciences, Leiden University Medical Center (LUMC), Leiden, the Netherlands.
AD  - Centre for Infectious Disease Control, National Institute for Public Health andthe Environment (RIVM), Bilthoven, the Netherlands.
LA  - eng
PT  - Journal Article
PL  - Sweden
TA  - Euro Surveill
JT  - Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
JID - 100887452
SB  - IM
MH  - *Disease Outbreaks
MH  - Humans
MH  - Infectious Disease Incubation Period
MH  - *Monkeypox/diagnosis/epidemiology
MH  - Monkeypox virus
MH  - Netherlands/epidemiology
PMC - PMC9205160
OTO - NOTNLM
OT  - Monkeypox
OT  - epidemiology
OT  - incubation period
OT  - modelling
OT  - poxvirus
OT  - quarantine
OT  - smallpox
OT  - statistics
OT  - symptom onset
OT  - varicella virus infection (chickenpox)
EDAT- 2022/06/18 06:00
MHDA- 2022/06/22 06:00
CRDT- 2022/06/17 05:13
PHST- 2022/06/17 05:13 [entrez]
PHST- 2022/06/18 06:00 [pubmed]
PHST- 2022/06/22 06:00 [medline]
AID - 10.2807/1560-7917.ES.2022.27.24.2200448 [doi]
PST - ppublish
SO  - Euro Surveill. 2022 Jun;27(24). doi: 10.2807/1560-7917.ES.2022.27.24.2200448.

PMID- 35713025
OWN - NLM
STAT- MEDLINE
DCOM- 20220620
LR  - 20220716
IS  - 1560-7917 (Electronic)
IS  - 1025-496X (Linking)
VI  - 27
IP  - 24
DP  - 2022 Jun
TI  - Monkeypox in Europe and beyond - tackling a neglected disease together.
LID - 10.2807/1560-7917.ES.2022.27.24.2200482 [doi]
FAU - Kluge, Hans
AU  - Kluge H
AD  - World Health Organization Regional Office for Europe (WHO/Europe), Copenhagen,Denmark.
FAU - Ammon, Andrea
AU  - Ammon A
AD  - European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
LA  - eng
GR  - 001/WHO_/World Health Organization/International
PT  - Journal Article
PL  - Sweden
TA  - Euro Surveill
JT  - Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
JID - 100887452
RN  - 0 (DNA, Viral)
SB  - IM
MH  - DNA, Viral
MH  - Europe/epidemiology
MH  - Humans
MH  - *Monkeypox/diagnosis/epidemiology/prevention & control
MH  - Monkeypox virus
MH  - Neglected Diseases/epidemiology/prevention & control
PMC - PMC9205161
OTO - NOTNLM
OT  - epidemiology
OT  - monkeypox
OT  - monkeypox virus (MPXV)
OT  - public health
OT  - research
EDAT- 2022/06/18 06:00
MHDA- 2022/06/22 06:00
CRDT- 2022/06/17 05:13
PHST- 2022/06/17 05:13 [entrez]
PHST- 2022/06/18 06:00 [pubmed]
PHST- 2022/06/22 06:00 [medline]
AID - 10.2807/1560-7917.ES.2022.27.24.2200482 [doi]
PST - ppublish
SO  - Euro Surveill. 2022 Jun;27(24). doi: 10.2807/1560-7917.ES.2022.27.24.2200482.

PMID- 35710608
OWN - NLM
STAT- Publisher
LR  - 20220726
IS  - 1873-4111 (Electronic)
IS  - 0378-5122 (Linking)
DP  - 2022 Jun 9
TI  - Rare monkeypox: Is it really a threat to the elderly?
LID - S0378-5122(22)00118-9 [pii]
LID - 10.1016/j.maturitas.2022.05.014 [doi]
FAU - Chavda, Vivek P
AU  - Chavda VP
AD  - Department of Pharmaceutics and Pharmaceutical Technology, L M College ofPharmacy, Ahmedabad 380009, India.
FAU - Apostolopoulos, Vasso
AU  - Apostolopoulos V
AD  - Institute for Health and Sport, Victoria University, Melbourne, VIC, Australia;Immunology Program, Australian Institute for Musculoskeletal Science (AIMSS),Melbourne VIC Australia. Electronic address: vasso.apostolopoulos@vu.edu.au.
LA  - eng
PT  - Editorial
DEP - 20220609
PL  - Ireland
TA  - Maturitas
JT  - Maturitas
JID - 7807333
SB  - IM
PMC - PMC9192136
OTO - NOTNLM
OT  - *Monkeypox
OT  - *Monkeypox outbreak
OT  - *Orthopoxvirus
OT  - *Treatment
OT  - *Vaccine
COIS- The authors declare no conflicts of interest concerning the authorship andpublication of this article.
EDAT- 2022/06/17 06:00
MHDA- 2022/06/17 06:00
CRDT- 2022/06/16 23:58
PHST- 2022/05/24 00:00 [received]
PHST- 2022/05/29 00:00 [accepted]
PHST- 2022/06/16 23:58 [entrez]
PHST- 2022/06/17 06:00 [pubmed]
PHST- 2022/06/17 06:00 [medline]
AID - S0378-5122(22)00118-9 [pii]
AID - 10.1016/j.maturitas.2022.05.014 [doi]
PST - aheadofprint
SO  - Maturitas. 2022 Jun 9. pii: S0378-5122(22)00118-9. doi:10.1016/j.maturitas.2022.05.014.

PMID- 35710105
OWN - NLM
STAT- MEDLINE
DCOM- 20220620
LR  - 20220711
IS  - 1756-1833 (Electronic)
IS  - 0959-8138 (Linking)
VI  - 377
DP  - 2022 Jun 16
TI  - Monkeypox: WHO to rename disease to prevent stigma.
PG  - o1489
LID - 10.1136/bmj.o1489 [doi]
FAU - Taylor, Luke
AU  - Taylor L
LA  - eng
PT  - Journal Article
DEP - 20220616
PL  - England
TA  - BMJ
JT  - BMJ (Clinical research ed.)
JID - 8900488
SB  - IM
MH  - Animals
MH  - Disease Outbreaks
MH  - Humans
MH  - *Monkeypox/epidemiology
MH  - Social Stigma
MH  - World Health Organization
MH  - Zoonoses
EDAT- 2022/06/17 06:00
MHDA- 2022/06/22 06:00
CRDT- 2022/06/16 20:32
PHST- 2022/06/16 20:32 [entrez]
PHST- 2022/06/17 06:00 [pubmed]
PHST- 2022/06/22 06:00 [medline]
AID - 10.1136/bmj.o1489 [doi]
PST - epublish
SO  - BMJ. 2022 Jun 16;377:o1489. doi: 10.1136/bmj.o1489.

PMID- 35710067
OWN - NLM
STAT- Publisher
LR  - 20220804
IS  - 1743-9159 (Electronic)
IS  - 1743-9159 (Linking)
VI  - 104
DP  - 2022 Jun 14
TI  - The 2022 monkeypox outbreak: Lessons from the 640 cases in 36 countries.
PG  - 106712
LID - S1743-9191(22)00489-7 [pii]
LID - 10.1016/j.ijsu.2022.106712 [doi]
FAU - Rahimi, Farid
AU  - Rahimi F
AD  - Research School of Biology, The Australian National University, Ngunnawal andNgambri Country, Canberra, Australia.
FAU - Talebi Bezmin Abadi, Amin
AU  - Talebi Bezmin Abadi A
AD  - Department of Bacteriology, Faculty of Medical Sciences, Tarbiat ModaresUniversity, Tehran, Iran. Electronic address: Amin.talebi@modares.ac.ir.
LA  - eng
PT  - Letter
DEP - 20220614
PL  - England
TA  - Int J Surg
JT  - International journal of surgery (London, England)
JID - 101228232
SB  - IM
OTO - NOTNLM
OT  - Africa
OT  - Disease outbreak
OT  - Endemic diseases
OT  - Monkeypox virus
EDAT- 2022/06/17 06:00
MHDA- 2022/06/17 06:00
CRDT- 2022/06/16 19:34
PHST- 2022/06/03 00:00 [received]
PHST- 2022/06/11 00:00 [accepted]
PHST- 2022/06/17 06:00 [pubmed]
PHST- 2022/06/17 06:00 [medline]
PHST- 2022/06/16 19:34 [entrez]
AID - S1743-9191(22)00489-7 [pii]
AID - 10.1016/j.ijsu.2022.106712 [doi]
PST - aheadofprint
SO  - Int J Surg. 2022 Jun 14;104:106712. doi: 10.1016/j.ijsu.2022.106712.

PMID- 35709341
OWN - NLM
STAT- Publisher
LR  - 20220616
IS  - 1539-3704 (Electronic)
IS  - 0003-4819 (Linking)
DP  - 2022 Jun 16
TI  - Monkeypox: Avoiding the Mistakes of Past Infectious Disease Epidemics.
LID - 10.7326/M22-1748 [doi]
FAU - Daskalakis, Demetre
AU  - Daskalakis D
AUID- ORCID: 0000-0002-9770-0155
AD  - Division of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia (D.D., R.P.M.).
FAU - McClung, R Paul
AU  - McClung RP
AD  - Division of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia (D.D., R.P.M.).
FAU - Mena, Leandro
AU  - Mena L
AUID- ORCID: 0000-0001-8994-6457
AD  - Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia (L.M.).
FAU - Mermin, Jonathan
AU  - Mermin J
AUID- ORCID: 0000-0001-9022-4961
AD  - National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers forDisease Control and Prevention, Atlanta, Georgia (J.M.).
CN  - Centers for Disease Control and Prevention's Monkeypox Response Team*
LA  - eng
PT  - Editorial
DEP - 20220616
PL  - United States
TA  - Ann Intern Med
JT  - Annals of internal medicine
JID - 0372351
SB  - IM
EDAT- 2022/06/17 06:00
MHDA- 2022/06/17 06:00
CRDT- 2022/06/16 15:02
PHST- 2022/06/16 15:02 [entrez]
PHST- 2022/06/17 06:00 [pubmed]
PHST- 2022/06/17 06:00 [medline]
AID - 10.7326/M22-1748 [doi]
PST - aheadofprint
SO  - Ann Intern Med. 2022 Jun 16. doi: 10.7326/M22-1748.

PMID- 35709274
OWN - NLM
STAT- MEDLINE
DCOM- 20220620
LR  - 20220624
IS  - 1095-9203 (Electronic)
IS  - 0036-8075 (Linking)
VI  - 376
IP  - 6599
DP  - 2022 Jun 17
TI  - Monkeypox could establish new reservoirs in animals.
PG  - 1258-1259
LID - 10.1126/science.add4868 [doi]
AB  - Concern grows that virus will get footholds in species outside Africa.
FAU - Cohen, Jon
AU  - Cohen J
LA  - eng
PT  - News
DEP - 20220616
PL  - United States
TA  - Science
JT  - Science (New York, N.Y.)
JID - 0404511
SB  - IM
MH  - Africa/epidemiology
MH  - Animals
MH  - *Disease Reservoirs/virology
MH  - Humans
MH  - *Monkeypox/epidemiology/transmission
MH  - *Monkeypox virus
MH  - *Viral Zoonoses/epidemiology/transmission
MH  - World Health Organization
EDAT- 2022/06/17 06:00
MHDA- 2022/06/22 06:00
CRDT- 2022/06/16 14:04
PHST- 2022/06/16 14:04 [entrez]
PHST- 2022/06/17 06:00 [pubmed]
PHST- 2022/06/22 06:00 [medline]
AID - 10.1126/science.add4868 [doi]
PST - ppublish
SO  - Science. 2022 Jun 17;376(6599):1258-1259. doi: 10.1126/science.add4868. Epub 2022Jun 16.

PMID- 35706050
OWN - NLM
STAT- MEDLINE
DCOM- 20220617
LR  - 20220716
IS  - 2054-9369 (Electronic)
IS  - 2054-9369 (Linking)
VI  - 9
IP  - 1
DP  - 2022 Jun 15
TI  - An unfolding monkeypox outbreak in Europe and beyond.
PG  - 31
LID - 10.1186/s40779-022-00394-z [doi]
FAU - Wallau, Gabriel Luz
AU  - Wallau GL
AUID- ORCID: 0000-0002-1419-5713
AD  - Departamento de Entomologia and Nucleo de Bioinformatica, Instituto AggeuMagalhaes (IAM), Fundacao Oswaldo Cruz (Fiocruz), Avenida Fernando SimoesBarbosa, s/n, Cidade Universitaria, Recife, Brazil. gabriel.wallau@fiocruz.br.
AD  - Department of Arbovirology, Bernhard Nocht Institute for Tropical Medicine, WHOCollaborating Center for Arbovirus and Hemorrhagic Fever Reference and Research, National Reference Center for Tropical Infectious Diseases,Bernhard-Nocht-Strasse 74, 20359, Hamburg, Germany. gabriel.wallau@fiocruz.br.
FAU - Maciel-de-Freitas, Rafael
AU  - Maciel-de-Freitas R
AD  - Department of Arbovirology, Bernhard Nocht Institute for Tropical Medicine, WHOCollaborating Center for Arbovirus and Hemorrhagic Fever Reference and Research, National Reference Center for Tropical Infectious Diseases,Bernhard-Nocht-Strasse 74, 20359, Hamburg, Germany.
AD  - Laboratorio de Mosquitos Transmissores de Hematozoarios, Instituto Oswaldo Cruz, Fundacao Oswaldo Cruz (Fiocruz), Avenida Brasil, 4365, Manguinhos, Rio deJaneiro, Brazil.
FAU - Schmidt-Chanasit, Jonas
AU  - Schmidt-Chanasit J
AD  - Department of Arbovirology, Bernhard Nocht Institute for Tropical Medicine, WHOCollaborating Center for Arbovirus and Hemorrhagic Fever Reference and Research, National Reference Center for Tropical Infectious Diseases,Bernhard-Nocht-Strasse 74, 20359, Hamburg, Germany.
AD  - Faculty of Mathematics, Informatics and Natural Sciences, University of Hamburg, Ohnhorststrasse 18, 22609, Hamburg, Germany.
LA  - eng
PT  - Letter
DEP - 20220615
PL  - England
TA  - Mil Med Res
JT  - Military Medical Research
JID - 101643181
SB  - IM
MH  - *Disease Outbreaks
MH  - Europe/epidemiology
MH  - Humans
MH  - *Monkeypox/epidemiology
PMC - PMC9198408
OTO - NOTNLM
OT  - *Human transmission
OT  - *Monkeypox virus
OT  - *Poxvirus
OT  - *Zoonotic virus
EDAT- 2022/06/16 06:00
MHDA- 2022/06/18 06:00
CRDT- 2022/06/15 23:46
PHST- 2022/06/04 00:00 [received]
PHST- 2022/06/04 00:00 [accepted]
PHST- 2022/06/15 23:46 [entrez]
PHST- 2022/06/16 06:00 [pubmed]
PHST- 2022/06/18 06:00 [medline]
AID - 10.1186/s40779-022-00394-z [doi]
AID - 10.1186/s40779-022-00394-z [pii]
PST - epublish
SO  - Mil Med Res. 2022 Jun 15;9(1):31. doi: 10.1186/s40779-022-00394-z.

PMID- 35706004
OWN - NLM
STAT- MEDLINE
DCOM- 20220617
LR  - 20220716
IS  - 1476-0711 (Electronic)
IS  - 1476-0711 (Linking)
VI  - 21
IP  - 1
DP  - 2022 Jun 15
TI  - Monkeypox outbreaks during COVID-19 pandemic: are we looking at an independentphenomenon or an overlapping pandemic?
PG  - 26
LID - 10.1186/s12941-022-00518-2 [doi]
FAU - Farahat, Ramadan Abdelmoez
AU  - Farahat RA
AD  - Faculty of Medicine, Kafrelsheikh University, Kafrelsheikh, Egypt.ramadan.med_2587@med.kfs.edu.eg.
FAU - Abdelaal, Abdelaziz
AU  - Abdelaal A
AD  - Research Scholar, Harvard Medical School, Boston, MA, USA.
AD  - MSc Candidate in Clinical Research, Boston University, Boston, MA, USA.
FAU - Shah, Jaffer
AU  - Shah J
AD  - New York State, Department of Health, Albany, NY, USA.
AD  - Medical Research Center, Kateb University, Kabul, Afghanistan.
FAU - Ghozy, Sherief
AU  - Ghozy S
AD  - Department of Neuroradiology, Mayo Clinic, Rochester, MN, USA.
AD  - Nuffield Department of Primary Care Health Sciences and Department for ContinuingEducation (EBHC Program), Oxford University, Oxford, UK.
FAU - Sah, Ranjit
AU  - Sah R
AD  - Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal.
FAU - Bonilla-Aldana, D Katterine
AU  - Bonilla-Aldana DK
AD  - Faculty of Medicine, Institucion Universitaria Vision de Las Americas, Pereira,Risaralda, Colombia.
AD  - Latin American network of MOnkeypox VIrus research (LAMOVI), Pereira, Risaralda, Colombia.
FAU - Rodriguez-Morales, Alfonso J
AU  - Rodriguez-Morales AJ
AD  - Faculty of Medicine, Institucion Universitaria Vision de Las Americas, Pereira,Risaralda, Colombia. alfonso.rodriguez@uam.edu.co.
AD  - Grupo de Investigacion Biomedicina, Faculty of Medicine, Fundacion Universitaria Autonoma de Las Americas, Pereira, Risaralda, Colombia.alfonso.rodriguez@uam.edu.co.
AD  - Master of Clinical Epidemiology and Biostatistics, Universidad Cientifica delSur, Lima, Peru. alfonso.rodriguez@uam.edu.co.
AD  - School of Medicine, Universidad Privada Franz Tamayo (UNIFRANZ), Cochabamba,Bolivia. alfonso.rodriguez@uam.edu.co.
FAU - McHugh, Timothy D
AU  - McHugh TD
AD  - UCL Centre for Clinical Microbiology, Division of Infection & Immunity, UCL,London, UK.
FAU - Leblebicioglu, Hakan
AU  - Leblebicioglu H
AD  - Department of Infectious Diseases, VM Medicalpark Samsun Hospital, Samsun,Turkey.
LA  - eng
PT  - Editorial
DEP - 20220615
PL  - England
TA  - Ann Clin Microbiol Antimicrob
JT  - Annals of clinical microbiology and antimicrobials
JID - 101152152
SB  - IM
MH  - Animals
MH  - *COVID-19/epidemiology
MH  - Disease Outbreaks
MH  - Humans
MH  - *Monkeypox/epidemiology
MH  - Pandemics
MH  - Zoonoses
PMC - PMC9199472
EDAT- 2022/06/16 06:00
MHDA- 2022/06/18 06:00
CRDT- 2022/06/15 23:43
PHST- 2022/06/03 00:00 [accepted]
PHST- 2022/06/15 23:43 [entrez]
PHST- 2022/06/16 06:00 [pubmed]
PHST- 2022/06/18 06:00 [medline]
AID - 10.1186/s12941-022-00518-2 [doi]
AID - 10.1186/s12941-022-00518-2 [pii]
PST - epublish
SO  - Ann Clin Microbiol Antimicrob. 2022 Jun 15;21(1):26. doi:10.1186/s12941-022-00518-2.

PMID- 35704742
OWN - NLM
STAT- MEDLINE
DCOM- 20220617
LR  - 20220711
IS  - 1433-6510 (Print)
IS  - 1433-6510 (Linking)
VI  - 68
IP  - 6
DP  - 2022 Jun 1
TI  - Magnitude of Increased Alanine Transaminase Level: a Summary on 21 MonkeypoxCases.
LID - 10.7754/Clin.Lab.2021.220535 [doi]
FAU - Joob, Beuy
AU  - Joob B
FAU - Wiwanitkit, Viroj
AU  - Wiwanitkit V
LA  - eng
PT  - Letter
PL  - Germany
TA  - Clin Lab
JT  - Clinical laboratory
JID - 9705611
RN  - EC 2.6.1.2 (Alanine Transaminase)
SB  - IM
MH  - *Alanine Transaminase
MH  - *Disease Outbreaks
MH  - Humans
MH  - *Monkeypox/epidemiology
EDAT- 2022/06/16 06:00
MHDA- 2022/06/18 06:00
CRDT- 2022/06/15 15:24
PHST- 2022/06/15 15:24 [entrez]
PHST- 2022/06/16 06:00 [pubmed]
PHST- 2022/06/18 06:00 [medline]
AID - 10.7754/Clin.Lab.2021.220535 [doi]
PST - ppublish
SO  - Clin Lab. 2022 Jun 1;68(6). doi: 10.7754/Clin.Lab.2021.220535.

PMID- 35704421
OWN - NLM
STAT- MEDLINE
DCOM- 20220708
LR  - 20220714
IS  - 1533-4406 (Electronic)
IS  - 0028-4793 (Linking)
VI  - 387
IP  - 1
DP  - 2022 Jul 7
TI  - Monkeypox Genital Lesions.
PG  - 66
LID - 10.1056/NEJMicm2206893 [doi]
FAU - Patrocinio-Jesus, Rita
AU  - Patrocinio-Jesus R
AD  - Hospital Professor Doutor Fernando Fonseca, Amadora, Portugala.jesus@campus.ul.pt.
FAU - Peruzzu, Francesca
AU  - Peruzzu F
AD  - Hospital Professor Doutor Fernando Fonseca, Amadora, Portugala.jesus@campus.ul.pt.
LA  - eng
PT  - Case Reports
PT  - Journal Article
DEP - 20220615
PL  - United States
TA  - N Engl J Med
JT  - The New England journal of medicine
JID - 0255562
SB  - IM
MH  - Animals
MH  - *Genital Diseases/pathology/virology
MH  - *Genitalia/pathology/virology
MH  - Humans
MH  - *Monkeypox/complications/pathology
MH  - Monkeypox virus
EDAT- 2022/06/16 06:00
MHDA- 2022/07/09 06:00
CRDT- 2022/06/15 12:22
PHST- 2022/06/16 06:00 [pubmed]
PHST- 2022/07/09 06:00 [medline]
PHST- 2022/06/15 12:22 [entrez]
AID - 10.1056/NEJMicm2206893 [doi]
PST - ppublish
SO  - N Engl J Med. 2022 Jul 7;387(1):66. doi: 10.1056/NEJMicm2206893. Epub 2022 Jun15.

PMID- 35704368
OWN - NLM
STAT- Publisher
LR  - 20220615
IS  - 1130-0108 (Print)
IS  - 1130-0108 (Linking)
DP  - 2022 Jun 15
TI  - Diarrhea and monkeypox: a consideration.
LID - 10.17235/reed.2022.8957/2022 [doi]
AB  - In addition to the well-known pox infections, novel zoonotic pox diseases haveemerged as a severe concern in infectious medicine. In May 2022, monkeypox hasalready been reported in many countries in Europe, creating a significant public health risk possibility. Human-to-human transfer is being researched right now.As the number of reported cases in various countries climbs, the medicalcommunity is concerned, and proper preparation is required.
FAU - Mungmunpuntipantip, Rujittika
AU  - Mungmunpuntipantip R
AD  - Consultant, Private Academic Consultant, .
FAU - Wiwanitkit, Viroj
AU  - Wiwanitkit V
AD  - Dr DY Patil University, India.
LA  - eng
PT  - Journal Article
DEP - 20220615
PL  - Spain
TA  - Rev Esp Enferm Dig
JT  - Revista espanola de enfermedades digestivas : organo oficial de la SociedadEspanola de Patologia Digestiva
JID - 9007566
SB  - IM
EDAT- 2022/06/16 06:00
MHDA- 2022/06/16 06:00
CRDT- 2022/06/15 11:53
PHST- 2022/06/15 11:53 [entrez]
PHST- 2022/06/16 06:00 [pubmed]
PHST- 2022/06/16 06:00 [medline]
AID - 10.17235/reed.2022.8957/2022 [doi]
PST - aheadofprint
SO  - Rev Esp Enferm Dig. 2022 Jun 15. doi: 10.17235/reed.2022.8957/2022.

PMID- 35700882
OWN - NLM
STAT- Publisher
LR  - 20220804
IS  - 1873-0442 (Electronic)
IS  - 1477-8939 (Linking)
VI  - 49
DP  - 2022 Jun 11
TI  - For how long can monkeypox reach the Balkan region?
PG  - 102382
LID - S1477-8939(22)00128-4 [pii]
LID - 10.1016/j.tmaid.2022.102382 [doi]
FAU - Puca, Edmond
AU  - Puca E
AD  - Service of Infectious Diseases, University Hospital Center, Tirane, Albania.Electronic address: edmond_puca@yahoo.com.
FAU - Shapo, Laidon
AU  - Shapo L
AD  - Head of Programme for Health and Social Care, London Borough of Southwark,England, United Kingdom.
LA  - eng
PT  - Letter
DEP - 20220611
PL  - Netherlands
TA  - Travel Med Infect Dis
JT  - Travel medicine and infectious disease
JID - 101230758
SB  - IM
OTO - NOTNLM
OT  - Balkan region
OT  - Migration
OT  - Monkeypox
OT  - Tourism
EDAT- 2022/06/15 06:00
MHDA- 2022/06/15 06:00
CRDT- 2022/06/14 19:25
PHST- 2022/06/03 00:00 [received]
PHST- 2022/06/06 00:00 [revised]
PHST- 2022/06/07 00:00 [accepted]
PHST- 2022/06/15 06:00 [pubmed]
PHST- 2022/06/15 06:00 [medline]
PHST- 2022/06/14 19:25 [entrez]
AID - S1477-8939(22)00128-4 [pii]
AID - 10.1016/j.tmaid.2022.102382 [doi]
PST - aheadofprint
SO  - Travel Med Infect Dis. 2022 Jun 11;49:102382. doi: 10.1016/j.tmaid.2022.102382.

PMID- 35699601
OWN - NLM
STAT- Publisher
LR  - 20220614
IS  - 1708-8305 (Electronic)
IS  - 1195-1982 (Linking)
DP  - 2022 Jun 14
TI  - Monkeypox 2022 outbreak: cases with exclusive genital lesions.
LID - taac077 [pii]
LID - 10.1093/jtm/taac077 [doi]
FAU - Davido, Benjamin
AU  - Davido B
AUID- ORCID: 0000-0002-2859-8417
AD  - Maladies Infectieuses, Hopital Universitaire Raymond-Poincare, AP-HP, Garches.
FAU - D'anglejan, Emma
AU  - D'anglejan E
AD  - Maladies Infectieuses, Hopital Universitaire Raymond-Poincare, AP-HP, Garches.
FAU - Jourdan, Juliette
AU  - Jourdan J
AD  - Maladies Infectieuses, Hopital Universitaire Raymond-Poincare, AP-HP, Garches.
FAU - Robinault, Amelie
AU  - Robinault A
AD  - Medecine Generale, Paris.
FAU - Davido, Guillaume
AU  - Davido G
AD  - Psychiatrie, Hopital Universitaire Bichat, AP-HP, Paris.
LA  - eng
PT  - Journal Article
DEP - 20220614
PL  - England
TA  - J Travel Med
JT  - Journal of travel medicine
JID - 9434456
SB  - IM
OTO - NOTNLM
OT  - Monkeypox
OT  - atypical
OT  - genital
OT  - penis
EDAT- 2022/06/15 06:00
MHDA- 2022/06/15 06:00
CRDT- 2022/06/14 10:05
PHST- 2022/05/31 00:00 [received]
PHST- 2022/06/03 00:00 [revised]
PHST- 2022/06/09 00:00 [accepted]
PHST- 2022/06/14 10:05 [entrez]
PHST- 2022/06/15 06:00 [pubmed]
PHST- 2022/06/15 06:00 [medline]
AID - 6607927 [pii]
AID - 10.1093/jtm/taac077 [doi]
PST - aheadofprint
SO  - J Travel Med. 2022 Jun 14. pii: 6607927. doi: 10.1093/jtm/taac077.

PMID- 35698241
OWN - NLM
STAT- MEDLINE
DCOM- 20220615
LR  - 20220716
IS  - 2054-9369 (Electronic)
IS  - 2054-9369 (Linking)
VI  - 9
IP  - 1
DP  - 2022 Jun 13
TI  - Monkeypox outbreak: A novel threat after COVID-19?
PG  - 29
LID - 10.1186/s40779-022-00395-y [doi]
FAU - Zhang, Yang
AU  - Zhang Y
AD  - Senior Department of Infectious Diseases, the Fifth Medical Center of Chinese PLAGeneral Hospital, National Clinical Research Center for Infectious Diseases,Beijing, 100039, China.
FAU - Zhang, Ji-Yuan
AU  - Zhang JY
AUID- ORCID: 0000-0003-4781-4477
AD  - Senior Department of Infectious Diseases, the Fifth Medical Center of Chinese PLAGeneral Hospital, National Clinical Research Center for Infectious Diseases,Beijing, 100039, China. uniquezjy@163.com.
FAU - Wang, Fu-Sheng
AU  - Wang FS
AD  - Senior Department of Infectious Diseases, the Fifth Medical Center of Chinese PLAGeneral Hospital, National Clinical Research Center for Infectious Diseases,Beijing, 100039, China. fswang302@163.com.
LA  - eng
PT  - Letter
DEP - 20220613
PL  - England
TA  - Mil Med Res
JT  - Military Medical Research
JID - 101643181
SB  - IM
MH  - Animals
MH  - *COVID-19
MH  - Disease Outbreaks
MH  - Humans
MH  - *Monkeypox/epidemiology
PMC - PMC9190192
OTO - NOTNLM
OT  - *Human-to-human transmission
OT  - *Monkeypox
OT  - *Outbreak
OT  - *Zoonosis
EDAT- 2022/06/14 06:00
MHDA- 2022/06/16 06:00
CRDT- 2022/06/13 23:50
PHST- 2022/06/04 00:00 [received]
PHST- 2022/06/04 00:00 [accepted]
PHST- 2022/06/13 23:50 [entrez]
PHST- 2022/06/14 06:00 [pubmed]
PHST- 2022/06/16 06:00 [medline]
AID - 10.1186/s40779-022-00395-y [doi]
AID - 10.1186/s40779-022-00395-y [pii]
PST - epublish
SO  - Mil Med Res. 2022 Jun 13;9(1):29. doi: 10.1186/s40779-022-00395-y.

PMID- 35697322
OWN - NLM
STAT- MEDLINE
LR  - 20220716
IS  - 1743-9159 (Electronic)
IS  - 1743-9159 (Linking)
VI  - 103
DP  - 2022 Jul
TI  - Unexpected sudden rise of human monkeypox cases in multiple non-endemic countriesamid COVID-19 pandemic and salient counteracting strategies: Another potentialglobal threat?
PG  - 106705
LID - S1743-9191(22)00482-4 [pii]
LID - 10.1016/j.ijsu.2022.106705 [doi]
FAU - Mohapatra, Ranjan K
AU  - Mohapatra RK
AD  - Department of Chemistry, Government College of Engineering, Keonjhar, 758002,Odisha, India. Electronic address: ranjank_mohapatra@yahoo.com.
FAU - Tuli, Hardeep Singh
AU  - Tuli HS
AD  - Department of Biotechnology, Maharishi Markandeshwar University, Mullana, Ambala,133207, Haryana, India.
FAU - Sarangi, Ashish K
AU  - Sarangi AK
AD  - Department of Chemistry, School of Applied Sciences, Centurion University ofTechnology and Management, Odisha, India.
FAU - Chakraborty, Sandip
AU  - Chakraborty S
AD  - Department of Veterinary Microbiology, College of Veterinary Sciences and Animal Husbandry, R.K. Nagar, West Tripura, Tripura, 799008, India.
FAU - Chandran, Deepak
AU  - Chandran D
AD  - Amrita School of Agricultural Sciences, Amrita Vishwa Vidyapeetham University,Coimbatore, 642109, Tamil Nadu, India.
FAU - Chakraborty, Chiranjib
AU  - Chakraborty C
AD  - Department of Biotechnology, School of Life Science and Biotechnology, AdamasUniversity, Kolkata, West Bengal, India.
FAU - Dhama, Kuldeep
AU  - Dhama K
AD  - Division of Pathology, ICAR-Indian Veterinary Research Institute, Bareilly,Izatnagar, Uttar Pradesh, 243122, India. Electronic address:kdhama@rediffmail.com.
LA  - eng
PT  - Letter
DEP - 20220611
PL  - England
TA  - Int J Surg
JT  - International journal of surgery (London, England)
JID - 101228232
SB  - IM
MH  - *COVID-19/epidemiology
MH  - Humans
MH  - *Monkeypox/epidemiology
MH  - Pandemics/prevention & control
PMC - PMC9187856
EDAT- 2022/06/14 06:00
MHDA- 2022/06/23 06:00
CRDT- 2022/06/13 19:33
PHST- 2022/05/23 00:00 [received]
PHST- 2022/06/08 00:00 [accepted]
PHST- 2022/06/14 06:00 [pubmed]
PHST- 2022/06/23 06:00 [medline]
PHST- 2022/06/13 19:33 [entrez]
AID - S1743-9191(22)00482-4 [pii]
AID - 10.1016/j.ijsu.2022.106705 [doi]
PST - ppublish
SO  - Int J Surg. 2022 Jul;103:106705. doi: 10.1016/j.ijsu.2022.106705. Epub 2022 Jun11.

PMID- 35696683
OWN - NLM
STAT- Publisher
LR  - 20220716
IS  - 1539-3704 (Electronic)
IS  - 0003-4819 (Linking)
DP  - 2022 Jun 14
TI  - Adding New Fuel to the Fire: Monkeypox in the Time of COVID-19-Implications forHealth Care Personnel.
LID - 10.7326/M22-1763 [doi]
FAU - Palmore, Tara N
AU  - Palmore TN
AD  - George Washington University School of Medicine, Washington, DC (T.N.P.).
FAU - Henderson, David K
AU  - Henderson DK
AUID- ORCID: 0000-0003-1589-8813
AD  - National Institutes of Health Clinical Center, Bethesda, Maryland (D.K.H.).
LA  - eng
PT  - Editorial
DEP - 20220614
PL  - United States
TA  - Ann Intern Med
JT  - Annals of internal medicine
JID - 0372351
SB  - IM
PMC - PMC9195139
EDAT- 2022/06/14 06:00
MHDA- 2022/06/14 06:00
CRDT- 2022/06/13 17:02
PHST- 2022/06/13 17:02 [entrez]
PHST- 2022/06/14 06:00 [pubmed]
PHST- 2022/06/14 06:00 [medline]
AID - 10.7326/M22-1763 [doi]
PST - aheadofprint
SO  - Ann Intern Med. 2022 Jun 14. doi: 10.7326/M22-1763.

PMID- 35696257
OWN - NLM
STAT- MEDLINE
DCOM- 20220714
LR  - 20220715
IS  - 1538-3598 (Electronic)
IS  - 0098-7484 (Linking)
VI  - 328
IP  - 2
DP  - 2022 Jul 12
TI  - Monkeypox in 2022-What Clinicians Need to Know.
PG  - 139-140
LID - 10.1001/jama.2022.10802 [doi]
FAU - Guarner, Jeannette
AU  - Guarner J
AD  - Department of Pathology and Laboratory Medicine, Emory University School ofMedicine, Atlanta, Georgia.
FAU - Del Rio, Carlos
AU  - Del Rio C
AD  - Division of Infectious Diseases, Department of Internal Medicine, EmoryUniversity School of Medicine, Atlanta, Georgia.
AD  - Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Georgia Grady Health System, Atlanta.
FAU - Malani, Preeti N
AU  - Malani PN
AD  - Division of Infectious Diseases, Department of Internal Medicine, University ofMichigan, Ann Arbor.
AD  - Associate Editor, JAMA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - JAMA
JT  - JAMA
JID - 7501160
SB  - IM
MH  - Animals
MH  - *Communicable Diseases, Emerging/epidemiology
MH  - Disease Outbreaks
MH  - Humans
MH  - *Monkeypox/epidemiology
EDAT- 2022/06/14 06:00
MHDA- 2022/07/15 06:00
CRDT- 2022/06/13 11:44
PHST- 2022/06/14 06:00 [pubmed]
PHST- 2022/07/15 06:00 [medline]
PHST- 2022/06/13 11:44 [entrez]
AID - 2793516 [pii]
AID - 10.1001/jama.2022.10802 [doi]
PST - ppublish
SO  - JAMA. 2022 Jul 12;328(2):139-140. doi: 10.1001/jama.2022.10802.

PMID- 35692117
OWN - NLM
STAT- Publisher
LR  - 20220617
IS  - 1096-9071 (Electronic)
IS  - 0146-6615 (Linking)
DP  - 2022 Jun 12
TI  - Epidemiological trends and clinical features of the ongoing monkeypox epidemic: Apreliminary pooled data analysis and literature review.
LID - 10.1002/jmv.27931 [doi]
AB  - An emerging outbreak of monkeypox infection is quickly spreading worldwide, beingcurrently reported in more than 30 countries, with slightly less than 1000 cases.In the present preliminary report, we collected and synthesized early dataconcerning epidemiological trends and clinical features of the ongoing outbreakand we compared them with those of previous outbreaks. Data were pooled from six clusters in Italy, Australia, the Czech Republic, Portugal, and the UnitedKingdom, totaling 124 cases (for 35 of which it was possible to retrieve detailedinformation). The ongoing epidemic differs from previous outbreaks in terms ofage (54.29% of individuals in their thirties), sex/gender (most cases beingmales), risk factors, and transmission route, with sexual transmission beinghighly likely. Also, the clinical presentation is atypical and unusual, beingcharacterized by anogenital lesions and rashes that relatively spare the face andextremities. The most prevalent sign/symptom reported was fever (in 54.29% ofcases) followed by inguinal lymphadenopathy (45.71%) and exanthema (40.00%).Asthenia, fatigue, and headache were described in 22.86% and 25.71% of thesubjects, respectively. Myalgia was present in 17.14% of the cases. Both genital and anal lesions (ulcers and vesicles) were reported in 31.43% of the cases.Finally, cervical lymphadenopathy was described in 11.43% of the sample, whilethe least commonly reported symptoms were diarrhea and axillary lymphadenopathy(5.71% of the case series for both symptoms). Some preliminary risk factors canbe identified (being a young male, having sex with other men, engaging in riskybehaviors and activities, including condomless sex, human immunodeficiency virus positivity (54.29% of the sample analyzed), and a story of previous sexuallytransmitted infections, including syphilis). On the other hand, being fullyvirally suppressed and undetectable may protect against a more severe infectious course. However, further research in the field is urgently needed.
CI  - (c) 2022 Wiley Periodicals LLC.
FAU - Bragazzi, Nicola L
AU  - Bragazzi NL
AD  - Laboratory for Industrial and Applied Mathematics (LIAM), Department ofMathematics and Statistics, York University, Toronto, Ontario, Canada.
FAU - Kong, Jude D
AU  - Kong JD
AD  - Laboratory for Industrial and Applied Mathematics (LIAM), Department ofMathematics and Statistics, York University, Toronto, Ontario, Canada.
FAU - Mahroum, Naim
AU  - Mahroum N
AD  - Department of Internal Medicine, International School of Medicine, IstanbulMedipol University, Istanbul, Turkey.
FAU - Tsigalou, Christina
AU  - Tsigalou C
AD  - Laboratory of Microbiology, Department of Medicine, Democritus University ofThrace, Dragana, Alexandroupolis, Greece.
FAU - Khamisy-Farah, Rola
AU  - Khamisy-Farah R
AD  - Clalit Health Services, Akko, Israel.
AD  - Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
FAU - Converti, Manlio
AU  - Converti M
AD  - ASL2 Napoli, Nord, Naples, Italy.
FAU - Wu, Jianhong
AU  - Wu J
AD  - Laboratory for Industrial and Applied Mathematics (LIAM), Department ofMathematics and Statistics, York University, Toronto, Ontario, Canada.
LA  - eng
PT  - Journal Article
DEP - 20220612
PL  - United States
TA  - J Med Virol
JT  - Journal of medical virology
JID - 7705876
SB  - IM
OTO - NOTNLM
OT  - emerging pathogen
OT  - monkeypox
OT  - outbreak
OT  - pooled data analysis
EDAT- 2022/06/14 06:00
MHDA- 2022/06/14 06:00
CRDT- 2022/06/13 01:42
PHST- 2022/06/07 00:00 [revised]
PHST- 2022/06/04 00:00 [received]
PHST- 2022/06/08 00:00 [accepted]
PHST- 2022/06/14 06:00 [pubmed]
PHST- 2022/06/14 06:00 [medline]
PHST- 2022/06/13 01:42 [entrez]
AID - 10.1002/jmv.27931 [doi]
PST - aheadofprint
SO  - J Med Virol. 2022 Jun 12. doi: 10.1002/jmv.27931.

PMID- 35691984
OWN - NLM
STAT- Publisher
LR  - 20220613
IS  - 1863-4362 (Electronic)
IS  - 0021-1265 (Linking)
DP  - 2022 Jun 13
TI  - Correction to: Multinational monkeypox outbreak: what do we know and what should we do?
LID - 10.1007/s11845-022-03064-0 [doi]
FAU - Memariani, Mojtaba
AU  - Memariani M
AD  - Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran,Iran. memaryani@gmail.com.
AD  - Department of Pathobiology, School of Public Health, Tehran University of MedicalSciences, Tehran, Iran. memaryani@gmail.com.
FAU - Memariani, Hamed
AU  - Memariani H
AD  - Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran,Iran.
AD  - Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.
LA  - eng
PT  - Published Erratum
DEP - 20220613
PL  - Ireland
TA  - Ir J Med Sci
JT  - Irish journal of medical science
JID - 7806864
SB  - IM
EFR - Ir J Med Sci. 2022 Jun 6;:. PMID: 35668338
EDAT- 2022/06/13 06:00
MHDA- 2022/06/13 06:00
CRDT- 2022/06/12 23:15
PHST- 2022/06/12 23:15 [entrez]
PHST- 2022/06/13 06:00 [pubmed]
PHST- 2022/06/13 06:00 [medline]
AID - 10.1007/s11845-022-03064-0 [doi]
AID - 10.1007/s11845-022-03064-0 [pii]
PST - aheadofprint
SO  - Ir J Med Sci. 2022 Jun 13. pii: 10.1007/s11845-022-03064-0. doi:10.1007/s11845-022-03064-0.

PMID- 35691542
OWN - NLM
STAT- Publisher
LR  - 20220804
IS  - 1873-0442 (Electronic)
IS  - 1477-8939 (Linking)
VI  - 49
DP  - 2022 Jun 9
TI  - Risk of monkeypox outbreak in Nepal.
PG  - 102381
LID - S1477-8939(22)00127-2 [pii]
LID - 10.1016/j.tmaid.2022.102381 [doi]
FAU - Subedi, Deepak
AU  - Subedi D
AD  - Paklihawa Campus, Institute of Agriculture and Animal Science, TribhuvanUniversity, Rupandehi, 32900, Nepal. Electronic address: subedideepu26@gmail.com.
FAU - Acharya, Krishna Prasad
AU  - Acharya KP
AD  - Animal Quarantine Office, Budhanilkantha, Kathmandu, 44600, Nepal. Electronicaddress: kriaasedu@gmail.com.
LA  - eng
PT  - Letter
DEP - 20220609
PL  - Netherlands
TA  - Travel Med Infect Dis
JT  - Travel medicine and infectious disease
JID - 101230758
SB  - IM
EDAT- 2022/06/13 06:00
MHDA- 2022/06/13 06:00
CRDT- 2022/06/12 19:26
PHST- 2022/06/03 00:00 [received]
PHST- 2022/06/06 00:00 [revised]
PHST- 2022/06/07 00:00 [accepted]
PHST- 2022/06/13 06:00 [pubmed]
PHST- 2022/06/13 06:00 [medline]
PHST- 2022/06/12 19:26 [entrez]
AID - S1477-8939(22)00127-2 [pii]
AID - 10.1016/j.tmaid.2022.102381 [doi]
PST - aheadofprint
SO  - Travel Med Infect Dis. 2022 Jun 9;49:102381. doi: 10.1016/j.tmaid.2022.102381.

PMID- 35691304
OWN - NLM
STAT- MEDLINE
DCOM- 20220628
LR  - 20220711
IS  - 1474-4457 (Electronic)
IS  - 1473-3099 (Linking)
VI  - 22
IP  - 7
DP  - 2022 Jul
TI  - Monkeypox: a neglected old foe.
PG  - 913
LID - S1473-3099(22)00377-2 [pii]
LID - 10.1016/S1473-3099(22)00377-2 [doi]
FAU - The Lancet Infectious Diseases
AU  - The Lancet Infectious Diseases
LA  - eng
PT  - Editorial
DEP - 20220609
PL  - United States
TA  - Lancet Infect Dis
JT  - The Lancet. Infectious diseases
JID - 101130150
SB  - IM
MH  - Disease Outbreaks
MH  - Humans
MH  - *Monkeypox/epidemiology
MH  - Monkeypox virus
EDAT- 2022/06/13 06:00
MHDA- 2022/06/29 06:00
CRDT- 2022/06/12 19:02
PHST- 2022/06/13 06:00 [pubmed]
PHST- 2022/06/29 06:00 [medline]
PHST- 2022/06/12 19:02 [entrez]
AID - S1473-3099(22)00377-2 [pii]
AID - 10.1016/S1473-3099(22)00377-2 [doi]
PST - ppublish
SO  - Lancet Infect Dis. 2022 Jul;22(7):913. doi: 10.1016/S1473-3099(22)00377-2. Epub2022 Jun 9.

PMID- 35690319
OWN - NLM
STAT- Publisher
LR  - 20220804
IS  - 1873-0442 (Electronic)
IS  - 1477-8939 (Linking)
VI  - 49
DP  - 2022 Jun 8
TI  - Concern over monkeypox outbreak: What can we learn from the top 100 highly cited articles in monkeypox research?
PG  - 102371
LID - S1477-8939(22)00117-X [pii]
LID - 10.1016/j.tmaid.2022.102371 [doi]
FAU - Cheng, Kunming
AU  - Cheng K
AD  - Department of Intensive Care Unit, The Second Affiliated Hospital of ZhengzhouUniversity, Zhengzhou, Henan, 450014, China.
FAU - Guo, Qiang
AU  - Guo Q
AD  - Department of Orthopaedics, Baodi Clinical College of Tianjin Medical University,Tianjin, 301800, China.
FAU - Zhou, Yan
AU  - Zhou Y
AD  - Department of Graduate School, Tianjin Medical University, Tianjin, 300070,China.
FAU - Wu, Haiyang
AU  - Wu H
AD  - Department of Graduate School, Tianjin Medical University, Tianjin, 300070,China. Electronic address: wuhaiyang2021@tmu.edu.cn.
LA  - eng
PT  - Letter
DEP - 20220608
PL  - Netherlands
TA  - Travel Med Infect Dis
JT  - Travel medicine and infectious disease
JID - 101230758
SB  - IM
EDAT- 2022/06/12 06:00
MHDA- 2022/06/12 06:00
CRDT- 2022/06/11 19:27
PHST- 2022/05/25 00:00 [received]
PHST- 2022/06/03 00:00 [revised]
PHST- 2022/06/04 00:00 [accepted]
PHST- 2022/06/12 06:00 [pubmed]
PHST- 2022/06/12 06:00 [medline]
PHST- 2022/06/11 19:27 [entrez]
AID - S1477-8939(22)00117-X [pii]
AID - 10.1016/j.tmaid.2022.102371 [doi]
PST - aheadofprint
SO  - Travel Med Infect Dis. 2022 Jun 8;49:102371. doi: 10.1016/j.tmaid.2022.102371.

PMID- 35690074
OWN - NLM
STAT- MEDLINE
DCOM- 20220628
LR  - 20220711
IS  - 1474-4457 (Electronic)
IS  - 1473-3099 (Linking)
VI  - 22
IP  - 7
DP  - 2022 Jul
TI  - Tracking the 2022 monkeypox outbreak with epidemiological data in real-time.
PG  - 941-942
LID - S1473-3099(22)00359-0 [pii]
LID - 10.1016/S1473-3099(22)00359-0 [doi]
FAU - Kraemer, Moritz U G
AU  - Kraemer MUG
AD  - Department of Biology, University of Oxford, Oxford OX1 3SY, UK; PandemicSciences Institute, University of Oxford, Oxford OX1 3SY, UK. Electronic address:moritz.kraemer@zoo.ox.ac.uk.
FAU - Tegally, Houriiyah
AU  - Tegally H
AD  - Centre for Epidemic Response and Innovation, School of Data Science andComputational Thinking, Stellenbosch University, Stellenbosch, South Africa.
FAU - Pigott, David M
AU  - Pigott DM
AD  - Institute for Health Metrics and Evaluation, University of Washington, DC, USA.
FAU - Dasgupta, Abhishek
AU  - Dasgupta A
AD  - Department of Biology, University of Oxford, Oxford OX1 3SY, UK; Department ofComputer Science, University of Oxford, Oxford OX1 3SY, UK.
FAU - Sheldon, James
AU  - Sheldon J
AD  - The Roux Institute, Northeastern University, Portland, ME, USA.
FAU - Wilkinson, Eduan
AU  - Wilkinson E
AD  - Centre for Epidemic Response and Innovation, School of Data Science andComputational Thinking, Stellenbosch University, Stellenbosch, South Africa.
FAU - Schultheiss, Marinanicole
AU  - Schultheiss M
AD  - Boston Children's Hospital, Harvard Medical School, Boston, MA 02215, USA.
FAU - Han, Aimee
AU  - Han A
AD  - Boston Children's Hospital, Harvard Medical School, Boston, MA 02215, USA.
FAU - Oglia, Mark
AU  - Oglia M
AD  - Boston Children's Hospital, Harvard Medical School, Boston, MA 02215, USA.
FAU - Marks, Spencer
AU  - Marks S
AD  - Boston Children's Hospital, Harvard Medical School, Boston, MA 02215, USA.
FAU - Kanner, Joshua
AU  - Kanner J
AD  - Boston Children's Hospital, Harvard Medical School, Boston, MA 02215, USA.
FAU - O'Brien, Katelynn
AU  - O'Brien K
AD  - Boston Children's Hospital, Harvard Medical School, Boston, MA 02215, USA.
FAU - Dandamudi, Sudheer
AU  - Dandamudi S
AD  - Boston Children's Hospital, Harvard Medical School, Boston, MA 02215, USA.
FAU - Rader, Benjamin
AU  - Rader B
AD  - Boston Children's Hospital, Harvard Medical School, Boston, MA 02215, USA.
FAU - Sewalk, Kara
AU  - Sewalk K
AD  - Boston Children's Hospital, Harvard Medical School, Boston, MA 02215, USA.
FAU - Bento, Ana I
AU  - Bento AI
AD  - School of Public Health, Indiana University, Bloomington, IN, USA; PandemicPrevention Institute, The Rockefeller Foundation, New York, NY, USA.
FAU - Scarpino, Samuel V
AU  - Scarpino SV
AD  - The Roux Institute, Northeastern University, Portland, ME, USA; PandemicPrevention Institute, The Rockefeller Foundation, New York, NY, USA; Santa FeInstitute, Santa Fe, NM, USA.
FAU - de Oliveira, Tulio
AU  - de Oliveira T
AD  - Centre for Epidemic Response and Innovation, School of Data Science andComputational Thinking, Stellenbosch University, Stellenbosch, South Africa.
FAU - Bogoch, Isaac I
AU  - Bogoch II
AD  - Department of Medicine, University of Toronto, Toronto, ON, Canada.
FAU - Katz, Rebecca
AU  - Katz R
AD  - Georgetown University, Washington, DC, USA.
FAU - Brownstein, John S
AU  - Brownstein JS
AD  - Boston Children's Hospital, Harvard Medical School, Boston, MA 02215, USA.Electronic address: john.brownstein@childrens.harvard.edu.
LA  - eng
PT  - Letter
DEP - 20220609
PL  - United States
TA  - Lancet Infect Dis
JT  - The Lancet. Infectious diseases
JID - 101130150
SB  - IM
MH  - Disease Outbreaks
MH  - Humans
MH  - *Monkeypox/epidemiology
MH  - Monkeypox virus/genetics
COIS- MUGK and JSB report funding from The Rockefeller Foundation and Google.org. TdOreceived fees from Illumina as a member of the Infectious Disease TestingAdvisory Board and received partial travel support to attend the Nobel Symposium of Medicine in May, 2022. IIB received consulting fees from BlueDot and NHLPlayers' Association. All other authors declare no competing interests.
EDAT- 2022/06/12 06:00
MHDA- 2022/06/29 06:00
CRDT- 2022/06/11 19:07
PHST- 2022/05/26 00:00 [received]
PHST- 2022/05/27 00:00 [accepted]
PHST- 2022/06/12 06:00 [pubmed]
PHST- 2022/06/29 06:00 [medline]
PHST- 2022/06/11 19:07 [entrez]
AID - S1473-3099(22)00359-0 [pii]
AID - 10.1016/S1473-3099(22)00359-0 [doi]
PST - ppublish
SO  - Lancet Infect Dis. 2022 Jul;22(7):941-942. doi: 10.1016/S1473-3099(22)00359-0.Epub 2022 Jun 9.

PMID- 35689039
OWN - NLM
STAT- MEDLINE
DCOM- 20220614
LR  - 20220716
IS  - 1476-5373 (Electronic)
IS  - 0007-0610 (Linking)
VI  - 232
IP  - 11
DP  - 2022 Jun
TI  - Monkeypox.
PG  - 760
LID - 10.1038/s41415-022-4358-8 [doi]
FAU - Murphy, S
AU  - Murphy S
AD  - By email, Dumfries, UK.
LA  - eng
PT  - Letter
PL  - England
TA  - Br Dent J
JT  - British dental journal
JID - 7513219
SB  - IM
MH  - Disease Outbreaks
MH  - Humans
MH  - *Monkeypox/epidemiology
PMC - PMC9185713
EDAT- 2022/06/11 06:00
MHDA- 2022/06/15 06:00
CRDT- 2022/06/10 23:29
PHST- 2022/06/10 23:29 [entrez]
PHST- 2022/06/11 06:00 [pubmed]
PHST- 2022/06/15 06:00 [medline]
AID - 10.1038/s41415-022-4358-8 [doi]
AID - 10.1038/s41415-022-4358-8 [pii]
PST - ppublish
SO  - Br Dent J. 2022 Jun;232(11):760. doi: 10.1038/s41415-022-4358-8.

PMID- 35688169
OWN - NLM
STAT- MEDLINE
DCOM- 20220802
LR  - 20220802
IS  - 2666-5247 (Electronic)
IS  - 2666-5247 (Linking)
VI  - 3
IP  - 8
DP  - 2022 Aug
TI  - Global human monkeypox outbreak: atypical presentation demanding urgent publichealth action.
PG  - e554-e555
LID - S2666-5247(22)00153-7 [pii]
LID - 10.1016/S2666-5247(22)00153-7 [doi]
FAU - Otu, Akaninyene
AU  - Otu A
AD  - Department of Microbiology, Leeds Teaching Hospitals NHS Trust, Leeds LS1 3EX,UK. Electronic address: akan.otu1@nhs.net.
FAU - Ebenso, Bassey
AU  - Ebenso B
AD  - Nuffield Centre for International Health and Development, Leeds Institute ofHealth Sciences, University of Leeds, Leeds, UK.
FAU - Walley, John
AU  - Walley J
AD  - Nuffield Centre for International Health and Development, Leeds Institute ofHealth Sciences, University of Leeds, Leeds, UK.
FAU - Barcelo, Josep Mercader
AU  - Barcelo JM
AD  - Department of Fundamental Biology and Health Sciences, University of the BalearicIslands, Palma, Spain.
FAU - Ochu, Chinwe Lucia
AU  - Ochu CL
AD  - Nigeria Centre for Disease Control, Abuja, Nigeria.
LA  - eng
PT  - Case Reports
PT  - Journal Article
DEP - 20220607
PL  - England
TA  - Lancet Microbe
JT  - The Lancet. Microbe
JID - 101769019
SB  - IM
MH  - Animals
MH  - Disease Outbreaks
MH  - Humans
MH  - *Monkeypox/diagnosis
MH  - Monkeypox virus
MH  - Public Health
COIS- We declare no competing interests. AO and BE contributed equally to this Comment.
EDAT- 2022/06/11 06:00
MHDA- 2022/08/03 06:00
CRDT- 2022/06/10 19:02
PHST- 2022/05/22 00:00 [received]
PHST- 2022/05/23 00:00 [accepted]
PHST- 2022/06/11 06:00 [pubmed]
PHST- 2022/08/03 06:00 [medline]
PHST- 2022/06/10 19:02 [entrez]
AID - S2666-5247(22)00153-7 [pii]
AID - 10.1016/S2666-5247(22)00153-7 [doi]
PST - ppublish
SO  - Lancet Microbe. 2022 Aug;3(8):e554-e555. doi: 10.1016/S2666-5247(22)00153-7. Epub2022 Jun 7.

PMID- 35687526
OWN - NLM
STAT- Publisher
LR  - 20220610
IS  - 1646-0758 (Electronic)
IS  - 0870-399X (Linking)
DP  - 2022 Jun 10
TI  - [Human Monkeypox].
LID - 10.20344/amp.18639 [doi]
FAU - Barbosa, Joana
AU  - Barbosa J
AD  - Servico de Dermatologia e Venereologia. Centro Hospitalar Universitario LisboaCentral. Lisboa. Portugal.
FAU - Caldeira, Margarida
AU  - Caldeira M
AD  - Servico de Dermatologia e Venereologia. Centro Hospitalar Universitario LisboaCentral. Lisboa. Portugal.
FAU - Fernandes, Candida
AU  - Fernandes C
AD  - Servico de Dermatologia e Venereologia. Centro Hospitalar Universitario LisboaCentral. Lisboa. Portugal.
LA  - por
PT  - Journal Article
TT  - Infecao Humana pelo Virus Monkeypox.
DEP - 20220610
PL  - Portugal
TA  - Acta Med Port
JT  - Acta medica portuguesa
JID - 7906803
SB  - IM
OTO - NOTNLM
OT  - Communicable Diseases, Emerging
OT  - Disease Outbreaks
OT  - Monkeypox
OT  - Monkeypox virus
EDAT- 2022/06/11 06:00
MHDA- 2022/06/11 06:00
CRDT- 2022/06/10 13:13
PHST- 2022/05/29 00:00 [received]
PHST- 2022/06/07 00:00 [accepted]
PHST- 2022/06/06 00:00 [revised]
PHST- 2022/06/10 13:13 [entrez]
PHST- 2022/06/11 06:00 [pubmed]
PHST- 2022/06/11 06:00 [medline]
AID - 10.20344/amp.18639 [doi]
PST - aheadofprint
SO  - Acta Med Port. 2022 Jun 10. doi: 10.20344/amp.18639.

PMID- 35686566
OWN - NLM
STAT- MEDLINE
DCOM- 20220613
LR  - 20220716
IS  - 1560-7917 (Electronic)
IS  - 1025-496X (Linking)
VI  - 27
IP  - 23
DP  - 2022 Jun
TI  - Letter to the editor: multiple introductions of MPX in Italy from differentgeographic areas.
LID - 10.2807/1560-7917.ES.2022.27.23.2200456 [doi]
FAU - Ferraro, Federica
AU  - Ferraro F
AD  - Directorate General of Health Prevention, Ministry of Health, Italy.
FAU - Caraglia, Anna
AU  - Caraglia A
AD  - Directorate General of Health Prevention, Ministry of Health, Italy.
FAU - Rapiti, Alessia
AU  - Rapiti A
AD  - Directorate General of Health Prevention, Ministry of Health, Italy.
FAU - Cereda, Danilo
AU  - Cereda D
AD  - Directorate General for Health, Lombardy Region, Milano, Italy.
FAU - Vairo, Francesco
AU  - Vairo F
AD  - National Institute of Infectious Diseases Lazzaro Spallanzani, Italy.
FAU - Mattei, Giovanna
AU  - Mattei G
AD  - General Directorate for personal care, health and welfare, Emilia Romagna Region,Bologna, Italy.
FAU - Maraglino, Francesco
AU  - Maraglino F
AD  - Directorate General of Health Prevention, Ministry of Health, Italy.
FAU - Rezza, Giovanni
AU  - Rezza G
AD  - Directorate General of Health Prevention, Ministry of Health, Italy.
LA  - eng
PT  - Journal Article
PL  - Sweden
TA  - Euro Surveill
JT  - Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
JID - 100887452
SB  - IM
MH  - Humans
MH  - Italy/epidemiology
MH  - *Monkeypox/epidemiology
MH  - *Monkeypox virus
PMC - PMC9198655
OTO - NOTNLM
OT  - Italy
OT  - monkeypox
OT  - rash
OT  - surveillance
EDAT- 2022/06/11 06:00
MHDA- 2022/06/14 06:00
CRDT- 2022/06/10 05:12
PHST- 2022/06/10 05:12 [entrez]
PHST- 2022/06/11 06:00 [pubmed]
PHST- 2022/06/14 06:00 [medline]
AID - 10.2807/1560-7917.ES.2022.27.23.2200456 [doi]
PST - ppublish
SO  - Euro Surveill. 2022 Jun;27(23). doi: 10.2807/1560-7917.ES.2022.27.23.2200456.

PMID- 35686457
OWN - NLM
STAT- MEDLINE
DCOM- 20220621
LR  - 20220716
IS  - 1875-5941 (Electronic)
IS  - 0165-2176 (Linking)
VI  - 42
IP  - 1
DP  - 2022 Dec
TI  - Is monkeypox another reemerging viral zoonosis with many animal hosts yet to bedefined?
PG  - 148-150
LID - 10.1080/01652176.2022.2088881 [doi]
FAU - Bonilla-Aldana, D Katterine
AU  - Bonilla-Aldana DK
AUID- ORCID: 0000-0002-9412-2556
AD  - Faculty of Medicine, Institucion Universitaria Vision de las Americas, Pereira,Risaralda, Colombia.
AD  - Grupo de Investigacion Biomedicina, Faculty of Medicine, Fundacion Universitaria Autonoma de las Americas, Pereira, Risaralda, Colombia.
AD  - Latin American network on MOnkeypox VIrus research (LAMOVI), Pereira, Risaralda, Colombia.
FAU - Rodriguez-Morales, Alfonso J
AU  - Rodriguez-Morales AJ
AD  - Faculty of Medicine, Institucion Universitaria Vision de las Americas, Pereira,Risaralda, Colombia.
AD  - Universidad Cientifica del Sur, Lima, Peru.
AD  - Grupo de Investigacion Biomedicina, Faculty of Medicine, Fundacion Universitaria Autonoma de las Americas, Pereira, Risaralda, Colombia.
AD  - Latin American network on MOnkeypox VIrus research (LAMOVI), Pereira, Risaralda, Colombia.
LA  - eng
PT  - Letter
PL  - England
TA  - Vet Q
JT  - The veterinary quarterly
JID - 7909485
SB  - IM
MH  - Animals
MH  - Disease Outbreaks
MH  - *Monkeypox/epidemiology/veterinary
MH  - Viral Zoonoses
MH  - Zoonoses/epidemiology
PMC - PMC9225742
EDAT- 2022/06/11 06:00
MHDA- 2022/06/22 06:00
CRDT- 2022/06/10 03:43
PHST- 2022/06/11 06:00 [pubmed]
PHST- 2022/06/22 06:00 [medline]
PHST- 2022/06/10 03:43 [entrez]
AID - 10.1080/01652176.2022.2088881 [doi]
PST - ppublish
SO  - Vet Q. 2022 Dec;42(1):148-150. doi: 10.1080/01652176.2022.2088881.

PMID- 35679976
OWN - NLM
STAT- MEDLINE
DCOM- 20220628
LR  - 20220716
IS  - 1678-4391 (Electronic)
IS  - 1413-8670 (Linking)
VI  - 26
IP  - 3
DP  - 2022 May-Jun
TI  - Human monkeypox preparedness in Latin America - Are we ready for the next viralzoonotic disease outbreak after COVID-19?
PG  - 102372
LID - S1413-8670(22)00059-9 [pii]
LID - 10.1016/j.bjid.2022.102372 [doi]
FAU - Cimerman, Sergio
AU  - Cimerman S
AD  - Instituto de Infectologia Emilio Ribas, Sao Paulo, SP, Brazil; Brazilian Society for Infectious Diseases, Sao Paulo, SP, Brazil; Latin American Network ofCoronavirus Disease 2019-COVID-19 Research (LANCOVID-19), Pereira, Colombia.Electronic address: sergiocimerman@gmail.com.
FAU - Chebabo, Alberto
AU  - Chebabo A
AD  - Brazilian Society for Infectious Diseases, Sao Paulo, SP, Brazil; UniversidadeFederal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
FAU - Cunha, Clovis Arns da
AU  - Cunha CAD
AD  - Brazilian Society for Infectious Diseases, Sao Paulo, SP, Brazil; UniversidadeFederal do Parana, Curitiba, PR, Brazil.
FAU - Barbosa, Alexandre Naime
AU  - Barbosa AN
AD  - Brazilian Society for Infectious Diseases, Sao Paulo, SP, Brazil; Departamento deInfectologia, Universidade Estadual Paulista (UNESP), Faculdade de Medicina,Botucatu, SP, Brazil.
FAU - Rodriguez-Morales, Alfonso J
AU  - Rodriguez-Morales AJ
AD  - Latin American Network of Coronavirus Disease 2019-COVID-19 Research(LANCOVID-19), Pereira, Colombia; Grupo de Investigacion Biomedicina, Faculty of Medicine, Fundacion Universitaria Autonoma de las Americas, Pereira, Risaralda,Colombia; Master in Clinical Epidemiology and Biostatistics, UniversidadCientifica del Sur, Lima, Peru; Colombian Association of Infectious Diseases,Bogota, Colombia. Electronic address: alfonso.rodriguez@uam.edu.co.
LA  - eng
PT  - Editorial
DEP - 20220603
PL  - Brazil
TA  - Braz J Infect Dis
JT  - The Brazilian journal of infectious diseases : an official publication of theBrazilian Society of Infectious Diseases
JID - 9812937
SB  - IM
MH  - Animals
MH  - *COVID-19
MH  - Disease Outbreaks/prevention & control
MH  - Humans
MH  - Latin America/epidemiology
MH  - *Monkeypox/epidemiology
MH  - Viral Zoonoses
PMC - PMC9163019
COIS- Conflicts of interest The authors declare no conflicts of interest
EDAT- 2022/06/10 06:00
MHDA- 2022/06/29 06:00
CRDT- 2022/06/09 19:24
PHST- 2022/05/25 00:00 [received]
PHST- 2022/05/26 00:00 [accepted]
PHST- 2022/06/10 06:00 [pubmed]
PHST- 2022/06/29 06:00 [medline]
PHST- 2022/06/09 19:24 [entrez]
AID - S1413-8670(22)00059-9 [pii]
AID - 10.1016/j.bjid.2022.102372 [doi]
PST - ppublish
SO  - Braz J Infect Dis. 2022 May-Jun;26(3):102372. doi: 10.1016/j.bjid.2022.102372.Epub 2022 Jun 3.

PMID- 35679422
OWN - NLM
STAT- MEDLINE
DCOM- 20220613
LR  - 20220615
IS  - 1095-9203 (Electronic)
IS  - 0036-8075 (Linking)
VI  - 376
IP  - 6598
DP  - 2022 Jun 10
TI  - Monkeypox vaccination plans take shape amid questions.
PG  - 1142-1143
LID - 10.1126/science.add3743 [doi]
AB  - Favored shot is a seemingly safer smallpox vaccine, but researchers debate howbest to use it.
FAU - Kupferschmidt, Kai
AU  - Kupferschmidt K
LA  - eng
PT  - News
DEP - 20220609
PL  - United States
TA  - Science
JT  - Science (New York, N.Y.)
JID - 0404511
RN  - 0 (Smallpox Vaccine)
SB  - IM
MH  - Animals
MH  - Humans
MH  - *Monkeypox/prevention & control
MH  - *Smallpox Vaccine/adverse effects/immunology/therapeutic use
MH  - *Vaccination/methods
EDAT- 2022/06/10 06:00
MHDA- 2022/06/14 06:00
CRDT- 2022/06/09 14:04
PHST- 2022/06/09 14:04 [entrez]
PHST- 2022/06/10 06:00 [pubmed]
PHST- 2022/06/14 06:00 [medline]
AID - 10.1126/science.add3743 [doi]
PST - ppublish
SO  - Science. 2022 Jun 10;376(6598):1142-1143. doi: 10.1126/science.add3743. Epub 2022Jun 9.

PMID- 35679181
OWN - NLM
STAT- MEDLINE
DCOM- 20220613
LR  - 20220716
IS  - 1545-861X (Electronic)
IS  - 0149-2195 (Linking)
VI  - 71
IP  - 23
DP  - 2022 Jun 10
TI  - Monkeypox Outbreak - Nine States, May 2022.
PG  - 764-769
LID - 10.15585/mmwr.mm7123e1 [doi]
AB  - On May 17, 2022, the Massachusetts Department of Public Health (MDPH) Laboratory Response Network (LRN) laboratory confirmed the presence of orthopoxvirus DNA viareal-time polymerase chain reaction (PCR) from lesion swabs obtained from aMassachusetts resident. Orthopoxviruses include Monkeypox virus, the causativeagent of monkeypox. Subsequent real-time PCR testing at CDC on May 18 confirmedthat the patient was infected with the West African clade of Monkeypox virus.Since then, confirmed cases* have been reported by nine states. In addition, 28countries and territories,(dagger) none of which has endemic monkeypox, havereported laboratory-confirmed cases. On May 17, CDC, in coordination with stateand local jurisdictions, initiated an emergency response to identify, monitor,and investigate additional monkeypox cases in the United States. This responsehas included releasing a Health Alert Network (HAN) Health Advisory, developinginterim public health and clinical recommendations, releasing guidance for LRNtesting, hosting clinician and public health partner outreach calls,disseminating health communication messages to the public, developing protocolsfor use and release of medical countermeasures, and facilitating delivery ofvaccine postexposure prophylaxis (PEP) and antivirals that have been stockpiledby the U.S. government for preparedness and response purposes. On May 19, a call center was established to provide guidance to states for the evaluation ofpossible cases of monkeypox, including recommendations for clinical diagnosis andorthopoxvirus testing. The call center also gathers information about possiblecases to identify interjurisdictional linkages. As of May 31, this investigation has identified 17( section sign) cases in the United States; most cases (16) werediagnosed in persons who identify as gay, bisexual, or men who have sex with men (MSM). Ongoing investigation suggests person-to-person community transmission,and CDC urges health departments, clinicians, and the public to remain vigilant, institute appropriate infection prevention and control measures, and notifypublic health authorities of suspected cases to reduce disease spread. Publichealth authorities are identifying cases and conducting investigations todetermine possible sources and prevent further spread. This activity was reviewedby CDC and conducted consistent with applicable federal law and CDC policy.(paragraph sign).
FAU - Minhaj, Faisal S
AU  - Minhaj FS
FAU - Ogale, Yasmin P
AU  - Ogale YP
FAU - Whitehill, Florence
AU  - Whitehill F
FAU - Schultz, Jordan
AU  - Schultz J
FAU - Foote, Mary
AU  - Foote M
FAU - Davidson, Whitni
AU  - Davidson W
FAU - Hughes, Christine M
AU  - Hughes CM
FAU - Wilkins, Kimberly
AU  - Wilkins K
FAU - Bachmann, Laura
AU  - Bachmann L
FAU - Chatelain, Ryan
AU  - Chatelain R
FAU - Donnelly, Marisa A P
AU  - Donnelly MAP
FAU - Mendoza, Rafael
AU  - Mendoza R
FAU - Downes, Barbara L
AU  - Downes BL
FAU - Roskosky, Mellisa
AU  - Roskosky M
FAU - Barnes, Meghan
AU  - Barnes M
FAU - Gallagher, Glen R
AU  - Gallagher GR
FAU - Basgoz, Nesli
AU  - Basgoz N
FAU - Ruiz, Victoria
AU  - Ruiz V
FAU - Kyaw, Nang Thu Thu
AU  - Kyaw NTT
FAU - Feldpausch, Amanda
AU  - Feldpausch A
FAU - Valderrama, Amy
AU  - Valderrama A
FAU - Alvarado-Ramy, Francisco
AU  - Alvarado-Ramy F
FAU - Dowell, Chad H
AU  - Dowell CH
FAU - Chow, Catherine C
AU  - Chow CC
FAU - Li, Yu
AU  - Li Y
FAU - Quilter, Laura
AU  - Quilter L
FAU - Brooks, John
AU  - Brooks J
FAU - Daskalakis, Demetre C
AU  - Daskalakis DC
FAU - McClung, R Paul
AU  - McClung RP
FAU - Petersen, Brett W
AU  - Petersen BW
FAU - Damon, Inger
AU  - Damon I
FAU - Hutson, Christina
AU  - Hutson C
FAU - McQuiston, Jennifer
AU  - McQuiston J
FAU - Rao, Agam K
AU  - Rao AK
FAU - Belay, Ermias
AU  - Belay E
FAU - McCollum, Andrea M
AU  - McCollum AM
CN  - Monkeypox Response Team 2022
LA  - eng
PT  - Journal Article
DEP - 20220610
PL  - United States
TA  - MMWR Morb Mortal Wkly Rep
JT  - MMWR. Morbidity and mortality weekly report
JID - 7802429
SB  - IM
MH  - Disease Outbreaks
MH  - Homosexuality, Male
MH  - Humans
MH  - *Malaria/diagnosis
MH  - Male
MH  - *Monkeypox/diagnosis/epidemiology
MH  - Population Surveillance
MH  - *Sexual and Gender Minorities
MH  - Travel
MH  - United States/epidemiology
PMC - PMC9181052
COIS- All authors have completed and submitted the International Committee of MedicalJournal Editors form for disclosure of potential conflicts of interest. Nopotential conflicts of interest were disclosed.
IR  - Angelo K
FIR - Angelo, Kristina
IRAD- CDC.
IR  - Arduino M
FIR - Arduino, Matt
IRAD- CDC.
IR  - Arthur R
FIR - Arthur, Ray
IRAD- CDC.
IR  - Baird N
FIR - Baird, Nicolle
IRAD- CDC.
IR  - Batross J
FIR - Batross, Jonathan
IRAD- CDC.
IR  - Beeson A
FIR - Beeson, Amy
IRAD- CDC.
IR  - Bhingarde J
FIR - Bhingarde, Jui
IRAD- CDC.
IR  - Bowen M
FIR - Bowen, Michael
IRAD- CDC.
IR  - Brown C
FIR - Brown, Clive
IRAD- CDC.
IR  - Brown CM
FIR - Brown, Catherine M
IRAD- Massachusetts Department of Health.
IR  - Burakoff A
FIR - Burakoff, Alexis
IRAD- Colorado Department of Public Health and Environment.
IR  - Charniga K
FIR - Charniga, Kelly
IRAD- CDC.
IR  - Chen TH
FIR - Chen, Tai-Ho
IRAD- CDC.
IR  - Chen S
FIR - Chen, Sherry
IRAD- CDC.
IR  - Clay P
FIR - Clay, Patrick
IRAD- CDC.
IR  - Cope J
FIR - Cope, James
IRAD- CDC.
IR  - Cope J
FIR - Cope, Jennifer
IRAD- CDC.
IR  - Dankwa MA
FIR - Dankwa, Michelle Addo
IRAD- Fairfax County Health Department.
IR  - Delaney L
FIR - Delaney, Lisa
IRAD- CDC.
IR  - Perio M
FIR - Perio, Marie De
IRAD- CDC.
IR  - Decenteceo M
FIR - Decenteceo, Michelle
IRAD- CDC.
IR  - Delea K
FIR - Delea, Kristin
IRAD- CDC.
IR  - Doty JB
FIR - Doty, Jeffrey B
IRAD- CDC.
IR  - Duchin J
FIR - Duchin, Jeffrey
IRAD- Public Health - Seattle & King County.
IR  - Dunlap J
FIR - Dunlap, Joseph
IRAD- CDC.
IR  - Fagan R
FIR - Fagan, Ryan
IRAD- CDC.
IR  - Furness B
FIR - Furness, Bryce
IRAD- CDC.
IR  - Gearhart S
FIR - Gearhart, Shannon
IRAD- CDC.
IR  - Gigante C
FIR - Gigante, Crystal
IRAD- CDC.
IR  - Gilliland A
FIR - Gilliland, Aubrey
IRAD- CDC.
IR  - Gosdin L
FIR - Gosdin, Lucas
IRAD- CDC.
IR  - Griffin I
FIR - Griffin, Isabel
IRAD- CDC.
IR  - Groccia A
FIR - Groccia, Amanda
IRAD- CDC.
IR  - Guagliardo S
FIR - Guagliardo, Sarah
IRAD- CDC.
IR  - Hercules Y
FIR - Hercules, Yonette
IRAD- CDC.
IR  - Jackson K
FIR - Jackson, Kelly
IRAD- CDC.
IR  - Jarquin P
FIR - Jarquin, Paulino
IRAD- CDC.
IR  - Kachur R
FIR - Kachur, Rachel
IRAD- CDC.
IR  - Kallen A
FIR - Kallen, Alexander
IRAD- CDC.
IR  - Kao R
FIR - Kao, Raymond
IRAD- CDC.
IR  - Kelly A
FIR - Kelly, Aubree
IRAD- CDC.
IR  - Khan M
FIR - Khan, Mohammed
IRAD- CDC.
IR  - Khan T
FIR - Khan, Theodora
IRAD- CDC.
IR  - Kofman A
FIR - Kofman, Aaron
IRAD- CDC.
IR  - Kornylo K
FIR - Kornylo, Krista
IRAD- CDC.
IR  - Kuhar D
FIR - Kuhar, David
IRAD- CDC.
IR  - LaFlam M
FIR - LaFlam, Michael
IRAD- CDC.
IR  - Lash R
FIR - Lash, Robert
IRAD- CDC.
IR  - Lashombe A
FIR - Lashombe, Andrew
IRAD- CDC.
IR  - Lowe D
FIR - Lowe, David
IRAD- CDC.
IR  - MacGurn A
FIR - MacGurn, Amanda
IRAD- CDC.
IR  - Masters N
FIR - Masters, Nina
IRAD- CDC.
IR  - McCaffrey K
FIR - McCaffrey, Keegan
IRAD- Utah Department of Health.
IR  - Mink JL
FIR - Mink, Jenna L
IRAD- CDC.
IR  - Monroe B
FIR - Monroe, Benjamin
IRAD- CDC.
IR  - Morgan CN
FIR - Morgan, Clint N
IRAD- CDC.
IR  - Nakazawa Y
FIR - Nakazawa, Yoshinori
IRAD- CDC.
IR  - Nash J
FIR - Nash, Julie
IRAD- California Department of Public Health.
IR  - Navarra T
FIR - Navarra, Terese
IRAD- CDC.
IR  - Newton D
FIR - Newton, Donovan
IRAD- CDC.
IR  - Osinubi M
FIR - Osinubi, Modupe
IRAD- CDC.
IR  - Osorio V
FIR - Osorio, Valentina
IRAD- CDC.
IR  - Pearson C
FIR - Pearson, Christine
IRAD- CDC.
IR  - Petras J
FIR - Petras, Julia
IRAD- CDC.
IR  - Philpott D
FIR - Philpott, David
IRAD- CDC.
IR  - Pickrel A
FIR - Pickrel, Amy
IRAD- CDC.
IR  - Potvin B
FIR - Potvin, Brandon
IRAD- CDC.
IR  - Priyamvada L
FIR - Priyamvada, Lalita
IRAD- CDC.
IR  - Rey A
FIR - Rey, Araceli
IRAD- CDC.
IR  - Ricketts E
FIR - Ricketts, Erin
IRAD- CDC.
IR  - Rodriguez S
FIR - Rodriguez, Sergio
IRAD- CDC.
IR  - Rushmore J
FIR - Rushmore, Julie
IRAD- CDC.
IR  - Satheshkumar PS
FIR - Satheshkumar, Panayampalli S
IRAD- CDC.
IR  - Segaloff H
FIR - Segaloff, Hannah
IRAD- CDC.
IR  - Sekkarie A
FIR - Sekkarie, Ahlia
IRAD- CDC.
IR  - Sharma A
FIR - Sharma, Artee
IRAD- CDC.
IR  - Sims E
FIR - Sims, Emily
IRAD- CDC.
IR  - Smith D
FIR - Smith, Dallas
IRAD- CDC.
IR  - Smith T
FIR - Smith, Teresa
IRAD- CDC.
IR  - Smith T
FIR - Smith, Todd
IRAD- CDC.
IR  - Solanky D
FIR - Solanky, Dipesh
IRAD- CDC.
IR  - Spiknall I
FIR - Spiknall, Ian
IRAD- CDC.
IR  - Stanek DR
FIR - Stanek, Danielle R
IRAD- Florida Department of Health.
IR  - Stenger M
FIR - Stenger, Mark
IRAD- CDC.
IR  - Strona F
FIR - Strona, Frank
IRAD- CDC.
IR  - Tardivel K
FIR - Tardivel, Kara
IRAD- CDC.
IR  - Tyagi E
FIR - Tyagi, Eishita
IRAD- CDC.
IR  - Wortley P
FIR - Wortley, Pascale
IRAD- Georgia Department of Public Health.
IR  - Valencia D
FIR - Valencia, Diana
IRAD- CDC.
IR  - Waltenburg M
FIR - Waltenburg, Michelle
IRAD- CDC.
IR  - Whitehouse E
FIR - Whitehouse, Erin
IRAD- CDC.
IR  - Wong M
FIR - Wong, Marcia
IRAD- New York City Department of Health and Mental Hygiene.
EDAT- 2022/06/10 06:00
MHDA- 2022/06/14 06:00
CRDT- 2022/06/09 13:13
PHST- 2022/06/09 13:13 [entrez]
PHST- 2022/06/10 06:00 [pubmed]
PHST- 2022/06/14 06:00 [medline]
AID - 10.15585/mmwr.mm7123e1 [doi]
PST - epublish
SO  - MMWR Morb Mortal Wkly Rep. 2022 Jun 10;71(23):764-769. doi:10.15585/mmwr.mm7123e1.

PMID- 35679066
OWN - NLM
STAT- MEDLINE
LR  - 20220715
IS  - 1538-3598 (Electronic)
IS  - 0098-7484 (Linking)
VI  - 328
IP  - 2
DP  - 2022 Jul 12
TI  - What Is Monkeypox?
PG  - 222
LID - 10.1001/jama.2022.10259 [doi]
FAU - Walter, Kristin
AU  - Walter K
AD  - Senior Editor, JAMA.
FAU - Malani, Preeti N
AU  - Malani PN
AD  - Associate Editor, JAMA.
AD  - Division of Infectious Diseases, University of Michigan Health System, Ann Arbor.
LA  - eng
PT  - Patient Education Handout
PL  - United States
TA  - JAMA
JT  - JAMA
JID - 7501160
SB  - IM
MH  - Animals
MH  - Disease Outbreaks
MH  - Humans
MH  - *Monkeypox/diagnosis/epidemiology/prevention & control
MH  - Zoonoses
EDAT- 2022/06/10 06:00
MHDA- 2022/07/15 06:00
CRDT- 2022/06/09 11:42
PHST- 2022/06/10 06:00 [pubmed]
PHST- 2022/07/15 06:00 [medline]
PHST- 2022/06/09 11:42 [entrez]
AID - 2793383 [pii]
AID - 10.1001/jama.2022.10259 [doi]
PST - ppublish
SO  - JAMA. 2022 Jul 12;328(2):222. doi: 10.1001/jama.2022.10259.

PMID- 35676362
OWN - NLM
STAT- MEDLINE
DCOM- 20220616
LR  - 20220617
IS  - 1476-4687 (Electronic)
IS  - 0028-0836 (Linking)
VI  - 606
IP  - 7914
DP  - 2022 Jun
TI  - Monkeypox vaccination begins - can the global outbreaks be contained?
PG  - 444-445
LID - 10.1038/d41586-022-01587-1 [doi]
FAU - Kozlov, Max
AU  - Kozlov M
LA  - eng
PT  - Journal Article
PL  - England
TA  - Nature
JT  - Nature
JID - 0410462
RN  - 0 (Viral Vaccines)
SB  - IM
MH  - *Disease Outbreaks/prevention & control/statistics & numerical data
MH  - Humans
MH  - *Internationality
MH  - *Monkeypox/epidemiology/prevention & control
MH  - *Vaccination/trends
MH  - *Viral Vaccines
OTO - NOTNLM
OT  - *Diseases
OT  - *Public health
OT  - *Virology
EDAT- 2022/06/09 06:00
MHDA- 2022/06/18 06:00
CRDT- 2022/06/08 23:21
PHST- 2022/06/09 06:00 [pubmed]
PHST- 2022/06/18 06:00 [medline]
PHST- 2022/06/08 23:21 [entrez]
AID - 10.1038/d41586-022-01587-1 [doi]
AID - 10.1038/d41586-022-01587-1 [pii]
PST - ppublish
SO  - Nature. 2022 Jun;606(7914):444-445. doi: 10.1038/d41586-022-01587-1.

PMID- 35676244
OWN - NLM
STAT- MEDLINE
DCOM- 20220712
LR  - 20220723
IS  - 1559-6834 (Electronic)
IS  - 0899-823X (Linking)
VI  - 43
IP  - 7
DP  - 2022 Jul
TI  - Monkeypox transmission following exposure in healthcare facilities in nonendemic settings: Low risk but limited literature.
PG  - 920-924
LID - 10.1017/ice.2022.152 [doi]
AB  - Transmission risk of monkeypox in healthcare settings outside endemic regions hasnot been well defined. A rapid review of the literature, including cases outside monkeypox-endemic regions from 2000 to 2022 identified a single reported case of transmission. Available literature is limited by nonstandardized exposuredefinitions and limited detail describing exposures.
FAU - Zachary, Kimon C
AU  - Zachary KC
AD  - Regional Emerging Special Pathogens Treatment Center, Massachusetts GeneralHospital, Boston, Massachusetts.
AD  - Infection Control Unit, Massachusetts General Hospital, Boston, Massachusetts.
AD  - Division of Infectious Diseases, Department of Medicine, Massachusetts GeneralHospital, Boston, Massachusetts.
AD  - Harvard Medical School, Boston, Massachusetts.
FAU - Shenoy, Erica S
AU  - Shenoy ES
AUID- ORCID: https://orcid.org/0000-0001-8086-1123
AD  - Regional Emerging Special Pathogens Treatment Center, Massachusetts GeneralHospital, Boston, Massachusetts.
AD  - Infection Control Unit, Massachusetts General Hospital, Boston, Massachusetts.
AD  - Division of Infectious Diseases, Department of Medicine, Massachusetts GeneralHospital, Boston, Massachusetts.
AD  - Harvard Medical School, Boston, Massachusetts.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20220609
PL  - United States
TA  - Infect Control Hosp Epidemiol
JT  - Infection control and hospital epidemiology
JID - 8804099
SB  - IM
MH  - Animals
MH  - Delivery of Health Care
MH  - Humans
MH  - *Monkeypox/epidemiology
MH  - Monkeypox virus
PMC - PMC9272466
EDAT- 2022/06/09 06:00
MHDA- 2022/07/14 06:00
CRDT- 2022/06/08 23:13
PHST- 2022/06/09 06:00 [pubmed]
PHST- 2022/07/14 06:00 [medline]
PHST- 2022/06/08 23:13 [entrez]
AID - S0899823X22001520 [pii]
AID - 10.1017/ice.2022.152 [doi]
PST - ppublish
SO  - Infect Control Hosp Epidemiol. 2022 Jul;43(7):920-924. doi: 10.1017/ice.2022.152.Epub 2022 Jun 9.

PMID- 35675925
OWN - NLM
STAT- MEDLINE
DCOM- 20220610
LR  - 20220711
IS  - 0379-5284 (Print)
IS  - 0379-5284 (Linking)
VI  - 43
IP  - 6
DP  - 2022 Jun
TI  - WHO working closely with countries responding to monkeypox.
PG  - 658
LA  - eng
PT  - Journal Article
PL  - Saudi Arabia
TA  - Saudi Med J
JT  - Saudi medical journal
JID - 7909441
SB  - IM
MH  - Disease Outbreaks
MH  - Humans
MH  - *Monkeypox/epidemiology
MH  - World Health Organization
EDAT- 2022/06/09 06:00
MHDA- 2022/06/11 06:00
CRDT- 2022/06/08 20:43
PHST- 2022/06/08 20:43 [entrez]
PHST- 2022/06/09 06:00 [pubmed]
PHST- 2022/06/11 06:00 [medline]
AID - 43/6/658 [pii]
PST - ppublish
SO  - Saudi Med J. 2022 Jun;43(6):658.

PMID- 35675097
OWN - NLM
STAT- MEDLINE
DCOM- 20220719
LR  - 20220719
IS  - 1468-3083 (Electronic)
IS  - 0926-9959 (Linking)
VI  - 36
IP  - 8
DP  - 2022 Aug
TI  - Monkeypox virus case with maculopapular exanthem and proctitis during the Spanishoutbreak in 2022.
PG  - e658-e660
LID - 10.1111/jdv.18300 [doi]
FAU - de Nicolas-Ruanes, B
AU  - de Nicolas-Ruanes B
AUID- ORCID: 0000-0002-3206-2826
AD  - Department of Dermatology, University Hospital Ramon y Cajal and IRYCIS,Universidad de Alcala, Madrid, Spain.
FAU - Vivancos, M J
AU  - Vivancos MJ
AUID- ORCID: 0000-0002-9373-6011
AD  - Department of Infectious Diseases, University Hospital Ramon y Cajal and IRYCIS, Universidad de Alcala, Madrid, Spain.
AD  - CIBER de Enfermedades Infecciosas, Madrid, Spain.
FAU - Azcarraga-Llobet, C
AU  - Azcarraga-Llobet C
AUID- ORCID: 0000-0001-8088-4077
AD  - Department of Dermatology, University Hospital Ramon y Cajal and IRYCIS,Universidad de Alcala, Madrid, Spain.
FAU - Moreno, A M
AU  - Moreno AM
AD  - Department of Infectious Diseases, University Hospital Ramon y Cajal and IRYCIS, Universidad de Alcala, Madrid, Spain.
AD  - CIBER de Enfermedades Infecciosas, Madrid, Spain.
FAU - Rodriguez-Dominguez, M
AU  - Rodriguez-Dominguez M
AD  - Department of Microbiology, University Hospital Ramon y Cajal and IRYCIS,Universidad de Alcala, Madrid, Spain.
AD  - CIBER en Epidermiologia y Salud Publica (CIBERESP), Madrid, Spain.
FAU - Berna-Rico, E D
AU  - Berna-Rico ED
AUID- ORCID: 0000-0003-0348-5421
AD  - Department of Dermatology, University Hospital Ramon y Cajal and IRYCIS,Universidad de Alcala, Madrid, Spain.
FAU - Garcia-Mouronte, E
AU  - Garcia-Mouronte E
AUID- ORCID: 0000-0001-9457-8361
AD  - Department of Dermatology, University Hospital Ramon y Cajal and IRYCIS,Universidad de Alcala, Madrid, Spain.
FAU - Carron-Herrero, A
AU  - Carron-Herrero A
AD  - Department of Dermatology, University Hospital Ramon y Cajal and IRYCIS,Universidad de Alcala, Madrid, Spain.
FAU - McGee, A
AU  - McGee A
AD  - Department of Preventive Medicine and Public Health, University Hospital Ramon y Cajal, Madrid, Spain.
FAU - Galan, J C
AU  - Galan JC
AD  - Department of Microbiology, University Hospital Ramon y Cajal and IRYCIS,Universidad de Alcala, Madrid, Spain.
AD  - CIBER en Epidermiologia y Salud Publica (CIBERESP), Madrid, Spain.
FAU - Moreno, S
AU  - Moreno S
AD  - Department of Infectious Diseases, University Hospital Ramon y Cajal and IRYCIS, Universidad de Alcala, Madrid, Spain.
AD  - CIBER de Enfermedades Infecciosas, Madrid, Spain.
FAU - Jaen-Olasolo, P
AU  - Jaen-Olasolo P
AD  - Department of Dermatology, University Hospital Ramon y Cajal and IRYCIS,Universidad de Alcala, Madrid, Spain.
FAU - Fernandez-Gonzalez, P
AU  - Fernandez-Gonzalez P
AUID- ORCID: 0000-0002-9419-6635
AD  - Department of Dermatology, University Hospital Ramon y Cajal and IRYCIS,Universidad de Alcala, Madrid, Spain.
LA  - eng
PT  - Letter
DEP - 20220614
PL  - England
TA  - J Eur Acad Dermatol Venereol
JT  - Journal of the European Academy of Dermatology and Venereology : JEADV
JID - 9216037
SB  - IM
MH  - Disease Outbreaks
MH  - *Drug Eruptions
MH  - Humans
MH  - Monkeypox virus
MH  - *Proctitis/epidemiology
EDAT- 2022/06/09 06:00
MHDA- 2022/07/20 06:00
CRDT- 2022/06/08 11:43
PHST- 2022/05/22 00:00 [received]
PHST- 2022/06/03 00:00 [accepted]
PHST- 2022/06/09 06:00 [pubmed]
PHST- 2022/07/20 06:00 [medline]
PHST- 2022/06/08 11:43 [entrez]
AID - 10.1111/jdv.18300 [doi]
PST - ppublish
SO  - J Eur Acad Dermatol Venereol. 2022 Aug;36(8):e658-e660. doi: 10.1111/jdv.18300.Epub 2022 Jun 14.

PMID- 35675087
OWN - NLM
STAT- MEDLINE
DCOM- 20220719
LR  - 20220719
IS  - 1468-3083 (Electronic)
IS  - 0926-9959 (Linking)
VI  - 36
IP  - 8
DP  - 2022 Aug
TI  - Monkeypox virus infection: what dermatologist needs to know?
PG  - e656-e658
LID - 10.1111/jdv.18299 [doi]
FAU - Bellinato, F
AU  - Bellinato F
AUID- ORCID: 0000-0002-6163-6921
AD  - Department of Medicine, Section of Dermatology and Venereology, University ofVerona, Verona, Italy.
FAU - Gisondi, P
AU  - Gisondi P
AUID- ORCID: 0000-0002-1777-9001
AD  - Department of Medicine, Section of Dermatology and Venereology, University ofVerona, Verona, Italy.
FAU - Girolomoni, G
AU  - Girolomoni G
AUID- ORCID: 0000-0001-8548-0493
AD  - Department of Medicine, Section of Dermatology and Venereology, University ofVerona, Verona, Italy.
LA  - eng
PT  - Letter
DEP - 20220614
PL  - England
TA  - J Eur Acad Dermatol Venereol
JT  - Journal of the European Academy of Dermatology and Venereology : JEADV
JID - 9216037
SB  - IM
MH  - Animals
MH  - Dermatologists
MH  - Humans
MH  - *Monkeypox
MH  - *Monkeypox virus
EDAT- 2022/06/09 06:00
MHDA- 2022/07/20 06:00
CRDT- 2022/06/08 11:43
PHST- 2022/05/24 00:00 [received]
PHST- 2022/06/03 00:00 [accepted]
PHST- 2022/06/09 06:00 [pubmed]
PHST- 2022/07/20 06:00 [medline]
PHST- 2022/06/08 11:43 [entrez]
AID - 10.1111/jdv.18299 [doi]
PST - ppublish
SO  - J Eur Acad Dermatol Venereol. 2022 Aug;36(8):e656-e658. doi: 10.1111/jdv.18299.Epub 2022 Jun 14.

PMID- 35672908
OWN - NLM
STAT- Publisher
LR  - 20220618
IS  - 1096-9071 (Electronic)
IS  - 0146-6615 (Linking)
DP  - 2022 Jun 7
TI  - The spreading of monkeypox in nonendemic countries has created panic across theworld: Could it be another threat?
LID - 10.1002/jmv.27919 [doi]
FAU - Islam, Md Rabiul
AU  - Islam MR
AUID- ORCID: http://orcid.org/0000-0003-2820-3144
AD  - Department of Pharmacy, University of Asia Pacific, Dhaka, Bangladesh.
FAU - Asaduzzaman, Md
AU  - Asaduzzaman M
AD  - Department of Pharmacy, University of Asia Pacific, Dhaka, Bangladesh.
FAU - Shahriar, Mohammad
AU  - Shahriar M
AD  - Department of Pharmacy, University of Asia Pacific, Dhaka, Bangladesh.
FAU - Bhuiyan, Mohiuddin Ahmed
AU  - Bhuiyan MA
AD  - Department of Pharmacy, University of Asia Pacific, Dhaka, Bangladesh.
LA  - eng
PT  - Letter
DEP - 20220607
PL  - United States
TA  - J Med Virol
JT  - Journal of medical virology
JID - 7705876
SB  - IM
EDAT- 2022/06/09 06:00
MHDA- 2022/06/09 06:00
CRDT- 2022/06/08 00:43
PHST- 2022/06/02 00:00 [revised]
PHST- 2022/05/24 00:00 [received]
PHST- 2022/06/03 00:00 [accepted]
PHST- 2022/06/09 06:00 [pubmed]
PHST- 2022/06/09 06:00 [medline]
PHST- 2022/06/08 00:43 [entrez]
AID - 10.1002/jmv.27919 [doi]
PST - aheadofprint
SO  - J Med Virol. 2022 Jun 7. doi: 10.1002/jmv.27919.

PMID- 35672392
OWN - NLM
STAT- MEDLINE
DCOM- 20220718
LR  - 20220718
IS  - 1740-1534 (Electronic)
IS  - 1740-1526 (Linking)
VI  - 20
IP  - 8
DP  - 2022 Aug
TI  - Case series of monkeypox infections.
PG  - 445
LID - 10.1038/s41579-022-00757-2 [doi]
FAU - Hofer, Ursula
AU  - Hofer U
AD  - Nature Reviews Microbiology, . nrmicro@nature.com.
LA  - eng
PT  - Journal Article
PL  - England
TA  - Nat Rev Microbiol
JT  - Nature reviews. Microbiology
JID - 101190261
SB  - IM
MH  - Animals
MH  - Disease Outbreaks
MH  - Humans
MH  - *Monkeypox/diagnosis/epidemiology
MH  - Research
EDAT- 2022/06/08 06:00
MHDA- 2022/07/19 06:00
CRDT- 2022/06/07 23:21
PHST- 2022/06/08 06:00 [pubmed]
PHST- 2022/07/19 06:00 [medline]
PHST- 2022/06/07 23:21 [entrez]
AID - 10.1038/s41579-022-00757-2 [doi]
AID - 10.1038/s41579-022-00757-2 [pii]
PST - ppublish
SO  - Nat Rev Microbiol. 2022 Aug;20(8):445. doi: 10.1038/s41579-022-00757-2.

PMID- 35672045
OWN - NLM
STAT- MEDLINE
DCOM- 20220609
LR  - 20220711
IS  - 1756-1833 (Electronic)
IS  - 0959-8138 (Linking)
VI  - 377
DP  - 2022 Jun 7
TI  - Monkeypox: Doctors in England will have to notify local agencies of all suspectedcases.
PG  - o1413
LID - 10.1136/bmj.o1413 [doi]
FAU - Iacobucci, Gareth
AU  - Iacobucci G
AD  - The BMJ.
LA  - eng
PT  - Journal Article
DEP - 20220607
PL  - England
TA  - BMJ
JT  - BMJ (Clinical research ed.)
JID - 8900488
SB  - IM
MH  - Disease Outbreaks
MH  - England
MH  - Humans
MH  - *Monkeypox/epidemiology
MH  - *Physicians
EDAT- 2022/06/08 06:00
MHDA- 2022/06/10 06:00
CRDT- 2022/06/07 20:43
PHST- 2022/06/07 20:43 [entrez]
PHST- 2022/06/08 06:00 [pubmed]
PHST- 2022/06/10 06:00 [medline]
AID - 10.1136/bmj.o1413 [doi]
PST - epublish
SO  - BMJ. 2022 Jun 7;377:o1413. doi: 10.1136/bmj.o1413.

PMID- 35671261
OWN - NLM
STAT- MEDLINE
DCOM- 20220801
LR  - 20220802
IS  - 1698-6997 (Electronic)
IS  - 1139-6121 (Linking)
VI  - 24
IP  - 2
DP  - 2022 Apr 1
TI  - International outbreak of monkeypox in men having sex with men.
PG  - 101-103
LID - 10.24875/AIDSRev.M22000051 [doi]
FAU - Soriano, Vicente
AU  - Soriano V
AD  - UNIR Health Sciences School & Medical Center, Madrid, Spain.
FAU - Corral, Octavio
AU  - Corral O
AD  - UNIR Health Sciences School & Medical Center, Madrid, Spain.
LA  - eng
PT  - Journal Article
DEP - 20220401
PL  - Spain
TA  - AIDS Rev
JT  - AIDS reviews
JID - 101134876
SB  - IM
MH  - Animals
MH  - Disease Outbreaks
MH  - *HIV Infections/epidemiology
MH  - Humans
MH  - Male
MH  - *Monkeypox/epidemiology
EDAT- 2022/06/08 06:00
MHDA- 2022/08/02 06:00
CRDT- 2022/06/07 13:31
PHST- 2022/06/07 13:31 [entrez]
PHST- 2022/06/08 06:00 [pubmed]
PHST- 2022/08/02 06:00 [medline]
AID - 10.24875/AIDSRev.M22000051 [doi]
PST - epublish
SO  - AIDS Rev. 2022 Apr 1;24(2):101-103. doi: 10.24875/AIDSRev.M22000051.

PMID- 35668692
OWN - NLM
STAT- MEDLINE
DCOM- 20220608
LR  - 20220716
IS  - 1598-6357 (Electronic)
IS  - 1011-8934 (Linking)
VI  - 37
IP  - 22
DP  - 2022 Jun 6
TI  - Once Bitten, Twice Shy: Our Attitude Towards Monkeypox.
PG  - e188
LID - 10.3346/jkms.2022.37.e188 [doi]
FAU - Yoo, Jin-Hong
AU  - Yoo JH
AUID- ORCID: 0000-0003-2611-3399
AD  - Division of Infectious Diseases, Department of Internal Medicine, Bucheon St.Mary's Hospital, Bucheon, Korea.
AD  - Division of Infectious Diseases, Department of Internal Medicine, College ofMedicine, The Catholic University of Korea, Seoul, Korea. jhyoo@catholic.ac.kr.
LA  - eng
PT  - Editorial
DEP - 20220606
PL  - Korea (South)
TA  - J Korean Med Sci
JT  - Journal of Korean medical science
JID - 8703518
SB  - IM
MH  - Humans
MH  - *Monkeypox
PMC - PMC9171345
COIS- The author has no potential conflict of interest to disclose.
EDAT- 2022/06/08 06:00
MHDA- 2022/06/09 06:00
CRDT- 2022/06/07 01:44
PHST- 2022/05/28 00:00 [received]
PHST- 2022/05/30 00:00 [accepted]
PHST- 2022/06/07 01:44 [entrez]
PHST- 2022/06/08 06:00 [pubmed]
PHST- 2022/06/09 06:00 [medline]
AID - 37.e188 [pii]
AID - 10.3346/jkms.2022.37.e188 [doi]
PST - epublish
SO  - J Korean Med Sci. 2022 Jun 6;37(22):e188. doi: 10.3346/jkms.2022.37.e188.

PMID- 35668338
OWN - NLM
STAT- Publisher
LR  - 20220716
IS  - 1863-4362 (Electronic)
IS  - 0021-1265 (Linking)
DP  - 2022 Jun 6
TI  - Multinational monkeypox outbreak: what do we know and what should we do?
LID - 10.1007/s11845-022-03052-4 [doi]
FAU - Memariani, Mojtaba
AU  - Memariani M
AUID- ORCID: http://orcid.org/0000-0002-4964-3117
AD  - Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran,Iran. memaryani@gmail.com.
AD  - Department of Pathobiology, School of Public Health, Tehran University of MedicalSciences, Tehran, Iran. memaryani@gmail.com.
FAU - Memariani, Hamed
AU  - Memariani H
AUID- ORCID: http://orcid.org/0000-0003-1026-140X
AD  - Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran,Iran.
AD  - Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.
LA  - eng
PT  - Letter
DEP - 20220606
PL  - Ireland
TA  - Ir J Med Sci
JT  - Irish journal of medical science
JID - 7806864
SB  - IM
EIN - Ir J Med Sci. 2022 Jun 13;:. PMID: 35691984
PMC - PMC9170238
EDAT- 2022/06/07 06:00
MHDA- 2022/06/07 06:00
CRDT- 2022/06/06 23:27
PHST- 2022/05/28 00:00 [received]
PHST- 2022/06/03 00:00 [accepted]
PHST- 2022/06/07 06:00 [pubmed]
PHST- 2022/06/07 06:00 [medline]
PHST- 2022/06/06 23:27 [entrez]
AID - 10.1007/s11845-022-03052-4 [doi]
AID - 10.1007/s11845-022-03052-4 [pii]
PST - aheadofprint
SO  - Ir J Med Sci. 2022 Jun 6. pii: 10.1007/s11845-022-03052-4. doi:10.1007/s11845-022-03052-4.

PMID- 35665517
OWN - NLM
STAT- Publisher
LR  - 20220611
IS  - 1096-9071 (Electronic)
IS  - 0146-6615 (Linking)
DP  - 2022 Jun 3
TI  - Viruses monkeying around with surgical safety: Monkeypox preparedness in surgicalsettings.
LID - 10.1002/jmv.27915 [doi]
FAU - Tsagkaris, Christos
AU  - Tsagkaris C
AUID- ORCID: http://orcid.org/0000-0002-4250-574X
AD  - European Student Think Tank, Public Health and Policy Working Group, Amsterdam,Netherlands.
FAU - Eleftheriades, Anna
AU  - Eleftheriades A
AUID- ORCID: http://orcid.org/0000-0002-0299-1317
AD  - European Student Think Tank, Public Health and Policy Working Group, Amsterdam,Netherlands.
FAU - Laubscher, Lily
AU  - Laubscher L
AD  - Department of Health Sciences and Technology, Swiss Federal Institute ofTechnology Zurich (ETH Zurich), Zurich, Switzerland.
FAU - Vladyckuk, Valeriia
AU  - Vladyckuk V
AD  - Faculty of Medicine, Bogomolets National Medical University, Kyiv, Ukraine.
FAU - Papadakis, Marios
AU  - Papadakis M
AUID- ORCID: http://orcid.org/0000-0002-9020-874X
AD  - Department of Surgery II, University of Witten-Herdecke, Wuppertal, Germany.
LA  - eng
PT  - Letter
DEP - 20220603
PL  - United States
TA  - J Med Virol
JT  - Journal of medical virology
JID - 7705876
SB  - IM
EDAT- 2022/06/07 06:00
MHDA- 2022/06/07 06:00
CRDT- 2022/06/06 14:34
PHST- 2022/05/31 00:00 [revised]
PHST- 2022/05/26 00:00 [received]
PHST- 2022/06/01 00:00 [accepted]
PHST- 2022/06/07 06:00 [pubmed]
PHST- 2022/06/07 06:00 [medline]
PHST- 2022/06/06 14:34 [entrez]
AID - 10.1002/jmv.27915 [doi]
PST - aheadofprint
SO  - J Med Virol. 2022 Jun 3. doi: 10.1002/jmv.27915.

PMID- 35664835
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220716
IS  - 2052-2975 (Print)
IS  - 2052-2975 (Linking)
VI  - 47
DP  - 2022 Apr-May
TI  - The new face of monkeypox virus: an emerging global emergency.
PG  - 100989
LID - 10.1016/j.nmni.2022.100989 [doi]
FAU - Jain, Nityanand
AU  - Jain N
AD  - Faculty of Medicine, Riga Stradins University, Dzirciema Street 16, LV-1007 Riga,Latvia.
FAU - Lansiaux, Edouard
AU  - Lansiaux E
AD  - Lille University School of Medicine, 2 Avenue Eugene Avinee, 59120 Loos, Lille,France.
FAU - Simanis, Raimonds
AU  - Simanis R
AD  - Department of Infectiology, Faculty of Medicine, Riga Stradins University,LV-1007 Riga, Latvia.
LA  - eng
PT  - Editorial
DEP - 20220527
PL  - England
TA  - New Microbes New Infect
JT  - New microbes and new infections
JID - 101624750
PMC - PMC9135499
OTO - NOTNLM
OT  - Global
OT  - infections
OT  - monkeypox virus
OT  - pandemic
OT  - sexual transmission
EDAT- 2022/06/07 06:00
MHDA- 2022/06/07 06:01
CRDT- 2022/06/06 14:20
PHST- 2022/06/07 06:00 [pubmed]
PHST- 2022/06/07 06:01 [medline]
PHST- 2022/06/06 14:20 [entrez]
AID - 10.1016/j.nmni.2022.100989 [doi]
AID - S2052-2975(22)00041-5 [pii]
PST - ppublish
SO  - New Microbes New Infect. 2022 Apr-May;47:100989. doi: 10.1016/j.nmni.2022.100989.Epub 2022 May 27.

PMID- 35664703
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220716
IS  - 2162-2531 (Print)
IS  - 2162-2531 (Linking)
VI  - 28
DP  - 2022 Jun 14
TI  - Lipid nanoparticle delivery of unmodified mRNAs encoding multiple monoclonalantibodies targeting poxviruses in rabbits.
PG  - 847-858
LID - 10.1016/j.omtn.2022.05.025 [doi]
AB  - Poxviruses are a large and complex family of viruses with members such asmonkeypox virus and variola virus. The possibility of an outbreak of monkeypoxvirus (or a related poxvirus) or the misuse of variola virus justifies thedevelopment of countermeasures. Furthermore, poxviruses can be a useful surrogatefor developing technology involving antibody therapies. In our experiments, weexplored the feasibility of utilizing unmodified mRNA that encodes threepreviously described monoclonal antibodies, c8A, c6C, and c7D11, ascountermeasures to smallpox in a relatively large (>3 kg) laboratory animal(rabbits). We confirmed in vitro translation, secretion, and biological activity of mRNA constructs and identified target monoclonal antibody levels from a murinevaccinia virus model that provided a clinical benefit. Individually, we were ableto detect c7D11, c8A, and c6C in the serum of rabbits within 1 day of anintramuscular jet injection of lipid nanoparticle (LNP)-formulated mRNA.Injection of a combination of three LNP-formulated mRNA constructs encoding thethree different antibodies produced near equivalent serum levels compared witheach individual construct administered alone. These data are among the firstdemonstrating the feasibility of launching multiple antibodies using mRNAconstructs in a large, nonrodent species. Based on empirically derived targetserum level and the observed decay rate, the antibody levels attained wereunlikely to provide protection.
FAU - Mucker, Eric M
AU  - Mucker EM
AD  - Virology Division, United States Army Medical Institute of Infectious Diseases,Fort Detrick, MD 21702, USA.
FAU - Thiele-Suess, Carolin
AU  - Thiele-Suess C
AD  - CureVac, 72076 Tubingen, Germany.
FAU - Baumhof, Patrick
AU  - Baumhof P
AD  - CureVac, 72076 Tubingen, Germany.
FAU - Hooper, Jay W
AU  - Hooper JW
AD  - Virology Division, United States Army Medical Institute of Infectious Diseases,Fort Detrick, MD 21702, USA.
LA  - eng
GR  - U01 DD001144/DD/NCBDD CDC HHS/United States
PT  - Journal Article
DEP - 20220510
PL  - United States
TA  - Mol Ther Nucleic Acids
JT  - Molecular therapy. Nucleic acids
JID - 101581621
PMC - PMC9149018
OTO - NOTNLM
OT  - MT: Delivery strategies
OT  - RNA
OT  - lipid nanoparticle
OT  - monoclonal antibodies
OT  - neutralizing antibody
OT  - nucleic acid
OT  - poxvirus
OT  - rabbits
COIS- P.B. and C.T.-S. are employed by CureVac, a company that has licensing rightsrelated to the mRNA utilized in these studies. J.W.H. is an inventor on a patent related to mAb c7D11 and antibody therapies generated using L1, A33, and B5 asantigens. These interests do not alter the authors' adherence to policies onsharing data and materials.
EDAT- 2022/06/07 06:00
MHDA- 2022/06/07 06:01
CRDT- 2022/06/06 14:18
PHST- 2021/11/15 00:00 [received]
PHST- 2022/05/07 00:00 [accepted]
PHST- 2022/06/06 14:18 [entrez]
PHST- 2022/06/07 06:00 [pubmed]
PHST- 2022/06/07 06:01 [medline]
AID - 10.1016/j.omtn.2022.05.025 [doi]
AID - S2162-2531(22)00138-X [pii]
PST - epublish
SO  - Mol Ther Nucleic Acids. 2022 May 10;28:847-858. doi: 10.1016/j.omtn.2022.05.025. eCollection 2022 Jun 14.

PMID- 35663342
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220607
IS  - 0262-4079 (Print)
IS  - 0262-4079 (Linking)
VI  - 254
IP  - 3388
DP  - 2022 May 28
TI  - Monkeypox: Key questions answered.
PG  - 8-9
LID - 10.1016/S0262-4079(22)00914-9 [doi]
AB  - Cases are rising worldwide, leaving some people anxious that the virus couldevolve into a pandemic alongside covid-19. Michael Le Page addresses monkeypox's risks.
CI  - (c) 2022.
FAU - Le Page, Michael
AU  - Le Page M
LA  - eng
PT  - Journal Article
DEP - 20220527
PL  - England
TA  - New Sci
JT  - New scientist (1971)
JID - 9815377
PMC - PMC9142165
EDAT- 2022/06/07 06:00
MHDA- 2022/06/07 06:01
CRDT- 2022/06/06 13:57
PHST- 2022/06/06 13:57 [entrez]
PHST- 2022/06/07 06:00 [pubmed]
PHST- 2022/06/07 06:01 [medline]
AID - 10.1016/S0262-4079(22)00914-9 [doi]
AID - S0262-4079(22)00914-9 [pii]
PST - ppublish
SO  - New Sci. 2022 May 28;254(3388):8-9. doi: 10.1016/S0262-4079(22)00914-9. Epub 2022May 27.

PMID- 35661824
OWN - NLM
STAT- Publisher
LR  - 20220804
IS  - 1873-0442 (Electronic)
IS  - 1477-8939 (Linking)
VI  - 49
DP  - 2022 Jun 2
TI  - Coinfection of syphilis and monkeypox in HIV positive man in Prague, CzechRepublic.
PG  - 102368
LID - S1477-8939(22)00114-4 [pii]
LID - 10.1016/j.tmaid.2022.102368 [doi]
FAU - Bizova, Beatrice
AU  - Bizova B
AD  - Department of Dermatovenerology, Second Faculty of Medicine, Charles University, University Hospital Bulovka, Prague, Czech Republic. Electronic address:beatrice.bizova@bulovka.cz.
FAU - Vesely, Dan
AU  - Vesely D
AD  - Department of Infectious and Tropical Diseases, First Faculty of Medicine,Charles University, University Hospital Bulovka, Prague, Czech Republic.
FAU - Trojanek, Milan
AU  - Trojanek M
AD  - Department of Infectious and Tropical Diseases, Second Faculty of Medicine,Charles University, University Hospital Bulovka, Prague, Czech Republic.
FAU - Rob, Filip
AU  - Rob F
AD  - Department of Dermatovenerology, Second Faculty of Medicine, Charles University, University Hospital Bulovka, Prague, Czech Republic.
LA  - eng
PT  - Journal Article
DEP - 20220602
PL  - Netherlands
TA  - Travel Med Infect Dis
JT  - Travel medicine and infectious disease
JID - 101230758
SB  - IM
OTO - NOTNLM
OT  - HIV
OT  - Monkeypox
OT  - Syphilis
EDAT- 2022/06/07 06:00
MHDA- 2022/06/07 06:00
CRDT- 2022/06/06 12:57
PHST- 2022/05/30 00:00 [received]
PHST- 2022/05/31 00:00 [accepted]
PHST- 2022/06/07 06:00 [pubmed]
PHST- 2022/06/07 06:00 [medline]
PHST- 2022/06/06 12:57 [entrez]
AID - S1477-8939(22)00114-4 [pii]
AID - 10.1016/j.tmaid.2022.102368 [doi]
PST - aheadofprint
SO  - Travel Med Infect Dis. 2022 Jun 2;49:102368. doi: 10.1016/j.tmaid.2022.102368.

PMID- 35661823
OWN - NLM
STAT- Publisher
LR  - 20220804
IS  - 1873-0442 (Electronic)
IS  - 1477-8939 (Linking)
VI  - 49
DP  - 2022 Jun 2
TI  - The resurgence of monkeypox cases: Reasons, threat assessment, and possiblepreventive measures.
PG  - 102367
LID - S1477-8939(22)00113-2 [pii]
LID - 10.1016/j.tmaid.2022.102367 [doi]
FAU - Dhawan, Manish
AU  - Dhawan M
AD  - Department of Microbiology, Punjab Agricultural University, Ludhiana, 141004,Punjab, India; Trafford College, Altrincham, Manchester, WA14 5PQ, UK.
FAU - Emran, Talha Bin
AU  - Emran TB
AD  - Department of Pharmacy, BGC Trust University Bangladesh, Chittagong, 4381,Bangladesh; Department of Pharmacy, Faculty of Allied Health Sciences, DaffodilInternational University, Dhaka, 1207, Bangladesh. Electronic address:talhabmb@bgctub.ac.bd.
FAU - Islam, Fahadul
AU  - Islam F
AD  - Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil InternationalUniversity, Dhaka, 1207, Bangladesh.
LA  - eng
PT  - Letter
DEP - 20220602
PL  - Netherlands
TA  - Travel Med Infect Dis
JT  - Travel medicine and infectious disease
JID - 101230758
SB  - IM
EDAT- 2022/06/07 06:00
MHDA- 2022/06/07 06:00
CRDT- 2022/06/06 12:57
PHST- 2022/05/26 00:00 [received]
PHST- 2022/05/29 00:00 [revised]
PHST- 2022/05/30 00:00 [accepted]
PHST- 2022/06/07 06:00 [pubmed]
PHST- 2022/06/07 06:00 [medline]
PHST- 2022/06/06 12:57 [entrez]
AID - S1477-8939(22)00113-2 [pii]
AID - 10.1016/j.tmaid.2022.102367 [doi]
PST - aheadofprint
SO  - Travel Med Infect Dis. 2022 Jun 2;49:102367. doi: 10.1016/j.tmaid.2022.102367.

PMID- 35660009
OWN - NLM
STAT- Publisher
LR  - 20220804
IS  - 1873-0442 (Electronic)
IS  - 1477-8939 (Linking)
VI  - 49
DP  - 2022 Jun 1
TI  - International outbreaks of Monkeypox virus infection with no established travel: A public health concern with significant knowledge gap.
PG  - 102364
LID - S1477-8939(22)00110-7 [pii]
LID - 10.1016/j.tmaid.2022.102364 [doi]
FAU - Al-Tawfiq, Jaffar A
AU  - Al-Tawfiq JA
AD  - Infectious Disease Unit, Specialty Internal Medicine, Quality and Patient Safety Department, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia; Department ofMedicine, Indiana University School of Medicine, Indianapolis, IN, USA;Department of Medicine, Johns Hopkins University School of Medicine, Baltimore,MD, USA.
FAU - Barry, Mazin
AU  - Barry M
AD  - College of Medicine, King Saud University, Riyadh, Saudi Arabia; Division ofInfectious Diseases, Department of Internal Medicine, King Saud UniversityMedical City, King Saud University, Riyadh, Saudi Arabia; Division of Infectious Diseases, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
FAU - Memish, Ziad A
AU  - Memish ZA
AD  - Director Research Center, King Saud Medical City, Ministry of Health, SaudiArabia; Al-Faisal University, Riyadh, Saudi Arabia; Hubert Department of GlobalHealth, Rollins School of Public Health, Emory University, Atlanta, GA, USA.Electronic address: zmemish@yahoo.com.
LA  - eng
PT  - Journal Article
DEP - 20220601
PL  - Netherlands
TA  - Travel Med Infect Dis
JT  - Travel medicine and infectious disease
JID - 101230758
SB  - IM
EDAT- 2022/06/07 06:00
MHDA- 2022/06/07 06:00
CRDT- 2022/06/06 11:17
PHST- 2022/05/23 00:00 [received]
PHST- 2022/05/25 00:00 [revised]
PHST- 2022/05/25 00:00 [accepted]
PHST- 2022/06/07 06:00 [pubmed]
PHST- 2022/06/07 06:00 [medline]
PHST- 2022/06/06 11:17 [entrez]
AID - S1477-8939(22)00110-7 [pii]
AID - 10.1016/j.tmaid.2022.102364 [doi]
PST - aheadofprint
SO  - Travel Med Infect Dis. 2022 Jun 1;49:102364. doi: 10.1016/j.tmaid.2022.102364.

PMID- 35659548
OWN - NLM
STAT- MEDLINE
DCOM- 20220804
LR  - 20220804
IS  - 1532-2742 (Electronic)
IS  - 0163-4453 (Linking)
VI  - 85
IP  - 3
DP  - 2022 Sep
TI  - Transmission of monkeypox virus through sexual contact - A novel route ofinfection.
PG  - 334-363
LID - S0163-4453(22)00335-8 [pii]
LID - 10.1016/j.jinf.2022.05.028 [doi]
FAU - Heskin, Joseph
AU  - Heskin J
AD  - Chelsea and Westminster NHS Foundation Trust, 369 Fulham Road, London, SW10 9NH, UK. Electronic address: j.heskin@nhs.net.
FAU - Belfield, Amy
AU  - Belfield A
AD  - Newcastle Hospitals NHS Foundation Trust, Richardson Rd Newcastle upon Tyne, NE1 4LP, UK.
FAU - Milne, Charlotte
AU  - Milne C
AD  - Newcastle Hospitals NHS Foundation Trust, Richardson Rd Newcastle upon Tyne, NE1 4LP, UK.
FAU - Brown, Nicklas
AU  - Brown N
AD  - Chelsea and Westminster NHS Foundation Trust, 369 Fulham Road, London, SW10 9NH, UK.
FAU - Walters, Yasmin
AU  - Walters Y
AD  - Chelsea and Westminster NHS Foundation Trust, 369 Fulham Road, London, SW10 9NH, UK.
FAU - Scott, Christopher
AU  - Scott C
AD  - Chelsea and Westminster NHS Foundation Trust, 369 Fulham Road, London, SW10 9NH, UK.
FAU - Bracchi, Margherita
AU  - Bracchi M
AD  - Chelsea and Westminster NHS Foundation Trust, 369 Fulham Road, London, SW10 9NH, UK.
FAU - Moore, Luke Sp
AU  - Moore LS
AD  - Chelsea and Westminster NHS Foundation Trust, 369 Fulham Road, London, SW10 9NH, UK; Imperial College Healthcare NHS Trust, London, UK; NIHR Health ProtectionResearch Unit in Healthcare Associated Infections & Antimicrobial Resistance,Imperial College London, Du Cane Road, London.
FAU - Mughal, Nabeela
AU  - Mughal N
AD  - Chelsea and Westminster NHS Foundation Trust, 369 Fulham Road, London, SW10 9NH, UK; Imperial College Healthcare NHS Trust, London, UK.
FAU - Rampling, Tommy
AU  - Rampling T
AD  - Rare and Imported Pathogens Laboratory, UK Health Security Agency, Porton Down,Salisbury UK.
FAU - Winston, Alan
AU  - Winston A
AD  - Imperial College Healthcare NHS Trust, London, UK.
FAU - Nelson, Mark
AU  - Nelson M
AD  - Chelsea and Westminster NHS Foundation Trust, 369 Fulham Road, London, SW10 9NH, UK.
FAU - Duncan, Sarah
AU  - Duncan S
AD  - Newcastle Hospitals NHS Foundation Trust, Richardson Rd Newcastle upon Tyne, NE1 4LP, UK.
FAU - Jones, Rachael
AU  - Jones R
AD  - Chelsea and Westminster NHS Foundation Trust, 369 Fulham Road, London, SW10 9NH, UK.
FAU - Price, D Ashley
AU  - Price DA
AD  - Newcastle Hospitals NHS Foundation Trust, Richardson Rd Newcastle upon Tyne, NE1 4LP, UK.
FAU - Mora-Peris, Borja
AU  - Mora-Peris B
AD  - Imperial College Healthcare NHS Trust, London, UK.
LA  - eng
PT  - Letter
DEP - 20220601
PL  - England
TA  - J Infect
JT  - The Journal of infection
JID - 7908424
SB  - IM
MH  - *Disease Outbreaks
MH  - Humans
MH  - *Monkeypox virus
EDAT- 2022/06/07 06:00
MHDA- 2022/08/05 06:00
CRDT- 2022/06/06 10:58
PHST- 2022/05/23 00:00 [received]
PHST- 2022/05/25 00:00 [accepted]
PHST- 2022/06/07 06:00 [pubmed]
PHST- 2022/08/05 06:00 [medline]
PHST- 2022/06/06 10:58 [entrez]
AID - S0163-4453(22)00335-8 [pii]
AID - 10.1016/j.jinf.2022.05.028 [doi]
PST - ppublish
SO  - J Infect. 2022 Sep;85(3):334-363. doi: 10.1016/j.jinf.2022.05.028. Epub 2022 Jun 1.

PMID- 35658858
OWN - NLM
STAT- MEDLINE
DCOM- 20220617
LR  - 20220716
IS  - 1875-5941 (Electronic)
IS  - 0165-2176 (Linking)
VI  - 42
IP  - 1
DP  - 2022 Jun 7
TI  - Appearance and re-appearance of zoonotic disease during the pandemic period:long-term monitoring and analysis of zoonosis is crucial to confirm the animalorigin of SARS-CoV-2 and monkeypox virus.
PG  - 119-124
LID - 10.1080/01652176.2022.2086718 [doi]
FAU - Chakraborty, Chiranjib
AU  - Chakraborty C
AUID- ORCID: 0000-0002-3958-239X
AD  - Department of Biotechnology, School of Life Science and Biotechnology, AdamasUniversity, Kolkata, West Bengal, India.
FAU - Bhattacharya, Manojit
AU  - Bhattacharya M
AUID- ORCID: 0000-0001-9669-1835
AD  - Department of Zoology, Fakir Mohan University, Balasore, Odisha, India.
FAU - Nandi, Shyam Sundar
AU  - Nandi SS
AUID- ORCID: 0000-0002-0243-7199
AD  - ICMR-National Institute of Virology, (Mumbai Unit), Indian Council of MedicalResearch, Haffkine Institute Compound, Mumbai, India.
FAU - Mohapatra, Ranjan K
AU  - Mohapatra RK
AUID- ORCID: 0000-0001-7623-3343
AD  - Department of Chemistry, Government College of Engineering, Keonjhar, Odisha,India.
FAU - Dhama, Kuldeep
AU  - Dhama K
AUID- ORCID: 0000-0001-7469-4752
AD  - Division of Pathology, ICAR-Indian Veterinary Research Institute, Bareilly, UttarPradesh, India.
FAU - Agoramoorthy, Govindasamy
AU  - Agoramoorthy G
AUID- ORCID: 0000-0002-8936-6978
AD  - College of Pharmacy and Health Care, Tajen University, Pingtung, Taiwan.
LA  - eng
PT  - Letter
PT  - Comment
PL  - England
TA  - Vet Q
JT  - The veterinary quarterly
JID - 7909485
SB  - IM
CON - Zool Res. 2020 May 18;41(3):213-219. PMID: 32314559
MH  - Animals
MH  - *COVID-19/epidemiology/veterinary
MH  - *Chiroptera
MH  - Monkeypox virus
MH  - Pandemics
MH  - SARS-CoV-2
MH  - Zoonoses/epidemiology
PMC - PMC9225752
OTO - NOTNLM
OT  - *SARS-CoV-2
OT  - *bats
OT  - *intermediate hosts
OT  - *monkey
OT  - *monkeypox virus
OT  - *natural reservoirs
EDAT- 2022/06/07 06:00
MHDA- 2022/06/18 06:00
CRDT- 2022/06/06 10:13
PHST- 2022/06/07 06:00 [pubmed]
PHST- 2022/06/18 06:00 [medline]
PHST- 2022/06/06 10:13 [entrez]
AID - 10.1080/01652176.2022.2086718 [doi]
PST - ppublish
SO  - Vet Q. 2022 Jun 7;42(1):119-124. doi: 10.1080/01652176.2022.2086718.

PMID- 35656836
OWN - NLM
STAT- MEDLINE
DCOM- 20220606
LR  - 20220716
IS  - 1560-7917 (Electronic)
IS  - 1025-496X (Linking)
VI  - 27
IP  - 22
DP  - 2022 Jun
TI  - Epidemiological, clinical and virological characteristics of four cases ofmonkeypox support transmission through sexual contact, Italy, May 2022.
LID - 10.2807/1560-7917.ES.2022.27.22.2200421 [doi]
AB  - Since May 2022, an outbreak of monkeypox has been ongoing in non-endemiccountries. We report four cases in Italy in young adult men reporting condomless sexual intercourse. The patients are in good clinical condition with no need for specific antiviral drugs. Biological samples from seminal fluid were positive formonkeypox viral DNA. For many other viruses found in semen there is no evidenceof sexual transmission. The possibility of sexual transmission of monkeypox virusneeds to be investigated.
FAU - Antinori, Andrea
AU  - Antinori A
AD  - National Institute for Infectious Diseases 'Lazzaro Spallanzani' (IRCCS), Rome,Italy.
FAU - Mazzotta, Valentina
AU  - Mazzotta V
AD  - National Institute for Infectious Diseases 'Lazzaro Spallanzani' (IRCCS), Rome,Italy.
FAU - Vita, Serena
AU  - Vita S
AD  - National Institute for Infectious Diseases 'Lazzaro Spallanzani' (IRCCS), Rome,Italy.
FAU - Carletti, Fabrizio
AU  - Carletti F
AD  - National Institute for Infectious Diseases 'Lazzaro Spallanzani' (IRCCS), Rome,Italy.
FAU - Tacconi, Danilo
AU  - Tacconi D
AD  - Department of Specialised and Internal Medicine, Infectious Diseases Unit, SanDonato Hospital, Arezzo, Italy.
FAU - Lapini, Laura Emma
AU  - Lapini LE
AD  - Department of Specialised and Internal Medicine, Infectious Diseases Unit, SanDonato Hospital, Arezzo, Italy.
FAU - D'Abramo, Alessandra
AU  - D'Abramo A
AD  - National Institute for Infectious Diseases 'Lazzaro Spallanzani' (IRCCS), Rome,Italy.
FAU - Cicalini, Stefania
AU  - Cicalini S
AD  - National Institute for Infectious Diseases 'Lazzaro Spallanzani' (IRCCS), Rome,Italy.
FAU - Lapa, Daniele
AU  - Lapa D
AD  - National Institute for Infectious Diseases 'Lazzaro Spallanzani' (IRCCS), Rome,Italy.
FAU - Pittalis, Silvia
AU  - Pittalis S
AD  - National Institute for Infectious Diseases 'Lazzaro Spallanzani' (IRCCS), Rome,Italy.
FAU - Puro, Vincenzo
AU  - Puro V
AD  - National Institute for Infectious Diseases 'Lazzaro Spallanzani' (IRCCS), Rome,Italy.
FAU - Rivano Capparuccia, Marco
AU  - Rivano Capparuccia M
AD  - Infectious and Tropical Disease Unit, AOU Policlinico Umberto I, Rome, Italy.
FAU - Giombini, Emanuela
AU  - Giombini E
AD  - National Institute for Infectious Diseases 'Lazzaro Spallanzani' (IRCCS), Rome,Italy.
FAU - Gruber, Cesare Ernesto Maria
AU  - Gruber CEM
AD  - National Institute for Infectious Diseases 'Lazzaro Spallanzani' (IRCCS), Rome,Italy.
FAU - Garbuglia, Anna Rosa
AU  - Garbuglia AR
AD  - National Institute for Infectious Diseases 'Lazzaro Spallanzani' (IRCCS), Rome,Italy.
FAU - Marani, Alessandra
AU  - Marani A
AD  - National Institute for Infectious Diseases 'Lazzaro Spallanzani' (IRCCS), Rome,Italy.
FAU - Vairo, Francesco
AU  - Vairo F
AD  - National Institute for Infectious Diseases 'Lazzaro Spallanzani' (IRCCS), Rome,Italy.
FAU - Girardi, Enrico
AU  - Girardi E
AD  - National Institute for Infectious Diseases 'Lazzaro Spallanzani' (IRCCS), Rome,Italy.
FAU - Vaia, Francesco
AU  - Vaia F
AD  - National Institute for Infectious Diseases 'Lazzaro Spallanzani' (IRCCS), Rome,Italy.
FAU - Nicastri, Emanuele
AU  - Nicastri E
AD  - National Institute for Infectious Diseases 'Lazzaro Spallanzani' (IRCCS), Rome,Italy.
CN  - INMI Monkeypox Group
AD  - The members of the group are listed under Collaborators.
LA  - eng
PT  - Journal Article
PL  - Sweden
TA  - Euro Surveill
JT  - Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
JID - 100887452
SB  - IM
MH  - Disease Outbreaks
MH  - Humans
MH  - Male
MH  - *Monkeypox/epidemiology/transmission
MH  - Monkeypox virus
MH  - Semen
MH  - *Sexual Behavior
MH  - Young Adult
PMC - PMC9164671
OTO - NOTNLM
OT  - MSM
OT  - emerging infectious diseases
OT  - monkeypox
OT  - seminal fluid
OT  - west African clade
IR  - Agresta A
FIR - Agresta, Alessandro
IR  - Baldini F
FIR - Baldini, Francesco
IR  - Bartoli TA
FIR - Bartoli, Tommaso Ascoli
IR  - Beccacece A
FIR - Beccacece, Alessia
IR  - Bellagamba R
FIR - Bellagamba, Rita
IR  - Bettini A
FIR - Bettini, Aurora
IR  - Bevilacqua N
FIR - Bevilacqua, Nazario
IR  - Camici M
FIR - Camici, Marta
IR  - Colavita F
FIR - Colavita, Francesca
IR  - Corpolongo A
FIR - Corpolongo, Angela
IR  - De Carli G
FIR - De Carli, Gabriella
IR  - De Zottis F
FIR - De Zottis, Federico
IR  - Faraglia F
FIR - Faraglia, Francesca
IR  - Francalancia M
FIR - Francalancia, Massimo
IR  - Fusco CM
FIR - Fusco, Concetta Maria
IR  - Gagliardini R
FIR - Gagliardini, Roberta
IR  - Gebremeskel S
FIR - Gebremeskel, Saba
IR  - Giancola ML
FIR - Giancola, Maria Letizia
IR  - Gramigna G
FIR - Gramigna, Giulia
IR  - Grilli E
FIR - Grilli, Elisabetta
IR  - Grisetti S
FIR - Grisetti, Susanna
IR  - Lanini S
FIR - Lanini, Simone
IR  - Maffongelli G
FIR - Maffongelli, Gaetano
IR  - Mariano A
FIR - Mariano, Andrea
IR  - Mastrorosa I
FIR - Mastrorosa, Ilaria
IR  - Matusali G
FIR - Matusali, Giulia
IR  - Meschi S
FIR - Meschi, Silvia
IR  - Minosse C
FIR - Minosse, Claudia
IR  - Moccione M
FIR - Moccione, Martina
IR  - Mondi A
FIR - Mondi, Annalisa
IR  - Mondillo V
FIR - Mondillo, Vanessa
IR  - Orchi N
FIR - Orchi, Nicoletta
IR  - Ottou S
FIR - Ottou, Sandrine
IR  - Pinnetti C
FIR - Pinnetti, Carmela
IR  - Rosati S
FIR - Rosati, Silvia
IR  - Rueca M
FIR - Rueca, Martina
IR  - Scorzolini L
FIR - Scorzolini, Laura
IR  - Specchiarello E
FIR - Specchiarello, Eliana
IR  - Vergori A
FIR - Vergori, Alessandra
EDAT- 2022/06/04 06:00
MHDA- 2022/06/07 06:00
CRDT- 2022/06/03 05:12
PHST- 2022/06/03 05:12 [entrez]
PHST- 2022/06/04 06:00 [pubmed]
PHST- 2022/06/07 06:00 [medline]
AID - 10.2807/1560-7917.ES.2022.27.22.2200421 [doi]
PST - ppublish
SO  - Euro Surveill. 2022 Jun;27(22). doi: 10.2807/1560-7917.ES.2022.27.22.2200421.

PMID- 35656835
OWN - NLM
STAT- MEDLINE
DCOM- 20220606
LR  - 20220716
IS  - 1560-7917 (Electronic)
IS  - 1025-496X (Linking)
VI  - 27
IP  - 22
DP  - 2022 Jun
TI  - Monkeypox infection presenting as genital rash, Australia, May 2022.
LID - 10.2807/1560-7917.ES.2022.27.22.2200411 [doi]
AB  - Rapid diagnosis and whole genome sequencing confirmed a case of monkeypox in anHIV-positive individual receiving antiretroviral therapy. The patient had anormal CD4+ T-cell count and suppressed HIV viral load and presented with agenital rash in Melbourne, Australia after return from Europe in May 2022. Hesubsequently developed systemic illness and disseminated rash and 11 days aftersymptom onset, he was hospitalised to manage painful bacterial cellulitis of the genital area.
FAU - Hammerschlag, Yael
AU  - Hammerschlag Y
AD  - Department of Infectious Diseases, Alfred Hospital and Monash University,Melbourne, Australia.
FAU - MacLeod, Gina
AU  - MacLeod G
AD  - Department of Infectious Diseases, Alfred Hospital and Monash University,Melbourne, Australia.
FAU - Papadakis, Georgina
AU  - Papadakis G
AD  - Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital atthe Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
FAU - Adan Sanchez, Asiel
AU  - Adan Sanchez A
AD  - Northside Clinic, North Fitzroy, Australia.
FAU - Druce, Julian
AU  - Druce J
AD  - Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital atthe Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
FAU - Taiaroa, George
AU  - Taiaroa G
AD  - Department of Infectious Diseases, University of Melbourne, Melbourne, Australia.
FAU - Savic, Ivana
AU  - Savic I
AD  - Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital atthe Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
FAU - Mumford, Jamie
AU  - Mumford J
AD  - Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital atthe Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
FAU - Roberts, Jason
AU  - Roberts J
AD  - Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital atthe Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
FAU - Caly, Leon
AU  - Caly L
AD  - Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital atthe Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
AD  - Department of Infectious Diseases, University of Melbourne, Melbourne, Australia.
FAU - Friedman, Deborah
AU  - Friedman D
AD  - Public Health Division, Victorian Government Department of Health, Melbourne,Australia.
FAU - Williamson, Deborah A
AU  - Williamson DA
AD  - Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital atthe Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
AD  - Department of Infectious Diseases, University of Melbourne, Melbourne, Australia.
FAU - Cheng, Allen C
AU  - Cheng AC
AD  - Department of Infectious Diseases, Alfred Hospital and Monash University,Melbourne, Australia.
FAU - McMahon, James H
AU  - McMahon JH
AD  - Department of Infectious Diseases, Alfred Hospital and Monash University,Melbourne, Australia.
AD  - Department of Infectious Diseases, Monash Medical Centre, Melbourne, Australia.
LA  - eng
PT  - Case Reports
PT  - Journal Article
PL  - Sweden
TA  - Euro Surveill
JT  - Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
JID - 100887452
SB  - IM
MH  - *Exanthema/etiology
MH  - Genitalia
MH  - *HIV Infections/complications/diagnosis/drug therapy
MH  - Humans
MH  - Male
MH  - *Monkeypox/diagnosis
MH  - Viral Load
PMC - PMC9164678
OTO - NOTNLM
OT  - HIV infection
OT  - imported viral diseases
OT  - monkeypox
OT  - viral infections
EDAT- 2022/06/04 06:00
MHDA- 2022/06/07 06:00
CRDT- 2022/06/03 05:12
PHST- 2022/06/03 05:12 [entrez]
PHST- 2022/06/04 06:00 [pubmed]
PHST- 2022/06/07 06:00 [medline]
AID - 10.2807/1560-7917.ES.2022.27.22.2200411 [doi]
PST - ppublish
SO  - Euro Surveill. 2022 Jun;27(22). doi: 10.2807/1560-7917.ES.2022.27.22.2200411.

PMID- 35656834
OWN - NLM
STAT- MEDLINE
DCOM- 20220606
LR  - 20220716
IS  - 1560-7917 (Electronic)
IS  - 1025-496X (Linking)
VI  - 27
IP  - 22
DP  - 2022 Jun
TI  - Community transmission of monkeypox in the United Kingdom, April to May 2022.
LID - 10.2807/1560-7917.ES.2022.27.22.2200422 [doi]
AB  - Between 7 and 25 May, 86 monkeypox cases were confirmed in the United Kingdom(UK). Only one case is known to have travelled to a monkeypox virus (MPXV)endemic country. Seventy-nine cases with information were male and 66 reportedbeing gay, bisexual, or other men who have sex with men. This is the firstreported sustained MPXV transmission in the UK, with human-to-human transmission through close contacts, including in sexual networks. Improving caseascertainment and onward-transmission preventive measures are ongoing.
FAU - Vivancos, Roberto
AU  - Vivancos R
AD  - UK Health Security Agency, London, England, United Kingdom.
AD  - NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, UKHSA, England, United Kingdom.
AD  - NIHR Health Protection Research Unit in Gastrointestinal Infections, UKHSA,England, United Kingdom.
FAU - Anderson, Charlotte
AU  - Anderson C
AD  - UK Health Security Agency, London, England, United Kingdom.
FAU - Blomquist, Paula
AU  - Blomquist P
AD  - UK Health Security Agency, London, England, United Kingdom.
FAU - Balasegaram, Sooria
AU  - Balasegaram S
AD  - UK Health Security Agency, London, England, United Kingdom.
FAU - Bell, Anita
AU  - Bell A
AD  - UK Health Security Agency, London, England, United Kingdom.
FAU - Bishop, Louise
AU  - Bishop L
AD  - UK Health Security Agency, London, England, United Kingdom.
FAU - Brown, Colin S
AU  - Brown CS
AD  - UK Health Security Agency, London, England, United Kingdom.
AD  - NIHR Health Protection Research Unit in Healthcare Acquired Infections andAntimicrobial Resistance, UKHSA, England, United Kingdom.
FAU - Chow, Yimmy
AU  - Chow Y
AD  - UK Health Security Agency, London, England, United Kingdom.
FAU - Edeghere, Obaghe
AU  - Edeghere O
AD  - UK Health Security Agency, London, England, United Kingdom.
FAU - Florence, Isaac
AU  - Florence I
AD  - UK Health Security Agency, London, England, United Kingdom.
FAU - Logan, Sarah
AU  - Logan S
AD  - University College London Hospitals NHS Trust, London, England, United Kingdom.
FAU - Manley, Petra
AU  - Manley P
AD  - UK Health Security Agency, London, England, United Kingdom.
FAU - Crowe, William
AU  - Crowe W
AD  - Health and Social Care Northern Ireland, Antrim, Northern Ireland, UnitedKingdom.
FAU - McAuley, Andrew
AU  - McAuley A
AD  - Public Health Scotland, Edinburgh, Scotland, United Kingdom.
FAU - Shankar, Ananda Giri
AU  - Shankar AG
AD  - Public Health Wales, Cardiff, Wales, United Kingdom.
FAU - Mora-Peris, Borja
AU  - Mora-Peris B
AD  - Imperial College Healthcare NHS Trust, London, England, United Kingdom.
FAU - Paranthaman, Karthik
AU  - Paranthaman K
AD  - UK Health Security Agency, London, England, United Kingdom.
FAU - Prochazka, Mateo
AU  - Prochazka M
AD  - UK Health Security Agency, London, England, United Kingdom.
FAU - Ryan, Cian
AU  - Ryan C
AD  - UK Health Security Agency, London, England, United Kingdom.
FAU - Simons, David
AU  - Simons D
AD  - UK Health Security Agency, London, England, United Kingdom.
FAU - Vipond, Richard
AU  - Vipond R
AD  - UK Health Security Agency, London, England, United Kingdom.
FAU - Byers, Chloe
AU  - Byers C
AD  - UK Health Security Agency, London, England, United Kingdom.
FAU - Watkins, Nicholas A
AU  - Watkins NA
AD  - UK Health Security Agency, London, England, United Kingdom.
CN  - UKHSA Monkeypox Incident Management team
AD  - Members of the UKHSA Monkeypox Incident Management team are listed underCollaborators.
FAU - Welfare, Will
AU  - Welfare W
AD  - UK Health Security Agency, London, England, United Kingdom.
FAU - Whittaker, Elizabeth
AU  - Whittaker E
AD  - Imperial College Healthcare NHS Trust, London, England, United Kingdom.
FAU - Dewsnap, Claire
AU  - Dewsnap C
AD  - The British Association for Sexual Health & HIV, England & Wales, United Kingdom.
FAU - Wilson, Allegra
AU  - Wilson A
AD  - UK Health Security Agency, London, England, United Kingdom.
FAU - Young, Yvonne
AU  - Young Y
AD  - UK Health Security Agency, London, England, United Kingdom.
FAU - Chand, Meera
AU  - Chand M
AD  - UK Health Security Agency, London, England, United Kingdom.
FAU - Riley, Steven
AU  - Riley S
AD  - UK Health Security Agency, London, England, United Kingdom.
FAU - Hopkins, Susan
AU  - Hopkins S
AD  - UK Health Security Agency, London, England, United Kingdom.
AD  - NIHR Health Protection Research Unit in Healthcare Acquired Infections andAntimicrobial Resistance, UKHSA, England, United Kingdom.
CN  - Monkeypox Incident Management Team
LA  - eng
PT  - Journal Article
PL  - Sweden
TA  - Euro Surveill
JT  - Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
JID - 100887452
SB  - IM
EIN - Euro Surveill. 2022 Jun;27(23):. PMID: 35686569
MH  - Female
MH  - Homosexuality, Male
MH  - Humans
MH  - Male
MH  - *Monkeypox/diagnosis/epidemiology/transmission
MH  - Monkeypox virus/genetics
MH  - *Sexual and Gender Minorities
MH  - United Kingdom/epidemiology
PMC - PMC9164677
OTO - NOTNLM
OT  - *Monkeypox
OT  - *United Kingdom
OT  - *monkeypox virus
OT  - *orthopoxvirus
OT  - *transmission
OT  - *viruses
OT  - *zoonoses
IR  - Charlett A
FIR - Charlett, Andre
IR  - Finnie T
FIR - Finnie, Thomas
IR  - McAuslane H
FIR - McAuslane, Helen
IR  - Weeple B
FIR - Weeple, Browne
IR  - Fifer H
FIR - Fifer, Helen
IR  - Sinka K
FIR - Sinka, Katy
IR  - Edwards D
FIR - Edwards, David
IR  - Lopez-Bernal J
FIR - Lopez-Bernal, Jamie
IR  - Rampling T
FIR - Rampling, Tommy
IR  - Lee A
FIR - Lee, Andrew
IR  - Mellon D
FIR - Mellon, Dominic
IR  - Kliner M
FIR - Kliner, Merav
IR  - Young N
FIR - Young, Nick
IR  - Makki S
FIR - Makki, Sophia
IR  - Coles S
FIR - Coles, Suzanne
IR  - Shepherd W
FIR - Shepherd, Wendi
IR  - Latham V
FIR - Latham, Victoria
IR  - Tabor R
FIR - Tabor, Ruby
IR  - Graham A
FIR - Graham, Alice
IR  - Yuan J
FIR - Yuan, JinMin
IR  - MacDonald N
FIR - MacDonald, Neil
IR  - Vusirikala A
FIR - Vusirikala, Amoolya
IR  - Ma T
FIR - Ma, Thomas
IR  - Cooper K
FIR - Cooper, Kristine
IR  - Saavedra-Campos M
FIR - Saavedra-Campos, Maria
EDAT- 2022/06/04 06:00
MHDA- 2022/06/07 06:00
CRDT- 2022/06/03 05:12
PHST- 2022/06/03 05:12 [entrez]
PHST- 2022/06/04 06:00 [pubmed]
PHST- 2022/06/07 06:00 [medline]
AID - 10.2807/1560-7917.ES.2022.27.22.2200422 [doi]
PST - ppublish
SO  - Euro Surveill. 2022 Jun;27(22). doi: 10.2807/1560-7917.ES.2022.27.22.2200422.

PMID- 35656830
OWN - NLM
STAT- MEDLINE
DCOM- 20220606
LR  - 20220716
IS  - 1560-7917 (Electronic)
IS  - 1025-496X (Linking)
VI  - 27
IP  - 22
DP  - 2022 Jun
TI  - Ongoing monkeypox virus outbreak, Portugal, 29 April to 23 May 2022.
LID - 10.2807/1560-7917.ES.2022.27.22.2200424 [doi]
AB  - Up to 27 May 2022, Portugal has detected 96 confirmed cases of monkeypox. Wedescribe 27 confirmed cases (median age: 33 years (range: 22-51); all males),with an earliest symptom onset date of 29 April. Almost all cases (n=25) live in the Lisbon and Tagus Valley health region. Most cases were neither part ofidentified transmission chains, nor linked to travel or had contact withsymptomatic persons or with animals, suggesting the possible previouslyundetected spread of monkeypox.
FAU - Perez Duque, Mariana
AU  - Perez Duque M
AD  - Directorate of Information and Analysis, Directorate-General of Health, Lisbon,Portugal.
FAU - Ribeiro, Sofia
AU  - Ribeiro S
AD  - Directorate of Information and Analysis, Directorate-General of Health, Lisbon,Portugal.
AD  - ECDC Fellowship Programme, Field Epidemiology path (EPIET), European Centre forDisease Prevention and Control (ECDC), Solna, Sweden.
FAU - Martins, Joao Vieira
AU  - Martins JV
AD  - Directorate of Information and Analysis, Directorate-General of Health, Lisbon,Portugal.
FAU - Casaca, Pedro
AU  - Casaca P
AD  - Directorate of Information and Analysis, Directorate-General of Health, Lisbon,Portugal.
FAU - Leite, Pedro Pinto
AU  - Leite PP
AD  - Directorate of Information and Analysis, Directorate-General of Health, Lisbon,Portugal.
FAU - Tavares, Margarida
AU  - Tavares M
AD  - National Plan Sexually Transmitted Infections and HIV, Directorate-General ofHealth, Lisbon, Portugal.
AD  - Department of infections, Department of Infectious Diseases, Centro HospitalarUniversitario de Sao Joao, Porto, Portugal.
AD  - EPI Unit, Instituto de Saude Publica da Universidade do Porto, Porto, Portugal.
AD  - University of Porto Medical School, Porto, Portugal.
FAU - Mansinho, Kamal
AU  - Mansinho K
AD  - Infectious Diseases and Tropical Medicine Service, Centro Hospitalar LisboaOcidental, EPE/Hospital de Egas Moniz, Lisbon, Portugal.
AD  - Hygiene and Tropical Medicine Institute/NOVA University of Lisbon, Lisbon,Portugal.
FAU - Duque, Luis Miguel
AU  - Duque LM
AD  - CheckpointLX, Grupo de Ativistas em Tratamentos (GAT), Lisbon, Portugal.
AD  - Hospital Garcia de Orta, Almada, Portugal.
FAU - Fernandes, Candida
AU  - Fernandes C
AD  - Sexual Transmitted Diseases Clinic, Dermatovenereology Department, CentroHospitalar e Universitario de Lisboa Central, Lisbon, Portugal.
FAU - Cordeiro, Rita
AU  - Cordeiro R
AD  - Department of Infectious Diseases, National Institute of Health Dr. RicardoJorge, Lisbon, Portugal.
FAU - Borrego, Maria Jose
AU  - Borrego MJ
AD  - Department of Infectious Diseases, National Institute of Health Dr. RicardoJorge, Lisbon, Portugal.
FAU - Pelerito, Ana
AU  - Pelerito A
AD  - Department of Infectious Diseases, National Institute of Health Dr. RicardoJorge, Lisbon, Portugal.
FAU - de Carvalho, Isabel Lopes
AU  - de Carvalho IL
AD  - Department of Infectious Diseases, National Institute of Health Dr. RicardoJorge, Lisbon, Portugal.
FAU - Nuncio, Sofia
AU  - Nuncio S
AD  - Department of Infectious Diseases, National Institute of Health Dr. RicardoJorge, Lisbon, Portugal.
FAU - Manageiro, Vera
AU  - Manageiro V
AD  - Department of Infectious Diseases, National Institute of Health Dr. RicardoJorge, Lisbon, Portugal.
AD  - ECDC Fellowship Programme, Public Health Microbiology path (EUPHEM), EuropeanCentre for Disease Prevention and Control (ECDC), Solna, Sweden.
FAU - Minetti, Corrado
AU  - Minetti C
AD  - Department of Infectious Diseases, National Institute of Health Dr. RicardoJorge, Lisbon, Portugal.
AD  - ECDC Fellowship Programme, Public Health Microbiology path (EUPHEM), EuropeanCentre for Disease Prevention and Control (ECDC), Solna, Sweden.
FAU - Machado, Jorge
AU  - Machado J
AD  - Department of Infectious Diseases, National Institute of Health Dr. RicardoJorge, Lisbon, Portugal.
FAU - Haussig, Joana M
AU  - Haussig JM
AD  - European Centre for Disease Prevention and Control (ECDC), Solna, Sweden.
FAU - Croci, Roberto
AU  - Croci R
AD  - European Centre for Disease Prevention and Control (ECDC), Solna, Sweden.
FAU - Spiteri, Gianfranco
AU  - Spiteri G
AD  - European Centre for Disease Prevention and Control (ECDC), Solna, Sweden.
FAU - Casal, Ana Sofia
AU  - Casal AS
AD  - Directorate of Health Promotion and Disease Prevention, Directorate-General ofHealth, Lisbon, Portugal.
FAU - Mendes, Diana
AU  - Mendes D
AD  - Division for Communication and Public Relations, Directorate-General of Health,Lisbon, Portugal.
FAU - Souto, Tiago
AU  - Souto T
AD  - Support Unit of National Health Authority and the Emergency Management in Public Health, Public Health Emergencies Operations Centre, Directorate-General ofHealth, Lisbon, Portugal.
FAU - Pocinho, Sara
AU  - Pocinho S
AD  - Support Unit of National Health Authority and the Emergency Management in Public Health, Public Health Emergencies Operations Centre, Directorate-General ofHealth, Lisbon, Portugal.
FAU - Fernandes, Teresa
AU  - Fernandes T
AD  - Directorate of Health Promotion and Disease Prevention, Directorate-General ofHealth, Lisbon, Portugal.
FAU - Firme, Ana
AU  - Firme A
AD  - Support Unit of National Health Authority and the Emergency Management in Public Health, Public Health Emergencies Operations Centre, Directorate-General ofHealth, Lisbon, Portugal.
FAU - Vasconcelos, Paula
AU  - Vasconcelos P
AD  - Support Unit of National Health Authority and the Emergency Management in Public Health, Public Health Emergencies Operations Centre, Directorate-General ofHealth, Lisbon, Portugal.
FAU - Freitas, Graca
AU  - Freitas G
AD  - National Health Authority, Directorate-General of Health, Lisbon, Portugal.
LA  - eng
PT  - Journal Article
PL  - Sweden
TA  - Euro Surveill
JT  - Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
JID - 100887452
SB  - IM
MH  - Disease Outbreaks
MH  - Humans
MH  - Male
MH  - *Monkeypox/diagnosis/epidemiology
MH  - *Monkeypox virus/genetics
MH  - Portugal/epidemiology
MH  - Travel
PMC - PMC9164676
OTO - NOTNLM
OT  - monkeypox
OT  - outbreak
OT  - surveillance
EDAT- 2022/06/04 06:00
MHDA- 2022/06/07 06:00
CRDT- 2022/06/03 05:12
PHST- 2022/06/03 05:12 [entrez]
PHST- 2022/06/04 06:00 [pubmed]
PHST- 2022/06/07 06:00 [medline]
AID - 10.2807/1560-7917.ES.2022.27.22.2200424 [doi]
PST - ppublish
SO  - Euro Surveill. 2022 Jun;27(22). doi: 10.2807/1560-7917.ES.2022.27.22.2200424.

PMID- 35655436
OWN - NLM
STAT- Publisher
LR  - 20220609
IS  - 1096-9071 (Electronic)
IS  - 0146-6615 (Linking)
DP  - 2022 Jun 2
TI  - Attaching a stigma to the LGBTQI+ community should be avoided during themonkeypox epidemic.
LID - 10.1002/jmv.27913 [doi]
FAU - Bragazzi, Nicola L
AU  - Bragazzi NL
AD  - Department of Mathematics and Statistics, Laboratory for Industrial and AppliedMathematics (LIAM), York University, Toronto, Ontario, Canada.
FAU - Khamisy-Farah, Rola
AU  - Khamisy-Farah R
AD  - Clalit Health Services, Akko, Israel.
AD  - Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
FAU - Tsigalou, Christina
AU  - Tsigalou C
AD  - Department of Medicine, Laboratory of Microbiology, Democritus University ofThrace, Dragana, Alexandroupolis, Greece.
FAU - Mahroum, Naim
AU  - Mahroum N
AD  - International School of Medicine, Istanbul Medipol University, Istanbul, Turkey.
FAU - Converti, Manlio
AU  - Converti M
AD  - ASL Napoli 2 Nord, Naples, Italy.
LA  - eng
PT  - Letter
DEP - 20220602
PL  - United States
TA  - J Med Virol
JT  - Journal of medical virology
JID - 7705876
SB  - IM
EDAT- 2022/06/04 06:00
MHDA- 2022/06/04 06:00
CRDT- 2022/06/03 01:47
PHST- 2022/05/30 00:00 [revised]
PHST- 2022/05/24 00:00 [received]
PHST- 2022/05/31 00:00 [accepted]
PHST- 2022/06/04 06:00 [pubmed]
PHST- 2022/06/04 06:00 [medline]
PHST- 2022/06/03 01:47 [entrez]
AID - 10.1002/jmv.27913 [doi]
PST - aheadofprint
SO  - J Med Virol. 2022 Jun 2. doi: 10.1002/jmv.27913.

PMID- 35654445
OWN - NLM
STAT- MEDLINE
DCOM- 20220622
LR  - 20220716
IS  - 1488-2329 (Electronic)
IS  - 0820-3946 (Linking)
VI  - 194
IP  - 24
DP  - 2022 Jun 20
TI  - The monkeypox virus.
PG  - E844
LID - 10.1503/cmaj.220795 [doi]
FAU - Halani, Sheliza
AU  - Halani S
AD  - Department of Medicine (Halani, Mishra, Bogoch), University of Toronto; Division of Infectious Diseases (Mishra), St. Michael's Hospital; Divisions of GeneralInternal Medicine and Infectious Diseases (Bogoch), University Health Network;Institute of Health Policy, Management and Evaluation and Institute of MedicalSciences (Mishra), University of Toronto. Toronto, Ont.Sheliza.halani@wchospital.ca.
FAU - Mishra, Sharmistha
AU  - Mishra S
AD  - Department of Medicine (Halani, Mishra, Bogoch), University of Toronto; Division of Infectious Diseases (Mishra), St. Michael's Hospital; Divisions of GeneralInternal Medicine and Infectious Diseases (Bogoch), University Health Network;Institute of Health Policy, Management and Evaluation and Institute of MedicalSciences (Mishra), University of Toronto. Toronto, Ont.
FAU - Bogoch, Isaac I
AU  - Bogoch II
AD  - Department of Medicine (Halani, Mishra, Bogoch), University of Toronto; Division of Infectious Diseases (Mishra), St. Michael's Hospital; Divisions of GeneralInternal Medicine and Infectious Diseases (Bogoch), University Health Network;Institute of Health Policy, Management and Evaluation and Institute of MedicalSciences (Mishra), University of Toronto. Toronto, Ont.
LA  - eng
PT  - Journal Article
DEP - 20220602
PL  - Canada
TA  - CMAJ
JT  - CMAJ : Canadian Medical Association journal = journal de l'Association medicalecanadienne
JID - 9711805
SB  - IM
MH  - Humans
MH  - *Monkeypox virus
PMC - PMC9261942
COIS- Competing interests: Isaac Bogoch is a consultant to BlueDot and the NationalHockey League Players' Association. No other competing interests were declared.
EDAT- 2022/06/03 06:00
MHDA- 2022/06/23 06:00
CRDT- 2022/06/02 20:32
PHST- 2022/06/03 06:00 [pubmed]
PHST- 2022/06/23 06:00 [medline]
PHST- 2022/06/02 20:32 [entrez]
AID - cmaj.220795 [pii]
AID - 10.1503/cmaj.220795 [doi]
PST - ppublish
SO  - CMAJ. 2022 Jun 20;194(24):E844. doi: 10.1503/cmaj.220795. Epub 2022 Jun 2.

PMID- 35653477
OWN - NLM
STAT- MEDLINE
DCOM- 20220606
LR  - 20220608
IS  - 1095-9203 (Electronic)
IS  - 0036-8075 (Linking)
VI  - 376
IP  - 6597
DP  - 2022 Jun 3
TI  - Global outbreak puts spotlight on neglected virus.
PG  - 1032-1033
LID - 10.1126/science.add2701 [doi]
AB  - The steady rise of monkeypox cases in Africa has received little attention-until now.
FAU - Cohen, Jon
AU  - Cohen J
LA  - eng
PT  - News
DEP - 20220602
PL  - United States
TA  - Science
JT  - Science (New York, N.Y.)
JID - 0404511
SB  - IM
MH  - Africa, Central/epidemiology
MH  - Africa, Western/epidemiology
MH  - Animals
MH  - *Disease Outbreaks
MH  - Humans
MH  - *Monkeypox/epidemiology/prevention & control
MH  - *Monkeypox virus
MH  - *Neglected Diseases/epidemiology/virology
EDAT- 2022/06/03 06:00
MHDA- 2022/06/07 06:00
CRDT- 2022/06/02 14:04
PHST- 2022/06/02 14:04 [entrez]
PHST- 2022/06/03 06:00 [pubmed]
PHST- 2022/06/07 06:00 [medline]
AID - 10.1126/science.add2701 [doi]
PST - ppublish
SO  - Science. 2022 Jun 3;376(6597):1032-1033. doi: 10.1126/science.add2701. Epub 2022 Jun 2.

PMID- 35653347
OWN - NLM
STAT- MEDLINE
DCOM- 20220606
LR  - 20220729
IS  - 1545-861X (Electronic)
IS  - 0149-2195 (Linking)
VI  - 71
IP  - 22
DP  - 2022 Jun 3
TI  - Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) forPreexposure Vaccination of Persons at Risk for Occupational Exposure toOrthopoxviruses: Recommendations of the Advisory Committee on ImmunizationPractices - United States, 2022.
PG  - 734-742
LID - 10.15585/mmwr.mm7122e1 [doi]
AB  - Certain laboratorians and health care personnel can be exposed to orthopoxvirusesthrough occupational activities. Because orthopoxvirus infections resulting from occupational exposures can be serious, the Advisory Committee on ImmunizationPractices (ACIP) has continued to recommend preexposure vaccination for thesepersons since 1980 (1), when smallpox was eradicated (2). In 2015, ACIP maderecommendations for the use of ACAM2000, the only orthopoxvirus vaccine availablein the United States at that time (3). During 2020-2021, ACIP considered evidencefor use of JYNNEOS, a replication-deficient Vaccinia virus vaccine, as analternative to ACAM2000. In November 2021, ACIP unanimously voted in favor ofJYNNEOS as an alternative to ACAM2000 for primary vaccination and booster doses. With these recommendations for use of JYNNEOS, two vaccines (ACAM2000 andJYNNEOS) are now available and recommended for preexposure prophylaxis againstorthopoxvirus infection among persons at risk for such exposures.
FAU - Rao, Agam K
AU  - Rao AK
FAU - Petersen, Brett W
AU  - Petersen BW
FAU - Whitehill, Florence
AU  - Whitehill F
FAU - Razeq, Jafar H
AU  - Razeq JH
FAU - Isaacs, Stuart N
AU  - Isaacs SN
FAU - Merchlinsky, Michael J
AU  - Merchlinsky MJ
FAU - Campos-Outcalt, Doug
AU  - Campos-Outcalt D
FAU - Morgan, Rebecca L
AU  - Morgan RL
FAU - Damon, Inger
AU  - Damon I
FAU - Sanchez, Pablo J
AU  - Sanchez PJ
FAU - Bell, Beth P
AU  - Bell BP
LA  - eng
PT  - Journal Article
DEP - 20220603
PL  - United States
TA  - MMWR Morb Mortal Wkly Rep
JT  - MMWR. Morbidity and mortality weekly report
JID - 7802429
RN  - 0 (Vaccines)
SB  - IM
EIN - MMWR Morb Mortal Wkly Rep. 2022 Jul 08;71(27):886. PMID: 35797206
MH  - Advisory Committees
MH  - Animals
MH  - Humans
MH  - Immunization
MH  - *Monkeypox
MH  - *Occupational Exposure
MH  - *Orthopoxvirus
MH  - *Smallpox/prevention & control
MH  - United States/epidemiology
MH  - Vaccination
MH  - *Vaccines
MH  - Vaccinia virus
PMC - PMC9169520
COIS- All authors have completed and submitted the International Committee of MedicalJournal Editors form for disclosure of potential conflicts of interest. Brett W. Petersen reports travel support from vaccine manufacturer Bavarian Nordic toparticipate in the Orthopox Viruses, Risk, Epidemiology, and Vaccine Responseseminar in London, England. Stuart N. Isaacs reports salary support from thePerelman School of Medicine, University of Pennsylvania; grant support from theNational Institute of Allergy and Infectious Diseases (NIAID), NationalInstitutes of Health (NIH) to conduct an international poxvirus conference;institutional support from BioNTech to investigate mRNA-based subunit vaccinesagainst poxviruses; and payment from UpToDate to author chapters onorthopoxviruses. Pablo J. Sanchez reports grant support from the Eunice KennedyShriver National Institute of Child Health and Human Development and NIAID, NIH. No other potential conflicts of interest were disclosed.
EDAT- 2022/06/03 06:00
MHDA- 2022/06/07 06:00
CRDT- 2022/06/02 13:33
PHST- 2022/06/02 13:33 [entrez]
PHST- 2022/06/03 06:00 [pubmed]
PHST- 2022/06/07 06:00 [medline]
AID - 10.15585/mmwr.mm7122e1 [doi]
PST - epublish
SO  - MMWR Morb Mortal Wkly Rep. 2022 Jun 3;71(22):734-742. doi:10.15585/mmwr.mm7122e1.

PMID- 35652380
OWN - NLM
STAT- MEDLINE
DCOM- 20220707
LR  - 20220711
IS  - 1469-0705 (Electronic)
IS  - 0960-7692 (Linking)
VI  - 60
IP  - 1
DP  - 2022 Jul
TI  - Monkeypox and pregnancy: what do obstetricians need to know?
PG  - 22-27
LID - 10.1002/uog.24968 [doi]
FAU - Khalil, A
AU  - Khalil A
AUID- ORCID: https://orcid.org/0000-0003-2802-7670
AD  - Fetal Medicine Unit, St George's University Hospitals NHS Foundation Trust,University of London, London, UK.
AD  - Vascular Biology Research Centre, Molecular and Clinical Sciences ResearchInstitute, St George's University of London, London, UK.
FAU - Samara, A
AU  - Samara A
AD  - Department of Women's and Children's Health, Karolinska Institute, Stockholm,Sweden.
AD  - Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm,Sweden.
FAU - O'Brien, P
AU  - O'Brien P
AD  - The Royal College of Obstetricians and Gynaecologists, London, UK.
AD  - University College London Hospitals NHS Foundation Trust, London, UK.
FAU - Morris, E
AU  - Morris E
AD  - The Royal College of Obstetricians and Gynaecologists, London, UK.
AD  - Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, Norfolk, UK.
FAU - Draycott, T
AU  - Draycott T
AD  - The Royal College of Obstetricians and Gynaecologists, London, UK.
AD  - North Bristol NHS Trust Department of Women's Health, Westbury on Trym, UK.
FAU - Lees, C
AU  - Lees C
AD  - Imperial College London, London, UK.
FAU - Ladhani, S
AU  - Ladhani S
AD  - Paediatric Infectious Diseases Research Group and Vaccine Institute, Institute ofInfection and Immunity, St George's University of London, London, UK.
AD  - Immunisation and Countermeasures Division, Public Health, England.
AD  - British Paediatric Surveillance Unit, Royal College of Paediatrics and ChildHealth, London, UK.
LA  - eng
PT  - Journal Article
PL  - England
TA  - Ultrasound Obstet Gynecol
JT  - Ultrasound in obstetrics & gynecology : the official journal of the InternationalSociety of Ultrasound in Obstetrics and Gynecology
JID - 9108340
SB  - IM
MH  - Female
MH  - Humans
MH  - *Monkeypox
MH  - Pregnancy
EDAT- 2022/06/03 06:00
MHDA- 2022/07/08 06:00
CRDT- 2022/06/02 05:43
PHST- 2022/05/31 00:00 [revised]
PHST- 2022/05/29 00:00 [received]
PHST- 2022/05/31 00:00 [accepted]
PHST- 2022/06/03 06:00 [pubmed]
PHST- 2022/07/08 06:00 [medline]
PHST- 2022/06/02 05:43 [entrez]
AID - 10.1002/uog.24968 [doi]
PST - ppublish
SO  - Ultrasound Obstet Gynecol. 2022 Jul;60(1):22-27. doi: 10.1002/uog.24968.

PMID- 35652133
OWN - NLM
STAT- Publisher
LR  - 20220618
IS  - 1096-9071 (Electronic)
IS  - 0146-6615 (Linking)
DP  - 2022 Jun 1
TI  - Re-emerging human monkeypox: A major public-health debacle.
LID - 10.1002/jmv.27902 [doi]
AB  - A multicountry outbreak of the monkeypox virus has gained global attention. As ofMay 25, 250 confirmed human monkeypox cases have been reported globally.Monkeypox is caused by the Monkeypox virus, which belongs to the Orthopoxvirusgenus and Poxviridae family. Monkeypox is often a self-limiting infection, withsymptoms lasting 2-4 weeks with the case fatality ratio around 3%-6%. Monkeypoxis transmitted to humans by direct contact with an infected person or animal orcontact with virus-contaminated material. Human monkeypox infections may lead to various medical complications such as fever, rash, and lymphadenopathies.Pneumonitis, encephalitis, sight-threatening keratitis, and subsequent bacterial infections are all possible complications of monkeypox. An antiviral agentdeveloped to treat smallpox has also been approved for use in the treatment ofmonkeypox in the United States. Vaccines used in the smallpox eradication programalso provided immunity to monkeypox. Newer vaccines have been developed, one ofwhich has been approved for monkeypox prevention. In this study, we provideinformation about the recent outbreaks of human monkeypox, epidemiology,transmission pattern, possible diagnosis techniques, therapeutics, and available preventive strategies.
CI  - (c) 2022 Wiley Periodicals LLC.
FAU - Saxena, Shailendra K
AU  - Saxena SK
AUID- ORCID: http://orcid.org/0000-0003-2856-4185
AD  - Centre for Advanced Research, Faculty of Medicine, King George's MedicalUniversity, Lucknow, India.
AD  - World Society for Virology, Massachusetts, USA.
AD  - The Indian Virological Society, New Delhi, India.
FAU - Ansari, Saniya
AU  - Ansari S
AD  - Centre for Advanced Research, Faculty of Medicine, King George's MedicalUniversity, Lucknow, India.
AD  - World Society for Virology, Massachusetts, USA.
FAU - Maurya, Vimal K
AU  - Maurya VK
AD  - Centre for Advanced Research, Faculty of Medicine, King George's MedicalUniversity, Lucknow, India.
AD  - World Society for Virology, Massachusetts, USA.
FAU - Kumar, Swatantra
AU  - Kumar S
AD  - Centre for Advanced Research, Faculty of Medicine, King George's MedicalUniversity, Lucknow, India.
AD  - World Society for Virology, Massachusetts, USA.
FAU - Jain, Amita
AU  - Jain A
AD  - Centre for Advanced Research, Faculty of Medicine, King George's MedicalUniversity, Lucknow, India.
AD  - Department of Microbiology, King George's Medical University, Lucknow, India.
FAU - Paweska, Janusz T
AU  - Paweska JT
AD  - World Society for Virology, Massachusetts, USA.
AD  - Centre for Emerging Zoonotic and Parasitic Diseases, National Institute forCommunicable Diseases of the National Health Laboratory Service,Sandringham-Johannesburg, South Africa.
FAU - Tripathi, Anil K
AU  - Tripathi AK
AD  - Centre for Advanced Research, Faculty of Medicine, King George's MedicalUniversity, Lucknow, India.
FAU - Abdel-Moneim, Ahmed S
AU  - Abdel-Moneim AS
AD  - World Society for Virology, Massachusetts, USA.
AD  - Department of Microbiology, Taif University, Al-Taif, Saudi Arabia.
AD  - Department of Virology, Beni-Suef University, Beni-Suef, Egypt.
LA  - eng
PT  - Journal Article
DEP - 20220601
PL  - United States
TA  - J Med Virol
JT  - Journal of medical virology
JID - 7705876
SB  - IM
OTO - NOTNLM
OT  - diagnosis
OT  - human
OT  - monkeypox
OT  - re-emergence
OT  - treatment
EDAT- 2022/06/03 06:00
MHDA- 2022/06/03 06:00
CRDT- 2022/06/02 02:19
PHST- 2022/05/28 00:00 [revised]
PHST- 2022/05/27 00:00 [received]
PHST- 2022/05/30 00:00 [accepted]
PHST- 2022/06/03 06:00 [pubmed]
PHST- 2022/06/03 06:00 [medline]
PHST- 2022/06/02 02:19 [entrez]
AID - 10.1002/jmv.27902 [doi]
PST - aheadofprint
SO  - J Med Virol. 2022 Jun 1. doi: 10.1002/jmv.27902.

PMID- 35650476
OWN - NLM
STAT- MEDLINE
DCOM- 20220603
LR  - 20220706
IS  - 1613-3560 (Electronic)
IS  - 1438-3276 (Linking)
VI  - 164
IP  - 11
DP  - 2022 Jun
PG  - 12
LID - 10.1007/s15006-022-1086-6 [doi]
FAU - Oberhofer, Elke
AU  - Oberhofer E
AD  - Springer Medizin Verlag GmbH, Aschauer Str. 30, 81549, Munchen, Germany.
LA  - ger
PT  - News
TT  - Affenpocken: Seien Sie wachsam!
PL  - Germany
TA  - MMW Fortschr Med
JT  - MMW Fortschritte der Medizin
JID - 100893959
SB  - IM
MH  - Animals
MH  - Humans
MH  - *Monkeypox
EDAT- 2022/06/02 06:00
MHDA- 2022/06/07 06:00
CRDT- 2022/06/01 23:31
PHST- 2022/06/01 23:31 [entrez]
PHST- 2022/06/02 06:00 [pubmed]
PHST- 2022/06/07 06:00 [medline]
AID - 10.1007/s15006-022-1086-6 [doi]
AID - 10.1007/s15006-022-1086-6 [pii]
PST - ppublish
SO  - MMW Fortschr Med. 2022 Jun;164(11):12. doi: 10.1007/s15006-022-1086-6.

PMID- 35649575
OWN - NLM
STAT- MEDLINE
DCOM- 20220603
LR  - 20220711
IS  - 1756-1833 (Electronic)
IS  - 0959-8138 (Linking)
VI  - 377
DP  - 2022 Jun 1
TI  - Monkeypox: Healthcare workers will be offered smallpox vaccine as UK buys 20 000 doses.
PG  - o1379
LID - 10.1136/bmj.o1379 [doi]
FAU - Mahase, Elisabeth
AU  - Mahase E
AD  - The BMJ.
LA  - eng
PT  - Journal Article
DEP - 20220601
PL  - England
TA  - BMJ
JT  - BMJ (Clinical research ed.)
JID - 8900488
RN  - 0 (Antigens, Viral)
RN  - 0 (Smallpox Vaccine)
SB  - IM
MH  - Antigens, Viral
MH  - Health Personnel
MH  - Humans
MH  - *Monkeypox/prevention & control
MH  - *Smallpox Vaccine
MH  - United Kingdom
EDAT- 2022/06/02 06:00
MHDA- 2022/06/07 06:00
CRDT- 2022/06/01 20:43
PHST- 2022/06/01 20:43 [entrez]
PHST- 2022/06/02 06:00 [pubmed]
PHST- 2022/06/07 06:00 [medline]
AID - 10.1136/bmj.o1379 [doi]
PST - epublish
SO  - BMJ. 2022 Jun 1;377:o1379. doi: 10.1136/bmj.o1379.

PMID- 35649489
OWN - NLM
STAT- MEDLINE
DCOM- 20220708
LR  - 20220708
IS  - 1532-2742 (Electronic)
IS  - 0163-4453 (Linking)
VI  - 85
IP  - 2
DP  - 2022 Aug
TI  - Monkeypox: A new threat at our doorstep!
PG  - e47-e48
LID - S0163-4453(22)00336-X [pii]
LID - 10.1016/j.jinf.2022.05.027 [doi]
FAU - Awan, Usman Ayub
AU  - Awan UA
AD  - Department of Medical Laboratory Technology, The University of Haripur, Haripur, Khyber Pakhtunkhwa, Pakistan. Electronic address: usman.ayub111@gmail.com.
FAU - Riasat, Sana
AU  - Riasat S
AD  - Department of Medical Laboratory Technology, The University of Haripur, Haripur, Khyber Pakhtunkhwa, Pakistan.
FAU - Naeem, Wajiha
AU  - Naeem W
AD  - Department of Medical Laboratory Technology, The University of Haripur, Haripur, Khyber Pakhtunkhwa, Pakistan.
FAU - Kamran, Shehrish
AU  - Kamran S
AD  - Department of Life Sciences, School of Science, University of Management andTechnology (UMT), Lahore, Pakistan.
FAU - Khattak, Aamer Ali
AU  - Khattak AA
AD  - Department of Medical Laboratory Technology, The University of Haripur, Haripur, Khyber Pakhtunkhwa, Pakistan.
FAU - Khan, Suliman
AU  - Khan S
AD  - Department of Medical Laboratory Technology, The University of Haripur, Haripur, Khyber Pakhtunkhwa, Pakistan.
LA  - eng
PT  - Letter
DEP - 20220529
PL  - England
TA  - J Infect
JT  - The Journal of infection
JID - 7908424
SB  - IM
MH  - Animals
MH  - Disease Outbreaks
MH  - Humans
MH  - *Monkeypox/epidemiology/prevention & control
OTO - NOTNLM
OT  - Infectious disease
OT  - Monkeypox
OT  - Outbreak
OT  - Public health
OT  - Vaccination
COIS- Declaration of Competing Interest We declare no conflict of interest.
EDAT- 2022/06/02 06:00
MHDA- 2022/07/09 06:00
CRDT- 2022/06/01 19:24
PHST- 2022/05/23 00:00 [received]
PHST- 2022/05/25 00:00 [accepted]
PHST- 2022/06/02 06:00 [pubmed]
PHST- 2022/07/09 06:00 [medline]
PHST- 2022/06/01 19:24 [entrez]
AID - S0163-4453(22)00336-X [pii]
AID - 10.1016/j.jinf.2022.05.027 [doi]
PST - ppublish
SO  - J Infect. 2022 Aug;85(2):e47-e48. doi: 10.1016/j.jinf.2022.05.027. Epub 2022 May 29.

PMID- 35645141
OWN - NLM
STAT- Publisher
LR  - 20220601
IS  - 1398-9995 (Electronic)
IS  - 0105-4538 (Linking)
DP  - 2022 May 29
TI  - Monkeypox outbreak in Europe, UK, North America, and Australia: A changing trend of a zoonotic disease.
LID - 10.1111/all.15393 [doi]
FAU - Cabanillas, Beatriz
AU  - Cabanillas B
AD  - Laboratory of Allergy, Research Institute Hospital 12 de Octubre (imas12),Madrid, Spain.
FAU - Valdelvira, Rafael
AU  - Valdelvira R
AD  - Laboratory of Allergy, Research Institute Hospital 12 de Octubre (imas12),Madrid, Spain.
FAU - Akdis, Cezmi A
AU  - Akdis CA
AUID- ORCID: https://orcid.org/0000-0001-8020-019X
AD  - Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich,Davos, Switzerland.
AD  - Christine Kuhne-Center for Allergy Research and Education, Davos, Switzerland.
LA  - eng
PT  - Editorial
DEP - 20220529
PL  - Denmark
TA  - Allergy
JT  - Allergy
JID - 7804028
SB  - IM
EDAT- 2022/06/02 06:00
MHDA- 2022/06/02 06:00
CRDT- 2022/06/01 11:05
PHST- 2022/05/27 00:00 [received]
PHST- 2022/05/28 00:00 [accepted]
PHST- 2022/06/01 11:05 [entrez]
PHST- 2022/06/02 06:00 [pubmed]
PHST- 2022/06/02 06:00 [medline]
AID - 10.1111/all.15393 [doi]
PST - aheadofprint
SO  - Allergy. 2022 May 29. doi: 10.1111/all.15393.

PMID- 35644836
OWN - NLM
STAT- Publisher
LR  - 20220603
IS  - 1096-9071 (Electronic)
IS  - 0146-6615 (Linking)
DP  - 2022 May 29
TI  - Bibliometric analysis of global research trends on monkeypox: Are we ready toface this challenge?
LID - 10.1002/jmv.27892 [doi]
FAU - Cheng, Kunming
AU  - Cheng K
AD  - Department of Intensive Care Unit, The Second Affiliated Hospital of ZhengzhouUniversity, Zhengzhou, Henan, China.
FAU - Zhou, Yan
AU  - Zhou Y
AD  - Department of Graduate School, Tianjin Medical University, Tianjin, China.
FAU - Wu, Haiyang
AU  - Wu H
AUID- ORCID: http://orcid.org/0000-0002-3215-1626
AD  - Department of Graduate School, Tianjin Medical University, Tianjin, China.
LA  - eng
PT  - Letter
DEP - 20220529
PL  - United States
TA  - J Med Virol
JT  - Journal of medical virology
JID - 7705876
SB  - IM
EDAT- 2022/06/02 06:00
MHDA- 2022/06/02 06:00
CRDT- 2022/06/01 10:52
PHST- 2022/05/26 00:00 [revised]
PHST- 2022/05/23 00:00 [received]
PHST- 2022/05/27 00:00 [accepted]
PHST- 2022/06/02 06:00 [pubmed]
PHST- 2022/06/02 06:00 [medline]
PHST- 2022/06/01 10:52 [entrez]
AID - 10.1002/jmv.27892 [doi]
PST - aheadofprint
SO  - J Med Virol. 2022 May 29. doi: 10.1002/jmv.27892.

PMID- 35643256
OWN - NLM
STAT- Publisher
LR  - 20220804
IS  - 1873-0442 (Electronic)
IS  - 1477-8939 (Linking)
VI  - 49
DP  - 2022 May 26
TI  - The never-ending global emergence of viral zoonoses after COVID-19? The risingconcern of monkeypox in Europe, North America and beyond.
PG  - 102362
LID - S1477-8939(22)00108-9 [pii]
LID - 10.1016/j.tmaid.2022.102362 [doi]
FAU - Leon-Figueroa, Darwin A
AU  - Leon-Figueroa DA
AD  - Facultad de Medicina Humana, Universidad de San Martin de Porres, Chiclayo, Peru;Emerge, Unidad de Investigacion en Enfermedades Emergentes y Cambio Climatico,Facultad de Salud Publica y Administracion, Universidad Peruana Cayetano Heredia,Lima, Peru.
FAU - Bonilla-Aldana, D Katterine
AU  - Bonilla-Aldana DK
AD  - Faculty de Medicine, Fundacion Universitaria Autonoma de las Americas, Pereira,Risaralda, Colombia; Latin American Network of COVID-19 Research (LANCOVID),Pereira, Risaralda, Colombia.
FAU - Pachar, Monica
AU  - Pachar M
AD  - Medicine Department-Infectious Diseases Service, Hospital Santo Tomas, PanamaCity, Panama.
FAU - Romani, Luccio
AU  - Romani L
AD  - Facultad de Medicina Humana, Universidad de San Martin de Porres, Chiclayo, Peru;Emerge, Unidad de Investigacion en Enfermedades Emergentes y Cambio Climatico,Facultad de Salud Publica y Administracion, Universidad Peruana Cayetano Heredia,Lima, Peru.
FAU - Saldana-Cumpa, Hortencia M
AU  - Saldana-Cumpa HM
AD  - Facultad de Medicina Humana, Universidad de San Martin de Porres, Chiclayo, Peru;Sociedad Cientifica de Estudiantes de Medicina Veritas (SCIEMVE), Chiclayo, Peru.
FAU - Anchay-Zuloeta, Claudia
AU  - Anchay-Zuloeta C
AD  - Facultad de Medicina Humana, Universidad de San Martin de Porres, Chiclayo, Peru;Sociedad Cientifica de Estudiantes de Medicina Veritas (SCIEMVE), Chiclayo, Peru.
FAU - Diaz-Torres, Milagros
AU  - Diaz-Torres M
AD  - Facultad de Medicina Humana, Universidad de San Martin de Porres, Chiclayo, Peru;Sociedad Cientifica de Estudiantes de Medicina Veritas (SCIEMVE), Chiclayo, Peru.
FAU - Franco-Paredes, Carlos
AU  - Franco-Paredes C
AD  - Hospital Infantil de Mexico, Federico Gomez, Mexico City, Mexico.
FAU - Suarez, Jose Antonio
AU  - Suarez JA
AD  - Investigador SNI Senacyt Panama, Clinical Research Deparment, InstitutoConmemorativo Gorgas de Estudios de la Salud, Panama City, Panama.
FAU - Ramirez, Juan David
AU  - Ramirez JD
AD  - Department of Pathology, Molecular, and Cell-Based Medicine, Icahn School ofMedicine at Mount Sinai, New York, NY, USA; Centro de Investigaciones enMicrobiologia y Biotecnologia-UR (CIMBIUR), Facultad de Ciencias Naturales,Universidad del Rosario, Bogota, Colombia.
FAU - Paniz-Mondolfi, Alberto
AU  - Paniz-Mondolfi A
AD  - Department of Pathology, Molecular, and Cell-Based Medicine, Icahn School ofMedicine at Mount Sinai, New York, NY, USA.
FAU - Rodriguez-Morales, Alfonso J
AU  - Rodriguez-Morales AJ
AD  - Latin American Network of COVID-19 Research (LANCOVID), Pereira, Risaralda,Colombia; Grupo de Investigacion Biomedicina, Faculty of Medicine, FundacionUniversitaria Autonoma de las Americas, Pereira, Risaralda, Colombia. Editor inChief, Travel Medicine and Infectious Diseases; Institucion Universitaria Vision de las Americas, Pereira, Risaralda, Colombia; Master of Clinical Epidemiologyand Biostatistics, Universidad Cientifica del Sur, Lima, Peru; School ofMedicine, Universidad Privada Franz Tamayo (UNIFRANZ), Cochabamba, Bolivia.Electronic address: arodriguezmo@cientifica.edu.pe.
LA  - eng
PT  - Editorial
DEP - 20220526
PL  - Netherlands
TA  - Travel Med Infect Dis
JT  - Travel medicine and infectious disease
JID - 101230758
SB  - IM
PMC - PMC9132678
OTO - NOTNLM
OT  - Human
OT  - Monekypox
OT  - Orthopoxvirus
OT  - Poxviridae
OT  - Reemerging
OT  - Zoonosis
EDAT- 2022/06/02 06:00
MHDA- 2022/06/02 06:00
CRDT- 2022/06/01 09:22
PHST- 2022/05/23 00:00 [received]
PHST- 2022/05/23 00:00 [accepted]
PHST- 2022/06/02 06:00 [pubmed]
PHST- 2022/06/02 06:00 [medline]
PHST- 2022/06/01 09:22 [entrez]
AID - S1477-8939(22)00108-9 [pii]
AID - 10.1016/j.tmaid.2022.102362 [doi]
PST - aheadofprint
SO  - Travel Med Infect Dis. 2022 May 26;49:102362. doi: 10.1016/j.tmaid.2022.102362.

PMID- 35642580
OWN - NLM
STAT- Publisher
LR  - 20220601
IS  - 1708-8305 (Electronic)
IS  - 1195-1982 (Linking)
DP  - 2022 May 31
TI  - Potential for monkeypox exportation from west and Central Africa through globaltravel networks.
LID - taac072 [pii]
LID - 10.1093/jtm/taac072 [doi]
AB  - A multinational monkeypox outbreak is currently underway in a growing number ofnon-endemic countries. Given the potential for future outbreaks, we evaluate the likely pathways for international exportation of monkeypox via commercial airtravel from endemic regions.
CI  - (c) The Author(s) 2022. Published by Oxford University Press on behalf ofInternational Society of Travel Medicine. All rights reserved. For permissions,please e-mail: journals.permissions@oup.com.
FAU - Au, Natalie H
AU  - Au NH
AD  - BlueDot, Toronto, Canada.
FAU - Portillo, Mariana Torres
AU  - Portillo MT
AD  - BlueDot, Toronto, Canada.
FAU - Marwah, Anindita
AU  - Marwah A
AD  - BlueDot, Toronto, Canada.
FAU - Thomas-Bachli, Andrea
AU  - Thomas-Bachli A
AD  - BlueDot, Toronto, Canada.
FAU - Demarsh, P Alex
AU  - Demarsh PA
AD  - BlueDot, Toronto, Canada.
FAU - Khan, Kamran
AU  - Khan K
AD  - BlueDot, Toronto, Canada.
AD  - Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Canada.
AD  - Department of Medicine, University of Toronto, Toronto, Canada.
FAU - Bogoch, Isaac I
AU  - Bogoch II
AUID- ORCID: 0000-0003-1590-6748
AD  - Department of Medicine, University of Toronto, Toronto, Canada.
AD  - Divisions of General Internal Medicine and Infectious Diseases, University HealthNetwork, Toronto, Canada.
LA  - eng
PT  - Journal Article
DEP - 20220531
PL  - England
TA  - J Travel Med
JT  - Journal of travel medicine
JID - 9434456
SB  - IM
OTO - NOTNLM
OT  - Africa
OT  - Air Travel
OT  - Monkeypox
OT  - Nigeria
OT  - Outbreak
OT  - Zoonosis
EDAT- 2022/06/02 06:00
MHDA- 2022/06/02 06:00
CRDT- 2022/06/01 05:23
PHST- 2022/05/20 00:00 [received]
PHST- 2022/05/24 00:00 [revised]
PHST- 2022/06/01 05:23 [entrez]
PHST- 2022/06/02 06:00 [pubmed]
PHST- 2022/06/02 06:00 [medline]
AID - 6596167 [pii]
AID - 10.1093/jtm/taac072 [doi]
PST - aheadofprint
SO  - J Travel Med. 2022 May 31. pii: 6596167. doi: 10.1093/jtm/taac072.

PMID- 35642552
OWN - NLM
STAT- Publisher
LR  - 20220606
IS  - 1096-9071 (Electronic)
IS  - 0146-6615 (Linking)
DP  - 2022 Jun 1
TI  - The emergence of monkeypox virus, new challenges to the healthcare settings inPakistan.
LID - 10.1002/jmv.27899 [doi]
FAU - Abdullah
AU  - Abdullah
AUID- ORCID: http://orcid.org/0000-0002-0803-6695
AD  - Department of Health and Biological Sciences, Abasyn University, KhyberPakhtunkhwa, Peshawar, Pakistan.
FAU - Ali, Sher
AU  - Ali S
AUID- ORCID: http://orcid.org/0000-0002-4604-9702
AD  - Department of Food Engineering, Faculty of Animal Science and Food Engineering(FZEA), University of Sao Paulo (USP), Pirassununga, Sao Paulo, Brazil.
FAU - Cancado, Fernando A C Q
AU  - Cancado FACQ
AUID- ORCID: http://orcid.org/0000-0002-1173-6502
AD  - Department of Basic Science, Faculty of Animal Science and Food Engineering,University of Sao Paulo (USP), Pirassununga, Sao Paulo, Brazil.
FAU - de Oliveira, Carlos A F
AU  - de Oliveira CAF
AUID- ORCID: http://orcid.org/0000-0001-5779-5287
AD  - Department of Food Engineering, Faculty of Animal Science and Food Engineering(FZEA), University of Sao Paulo (USP), Pirassununga, Sao Paulo, Brazil.
LA  - eng
GR  - 2022/03952-1/The authors highly acknowledge Fundacao de Amparo a Pesquisa doEstado de Sao Paulo (FAPESP) for funding support.
PT  - Letter
DEP - 20220601
PL  - United States
TA  - J Med Virol
JT  - Journal of medical virology
JID - 7705876
SB  - IM
EDAT- 2022/06/02 06:00
MHDA- 2022/06/02 06:00
CRDT- 2022/06/01 04:54
PHST- 2022/05/27 00:00 [revised]
PHST- 2022/05/24 00:00 [received]
PHST- 2022/05/28 00:00 [accepted]
PHST- 2022/06/02 06:00 [pubmed]
PHST- 2022/06/02 06:00 [medline]
PHST- 2022/06/01 04:54 [entrez]
AID - 10.1002/jmv.27899 [doi]
PST - aheadofprint
SO  - J Med Virol. 2022 Jun 1. doi: 10.1002/jmv.27899.

PMID- 35640830
OWN - NLM
STAT- Publisher
LR  - 20220614
IS  - 1878-3511 (Electronic)
IS  - 1201-9712 (Linking)
VI  - 122
DP  - 2022 May 29
TI  - Increased outbreaks of monkeypox highlight gaps in actual disease burden inSub-Saharan Africa and in animal reservoirs.
PG  - 107-111
LID - S1201-9712(22)00322-8 [pii]
LID - 10.1016/j.ijid.2022.05.058 [doi]
AB  - We explain research gaps on Monkeypox (MPX) virus epidemiology in endemiccountries and present hypotheses for the recent increase of MPX cases in WestAfrica as a possible explanation for the current epidemic in Europe, America, andAustralia. The detection of >400 MPX cases in less than a month in May 2022,across many countries underscores the epidemic potential of MPX in humans anddemonstrates several important research gaps. First, the true burden of MPX inWest and Central Africa is poorly understood, although it is critical forprevention and control of future outbreaks. Second, the diversity and extent ofthe animal reservoir remain unknown. We hypothesize that the synanthropic rodent population has increased in recent years in Africa leading to more human-rodentinteractions and thus increased transmission of MPXV. We further hypothesise thatnearly 45 years after the end of routine smallpox vaccination, the larger andmore interconnected immune-naive population has crossed a threshold resulting in more sustainable human-to-human transmission of MPXV. The current epidemic in theWestern World is possibly a consequence of increased local transmission of MPXVin Africa. A new estimation of the basic and effective reproduction rate (R0 and Re) in different populations is required. National, regional, and internationalcollaborations are needed to address research gaps related to MPX outbreaks.
CI  - Copyright (c) 2022 The Author(s). Published by Elsevier Ltd.. All rightsreserved.
FAU - Haider, Najmul
AU  - Haider N
AD  - The Royal Veterinary College, University of London, Hawkshead Lane, North Mymms, Hatfield, Hertfordshire, United Kingdom. Electronic address: nhaider@rvc.ac.uk.
FAU - Guitian, Javier
AU  - Guitian J
AD  - The Royal Veterinary College, University of London, Hawkshead Lane, North Mymms, Hatfield, Hertfordshire, United Kingdom. Electronic address: JGuitian@RVC.AC.UK.
FAU - Simons, David
AU  - Simons D
AD  - The Royal Veterinary College, University of London, Hawkshead Lane, North Mymms, Hatfield, Hertfordshire, United Kingdom. Electronic address: dsimons19@rvc.ac.uk.
FAU - Asogun, Danny
AU  - Asogun D
AD  - Irrua Specialized Teaching Hospital, Irrua, Nigeria. Electronic address:asogun2001@yahoo.com.
FAU - Ansumana, Rashid
AU  - Ansumana R
AD  - School of Community Health Science, Njala University, Bo Campus, Sierra Leone.Electronic address: r.ansumana@njala.edu.sl.
FAU - Honeyborne, Isobella
AU  - Honeyborne I
AD  - Division of Infection and Immunity, Centre for Clinical Microbiology, University College London, United Kingdom. Electronic address: i.honeyborne@ucl.ac.uk.
FAU - Velavan, Thirumalaisamy P
AU  - Velavan TP
AD  - Institute of Tropical Medicine, University of Tubingen, Tubingen, Germany;Vietnamese-German Center for Medical Research (VG-CARE), Hanoi, Vietnam.Electronic address: velavan@medizin.uni-tuebingen.de.
FAU - Ntoumi, Francine
AU  - Ntoumi F
AD  - Institute of Tropical Medicine, University of Tubingen, Tubingen, Germany;Congolese Foundation for Medical Research, Brazzaville, Republic of Congo.Electronic address: ffntoumi@hotmail.com.
FAU - Valdoleiros, Sofia R
AU  - Valdoleiros SR
AD  - Infectious Diseases Department, Centro Hospitalar Universitario de Sao Joao,Porto, Portugal; European Society for Clinical Microbiology and InfectiousDiseases, Basel, Switzerland. Electronic address:sofia.valdoleiros@chsj.min-saude.pt.
FAU - Petersen, Eskild
AU  - Petersen E
AD  - European Society for Clinical Microbiology and Infectious Diseases, Basel,Switzerland; Institute for Clinical Medicine, Aarhus University, Aarhus, Denmark.Electronic address: eskild.petersen@gmail.com.
FAU - Kock, Richard
AU  - Kock R
AD  - The Royal Veterinary College, University of London, Hawkshead Lane, North Mymms, Hatfield, Hertfordshire, United Kingdom. Electronic address: rkock@rvc.ac.uk.
FAU - Zumla, Alimuddin
AU  - Zumla A
AD  - Division of Infection and Immunity, Centre for Clinical Microbiology, University College London, United Kingdom; NIHR-BRC, University College London Hospitals,London, United Kingdom. Electronic address: a.zumla@ucl.ac.uk.
LA  - eng
PT  - Journal Article
DEP - 20220529
PL  - Canada
TA  - Int J Infect Dis
JT  - International journal of infectious diseases : IJID : official publication of theInternational Society for Infectious Diseases
JID - 9610933
SB  - IM
OTO - NOTNLM
OT  - MPX
OT  - Monkeypox virus
OT  - Nigeria
OT  - Reservoirs
OT  - West Africa
OT  - outbreaks
OT  - smallpox vaccine
COIS- Conflict of interest The authors declare that they have no conflict of interest
EDAT- 2022/06/01 06:00
MHDA- 2022/06/01 06:00
CRDT- 2022/05/31 19:26
PHST- 2022/05/23 00:00 [received]
PHST- 2022/05/25 00:00 [revised]
PHST- 2022/05/25 00:00 [accepted]
PHST- 2022/06/01 06:00 [pubmed]
PHST- 2022/06/01 06:00 [medline]
PHST- 2022/05/31 19:26 [entrez]
AID - S1201-9712(22)00322-8 [pii]
AID - 10.1016/j.ijid.2022.05.058 [doi]
PST - aheadofprint
SO  - Int J Infect Dis. 2022 May 29;122:107-111. doi: 10.1016/j.ijid.2022.05.058.

PMID- 35637363
OWN - NLM
STAT- Publisher
LR  - 20220606
IS  - 1096-9071 (Electronic)
IS  - 0146-6615 (Linking)
DP  - 2022 May 30
TI  - Human monkeypox outbreak in 2022.
LID - 10.1002/jmv.27894 [doi]
FAU - Kumar, Suresh
AU  - Kumar S
AUID- ORCID: http://orcid.org/0000-0001-5682-0938
AD  - Department of Diagnostic & Allied Health Science, Faculty of Health and LifeSciences, Management and Science University, ShahAlam, Selangor, Malaysia.
FAU - Subramaniam, Gunasekaran
AU  - Subramaniam G
AD  - Department of Physiology, Anatomy, and Genetics, University of Oxford, Oxford,UK.
FAU - Karuppanan, Kalimuthu
AU  - Karuppanan K
AD  - Division of Cardiovascular Medicine, Radcliffe Department of Medicine, WellcomeCentre for Human Genetics, University of Oxford, Oxford, UK.
LA  - eng
PT  - Letter
DEP - 20220530
PL  - United States
TA  - J Med Virol
JT  - Journal of medical virology
JID - 7705876
SB  - IM
EDAT- 2022/06/01 06:00
MHDA- 2022/06/01 06:00
CRDT- 2022/05/31 13:59
PHST- 2022/05/26 00:00 [revised]
PHST- 2022/05/23 00:00 [received]
PHST- 2022/05/27 00:00 [accepted]
PHST- 2022/06/01 06:00 [pubmed]
PHST- 2022/06/01 06:00 [medline]
PHST- 2022/05/31 13:59 [entrez]
AID - 10.1002/jmv.27894 [doi]
PST - aheadofprint
SO  - J Med Virol. 2022 May 30. doi: 10.1002/jmv.27894.

PMID- 35636447
OWN - NLM
STAT- MEDLINE
DCOM- 20220628
LR  - 20220716
IS  - 1474-4457 (Electronic)
IS  - 1473-3099 (Linking)
VI  - 22
IP  - 7
DP  - 2022 Jul
TI  - Monkeypox outbreaks outside endemic regions: scientific and social priorities.
PG  - 929-931
LID - S1473-3099(22)00354-1 [pii]
LID - 10.1016/S1473-3099(22)00354-1 [doi]
FAU - Zumla, Alimuddin
AU  - Zumla A
AD  - Department of Infection, Division of Infection and Immunity, Centre for Clinical Microbiology, University College London, London, UK; NIHR Biomedical ResearchCentre, University College London Hospitals NHS Foundation Trust, London NW1 OPE,UK. Electronic address: a.zumla@ucl.ac.uk.
FAU - Valdoleiros, Sofia R
AU  - Valdoleiros SR
AD  - Infectious Diseases Department, Centro Hospitalar Universitario de Sao Joao,Porto, Portugal.
FAU - Haider, Najmul
AU  - Haider N
AD  - The Royal Veterinary College, North Mymms, Hatfield, Hertfordshire, UK.
FAU - Asogun, Danny
AU  - Asogun D
AD  - Irrua Specialized Teaching Hospital, Irrua, Nigeria.
FAU - Ntoumi, Francine
AU  - Ntoumi F
AD  - Congolese Foundation for Medical Research, Brazzaville, Republic of the Congo.
FAU - Petersen, Eskild
AU  - Petersen E
AD  - Institute for Clinical Medicine, Aarhus University, Aarhus, Denmark.
FAU - Kock, Richard
AU  - Kock R
AD  - The Royal Veterinary College, North Mymms, Hatfield, Hertfordshire, UK.
LA  - eng
PT  - Journal Article
DEP - 20220527
PL  - United States
TA  - Lancet Infect Dis
JT  - The Lancet. Infectious diseases
JID - 101130150
SB  - IM
MH  - Disease Outbreaks
MH  - Humans
MH  - *Monkeypox/epidemiology
MH  - Monkeypox virus
PMC - PMC9141675
COIS- AZ, NH, DA, FN, and RK are members of the Pan-African Network for Rapid Research,Response, Relief and Preparedness for Infectious Diseases Epidemics funded by theEuropean and Developing Countries Clinical Trials Partnership, which is supportedby Horizon 2020, the EU's Framework Programme for Research and Innovation. AZholds a UK National Institute of Health Research Senior Investigator Award and isa Mahathir Science Prize and Pascoal Mocumbi Prize laureate. All authors have an interest in epidemic infections.
EDAT- 2022/06/01 06:00
MHDA- 2022/06/29 06:00
CRDT- 2022/05/31 13:22
PHST- 2022/05/23 00:00 [received]
PHST- 2022/05/23 00:00 [accepted]
PHST- 2022/06/01 06:00 [pubmed]
PHST- 2022/06/29 06:00 [medline]
PHST- 2022/05/31 13:22 [entrez]
AID - S1473-3099(22)00354-1 [pii]
AID - 10.1016/S1473-3099(22)00354-1 [doi]
PST - ppublish
SO  - Lancet Infect Dis. 2022 Jul;22(7):929-931. doi: 10.1016/S1473-3099(22)00354-1.Epub 2022 May 27.

PMID- 35635851
OWN - NLM
STAT- MEDLINE
DCOM- 20220720
LR  - 20220802
IS  - 1539-3704 (Electronic)
IS  - 0003-4819 (Linking)
VI  - 175
IP  - 7
DP  - 2022 Jul
TI  - Web Exclusive. Annals On Call - Monkeypox: Should We Worry About AnotherPandemic?
PG  - OC1
LID - 10.7326/A21-0014 [doi]
FAU - Centor, Robert M
AU  - Centor RM
AD  - Huntsville Regional Medical Campus, University of Alabama Birmingham School ofMedicine, Birmingham, Alabama (R.M.C.).
FAU - Adalja, Amesh
AU  - Adalja A
AD  - Johns Hopkins Center for Health Security, Baltimore, Maryland (A.A.).
LA  - eng
PT  - Journal Article
DEP - 20220531
PL  - United States
TA  - Ann Intern Med
JT  - Annals of internal medicine
JID - 0372351
SB  - IM
MH  - Animals
MH  - Anxiety
MH  - Disease Outbreaks/prevention & control
MH  - Humans
MH  - *Monkeypox/epidemiology
MH  - Pandemics
MH  - Zoonoses
EDAT- 2022/06/01 06:00
MHDA- 2022/07/22 06:00
CRDT- 2022/05/31 13:00
PHST- 2022/06/01 06:00 [pubmed]
PHST- 2022/07/22 06:00 [medline]
PHST- 2022/05/31 13:00 [entrez]
AID - 10.7326/A21-0014 [doi]
PST - ppublish
SO  - Ann Intern Med. 2022 Jul;175(7):OC1. doi: 10.7326/A21-0014. Epub 2022 May 31.

PMID- 35633308
OWN - NLM
STAT- MEDLINE
LR  - 20220805
IS  - 1365-3156 (Electronic)
IS  - 1360-2276 (Linking)
VI  - 27
IP  - 7
DP  - 2022 Jul
TI  - Monkeypox 2022 outbreak: An update.
PG  - 604-605
LID - 10.1111/tmi.13785 [doi]
FAU - Velavan, Thirumalaisamy P
AU  - Velavan TP
AD  - Institute of Tropical Medicine, Universitatsklinikum Tubingen, Tubingen, Germany.
AD  - Vietnamese German Center for Medical Research (VG-CARE), Hanoi, Vietnam.
AD  - Faculty of Medicine, Duy Tan University, Da Nang, Vietnam.
FAU - Meyer, Christian G
AU  - Meyer CG
AD  - Institute of Tropical Medicine, Universitatsklinikum Tubingen, Tubingen, Germany.
AD  - Vietnamese German Center for Medical Research (VG-CARE), Hanoi, Vietnam.
AD  - Faculty of Medicine, Duy Tan University, Da Nang, Vietnam.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20220614
PL  - England
TA  - Trop Med Int Health
JT  - Tropical medicine & international health : TM & IH
JID - 9610576
RN  - 0 (DNA, Viral)
SB  - IM
MH  - DNA, Viral
MH  - Disease Outbreaks
MH  - Humans
MH  - *Monkeypox/epidemiology
OTO - NOTNLM
OT  - *2022 outbreak
OT  - *Genetic relatedness
OT  - *Human to Human
OT  - *MPXV
OT  - *West African clade
OT  - *Zoonotic
OT  - *monkeypox
EDAT- 2022/05/29 06:00
MHDA- 2022/07/09 06:00
CRDT- 2022/05/28 10:02
PHST- 2022/05/29 06:00 [pubmed]
PHST- 2022/07/09 06:00 [medline]
PHST- 2022/05/28 10:02 [entrez]
AID - 10.1111/tmi.13785 [doi]
PST - ppublish
SO  - Trop Med Int Health. 2022 Jul;27(7):604-605. doi: 10.1111/tmi.13785. Epub 2022Jun 14.

PMID- 35624160
OWN - NLM
STAT- MEDLINE
DCOM- 20220609
LR  - 20220613
IS  - 1476-4687 (Electronic)
IS  - 0028-0836 (Linking)
VI  - 606
IP  - 7913
DP  - 2022 Jun
TI  - Monkeypox outbreaks: 4 key questions researchers have.
PG  - 238-239
LID - 10.1038/d41586-022-01493-6 [doi]
FAU - Kozlov, Max
AU  - Kozlov M
LA  - eng
PT  - News
PL  - England
TA  - Nature
JT  - Nature
JID - 0410462
SB  - IM
MH  - *Disease Outbreaks/prevention & control/statistics & numerical data
MH  - Humans
MH  - *Monkeypox/epidemiology/prevention & control
MH  - Public Health/statistics & numerical data
MH  - *Research Personnel
OTO - NOTNLM
OT  - *Diseases
OT  - *Public health
OT  - *Virology
EDAT- 2022/05/28 06:00
MHDA- 2022/06/10 06:00
CRDT- 2022/05/27 23:18
PHST- 2022/05/28 06:00 [pubmed]
PHST- 2022/06/10 06:00 [medline]
PHST- 2022/05/27 23:18 [entrez]
AID - 10.1038/d41586-022-01493-6 [doi]
AID - 10.1038/d41586-022-01493-6 [pii]
PST - ppublish
SO  - Nature. 2022 Jun;606(7913):238-239. doi: 10.1038/d41586-022-01493-6.

PMID- 35623380
OWN - NLM
STAT- MEDLINE
DCOM- 20220726
LR  - 20220802
IS  - 1474-4457 (Electronic)
IS  - 1473-3099 (Linking)
VI  - 22
IP  - 8
DP  - 2022 Aug
TI  - Clinical features and management of human monkeypox: a retrospectiveobservational study in the UK.
PG  - 1153-1162
LID - S1473-3099(22)00228-6 [pii]
LID - 10.1016/S1473-3099(22)00228-6 [doi]
AB  - BACKGROUND: Cases of human monkeypox are rarely seen outside of west and central Africa. There are few data regarding viral kinetics or the duration of viralshedding and no licensed treatments. Two oral drugs, brincidofovir andtecovirimat, have been approved for treatment of smallpox and have demonstratedefficacy against monkeypox in animals. Our aim was to describe the longitudinalclinical course of monkeypox in a high-income setting, coupled with viraldynamics, and any adverse events related to novel antiviral therapies. METHODS:In this retrospective observational study, we report the clinical features,longitudinal virological findings, and response to off-label antivirals in seven patients with monkeypox who were diagnosed in the UK between 2018 and 2021,identified through retrospective case-note review. This study included allpatients who were managed in dedicated high consequence infectious diseases(HCID) centres in Liverpool, London, and Newcastle, coordinated via a nationalHCID network. FINDINGS: We reviewed all cases since the inception of the HCID(airborne) network between Aug 15, 2018, and Sept 10, 2021, identifying sevenpatients. Of the seven patients, four were men and three were women. Threeacquired monkeypox in the UK: one patient was a health-care worker who acquiredthe virus nosocomially, and one patient who acquired the virus abroad transmittedit to an adult and child within their household cluster. Notable disease featuresincluded viraemia, prolonged monkeypox virus DNA detection in upper respiratorytract swabs, reactive low mood, and one patient had a monkeypox virusPCR-positive deep tissue abscess. Five patients spent more than 3 weeks (range22-39 days) in isolation due to prolonged PCR positivity. Three patients weretreated with brincidofovir (200 mg once a week orally), all of whom developedelevated liver enzymes resulting in cessation of therapy. One patient was treatedwith tecovirimat (600 mg twice daily for 2 weeks orally), experienced no adverse effects, and had a shorter duration of viral shedding and illness (10 dayshospitalisation) compared with the other six patients. One patient experienced a mild relapse 6 weeks after hospital discharge. INTERPRETATION: Human monkeypoxposes unique challenges, even to well resourced health-care systems with HCIDnetworks. Prolonged upper respiratory tract viral DNA shedding after skin lesion resolution challenged current infection prevention and control guidance. There isan urgent need for prospective studies of antivirals for this disease. FUNDING:None.
CI  - Copyright (c) 2022 The Author(s). Published by Elsevier Ltd. This is an OpenAccess article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. Allrights reserved.
FAU - Adler, Hugh
AU  - Adler H
AD  - Tropical and Infectious Disease Unit, Liverpool University Hospitals NHSFoundation Trust, Liverpool, UK; Department of Clinical Sciences, LiverpoolSchool of Tropical Medicine, Liverpool, UK.
FAU - Gould, Susan
AU  - Gould S
AD  - Tropical and Infectious Disease Unit, Liverpool University Hospitals NHSFoundation Trust, Liverpool, UK; Department of Clinical Sciences, LiverpoolSchool of Tropical Medicine, Liverpool, UK.
FAU - Hine, Paul
AU  - Hine P
AD  - Tropical and Infectious Disease Unit, Liverpool University Hospitals NHSFoundation Trust, Liverpool, UK; Department of Clinical Sciences, LiverpoolSchool of Tropical Medicine, Liverpool, UK.
FAU - Snell, Luke B
AU  - Snell LB
AD  - Directorate of Infection, Guy's & St Thomas' NHS Foundation Trust, London, UK.
FAU - Wong, Waison
AU  - Wong W
AD  - Department of Paediatric Infectious Diseases, Alder Hey Children's NHS FoundationTrust, Liverpool, UK.
FAU - Houlihan, Catherine F
AU  - Houlihan CF
AD  - Rare and Imported Pathogens Laboratory, UK Health Security Agency, Porton Down,Salisbury, UK; University College London, London, UK.
FAU - Osborne, Jane C
AU  - Osborne JC
AD  - Rare and Imported Pathogens Laboratory, UK Health Security Agency, Porton Down,Salisbury, UK.
FAU - Rampling, Tommy
AU  - Rampling T
AD  - Rare and Imported Pathogens Laboratory, UK Health Security Agency, Porton Down,Salisbury, UK; University College London, London, UK.
FAU - Beadsworth, Mike Bj
AU  - Beadsworth MB
AD  - Tropical and Infectious Disease Unit, Liverpool University Hospitals NHSFoundation Trust, Liverpool, UK; Department of Clinical Sciences, LiverpoolSchool of Tropical Medicine, Liverpool, UK.
FAU - Duncan, Christopher Ja
AU  - Duncan CJ
AD  - Department of Infection and Tropical Medicine, Newcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle, UK; Translational and Clinical Research Institute,Immunity and Inflammation Theme, Newcastle University, Newcastle Upon Tyne, UK.
FAU - Dunning, Jake
AU  - Dunning J
AD  - Department of Infectious Diseases, Royal Free London NHS Foundation Trust,London, UK; Centre for Tropical Medicine and Global Health, University of Oxford,Oxford, UK; National Infection Service, UK Health Security Agency, London, UK.
FAU - Fletcher, Tom E
AU  - Fletcher TE
AD  - Tropical and Infectious Disease Unit, Liverpool University Hospitals NHSFoundation Trust, Liverpool, UK; Department of Clinical Sciences, LiverpoolSchool of Tropical Medicine, Liverpool, UK.
FAU - Hunter, Ewan R
AU  - Hunter ER
AD  - Department of Infection and Tropical Medicine, Newcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle, UK.
FAU - Jacobs, Michael
AU  - Jacobs M
AD  - University College London, London, UK; Department of Infectious Diseases, RoyalFree London NHS Foundation Trust, London, UK.
FAU - Khoo, Saye H
AU  - Khoo SH
AD  - Tropical and Infectious Disease Unit, Liverpool University Hospitals NHSFoundation Trust, Liverpool, UK; Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.
FAU - Newsholme, William
AU  - Newsholme W
AD  - Directorate of Infection, Guy's & St Thomas' NHS Foundation Trust, London, UK.
FAU - Porter, David
AU  - Porter D
AD  - Department of Paediatric Infectious Diseases, Alder Hey Children's NHS FoundationTrust, Liverpool, UK.
FAU - Porter, Robert J
AU  - Porter RJ
AD  - Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
FAU - Ratcliffe, Libuse
AU  - Ratcliffe L
AD  - Tropical and Infectious Disease Unit, Liverpool University Hospitals NHSFoundation Trust, Liverpool, UK.
FAU - Schmid, Matthias L
AU  - Schmid ML
AD  - Department of Infection and Tropical Medicine, Newcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle, UK.
FAU - Semple, Malcolm G
AU  - Semple MG
AD  - Respiratory Unit, Alder Hey Children's NHS Foundation Trust, Liverpool, UK; NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Institute ofInfection Veterinary and Ecological Sciences, University of Liverpool, Liverpool,UK.
FAU - Tunbridge, Anne J
AU  - Tunbridge AJ
AD  - Department of Infectious Diseases, Sheffield Teaching Hospitals NHS FoundationTrust, Royal Hallamshire Hospital, Sheffield.
FAU - Wingfield, Tom
AU  - Wingfield T
AD  - Tropical and Infectious Disease Unit, Liverpool University Hospitals NHSFoundation Trust, Liverpool, UK; Department of Clinical Sciences, LiverpoolSchool of Tropical Medicine, Liverpool, UK; World Health OrganizationCollaborating Centre on Tuberculosis and Social Medicine, Department of GlobalPublic Health, Karolinska Institute, Stockholm, Sweden.
FAU - Price, Nicholas M
AU  - Price NM
AD  - Directorate of Infection, Guy's & St Thomas' NHS Foundation Trust, London, UK.Electronic address: nicholas.price@gstt.nhs.uk.
CN  - NHS England High Consequence Infectious Diseases (Airborne) Network
LA  - eng
GR  - WT_/Wellcome Trust/United Kingdom
PT  - Journal Article
PT  - Observational Study
DEP - 20220524
PL  - United States
TA  - Lancet Infect Dis
JT  - The Lancet. Infectious diseases
JID - 101130150
RN  - 0 (Antiviral Agents)
SB  - IM
EIN - Lancet Infect Dis. 2022 Jul;22(7):e177. PMID: 35644159
EIN - Lancet Infect Dis. 2022 Jul;22(7):e177. PMID: 35659001
MH  - Adult
MH  - Animals
MH  - Antiviral Agents/therapeutic use
MH  - Child
MH  - Female
MH  - Humans
MH  - Male
MH  - *Monkeypox/diagnosis/drug therapy/epidemiology
MH  - Prospective Studies
MH  - Retrospective Studies
MH  - United Kingdom/epidemiology
PMC - PMC9300470
COIS- Declaration of interests JD reports an unremunerated role on a Data Safety andMonitoring Board (DSMB) for an extended access programme for tecovirimat. MGSreports non-remunerated roles in a DSMB for Pfizer's mRNA vaccine programme, the UK Scientific Advisory Group for Emergencies, and New Emerging Respiratory Virus Threats Advisory Group; and reports chairing a Scientific Advisory Board andholding stock or stock options in Integrum Scientific LLC, Greensboro, NC, USA.SHK reports grants (unrelated to the current work) from ViiV, Merck, and GileadSciences; advisory board membership for ViiV and Merck; honoraria from ViiV; and being an unremunerated chair of a DSMB for a Gates Foundation-funded trial.
IR  - Abouyannis M
FIR - Abouyannis, Mike
IR  - Al-Balushi A
FIR - Al-Balushi, Asma
IR  - Aston S
FIR - Aston, Stephen
IR  - Ball R
FIR - Ball, Robert
IR  - Beeching NJ
FIR - Beeching, Nicholas J
IR  - Blanchard TJ
FIR - Blanchard, Thomas J
IR  - Carlin F
FIR - Carlin, Ffion
IR  - Davies G
FIR - Davies, Geraint
IR  - Gillespie A
FIR - Gillespie, Angela
IR  - Hicks SR
FIR - Hicks, Scott R
IR  - Hoyle MC
FIR - Hoyle, Marie-Claire
IR  - Ilozue C
FIR - Ilozue, Chinenye
IR  - Mair L
FIR - Mair, Luke
IR  - Marshall S
FIR - Marshall, Suzanne
IR  - Neary A
FIR - Neary, Anne
IR  - Nsutebu E
FIR - Nsutebu, Emmanuel
IR  - Parker S
FIR - Parker, Samantha
IR  - Ryan H
FIR - Ryan, Hannah
IR  - Turtle L
FIR - Turtle, Lance
IR  - Smith C
FIR - Smith, Chris
IR  - van Aartsen J
FIR - van Aartsen, Jon
IR  - Walker NF
FIR - Walker, Naomi F
IR  - Woolley S
FIR - Woolley, Stephen
IR  - Chawla A
FIR - Chawla, Anu
IR  - Hart I
FIR - Hart, Ian
IR  - Smielewska A
FIR - Smielewska, Anna
IR  - Joekes E
FIR - Joekes, Elizabeth
IR  - Benson C
FIR - Benson, Cathryn
IR  - Brindley C
FIR - Brindley, Cheryl
IR  - Das U
FIR - Das, Urmi
IR  - Eyton-Chong CK
FIR - Eyton-Chong, Chin K
IR  - Gnanalingham C
FIR - Gnanalingham, Claire
IR  - Halfhide C
FIR - Halfhide, Clare
IR  - Larru B
FIR - Larru, Beatriz
IR  - Mayell S
FIR - Mayell, Sarah
IR  - McBride J
FIR - McBride, Joanna
IR  - Oliver C
FIR - Oliver, Claire
IR  - Paul P
FIR - Paul, Princy
IR  - Riordan A
FIR - Riordan, Andrew
IR  - Sridhar L
FIR - Sridhar, Lekha
IR  - Storey M
FIR - Storey, Megan
IR  - Abdul A
FIR - Abdul, Audrey
IR  - Abrahamsen J
FIR - Abrahamsen, Jennifer
IR  - Athan B
FIR - Athan, Breda
IR  - Bhagani S
FIR - Bhagani, Sanjay
IR  - Brown CS
FIR - Brown, Colin S
IR  - Carpenter O
FIR - Carpenter, Oliver
IR  - Cropley I
FIR - Cropley, Ian
IR  - Frost K
FIR - Frost, Kerrie
IR  - Hopkins S
FIR - Hopkins, Susan
IR  - Joyce J
FIR - Joyce, Jessica
IR  - Lamb L
FIR - Lamb, Lucy
IR  - Lyons A
FIR - Lyons, Adrian
IR  - Mahungu T
FIR - Mahungu, Tabitha
IR  - Mepham S
FIR - Mepham, Stephen
IR  - Mukwaira E
FIR - Mukwaira, Edina
IR  - Rodger A
FIR - Rodger, Alison
IR  - Taylor C
FIR - Taylor, Caroline
IR  - Warren S
FIR - Warren, Simon
IR  - Williams A
FIR - Williams, Alan
IR  - Levitt D
FIR - Levitt, Debbie
IR  - Allen D
FIR - Allen, Denise
IR  - Dixon J
FIR - Dixon, Jill
IR  - Evans A
FIR - Evans, Adam
IR  - McNicholas P
FIR - McNicholas, Pauline
IR  - Payne B
FIR - Payne, Brendan
IR  - Price DA
FIR - Price, D Ashley
IR  - Schwab U
FIR - Schwab, Uli
IR  - Sykes A
FIR - Sykes, Allison
IR  - Taha Y
FIR - Taha, Yusri
IR  - Ward M
FIR - Ward, Margaret
IR  - Emonts M
FIR - Emonts, Marieke
IR  - Owens S
FIR - Owens, Stephen
IR  - Botgros A
FIR - Botgros, Alina
IR  - Douthwaite ST
FIR - Douthwaite, Sam T
IR  - Goodman A
FIR - Goodman, Anna
IR  - Luintel A
FIR - Luintel, Akish
IR  - MacMahon E
FIR - MacMahon, Eithne
IR  - Nebbia G
FIR - Nebbia, Gaia
IR  - O'Hara G
FIR - O'Hara, Geraldine
IR  - Parsons J
FIR - Parsons, Joseph
IR  - Sen A
FIR - Sen, Ashwin
IR  - Stevenson D
FIR - Stevenson, Daniel
IR  - Sullivan T
FIR - Sullivan, Tadgh
IR  - Taj U
FIR - Taj, Usman
IR  - van Nipsen Tot Pannerden C
FIR - van Nipsen Tot Pannerden, Claire
IR  - Winslow H
FIR - Winslow, Helen
IR  - Zatyka E
FIR - Zatyka, Ewa
IR  - Alozie-Otuka E
FIR - Alozie-Otuka, Ekene
IR  - Beviz C
FIR - Beviz, Csaba
IR  - Ceesay Y
FIR - Ceesay, Yusupha
IR  - Gargee L
FIR - Gargee, Latchmin
IR  - Kabia M
FIR - Kabia, Morloh
IR  - Mitchell H
FIR - Mitchell, Hannah
IR  - Perkins S
FIR - Perkins, Shona
IR  - Sasson M
FIR - Sasson, Mingaile
IR  - Sehmbey K
FIR - Sehmbey, Kamal
IR  - Tabios F
FIR - Tabios, Federico
IR  - Wigglesworth N
FIR - Wigglesworth, Neil
IR  - Aarons EJ
FIR - Aarons, Emma J
IR  - Brooks T
FIR - Brooks, Tim
IR  - Dryden M
FIR - Dryden, Matthew
IR  - Furneaux J
FIR - Furneaux, Jenna
IR  - Gibney B
FIR - Gibney, Barry
IR  - Small J
FIR - Small, Jennifer
IR  - Truelove E
FIR - Truelove, Elizabeth
IR  - Warrell CE
FIR - Warrell, Clare E
IR  - Firth R
FIR - Firth, Richard
IR  - Hobson G
FIR - Hobson, Gemma
IR  - Johnson C
FIR - Johnson, Christopher
IR  - Dewynter A
FIR - Dewynter, Alison
IR  - Nixon S
FIR - Nixon, Sebastian
IR  - Spence O
FIR - Spence, Oliver
IR  - Bugert JJ
FIR - Bugert, Joachim J
IR  - Hruby DE
FIR - Hruby, Dennis E
EDAT- 2022/05/28 06:00
MHDA- 2022/07/27 06:00
CRDT- 2022/05/27 19:02
PHST- 2022/01/31 00:00 [received]
PHST- 2022/03/25 00:00 [revised]
PHST- 2022/03/29 00:00 [accepted]
PHST- 2022/05/28 06:00 [pubmed]
PHST- 2022/07/27 06:00 [medline]
PHST- 2022/05/27 19:02 [entrez]
AID - S1473-3099(22)00228-6 [pii]
AID - 10.1016/S1473-3099(22)00228-6 [doi]
PST - ppublish
SO  - Lancet Infect Dis. 2022 Aug;22(8):1153-1162. doi: 10.1016/S1473-3099(22)00228-6. Epub 2022 May 24.

PMID- 35622356
OWN - NLM
STAT- MEDLINE
DCOM- 20220623
LR  - 20220628
IS  - 1538-3598 (Electronic)
IS  - 0098-7484 (Linking)
VI  - 327
IP  - 23
DP  - 2022 Jun 21
TI  - What to Know About Monkeypox.
PG  - 2278-2279
LID - 10.1001/jama.2022.9499 [doi]
FAU - Harris, Emily
AU  - Harris E
LA  - eng
PT  - Journal Article
PL  - United States
TA  - JAMA
JT  - JAMA
JID - 7501160
SB  - IM
MH  - Animals
MH  - Disease Outbreaks
MH  - *Monkeypox/diagnosis/epidemiology
MH  - *Zoonoses/diagnosis/epidemiology
EDAT- 2022/05/28 06:00
MHDA- 2022/06/24 06:00
CRDT- 2022/05/27 11:32
PHST- 2022/05/28 06:00 [pubmed]
PHST- 2022/06/24 06:00 [medline]
PHST- 2022/05/27 11:32 [entrez]
AID - 2793012 [pii]
AID - 10.1001/jama.2022.9499 [doi]
PST - ppublish
SO  - JAMA. 2022 Jun 21;327(23):2278-2279. doi: 10.1001/jama.2022.9499.

PMID- 35622346
OWN - NLM
STAT- MEDLINE
DCOM- 20220531
LR  - 20220716
IS  - 2047-2986 (Electronic)
IS  - 2047-2978 (Linking)
VI  - 22
DP  - 2022 May 28
TI  - The COVID-19 pandemic: SARS-CoV-2, childhood hepatitis and monkeypox raise fivenew questions for the global health research community.
PG  - 01002
LID - 10.7189/jogh.12.01002 [doi]
FAU - Rudan, Igor
AU  - Rudan I
LA  - eng
PT  - Editorial
DEP - 20220528
PL  - Scotland
TA  - J Glob Health
JT  - Journal of global health
JID - 101578780
SB  - IM
MH  - *COVID-19
MH  - Child
MH  - Global Health
MH  - *Hepatitis
MH  - Humans
MH  - *Monkeypox
MH  - Pandemics
MH  - SARS-CoV-2
PMC - PMC9138816
COIS- Competing interests: The author is a scientific advisor to the Government of the Republic of Croatia for COVID-19 response and co-Editor-in-Chief of the Journalof Global Health. The author has completed the ICMJE Unified Competing InterestForm (available upon request from the author) and declares no further competinginterest.
EDAT- 2022/05/28 06:00
MHDA- 2022/06/01 06:00
CRDT- 2022/05/27 11:23
PHST- 2022/05/27 11:23 [entrez]
PHST- 2022/05/28 06:00 [pubmed]
PHST- 2022/06/01 06:00 [medline]
AID - 10.7189/jogh.12.01002 [doi]
PST - epublish
SO  - J Glob Health. 2022 May 28;22:01002. doi: 10.7189/jogh.12.01002.

PMID- 35618293
OWN - NLM
STAT- MEDLINE
DCOM- 20220530
LR  - 20220711
IS  - 1756-1833 (Electronic)
IS  - 0959-8138 (Linking)
VI  - 377
DP  - 2022 May 26
TI  - Investigating the monkeypox outbreak.
PG  - o1314
LID - 10.1136/bmj.o1314 [doi]
FAU - Dye, Christopher
AU  - Dye C
AD  - Department of Biology, University of Oxford, UK christopher.dye@zoo.ox.ac.uk.
FAU - Kraemer, Moritz U G
AU  - Kraemer MUG
AD  - Department of Biology, University of Oxford, UK.
LA  - eng
PT  - Editorial
DEP - 20220526
PL  - England
TA  - BMJ
JT  - BMJ (Clinical research ed.)
JID - 8900488
SB  - IM
MH  - Disease Outbreaks/prevention & control
MH  - Humans
MH  - *Monkeypox/epidemiology
COIS- Competing interests: The BMJ has judged that there are no disqualifying financialties to commercial companies. The authors declare no other interests. Furtherdetails of The BMJ policy on financial interests are here:https://www.bmj.com/sites/default/files/attachments/resources/2016/03/16-current-bmj-education-coi-form.pdf.
EDAT- 2022/05/27 06:00
MHDA- 2022/05/31 06:00
CRDT- 2022/05/26 20:33
PHST- 2022/05/26 20:33 [entrez]
PHST- 2022/05/27 06:00 [pubmed]
PHST- 2022/05/31 06:00 [medline]
AID - 10.1136/bmj.o1314 [doi]
PST - epublish
SO  - BMJ. 2022 May 26;377:o1314. doi: 10.1136/bmj.o1314.

PMID- 35617408
OWN - NLM
STAT- MEDLINE
DCOM- 20220530
LR  - 20220602
IS  - 1095-9203 (Electronic)
IS  - 0036-8075 (Linking)
VI  - 376
IP  - 6596
DP  - 2022 May 27
TI  - Monkeypox outbreak questions intensify as cases soar.
PG  - 902-903
LID - 10.1126/science.add1583 [doi]
AB  - Rapid emergence of hundreds of cases around the world alarms public healthofficials and scientists.
FAU - Cohen, Jon
AU  - Cohen J
LA  - eng
PT  - News
DEP - 20220526
PL  - United States
TA  - Science
JT  - Science (New York, N.Y.)
JID - 0404511
SB  - IM
MH  - Animals
MH  - *Communicable Diseases, Emerging/epidemiology/virology
MH  - *Disease Outbreaks
MH  - *Global Health
MH  - Humans
MH  - Laboratory Personnel
MH  - *Monkeypox/epidemiology
MH  - Monkeypox virus/isolation & purification/ultrastructure
MH  - Public Health
EDAT- 2022/05/27 06:00
MHDA- 2022/05/31 06:00
CRDT- 2022/05/26 14:04
PHST- 2022/05/26 14:04 [entrez]
PHST- 2022/05/27 06:00 [pubmed]
PHST- 2022/05/31 06:00 [medline]
AID - 10.1126/science.add1583 [doi]
PST - ppublish
SO  - Science. 2022 May 27;376(6596):902-903. doi: 10.1126/science.add1583. Epub 2022May 26.

PMID- 35614026
OWN - NLM
STAT- MEDLINE
DCOM- 20220715
LR  - 20220716
IS  - 1096-9071 (Electronic)
IS  - 0146-6615 (Linking)
VI  - 94
IP  - 9
DP  - 2022 Sep
TI  - Monkeypox: A potential global threat?
PG  - 4034-4036
LID - 10.1002/jmv.27884 [doi]
FAU - Yang, Zhilong
AU  - Yang Z
AUID- ORCID: http://orcid.org/0000-0001-8995-2654
AD  - Department of Veterinary Pathobiology, College of Veterinary Medicine &Biomedical Sciences, Texas A&M University, College Station, Texas, USA.
LA  - eng
GR  - R01 AI143709/AI/NIAID NIH HHS/United States
GR  - R01AI143709/NH/NIH HHS/United States
PT  - Journal Article
DEP - 20220602
PL  - United States
TA  - J Med Virol
JT  - Journal of medical virology
JID - 7705876
SB  - IM
MH  - Animals
MH  - Humans
MH  - *Monkeypox/epidemiology
MH  - Monkeypox virus
MH  - Zoonoses
PMC - PMC9283296
MID - NIHMS1811314
OTO - NOTNLM
OT  - Monkeypox
OT  - endemic infection
OT  - epidemiology
OT  - poxvirus
OT  - zoonoses
EDAT- 2022/05/26 06:00
MHDA- 2022/07/16 06:00
CRDT- 2022/05/25 22:32
PMCR- 2023/09/01 00:00
PHST- 2022/05/23 00:00 [revised]
PHST- 2022/05/22 00:00 [received]
PHST- 2022/05/24 00:00 [accepted]
PHST- 2023/09/01 00:00 [pmc-release]
PHST- 2022/05/26 06:00 [pubmed]
PHST- 2022/07/16 06:00 [medline]
PHST- 2022/05/25 22:32 [entrez]
AID - 10.1002/jmv.27884 [doi]
PST - ppublish
SO  - J Med Virol. 2022 Sep;94(9):4034-4036. doi: 10.1002/jmv.27884. Epub 2022 Jun 2.

PMID- 35613732
OWN - NLM
STAT- MEDLINE
LR  - 20220531
IS  - 1756-1833 (Electronic)
IS  - 0959-8138 (Linking)
VI  - 377
DP  - 2022 May 25
TI  - Waking up to monkeypox.
PG  - o1321
LID - 10.1136/bmj.o1321 [doi]
FAU - Nakoune, Emmanuel
AU  - Nakoune E
AD  - Institut Pasteur Bangui, Central African Republic.
FAU - Olliaro, Piero
AU  - Olliaro P
AD  - International Severe Acute Respiratory and emerging Infection Consortium,Pandemic Sciences Institute, University of Oxford, UK.
LA  - eng
PT  - Journal Article
DEP - 20220525
PL  - England
TA  - BMJ
JT  - BMJ (Clinical research ed.)
JID - 8900488
SB  - IM
MH  - Animals
MH  - Disease Outbreaks
MH  - Humans
MH  - *Monkeypox/diagnosis/epidemiology
COIS- Competing interests: We are involved in research studying the outcomes oftreatment of monkeypox with tecovirimat (EUP, Registration number:ISRCTN43307947). Institute Pasteur Bangui has received financial support from thedrug manufacturer, SIGA.
EDAT- 2022/05/26 06:00
MHDA- 2022/05/28 06:00
CRDT- 2022/05/25 20:33
PHST- 2022/05/25 20:33 [entrez]
PHST- 2022/05/26 06:00 [pubmed]
PHST- 2022/05/28 06:00 [medline]
AID - 10.1136/bmj.o1321 [doi]
PST - epublish
SO  - BMJ. 2022 May 25;377:o1321. doi: 10.1136/bmj.o1321.

PMID- 35606433
OWN - NLM
STAT- Publisher
LR  - 20220523
IS  - 1476-4687 (Electronic)
IS  - 0028-0836 (Linking)
DP  - 2022 May 20
TI  - Daily briefing: Why scientists are worried about monkeypox.
LID - 10.1038/d41586-022-01455-y [doi]
FAU - Graham, Flora
AU  - Graham F
LA  - eng
PT  - News
DEP - 20220520
PL  - England
TA  - Nature
JT  - Nature
JID - 0410462
SB  - IM
EDAT- 2022/05/24 06:00
MHDA- 2022/05/24 06:00
CRDT- 2022/05/23 23:19
PHST- 2022/05/23 23:19 [entrez]
PHST- 2022/05/24 06:00 [pubmed]
PHST- 2022/05/24 06:00 [medline]
AID - 10.1038/d41586-022-01455-y [doi]
AID - 10.1038/d41586-022-01455-y [pii]
PST - aheadofprint
SO  - Nature. 2022 May 20. pii: 10.1038/d41586-022-01455-y. doi:10.1038/d41586-022-01455-y.

PMID- 35605243
OWN - NLM
STAT- Publisher
LR  - 20220523
IS  - 1539-3704 (Electronic)
IS  - 0003-4819 (Linking)
DP  - 2022 May 24
TI  - A Novel International Monkeypox Outbreak.
LID - 10.7326/M22-1581 [doi]
FAU - Adalja, Amesh
AU  - Adalja A
AD  - Johns Hopkins Center for Health Security, Baltimore, Maryland (A.A.).
FAU - Inglesby, Tom
AU  - Inglesby T
AD  - Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland (T.I.).
LA  - eng
PT  - Editorial
DEP - 20220524
PL  - United States
TA  - Ann Intern Med
JT  - Annals of internal medicine
JID - 0372351
SB  - IM
EDAT- 2022/05/24 06:00
MHDA- 2022/05/24 06:00
CRDT- 2022/05/23 16:53
PHST- 2022/05/23 16:53 [entrez]
PHST- 2022/05/24 06:00 [pubmed]
PHST- 2022/05/24 06:00 [medline]
AID - 10.7326/M22-1581 [doi]
PST - aheadofprint
SO  - Ann Intern Med. 2022 May 24. doi: 10.7326/M22-1581.

PMID- 35595996
OWN - NLM
STAT- MEDLINE
DCOM- 20220602
LR  - 20220603
IS  - 1476-4687 (Electronic)
IS  - 0028-0836 (Linking)
VI  - 606
IP  - 7912
DP  - 2022 Jun
TI  - Monkeypox goes global: why scientists are on alert.
PG  - 15-16
LID - 10.1038/d41586-022-01421-8 [doi]
FAU - Kozlov, Max
AU  - Kozlov M
LA  - eng
PT  - News
PL  - England
TA  - Nature
JT  - Nature
JID - 0410462
SB  - IM
MH  - Animals
MH  - Global Health
MH  - Humans
MH  - *Monkeypox/epidemiology
MH  - *Physicians
OTO - NOTNLM
OT  - *Diseases
OT  - *Public health
OT  - *Virology
EDAT- 2022/05/21 06:00
MHDA- 2022/06/03 06:00
CRDT- 2022/05/20 23:29
PHST- 2022/05/21 06:00 [pubmed]
PHST- 2022/06/03 06:00 [medline]
PHST- 2022/05/20 23:29 [entrez]
AID - 10.1038/d41586-022-01421-8 [doi]
AID - 10.1038/d41586-022-01421-8 [pii]
PST - ppublish
SO  - Nature. 2022 Jun;606(7912):15-16. doi: 10.1038/d41586-022-01421-8.

PMID- 35595274
OWN - NLM
STAT- MEDLINE
DCOM- 20220524
LR  - 20220711
IS  - 1756-1833 (Electronic)
IS  - 0959-8138 (Linking)
VI  - 377
DP  - 2022 May 20
TI  - Monkeypox: What do we know about the outbreaks in Europe and North America?
PG  - o1274
LID - 10.1136/bmj.o1274 [doi]
FAU - Mahase, Elisabeth
AU  - Mahase E
AD  - The BMJ.
LA  - eng
PT  - Journal Article
DEP - 20220520
PL  - England
TA  - BMJ
JT  - BMJ (Clinical research ed.)
JID - 8900488
SB  - IM
MH  - Disease Outbreaks/prevention & control
MH  - Europe/epidemiology
MH  - Humans
MH  - *Monkeypox/epidemiology
MH  - North America/epidemiology
EDAT- 2022/05/21 06:00
MHDA- 2022/05/25 06:00
CRDT- 2022/05/20 20:43
PHST- 2022/05/20 20:43 [entrez]
PHST- 2022/05/21 06:00 [pubmed]
PHST- 2022/05/25 06:00 [medline]
AID - 10.1136/bmj.o1274 [doi]
PST - epublish
SO  - BMJ. 2022 May 20;377:o1274. doi: 10.1136/bmj.o1274.

PMID- 35580887
OWN - NLM
STAT- MEDLINE
DCOM- 20220520
LR  - 20220711
IS  - 1756-1833 (Electronic)
IS  - 0959-8138 (Linking)
VI  - 377
DP  - 2022 May 17
TI  - Seven monkeypox cases are confirmed in England.
PG  - o1239
LID - 10.1136/bmj.o1239 [doi]
FAU - Mahase, Elisabeth
AU  - Mahase E
AD  - The BMJ.
LA  - eng
PT  - Journal Article
DEP - 20220517
PL  - England
TA  - BMJ
JT  - BMJ (Clinical research ed.)
JID - 8900488
SB  - IM
MH  - Disease Outbreaks
MH  - England
MH  - Humans
MH  - *Monkeypox/epidemiology
EDAT- 2022/05/18 06:00
MHDA- 2022/05/21 06:00
CRDT- 2022/05/17 20:43
PHST- 2022/05/17 20:43 [entrez]
PHST- 2022/05/18 06:00 [pubmed]
PHST- 2022/05/21 06:00 [medline]
AID - 10.1136/bmj.o1239 [doi]
PST - epublish
SO  - BMJ. 2022 May 17;377:o1239. doi: 10.1136/bmj.o1239.

PMID- 35393265
OWN - NLM
STAT- MEDLINE
DCOM- 20220622
LR  - 20220716
IS  - 1995-820X (Electronic)
IS  - 1995-820X (Linking)
VI  - 37
IP  - 3
DP  - 2022 Jun
TI  - Efficient assembly of a large fragment of monkeypox virus genome as a qPCRtemplate using dual-selection based transformation-associated recombination.
PG  - 341-347
LID - S1995-820X(22)00041-4 [pii]
LID - 10.1016/j.virs.2022.02.009 [doi]
AB  - Transformation-associated recombination (TAR) has been widely used to assemblelarge DNA constructs. One of the significant obstacles hindering assemblyefficiency is the presence of error-prone DNA repair pathways in yeast, whichresults in vector backbone recircularization or illegitimate recombinationproducts. To increase TAR assembly efficiency, we prepared a dual-selective TARvector, pGFCS, by adding a PADH1-URA3 cassette to a previously describedyeast-bacteria shuttle vector, pGF, harboring a PHIS3-HIS3 cassette as a positiveselection marker. This new cassette works as a negative selection marker toensure that yeast harboring a recircularized vector cannot propagate in thepresence of 5-fluoroorotic acid. To prevent pGFCS bearing ura3 from recombiningwith endogenous ura3-52 in the yeast genome, a highly transformable Saccharomycescerevisiae strain, VL6-48B, was prepared by chromosomal substitution of ura3-52with a transgene conferring resistance to blasticidin. A 55-kb genomic fragmentof monkeypox virus encompassing primary detection targets for quantitative PCRwas assembled by TAR using pGFCS in VL6-48B. The pGFCS-mediated TAR assemblyshowed a zero rate of vector recircularization and an average correct assemblyyield of 79% indicating that the dual-selection strategy provides an efficientapproach to optimizing TAR assembly.
CI  - Copyright (c) 2022 The Authors. Publishing services by Elsevier B.V. All rightsreserved.
FAU - Yang, Lei
AU  - Yang L
AD  - State Key Laboratory of Virology, Wuhan Institute of Virology, Center forBiosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, China;University of Chinese Academy of Sciences, Beijing, 100049, China.
FAU - Tian, Lingqian
AU  - Tian L
AD  - State Key Laboratory of Virology, Wuhan Institute of Virology, Center forBiosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, China;University of Chinese Academy of Sciences, Beijing, 100049, China.
FAU - Li, Leshan
AU  - Li L
AD  - State Key Laboratory of Virology, Wuhan Institute of Virology, Center forBiosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, China;University of Chinese Academy of Sciences, Beijing, 100049, China.
FAU - Liu, Qiuhong
AU  - Liu Q
AD  - State Key Laboratory of Virology, Wuhan Institute of Virology, Center forBiosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, China;University of Chinese Academy of Sciences, Beijing, 100049, China.
FAU - Guo, Xiang
AU  - Guo X
AD  - State Key Laboratory of Virology, Wuhan Institute of Virology, Center forBiosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, China;University of Chinese Academy of Sciences, Beijing, 100049, China.
FAU - Zhou, Yuan
AU  - Zhou Y
AD  - State Key Laboratory of Virology, Wuhan Institute of Virology, Center forBiosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, China.
FAU - Pei, Rongjuan
AU  - Pei R
AD  - State Key Laboratory of Virology, Wuhan Institute of Virology, Center forBiosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, China.
FAU - Chen, Xinwen
AU  - Chen X
AD  - State Key Laboratory of Virology, Wuhan Institute of Virology, Center forBiosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, China.Electronic address: chenxw@wh.iov.cn.
FAU - Wang, Yun
AU  - Wang Y
AD  - State Key Laboratory of Virology, Wuhan Institute of Virology, Center forBiosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, China.Electronic address: wangyun@wh.iov.cn.
LA  - eng
PT  - Journal Article
DEP - 20220228
PL  - Netherlands
TA  - Virol Sin
JT  - Virologica Sinica
JID - 101514185
SB  - IM
MH  - Cloning, Molecular
MH  - Genetic Vectors
MH  - *Monkeypox virus/genetics
MH  - Recombination, Genetic
MH  - *Saccharomyces cerevisiae/genetics/metabolism
MH  - Transformation, Genetic
PMC - PMC9243609
OTO - NOTNLM
OT  - Monkeypox virus
OT  - TAR assembly
OT  - Transformation-associated recombination (TAR)
COIS- Conflict of interest The authors declare that they have no conflicts of interest.
EDAT- 2022/04/09 06:00
MHDA- 2022/06/23 06:00
CRDT- 2022/04/08 05:30
PHST- 2021/08/10 00:00 [received]
PHST- 2022/02/23 00:00 [accepted]
PHST- 2022/04/09 06:00 [pubmed]
PHST- 2022/06/23 06:00 [medline]
PHST- 2022/04/08 05:30 [entrez]
AID - S1995-820X(22)00041-4 [pii]
AID - 10.1016/j.virs.2022.02.009 [doi]
PST - ppublish
SO  - Virol Sin. 2022 Jun;37(3):341-347. doi: 10.1016/j.virs.2022.02.009. Epub 2022 Feb28.

PMID- 35389974
OWN - NLM
STAT- MEDLINE
DCOM- 20220411
LR  - 20220711
IS  - 1545-861X (Electronic)
IS  - 0149-2195 (Linking)
VI  - 71
IP  - 14
DP  - 2022 Apr 8
TI  - Monkeypox in a Traveler Returning from Nigeria - Dallas, Texas, July 2021.
PG  - 509-516
LID - 10.15585/mmwr.mm7114a1 [doi]
AB  - Monkeypox is a rare, sometimes life-threatening zoonotic infection that occurs inwest and central Africa. It is caused by Monkeypox virus, an orthopoxvirussimilar to Variola virus (the causative agent of smallpox) and Vaccinia virus(the live virus component of orthopoxvirus vaccines) and can spread to humans.After 39 years without detection of human disease in Nigeria, an outbreakinvolving 118 confirmed cases was identified during 2017-2018 (1); sporadic casescontinue to occur. During September 2018-May 2021, six unrelated personstraveling from Nigeria received diagnoses of monkeypox in non-African countries: four in the United Kingdom and one each in Israel and Singapore. In July 2021, a man who traveled from Lagos, Nigeria, to Dallas, Texas, became the seventhtraveler to a non-African country with diagnosed monkeypox. Among 194 monitoredcontacts, 144 (74%) were flight contacts. The patient received tecovirimat, anantiviral for treatment of orthopoxvirus infections, and his home requiredlarge-scale decontamination. Whole genome sequencing showed that the virus wasconsistent with a strain of Monkeypox virus known to circulate in Nigeria, butthe specific source of the patient's infection was not identified. Noepidemiologically linked cases were reported in Nigeria; no contact receivedpostexposure prophylaxis (PEP) with the orthopoxvirus vaccine ACAM2000.
FAU - Rao, Agam K
AU  - Rao AK
FAU - Schulte, Joann
AU  - Schulte J
FAU - Chen, Tai-Ho
AU  - Chen TH
FAU - Hughes, Christine M
AU  - Hughes CM
FAU - Davidson, Whitni
AU  - Davidson W
FAU - Neff, Justin M
AU  - Neff JM
FAU - Markarian, Mary
AU  - Markarian M
FAU - Delea, Kristin C
AU  - Delea KC
FAU - Wada, Suzanne
AU  - Wada S
FAU - Liddell, Allison
AU  - Liddell A
FAU - Alexander, Shane
AU  - Alexander S
FAU - Sunshine, Brittany
AU  - Sunshine B
FAU - Huang, Philip
AU  - Huang P
FAU - Honza, Heidi Threadgill
AU  - Honza HT
FAU - Rey, Araceli
AU  - Rey A
FAU - Monroe, Benjamin
AU  - Monroe B
FAU - Doty, Jeffrey
AU  - Doty J
FAU - Christensen, Bryan
AU  - Christensen B
FAU - Delaney, Lisa
AU  - Delaney L
FAU - Massey, Joel
AU  - Massey J
FAU - Waltenburg, Michelle
AU  - Waltenburg M
FAU - Schrodt, Caroline A
AU  - Schrodt CA
FAU - Kuhar, David
AU  - Kuhar D
FAU - Satheshkumar, Panayampalli S
AU  - Satheshkumar PS
FAU - Kondas, Ashley
AU  - Kondas A
FAU - Li, Yu
AU  - Li Y
FAU - Wilkins, Kimberly
AU  - Wilkins K
FAU - Sage, Kylie M
AU  - Sage KM
FAU - Yu, Yon
AU  - Yu Y
FAU - Yu, Patricia
AU  - Yu P
FAU - Feldpausch, Amanda
AU  - Feldpausch A
FAU - McQuiston, Jennifer
AU  - McQuiston J
FAU - Damon, Inger K
AU  - Damon IK
FAU - McCollum, Andrea M
AU  - McCollum AM
CN  - July 2021 Monkeypox Response Team
LA  - eng
PT  - Journal Article
DEP - 20220408
PL  - United States
TA  - MMWR Morb Mortal Wkly Rep
JT  - MMWR. Morbidity and mortality weekly report
JID - 7802429
SB  - IM
MH  - Humans
MH  - Male
MH  - *Monkeypox/diagnosis/epidemiology/prevention & control
MH  - Monkeypox virus/genetics
MH  - Nigeria/epidemiology
MH  - Texas/epidemiology
PMC - PMC8989376
COIS- All authors have completed and submitted the International Committee of MedicalJournal Editors form for disclosure of potential conflicts of interest. Nopotential conflicts of interest were disclosed.
IR  - Aminu-Alhaji A
FIR - Aminu-Alhaji, Asma'u
IRAD- CDC.
IR  - Andersen L
FIR - Andersen, Lauren
IRAD- CDC.
IR  - Arduino M
FIR - Arduino, Matthew
IRAD- CDC.
IR  - Bestul N
FIR - Bestul, Nicolette
IRAD- CDC.
IR  - Bias M
FIR - Bias, Megan
IRAD- CDC.
IR  - Choi MJ
FIR - Choi, Mary J
IRAD- CDC.
IR  - Gigante C
FIR - Gigante, Crystal
IRAD- CDC.
IR  - Harkey M
FIR - Harkey, Madison
IRAD- CDC.
IR  - Hendricks K
FIR - Hendricks, Kate
IRAD- CDC.
IR  - Hercules Y
FIR - Hercules, Yonette
IRAD- CDC.
IR  - Husain F
FIR - Husain, Farah
IRAD- CDC.
IR  - Ipadeola O
FIR - Ipadeola, Oladipupo
IRAD- CDC.
IR  - Jungerman R
FIR - Jungerman, Robynne
IRAD- CDC.
IR  - Khan T
FIR - Khan, Theodora
IRAD- CDC.
IR  - Kharod G
FIR - Kharod, Grishma
IRAD- CDC.
IR  - Kunkel A
FIR - Kunkel, Amber
IRAD- CDC.
IR  - MacGurn A
FIR - MacGurn, Amanda
IRAD- CDC.
IR  - Matheny A
FIR - Matheny, Audrey
IRAD- CDC.
IR  - McCleod T
FIR - McCleod, Timothy
IRAD- CDC.
IR  - Minhaj FS
FIR - Minhaj, Faisal S
IRAD- CDC.
IR  - Mink J
FIR - Mink, Jenna
IRAD- CDC.
IR  - Morgan C
FIR - Morgan, Clint
IRAD- CDC.
IR  - Nakazawa Y
FIR - Nakazawa, Yoshinori
IRAD- CDC.
IR  - Newton D
FIR - Newton, Donovan
IRAD- CDC.
IR  - Ortega E
FIR - Ortega, Eddy
IRAD- CDC.
IR  - Priyamvada L
FIR - Priyamvada, Lalita
IRAD- CDC.
IR  - Radford K
FIR - Radford, Kay
IRAD- CDC.
IR  - Rehfus J
FIR - Rehfus, Joseph
IRAD- CDC.
IR  - Saleh MM
FIR - Saleh, Muhammad Muhammad
IRAD- CDC.
IR  - Townsend MB
FIR - Townsend, Michael B
IRAD- CDC.
IR  - Traxler R
FIR - Traxler, Rita
IRAD- CDC.
IR  - Whitehill F
FIR - Whitehill, Florence
IRAD- CDC.
IR  - Wu X
FIR - Wu, Xianfu
IRAD- CDC.
IR  - Zhao H
FIR - Zhao, Hui
IRAD- CDC.
IR  - Carruthers M
FIR - Carruthers, Michelle
IRAD- Dallas County Health Department, Texas.
IR  - Gomez I
FIR - Gomez, Ivory
IRAD- Dallas County Health Department, Texas.
IR  - Groppell S
FIR - Groppell, Samantha
IRAD- Dallas County Health Department, Texas.
IR  - Jaramillo J
FIR - Jaramillo, Juan
IRAD- Dallas County Health Department, Texas.
IR  - Serinaldi D
FIR - Serinaldi, Daniel
IRAD- Dallas County Health Department, Texas.
IR  - Serrano J
FIR - Serrano, Jose
IRAD- Dallas County Health Department, Texas.
IR  - Stringer J
FIR - Stringer, Joey
IRAD- Dallas County Health Department, Texas.
IR  - Gettings J
FIR - Gettings, Jenna
IRAD- Georgia Department of Public Health.
IR  - Pavlick J
FIR - Pavlick, Jessica
IRAD- Georgia Department of Public Health.
IR  - Retana JD
FIR - Retana, Jose David
IRAD- Texas Department of State Health Services.
IR  - Stonecipher S
FIR - Stonecipher, Shelley
IRAD- Texas Department of State Health Services.
IR  - Straver R
FIR - Straver, Rachael
IRAD- Texas Department of State Health Services.
IR  - Vilcins IM
FIR - Vilcins, Inger-Marie
IRAD- Texas Department of State Health Services.
IR  - Nolen LD
FIR - Nolen, Leisha D
IRAD- Utah Department of Health.
EDAT- 2022/04/08 06:00
MHDA- 2022/04/12 06:00
CRDT- 2022/04/07 17:13
PHST- 2022/04/07 17:13 [entrez]
PHST- 2022/04/08 06:00 [pubmed]
PHST- 2022/04/12 06:00 [medline]
AID - 10.15585/mmwr.mm7114a1 [doi]
PST - epublish
SO  - MMWR Morb Mortal Wkly Rep. 2022 Apr 8;71(14):509-516. doi:10.15585/mmwr.mm7114a1.

PMID- 35263559
OWN - NLM
STAT- MEDLINE
DCOM- 20220421
LR  - 20220711
IS  - 1080-6059 (Electronic)
IS  - 1080-6040 (Linking)
VI  - 28
IP  - 5
DP  - 2022 May
TI  - Imported Monkeypox from International Traveler, Maryland, USA, 2021.
PG  - 1002-1005
LID - 10.3201/eid2805.220292 [doi]
AB  - A case of monkeypox was diagnosed in a returning traveler from Nigeria toMaryland, USA. Prompt infection control measures led to no secondary cases in 40 exposed healthcare workers. Given the global health implications, public healthsystems should be aware of effective strategies to mitigate the potential spread of monkeypox.
FAU - Costello, Varea
AU  - Costello V
FAU - Sowash, Madeleine
AU  - Sowash M
FAU - Gaur, Aahana
AU  - Gaur A
FAU - Cardis, Michael
AU  - Cardis M
FAU - Pasieka, Helena
AU  - Pasieka H
FAU - Wortmann, Glenn
AU  - Wortmann G
FAU - Ramdeen, Sheena
AU  - Ramdeen S
LA  - eng
PT  - Case Reports
PT  - Journal Article
DEP - 20220309
PL  - United States
TA  - Emerg Infect Dis
JT  - Emerging infectious diseases
JID - 9508155
SB  - IM
MH  - Health Personnel
MH  - Humans
MH  - Infection Control
MH  - Maryland
MH  - *Monkeypox/diagnosis/epidemiology
MH  - Monkeypox virus
PMC - PMC9045429
OTO - NOTNLM
OT  - *Maryland
OT  - *Nigeria
OT  - *United States
OT  - *global health
OT  - *international traveler
OT  - *monkeypox
OT  - *monkeypox viruses
OT  - *orthopoxvirus
OT  - *travel medicine
OT  - *viruses
OT  - *zoonoses
EDAT- 2022/03/10 06:00
MHDA- 2022/04/22 06:00
CRDT- 2022/03/09 20:06
PHST- 2022/03/10 06:00 [pubmed]
PHST- 2022/04/22 06:00 [medline]
PHST- 2022/03/09 20:06 [entrez]
AID - 10.3201/eid2805.220292 [doi]
PST - ppublish
SO  - Emerg Infect Dis. 2022 May;28(5):1002-1005. doi: 10.3201/eid2805.220292. Epub2022 Mar 9.

PMID- 35215981
OWN - NLM
STAT- MEDLINE
DCOM- 20220314
LR  - 20220314
IS  - 1999-4915 (Electronic)
IS  - 1999-4915 (Linking)
VI  - 14
IP  - 2
DP  - 2022 Feb 14
TI  - An Update of Orthopoxvirus Molecular Evolution.
LID - 388 [pii]
LID - 10.3390/v14020388 [doi]
AB  - Although variola virus (VARV) has been eradicated through widespread vaccination,other orthopoxviruses pathogenic for humans circulate in nature. Recently, neworthopoxviruses, including some able to infect humans, have been found and their complete genomes have been sequenced. Questions about the orthopoxvirus mutation rate and the emergence of new threats to humankind as a result of the evolutionof circulating orthopoxviruses remain open. Based on contemporary data on ancientVARV DNA and DNA of new orthopoxvirus species, an analysis of the molecularevolution of orthopoxviruses was carried out and the timescale of their emergencewas estimated. It was calculated that the orthopoxviruses of the Old and NewWorlds separated approximately 40,000 years ago; the recently discovered Akhmeta virus and Alaskapox virus separated from other orthopoxviruses approximately10,000-20,000 years ago; the rest of modern orthopoxvirus species originated from1700 to 6000 years ago, with the exception of VARV, which emerged inapproximately 300 AD. Later, there was a separation of genetic variants of someorthopoxvirus species, so the monkeypox virus West African subtype originatedapproximately 600 years ago, and the VARV minor alastrim subtype emergedapproximately 300 years ago.
FAU - Babkin, Igor V
AU  - Babkin IV
AD  - Laboratory of Molecular Microbiology, Institute of Chemical Biology andFundamental Medicine, 630090 Novosibirsk, Russia.
FAU - Babkina, Irina N
AU  - Babkina IN
AD  - JSC VECTOR-BEST, 630559 Novosibirsk, Russia.
FAU - Tikunova, Nina V
AU  - Tikunova NV
AD  - Laboratory of Molecular Microbiology, Institute of Chemical Biology andFundamental Medicine, 630090 Novosibirsk, Russia.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20220214
PL  - Switzerland
TA  - Viruses
JT  - Viruses
JID - 101509722
SB  - IM
MH  - Animals
MH  - Databases, Genetic
MH  - *Evolution, Molecular
MH  - Mutation Rate
MH  - Orthopoxvirus/classification/*genetics
MH  - Phylogeny
MH  - Poxviridae Infections/*veterinary/virology
PMC - PMC8875945
OTO - NOTNLM
OT  - *evolution
OT  - *origin
OT  - *orthopoxvirus
OT  - *variola virus
EDAT- 2022/02/27 06:00
MHDA- 2022/03/15 06:00
CRDT- 2022/02/26 01:07
PHST- 2021/12/03 00:00 [received]
PHST- 2022/02/04 00:00 [revised]
PHST- 2022/02/10 00:00 [accepted]
PHST- 2022/02/26 01:07 [entrez]
PHST- 2022/02/27 06:00 [pubmed]
PHST- 2022/03/15 06:00 [medline]
AID - v14020388 [pii]
AID - 10.3390/v14020388 [doi]
PST - epublish
SO  - Viruses. 2022 Feb 14;14(2). pii: v14020388. doi: 10.3390/v14020388.

PMID- 35148313
OWN - NLM
STAT- MEDLINE
DCOM- 20220311
LR  - 20220711
IS  - 1935-2735 (Electronic)
IS  - 1935-2727 (Linking)
VI  - 16
IP  - 2
DP  - 2022 Feb
TI  - The changing epidemiology of human monkeypox-A potential threat? A systematicreview.
PG  - e0010141
LID - 10.1371/journal.pntd.0010141 [doi]
AB  - Monkeypox, a zoonotic disease caused by an orthopoxvirus, results in asmallpox-like disease in humans. Since monkeypox in humans was initiallydiagnosed in 1970 in the Democratic Republic of the Congo (DRC), it has spread toother regions of Africa (primarily West and Central), and cases outside Africahave emerged in recent years. We conducted a systematic review of peer-reviewedand grey literature on how monkeypox epidemiology has evolved, with particularemphasis on the number of confirmed, probable, and/or possible cases, age atpresentation, mortality, and geographical spread. The review is registered withPROSPERO (CRD42020208269). We identified 48 peer-reviewed articles and 18 greyliterature sources for data extraction. The number of human monkeypox cases hasbeen on the rise since the 1970s, with the most dramatic increases occurring inthe DRC. The median age at presentation has increased from 4 (1970s) to 21 years (2010-2019). There was an overall case fatality rate of 8.7%, with a significant difference between clades-Central African 10.6% (95% CI: 8.4%- 13.3%) vs. WestAfrican 3.6% (95% CI: 1.7%- 6.8%). Since 2003, import- and travel-related spread outside of Africa has occasionally resulted in outbreaks. Interactions/activitieswith infected animals or individuals are risk behaviors associated with acquiringmonkeypox. Our review shows an escalation of monkeypox cases, especially in thehighly endemic DRC, a spread to other countries, and a growing median age fromyoung children to young adults. These findings may be related to the cessation ofsmallpox vaccination, which provided some cross-protection against monkeypox,leading to increased human-to-human transmission. The appearance of outbreaksbeyond Africa highlights the global relevance of the disease. Increasedsurveillance and detection of monkeypox cases are essential tools forunderstanding the continuously changing epidemiology of this resurging disease.
FAU - Bunge, Eveline M
AU  - Bunge EM
AUID- ORCID: 0000-0001-7988-909X
AD  - Pallas Health Research and Consultancy, Rotterdam, The Netherlands.
FAU - Hoet, Bernard
AU  - Hoet B
AUID- ORCID: 0000-0002-5345-3236
AD  - Bavarian Nordic AG, Zug, Switzerland.
FAU - Chen, Liddy
AU  - Chen L
AD  - Bavarian Nordic, Inc., Morrisville, North Carolina, United States of America.
FAU - Lienert, Florian
AU  - Lienert F
AUID- ORCID: 0000-0002-9161-7107
AD  - Bavarian Nordic AG, Zug, Switzerland.
FAU - Weidenthaler, Heinz
AU  - Weidenthaler H
AUID- ORCID: 0000-0002-6866-4028
AD  - Bavarian Nordic GmbH, Martinsried, Germany.
FAU - Baer, Lorraine R
AU  - Baer LR
AD  - Baer PharMed Consulting, Ltd., Skokie, Illinois, United States of America.
FAU - Steffen, Robert
AU  - Steffen R
AUID- ORCID: 0000-0001-7917-1141
AD  - Epidemiology, Biostatistics and Prevention Institute, WHO Collaborating Center onTravelers' Health, University of Zurich, Zurich, Switzerland.
AD  - Department of Epidemiology, Human Genetics and Environmental Sciences, Universityof Texas School of Public Health, Houston, Texas, United States of America.
LA  - eng
PT  - Historical Article
PT  - Journal Article
PT  - Meta-Analysis
PT  - Research Support, Non-U.S. Gov't
PT  - Systematic Review
DEP - 20220211
PL  - United States
TA  - PLoS Negl Trop Dis
JT  - PLoS neglected tropical diseases
JID - 101291488
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Child
MH  - Child, Preschool
MH  - Democratic Republic of the Congo
MH  - Female
MH  - History, 20th Century
MH  - History, 21st Century
MH  - Humans
MH  - Male
MH  - Monkeypox/*epidemiology/history/mortality/virology
MH  - Monkeypox virus/genetics/*physiology
MH  - Travel-Related Illness
MH  - Young Adult
PMC - PMC8870502
COIS- I have read the journal's policy and the authors of this manuscript have thefollowing competing interests: Bernard Hoet, Liddy Chen, Florian Lienert, andHeinz Weidenthaler are employees of Bavarian Nordic. Eveline M. Bunge is anemployee of Pallas Health Research Consultancy. Lorraine R. Baer is an employeeof Baer PharMed Consulting, Ltd., which received funding for the preparation ofthe manuscript. Robert Steffen has been paid for lectures and participation inadvisory boards by various vaccine manufacturers, including Bavarian Nordic.Please note that the study was fully funded by Bavarian Nordic with twocontracts, first with Pallas Health Research and Consultancy to perform thesystematic review, second with Baer PharMed Consulting, Ltd to support manuscriptdevelopment. It is only after reviewing the data acknowledging the public health importance that the authors decided to submit a manuscript on the subject. Thefollowing authors received salary from the funder (BH, LC, FL, HW). The funderhad a role in study design, data collection and analysis, decision to publish,and preparation of the manuscript.
EDAT- 2022/02/12 06:00
MHDA- 2022/03/12 06:00
CRDT- 2022/02/11 17:11
PHST- 2021/06/22 00:00 [received]
PHST- 2022/01/04 00:00 [accepted]
PHST- 2022/02/24 00:00 [revised]
PHST- 2022/02/12 06:00 [pubmed]
PHST- 2022/03/12 06:00 [medline]
PHST- 2022/02/11 17:11 [entrez]
AID - 10.1371/journal.pntd.0010141 [doi]
AID - PNTD-D-21-00919 [pii]
PST - epublish
SO  - PLoS Negl Trop Dis. 2022 Feb 11;16(2):e0010141. doi:10.1371/journal.pntd.0010141. eCollection 2022 Feb.

PMID- 35038257
OWN - NLM
STAT- MEDLINE
DCOM- 20220119
LR  - 20220430
IS  - 0189-160X (Print)
IS  - 0189-160X (Linking)
VI  - 38
IP  - 12
DP  - 2021 Dec 30
TI  - Human Monkey Pox Virus Infection in Plateau State, North Central Nigeria: AReport of Two Cases.
PG  - 1242-1246
LID - West Afr J Med [pii]
AB  - BACKGROUND: Human Monkey Pox Virus (HMPV) infection is a zoonotic infection that is endemic in the Congo basin and West Africa. Its similarity to smallpoxinfection, increased susceptibility infection in human populations, lack of adefinitive therapy and its potential for use as a bioterrorism tool underscoresits public health importance. OBJECTIVE: To describe the characteristics of HMPV infection in Plateau State, North Central Nigeria. METHODS: This was a case studyof HMPV infection occurring in two Nigerian adults, seen in 2018, at BinghamUniversity Teaching Hospital in Jos, Plateau State, Nigeria. The cases involvedtwo siblings, and these were the first reported cases in Plateau State ofNigeria, which has an estimated population of 3.5 million persons. The diagnosis was based on a combination of clinical features and positive PCR tests on samplesfrom the skin lesions and blood. RESULTS: The first case, a 20-year-old male,presented with a one week history of fever, headache, pain on swallowing andmicturition, and generalised skin lesions. The second case is a 20 year old step brother of the first case, and the primary care provider to first case when hetook ill. He also presented with a one-week history of fever, headache, pain onswallowing, and skin lesions which were less intense than in the first case. PCR assays of samples from the skin lesions and blood were positive in both cases.The other comorbidity in both cases was pharyngotonsillitis. Blood, throat,stool, and urine cultures for suspected sepsis and urinary tract infection wereall negative. Both cases were admitted and discharged after receiving a course ofantibiotics, antihistamine, Non-Steroidal Anti-Inflammatory Drugs, andmultivitamins. Universal precautions were observed. CONCLUSION: HMPV infection inour environment underscores the need to strengthen preventive health strategiesagainst this infection.
CI  - Copyright (c) 2021 by West African Journal of Medicine.
FAU - Eseigbe, E E
AU  - Eseigbe EE
AD  - Pinneo Centre for Infectious Diseases, Bingham University Teaching Hospital, Jos,Nigeria.
AD  - Department of Paediatrics, Bingham University Teaching Hospital, Jos, Nigeria.
AD  - Department of Paediatrics, Benue State University, Makurdi, Nigeria.
FAU - Akude, C
AU  - Akude C
AD  - Pinneo Centre for Infectious Diseases, Bingham University Teaching Hospital, Jos,Nigeria.
AD  - Department of Family Medicine, Bingham University Teaching Hospital, Jos,Nigeria.
FAU - Osagie, I A
AU  - Osagie IA
AD  - Department of Community Medicine, Bingham University Teaching Hospital, Jos,Nigeria.
FAU - Eseigbe, P
AU  - Eseigbe P
AD  - Department of Family Medicine, Bingham University Teaching Hospital, Jos,Nigeria.
LA  - eng
PT  - Case Reports
PL  - Nigeria
TA  - West Afr J Med
JT  - West African journal of medicine
JID - 8301891
SB  - IM
MH  - Health Personnel
MH  - *Hospitals, Teaching
MH  - Hospitals, University
MH  - Humans
MH  - Male
MH  - *Monkeypox virus
MH  - Nigeria
OTO - NOTNLM
OT  - Clinical presentation
OT  - Human Monkey Pox Virus
OT  - Nigeria
COIS- The Authors declare that no competing interest exists
EDAT- 2022/01/18 06:00
MHDA- 2022/01/20 06:00
CRDT- 2022/01/17 12:47
PHST- 2022/01/17 12:47 [entrez]
PHST- 2022/01/18 06:00 [pubmed]
PHST- 2022/01/20 06:00 [medline]
AID - West Afr J Med. 2021 December; 38 (12): 1242-1246 [pii]
PST - ppublish
SO  - West Afr J Med. 2021 Dec 30;38(12):1242-1246.

PMID- 34949827
OWN - NLM
STAT- MEDLINE
DCOM- 20220222
LR  - 20220418
IS  - 2058-5276 (Electronic)
IS  - 2058-5276 (Linking)
VI  - 7
IP  - 1
DP  - 2022 Jan
TI  - Molecular mimicry of NF-kappaB by vaccinia virus protein enables selectiveinhibition of antiviral responses.
PG  - 154-168
LID - 10.1038/s41564-021-01004-9 [doi]
AB  - Infection of mammalian cells with viruses activates NF-kappaB to induce theexpression of cytokines and chemokines and initiate an antiviral response. Here, we show that a vaccinia virus protein mimics the transactivation domain of thep65 subunit of NF-kappaB to inhibit selectively the expression ofNF-kappaB-regulated genes. Using co-immunoprecipitation assays, we found that thevaccinia virus protein F14 associates with NF-kappaB co-activator CREB-bindingprotein (CBP) and disrupts the interaction between p65 and CBP. This abrogatesCBP-mediated acetylation of p65, after which it reduces promoter recruitment ofthe transcriptional regulator BRD4 and diminishes stimulation ofNF-kappaB-regulated genes CXCL10 and CCL2. Recruitment of BRD4 to the promotersof NFKBIA and CXCL8 remains unaffected by either F14 or JQ1 (a competitiveinhibitor of BRD4 bromodomains), indicating that BRD4 recruitment isacetylation-independent. Unlike other viral proteins that are general antagonistsof NF-kappaB, F14 is a selective inhibitor of NF-kappaB-dependent geneexpression. An in vivo model of infection demonstrated that F14 promotesvirulence. Molecular mimicry of NF-kappaB may be conserved because otherorthopoxviruses, including variola, monkeypox and cowpox viruses, encodeorthologues of F14.
CI  - (c) 2021. The Author(s), under exclusive licence to Springer Nature Limited.
FAU - Albarnaz, Jonas D
AU  - Albarnaz JD
AUID- ORCID: http://orcid.org/0000-0002-8792-813X
AD  - Department of Pathology, University of Cambridge, Cambridge, UK. jd732@cam.ac.uk.
AD  - Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK.jd732@cam.ac.uk.
FAU - Ren, Hongwei
AU  - Ren H
AD  - Department of Pathology, University of Cambridge, Cambridge, UK.
AD  - Department of Immunology and Inflammation, Imperial College London, HammersmithCampus, London, UK.
FAU - Torres, Alice A
AU  - Torres AA
AUID- ORCID: http://orcid.org/0000-0003-2352-2584
AD  - Department of Pathology, University of Cambridge, Cambridge, UK.
FAU - Shmeleva, Evgeniya V
AU  - Shmeleva EV
AUID- ORCID: http://orcid.org/0000-0002-7654-2960
AD  - Department of Pathology, University of Cambridge, Cambridge, UK.
AD  - Department of Obstetrics and Gynaecology, University of Cambridge, Cambridge, UK.
FAU - Melo, Carlos A
AU  - Melo CA
AD  - The Gurdon Institute, University of Cambridge, Cambridge, UK.
FAU - Bannister, Andrew J
AU  - Bannister AJ
AUID- ORCID: http://orcid.org/0000-0002-6312-4436
AD  - The Gurdon Institute, University of Cambridge, Cambridge, UK.
FAU - Brember, Matthew P
AU  - Brember MP
AD  - Department of Pathology, University of Cambridge, Cambridge, UK.
FAU - Chung, Betty Y-W
AU  - Chung BY
AD  - Department of Pathology, University of Cambridge, Cambridge, UK.
FAU - Smith, Geoffrey L
AU  - Smith GL
AUID- ORCID: http://orcid.org/0000-0002-3730-9955
AD  - Department of Pathology, University of Cambridge, Cambridge, UK. gls37@cam.ac.uk.
LA  - eng
GR  - MR/R021821/1/MRC_/Medical Research Council/United Kingdom
GR  - BB/V017780.1/BB_/Biotechnology and Biological Sciences Research Council/UnitedKingdom
GR  - 090315/WT_/Wellcome Trust/United Kingdom
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20211223
PL  - England
TA  - Nat Microbiol
JT  - Nature microbiology
JID - 101674869
RN  - 0 (NF-kappa B)
RN  - 0 (Viral Proteins)
RN  - EC 2.3.1.48 (CREB-Binding Protein)
RN  - EC 2.3.1.48 (CREBBP protein, human)
SB  - IM
MH  - CREB-Binding Protein/metabolism
MH  - HEK293 Cells
MH  - Host-Pathogen Interactions/*genetics/immunology
MH  - Humans
MH  - *Molecular Mimicry
MH  - NF-kappa B/*genetics/metabolism
MH  - Signal Transduction
MH  - Transcription, Genetic
MH  - Vaccinia/virology
MH  - Vaccinia virus/*genetics/immunology/pathogenicity
MH  - Viral Proteins/*genetics/immunology/metabolism
EDAT- 2021/12/25 06:00
MHDA- 2022/02/23 06:00
CRDT- 2021/12/24 05:42
PHST- 2020/10/24 00:00 [received]
PHST- 2021/10/21 00:00 [accepted]
PHST- 2021/12/25 06:00 [pubmed]
PHST- 2022/02/23 06:00 [medline]
PHST- 2021/12/24 05:42 [entrez]
AID - 10.1038/s41564-021-01004-9 [doi]
AID - 10.1038/s41564-021-01004-9 [pii]
PST - ppublish
SO  - Nat Microbiol. 2022 Jan;7(1):154-168. doi: 10.1038/s41564-021-01004-9. Epub 2021 Dec 23.

PMID- 34851148
OWN - NLM
STAT- MEDLINE
DCOM- 20220228
LR  - 20220228
IS  - 1098-5514 (Electronic)
IS  - 0022-538X (Linking)
VI  - 96
IP  - 3
DP  - 2022 Feb 9
TI  - A Nucleic Acid-Based Orthopoxvirus Vaccine Targeting the Vaccinia Virus L1, A27, B5, and A33 Proteins Protects Rabbits against Lethal Rabbitpox Virus AerosolChallenge.
PG  - e0150421
LID - 10.1128/JVI.01504-21 [doi]
AB  - In the age of COVID, nucleic acid vaccines have garnered much attention, at leastin part, because of the simplicity of construction, production, and flexibilityto adjust and adapt to an evolving outbreak. Orthopoxviruses remain a threat onmultiple fronts, especially as emerging zoonoses. In response, we developed a DNAvaccine, termed 4pox, that protected nonhuman primates against monkeypox virus(MPXV)-induced severe disease. Here, we examined the protective efficacy of the4pox DNA vaccine delivered by intramuscular (i.m.) electroporation (EP) inrabbits challenged with aerosolized rabbitpox virus (RPXV), a model thatrecapitulates the respiratory route of exposure and low dose associated withnatural smallpox exposure in humans. We found that 4pox-vaccinated rabbitsdeveloped immunogen-specific antibodies, including neutralizing antibodies, anddid not develop any clinical disease, indicating protection against aerosolizedRPXV. In contrast, unvaccinated animals developed significant signs of disease,including lesions, and were euthanized. These findings demonstrate that anunformulated, nonadjuvanted DNA vaccine delivered i.m. can protect against anaerosol exposure. IMPORTANCE The eradication of smallpox and subsequent cessationof vaccination have left a majority of the population susceptible to variolavirus or other emerging poxviruses. This is exemplified by human monkeypox, asevidenced by the increase in reported endemic and imported cases over the pastdecades. Therefore, a malleable vaccine technology that can be mass produced and does not require complex conditions for distribution and storage is sought.Herein, we show that a DNA vaccine, in the absence of a specialized formulationor adjuvant, can protect against a lethal aerosol insult of rabbitpox virus.
FAU - Mucker, Eric M
AU  - Mucker EM
AUID- ORCID: 0000-0002-4656-5379
AD  - Virology Division, United States Army Medical Research Institute of InfectiousDiseasesgrid.416900.a, Fort Detrick, Maryland, USA.
FAU - Golden, Joseph W
AU  - Golden JW
AD  - Virology Division, United States Army Medical Research Institute of InfectiousDiseasesgrid.416900.a, Fort Detrick, Maryland, USA.
FAU - Hammerbeck, Christopher D
AU  - Hammerbeck CD
AD  - Virology Division, United States Army Medical Research Institute of InfectiousDiseasesgrid.416900.a, Fort Detrick, Maryland, USA.
FAU - Kishimori, Jennifer M
AU  - Kishimori JM
AD  - Headquarters Division, United States Army Medical Research Institute ofInfectious Diseasesgrid.416900.a, Fort Detrick, Maryland, USA.
FAU - Royals, Michael
AU  - Royals M
AD  - Consultant, Fort Collins, Colorado, USA.
FAU - Joselyn, Mathew D
AU  - Joselyn MD
AD  - Virology Division, United States Army Medical Research Institute of InfectiousDiseasesgrid.416900.a, Fort Detrick, Maryland, USA.
FAU - Ballantyne, John
AU  - Ballantyne J
AD  - Aldevron LLC, Fargo, North Dakota, USA.
FAU - Nalca, Aysegul
AU  - Nalca A
AD  - Center for Aerobiological Sciences, United States Army Medical Research Instituteof Infectious Diseasesgrid.416900.a, Fort Detrick, Maryland, USA.
FAU - Hooper, Jay W
AU  - Hooper JW
AUID- ORCID: 0000-0002-4475-0415
AD  - Virology Division, United States Army Medical Research Institute of InfectiousDiseasesgrid.416900.a, Fort Detrick, Maryland, USA.
LA  - eng
GR  - IAA Y1-AI-9426-02/U.S. Department of Health and Human Services (HHS)
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20211201
PL  - United States
TA  - J Virol
JT  - Journal of virology
JID - 0113724
RN  - 0 (Nucleic Acid-Based Vaccines)
RN  - 0 (Oligodeoxyribonucleotides)
RN  - 0 (Vaccines, DNA)
RN  - 0 (Viral Proteins)
RN  - 0 (Viral Vaccines)
SB  - IM
MH  - Animals
MH  - B-Lymphocytes/immunology/metabolism
MH  - Dose-Response Relationship, Immunologic
MH  - Electroporation
MH  - Female
MH  - Immunization/methods
MH  - Immunogenicity, Vaccine
MH  - Lymphocyte Activation/immunology
MH  - Nucleic Acid-Based Vaccines/administration & dosage/*immunology
MH  - Oligodeoxyribonucleotides/administration & dosage/immunology
MH  - Orthopoxvirus/*immunology
MH  - Poxviridae Infections/*prevention & control
MH  - Rabbits
MH  - Vaccines, DNA/immunology
MH  - Vaccinia/*prevention & control
MH  - Vaccinia virus/genetics/*immunology
MH  - Viral Proteins/*immunology
MH  - Viral Vaccines/administration & dosage/*immunology
PMC - PMC8826804
OTO - NOTNLM
OT  - *DNA vaccines
OT  - *aerosols
OT  - *neutralizing antibodies
OT  - *nucleic acid technology
OT  - *poxvirus
OT  - *rabbitpox
OT  - *smallpox
EDAT- 2021/12/02 06:00
MHDA- 2022/03/01 06:00
CRDT- 2021/12/01 12:14
PMCR- 2022/08/09 00:00
PHST- 2022/08/09 00:00 [pmc-release]
PHST- 2021/12/02 06:00 [pubmed]
PHST- 2022/03/01 06:00 [medline]
PHST- 2021/12/01 12:14 [entrez]
AID - 10.1128/JVI.01504-21 [doi]
PST - ppublish
SO  - J Virol. 2022 Feb 9;96(3):e0150421. doi: 10.1128/JVI.01504-21. Epub 2021 Dec 1.

PMID- 34667829
OWN - NLM
STAT- Publisher
LR  - 20220716
IS  - 2363-6203 (Print)
DP  - 2021 Oct 15
TI  - Transmission dynamics of Monkeypox virus: a mathematical modelling approach.
PG  - 1-12
LID - 10.1007/s40808-021-01313-2 [doi]
AB  - Monkeypox (MPX), similar to both smallpox and cowpox, is caused by the monkeypox virus (MPXV). It occurs mostly in remote Central and West African communities,close to tropical rain forests. It is caused by the monkeypox virus in thePoxviridae family, which belongs to the genus Orthopoxvirus. We develop andanalyse a deterministic mathematical model for the monkeypox virus. Both localand global asymptotic stability conditions for disease-free and endemicequilibria are determined. It is shown that the model undergo backwardbifurcation, where the locally stable disease-free equilibrium co-exists with an endemic equilibrium. Furthermore, we determine conditions under which thedisease-free equilibrium of the model is globally asymptotically stable. Finally,numerical simulations to demonstrate our findings and brief discussions areprovided. The findings indicate that isolation of infected individuals in thehuman population helps to reduce disease transmission.
CI  - (c) The Author(s), under exclusive licence to Springer Nature Switzerland AG2021.
FAU - Peter, Olumuyiwa James
AU  - Peter OJ
AUID- ORCID: 0000-0001-9448-1164
AD  - Department of Mathematics, University of Ilorin, Ilorin,Nigeria.grid.412974.d0000 0001 0625 9425
FAU - Kumar, Sumit
AU  - Kumar S
AD  - School of Basic Sciences, Indian Institute of Technology Mandi, Mandi, HimachalPradesh 175001 India.grid.462387.c0000 0004 1775 7851
FAU - Kumari, Nitu
AU  - Kumari N
AD  - School of Basic Sciences, Indian Institute of Technology Mandi, Mandi, HimachalPradesh 175001 India.grid.462387.c0000 0004 1775 7851
FAU - Oguntolu, Festus Abiodun
AU  - Oguntolu FA
AD  - Department of Mathematics, Federal University of Technology Minna, Minna,Nigeria.grid.442636.10000 0004 1760 2083
FAU - Oshinubi, Kayode
AU  - Oshinubi K
AD  - AGIES Research Unit, Universite Grenoble Alpes, Alpes, France.grid.450307.5
FAU - Musa, Rabiu
AU  - Musa R
AD  - School of Mathematics, Statistics and Computer Science, University ofKwaZulu-Natal, Durban, South Africa.grid.16463.360000 0001 0723 4123
LA  - eng
PT  - Journal Article
DEP - 20211015
PL  - Netherlands
TA  - Model Earth Syst Environ
JT  - Modeling earth systems and environment
JID - 101675633
PMC - PMC8516625
OTO - NOTNLM
OT  - Backward bifurcation
OT  - Mathematical model
OT  - Monkeypox virus
OT  - Stability
EDAT- 2021/10/21 06:00
MHDA- 2021/10/21 06:00
CRDT- 2021/10/20 06:46
PHST- 2021/07/21 00:00 [received]
PHST- 2021/09/30 00:00 [accepted]
PHST- 2021/10/20 06:46 [entrez]
PHST- 2021/10/21 06:00 [pubmed]
PHST- 2021/10/21 06:00 [medline]
AID - 10.1007/s40808-021-01313-2 [doi]
AID - 1313 [pii]
PST - aheadofprint
SO  - Model Earth Syst Environ. 2021 Oct 15:1-12. doi: 10.1007/s40808-021-01313-2.

PMID- 34662033
STAT- Publisher
DA  - 20211019
CTDT- 20220716
PB  - StatPearls Publishing
DP  - 2022 Jan
TI  - Monkeypox
BTI - StatPearls
AB  - Monkeypox virus was first isolated and identified in 1958 when monkeys shippedfrom Singapore to a Denmark research facility fell ill.[1] However, the firstconfirmed human case was in 1970 when the virus was isolated from a child in the Democratic Republic of Congo suspected to have smallpox.[2] Coincident immunityto monkeypox virus was previously achieved with vaccinia vaccination; however,eradicating smallpox and subsequent lack of vaccination efforts paved the way formonkeypox to gain clinical relevance.[3] Furthermore, because most cases ofmonkeypox occur in rural Africa, suspected underreporting may translate to anunderestimation of the potential threat of this pathogen.[4]
CI  - Copyright (c) 2022, StatPearls Publishing LLC.
FAU - Moore, Marlyn J.
AU  - Moore MJ
FAU - Rathish, Balram
AU  - Rathish B
FAU - Zahra, Farah
AU  - Zahra F
LA  - eng
PT  - Study Guide
PT  - Book Chapter
PL  - Treasure Island (FL)
EDAT- 2021/10/19 06:01
MHDA- 2021/10/19 06:01
CDAT- 2021/10/19 06:01
AID - NBK574519 [bookaccession]

PMID- 34563454
OWN - NLM
STAT- MEDLINE
DCOM- 20220125
LR  - 20220125
IS  - 1545-1534 (Electronic)
IS  - 1080-6032 (Linking)
VI  - 32
IP  - 4
DP  - 2021 Dec
TI  - The Disease Ecology, Epidemiology, Clinical Manifestations, Management,Prevention, and Control of Increasing Human Infections with AnimalOrthopoxviruses.
PG  - 528-536
LID - S1080-6032(21)00157-5 [pii]
LID - 10.1016/j.wem.2021.08.003 [doi]
AB  - Zoonotic orthopoxvirus outbreaks have occurred repeatedly worldwide, includingmonkeypox in Africa and the United States, cowpox in Europe, camelpox in theMiddle East and India, buffalopox in India, vaccinia in South America, and novel emerging orthopoxvirus infections in the United States, Europe, Asia, and SouthAmerica. Waning smallpox immunity may increase the potential for animal-to-human transmission followed by further community transmission person-to-person (asdemonstrated by monkeypox and buffalopox outbreaks) and by contact with fomites(as demonstrated by camelpox, cowpox, and, possibly, Alaskapox). The objectivesof this review are to describe the disease ecology, epidemiology, clinicalmanifestations, prevention, and control of human infections with animalorthopoxviruses and to discuss the association with diminished population herdimmunity formerly induced by vaccinia vaccination against smallpox. Internetsearch engines were queried with key words, and case reports, case series,seroprevalence studies, and epidemiologic investigations were found for review.
CI  - Copyright (c) 2021 Wilderness Medical Society. Published by Elsevier Inc. Allrights reserved.
FAU - Diaz, James H
AU  - Diaz JH
AD  - Environmental and Occupational Health Sciences, LSU School of Public Health,Louisiana State University Health Sciences Center, New Orleans, Louisianna.Electronic address: jdiaz@lsuhsc.edu.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20210922
PL  - United States
TA  - Wilderness Environ Med
JT  - Wilderness & environmental medicine
JID - 9505185
SB  - IM
MH  - Animals
MH  - Humans
MH  - *Orthopoxvirus
MH  - *Poxviridae Infections/epidemiology/prevention & control
MH  - Seroepidemiologic Studies
MH  - United States
MH  - Vaccinia virus
MH  - *Variola virus
OTO - NOTNLM
OT  - buffalopox
OT  - camelpox
OT  - cowpox
OT  - monkeypox
OT  - smallpox
OT  - vaccinia
OT  - variola
OT  - zoonoses
EDAT- 2021/09/27 06:00
MHDA- 2022/01/27 06:00
CRDT- 2021/09/26 20:37
PHST- 2020/12/01 00:00 [received]
PHST- 2021/08/09 00:00 [revised]
PHST- 2021/08/15 00:00 [accepted]
PHST- 2021/09/27 06:00 [pubmed]
PHST- 2022/01/27 06:00 [medline]
PHST- 2021/09/26 20:37 [entrez]
AID - S1080-6032(21)00157-5 [pii]
AID - 10.1016/j.wem.2021.08.003 [doi]
PST - ppublish
SO  - Wilderness Environ Med. 2021 Dec;32(4):528-536. doi: 10.1016/j.wem.2021.08.003.Epub 2021 Sep 22.

PMID- 34530009
OWN - NLM
STAT- MEDLINE
DCOM- 20220225
LR  - 20220225
IS  - 1872-9096 (Electronic)
IS  - 0166-3542 (Linking)
VI  - 195
DP  - 2021 Nov
TI  - A human recombinant analogue to plasma-derived vaccinia immunoglobulinprophylactically and therapeutically protects against lethal orthopoxviruschallenge.
PG  - 105179
LID - S0166-3542(21)00169-8 [pii]
LID - 10.1016/j.antiviral.2021.105179 [doi]
AB  - Orthopoxviruses such as variola and monkeypox viruses continue to threaten thehuman population. Monkeypox virus is endemic in central and western Africa andoutbreaks have reached as far as the U.S. Although variola virus, the etiologicagent of smallpox, has been eradicated by a successful vaccination program,official and likely clandestine stocks of the virus exist. Moreover, studies withectromelia virus (the etiological agent of mousepox) have revealed that IL-4recombinant viruses are significantly more virulent than wild-type viruses evenin mice treated with vaccines and/or antivirals. For these reasons, it iscritical that antiviral modalities are developed to treat these viruses shouldoutbreaks, or deliberate dissemination, occur. Currently, 2 antivirals(brincidofovir and tecovirimat) are in the U.S. stockpile allowing for emergency use of the drugs to treat smallpox. Both antivirals have advantages anddisadvantages in a clinical and emergency setting. Here we report on the efficacyof a recombinant immunoglobulin (rVIG) that demonstrated efficacy against severalorthopoxviruses in vitro and in vivo in both a prophylactic and therapeuticfashion. A single intraperitoneal injection of rVIG significantly protected mice when given up to 14 days before or as late as 6 days post challenge. Moreover,rVIG reduced morbidity, as measured by weight-change, as well as severalpreviously established biomarkers of disease. In rVIG treated mice, we found thatvDNA levels in blood were significantly reduced, as was ALT (a marker of liverdamage) and infectious virus levels in the liver. No apparent adverse events wereobserved in rVIG treated mice, suggesting the immunoglobulin is well tolerated.These findings suggest that recombinant immunoglobulins could be candidates forfurther evaluation and possible licensure under the FDA Animal Rule.
CI  - Copyright (c) 2021. Published by Elsevier B.V.
FAU - Parker, Scott
AU  - Parker S
AD  - Division of Infectious Diseases, Department of Internal Medicine, Saint LouisUniversity, and St. Louis VA Medical Center, St. Louis, MO, 63104, USA.
FAU - D'Angelo, June
AU  - D'Angelo J
AD  - Division of Infectious Diseases, Department of Internal Medicine, Saint LouisUniversity, and St. Louis VA Medical Center, St. Louis, MO, 63104, USA.
FAU - Buller, R Mark
AU  - Buller RM
AD  - Department of Molecular Microbiology and Immunology, Saint Louis University, St. Louis, MO, 63104, USA.
FAU - Smee, Donald F
AU  - Smee DF
AD  - Department of Animal, Dairy and Veterinary Sciences, Utah State University,Logan, UT, 84322, USA.
FAU - Lantto, Johan
AU  - Lantto J
AD  - Symphogen, Pederstrupvej 93, DK-2750, Ballerup, Denmark.
FAU - Nielsen, Henriette
AU  - Nielsen H
AD  - Symphogen, Pederstrupvej 93, DK-2750, Ballerup, Denmark.
FAU - Jensen, Allan
AU  - Jensen A
AD  - Symphogen, Pederstrupvej 93, DK-2750, Ballerup, Denmark.
FAU - Prichard, Mark
AU  - Prichard M
AD  - Department of Pediatrics, University of Alabama, Birmingham, AL, 35233, USA.
FAU - George, Sarah L
AU  - George SL
AD  - Division of Infectious Diseases, Department of Internal Medicine, Saint LouisUniversity, and St. Louis VA Medical Center, St. Louis, MO, 63104, USA.Electronic address: sarah.george@health.slu.edu.
LA  - eng
GR  - HHSN272201000021I/AI/NIAID NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20210913
PL  - Netherlands
TA  - Antiviral Res
JT  - Antiviral research
JID - 8109699
RN  - 0 (Antiviral Agents)
RN  - 0 (Benzamides)
RN  - 0 (Immunoglobulins)
RN  - 0 (Isoindoles)
RN  - 0 (Organophosphonates)
RN  - 0 (Smallpox Vaccine)
RN  - 0 (Vaccines, DNA)
RN  - 6794O900AX (brincidofovir)
RN  - 8J337D1HZY (Cytosine)
RN  - F925RR824R (Tecovirimat)
SB  - IM
MH  - Animals
MH  - Antiviral Agents/administration & dosage/*therapeutic use
MH  - Benzamides
MH  - Cell Line
MH  - Chlorocebus aethiops
MH  - Cytosine/analogs & derivatives
MH  - Female
MH  - Humans
MH  - Immunoglobulins/*therapeutic use
MH  - Isoindoles
MH  - Mice
MH  - Mice, Inbred BALB C
MH  - Organophosphonates
MH  - Orthopoxvirus/*drug effects
MH  - Smallpox/*drug therapy/prevention & control/virology
MH  - Smallpox Vaccine/administration & dosage
MH  - Vaccines, DNA/administration & dosage
MH  - Vaccinia/*drug therapy/prevention & control/virology
OTO - NOTNLM
OT  - *Antiviral
OT  - *Ectromelia
OT  - *Immunoglobulin
OT  - *Monkeypox
OT  - *Smallpox
OT  - *Vaccinia
EDAT- 2021/09/17 06:00
MHDA- 2022/02/26 06:00
CRDT- 2021/09/16 20:13
PHST- 2021/05/26 00:00 [received]
PHST- 2021/09/08 00:00 [revised]
PHST- 2021/09/10 00:00 [accepted]
PHST- 2021/09/17 06:00 [pubmed]
PHST- 2022/02/26 06:00 [medline]
PHST- 2021/09/16 20:13 [entrez]
AID - S0166-3542(21)00169-8 [pii]
AID - 10.1016/j.antiviral.2021.105179 [doi]
PST - ppublish
SO  - Antiviral Res. 2021 Nov;195:105179. doi: 10.1016/j.antiviral.2021.105179. Epub2021 Sep 13.

PMID- 34469446
OWN - NLM
STAT- MEDLINE
DCOM- 20210913
LR  - 20210913
IS  - 1932-6203 (Electronic)
IS  - 1932-6203 (Linking)
VI  - 16
IP  - 9
DP  - 2021
TI  - News media narratives of Covid-19 across 20 countries: Early global convergenceand later regional divergence.
PG  - e0256358
LID - 10.1371/journal.pone.0256358 [doi]
AB  - BACKGROUND: Seldom in history does one get a 'front row seat'-with large-scaledynamic data-on how online news media narratives shift with a global pandemic.News media narratives matter because they shape societal perceptions andinfluence the core tent poles of our society, from the economy to elections.Given its importance-and with the benefit of hindsight-we provide a systematicframework to analyze news narratives of Covid-19, laying the groundwork toevaluate policy and risk communications. OBJECTIVES: We leverage a10-billion-word-database of online news, taken from over 7,000 English newspapersand magazines across 20 countries, culminating in 28 million articles. First, we track the volume of Covid-19 conversations across 20 countries from before toduring the pandemic (Oct'19 to May'20). Second, we distill the phases of globalpandemic narratives, and elucidate regional differences. METHODS: To track thevolume of Covid-19 narratives, we identified 10 target terms-Coronavirus,Covid-19, Covid, nCoV, SARS-CoV-2, Wuhan Virus, Virus, Disease, Epidemic,Pandemic-and tracked their combined monthly prevalence across eight months fromOctober 2019 through May 2020. Globally, across 20 countries, we identified18,042,855 descriptors of the target terms. Further, these descriptors wereanalysed with natural language processing models to generate the top five topics of Covid-19 that were labelled by two independent researchers. This process wasrepeated across six continents to distil regional topics. RESULTS: Our modelfound four phases of online news media narratives: Pre-pandemic, Early, Peak and Recovery. Pre-pandemic narratives (Oct'19-Dec'19) were divergent across regionswith Africa focused on monkeypox, Asia on dengue fever, and North America on Lymedisease and AIDS. Early (Jan-Feb'20) and Peak Pandemic (Mar-May'20) evidenced aglobal convergence, reflecting the omnipresence of Covid-19. The brief transitionfrom early to peak pandemic narratives underscored the pandemic's rapid spread.Emerging from the embers of the pandemic's peak were nascent recovery words that are regionally divergent-Oceania focused on hope and an uncertain future whileNorth America centered on re-opening the economy and tackling discrimination.CONCLUSIONS: Practically, we presented a media barometer of Covid-19, andprovided a framework to analyse the pandemic's impact on societalperceptions-laying the important groundwork for policy makers to evaluate policy communications, and design risk communication strategies.
FAU - Ng, Reuben
AU  - Ng R
AUID- ORCID: 0000-0002-1186-0570
AD  - Lee Kuan Yew School of Public Policy, National University of Singapore,Singapore, Singapore.
FAU - Chow, Ting Yu Joanne
AU  - Chow TYJ
AD  - Lee Kuan Yew School of Public Policy, National University of Singapore,Singapore, Singapore.
FAU - Yang, Wenshu
AU  - Yang W
AD  - Lloyd's Register Institute for the Public Understanding of Risk, NationalUniversity of Singapore, Singapore, Singapore.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20210901
PL  - United States
TA  - PLoS One
JT  - PloS one
JID - 101285081
SB  - IM
MH  - COVID-19/*epidemiology
MH  - Humans
MH  - *Mass Media
MH  - *Narration
MH  - *Pandemics
MH  - *SARS-CoV-2
MH  - *Social Media
PMC - PMC8409659
COIS- The authors have declared that no competing interests exist.
EDAT- 2021/09/02 06:00
MHDA- 2021/09/14 06:00
CRDT- 2021/09/01 17:21
PHST- 2021/03/02 00:00 [received]
PHST- 2021/08/05 00:00 [accepted]
PHST- 2021/09/01 17:21 [entrez]
PHST- 2021/09/02 06:00 [pubmed]
PHST- 2021/09/14 06:00 [medline]
AID - 10.1371/journal.pone.0256358 [doi]
AID - PONE-D-21-06950 [pii]
PST - epublish
SO  - PLoS One. 2021 Sep 1;16(9):e0256358. doi: 10.1371/journal.pone.0256358.eCollection 2021.

PMID- 34453755
OWN - NLM
STAT- MEDLINE
DCOM- 20220603
LR  - 20220711
IS  - 1096-9071 (Electronic)
IS  - 0146-6615 (Linking)
VI  - 94
IP  - 3
DP  - 2022 Mar
TI  - Re-Emergence of monkeypox amidst delta variant concerns: A point of contentionfor public health virology?
PG  - 805-806
LID - 10.1002/jmv.27306 [doi]
FAU - Sarwar, Sarosh
AU  - Sarwar S
AD  - Division of Clinical and Translational Research, Larkin Community Hospital, SouthMiami, Florida, USA.
FAU - Maskey, Upasana
AU  - Maskey U
AD  - Division of Clinical and Translational Research, Larkin Community Hospital, SouthMiami, Florida, USA.
FAU - Thada, Pawan Kumar
AU  - Thada PK
AD  - Division of Clinical and Translational Research, Larkin Community Hospital, SouthMiami, Florida, USA.
FAU - Mustansir, Manaal
AU  - Mustansir M
AD  - Division of Clinical and Translational Research, Larkin Community Hospital, SouthMiami, Florida, USA.
FAU - Sarfraz, Azza
AU  - Sarfraz A
AUID- ORCID: 0000-0001-8206-5745
AD  - Division of Clinical and Translational Research, Larkin Community Hospital, SouthMiami, Florida, USA.
AD  - Department of Pediatrics and Child Health, The Aga Khan University, Karachi,Pakistan.
FAU - Sarfraz, Zouina
AU  - Sarfraz Z
AUID- ORCID: 0000-0002-5132-7455
AD  - Division of Clinical and Translational Research, Larkin Community Hospital, SouthMiami, Florida, USA.
AD  - Department of Research and Publications, Fatima Jinnah Medical University,Lahore, Pakistan.
LA  - eng
PT  - Letter
DEP - 20210904
PL  - United States
TA  - J Med Virol
JT  - Journal of medical virology
JID - 7705876
SB  - IM
MH  - Humans
MH  - *Monkeypox/epidemiology
MH  - Monkeypox virus/genetics
MH  - *Public Health
EDAT- 2021/08/29 06:00
MHDA- 2022/06/07 06:00
CRDT- 2021/08/28 12:15
PHST- 2021/08/12 00:00 [received]
PHST- 2021/08/18 00:00 [accepted]
PHST- 2021/08/29 06:00 [pubmed]
PHST- 2022/06/07 06:00 [medline]
PHST- 2021/08/28 12:15 [entrez]
AID - 10.1002/jmv.27306 [doi]
PST - ppublish
SO  - J Med Virol. 2022 Mar;94(3):805-806. doi: 10.1002/jmv.27306. Epub 2021 Sep 4.

PMID- 34387184
OWN - NLM
STAT- MEDLINE
DCOM- 20210817
LR  - 20220711
IS  - 1560-7917 (Electronic)
IS  - 1025-496X (Linking)
VI  - 26
IP  - 32
DP  - 2021 Aug
TI  - Family cluster of three cases of monkeypox imported from Nigeria to the UnitedKingdom, May 2021.
LID - 10.2807/1560-7917.ES.2021.26.32.2100745 [doi]
AB  - Most reported cases of human monkeypox occur in Central and West Africa, wherethe causing virus is endemic. We describe the identification and public healthresponse to an imported case of West African monkeypox from Nigeria to the UnitedKingdom (UK) in May 2021. Secondary transmission from the index case occurredwithin the family to another adult and a toddler. Concurrent COVID-19-relatedcontrol measures upon arrival and at the hospital, facilitated detection andlimited the number of potential contacts.
FAU - Hobson, Gemma
AU  - Hobson G
AD  - Health Protection, Public Health Wales, Cardiff, United Kingdom.
FAU - Adamson, James
AU  - Adamson J
AD  - Health Protection, Public Health Wales, Cardiff, United Kingdom.
FAU - Adler, Hugh
AU  - Adler H
AD  - Tropical and Infectious Disease Unit, Liverpool University Hospitals NHSFoundation Trust, Liverpool, United Kingdom.
AD  - Departments of International Public Health and Clinical Sciences, LiverpoolSchool of Tropical Medicine, Liverpool, United Kingdom.
FAU - Firth, Richard
AU  - Firth R
AD  - Health Protection, Public Health Wales, Cardiff, United Kingdom.
FAU - Gould, Susan
AU  - Gould S
AD  - Tropical and Infectious Disease Unit, Liverpool University Hospitals NHSFoundation Trust, Liverpool, United Kingdom.
AD  - Departments of International Public Health and Clinical Sciences, LiverpoolSchool of Tropical Medicine, Liverpool, United Kingdom.
FAU - Houlihan, Catherine
AU  - Houlihan C
AD  - Rare and Imported Pathogens Laboratory, Public Health England, Porton, Salisbury,United Kingdom.
AD  - Department of Virology, University College Hospital London, London, UnitedKingdom.
FAU - Johnson, Christopher
AU  - Johnson C
AD  - Health Protection, Public Health Wales, Cardiff, United Kingdom.
FAU - Porter, David
AU  - Porter D
AD  - Department of Paediatric Infectious Diseases, Alder Hey Children's NHS FoundationTrust, Liverpool, United Kingdom.
FAU - Rampling, Tommy
AU  - Rampling T
AD  - Rare and Imported Pathogens Laboratory, Public Health England, Porton, Salisbury,United Kingdom.
AD  - Hospital for Tropical Diseases, University College London Hospitals NHSFoundation Trust, London, United Kingdom.
FAU - Ratcliffe, Libuse
AU  - Ratcliffe L
AD  - Tropical and Infectious Disease Unit, Liverpool University Hospitals NHSFoundation Trust, Liverpool, United Kingdom.
FAU - Russell, Katherine
AU  - Russell K
AD  - Emerging Infections and Zoonoses Section, National Infection Service, PublicHealth England, Colindale, London, United Kingdom.
FAU - Shankar, Ananda Giri
AU  - Shankar AG
AD  - Health Protection, Public Health Wales, Cardiff, United Kingdom.
FAU - Wingfield, Tom
AU  - Wingfield T
AD  - Tropical and Infectious Disease Unit, Liverpool University Hospitals NHSFoundation Trust, Liverpool, United Kingdom.
AD  - Departments of International Public Health and Clinical Sciences, LiverpoolSchool of Tropical Medicine, Liverpool, United Kingdom.
AD  - World Health Organization Collaborating Centre on Tuberculosis and SocialMedicine, Department of Global Public Health, Karolinska Institute, Stockholm,Sweden.
LA  - eng
GR  - MR/V004832/1/MRC_/Medical Research Council/United Kingdom
PT  - Journal Article
PL  - Sweden
TA  - Euro Surveill
JT  - Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
JID - 100887452
SB  - IM
MH  - Adult
MH  - *COVID-19
MH  - Humans
MH  - *Monkeypox/diagnosis/epidemiology
MH  - Monkeypox virus
MH  - Nigeria
MH  - SARS-CoV-2
MH  - United Kingdom/epidemiology
PMC - PMC8365177
OTO - NOTNLM
OT  - *England
OT  - *Monkeypox
OT  - *Nigeria
OT  - *Orthopox
OT  - *Wales
OT  - *health protection
EDAT- 2021/08/14 06:00
MHDA- 2021/08/18 06:00
CRDT- 2021/08/13 08:42
PHST- 2021/08/13 08:42 [entrez]
PHST- 2021/08/14 06:00 [pubmed]
PHST- 2021/08/18 06:00 [medline]
AID - 10.2807/1560-7917.ES.2021.26.32.2100745 [doi]
PST - ppublish
SO  - Euro Surveill. 2021 Aug;26(32). doi: 10.2807/1560-7917.ES.2021.26.32.2100745.

PMID- 34316355
OWN - NLM
STAT- MEDLINE
DCOM- 20210802
LR  - 20210802
IS  - 2046-1402 (Electronic)
IS  - 2046-1402 (Linking)
VI  - 10
DP  - 2021
TI  - iCAT: diagnostic assessment tool of immunological history using high-throughputT-cell receptor sequencing.
PG  - 65
LID - 10.12688/f1000research.27214.2 [doi]
AB  - The pathogen exposure history of an individual is recorded in their T-cellrepertoire and can be accessed through the study of T-cell receptors (TCRs) ifthe tools to identify them were available. For each T-cell, the TCR lociundergoes genetic rearrangement that creates a unique DNA sequence. In theorythese unique sequences can be used as biomarkers for tracking T-cell responsesand cataloging immunological history. We developed the immune Cell Analysis Tool (iCAT), an R software package that analyzes TCR sequencing data from exposed(positive) and unexposed (negative) samples to identify TCR sequencesstatistically associated with positive samples. The presence and absence ofassociated sequences in samples trains a classifier to diagnose pathogen-specificexposure. We demonstrate the high accuracy of iCAT by testing on three TCRsequencing datasets. First, iCAT successfully diagnosed smallpox vaccinatedversus naive samples in an independent cohort of mice with 95% accuracy. Second, iCAT displayed 100% accuracy classifying naive and monkeypox vaccinated mice.Finally, we demonstrate the use of iCAT on human samples before and afterexposure to SARS-CoV-2, the virus behind the COVID-19 global pandemic. We wereable to correctly classify the exposed samples with perfect accuracy. Theseexperimental results show that iCAT capitalizes on the power of TCR sequencing tosimplify infection diagnostics. iCAT provides the option of a graphical,user-friendly interface on top of usual R interface allowing it to reach a wider audience.
CI  - Copyright: (c) 2021 Rajeh A et al.
FAU - Rajeh, Ahmad
AU  - Rajeh A
AUID- ORCID: 0000-0002-8916-6845
AD  - Program in Bioinformatics and Computational Biology, Saint Louis University, St. Louis, MO, 63103, USA.
FAU - Wolf, Kyle
AU  - Wolf K
AD  - Molecular Microbiology and Immunology, Saint Louis University School of Medicine,St. Louis, MO, 63104, USA.
FAU - Schiebout, Courtney
AU  - Schiebout C
AD  - Program in Bioinformatics and Computational Biology, Saint Louis University, St. Louis, MO, 63103, USA.
FAU - Sait, Nabeel
AU  - Sait N
AD  - Computer Science, Saint Louis University, St. Louis, MO, 63103, USA.
FAU - Kosfeld, Tim
AU  - Kosfeld T
AD  - Computer Science, Saint Louis University, St. Louis, MO, 63103, USA.
FAU - DiPaolo, Richard J
AU  - DiPaolo RJ
AD  - Molecular Microbiology and Immunology, Saint Louis University School of Medicine,St. Louis, MO, 63104, USA.
FAU - Ahn, Tae-Hyuk
AU  - Ahn TH
AUID- ORCID: 0000-0002-7281-9459
AD  - Program in Bioinformatics and Computational Biology, Saint Louis University, St. Louis, MO, 63103, USA.
AD  - Computer Science, Saint Louis University, St. Louis, MO, 63103, USA.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20210203
PL  - England
TA  - F1000Res
JT  - F1000Research
JID - 101594320
RN  - 0 (Receptors, Antigen, T-Cell)
SB  - IM
MH  - Animals
MH  - *COVID-19
MH  - High-Throughput Nucleotide Sequencing
MH  - Humans
MH  - Mice
MH  - Receptors, Antigen, T-Cell/genetics
MH  - SARS-CoV-2
MH  - Software
PMC - PMC8276190
OTO - NOTNLM
OT  - *R-package
OT  - *T-cell receptor sequencing
OT  - *biomarkers
OT  - *diagnostic classification
COIS- No competing interests were disclosed.
EDAT- 2021/07/30 06:00
MHDA- 2021/08/03 06:00
CRDT- 2021/07/29 06:50
PHST- 2021/06/10 00:00 [accepted]
PHST- 2021/07/29 06:50 [entrez]
PHST- 2021/07/30 06:00 [pubmed]
PHST- 2021/08/03 06:00 [medline]
AID - 10.12688/f1000research.27214.2 [doi]
PST - epublish
SO  - F1000Res. 2021 Feb 3;10:65. doi: 10.12688/f1000research.27214.2. eCollection2021.

PMID- 34158533
OWN - NLM
STAT- MEDLINE
DCOM- 20211108
LR  - 20220711
IS  - 2045-2322 (Electronic)
IS  - 2045-2322 (Linking)
VI  - 11
IP  - 1
DP  - 2021 Jun 22
TI  - Genomic history of human monkey pox infections in the Central African Republicbetween 2001 and 2018.
PG  - 13085
LID - 10.1038/s41598-021-92315-8 [doi]
AB  - Monkeypox is an emerging infectious disease, which has a clinical presentationsimilar to smallpox. In the two past decades, Central Africa has seen an increasein the frequency of cases, with many monkeypox virus (MPXV) isolates detected in the Democratic Republic of Congo (DRC) and the Central African Republic (CAR). Todate, no complete MPXV viral genome has been published from the human casesidentified in the CAR. The objective of this study was to sequence the fullgenome of 10 MPXV isolates collected during the CAR epidemics between 2001 and2018 in order to determine their phylogenetic relationships among MPXV lineagespreviously described in Central Africa and West Africa. Our phylogenetic results indicate that the 10 CAR isolates belong to three lineages closely related tothose found in DRC. The phylogenetic pattern shows that all of them emerged inthe rainforest block of the Congo Basin. Since most human index cases in CARoccurred at the northern edge of western and eastern rainforests, transmissionsfrom wild animals living in the rainforest is the most probable hypothesis. Inaddition, molecular dating estimates suggest that periods of intense politicalinstability resulting in population movements within the country often associatedalso with increased poverty may have led to more frequent contact with host wild animals. The CAR socio-economic situation, armed conflicts and ecologicaldisturbances will likely incite populations to interact more and more with wildanimals and thus increase the risk of zoonotic spillover.
FAU - Berthet, Nicolas
AU  - Berthet N
AD  - The Center for Microbes, Development and Health, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai-Chinese Academy ofSciences, Discovery and Molecular Characterization of Pathogens, No. 320 Yueyang Road, XuHui District, Shanghai, 200031, China. nicolas.berthet@pasteur.fr.
AD  - Institut Pasteur, Unite Environnement et Risque Infectieux, Celluled'Intervention Biologique d'Urgence, Paris, France. nicolas.berthet@pasteur.fr.
AD  - Centre International de Recherches Medicales de Franceville (CIRMF), Franceville,Gabon. nicolas.berthet@pasteur.fr.
FAU - Descorps-Declere, Stephane
AU  - Descorps-Declere S
AD  - Institut Pasteur, Centre of Bioinformatics, Biostatistics and Integrative Biology(C3BI), Paris, France.
FAU - Besombes, Camille
AU  - Besombes C
AD  - Institut Pasteur, Emerging Diseases Epidemiology Unit, Paris, France.
FAU - Curaudeau, Manon
AU  - Curaudeau M
AD  - Institut de Systematique, Evolution, Biodiversite (ISYEB), Sorbonne Universite,MNHN, CNRS, EPHE, UA, Paris, France.
FAU - Nkili Meyong, Andriniaina Andy
AU  - Nkili Meyong AA
AD  - Centre International de Recherches Medicales de Franceville (CIRMF), Franceville,Gabon.
FAU - Selekon, Benjamin
AU  - Selekon B
AD  - Institut Pasteur de Bangui, Bangui, Central African Republic.
FAU - Labouba, Ingrid
AU  - Labouba I
AD  - Centre International de Recherches Medicales de Franceville (CIRMF), Franceville,Gabon.
FAU - Gonofio, Ella Cyrielle
AU  - Gonofio EC
AD  - Institut Pasteur de Bangui, Bangui, Central African Republic.
FAU - Ouilibona, Rita Sem
AU  - Ouilibona RS
AD  - Institut Pasteur de Bangui, Bangui, Central African Republic.
FAU - Simo Tchetgna, Huguette Dorine
AU  - Simo Tchetgna HD
AD  - Centre International de Recherches Medicales de Franceville (CIRMF), Franceville,Gabon.
FAU - Feher, Maxence
AU  - Feher M
AD  - Institut Pasteur, Unite Environnement et Risque Infectieux, Celluled'Intervention Biologique d'Urgence, Paris, France.
FAU - Fontanet, Arnaud
AU  - Fontanet A
AD  - Institut Pasteur, Emerging Diseases Epidemiology Unit, Paris, France.
AD  - Unite Pasteur-CNAM Risques Infectieux et Emergents (PACRI), ConservatoireNational des Arts et Metiers, Paris, France.
FAU - Kazanji, Mirdad
AU  - Kazanji M
AD  - Institut Pasteur de Bangui, Bangui, Central African Republic.
FAU - Manuguerra, Jean-Claude
AU  - Manuguerra JC
AD  - Institut Pasteur, Unite Environnement et Risque Infectieux, Celluled'Intervention Biologique d'Urgence, Paris, France.
FAU - Hassanin, Alexandre
AU  - Hassanin A
AD  - Institut Pasteur, Emerging Diseases Epidemiology Unit, Paris, France.
FAU - Gessain, Antoine
AU  - Gessain A
AD  - Institut Pasteur, Unite d'Epidemiologie et Physiopathologie des Virus Oncogenes, Departement de Virologie, Paris, France.
AD  - Centre National de Recherche Scientifique (CNRS) UMR3569, Paris, France.
FAU - Nakoune, Emmanuel
AU  - Nakoune E
AD  - Institut Pasteur de Bangui, Bangui, Central African Republic.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20210622
PL  - England
TA  - Sci Rep
JT  - Scientific reports
JID - 101563288
SB  - IM
MH  - Biological Evolution
MH  - Central African Republic/epidemiology
MH  - Evolution, Molecular
MH  - Genomics
MH  - Humans
MH  - Monkeypox/epidemiology/*genetics
MH  - Monkeypox virus/*genetics/isolation & purification/pathogenicity
MH  - Phylogeny
PMC - PMC8219716
EDAT- 2021/06/24 06:00
MHDA- 2021/11/09 06:00
CRDT- 2021/06/23 06:58
PHST- 2021/03/18 00:00 [received]
PHST- 2021/06/02 00:00 [accepted]
PHST- 2021/06/23 06:58 [entrez]
PHST- 2021/06/24 06:00 [pubmed]
PHST- 2021/11/09 06:00 [medline]
AID - 10.1038/s41598-021-92315-8 [doi]
AID - 10.1038/s41598-021-92315-8 [pii]
PST - epublish
SO  - Sci Rep. 2021 Jun 22;11(1):13085. doi: 10.1038/s41598-021-92315-8.

PMID- 33992710
OWN - NLM
STAT- MEDLINE
DCOM- 20211203
LR  - 20211214
IS  - 1872-9096 (Electronic)
IS  - 0166-3542 (Linking)
VI  - 191
DP  - 2021 Jul
TI  - New methylene blue derivatives suggest novel anti-orthopoxviral strategies.
PG  - 105086
LID - S0166-3542(21)00076-0 [pii]
LID - 10.1016/j.antiviral.2021.105086 [doi]
AB  - Decades after the eradication of smallpox and the discontinuation of routinesmallpox vaccination, over half of the world's population is immunologicallynaive to variola virus and other orthopoxviruses (OPXVs). Even in thosepreviously vaccinated against smallpox, protective immunity wanes over time. Assuch, there is a concomitant increase in the incidence of human OPXV infectionsworldwide. To identify novel antiviral compounds with potent anti-OPXV potential,we characterized the inhibitory activity of PAV-866 and other methylene bluederivatives against the prototypic poxvirus, vaccinia virus (VACV). Thesecompounds inactivated virions prior to infection and consequently inhibited viralbinding, fusion and entry. The compounds exhibited strong virucidal activity atnon-cytotoxic concentrations, and inhibited VACV infection when added before,during or after viral adsorption. The compounds were effective against otherOPXVs including monkeypox virus, cowpox virus and the newly identified Akhmetavirus. Altogether, these findings reveal a novel mode of inhibition that has not previously been demonstrated for small molecule compounds against VACV.Additional studies are in progress to determine the in vivo efficacy of thesecompounds against OPXVs and further characterize the anti-viral effects of these derivatives.
CI  - Copyright (c) 2021 The Author(s). Published by Elsevier B.V. All rights reserved.
FAU - Priyamvada, Lalita
AU  - Priyamvada L
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, 1600Clifton Rd, Atlanta, GA, 30329, USA.
FAU - Burgado, Jillybeth
AU  - Burgado J
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, 1600Clifton Rd, Atlanta, GA, 30329, USA.
FAU - Baker-Wagner, Marissa
AU  - Baker-Wagner M
AD  - Prosetta Biosciences, 670 5th Street, San Francisco, CA, 94107, USA.
FAU - Kitaygorodskyy, Anatoliy
AU  - Kitaygorodskyy A
AD  - Prosetta Biosciences, 670 5th Street, San Francisco, CA, 94107, USA.
FAU - Olson, Victoria
AU  - Olson V
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, 1600Clifton Rd, Atlanta, GA, 30329, USA.
FAU - Lingappa, Vishwanath R
AU  - Lingappa VR
AD  - Prosetta Biosciences, 670 5th Street, San Francisco, CA, 94107, USA. Electronicaddress: vlingappa@prosetta.com.
FAU - Satheshkumar, Panayampalli Subbian
AU  - Satheshkumar PS
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, 1600Clifton Rd, Atlanta, GA, 30329, USA. Electronic address: xdv3@cdc.gov.
LA  - eng
PT  - Journal Article
PT  - Research Support, U.S. Gov't, P.H.S.
DEP - 20210513
PL  - Netherlands
TA  - Antiviral Res
JT  - Antiviral research
JID - 8109699
RN  - 0 (Antiviral Agents)
RN  - T42P99266K (Methylene Blue)
SB  - IM
MH  - Antiviral Agents/chemistry/*pharmacology
MH  - Cell Line
MH  - Cowpox virus/drug effects
MH  - HeLa Cells
MH  - Humans
MH  - Methylene Blue/*chemistry/*pharmacology
MH  - Monkeypox virus/drug effects
MH  - Orthopoxvirus/classification/*drug effects
MH  - Vaccinia virus/drug effects
MH  - Virus Attachment/drug effects
OTO - NOTNLM
OT  - *Antiviral
OT  - *Methylene blue
OT  - *Novel inhibitor
OT  - *PAV-866
OT  - *Poxviruses
OT  - *Vaccinia virus
EDAT- 2021/05/17 06:00
MHDA- 2021/12/15 06:00
CRDT- 2021/05/16 20:37
PHST- 2020/09/16 00:00 [received]
PHST- 2021/04/29 00:00 [revised]
PHST- 2021/05/01 00:00 [accepted]
PHST- 2021/05/17 06:00 [pubmed]
PHST- 2021/12/15 06:00 [medline]
PHST- 2021/05/16 20:37 [entrez]
AID - S0166-3542(21)00076-0 [pii]
AID - 10.1016/j.antiviral.2021.105086 [doi]
PST - ppublish
SO  - Antiviral Res. 2021 Jul;191:105086. doi: 10.1016/j.antiviral.2021.105086. Epub2021 May 13.

PMID- 33965861
OWN - NLM
STAT- MEDLINE
DCOM- 20210806
LR  - 20210806
IS  - 1768-3254 (Electronic)
IS  - 0223-5234 (Linking)
VI  - 221
DP  - 2021 Oct 5
TI  - Adamantane derivatives as potential inhibitors of p37 major envelope protein and poxvirus reproduction. Design, synthesis and antiviral activity.
PG  - 113485
LID - S0223-5234(21)00334-2 [pii]
LID - 10.1016/j.ejmech.2021.113485 [doi]
AB  - Currently, smallpox, caused by the variola virus belonging to the poxvirusfamily, has been completely eradicated according to the WHO. However, otherrepresentatives of poxviruses, such as vaccinia virus, cowpox virus, ectromeliavirus, monkeypox virus, mousepox virus and others, remain in the naturalenvironment and can infect both animals and humans. The pathogens of animaldiseases, belonging to the category with a high epidemic risk, have alreadycaused several outbreaks among humans, and can, in an unfavorable combination of circumstances, cause not only an epidemic, but also a pandemic. Despite the fact that there are protocols for the treatment of poxvirus infections, the targeteddesign of new drugs will increase their availability and expand the arsenal ofantiviral chemotherapeutic agents. One of the potential targets of poxviruses is the p37 protein, which is a tecovirimat target. This protein is relatively small,has no homologs among proteins of humans and other mammals and is necessary forthe replication of viral particles, which makes it attractive target for virtual screening. Using the I-TASSER modelling and molecular dynamics refinement the p37orthopox virus protein model was obtained and its was confirmed by ramachandranplot analysis and superimposition of the model with the template protein withsimilar function. A virtual library of adamantane containing compounds wasgenerated and a number of potential inhibitors were chosen from virtual libraryusing molecular docking. Several compounds bearing adamantane moiety weresynthesized and their biological activity was tested in vitro on vaccinia, cowpoxand mousepox viruses. The new compounds inhibiting vaccinia virus replicationwith IC50 concentrations between 0.133 and 0.515 muM were found as a result ofthe research. The applied approach can be useful in the search of new inhibitors of orthopox reproduction. The proposed approach may be suitable for the design ofnew poxvirus inhibitors containing cage structural moiety.
CI  - Copyright (c) 2021 Elsevier Masson SAS. All rights reserved.
FAU - Shiryaev, Vadim A
AU  - Shiryaev VA
AD  - Department of Organic Chemistry, Samara State Technical University, 244Molodogvardeyskaya St., Samara, Samara Region, 443100, Russia. Electronicaddress: shiryaev.va@samgtu.ru.
FAU - Skomorohov, Michael Yu
AU  - Skomorohov MY
AD  - Department of Organic Chemistry, Samara State Technical University, 244Molodogvardeyskaya St., Samara, Samara Region, 443100, Russia.
FAU - Leonova, Marina V
AU  - Leonova MV
AD  - Department of Organic Chemistry, Samara State Technical University, 244Molodogvardeyskaya St., Samara, Samara Region, 443100, Russia.
FAU - Bormotov, Nikolai I
AU  - Bormotov NI
AD  - State Research Centre of Virology and Biotechnology VECTOR, Koltsovo, NovosibirskRegion, 630559, Russia.
FAU - Serova, Olga A
AU  - Serova OA
AD  - State Research Centre of Virology and Biotechnology VECTOR, Koltsovo, NovosibirskRegion, 630559, Russia.
FAU - Shishkina, Larisa N
AU  - Shishkina LN
AD  - State Research Centre of Virology and Biotechnology VECTOR, Koltsovo, NovosibirskRegion, 630559, Russia.
FAU - Agafonov, Alexander P
AU  - Agafonov AP
AD  - State Research Centre of Virology and Biotechnology VECTOR, Koltsovo, NovosibirskRegion, 630559, Russia.
FAU - Maksyutov, Rinat A
AU  - Maksyutov RA
AD  - State Research Centre of Virology and Biotechnology VECTOR, Koltsovo, NovosibirskRegion, 630559, Russia.
FAU - Klimochkin, Yuri N
AU  - Klimochkin YN
AD  - Department of Organic Chemistry, Samara State Technical University, 244Molodogvardeyskaya St., Samara, Samara Region, 443100, Russia.
LA  - eng
PT  - Journal Article
DEP - 20210429
PL  - France
TA  - Eur J Med Chem
JT  - European journal of medicinal chemistry
JID - 0420510
RN  - 0 (Antiviral Agents)
RN  - 0 (Membrane Proteins)
RN  - 0 (Viral Envelope Proteins)
RN  - 0 (p37 protein, Vaccinia virus)
RN  - PJY633525U (Adamantane)
SB  - IM
MH  - Adamantane/chemical synthesis/chemistry/*pharmacology
MH  - Antiviral Agents/chemical synthesis/chemistry/*pharmacology
MH  - Dose-Response Relationship, Drug
MH  - *Drug Design
MH  - Membrane Proteins/*antagonists & inhibitors/metabolism
MH  - Microbial Sensitivity Tests
MH  - Molecular Structure
MH  - Poxviridae/*drug effects
MH  - Structure-Activity Relationship
MH  - Viral Envelope Proteins/*antagonists & inhibitors/metabolism
OTO - NOTNLM
OT  - Adamantane
OT  - Antiviral activity
OT  - Drug design
OT  - Molecular modelling
OT  - Orthopox viruses
COIS- Declaration of competing interest The authors declare that they have no knowncompeting financial interests or personal relationships that could have appeared to influence the work reported in this paper.
EDAT- 2021/05/10 06:00
MHDA- 2021/08/07 06:00
CRDT- 2021/05/09 20:52
PHST- 2021/03/12 00:00 [received]
PHST- 2021/04/13 00:00 [revised]
PHST- 2021/04/15 00:00 [accepted]
PHST- 2021/05/10 06:00 [pubmed]
PHST- 2021/08/07 06:00 [medline]
PHST- 2021/05/09 20:52 [entrez]
AID - S0223-5234(21)00334-2 [pii]
AID - 10.1016/j.ejmech.2021.113485 [doi]
PST - ppublish
SO  - Eur J Med Chem. 2021 Oct 5;221:113485. doi: 10.1016/j.ejmech.2021.113485. Epub2021 Apr 29.

PMID- 33902775
OWN - NLM
STAT- MEDLINE
DCOM- 20210428
LR  - 20210608
IS  - 2045-7979 (Electronic)
IS  - 2045-7960 (Linking)
VI  - 30
DP  - 2021 Apr 27
TI  - Suicide, self-harm and thoughts of suicide or self-harm in infectious diseaseepidemics: a systematic review and meta-analysis.
PG  - e32
LID - 10.1017/S2045796021000214 [doi]
AB  - AIMS: Suicide accounts for 2.2% of all years of life lost worldwide. We aimed to establish whether infectious epidemics are associated with any changes in theincidence of suicide or the period prevalence of self-harm, or thoughts ofsuicide or self-harm, with a secondary objective of establishing the frequency ofthese outcomes. METHODS: In this systematic review and meta-analysis, MEDLINE,Embase, PsycINFO and AMED were searched from inception to 9 September 2020.Studies of infectious epidemics reporting outcomes of (a) death by suicide, (b)self-harm or (c) thoughts of suicide or self-harm were identified. Arandom-effects model meta-analysis for the period prevalence of thoughts ofsuicide or self-harm was conducted. RESULTS: In total, 1354 studies were screenedwith 57 meeting eligibility criteria, of which 7 described death by suicide, 9 byself-harm, and 45 thoughts of suicide or self-harm. The observation period rangedfrom 1910 to 2020 and included epidemics of Spanish Flu, severe acute respiratorysyndrome, human monkeypox, Ebola virus disease and coronavirus disease 2019(COVID-19). Regarding death by suicide, data with a clear longitudinal comparisongroup were available for only two epidemics: SARS in Hong Kong, finding anincrease in suicides among the elderly, and COVID-19 in Japan, finding no change in suicides among children and adolescents. In terms of self-harm, five studiesexamined emergency department attendances in epidemic and non-epidemic periods,of which four found no difference and one showed a reduction during the epidemic.In studies of thoughts of suicide or self-harm, one large survey showed asubstantial increase in period prevalence compared to non-epidemic periods, butsmaller studies showed no difference. As a secondary objective, a meta-analysisof thoughts of suicide and self-harm found that the pooled prevalence was 8.0%overall (95% confidence interval (CI) 5.2-12.0%; 14 820 of 99 238 cases in 24studies) over a time period of between seven days and six months. The qualityassessment found 42 studies were of high quality, nine of moderate quality andsix of high quality. CONCLUSIONS: There is little robust evidence on theassociation of infectious epidemics with suicide, self-harm and thoughts ofsuicide or self-harm. There was an increase in suicides among the elderly in HongKong during SARS and no change in suicides among young people in Japan duringCOVID-19, but it is unclear how far these findings may be generalised. Thedevelopment of up-to-date self-harm and suicide statistics to monitor the effect of the current pandemic is an urgent priority.
FAU - Rogers, J P
AU  - Rogers JP
AUID- ORCID: https://orcid.org/0000-0002-4671-5410
AD  - Division of Psychiatry, University College London, London, UK.
AD  - South London and Maudsley NHS Foundation Trust, London, UK.
FAU - Chesney, E
AU  - Chesney E
AD  - South London and Maudsley NHS Foundation Trust, London, UK.
AD  - Department of Psychosis Studies, King's College London, London, UK.
FAU - Oliver, D
AU  - Oliver D
AD  - Department of Psychosis Studies, King's College London, London, UK.
FAU - Begum, N
AU  - Begum N
AD  - GKT School of Medical Education, King's College London, London, UK.
FAU - Saini, A
AU  - Saini A
AD  - Medical School, University College London, London, UK.
FAU - Wang, S
AU  - Wang S
AD  - Department of Psychology, King's College London, London, UK.
FAU - McGuire, P
AU  - McGuire P
AD  - Department of Psychosis Studies, King's College London, London, UK.
FAU - Fusar-Poli, P
AU  - Fusar-Poli P
AUID- ORCID: https://orcid.org/0000-0003-3582-6788
AD  - Department of Psychosis Studies, King's College London, London, UK.
AD  - Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
FAU - Lewis, G
AU  - Lewis G
AUID- ORCID: https://orcid.org/0000-0001-5205-8245
AD  - Division of Psychiatry, University College London, London, UK.
FAU - David, A S
AU  - David AS
AD  - UCL Institute of Mental Health, University College London, London, UK.
LA  - eng
PT  - Historical Article
PT  - Journal Article
PT  - Meta-Analysis
PT  - Systematic Review
DEP - 20210427
PL  - England
TA  - Epidemiol Psychiatr Sci
JT  - Epidemiology and psychiatric sciences
JID - 101561091
SB  - IM
MH  - Adolescent
MH  - Aged
MH  - *COVID-19
MH  - Child
MH  - *Communicable Diseases/epidemiology
MH  - History, 20th Century
MH  - Hong Kong
MH  - Humans
MH  - *Influenza Pandemic, 1918-1919
MH  - Japan
MH  - SARS-CoV-2
MH  - *Self-Injurious Behavior/epidemiology
MH  - *Suicide
PMC - PMC7610720
MID - EMS120233
OTO - NOTNLM
OT  - epidemic
OT  - infection
OT  - self-harm
OT  - suicide
OT  - systematic review
EDAT- 2021/04/28 06:00
MHDA- 2021/04/29 06:00
CRDT- 2021/04/27 05:52
PHST- 2021/04/27 05:52 [entrez]
PHST- 2021/04/28 06:00 [pubmed]
PHST- 2021/04/29 06:00 [medline]
AID - 10.1017/S2045796021000214 [doi]
AID - S2045796021000214 [pii]
PST - epublish
SO  - Epidemiol Psychiatr Sci. 2021 Apr 27;30:e32. doi: 10.1017/S2045796021000214.

PMID- 33871010
OWN - NLM
STAT- MEDLINE
DCOM- 20220103
LR  - 20220711
IS  - 1537-6613 (Electronic)
IS  - 0022-1899 (Linking)
VI  - 223
IP  - 11
DP  - 2021 Jun 4
TI  - The Evolving Epidemiology of Human Monkeypox: Questions Still to Be Answered.
PG  - 1839-1841
LID - 10.1093/infdis/jiab135 [doi]
FAU - Heymann, David L
AU  - Heymann DL
AD  - Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
FAU - Simpson, Karl
AU  - Simpson K
AD  - JKS Bioscience Limited, Southampton, United Kingdom.
LA  - eng
PT  - Editorial
PT  - Comment
PL  - United States
TA  - J Infect Dis
JT  - The Journal of infectious diseases
JID - 0413675
SB  - IM
CON - J Infect Dis. 2021 Jun 4;223(11):1870-1878. PMID: 33728469
MH  - Humans
MH  - *Monkeypox/epidemiology
MH  - Monkeypox virus/genetics
OTO - NOTNLM
OT  - *Democratic Republic of Congo
OT  - *West Africa
OT  - *emerging infection
OT  - *human monkeypox
OT  - *smallpox eradication
EDAT- 2021/04/20 06:00
MHDA- 2022/01/04 06:00
CRDT- 2021/04/19 08:51
PHST- 2021/03/09 00:00 [received]
PHST- 2021/03/10 00:00 [accepted]
PHST- 2021/04/20 06:00 [pubmed]
PHST- 2022/01/04 06:00 [medline]
PHST- 2021/04/19 08:51 [entrez]
AID - 6237479 [pii]
AID - 10.1093/infdis/jiab135 [doi]
PST - ppublish
SO  - J Infect Dis. 2021 Jun 4;223(11):1839-1841. doi: 10.1093/infdis/jiab135.

PMID- 33756100
OWN - NLM
STAT- MEDLINE
DCOM- 20210705
LR  - 20210705
IS  - 1080-6059 (Electronic)
IS  - 1080-6040 (Linking)
VI  - 27
IP  - 4
DP  - 2021 Apr
TI  - Reemergence of Human Monkeypox and Declining Population Immunity in the Contextof Urbanization, Nigeria, 2017-2020.
LID - 10.3201/eid2704.203569 [doi]
AB  - A monkeypox outbreak in Nigeria during 2017-2020 provides an illustrative casestudy for emerging zoonoses. We built a statistical model to simulate decliningimmunity from monkeypox at 2 levels: At the individual level, we used a constant rate of decline in immunity of 1.29% per year as smallpox vaccination rates fell.At the population level, the cohort of vaccinated residents decreased over timebecause of deaths and births. By 2016, only 10.1% of the total population inNigeria was vaccinated against smallpox; the serologic immunity level was 25.7%among vaccinated persons and 2.6% in the overall population. The substantialresurgence of monkeypox in Nigeria in 2017 appears to have been driven by acombination of population growth, accumulation of unvaccinated cohorts, anddecline in smallpox vaccine immunity. The expanding unvaccinated population meansthat entire households, not just children, are now more susceptible to monkeypox,increasing risk of human-to-human transmission.
FAU - Nguyen, Phi-Yen
AU  - Nguyen PY
FAU - Ajisegiri, Whenayon Simeon
AU  - Ajisegiri WS
FAU - Costantino, Valentina
AU  - Costantino V
FAU - Chughtai, Abrar A
AU  - Chughtai AA
FAU - MacIntyre, C Raina
AU  - MacIntyre CR
LA  - eng
PT  - Journal Article
PT  - Review
PL  - United States
TA  - Emerg Infect Dis
JT  - Emerging infectious diseases
JID - 9508155
RN  - 0 (Smallpox Vaccine)
SB  - IM
MH  - Animals
MH  - Child
MH  - Humans
MH  - *Monkeypox
MH  - Monkeypox virus
MH  - Nigeria
MH  - *Smallpox Vaccine
MH  - Urbanization
MH  - Zoonoses
PMC - PMC8007331
OTO - NOTNLM
OT  - *Nigeria
OT  - *West Africa
OT  - *human-to-human transmission
OT  - *immunity
OT  - *immunoglobulin
OT  - *monkeypox
OT  - *neutralizing antibodies
OT  - *reemerging diseases
OT  - *smallpox
OT  - *urbanization
OT  - *vaccination
OT  - *viruses
OT  - *waning immunity
OT  - *zoonoses
EDAT- 2021/03/24 06:00
MHDA- 2021/07/06 06:00
CRDT- 2021/03/23 20:09
PHST- 2021/03/23 20:09 [entrez]
PHST- 2021/03/24 06:00 [pubmed]
PHST- 2021/07/06 06:00 [medline]
AID - 10.3201/eid2704.203569 [doi]
PST - ppublish
SO  - Emerg Infect Dis. 2021 Apr;27(4). doi: 10.3201/eid2704.203569.

PMID- 33728469
OWN - NLM
STAT- MEDLINE
DCOM- 20220211
LR  - 20220711
IS  - 1537-6613 (Electronic)
IS  - 0022-1899 (Linking)
VI  - 223
IP  - 11
DP  - 2021 Jun 4
TI  - Clinical and Epidemiological Findings from Enhanced Monkeypox Surveillance inTshuapa Province, Democratic Republic of the Congo During 2011-2015.
PG  - 1870-1878
LID - 10.1093/infdis/jiab133 [doi]
AB  - BACKGROUND: Monkeypox is a poorly described emerging zoonosis endemic to Central and Western Africa. METHODS: Using surveillance data from Tshuapa Province,Democratic Republic of the Congo during 2011-2015, we evaluated differences inincidence, exposures, and clinical presentation of polymerase chainreaction-confirmed cases by sex and age. RESULTS: We report 1057 confirmed cases.The average annual incidence was 14.1 per 100 000 (95% confidence interval,13.3-15.0). The incidence was higher in male patients (incidence rate ratiocomparing males to females, 1.21; 95% confidence interval, 1.07-1.37), exceptamong those 20-29 years old (0.70; .51-.95). Females aged 20-29 years alsoreported a high frequency of exposures (26.2%) to people with monkeypox-likesymptoms.The highest incidence was among 10-19-year-old males, the cohortreporting the highest proportion of animal exposures (37.5%). The incidence waslower among those presumed to have received smallpox vaccination than among thosepresumed unvaccinated. No differences were observed by age group in lesion count or lesion severity score. CONCLUSIONS: Monkeypox incidence was twice thatreported during 1980-1985, an increase possibly linked to declining immunityprovided by smallpox vaccination. The high proportion of cases attributed tohuman exposures suggests changing exposure patterns. Cases were distributedacross age and sex, suggesting frequent exposures that follow socioculturalnorms.
CI  - Published by Oxford University Press for the Infectious Diseases Society ofAmerica 2021.
FAU - Whitehouse, Erin R
AU  - Whitehouse ER
AUID- ORCID: 0000-0002-5158-0282
AD  - Epidemic Intelligence Service, US Centers for Disease Control and Prevention,Atlanta, Georgia, USA.
AD  - Division of High Consequence Pathogens and Pathology, US Centers for DiseaseControl and Prevention, Atlanta, Georgia, USA.
FAU - Bonwitt, Jesse
AU  - Bonwitt J
AD  - Division of High Consequence Pathogens and Pathology, US Centers for DiseaseControl and Prevention, Atlanta, Georgia, USA.
FAU - Hughes, Christine M
AU  - Hughes CM
AD  - Division of High Consequence Pathogens and Pathology, US Centers for DiseaseControl and Prevention, Atlanta, Georgia, USA.
FAU - Lushima, Robert Shongo
AU  - Lushima RS
AD  - Ministere de la Sante Publique, Kinshasa, Democratic Republic of the Congo.
FAU - Likafi, Toutou
AU  - Likafi T
AD  - Ecole de Sante Publique de Kinshasa, Kinshasa, Democratic Republic of the Congo.
FAU - Nguete, Beatrice
AU  - Nguete B
AD  - Ecole de Sante Publique de Kinshasa, Kinshasa, Democratic Republic of the Congo.
FAU - Kabamba, Joelle
AU  - Kabamba J
AD  - US Centers for Disease Control and Prevention, Kinshasa, Democratic Republic ofthe Congo.
FAU - Monroe, Benjamin
AU  - Monroe B
AD  - Division of High Consequence Pathogens and Pathology, US Centers for DiseaseControl and Prevention, Atlanta, Georgia, USA.
FAU - Doty, Jeffrey B
AU  - Doty JB
AD  - Division of High Consequence Pathogens and Pathology, US Centers for DiseaseControl and Prevention, Atlanta, Georgia, USA.
FAU - Nakazawa, Yoshinori
AU  - Nakazawa Y
AD  - Division of High Consequence Pathogens and Pathology, US Centers for DiseaseControl and Prevention, Atlanta, Georgia, USA.
FAU - Damon, Inger
AU  - Damon I
AD  - Division of High Consequence Pathogens and Pathology, US Centers for DiseaseControl and Prevention, Atlanta, Georgia, USA.
FAU - Malekani, Jean
AU  - Malekani J
AD  - Faculty of Science, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.
FAU - Davidson, Whitni
AU  - Davidson W
AD  - Division of High Consequence Pathogens and Pathology, US Centers for DiseaseControl and Prevention, Atlanta, Georgia, USA.
FAU - Wilkins, Kimberly
AU  - Wilkins K
AD  - Division of High Consequence Pathogens and Pathology, US Centers for DiseaseControl and Prevention, Atlanta, Georgia, USA.
FAU - Li, Yu
AU  - Li Y
AD  - Division of High Consequence Pathogens and Pathology, US Centers for DiseaseControl and Prevention, Atlanta, Georgia, USA.
FAU - Radford, Kay W
AU  - Radford KW
AD  - Division of Viral Diseases, US Centers for Disease Control and Prevention,Atlanta, Georgia,USA.
FAU - Schmid, D Scott
AU  - Schmid DS
AD  - Division of Viral Diseases, US Centers for Disease Control and Prevention,Atlanta, Georgia,USA.
FAU - Pukuta, Elisabeth
AU  - Pukuta E
AD  - Institut National de Recherche Biomedicale, Kinshasa, Democratic Republic of the Congo.
FAU - Muyamuna, Elisabeth
AU  - Muyamuna E
AD  - Institut National de Recherche Biomedicale, Kinshasa, Democratic Republic of the Congo.
FAU - Karhemere, Stomy
AU  - Karhemere S
AD  - Institut National de Recherche Biomedicale, Kinshasa, Democratic Republic of the Congo.
FAU - Tamfum, Jean-Jacques Muyembe
AU  - Tamfum JM
AD  - Institut National de Recherche Biomedicale, Kinshasa, Democratic Republic of the Congo.
FAU - Okitolonda, Emile Wemakoy
AU  - Okitolonda EW
AD  - Ecole de Sante Publique de Kinshasa, Kinshasa, Democratic Republic of the Congo.
FAU - McCollum, Andrea M
AU  - McCollum AM
AD  - Division of High Consequence Pathogens and Pathology, US Centers for DiseaseControl and Prevention, Atlanta, Georgia, USA.
FAU - Reynolds, Mary G
AU  - Reynolds MG
AD  - Division of High Consequence Pathogens and Pathology, US Centers for DiseaseControl and Prevention, Atlanta, Georgia, USA.
LA  - eng
PT  - Journal Article
PT  - Research Support, U.S. Gov't, P.H.S.
PL  - United States
TA  - J Infect Dis
JT  - The Journal of infectious diseases
JID - 0413675
RN  - 0 (Smallpox Vaccine)
SB  - IM
CIN - J Infect Dis. 2021 Jun 4;223(11):1839-1841. PMID: 33871010
MH  - Adolescent
MH  - Adult
MH  - Child
MH  - Democratic Republic of the Congo/epidemiology
MH  - Female
MH  - Humans
MH  - Male
MH  - *Monkeypox/diagnosis/epidemiology
MH  - Monkeypox virus/genetics
MH  - Smallpox Vaccine
MH  - Young Adult
OTO - NOTNLM
OT  - *Democratic Republic of the Congo
OT  - *Monkeypox
OT  - *Monkeypox virus
OT  - *Orthopoxvirus
OT  - *Surveillance
EDAT- 2021/03/18 06:00
MHDA- 2022/02/12 06:00
CRDT- 2021/03/17 06:56
PHST- 2020/11/20 00:00 [received]
PHST- 2021/03/15 00:00 [accepted]
PHST- 2021/03/18 06:00 [pubmed]
PHST- 2022/02/12 06:00 [medline]
PHST- 2021/03/17 06:56 [entrez]
AID - 6174433 [pii]
AID - 10.1093/infdis/jiab133 [doi]
PST - ppublish
SO  - J Infect Dis. 2021 Jun 4;223(11):1870-1878. doi: 10.1093/infdis/jiab133.

PMID- 33692745
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20210312
IS  - 1664-2295 (Print)
IS  - 1664-2295 (Linking)
VI  - 12
DP  - 2021
TI  - Neurologic Manifestations of the World Health Organization's List of Pandemic andEpidemic Diseases.
PG  - 634827
LID - 10.3389/fneur.2021.634827 [doi]
AB  - The World Health Organization (WHO) monitors the spread of diseases globally and maintains a list of diseases with epidemic or pandemic potential. Currentlylisted diseases include Chikungunya, cholera, Crimean-Congo hemorrhagic fever,Ebola virus disease, Hendra virus infection, influenza, Lassa fever, Marburgvirus disease, Neisseria meningitis, MERS-CoV, monkeypox, Nipah virus infection, novel coronavirus (COVID-19), plague, Rift Valley fever, SARS, smallpox,tularemia, yellow fever, and Zika virus disease. The associated pathogens areincreasingly important on the global stage. The majority of these diseases haveneurological manifestations. Those with less frequent neurological manifestationsmay also have important consequences. This is highlighted now in particularthrough the ongoing COVID-19 pandemic and reinforces that pathogens with thepotential to spread rapidly and widely, in spite of concerted global efforts, mayaffect the nervous system. We searched the scientific literature, dating from1934 to August 2020, to compile data on the cause, epidemiology, clinicalpresentation, neuroimaging features, and treatment of each of the diseases ofepidemic or pandemic potential as viewed through a neurologist's lens. Weincluded articles with an abstract or full text in English in this topical andscoping review. Diseases with epidemic and pandemic potential can be spreaddirectly from human to human, animal to human, via mosquitoes or other insects,or via environmental contamination. Manifestations include central neurologicconditions (meningitis, encephalitis, intraparenchymal hemorrhage, seizures),peripheral and cranial nerve syndromes (sensory neuropathy, sensorineural hearingloss, ophthalmoplegia), post-infectious syndromes (acute inflammatorypolyneuropathy), and congenital syndromes (fetal microcephaly), among others.Some diseases have not been well-characterized from a neurological standpoint,but all have at least scattered case reports of neurological features. Some ofthe diseases have curative treatments available while in other cases, supportive care remains the only management option. Regardless of the pathogen, prompt, and aggressive measures to control the spread of these agents are the most important factors in lowering the overall morbidity and mortality they can cause.
CI  - Copyright (c) 2021 McEntire, Song, McInnis, Rhee, Young, Williams, Wibecan,Nolan, Nagy, Gluckstein, Mukerji and Mateen.
FAU - McEntire, Caleb R S
AU  - McEntire CRS
AD  - Massachusetts General Hospital (MGH)-Brigham Neurology Residency Program, Boston,MA, United States.
FAU - Song, Kun-Wei
AU  - Song KW
AD  - Massachusetts General Hospital (MGH)-Brigham Neurology Residency Program, Boston,MA, United States.
FAU - McInnis, Robert P
AU  - McInnis RP
AD  - Massachusetts General Hospital (MGH)-Brigham Neurology Residency Program, Boston,MA, United States.
FAU - Rhee, John Y
AU  - Rhee JY
AD  - Massachusetts General Hospital (MGH)-Brigham Neurology Residency Program, Boston,MA, United States.
FAU - Young, Michael
AU  - Young M
AD  - Massachusetts General Hospital (MGH)-Brigham Neurology Residency Program, Boston,MA, United States.
FAU - Williams, Erika
AU  - Williams E
AD  - Massachusetts General Hospital (MGH)-Brigham Neurology Residency Program, Boston,MA, United States.
FAU - Wibecan, Leah L
AU  - Wibecan LL
AD  - Massachusetts General Hospital (MGH)-Brigham Pediatric Neurology ResidencyProgram, Boston, MA, United States.
FAU - Nolan, Neal
AU  - Nolan N
AD  - Massachusetts General Hospital (MGH)-Brigham Neurology Residency Program, Boston,MA, United States.
FAU - Nagy, Amanda M
AU  - Nagy AM
AD  - Massachusetts General Hospital (MGH)-Brigham Pediatric Neurology ResidencyProgram, Boston, MA, United States.
FAU - Gluckstein, Jeffrey
AU  - Gluckstein J
AD  - Massachusetts General Hospital (MGH)-Brigham Neurology Residency Program, Boston,MA, United States.
FAU - Mukerji, Shibani S
AU  - Mukerji SS
AD  - Department of Neurology, Massachusetts General Hospital, Boston, MA, UnitedStates.
FAU - Mateen, Farrah J
AU  - Mateen FJ
AD  - Department of Neurology, Massachusetts General Hospital, Boston, MA, UnitedStates.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20210222
PL  - Switzerland
TA  - Front Neurol
JT  - Frontiers in neurology
JID - 101546899
PMC - PMC7937722
OTO - NOTNLM
OT  - clinical neurology
OT  - epidemic
OT  - neuroviral epidemics
OT  - pandemic
OT  - tropical medicine
COIS- The authors declare that the research was conducted in the absence of anycommercial or financial relationships that could be construed as a potentialconflict of interest.
EDAT- 2021/03/12 06:00
MHDA- 2021/03/12 06:01
CRDT- 2021/03/11 06:35
PHST- 2020/11/29 00:00 [received]
PHST- 2021/01/25 00:00 [accepted]
PHST- 2021/03/11 06:35 [entrez]
PHST- 2021/03/12 06:00 [pubmed]
PHST- 2021/03/12 06:01 [medline]
AID - 10.3389/fneur.2021.634827 [doi]
PST - epublish
SO  - Front Neurol. 2021 Feb 22;12:634827. doi: 10.3389/fneur.2021.634827. eCollection 2021.

PMID- 33605479
OWN - NLM
STAT- MEDLINE
DCOM- 20211203
LR  - 20211214
IS  - 1521-4184 (Electronic)
IS  - 0365-6233 (Linking)
VI  - 354
IP  - 6
DP  - 2021 Jun
TI  - (+)-Camphor and (-)-borneol derivatives as potential anti-orthopoxvirus agents.
PG  - e2100038
LID - 10.1002/ardp.202100038 [doi]
AB  - Although the World Health Organisation had announced that smallpox was eradicatedover 40 years ago, the disease and other related pathogenic poxviruses such asmonkeypox remain potential bioterrorist weapons and could also re-emerge asnatural infections. We have previously reported (+)-camphor and (-)-borneolderivatives with an antiviral activity against the vaccinia virus. This virus is similar to the variola virus (VARV), the causative agent of smallpox, but can be studied at BSL-2 facilities. In the present study, we evaluated the antiviralactivity of the most potent compounds against VARV, cowpox virus, and ectromelia virus (ECTV). Among the compounds tested,4-bromo-N'-((1R,4R)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-ylidene)benzohydrazide 18 is the most effective compound against various orthopoxviruses, includingVARV, with an EC50 value of 13.9 muM and a selectivity index of 206. Also,(+)-camphor thiosemicarbazone 9 was found to be active against VARV and ECTV.
CI  - (c) 2021 Deutsche Pharmazeutische Gesellschaft.
FAU - Sokolova, Anastasiya S
AU  - Sokolova AS
AUID- ORCID: https://orcid.org/0000-0001-5227-9996
AD  - N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian BranchRussian Academy of Sciences, Novosibirsk, Russian Federation.
FAU - Kovaleva, Kseniya S
AU  - Kovaleva KS
AD  - N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian BranchRussian Academy of Sciences, Novosibirsk, Russian Federation.
FAU - Yarovaya, Olga I
AU  - Yarovaya OI
AD  - N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian BranchRussian Academy of Sciences, Novosibirsk, Russian Federation.
FAU - Bormotov, Nikolay I
AU  - Bormotov NI
AD  - State Research Centre of Virology and Biotechnology VECTOR, Rospotrebnadzor,Novosibirsk, Russian Federation.
FAU - Shishkina, Larisa N
AU  - Shishkina LN
AD  - State Research Centre of Virology and Biotechnology VECTOR, Rospotrebnadzor,Novosibirsk, Russian Federation.
FAU - Serova, Olga A
AU  - Serova OA
AD  - State Research Centre of Virology and Biotechnology VECTOR, Rospotrebnadzor,Novosibirsk, Russian Federation.
FAU - Sergeev, Alexander A
AU  - Sergeev AA
AD  - State Research Centre of Virology and Biotechnology VECTOR, Rospotrebnadzor,Novosibirsk, Russian Federation.
FAU - Agafonov, Alexander P
AU  - Agafonov AP
AD  - State Research Centre of Virology and Biotechnology VECTOR, Rospotrebnadzor,Novosibirsk, Russian Federation.
FAU - Maksuytov, Rinat A
AU  - Maksuytov RA
AD  - State Research Centre of Virology and Biotechnology VECTOR, Rospotrebnadzor,Novosibirsk, Russian Federation.
FAU - Salakhutdinov, Nariman F
AU  - Salakhutdinov NF
AD  - N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian BranchRussian Academy of Sciences, Novosibirsk, Russian Federation.
LA  - eng
GR  - 20-33-70067/Russian Foundation for Basic Research
PT  - Journal Article
DEP - 20210219
PL  - Germany
TA  - Arch Pharm (Weinheim)
JT  - Archiv der Pharmazie
JID - 0330167
RN  - 0 (Antiviral Agents)
RN  - 0 (Camphanes)
RN  - 0 (Isoindoles)
RN  - 0 (Thiosemicarbazones)
RN  - 76-22-2 (Camphor)
RN  - L88RA8N5EG (isoborneol)
SB  - IM
MH  - Animals
MH  - Antiviral Agents/chemical synthesis/chemistry/pharmacology
MH  - *Camphanes/chemical synthesis/chemistry/pharmacology
MH  - *Camphor/analogs & derivatives/chemistry/pharmacology
MH  - Cells, Cultured
MH  - Humans
MH  - *Isoindoles/chemical synthesis/chemistry/pharmacology
MH  - Orthopoxvirus/classification/*drug effects/pathogenicity/physiology
MH  - Poxviridae Infections/drug therapy/virology
MH  - Thiosemicarbazones/chemistry/pharmacology
OTO - NOTNLM
OT  - (+)-camphor
OT  - (-)-borneol
OT  - cowpox virus
OT  - ectromelia virus
OT  - vaccinia virus
OT  - variola virus
EDAT- 2021/02/20 06:00
MHDA- 2021/12/15 06:00
CRDT- 2021/02/19 08:41
PHST- 2021/01/28 00:00 [received]
PHST- 2021/01/30 00:00 [accepted]
PHST- 2021/02/20 06:00 [pubmed]
PHST- 2021/12/15 06:00 [medline]
PHST- 2021/02/19 08:41 [entrez]
AID - 10.1002/ardp.202100038 [doi]
PST - ppublish
SO  - Arch Pharm (Weinheim). 2021 Jun;354(6):e2100038. doi: 10.1002/ardp.202100038.Epub 2021 Feb 19.

PMID- 33597175
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20211028
IS  - 2379-5042 (Electronic)
IS  - 2379-5042 (Linking)
VI  - 6
IP  - 1
DP  - 2021 Feb 17
TI  - Correction for Hutson et al., "Pharmacokinetics and Efficacy of a PotentialSmallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model".
LID - e00126-21 [pii]
LID - 10.1128/mSphere.00126-21 [doi]
FAU - Hutson, Christina L
AU  - Hutson CL
AUID- ORCID: https://orcid.org/0000-0001-7998-9728
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA zuu6@cdc.gov.
FAU - Kondas, Ashley V
AU  - Kondas AV
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
FAU - Mauldin, Mathew R
AU  - Mauldin MR
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
FAU - Doty, Jeffrey B
AU  - Doty JB
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
FAU - Grossi, Irma M
AU  - Grossi IM
AD  - Chimerix, Durham, North Carolina, USA.
FAU - Morgan, Clint N
AU  - Morgan CN
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
AD  - Oak Ridge Institute for Science and Education, CDC Fellowship Program, Oak Ridge,Tennessee, USA.
FAU - Ostergaard, Sharon Dietz
AU  - Ostergaard SD
AD  - Animal Resources Branch, Centers for Disease Control and Prevention, Atlanta,Georgia, USA.
FAU - Hughes, Christine M
AU  - Hughes CM
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
FAU - Nakazawa, Yoshinori
AU  - Nakazawa Y
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
FAU - Kling, Chantal
AU  - Kling C
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
FAU - Martin, Brock E
AU  - Martin BE
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
FAU - Ellison, James A
AU  - Ellison JA
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
FAU - Carroll, Darin S
AU  - Carroll DS
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
FAU - Gallardo-Romero, Nadia F
AU  - Gallardo-Romero NF
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
FAU - Olson, Victoria A
AU  - Olson VA
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
LA  - eng
PT  - Journal Article
PT  - Published Erratum
DEP - 20210217
PL  - United States
TA  - mSphere
JT  - mSphere
JID - 101674533
SB  - IM
EFR - mSphere. 2021 Feb 3;6(1):. PMID: 33536322
PMC - PMC8544885
EDAT- 2021/02/19 06:00
MHDA- 2021/02/19 06:01
CRDT- 2021/02/18 05:54
PHST- 2021/02/18 05:54 [entrez]
PHST- 2021/02/19 06:00 [pubmed]
PHST- 2021/02/19 06:01 [medline]
AID - 6/1/e00126-21 [pii]
AID - 10.1128/mSphere.00126-21 [doi]
PST - epublish
SO  - mSphere. 2021 Feb 17;6(1). pii: 6/1/e00126-21. doi: 10.1128/mSphere.00126-21.

PMID- 33536322
OWN - NLM
STAT- MEDLINE
DCOM- 20210216
LR  - 20210218
IS  - 2379-5042 (Electronic)
IS  - 2379-5042 (Linking)
VI  - 6
IP  - 1
DP  - 2021 Feb 3
TI  - Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir,in a Lethal Monkeypox Virus Animal Model.
LID - e00927-20 [pii]
LID - 10.1128/mSphere.00927-20 [doi]
AB  - Smallpox, caused by Variola virus (VARV), was eradicated in 1980; however, VARVbioterrorist threats still exist, necessitating readily available therapeutics.Current preparedness activities recognize the importance of oral antivirals andrecommend therapeutics with different mechanisms of action. Monkeypox virus(MPXV) is closely related to VARV, causing a highly similar clinical humandisease, and can be used as a surrogate for smallpox antiviral testing. Theprairie dog MPXV model has been characterized and used to study the efficacy ofantipoxvirus therapeutics, including recently approved TPOXX (tecovirimat).Brincidofovir (BCV; CMX001) has shown antiviral activity against double-stranded DNA viruses, including poxviruses. To determine the exposure of BCV followingoral administration to prairie dogs, a pharmacokinetics (PK) study was performed.Analysis of BCV plasma concentrations indicated variability, conceivably due tothe outbred nature of the animals. To determine BCV efficacy in the MPXV prairie dog model, groups of animals were intranasally challenged with 9 x 10(5)plaque-forming units (PFU; 90% lethal dose [LD90]) of MPXV on inoculation day 0(ID0). Animals were divided into groups based on the first day of BCV treatmentrelative to inoculation day (ID-1, ID0, or ID1). A trend in efficacy was noteddependent upon treatment initiation (57% on ID-1, 43% on ID0, and 29% on ID1) butwas lower than demonstrated in other animal models. Analysis of the PK dataindicated that BCV plasma exposure (maximum concentration [C max]) and the timeof the last quantifiable concentration (AUClast) were lower than in other animal models administered the same doses, indicating that suboptimal BCV exposure mayexplain the lower protective effect on survival.IMPORTANCE Preparednessactivities against highly transmissible viruses with high mortality rates havebeen highlighted during the ongoing coronavirus disease 2019 (COVID-19) pandemic.Smallpox, caused by variola virus (VARV) infection, is highly transmissible, withan estimated 30% mortality. Through an intensive vaccination campaign, smallpoxwas declared eradicated in 1980, and routine smallpox vaccination of individuals ceased. Today's current population has little/no immunity against VARV. Ifsmallpox were to reemerge, the worldwide results would be devastating. Recent FDAapproval of one smallpox antiviral (tecovirimat) was a successful step inbiothreat preparedness; however, orthopoxviruses can become resistant totreatment, suggesting the need for multiple therapeutics. Our paper details theefficacy of the investigational smallpox drug brincidofovir in a monkeypox virus (MPXV) animal model. Since brincidofovir has not been tested in vivo againstsmallpox, studies with the related virus MPXV are critical in understandingwhether it would be protective in the event of a smallpox outbreak.
FAU - Hutson, Christina L
AU  - Hutson CL
AUID- ORCID: 0000-0001-7998-9728
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA zuu6@cdc.gov.
FAU - Kondas, Ashley V
AU  - Kondas AV
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
FAU - Mauldin, Mathew R
AU  - Mauldin MR
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
FAU - Doty, Jeffrey B
AU  - Doty JB
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
FAU - Grossi, Irma M
AU  - Grossi IM
AD  - Chimerix, Durham, North Carolina, USA.
FAU - Morgan, Clint N
AU  - Morgan CN
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
AD  - Oak Ridge Institute for Science and Education, CDC Fellowship Program, Oak Ridge,Tennessee, USA.
FAU - Ostergaard, Sharon Dietz
AU  - Ostergaard SD
AD  - Animal Resources Branch, Centers for Disease Control and Prevention, Atlanta,Georgia, USA.
FAU - Hughes, Christine M
AU  - Hughes CM
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
FAU - Nakazawa, Yoshinori
AU  - Nakazawa Y
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
FAU - Kling, Chantal
AU  - Kling C
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
FAU - Martin, Brock E
AU  - Martin BE
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
FAU - Ellison, James A
AU  - Ellison JA
AUID- ORCID: 0000-0003-4492-4857
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
FAU - Carroll, Darin S
AU  - Carroll DS
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
FAU - Gallardo-Romero, Nadia F
AU  - Gallardo-Romero NF
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
FAU - Olson, Victoria A
AU  - Olson VA
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
LA  - eng
PT  - Journal Article
DEP - 20210203
PL  - United States
TA  - mSphere
JT  - mSphere
JID - 101674533
RN  - 0 (Antiviral Agents)
RN  - 0 (Benzamides)
RN  - 0 (Isoindoles)
RN  - 0 (Organophosphonates)
RN  - 6794O900AX (brincidofovir)
RN  - 8J337D1HZY (Cytosine)
RN  - F925RR824R (Tecovirimat)
SB  - IM
EIN - mSphere. 2021 Feb 17;6(1):. PMID: 33597175
MH  - Animals
MH  - Antiviral Agents/pharmacokinetics/pharmacology
MH  - Benzamides/pharmacokinetics/pharmacology
MH  - Cytosine/*analogs & derivatives/pharmacokinetics/pharmacology
MH  - Disease Models, Animal
MH  - Dogs
MH  - Female
MH  - Isoindoles/pharmacokinetics/pharmacology
MH  - Male
MH  - Monkeypox virus/*drug effects
MH  - Organophosphonates/*pharmacokinetics/*pharmacology
MH  - Smallpox/*drug therapy
MH  - Variola virus/drug effects
PMC - PMC7860987
OTO - NOTNLM
OT  - *animal models
OT  - *experimental therapeutics
OT  - *monkeypox
OT  - *smallpox
OT  - *virology
EDAT- 2021/02/05 06:00
MHDA- 2021/02/17 06:00
CRDT- 2021/02/04 05:41
PHST- 2021/02/04 05:41 [entrez]
PHST- 2021/02/05 06:00 [pubmed]
PHST- 2021/02/17 06:00 [medline]
AID - 6/1/e00927-20 [pii]
AID - 10.1128/mSphere.00927-20 [doi]
PST - epublish
SO  - mSphere. 2021 Feb 3;6(1). pii: 6/1/e00927-20. doi: 10.1128/mSphere.00927-20.

PMID- 33517914
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20210206
IS  - 2055-0936 (Print)
IS  - 2055-0936 (Linking)
VI  - 7
IP  - 1
DP  - 2021 Jan 31
TI  - COVID-19 in comparison with other emerging viral diseases: risk of geographicspread via travel.
PG  - 3
LID - 10.1186/s40794-020-00129-9 [doi]
AB  - PURPOSE OF REVIEW: The COVID-19 pandemic poses a major global health threat. The rapid spread was facilitated by air travel although rigorous travel bans andlockdowns were able to slow down the spread. How does COVID-19 compare with otheremerging viral diseases of the past two decades? RECENT FINDINGS: Viral outbreaksdiffer in many ways, such as the individuals most at risk e.g. pregnant women forZika and the elderly for COVID-19, their vectors of transmission, their fatality rate, and their transmissibility often measured as basic reproduction number. Therisk of geographic spread via air travel differs significantly between emerginginfectious diseases. COVID-19 is not associated with the highest case fatalityrate compared with other emerging viral diseases such as SARS and Ebola, but the combination of a high reproduction number, superspreading events and a globallyimmunologically naive population has led to the highest global number of deathsin the past 20 decade compared to any other pandemic.
FAU - Wilder-Smith, A
AU  - Wilder-Smith A
AD  - Department of Disease Control, London School of Hygiene and Tropical Medicine,London, UK. anneliesws@gmail.com.
AD  - Heidelberg Institute of Global Health, University of Heidelberg, Heidelberg,Germany. anneliesws@gmail.com.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20210131
PL  - England
TA  - Trop Dis Travel Med Vaccines
JT  - Tropical diseases, travel medicine and vaccines
JID - 101674442
PMC - PMC7847598
OTO - NOTNLM
OT  - Chikungunya
OT  - Dengue
OT  - Ebola
OT  - Japanese encephalitis
OT  - Measles
OT  - Monkeypox
OT  - SARS
OT  - West Nile encephalitis
OT  - Yellow fever
OT  - Zika
EDAT- 2021/02/02 06:00
MHDA- 2021/02/02 06:01
CRDT- 2021/02/01 05:30
PHST- 2020/11/19 00:00 [received]
PHST- 2020/12/26 00:00 [accepted]
PHST- 2021/02/01 05:30 [entrez]
PHST- 2021/02/02 06:00 [pubmed]
PHST- 2021/02/02 06:01 [medline]
AID - 10.1186/s40794-020-00129-9 [doi]
AID - 10.1186/s40794-020-00129-9 [pii]
PST - epublish
SO  - Trop Dis Travel Med Vaccines. 2021 Jan 31;7(1):3. doi:10.1186/s40794-020-00129-9.

PMID- 33448254
OWN - NLM
STAT- MEDLINE
DCOM- 20210125
LR  - 20210127
IS  - 2150-1327 (Electronic)
IS  - 2150-1319 (Linking)
VI  - 12
DP  - 2021 Jan-Dec
TI  - Superspreaders: A Lurking Danger in the Community.
PG  - 2150132720987432
LID - 10.1177/2150132720987432 [doi]
AB  - A "superspreader" refers to an unusually contagious organism infected with adisease. With respect to a human borne illnesses, a superspreader is someone who is more likely to infect other humans when compared to a typically infectedperson. The existence of human superspreaders is deeply entrenched in history;the most famous case being that of Typhoid Mary. Through contact tracing,epidemiologists have identified human superspreaders in measles, tuberculosis,rubella, monkeypox, smallpox, Ebola hemorrhagic fever, and SARS. The recentoutbreak of Coronavirus disease (COVID-19) has shifted the focus back on thesuperspreaders. We herein present a case report of a COVID-19 superspreader with a hitherto unusually high number of infected contacts. The index case was a 33year old male who resided in a low income settlement comprising of rehabilitated slum dwellers and worked as a healthcare worker (HCW) in a tertiary care hospitaland had tested positive for COVID-19.On contact tracing, he had a total of 125contacts, of which 49 COVID-19 infections had direct or indirect contact with theindex case, qualifying him as a "superspreader." This propagated infection led toan outbreak in the community. Contact tracing, testing and isolation of suchsuperspreaders from the other members of the community is essential to stop thespread of this disease and contain the COVID-19 pandemic.
FAU - Mohindra, Ritin
AU  - Mohindra R
AD  - Post Graduate Institute of Medical Education and Research, Chandigarh, India.
FAU - Ghai, Arushi
AU  - Ghai A
AD  - Lady Hardinge Medical College New Delhi, Delhi, India.
FAU - Brar, Rinnie
AU  - Brar R
AD  - Post Graduate Institute of Medical Education and Research, Chandigarh, India.
FAU - Khandelwal, Neha
AU  - Khandelwal N
AD  - Post Graduate Institute of Medical Education and Research, Chandigarh, India.
FAU - Biswal, Manisha
AU  - Biswal M
AD  - Post Graduate Institute of Medical Education and Research, Chandigarh, India.
FAU - Suri, Vikas
AU  - Suri V
AD  - Post Graduate Institute of Medical Education and Research, Chandigarh, India.
FAU - Goyal, Kapil
AU  - Goyal K
AD  - Post Graduate Institute of Medical Education and Research, Chandigarh, India.
FAU - Singh, Mini P
AU  - Singh MP
AD  - Post Graduate Institute of Medical Education and Research, Chandigarh, India.
FAU - Bhalla, Ashish
AU  - Bhalla A
AD  - Post Graduate Institute of Medical Education and Research, Chandigarh, India.
FAU - Rana, Kirtan
AU  - Rana K
AD  - Post Graduate Institute of Medical Education and Research, Chandigarh, India.
FAU - Lakshmi, P V M
AU  - Lakshmi PVM
AUID- ORCID: 0000-0002-6921-9794
AD  - Post Graduate Institute of Medical Education and Research, Chandigarh, India.
LA  - eng
PT  - Case Reports
PT  - Journal Article
PL  - United States
TA  - J Prim Care Community Health
JT  - Journal of primary care & community health
JID - 101518419
SB  - IM
MH  - Adult
MH  - *Basic Reproduction Number
MH  - COVID-19/physiopathology/*transmission
MH  - *Contact Tracing
MH  - Cough/physiopathology
MH  - Disease Outbreaks
MH  - Fever/physiopathology
MH  - *Health Personnel
MH  - Humans
MH  - India
MH  - Male
MH  - Pharyngitis/physiopathology
MH  - Poverty Areas
MH  - SARS-CoV-2
MH  - Tertiary Care Centers
MH  - Workplace
PMC - PMC7812391
OTO - NOTNLM
OT  - *COVID 19
OT  - *community
OT  - *contagious
OT  - *infection
OT  - *outbreak
OT  - *superspreader
EDAT- 2021/01/16 06:00
MHDA- 2021/01/26 06:00
CRDT- 2021/01/15 08:42
PHST- 2021/01/15 08:42 [entrez]
PHST- 2021/01/16 06:00 [pubmed]
PHST- 2021/01/26 06:00 [medline]
AID - 10.1177/2150132720987432 [doi]
PST - ppublish
SO  - J Prim Care Community Health. 2021 Jan-Dec;12:2150132720987432. doi:10.1177/2150132720987432.

PMID- 33396609
OWN - NLM
STAT- MEDLINE
DCOM- 20210223
LR  - 20210223
IS  - 1999-4915 (Electronic)
IS  - 1999-4915 (Linking)
VI  - 13
IP  - 1
DP  - 2020 Dec 30
TI  - Here, There, and Everywhere: The Wide Host Range and Geographic Distribution ofZoonotic Orthopoxviruses.
LID - E43 [pii]
LID - 10.3390/v13010043 [doi]
AB  - The global emergence of zoonotic viruses, including poxviruses, poses one of the greatest threats to human and animal health. Forty years after the eradication ofsmallpox, emerging zoonotic orthopoxviruses, such as monkeypox, cowpox, andvaccinia viruses continue to infect humans as well as wild and domestic animals. Currently, the geographical distribution of poxviruses in a broad range of hosts worldwide raises concerns regarding the possibility of outbreaks or viraldissemination to new geographical regions. Here, we review the global host rangesand current epidemiological understanding of zoonotic orthopoxviruses whilefocusing on orthopoxviruses with epidemic potential, including monkeypox, cowpox,and vaccinia viruses.
FAU - Silva, Natalia Ingrid Oliveira
AU  - Silva NIO
AD  - Laboratorio de Virus, Departamento de Microbiologia, Instituto de CienciasBiologicas, Universidade Federal de Minas Gerais: Belo Horizonte, Minas Gerais31270-901, Brazil.
FAU - de Oliveira, Jaqueline Silva
AU  - de Oliveira JS
AD  - Laboratorio de Virus, Departamento de Microbiologia, Instituto de CienciasBiologicas, Universidade Federal de Minas Gerais: Belo Horizonte, Minas Gerais31270-901, Brazil.
FAU - Kroon, Erna Geessien
AU  - Kroon EG
AUID- ORCID: 0000-0003-2721-3826
AD  - Laboratorio de Virus, Departamento de Microbiologia, Instituto de CienciasBiologicas, Universidade Federal de Minas Gerais: Belo Horizonte, Minas Gerais31270-901, Brazil.
FAU - Trindade, Giliane de Souza
AU  - Trindade GS
AD  - Laboratorio de Virus, Departamento de Microbiologia, Instituto de CienciasBiologicas, Universidade Federal de Minas Gerais: Belo Horizonte, Minas Gerais31270-901, Brazil.
FAU - Drumond, Betania Paiva
AU  - Drumond BP
AD  - Laboratorio de Virus, Departamento de Microbiologia, Instituto de CienciasBiologicas, Universidade Federal de Minas Gerais: Belo Horizonte, Minas Gerais31270-901, Brazil.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, P.H.S.
PT  - Review
DEP - 20201230
PL  - Switzerland
TA  - Viruses
JT  - Viruses
JID - 101509722
SB  - IM
MH  - Animals
MH  - Geography, Medical
MH  - *Host Specificity
MH  - Humans
MH  - Orthopoxvirus/classification/*physiology
MH  - Poxviridae Infections/*epidemiology/*virology
MH  - Viral Zoonoses/*epidemiology/*virology
PMC - PMC7823380
OTO - NOTNLM
OT  - *Cowpox virus
OT  - *Monkeypox virus
OT  - *Orthopoxvirus
OT  - *Poxviridae
OT  - *Vaccinia virus
OT  - *emergent viruses
OT  - *host range
OT  - *outbreak
OT  - *wild and domestic animals
OT  - *zoonosis
EDAT- 2021/01/06 06:00
MHDA- 2021/02/24 06:00
CRDT- 2021/01/05 01:15
PHST- 2020/11/14 00:00 [received]
PHST- 2020/12/23 00:00 [revised]
PHST- 2020/12/24 00:00 [accepted]
PHST- 2021/01/05 01:15 [entrez]
PHST- 2021/01/06 06:00 [pubmed]
PHST- 2021/02/24 06:00 [medline]
AID - v13010043 [pii]
AID - 10.3390/v13010043 [doi]
PST - epublish
SO  - Viruses. 2020 Dec 30;13(1). pii: v13010043. doi: 10.3390/v13010043.

PMID- 33289470
OWN - NLM
STAT- MEDLINE
DCOM- 20220208
LR  - 20220208
IS  - 1476-1645 (Electronic)
IS  - 0002-9637 (Linking)
VI  - 104
IP  - 2
DP  - 2020 Dec 7
TI  - A Tale of Two Viruses: Coinfections of Monkeypox and Varicella Zoster Virus inthe Democratic Republic of Congo.
PG  - 604-611
LID - 10.4269/ajtmh.20-0589 [doi]
LID - tpmd200589 [pii]
AB  - Recent enhanced monkeypox (MPX) surveillance in the Democratic Republic of Congo,where MPX is endemic, has uncovered multiple cases of MPX and varicella zostervirus (VZV) coinfections. The purpose of this study was to verify if coinfectionsoccur and to characterize the clinical nature of these cases. Clinical,epidemiological, and laboratory results were used to investigate MPX/VZVcoinfections. A coinfection was defined as a patient with at least oneOrthopoxvirus/MPX-positive sample and at least one VZV-positive sample within thesame disease event. Between September 2009 and April 2014, 134 of the 1,107(12.1%) suspected MPX cases were confirmed as MPX/VZV coinfections. Coinfections were more likely to report symptoms than VZV-alone cases and less likely thanMPX-alone cases. Significantly higher lesion counts were observed for coinfectioncases than for VZV-alone but less than MPX-alone cases. Discernible differencesin symptom and rash severity were detected for coinfection cases compared withthose with MPX or VZV alone. Findings indicate infection with both MPX and VZVcould modulate infection severity. Collection of multiple lesion samples allowsfor the opportunity to detect coinfections. As this program continues, it will beimportant to continue these procedures to assess variations in the proportion of coinfected cases over time.
FAU - Hughes, Christine M
AU  - Hughes CM
AD  - 1Poxvirus and Rabies Branch, Division of High-Consequence Pathogens andPathology, National Center for Emerging and Zoonotic Infectious Diseases, U.S.Centers for Disease Control and Prevention, Atlanta, Georgia.
FAU - Liu, Lindy
AU  - Liu L
AD  - 2Bacterial Special Pathogens Branch, Division of High-Consequence Pathogens andPathology, National Center for Emerging and Zoonotic Infectious Diseases, U.S.Centers for Disease Control and Prevention, Atlanta, Georgia.
AD  - 3Infectious Diseases Pathology Branch, Division of High-Consequence Pathogens andPathology, National Center for Emerging and Zoonotic Infectious Diseases, U.S.Centers for Disease Control and Prevention, Atlanta, Georgia.
FAU - Davidson, Whitni B
AU  - Davidson WB
AD  - 1Poxvirus and Rabies Branch, Division of High-Consequence Pathogens andPathology, National Center for Emerging and Zoonotic Infectious Diseases, U.S.Centers for Disease Control and Prevention, Atlanta, Georgia.
FAU - Radford, Kay W
AU  - Radford KW
AD  - 4Viral Vaccine Preventable Diseases Branch, Division of Viral Diseases, National Center for Immunizations and Respiratory Diseases, U.S. Centers for DiseaseControl and Prevention, Atlanta, Georgia.
FAU - Wilkins, Kimberly
AU  - Wilkins K
AD  - 1Poxvirus and Rabies Branch, Division of High-Consequence Pathogens andPathology, National Center for Emerging and Zoonotic Infectious Diseases, U.S.Centers for Disease Control and Prevention, Atlanta, Georgia.
FAU - Monroe, Benjamin
AU  - Monroe B
AD  - 1Poxvirus and Rabies Branch, Division of High-Consequence Pathogens andPathology, National Center for Emerging and Zoonotic Infectious Diseases, U.S.Centers for Disease Control and Prevention, Atlanta, Georgia.
FAU - Metcalfe, Maureen G
AU  - Metcalfe MG
AD  - 3Infectious Diseases Pathology Branch, Division of High-Consequence Pathogens andPathology, National Center for Emerging and Zoonotic Infectious Diseases, U.S.Centers for Disease Control and Prevention, Atlanta, Georgia.
FAU - Likafi, Toutou
AU  - Likafi T
AD  - 5Kinshasa School of Public Health, Kinshasa, Democratic Republic of Congo.
FAU - Lushima, Robert Shongo
AU  - Lushima RS
AD  - 6Ministry of Health, Kinshasa, Democratic Republic of Congo.
FAU - Kabamba, Joelle
AU  - Kabamba J
AD  - 7U.S. Centers for Disease Control and Prevention, Kinshasa, Democratic Republicof Congo.
FAU - Nguete, Beatrice
AU  - Nguete B
AD  - 5Kinshasa School of Public Health, Kinshasa, Democratic Republic of Congo.
FAU - Malekani, Jean
AU  - Malekani J
AD  - 8Department of Biology, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
FAU - Pukuta, Elisabeth
AU  - Pukuta E
AD  - 9Institut National de Recherche Biomedicale, Kinshasa, Democratic Republic ofCongo.
FAU - Karhemere, Stomy
AU  - Karhemere S
AD  - 9Institut National de Recherche Biomedicale, Kinshasa, Democratic Republic ofCongo.
FAU - Muyembe Tamfum, Jean-Jacques
AU  - Muyembe Tamfum JJ
AD  - 9Institut National de Recherche Biomedicale, Kinshasa, Democratic Republic ofCongo.
FAU - Okitolonda Wemakoy, Emile
AU  - Okitolonda Wemakoy E
AD  - 5Kinshasa School of Public Health, Kinshasa, Democratic Republic of Congo.
FAU - Reynolds, Mary G
AU  - Reynolds MG
AD  - 1Poxvirus and Rabies Branch, Division of High-Consequence Pathogens andPathology, National Center for Emerging and Zoonotic Infectious Diseases, U.S.Centers for Disease Control and Prevention, Atlanta, Georgia.
FAU - Schmid, D Scott
AU  - Schmid DS
AD  - 4Viral Vaccine Preventable Diseases Branch, Division of Viral Diseases, National Center for Immunizations and Respiratory Diseases, U.S. Centers for DiseaseControl and Prevention, Atlanta, Georgia.
FAU - McCollum, Andrea M
AU  - McCollum AM
AD  - 1Poxvirus and Rabies Branch, Division of High-Consequence Pathogens andPathology, National Center for Emerging and Zoonotic Infectious Diseases, U.S.Centers for Disease Control and Prevention, Atlanta, Georgia.
LA  - eng
PT  - Journal Article
DEP - 20201207
PL  - United States
TA  - Am J Trop Med Hyg
JT  - The American journal of tropical medicine and hygiene
JID - 0370507
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Child
MH  - Child, Preschool
MH  - Coinfection/*epidemiology/*virology
MH  - Democratic Republic of the Congo/epidemiology
MH  - Epidemiological Monitoring
MH  - Female
MH  - Herpes Zoster/*epidemiology
MH  - Herpesvirus 3, Human/*genetics/isolation & purification
MH  - Humans
MH  - Infant
MH  - Male
MH  - Middle Aged
MH  - Monkeypox/*epidemiology
MH  - Monkeypox virus/*genetics/isolation & purification
MH  - Young Adult
PMC - PMC7866336
EDAT- 2020/12/09 06:00
MHDA- 2022/02/09 06:00
CRDT- 2020/12/08 08:34
PHST- 2020/06/03 00:00 [received]
PHST- 2020/09/17 00:00 [accepted]
PHST- 2020/12/09 06:00 [pubmed]
PHST- 2022/02/09 06:00 [medline]
PHST- 2020/12/08 08:34 [entrez]
AID - tpmd200589 [pii]
AID - 10.4269/ajtmh.20-0589 [doi]
PST - epublish
SO  - Am J Trop Med Hyg. 2020 Dec 7;104(2):604-611. doi: 10.4269/ajtmh.20-0589.

PMID- 33168908
OWN - NLM
STAT- MEDLINE
DCOM- 20210503
LR  - 20220804
IS  - 2045-2322 (Electronic)
IS  - 2045-2322 (Linking)
VI  - 10
IP  - 1
DP  - 2020 Nov 9
TI  - CRISPR/Cas9 as an antiviral against Orthopoxviruses using an AAV vector.
PG  - 19307
LID - 10.1038/s41598-020-76449-9 [doi]
AB  - A vaccine for smallpox is no longer administered to the general public, and thereis no proven, safe treatment specific to poxvirus infections, leaving peoplesusceptible to infections by smallpox and other zoonotic Orthopoxviruses such as monkeypox. Using vaccinia virus (VACV) as a model organism for otherOrthopoxviruses, CRISPR-Cas9 technology was used to target three essential genes that are conserved across the genus, including A17L, E3L, and I2L. Threeindividual single guide RNAs (sgRNAs) were designed per gene to facilitateredundancy in rendering the genes inactive, thereby reducing the reproduction of the virus. The efficacy of the CRISPR targets was tested by transfecting humanembryonic kidney (HEK293) cells with plasmids encoding both SaCas9 and anindividual sgRNA. This resulted in a reduction of VACV titer by up to 93.19% per target. Following the verification of CRISPR targets, safe and targeted delivery of the VACV CRISPR antivirals was tested using adeno-associated virus (AAV) as a packaging vector for both SaCas9 and sgRNA. Similarly, AAV delivery of the CRISPRantivirals resulted in a reduction of viral titer by up to 92.97% for anindividual target. Overall, we have identified highly specific CRISPR targetsthat significantly reduce VACV titer as well as an appropriate vector fordelivering these CRISPR antiviral components to host cells in vitro.
FAU - Siegrist, Cathryn M
AU  - Siegrist CM
AD  - WMD Threats and Aerosol Science, Sandia National Laboratories, Albuquerque, NM,USA. cmsiegr@sandia.gov.
AD  - University of Nebraska Medical Center, Omaha, NE, USA. cmsiegr@sandia.gov.
FAU - Kinahan, Sean M
AU  - Kinahan SM
AD  - University of Nebraska Medical Center, Omaha, NE, USA.
AD  - CWMD Research, National Strategic Research Institute, Albuquerque, NM, USA.
FAU - Settecerri, Taylor
AU  - Settecerri T
AD  - WMD Threats and Aerosol Science, Sandia National Laboratories, Albuquerque, NM,USA.
FAU - Greene, Adrienne C
AU  - Greene AC
AD  - TCR Discovery, Gritstone Oncology, Inc., Cambridge, MA, USA.
FAU - Santarpia, Joshua L
AU  - Santarpia JL
AD  - University of Nebraska Medical Center, Omaha, NE, USA.
AD  - CWMD Research, National Strategic Research Institute, Albuquerque, NM, USA.
LA  - eng
PT  - Journal Article
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20201109
PL  - England
TA  - Sci Rep
JT  - Scientific reports
JID - 101563288
RN  - 0 (Antiviral Agents)
RN  - 0 (Bacterial Proteins)
RN  - 0 (RNA, Guide)
RN  - 147336-22-9 (Green Fluorescent Proteins)
SB  - IM
MH  - Antiviral Agents
MH  - Bacterial Proteins/metabolism
MH  - *CRISPR-Cas Systems
MH  - Dependovirus/*genetics
MH  - Gene Editing/methods
MH  - Genetic Vectors
MH  - Green Fluorescent Proteins/metabolism
MH  - HEK293 Cells
MH  - Humans
MH  - Monkeypox/*therapy/virology
MH  - Orthopoxvirus/*metabolism
MH  - Plasmids/metabolism
MH  - RNA, Guide/*metabolism
MH  - Smallpox/*therapy/virology
MH  - Transfection
MH  - Vaccinia virus
PMC - PMC7653928
EDAT- 2020/11/11 06:00
MHDA- 2021/05/04 06:00
CRDT- 2020/11/10 05:42
PHST- 2020/08/27 00:00 [received]
PHST- 2020/10/26 00:00 [accepted]
PHST- 2020/11/10 05:42 [entrez]
PHST- 2020/11/11 06:00 [pubmed]
PHST- 2021/05/04 06:00 [medline]
AID - 10.1038/s41598-020-76449-9 [doi]
AID - 10.1038/s41598-020-76449-9 [pii]
PST - epublish
SO  - Sci Rep. 2020 Nov 9;10(1):19307. doi: 10.1038/s41598-020-76449-9.

PMID- 33167496
OWN - NLM
STAT- MEDLINE
DCOM- 20210305
LR  - 20210305
IS  - 1999-4915 (Electronic)
IS  - 1999-4915 (Linking)
VI  - 12
IP  - 11
DP  - 2020 Nov 5
TI  - Monkeypox Virus in Nigeria: Infection Biology, Epidemiology, and Evolution.
LID - E1257 [pii]
LID - 10.3390/v12111257 [doi]
AB  - Monkeypox is a zoonotic disease caused by monkeypox virus (MPXV), which is amember of orthopoxvirus genus. The reemergence of MPXV in 2017 (at Bayelsa state)after 39 years of no reported case in Nigeria, and the export of travelers'monkeypox (MPX) from Nigeria to other parts of the world, in 2018 and 2019,respectively, have raised concern that MPXV may have emerged to occupy theecological and immunological niche vacated by smallpox virus. This review X-rays the current state of knowledge pertaining the infection biology, epidemiology,and evolution of MPXV in Nigeria and worldwide, especially with regard to thehuman, cellular, and viral factors that modulate the virus transmission dynamics,infection, and its maintenance in nature. This paper also elucidates the role of recombination, gene loss and gene gain in MPXV evolution, chronicles the role of signaling in MPXV infection, and reviews the current therapeutic optionsavailable for the treatment and prevention of MPX. Additionally, genome-widephylogenetic analysis was undertaken, and we show that MPXV isolates from recent 2017 outbreak in Nigeria were monophyletic with the isolate exported to Israelfrom Nigeria but do not share the most recent common ancestor with isolatesobtained from earlier outbreaks, in 1971 and 1978, respectively. Finally, thereview highlighted gaps in knowledge particularly the non-identification of adefinitive reservoir host animal for MPXV and proposed future research endeavors to address the unresolved questions.
FAU - Alakunle, Emmanuel
AU  - Alakunle E
AUID- ORCID: 0000-0003-1960-6152
AD  - Department of Natural and Environmental Sciences, Biomedical ScienceConcentration, School of Arts and Sciences, American University of Nigeria, 98Lamido Zubairu Way, PMB 2250 Yola, Nigeria.
FAU - Moens, Ugo
AU  - Moens U
AD  - Molecular Inflammation Research Group, Institute of Medical Biology, University iTromso (UIT)-The Arctic University of Norway, N-9037 Tromso, Norway.
FAU - Nchinda, Godwin
AU  - Nchinda G
AD  - Laboratory of Vaccinology and Immunology, The Chantal Biya InternationalReference Center for Research on the Prevention and Management HIV/AIDS (CIRCB), P.O Box 3077 Yaounde-Messa, Cameroon.
AD  - Department of Pharmaceutical Microbiology & Biotechnology, Faculty ofPharmaceutical Sciences, Nnamdi Azikiwe University, P.O Box 420110 Awka, Nigeria.
FAU - Okeke, Malachy Ifeanyi
AU  - Okeke MI
AUID- ORCID: 0000-0002-7137-9551
AD  - Department of Natural and Environmental Sciences, Biomedical ScienceConcentration, School of Arts and Sciences, American University of Nigeria, 98Lamido Zubairu Way, PMB 2250 Yola, Nigeria.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Review
DEP - 20201105
PL  - Switzerland
TA  - Viruses
JT  - Viruses
JID - 101509722
RN  - 0 (DNA, Viral)
SB  - IM
MH  - Animals
MH  - DNA, Viral/genetics
MH  - *Evolution, Molecular
MH  - Humans
MH  - Mice
MH  - Monkeypox/*epidemiology/transmission
MH  - Monkeypox virus/*genetics/pathogenicity
MH  - Nigeria/epidemiology
MH  - Phylogeny
MH  - Recombination, Genetic
MH  - Viral Zoonoses/*epidemiology/transmission
PMC - PMC7694534
OTO - NOTNLM
OT  - *Nigeria
OT  - *Poxviridae
OT  - *antiviral drugs
OT  - *epidemiology
OT  - *gene loss
OT  - *monkeypox viruses
OT  - *orthopoxviruses
OT  - *phylogeny
OT  - *recombination
OT  - *signaling
EDAT- 2020/11/11 06:00
MHDA- 2021/03/06 06:00
CRDT- 2020/11/10 01:05
PHST- 2020/09/30 00:00 [received]
PHST- 2020/10/22 00:00 [revised]
PHST- 2020/10/30 00:00 [accepted]
PHST- 2020/11/10 01:05 [entrez]
PHST- 2020/11/11 06:00 [pubmed]
PHST- 2021/03/06 06:00 [medline]
AID - v12111257 [pii]
AID - 10.3390/v12111257 [doi]
PST - epublish
SO  - Viruses. 2020 Nov 5;12(11). pii: v12111257. doi: 10.3390/v12111257.

PMID- 33077299
OWN - NLM
STAT- MEDLINE
DCOM- 20210527
LR  - 20210527
IS  - 1873-2518 (Electronic)
IS  - 0264-410X (Linking)
VI  - 39
IP  - 22
DP  - 2021 May 21
TI  - The Brighton Collaboration standardized template for collection of keyinformation for risk/benefit assessment of a Modified Vaccinia Ankara (MVA)vaccine platform.
PG  - 3067-3080
LID - S0264-410X(20)31091-4 [pii]
LID - 10.1016/j.vaccine.2020.08.050 [doi]
AB  - The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) wasformed to evaluate the safety and characteristics of live, recombinant viralvector vaccines. The Modified Vaccinia Ankara (MVA) vector system is beingexplored as a platform for development of multiple vaccines. This paper reviewsthe molecular and biological features specifically of the MVA-BN vector system,followed by a template with details on the safety and characteristics of anMVA-BN based vaccine against Zaire ebolavirus and other filovirus strains. TheMVA-BN-Filo vaccine is based on a live, highly attenuated poxviral vectorincapable of replicating in human cells and encodes glycoproteins of Ebola virus Zaire, Sudan virus and Marburg virus and the nucleoprotein of the Thai Forestvirus. This vaccine has been approved in the European Union in July 2020 as part of a heterologous Ebola vaccination regimen. The MVA-BN vector is attenuatedfollowing over 500 serial passages in eggs, showing restricted host tropism andincompetence to replicate in human cells. MVA has six major deletions and othermutations of genes outside these deletions, which all contribute to thereplication deficiency in human and other mammalian cells. Attenuation of MVA-BN was demonstrated by safe administration in immunocompromised mice and non-humanprimates. In multiple clinical trials with the MVA-BN backbone, more than 7800participants have been vaccinated, demonstrating a safety profile consistent withother licensed, modern vaccines. MVA-BN has been approved as smallpox vaccine in Europe and Canada in 2013, and as smallpox and monkeypox vaccine in the US in2019. No signal for inflammatory cardiac disorders was identified throughout the MVA-BN development program. This is in sharp contrast to the older, replicatingvaccinia smallpox vaccines, which have a known risk for myocarditis and/orpericarditis in up to 1 in 200 vaccinees. MVA-BN-Filo as part of a heterologousEbola vaccination regimen (Ad26.ZEBOV/MVA-BN-Filo) has undergone clinical testingincluding Phase III in West Africa and is currently in use in large scalevaccination studies in Central African countries. This paper provides acomprehensive picture of the MVA-BN vector, which has reached regulatoryapprovals, both as MVA-BN backbone for smallpox/monkeypox, as well as for theMVA-BN-Filo construct as part of an Ebola vaccination regimen, and therefore aimsto provide solutions to prevent disease from high-consequence human pathogens.
CI  - Copyright (c) 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.
FAU - Volkmann, Ariane
AU  - Volkmann A
AD  - Bavarian Nordic, Germany.
FAU - Williamson, Anna-Lise
AU  - Williamson AL
AD  - Institute of Infectious Disease and Molecular Medicine at the University of Cape Town, South Africa.
FAU - Weidenthaler, Heinz
AU  - Weidenthaler H
AD  - Bavarian Nordic, Germany.
FAU - Meyer, Thomas P H
AU  - Meyer TPH
AD  - Bavarian Nordic, Germany.
FAU - Robertson, James S
AU  - Robertson JS
AD  - Independent Adviser, United Kingdom.
FAU - Excler, Jean-Louis
AU  - Excler JL
AD  - International Vaccine Institute, Seoul, Republic of Korea.
FAU - Condit, Richard C
AU  - Condit RC
AD  - Department of Molecular Genetics and Microbiology, University of Florida,Gainesville, FL 32610, USA.
FAU - Evans, Eric
AU  - Evans E
AD  - Brighton Collaboration, a Program of the Task Force for Global Health, Decatur,GA, USA.
FAU - Smith, Emily R
AU  - Smith ER
AD  - Brighton Collaboration, a Program of the Task Force for Global Health, Decatur,GA, USA. Electronic address: bc-coordinator@taskforce.org.
FAU - Kim, Denny
AU  - Kim D
AD  - Janssen Pharmaceuticals, Titusville, NJ, USA.
FAU - Chen, Robert T
AU  - Chen RT
AD  - Brighton Collaboration, a Program of the Task Force for Global Health, Decatur,GA, USA.
CN  - Brighton Collaboration Viral Vector Vaccines Safety Working Group V3SWG
LA  - eng
GR  - HHSN272201200018C/AI/NIAID NIH HHS/United States
GR  - N01AI30016/AI/NIAID NIH HHS/United States
GR  - N01AI40072/AI/NIAID NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PT  - Review
DEP - 20201017
PL  - Netherlands
TA  - Vaccine
JT  - Vaccine
JID - 8406899
RN  - 0 (Ebola Vaccines)
SB  - IM
MH  - Africa, Western
MH  - Animals
MH  - Canada
MH  - *Ebola Vaccines
MH  - Europe
MH  - Mice
MH  - *Vaccinia
MH  - Vaccinia virus/genetics
PMC - PMC7568176
OTO - NOTNLM
OT  - *Brighton Collaboration
OT  - *Ebola vaccine
OT  - *Modified Vaccinia Ankara
OT  - *Risk/benefit assessment
OT  - *Smallpox vaccine
OT  - *Vaccine safety
OT  - *Vaccines
OT  - *Vaccinia
OT  - *Viral vector
COIS- Declaration of Competing Interest The authors declare the following financialinterests/personal relationships which may be considered as potential competinginterests: The authors Ariane Volkmann, Heinz Weidenthaler, and Thomas Meyer are employees of Bavarian Nordic.
EDAT- 2020/10/21 06:00
MHDA- 2021/05/28 06:00
CRDT- 2020/10/20 05:44
PHST- 2020/08/13 00:00 [received]
PHST- 2020/08/18 00:00 [accepted]
PHST- 2020/10/21 06:00 [pubmed]
PHST- 2021/05/28 06:00 [medline]
PHST- 2020/10/20 05:44 [entrez]
AID - S0264-410X(20)31091-4 [pii]
AID - 10.1016/j.vaccine.2020.08.050 [doi]
PST - ppublish
SO  - Vaccine. 2021 May 21;39(22):3067-3080. doi: 10.1016/j.vaccine.2020.08.050. Epub2020 Oct 17.

PMID- 33012864
OWN - NLM
STAT- MEDLINE
DCOM- 20210804
LR  - 20210804
IS  - 1564-0604 (Electronic)
IS  - 0042-9686 (Linking)
VI  - 98
IP  - 9
DP  - 2020 Sep 1
TI  - Modelling human-to-human transmission of monkeypox.
PG  - 638-640
LID - 10.2471/BLT.19.242347 [doi]
FAU - Grant, Rebecca
AU  - Grant R
AD  - Institut Pasteur, Emerging Diseases Epidemiology Unit, 25-28 rue du Dr. Roux,75015 Paris, France.
FAU - Nguyen, Liem-Binh Luong
AU  - Nguyen LL
AD  - Institut Pasteur, Emerging Diseases Epidemiology Unit, 25-28 rue du Dr. Roux,75015 Paris, France.
FAU - Breban, Romulus
AU  - Breban R
AD  - Institut Pasteur, Emerging Diseases Epidemiology Unit, 25-28 rue du Dr. Roux,75015 Paris, France.
LA  - eng
PT  - Journal Article
DEP - 20200708
PL  - Switzerland
TA  - Bull World Health Organ
JT  - Bulletin of the World Health Organization
JID - 7507052
SB  - IM
MH  - Humans
MH  - *Models, Theoretical
MH  - Monkeypox/*epidemiology/immunology/*transmission
MH  - Smallpox/epidemiology/immunology
PMC - PMC7463189
EDAT- 2020/10/06 06:00
MHDA- 2021/08/05 06:00
CRDT- 2020/10/05 06:12
PHST- 2019/08/05 00:00 [received]
PHST- 2020/03/18 00:00 [revised]
PHST- 2020/05/12 00:00 [accepted]
PHST- 2020/10/05 06:12 [entrez]
PHST- 2020/10/06 06:00 [pubmed]
PHST- 2021/08/05 06:00 [medline]
AID - 10.2471/BLT.19.242347 [doi]
AID - BLT.19.242347 [pii]
PST - ppublish
SO  - Bull World Health Organ. 2020 Sep 1;98(9):638-640. doi: 10.2471/BLT.19.242347.Epub 2020 Jul 8.

PMID- 32986741
OWN - NLM
STAT- MEDLINE
DCOM- 20201118
LR  - 20201118
IS  - 1932-6203 (Electronic)
IS  - 1932-6203 (Linking)
VI  - 15
IP  - 9
DP  - 2020
TI  - Attitudes, practices, and zoonoses awareness of community members involved in thebushmeat trade near Murchison Falls National Park, northern Uganda.
PG  - e0239599
LID - 10.1371/journal.pone.0239599 [doi]
AB  - The harvest of bushmeat is widespread in the tropics and sub-tropics. Often inthese communities, there is a dependence on bushmeat for both food security andbasic income. Despite the importance of bushmeat for households worldwide, thepractice raises concern for transmission of zoonotic pathogens through hunting,food preparation, and consumption. In Uganda, harvest of wildlife is illegal, butbushmeat hunting, is commonplace. We interviewed 292 women who cook for theirhouseholds and 180 self-identified hunters from 21 villages bordering MurchisonFalls National Park in Uganda to gain insights into bushmeat preferences,opportunity for zoonotic pathogen transmission, and awareness of commonwildlife-associated zoonoses. Both hunters and women who cook considered primatesto be the most likely wildlife species to carry diseases humans can catch. Among common zoonotic pathogens, the greatest proportions of women who cook and huntersbelieved that pathogens causing stomach ache or diarrhea and monkeypox can betransmitted by wildlife. Neither women who cook nor hunters report beingfrequently injury during cooking, butchering, or hunting, and few report takingprecautions while handling bushmeat. The majority of women who cook believe that hunters and dealers never or rarely disguise primate meat as another kind of meatin market, while the majority of hunters report that they usually disguiseprimate meat as another kind of meat. These data play a crucial role in ourunderstanding of potential for exposure to and infection with zoonotic pathogens in the bushmeat trade. Expanding our knowledge of awareness, perceptions andrisks enables us to identify opportunities to mitigate infections and injury riskand promote safe handling practices.
FAU - Dell, BreeAnna M
AU  - Dell BM
AUID- ORCID: 0000-0002-4162-2979
AD  - Department of Biomedical & Diagnostic Sciences, University of Tennessee,Knoxville, Tennessee, United States of America.
FAU - Souza, Marcy J
AU  - Souza MJ
AD  - Department of Biomedical & Diagnostic Sciences, University of Tennessee,Knoxville, Tennessee, United States of America.
FAU - Willcox, Adam S
AU  - Willcox AS
AD  - Department of Forestry, Wildlife and Fisheries, University of Tennessee,Knoxville, Tennessee, United States of America.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20200928
PL  - United States
TA  - PLoS One
JT  - PloS one
JID - 101285081
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Animals
MH  - Animals, Wild
MH  - *Attitude to Health
MH  - *Awareness
MH  - Cooking
MH  - Female
MH  - Food Supply
MH  - Foodborne Diseases/epidemiology/*microbiology
MH  - Humans
MH  - Income
MH  - Male
MH  - Meat/*microbiology
MH  - Middle Aged
MH  - Parks, Recreational
MH  - Risk Factors
MH  - Surveys and Questionnaires
MH  - Uganda/epidemiology
MH  - Young Adult
MH  - Zoonoses/epidemiology/microbiology/*psychology/transmission
PMC - PMC7521682
COIS- The authors have declared that no competing interests exist.
EDAT- 2020/09/29 06:00
MHDA- 2020/11/20 06:00
CRDT- 2020/09/28 17:12
PHST- 2020/06/18 00:00 [received]
PHST- 2020/09/10 00:00 [accepted]
PHST- 2020/09/28 17:12 [entrez]
PHST- 2020/09/29 06:00 [pubmed]
PHST- 2020/11/20 06:00 [medline]
AID - 10.1371/journal.pone.0239599 [doi]
AID - PONE-D-20-18762 [pii]
PST - epublish
SO  - PLoS One. 2020 Sep 28;15(9):e0239599. doi: 10.1371/journal.pone.0239599.eCollection 2020.

PMID- 32979762
OWN - NLM
STAT- MEDLINE
DCOM- 20210309
LR  - 20210309
IS  - 1090-2163 (Electronic)
IS  - 0008-8749 (Linking)
VI  - 357
DP  - 2020 Nov
TI  - Human and murine memory gammadelta T cells: Evidence for acquired immune memoryin bacterial and viral infections and autoimmunity.
PG  - 104217
LID - S0008-8749(20)30377-4 [pii]
LID - 10.1016/j.cellimm.2020.104217 [doi]
AB  - gammadelta T cells are unconventional lymphocytes that could play a role inbridging the innate and adaptive immune system. Upon initial exposure to anantigen, some activated T cells become memory T cells that could be reactivatedupon secondary immune challenge. Recently, subsets of gammadelta T cells with arestricted antigen repertoire and long-term persistence have been observed after clearance of viral and bacterial infections. These gammadelta T cells possess thehallmark ability of memory T cells to respond more strongly and proliferate to a higher extent upon secondary infection. Murine and primate models of Listeriamonocytogenes and cytomegalovirus infection display these memory hallmarks anddemonstrate gammadelta T cell memory responses. In addition, human and non-human primate infections with Mycobacterium tuberculosis, as well as non-human primate infection with monkeypox and studies on patients suffering from autoimmunedisease (rheumatoid arthritis and multiple sclerosis) reveal memory-likeresponses corresponding with disease. Murine models of psoriatic disease(imiquimod) and parasite infections (malaria) exhibited shifts to memoryphenotypes with repeated immune challenge. These studies provide strong supportfor the formation of immune memory in gammadelta T cells, and memory gammadelta Tcells may have a widespread role in protective immunity and autoimmunity.
CI  - Copyright (c) 2020. Published by Elsevier Inc.
FAU - Comeau, Kevin
AU  - Comeau K
AD  - Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish GeneralHospital, McGill University, 3755 Cote-Ste-Catherine Rd., Montreal, Quebec H3T1E2, Canada.
FAU - Paradis, Pierre
AU  - Paradis P
AD  - Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish GeneralHospital, McGill University, 3755 Cote-Ste-Catherine Rd., Montreal, Quebec H3T1E2, Canada.
FAU - Schiffrin, Ernesto L
AU  - Schiffrin EL
AD  - Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish GeneralHospital, McGill University, 3755 Cote-Ste-Catherine Rd., Montreal, Quebec H3T1E2, Canada; Department of Medicine, Sir Mortimer B. Davis-Jewish GeneralHospital, McGill University, 3755 Cote-Ste-Catherine Rd., Montreal, Quebec H3T1E2, Canada. Electronic address: ernesto.schiffrin@mcgill.ca.
LA  - eng
GR  - CIHR/Canada
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Review
DEP - 20200916
PL  - Netherlands
TA  - Cell Immunol
JT  - Cellular immunology
JID - 1246405
RN  - 0 (Receptors, Antigen, T-Cell, gamma-delta)
SB  - IM
MH  - Adaptive Immunity/*immunology
MH  - Animals
MH  - Autoimmunity/immunology
MH  - Bacterial Infections/immunology
MH  - Humans
MH  - Immunity, Innate/immunology
MH  - Immunologic Memory/*immunology
MH  - Lymphocyte Activation/immunology
MH  - Mice
MH  - Receptors, Antigen, T-Cell, gamma-delta/*immunology/metabolism
MH  - T-Lymphocyte Subsets/immunology
MH  - T-Lymphocytes/immunology
MH  - Virus Diseases/immunology
OTO - NOTNLM
OT  - *Adaptive immunity
OT  - *Autoimmunity
OT  - *Gamma delta T cell
OT  - *Immune memory
OT  - *Infections
EDAT- 2020/09/27 06:00
MHDA- 2021/03/10 06:00
CRDT- 2020/09/26 20:15
PHST- 2020/07/16 00:00 [received]
PHST- 2020/08/27 00:00 [revised]
PHST- 2020/09/11 00:00 [accepted]
PHST- 2020/09/27 06:00 [pubmed]
PHST- 2021/03/10 06:00 [medline]
PHST- 2020/09/26 20:15 [entrez]
AID - S0008-8749(20)30377-4 [pii]
AID - 10.1016/j.cellimm.2020.104217 [doi]
PST - ppublish
SO  - Cell Immunol. 2020 Nov;357:104217. doi: 10.1016/j.cellimm.2020.104217. Epub 2020 Sep 16.

PMID- 32895964
OWN - NLM
STAT- MEDLINE
DCOM- 20210225
LR  - 20210225
IS  - 1440-0960 (Electronic)
IS  - 0004-8380 (Linking)
VI  - 62
IP  - 1
DP  - 2021 Feb
TI  - Cutaneous manifestations of viral outbreaks.
PG  - 27-36
LID - 10.1111/ajd.13421 [doi]
AB  - As the world tries to grapple with the COVID-19 pandemic, dermatologists are leftin a lurch as there is a lacuna in dermatologic literature as well as trainingregarding the cutaneous manifestations of varied viral agents capable of causing epidemics/pandemics or the potential to be bio-weaponised. Such outbreaks havethe potential to become a pandemic given this age of globalisation. The quote by George Santayana stands true 'Those who cannot remember the past are condemned torepeat it'. Thus, this article lends a perspective to the recent viral outbreaks and is aimed at summarising these agents and their clinical features to serve as a quick reference for dermatologists.
CI  - (c) 2020 The Australasian College of Dermatologists.
FAU - Bothra, Atul
AU  - Bothra A
AUID- ORCID: https://orcid.org/0000-0002-7331-273X
AD  - Department of Dermatology, Gauhati Medical College & Hospital, Guwahati, India.
FAU - Maheswari, Anshu
AU  - Maheswari A
AUID- ORCID: https://orcid.org/0000-0001-7146-4521
AD  - Consultant Dermatologist, Private Practice, New Delhi, India.
FAU - Singh, Mehak
AU  - Singh M
AD  - Department of Dermatology, JK Medical College & LN Hospital, Bhopal, India.
FAU - Pawar, Manoj
AU  - Pawar M
AUID- ORCID: https://orcid.org/0000-0001-6076-4908
AD  - Department of Dermatology, MVP's Dr.V.P Medical College & Hospital & Researchcenter, Nashik, India.
FAU - Jodhani, Kirti
AU  - Jodhani K
AD  - Department of Dermatology, Gauhati Medical College & Hospital, Guwahati, India.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20200908
PL  - Australia
TA  - Australas J Dermatol
JT  - The Australasian journal of dermatology
JID - 0135232
SB  - IM
MH  - Biopsy
MH  - COVID-19/*complications/diagnosis/pathology
MH  - *COVID-19 Testing
MH  - Dermatology/standards
MH  - Diagnosis, Differential
MH  - Disease Management
MH  - Early Diagnosis
MH  - Humans
MH  - SARS-CoV-2/*isolation & purification
MH  - Skin Diseases, Viral/diagnosis/*pathology
OTO - NOTNLM
OT  - COVID-19/SARS-CoV-2
OT  - Ebola
OT  - Lassa fever
OT  - bioweapon
OT  - chikungunya
OT  - dengue
OT  - monkeypox
OT  - oropouche fever
OT  - outbreaks
OT  - yellow fever
OT  - zika
EDAT- 2020/09/09 06:00
MHDA- 2021/02/26 06:00
CRDT- 2020/09/08 05:26
PHST- 2020/05/02 00:00 [received]
PHST- 2020/07/02 00:00 [revised]
PHST- 2020/07/03 00:00 [accepted]
PHST- 2020/09/09 06:00 [pubmed]
PHST- 2021/02/26 06:00 [medline]
PHST- 2020/09/08 05:26 [entrez]
AID - 10.1111/ajd.13421 [doi]
PST - ppublish
SO  - Australas J Dermatol. 2021 Feb;62(1):27-36. doi: 10.1111/ajd.13421. Epub 2020 Sep8.

PMID- 32882158
OWN - NLM
STAT- MEDLINE
DCOM- 20210927
LR  - 20220711
IS  - 1744-8336 (Electronic)
IS  - 1478-7210 (Linking)
VI  - 19
IP  - 3
DP  - 2021 Mar
TI  - An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirusapplications.
PG  - 331-344
LID - 10.1080/14787210.2020.1819791 [doi]
AB  - INTRODUCTION: Tecovirimat (TPOXX(R); ST-246) was approved for the treatment ofsymptomatic smallpox by the USFDA in July of 2018 and has been stockpiled by the US government for use in a smallpox outbreak. While there has not been a reportedcase of smallpox since 1978 it is still considered a serious bioterrorism threat.AREAS COVERED: A brief history of smallpox from its proposed origins as a humandisease through its eradication in the late 20th century is presented. Thecurrent smallpox threat and the current public health response plans aredescribed. The discovery, and development of tecovirimat through NDA submissionand subsequent approval for treatment of smallpox are discussed. Google Scholarand PubMed were searched over all available dates for relevant publications.EXPERT OPINION: Approval of tecovirimat to treat smallpox represents an importantmilestone in biosecurity preparedness. Incorporating tecovirimat into the CDCsmallpox response plan, development of pediatric liquid and intravenousformulations, and approval for post-exposure prophylaxis would provide additionalhealth security benefit.Tecovirimat shows broad efficacy against orthopoxviruses in vitro and in vivo and could be developed for use against emergingorthopoxvirus diseases such as monkeypox, vaccination-associated adverse events, and side effects of vaccinia oncolytic virus therapy.
FAU - Russo, Andrew T
AU  - Russo AT
AD  - Poxvirus Research Group, SIGA Technologies, Inc, Corvallis, OR, USA.
FAU - Grosenbach, Douglas W
AU  - Grosenbach DW
AD  - Poxvirus Research Group, SIGA Technologies, Inc, Corvallis, OR, USA.
FAU - Chinsangaram, Jarasvech
AU  - Chinsangaram J
AD  - Program Management, SIGA Technologies, Inc, Corvallis, OR, USA.
FAU - Honeychurch, Kady M
AU  - Honeychurch KM
AD  - Program Management, SIGA Technologies, Inc, Corvallis, OR, USA.
FAU - Long, Paul G
AU  - Long PG
AD  - Regulatory Affairs, SIGA Technologies, Inc, Corvallis, OR, USA.
FAU - Lovejoy, Candace
AU  - Lovejoy C
AD  - Program Management, SIGA Technologies, Inc, Corvallis, OR, USA.
FAU - Maiti, Biswajit
AU  - Maiti B
AD  - Drug Metabolism & Pharmacokinetics, SIGA Technologies, Inc, Corvallis, OR, USA.
FAU - Meara, Ingrid
AU  - Meara I
AD  - Clinical Research, SIGA Technologies, Inc, Corvallis, OR, USA.
FAU - Hruby, Dennis E
AU  - Hruby DE
AD  - Chief Scientific Officer, SIGA Technologies, Inc, Corvallis, OR, USA.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20200915
PL  - England
TA  - Expert Rev Anti Infect Ther
JT  - Expert review of anti-infective therapy
JID - 101181284
RN  - 0 (Antiviral Agents)
RN  - 0 (Benzamides)
RN  - 0 (Isoindoles)
RN  - F925RR824R (Tecovirimat)
SB  - IM
MH  - Antiviral Agents/*administration & dosage/pharmacology
MH  - Benzamides/*administration & dosage/pharmacology
MH  - Bioterrorism/prevention & control
MH  - Humans
MH  - Isoindoles/*administration & dosage/pharmacology
MH  - Orthopoxvirus/drug effects/isolation & purification
MH  - Poxviridae Infections/drug therapy/virology
MH  - Smallpox/*drug therapy
OTO - NOTNLM
OT  - *Animal Rule
OT  - *ST-246
OT  - *Smallpox
OT  - *biodefense
OT  - *health security
OT  - *monkeypox
OT  - *tecovirimat
OT  - *vaccinia
OT  - *variola
EDAT- 2020/09/04 06:00
MHDA- 2021/09/28 06:00
CRDT- 2020/09/04 06:00
PHST- 2020/09/04 06:00 [pubmed]
PHST- 2021/09/28 06:00 [medline]
PHST- 2020/09/04 06:00 [entrez]
AID - 10.1080/14787210.2020.1819791 [doi]
PST - ppublish
SO  - Expert Rev Anti Infect Ther. 2021 Mar;19(3):331-344. doi:10.1080/14787210.2020.1819791. Epub 2020 Sep 15.

PMID- 32880628
OWN - NLM
STAT- MEDLINE
LR  - 20220716
IS  - 1537-6613 (Electronic)
IS  - 0022-1899 (Linking)
VI  - 225
IP  - 8
DP  - 2022 Apr 19
TI  - Exportation of Monkeypox Virus From the African Continent.
PG  - 1367-1376
LID - 10.1093/infdis/jiaa559 [doi]
AB  - BACKGROUND: The largest West African monkeypox outbreak began September 2017, in Nigeria. Four individuals traveling from Nigeria to the United Kingdom (n = 2),Israel (n = 1), and Singapore (n = 1) became the first human monkeypox casesexported from Africa, and a related nosocomial transmission event in the UnitedKingdom became the first confirmed human-to-human monkeypox transmission eventoutside of Africa. METHODS: Epidemiological and molecular data for exported andNigerian cases were analyzed jointly to better understand the exportations in thetemporal and geographic context of the outbreak. RESULTS: Isolates from alltravelers and a Bayelsa case shared a most recent common ancestor and traveled toBayelsa, Delta, or Rivers states. Genetic variation for this cluster was lowerthan would be expected from a random sampling of genomes from this outbreak, but data did not support direct links between travelers. CONCLUSIONS: Monophyly ofexportation cases and the Bayelsa sample, along with the intermediate levels ofgenetic variation, suggest a small pool of related isolates is the likely source for the exported infections. This may be the result of the level of geneticvariation present in monkeypox isolates circulating within the contiguous region of Bayelsa, Delta, and Rivers states, or another more restricted, yetunidentified source pool.
CI  - (c) The Author(s) 2020. Published by Oxford University Press for the InfectiousDiseases Society of America.
FAU - Mauldin, Matthew R
AU  - Mauldin MR
AUID- ORCID: 0000-0002-3807-2339
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
FAU - McCollum, Andrea M
AU  - McCollum AM
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
FAU - Nakazawa, Yoshinori J
AU  - Nakazawa YJ
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
FAU - Mandra, Anna
AU  - Mandra A
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
AD  - Epidemic Intelligence Service, Centers for Disease Control and Prevention,Atlanta, Georgia, USA.
FAU - Whitehouse, Erin R
AU  - Whitehouse ER
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
AD  - Epidemic Intelligence Service, Centers for Disease Control and Prevention,Atlanta, Georgia, USA.
FAU - Davidson, Whitni
AU  - Davidson W
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
FAU - Zhao, Hui
AU  - Zhao H
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
FAU - Gao, Jinxin
AU  - Gao J
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
FAU - Li, Yu
AU  - Li Y
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
FAU - Doty, Jeffrey
AU  - Doty J
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
FAU - Yinka-Ogunleye, Adesola
AU  - Yinka-Ogunleye A
AD  - Nigerian Centre for Disease Control, Abuja, Nigeria.
FAU - Akinpelu, Afolabi
AU  - Akinpelu A
AD  - Nigerian Centre for Disease Control, Abuja, Nigeria.
FAU - Aruna, Olusola
AU  - Aruna O
AD  - International Health Regulations Strengthening Project, Global Public Health,Public Health England, London, United Kingdom.
FAU - Naidoo, Dhamari
AU  - Naidoo D
AD  - World Health Organization Country Office, Abuja, Nigeria.
FAU - Lewandowski, Kuiama
AU  - Lewandowski K
AD  - Public Health England, London, United Kingdom.
FAU - Afrough, Babak
AU  - Afrough B
AD  - Public Health England, London, United Kingdom.
FAU - Graham, Victoria
AU  - Graham V
AD  - Public Health England, London, United Kingdom.
FAU - Aarons, Emma
AU  - Aarons E
AD  - Public Health England, London, United Kingdom.
FAU - Hewson, Roger
AU  - Hewson R
AD  - Public Health England, London, United Kingdom.
FAU - Vipond, Richard
AU  - Vipond R
AD  - Public Health England, London, United Kingdom.
FAU - Dunning, Jake
AU  - Dunning J
AD  - Public Health England, London, United Kingdom.
FAU - Chand, Meera
AU  - Chand M
AD  - Public Health England, London, United Kingdom.
FAU - Brown, Colin
AU  - Brown C
AD  - Public Health England, London, United Kingdom.
FAU - Cohen-Gihon, Inbar
AU  - Cohen-Gihon I
AD  - Department of Biochemistry and Molecular Biology, Israel Institute for BiologicalResearch, Ness-Ziona, Israel.
FAU - Erez, Noam
AU  - Erez N
AD  - Department of Infectious Diseases, Israel Institute for Biological Research,Ness-Ziona, Israel.
FAU - Shifman, Ohad
AU  - Shifman O
AD  - Department of Biochemistry and Molecular Biology, Israel Institute for BiologicalResearch, Ness-Ziona, Israel.
FAU - Israeli, Ofir
AU  - Israeli O
AD  - Department of Biochemistry and Molecular Biology, Israel Institute for BiologicalResearch, Ness-Ziona, Israel.
FAU - Sharon, Melamed
AU  - Sharon M
AD  - Department of Infectious Diseases, Israel Institute for Biological Research,Ness-Ziona, Israel.
FAU - Schwartz, Eli
AU  - Schwartz E
AD  - Institute of Tropical Medicine, Chaim Sheba Medical Center, Tel Hashomer, Israel.
AD  - Faculty of Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv,Israel.
FAU - Beth-Din, Adi
AU  - Beth-Din A
AD  - Department of Biochemistry and Molecular Biology, Israel Institute for BiologicalResearch, Ness-Ziona, Israel.
FAU - Zvi, Anat
AU  - Zvi A
AD  - Department of Biochemistry and Molecular Biology, Israel Institute for BiologicalResearch, Ness-Ziona, Israel.
FAU - Mak, Tze Minn
AU  - Mak TM
AD  - National Public Health Laboratory, National Centre for Infectious Diseases,Singapore.
FAU - Ng, Yi Kai
AU  - Ng YK
AD  - National Public Health Laboratory, National Centre for Infectious Diseases,Singapore.
FAU - Cui, Lin
AU  - Cui L
AD  - National Public Health Laboratory, National Centre for Infectious Diseases,Singapore.
FAU - Lin, Raymond T P
AU  - Lin RTP
AD  - National Public Health Laboratory, National Centre for Infectious Diseases,Singapore.
FAU - Olson, Victoria A
AU  - Olson VA
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
FAU - Brooks, Tim
AU  - Brooks T
AD  - Public Health England, London, United Kingdom.
FAU - Paran, Nir
AU  - Paran N
AD  - Department of Infectious Diseases, Israel Institute for Biological Research,Ness-Ziona, Israel.
FAU - Ihekweazu, Chikwe
AU  - Ihekweazu C
AD  - Nigerian Centre for Disease Control, Abuja, Nigeria.
FAU - Reynolds, Mary G
AU  - Reynolds MG
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
LA  - eng
GR  - 001/WHO_/World Health Organization/International
GR  - CDC's Global Disease Detection Program
PT  - Journal Article
PT  - Research Support, U.S. Gov't, P.H.S.
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - J Infect Dis
JT  - The Journal of infectious diseases
JID - 0413675
SB  - IM
MH  - Animals
MH  - Disease Outbreaks
MH  - Humans
MH  - *Monkeypox/epidemiology
MH  - *Monkeypox virus/genetics
MH  - Nigeria/epidemiology
MH  - United Kingdom
PMC - PMC9016419
OTO - NOTNLM
OT  - *border health
OT  - *exportation
OT  - *haplotype networks
OT  - *monkeypox virus
OT  - *travel epidemiology
OT  - *viral genomes
EDAT- 2020/09/04 06:00
MHDA- 2022/04/21 06:00
CRDT- 2020/09/04 06:00
PHST- 2020/06/01 00:00 [received]
PHST- 2020/08/28 00:00 [accepted]
PHST- 2020/09/04 06:00 [pubmed]
PHST- 2022/04/21 06:00 [medline]
PHST- 2020/09/04 06:00 [entrez]
AID - 5901023 [pii]
AID - 10.1093/infdis/jiaa559 [doi]
PST - ppublish
SO  - J Infect Dis. 2022 Apr 19;225(8):1367-1376. doi: 10.1093/infdis/jiaa559.

PMID- 32874456
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20210420
IS  - 2036-7430 (Print)
IS  - 2036-7430 (Linking)
VI  - 12
IP  - Suppl 1
DP  - 2020 Jul 7
TI  - An adult patient with suspected of monkeypox infection differential diagnosed to chickenpox.
PG  - 8724
LID - 10.4081/idr.2020.8724 [doi]
AB  - Background: Monkeypox is a zoonosis. The disease has a similar appearance tochickenpox caused by the varicella-zoster virus (VZV). On May 9(th) 2019, therewas one laboratory-confirmed case of monkeypox reported in Singapore. A man wasalso suspected of having monkeypox on June 1(st) 2019 in Surabaya, Indonesia, aneighboring country. Objective: To report on a suspected case of monkeypox withdifferential diagnosis to chickenpox. Case: A 51-year-old male was suspected ofhaving monkeypox after a differential diagnosis of chickenpox. His chiefcomplaint was multiple blisters on his body. From the dermatological status onhis facial, trunk and extremity regions, there were multiple pleiomorphicvesicles, some with umbilication, with a centripetal distribution, and crusts.Methods and Results: A PCR using VZV specific primers, followed by genomesequencing showed homologies of more than 99 % to other VZVs and less than 50% toMonkeypox sequences. Conclusion: Molecular laboratory techniques have confirmedthe case as chickenpox.
CI  - (c)Copyright: the Author(s).
FAU - Tumewu, Junis
AU  - Tumewu J
AD  - Department of Clinical Microbiology.
AD  - Naval Medical Department, National Armed Forces, Indonesia.
FAU - Wardiana, Maya
AU  - Wardiana M
AD  - Department of Dermatology and Venereology, Faculty of Medicine UniversitasAirlangga, Surabaya.
AD  - Dr. Soetomo Academic Hospital Surabaya.
FAU - Ervianty, Evy
AU  - Ervianty E
AD  - Department of Dermatology and Venereology, Faculty of Medicine UniversitasAirlangga, Surabaya.
AD  - Dr. Soetomo Academic Hospital Surabaya.
FAU - Sawitri
AU  - Sawitri
AD  - Department of Dermatology and Venereology, Faculty of Medicine UniversitasAirlangga, Surabaya.
AD  - Dr. Soetomo Academic Hospital Surabaya.
FAU - Rahmadewi
AU  - Rahmadewi
AD  - Department of Dermatology and Venereology, Faculty of Medicine UniversitasAirlangga, Surabaya.
AD  - Dr. Soetomo Academic Hospital Surabaya.
FAU - Astindari
AU  - Astindari
AD  - Department of Dermatology and Venereology, Faculty of Medicine UniversitasAirlangga, Surabaya.
AD  - Dr. Soetomo Academic Hospital Surabaya.
FAU - Anggraeni, Sylvia
AU  - Anggraeni S
AD  - Department of Dermatology and Venereology, Faculty of Medicine UniversitasAirlangga, Surabaya.
AD  - Dr. Soetomo Academic Hospital Surabaya.
FAU - Widia, Yuri
AU  - Widia Y
AD  - Department of Dermatology and Venereology, Faculty of Medicine UniversitasAirlangga, Surabaya.
AD  - Dr. Soetomo Academic Hospital Surabaya.
FAU - Amin, Mochamad
AU  - Amin M
AD  - Institute of Tropical Disease, Universitas Airlangga, Surabaya.
FAU - Sulichah, Siti Rochmanah Oktaviani
AU  - Sulichah SRO
AD  - Department of Clinical Microbiology.
AD  - Dr. Soetomo Academic Hospital Surabaya.
FAU - Kuntaman, K
AU  - Kuntaman K
AD  - Department of Clinical Microbiology.
AD  - Dr. Soetomo Academic Hospital Surabaya.
AD  - Institute of Tropical Disease, Universitas Airlangga, Surabaya.
FAU - Juniastuti
AU  - Juniastuti
AD  - Department of Clinical Microbiology.
AD  - Institute of Tropical Disease, Universitas Airlangga, Surabaya.
FAU - Lusida, Maria Inge
AU  - Lusida MI
AD  - Department of Clinical Microbiology.
AD  - Dr. Soetomo Academic Hospital Surabaya.
AD  - Institute of Tropical Disease, Universitas Airlangga, Surabaya.
LA  - eng
PT  - Journal Article
DEP - 20200706
PL  - Switzerland
TA  - Infect Dis Rep
JT  - Infectious disease reports
JID - 101537203
PMC - PMC7447953
OTO - NOTNLM
OT  - *Indonesia
OT  - *adult
OT  - *chickenpox
OT  - *monkeypox
COIS- Conflict of interest: the authors declare no potential conflict of interest.
EDAT- 2020/09/03 06:00
MHDA- 2020/09/03 06:01
CRDT- 2020/09/03 06:00
PHST- 2020/02/17 00:00 [received]
PHST- 2020/07/01 00:00 [accepted]
PHST- 2020/09/03 06:00 [entrez]
PHST- 2020/09/03 06:00 [pubmed]
PHST- 2020/09/03 06:01 [medline]
AID - 10.4081/idr.2020.8724 [doi]
PST - epublish
SO  - Infect Dis Rep. 2020 Jul 6;12(Suppl 1):8724. doi: 10.4081/idr.2020.8724.eCollection 2020 Jul 7.

PMID- 32861468
OWN - NLM
STAT- MEDLINE
DCOM- 20210427
LR  - 20220711
IS  - 1873-2518 (Electronic)
IS  - 0264-410X (Linking)
VI  - 38
IP  - 43
DP  - 2020 Oct 7
TI  - Acceptance and willingness to pay for a hypothetical vaccine against monkeypoxviral infection among frontline physicians: A cross-sectional study in Indonesia.
PG  - 6800-6806
LID - S0264-410X(20)31075-6 [pii]
LID - 10.1016/j.vaccine.2020.08.034 [doi]
AB  - BACKGROUND: A clinical trial is ongoing to evaluate the safety and efficacy of a monkeypox vaccine among healthcare workers (HCWs). The critical question thatneeds to be addressed is whether HCWs are willing to accept and purchase thisvaccine. The objective of this study was to evaluate the acceptance andwillingness to pay (WTP) for the vaccine among HCWs. METHODS: From May to July2019, a cross-sectional study was conducted among registered generalpractitioners (GPs) in Indonesia. A contingent valuation method was employed toevaluate the WTP. Besides acceptance and WTP, various explanatory variables were also collected and assessed. A logistic regression and a multivariable linearregression were used to explore the explanatory variables influencing acceptance and WTP, respectively. RESULTS: Among 407 respondents, 391 (96.0%) expressedacceptance of a free vaccination. The mean and median WTP was US$ 37.0(95%CI:US$ 32.76-US$ 41.23) and US$ 17.90(95%CI:US$ 17.90-US$ 17.90), respectively. In anunadjusted analysis, those 30 years old or younger had 2.94 times greater odds ofvaccine acceptance compared to those who were older (95%CI: 1.07-8.08). Location of alma mater, type of workplace, length of individual medical experience, andmonthly income of GPs were all significantly associated with WTP. CONCLUSION:Although the vast majority of GPs would accept a freely provided vaccine, theywere also somewhat price sensitive. This finding indicates that partial subsidymaybe required to achieve high vaccine coverage, particularly among GPs atcommunity health centres or those with a shorter duration of medical practice.
CI  - Copyright (c) 2020 Elsevier Ltd. All rights reserved.
FAU - Harapan, Harapan
AU  - Harapan H
AD  - Medical Research Unit, School of Medicine, Syiah Kuala University, Banda Aceh,Aceh 23111, Indonesia; Tropical Disease Centre, School of Medicine, Syiah KualaUniversity, Banda Aceh, Aceh 23111, Indonesia; Department of Microbiology, Schoolof Medicine, Syiah Kuala University, Banda Aceh, Aceh 23111, Indonesia.Electronic address: harapan@unsyiah.ac.id.
FAU - Wagner, Abram L
AU  - Wagner AL
AD  - Department of Epidemiology, University of Michigan, Ann Arbor, MI 48109, USA.
FAU - Yufika, Amanda
AU  - Yufika A
AD  - Department of Family Medicine, School of Medicine, Syiah Kuala University, Banda Aceh, Aceh 23111, Indonesia.
FAU - Setiawan, Abdul M
AU  - Setiawan AM
AD  - Department of Microbiology, Faculty of Medicine and Health Sciences, MaulanaMalik Ibrahim State Islamic University of Malang, Malang, East Java 65144,Indonesia.
FAU - Anwar, Samsul
AU  - Anwar S
AD  - Department of Statistics, Faculty of Mathematics and Natural Sciences, SyiahKuala University, Banda Aceh, Aceh 23111, Indonesia.
FAU - Wahyuni, Sri
AU  - Wahyuni S
AD  - Faculty of Medicine, Universitas Malikussaleh, Lhokseumawe, Aceh 24531,Indonesia.
FAU - Asrizal, Febrivan W
AU  - Asrizal FW
AD  - Mohammad Natsir Hospital, Solok, West Sumatra 27361, Indonesia.
FAU - Sufri, Muhammad R
AU  - Sufri MR
AD  - Banda Aceh Port Health Office, Ministry of Health, Aceh Besar, Aceh 23352,Indonesia.
FAU - Putra, Reza P
AU  - Putra RP
AD  - Medical Research Unit, School of Medicine, Syiah Kuala University, Banda Aceh,Aceh 23111, Indonesia.
FAU - Wijayanti, Nanda P
AU  - Wijayanti NP
AD  - Sabang Hospital, Sabang, Aceh 23522, Indonesia.
FAU - Salwiyadi, Salwiyadi
AU  - Salwiyadi S
AD  - Department of Internal Medicine, School of Medicine, Universitas Syiah Kuala,Banda Aceh, Aceh 23111, Indonesia.
FAU - Maulana, Razi
AU  - Maulana R
AD  - Department of Obstetrics and Gynecology, School of Medicine, Universitas SyiahKuala, Banda Aceh, Aceh 23111, Indonesia.
FAU - Khusna, Afriyani
AU  - Khusna A
AD  - Meuraxa Hospital, Banda Aceh, Aceh 23231, Indonesia.
FAU - Nusrina, Ina
AU  - Nusrina I
AD  - Department of Health Service, District Health Office, Aceh Besar, Aceh 23912,Indonesia.
FAU - Shidiq, Muhammad
AU  - Shidiq M
AD  - Nusa Jaya Community Health Center, Halmahera Timur, North Maluku 97863,Indonesia.
FAU - Fitriani, Devi
AU  - Fitriani D
AD  - Teunom Community Health Center, Aceh Jaya, Aceh 23653, Indonesia.
FAU - Muharrir, Muharrir
AU  - Muharrir M
AD  - Medical Research Unit, School of Medicine, Syiah Kuala University, Banda Aceh,Aceh 23111, Indonesia.
FAU - Husna, Cut A
AU  - Husna CA
AD  - Department of Microbiology, Universitas Malikussaleh, Lhokseumawe, Aceh 24531,Indonesia.
FAU - Yusri, Fitria
AU  - Yusri F
AD  - Faculty of Medicine, Universitas Malikussaleh, Lhokseumawe, Aceh 24531,Indonesia.
FAU - Maulana, Reza
AU  - Maulana R
AD  - Medical Research Unit, School of Medicine, Syiah Kuala University, Banda Aceh,Aceh 23111, Indonesia.
FAU - Rajamoorthy, Yogambigai
AU  - Rajamoorthy Y
AD  - Department of Economics, Faculty of Accountancy and Management, Universiti Tunku Abdul Rahman, Kajang, Selangor 43200, Malaysia.
FAU - Groneberg, David Alexander
AU  - Groneberg DA
AD  - Institute of Occupational Medicine, Social Medicine and Environmental Medicine,Goethe University, Frankfurt am Main, Germany.
FAU - Muller, Ruth
AU  - Muller R
AD  - Institute of Occupational Medicine, Social Medicine and Environmental Medicine,Goethe University, Frankfurt am Main, Germany; Unit of Medical Entomology,Institute of Tropical Medicine, Antwerp, Belgium.
FAU - Mudatsir, Mudatsir
AU  - Mudatsir M
AD  - Medical Research Unit, School of Medicine, Syiah Kuala University, Banda Aceh,Aceh 23111, Indonesia; Tropical Disease Centre, School of Medicine, Syiah KualaUniversity, Banda Aceh, Aceh 23111, Indonesia; Department of Microbiology, Schoolof Medicine, Syiah Kuala University, Banda Aceh, Aceh 23111, Indonesia.
LA  - eng
PT  - Journal Article
DEP - 20200827
PL  - Netherlands
TA  - Vaccine
JT  - Vaccine
JID - 8406899
RN  - 0 (Vaccines)
SB  - IM
MH  - Adult
MH  - Cross-Sectional Studies
MH  - Humans
MH  - Indonesia
MH  - *Monkeypox
MH  - Monkeypox virus
MH  - Patient Acceptance of Health Care
MH  - Surveys and Questionnaires
MH  - *Vaccines
OTO - NOTNLM
OT  - *Indonesia
OT  - *Monkeypox
OT  - *Prevention
OT  - *Vaccine acceptance
OT  - *Willingness to pay
COIS- Declaration of Competing Interest The authors declare that they have no knowncompeting financial interests or personal relationships that could have appeared to influence the work reported in this paper.
EDAT- 2020/08/31 06:00
MHDA- 2021/04/28 06:00
CRDT- 2020/08/31 06:00
PHST- 2020/01/21 00:00 [received]
PHST- 2020/08/01 00:00 [revised]
PHST- 2020/08/14 00:00 [accepted]
PHST- 2020/08/31 06:00 [pubmed]
PHST- 2021/04/28 06:00 [medline]
PHST- 2020/08/31 06:00 [entrez]
AID - S0264-410X(20)31075-6 [pii]
AID - 10.1016/j.vaccine.2020.08.034 [doi]
PST - ppublish
SO  - Vaccine. 2020 Oct 7;38(43):6800-6806. doi: 10.1016/j.vaccine.2020.08.034. Epub2020 Aug 27.

PMID- 32759969
OWN - NLM
STAT- MEDLINE
DCOM- 20201207
LR  - 20210805
IS  - 2045-2322 (Electronic)
IS  - 2045-2322 (Linking)
VI  - 10
IP  - 1
DP  - 2020 Aug 5
TI  - Heterotypic immunity against vaccinia virus in an HLA-B*07:02 transgenic mousepoxinfection model.
PG  - 13167
LID - 10.1038/s41598-020-69897-w [doi]
AB  - Vaccination with vaccinia virus (VACV) elicits heterotypic immunity to smallpox, monkeypox, and mousepox, the mechanistic basis for which is poorly understood. Itis generally assumed that heterotypic immunity arises from the presentation of a wide array of VACV-derived, CD8(+) T cell epitopes that share homology with otherpoxviruses. Herein this assumption was tested using a large panel of VACV-derivedpeptides presented by HLA-B*07:02 (B7.2) molecules in a mousepox/ectromelia virus(ECTV)-infection, B7.2 transgenic mouse model. Most dominant epitopes recognized by ECTV- and VACV-reactive CD8(+) T cells overlapped significantly withoutaltering immunodominance hierarchy. Further, several epitopes recognized byECTV-reactive CD8(+) T cells were not recognized by VACV-reactive CD8(+) T cells,and vice versa. In one instance, the lack of recognition owed to a N72K variationin the ECTV C4R70-78 variant of the dominant VACV B8R70-78 epitope. C4R70-78 doesnot bind to B7.2 and, hence, it was neither immunogenic nor antigenic. Thesefindings provide a mechanistic basis for VACV vaccination-induced heterotypicimmunity which can protect against Variola and Monkeypox disease. Theunderstanding of how cross-reactive responses develop is essential for therational design of a subunit-based vaccine that would be safe, and effectivelyprotect against heterologous infection.
FAU - Kumar, Amrendra
AU  - Kumar A
AD  - Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville,TN, USA.
AD  - Department of Pathology, Microbiology and Immunology, Vanderbilt UniversityMedical Centre, Nashville, TN, USA.
FAU - Suryadevara, Naveen Chandra
AU  - Suryadevara NC
AUID- ORCID: http://orcid.org/0000-0003-2571-1290
AD  - Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville,TN, USA.
AD  - Department of Pathology, Microbiology and Immunology, Vanderbilt UniversityMedical Centre, Nashville, TN, USA.
FAU - Wolf, Kyle J
AU  - Wolf KJ
AUID- ORCID: http://orcid.org/0000-0003-4874-2911
AD  - Department of Molecular Microbiology and Immunology, Saint Louis UniversitySchool of Medicine, St. Louis, MO, USA.
FAU - Wilson, John T
AU  - Wilson JT
AUID- ORCID: http://orcid.org/0000-0002-9144-2634
AD  - Department of Chemical and Biomolecular Engineering, Vanderbilt University,Nashville, TN, USA.
FAU - Di Paolo, Richard J
AU  - Di Paolo RJ
AUID- ORCID: http://orcid.org/0000-0002-2191-6689
AD  - Department of Molecular Microbiology and Immunology, Saint Louis UniversitySchool of Medicine, St. Louis, MO, USA.
FAU - Brien, James D
AU  - Brien JD
AUID- ORCID: http://orcid.org/0000-0002-1670-8041
AD  - Department of Molecular Microbiology and Immunology, Saint Louis UniversitySchool of Medicine, St. Louis, MO, USA.
FAU - Joyce, Sebastian
AU  - Joyce S
AUID- ORCID: http://orcid.org/0000-0002-3183-1451
AD  - Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville,TN, USA. sebastian.joyce@vumc.org.
AD  - Department of Pathology, Microbiology and Immunology, Vanderbilt UniversityMedical Centre, Nashville, TN, USA. sebastian.joyce@vumc.org.
LA  - eng
GR  - I01 BX001444/BX/BLRD VA/United States
GR  - IK6 BX004595/BX/BLRD VA/United States
GR  - M01 RR000095/RR/NCRR NIH HHS/United States
GR  - R01 AI137082/AI/NIAID NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20200805
PL  - England
TA  - Sci Rep
JT  - Scientific reports
JID - 101563288
RN  - 0 (HLA-B*07 antigen)
RN  - 0 (HLA-B7 Antigen)
RN  - 0 (Immunodominant Epitopes)
RN  - 0 (Peptides)
RN  - 0 (Viral Proteins)
RN  - 0 (Viral Vaccines)
SB  - IM
MH  - Animals
MH  - CD8-Positive T-Lymphocytes/metabolism
MH  - Disease Models, Animal
MH  - Ectromelia virus/pathogenicity
MH  - Ectromelia, Infectious/immunology/*prevention & control
MH  - HLA-B7 Antigen/*genetics/metabolism
MH  - Immunodominant Epitopes/metabolism
MH  - Male
MH  - Mice
MH  - Mice, Inbred C57BL
MH  - Mice, Transgenic
MH  - Peptides/*immunology
MH  - Vaccinia virus/*immunology
MH  - Viral Proteins/*chemistry
MH  - Viral Vaccines/administration & dosage/immunology
PMC - PMC7406653
EDAT- 2020/08/08 06:00
MHDA- 2020/12/15 06:00
CRDT- 2020/08/08 06:00
PHST- 2020/02/25 00:00 [received]
PHST- 2020/07/13 00:00 [accepted]
PHST- 2020/08/08 06:00 [entrez]
PHST- 2020/08/08 06:00 [pubmed]
PHST- 2020/12/15 06:00 [medline]
AID - 10.1038/s41598-020-69897-w [doi]
AID - 10.1038/s41598-020-69897-w [pii]
PST - epublish
SO  - Sci Rep. 2020 Aug 5;10(1):13167. doi: 10.1038/s41598-020-69897-w.

PMID- 32747299
OWN - NLM
STAT- MEDLINE
DCOM- 20210212
LR  - 20210212
IS  - 1477-2566 (Electronic)
IS  - 1465-3249 (Linking)
VI  - 22
IP  - 11
DP  - 2020 Nov
TI  - Identification of protective T-cell antigens for smallpox vaccines.
PG  - 642-652
LID - S1465-3249(20)30655-1 [pii]
LID - 10.1016/j.jcyt.2020.04.098 [doi]
AB  - Background aims: E3L is an immediate-early protein of vaccinia virus (VV) that isdetected within 0.5 h of infection, potentially before the many immune evasiongenes of vaccinia can exert their protective effects. E3L is highly conservedamong orthopoxviruses and hence could provide important protective T-cellepitopes that should be retained in any subunit or attenuated vaccine. We havetherefore evaluated the immunogenicity of E3L in healthy VV-vaccinated donors.Methods: Peripheral blood mononuclear cells from healthy volunteers (n = 13) who had previously received a smallpox vaccine (Dryvax) were activated and expandedusing overlapping E3L peptides and their function, specificity and antiviralactivity was analyzed. E3L-specific T cells were expanded from 7 of 12 (58.3%)vaccinated healthy donors. Twenty-five percent of these produced CD8+ T-cellresponses and 87.5% produced CD4+ T cells. We identified epitopes restricted byHLA-B35 and HLA-DR15. Results: E3L-specific T cells killed peptide-loaded target cells as well as vaccinia-infected cells, but only CD8+ T cells could prevent thespread of infectious virus in virus inhibition assays. The epitopes recognized byE3L-specific T cells were shared with monkeypox, and although there was a single amino acid change in the variola epitope homolog, it was recognized byvaccinia-specific T-cells. Conclusions: It might be important to include E3L inany deletion mutant or subunit vaccine and E3L could provide a useful antigen to monitor protective immunity in humans.
CI  - 38; Gene Therapy. Published by Elsevier Inc. All rights reserved.
FAU - Ando, Jun
AU  - Ando J
AD  - Center for Cell and Gene Therapy, Departments of Pediatrics, Baylor College ofMedicine, Houston, Texas, USA; Department of Hematology, Juntendo UniversitySchool of Medicine, Tokyo, Japan. Electronic address: j-ando@juntendo.ac.jp.
FAU - Ngo, Minhtran C
AU  - Ngo MC
AD  - Center for Cell and Gene Therapy, Departments of Pediatrics, Baylor College ofMedicine, Houston, Texas, USA.
FAU - Ando, Miki
AU  - Ando M
AD  - Center for Cell and Gene Therapy, Departments of Pediatrics, Baylor College ofMedicine, Houston, Texas, USA; Department of Hematology, Juntendo UniversitySchool of Medicine, Tokyo, Japan.
FAU - Leen, Ann
AU  - Leen A
AD  - Center for Cell and Gene Therapy, Departments of Pediatrics, Baylor College ofMedicine, Houston, Texas, USA.
FAU - Rooney, Cliona M
AU  - Rooney CM
AD  - Center for Cell and Gene Therapy, Departments of Pediatrics, Baylor College ofMedicine, Houston, Texas, USA. Electronic address: crooney@bcm.edu.
LA  - eng
GR  - T32 GM007330/GM/NIGMS NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20200508
PL  - England
TA  - Cytotherapy
JT  - Cytotherapy
JID - 100895309
RN  - 0 (Antigens, Viral)
RN  - 0 (Epitopes, T-Lymphocyte)
RN  - 0 (Peptides)
RN  - 0 (Smallpox Vaccine)
RN  - 82115-62-6 (Interferon-gamma)
SB  - IM
MH  - Amino Acid Sequence
MH  - Animals
MH  - Antigens, Viral/*immunology
MH  - CD4-Positive T-Lymphocytes/immunology
MH  - CD8-Positive T-Lymphocytes/immunology
MH  - Epitopes, T-Lymphocyte/genetics
MH  - Humans
MH  - Interferon-gamma/metabolism
MH  - Leukocytes, Mononuclear/immunology
MH  - Peptides/chemistry/immunology
MH  - Smallpox/*immunology/prevention & control
MH  - Smallpox Vaccine/*immunology
MH  - T-Lymphocytes/*immunology
MH  - Tissue Donors
MH  - Vaccination
MH  - Vaccinia virus/genetics/immunology
MH  - Virion/immunology
MH  - Virus Replication/physiology
PMC - PMC7205715
OTO - NOTNLM
OT  - *E3L
OT  - *smallpox
OT  - *vaccinia virus (VV)
OT  - *variola virus
OT  - *virus-specific T cells
COIS- The authors have no commercial, proprietary, or financial interest in theproducts or companies described in this article.
EDAT- 2020/08/05 06:00
MHDA- 2021/02/13 06:00
CRDT- 2020/08/05 06:00
PHST- 2020/02/25 00:00 [received]
PHST- 2020/04/27 00:00 [accepted]
PHST- 2020/08/05 06:00 [pubmed]
PHST- 2021/02/13 06:00 [medline]
PHST- 2020/08/05 06:00 [entrez]
AID - S1465-3249(20)30655-1 [pii]
AID - 10.1016/j.jcyt.2020.04.098 [doi]
PST - ppublish
SO  - Cytotherapy. 2020 Nov;22(11):642-652. doi: 10.1016/j.jcyt.2020.04.098. Epub 2020 May 8.

PMID- 32745153
OWN - NLM
STAT- MEDLINE
DCOM- 20200922
LR  - 20210507
IS  - 1553-7374 (Electronic)
IS  - 1553-7366 (Linking)
VI  - 16
IP  - 8
DP  - 2020 Aug
TI  - Ectromelia-encoded virulence factor C15 specifically inhibits antigenpresentation to CD4+ T cells post peptide loading.
PG  - e1008685
LID - 10.1371/journal.ppat.1008685 [doi]
AB  - Smallpox and monkeypox pose severe threats to human health. Other orthopoxvirusesare comparably virulent in their natural hosts, including ectromelia, the causeof mousepox. Disease severity is linked to an array of immunomodulatory proteins including the B22 family, which has homologs in all pathogenic orthopoxvirusesbut not attenuated vaccine strains. We demonstrate that the ectromelia B22member, C15, is necessary and sufficient for selective inhibition of CD4+ but notCD8+ T cell activation by immunogenic peptide and superantigen. Inhibition isachieved not by down-regulation of surface MHC- II or co-stimulatory proteinsurface expression but rather by interference with antigen presentation. Theappreciable outcome is interference with CD4+ T cell synapse formation asdetermined by imaging studies and lipid raft disruption. Consequently, CD4+ Tcell activating stimulus shifts to uninfected antigen-presenting cells that have received antigen from infected cells. This work provides insight into theimmunomodulatory strategies of orthopoxviruses by elucidating a mechanism forspecific targeting of CD4+ T cell activation, reflecting the importance of thiscell type in control of the virus.
FAU - Forsyth, Katherine S
AU  - Forsyth KS
AUID- ORCID: 0000-0002-4991-1601
AD  - Department of Pathology and Laboratory Medicine, Perelman School of Medicine,University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
FAU - Roy, Nathan H
AU  - Roy NH
AD  - Department of Pathology and Laboratory Medicine, Perelman School of Medicine,University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
FAU - Peauroi, Elise
AU  - Peauroi E
AUID- ORCID: 0000-0001-7935-6277
AD  - Department of Pathology and Laboratory Medicine, Perelman School of Medicine,University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
FAU - DeHaven, Brian C
AU  - DeHaven BC
AD  - Department of Biology, La Salle University, Philadelphia, Pennsylvania, UnitedStates of America.
FAU - Wold, Erik D
AU  - Wold ED
AD  - Department of Pathology and Laboratory Medicine, Perelman School of Medicine,University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
FAU - Hersperger, Adam R
AU  - Hersperger AR
AD  - Department of Biology, Albright College, Reading, Pennsylvania, United States of America.
FAU - Burkhardt, Janis K
AU  - Burkhardt JK
AUID- ORCID: 0000-0002-8176-1375
AD  - Department of Pathology and Laboratory Medicine, Perelman School of Medicine,University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
AD  - Children's Hospital of Philadelphia Research Institute, Philadelphia,Pennsylvania, United States of America.
FAU - Eisenlohr, Laurence C
AU  - Eisenlohr LC
AUID- ORCID: 0000-0002-8475-7910
AD  - Department of Pathology and Laboratory Medicine, Perelman School of Medicine,University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
AD  - Children's Hospital of Philadelphia Research Institute, Philadelphia,Pennsylvania, United States of America.
LA  - eng
GR  - F31 CA206338/CA/NCI NIH HHS/United States
GR  - R01 AI110542/AI/NIAID NIH HHS/United States
GR  - T32 AI070077/AI/NIAID NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20200803
PL  - United States
TA  - PLoS Pathog
JT  - PLoS pathogens
JID - 101238921
RN  - 0 (Histocompatibility Antigens Class II)
RN  - 0 (Viral Proteins)
SB  - IM
MH  - Animals
MH  - Antigen Presentation/*immunology
MH  - CD4-Positive T-Lymphocytes/*immunology
MH  - CD8-Positive T-Lymphocytes/*immunology
MH  - Ectromelia virus/*immunology
MH  - Ectromelia, Infectious/*immunology/metabolism/virology
MH  - Female
MH  - Histocompatibility Antigens Class II/*immunology
MH  - Lymphocyte Activation
MH  - Mice
MH  - Mice, Inbred BALB C
MH  - Mice, Inbred C57BL
MH  - Viral Proteins/*immunology/metabolism
MH  - Virulence
PMC - PMC7425992
COIS- The authors have declared that no competing interests exist.
EDAT- 2020/08/04 06:00
MHDA- 2020/09/23 06:00
CRDT- 2020/08/04 06:00
PHST- 2020/03/02 00:00 [received]
PHST- 2020/06/06 00:00 [accepted]
PHST- 2020/08/13 00:00 [revised]
PHST- 2020/08/04 06:00 [pubmed]
PHST- 2020/09/23 06:00 [medline]
PHST- 2020/08/04 06:00 [entrez]
AID - 10.1371/journal.ppat.1008685 [doi]
AID - PPATHOGENS-D-20-00394 [pii]
PST - epublish
SO  - PLoS Pathog. 2020 Aug 3;16(8):e1008685. doi: 10.1371/journal.ppat.1008685.eCollection 2020 Aug.

PMID- 32741672
OWN - NLM
STAT- MEDLINE
DCOM- 20210427
LR  - 20210828
IS  - 1873-2518 (Electronic)
IS  - 0264-410X (Linking)
VI  - 38
IP  - 38
DP  - 2020 Aug 27
TI  - Short-term and longer-term protective immune responses generated by subunitvaccination with smallpox A33, B5, L1 or A27 proteins adjuvanted with aluminumhydroxide and CpG in mice challenged with vaccinia virus.
PG  - 6007-6018
LID - S0264-410X(20)30931-2 [pii]
LID - 10.1016/j.vaccine.2020.07.018 [doi]
AB  - Smallpox, a contagious and deadly disease caused by variola virus, was eradicatedby a strategy that included vaccination with vaccinia virus, a live-virusvaccine. Because the threat of bioterrorism with smallpox persists and infectionswith zoonotic poxvirus infections like monkeypox continue, and there may be atime when an alternative vaccine platform is needed, recombinant-subunit vaccine strategies for poxviruses have been pursued. Our prior work focused onunderstanding the immune responses generated to vaccine-formulations containingthe virus protein L1. In this work, we examine vaccine-formulations withadditional key protein targets: A33 and B5 (components of the extracellularvirus) and another protein on the mature virus (A27) adjuvanted with aluminumhydroxide (AH) with and without CpG- oligonucleotide. Each vaccine was formulatedto allow either adsorption or non-adsorption of the protein (and CpG) to AH. Micegiven a prime and single boost produced long-lasting antibody responses. A secondboost (given ~5-months after the first) further increased antibody titers.Similar to our prior findings with L1 vaccine-formulations, the most protectiveA33 vaccine-formulations included CpG, resulted in the generation ofIgG2a-antibody responses. Unlike the prior findings with L1 (where formulationsthat adsorbed both the protein and the CpG to AH resulted in 100% survival after challenge and minimal weight loss), the AH-adsorption status of A33 and CpG didnot play as important a role, since both AH-adsorbed and non-adsorbed groups lostweight after challenge and had similar survival. Vaccination with B5-formulationsgave different results. While CpG-containing formulations were the only ones thatgenerated IgG2a-antibody responses, the vaccine-formulation that adsorbed B5 toAH (without CpG) was as equally effective in protecting mice after challenge.These results indicate that the mechanism of how antibodies against A33 and B5protect differ. The data also show the complexity of designing optimizedvaccine-formulations containing multiple adjuvants and recombinant protein-based antigens.
CI  - Copyright (c) 2020 Elsevier Ltd. All rights reserved.
FAU - Xiao, Yuhong
AU  - Xiao Y
AD  - Perelman School of Medicine at the University of Pennsylvania, Department ofMedicine, Division of Infectious Diseases, Philadelphia, PA 19104-6073, UnitedStates.
FAU - Zeng, Yuhong
AU  - Zeng Y
AD  - University of Kansas, Macromolecular and Vaccine Stabilization Center, Departmentof Pharmaceutical Chemistry, 2030 Becker Drive, Lawrence, KS 66047, UnitedStates.
FAU - Schante, Carole
AU  - Schante C
AD  - University of Kansas, Macromolecular and Vaccine Stabilization Center, Departmentof Pharmaceutical Chemistry, 2030 Becker Drive, Lawrence, KS 66047, UnitedStates.
FAU - Joshi, Sangeeta B
AU  - Joshi SB
AD  - University of Kansas, Macromolecular and Vaccine Stabilization Center, Departmentof Pharmaceutical Chemistry, 2030 Becker Drive, Lawrence, KS 66047, UnitedStates.
FAU - Buchman, George W
AU  - Buchman GW
AD  - Chesapeake-Perl, Inc., 8510 A Corridor Rd., Savage, MD 20763, United States.
FAU - Volkin, David B
AU  - Volkin DB
AD  - University of Kansas, Macromolecular and Vaccine Stabilization Center, Departmentof Pharmaceutical Chemistry, 2030 Becker Drive, Lawrence, KS 66047, UnitedStates.
FAU - Middaugh, C Russell
AU  - Middaugh CR
AD  - University of Kansas, Macromolecular and Vaccine Stabilization Center, Departmentof Pharmaceutical Chemistry, 2030 Becker Drive, Lawrence, KS 66047, UnitedStates.
FAU - Isaacs, Stuart N
AU  - Isaacs SN
AD  - Perelman School of Medicine at the University of Pennsylvania, Department ofMedicine, Division of Infectious Diseases, Philadelphia, PA 19104-6073, UnitedStates. Electronic address: isaacs@PennMedicine.upenn.edu.
LA  - eng
GR  - U01 AI077913/AI/NIAID NIH HHS/United States
GR  - U54 AI057168/AI/NIAID NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20200730
PL  - Netherlands
TA  - Vaccine
JT  - Vaccine
JID - 8406899
RN  - 0 (Antibodies, Viral)
RN  - 0 (Smallpox Vaccine)
RN  - 0 (Vaccines, Subunit)
RN  - 5QB0T2IUN0 (Aluminum Hydroxide)
SB  - IM
MH  - Aluminum Hydroxide
MH  - Animals
MH  - Antibodies, Viral
MH  - Mice
MH  - Mice, Inbred BALB C
MH  - *Smallpox/prevention & control
MH  - *Smallpox Vaccine
MH  - Vaccination
MH  - Vaccines, Subunit
MH  - Vaccinia virus
MH  - *Variola virus
PMC - PMC7456309
MID - NIHMS1618265
OTO - NOTNLM
OT  - *Adjuvants, aluminum hydroxide
OT  - *Antibody responses
OT  - *CpG oligonucleotide
OT  - *Mice
OT  - *Monkeypox, vaccinia virus
OT  - *Smallpox, variola virus
COIS- Declaration of Competing Interest The authors declare that they have no knowncompeting financial interests or personal relationships that could have appeared to influence the work reported in this paper.
EDAT- 2020/08/04 06:00
MHDA- 2021/04/28 06:00
CRDT- 2020/08/04 06:00
PHST- 2019/12/07 00:00 [received]
PHST- 2020/04/08 00:00 [revised]
PHST- 2020/07/10 00:00 [accepted]
PHST- 2020/08/04 06:00 [pubmed]
PHST- 2021/04/28 06:00 [medline]
PHST- 2020/08/04 06:00 [entrez]
AID - S0264-410X(20)30931-2 [pii]
AID - 10.1016/j.vaccine.2020.07.018 [doi]
PST - ppublish
SO  - Vaccine. 2020 Aug 27;38(38):6007-6018. doi: 10.1016/j.vaccine.2020.07.018. Epub2020 Jul 30.

PMID- 32717786
OWN - NLM
STAT- MEDLINE
DCOM- 20210226
LR  - 20210226
IS  - 1999-4915 (Electronic)
IS  - 1999-4915 (Linking)
VI  - 12
IP  - 8
DP  - 2020 Jul 23
TI  - Comparison of Multiplexed Immunofluorescence Imaging to ChromogenicImmunohistochemistry of Skin Biomarkers in Response to Monkeypox Virus Infection.
LID - E787 [pii]
LID - 10.3390/v12080787 [doi]
AB  - Over the last 15 years, advances in immunofluorescence-imaging based cyclingmethods, antibody conjugation methods, and automated image processing havefacilitated the development of a high-resolution, multiplexed tissueimmunofluorescence (MxIF) method with single cell-level quantitation termed Cell DIVE(TM). Originally developed for fixed oncology samples, here it was evaluated in highly fixed (up to 30 days), archived monkeypox virus-induced inflammatoryskin lesions from a retrospective study in 11 rhesus monkeys to determine whetherMxIF was comparable to manual H-scoring of chromogenic stains. Six proteinmarkers related to immune and cellular response (CD68, CD3, Hsp70, Hsp90, ERK1/2,ERK1/2 pT202_pY204) were manually quantified (H-scores) by a pathologist fromchromogenic IHC double stains on serial sections and compared to MxIF automatedsingle cell quantification of the same markers that were multiplexed on a single tissue section. Overall, there was directional consistency between the H-scoreand the MxIF results for all markers except phosphorylated ERK1/2 (ERK1/2pT202_pY204), which showed a decrease in the lesion compared to the adjacentnon-lesioned skin by MxIF vs an increase via H-score. Improvements to automatedsegmentation using machine learning and adding additional cell markers for cellviability are future options for improvement. This method could be useful ininfectious disease research as it conserves tissue, provides markercolocalization data on thousands of cells, allowing further cell level datamining as well as a reduction in user bias.
FAU - Sood, Anup
AU  - Sood A
AD  - GE Research, 1 Research Circle, Niskayuna, NY 12309, USA.
FAU - Sui, Yunxia
AU  - Sui Y
AD  - GE Research, 1 Research Circle, Niskayuna, NY 12309, USA.
FAU - McDonough, Elizabeth
AU  - McDonough E
AD  - GE Research, 1 Research Circle, Niskayuna, NY 12309, USA.
FAU - Santamaria-Pang, Alberto
AU  - Santamaria-Pang A
AD  - GE Research, 1 Research Circle, Niskayuna, NY 12309, USA.
FAU - Al-Kofahi, Yousef
AU  - Al-Kofahi Y
AD  - GE Research, 1 Research Circle, Niskayuna, NY 12309, USA.
FAU - Pang, Zhengyu
AU  - Pang Z
AD  - GE Research, 1 Research Circle, Niskayuna, NY 12309, USA.
FAU - Jahrling, Peter B
AU  - Jahrling PB
AD  - Integrated Research Facility at Fort Detrick, National Institute of Allergy andInfectious Diseases, National Institutes of Health, B-8200 Research Plaza,Frederick, MD 21702, USA.
FAU - Kuhn, Jens H
AU  - Kuhn JH
AUID- ORCID: 0000-0002-7800-6045
AD  - Integrated Research Facility at Fort Detrick, National Institute of Allergy andInfectious Diseases, National Institutes of Health, B-8200 Research Plaza,Frederick, MD 21702, USA.
FAU - Ginty, Fiona
AU  - Ginty F
AUID- ORCID: 0000-0001-6638-683X
AD  - GE Research, 1 Research Circle, Niskayuna, NY 12309, USA.
LA  - eng
GR  - HHSN272201800013C/AI/NIAID NIH HHS/United States
GR  - HHSN272200700016I/AI/NIAID NIH HHS/United States
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20200723
PL  - Switzerland
TA  - Viruses
JT  - Viruses
JID - 101509722
RN  - 0 (Biomarkers)
RN  - 0 (Chromogenic Compounds)
SB  - IM
MH  - Animals
MH  - Biomarkers/analysis
MH  - Chromogenic Compounds
MH  - Female
MH  - Fluorescent Antibody Technique/*methods
MH  - Image Processing, Computer-Assisted
MH  - Immunohistochemistry/*methods
MH  - Macaca mulatta
MH  - Male
MH  - Monkeypox/*pathology
MH  - Monkeypox virus/pathogenicity
MH  - Retrospective Studies
MH  - Single-Cell Analysis
MH  - Skin/pathology/*virology
MH  - Staining and Labeling
PMC - PMC7472296
OTO - NOTNLM
OT  - *IHC
OT  - *MPXV
OT  - *MxIF
OT  - *Orthopoxvirus
OT  - *Poxviridae
OT  - *immunohistochemistry
OT  - *monkeypox
OT  - *monkeypox virus
OT  - *multiplexed immunofluorescence
OT  - *poxvirus
EDAT- 2020/07/29 06:00
MHDA- 2021/02/27 06:00
CRDT- 2020/07/29 06:00
PHST- 2020/05/23 00:00 [received]
PHST- 2020/07/15 00:00 [revised]
PHST- 2020/07/19 00:00 [accepted]
PHST- 2020/07/29 06:00 [entrez]
PHST- 2020/07/29 06:00 [pubmed]
PHST- 2021/02/27 06:00 [medline]
AID - v12080787 [pii]
AID - 10.3390/v12080787 [doi]
PST - epublish
SO  - Viruses. 2020 Jul 23;12(8). pii: v12080787. doi: 10.3390/v12080787.

PMID- 32698399
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20201027
IS  - 2076-393X (Print)
IS  - 2076-393X (Linking)
VI  - 8
IP  - 3
DP  - 2020 Jul 20
TI  - IMVAMUNE((R)) and ACAM2000((R)) Provide Different Protection against Disease WhenAdministered Postexposure in an Intranasal Monkeypox Challenge Prairie Dog Model.
LID - E396 [pii]
LID - 10.3390/vaccines8030396 [doi]
AB  - The protection provided by smallpox vaccines when used after exposure toOrthopoxviruses is poorly understood. Postexposu re administration of 1stgeneration smallpox vaccines was effective during eradication. However,historical epidemiological reports and animal studies on postexposure vaccinationare difficult to extrapolate to today's populations, and 2nd and 3rd generationvaccines, developed after eradication, have not been widely tested inpostexposure vaccination scenarios. In addition to concerns about preparednessfor a potential malevolent reintroduction of variola virus, humans are becomingincreasingly exposed to naturally occurring zoonotic orthopoxviruses and,following these exposures, disease severity is worse in individuals who neverreceived smallpox vaccination. This study investigated whether postexposurevaccination of prairie dogs with 2nd and 3rd generation smallpox vaccines wasprotective against monkeypox disease in four exposure scenarios. We infectedanimals with monkeypox virus at doses of 10(4) pfu (2x LD50) or 10(6) pfu (170xLD50) and vaccinated the animals with IMVAMUNE((R)) or ACAM2000((R)) either 1 or 3 days after challenge. Our results indicated that postexposure vaccinationprotected the animals to some degree from the 2x LD50, but not the 170x LD5challenge. In the 2x LD50 challenge, we also observed that administration ofvaccine at 1 day was more effective than administration at 3 days postexposurefor IMVAMUNE((R)), but ACAM2000((R)) was similarly effective at eitherpostexposure vaccination time-point. The effects of postexposure vaccination and correlations with survival of total and neutralizing antibody responses, protein targets, take formation, weight loss, rash burden, and viral DNA are alsopresented.
FAU - Keckler, M Shannon
AU  - Keckler MS
AUID- ORCID: 0000-0002-2275-4730
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,Centers for Disease Control and Prevention, U.S. Department of Health and HumanServices, Atlanta, GA 30333, USA.
AD  - Clinical and Environmental Microbiology Branch, Division of Healthcare QualityPromotion, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, Atlanta, GA 30333, USA.
FAU - Salzer, Johanna S
AU  - Salzer JS
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,Centers for Disease Control and Prevention, U.S. Department of Health and HumanServices, Atlanta, GA 30333, USA.
AD  - Bacterial Special Pathogens Branch, Division of High-Consequence Pathogens andPathology, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, Atlanta, GA 30333, USA.
FAU - Patel, Nishi
AU  - Patel N
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,Centers for Disease Control and Prevention, U.S. Department of Health and HumanServices, Atlanta, GA 30333, USA.
AD  - Respiratory Diseases Branch, Division of Bacterial Diseases, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, Atlanta, GA30333, USA.
FAU - Townsend, Michael B
AU  - Townsend MB
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,Centers for Disease Control and Prevention, U.S. Department of Health and HumanServices, Atlanta, GA 30333, USA.
FAU - Nakazawa, Yoshinori J
AU  - Nakazawa YJ
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,Centers for Disease Control and Prevention, U.S. Department of Health and HumanServices, Atlanta, GA 30333, USA.
FAU - Doty, Jeffrey B
AU  - Doty JB
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,Centers for Disease Control and Prevention, U.S. Department of Health and HumanServices, Atlanta, GA 30333, USA.
FAU - Gallardo-Romero, Nadia F
AU  - Gallardo-Romero NF
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,Centers for Disease Control and Prevention, U.S. Department of Health and HumanServices, Atlanta, GA 30333, USA.
FAU - Satheshkumar, Panayampalli S
AU  - Satheshkumar PS
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,Centers for Disease Control and Prevention, U.S. Department of Health and HumanServices, Atlanta, GA 30333, USA.
FAU - Carroll, Darin S
AU  - Carroll DS
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,Centers for Disease Control and Prevention, U.S. Department of Health and HumanServices, Atlanta, GA 30333, USA.
AD  - Office of the Director, National Center for Emerging and Zoonotic Diseases,Centers for Disease Control and Prevention, U.S. Department of Health and HumanServices, Atlanta, GA 30333, USA.
FAU - Karem, Kevin L
AU  - Karem KL
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,Centers for Disease Control and Prevention, U.S. Department of Health and HumanServices, Atlanta, GA 30333, USA.
AD  - Office of the Director, Center for Global Health, Centers for Disease Control andPrevention, U.S. Department of Health and Human Services, Atlanta, GA 30333, USA.
FAU - Damon, Inger K
AU  - Damon IK
AUID- ORCID: 0000-0002-0749-0677
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,Centers for Disease Control and Prevention, U.S. Department of Health and HumanServices, Atlanta, GA 30333, USA.
LA  - eng
PT  - Journal Article
DEP - 20200720
PL  - Switzerland
TA  - Vaccines (Basel)
JT  - Vaccines
JID - 101629355
PMC - PMC7565152
OTO - NOTNLM
OT  - monkeypox virus
OT  - postexposure vaccination
OT  - prairie dog model
OT  - smallpox vaccines
EDAT- 2020/07/24 06:00
MHDA- 2020/07/24 06:01
CRDT- 2020/07/24 06:00
PHST- 2020/05/18 00:00 [received]
PHST- 2020/07/13 00:00 [revised]
PHST- 2020/07/14 00:00 [accepted]
PHST- 2020/07/24 06:00 [entrez]
PHST- 2020/07/24 06:00 [pubmed]
PHST- 2020/07/24 06:01 [medline]
AID - vaccines8030396 [pii]
AID - 10.3390/vaccines8030396 [doi]
PST - epublish
SO  - Vaccines (Basel). 2020 Jul 20;8(3). pii: vaccines8030396. doi:10.3390/vaccines8030396.

PMID- 32629851
OWN - NLM
STAT- MEDLINE
DCOM- 20210226
LR  - 20210226
IS  - 1999-4915 (Electronic)
IS  - 1999-4915 (Linking)
VI  - 12
IP  - 7
DP  - 2020 Jun 30
TI  - Conserved Oligomeric Golgi (COG) Complex Proteins Facilitate Orthopoxvirus Entry,Fusion and Spread.
LID - E707 [pii]
LID - 10.3390/v12070707 [doi]
AB  - Although orthopoxviruses (OPXV) are known to encode a majority of the genesrequired for replication in host cells, genome-wide genetic screens have revealedthat several host pathways are indispensable for OPXV infection. Through ahaploid genetic screen, we previously identified several host genes required for monkeypox virus (MPXV) infection, including the individual genes that form theconserved oligomeric Golgi (COG) complex. The COG complex is an eight-protein(COG1-COG8) vesicle tethering complex important for regulating membranetrafficking, glycosylation enzymes, and maintaining Golgi structure. In thisstudy, we investigated the role of the COG complex in OPXV infection using celllines with individual COG gene knockout (KO) mutations. COG KO cells infectedwith MPXV and vaccinia virus (VACV) produced small plaques and a lower virusyield compared to wild type (WT) cells. In cells where the KO phenotype wasreversed using a rescue plasmid, the size of virus plaques increaseddemonstrating a direct link between the decrease in viral spread and the KO ofCOG genes. KO cells infected with VACV displayed lower levels of viral fusion andentry compared to WT suggesting that the COG complex is important for earlyevents in OPXV infection. Additionally, fewer actin tails were observed inVACV-infected KO cells compared to WT. Since COG complex proteins are requiredfor cellular trafficking of glycosylated membrane proteins, the disruption ofthis process due to lack of individual COG complex proteins may potentiallyimpair the virus-cell interactions required for viral entry and egress. Thesedata validate that the COG complex previously identified in our genetic screensplays a role in OPXV infection.
FAU - Realegeno, Susan
AU  - Realegeno S
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, GA 3033, USA.
FAU - Priyamvada, Lalita
AU  - Priyamvada L
AUID- ORCID: 0000-0002-0479-0164
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, GA 3033, USA.
FAU - Kumar, Amrita
AU  - Kumar A
AD  - Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 3033,USA.
FAU - Blackburn, Jessica B
AU  - Blackburn JB
AD  - Department of Physiology and Biophysics, University of Arkansas for MedicalSciences, Little Rock, AR 72205, USA.
FAU - Hartloge, Claire
AU  - Hartloge C
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, GA 3033, USA.
FAU - Puschnik, Andreas S
AU  - Puschnik AS
AD  - Department of Microbiology and Immunology, Stanford University, Stanford, CA94035, USA.
FAU - Sambhara, Suryaprakash
AU  - Sambhara S
AD  - Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 3033,USA.
FAU - Olson, Victoria A
AU  - Olson VA
AUID- ORCID: 0000-0001-7729-7680
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, GA 3033, USA.
FAU - Carette, Jan E
AU  - Carette JE
AD  - Department of Microbiology and Immunology, Stanford University, Stanford, CA94035, USA.
FAU - Lupashin, Vladimir
AU  - Lupashin V
AD  - Department of Physiology and Biophysics, University of Arkansas for MedicalSciences, Little Rock, AR 72205, USA.
FAU - Satheshkumar, Panayampalli Subbian
AU  - Satheshkumar PS
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, GA 3033, USA.
LA  - eng
GR  - R01 GM083144/GM/NIGMS NIH HHS/United States
GR  - R01 AI130123/NH/NIH HHS/United States
GR  - R01 GM083144/NH/NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20200630
PL  - Switzerland
TA  - Viruses
JT  - Viruses
JID - 101509722
RN  - 0 (Adaptor Proteins, Vesicular Transport)
SB  - IM
MH  - Adaptor Proteins, Vesicular Transport/genetics/*metabolism
MH  - Glycosylation
MH  - Golgi Apparatus
MH  - HEK293 Cells
MH  - Host-Pathogen Interactions
MH  - Humans
MH  - Mutation
MH  - Orthopoxvirus/genetics/*physiology
MH  - Poxviridae Infections/genetics/*metabolism/*virology
MH  - *Virus Internalization
PMC - PMC7411930
OTO - NOTNLM
OT  - *COG complex
OT  - *glycosylation
OT  - *monkeypox
OT  - *vaccinia
OT  - *viral attachment
OT  - *viral entry
EDAT- 2020/07/08 06:00
MHDA- 2021/02/27 06:00
CRDT- 2020/07/08 06:00
PHST- 2020/05/26 00:00 [received]
PHST- 2020/06/25 00:00 [accepted]
PHST- 2020/07/08 06:00 [entrez]
PHST- 2020/07/08 06:00 [pubmed]
PHST- 2021/02/27 06:00 [medline]
AID - v12070707 [pii]
AID - 10.3390/v12070707 [doi]
PST - epublish
SO  - Viruses. 2020 Jun 30;12(7). pii: v12070707. doi: 10.3390/v12070707.

PMID- 32607280
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20200928
IS  - 2167-8359 (Print)
IS  - 2167-8359 (Linking)
VI  - 8
DP  - 2020
TI  - A game-theoretic model of Monkeypox to assess vaccination strategies.
PG  - e9272
LID - 10.7717/peerj.9272 [doi]
AB  - Monkeypox (MPX) is a zoonotic disease similar to smallpox. Its fatality rate isabout 11% and it is endemic to the Central and West African countries. In thispaper, we analyze a compartmental model of MPX dynamics. Our goal is to seewhether MPX can be controlled and eradicated by voluntary vaccinations. We showthat there are three equilibria-disease free, fully endemic and previouslyneglected semi-endemic (with disease existing only among humans). The existenceof semi-endemic equilibrium has severe implications should the MPX virus mutateto increased viral fitness in humans. We find that MPX is controllable and can beeradicated in a semi-endemic equilibrium by vaccination. However, in a fullyendemic equilibrium, MPX cannot be eradicated by vaccination alone.
CI  - (c)2020 Bankuru et al.
FAU - Bankuru, Sri Vibhaav
AU  - Bankuru SV
AD  - Department of Biomedical Engineering, Virginia Commonwealth University, Richmond,VA, United States of America.
FAU - Kossol, Samuel
AU  - Kossol S
AD  - Department of Biomedical Engineering, Virginia Commonwealth University, Richmond,VA, United States of America.
FAU - Hou, William
AU  - Hou W
AD  - Department of Kinesiology and Health Sciences, Virginia Commonwealth University, Richmond, VA, United States of America.
FAU - Mahmoudi, Parsa
AU  - Mahmoudi P
AD  - Department of Biology, Virginia Commonwealth University, Richmond, VA, UnitedStates of America.
FAU - Rychtar, Jan
AU  - Rychtar J
AD  - Department of Mathematics and Applied Mathematics, Virginia CommonwealthUniversity, Richmond, VA, United States of America.
FAU - Taylor, Dewey
AU  - Taylor D
AD  - Department of Mathematics and Applied Mathematics, Virginia CommonwealthUniversity, Richmond, VA, United States of America.
LA  - eng
PT  - Journal Article
DEP - 20200622
PL  - United States
TA  - PeerJ
JT  - PeerJ
JID - 101603425
PMC - PMC7316080
OTO - NOTNLM
OT  - Game theory
OT  - Monkeypox
OT  - Nash equilibrium
OT  - Smallpox
OT  - Vaccination
COIS- The authors declare there are no competing interests.
EDAT- 2020/07/02 06:00
MHDA- 2020/07/02 06:01
CRDT- 2020/07/02 06:00
PHST- 2020/01/08 00:00 [received]
PHST- 2020/05/11 00:00 [accepted]
PHST- 2020/07/02 06:00 [entrez]
PHST- 2020/07/02 06:00 [pubmed]
PHST- 2020/07/02 06:01 [medline]
AID - 10.7717/peerj.9272 [doi]
AID - 9272 [pii]
PST - epublish
SO  - PeerJ. 2020 Jun 22;8:e9272. doi: 10.7717/peerj.9272. eCollection 2020.

PMID- 32587376
OWN - NLM
STAT- MEDLINE
DCOM- 20201009
LR  - 20210406
IS  - 2058-5276 (Electronic)
IS  - 2058-5276 (Linking)
VI  - 5
IP  - 7
DP  - 2020 Jul
TI  - Wildlife surveillance for emergent disease.
PG  - 885-886
LID - 10.1038/s41564-020-0747-4 [doi]
FAU - Kuhn, Jens H
AU  - Kuhn JH
AUID- ORCID: http://orcid.org/0000-0002-7800-6045
AD  - Integrated Research Facility at Fort Detrick, National Institute of Allergy andInfectious Diseases, National Institutes of Health, Frederick, MD, USA.kuhnjens@mail.nih.gov.
LA  - eng
GR  - HHSN272201800013C/AI/NIAID NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Comment
PL  - England
TA  - Nat Microbiol
JT  - Nature microbiology
JID - 101674869
SB  - IM
CON - Nat Microbiol. 2020 Jul;5(7):955-965. PMID: 32341480
MH  - Animals
MH  - Animals, Wild
MH  - *Monkeypox virus
MH  - *Pan troglodytes
EDAT- 2020/06/27 06:00
MHDA- 2020/10/10 06:00
CRDT- 2020/06/27 06:00
PHST- 2020/06/27 06:00 [entrez]
PHST- 2020/06/27 06:00 [pubmed]
PHST- 2020/10/10 06:00 [medline]
AID - 10.1038/s41564-020-0747-4 [doi]
AID - 10.1038/s41564-020-0747-4 [pii]
PST - ppublish
SO  - Nat Microbiol. 2020 Jul;5(7):885-886. doi: 10.1038/s41564-020-0747-4.

PMID- 32417140
OWN - NLM
STAT- MEDLINE
DCOM- 20210427
LR  - 20220711
IS  - 1873-2518 (Electronic)
IS  - 0264-410X (Linking)
VI  - 38
IP  - 33
DP  - 2020 Jul 14
TI  - Human monkeypox - After 40 years, an unintended consequence of smallpoxeradication.
PG  - 5077-5081
LID - S0264-410X(20)30579-X [pii]
LID - 10.1016/j.vaccine.2020.04.062 [doi]
AB  - Smallpox eradication, coordinated by the WHO and certified 40 years ago, led tothe cessation of routine smallpox vaccination in most countries. It is estimated that over 70% of the world's population is no longer protected against smallpox, and through cross-immunity, to closely related orthopox viruses such asmonkeypox. Monkeypox is now a re-emerging disease. Monkeypox is endemic in as yetunconfirmed animal reservoirs in sub-Saharan Africa, while its human epidemiologyappears to be changing. Monkeypox in small animals imported from Ghana as exotic pets was at the origin of an outbreak of human monkeypox in the USA in 2003.Travellers infected in Nigeria were at the origin of monkeypox cases in the UK in2018 and 2019, Israel in 2018 and Singapore in2019. Together with sporadicreports of human infections with other orthopox viruses, these facts invitespeculation that emergent or re-emergent human monkeypox might fill theepidemiological niche vacated by smallpox. An ad-hoc and unofficial group ofinterested experts met to consider these issues at Chatham House, London in June 2019, in order to review available data and identify monkeypox-related researchgaps. Gaps identified by the experts included:The experts further agreed on theneed for a better understanding of the genomic evolution and changingepidemiology of orthopox viruses, the usefulness of in-field genomic diagnostics,and the best disease control strategies, including the possibility of vaccinationwith new generation non-replicating smallpox vaccines and treatment with recentlydeveloped antivirals.
CI  - Copyright (c) 2020.
FAU - Simpson, Karl
AU  - Simpson K
AD  - JKS Bioscience Limited, 2 Midanbury Court, 44 Midanbury Lane, Southampton SO184HF, UK. Electronic address: karl.simpson@jksbioscience.co.uk.
FAU - Heymann, David
AU  - Heymann D
AD  - London School of Hygiene & Tropical Medicine, Keppel St, Bloomsbury, London WC1E 7HT, UK. Electronic address: David.Heymann@LSHTM.ac.uk.
FAU - Brown, Colin S
AU  - Brown CS
AD  - Public Health England, Colindale, 61 Colindale Avenue, London NW9 5EQ, UK.Electronic address: Colin.Brown@phe.gov.uk.
FAU - Edmunds, W John
AU  - Edmunds WJ
AD  - London School of Hygiene & Tropical Medicine, Keppel St, Bloomsbury, London WC1E 7HT, UK. Electronic address: John.Edmunds@LSHTM.ac.uk.
FAU - Elsgaard, Jesper
AU  - Elsgaard J
AD  - Bavarian Nordic A/S, Hejreskovvej 10A, DK-3490 Kvistgard, Denmark. Electronicaddress: jesper.elsgaard@bavarian-nordic.com.
FAU - Fine, Paul
AU  - Fine P
AD  - London School of Hygiene & Tropical Medicine, Keppel St, Bloomsbury, London WC1E 7HT, UK. Electronic address: Paul.Fine@lshtm.ac.uk.
FAU - Hochrein, Hubertus
AU  - Hochrein H
AD  - Bavarian Nordic GmbH, Fraunhoferstrasse 13, 82152 Planegg, Germany. Electronicaddress: Hubertus.Hochrein@bavarian-nordic.com.
FAU - Hoff, Nicole A
AU  - Hoff NA
AD  - Fielding School of Public Health, UCLA, 50 Charles E Young Dr S, Los Angeles, CA 90095, United States. Electronic address: nhoff84@ucla.edu.
FAU - Green, Andrew
AU  - Green A
AD  - Royal Centre of Defence Medicine, Level 2 QEHB, Mindelsohn Way, Edgbaston,Birmingham B15 2WB,UK. Electronic address: andy.green735@mod.gov.uk.
FAU - Ihekweazu, Chikwe
AU  - Ihekweazu C
AD  - Nigeria CDC, Plot 801, Ebitu Ukiwe Street, Jabi, Abuja, Nigeria. Electronicaddress: chikwe.ihekweazu@ncdc.gov.ng.
FAU - Jones, Terry C
AU  - Jones TC
AD  - Centre for Pathogen Evolution, Department of Zoology, University of Cambridge,Downing St., Cambridge CB2 3EJ, UK; Institute of Virology, Charite,Universitatsmedizin Chariteplatz 1, 10117 Berlin, Germany. Electronic address:tcj25@cam.ac.uk.
FAU - Lule, Swaib
AU  - Lule S
AD  - University College London, Faculty of Population Health Sciences, 30 GuilfordStreet, London WC1N 1EH, UK. Electronic address: s.lule@ucl.ac.uk.
FAU - Maclennan, Jane
AU  - Maclennan J
AD  - Bavarian Nordic GmbH, Fraunhoferstrasse 13, 82152 Planegg, Germany. Electronicaddress: Jane.maclennan@bavarian-nordic.com.
FAU - McCollum, Andrea
AU  - McCollum A
AD  - Centers for Disease Control and Prevention, 1600 Clifton Rd. NE, CDC, Atlanta, GA30333, USA. Electronic address: azv4@cdc.gov.
FAU - Muhlemann, Barbara
AU  - Muhlemann B
AD  - Centre for Pathogen Evolution, Department of Zoology, University of Cambridge,Downing St., Cambridge CB2 3EJ, UK; Institute of Virology, Charite,Universitatsmedizin Chariteplatz 1, 10117 Berlin, Germany. Electronic address:bm446@cam.ac.uk.
FAU - Nightingale, Emily
AU  - Nightingale E
AD  - The Forge Veterinary Centre, 93b Head Street, Halstead, Essex CO9 2AZ, UK.Electronic address: emily@herskind.co.uk.
FAU - Ogoina, Dimie
AU  - Ogoina D
AD  - Niger Delta University/Niger Delta University Teaching Hospital, Bayelsa,Nigeria.
FAU - Ogunleye, Adesola
AU  - Ogunleye A
AD  - Nigeria CDC, Plot 801, Ebitu Ukiwe Street, Jabi, Abuja, Nigeria. Electronicaddress: adesola.ogunleye@ncdc.gov.ng.
FAU - Petersen, Brett
AU  - Petersen B
AD  - Centers for Disease Control and Prevention, 1600 Clifton Rd. NE, CDC, Atlanta, GA30333, USA. Electronic address: ige3@cdc.gov.
FAU - Powell, Jacqueline
AU  - Powell J
AD  - Bavarian Nordic Inc, 3025 Carrington Mill Blvd, Morrisville, NC 27560, USA.Electronic address: Jacqueline.Powell@bavarian-nordic.com.
FAU - Quantick, Ollie
AU  - Quantick O
AD  - SO1 Public Health and Health Protection, Army Headquarters, Ground Floor, Zone1, Blenheim Bd, Marlborough Lines, Monxton Road, Andover, Hampshire SP11 8HJ, UK.Electronic address: oliver.quantick180@mod.gov.uk.
FAU - Rimoin, Anne W
AU  - Rimoin AW
AD  - Fielding School of Public Health, UCLA, 50 Charles E Young Dr S, Los Angeles, CA 90095, United States. Electronic address: arimoin@ucla.edu.
FAU - Ulaeato, David
AU  - Ulaeato D
AD  - CBR Division, Defence Science & Technology Laboratory, Porton Down, Salisbury SP40JQ, UK. Electronic address: dulaeto@dstl.gov.uk.
FAU - Wapling, Andy
AU  - Wapling A
AD  - Regional Head of Emergency Preparedness, Resilience and Response, NHS England(South West & South East), UK. Electronic address: andy.wapling@nhs.net.
LA  - eng
PT  - Journal Article
DEP - 20200513
PL  - Netherlands
TA  - Vaccine
JT  - Vaccine
JID - 8406899
RN  - 0 (Smallpox Vaccine)
SB  - IM
MH  - Ghana
MH  - Humans
MH  - Israel
MH  - London
MH  - *Monkeypox/epidemiology/prevention & control
MH  - Monkeypox virus
MH  - Nigeria
MH  - Singapore
MH  - *Smallpox/epidemiology/prevention & control
MH  - *Smallpox Vaccine/adverse effects
OTO - NOTNLM
OT  - *Epidemiology
OT  - *Eradication
OT  - *Monkeypox
OT  - *Orthopox
OT  - *Risk
OT  - *Smallpox
OT  - *Vaccines
COIS- Declaration of Competing Interest The authors declare the following financialinterests/personal relationships which may be considered as potential competinginterests: Authors Elsgaard, Hochrein, Maclennan and Powell are employees ofBavarian Nordic, manufacturer of a vaccine registered as Jynneos for smallpox andmonkeypox indications in the USA (Imvanex for smallpox only in Europe andImvamune for smallpox only in Canada. Simpson works as a consultant for Bavarian Nordic.
EDAT- 2020/05/18 06:00
MHDA- 2021/04/28 06:00
CRDT- 2020/05/18 06:00
PHST- 2020/02/26 00:00 [received]
PHST- 2020/04/26 00:00 [accepted]
PHST- 2020/05/18 06:00 [pubmed]
PHST- 2021/04/28 06:00 [medline]
PHST- 2020/05/18 06:00 [entrez]
AID - S0264-410X(20)30579-X [pii]
AID - 10.1016/j.vaccine.2020.04.062 [doi]
PST - ppublish
SO  - Vaccine. 2020 Jul 14;38(33):5077-5081. doi: 10.1016/j.vaccine.2020.04.062. Epub2020 May 13.

PMID- 32412687
OWN - NLM
STAT- MEDLINE
DCOM- 20210511
LR  - 20210511
IS  - 1742-4658 (Electronic)
IS  - 1742-464X (Linking)
VI  - 287
IP  - 17
DP  - 2020 Sep
TI  - Structural insight into tanapoxvirus-mediated inhibition of apoptosis.
PG  - 3733-3750
LID - 10.1111/febs.15365 [doi]
AB  - Premature programmed cell death or apoptosis of cells is a strategy utilized bymulticellular organisms to counter microbial threats. Tanapoxvirus (TANV) is alarge double-stranded DNA virus belonging to the poxviridae that causes mildmonkeypox-like infections in humans and primates. TANV encodes for a putativeapoptosis inhibitory protein 16L. We show that TANV16L is able to bind to a rangeof peptides spanning the BH3 motif of human proapoptotic Bcl-2 proteins and isable to counter growth arrest of yeast induced by human Bak and Bax. We thendetermined the crystal structures of TANV16L bound to three identifiedinteractors, Bax, Bim and Puma BH3. TANV16L adopts a globular Bcl-2 foldcomprising 7 alpha-helices and utilizes the canonical Bcl-2 binding groove toengage proapoptotic host cell Bcl-2 proteins. Unexpectedly, TANV16L is able toadopt both a monomeric and a domain-swapped dimeric topology where the alpha1helix from one protomer is swapped into a neighbouring unit. Despite adopting twodifferent oligomeric forms, the canonical ligand binding groove in TANV16Lremains unchanged from monomer to domain-swapped dimer. Our results provide astructural and mechanistic basis for tanapoxvirus-mediated inhibition of hostcell apoptosis and reveal the capacity of Bcl-2 proteins to adopt differentialoligomeric states whilst maintaining the canonical ligand binding groove in anunchanged state. DATABASE: Structural data are available in the Protein Data Bank(PDB) under the accession numbers 6TPQ, 6TQQ and 6TRR.
CI  - (c) 2020 Federation of European Biochemical Societies.
FAU - Suraweera, Chathura D
AU  - Suraweera CD
AUID- ORCID: 0000-0001-9185-6063
AD  - Department of Biochemistry and Genetics, La Trobe Institute for MolecularScience, La Trobe University, Melbourne, Australia.
FAU - Anasir, Mohd Ishtiaq
AU  - Anasir MI
AD  - Department of Biochemistry and Genetics, La Trobe Institute for MolecularScience, La Trobe University, Melbourne, Australia.
FAU - Chugh, Srishti
AU  - Chugh S
AD  - Department of Biochemistry and Genetics, La Trobe Institute for MolecularScience, La Trobe University, Melbourne, Australia.
FAU - Javorsky, Airah
AU  - Javorsky A
AD  - Department of Biochemistry and Genetics, La Trobe Institute for MolecularScience, La Trobe University, Melbourne, Australia.
FAU - Impey, Rachael E
AU  - Impey RE
AD  - Department of Biochemistry and Genetics, La Trobe Institute for MolecularScience, La Trobe University, Melbourne, Australia.
FAU - Hasan Zadeh, Mohammad
AU  - Hasan Zadeh M
AD  - Department of Biochemistry and Genetics, La Trobe Institute for MolecularScience, La Trobe University, Melbourne, Australia.
FAU - Soares da Costa, Tatiana P
AU  - Soares da Costa TP
AUID- ORCID: 0000-0002-6275-7485
AD  - Department of Biochemistry and Genetics, La Trobe Institute for MolecularScience, La Trobe University, Melbourne, Australia.
FAU - Hinds, Mark G
AU  - Hinds MG
AUID- ORCID: 0000-0002-2856-5375
AD  - Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne,Parkville, Australia.
FAU - Kvansakul, Marc
AU  - Kvansakul M
AUID- ORCID: 0000-0003-2639-2498
AD  - Department of Biochemistry and Genetics, La Trobe Institute for MolecularScience, La Trobe University, Melbourne, Australia.
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20200531
PL  - England
TA  - FEBS J
JT  - The FEBS journal
JID - 101229646
RN  - 0 (Apoptosis Regulatory Proteins)
RN  - 0 (BAK1 protein, human)
RN  - 0 (BAX protein, human)
RN  - 0 (BBC3 protein, human)
RN  - 0 (Bcl-2-Like Protein 11)
RN  - 0 (HRK protein, human)
RN  - 0 (Proto-Oncogene Proteins)
RN  - 0 (Proto-Oncogene Proteins c-bcl-2)
RN  - 0 (Recombinant Proteins)
RN  - 0 (Viral Nonstructural Proteins)
RN  - 0 (bcl-2 Homologous Antagonist-Killer Protein)
RN  - 0 (bcl-2-Associated X Protein)
SB  - IM
MH  - Amino Acid Sequence
MH  - *Apoptosis
MH  - Apoptosis Regulatory Proteins/*chemistry/metabolism
MH  - Bcl-2-Like Protein 11/metabolism
MH  - Humans
MH  - Models, Molecular
MH  - Protein Binding
MH  - Protein Conformation
MH  - Protein Domains
MH  - Protein Interaction Mapping
MH  - Proto-Oncogene Proteins/metabolism
MH  - Proto-Oncogene Proteins c-bcl-2/*metabolism
MH  - Recombinant Proteins/metabolism
MH  - Saccharomyces cerevisiae/genetics
MH  - Sequence Alignment
MH  - Sequence Homology, Amino Acid
MH  - Structure-Activity Relationship
MH  - Viral Nonstructural Proteins/*chemistry/metabolism
MH  - Yatapoxvirus/*physiology
MH  - bcl-2 Homologous Antagonist-Killer Protein/physiology
MH  - bcl-2-Associated X Protein/metabolism/physiology
OTO - NOTNLM
OT  - *Bcl-2
OT  - *X-ray crystallography
OT  - *apoptosis
OT  - *poxvirus
OT  - *tanapoxvirus
EDAT- 2020/05/16 06:00
MHDA- 2021/05/12 06:00
CRDT- 2020/05/16 06:00
PHST- 2020/01/23 00:00 [received]
PHST- 2020/04/26 00:00 [revised]
PHST- 2020/05/12 00:00 [accepted]
PHST- 2020/05/16 06:00 [pubmed]
PHST- 2021/05/12 06:00 [medline]
PHST- 2020/05/16 06:00 [entrez]
AID - 10.1111/febs.15365 [doi]
PST - ppublish
SO  - FEBS J. 2020 Sep;287(17):3733-3750. doi: 10.1111/febs.15365. Epub 2020 May 31.

PMID- 32390964
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20200928
IS  - 1664-302X (Print)
IS  - 1664-302X (Linking)
VI  - 11
DP  - 2020
TI  - Discovery of Retro-1 Analogs Exhibiting Enhanced Anti-vaccinia Virus Activity.
PG  - 603
LID - 10.3389/fmicb.2020.00603 [doi]
AB  - Orthopoxviruses (OPXVs) are an increasing threat to human health due to thegrowing population of OPXV-naive individuals after the discontinuation of routinesmallpox vaccination. Antiviral drugs that are effective as postexposuretreatments against variola virus (the causative agent of smallpox) or other OPXVsare critical in the event of an OPXV outbreak or exposure. The only US Food andDrug Administration-approved drug to treat smallpox, Tecovirimat (ST-246), exertsits antiviral effect by inhibiting extracellular virus (EV) formation, therebypreventing cell-cell and long-distance spread. We and others have previouslydemonstrated that host Golgi-associated retrograde proteins play an importantrole in monkeypox virus (MPXV) and vaccinia virus (VACV) EV formation. Inhibitionof the retrograde pathway by small molecules such as Retro-2 has been shown todecrease VACV infection in vitro and to a lesser extent in vivo. To identify morepotent inhibitors of the retrograde pathway, we screened a large panel ofcompounds containing a benzodiazepine scaffold like that of Retro-1, against VACVinfection. We found that a subset of these compounds displayed better anti-VACVactivity, causing a reduction in EV particle formation and viral spread compared to Retro-1. PA104 emerged as the most potent analog, inhibiting 90% viral spread at 1.3 muM with a high selectivity index. In addition, PA104 strongly inhibitedtwo distinct ST-246-resistant viruses, demonstrating its potential benefit foruse in combination therapy with ST-246. These data and further characterizations of the specific protein targets and in vivo efficacy of PA104 may have important implications for the design of effective antivirals against OPXV.
CI  - Copyright (c) 2020 Priyamvada, Alabi, Leon, Kumar, Sambhara, Olson, Sello andSatheshkumar.
FAU - Priyamvada, Lalita
AU  - Priyamvada L
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, GA, United States.
FAU - Alabi, Philip
AU  - Alabi P
AD  - Department of Chemistry, Brown University, Providence, RI, United States.
FAU - Leon, Andres
AU  - Leon A
AD  - Department of Chemistry, Brown University, Providence, RI, United States.
FAU - Kumar, Amrita
AU  - Kumar A
AD  - Immunology and Pathogenesis Branch, Influenza Division, Centers for DiseaseControl and Prevention, Atlanta, GA, United States.
FAU - Sambhara, Suryaprakash
AU  - Sambhara S
AD  - Immunology and Pathogenesis Branch, Influenza Division, Centers for DiseaseControl and Prevention, Atlanta, GA, United States.
FAU - Olson, Victoria A
AU  - Olson VA
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, GA, United States.
FAU - Sello, Jason K
AU  - Sello JK
AD  - Department of Chemistry, Brown University, Providence, RI, United States.
FAU - Satheshkumar, Panayampalli S
AU  - Satheshkumar PS
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, GA, United States.
LA  - eng
PT  - Journal Article
DEP - 20200423
PL  - Switzerland
TA  - Front Microbiol
JT  - Frontiers in microbiology
JID - 101548977
PMC - PMC7190985
OTO - NOTNLM
OT  - Retro-1
OT  - ST-246
OT  - antiviral agent
OT  - poxvirus
OT  - retrograde inhibitor
OT  - retrograde transport
OT  - vaccinia virus
OT  - viral inhibitor
EDAT- 2020/05/12 06:00
MHDA- 2020/05/12 06:01
CRDT- 2020/05/12 06:00
PHST- 2019/11/26 00:00 [received]
PHST- 2020/03/18 00:00 [accepted]
PHST- 2020/05/12 06:00 [entrez]
PHST- 2020/05/12 06:00 [pubmed]
PHST- 2020/05/12 06:01 [medline]
AID - 10.3389/fmicb.2020.00603 [doi]
PST - epublish
SO  - Front Microbiol. 2020 Apr 23;11:603. doi: 10.3389/fmicb.2020.00603. eCollection2020.

PMID- 32341480
OWN - NLM
STAT- MEDLINE
DCOM- 20201020
LR  - 20210406
IS  - 2058-5276 (Electronic)
IS  - 2058-5276 (Linking)
VI  - 5
IP  - 7
DP  - 2020 Jul
TI  - Monkeypox virus emergence in wild chimpanzees reveals distinct clinical outcomes and viral diversity.
PG  - 955-965
LID - 10.1038/s41564-020-0706-0 [doi]
AB  - Monkeypox is a viral zoonotic disease on the rise across endemic habitats.Despite the growing importance of monkeypox virus, our knowledge on its hostspectrum and sylvatic maintenance is limited. Here, we describe the recentrepeated emergence of monkeypox virus in a wild, human-habituated westernchimpanzee (Pan troglodytes verus, hereafter chimpanzee) population from TaiNational Park, Ivory Coast. Through daily monitoring, we show that further tocausing its typical exanthematous syndrome, monkeypox can present itself as asevere respiratory disease without a diffuse rash. By analysing 949non-invasively collected samples, we identify the circulation of at least twodistinct monkeypox virus lineages and document the shedding of infectiousparticles in faeces and flies, suggesting that they could mediate indirecttransmission. We also show that the carnivorous component of the Tai chimpanzees'diet, mainly consisting of the sympatric monkeys they regularly hunt, did notchange nor shift towards rodent consumption (the presumed reservoir) before theoutbreaks, suggesting that the sudden emergence of monkeypox virus in thispopulation is probably due to changes in the ecology of the virus itself. Usinglong-term mortality surveillance data from Tai National Park, we provide evidenceof little to no prior viral activity over at least two decades. We conclude that great ape sentinel systems devoted to the longitudinal collection of behavioural and health data can help clarify the epidemiology and clinical presentation ofzoonotic pathogens.
FAU - Patrono, Livia V
AU  - Patrono LV
AD  - Project Group Epidemiology of Highly Pathogenic Microorganisms, Robert KochInstitute, Berlin, Germany.
FAU - Pleh, Kamilla
AU  - Pleh K
AD  - Project Group Epidemiology of Highly Pathogenic Microorganisms, Robert KochInstitute, Berlin, Germany.
AD  - Tai Chimpanzee Project, Centre Suisse de Recherches Scientifiques, Abidjan, IvoryCoast.
FAU - Samuni, Liran
AU  - Samuni L
AD  - Tai Chimpanzee Project, Centre Suisse de Recherches Scientifiques, Abidjan, IvoryCoast.
AD  - Department of Primatology, Max Planck Institute for Evolutionary Anthropology,Leipzig, Germany.
FAU - Ulrich, Markus
AU  - Ulrich M
AD  - Project Group Epidemiology of Highly Pathogenic Microorganisms, Robert KochInstitute, Berlin, Germany.
FAU - Rothemeier, Caroline
AU  - Rothemeier C
AD  - Project Group Epidemiology of Highly Pathogenic Microorganisms, Robert KochInstitute, Berlin, Germany.
FAU - Sachse, Andreas
AU  - Sachse A
AD  - Project Group Epidemiology of Highly Pathogenic Microorganisms, Robert KochInstitute, Berlin, Germany.
FAU - Muschter, Silvia
AU  - Muschter S
AD  - Centre for Biological Threats and Special Pathogens and German ReferenceLaboratory for Poxviruses (ZBS1), Robert Koch Institute, Berlin, Germany.
FAU - Nitsche, Andreas
AU  - Nitsche A
AD  - Centre for Biological Threats and Special Pathogens and German ReferenceLaboratory for Poxviruses (ZBS1), Robert Koch Institute, Berlin, Germany.
FAU - Couacy-Hymann, Emmanuel
AU  - Couacy-Hymann E
AD  - Laboratoire National D'appui au Developpement Agricole/Laboratoire Central dePathologie Animale, Bingerville, Ivory Coast.
FAU - Boesch, Christophe
AU  - Boesch C
AD  - Tai Chimpanzee Project, Centre Suisse de Recherches Scientifiques, Abidjan, IvoryCoast.
AD  - Department of Primatology, Max Planck Institute for Evolutionary Anthropology,Leipzig, Germany.
FAU - Wittig, Roman M
AU  - Wittig RM
AUID- ORCID: http://orcid.org/0000-0001-6490-4031
AD  - Tai Chimpanzee Project, Centre Suisse de Recherches Scientifiques, Abidjan, IvoryCoast.
AD  - Department of Primatology, Max Planck Institute for Evolutionary Anthropology,Leipzig, Germany.
FAU - Calvignac-Spencer, Sebastien
AU  - Calvignac-Spencer S
AD  - Project Group Epidemiology of Highly Pathogenic Microorganisms, Robert KochInstitute, Berlin, Germany.
FAU - Leendertz, Fabian H
AU  - Leendertz FH
AUID- ORCID: http://orcid.org/0000-0002-2169-7375
AD  - Project Group Epidemiology of Highly Pathogenic Microorganisms, Robert KochInstitute, Berlin, Germany. LeendertzF@rki.de.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20200427
PL  - England
TA  - Nat Microbiol
JT  - Nature microbiology
JID - 101674869
RN  - GAN16C9B8O (Glutathione)
SB  - IM
CIN - Nat Microbiol. 2020 Jul;5(7):885-886. PMID: 32587376
MH  - Animals
MH  - *Animals, Wild
MH  - Ecosystem
MH  - Exanthema/etiology/metabolism/pathology
MH  - Extracellular Space/metabolism
MH  - Feces/virology
MH  - Genome, Viral
MH  - Genomics/methods
MH  - Glutathione/metabolism
MH  - High-Throughput Nucleotide Sequencing
MH  - Monkeypox/complications/metabolism/mortality/*virology
MH  - Monkeypox virus/classification/isolation & purification/*physiology
MH  - Pan troglodytes/metabolism/*virology
MH  - Phylogeny
MH  - Respiration Disorders/etiology/metabolism
EDAT- 2020/04/29 06:00
MHDA- 2020/10/21 06:00
CRDT- 2020/04/29 06:00
PHST- 2019/09/30 00:00 [received]
PHST- 2020/03/09 00:00 [accepted]
PHST- 2020/04/29 06:00 [pubmed]
PHST- 2020/10/21 06:00 [medline]
PHST- 2020/04/29 06:00 [entrez]
AID - 10.1038/s41564-020-0706-0 [doi]
AID - 10.1038/s41564-020-0706-0 [pii]
PST - ppublish
SO  - Nat Microbiol. 2020 Jul;5(7):955-965. doi: 10.1038/s41564-020-0706-0. Epub 2020Apr 27.

PMID- 32338590
OWN - NLM
STAT- MEDLINE
DCOM- 20210618
LR  - 20220711
IS  - 1080-6059 (Electronic)
IS  - 1080-6040 (Linking)
VI  - 26
IP  - 8
DP  - 2020 Aug
TI  - Imported Monkeypox, Singapore.
PG  - 1826-1830
LID - 10.3201/eid2608.191387 [doi]
AB  - In May 2019, we investigated monkeypox in a traveler from Nigeria to Singapore.The public health response included rapid identification of contacts, use ofquarantine, and postexposure smallpox vaccination. No secondary cases wereidentified. Countries should develop surveillance systems to detect emerginginfectious diseases globally.
FAU - Yong, Sarah Ee Fang
AU  - Yong SEF
FAU - Ng, Oon Tek
AU  - Ng OT
FAU - Ho, Zheng Jie Marc
AU  - Ho ZJM
FAU - Mak, Tze Minn
AU  - Mak TM
FAU - Marimuthu, Kalisvar
AU  - Marimuthu K
FAU - Vasoo, Shawn
AU  - Vasoo S
FAU - Yeo, Tsin Wen
AU  - Yeo TW
FAU - Ng, Yi Kai
AU  - Ng YK
FAU - Cui, Lin
AU  - Cui L
FAU - Ferdous, Zannatul
AU  - Ferdous Z
FAU - Chia, Po Ying
AU  - Chia PY
FAU - Aw, Bryan Jun Wei
AU  - Aw BJW
FAU - Manauis, Charmaine Malenab
AU  - Manauis CM
FAU - Low, Constance Khia Ki
AU  - Low CKK
FAU - Chan, Guanhao
AU  - Chan G
FAU - Peh, Xinyi
AU  - Peh X
FAU - Lim, Poh Lian
AU  - Lim PL
FAU - Chow, Li Ping Angela
AU  - Chow LPA
FAU - Chan, Monica
AU  - Chan M
FAU - Lee, Vernon Jian Ming
AU  - Lee VJM
FAU - Lin, Raymond Tzer Pin
AU  - Lin RTP
FAU - Heng, Mok Kwee Derrick
AU  - Heng MKD
FAU - Leo, Yee Sin
AU  - Leo YS
LA  - eng
PT  - Journal Article
DEP - 20200427
PL  - United States
TA  - Emerg Infect Dis
JT  - Emerging infectious diseases
JID - 9508155
SB  - IM
MH  - *Communicable Diseases, Emerging/epidemiology
MH  - Humans
MH  - *Monkeypox/diagnosis/epidemiology
MH  - Monkeypox virus/genetics
MH  - Nigeria
MH  - Singapore/epidemiology
PMC - PMC7392406
OTO - NOTNLM
OT  - *Monkeypox
OT  - *Nigeria
OT  - *Singapore
OT  - *communicable disease control
OT  - *disease outbreaks
OT  - *imported infectious diseases
OT  - *monkeypox virus
OT  - *orthopoxvirus
OT  - *viruses
OT  - *zoonoses
EDAT- 2020/04/28 06:00
MHDA- 2021/06/22 06:00
CRDT- 2020/04/28 06:00
PHST- 2020/04/28 06:00 [pubmed]
PHST- 2021/06/22 06:00 [medline]
PHST- 2020/04/28 06:00 [entrez]
AID - 10.3201/eid2608.191387 [doi]
PST - ppublish
SO  - Emerg Infect Dis. 2020 Aug;26(8):1826-1830. doi: 10.3201/eid2608.191387. Epub2020 Apr 27.

PMID- 32328334
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20200928
IS  - 2090-6803 (Print)
VI  - 2020
DP  - 2020
TI  - A Case Report of Monkeypox in a 4-Year-Old Boy from the DR Congo: Challenges ofDiagnosis and Management.
PG  - 8572596
LID - 10.1155/2020/8572596 [doi]
AB  - Monkeypox (MP) is a rare zoonotic disease that most commonly transmits from bush animals to humans in the Congo Basin of Africa. However, an increase in cases of MP has been observed over the past decades with frequent outbreaks as well asexport of the disease out of the African continent. MP belongs to the same genus of viruses as smallpox, the Orthopoxvirus, and vaccination against smallpox givessome protection against MP. With the eradication of smallpox in 1980, vaccinationagainst smallpox has ceased. The resulting decrease of immunity againstOrthopoxvirus is thought to be related to the increase in MP cases. Furthermore, closer contact between humans and bush animals could play a role along with theongoing difficulties of controlling HIV in the same geographical area. MP remainsa diagnostic challenge. Lack of knowledge about the disease among healthpersonnel plays an important role, as well as access to diagnostic tools islimited. Treatment of MP is for now symptomatic. We report the case of a4-year-old boy from the DR Congo with the clinical diagnosis of MP. This caseillustrates some of the abovementioned challenges related to the management of MPin the field.
CI  - Copyright (c) 2020 Anna Korsgaard Eltvedt et al.
FAU - Eltvedt, Anna Korsgaard
AU  - Eltvedt AK
AUID- ORCID: https://orcid.org/0000-0002-8086-6757
AD  - Global Health Unit, Department of Paediatric and Adolescent Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen O, Denmark.
AD  - Department of Congenital Disordes, Statens Serum Institut, Copenhagen S, Denmark.
FAU - Christiansen, Michael
AU  - Christiansen M
AD  - Department of Congenital Disordes, Statens Serum Institut, Copenhagen S, Denmark.
FAU - Poulsen, Anja
AU  - Poulsen A
AD  - Global Health Unit, Department of Paediatric and Adolescent Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen O, Denmark.
LA  - eng
PT  - Case Reports
DEP - 20200409
PL  - United States
TA  - Case Rep Pediatr
JT  - Case reports in pediatrics
JID - 101581030
PMC - PMC7171673
COIS- The authors declare that there are no conflicts of interest regarding thepublication of this article.
EDAT- 2020/04/25 06:00
MHDA- 2020/04/25 06:01
CRDT- 2020/04/25 06:00
PHST- 2019/09/12 00:00 [received]
PHST- 2020/03/05 00:00 [accepted]
PHST- 2020/04/25 06:00 [entrez]
PHST- 2020/04/25 06:00 [pubmed]
PHST- 2020/04/25 06:01 [medline]
AID - 10.1155/2020/8572596 [doi]
PST - epublish
SO  - Case Rep Pediatr. 2020 Apr 9;2020:8572596. doi: 10.1155/2020/8572596. eCollection2020.

PMID- 32325980
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20200928
IS  - 2076-0817 (Print)
IS  - 2076-0817 (Linking)
VI  - 9
IP  - 4
DP  - 2020 Apr 20
TI  - Systematic Review of Important Viral Diseases in Africa in Light of the 'OneHealth' Concept.
LID - E301 [pii]
LID - 10.3390/pathogens9040301 [doi]
AB  - Emerging and re-emerging viral diseases are of great public health concern. Therecent emergence of Severe Acute Respiratory Syndrome (SARS) related coronavirus (SARS-CoV-2) in December 2019 in China, which causes COVID-19 disease in humans, and its current spread to several countries, leading to the first pandemic inhistory to be caused by a coronavirus, highlights the significance of zoonoticviral diseases. Rift Valley fever, rabies, West Nile, chikungunya, dengue, yellowfever, Crimean-Congo hemorrhagic fever, Ebola, and influenza viruses among manyother viruses have been reported from different African countries. The paucity ofinformation, lack of knowledge, limited resources, and climate change, coupledwith cultural traditions make the African continent a hotspot for vector-borneand zoonotic viral diseases, which may spread globally. Currently, there is noinformation available on the status of virus diseases in Africa. This systematic review highlights the available information about viral diseases, includingzoonotic and vector-borne diseases, reported in Africa. The findings will help usunderstand the trend of emerging and re-emerging virus diseases within theAfrican continent. The findings recommend active surveillance of viral diseasesand strict implementation of One Health measures in Africa to improve humanpublic health and reduce the possibility of potential pandemics due to zoonoticviruses.
FAU - Chauhan, Ravendra P
AU  - Chauhan RP
AUID- ORCID: 0000-0002-4674-8255
AD  - School of Laboratory Medicine and Medical Sciences, College of Health Sciences,University of KwaZulu-Natal, Durban 4001, South Africa.
FAU - Dessie, Zelalem G
AU  - Dessie ZG
AUID- ORCID: 0000-0001-9056-6822
AD  - School of Mathematics, Statistics and Computer Science, University ofKwaZulu-Natal, Durban 4001, South Africa.
AD  - Department of Statistics, College of Science, Bahir Dar University, Bahir Dar6000, Ethiopia.
FAU - Noreddin, Ayman
AU  - Noreddin A
AUID- ORCID: 0000-0003-4899-1168
AD  - Infectious Diseases and Anti-Infective Therapy Research Group, Sharjah MedicalResearch Institute and College of Pharmacy, University of Sharjah, Sharjah 27272,UAE.
AD  - Department of Medicine, School of Medicine, University of California, Irvine, CA 92868, USA.
FAU - El Zowalaty, Mohamed E
AU  - El Zowalaty ME
AUID- ORCID: 0000-0002-1056-4761
AD  - Infectious Diseases and Anti-Infective Therapy Research Group, Sharjah MedicalResearch Institute and College of Pharmacy, University of Sharjah, Sharjah 27272,UAE.
AD  - Zoonosis Science Center, Department of Medical Biochemistry and Microbiology,Uppsala University, SE 75185 Uppsala, Sweden.
AD  - Division of Virology, Department of Infectious Diseases and St. Jude Center ofExcellence for Influenza Research and Surveillance (CEIRS), St Jude ChildrenResearch Hospital, Memphis, TN 38105, USA.
LA  - eng
PT  - Journal Article
DEP - 20200420
PL  - Switzerland
TA  - Pathogens
JT  - Pathogens (Basel, Switzerland)
JID - 101596317
PMC - PMC7238228
OTO - NOTNLM
OT  - Africa
OT  - COVID-19
OT  - Ebola
OT  - Rift Valley fever virus
OT  - SARS-CoV-2
OT  - West Nile virus
OT  - avian influenza
OT  - coronaviruses
OT  - dengue
OT  - emerging
OT  - epidemiology
OT  - hemorrhagic fever
OT  - infectious diseases
OT  - influenza A virus
OT  - monkeypox
OT  - one health
OT  - pandemic
OT  - rabies
OT  - re-emerging
OT  - simian immunodeficiency
OT  - vector-borne
OT  - virus
OT  - zoonosis
EDAT- 2020/04/25 06:00
MHDA- 2020/04/25 06:01
CRDT- 2020/04/25 06:00
PHST- 2020/02/17 00:00 [received]
PHST- 2020/04/03 00:00 [revised]
PHST- 2020/04/07 00:00 [accepted]
PHST- 2020/04/25 06:00 [entrez]
PHST- 2020/04/25 06:00 [pubmed]
PHST- 2020/04/25 06:01 [medline]
AID - pathogens9040301 [pii]
AID - 10.3390/pathogens9040301 [doi]
PST - epublish
SO  - Pathogens. 2020 Apr 20;9(4). pii: pathogens9040301. doi:10.3390/pathogens9040301.

PMID- 32320436
OWN - NLM
STAT- MEDLINE
DCOM- 20200804
LR  - 20200804
IS  - 1553-7374 (Electronic)
IS  - 1553-7366 (Linking)
VI  - 16
IP  - 4
DP  - 2020 Apr
TI  - Natural killer cells expanded in vivo or ex vivo with IL-15 overcomes theinherent susceptibility of CAST mice to lethal infection with orthopoxviruses.
PG  - e1008505
LID - 10.1371/journal.ppat.1008505 [doi]
AB  - The wild-derived inbred CAST/EiJ mouse, one of eight founder strains in theCollaborative Cross panel, is an exceptional model for studying monkeypox virus(MPXV), an emerging human pathogen, and other orthopoxviruses including vaccinia virus (VACV). Previous studies suggested that the extreme susceptibility of theCAST mouse to orthopoxviruses is due to an insufficient innate immune response.Here, we focused on the low number of natural killer (NK) cells in the naive CASTmouse as a contributing factor to this condition. Administration of IL-15 to CASTmice transiently increased NK and CD8+ T cells that could express IFN-gamma,indicating that the progenitor cells were capable of responding to cytokines.However, the number of NK cells rapidly declined indicating a defect in theirhomeostasis. Furthermore, IL-15-treated mice were protected from an otherwiselethal challenge with VACV or MPXV. IL-15 decreased virus spread and delayeddeath even when CD4+/CD8+ T cells were depleted with antibody, supporting anearly protective role of the expanded NK cells. Purified splenic NK cells fromCAST mice proliferated in vitro in response to IL-15 and could be activated with IL-12/IL-18 to secrete interferon-gamma. Passive transfer of non-activated oractivated CAST NK cells reduced VACV spread but only the latter completelyprevented death at the virus dose used. Moreover, antibodies to interferon-gamma abrogated the protection by activated NK cells. Thus, the inherent susceptibilityof CAST mice to orthopoxviruses can be explained by a low level of NK cells andthis vulnerability can be overcome either by expanding their NK cells in vivowith IL-15 or by passive transfer of purified NK cells that were expanded andactivated in vitro.
FAU - Earl, Patricia L
AU  - Earl PL
AD  - Laboratory of Viral Diseases, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, Bethesda, Maryland, United States ofAmerica.
FAU - Americo, Jeffrey L
AU  - Americo JL
AD  - Laboratory of Viral Diseases, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, Bethesda, Maryland, United States ofAmerica.
FAU - Moss, Bernard
AU  - Moss B
AUID- ORCID: 0000-0002-2154-8564
AD  - Laboratory of Viral Diseases, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, Bethesda, Maryland, United States ofAmerica.
LA  - eng
PT  - Journal Article
PT  - Research Support, N.I.H., Intramural
DEP - 20200422
PL  - United States
TA  - PLoS Pathog
JT  - PLoS pathogens
JID - 101238921
RN  - 0 (Cytokines)
RN  - 0 (Interleukin-15)
RN  - 82115-62-6 (Interferon-gamma)
SB  - IM
MH  - Animals
MH  - CD8-Positive T-Lymphocytes/drug effects/immunology
MH  - Cytokines/immunology
MH  - Female
MH  - Immunity, Innate/drug effects
MH  - Interferon-gamma/immunology
MH  - Interleukin-15/immunology/*pharmacology
MH  - Killer Cells, Natural/drug effects/*immunology
MH  - Mice
MH  - Mice, Inbred C57BL
MH  - Mice, Inbred Strains
MH  - Orthopoxvirus/drug effects/*immunology/pathogenicity
MH  - Poxviridae Infections/drug therapy/*immunology
MH  - Signal Transduction/drug effects
MH  - Spleen/drug effects/pathology/virology
MH  - Vaccinia virus/immunology
PMC - PMC7197867
COIS- The authors have declared that no competing interests exist.
EDAT- 2020/04/23 06:00
MHDA- 2020/08/05 06:00
CRDT- 2020/04/23 06:00
PHST- 2019/08/20 00:00 [received]
PHST- 2020/03/26 00:00 [accepted]
PHST- 2020/05/04 00:00 [revised]
PHST- 2020/04/23 06:00 [pubmed]
PHST- 2020/08/05 06:00 [medline]
PHST- 2020/04/23 06:00 [entrez]
AID - 10.1371/journal.ppat.1008505 [doi]
AID - PPATHOGENS-D-19-01518 [pii]
PST - epublish
SO  - PLoS Pathog. 2020 Apr 22;16(4):e1008505. doi: 10.1371/journal.ppat.1008505.eCollection 2020 Apr.

PMID- 34285423
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20210722
IS  - 0037-5497 (Print)
IS  - 0037-5497 (Linking)
VI  - 96
IP  - 4
DP  - 2020 Apr
TI  - Misinformation making a disease outbreak worse: outcomes compared for influenza, monkeypox, and norovirus.
PG  - 365-374
LID - 10.1177/0037549719885021 [doi]
AB  - Health misinformation can exacerbate infectious disease outbreaks. Especiallypernicious advice could be classified as "fake news": manufactured with norespect for accuracy and often integrated with emotive or conspiracy-framednarratives. We built an agent-based model that simulated separate but linkedcirculating contagious disease and sharing of health advice (classified as usefulor harmful). Such advice has potential to influence human risk-taking behaviorand therefore the risk of acquiring infection, especially as people are morelikely in observed social networks to share bad advice. We test strategiesproposed in the recent literature for countering misinformation. Reducing harmfuladvice from 50% to 40% of circulating information, or making at least 20% of the population unable to share or believe harmful advice, mitigated the influence of bad advice in the disease outbreak outcomes. How feasible it is to try to makepeople "immune" to misinformation or control spread of harmful advice should beexplored.
CI  - (c) The Author(s) 2019.
FAU - Brainard, Julii
AU  - Brainard J
AUID- ORCID: https://orcid.org/0000-0002-5272-7995
AD  - Norwich Medical School, University of East Anglia, UK.
FAU - Hunter, Paul R
AU  - Hunter PR
AD  - Norwich Medical School, University of East Anglia, UK.
LA  - eng
PT  - Journal Article
PL  - England
TA  - Simulation
JT  - Simulation
JID - 9881268
PMC - PMC8282656
OTO - NOTNLM
OT  - Agent-based models
OT  - fake news
OT  - influenza
OT  - monkeypox
OT  - norovirus
OT  - social networks
EDAT- 2020/04/01 00:00
MHDA- 2020/04/01 00:01
CRDT- 2021/07/21 06:30
PHST- 2021/07/21 06:30 [entrez]
PHST- 2020/04/01 00:00 [pubmed]
PHST- 2020/04/01 00:01 [medline]
AID - 10.1177/0037549719885021 [doi]
AID - 10.1177_0037549719885021 [pii]
PST - ppublish
SO  - Simulation. 2020 Apr;96(4):365-374. doi: 10.1177/0037549719885021.

PMID- 32202967
OWN - NLM
STAT- MEDLINE
DCOM- 20210408
LR  - 20210408
IS  - 2047-7732 (Electronic)
IS  - 2047-7724 (Linking)
VI  - 114
IP  - 2
DP  - 2020 Mar
TI  - Knowledge of human monkeypox viral infection among general practitioners: across-sectional study in Indonesia.
PG  - 68-75
LID - 10.1080/20477724.2020.1743037 [doi]
AB  - After the first, imported, laboratory-confirmed case of monkeypox in human wasreported in Singapore on May 2019, countries in Asia started to strengthendisease surveillance systems. One challenge in preventing monkeypox is a lack of knowledge, particularly among healthcare workers. The aim of this study was toassess the knowledge of monkeypox among general practitioners (GPs) in Indonesia.A cross-sectional online survey was conducted. The survey collected participants'knowledge on a 21-item scale and explanatory variables. A two-step logisticregression analysis was employed to assess the predictors of knowledge ofmonkeypox. A total of 432 GPs were included; 10.0% and 36.5% of them had a goodknowledge using an 80% and 70% cutoff point for knowledge domain, respectively.No explanatory variables were associated with knowledge when using 80% cutoffpoint. Using the lower cutoff, there was lower knowledge among GPs who graduated from universities located in Sumatra or other islands versus Java (adjusted odds ratio (aOR): 0.53; 95%CI: 0.28-0.97, p = 0.041) and among those were older than30 years compared to younger GPs (aOR: 0.61; 95%CI: 0.39-0.96, p = 0.033). GPsworking in private clinics had less knowledge compared to GPs in community healthcenters (aOR: 0.55; 95%CI: 0.31-0.99, p = 0.047). In conclusion, knowledge ofmonkeypox among GPs in Indonesia is relatively low in all groups. Increasingknowledge of monkeypox will be key to improving the capacity of GPs to respond tohuman monkeypox cases and to report into a disease surveillance system.
FAU - Harapan, Harapan
AU  - Harapan H
AUID- ORCID: 0000-0001-7630-8413
AD  - Medical Research Unit, School of Medicine, Universitas Syiah Kuala, Banda Aceh,Indonesia.
AD  - Tropical Disease Centre, School of Medicine, Universitas Syiah Kuala, Banda Aceh,Indonesia.
AD  - Department of Microbiology, School of Medicine, Universitas Syiah Kuala, BandaAceh, Indonesia.
FAU - Setiawan, Abdul M
AU  - Setiawan AM
AD  - Department of Microbiology, Faculty of Medicine and Health Sciences, MaulanaMalik Ibrahim State Islamic University of Malang, Malang, Indonesia.
FAU - Yufika, Amanda
AU  - Yufika A
AD  - Department of Family Medicine, School of Medicine, Universitas Syiah Kuala, BandaAceh, Indonesia.
FAU - Anwar, Samsul
AU  - Anwar S
AUID- ORCID: 0000-0003-3165-2151
AD  - Department of Statistics, Faculty of Mathematics and Natural Sciences,Universitas Syiah Kuala, Banda Aceh, Indonesia.
FAU - Wahyuni, Sri
AU  - Wahyuni S
AD  - Faculty of Medicine, Universitas Malikussaleh, Lhokseumawe, Indonesia.
FAU - Asrizal, Febrivan W
AU  - Asrizal FW
AD  - Mohammad Natsir Hospital, Solok, Indonesia.
FAU - Sufri, Muhammad R
AU  - Sufri MR
AD  - Banda Aceh Port Health Office, Ministry of Health, Aceh Besar, Indonesia.
FAU - Putra, Reza P
AU  - Putra RP
AD  - Medical Research Unit, School of Medicine, Universitas Syiah Kuala, Banda Aceh,Indonesia.
FAU - Wijayanti, Nanda P
AU  - Wijayanti NP
AD  - Sabang Hospital, Sabang, Indonesia.
FAU - Salwiyadi, Salwiyadi
AU  - Salwiyadi S
AD  - Department of Internal Medicine, School of Medicine, Universitas Syiah Kuala,Banda Aceh, Indonesia.
FAU - Maulana, Razi
AU  - Maulana R
AD  - Department of Obstetrics and Gynecology, School of Medicine, Universitas SyiahKuala, Banda Aceh, Indonesia.
AD  - Department of Obstetrics and Gynecology, Zainoel Abidin Hospital, Banda Aceh,Indonesia.
FAU - Khusna, Afriyani
AU  - Khusna A
AD  - Meuraxa Hospital, Banda Aceh, Indonesia.
FAU - Nusrina, Ina
AU  - Nusrina I
AUID- ORCID: 0000-0003-4000-1123
AD  - Department of Health Service, District Health Office, Aceh Besar, Indonesia.
FAU - Shidiq, Muhammad
AU  - Shidiq M
AD  - Nusa Jaya Community Health Center, Halmahera Timur, Indonesia.
FAU - Fitriani, Devi
AU  - Fitriani D
AD  - Teunom Community Health Center, Aceh Jaya, Indonesia.
FAU - Muharrir, Muharrir
AU  - Muharrir M
AD  - Medical Research Unit, School of Medicine, Universitas Syiah Kuala, Banda Aceh,Indonesia.
FAU - Husna, Cut A
AU  - Husna CA
AD  - Department of Microbiology, Universitas Malikussaleh, Lhokseumawe, Indonesia.
FAU - Yusri, Fitria
AU  - Yusri F
AD  - Faculty of Medicine, Universitas Malikussaleh, Lhokseumawe, Indonesia.
FAU - Maulana, Reza
AU  - Maulana R
AD  - Medical Research Unit, School of Medicine, Universitas Syiah Kuala, Banda Aceh,Indonesia.
FAU - Andalas, Mohd
AU  - Andalas M
AD  - Medical Research Unit, School of Medicine, Universitas Syiah Kuala, Banda Aceh,Indonesia.
AD  - Department of Obstetrics and Gynecology, School of Medicine, Universitas SyiahKuala, Banda Aceh, Indonesia.
AD  - Department of Obstetrics and Gynecology, Zainoel Abidin Hospital, Banda Aceh,Indonesia.
FAU - Wagner, Abram L
AU  - Wagner AL
AUID- ORCID: 0000-0003-4691-7802
AD  - Department of Epidemiology, University of Michigan, Ann Arbor, MI, USA.
FAU - Mudatsir, Mudatsir
AU  - Mudatsir M
AUID- ORCID: 0000-0002-5643-9384
AD  - Medical Research Unit, School of Medicine, Universitas Syiah Kuala, Banda Aceh,Indonesia.
AD  - Tropical Disease Centre, School of Medicine, Universitas Syiah Kuala, Banda Aceh,Indonesia.
AD  - Department of Microbiology, School of Medicine, Universitas Syiah Kuala, BandaAceh, Indonesia.
LA  - eng
PT  - Journal Article
DEP - 20200323
PL  - England
TA  - Pathog Glob Health
JT  - Pathogens and global health
JID - 101583421
SB  - IM
MH  - Adult
MH  - Cross-Sectional Studies
MH  - Data Collection
MH  - Female
MH  - General Practitioners
MH  - Health Knowledge, Attitudes, Practice
MH  - Humans
MH  - Indonesia/epidemiology
MH  - Male
MH  - Monkeypox/*diagnosis/*epidemiology/virology
MH  - *Monkeypox virus
MH  - Odds Ratio
MH  - Surveys and Questionnaires
PMC - PMC7170312
OTO - NOTNLM
OT  - *Indonesia
OT  - *Monkeypox
OT  - *general practitioner
OT  - *healthcare provider
OT  - *knowledge
OT  - *online survey
EDAT- 2020/03/24 06:00
MHDA- 2021/04/10 06:00
CRDT- 2020/03/24 06:00
PHST- 2020/03/24 06:00 [pubmed]
PHST- 2021/04/10 06:00 [medline]
PHST- 2020/03/24 06:00 [entrez]
AID - 10.1080/20477724.2020.1743037 [doi]
PST - ppublish
SO  - Pathog Glob Health. 2020 Mar;114(2):68-75. doi: 10.1080/20477724.2020.1743037.Epub 2020 Mar 23.

PMID- 32194068
OWN - NLM
STAT- MEDLINE
DCOM- 20200918
LR  - 20210110
IS  - 1873-6254 (Electronic)
IS  - 0001-706X (Linking)
VI  - 206
DP  - 2020 Jun
TI  - Confidence in managing human monkeypox cases in Asia: A cross-sectional surveyamong general practitioners in Indonesia.
PG  - 105450
LID - S0001-706X(20)30005-X [pii]
LID - 10.1016/j.actatropica.2020.105450 [doi]
AB  - The current re-emergence of human monkeypox (HMPX) is a global concern forendemic and non-endemic countries, but healthcare workers in some regions, likeAsia, have less experience with identifying and treating HMPX cases. This studyaimed to assess the confidence and its predictors in HMPX case management amonggeneral practitioners (GPs), the frontline doctors in Indonesia, and to exploretheir perspectives on HMPX. Between May and July 2019, GPs in Indonesia completedan online-based survey. The questionnaire collected information on GPs'confidence, perspective, sociodemographic, workplace and professionalcharacteristics, exposure to HMPX information and knowledge on HMPX. A logisticregression analysis was employed to explore the explanatory variables influencingthe confidence and the perspective. We included 395 GPs in our analysis (77.4%out of 510 responses received) of which 10.1% and 34.9% were classified havinggood confidence using an 80% and 70% cut-off for confidence score, respectively. In the adjusted analysis, receiving information about HMPX during medicaltraining was the only variable significantly associated with good confidence(adjusted odds ratio 2.74, 95% confidence interval 1.57 to 4.78 and p < 0.001).Approximately 73.6% and 77.9% of GPs agreed that HMPX is an important infectious disease and it has potential to detrimentally impact the Indonesian economy,respectively. In addition, 88.8% of GPs suggested that the disease should beincorporated into the National Medical Curriculum of Indonesia. In conclusion, incase of HMPX outbreak, majority of the GPs in Indonesia seem to be less confidentin diagnosing and treating cases, using their current knowledge, skills and theirworkplace facilities. Therefore, a systematic strategy to improve theirconfidence in managing HMPX is required.
CI  - Copyright (c) 2020 Elsevier B.V. All rights reserved.
FAU - Harapan, Harapan
AU  - Harapan H
AD  - Medical Research Unit, School of Medicine, Universitas Syiah Kuala, Banda Aceh,Aceh 23111, Indonesia; Tropical Disease Centre, School of Medicine, UniversitasSyiah Kuala, Banda Aceh, Aceh 23111, Indonesia; Department of Microbiology,School of Medicine, Universitas Syiah Kuala, Banda Aceh, Aceh 23111, Indonesia.Electronic address: harapan@unsyiah.ac.id.
FAU - Setiawan, Abdul M
AU  - Setiawan AM
AD  - Department of Microbiology, Faculty of Medicine and Health Sciences, MaulanaMalik Ibrahim State Islamic University of Malang, Malang, East Java 65144,Indonesia.
FAU - Yufika, Amanda
AU  - Yufika A
AD  - Department of Family Medicine, School of Medicine, Universitas Syiah Kuala, BandaAceh, Aceh 23111, Indonesia.
FAU - Anwar, Samsul
AU  - Anwar S
AD  - Department of Statistics, Faculty of Mathematics and Natural Sciences,Universitas Syiah Kuala, Banda Aceh, Aceh 23111, Indonesia.
FAU - Wahyuni, Sri
AU  - Wahyuni S
AD  - Faculty of Medicine, Universitas Malikussaleh, Lhokseumawe, Aceh 24531,Indonesia.
FAU - Asrizal, Febrivan W
AU  - Asrizal FW
AD  - Mohammad Natsir Hospital, Solok, West Sumatra 27361, Indonesia.
FAU - Sufri, Muhammad R
AU  - Sufri MR
AD  - Banda Aceh Port Health Office, Ministry of Health, Aceh Besar, Aceh 23352,Indonesia.
FAU - Putra, Reza P
AU  - Putra RP
AD  - Medical Research Unit, School of Medicine, Universitas Syiah Kuala, Banda Aceh,Aceh 23111, Indonesia.
FAU - Wijayanti, Nanda P
AU  - Wijayanti NP
AD  - Sabang Hospital, Sabang, Aceh 23522, Indonesia.
FAU - Salwiyadi, Salwiyadi
AU  - Salwiyadi S
AD  - Department of Internal Medicine, School of Medicine, Universitas Syiah KualaBanda Aceh, Aceh 23111, Indonesia.
FAU - Maulana, Razi
AU  - Maulana R
AD  - Department of Obstetrics and Gynecology, School of Medicine, Universitas SyiahKuala, Banda Aceh, Aceh 23111, Indonesia; Department of Obstetrics andGynecology, Zainoel Abidin Hospital, Banda Aceh, Aceh 24415, Indonesia.
FAU - Khusna, Afriyani
AU  - Khusna A
AD  - Meuraxa Hospital, Banda Aceh, Aceh 23231, Indonesia.
FAU - Nusrina, Ina
AU  - Nusrina I
AD  - Department of Health Service, District Health Office, Aceh Besar, Aceh 23912,Indonesia.
FAU - Shidiq, Muhammad
AU  - Shidiq M
AD  - Nusa Jaya Public Health Center, Halmahera Timur, North Maluku 97863, Indonesia.
FAU - Fitriani, Devi
AU  - Fitriani D
AD  - Teunom Public Health Center, Aceh Jaya, Aceh 23653, Indonesia.
FAU - Muharrir, Muharrir
AU  - Muharrir M
AD  - Medical Research Unit, School of Medicine, Universitas Syiah Kuala, Banda Aceh,Aceh 23111, Indonesia.
FAU - Husna, Cut A
AU  - Husna CA
AD  - Department of Microbiology, Universitas Malikussaleh, Lhokseumawe, Aceh 24531,Indonesia.
FAU - Yusri, Fitria
AU  - Yusri F
AD  - Faculty of Medicine, Universitas Malikussaleh, Lhokseumawe, Aceh 24531,Indonesia.
FAU - Maulana, Reza
AU  - Maulana R
AD  - Medical Research Unit, School of Medicine, Universitas Syiah Kuala, Banda Aceh,Aceh 23111, Indonesia.
FAU - Utomo, Prattama S
AU  - Utomo PS
AD  - Department of Medical Education and Bioethics, Faculty of Medicine, Public Healthand Nursing, Universitas Gadjah Mada, Yogjakarta, 55281, Indonesia.
FAU - Andalas, Mohd
AU  - Andalas M
AD  - Medical Research Unit, School of Medicine, Universitas Syiah Kuala, Banda Aceh,Aceh 23111, Indonesia; Department of Obstetrics and Gynecology, School ofMedicine, Universitas Syiah Kuala, Banda Aceh, Aceh 23111, Indonesia; Department of Obstetrics and Gynecology, Zainoel Abidin Hospital, Banda Aceh, Aceh 24415,Indonesia.
FAU - Wagner, Abram L
AU  - Wagner AL
AD  - Department of Epidemiology, University of Michigan, Ann Arbor, Michigan, MI48109, USA.
FAU - Mudatsir, Mudatsir
AU  - Mudatsir M
AD  - Medical Research Unit, School of Medicine, Universitas Syiah Kuala, Banda Aceh,Aceh 23111, Indonesia; Tropical Disease Centre, School of Medicine, UniversitasSyiah Kuala, Banda Aceh, Aceh 23111, Indonesia; Department of Microbiology,School of Medicine, Universitas Syiah Kuala, Banda Aceh, Aceh 23111, Indonesia.
LA  - eng
PT  - Journal Article
DEP - 20200316
PL  - Netherlands
TA  - Acta Trop
JT  - Acta tropica
JID - 0370374
SB  - IM
MH  - Adult
MH  - Aged
MH  - Attitude of Health Personnel
MH  - Cross-Sectional Studies
MH  - Curriculum
MH  - Female
MH  - General Practitioners/education
MH  - Humans
MH  - Logistic Models
MH  - Male
MH  - Middle Aged
MH  - Monkeypox/*therapy
PMC - PMC7111046
OTO - NOTNLM
OT  - Confidence
OT  - General practitioner
OT  - Human monkeypox
OT  - Monkeypox
OT  - Perspective
COIS- Declaration of Competing Interest The authors declare that they have no competinginterests.
EDAT- 2020/03/21 06:00
MHDA- 2020/09/20 06:00
CRDT- 2020/03/21 06:00
PHST- 2020/01/04 00:00 [received]
PHST- 2020/03/14 00:00 [revised]
PHST- 2020/03/14 00:00 [accepted]
PHST- 2020/03/21 06:00 [pubmed]
PHST- 2020/09/20 06:00 [medline]
PHST- 2020/03/21 06:00 [entrez]
AID - S0001-706X(20)30005-X [pii]
AID - 10.1016/j.actatropica.2020.105450 [doi]
PST - ppublish
SO  - Acta Trop. 2020 Jun;206:105450. doi: 10.1016/j.actatropica.2020.105450. Epub 2020Mar 16.

PMID- 32139560
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20200928
IS  - 2576-098X (Electronic)
IS  - 2576-098X (Linking)
VI  - 9
IP  - 10
DP  - 2020 Mar 5
TI  - Identification and Whole-Genome Sequencing of a Monkeypox Virus Strain Isolatedin Israel.
LID - e01524-19 [pii]
LID - 10.1128/MRA.01524-19 [doi]
AB  - We report the whole-genome sequence of a monkeypox virus strain isolated inIsrael. The strain was isolated in 2018 from a patient travelling back from West Africa. The virus was fully sequenced on the Illumina MiSeq and Oxford NanoporeTechnologies MinION platforms.
CI  - Copyright (c) 2020 Cohen-Gihon et al.
FAU - Cohen-Gihon, Inbar
AU  - Cohen-Gihon I
AD  - Department of Biochemistry and Molecular Genetics, Israel Institute forBiological Research, Ness Ziona, Israel.
FAU - Israeli, Ofir
AU  - Israeli O
AD  - Department of Biochemistry and Molecular Genetics, Israel Institute forBiological Research, Ness Ziona, Israel ofiri@iibr.gov.il.
FAU - Shifman, Ohad
AU  - Shifman O
AD  - Department of Biochemistry and Molecular Genetics, Israel Institute forBiological Research, Ness Ziona, Israel.
FAU - Erez, Noam
AU  - Erez N
AD  - Department of Infectious Diseases, Israel Institute for Biological Research, NessZiona, Israel.
FAU - Melamed, Sharon
AU  - Melamed S
AD  - Department of Infectious Diseases, Israel Institute for Biological Research, NessZiona, Israel.
FAU - Paran, Nir
AU  - Paran N
AD  - Department of Infectious Diseases, Israel Institute for Biological Research, NessZiona, Israel.
FAU - Beth-Din, Adi
AU  - Beth-Din A
AD  - Department of Biochemistry and Molecular Genetics, Israel Institute forBiological Research, Ness Ziona, Israel.
FAU - Zvi, Anat
AU  - Zvi A
AD  - Department of Biochemistry and Molecular Genetics, Israel Institute forBiological Research, Ness Ziona, Israel.
LA  - eng
PT  - Journal Article
DEP - 20200305
PL  - United States
TA  - Microbiol Resour Announc
JT  - Microbiology resource announcements
JID - 101728794
PMC - PMC7171222
EDAT- 2020/03/07 06:00
MHDA- 2020/03/07 06:01
CRDT- 2020/03/07 06:00
PHST- 2020/03/07 06:00 [entrez]
PHST- 2020/03/07 06:00 [pubmed]
PHST- 2020/03/07 06:01 [medline]
AID - 9/10/e01524-19 [pii]
AID - 10.1128/MRA.01524-19 [doi]
PST - epublish
SO  - Microbiol Resour Announc. 2020 Mar 5;9(10). pii: 9/10/e01524-19. doi:10.1128/MRA.01524-19.

PMID- 32096659
OWN - NLM
STAT- MEDLINE
DCOM- 20210311
LR  - 20220711
IS  - 1744-8336 (Electronic)
IS  - 1478-7210 (Linking)
VI  - 18
IP  - 5
DP  - 2020 May
TI  - Importance of epidemiological research of monkeypox: is incidence increasing?
PG  - 389-392
LID - 10.1080/14787210.2020.1735361 [doi]
FAU - Ihekweazu, Chikwe
AU  - Ihekweazu C
AD  - Nigeria Centre for Disease Control, Abuja, Nigeria.
FAU - Yinka-Ogunleye, Adesola
AU  - Yinka-Ogunleye A
AD  - Nigeria Centre for Disease Control, Abuja, Nigeria.
FAU - Lule, Swaib
AU  - Lule S
AD  - Institute for Global Health, University College London, London, UK.
FAU - Ibrahim, Abubakar
AU  - Ibrahim A
AD  - Institute for Global Health, University College London, London, UK.
LA  - eng
PT  - Editorial
PT  - Research Support, Non-U.S. Gov't
DEP - 20200302
PL  - England
TA  - Expert Rev Anti Infect Ther
JT  - Expert review of anti-infective therapy
JID - 101181284
SB  - IM
MH  - *Epidemiologic Research Design
MH  - Humans
MH  - Incidence
MH  - Monkeypox/*epidemiology
MH  - Monkeypox virus/isolation & purification
OTO - NOTNLM
OT  - *Monkeypox
OT  - *epidemiology
OT  - *global health security
OT  - *infectious diseases
OT  - *viruses
EDAT- 2020/02/26 06:00
MHDA- 2021/03/12 06:00
CRDT- 2020/02/26 06:00
PHST- 2020/02/26 06:00 [pubmed]
PHST- 2021/03/12 06:00 [medline]
PHST- 2020/02/26 06:00 [entrez]
AID - 10.1080/14787210.2020.1735361 [doi]
PST - ppublish
SO  - Expert Rev Anti Infect Ther. 2020 May;18(5):389-392. doi:10.1080/14787210.2020.1735361. Epub 2020 Mar 2.

PMID- 32052029
OWN - NLM
STAT- MEDLINE
DCOM- 20210427
LR  - 20220711
IS  - 1537-6591 (Electronic)
IS  - 1058-4838 (Linking)
VI  - 71
IP  - 8
DP  - 2020 Nov 5
TI  - Clinical Course and Outcome of Human Monkeypox in Nigeria.
PG  - e210-e214
LID - 10.1093/cid/ciaa143 [doi]
AB  - In a retrospective review of hospital records of 40 human monkeypox cases fromNigeria, the majority developed fever and self-limiting vesiculopustular skineruptions. Five deaths were reported. Compared to human immunodeficiency virus(HIV)-negative cases, HIV type 1-coinfected cases had more prolonged illness,larger lesions, and higher rates of both secondary bacterial skin infections and genital ulcers.
CI  - (c) The Author(s) 2020. Published by Oxford University Press for the InfectiousDiseases Society of America. All rights reserved. For permissions, e-mail:journals.permissions@oup.com.
FAU - Ogoina, Dimie
AU  - Ogoina D
AD  - Infectious Disease Unit, Niger Delta University Teaching Hospital, Okolobiri,Bayelsa, Nigeria.
FAU - Iroezindu, Michael
AU  - Iroezindu M
AD  - Infectious Disease Unit, Federal Medical Centre Owerri/University of NigeriaTeaching Hospital, Enugu, Nigeria.
FAU - James, Hendris Izibewule
AU  - James HI
AD  - Infectious Disease Unit, Niger Delta University Teaching Hospital, Okolobiri,Bayelsa, Nigeria.
FAU - Oladokun, Regina
AU  - Oladokun R
AD  - Paediatric Infectious Disease Unit, University College Hospital, Ibadan, OyoState, Nigeria.
FAU - Yinka-Ogunleye, Adesola
AU  - Yinka-Ogunleye A
AD  - Nigerian Centre for Disease Control, Abuja, Federal Capital Territory, Nigeria.
FAU - Wakama, Paul
AU  - Wakama P
AD  - Nigerian Prison Services, Port Harcourt, Rivers State, Nigeria.
FAU - Otike-Odibi, Bolaji
AU  - Otike-Odibi B
AD  - Department of Medicine, University of Port Harcourt Teaching Hospital, PortHarcourt, Rivers State, Nigeria.
FAU - Usman, Liman Muhammed
AU  - Usman LM
AD  - Ministry of Health, Nasarawa, Nasarawa State, Nigeria.
FAU - Obazee, Emmanuel
AU  - Obazee E
AD  - Department of Medicine, University of Port Harcourt Teaching Hospital, PortHarcourt, Rivers State, Nigeria.
FAU - Aruna, Olusola
AU  - Aruna O
AD  - Global Public Health Department, Public Health England, London, United Kingdom.
FAU - Ihekweazu, Chikwe
AU  - Ihekweazu C
AD  - Nigerian Centre for Disease Control, Abuja, Federal Capital Territory, Nigeria.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Clin Infect Dis
JT  - Clinical infectious diseases : an official publication of the Infectious DiseasesSociety of America
JID - 9203213
SB  - IM
MH  - *Exanthema
MH  - Humans
MH  - *Monkeypox/epidemiology
MH  - Monkeypox virus
MH  - Nigeria/epidemiology
MH  - Retrospective Studies
OTO - NOTNLM
OT  - *HIV/AIDS
OT  - *Nigeria
OT  - *clinical course
OT  - *human monkeypox
OT  - *outcome
EDAT- 2020/02/14 06:00
MHDA- 2021/04/28 06:00
CRDT- 2020/02/14 06:00
PHST- 2019/10/10 00:00 [received]
PHST- 2020/02/10 00:00 [accepted]
PHST- 2020/02/14 06:00 [pubmed]
PHST- 2021/04/28 06:00 [medline]
PHST- 2020/02/14 06:00 [entrez]
AID - 5734993 [pii]
AID - 10.1093/cid/ciaa143 [doi]
PST - ppublish
SO  - Clin Infect Dis. 2020 Nov 5;71(8):e210-e214. doi: 10.1093/cid/ciaa143.

PMID- 32023204
OWN - NLM
STAT- MEDLINE
DCOM- 20210618
LR  - 20220711
IS  - 1080-6059 (Electronic)
IS  - 1080-6040 (Linking)
VI  - 26
IP  - 4
DP  - 2020 Apr
TI  - Human-to-Human Transmission of Monkeypox Virus, United Kingdom, October 2018.
PG  - 782-785
LID - 10.3201/eid2604.191164 [doi]
AB  - In September 2018, monkeypox virus was transmitted from a patient to a healthcareworker in the United Kingdom. Transmission was probably through contact withcontaminated bedding. Infection control precautions for contacts (vaccination,daily monitoring, staying home from work) were implemented. Of 134 potentialcontacts, 4 became ill; all patients survived.
FAU - Vaughan, Aisling
AU  - Vaughan A
FAU - Aarons, Emma
AU  - Aarons E
FAU - Astbury, John
AU  - Astbury J
FAU - Brooks, Tim
AU  - Brooks T
FAU - Chand, Meera
AU  - Chand M
FAU - Flegg, Peter
AU  - Flegg P
FAU - Hardman, Angela
AU  - Hardman A
FAU - Harper, Nick
AU  - Harper N
FAU - Jarvis, Richard
AU  - Jarvis R
FAU - Mawdsley, Sharon
AU  - Mawdsley S
FAU - McGivern, Mark
AU  - McGivern M
FAU - Morgan, Dilys
AU  - Morgan D
FAU - Morris, Gwyn
AU  - Morris G
FAU - Nixon, Grainne
AU  - Nixon G
FAU - O'Connor, Catherine
AU  - O'Connor C
FAU - Palmer, Ruth
AU  - Palmer R
FAU - Phin, Nick
AU  - Phin N
FAU - Price, D Ashley
AU  - Price DA
FAU - Russell, Katherine
AU  - Russell K
FAU - Said, Bengu
AU  - Said B
FAU - Schmid, Matthias L
AU  - Schmid ML
FAU - Vivancos, Roberto
AU  - Vivancos R
FAU - Walsh, Amanda
AU  - Walsh A
FAU - Welfare, William
AU  - Welfare W
FAU - Wilburn, Jennifer
AU  - Wilburn J
FAU - Dunning, Jake
AU  - Dunning J
LA  - eng
PT  - Journal Article
DEP - 20200417
PL  - United States
TA  - Emerg Infect Dis
JT  - Emerging infectious diseases
JID - 9508155
SB  - IM
MH  - Health Personnel
MH  - Humans
MH  - *Monkeypox/epidemiology
MH  - *Monkeypox virus/genetics
MH  - United Kingdom/epidemiology
MH  - Vaccination
PMC - PMC7101111
OTO - NOTNLM
OT  - *Monkeypox
OT  - *United Kingdom
OT  - *human
OT  - *monkeypox virus
OT  - *nosocomial
OT  - *orthopoxvirus
OT  - *transmission
OT  - *viruses
OT  - *zoonoses
EDAT- 2020/02/06 06:00
MHDA- 2021/06/22 06:00
CRDT- 2020/02/06 06:00
PHST- 2020/02/06 06:00 [pubmed]
PHST- 2021/06/22 06:00 [medline]
PHST- 2020/02/06 06:00 [entrez]
AID - 10.3201/eid2604.191164 [doi]
PST - ppublish
SO  - Emerg Infect Dis. 2020 Apr;26(4):782-785. doi: 10.3201/eid2604.191164. Epub 2020 Apr 17.

PMID- 32019881
OWN - NLM
STAT- MEDLINE
DCOM- 20200710
LR  - 20200804
IS  - 1091-6490 (Electronic)
IS  - 0027-8424 (Linking)
VI  - 117
IP  - 7
DP  - 2020 Feb 18
TI  - Repair of a previously uncharacterized second host-range gene contributes to fullreplication of modified vaccinia virus Ankara (MVA) in human cells.
PG  - 3759-3767
LID - 10.1073/pnas.1921098117 [doi]
AB  - Modified vaccinia virus Ankara (MVA), a widely used vaccine vector for expressionof genes of unrelated pathogens, is safe, immunogenic, and can incorporate large amounts of added DNA. MVA was derived by extensively passaging thechorioallantois vaccinia virus Ankara (CVA) vaccine strain in chicken embryofibroblasts during which numerous mutations and deletions occurred with loss ofreplicative ability in most mammalian cells. Restoration of the deleted C12Lgene, encoding serine protease inhibitor 1, enhances replication of MVA in human MRC-5 cells but only slightly in other human cells. Here we show that repair ofthe inactivated C16L/B22R gene of MVA enhances replication in numerous human celllines. This previously uncharacterized gene is present at both ends of the genomeof many orthopoxviruses and is highly conserved in most, including smallpox andmonkeypox viruses. The C16L/B22R gene is expressed early in infection from thesecond methionine of the previously annotated Copenhagen strain open readingframe (ORF) as a 17.4-kDa protein. The C16/B22 and C12 proteins together promote MVA replication in human cells to levels that are comparable to titers in chickenembryo fibroblasts. Both proteins enhance virion assembly, but C16/B22 increases proteolytic processing of core proteins in A549 cells consistent with higherinfectious virus titers. Furthermore, human A549 cells expressing codon-optimizedC16L/B22R and C12L genes support higher levels of MVA replication than cell linesexpressing neither or either alone. Identification of the genes responsible forthe host-range defect of MVA may allow more rational engineering of vaccines for efficacy, safety, and propagation.
FAU - Peng, Chen
AU  - Peng C
AUID- ORCID: 0000-0001-6141-8775
AD  - Laboratory of Viral Diseases, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, Bethesda, MD 20892.
FAU - Moss, Bernard
AU  - Moss B
AUID- ORCID: 0000-0002-2154-8564
AD  - Laboratory of Viral Diseases, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, Bethesda, MD 20892 bmoss@nih.gov.
LA  - eng
PT  - Journal Article
PT  - Research Support, N.I.H., Intramural
DEP - 20200204
PL  - United States
TA  - Proc Natl Acad Sci U S A
JT  - Proceedings of the National Academy of Sciences of the United States of America
JID - 7505876
RN  - 0 (C12L protein, vaccinia virus)
RN  - 0 (Viral Proteins)
SB  - IM
CIN - Proc Natl Acad Sci U S A. 2020 Mar 24;117(12):6289-6291. PMID: 32179684
MH  - Amino Acid Sequence
MH  - Animals
MH  - Cell Line
MH  - Chick Embryo
MH  - Gene Deletion
MH  - *Host Specificity
MH  - Humans
MH  - Sequence Alignment
MH  - Vaccinia/*virology
MH  - Vaccinia virus/genetics/*physiology
MH  - Viral Proteins/genetics/metabolism
MH  - *Virus Replication
PMC - PMC7035496
OTO - NOTNLM
OT  - *host range
OT  - *poxvirus
OT  - *vaccine vector
OT  - *vaccinia virus
COIS- Competing interest statement: C.P. and B.M. are listed as inventors on a patentfiled by the US government that contains findings from this study.
EDAT- 2020/02/06 06:00
MHDA- 2020/07/11 06:00
CRDT- 2020/02/06 06:00
PHST- 2020/02/06 06:00 [pubmed]
PHST- 2020/07/11 06:00 [medline]
PHST- 2020/02/06 06:00 [entrez]
AID - 1921098117 [pii]
AID - 10.1073/pnas.1921098117 [doi]
PST - ppublish
SO  - Proc Natl Acad Sci U S A. 2020 Feb 18;117(7):3759-3767. doi:10.1073/pnas.1921098117. Epub 2020 Feb 4.

PMID- 32000354
OWN - NLM
STAT- MEDLINE
DCOM- 20200213
LR  - 20200219
IS  - 1536-5964 (Electronic)
IS  - 0025-7974 (Linking)
VI  - 99
IP  - 5
DP  - 2020 Jan
TI  - Assessment of media reportage of monkeypox in southern Nigeria.
PG  - e17985
LID - 10.1097/MD.0000000000017985 [doi]
AB  - Monkeypox is a zoonotic viral disease. Media campaigns are planned to createawareness about the disease. This is because mass media is often the leadingsource of information and mobilization during important health issues or crisis. The main objective of this study was to assess the media coverage of monkeypoxoutbreak in Nigeria.The study adopted a cross-sectional survey of residents inSouthern Nigeria. A total of 600 respondents were sampled for this study through a multi-stage cluster random sampling technique. Research assistants helped incollecting data from respondents through structured questionnaire. The datacollected was analyzed using percentages, mean score, and univariate analysis of variance (ANOVA).Respondents had little or no knowledge of monkeypox virus, itsnature, mode of transmission, and prevention mechanism (2.30 +/- .918, P = .000).Respondents stated that they learnt about the virus through friends and socialinstitutions instead of media (4.44 +/- .945, P = .006). Media failed to createeffective and comprehensive awareness campaigns to mobilize the public (1.86 +/- 1.196, P = .001), while inappropriate and insufficient media programs and lack offunds were blamed for media ineffectiveness (4.18 +/- 1.352, P = .004).Theoutbreak of monkeypox virus is a public health concern in Nigeria. Mediacampaigns are planned to raise awareness about the disease; however, thesecampaigns have not demonstrated effectiveness in changing people's healthbehavior toward monkeypox. Media, health professionals, and government shouldsynergize to promote a consistent health policy for the control and prevention ofmonkeypox virus.
FAU - Wogu, Joseph Oluchukwu
AU  - Wogu JO
AD  - Department of Mass Communication, University of Nigeria Nsukka, Enugu State.
FAU - Chukwu, Christiana Ogeri
AU  - Chukwu CO
AD  - Department of Mass Communication, Alex Ekwueme Federal University, Ndufu-AlikeIkwo, Abakaliki, Ebonyi State.
FAU - Orekyeh, Emeka S S
AU  - Orekyeh ESS
AD  - Department of Mass Communication, University of Nigeria Nsukka, Enugu State.
FAU - Nwankiti, Chukwuemeka Ononuju
AU  - Nwankiti CO
AD  - Department of Mass Communication, Alex Ekwueme Federal University, Ndufu-AlikeIkwo, Abakaliki, Ebonyi State.
FAU - Okoye-Ugwu, Stella
AU  - Okoye-Ugwu S
AD  - Department of English and Literary Studies, University of Nigeria Nsukka, EnuguState, Nigeria.
LA  - eng
PT  - Journal Article
PT  - Observational Study
PL  - United States
TA  - Medicine (Baltimore)
JT  - Medicine
JID - 2985248R
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - *Communications Media
MH  - Cross-Sectional Studies
MH  - Female
MH  - *Health Knowledge, Attitudes, Practice
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - *Monkeypox
MH  - *Monkeypox virus
MH  - Nigeria
MH  - Young Adult
PMC - PMC7004708
EDAT- 2020/02/01 06:00
MHDA- 2020/02/14 06:00
CRDT- 2020/02/01 06:00
PHST- 2020/02/01 06:00 [entrez]
PHST- 2020/02/01 06:00 [pubmed]
PHST- 2020/02/14 06:00 [medline]
AID - 10.1097/MD.0000000000017985 [doi]
AID - 00005792-202001310-00001 [pii]
PST - ppublish
SO  - Medicine (Baltimore). 2020 Jan;99(5):e17985. doi: 10.1097/MD.0000000000017985.

PMID- 31961314
OWN - NLM
STAT- MEDLINE
DCOM- 20210104
LR  - 20210104
IS  - 1080-6059 (Electronic)
IS  - 1080-6040 (Linking)
VI  - 26
IP  - 2
DP  - 2020 Feb
TI  - Use of Surveillance Outbreak Response Management and Analysis System for HumanMonkeypox Outbreak, Nigeria, 2017-2019.
PG  - 345-349
LID - 10.3201/eid2602.191139 [doi]
AB  - In November 2017, the mobile digital Surveillance Outbreak Response Managementand Analysis System was deployed in 30 districts in Nigeria in response to anoutbreak of monkeypox. Adaptation and activation of the system took 14 days, and its use improved timeliness, completeness, and overall capacity of the response.
FAU - Silenou, Bernard C
AU  - Silenou BC
FAU - Tom-Aba, Daniel
AU  - Tom-Aba D
FAU - Adeoye, Olawunmi
AU  - Adeoye O
FAU - Arinze, Chinedu C
AU  - Arinze CC
FAU - Oyiri, Ferdinand
AU  - Oyiri F
FAU - Suleman, Anthony K
AU  - Suleman AK
FAU - Yinka-Ogunleye, Adesola
AU  - Yinka-Ogunleye A
FAU - Dorrbecker, Juliane
AU  - Dorrbecker J
FAU - Ihekweazu, Chikwe
AU  - Ihekweazu C
FAU - Krause, Gerard
AU  - Krause G
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Emerg Infect Dis
JT  - Emerging infectious diseases
JID - 9508155
SB  - IM
MH  - *Disease Outbreaks
MH  - Humans
MH  - Monkeypox/*epidemiology/etiology
MH  - *Monkeypox virus
MH  - Nigeria/epidemiology
MH  - *Population Surveillance
PMC - PMC6986835
OTO - NOTNLM
OT  - *Africa
OT  - *Nigeria
OT  - *SORMAS
OT  - *Surveillance Outbreak Response Management and Analysis System
OT  - *contact tracing
OT  - *digital health
OT  - *mHealth
OT  - *mobile health
OT  - *monkeypox virus
OT  - *outbreak detection
OT  - *surveillance
OT  - *viruses
EDAT- 2020/01/22 06:00
MHDA- 2021/01/05 06:00
CRDT- 2020/01/22 06:00
PHST- 2020/01/22 06:00 [entrez]
PHST- 2020/01/22 06:00 [pubmed]
PHST- 2021/01/05 06:00 [medline]
AID - 10.3201/eid2602.191139 [doi]
PST - ppublish
SO  - Emerg Infect Dis. 2020 Feb;26(2):345-349. doi: 10.3201/eid2602.191139.

PMID- 31915078
OWN - NLM
STAT- MEDLINE
DCOM- 20210504
LR  - 20210504
IS  - 1559-6834 (Electronic)
IS  - 0899-823X (Linking)
VI  - 41
IP  - 3
DP  - 2020 Mar
TI  - Monitoring healthcare professionals after monkeypox exposure: Experience from thefirst case imported to Asia.
PG  - 373-375
LID - 10.1017/ice.2019.362 [doi]
FAU - Kyaw, Win Mar
AU  - Kyaw WM
AD  - Department of Clinical Epidemiology, Tan Tock Seng Hospital, Singapore.
FAU - Vasoo, Shawn
AU  - Vasoo S
AD  - Infectious Disease Department, Tan Tock Seng Hospital, Singapore.
AD  - National Centre for Infectious Diseases, Singapore.
FAU - Ho, Hanley Jian An
AU  - Ho HJA
AD  - Department of Clinical Epidemiology, Tan Tock Seng Hospital, Singapore.
FAU - Chan, Monica
AU  - Chan M
AD  - Infectious Disease Department, Tan Tock Seng Hospital, Singapore.
AD  - National Centre for Infectious Diseases, Singapore.
FAU - Yeo, Tsin Wen
AU  - Yeo TW
AD  - Infectious Disease Department, Tan Tock Seng Hospital, Singapore.
AD  - National Centre for Infectious Diseases, Singapore.
FAU - Manauis, Charmaine Malenab
AU  - Manauis CM
AD  - Emergency Department, Tan Tock Seng Hospital, Singapore.
FAU - Ang, Hou
AU  - Ang H
AD  - Emergency Department, Tan Tock Seng Hospital, Singapore.
FAU - Pratim De, Partha
AU  - Pratim De P
AD  - Department of Laboratory Medicine, Tan Tock Seng Hospital, Singapore.
FAU - Ang, Brenda Sze Peng
AU  - Ang BSP
AD  - National Centre for Infectious Diseases, Singapore.
AD  - Infection Prevention and Control Unit, Tan Tock Seng Hospital, Singapore.
FAU - Chow, Angela Li Ping
AU  - Chow ALP
AD  - National Centre for Infectious Diseases, Singapore.
AD  - Department of Clinical Epidemiology, Tan Tock Seng Hospital, Singapore.
LA  - eng
PT  - Letter
DEP - 20200109
PL  - United States
TA  - Infect Control Hosp Epidemiol
JT  - Infection control and hospital epidemiology
JID - 8804099
SB  - IM
MH  - Asia/epidemiology
MH  - Cross Infection/prevention & control/*transmission/*virology
MH  - Disease Outbreaks
MH  - Health Personnel
MH  - Humans
MH  - Monkeypox/epidemiology/prevention & control/*transmission
MH  - Nigeria
MH  - Personal Protective Equipment
MH  - Singapore/epidemiology
EDAT- 2020/01/10 06:00
MHDA- 2021/05/05 06:00
CRDT- 2020/01/10 06:00
PHST- 2020/01/10 06:00 [pubmed]
PHST- 2021/05/05 06:00 [medline]
PHST- 2020/01/10 06:00 [entrez]
AID - S0899823X19003623 [pii]
AID - 10.1017/ice.2019.362 [doi]
PST - ppublish
SO  - Infect Control Hosp Epidemiol. 2020 Mar;41(3):373-375. doi: 10.1017/ice.2019.362.Epub 2020 Jan 9.

PMID- 31875271
OWN - NLM
STAT- MEDLINE
DCOM- 20210525
LR  - 20220728
IS  - 1612-9210 (Electronic)
IS  - 1612-9202 (Linking)
VI  - 17
IP  - 1
DP  - 2020 Mar
TI  - Monkeypox Rash Severity and Animal Exposures in the Democratic Republic of theCongo.
PG  - 64-73
LID - 10.1007/s10393-019-01459-7 [doi]
AB  - Experimental studies have suggested a larger inoculum of monkeypox virus may beassociated with increased rash severity; however, little data are available onthe relationship between specific animal exposures and rash severity in endemicregions. Using cross-sectional data from an active surveillance program conductedbetween 2005 and 2007 in the Sankuru Province of the Democratic Republic of theCongo, we explored the possible relationship between rash severity and exposures to rodents and non-human primates among confirmed MPX cases. Among the 223PCR-confirmed MPX cases identified during active surveillance, the majority ofcases (n = 149) presented with mild rash (5-100 lesions) and 33% had a moreserious presentation (> 100 lesions). No association between exposure to rodents and rash severity was found in the multivariable analysis. Those thatself-reported hunting NHP 3 weeks prior to onset of MPX symptoms had 2.78 timesthe odds of severe rash than those that did not report such exposure (95% CI:1.18, 6.58). This study provides a preliminary step in understanding theassociation between animal exposure and rash severity and demonstratescorrelation with exposure to NHPs and human MPX presentation. Additional researchexploring the relationship between rash severity and NHPs is warranted.
FAU - Doshi, Reena H
AU  - Doshi RH
AD  - Department of Epidemiology, Fielding School of Public Health, University ofCalifornia, Los Angeles, USA.
FAU - Alfonso, Vivian H
AU  - Alfonso VH
AD  - Department of Epidemiology, Fielding School of Public Health, University ofCalifornia, Los Angeles, USA.
FAU - Morier, Douglas
AU  - Morier D
AD  - Department of Epidemiology, Fielding School of Public Health, University ofCalifornia, Los Angeles, USA.
FAU - Hoff, Nicole A
AU  - Hoff NA
AD  - Department of Epidemiology, Fielding School of Public Health, University ofCalifornia, Los Angeles, USA.
FAU - Sinai, Cyrus
AU  - Sinai C
AD  - Department of Epidemiology, Fielding School of Public Health, University ofCalifornia, Los Angeles, USA.
FAU - Mulembakani, Prime
AU  - Mulembakani P
AD  - Kinshasa School of Public Health, Kinshasa, Democratic Republic of the Congo.
FAU - Kisalu, Neville
AU  - Kisalu N
AD  - Vaccine Research Center, National Institute of Allergy and Infectious Diseases,Bethesda, MD, USA.
FAU - Cheng, Alvan
AU  - Cheng A
AD  - Department of Epidemiology, Fielding School of Public Health, University ofCalifornia, Los Angeles, USA.
FAU - Ashbaugh, Hayley
AU  - Ashbaugh H
AD  - Department of Epidemiology, Fielding School of Public Health, University ofCalifornia, Los Angeles, USA.
FAU - Gadoth, Adva
AU  - Gadoth A
AD  - Department of Epidemiology, Fielding School of Public Health, University ofCalifornia, Los Angeles, USA.
FAU - Cowell, Brian
AU  - Cowell B
AD  - Texas A&M School of Public Health, College Station, TX, USA.
FAU - Okitolonda, Emile W
AU  - Okitolonda EW
AD  - Kinshasa School of Public Health, Kinshasa, Democratic Republic of the Congo.
FAU - Muyembe-Tamfum, Jean-Jacques
AU  - Muyembe-Tamfum JJ
AD  - Institut National de Recherche Biomedicale, Kinshasa, Democratic Republic of the Congo.
FAU - Rimoin, Anne W
AU  - Rimoin AW
AD  - Department of Epidemiology, Fielding School of Public Health, University ofCalifornia, Los Angeles, USA. arimoin@ucla.edu.
AD  - , Los Angeles, USA. arimoin@ucla.edu.
LA  - eng
GR  - K01 AI074810/AI/NIAID NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20191224
PL  - United States
TA  - Ecohealth
JT  - EcoHealth
JID - 101222144
SB  - IM
MH  - Animals
MH  - Cross-Sectional Studies
MH  - Democratic Republic of the Congo/epidemiology
MH  - Exanthema
MH  - Female
MH  - Humans
MH  - Male
MH  - Monkeypox/*epidemiology
MH  - Monkeypox virus
MH  - Polymerase Chain Reaction
MH  - Viral Zoonoses/*epidemiology
OTO - NOTNLM
OT  - *Animal exposure
OT  - *Monkeypox
OT  - *Rash illness
OT  - *Rash severity
EDAT- 2019/12/26 06:00
MHDA- 2021/05/26 06:00
CRDT- 2019/12/26 06:00
PHST- 2018/04/17 00:00 [received]
PHST- 2019/11/07 00:00 [accepted]
PHST- 2019/12/26 06:00 [pubmed]
PHST- 2021/05/26 06:00 [medline]
PHST- 2019/12/26 06:00 [entrez]
AID - 10.1007/s10393-019-01459-7 [doi]
AID - 10.1007/s10393-019-01459-7 [pii]
PST - ppublish
SO  - Ecohealth. 2020 Mar;17(1):64-73. doi: 10.1007/s10393-019-01459-7. Epub 2019 Dec24.

PMID- 31828053
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20201001
IS  - 2296-2565 (Print)
IS  - 2296-2565 (Linking)
VI  - 7
DP  - 2019
TI  - Infectious Disease Risk Across the Growing Human-Non Human Primate Interface: AReview of the Evidence.
PG  - 305
LID - 10.3389/fpubh.2019.00305 [doi]
AB  - Most of the human pandemics reported to date can be classified as zoonoses. Amongthese, there is a long history of infectious diseases that have spread fromnon-human primates (NHP) to humans. For millennia, indigenous groups that depend on wildlife for their survival were exposed to the risk of NHP pathogens'transmission through animal hunting and wild meat consumption. Usually, exposure is of no consequence or is limited to mild infections. In rare situations, it canbe more severe or even become a real public health concern. Since the emergenceof acquired immune deficiency syndrome (AIDS), nobody can ignore that an emerginginfectious diseases (EID) might spread from NHP into the human population. Inlarge parts of Central Africa and Asia, wildlife remains the primary source ofmeat and income for millions of people living in rural areas. However, in thepast few decades the risk of exposure to an NHP pathogen has taken on a newdimension. Unprecedented breaking down of natural barriers between NHP and humanshas increased exposure to health risks for a much larger population, includingpeople living in urban areas. There are several reasons for this: (i) due to roaddevelopment and massive destruction of ecosystems for agricultural needs,wildlife and humans come into contact more frequently; (ii) due to ecologicalawareness, many long distance travelers are in search of wildlife discovery, witha particular fascination for African great apes; (iii) due to the attraction for ancient temples and mystical practices, others travelers visit Asian placescolonized by NHP. In each case, there is a risk of pathogen transmission through a bite or another route of infection. Beside the individual risk of contracting apathogen, there is also the possibility of starting a new pandemic. This article reviews the known cases of NHP pathogens' transmission to humans whether they arehunters, travelers, ecotourists, veterinarians, or scientists working on NHP.Although pathogen transmission is supposed to be a rare outcome, Rabies virus,Herpes B virus, Monkeypox virus, Ebola virus, or Yellow fever virus infectionsare of greater concern and require quick countermeasures from public healthprofessionals.
CI  - Copyright (c) 2019 Devaux, Mediannikov, Medkour and Raoult.
FAU - Devaux, Christian A
AU  - Devaux CA
AD  - Aix-Marseille Univ, IRD, APHM, MEPHI, IHU-Mediterranee Infection, Marseille,France.
AD  - CNRS, Marseille, France.
FAU - Mediannikov, Oleg
AU  - Mediannikov O
AD  - Aix-Marseille Univ, IRD, APHM, MEPHI, IHU-Mediterranee Infection, Marseille,France.
FAU - Medkour, Hacene
AU  - Medkour H
AD  - Aix-Marseille Univ, IRD, APHM, MEPHI, IHU-Mediterranee Infection, Marseille,France.
FAU - Raoult, Didier
AU  - Raoult D
AD  - Aix-Marseille Univ, IRD, APHM, MEPHI, IHU-Mediterranee Infection, Marseille,France.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20191105
PL  - Switzerland
TA  - Front Public Health
JT  - Frontiers in public health
JID - 101616579
PMC - PMC6849485
OTO - NOTNLM
OT  - emerging disease
OT  - interspecies adaptation
OT  - monkey alarm calls
OT  - threat
OT  - zoonoses
EDAT- 2019/12/13 06:00
MHDA- 2019/12/13 06:01
CRDT- 2019/12/13 06:00
PHST- 2019/05/15 00:00 [received]
PHST- 2019/10/07 00:00 [accepted]
PHST- 2019/12/13 06:00 [entrez]
PHST- 2019/12/13 06:00 [pubmed]
PHST- 2019/12/13 06:01 [medline]
AID - 10.3389/fpubh.2019.00305 [doi]
PST - epublish
SO  - Front Public Health. 2019 Nov 5;7:305. doi: 10.3389/fpubh.2019.00305. eCollection2019.

PMID- 31823763
OWN - NLM
STAT- MEDLINE
DCOM- 20200304
LR  - 20200304
IS  - 1471-2458 (Electronic)
IS  - 1471-2458 (Linking)
VI  - 19
IP  - 1
DP  - 2019 Dec 10
TI  - Evaluation of the influenza sentinel surveillance system in the DemocraticRepublic of Congo, 2012-2015.
PG  - 1652
LID - 10.1186/s12889-019-8008-2 [doi]
AB  - BACKGROUND: The World Health Organization recommends periodic evaluations ofinfluenza surveillance systems to identify areas for improvement and provideevidence of data reliability for policymaking. However, data about theperformance of established influenza surveillance systems are limited in Africa, including in the Democratic Republic of Congo (DRC). METHODS: We used the Centersfor Disease Control and Prevention guidelines to evaluate the performance of the influenza sentinel surveillance system (ISSS) in DRC during 2012-2015. Theperformance of the system was evaluated using eight surveillance attributes: (i) data quality and completeness for key variables, (ii) timeliness, (iii)representativeness, (iv) flexibility, (v) simplicity, (vi) acceptability, (vii)stability and (viii) utility. For each attribute, specific indicators weredeveloped and described using quantitative and qualitative methods. Scores foreach indicator were as follows: < 60% weak performance; 60-79% moderateperformance; >/=80% good performance. RESULTS: During 2012-2015, we enrolled and tested 4339 patients with influenza-like illness (ILI) and 2869 patients withsevere acute respiratory illness (SARI) from 11 sentinel sites situated in 5 of11 provinces. Influenza viruses were detected in 446 (10.3%) samples frompatients with ILI and in 151 (5.5%) samples from patients with SARI with higherdetection during December-May. Data quality and completeness was > 90% for allevaluated indicators. Other strengths of the system were timeliness, simplicity, stability and utility that scored > 70% each. Representativeness, flexibility andacceptability had moderate performance. It was reported that the ISSS contributedto: (i) a better understanding of the epidemiology, circulating patterns andproportional contribution of influenza virus among patients with ILI or SARI;(ii) acquisition of new key competences related to influenza surveillance anddiagnosis; and (iii) continuous education of surveillance staff and clinicians atsentinel sites about influenza. However, due to limited resources no actions wereundertaken to mitigate the impact of seasonal influenza epidemics. CONCLUSIONS:The system performed overall satisfactorily and provided reliable and timely dataabout influenza circulation in DRC. The simplicity of the system contributed toits stability. A better use of the available data could be made to inform andpromote prevention interventions especially among the most vulnerable groups.
FAU - Babakazo, Pelagie
AU  - Babakazo P
AUID- ORCID: http://orcid.org/0000-0001-5561-696X
AD  - Kinshasa School of Public Health, University of Kinshasa, Kinshasa, DemocraticRepublic of Congo. pbabakazo@yahoo.fr.
FAU - Kabamba-Tshilobo, Joelle
AU  - Kabamba-Tshilobo J
AD  - Influenza and Monkeypox Program, Centers for Disease Control and Prevention,Kinshasa, Democratic Republic of Congo.
FAU - Wemakoy, Emile Okitolonda
AU  - Wemakoy EO
AD  - Kinshasa School of Public Health, University of Kinshasa, Kinshasa, DemocraticRepublic of Congo.
FAU - Lubula, Leopold
AU  - Lubula L
AD  - Division de Lutte Contre la Maladie, Ministry of Health, Kinshasa, DemocraticRepublic of Congo.
FAU - Manya, Leonie Kitoko
AU  - Manya LK
AD  - Division de Lutte Contre la Maladie, Ministry of Health, Kinshasa, DemocraticRepublic of Congo.
FAU - Ilunga, Benoit Kebela
AU  - Ilunga BK
AD  - Division de Lutte Contre la Maladie, Ministry of Health, Kinshasa, DemocraticRepublic of Congo.
FAU - Disasuani, Wally
AU  - Disasuani W
AD  - Kinshasa School of Public Health, University of Kinshasa, Kinshasa, DemocraticRepublic of Congo.
FAU - Nkwembe, Edith
AU  - Nkwembe E
AD  - Institut National de Recherche Biomedicale, Ministry of Health, Kinshasa,Democratic Republic of Congo.
FAU - Kavunga-Membo, Hugo
AU  - Kavunga-Membo H
AD  - Institut National de Recherche Biomedicale, Ministry of Health, Kinshasa,Democratic Republic of Congo.
FAU - Changachanga, Jean-Claude
AU  - Changachanga JC
AD  - Institut National de Recherche Biomedicale, Ministry of Health, Kinshasa,Democratic Republic of Congo.
FAU - Muhemedi, Saleh
AU  - Muhemedi S
AD  - Kinshasa School of Public Health, University of Kinshasa, Kinshasa, DemocraticRepublic of Congo.
FAU - Tamfum, Jean-Jacques Muyembe
AU  - Tamfum JM
AD  - Institut National de Recherche Biomedicale, Ministry of Health, Kinshasa,Democratic Republic of Congo.
FAU - Tempia, Stefano
AU  - Tempia S
AD  - Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA.stefanot@nicd.ac.za.
AD  - Influenza Program, Centers for Disease Control and Prevention, Pretoria, SouthAfrica. stefanot@nicd.ac.za.
AD  - MassGenics, Duluth, GA, USA. stefanot@nicd.ac.za.
AD  - Center for Respiratory Diseases and Meningitis, National Institute forCommunicable Diseases, Private Bag X4, Sandringham, Gauteng, 2131, South Africa. stefanot@nicd.ac.za.
LA  - eng
GR  - U51IP000602/CC/CDC HHS/United States
PT  - Evaluation Study
PT  - Journal Article
DEP - 20191210
PL  - England
TA  - BMC Public Health
JT  - BMC public health
JID - 100968562
SB  - IM
MH  - *Data Accuracy
MH  - Democratic Republic of the Congo/epidemiology
MH  - Humans
MH  - Influenza, Human/*epidemiology
MH  - Orthomyxoviridae/isolation & purification
MH  - Reproducibility of Results
MH  - *Sentinel Surveillance
PMC - PMC6902419
OTO - NOTNLM
OT  - Democratic Republic of Congo
OT  - Evaluation
OT  - Influenza
OT  - Surveillance
EDAT- 2019/12/12 06:00
MHDA- 2020/03/05 06:00
CRDT- 2019/12/12 06:00
PHST- 2019/07/19 00:00 [received]
PHST- 2019/11/27 00:00 [accepted]
PHST- 2019/12/12 06:00 [entrez]
PHST- 2019/12/12 06:00 [pubmed]
PHST- 2020/03/05 06:00 [medline]
AID - 10.1186/s12889-019-8008-2 [doi]
AID - 10.1186/s12889-019-8008-2 [pii]
PST - epublish
SO  - BMC Public Health. 2019 Dec 10;19(1):1652. doi: 10.1186/s12889-019-8008-2.

PMID- 31799006
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20191207
IS  - 2059-7908 (Print)
IS  - 2059-7908 (Linking)
VI  - 4
IP  - 6
DP  - 2019
TI  - Lay media reporting of monkeypox in Nigeria.
PG  - e002019
LID - 10.1136/bmjgh-2019-002019 [doi]
FAU - Oyebanji, Oyeronke
AU  - Oyebanji O
AUID- ORCID: 0000-0002-2935-2435
AD  - Office of the Director General, Nigeria Centre for Disease Control, Abuja,Nigeria.
FAU - Ofonagoro, Ugonna
AU  - Ofonagoro U
AD  - EpiAfric, Abuja, Nigeria.
FAU - Akande, Oluwatosin
AU  - Akande O
AD  - Department of Epidemiology and Community Health, University of Ilorin TeachingHospital, Ilorin, Nigeria.
FAU - Nsofor, Ifeanyi
AU  - Nsofor I
AD  - EpiAfric, Abuja, Nigeria.
FAU - Ukenedo, Chika
AU  - Ukenedo C
AD  - University of Maryland, Baltimore, Baltimore, Maryland, USA.
FAU - Mohammed, Tarik Benjamin
AU  - Mohammed TB
AD  - Office of the Director General, Nigeria Centre for Disease Control, Abuja,Nigeria.
FAU - Anueyiagu, Chimezie
AU  - Anueyiagu C
AD  - Department of Prevention and Knowledge Management, Nigeria Centre for DiseaseControl, Abuja, Nigeria.
FAU - Agenyi, Jeremiah
AU  - Agenyi J
AD  - Office of the Director General, Nigeria Centre for Disease Control, Abuja,Nigeria.
FAU - Yinka-Ogunleye, Adesola
AU  - Yinka-Ogunleye A
AD  - Department of Disease Surveillance and Epidemiology, Nigeria Centre for DiseaseControl, Abuja, Nigeria.
FAU - Ihekweazu, Chikwe
AU  - Ihekweazu C
AD  - Office of the Director General, Nigeria Centre for Disease Control, Abuja,Nigeria.
LA  - eng
PT  - Journal Article
DEP - 20191112
PL  - England
TA  - BMJ Glob Health
JT  - BMJ global health
JID - 101685275
PMC - PMC6861118
OTO - NOTNLM
OT  - event-based surveillance
OT  - monkeypox
OT  - outbreak communication
OT  - risk communications
COIS- Competing interests: None declared.
EDAT- 2019/12/05 06:00
MHDA- 2019/12/05 06:01
CRDT- 2019/12/05 06:00
PHST- 2019/09/24 00:00 [received]
PHST- 2019/09/28 00:00 [accepted]
PHST- 2019/12/05 06:00 [entrez]
PHST- 2019/12/05 06:00 [pubmed]
PHST- 2019/12/05 06:01 [medline]
AID - 10.1136/bmjgh-2019-002019 [doi]
AID - bmjgh-2019-002019 [pii]
PST - epublish
SO  - BMJ Glob Health. 2019 Nov 12;4(6):e002019. doi: 10.1136/bmjgh-2019-002019.eCollection 2019.

PMID- 31769405
OWN - NLM
STAT- MEDLINE
DCOM- 20200421
LR  - 20211204
IS  - 1476-1645 (Electronic)
IS  - 0002-9637 (Linking)
VI  - 102
IP  - 1
DP  - 2020 Jan
TI  - Do Monkeypox Exposures Vary by Ethnicity? Comparison of Aka and Bantu SuspectedMonkeypox Cases.
PG  - 202-205
LID - 10.4269/ajtmh.19-0457 [doi]
AB  - In 2017, a monkeypox outbreak occurred in Likouala Department, Republic of theCongo. Many of the affected individuals were of Aka ethnicity, hunter-gatherersindigenous to Central Africa who have worse health outcomes in comparison withother forest-dwelling peoples. To test the hypothesis that Aka people havedifferent risk factors for monkeypox, we analyzed questionnaire data for 39suspected cases, comparing Aka and Bantu groups. Aka people were more likely totouch animal urine/feces, find dead animals in/around the home, eat an animalthat was found dead, or to have been scratched or bitten by an animal (P < 0.05, all variables). They were also more likely to visit the forest >/= once/week,sleep outside, or sleep on the ground (P < 0.001, all variables), providingopportunities for contact with monkeypox reservoirs during the night. The Aka andpossibly other vulnerable groups may warrant special attention during educationaland health promotion programs.
FAU - Guagliardo, Sarah Anne J
AU  - Guagliardo SAJ
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,National Center for Emerging and Zoonotic Infectious Diseases, Centers forDisease Control and Prevention, Atlanta, Georgia.
AD  - Epidemic Intelligence Service, Centers for Disease Control and Prevention,Atlanta, Georgia.
FAU - Doshi, Reena H
AU  - Doshi RH
AD  - Division of Global HIV and Tuberculosis, Center for Global Health, Centers forDisease Control and Prevention, Atlanta, Georgia.
AD  - Epidemic Intelligence Service, Centers for Disease Control and Prevention,Atlanta, Georgia.
FAU - Reynolds, Mary G
AU  - Reynolds MG
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,National Center for Emerging and Zoonotic Infectious Diseases, Centers forDisease Control and Prevention, Atlanta, Georgia.
FAU - Dzabatou-Babeaux, Angelie
AU  - Dzabatou-Babeaux A
AD  - Ministry of Health, Brazzaville, Republic of Congo.
FAU - Ndakala, Nestor
AU  - Ndakala N
AD  - Field Epidemiology Training Program, Centers for Disease Control and Prevention, Kinshasa, Democratic Republic of the Congo.
FAU - Moses, Cynthia
AU  - Moses C
AD  - International Communication and Education Fund, Kinshasa, Democratic Republic of the Congo.
FAU - McCollum, Andrea M
AU  - McCollum AM
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,National Center for Emerging and Zoonotic Infectious Diseases, Centers forDisease Control and Prevention, Atlanta, Georgia.
FAU - Petersen, Brett W
AU  - Petersen BW
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,National Center for Emerging and Zoonotic Infectious Diseases, Centers forDisease Control and Prevention, Atlanta, Georgia.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Am J Trop Med Hyg
JT  - The American journal of tropical medicine and hygiene
JID - 0370507
SB  - IM
MH  - Adult
MH  - Animals
MH  - Congo/epidemiology
MH  - *Disease Outbreaks
MH  - *Ethnicity
MH  - Female
MH  - Humans
MH  - Male
MH  - Monkeypox/*epidemiology/*ethnology
MH  - Risk Factors
MH  - *Zoonoses
PMC - PMC6947767
EDAT- 2019/11/27 06:00
MHDA- 2020/04/22 06:00
CRDT- 2019/11/27 06:00
PHST- 2019/11/27 06:00 [pubmed]
PHST- 2020/04/22 06:00 [medline]
PHST- 2019/11/27 06:00 [entrez]
AID - 10.4269/ajtmh.19-0457 [doi]
PST - ppublish
SO  - Am J Trop Med Hyg. 2020 Jan;102(1):202-205. doi: 10.4269/ajtmh.19-0457.

PMID- 31769389
OWN - NLM
STAT- MEDLINE
DCOM- 20200421
LR  - 20210110
IS  - 1476-1645 (Electronic)
IS  - 0002-9637 (Linking)
VI  - 102
IP  - 1
DP  - 2020 Jan
TI  - Asymptomatic Orthopoxvirus Circulation in Humans in the Wake of a MonkeypoxOutbreak among Chimpanzees in Cameroon.
PG  - 206-212
LID - 10.4269/ajtmh.19-0467 [doi]
AB  - Monkeypox virus is a zoonotic Orthopoxvirus (OPXV) that causes smallpox-likeillness in humans. In Cameroon, human monkeypox cases were confirmed in 2018, andoutbreaks in captive chimpanzees occurred in 2014 and 2016. We investigated theOPXV serological status among staff at a primate sanctuary (where the 2016chimpanzee outbreak occurred) and residents from nearby villages, and describecontact with possible monkeypox reservoirs. We focused specifically on Gambianrats (Cricetomys spp.) because they are recognized possible reservoirs andbecause contact with Gambian rats was common enough to render sufficientstatistical power. We collected one 5-mL whole blood specimen from eachparticipant to perform a generic anti-OPXV ELISA test for IgG and IgM antibodies and administered a questionnaire about prior symptoms of monkeypox-like illnessand contact with possible reservoirs. Our results showed evidence of OPXVexposures (IgG positive, 6.3%; IgM positive, 1.6%) among some of those too young to have received smallpox vaccination (born after 1980, n = 63). No participants reported prior symptoms consistent with monkeypox. After adjusting for education level, participants who frequently visited the forest were more likely to haverecently eaten Gambian rats (OR: 3.36, 95% CI: 1.91-5.92, P < 0.001) and primate sanctuary staff were less likely to have touched or sold Gambian rats (OR: 0.23, 95% CI: 0.19-0.28, P < 0.001). The asymptomatic or undetected circulation ofOPXVs in humans in Cameroon is likely, and contact with monkeypox reservoirs iscommon, raising the need for continued surveillance for human and animal disease.
FAU - Guagliardo, Sarah Anne J
AU  - Guagliardo SAJ
AD  - Poxvirus and Rabies Branch, U.S. Centers for Disease Control and Prevention,Atlanta, Georgia.
AD  - Epidemic Intelligence Service, U.S. Centers for Disease Control and Prevention,Atlanta, Georgia.
FAU - Monroe, Benjamin
AU  - Monroe B
AD  - Poxvirus and Rabies Branch, U.S. Centers for Disease Control and Prevention,Atlanta, Georgia.
FAU - Moundjoa, Christian
AU  - Moundjoa C
AD  - Field Epidemiology Training Program, U.S. Centers for Disease Control andPrevention Cameroon Office, Yaounde, Cameroon.
AD  - Ministry of Livestock, Fisheries, and Animal Industries, Yaounde, Cameroon.
FAU - Athanase, Ateba
AU  - Athanase A
AD  - National Zoonoses Program, Ministry of Health, Yaounde, Cameroon.
AD  - Field Epidemiology Training Program, U.S. Centers for Disease Control andPrevention Cameroon Office, Yaounde, Cameroon.
FAU - Okpu, Gordon
AU  - Okpu G
AD  - U.S. Centers for Disease Control and Prevention Cameroon Office, Yaounde,Cameroon.
FAU - Burgado, Jillybeth
AU  - Burgado J
AD  - Poxvirus and Rabies Branch, U.S. Centers for Disease Control and Prevention,Atlanta, Georgia.
FAU - Townsend, Michael B
AU  - Townsend MB
AD  - Poxvirus and Rabies Branch, U.S. Centers for Disease Control and Prevention,Atlanta, Georgia.
FAU - Satheshkumar, Panayampalli S
AU  - Satheshkumar PS
AD  - Poxvirus and Rabies Branch, U.S. Centers for Disease Control and Prevention,Atlanta, Georgia.
FAU - Epperson, Scott
AU  - Epperson S
AD  - Hubert Humphrey Global Health Fellowship Program, U.S. Centers for DiseaseControl and Prevention, Atlanta, Georgia.
FAU - Doty, Jeffrey B
AU  - Doty JB
AD  - Poxvirus and Rabies Branch, U.S. Centers for Disease Control and Prevention,Atlanta, Georgia.
FAU - Reynolds, Mary G
AU  - Reynolds MG
AD  - Poxvirus and Rabies Branch, U.S. Centers for Disease Control and Prevention,Atlanta, Georgia.
FAU - Dibongue, Elisabeth
AU  - Dibongue E
AD  - National Zoonoses Program, Ministry of Health, Yaounde, Cameroon.
FAU - Etoundi, Georges Alain
AU  - Etoundi GA
AD  - Disease Control, Ministry of Health, Yaounde, Cameroon.
FAU - Mathieu, Els
AU  - Mathieu E
AD  - U.S. Centers for Disease Control and Prevention Cameroon Office, Yaounde,Cameroon.
FAU - McCollum, Andrea M
AU  - McCollum AM
AD  - Poxvirus and Rabies Branch, U.S. Centers for Disease Control and Prevention,Atlanta, Georgia.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Am J Trop Med Hyg
JT  - The American journal of tropical medicine and hygiene
JID - 0370507
RN  - 0 (Antibodies, Viral)
RN  - 0 (Immunoglobulin G)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Animals
MH  - Antibodies, Viral/*blood
MH  - Ape Diseases/epidemiology/*virology
MH  - Cameroon/epidemiology
MH  - Disease Outbreaks/veterinary
MH  - Female
MH  - Humans
MH  - Immunoglobulin G/blood
MH  - Male
MH  - Middle Aged
MH  - Monkeypox/epidemiology/*veterinary
MH  - Odds Ratio
MH  - *Orthopoxvirus
MH  - Pan troglodytes/*virology
MH  - Risk Factors
MH  - Young Adult
PMC - PMC6947779
EDAT- 2019/11/27 06:00
MHDA- 2020/04/22 06:00
CRDT- 2019/11/27 06:00
PHST- 2019/11/27 06:00 [pubmed]
PHST- 2020/04/22 06:00 [medline]
PHST- 2019/11/27 06:00 [entrez]
AID - 10.4269/ajtmh.19-0467 [doi]
PST - ppublish
SO  - Am J Trop Med Hyg. 2020 Jan;102(1):206-212. doi: 10.4269/ajtmh.19-0467.

PMID- 31699941
OWN - NLM
STAT- MEDLINE
DCOM- 20200415
LR  - 20200415
IS  - 0125-9326 (Print)
IS  - 0125-9326 (Linking)
VI  - 51
IP  - 3
DP  - 2019 Jul
TI  - The Threat of Emerging and Re-emerging Infections in Indonesia.
PG  - 195-196
AB  - Human immunodeficiency virus (HIV) is one example of an emerging infection withtotal of 386 district of all province in Indonesia reported having suchinfection; with cumulative number of HIV infected patient from the year 1987 to2014 is 150,296 while AIDS is 55,799 patients. The access to care only available for 153,887 patients among all HIV/AIDS patients of whom 70% are eligible foranti-retroviral (ARV) treatment and of these only half adhered to ARV treatment. In addition to that, there is an increased risk of other emerging diseases suchas Zika virus, Monkey pox or Hanta pulmonary syndrome since a sporadic cases werereported around the region.Beside new diseases, tuberculosis, dengue virus,malaria and diphteria are continuously reported in Indonesia and classified asre-emerging illnesses. On this edition data on diphteria epidemiology inIndonesia will be shown by Karyanti et al.6 A recent outbreak of diphteria inIndonesia which involved almost all province in the country has led to a responsenamed ORI (outbreak response of Immunization). Regardless of immunization, propertreatment including the distribution of anti-toxin and antibiotics are needed to stop the spread of this particular bacteria, further decreasing the mortalityrate. In conclusion, the author of this paper mentioned that immunization gapneeds to be handle systematically. Immunization data released on 2017 showed thatcomplete immunization was given only to 20% of targeted group, while almost 75%were either unvaccinated or unknown. During the outbreak of diphteria inIndonesia, the WHO also reported several countries with similar problem such asBangladesh, Haiti and Yamen. It was shown that a coordination between doctors in clinic/hospital with public health officer to conduct an epidemiologicalinvestigation, in conjunction with giving prophylaxis and assuring the logistics of anti-diphteria toxin and antibiotics were accessible were the key of successin eliminating diphteria like it was in Bangladesh.Adherence to treatment aremultifactorial for all illnesses. First, is the duration of treatment and thepotential adverse event due to the medication. The Ministry of Health of theRepublic of Indonesia has support the early diagnosis of HIV and deliveringtreatment as soon as possible, in order to avoid transmission of the disease.Second, looking at another side of the story for HIV infected patients, receivingARV treatment as a long life treatment could possibly cause an adverse eventsomewhere along the line. Budiman et.al reported factors that might contribute toliver injury. His study shows that measuring baseline liver function test ASTroutinely might minimize the toxicity of ARV to patients particularly with a low body mass index. Last, despite the adherence to treatment and procedures inminimizing the risk of adverse event to medication, we are now facing the primaryresistance virus that transmitted in the community as mentioned by Megasari etal.8 on her report regarding the transmission of drug resistance HIV virus tonaive patients in Bali.The Indonesian government through the Indonesian Ministry of Health has established a collaboration and one health approaches to tackle thethreat of diseases in the country, particularly in infectious diseases.
FAU - Nelwan, Erni Juwita
AU  - Nelwan EJ
AD  - Department of Internal Medicine, Faculty of Medicine Universitas Indonesia -Cipto Mangunkusumo Hospital, Jakarta, Indonesia. erni.juwita@ui.ac.id.
LA  - eng
PT  - Editorial
PT  - Introductory Journal Article
PL  - Indonesia
TA  - Acta Med Indones
JT  - Acta medica Indonesiana
JID - 7901042
SB  - IM
MH  - Communicable Diseases, Emerging/*epidemiology
MH  - Cost of Illness
MH  - Diphtheria/epidemiology
MH  - HIV Infections/epidemiology
MH  - Humans
MH  - Indonesia/epidemiology
MH  - Tuberculosis/epidemiology
OTO - NOTNLM
OT  - AIDS
OT  - HIV
OT  - Infection
OT  - Virus
EDAT- 2019/11/09 06:00
MHDA- 2020/04/16 06:00
CRDT- 2019/11/09 06:00
PHST- 2019/11/09 06:00 [entrez]
PHST- 2019/11/09 06:00 [pubmed]
PHST- 2020/04/16 06:00 [medline]
PST - ppublish
SO  - Acta Med Indones. 2019 Jul;51(3):195-196.

PMID- 31677948
OWN - NLM
STAT- MEDLINE
DCOM- 20210212
LR  - 20210212
IS  - 1873-2518 (Electronic)
IS  - 0264-410X (Linking)
VI  - 38
IP  - 3
DP  - 2020 Jan 16
TI  - Co-administration of tecovirimat and ACAM2000 in non-human primates: Effect oftecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethalmonkeypox virus challenge.
PG  - 644-654
LID - S0264-410X(19)31429-X [pii]
LID - 10.1016/j.vaccine.2019.10.049 [doi]
AB  - Naturally occurring smallpox has been eradicated but research stocks of variolavirus (VARV), the causative agent of smallpox, still exist in securelaboratories. Clandestine stores of the virus or resurrection of VARV viasynthetic biology are possible and have led to concerns that VARV could be usedas a biological weapon. The US government has prepared for such an event bystockpiling smallpox vaccines and TPOXX(R), SIGA Technologies' smallpox antiviraldrug. While vaccination is effective as a pre-exposure prophylaxis, protection islimited when administered following exposure. Safety concerns preclude generaluse of the vaccine unless there is a smallpox outbreak. TPOXX is approved by the FDA for use after confirmed diagnosis of smallpox disease. Tecovirimat, theactive pharmaceutical ingredient in TPOXX, targets a highly conservedorthopoxviral protein, inhibiting long-range dissemination of virus. Althoughindications for use of the vaccine and TPOXX do not overlap, concomitant use ispossible, especially if the TPOXX indication is expanded to include post-exposureprophylaxis. It is therefore important to understand how vaccine and TPOXX mayinteract. In studies presented here, monkeys were vaccinated with theACAM2000(TM) live attenuated smallpox vaccine and concomitantly treated withtecovirimat or placebo. Immune responses to the vaccine and protective efficacyversus a lethal monkeypox virus (MPXV) challenge were evaluated. In two studies, primary and anamnestic humoral immune responses were similar regardless oftecovirimat treatment while the third study showed reduction in vaccine elicited humoral immunity. Following lethal MPXV challenge, all (12 of 12)vaccinated/placebo treated animals survived, and 12 of 13 vaccinated/tecovirimat treated animals survived. Clinical signs of disease were elevated in tecovirimat treated animals compared to placebo treated animals. This suggests that TPOXX mayaffect the immunogenicity of ACAM2000 if administered concomitantly. Thesestudies may inform on how vaccine and TPOXX are used during a smallpox outbreak.
CI  - Copyright (c) 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.
FAU - Russo, Andrew T
AU  - Russo AT
AD  - Poxvirus Research Group, SIGA Technologies Inc., Corvallis, OR, United States.Electronic address: arusso@siga.com.
FAU - Berhanu, Aklile
AU  - Berhanu A
AD  - SIGA Technologies, Corvallis, OR, United States.
FAU - Bigger, Catherine B
AU  - Bigger CB
AD  - Battelle Biomedical Research Center, Columbus, OH, United States. Electronicaddress: catherine.a.bigger.ctr@mail.mil.
FAU - Prigge, Jon
AU  - Prigge J
AD  - Southern Research Institute, Frederick, MD, United States.
FAU - Silvera, Peter M
AU  - Silvera PM
AD  - Southern Research Institute, Frederick, MD, United States.
FAU - Grosenbach, Douglas W
AU  - Grosenbach DW
AD  - Poxvirus Research Group, SIGA Technologies, Inc., Corvallis, OR 97333, UnitedStates. Electronic address: dgrosenbach@siga.com.
FAU - Hruby, Dennis
AU  - Hruby D
AD  - SIGA Technologies, Inc., Corvallis, OR 97333, United States.
LA  - eng
GR  - N01AI30063/AI/NIAID NIH HHS/United States
GR  - R44 AI075747/AI/NIAID NIH HHS/United States
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20191031
PL  - Netherlands
TA  - Vaccine
JT  - Vaccine
JID - 8406899
RN  - 0 (ACAM2000)
RN  - 0 (Benzamides)
RN  - 0 (Isoindoles)
RN  - 0 (Smallpox Vaccine)
RN  - F925RR824R (Tecovirimat)
SB  - IM
MH  - Animals
MH  - Benzamides/*administration & dosage/immunology
MH  - Drug Therapy, Combination
MH  - Female
MH  - Immunogenicity, Vaccine/*drug effects/immunology
MH  - Isoindoles/*administration & dosage/immunology
MH  - Macaca fascicularis
MH  - Macaca mulatta
MH  - Male
MH  - Monkeypox/immunology/*prevention & control
MH  - Monkeypox virus/*drug effects/immunology
MH  - Primates
MH  - Smallpox Vaccine/*administration & dosage/immunology
MH  - Treatment Outcome
PMC - PMC6954297
MID - NIHMS1542195
OTO - NOTNLM
OT  - *ACAM2000
OT  - *Animal Rule
OT  - *Antiviral
OT  - *Biodefense
OT  - *Monkeypox virus
OT  - *ST-246(R)
OT  - *Smallpox
OT  - *TPOXX(R)
OT  - *Tecovirimat
OT  - *Vaccinia
OT  - *Variola
EDAT- 2019/11/05 06:00
MHDA- 2021/02/13 06:00
CRDT- 2019/11/04 06:00
PHST- 2019/05/15 00:00 [received]
PHST- 2019/10/08 00:00 [revised]
PHST- 2019/10/17 00:00 [accepted]
PHST- 2019/11/05 06:00 [pubmed]
PHST- 2021/02/13 06:00 [medline]
PHST- 2019/11/04 06:00 [entrez]
AID - S0264-410X(19)31429-X [pii]
AID - 10.1016/j.vaccine.2019.10.049 [doi]
PST - ppublish
SO  - Vaccine. 2020 Jan 16;38(3):644-654. doi: 10.1016/j.vaccine.2019.10.049. Epub 2019Oct 31.

PMID- 31657773
OWN - NLM
STAT- MEDLINE
DCOM- 20200527
LR  - 20200527
IS  - 1474-4457 (Electronic)
IS  - 1473-3099 (Linking)
VI  - 19
IP  - 11
DP  - 2019 Nov
TI  - A case of imported Monkeypox in Singapore.
PG  - 1166
LID - S1473-3099(19)30537-7 [pii]
LID - 10.1016/S1473-3099(19)30537-7 [doi]
FAU - Ng, Oon Tek
AU  - Ng OT
AD  - National Centre for Infectious Diseases, Singapore 308422, Singapore; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
FAU - Lee, Vernon
AU  - Lee V
AD  - Ministry of Health Singapore, Singapore.
FAU - Marimuthu, Kalisvar
AU  - Marimuthu K
AD  - National Centre for Infectious Diseases, Singapore 308422, Singapore; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore; Yong Loo Lin School ofMedicine, National University of Singapore, Singapore.
FAU - Vasoo, Shawn
AU  - Vasoo S
AD  - National Centre for Infectious Diseases, Singapore 308422, Singapore; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
FAU - Chan, Guanhao
AU  - Chan G
AD  - Ministry of Health Singapore, Singapore.
FAU - Lin, Raymond Tzer Pin
AU  - Lin RTP
AD  - National Centre for Infectious Diseases, Singapore 308422, Singapore; Yong LooLin School of Medicine, National University of Singapore, Singapore.
FAU - Leo, Yee Sin
AU  - Leo YS
AD  - National Centre for Infectious Diseases, Singapore 308422, Singapore; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Yong Loo Lin School of Medicine, National University of Singapore, Singapore. Electronic address:yee_sin_leo@ncid.sg.
LA  - eng
PT  - Letter
PT  - Comment
PL  - United States
TA  - Lancet Infect Dis
JT  - The Lancet. Infectious diseases
JID - 101130150
SB  - IM
CON - Lancet Infect Dis. 2019 Aug;19(8):872-879. PMID: 31285143
MH  - Animals
MH  - Disease Outbreaks
MH  - Humans
MH  - Monkeypox/*epidemiology
MH  - Monkeypox virus
MH  - Nigeria
MH  - Singapore
PMC - PMC7129797
EDAT- 2019/10/29 06:00
MHDA- 2020/05/28 06:00
CRDT- 2019/10/29 06:00
PHST- 2019/09/11 00:00 [received]
PHST- 2019/09/11 00:00 [accepted]
PHST- 2019/10/29 06:00 [entrez]
PHST- 2019/10/29 06:00 [pubmed]
PHST- 2020/05/28 06:00 [medline]
AID - S1473-3099(19)30537-7 [pii]
AID - 10.1016/S1473-3099(19)30537-7 [doi]
PST - ppublish
SO  - Lancet Infect Dis. 2019 Nov;19(11):1166. doi: 10.1016/S1473-3099(19)30537-7.

PMID- 31618206
OWN - NLM
STAT- MEDLINE
DCOM- 20200203
LR  - 20200203
IS  - 1935-2735 (Electronic)
IS  - 1935-2727 (Linking)
VI  - 13
IP  - 10
DP  - 2019 Oct
TI  - A systematic review of the epidemiology of human monkeypox outbreaks andimplications for outbreak strategy.
PG  - e0007791
LID - 10.1371/journal.pntd.0007791 [doi]
AB  - Monkeypox is a vesicular-pustular illness that carries a secondary attack rate inthe order of 10% in contacts unvaccinated against smallpox. Case fatality ratesrange from 1 to 11%, but scarring and other sequelae are common in survivors. It continues to cause outbreaks in remote populations in Central and West Africa, inareas with poor access and weakened or disrupted surveillance capacity andinformation networks. Recent outbreaks in Nigeria (2017-18) and Cameroon (2018)have occurred where monkeypox has not been reported for over 20 years. This hasprompted concerns over whether there have been changes in the biology andepidemiology of the disease that may in turn have implications for how outbreaks and cases should best be managed. A systematic review was carried out to examine reported data on human monkeypox outbreaks over time, and to identify if and how epidemiology has changed. Published and grey literature were critically analysed,and data extracted to inform recommendations on outbreak response, use of casedefinitions and public health advice. The level of detail, validity of data,geographical coverage and consistency of reporting varied considerably across the71 monkeypox outbreak documents obtained. An increase in cases reported over timewas supported by literature from the Democratic Republic of Congo (DRC). Datawere insufficient to measure trends in secondary attack rates and case fatalityrates. Phylogenetic analyses consistently identify two strains of the viruswithout evidence of emergence of a new strain. Understanding of monkeypoxvirulence with regard to clinical presentation by strain is minimal, withinfrequent sample collection and laboratory analysis. A variety of clinical andsurveillance case definitions are described in the literature: two definitionshave been formally evaluated and showed high sensitivity but low specificity.These were specific to a Congo-Basin (CB) strain-affected area of the DRC wherethey were used. Evidence on use of antibiotics for prophylaxis against secondary cutaneous infection is anecdotal and limited. Current evidence suggests there hasbeen an increase in total monkeypox cases reported by year in the DRCirrespective of advancements in the national Integrated Disease Surveillance and Response (IDSR) system. There has been a marked increase in number of individual monkeypox outbreak reports, from outside the DRC in between 2010 and 2018,particularly in the Central African Republic (CAR) although this does notnecessarily indicate an increase in annual cases over time in these areas. Thegeographical pattern reported in the Nigeria outbreak suggests a possible new andwidespread zoonotic reservoir requiring further investigation and research. With regards to outbreak response, increased attention is warranted for high-riskpatient groups, and nosocomial transmission risks. The animal reservoir remainsunknown and there is a dearth of literature informing case management andsuccessful outbreak response strategies. Up-to-date complete, consistent andlonger-term research is sorely needed to inform and guide evidence-based responseand management of monkeypox outbreaks.
FAU - Beer, Ellen M
AU  - Beer EM
AD  - Department of Infectious Diseases Epidemiology, London School of Hygiene andTropical Medicine, London, United Kingdom.
FAU - Rao, V Bhargavi
AU  - Rao VB
AUID- ORCID: 0000-0002-4406-1636
AD  - Manson Unit, Medecins sans Frontieres (MSF) UK, London, United Kingdom.
LA  - eng
PT  - Journal Article
PT  - Meta-Analysis
PT  - Systematic Review
DEP - 20191016
PL  - United States
TA  - PLoS Negl Trop Dis
JT  - PLoS neglected tropical diseases
JID - 101291488
SB  - IM
MH  - Africa, Western/epidemiology
MH  - Animals
MH  - Central African Republic/epidemiology
MH  - Databases, Factual
MH  - *Disease Outbreaks
MH  - Humans
MH  - Monkeypox/*epidemiology/transmission/*virology
MH  - Monkeypox virus/classification
MH  - Phylogeny
MH  - Public Health
MH  - Virulence
PMC - PMC6816577
COIS- The authors have declared that no competing interests exist.
EDAT- 2019/10/17 06:00
MHDA- 2020/02/06 06:00
CRDT- 2019/10/17 06:00
PHST- 2019/03/06 00:00 [received]
PHST- 2019/09/17 00:00 [accepted]
PHST- 2019/10/28 00:00 [revised]
PHST- 2019/10/17 06:00 [pubmed]
PHST- 2020/02/06 06:00 [medline]
PHST- 2019/10/17 06:00 [entrez]
AID - 10.1371/journal.pntd.0007791 [doi]
AID - PNTD-D-19-00174 [pii]
PST - epublish
SO  - PLoS Negl Trop Dis. 2019 Oct 16;13(10):e0007791. doi:10.1371/journal.pntd.0007791. eCollection 2019 Oct.

PMID- 31593747
OWN - NLM
STAT- MEDLINE
DCOM- 20210205
LR  - 20210205
IS  - 1872-7492 (Electronic)
IS  - 0168-1702 (Linking)
VI  - 275
DP  - 2020 Jan 2
TI  - Use of live Variola virus to determine whether CAST/EiJ mice are a suitablesurrogate animal model for human smallpox.
PG  - 197772
LID - S0168-1702(19)30602-1 [pii]
LID - 10.1016/j.virusres.2019.197772 [doi]
AB  - Numerous animal models of systemic orthopoxvirus disease have been developed toevaluate therapeutics against variola virus (VARV), the causative agent ofsmallpox. These animal models do not resemble the disease presentation in humansmallpox and most used surrogate Orthopoxviruses. A rodent model using VARV has amultitude of advantages, and previous investigations identified the CAST/EiJmouse as highly susceptible to monkeypox virus infection, making it of interestto determine if these rodents are also susceptible to VARV infection. In thisstudy, we inoculated CAST/EiJ mice with a range of VARV doses (10(2)-10(6) plaqueforming units). Some animals had detectable viable VARV from the oropharynxbetween days 3 and 12 post inoculation. Despite evidence of disease, the CAST/EiJmouse does not provide a model for clinical smallpox due to mild signs ofmorbidity and limited skin lesions. However, in contrast to previous rodentmodels using VARV challenge (i.e. prairie dogs and SCID mice), a robust immuneresponse was observed in the CAST/EiJ mice (measured by Immunoglobulin Genzyme-linked immunosorbent assay). This is an advantage of this model for thestudy of VARV and presents a unique potential for the study of theimmunomodulatory pathways following VARV infection.
CI  - Published by Elsevier B.V.
FAU - Gallardo-Romero, Nadia F
AU  - Gallardo-Romero NF
AD  - Centers for Disease Control and Prevention, National Center for Emerging andZoonotic Infectious Diseases, Division of High-Consequence Pathogens andPathology, Poxvirus and Rabies Branch, 1600 Clifton Rd. NE, Atlanta, GA, 30333,USA. Electronic address: hfa5@cdc.gov.
FAU - Hutson, Christina L
AU  - Hutson CL
AD  - Centers for Disease Control and Prevention, National Center for Emerging andZoonotic Infectious Diseases, Division of High-Consequence Pathogens andPathology, Poxvirus and Rabies Branch, 1600 Clifton Rd. NE, Atlanta, GA, 30333,USA. Electronic address: zuu6@cdc.gov.
FAU - Carroll, Darin
AU  - Carroll D
AD  - Centers for Disease Control and Prevention, National Center for Emerging andZoonotic Infectious Diseases, Division of High-Consequence Pathogens andPathology, Poxvirus and Rabies Branch, 1600 Clifton Rd. NE, Atlanta, GA, 30333,USA. Electronic address: zuz4@cdc.gov.
FAU - Kondas, Ashley V
AU  - Kondas AV
AD  - Centers for Disease Control and Prevention, National Center for Emerging andZoonotic Infectious Diseases, Division of High-Consequence Pathogens andPathology, Poxvirus and Rabies Branch, 1600 Clifton Rd. NE, Atlanta, GA, 30333,USA. Electronic address: vga6@cdc.gov.
FAU - Salzer, Johanna S
AU  - Salzer JS
AD  - Centers for Disease Control and Prevention, National Center for Emerging andZoonotic Infectious Diseases, Division of High-Consequence Pathogens andPathology, Poxvirus and Rabies Branch, 1600 Clifton Rd. NE, Atlanta, GA, 30333,USA. Electronic address: hio7@cdc.gov.
FAU - Dietz-Ostergaard, Sharon
AU  - Dietz-Ostergaard S
AD  - Centers for Disease Control and Prevention, National Center for Emerging andZoonotic Infectious Diseases, Division of Scientific resources, ComparativeMedicine Branch, 1600 Clifton Rd. NE, Atlanta, GA, 30333, USA. Electronicaddress: Sharon.ostergaard@bms.com.
FAU - Smith, Scott
AU  - Smith S
AD  - Centers for Disease Control and Prevention, National Center for Emerging andZoonotic Infectious Diseases, Division of High-Consequence Pathogens andPathology, Poxvirus and Rabies Branch, 1600 Clifton Rd. NE, Atlanta, GA, 30333,USA. Electronic address: sks5@cdc.gov.
FAU - Hudson, Paul
AU  - Hudson P
AD  - Centers for Disease Control and Prevention, National Center for Emerging andZoonotic Infectious Diseases, Division of High-Consequence Pathogens andPathology, Poxvirus and Rabies Branch, 1600 Clifton Rd. NE, Atlanta, GA, 30333,USA. Electronic address: fst6@cdc.gov.
FAU - Olson, Victoria
AU  - Olson V
AD  - Centers for Disease Control and Prevention, National Center for Emerging andZoonotic Infectious Diseases, Division of High-Consequence Pathogens andPathology, Poxvirus and Rabies Branch, 1600 Clifton Rd. NE, Atlanta, GA, 30333,USA. Electronic address: vao9@cdc.gov.
FAU - Damon, Inger
AU  - Damon I
AD  - Centers for Disease Control and Prevention, National Center for Emerging andZoonotic Infectious Diseases, Division of High-Consequence Pathogens andPathology, Poxvirus and Rabies Branch, 1600 Clifton Rd. NE, Atlanta, GA, 30333,USA. Electronic address: iad7@cdc.gov.
LA  - eng
PT  - Journal Article
DEP - 20191005
PL  - Netherlands
TA  - Virus Res
JT  - Virus research
JID - 8410979
SB  - IM
MH  - Animals
MH  - *Disease Models, Animal
MH  - Female
MH  - Humans
MH  - *Mice
MH  - Mice, SCID
MH  - Smallpox/*immunology/physiopathology/virology
MH  - Variola virus/*immunology/*pathogenicity
OTO - NOTNLM
OT  - *CAST/EiJ mice
OT  - *Immune response
OT  - *Orthopoxvirus
OT  - *Smallpox
OT  - *Variola virus
EDAT- 2019/10/09 06:00
MHDA- 2021/02/07 06:00
CRDT- 2019/10/09 06:00
PHST- 2019/08/20 00:00 [received]
PHST- 2019/09/30 00:00 [revised]
PHST- 2019/10/01 00:00 [accepted]
PHST- 2019/10/09 06:00 [pubmed]
PHST- 2021/02/07 06:00 [medline]
PHST- 2019/10/09 06:00 [entrez]
AID - S0168-1702(19)30602-1 [pii]
AID - 10.1016/j.virusres.2019.197772 [doi]
PST - ppublish
SO  - Virus Res. 2020 Jan 2;275:197772. doi: 10.1016/j.virusres.2019.197772. Epub 2019 Oct 5.

PMID- 31557167
OWN - NLM
STAT- MEDLINE
DCOM- 20200311
LR  - 20200311
IS  - 1932-6203 (Electronic)
IS  - 1932-6203 (Linking)
VI  - 14
IP  - 9
DP  - 2019
TI  - Characterization of Monkeypox virus dissemination in the black-tailed prairie dog(Cynomys ludovicianus) through in vivo bioluminescent imaging.
PG  - e0222612
LID - 10.1371/journal.pone.0222612 [doi]
AB  - Monkeypox virus (MPXV) is a member of the genus Orthopoxvirus, endemic in Centraland West Africa. This viral zoonosis was introduced into the United States in2003 via African rodents imported for the pet trade and caused 37 human cases,all linked to exposure to MPXV-infected black-tailed prairie dogs (Cynomysludovicianus). Prairie dogs have since become a useful model of MPXV disease,utilized for testing of potential medical countermeasures. In this study, we usedrecombinant MPXV containing the firefly luciferase gene (luc) and in vivo imagingtechnology to characterize MPXV pathogenesis in the black-tailed prairie dog inreal time. West African (WA) MPXV could be visualized using in vivo imaging inthe nose, lymph nodes, intestines, heart, lung, kidneys, and liver as early asday 6 post infection (p.i.). By day 9 p.i., lesions became visible on the skinand in some cases in the spleen. After day 9 p.i., luminescent signalrepresenting MPXV replication either increased, indicating a progression to what would be a fatal infection, or decreased as infection was resolved. Use ofrecombinant luc+ MPXV allowed for a greater understanding of how MPXVdisseminates throughout the body in prairie dogs during the course of infection. This technology will be used to reduce the number of animals required in futurepathogenesis studies as well as aid in determining the effectiveness of potentialmedical countermeasures.
FAU - Weiner, Zachary P
AU  - Weiner ZP
AUID- ORCID: 0000-0002-8337-1354
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United states of America.
AD  - Laboratory Leadership Service assigned to Poxvirus and Rabies Branch, Centers forDisease Control and Prevention, Atlanta, Georgia, United states of America.
FAU - Salzer, Johanna S
AU  - Salzer JS
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United states of America.
FAU - LeMasters, Elizabeth
AU  - LeMasters E
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United states of America.
FAU - Ellison, James A
AU  - Ellison JA
AUID- ORCID: 0000-0003-4492-4857
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United states of America.
FAU - Kondas, Ashley V
AU  - Kondas AV
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United states of America.
FAU - Morgan, Clint N
AU  - Morgan CN
AUID- ORCID: 0000-0001-8646-8920
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United states of America.
FAU - Doty, Jeffery B
AU  - Doty JB
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United states of America.
FAU - Martin, Brock E
AU  - Martin BE
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United states of America.
FAU - Satheshkumar, Panayampalli Subbian
AU  - Satheshkumar PS
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United states of America.
FAU - Olson, Victoria A
AU  - Olson VA
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United states of America.
FAU - Hutson, Christina L
AU  - Hutson CL
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United states of America.
LA  - eng
PT  - Journal Article
DEP - 20190926
PL  - United States
TA  - PLoS One
JT  - PloS one
JID - 101285081
SB  - IM
MH  - Animals
MH  - Disease Models, Animal
MH  - Female
MH  - Heart/virology
MH  - Intestines/virology
MH  - Kidney/virology
MH  - Liver/virology
MH  - Luminescent Measurements/veterinary
MH  - Lung/virology
MH  - Lymph Nodes/virology
MH  - Male
MH  - Monkeypox/pathology/*veterinary/virology
MH  - *Monkeypox virus
MH  - Nose/virology
MH  - Sciuridae/*virology
PMC - PMC6762066
COIS- The authors have declared that no competing interests exist.
EDAT- 2019/09/27 06:00
MHDA- 2020/03/12 06:00
CRDT- 2019/09/27 06:00
PHST- 2019/06/14 00:00 [received]
PHST- 2019/09/03 00:00 [accepted]
PHST- 2019/09/27 06:00 [entrez]
PHST- 2019/09/27 06:00 [pubmed]
PHST- 2020/03/12 06:00 [medline]
AID - 10.1371/journal.pone.0222612 [doi]
AID - PONE-D-19-16949 [pii]
PST - epublish
SO  - PLoS One. 2019 Sep 26;14(9):e0222612. doi: 10.1371/journal.pone.0222612.eCollection 2019.

PMID- 31410720
OWN - NLM
STAT- MEDLINE
DCOM- 20200526
LR  - 20220728
IS  - 1612-9210 (Electronic)
IS  - 1612-9202 (Linking)
VI  - 16
IP  - 3
DP  - 2019 Sep
TI  - Temporal and Spatial Dynamics of Monkeypox in Democratic Republic of Congo,2000-2015.
PG  - 476-487
LID - 10.1007/s10393-019-01435-1 [doi]
AB  - Monkeypox is a viral disease with a clinical presentation resembling that ofsmallpox. Although monkeypox is considered to be an important zoonotic viraldisease, its epidemiology remains poorly understood, especially the spatial andtemporal distribution of the disease. The present study examined weekly reportsof monkeypox cases collected from 2000 to 2015 at the health zone scale in theDemocratic Republic of Congo. SaTScan((R)) was performed to identify spatial and temporal clusters of monkeypox cases. Significant primary spatial clusters weredetected in the districts of Sankuru and Tshuapa. A centrifugal pattern wasfound, with significant primary spatial clusters extending over time from Sankuruand Tshuapa to several neighboring districts. Peaks of cases occurred from Julyto September for the 2000-2002 and 2003-2009 sub-periods and from January toMarch for the 2010-2015 sub-period. Despite the lack of additional data forconfirmation, the increasing of monkeypox reported incidence was observed in the Democratic Republic of Congo during 2000-2015 period and this increase cannot be explain only by the improvements of surveillance systems. The detected spatialclusters were located in the dense rainforest of the Congo basin. The reasons forthe excess incidence of monkeypox cases in the central region of the country are unknown, and the relative influence of ecological, environmental, and humanfactors on the mechanism of emergence of monkeypox has yet to be identified.
FAU - Mandja, Bien-Aime Makasa
AU  - Mandja BM
AUID- ORCID: 0000-0003-3846-5746
AD  - Service de Microbiologie, Faculte de Medecine, Universite de Kinshasa, KIN XI,Quartier Lemba, BP 834, Kinshasa, Democratic Republic of the Congo.mmandja@gmail.com.
AD  - Laboratoire Chrono-Environnement, UMR 6249, CNRS, Universite de BourgogneFranche-Comte, Besancon, France. mmandja@gmail.com.
FAU - Brembilla, Alice
AU  - Brembilla A
AD  - Laboratoire Chrono-Environnement, UMR 6249, CNRS, Universite de BourgogneFranche-Comte, Besancon, France.
AD  - Centre Hospitalier Universitaire de Besancon, Besancon, France.
FAU - Handschumacher, Pascal
AU  - Handschumacher P
AD  - UMR 1252 SESSTIM, INSERM, IRD, Universite d'Aix Marseille, Strasbourg, France.
FAU - Bompangue, Didier
AU  - Bompangue D
AD  - Service de Microbiologie, Faculte de Medecine, Universite de Kinshasa, KIN XI,Quartier Lemba, BP 834, Kinshasa, Democratic Republic of the Congo.
AD  - Laboratoire Chrono-Environnement, UMR 6249, CNRS, Universite de BourgogneFranche-Comte, Besancon, France.
FAU - Gonzalez, Jean-Paul
AU  - Gonzalez JP
AD  - Department of Microbiology and Immunology, Division of Biomedical GraduateResearch Organization, Georgetown University School of Medicine, 4000 ReservoirRoad, Washington, DC, 20057, USA.
FAU - Muyembe, Jean-Jacques
AU  - Muyembe JJ
AD  - Service de Microbiologie, Faculte de Medecine, Universite de Kinshasa, KIN XI,Quartier Lemba, BP 834, Kinshasa, Democratic Republic of the Congo.
AD  - Institut National de Recherche Biomedicale, Gombe, Kinshasa, Democratic Republic of the Congo.
FAU - Mauny, Frederic
AU  - Mauny F
AD  - Laboratoire Chrono-Environnement, UMR 6249, CNRS, Universite de BourgogneFranche-Comte, Besancon, France.
AD  - Centre Hospitalier Universitaire de Besancon, Besancon, France.
LA  - eng
GR  - 263320/PICS CNRS France 2015/International
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20190813
PL  - United States
TA  - Ecohealth
JT  - EcoHealth
JID - 101222144
SB  - IM
MH  - Animals
MH  - Democratic Republic of the Congo/epidemiology
MH  - Humans
MH  - Incidence
MH  - Monkeypox/*epidemiology
MH  - Paraplegia/epidemiology
MH  - Seasons
MH  - Spatio-Temporal Analysis
MH  - Tetany/epidemiology
MH  - Zoonoses
OTO - NOTNLM
OT  - *Democratic Republic of Congo
OT  - *Emerging infectious disease
OT  - *Monkeypox
OT  - *SaTScan
OT  - *Spatio-temporal clusters
OT  - *Surveillance data
EDAT- 2019/08/15 06:00
MHDA- 2020/05/27 06:00
CRDT- 2019/08/15 06:00
PHST- 2018/10/25 00:00 [received]
PHST- 2019/07/08 00:00 [accepted]
PHST- 2019/06/04 00:00 [revised]
PHST- 2019/08/15 06:00 [pubmed]
PHST- 2020/05/27 06:00 [medline]
PHST- 2019/08/15 06:00 [entrez]
AID - 10.1007/s10393-019-01435-1 [doi]
AID - 10.1007/s10393-019-01435-1 [pii]
PST - ppublish
SO  - Ecohealth. 2019 Sep;16(3):476-487. doi: 10.1007/s10393-019-01435-1. Epub 2019 Aug13.

PMID- 31345445
OWN - NLM
STAT- MEDLINE
DCOM- 20200527
LR  - 20200527
IS  - 1474-4457 (Electronic)
IS  - 1473-3099 (Linking)
VI  - 19
IP  - 8
DP  - 2019 Aug
TI  - Rinderpest, smallpox, and the imperative of destruction.
PG  - 789
LID - S1473-3099(19)30358-5 [pii]
LID - 10.1016/S1473-3099(19)30358-5 [doi]
FAU - The Lancet Infectious Diseases
AU  - The Lancet Infectious Diseases
LA  - eng
PT  - Editorial
PT  - Comment
PL  - United States
TA  - Lancet Infect Dis
JT  - The Lancet. Infectious diseases
JID - 101130150
SB  - IM
CON - Lancet Infect Dis. 2019 Aug;19(8):872-879. PMID: 31285143
MH  - Animals
MH  - Disease Outbreaks
MH  - Humans
MH  - *Monkeypox
MH  - Nigeria
MH  - *Rinderpest
MH  - *Smallpox
EDAT- 2019/07/28 06:00
MHDA- 2020/05/28 06:00
CRDT- 2019/07/27 06:00
PHST- 2019/07/27 06:00 [entrez]
PHST- 2019/07/28 06:00 [pubmed]
PHST- 2020/05/28 06:00 [medline]
AID - S1473-3099(19)30358-5 [pii]
AID - 10.1016/S1473-3099(19)30358-5 [doi]
PST - ppublish
SO  - Lancet Infect Dis. 2019 Aug;19(8):789. doi: 10.1016/S1473-3099(19)30358-5.

PMID- 31285143
OWN - NLM
STAT- MEDLINE
DCOM- 20200610
LR  - 20220708
IS  - 1474-4457 (Electronic)
IS  - 1473-3099 (Linking)
VI  - 19
IP  - 8
DP  - 2019 Aug
TI  - Outbreak of human monkeypox in Nigeria in 2017-18: a clinical and epidemiologicalreport.
PG  - 872-879
LID - S1473-3099(19)30294-4 [pii]
LID - 10.1016/S1473-3099(19)30294-4 [doi]
AB  - BACKGROUND: In September, 2017, human monkeypox re-emerged in Nigeria, 39 yearsafter the last reported case. We aimed to describe the clinical andepidemiological features of the 2017-18 human monkeypox outbreak in Nigeria.METHODS: We reviewed the epidemiological and clinical characteristics of cases ofhuman monkeypox that occurred between Sept 22, 2017, and Sept 16, 2018. Data werecollected with a standardised case investigation form, with a case definition of human monkeypox that was based on previously established guidelines. Diagnosiswas confirmed by viral identification with real-time PCR and by detection ofpositive anti-orthopoxvirus IgM antibodies. Whole-genome sequencing was done for seven cases. Haplotype analysis results, genetic distance data, andepidemiological data were used to infer a likely series of events for potentialhuman-to-human transmission of the west African clade of monkeypox virus.FINDINGS: 122 confirmed or probable cases of human monkeypox were recorded in 17 states, including seven deaths (case fatality rate 6%). People infected withmonkeypox virus were aged between 2 days and 50 years (median 29 years [IQR 14]),and 84 (69%) were male. All 122 patients had vesiculopustular rash, and fever,pruritus, headache, and lymphadenopathy were also common. The rash affected allparts of the body, with the face being most affected. The distribution of casesand contacts suggested both primary zoonotic and secondary human-to-humantransmission. Two cases of health-care-associated infection were recorded.Genomic analysis suggested multiple introductions of the virus and a singleintroduction along with human-to-human transmission in a prison facility.INTERPRETATION: This study describes the largest documented human outbreak of thewest African clade of the monkeypox virus. Our results suggest endemicity ofmonkeypox virus in Nigeria, with some evidence of human-to-human transmission.Further studies are necessary to explore animal reservoirs and risk factors fortransmission of the virus in Nigeria. FUNDING: None.
CI  - Copyright (c) 2019 World Health Organization. Published by Elsevier Ltd. Allrights reserved. Published by Elsevier Ltd.. All rights reserved.
FAU - Yinka-Ogunleye, Adesola
AU  - Yinka-Ogunleye A
AD  - Nigeria Centre for Disease Control, Abuja, Nigeria. Electronic address:adesola.ogunleye@ncdc.gov.ng.
FAU - Aruna, Olusola
AU  - Aruna O
AD  - Nigeria Centre for Disease Control, Abuja, Nigeria; International HealthRegulations Strengthening Programme in Nigeria, Public Health England, Abuja,Nigeria.
FAU - Dalhat, Mahmood
AU  - Dalhat M
AD  - African Field Epidemiology Network, Abuja, Nigeria.
FAU - Ogoina, Dimie
AU  - Ogoina D
AD  - Niger Delta University Teaching Hospital, Niger Delta University, Yenagoa,Nigeria.
FAU - McCollum, Andrea
AU  - McCollum A
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,US Centers for Disease Control and Prevention, Atlanta, GA, USA.
FAU - Disu, Yahyah
AU  - Disu Y
AD  - Nigeria Centre for Disease Control, Abuja, Nigeria.
FAU - Mamadu, Ibrahim
AU  - Mamadu I
AD  - WHO Country Office, Abuja, Nigeria.
FAU - Akinpelu, Afolabi
AU  - Akinpelu A
AD  - Nigeria Centre for Disease Control, Abuja, Nigeria.
FAU - Ahmad, Adama
AU  - Ahmad A
AD  - Nigeria Centre for Disease Control, Abuja, Nigeria.
FAU - Burga, Joel
AU  - Burga J
AD  - Nigeria Centre for Disease Control, Abuja, Nigeria.
FAU - Ndoreraho, Adolphe
AU  - Ndoreraho A
AD  - Nigeria Field Epidemiology and Laboratory Training Programme, Abuja, Nigeria.
FAU - Nkunzimana, Edouard
AU  - Nkunzimana E
AD  - Nigeria Field Epidemiology and Laboratory Training Programme, Abuja, Nigeria.
FAU - Manneh, Lamin
AU  - Manneh L
AD  - Nigeria Field Epidemiology and Laboratory Training Programme, Abuja, Nigeria.
FAU - Mohammed, Amina
AU  - Mohammed A
AD  - Nigeria Centre for Disease Control, Abuja, Nigeria.
FAU - Adeoye, Olawunmi
AU  - Adeoye O
AD  - Nigeria Centre for Disease Control, Abuja, Nigeria.
FAU - Tom-Aba, Daniel
AU  - Tom-Aba D
AD  - Helmholtz Centre for Infection Research, Braunschweig, Germany; German Centre forInfection Research, Braunschweig, Germany.
FAU - Silenou, Bernard
AU  - Silenou B
AD  - Helmholtz Centre for Infection Research, Braunschweig, Germany; German Centre forInfection Research, Braunschweig, Germany.
FAU - Ipadeola, Oladipupo
AU  - Ipadeola O
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,US Centers for Disease Control and Prevention, Atlanta, GA, USA.
FAU - Saleh, Muhammad
AU  - Saleh M
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,US Centers for Disease Control and Prevention, Atlanta, GA, USA.
FAU - Adeyemo, Ayodele
AU  - Adeyemo A
AD  - e-Health Africa, Abuja, Nigeria.
FAU - Nwadiutor, Ifeoma
AU  - Nwadiutor I
AD  - Rivers State Ministry of Health, Port Harcourt, Nigeria.
FAU - Aworabhi, Neni
AU  - Aworabhi N
AD  - Bayelsa State Ministry of Health, Yenagoa, Nigeria.
FAU - Uke, Patience
AU  - Uke P
AD  - Cross State Ministry of Health, Calabar, Nigeria.
FAU - John, Doris
AU  - John D
AD  - Department of Health, Federal Capital Territory, Abuja, Nigeria.
FAU - Wakama, Paul
AU  - Wakama P
AD  - Nigeria Prison Services, Port Harcourt, Rivers State, Nigeria.
FAU - Reynolds, Mary
AU  - Reynolds M
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,US Centers for Disease Control and Prevention, Atlanta, GA, USA.
FAU - Mauldin, Matthew R
AU  - Mauldin MR
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,US Centers for Disease Control and Prevention, Atlanta, GA, USA.
FAU - Doty, Jeffrey
AU  - Doty J
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,US Centers for Disease Control and Prevention, Atlanta, GA, USA.
FAU - Wilkins, Kimberly
AU  - Wilkins K
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,US Centers for Disease Control and Prevention, Atlanta, GA, USA.
FAU - Musa, Joy
AU  - Musa J
AD  - University Of Maryland, Abuja, Nigeria.
FAU - Khalakdina, Asheena
AU  - Khalakdina A
AD  - WHO, Geneva, Switzerland.
FAU - Adedeji, Adebayo
AU  - Adedeji A
AD  - Nigeria Centre for Disease Control, Abuja, Nigeria.
FAU - Mba, Nwando
AU  - Mba N
AD  - Nigeria Centre for Disease Control, Abuja, Nigeria.
FAU - Ojo, Olubunmi
AU  - Ojo O
AD  - Nigeria Centre for Disease Control, Abuja, Nigeria.
FAU - Krause, Gerard
AU  - Krause G
AD  - Helmholtz Centre for Infection Research, Braunschweig, Germany; German Centre forInfection Research, Braunschweig, Germany.
FAU - Ihekweazu, Chikwe
AU  - Ihekweazu C
AD  - Nigeria Centre for Disease Control, Abuja, Nigeria.
CN  - CDC Monkeypox Outbreak Team
LA  - eng
GR  - 001/WHO_/World Health Organization/International
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20190705
PL  - United States
TA  - Lancet Infect Dis
JT  - The Lancet. Infectious diseases
JID - 101130150
SB  - IM
CIN - Lancet Infect Dis. 2019 Aug;19(8):797-799. PMID: 31285141
CIN - Lancet Infect Dis. 2019 Aug;19(8):789. PMID: 31345445
CIN - Lancet Infect Dis. 2019 Nov;19(11):1166. PMID: 31657773
CIN - Nature. 2022 Jul;607(7917):17-18. PMID: 35739391
MH  - Adult
MH  - Animals
MH  - *Disease Outbreaks
MH  - Exanthema/etiology
MH  - Female
MH  - Fever/etiology
MH  - Humans
MH  - Male
MH  - Monkeypox/*diagnosis/*epidemiology
MH  - Monkeypox virus/*genetics/isolation & purification
MH  - Nigeria/epidemiology
MH  - Whole Genome Sequencing
IR  - Mandra A
FIR - Mandra, Anna
IR  - Davidson W
FIR - Davidson, Whitni
IR  - Olson V
FIR - Olson, Victoria
IR  - Li Y
FIR - Li, Yu
IR  - Radford K
FIR - Radford, Kay
IR  - Zhao H
FIR - Zhao, Hui
IR  - Townsend M
FIR - Townsend, Michael
IR  - Burgado J
FIR - Burgado, Jillybeth
IR  - Satheshkumar PS
FIR - Satheshkumar, Panayampalli S
EDAT- 2019/07/10 06:00
MHDA- 2020/06/11 06:00
CRDT- 2019/07/10 06:00
PHST- 2018/12/09 00:00 [received]
PHST- 2019/03/25 00:00 [revised]
PHST- 2019/04/05 00:00 [accepted]
PHST- 2019/07/10 06:00 [pubmed]
PHST- 2020/06/11 06:00 [medline]
PHST- 2019/07/10 06:00 [entrez]
AID - S1473-3099(19)30294-4 [pii]
AID - 10.1016/S1473-3099(19)30294-4 [doi]
PST - ppublish
SO  - Lancet Infect Dis. 2019 Aug;19(8):872-879. doi: 10.1016/S1473-3099(19)30294-4.Epub 2019 Jul 5.

PMID- 31285141
OWN - NLM
STAT- MEDLINE
DCOM- 20200527
LR  - 20200527
IS  - 1474-4457 (Electronic)
IS  - 1473-3099 (Linking)
VI  - 19
IP  - 8
DP  - 2019 Aug
TI  - Emergence of human monkeypox in west Africa.
PG  - 797-799
LID - S1473-3099(19)30281-6 [pii]
LID - 10.1016/S1473-3099(19)30281-6 [doi]
FAU - Rezza, Giovanni
AU  - Rezza G
AD  - Department of Infectious Diseases, Istituto Superiore di Sanita, Rome 00142,Italy. Electronic address: giovanni.rezza@iss.it.
LA  - eng
PT  - Journal Article
PT  - Comment
DEP - 20190705
PL  - United States
TA  - Lancet Infect Dis
JT  - The Lancet. Infectious diseases
JID - 101130150
SB  - IM
CON - Lancet Infect Dis. 2019 Aug;19(8):872-879. PMID: 31285143
MH  - Africa, Western
MH  - Animals
MH  - Disease Outbreaks
MH  - Humans
MH  - Monkeypox/*epidemiology
MH  - Monkeypox virus
MH  - Nigeria
EDAT- 2019/07/10 06:00
MHDA- 2020/05/28 06:00
CRDT- 2019/07/10 06:00
PHST- 2019/04/26 00:00 [received]
PHST- 2019/05/08 00:00 [accepted]
PHST- 2019/07/10 06:00 [pubmed]
PHST- 2020/05/28 06:00 [medline]
PHST- 2019/07/10 06:00 [entrez]
AID - S1473-3099(19)30281-6 [pii]
AID - 10.1016/S1473-3099(19)30281-6 [doi]
PST - ppublish
SO  - Lancet Infect Dis. 2019 Aug;19(8):797-799. doi: 10.1016/S1473-3099(19)30281-6.Epub 2019 Jul 5.

PMID- 31240676
OWN - NLM
STAT- MEDLINE
DCOM- 20200330
LR  - 20200330
IS  - 1940-6029 (Electronic)
IS  - 1064-3745 (Linking)
VI  - 2023
DP  - 2019
TI  - Preliminary Screening and In Vitro Confirmation of Orthopoxvirus Antivirals.
PG  - 143-155
LID - 10.1007/978-1-4939-9593-6_9 [doi]
AB  - The lack of antiviral drugs for the treatment of orthopoxvirus disease representsan unmet medical need, particularly due to the threat of variola virus (thecausative agent of smallpox) as an agent of biowarfare or bioterrorism(Henderson, 283:1279-1282, 1999). In addition to variola, monkeypox, cowpox, and vaccinia viruses are orthopoxviruses of concern to human health (Lewis-Jones,17:81-89, 2004). Smallpox vaccination, using the closely related vaccinia virus, is no longer provided to the general public leading to a worldwide populationincreasingly susceptible not only to variola but to monkeypox, cowpox, andvaccinia viruses as well. Orthopoxviruses share similar life cycles (Fenner etal., WHO, Geneva, 1988), and significant nucleotide and protein homology, and areimmunologically cross-protective against other species within the genus, whichwas the basis of the highly successful vaccinia virus vaccine. These similaritiesalso serve as the basis for screening for antivirals for dangerous pathogens suchas variola and monkeypox virus using generally safer viruses such as cowpox andvaccinia. Methods for preliminary screening and initial characterization ofpotential orthopoxvirus antivirals in vitro, using vaccinia virus as a relativelysafe surrogate for more pathogenic orthopoxviruses, are described herein. Theyinclude candidate identification in a viral cytopathic effect (CPE) assay as wellas evaluation of the antiviral activity in inhibition assays to determine meaneffective (or inhibitory) concentrations (EC50 or IC50). These assays wereutilized in the identification and early characterization of tecovirimat (ST-246)(Yang et al., 79:13,139-13,149, 2005). These initial steps in identifying andcharacterizing the antiviral activity should be followed up with additional invitro studies including specificity testing (for other orthopoxviruses andagainst other viruses), single-cycle growth curves, time of addition assays,cytotoxicity testing, and identification of the drug target.
FAU - Grosenbach, Douglas W
AU  - Grosenbach DW
AD  - SIGA Technologies, Inc., Corvallis, OR, USA.
FAU - Hruby, Dennis E
AU  - Hruby DE
AD  - SIGA Technologies, Inc., Corvallis, OR, USA. dhruby@siga.com.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Methods Mol Biol
JT  - Methods in molecular biology (Clifton, N.J.)
JID - 9214969
RN  - 0 (Antiviral Agents)
RN  - 0 (Benzamides)
RN  - 0 (Isoindoles)
RN  - F925RR824R (Tecovirimat)
SB  - IM
MH  - Antiviral Agents/*pharmacology
MH  - Benzamides/pharmacology
MH  - Drug Development
MH  - Isoindoles/pharmacology
MH  - Monkeypox virus/drug effects/genetics
MH  - Orthopoxvirus/*drug effects/genetics
MH  - Variola virus/drug effects/genetics
MH  - Viral Plaque Assay
OTO - NOTNLM
OT  - *Antiviral
OT  - *CPE assay
OT  - *Drug development
OT  - *Drug screening
OT  - *EC50 assay
OT  - *In vitro
OT  - *Orthopoxvirus
EDAT- 2019/06/27 06:00
MHDA- 2020/03/31 06:00
CRDT- 2019/06/27 06:00
PHST- 2019/06/27 06:00 [entrez]
PHST- 2019/06/27 06:00 [pubmed]
PHST- 2020/03/31 06:00 [medline]
AID - 10.1007/978-1-4939-9593-6_9 [doi]
PST - ppublish
SO  - Methods Mol Biol. 2019;2023:143-155. doi: 10.1007/978-1-4939-9593-6_9.

PMID- 31216261
OWN - NLM
STAT- MEDLINE
DCOM- 20191223
LR  - 20200225
IS  - 1080-6059 (Electronic)
IS  - 1080-6040 (Linking)
VI  - 25
IP  - 8
DP  - 2019 Aug
TI  - Intrafamily Transmission of Monkeypox Virus, Central African Republic, 2018.
PG  - 1602-1604
LID - 10.3201/eid2508.190112 [doi]
AB  - Monkeypox is a rare viral zoonotic disease; primary infections are reported from remote forest areas of Central and West Africa. We report an investigation of amonkeypox outbreak in Lobaye, southwest Central African Republic, in October2018.
FAU - Besombes, Camille
AU  - Besombes C
FAU - Gonofio, Ella
AU  - Gonofio E
FAU - Konamna, Xavier
AU  - Konamna X
FAU - Selekon, Benjamin
AU  - Selekon B
FAU - Grant, Rebecca
AU  - Grant R
FAU - Gessain, Antoine
AU  - Gessain A
FAU - Berthet, Nicolas
AU  - Berthet N
FAU - Manuguerra, Jean-Claude
AU  - Manuguerra JC
FAU - Fontanet, Arnaud
AU  - Fontanet A
FAU - Nakoune, Emmanuel
AU  - Nakoune E
LA  - eng
PT  - Historical Article
PT  - Journal Article
DEP - 20190817
PL  - United States
TA  - Emerg Infect Dis
JT  - Emerging infectious diseases
JID - 9508155
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Animals
MH  - Central African Republic/epidemiology
MH  - Child
MH  - Child, Preschool
MH  - Disease Outbreaks
MH  - Family
MH  - Female
MH  - Health Personnel
MH  - History, 21st Century
MH  - Humans
MH  - Infant
MH  - Male
MH  - Monkeypox/*epidemiology/history/*transmission/virology
MH  - *Monkeypox virus
MH  - Young Adult
MH  - Zoonoses
PMC - PMC6649310
OTO - NOTNLM
OT  - *Central Africa
OT  - *Monkeypox virus
OT  - *Orthopoxvirus
OT  - *outbreak investigation
OT  - *viruses
OT  - *zoonoses
EDAT- 2019/06/20 06:00
MHDA- 2019/12/24 06:00
CRDT- 2019/06/20 06:00
PHST- 2019/06/20 06:00 [pubmed]
PHST- 2019/12/24 06:00 [medline]
PHST- 2019/06/20 06:00 [entrez]
AID - 10.3201/eid2508.190112 [doi]
PST - ppublish
SO  - Emerg Infect Dis. 2019 Aug;25(8):1602-1604. doi: 10.3201/eid2508.190112. Epub2019 Aug 17.

PMID- 31142401
OWN - NLM
STAT- MEDLINE
DCOM- 20200522
LR  - 20200522
IS  - 1559-6109 (Print)
IS  - 1559-6109 (Linking)
VI  - 58
IP  - 4
DP  - 2019 Jul 1
TI  - Analgesia during Monkeypox Virus Experimental Challenge Studies in Prairie Dogs(Cynomys ludovicianus).
PG  - 485-500
LID - 10.30802/AALAS-JAALAS-18-000036 [doi]
AB  - Because human patients with monkeypox virus (MPXV) infection report painfulsymptoms, it is reasonable to assume that animals infected with MPXV experiencesome degree of pain. Understanding whether and how analgesics affect MPXV diseaseprogression is crucial when planning in vivo challenge experiments. In thecurrent study, we challenged prairie dogs with a low dose (4 x10(3) pfu) of MPXV and treated with meloxicam (NSAID) or buprenorphine (opioid); control animals didnot receive analgesia or received analgesia without MPXV challenge. Subsets ofanimals from each group were serially euthanized during the course of the study. Disease progression and viral kinetics were similar between groups, butMXPVinfected, meloxicam-treated animals showed increasing trends of morbidity andmortality compared with other groups. Differences between no-analgesiaMPXV-infected control animals and MPXV-infected animals treated withbuprenorphine were minimal. The findings in the current study allow more informeddecisions concerning the use of analgesics during experimental MPXV challengestudies, thereby improving animal welfare. In light of these findings, we havemodified our pain scale for this animal model to include the use of buprenorphinefor pain relief when warranted after MPXV challenge.
FAU - Hutson, Christina L
AU  - Hutson CL
AD  - Centers for Disease Control and Prevention, The University of Georgia, Athens,Georgia; The University of Georgia, Athens, Georgia; Georgia;, Email:zuu6@cdc.gov.
FAU - Gallardo-Romero, Nadia
AU  - Gallardo-Romero N
AD  - Centers for Disease Control and Prevention, The University of Georgia, Athens,Georgia.
FAU - Carroll, Darin S
AU  - Carroll DS
AD  - Centers for Disease Control and Prevention, The University of Georgia, Athens,Georgia.
FAU - Salzer, Johanna S
AU  - Salzer JS
AD  - Centers for Disease Control and Prevention, The University of Georgia, Athens,Georgia.
FAU - Ayers, Jessica D
AU  - Ayers JD
AD  - Centers for Disease Control and Prevention, The University of Georgia, Athens,Georgia.
FAU - Doty, Jeff B
AU  - Doty JB
AD  - Centers for Disease Control and Prevention, The University of Georgia, Athens,Georgia.
FAU - Hughes, Christine M
AU  - Hughes CM
AD  - Centers for Disease Control and Prevention, The University of Georgia, Athens,Georgia.
FAU - Nakazawa, Yoshi
AU  - Nakazawa Y
AD  - Centers for Disease Control and Prevention, The University of Georgia, Athens,Georgia.
FAU - Hudson, Paul
AU  - Hudson P
AD  - Centers for Disease Control and Prevention, The University of Georgia, Athens,Georgia.
FAU - Patel, Nishi
AU  - Patel N
AD  - Centers for Disease Control and Prevention, The University of Georgia, Athens,Georgia.
FAU - Keckler, M S
AU  - Keckler MS
AD  - Centers for Disease Control and Prevention, The University of Georgia, Athens,Georgia.
FAU - Olson, Victoria A
AU  - Olson VA
AD  - Centers for Disease Control and Prevention, The University of Georgia, Athens,Georgia.
FAU - Nagy, Tamas
AU  - Nagy T
AD  - The University of Georgia, Athens, Georgia.
LA  - eng
PT  - Clinical Trial, Veterinary
PT  - Journal Article
DEP - 20190529
PL  - United States
TA  - J Am Assoc Lab Anim Sci
JT  - Journal of the American Association for Laboratory Animal Science : JAALAS
JID - 101269489
RN  - 0 (Analgesics, Opioid)
RN  - 0 (Anti-Inflammatory Agents, Non-Steroidal)
RN  - 40D3SCR4GZ (Buprenorphine)
RN  - VG2QF83CGL (Meloxicam)
SB  - IM
MH  - Analgesia/*veterinary
MH  - Analgesics, Opioid
MH  - Animals
MH  - Anti-Inflammatory Agents, Non-Steroidal
MH  - Buprenorphine/*therapeutic use
MH  - Disease Models, Animal
MH  - Female
MH  - Humans
MH  - Meloxicam/*therapeutic use
MH  - Monkeypox/complications/*veterinary
MH  - Monkeypox virus
MH  - Pain/etiology/prevention & control/*veterinary
MH  - Pain Management/*veterinary
MH  - *Sciuridae
PMC - PMC6643093
EDAT- 2019/05/31 06:00
MHDA- 2020/05/23 06:00
CRDT- 2019/05/31 06:00
PHST- 2019/05/31 06:00 [pubmed]
PHST- 2020/05/23 06:00 [medline]
PHST- 2019/05/31 06:00 [entrez]
AID - 10.30802/AALAS-JAALAS-18-000036 [doi]
PST - ppublish
SO  - J Am Assoc Lab Anim Sci. 2019 Jul 1;58(4):485-500. doi:10.30802/AALAS-JAALAS-18-000036. Epub 2019 May 29.

PMID- 31126795
OWN - NLM
STAT- MEDLINE
DCOM- 20191217
LR  - 20191217
IS  - 1879-0070 (Electronic)
IS  - 0732-8893 (Linking)
VI  - 95
IP  - 1
DP  - 2019 Sep
TI  - Recombinase polymerase amplification assay for rapid detection of Monkeypoxvirus.
PG  - 41-45
LID - S0732-8893(18)30746-6 [pii]
LID - 10.1016/j.diagmicrobio.2019.03.015 [doi]
AB  - In this study, a rapid method for the detection of Central and West Africa cladesof Monkeypox virus (MPXV) using recombinase polymerase amplification (RPA) assay targeting the G2R gene was developed. MPXV, an Orthopoxvirus, is a zoonotic dsDNAvirus, which is listed as a biothreat agent. RPA was operated at a singleconstant temperature of 42 degrees C and produced results within 3 to 10 minutes.The MPXV-RPA-assay was highly sensitive with a limit of detection of 16 DNAmolecules/mul. The clinical performance of the MPXV-RPA-assay was tested using 47sera and whole blood samples from humans collected during the recent MPXVoutbreak in Nigeria as well as 48 plasma samples from monkeys some of which were experimentally infected with MPXV. The specificity of the MPXV-RPA-assay was 100%(50/50), while the sensitivity was 95% (43/45). This new MPXV-RPA-assay is fastand can be easily utilised at low resource settings using a solar powered mobile suitcase laboratory.
CI  - Copyright (c) 2019 Elsevier Inc. All rights reserved.
FAU - Davi, Saskia Dede
AU  - Davi SD
AD  - Institute of Microbiology and Virology, Brandenburg Medical School TheodorFontane, Senftenberg, Germany.
FAU - Kissenkotter, Jonas
AU  - Kissenkotter J
AD  - Department of Animal Sciences, Microbiology and Animal Hygiene,Georg-August-University of Goettingen, Goettingen, Germany.
FAU - Faye, Martin
AU  - Faye M
AD  - Institute Pasteur de Dakar, Dakar, Senegal.
FAU - Bohlken-Fascher, Susanne
AU  - Bohlken-Fascher S
AD  - Department of Animal Sciences, Microbiology and Animal Hygiene,Georg-August-University of Goettingen, Goettingen, Germany.
FAU - Stahl-Hennig, Christiane
AU  - Stahl-Hennig C
AD  - Unit of Infection Models, German Primate Center DPZ, Goettingen, Germany.
FAU - Faye, Oumar
AU  - Faye O
AD  - Institute Pasteur de Dakar, Dakar, Senegal.
FAU - Faye, Ousmane
AU  - Faye O
AD  - Institute Pasteur de Dakar, Dakar, Senegal.
FAU - Sall, Amadou A
AU  - Sall AA
AD  - Institute Pasteur de Dakar, Dakar, Senegal.
FAU - Weidmann, Manfred
AU  - Weidmann M
AD  - Institute of Aquaculture, University of Stirling, Stirling, Scotland, UnitedKingdom.
FAU - Ademowo, Olusegun George
AU  - Ademowo OG
AD  - Institute for Advanced Medical Research and Training, College of Medicine,University of Ibadan, Ibadan, Nigeria.
FAU - Hufert, Frank T
AU  - Hufert FT
AD  - Institute of Microbiology and Virology, Brandenburg Medical School TheodorFontane, Senftenberg, Germany.
FAU - Czerny, Claus-Peter
AU  - Czerny CP
AD  - Department of Animal Sciences, Microbiology and Animal Hygiene,Georg-August-University of Goettingen, Goettingen, Germany.
FAU - Abd El Wahed, Ahmed
AU  - Abd El Wahed A
AD  - Department of Animal Sciences, Microbiology and Animal Hygiene,Georg-August-University of Goettingen, Goettingen, Germany. Electronic address:abdelwahed@gwdg.de.
LA  - eng
PT  - Evaluation Study
PT  - Journal Article
DEP - 20190411
PL  - United States
TA  - Diagn Microbiol Infect Dis
JT  - Diagnostic microbiology and infectious disease
JID - 8305899
RN  - 0 (DNA, Viral)
RN  - 0 (Recombinases)
RN  - 0 (Viral Proteins)
SB  - IM
MH  - Animals
MH  - DNA, Viral/genetics
MH  - Humans
MH  - Mobile Health Units
MH  - Monkeypox/*diagnosis/virology
MH  - Monkeypox virus/genetics/*isolation & purification
MH  - Nucleic Acid Amplification Techniques/*methods/standards
MH  - *Recombinases
MH  - Sensitivity and Specificity
MH  - Time Factors
MH  - Viral Proteins/genetics
OTO - NOTNLM
OT  - Monkeypox Virus
OT  - Recombinase polymerase amplification assay
OT  - mobile suitcase
OT  - point of need
OT  - rapid detection system
EDAT- 2019/05/28 06:00
MHDA- 2019/12/18 06:00
CRDT- 2019/05/26 06:00
PHST- 2018/12/11 00:00 [received]
PHST- 2019/03/04 00:00 [revised]
PHST- 2019/03/28 00:00 [accepted]
PHST- 2019/05/28 06:00 [pubmed]
PHST- 2019/12/18 06:00 [medline]
PHST- 2019/05/26 06:00 [entrez]
AID - S0732-8893(18)30746-6 [pii]
AID - 10.1016/j.diagmicrobio.2019.03.015 [doi]
PST - ppublish
SO  - Diagn Microbiol Infect Dis. 2019 Sep;95(1):41-45. doi:10.1016/j.diagmicrobio.2019.03.015. Epub 2019 Apr 11.

PMID- 31079914
OWN - NLM
STAT- MEDLINE
DCOM- 20191226
LR  - 20191226
IS  - 0151-9638 (Print)
IS  - 0151-9638 (Linking)
VI  - 146
IP  - 5
DP  - 2019 May
TI  - [Human poxvirus infections].
PG  - 387-398
LID - S0151-9638(19)30093-6 [pii]
LID - 10.1016/j.annder.2019.03.001 [doi]
AB  - Poxvirus (PXV) infections are a common cause of cutaneous signs. In France,certain forms of poxvirus are frequent and benign (molluscum contagiosum), while others are rare but potentially serious (cowpox virus [CPXV]). Whereas onlysmallpox and molluscum contagiosum viruses have a human reservoir and aretransmitted between humans, most poxvirus infections are zoonoses having onlyanimal reservoirs. Only a small number of poxviruses are responsible forinfection in humans, but the increasing number of new pets, some of which areexotic, coupled with the rapid rise in international travel are creating agreater risk of transmission of zoonotic PXV to new vectors and of spread ofthese diseases to new regions throughout the world. In France, molluscumcontagiosum, orf and milkers' nodule give rise to numerous consultations and are well known to dermatologists. However, dermatologists must also be able toidentify other parapoxviruses of similar presentation to orf; thus, CPXV andmonkeypox are considered potentially emergent viruses with a high risk ofepidemic and spread due to increasing international transport and the loss of themaximum protection against smallpox. Finally, despite its declared eradication,smallpox is currently being monitored because of the potential risk ofreintroduction, whether accidentally or deliberately through bioterrorism.
CI  - Copyright (c) 2019 Elsevier Masson SAS. All rights reserved.
FAU - Bohelay, G
AU  - Bohelay G
AD  - Service de dermatologie, Hopital Avicenne, AP-HP, 125, rue de Stalingrad, 93009Bobigny, France.
FAU - Duong, T-A
AU  - Duong TA
AD  - Service de dermatologie, Hopital Henri-Mondor, AP-HP, 51, avenue duMarechal-de-Lattre-de-Tassigny, 94010 Creteil, France. Electronic address:tu-anh.duong@aphp.fr.
LA  - fre
PT  - Journal Article
PT  - Review
TT  - Infections humaines a poxvirus.
DEP - 20190509
PL  - France
TA  - Ann Dermatol Venereol
JT  - Annales de dermatologie et de venereologie
JID - 7702013
SB  - IM
MH  - Animals
MH  - Communicable Diseases, Emerging/diagnosis/drug therapy/transmission/virology
MH  - Cowpox/diagnosis/drug therapy/transmission/virology
MH  - Diagnosis, Differential
MH  - Disease Reservoirs/virology
MH  - France
MH  - Humans
MH  - Molluscum Contagiosum/diagnosis/drug therapy/transmission
MH  - Pets/virology
MH  - *Poxviridae Infections/diagnosis/drug therapy/transmission/virology
MH  - *Skin Diseases, Viral/diagnosis/drug therapy/transmission/virology
MH  - Smallpox/transmission/virology
MH  - Zoonoses/transmission/virology
OTO - NOTNLM
OT  - Molluscum contagiosum
OT  - Orf
OT  - Orthopoxvirus
OT  - Parapoxvirus
OT  - Poxvirus
OT  - Smallpox
OT  - Variole
EDAT- 2019/05/14 06:00
MHDA- 2019/12/27 06:00
CRDT- 2019/05/14 06:00
PHST- 2019/05/14 06:00 [pubmed]
PHST- 2019/12/27 06:00 [medline]
PHST- 2019/05/14 06:00 [entrez]
AID - S0151-9638(19)30093-6 [pii]
AID - 10.1016/j.annder.2019.03.001 [doi]
PST - ppublish
SO  - Ann Dermatol Venereol. 2019 May;146(5):387-398. doi:10.1016/j.annder.2019.03.001. Epub 2019 May 9.

PMID- 31062445
OWN - NLM
STAT- MEDLINE
DCOM- 20200615
LR  - 20220126
IS  - 1365-3156 (Electronic)
IS  - 1360-2276 (Linking)
VI  - 24
IP  - 7
DP  - 2019 Jul
TI  - Varicella in Tshuapa Province, Democratic Republic of Congo, 2009-2014.
PG  - 839-848
LID - 10.1111/tmi.13243 [doi]
AB  - OBJECTIVE: To describe varicella cases in Tshuapa Province of the DemocraticRepublic of the Congo identified during monkeypox surveillance. METHODS:Demographic, clinical and epidemiological data were collected from each suspectedmonkeypox case 2009-2014. Samples were tested by PCR for both Orthopoxviruses andvaricella-zoster virus (VZV); a subset of VZV-positive samples was genotyped. We defined a varicella case as a rash illness with laboratory-confirmed VZV.RESULTS: There were 366 varicella cases were identified; 66% were </=19 yearsold. Most patients had non-typical varicella rash with lesions reported as thesame size and stage of evolution (86%), deep and profound (91%), on palms ofhands and/or soles of feet (86%) and not itchy (49%). Many had non-typical signs and symptoms, such as lymphadenopathy (70%) and sensitivity to light (23%). Ahigher proportion of persons aged >/=20 years than persons aged </=19 years had>/=50 lesions (79% vs. 65%, P = 0.007) and were bedridden (15% vs. 9%, P =0.056). All VZV isolates genotyped from 79 varicella cases were clade 5. Duringthe surveillance period, one possible VZV-related death occurred in a 7-year-old child. CONCLUSIONS: A large proportion of patients presented with non-typicalvaricella rash and clinical signs and symptoms, highlighting challengesidentifying varicella in an area with endemic monkeypox. Continued surveillanceand laboratory diagnosis will help in rapid identification and control of bothmonkeypox and varicella and improve our understanding of varicella epidemiologyin Africa.
CI  - (c) 2019 John Wiley & Sons Ltd This article has been contributed to by USGovernment employees and their work is in the public domain in the USA.
FAU - Leung, Jessica
AU  - Leung J
AD  - National Center for Immunization and Respiratory Diseases, Centers for DiseaseControl and Prevention, Atlanta, GA, USA.
FAU - McCollum, Andrea M
AU  - McCollum AM
AD  - National Center for Emerging and Zoonotic Infectious Diseases, Centers forDisease Control and Prevention, Atlanta, GA, USA.
FAU - Radford, Kay
AU  - Radford K
AD  - National Center for Immunization and Respiratory Diseases, Centers for DiseaseControl and Prevention, Atlanta, GA, USA.
FAU - Hughes, Christine
AU  - Hughes C
AD  - National Center for Emerging and Zoonotic Infectious Diseases, Centers forDisease Control and Prevention, Atlanta, GA, USA.
FAU - Lopez, Adriana S
AU  - Lopez AS
AD  - National Center for Immunization and Respiratory Diseases, Centers for DiseaseControl and Prevention, Atlanta, GA, USA.
FAU - Guagliardo, Sarah Anne J
AU  - Guagliardo SAJ
AD  - National Center for Emerging and Zoonotic Infectious Diseases, Centers forDisease Control and Prevention, Atlanta, GA, USA.
AD  - Epidemic Intelligence Service, Centers for Disease Control and Prevention,Atlanta, GA, USA.
FAU - Nguete, Beatrice
AU  - Nguete B
AD  - Kinshasa School of Public Health, Kinshasa, Democratic Republic of Congo.
FAU - Likafi, Toutou
AU  - Likafi T
AD  - Kinshasa School of Public Health, Kinshasa, Democratic Republic of Congo.
FAU - Kabamba, Joelle
AU  - Kabamba J
AD  - U.S. Centers for Disease Control and Prevention, Kinshasa, Democratic Republic ofCongo.
FAU - Malekani, Jean
AU  - Malekani J
AD  - Department of Biology, University of Kinshasa, Kinshasa, Democratic Republic ofCongo.
FAU - Shongo Lushima, Robert
AU  - Shongo Lushima R
AD  - Ministry of Health, Kinshasa, Democratic Republic of Congo.
FAU - Pukuta, Elisabeth
AU  - Pukuta E
AD  - Institut National de Recherche Biomedicale, Kinshasa, Democratic Republic ofCongo.
FAU - Karhemere, Stomy
AU  - Karhemere S
AD  - Institut National de Recherche Biomedicale, Kinshasa, Democratic Republic ofCongo.
FAU - Muyembe Tamfum, Jean Jacques
AU  - Muyembe Tamfum JJ
AD  - Institut National de Recherche Biomedicale, Kinshasa, Democratic Republic ofCongo.
FAU - Reynolds, Mary G
AU  - Reynolds MG
AD  - National Center for Emerging and Zoonotic Infectious Diseases, Centers forDisease Control and Prevention, Atlanta, GA, USA.
FAU - Wemakoy Okitolonda, Emile
AU  - Wemakoy Okitolonda E
AD  - Kinshasa School of Public Health, Kinshasa, Democratic Republic of Congo.
FAU - Schmid, D Scott
AU  - Schmid DS
AD  - National Center for Immunization and Respiratory Diseases, Centers for DiseaseControl and Prevention, Atlanta, GA, USA.
FAU - Marin, Mona
AU  - Marin M
AD  - National Center for Immunization and Respiratory Diseases, Centers for DiseaseControl and Prevention, Atlanta, GA, USA.
LA  - eng
GR  - CC999999/ImCDC/Intramural CDC HHS/United States
PT  - Journal Article
DEP - 20190522
PL  - England
TA  - Trop Med Int Health
JT  - Tropical medicine & international health : TM & IH
JID - 9610576
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Chickenpox/*diagnosis/*epidemiology
MH  - Child
MH  - Child, Preschool
MH  - Democratic Republic of the Congo/epidemiology
MH  - Female
MH  - Humans
MH  - Infant
MH  - Male
MH  - Middle Aged
MH  - Monkeypox/diagnosis/epidemiology
MH  - Polymerase Chain Reaction
MH  - Young Adult
PMC - PMC8786670
MID - NIHMS1066977
OTO - NOTNLM
OT  - * RDC
OT  - *Africa
OT  - *Afrique
OT  - *Democratic Republic of Congo, DRC
OT  - *Republique Democratique du Congo
OT  - *chickenpox
OT  - *epidemiology
OT  - *monkeypox
OT  - *varicella
OT  - *varicella-zoster virus
OT  - *varicelle
OT  - *variole du singe monkeypox
OT  - *virus varicelle-zona
OT  - *Epidemiologie
EDAT- 2019/05/08 06:00
MHDA- 2020/06/17 06:00
CRDT- 2019/05/08 06:00
PHST- 2019/05/08 06:00 [pubmed]
PHST- 2020/06/17 06:00 [medline]
PHST- 2019/05/08 06:00 [entrez]
AID - 10.1111/tmi.13243 [doi]
PST - ppublish
SO  - Trop Med Int Health. 2019 Jul;24(7):839-848. doi: 10.1111/tmi.13243. Epub 2019May 22.

PMID- 31016025
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20201001
IS  - 2055-0936 (Print)
IS  - 2055-0936 (Linking)
VI  - 5
DP  - 2019
TI  - 2018 in review: five hot topics in tropical medicine.
PG  - 5
LID - 10.1186/s40794-019-0082-z [doi]
AB  - The year 2018 heralded many new developments in the field of tropical medicine,including licensure of novel drugs for novel indications, licensure of existingdrugs for existing indications but in novel settings, and globalized outbreaks ofboth vector-borne and zoonotic diseases. We herein describe five top stories intropical medicine that occurred during 2018, and illuminate the practice-changingdevelopment within each story.
FAU - Makhani, Leila
AU  - Makhani L
AD  - 1Department of Family and Community Medicine, University of Toronto, Toronto,Canada.0000 0001 2157 2938grid.17063.33
AD  - 2Tropical Disease Unit, Toronto General Hospital, 200 Elizabeth Street, 13EN-218,Toronto, ON M5G 2C4 Canada.0000 0001 0661 1177grid.417184.f
FAU - Khatib, Aisha
AU  - Khatib A
AD  - 1Department of Family and Community Medicine, University of Toronto, Toronto,Canada.0000 0001 2157 2938grid.17063.33
AD  - 2Tropical Disease Unit, Toronto General Hospital, 200 Elizabeth Street, 13EN-218,Toronto, ON M5G 2C4 Canada.0000 0001 0661 1177grid.417184.f
FAU - Corbeil, Antoine
AU  - Corbeil A
AD  - 3Department of Laboratory Medicine and Pathobiology, University of Toronto,Toronto, Canada.0000 0001 2157 2938grid.17063.33
FAU - Kariyawasam, Ruwandi
AU  - Kariyawasam R
AD  - 4Institute of Medical Science, University of Toronto, Toronto, Canada.0000 00012157 2938grid.17063.33
FAU - Raheel, Hira
AU  - Raheel H
AD  - 5Faculty of Medicine, University of Toronto, Toronto, Canada.0000 0001 21572938grid.17063.33
FAU - Clarke, Shareese
AU  - Clarke S
AD  - 2Tropical Disease Unit, Toronto General Hospital, 200 Elizabeth Street, 13EN-218,Toronto, ON M5G 2C4 Canada.0000 0001 0661 1177grid.417184.f
FAU - Challa, Priyanka
AU  - Challa P
AD  - 6Department of Life Science, University of Toronto, Toronto, Canada.0000 00012157 2938grid.17063.33
FAU - Hagopian, Emma
AU  - Hagopian E
AD  - 7Department of Arts and Science, University of Toronto, Toronto, Canada.0000 00012157 2938grid.17063.33
FAU - Chakrabarti, Sumontra
AU  - Chakrabarti S
AD  - 2Tropical Disease Unit, Toronto General Hospital, 200 Elizabeth Street, 13EN-218,Toronto, ON M5G 2C4 Canada.0000 0001 0661 1177grid.417184.f
AD  - 8Department of Medicine, University of Toronto, Toronto, Canada.0000 0001 21572938grid.17063.33
AD  - 9Division of Infectious Diseases, Trillium Health Partners, Mississauga,Canada.0000 0004 0459 7334grid.417293.a
FAU - Schwartz, Kevin L
AU  - Schwartz KL
AD  - 2Tropical Disease Unit, Toronto General Hospital, 200 Elizabeth Street, 13EN-218,Toronto, ON M5G 2C4 Canada.0000 0001 0661 1177grid.417184.f
AD  - 10Division of Infectious Diseases, St. Joseph's Health Centre, Toronto,Canada.grid.416449.a
AD  - 11Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.00000001 2157 2938grid.17063.33
AD  - 12Public Health Ontario, Toronto, Canada.0000 0001 1505 2354grid.415400.4
FAU - Boggild, Andrea K
AU  - Boggild AK
AD  - 2Tropical Disease Unit, Toronto General Hospital, 200 Elizabeth Street, 13EN-218,Toronto, ON M5G 2C4 Canada.0000 0001 0661 1177grid.417184.f
AD  - 4Institute of Medical Science, University of Toronto, Toronto, Canada.0000 00012157 2938grid.17063.33
AD  - 8Department of Medicine, University of Toronto, Toronto, Canada.0000 0001 21572938grid.17063.33
AD  - 12Public Health Ontario, Toronto, Canada.0000 0001 1505 2354grid.415400.4
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20190415
PL  - England
TA  - Trop Dis Travel Med Vaccines
JT  - Tropical diseases, travel medicine and vaccines
JID - 101674442
PMC - PMC6466725
OTO - NOTNLM
OT  - Human African trypanosomiasis
OT  - Ivermectin
OT  - Monkeypox
OT  - Plasmodium vivax
OT  - Strongyloidiasis
OT  - Tafenoquine
OT  - Yellow fever
COIS- N/A.N/A.The authors declare that they have no competing interests.Springer Natureremains neutral with regard to jurisdictional claims in published maps andinstitutional affiliations.
EDAT- 2019/04/25 06:00
MHDA- 2019/04/25 06:01
CRDT- 2019/04/25 06:00
PHST- 2019/03/04 00:00 [received]
PHST- 2019/03/28 00:00 [accepted]
PHST- 2019/04/25 06:00 [entrez]
PHST- 2019/04/25 06:00 [pubmed]
PHST- 2019/04/25 06:01 [medline]
AID - 10.1186/s40794-019-0082-z [doi]
AID - 82 [pii]
PST - epublish
SO  - Trop Dis Travel Med Vaccines. 2019 Apr 15;5:5. doi: 10.1186/s40794-019-0082-z.eCollection 2019.

PMID- 30996093
OWN - NLM
STAT- MEDLINE
DCOM- 20200528
LR  - 20200528
IS  - 1098-5514 (Electronic)
IS  - 0022-538X (Linking)
VI  - 93
IP  - 13
DP  - 2019 Jul 1
TI  - A Genome-Wide Haploid Genetic Screen Identifies Heparan Sulfate-Associated Genes and the Macropinocytosis Modulator TMED10 as Factors Supporting Vaccinia VirusInfection.
LID - e02160-18 [pii]
LID - 10.1128/JVI.02160-18 [doi]
AB  - Vaccinia virus is a promising viral vaccine and gene delivery candidate and hashistorically been used as a model to study poxvirus-host cell interactions. Weemployed a genome-wide insertional mutagenesis approach in human haploid cells toidentify host factors crucial for vaccinia virus infection. A library ofmutagenized HAP1 cells was exposed to modified vaccinia virus Ankara (MVA).Deep-sequencing analysis of virus-resistant cells identified host factorsinvolved in heparan sulfate synthesis, Golgi organization, and vesicular protein trafficking. We validated EXT1, TM9SF2, and TMED10 (TMP21/p23/p24delta) asimportant host factors for vaccinia virus infection. The critical roles of EXT1in heparan sulfate synthesis and vaccinia virus infection were confirmed. TM9SF2 was validated as a player mediating heparan sulfate expression, explaining itscontribution to vaccinia virus infection. In addition, TMED10 was found to becrucial for virus-induced plasma membrane blebbing and phosphatidylserine-inducedmacropinocytosis, presumably by regulating the cell surface expression of the TAMreceptor Axl.IMPORTANCE Poxviruses are large DNA viruses that can infect a widerange of host species. A number of these viruses are clinically important tohumans, including variola virus (smallpox) and vaccinia virus. Since theeradication of smallpox, zoonotic infections with monkeypox virus and cowpoxvirus are emerging. Additionally, poxviruses can be engineered to specificallytarget cancer cells and are used as a vaccine vector against tuberculosis,influenza, and coronaviruses. Poxviruses rely on host factors for most stages of their life cycle, including attachment to the cell and entry. These host factors are crucial for virus infectivity and host cell tropism. We used a genome-wideknockout library of host cells to identify host factors necessary for vacciniavirus infection. We confirm a dominant role for heparin sulfate in mediatingvirus attachment. Additionally, we show that TMED10, previously not implicated invirus infections, facilitates virus uptake by modulating the cellular response tophosphatidylserine.
CI  - Copyright (c) 2019 American Society for Microbiology.
FAU - Luteijn, Rutger D
AU  - Luteijn RD
AD  - Department of Medical Microbiology, University Medical Center Utrecht, Utrecht,The Netherlands.
FAU - van Diemen, Ferdy
AU  - van Diemen F
AD  - Department of Medical Microbiology, University Medical Center Utrecht, Utrecht,The Netherlands.
FAU - Blomen, Vincent A
AU  - Blomen VA
AD  - Netherlands Cancer Institute, Amsterdam, The Netherlands.
FAU - Boer, Ingrid G J
AU  - Boer IGJ
AD  - Department of Medical Microbiology, University Medical Center Utrecht, Utrecht,The Netherlands.
FAU - Manikam Sadasivam, Saravanan
AU  - Manikam Sadasivam S
AD  - Department of Membrane Biochemistry and Biophysics, Utrecht University, Utrecht, The Netherlands.
FAU - van Kuppevelt, Toin H
AU  - van Kuppevelt TH
AD  - Department of Biochemistry, Radboud University Medical Center, Nijmegen, TheNetherlands.
FAU - Drexler, Ingo
AU  - Drexler I
AD  - Institute for Virology, Universitatsklinikum Dusseldorf, Heinrich HeineUniversity, Dusseldorf, Germany.
FAU - Brummelkamp, Thijn R
AU  - Brummelkamp TR
AD  - Netherlands Cancer Institute, Amsterdam, The Netherlands.
FAU - Lebbink, Robert Jan
AU  - Lebbink RJ
AD  - Department of Medical Microbiology, University Medical Center Utrecht, Utrecht,The Netherlands.
FAU - Wiertz, Emmanuel J
AU  - Wiertz EJ
AD  - Department of Medical Microbiology, University Medical Center Utrecht, Utrecht,The Netherlands ewiertz@umcutrecht.nl.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20190614
PL  - United States
TA  - J Virol
JT  - Journal of virology
JID - 0113724
RN  - 0 (Membrane Proteins)
RN  - 0 (Phosphatidylserines)
RN  - 0 (TM9SF2 protein, human)
RN  - 0 (Vesicular Transport Proteins)
RN  - 9050-30-0 (Heparitin Sulfate)
RN  - EC 2.4.1.- (N-Acetylglucosaminyltransferases)
RN  - EC 2.4.1.224 (exostosin-1)
SB  - IM
MH  - CRISPR-Cas Systems
MH  - Cell Line, Tumor
MH  - Cowpox virus/genetics
MH  - DNA Viruses
MH  - Gene Knockout Techniques
MH  - Genetic Testing
MH  - Golgi Apparatus
MH  - HEK293 Cells
MH  - *Haploidy
MH  - HeLa Cells
MH  - Heparitin Sulfate/*genetics/*isolation & purification/metabolism
MH  - Host Specificity
MH  - Host-Pathogen Interactions
MH  - Humans
MH  - Membrane Proteins
MH  - Monkeypox virus/genetics
MH  - N-Acetylglucosaminyltransferases
MH  - Phosphatidylserines/metabolism
MH  - Pinocytosis/*physiology
MH  - Poxviridae/genetics
MH  - Vaccinia/*virology
MH  - Vaccinia virus/*genetics/*metabolism
MH  - Vesicular Transport Proteins/*metabolism
MH  - Virus Attachment
PMC - PMC6580964
OTO - NOTNLM
OT  - *TMED10
OT  - *genome-wide screen
OT  - *heparan sulfate
OT  - *macropinocytosis
OT  - *phosphatidylserine
OT  - *poxvirus
OT  - *vaccinia virus
EDAT- 2019/04/19 06:00
MHDA- 2020/05/29 06:00
CRDT- 2019/04/19 06:00
PHST- 2018/12/11 00:00 [received]
PHST- 2019/04/11 00:00 [accepted]
PHST- 2019/04/19 06:00 [pubmed]
PHST- 2020/05/29 06:00 [medline]
PHST- 2019/04/19 06:00 [entrez]
AID - JVI.02160-18 [pii]
AID - 10.1128/JVI.02160-18 [doi]
PST - epublish
SO  - J Virol. 2019 Jun 14;93(13). pii: JVI.02160-18. doi: 10.1128/JVI.02160-18. Print 2019 Jul 1.

PMID- 30995249
OWN - NLM
STAT- MEDLINE
DCOM- 20191218
LR  - 20200309
IS  - 1932-6203 (Electronic)
IS  - 1932-6203 (Linking)
VI  - 14
IP  - 4
DP  - 2019
TI  - The 2017 human monkeypox outbreak in Nigeria-Report of outbreak experience andresponse in the Niger Delta University Teaching Hospital, Bayelsa State, Nigeria.
PG  - e0214229
LID - 10.1371/journal.pone.0214229 [doi]
AB  - BACKGROUND: In September 2017, Nigeria experienced a large outbreak of humanmonkeypox (HMPX). In this study, we report the outbreak experience and responsein the Niger Delta University Teaching Hospital (NDUTH), Bayelsa state, where theindex case and majority of suspected cases were reported. METHODS: In across-sectional study between September 25th and 31st December 2017, we reviewed the clinical and laboratory characteristics of all suspected and confirmed cases of HMPX seen at the NDUTH and appraised the plans, activities and challenges ofthe hospital in response to the outbreak based on documented observations of the hospital's infection control committee (IPC). Monkeypox cases were defined using the interim national guidelines as provided by the Nigerian Centre for DiseaseControl (NCDC). RESULTS: Of 38 suspected cases of HMPX, 18(47.4%) were laboratoryconfirmed, 3(7.9%) were probable, while 17 (18.4%) did not fit the casedefinition for HMPX. Majority of the confirmed/probable cases were adults (80.9%)and males (80.9%). There was concomitant chicken pox, syphilis and HIV-1infections in two confirmed cases and a case of nosocomial infection in onehealthcare worker (HCW). The hospital established a make-shift isolation ward forcase management, constituted a HMPX response team and provided IPC resources. At the outset, some HCWs were reluctant to participate in the outbreak and othersavoided suspected patients. Some patients and their family members experiencedstigma and discrimination and there were cases of refusal of isolation. Repeated trainings and collaborative efforts by all stakeholders addressed some of thesechallenges and eventually led to successful containment of the outbreak.CONCLUSION: While the 2017 outbreak of human monkeypox in Nigeria was contained, our report reveals gaps in outbreak response that could serve as lessons to otherhospitals to strengthen epidemic preparedness and response activities in thehospital setting.
FAU - Ogoina, Dimie
AU  - Ogoina D
AUID- ORCID: 0000-0002-2098-6300
AD  - Department of Internal Medicine, Infectious Disease Unit, Niger Delta University Teaching Hospital, Okolobiri, Bayelsa State, Nigeria.
FAU - Izibewule, James Hendris
AU  - Izibewule JH
AD  - Department of Internal Medicine, Infectious Disease Unit, Niger Delta University Teaching Hospital, Okolobiri, Bayelsa State, Nigeria.
FAU - Ogunleye, Adesola
AU  - Ogunleye A
AD  - Nigerian Centre for Disease Control, Abuja, Nigeria.
FAU - Ederiane, Ebi
AU  - Ederiane E
AD  - Department of Paediatrics and Child Health, Niger Delta University TeachingHospital, Okolobiri, Bayelsa State, Nigeria.
FAU - Anebonam, Uchenna
AU  - Anebonam U
AUID- ORCID: 0000-0002-8114-6698
AD  - Nigerian Centre for Disease Control, Abuja, Nigeria.
FAU - Neni, Aworabhi
AU  - Neni A
AD  - Bayelsa State Ministry of Health, Bayelsa, Nigeria.
FAU - Oyeyemi, Abisoye
AU  - Oyeyemi A
AD  - Department of Community Medicine, Niger Delta University Teaching Hospital,Okolobiri, Bayelsa State, Nigeria.
FAU - Etebu, Ebimitula Nicholas
AU  - Etebu EN
AD  - Bayelsa State Ministry of Health, Bayelsa, Nigeria.
FAU - Ihekweazu, Chikwe
AU  - Ihekweazu C
AD  - Nigerian Centre for Disease Control, Abuja, Nigeria.
LA  - eng
PT  - Journal Article
DEP - 20190417
PL  - United States
TA  - PLoS One
JT  - PloS one
JID - 101285081
SB  - IM
MH  - Child
MH  - Communications Media
MH  - *Disease Outbreaks
MH  - Health Knowledge, Attitudes, Practice
MH  - *Hospitals, Teaching
MH  - *Hospitals, University
MH  - Humans
MH  - Male
MH  - Monkeypox/*epidemiology
MH  - Nigeria/epidemiology
MH  - *Research Report
PMC - PMC6469755
COIS- The authors have declared that no competing interests exist.
EDAT- 2019/04/18 06:00
MHDA- 2019/12/19 06:00
CRDT- 2019/04/18 06:00
PHST- 2018/09/29 00:00 [received]
PHST- 2019/03/08 00:00 [accepted]
PHST- 2019/04/18 06:00 [entrez]
PHST- 2019/04/18 06:00 [pubmed]
PHST- 2019/12/19 06:00 [medline]
AID - 10.1371/journal.pone.0214229 [doi]
AID - PONE-D-18-28410 [pii]
PST - epublish
SO  - PLoS One. 2019 Apr 17;14(4):e0214229. doi: 10.1371/journal.pone.0214229.eCollection 2019.

PMID- 30981594
OWN - NLM
STAT- MEDLINE
DCOM- 20200323
LR  - 20200323
IS  - 1557-9824 (Electronic)
IS  - 0891-5520 (Linking)
VI  - 33
IP  - 4
DP  - 2019 Dec
TI  - Human Monkeypox: Epidemiologic and Clinical Characteristics, Diagnosis, andPrevention.
PG  - 1027-1043
LID - S0891-5520(19)30017-0 [pii]
LID - 10.1016/j.idc.2019.03.001 [doi]
AB  - Recently, concern has been raised about the emergence of human monkeypox virusand the occasionally severe clinical presentation bearing resemblance to that of smallpox. In 2018 3 patients in the UK were diagnosed with monkeypox, and thefrequency and geographic distribution of cases across West and Central Africahave increased in recent years. In Nigeria, most monkeypox patients are aged <40 years and lack cross-protective immunity because they were born afterdiscontinuation of the smallpox eradication campaign. This article reviews theepidemiology, clinical features, and management of monkeypox and discusses itsgrowing public health threat in this context.
CI  - Copyright (c) 2019 Elsevier Inc. All rights reserved.
FAU - Petersen, Eskild
AU  - Petersen E
AD  - Institute of Clinical Medicine, University of Aarhus, Palle Juul-JensensBoulevard 82, Aarhus N DK-8200, Denmark; The Royal Hospital, Muscat, Oman;European Society for Clinical Microbiology and Infectious Diseases, Task Forcefor Emerging Infections, Basel, Switzerland. Electronic address:eskild.petersen@gmail.com.
FAU - Kantele, Anu
AU  - Kantele A
AD  - Inflammation Center, Helsinki University Hospital and Helsinki University,Stenbackinkatu 9, PO BOX 100, Helsinki FI-00029 HUS, Finland.
FAU - Koopmans, Marion
AU  - Koopmans M
AD  - Viroscience Department, Erasmus Medical Centre, Postbus 2040, Rotterdam 3000 CA, the Netherlands.
FAU - Asogun, Danny
AU  - Asogun D
AD  - Department of Public Health, College of Medicine, Ambrose Alli University,Ekpoma, Nigeria; Department of Public Health, and Institute of Lassa FeverResearch and Control, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
FAU - Yinka-Ogunleye, Adesola
AU  - Yinka-Ogunleye A
AD  - Nigeria Centre for Disease Control, Plot 801, Ebitu Ukiwe Street, Jabi, Abuja,Nigeria.
FAU - Ihekweazu, Chikwe
AU  - Ihekweazu C
AD  - Nigeria Centre for Disease Control, Plot 801, Ebitu Ukiwe Street, Jabi, Abuja,Nigeria.
FAU - Zumla, Alimuddin
AU  - Zumla A
AD  - Division of Infection and Immunity, Center for Clinical Microbiology, University College London, The National Institute of Health Research Biomedical ResearchCentre at UCL Hospitals, Gower Street, London WC1E 6BT, UK.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Review
DEP - 20190411
PL  - United States
TA  - Infect Dis Clin North Am
JT  - Infectious disease clinics of North America
JID - 8804508
SB  - IM
MH  - Africa/epidemiology
MH  - Animals
MH  - Humans
MH  - Monkeypox/*epidemiology/pathology/*virology
MH  - Monkeypox virus/*physiology
MH  - Risk Factors
MH  - Zoonoses
OTO - NOTNLM
OT  - *Epidemic
OT  - *Monkeypox
OT  - *Smallpox
OT  - *West Africa
EDAT- 2019/04/15 06:00
MHDA- 2020/03/24 06:00
CRDT- 2019/04/15 06:00
PHST- 2019/04/15 06:00 [pubmed]
PHST- 2020/03/24 06:00 [medline]
PHST- 2019/04/15 06:00 [entrez]
AID - S0891-5520(19)30017-0 [pii]
AID - 10.1016/j.idc.2019.03.001 [doi]
PST - ppublish
SO  - Infect Dis Clin North Am. 2019 Dec;33(4):1027-1043. doi:10.1016/j.idc.2019.03.001. Epub 2019 Apr 11.

PMID- 30918078
OWN - NLM
STAT- MEDLINE
DCOM- 20200623
LR  - 20210109
IS  - 1098-5514 (Electronic)
IS  - 0022-538X (Linking)
VI  - 93
IP  - 12
DP  - 2019 Jun 15
TI  - Identification of CP77 as the Third Orthopoxvirus SAMD9 and SAMD9L Inhibitor withUnique Specificity for a Rodent SAMD9L.
LID - e00225-19 [pii]
LID - 10.1128/JVI.00225-19 [doi]
AB  - Orthopoxviruses (OPXVs) have a broad host range in mammalian cells, but Chinesehamster ovary (CHO) cells are nonpermissive for vaccinia virus (VACV). Here, werevealed a species-specific difference in host restriction factor SAMD9L as thecause for the restriction and identified orthopoxvirus CP77 as a unique inhibitorcapable of antagonizing Chinese hamster SAMD9L (chSAMD9L). Two known VACVinhibitors of SAMD9 and SAMD9L (SAMD9&L), K1 and C7, can bind human and mouseSAMD9&L, but neither can bind chSAMD9L. Clustered regularly interspaced shortpalindromic repeat (CRISPR)-Cas9 knockout of chSAMD9L from CHO cells removed the restriction for VACV, while ectopic expression of chSAMD9L imposed therestriction for VACV in a human cell line, demonstrating that chSAMD9L is apotent restriction factor for VACV. In contrast to K1 and C7, cowpox virus CP77can bind chSAMD9L and rescue VACV replication in cells expressing chSAMD9L,indicating that CP77 is yet another SAMD9L inhibitor but has a unique specificityfor chSAMD9L. Binding studies showed that the N-terminal 382 amino acids of CP77 were sufficient for binding chSAMD9L and that both K1 and CP77 target a commoninternal region of SAMD9L. Growth studies with nearly all OPXV species showedthat the ability of OPXVs to antagonize chSAMD9L correlates with CP77 gene statusand that a functional CP77 ortholog was maintained in many OPXVs, includingmonkeypox virus. Our data suggest that a species-specific difference in rodentSAMD9L poses a barrier for cross-species OPXV infection and that OPXVs haveevolved three SAMD9&L inhibitors with different specificities to overcome thisbarrier.IMPORTANCE Several OPXV species, including monkeypox virus and cowpoxvirus, cause zoonotic infection in humans. They are believed to use wild rodents as the reservoir or intermediate hosts, but the host or viral factors that areimportant for OPXV host range in rodents are unknown. Here, we showed that theabortive replication of several OPXV species in a Chinese hamster cell line wascaused by a species-specific difference in the host antiviral factor SAMD9L,suggesting that SAMD9L divergence in different rodent species poses a barrier forcross-species OPXV infection. While the Chinese hamster SAMD9L could not beinhibited by two previously identified OPXV inhibitors of human and mouseSAMD9&L, it can be inhibited by cowpox virus CP77, indicating that OPXVs encodethree SAMD9&L inhibitors with different specificities. Our data suggest that OPXVhost range in broad rodent species depends on three SAMD9&L inhibitors withdifferent specificities.
CI  - Copyright (c) 2019 American Society for Microbiology.
FAU - Zhang, Fushun
AU  - Zhang F
AD  - Department of Microbiology, Immunology and Molecular Genetics, University ofTexas Health Science Center at San Antonio, San Antonio, Texas, USA.
FAU - Meng, Xiangzhi
AU  - Meng X
AD  - Department of Microbiology, Immunology and Molecular Genetics, University ofTexas Health Science Center at San Antonio, San Antonio, Texas, USA.
FAU - Townsend, Michael B
AU  - Townsend MB
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
FAU - Satheshkumar, Panayampalli Subbian
AU  - Satheshkumar PS
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
FAU - Xiang, Yan
AU  - Xiang Y
AUID- ORCID: 0000-0002-7633-1629
AD  - Department of Microbiology, Immunology and Molecular Genetics, University ofTexas Health Science Center at San Antonio, San Antonio, Texas, USAxiangy@uthscsa.edu.
LA  - eng
GR  - R01 AI079217/AI/NIAID NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20190529
PL  - United States
TA  - J Virol
JT  - Journal of virology
JID - 0113724
RN  - 0 (Intracellular Signaling Peptides and Proteins)
RN  - 0 (SAMD9 protein, human)
RN  - 0 (SAMD9L protein, human)
RN  - 0 (Tumor Suppressor Proteins)
RN  - 0 (Viral Proteins)
SB  - IM
MH  - Animals
MH  - CHO Cells
MH  - Cell Line
MH  - Chlorocebus aethiops
MH  - Cricetinae
MH  - Cricetulus
MH  - HeLa Cells
MH  - Host Specificity
MH  - Humans
MH  - Intracellular Signaling Peptides and Proteins/*genetics/*metabolism
MH  - Mice
MH  - NIH 3T3 Cells
MH  - Orthopoxvirus/*genetics/metabolism
MH  - Rodentia
MH  - Tumor Suppressor Proteins/genetics/metabolism
MH  - Vaccinia
MH  - Vaccinia virus/genetics
MH  - Vero Cells
MH  - Viral Proteins/metabolism
MH  - Virus Replication
PMC - PMC6613757
OTO - NOTNLM
OT  - *host range
OT  - *host restriction factor
OT  - *poxvirus
OT  - *vaccinia virus
EDAT- 2019/03/29 06:00
MHDA- 2020/06/24 06:00
CRDT- 2019/03/29 06:00
PHST- 2019/02/08 00:00 [received]
PHST- 2019/03/20 00:00 [accepted]
PHST- 2019/03/29 06:00 [pubmed]
PHST- 2020/06/24 06:00 [medline]
PHST- 2019/03/29 06:00 [entrez]
AID - JVI.00225-19 [pii]
AID - 10.1128/JVI.00225-19 [doi]
PST - epublish
SO  - J Virol. 2019 May 29;93(12). pii: JVI.00225-19. doi: 10.1128/JVI.00225-19. Print 2019 Jun 15.

PMID- 30900976
OWN - NLM
STAT- MEDLINE
DCOM- 20191223
LR  - 20200309
IS  - 1080-6059 (Electronic)
IS  - 1080-6040 (Linking)
VI  - 25
IP  - 6
DP  - 2019 Jun
TI  - Molecular Evidence of Human Monkeypox Virus Infection, Sierra Leone.
PG  - 1220-1222
LID - 10.3201/eid2506.180296 [doi]
AB  - Monkeypox virus is a zoonotic disease endemic to Africa. In 2017, we confirmed a case of human monkeypox virus in Sierra Leone by molecular and serologic methods.Sequencing analysis indicated the virus belongs to the West African clade anddata suggest it was likely transmitted by wild animals.
FAU - Ye, Fei
AU  - Ye F
FAU - Song, Jingdong
AU  - Song J
FAU - Zhao, Li
AU  - Zhao L
FAU - Zhang, Yi
AU  - Zhang Y
FAU - Xia, Lianxu
AU  - Xia L
FAU - Zhu, Lingwei
AU  - Zhu L
FAU - Kamara, Idrissa Laybohr
AU  - Kamara IL
FAU - Ren, Jiao
AU  - Ren J
FAU - Wang, Wenling
AU  - Wang W
FAU - Tian, Houwen
AU  - Tian H
FAU - Wu, Guizhen
AU  - Wu G
FAU - Tan, Wenjie
AU  - Tan W
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20190617
PL  - United States
TA  - Emerg Infect Dis
JT  - Emerging infectious diseases
JID - 9508155
SB  - IM
MH  - Animals
MH  - Genome, Viral
MH  - Genomics/methods
MH  - Humans
MH  - Monkeypox/*epidemiology/*virology
MH  - *Monkeypox virus/classification/genetics
MH  - Phylogeny
MH  - Sierra Leone/epidemiology
MH  - Zoonoses
PMC - PMC6537715
OTO - NOTNLM
OT  - *Sierra Leone
OT  - *molecular signature
OT  - *monkeypox virus
OT  - *sequence
OT  - *viruses
OT  - *zoonotic disease,
EDAT- 2019/03/23 06:00
MHDA- 2019/12/24 06:00
CRDT- 2019/03/23 06:00
PHST- 2019/03/23 06:00 [pubmed]
PHST- 2019/12/24 06:00 [medline]
PHST- 2019/03/23 06:00 [entrez]
AID - 10.3201/eid2506.180296 [doi]
PST - ppublish
SO  - Emerg Infect Dis. 2019 Jun;25(6):1220-1222. doi: 10.3201/eid2506.180296. Epub2019 Jun 17.

PMID- 30848724
OWN - NLM
STAT- MEDLINE
DCOM- 20191223
LR  - 20200309
IS  - 1080-6059 (Electronic)
IS  - 1080-6040 (Linking)
VI  - 25
IP  - 5
DP  - 2019 May
TI  - Diagnosis of Imported Monkeypox, Israel, 2018.
PG  - 980-983
LID - 10.3201/eid2505.190076 [doi]
AB  - We report a case of monkeypox in a man who returned from Nigeria to Israel in2018. Virus was detected in pustule swabs by transmission electron microscopy andPCR and confirmed by immunofluorescence assay, tissue culture, and ELISA. TheWest Africa monkeypox outbreak calls for increased awareness by public healthauthorities worldwide.
FAU - Erez, Noam
AU  - Erez N
FAU - Achdout, Hagit
AU  - Achdout H
FAU - Milrot, Elad
AU  - Milrot E
FAU - Schwartz, Yuval
AU  - Schwartz Y
FAU - Wiener-Well, Yonit
AU  - Wiener-Well Y
FAU - Paran, Nir
AU  - Paran N
FAU - Politi, Boaz
AU  - Politi B
FAU - Tamir, Hadas
AU  - Tamir H
FAU - Israely, Tomer
AU  - Israely T
FAU - Weiss, Shay
AU  - Weiss S
FAU - Beth-Din, Adi
AU  - Beth-Din A
FAU - Shifman, Ohad
AU  - Shifman O
FAU - Israeli, Ofir
AU  - Israeli O
FAU - Yitzhaki, Shmuel
AU  - Yitzhaki S
FAU - Shapira, Shmuel C
AU  - Shapira SC
FAU - Melamed, Sharon
AU  - Melamed S
FAU - Schwartz, Eli
AU  - Schwartz E
LA  - eng
PT  - Historical Article
PT  - Journal Article
DEP - 20190517
PL  - United States
TA  - Emerg Infect Dis
JT  - Emerging infectious diseases
JID - 9508155
SB  - IM
MH  - Animals
MH  - Biopsy
MH  - Chlorocebus aethiops
MH  - Communicable Diseases, Imported/*diagnosis/*epidemiology/history/virology
MH  - *Disease Outbreaks
MH  - History, 21st Century
MH  - Humans
MH  - Israel/epidemiology
MH  - Monkeypox/*diagnosis/*epidemiology/history/virology
MH  - *Monkeypox virus
MH  - Skin/pathology/virology
MH  - Vero Cells
PMC - PMC6478227
OTO - NOTNLM
OT  - *Israel
OT  - *Monkeypox
OT  - *West Africa
OT  - *disease outbreaks
OT  - *monkeypox virus
OT  - *orthopoxvirus
OT  - *outbreak
OT  - *transmission electron microscopy
OT  - *viruses
OT  - *zoonoses
EDAT- 2019/03/09 06:00
MHDA- 2019/12/24 06:00
CRDT- 2019/03/09 06:00
PHST- 2019/03/09 06:00 [pubmed]
PHST- 2019/12/24 06:00 [medline]
PHST- 2019/03/09 06:00 [entrez]
AID - 10.3201/eid2505.190076 [doi]
PST - ppublish
SO  - Emerg Infect Dis. 2019 May;25(5):980-983. doi: 10.3201/eid2505.190076. Epub 2019 May 17.

PMID- 30753125
OWN - NLM
STAT- MEDLINE
DCOM- 20191223
LR  - 20200309
IS  - 1080-6059 (Electronic)
IS  - 1080-6040 (Linking)
VI  - 25
IP  - 5
DP  - 2019 May
TI  - Human Monkeypox in Sierra Leone after 44-Year Absence of Reported Cases.
PG  - 1023-1025
LID - 10.3201/eid2505.180832 [doi]
AB  - We note the reemergence of human monkeypox in Sierra Leone following a 44-yearabsence of reported disease. The persons affected were an 11-month-old boy and,several years later, a 35-year-old man. The reappearance of monkeypox in thiscountry suggests a need for renewed vigilance and awareness of the disease andits manifestations.
FAU - Reynolds, Mary G
AU  - Reynolds MG
FAU - Wauquier, Nadia
AU  - Wauquier N
FAU - Li, Yu
AU  - Li Y
FAU - Satheshkumar, Panayampalli Subbian
AU  - Satheshkumar PS
FAU - Kanneh, Lansana D
AU  - Kanneh LD
FAU - Monroe, Benjamin
AU  - Monroe B
FAU - Maikere, Jacob
AU  - Maikere J
FAU - Saffa, Gbessay
AU  - Saffa G
FAU - Gonzalez, Jean-Paul
AU  - Gonzalez JP
FAU - Fair, Joseph
AU  - Fair J
FAU - Carroll, Darin S
AU  - Carroll DS
FAU - Jambai, Amara
AU  - Jambai A
FAU - Dafae, Foday
AU  - Dafae F
FAU - Khan, Sheik Humarr
AU  - Khan SH
FAU - Moses, Lina M
AU  - Moses LM
LA  - eng
PT  - Case Reports
PT  - Letter
PT  - Research Support, Non-U.S. Gov't
DEP - 20190517
PL  - United States
TA  - Emerg Infect Dis
JT  - Emerging infectious diseases
JID - 9508155
SB  - IM
MH  - Adult
MH  - Communicable Diseases, Emerging/*diagnosis/*epidemiology/virology
MH  - Disease Notification
MH  - Humans
MH  - Infant
MH  - Male
MH  - Monkeypox/*diagnosis/*epidemiology/virology
MH  - Public Health Surveillance
MH  - Sentinel Surveillance
MH  - Sierra Leone/epidemiology
PMC - PMC6478203
OTO - NOTNLM
OT  - *Sierra Leone
OT  - *case report
OT  - *epidemiology
OT  - *monkeypox
OT  - *orthopoxvirus
OT  - *viruses
EDAT- 2019/02/13 06:00
MHDA- 2019/12/24 06:00
CRDT- 2019/02/13 06:00
PHST- 2019/02/13 06:00 [pubmed]
PHST- 2019/12/24 06:00 [medline]
PHST- 2019/02/13 06:00 [entrez]
AID - 10.3201/eid2505.180832 [doi]
PST - ppublish
SO  - Emerg Infect Dis. 2019 May;25(5):1023-1025. doi: 10.3201/eid2505.180832. Epub2019 May 17.

PMID- 30666937
OWN - NLM
STAT- MEDLINE
DCOM- 20190729
LR  - 20200209
IS  - 1080-6059 (Electronic)
IS  - 1080-6040 (Linking)
VI  - 25
IP  - 2
DP  - 2019 Feb
TI  - Epidemiologic and Ecologic Investigations of Monkeypox, Likouala Department,Republic of the Congo, 2017.
PG  - 281-289
LID - 10.3201/eid2502.181222 [doi]
AB  - Monkeypox, caused by a zoonotic orthopoxvirus, is endemic in Central and WestAfrica. Monkeypox has been sporadically reported in the Republic of the Congo.During March 22-April 5, 2017, we investigated 43 suspected human monkeypoxcases. We interviewed suspected case-patients and collected dried blood stripsand vesicular and crust specimens (active lesions), which we tested fororthopoxvirus antibodies by ELISA and monkeypox virus and varicella zoster virus DNA by PCR. An ecologic investigation was conducted around Manfouete, andspecimens from 105 small mammals were tested for anti-orthopoxvirus antibodies orDNA. Among the suspected human cases, 22 met the confirmed, probable, andpossible case definitions. Only 18 patients had available dried blood strips;100% were IgG positive, and 88.9% (16/18) were IgM positive. Among animals, only specimens from Cricetomys giant pouched rats showed presence of orthopoxvirusantibodies, adding evidence to this species' involvement in the transmission and maintenance of monkeypox virus in nature.
FAU - Doshi, Reena H
AU  - Doshi RH
FAU - Guagliardo, Sarah Anne J
AU  - Guagliardo SAJ
FAU - Doty, Jeffrey B
AU  - Doty JB
FAU - Babeaux, Angelie Dzabatou
AU  - Babeaux AD
FAU - Matheny, Audrey
AU  - Matheny A
FAU - Burgado, Jillybeth
AU  - Burgado J
FAU - Townsend, Michael B
AU  - Townsend MB
FAU - Morgan, Clint N
AU  - Morgan CN
FAU - Satheshkumar, Panayampalli Subbian
AU  - Satheshkumar PS
FAU - Ndakala, Nestor
AU  - Ndakala N
FAU - Kanjingankolo, Therese
AU  - Kanjingankolo T
FAU - Kitembo, Lambert
AU  - Kitembo L
FAU - Malekani, Jean
AU  - Malekani J
FAU - Kalemba, Lem's
AU  - Kalemba L
FAU - Pukuta, Elisabeth
AU  - Pukuta E
FAU - N'kaya, Tobi
AU  - N'kaya T
FAU - Kangoula, Fabien
AU  - Kangoula F
FAU - Moses, Cynthia
AU  - Moses C
FAU - McCollum, Andrea M
AU  - McCollum AM
FAU - Reynolds, Mary G
AU  - Reynolds MG
FAU - Mombouli, Jean-Vivien
AU  - Mombouli JV
FAU - Nakazawa, Yoshinori
AU  - Nakazawa Y
FAU - Petersen, Brett W
AU  - Petersen BW
LA  - eng
GR  - U01 CK000539/CK/NCEZID CDC HHS/United States
PT  - Journal Article
PL  - United States
TA  - Emerg Infect Dis
JT  - Emerging infectious diseases
JID - 9508155
MH  - Adolescent
MH  - Adult
MH  - Animals
MH  - Child
MH  - Child, Preschool
MH  - Congo/epidemiology
MH  - Disease Outbreaks
MH  - *Ecology
MH  - Enzyme-Linked Immunosorbent Assay
MH  - Female
MH  - Humans
MH  - Infant
MH  - Male
MH  - Monkeypox/diagnosis/*epidemiology/*virology
MH  - *Monkeypox virus/genetics/immunology
MH  - Polymerase Chain Reaction
MH  - Public Health Surveillance
MH  - Sentinel Surveillance
MH  - Young Adult
PMC - PMC6346463
OTO - NOTNLM
OT  - *Republic of the Congo
OT  - *ecology
OT  - *epidemiology
OT  - *monkeypox
OT  - *orthopoxvirus
OT  - *viruses
OT  - *zoonoses
EDAT- 2019/01/23 06:00
MHDA- 2019/07/30 06:00
CRDT- 2019/01/23 06:00
PHST- 2019/01/23 06:00 [entrez]
PHST- 2019/01/23 06:00 [pubmed]
PHST- 2019/07/30 06:00 [medline]
AID - 10.3201/eid2502.181222 [doi]
PST - ppublish
SO  - Emerg Infect Dis. 2019 Feb;25(2):281-289. doi: 10.3201/eid2502.181222.

PMID- 30657959
OWN - NLM
STAT- MEDLINE
DCOM- 20200608
LR  - 20200611
IS  - 1708-8305 (Electronic)
IS  - 1195-1982 (Linking)
VI  - 26
IP  - 5
DP  - 2019 Jun 11
TI  - Monkeypox transmission among international travellers-serious monkey business?
LID - taz002 [pii]
LID - 10.1093/jtm/taz002 [doi]
FAU - Angelo, Kristina M
AU  - Angelo KM
AD  - Division of Global Migration and Quarantine, Centers for Disease Control andPrevention, Atlanta, GA, USA.
FAU - Petersen, Brett W
AU  - Petersen BW
AD  - Division of High Consequence Pathogens and Pathology, Centers for Disease Controland Prevention, Atlanta, GA, USA.
FAU - Hamer, Davidson H
AU  - Hamer DH
AD  - Department of Global Health, Boston University School of Public Health, Boston,MA, USA.
AD  - Section of Infectious Diseases, Department of Medicine, Boston Medical Center,Boston, MA, USA.
FAU - Schwartz, Eli
AU  - Schwartz E
AD  - Center for Geographical Medicine, Sheba Medical Center, Tel-Hashomer, Israel.
AD  - Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
FAU - Brunette, Gary
AU  - Brunette G
AD  - Division of Global Migration and Quarantine, Centers for Disease Control andPrevention, Atlanta, GA, USA.
LA  - eng
GR  - CC999999/Intramural CDC HHS/United States
GR  - U50 CK000189/CK/NCEZID CDC HHS/United States
PT  - Editorial
PL  - England
TA  - J Travel Med
JT  - Journal of travel medicine
JID - 9434456
SB  - IM
MH  - Animals
MH  - Humans
MH  - Monkeypox/epidemiology/*transmission
MH  - *Travel
PMC - PMC6682460
MID - NIHMS1042228
EDAT- 2019/01/19 06:00
MHDA- 2020/06/09 06:00
CRDT- 2019/01/19 06:00
PHST- 2019/01/03 00:00 [received]
PHST- 2019/01/07 00:00 [revised]
PHST- 2019/01/16 00:00 [accepted]
PHST- 2019/01/19 06:00 [pubmed]
PHST- 2020/06/09 06:00 [medline]
PHST- 2019/01/19 06:00 [entrez]
AID - 5292570 [pii]
AID - 10.1093/jtm/taz002 [doi]
PST - ppublish
SO  - J Travel Med. 2019 Jun 11;26(5). pii: 5292570. doi: 10.1093/jtm/taz002.

PMID- 30634001
OWN - NLM
STAT- MEDLINE
DCOM- 20200115
LR  - 20200115
IS  - 1567-7257 (Electronic)
IS  - 1567-1348 (Linking)
VI  - 69
DP  - 2019 Apr
TI  - Monkeypox virus phylogenetic similarities between a human case detected inCameroon in 2018 and the 2017-2018 outbreak in Nigeria.
PG  - 8-11
LID - S1567-1348(18)30844-X [pii]
LID - 10.1016/j.meegid.2019.01.006 [doi]
AB  - A monkeypox virus was detected from a human clinical case in 2018 in Cameroon; a country where no human cases were reported since 1989. The virus exhibited close genetic relatedness with another monkeypox virus isolated in Nigeria during the2017-2018 outbreak. Although our molecular findings argue in favor of anextension of the monkeypox outbreak from Nigeria into Cameroon, the possibilitythat the monkeypox virus detected could be indigenous to Cameroon cannot be ruledout.
CI  - Copyright (c) 2019.
FAU - Sadeuh-Mba, Serge Alain
AU  - Sadeuh-Mba SA
AD  - Virology Service, Centre Pasteur of Cameroon, Yaounde, Cameroon.
FAU - Yonga, Martial Gide
AU  - Yonga MG
AD  - Virology Service, Centre Pasteur of Cameroon, Yaounde, Cameroon.
FAU - Els, Mathieu
AU  - Els M
AD  - Cameroon Field Epidemiology Training Program, Yaounde, Cameroon.
FAU - Batejat, Christophe
AU  - Batejat C
AD  - Cellule d'Intervention Biologique d'Urgence, Institut Pasteur, Paris, France.
FAU - Eyangoh, Sara
AU  - Eyangoh S
AD  - Virology Service, Centre Pasteur of Cameroon, Yaounde, Cameroon.
FAU - Caro, Valerie
AU  - Caro V
AD  - Cellule d'Intervention Biologique d'Urgence, Institut Pasteur, Paris, France.
FAU - Etoundi, Alain
AU  - Etoundi A
AD  - Direction de la Lutte contre la Maladie, les Epidemies et les Pandemies, Ministryof Public Health, Yaounde, Cameroon.
FAU - Carniel, Elisabeth
AU  - Carniel E
AD  - Virology Service, Centre Pasteur of Cameroon, Yaounde, Cameroon.
FAU - Njouom, Richard
AU  - Njouom R
AD  - Virology Service, Centre Pasteur of Cameroon, Yaounde, Cameroon. Electronicaddress: njouom@pasteur-yaounde.org.
LA  - eng
PT  - Letter
PT  - Research Support, Non-U.S. Gov't
DEP - 20190108
PL  - Netherlands
TA  - Infect Genet Evol
JT  - Infection, genetics and evolution : journal of molecular epidemiology andevolutionary genetics in infectious diseases
JID - 101084138
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Animals
MH  - Cameroon/epidemiology
MH  - Child
MH  - *Disease Outbreaks
MH  - Female
MH  - Genome, Viral
MH  - Humans
MH  - Infant, Newborn
MH  - Male
MH  - Middle Aged
MH  - Monkeypox/*epidemiology/transmission/*virology
MH  - Monkeypox virus/*classification/*genetics
MH  - Nigeria/epidemiology
MH  - *Phylogeny
MH  - Public Health Surveillance
MH  - Young Adult
OTO - NOTNLM
OT  - *Cameroon
OT  - *Monkeypox virus
OT  - *Phylogenetic relationships
OT  - *West African clade
EDAT- 2019/01/12 06:00
MHDA- 2020/01/16 06:00
CRDT- 2019/01/12 06:00
PHST- 2018/11/01 00:00 [received]
PHST- 2019/01/08 00:00 [revised]
PHST- 2019/01/08 00:00 [accepted]
PHST- 2019/01/12 06:00 [pubmed]
PHST- 2020/01/16 06:00 [medline]
PHST- 2019/01/12 06:00 [entrez]
AID - S1567-1348(18)30844-X [pii]
AID - 10.1016/j.meegid.2019.01.006 [doi]
PST - ppublish
SO  - Infect Genet Evol. 2019 Apr;69:8-11. doi: 10.1016/j.meegid.2019.01.006. Epub 2019Jan 8.

PMID- 30625020
OWN - NLM
STAT- MEDLINE
DCOM- 20190502
LR  - 20200309
IS  - 1744-8336 (Electronic)
IS  - 1478-7210 (Linking)
VI  - 17
IP  - 2
DP  - 2019 Feb
TI  - Monkeypox re-emergence in Africa: a call to expand the concept and practice ofOne Health.
PG  - 129-139
LID - 10.1080/14787210.2019.1567330 [doi]
AB  - INTRODUCTION: Monkeypox is a re-emerging viral zoonosis that occurs naturally in heavily forested regions of West and Central Africa. Inter-human transmission of monkeypox virus, although limited, drives outbreaks, particularly in householdand health-care settings. But the available evidence suggests that withoutrepeated zoonotic introductions, human infections would eventually cease tooccur. Therefore, interrupting virus transmission from animals to humans is keyto combating this disease. Areas covered: Herein we review laboratory and fieldstudies examining the susceptibility of various animal taxa to monkeypox virusinfection, and note the competence of various species to serve as reservoirs ortransmission hosts. In addition, we discuss early socio-ecologic theories ofmonkeypox virus transmission in rural settings and review current modes ofecologic investigation - including ecologic niche modeling, and ecologic sampling- in light of their potential to identify specific animal species and features ofthe environment that are associated with heightened risk for human disease.Expert opinion: The role of disease ecology and scientific research in ongoingdisease prevention efforts should be reinforced, particularly forwildlife-associated zoonoses such as monkeypox. Such efforts alongside thoseaimed at nurturing 'One Health' collaborations may ultimately hold the greatestpromise for reducing human infections with this pathogen.
FAU - Reynolds, Mary G
AU  - Reynolds MG
AD  - a US Centers for Disease Control and Prevention, Poxvirus and Rabies Branch ,Atlanta , GA , USA.
FAU - Doty, Jeffry B
AU  - Doty JB
AD  - a US Centers for Disease Control and Prevention, Poxvirus and Rabies Branch ,Atlanta , GA , USA.
FAU - McCollum, Andrea M
AU  - McCollum AM
AD  - a US Centers for Disease Control and Prevention, Poxvirus and Rabies Branch ,Atlanta , GA , USA.
FAU - Olson, Victoria A
AU  - Olson VA
AD  - a US Centers for Disease Control and Prevention, Poxvirus and Rabies Branch ,Atlanta , GA , USA.
FAU - Nakazawa, Yoshinori
AU  - Nakazawa Y
AD  - a US Centers for Disease Control and Prevention, Poxvirus and Rabies Branch ,Atlanta , GA , USA.
LA  - eng
GR  - CC999999/Intramural CDC HHS/United States
GR  - U01 CK000359/CK/NCEZID CDC HHS/United States
GR  - U01 CK000539/CK/NCEZID CDC HHS/United States
PT  - Journal Article
PT  - Review
DEP - 20190121
PL  - England
TA  - Expert Rev Anti Infect Ther
JT  - Expert review of anti-infective therapy
JID - 101181284
SB  - IM
MH  - Africa, Central/epidemiology
MH  - Africa, Western/epidemiology
MH  - Animals
MH  - Animals, Wild
MH  - Disease Outbreaks/prevention & control
MH  - Humans
MH  - Monkeypox/epidemiology/*prevention & control/transmission
MH  - Monkeypox virus/*isolation & purification
MH  - One Health
MH  - Zoonoses/epidemiology/*prevention & control/transmission
PMC - PMC6438170
MID - NIHMS1009766
OTO - NOTNLM
OT  - *Monkeypox
OT  - *One Health
OT  - *orthopoxvirus
OT  - *zoonosis
OT  - *
EDAT- 2019/01/10 06:00
MHDA- 2019/05/03 06:00
CRDT- 2019/01/10 06:00
PHST- 2019/01/10 06:00 [pubmed]
PHST- 2019/05/03 06:00 [medline]
PHST- 2019/01/10 06:00 [entrez]
AID - 10.1080/14787210.2019.1567330 [doi]
PST - ppublish
SO  - Expert Rev Anti Infect Ther. 2019 Feb;17(2):129-139. doi:10.1080/14787210.2019.1567330. Epub 2019 Jan 21.

PMID- 30571693
OWN - NLM
STAT- MEDLINE
DCOM- 20190125
LR  - 20200225
IS  - 1935-2735 (Electronic)
IS  - 1935-2727 (Linking)
VI  - 12
IP  - 12
DP  - 2018 Dec
TI  - Sounding the alarm: Defining thresholds to trigger a public health response tomonkeypox.
PG  - e0007034
LID - 10.1371/journal.pntd.0007034 [doi]
AB  - Endemic to the Democratic Republic of the Congo (DRC), monkeypox is a zoonoticdisease that causes smallpox-like illness in humans. Observed fluctuations inreported cases over time raises questions about when it is appropriate to mount apublic health response, and what specific actions should be taken. We evaluatedthree different thresholds to differentiate between baseline and heighteneddisease incidence, and propose a novel, tiered algorithm for public healthaction. Monkeypox surveillance data from Tshuapa Province, 2011-2013, were usedto calculate three different statistical thresholds: Cullen, c-sum, and a WorldHealth Organization (WHO) method based on monthly incidence. When the observedcases exceeded the threshold for a given month, that month was considered to be'aberrant'. For each approach, the number of aberrant months detected was summed by year-each method produced vastly different results. The Cullen approachgenerated a number of aberrant signals over the period of consideration (9/36months). The c-sum method was the most sensitive (30/36 months), followed by the WHO method (12/24 months). We conclude that triggering public health action basedon signals detected by a single method may be inefficient and overly simplisticfor monkeypox. We propose instead a response algorithm that integrates anobjective threshold (WHO method) with contextual information aboutepidemiological and spatiotemporal links between suspected cases to determinewhether a response should be operating under i) routine surveillance ii) alertstatus, or iii) outbreak status. This framework could be modified and adopted by national and zone level health workers in monkeypox-endemic countries. Lastly, wediscuss considerations for selecting thresholds for monkeypox outbreaks acrossgradients of endemicity and public health resources.
FAU - Guagliardo, Sarah Anne J
AU  - Guagliardo SAJ
AUID- ORCID: 0000-0002-4217-8195
AD  - Epidemic Intelligence Service, Centers for Disease Control and Prevention,Atlanta, Georgia, United States of America.
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,Centers for Disease Control and Prevention, Atlanta, Georgia, United States ofAmerica.
FAU - Reynolds, Mary G
AU  - Reynolds MG
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,Centers for Disease Control and Prevention, Atlanta, Georgia, United States ofAmerica.
FAU - Kabamba, Joelle
AU  - Kabamba J
AD  - Centers for Disease Control and Prevention, Kinshasa, Democratic Republic of the Congo.
FAU - Nguete, Beata
AU  - Nguete B
AD  - Kinshasa School of Public Health, Kinshasa, Democratic Republic of the Congo.
FAU - Shongo Lushima, Robert
AU  - Shongo Lushima R
AD  - Ministry of Health, Kinshasa, Democratic Republic of the Congo.
FAU - Wemakoy, Okito E
AU  - Wemakoy OE
AD  - Kinshasa School of Public Health, Kinshasa, Democratic Republic of the Congo.
FAU - McCollum, Andrea M
AU  - McCollum AM
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,Centers for Disease Control and Prevention, Atlanta, Georgia, United States ofAmerica.
LA  - eng
GR  - U01 CK000539/CK/NCEZID CDC HHS/United States
PT  - Journal Article
PT  - Research Support, U.S. Gov't, P.H.S.
DEP - 20181220
PL  - United States
TA  - PLoS Negl Trop Dis
JT  - PLoS neglected tropical diseases
JID - 101291488
SB  - IM
MH  - Animals
MH  - Democratic Republic of the Congo/epidemiology
MH  - Disease Outbreaks
MH  - Humans
MH  - Monkeypox/*epidemiology/transmission
MH  - Monkeypox virus/genetics/isolation & purification/physiology
MH  - Public Health
MH  - Seasons
MH  - World Health Organization
MH  - Zoonoses/epidemiology/transmission
PMC - PMC6319745
COIS- The authors have declared that no competing interests exist.
EDAT- 2018/12/21 06:00
MHDA- 2019/01/27 06:00
CRDT- 2018/12/21 06:00
PHST- 2018/07/16 00:00 [received]
PHST- 2018/11/28 00:00 [accepted]
PHST- 2019/01/04 00:00 [revised]
PHST- 2018/12/21 06:00 [pubmed]
PHST- 2019/01/27 06:00 [medline]
PHST- 2018/12/21 06:00 [entrez]
AID - 10.1371/journal.pntd.0007034 [doi]
AID - PNTD-D-18-01084 [pii]
PST - epublish
SO  - PLoS Negl Trop Dis. 2018 Dec 20;12(12):e0007034. doi:10.1371/journal.pntd.0007034. eCollection 2018 Dec.

PMID- 30485806
OWN - NLM
STAT- MEDLINE
DCOM- 20191211
LR  - 20201230
IS  - 2211-1247 (Electronic)
VI  - 25
IP  - 9
DP  - 2018 Nov 27
TI  - Identifying and Tracking Low-Frequency Virus-Specific TCR Clonotypes UsingHigh-Throughput Sequencing.
PG  - 2369-2378.e4
LID - S2211-1247(18)31755-8 [pii]
LID - 10.1016/j.celrep.2018.11.009 [doi]
AB  - Tracking antigen-specific T cell responses over time within individuals isdifficult because of lack of knowledge of antigen-specific TCR sequences,limitations in sample size, and assay sensitivities. We hypothesized thatanalyses of high-throughput sequencing of TCR clonotypes could provide functionalreadouts of individuals' immunological histories. Using high-throughput TCRsequencing, we develop a database of TCRbeta sequences from large cohorts of micebefore (naive) and after smallpox vaccination. We computationally identify 315vaccine-associated TCR sequences (VATS) that are used to train a diagnosticclassifier that distinguishes naive from vaccinated samples in mice up to 9months post-vaccination with >99% accuracy. We determine that the VATS librarycontains virus-responsive TCRs by in vitro expansion assays and virus-specifictetramer sorting. These data outline a platform for advancing our capabilities toidentify pathogen-specific TCR sequences, which can be used to identify andquantitate low-frequency pathogen-specific TCR sequences in circulation over timewith exceptional sensitivity.
CI  - Copyright (c) 2018 The Author(s). Published by Elsevier Inc. All rights reserved.
FAU - Wolf, Kyle
AU  - Wolf K
AD  - Department of Molecular Microbiology and Immunology, Saint Louis University,Saint Louis, MO 63104, USA.
FAU - Hether, Tyler
AU  - Hether T
AD  - Adaptive Biotechnologies, Seattle, WA 98102, USA.
FAU - Gilchuk, Pavlo
AU  - Gilchuk P
AD  - Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, TN37212, USA; Department of Pathology, Microbiology, and Immunology, VanderbiltUniversity, Nashville, TN 37232, USA.
FAU - Kumar, Amrendra
AU  - Kumar A
AD  - Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, TN37212, USA; Department of Pathology, Microbiology, and Immunology, VanderbiltUniversity, Nashville, TN 37232, USA.
FAU - Rajeh, Ahmad
AU  - Rajeh A
AD  - Program in Bioinformatics and Computational Biology, Saint Louis University,Saint Louis, MO 63104, USA.
FAU - Schiebout, Courtney
AU  - Schiebout C
AD  - Program in Bioinformatics and Computational Biology, Saint Louis University,Saint Louis, MO 63104, USA.
FAU - Maybruck, Julie
AU  - Maybruck J
AD  - Federal Bureau of Investigation, Washington, DC 20535, USA.
FAU - Buller, R Mark
AU  - Buller RM
AD  - Department of Molecular Microbiology and Immunology, Saint Louis University,Saint Louis, MO 63104, USA.
FAU - Ahn, Tae-Hyuk
AU  - Ahn TH
AD  - Department of Computer Science, Saint Louis University, Saint Louis, MO 63104,USA; Program in Bioinformatics and Computational Biology, Saint Louis University,Saint Louis, MO 63104, USA.
FAU - Joyce, Sebastian
AU  - Joyce S
AD  - Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, TN37212, USA; Department of Pathology, Microbiology, and Immunology, VanderbiltUniversity, Nashville, TN 37232, USA.
FAU - DiPaolo, Richard J
AU  - DiPaolo RJ
AD  - Department of Molecular Microbiology and Immunology, Saint Louis University,Saint Louis, MO 63104, USA. Electronic address: richard.dipaolo@health.slu.edu.
LA  - eng
GR  - I01 BX001444/BX/BLRD VA/United States
GR  - IK6 BX004595/BX/BLRD VA/United States
GR  - R01 AI137082/AI/NIAID NIH HHS/United States
GR  - R01 HL121139/HL/NHLBI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, U.S. Gov't, Non-P.H.S.
PL  - United States
TA  - Cell Rep
JT  - Cell reports
JID - 101573691
RN  - 0 (Peptides)
RN  - 0 (Receptors, Antigen, T-Cell)
SB  - IM
MH  - Amino Acid Sequence
MH  - Animals
MH  - *Cell Tracking
MH  - Clone Cells
MH  - Female
MH  - Gene Library
MH  - High-Throughput Nucleotide Sequencing/*methods
MH  - Male
MH  - Mice, Inbred C57BL
MH  - Orthopoxvirus
MH  - Peptides/chemistry
MH  - Poxviridae Infections/virology
MH  - Receptors, Antigen, T-Cell/chemistry/*metabolism
MH  - Vaccination
MH  - Viruses/*metabolism
PMC - PMC7770954
MID - NIHMS1654217
OTO - NOTNLM
OT  - *DNA sequencing
OT  - *HLA-A2
OT  - *T cell receptor
OT  - *biomarkers
OT  - *monkeypox
OT  - *vaccinia
EDAT- 2018/11/30 06:00
MHDA- 2019/12/18 06:00
CRDT- 2018/11/29 06:00
PHST- 2018/04/11 00:00 [received]
PHST- 2018/09/18 00:00 [revised]
PHST- 2018/10/31 00:00 [accepted]
PHST- 2018/11/29 06:00 [entrez]
PHST- 2018/11/30 06:00 [pubmed]
PHST- 2019/12/18 06:00 [medline]
AID - S2211-1247(18)31755-8 [pii]
AID - 10.1016/j.celrep.2018.11.009 [doi]
PST - ppublish
SO  - Cell Rep. 2018 Nov 27;25(9):2369-2378.e4. doi: 10.1016/j.celrep.2018.11.009.

PMID- 30480506
OWN - NLM
STAT- MEDLINE
DCOM- 20190409
LR  - 20190508
IS  - 2326-5108 (Electronic)
IS  - 2326-5094 (Linking)
VI  - 16
IP  - S1
DP  - 2018 Fall
TI  - Assessing the Surveillance System for Priority Zoonotic Diseases in theDemocratic Republic of the Congo, 2017.
PG  - S44-S53
LID - 10.1089/hs.2018.0060 [doi]
AB  - High-functioning communicable disease surveillance systems are critical forpublic health preparedness. Countries that cannot quickly detect and containdiseases are a risk to the global community. The ability of all countries tocomply with the International Health Regulations is paramount for global healthsecurity. Zoonotic diseases can be particularly dangerous for humans. Weconducted a surveillance system assessment of institutional and individualcapacity in Kinshasa and Haut Katanga provinces in the Democratic Republic of theCongo for nationally identified priority zoonotic diseases (eg, viral hemorrhagicfever [VHF], yellow fever, rabies, monkeypox, and influenza monitored throughacute respiratory infections). Data were collected from 79 health workersresponsible for disease surveillance at 2 provincial health offices, 9 healthzone offices, 9 general reference hospitals, and 18 health centers andcommunities. A set of questionnaires was used to assess health worker training indisease surveillance methods; knowledge of case definitions; availability ofmaterials and tools to support timely case detection, reporting, and datainterpretation; timeliness and completeness of reporting; and supervision fromhealth authorities. We found that health workers either had not been recently or ever trained in surveillance methods and that their knowledge of case definitionswas low. Timeliness and completeness of weekly notification of epidemic-pronediseases was generally well performed, but the lack of available standardizedreporting forms and archive of completed forms affected the quality of datacollected. Lessons learned from our assessment can be used for targetedstrengthening efforts to improve global health security.
FAU - Stolka, Kristen B
AU  - Stolka KB
AD  - Kristen B. Stolka, MPH, is a Research Public Health Analyst, Biostatistics andEpidemiology, RTI International, Durham, North Carolina.
FAU - Ngoyi, Bonaventure Fuamba
AU  - Ngoyi BF
AD  - Bonaventure Fuamba Ngoyi, MD, MPH-FELTP, is a Surveillance Officer, Biostatisticsand Epidemiology, RTI International, Durham, North Carolina.
FAU - Grimes, Kathyrn E L
AU  - Grimes KEL
AD  - Kathyrn E. L. Grimes, MPH, is a Research Public Health Analyst, Biostatistics andEpidemiology, RTI International, Durham, North Carolina.
FAU - Hemingway-Foday, Jennifer J
AU  - Hemingway-Foday JJ
AD  - Jennifer J. Hemingway-Foday, MPH, is a Research Epidemiologist, Biostatistics andEpidemiology, RTI International, Durham, North Carolina.
FAU - Lubula, Leopold
AU  - Lubula L
AD  - Leopold Lubula, MD, MPH-FELTP, is a Surveillance Manager, the Directorate ofDisease Control, Ministry of Public Health, Kinshasa, Democratic Republic of the Congo.
FAU - Nzanzu Magazani, Alain
AU  - Nzanzu Magazani A
AD  - Alain Nzanzu Magazani, MD, MPH-FELTP, is a Technical Expert, the Directorate ofDisease Control, Ministry of Public Health, Kinshasa, Democratic Republic of the Congo.
FAU - Bikuku, Joseph
AU  - Bikuku J
AD  - Joseph Bikuku, MD, MPH, is a Technical Expert, the Directorate of DiseaseControl, Ministry of Public Health, Kinshasa, Democratic Republic of the Congo.
FAU - Mossoko, Mathias
AU  - Mossoko M
AD  - Mathias Mossoko, MSc, is an Epidemiologist and Data Manager, the Directorate ofDisease Control, Ministry of Public Health, Kinshasa, Democratic Republic of the Congo.
FAU - Manya Kitoto, Leonie
AU  - Manya Kitoto L
AD  - Leonie Manya Kitoto, MD, MPH, is a Technical Expert, the Directorate of DiseaseControl, Ministry of Public Health, Kinshasa, Democratic Republic of the Congo.
FAU - Mpangi Bashilebo, Sylvie
AU  - Mpangi Bashilebo S
AD  - Sylvie Mpangi Bashilebo, MSc, is an Epidemiologist and Surveillance Supervisor,the Directorate of Disease Control, Ministry of Public Health, Kinshasa,Democratic Republic of the Congo.
FAU - Lufwa Maya, Dieudonne
AU  - Lufwa Maya D
AD  - Dieudonne Lufwa Maya, MD, MPH, is a Database Analyst, the Directorate of Disease Control, Ministry of Public Health, Kinshasa, Democratic Republic of the Congo.
FAU - Kebela Ilunga, Benoit
AU  - Kebela Ilunga B
AD  - Benoit Kebela Ilunga, MD, MPH, is Director, the Directorate of Disease Control,Ministry of Public Health, Kinshasa, Democratic Republic of the Congo.
FAU - Rhea, Sarah
AU  - Rhea S
AD  - Sarah Rhea, DVM, PhD, is a Research Epidemiologist, Biostatistics andEpidemiology, RTI International, Durham, North Carolina.
FAU - MacDonald, Pia D M
AU  - MacDonald PDM
AD  - Pia D. M. MacDonald, PhD, CPH, is a Senior Epidemiologist, Biostatistics andEpidemiology, RTI International, Durham, North Carolina.
LA  - eng
GR  - U2G GH001722/GH/CGH CDC HHS/United States
PT  - Journal Article
PL  - United States
TA  - Health Secur
JT  - Health security
JID - 101654694
SB  - IM
MH  - Animals
MH  - Communicable Diseases/*epidemiology
MH  - Data Collection/standards
MH  - Democratic Republic of the Congo/epidemiology
MH  - Disease Outbreaks/*prevention & control
MH  - Health Knowledge, Attitudes, Practice
MH  - Health Personnel/standards
MH  - Humans
MH  - Population Surveillance/*methods
MH  - Public Health/standards
MH  - Surveys and Questionnaires
MH  - *Zoonoses
OTO - NOTNLM
OT  - Communicable diseases
OT  - Health workers
OT  - Outbreaks
OT  - Surveillance
OT  - Viral hemorrhagic fever
OT  - Zoonotic diseases
OT  - the Democratic Republic of the Congo
EDAT- 2018/11/28 06:00
MHDA- 2019/04/10 06:00
CRDT- 2018/11/28 06:00
PHST- 2018/11/28 06:00 [entrez]
PHST- 2018/11/28 06:00 [pubmed]
PHST- 2019/04/10 06:00 [medline]
AID - 10.1089/hs.2018.0060 [doi]
PST - ppublish
SO  - Health Secur. 2018 Fall;16(S1):S44-S53. doi: 10.1089/hs.2018.0060.

PMID- 30453097
OWN - NLM
STAT- MEDLINE
DCOM- 20190205
LR  - 20200409
IS  - 1878-3511 (Electronic)
IS  - 1201-9712 (Linking)
VI  - 78
DP  - 2019 Jan
TI  - Monkeypox - Enhancing public health preparedness for an emerging lethal humanzoonotic epidemic threat in the wake of the smallpox post-eradication era.
PG  - 78-84
LID - S1201-9712(18)34587-9 [pii]
LID - 10.1016/j.ijid.2018.11.008 [doi]
AB  - The identification of monkeypox in 3 separate patients in the United Kingdom inSeptember raised media and political attention on an emerging public healththreat. Nigeria, whose last confirmed case of monkeypox was in 1978, is currentlyexperiencing an unusually large and outbreak of human monkeypox cases, a 'OneHuman-Environmental-Animal Health' approach is being effectively used to defineand tackle the outbreak. As of 13th October 2018, there have been one hundred andsixteen confirmed cases the majority of whom are under 40 years. Over the past 20years ten Central and West African countries have reported monkeypox cases which have risen exponentially. We review the history and evolution of monkeypoxoutbreaks in Africa and USA, the changing clinical presentations, and discusspossible factors underlying the increasing numbers being detected including thecessation of smallpox vaccination programs. Major knowledge gaps remain on theepidemiology, host reservoir, and emergence, transmission, pathogenesis andprevention of monkeypoz.
CI  - Copyright (c) 2018 The Author(s). Published by Elsevier Ltd.. All rightsreserved.
FAU - Petersen, Eskild
AU  - Petersen E
AD  - Institute of Clinical Medicine, University of Aarhus, Denmark; The RoyalHospital, Muscat, Oman; ESCMID Emerging Infections Task Force, Basel,Switzerland. Electronic address: eskildp@dadlnet.dk.
FAU - Abubakar, Ibrahim
AU  - Abubakar I
AD  - Institute for Global Health, University College London, London, United Kingdom.Electronic address: i.abubakar@ucl.ac.uk.
FAU - Ihekweazu, Chikwe
AU  - Ihekweazu C
AD  - Nigeria Centre for Disease Control, Jabi, Abuja, Nigeria. Electronic address:chikwe.ihekweazu@gmail.com.
FAU - Heymann, David
AU  - Heymann D
AD  - Faculty of Epidemiology and Population Health, Department of Infectious DiseaseEpidemiology, London School of Hygiene and Tropical Medicine, London, UnitedKingdom. Electronic address: David.Heymann@lshtm.ac.uk.
FAU - Ntoumi, Francine
AU  - Ntoumi F
AD  - University Marien NGouabi and Fondation Congolaise pour la Recherche Medicale(FCRM), Brazzaville, Congo. Electronic address: ffntoumi@hotmail.com.
FAU - Blumberg, Lucille
AU  - Blumberg L
AD  - National Institute for Communicable Diseases, Johannesburg, South Africa.Electronic address: lucilleb@nicd.ac.za.
FAU - Asogun, Danny
AU  - Asogun D
AD  - Department of Public Health, Faculty of Clinical Sciences, College of Medicine,Ambrose Alli University, Ekpoma, Nigeria. Electronic address:asogun2001@yahoo.com.
FAU - Mukonka, Victor
AU  - Mukonka V
AD  - Zambia National Public Health Institute, Ministry of Health, Lusaka, Zambia.Electronic address: vmukonka@gmail.com.
FAU - Lule, Swaib Abubaker
AU  - Lule SA
AD  - Institute for Global Health, University College London, London, United Kingdom.Electronic address: swaiblule@gmail.com.
FAU - Bates, Matthew
AU  - Bates M
AD  - HerpeZ and UNZA-UCLMS Project, University Teaching Hospital, Lusaka, Zambia;School of Life Sciences, University of Lincoln, Lincoln, United Kingdom.Electronic address: MBates@lincoln.ac.uk.
FAU - Honeyborne, Isobella
AU  - Honeyborne I
AD  - Division of Infection and Immunity, Center for Clinical Microbiology, University College London, London, United Kingdom. Electronic address:i.honeyborne@ucl.ac.uk.
FAU - Mfinanga, Sayoki
AU  - Mfinanga S
AD  - National Institute of Medical Research Muhimbili, Dar es Salaam, Tanzania.Electronic address: gsmfinanga@yahoo.com.
FAU - Mwaba, Peter
AU  - Mwaba P
AD  - UNZA-UCLMS Project, and Lusaka Apex University Medical School, Lusaka, Zambia.Electronic address: pbmwaba2000@gmail.com.
FAU - Dar, Osman
AU  - Dar O
AD  - Public Health England, London, United Kingdom; Chatham House Centre on GlobalHealth Security, London, United Kingdom. Electronic address:Osman.Dar@phe.gov.uk.
FAU - Vairo, Francesco
AU  - Vairo F
AD  - National Institute for Infectious Diseases, Lazzaro Spallanzani, IRCCS, Rome,Italy. Electronic address: francesco.vairo@inmi.it.
FAU - Mukhtar, Maowia
AU  - Mukhtar M
AD  - Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan.Electronic address: mmukhtar@tropmedicine.org.
FAU - Kock, Richard
AU  - Kock R
AD  - Department of Pathobiology and Population Sciences, The Royal Veterinary College,Hertfordshire, United Kingdom. Electronic address: rkock@rvc.ac.uk.
FAU - McHugh, Timothy D
AU  - McHugh TD
AD  - Division of Infection and Immunity, Center for Clinical Microbiology, University College London, London, United Kingdom. Electronic address: t.mchugh@ucl.ac.uk.
FAU - Ippolito, Giuseppe
AU  - Ippolito G
AD  - National Institute for Infectious Diseases, Lazzaro Spallanzani, IRCCS, Rome,Italy. Electronic address: giuseppe.ippolito@inmi.it.
FAU - Zumla, Alimuddin
AU  - Zumla A
AD  - Division of Infection and Immunity, Center for Clinical Microbiology, University College London, United Kingdom; The National Institute of Health ResearchBiomedical Research Centre at UCL Hospitals, London, United Kingdom. Electronicaddress: a.zumla@ucl.ac.uk.
LA  - eng
PT  - Editorial
PT  - Review
DEP - 20181116
PL  - Canada
TA  - Int J Infect Dis
JT  - International journal of infectious diseases : IJID : official publication of theInternational Society for Infectious Diseases
JID - 9610933
SB  - IM
MH  - Animals
MH  - Disease Outbreaks
MH  - Disease Reservoirs
MH  - Epidemics
MH  - Humans
MH  - Monkeypox/epidemiology/*prevention & control
MH  - *Public Health
MH  - Smallpox/*prevention & control
MH  - Vaccination
MH  - Zoonoses/epidemiology/*prevention & control
PMC - PMC7129336
EDAT- 2018/11/20 06:00
MHDA- 2019/02/06 06:00
CRDT- 2018/11/20 06:00
PHST- 2018/11/20 06:00 [pubmed]
PHST- 2019/02/06 06:00 [medline]
PHST- 2018/11/20 06:00 [entrez]
AID - S1201-9712(18)34587-9 [pii]
AID - 10.1016/j.ijid.2018.11.008 [doi]
PST - ppublish
SO  - Int J Infect Dis. 2019 Jan;78:78-84. doi: 10.1016/j.ijid.2018.11.008. Epub 2018Nov 16.

PMID- 30445121
OWN - NLM
STAT- MEDLINE
DCOM- 20200210
LR  - 20200309
IS  - 1872-9096 (Electronic)
IS  - 0166-3542 (Linking)
VI  - 162
DP  - 2019 Feb
TI  - Vaccinating against monkeypox in the Democratic Republic of the Congo.
PG  - 171-177
LID - S0166-3542(18)30596-5 [pii]
LID - 10.1016/j.antiviral.2018.11.004 [doi]
AB  - Healthcare-associated transmission of monkeypox has been observed on multipleoccasions in areas where the disease is endemic. Data collected by the US Centersfor Disease Control and Prevention (CDC) from an ongoing CDC-supported program ofenhanced surveillance in the Tshuapa Province of the Democratic Republic of theCongo, where the annual incidence of human monkeypox is estimated to be3.5-5/10,000, suggests that there is approximately one healthcare workerinfection for every 100 confirmed monkeypox cases. Herein, we describe a studythat commenced in February 2017, the intent of which is to evaluate theeffectiveness, immunogenicity, and safety of a third-generation smallpox vaccine,IMVAMUNE((R)), in healthcare personnel at risk of monkeypox virus (MPXV)infection. We describe procedures for documenting exposures to monkeypox virusinfection in study participants, and outline lessons learned that may be ofrelevance for studies of other investigational medical countermeasures in hard toreach, under-resourced populations.
CI  - Copyright (c) 2018. Published by Elsevier B.V.
FAU - Petersen, Brett W
AU  - Petersen BW
AD  - U.S. Centers for Disease Control and Prevention, Atlanta, USA. Electronicaddress: bpetersen@cdc.gov.
FAU - Kabamba, Joelle
AU  - Kabamba J
AD  - U.S. Centers for Disease Control and Prevention, Kinshasa, Democratic Republic ofthe Congo.
FAU - McCollum, Andrea M
AU  - McCollum AM
AD  - U.S. Centers for Disease Control and Prevention, Atlanta, USA.
FAU - Lushima, Robert Shongo
AU  - Lushima RS
AD  - Hemorrhagic Fever and Monkeypox Program, Ministry of Health, Kinshasa, DemocraticRepublic of the Congo.
FAU - Wemakoy, Emile Okitolonda
AU  - Wemakoy EO
AD  - Kinshasa School of Public Health, Kinshasa, Democratic Republic of the Congo.
FAU - Muyembe Tamfum, Jean-Jacques
AU  - Muyembe Tamfum JJ
AD  - National Institute for Biomedical Research, Kinshasa, Democratic Republic of the Congo.
FAU - Nguete, Beatrice
AU  - Nguete B
AD  - Kinshasa School of Public Health, Kinshasa, Democratic Republic of the Congo.
FAU - Hughes, Christine M
AU  - Hughes CM
AD  - U.S. Centers for Disease Control and Prevention, Atlanta, USA.
FAU - Monroe, Benjamin P
AU  - Monroe BP
AD  - U.S. Centers for Disease Control and Prevention, Atlanta, USA.
FAU - Reynolds, Mary G
AU  - Reynolds MG
AD  - U.S. Centers for Disease Control and Prevention, Atlanta, USA.
LA  - eng
GR  - CC999999/Intramural CDC HHS/United States
GR  - U01 CK000539/CK/NCEZID CDC HHS/United States
PT  - Journal Article
PT  - Research Support, U.S. Gov't, P.H.S.
PT  - Review
DEP - 20181114
PL  - Netherlands
TA  - Antiviral Res
JT  - Antiviral research
JID - 8109699
RN  - 0 (Smallpox Vaccine)
RN  - 0 (Vaccines, Attenuated)
RN  - TU8J357395 (imvamune)
SB  - IM
MH  - Animals
MH  - Clinical Trials as Topic
MH  - Democratic Republic of the Congo/epidemiology
MH  - *Health Personnel
MH  - Health Resources
MH  - Humans
MH  - Immunogenicity, Vaccine
MH  - Monkeypox/epidemiology/*prevention & control
MH  - Monkeypox virus
MH  - Occupational Diseases/epidemiology/*prevention & control/virology
MH  - Risk Factors
MH  - Rural Population
MH  - Smallpox Vaccine/*administration & dosage/immunology
MH  - Vaccination
MH  - Vaccines, Attenuated/administration & dosage/immunology
PMC - PMC6438175
MID - NIHMS1009764
OTO - NOTNLM
OT  - *Clinical trial
OT  - *Democratic Republic of the Congo
OT  - *IMVAMUNE
OT  - *Monkeypox
OT  - *Smallpox vaccine
EDAT- 2018/11/18 06:00
MHDA- 2020/02/11 06:00
CRDT- 2018/11/17 06:00
PHST- 2018/10/03 00:00 [received]
PHST- 2018/11/09 00:00 [revised]
PHST- 2018/11/12 00:00 [accepted]
PHST- 2018/11/18 06:00 [pubmed]
PHST- 2020/02/11 06:00 [medline]
PHST- 2018/11/17 06:00 [entrez]
AID - S0166-3542(18)30596-5 [pii]
AID - 10.1016/j.antiviral.2018.11.004 [doi]
PST - ppublish
SO  - Antiviral Res. 2019 Feb;162:171-177. doi: 10.1016/j.antiviral.2018.11.004. Epub2018 Nov 14.

PMID- 30429979
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20201001
IS  - 2040-2511 (Electronic)
IS  - 2040-2503 (Linking)
VI  - 9
IP  - 10
DP  - 2018 Oct 1
TI  - Synthesis and antiviral activity of camphor-based 1,3-thiazolidin-4-one andthiazole derivatives as Orthopoxvirus-reproduction inhibitors.
PG  - 1746-1753
LID - 10.1039/c8md00347e [doi]
AB  - The Orthopoxvirus genus belongs to the Poxviridae family and includes variolavirus (smallpox), cowpox virus, monkeypox virus and vaccinia virus (VV). Smallpoxis considered one of the great epidemic disease scourges in human history. It hascurrently been eradicated; however, it remains a considerable threat as abiowarfare or bioterrorist weapon. The poxvirus, VV, serves as a model virus fromwhich new antiviral therapies against Orthopoxviruses can be identified. Here, a series of nitrogen-sulphur containing heterocycles such as 1,3-thiazolidin-4-one and thiazoles containing a 1,7,7-trimethylbicyclo[2.2.1]heptan scaffold weresynthesized and screened for their antiviral activity. The bioassay resultsshowed that the 4b, 4c and 4e thiazoles, which contained a substituted benzenering, were able to inhibit VV reproduction with IC50 values in the 2.4-3.7micromolar range whilst exhibiting moderate cytotoxicity. Among thethiazolidin-4-one derivatives, compound 8b, which contained a 4-methylbenzylidenegroup, displayed good inhibitory activity (IC50 = 9.5 muM) and moderate toxicity.
FAU - Sokolova, Anastasiya S
AU  - Sokolova AS
AUID- ORCID: 0000-0001-5227-9996
AD  - Novosibirsk Institute of Organic Chemistry , Siberian Branch of the RussianAcademy of Sciences , Lavrentjev Avenue 9 , 630090 Novosibirsk , Russia . Email: asokolova@nioch.nsc.ru.
FAU - Yarovaya, Olga I
AU  - Yarovaya OI
AUID- ORCID: 0000-0002-2333-4893
AD  - Novosibirsk Institute of Organic Chemistry , Siberian Branch of the RussianAcademy of Sciences , Lavrentjev Avenue 9 , 630090 Novosibirsk , Russia . Email: asokolova@nioch.nsc.ru.
AD  - Novosibirsk State University , Pirogova St. 2 , 630090 Novosibirsk , Russia.
FAU - Bormotov, Nikolay I
AU  - Bormotov NI
AD  - State Research Center of Virology and Biotechnology VECTOR , Koltsovo ,Novosibirsk Region 630559 , Russia.
FAU - Shishkina, Larisa N
AU  - Shishkina LN
AD  - State Research Center of Virology and Biotechnology VECTOR , Koltsovo ,Novosibirsk Region 630559 , Russia.
FAU - Salakhutdinov, Nariman F
AU  - Salakhutdinov NF
AD  - Novosibirsk Institute of Organic Chemistry , Siberian Branch of the RussianAcademy of Sciences , Lavrentjev Avenue 9 , 630090 Novosibirsk , Russia . Email: asokolova@nioch.nsc.ru.
AD  - Novosibirsk State University , Pirogova St. 2 , 630090 Novosibirsk , Russia.
LA  - eng
PT  - Journal Article
DEP - 20180919
PL  - England
TA  - Medchemcomm
JT  - MedChemComm
JID - 101531525
PMC - PMC6194496
EDAT- 2018/11/16 06:00
MHDA- 2018/11/16 06:01
CRDT- 2018/11/16 06:00
PHST- 2018/07/11 00:00 [received]
PHST- 2018/09/09 00:00 [accepted]
PHST- 2018/11/16 06:00 [entrez]
PHST- 2018/11/16 06:00 [pubmed]
PHST- 2018/11/16 06:01 [medline]
AID - 10.1039/c8md00347e [doi]
AID - c8md00347e [pii]
PST - epublish
SO  - Medchemcomm. 2018 Sep 19;9(10):1746-1753. doi: 10.1039/c8md00347e. eCollection2018 Oct 1.

PMID- 30402252
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20210119
IS  - 2052-2975 (Print)
IS  - 2052-2975 (Linking)
VI  - 26
DP  - 2018 Nov
TI  - Studies of nonhuman primates: key sources of data on zoonoses and microbiota.
PG  - S104-S108
LID - 10.1016/j.nmni.2018.08.014 [doi]
AB  - The genetic and morphologic similarities between primates and humans means thatmuch information obtained from primates may be applied to humans, and vice versa.However, habitat loss, hunting and the continued presence of humans have anegative effect on the biology and behaviour of almost all nonhuman primates.Noninvasive methods such as stool collection are among the safest alternativeways to study the multiple aspects of the biology of primates. Many epidemiologicissues (e.g. pathogen detection, microbiota studies) may be easily studied using stool samples from primates. Primates are undoubtedly among the first candidates suspected of becoming the source of one of the next emerging epidemic of zoonoticorigin, as has already been observed with HIV, malaria and monkeypox. TheInstitut Hospitalo-Universitaire Mediterranee Infection in Marseille activelyparticipates in the study, mostly epidemiologic, of nonhuman primates, usingmostly stool samples.
FAU - Davoust, B
AU  - Davoust B
AD  - Microbes, Evolution, Phylogeny and Infection (MEcapital EF, CyrillicI), UMRAix-Marseille Universite, IRD, APHM, IHU Mediterranee Infection, Marseille,France.
FAU - Levasseur, A
AU  - Levasseur A
AD  - Microbes, Evolution, Phylogeny and Infection (MEcapital EF, CyrillicI), UMRAix-Marseille Universite, IRD, APHM, IHU Mediterranee Infection, Marseille,France.
FAU - Mediannikov, O
AU  - Mediannikov O
AD  - Microbes, Evolution, Phylogeny and Infection (MEcapital EF, CyrillicI), UMRAix-Marseille Universite, IRD, APHM, IHU Mediterranee Infection, Marseille,France.
LA  - eng
PT  - Journal Article
DEP - 20180830
PL  - England
TA  - New Microbes New Infect
JT  - New microbes and new infections
JID - 101624750
PMC - PMC6205567
OTO - NOTNLM
OT  - Culturomics
OT  - faecal samples
OT  - great apes
OT  - microbiota
OT  - nonhuman primates
OT  - zoonoses
EDAT- 2018/11/08 06:00
MHDA- 2018/11/08 06:01
CRDT- 2018/11/08 06:00
PHST- 2018/03/02 00:00 [received]
PHST- 2018/08/21 00:00 [revised]
PHST- 2018/08/21 00:00 [accepted]
PHST- 2018/11/08 06:00 [entrez]
PHST- 2018/11/08 06:00 [pubmed]
PHST- 2018/11/08 06:01 [medline]
AID - 10.1016/j.nmni.2018.08.014 [doi]
AID - S2052-2975(18)30074-X [pii]
PST - epublish
SO  - New Microbes New Infect. 2018 Aug 30;26:S104-S108. doi:10.1016/j.nmni.2018.08.014. eCollection 2018 Nov.

PMID- 30357851
OWN - NLM
STAT- MEDLINE
DCOM- 20200317
LR  - 20200317
IS  - 1096-9071 (Electronic)
IS  - 0146-6615 (Linking)
VI  - 91
IP  - 4
DP  - 2019 Apr
TI  - A review of the monkeypox virus and a recent outbreak of skin rash disease inNigeria.
PG  - 533-540
LID - 10.1002/jmv.25348 [doi]
AB  - Since the eradication of smallpox approximately 39 years ago, monkeypox virusremains the most pathogenic poxvirus, being mainly restricted to Central and WestAfrica. Before 1970, there were no reports of human monkeypox in Nigeria, whilebetween 1971 and 1978 there were three cases, with none having been reportedthereafter. However, in September 2017, a case of contagious skin rash disease,typical of monkeypox, was observed in an 11-year-old boy from the southern partof the country and confirmed to be associated with the monkeypox virus. Thislarge outbreak consisted of 262 suspected, 115 confirmed cases, and 7 mortalitiesacross 26 states and the Federal Capital Territory (FCT), Abuja. The aim of this manuscript is to provide an updated, comprehensive, and timely review ofmonkeypox, an important emerging infection in Nigeria. Monkeypox is now a majorthreat to global health security, requiring an urgent multidisciplinary approach involving veterinarians, physicians, virologists, and public health experts tofast-track the development of diagnostic assays, vaccines, antivirals, and other control strategies.
CI  - (c) 2018 Wiley Periodicals, Inc.
FAU - Kabuga, Auwal I
AU  - Kabuga AI
AUID- ORCID: 0000-0002-9317-3407
AD  - Department of Medical Microbiology and Parasitology, College of Health Sciences, Faculty of Clinical Sciences, Bayero University, Kano, Nigeria.
FAU - El Zowalaty, Mohamed E
AU  - El Zowalaty ME
AUID- ORCID: 0000-0002-1056-4761
AD  - Virology, Microbiology and Infectious Diseases Research Group, School of HealthSciences, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20181119
PL  - United States
TA  - J Med Virol
JT  - Journal of medical virology
JID - 7705876
SB  - IM
MH  - Communicable Diseases, Emerging/*epidemiology/mortality/virology
MH  - *Disease Outbreaks
MH  - Exanthema/*epidemiology/mortality/virology
MH  - Humans
MH  - Incidence
MH  - Monkeypox/*epidemiology/mortality/virology
MH  - Monkeypox virus/*isolation & purification
MH  - Nigeria/epidemiology
MH  - Survival Analysis
OTO - NOTNLM
OT  - *Africa
OT  - *Nigeria
OT  - *antipoxvirus agents
OT  - *epidemiology
OT  - *infectious diseases
OT  - *monkeypox
OT  - *outbreak
OT  - *poxviruses
OT  - *re-emerging infection
OT  - *zoonotic
EDAT- 2018/10/26 06:00
MHDA- 2020/03/18 06:00
CRDT- 2018/10/26 06:00
PHST- 2018/07/25 00:00 [received]
PHST- 2018/10/17 00:00 [accepted]
PHST- 2018/10/26 06:00 [pubmed]
PHST- 2020/03/18 06:00 [medline]
PHST- 2018/10/26 06:00 [entrez]
AID - 10.1002/jmv.25348 [doi]
PST - ppublish
SO  - J Med Virol. 2019 Apr;91(4):533-540. doi: 10.1002/jmv.25348. Epub 2018 Nov 19.

PMID- 30301229
OWN - NLM
STAT- MEDLINE
DCOM- 20190418
LR  - 20190418
IS  - 1999-4915 (Electronic)
IS  - 1999-4915 (Linking)
VI  - 10
IP  - 10
DP  - 2018 Oct 6
TI  - Whole Genome Characterization of Orthopoxvirus (OPV) Abatino, a Zoonotic VirusRepresenting a Putative Novel Clade of Old World Orthopoxviruses.
LID - E546 [pii]
LID - 10.3390/v10100546 [doi]
AB  - Orthopoxviruses (OPVs) are diffused over the complete Eurasian continent, butpreviously described strains are mostly from northern Europe, and few infections have been reported from Italy. Here we present the extended genomiccharacterization of OPV Abatino, a novel OPV isolated in Italy from an infectedTonkean macaque, with zoonotic potential. Phylogenetic analysis based on 102conserved OPV genes (core gene set) showed that OPV Abatino is most closelyrelated to the Ectromelia virus species (ECTV), although placed on a separatebranch of the phylogenetic tree, bringing substantial support to the hypothesisthat this strain may be part of a novel OPV clade. Extending the analysis to the entire set of genes (coding sequences, CDS) further substantiated thishypothesis. In fact the genome of OPV Abatino included more CDS than ECTV; mostof the extra genes (mainly located in the terminal genome regions), showed thehighest similarity with cowpox virus (CPXV); however vaccinia virus (VACV) andmonkeypox virus (MPXV) were the closest OPV for certain CDS. These findingssuggest that OPV Abatino could be the result of complex evolutionary events,diverging from any other previously described OPV, and may indicate thatpreviously reported cases in Italy could represent the tip of the iceberg yet to be explored.
FAU - Gruber, Cesare E M
AU  - Gruber CEM
AUID- ORCID: 0000-0002-8831-3380
AD  - National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, viaPortuense 292, 00149 Rome, Italy. cesare.gruber@inmi.it.
FAU - Giombini, Emanuela
AU  - Giombini E
AUID- ORCID: 0000-0003-2237-9755
AD  - National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, viaPortuense 292, 00149 Rome, Italy. emanuela.giombini@inmi.it.
FAU - Selleri, Marina
AU  - Selleri M
AUID- ORCID: 0000-0001-9131-7502
AD  - National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, viaPortuense 292, 00149 Rome, Italy. marina.selleri@inmi.it.
FAU - Tausch, Simon H
AU  - Tausch SH
AUID- ORCID: 0000-0002-6874-233X
AD  - Robert Koch Institute, Centre for Biological Threats and Special Pathogens 1,Seestrasse 10, 13353 Berlin, Germany. simon.tausch@bfr.bund.de.
FAU - Andrusch, Andreas
AU  - Andrusch A
AD  - Robert Koch Institute, Centre for Biological Threats and Special Pathogens 1,Seestrasse 10, 13353 Berlin, Germany. andruscha@rki.de.
FAU - Tyshaieva, Alona
AU  - Tyshaieva A
AD  - Robert Koch Institute, Centre for Biological Threats and Special Pathogens 1,Seestrasse 10, 13353 Berlin, Germany. tyshaievaa@rki.de.
FAU - Cardeti, Giusy
AU  - Cardeti G
AUID- ORCID: 0000-0003-3365-9437
AD  - Istituto Zooprofilattico Sperimentale del Lazio e della Toscana M. Aleandri, via Appia Nuova 1411, 00178 Rome, Italy. giusy.cardeti@izslt.it.
FAU - Lorenzetti, Raniero
AU  - Lorenzetti R
AD  - Istituto Zooprofilattico Sperimentale del Lazio e della Toscana M. Aleandri, via Appia Nuova 1411, 00178 Rome, Italy. raniero.lorenzetti@izslt.it.
FAU - De Marco, Lorenzo
AU  - De Marco L
AD  - Parco Faunistico Piano dell'Abatino, via Capo Farfa 50, 02030 Poggio San Lorenzo,Italy. lorenzodem@gmail.com.
FAU - Carletti, Fabrizio
AU  - Carletti F
AD  - National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, viaPortuense 292, 00149 Rome, Italy. fabrizio.carletti@inmi.it.
FAU - Nitsche, Andreas
AU  - Nitsche A
AD  - Robert Koch Institute, Centre for Biological Threats and Special Pathogens 1,Seestrasse 10, 13353 Berlin, Germany. nitschea@rki.de.
FAU - Capobianchi, Maria R
AU  - Capobianchi MR
AD  - National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, viaPortuense 292, 00149 Rome, Italy. maria.capobianchi@inmi.it.
FAU - Ippolito, Giuseppe
AU  - Ippolito G
AUID- ORCID: 0000-0002-1076-2979
AD  - National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, viaPortuense 292, 00149 Rome, Italy. giuseppe.ippolito@inmi.it.
FAU - Autorino, Gian Luca
AU  - Autorino GL
AD  - Istituto Zooprofilattico Sperimentale del Lazio e della Toscana M. Aleandri, via Appia Nuova 1411, 00178 Rome, Italy. gianluca.autorino@izslt.it.
FAU - Castilletti, Concetta
AU  - Castilletti C
AUID- ORCID: 0000-0001-9819-236X
AD  - National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, viaPortuense 292, 00149 Rome, Italy. concetta.castilletti@inmi.it.
LA  - eng
GR  - Ricerca Corrente INMI and IZSLT/Ministero della Salute/International
GR  - 653316/Horizon 2020/International
GR  - 677066/Consumers, Health, Agriculture and Food Executive Agency/International
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20181006
PL  - Switzerland
TA  - Viruses
JT  - Viruses
JID - 101509722
RN  - 0 (DNA, Viral)
SB  - IM
MH  - Animals
MH  - Cercopithecidae/*virology
MH  - DNA, Viral/genetics
MH  - Genes, Viral/genetics
MH  - Genome, Viral/*genetics
MH  - Orthopoxvirus/*classification/*genetics
MH  - *Phylogeny
MH  - Sequence Analysis, DNA
MH  - Sequence Homology, Nucleic Acid
PMC - PMC6212904
OTO - NOTNLM
OT  - *OPV Abatino
OT  - *core gene set
OT  - *cowpox virus
OT  - *ectromelia virus
OT  - *orthopoxvirus
OT  - *phylogenetic tree
EDAT- 2018/10/12 06:00
MHDA- 2019/04/19 06:00
CRDT- 2018/10/11 06:00
PHST- 2018/09/20 00:00 [received]
PHST- 2018/10/02 00:00 [revised]
PHST- 2018/10/03 00:00 [accepted]
PHST- 2018/10/11 06:00 [entrez]
PHST- 2018/10/12 06:00 [pubmed]
PHST- 2019/04/19 06:00 [medline]
AID - v10100546 [pii]
AID - 10.3390/v10100546 [doi]
PST - epublish
SO  - Viruses. 2018 Oct 6;10(10). pii: v10100546. doi: 10.3390/v10100546.

PMID- 30281950
OWN - NLM
STAT- MEDLINE
DCOM- 20190603
LR  - 20190603
IS  - 1934-8533 (Electronic)
IS  - 1934-8525 (Linking)
VI  - 51
IP  - 1
DP  - 2018 Nov
TI  - Propagation and Purification of Ectromelia Virus.
PG  - e65
LID - 10.1002/cpmc.65 [doi]
AB  - Ectromelia virus (ECTV) is an orthopoxvirus that causes mousepox in mice. Membersof the genus orthopoxvirus are closely related and include variola (the causativeagent of smallpox in humans), monkeypox, and vaccinia. Common features of variolavirus and ECTV further include a restricted host range and similar diseaseprogression in their respective hosts. Mousepox makes an excellent small animalmodel for smallpox to investigate pathogenesis, vaccine and antiviral agenttesting, host-virus interactions, and immune and inflammatory responses. Theavailability of a wide variety of inbred, congenic, and gene-knockout mice allowsdetailed analyses of the host response. ECTV mutant viruses lacking one or moregenes encoding immunomodulatory proteins are being used in numerous studies inconjunction with wild-type or gene-knockout mice to study the functions of these genes in host-virus interactions. The methods used for propagation of ECTV incell culture, purification, and quantification of infectious particles throughviral plaque assay are described. (c) 2018 by John Wiley & Sons, Inc.
CI  - (c) 2018 John Wiley & Sons, Inc.
FAU - Chaudhri, Geeta
AU  - Chaudhri G
AD  - Research School of Population Health, College of Health and Medicine, Australian National University, Canberra, Australia.
FAU - Kaladimou, Georgina
AU  - Kaladimou G
AD  - School of Medicine, College of Health and Medicine, University of Tasmania,Hobart, Australia.
FAU - Pandey, Pratikshya
AU  - Pandey P
AD  - School of Medicine, College of Health and Medicine, University of Tasmania,Hobart, Australia.
FAU - Karupiah, Gunasegaran
AU  - Karupiah G
AD  - School of Medicine, College of Health and Medicine, University of Tasmania,Hobart, Australia.
LA  - eng
GR  - National Health and Medical Research Council/International
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20181003
PL  - United States
TA  - Curr Protoc Microbiol
JT  - Current protocols in microbiology
JID - 101257113
SB  - IM
MH  - Animals
MH  - Cell Line
MH  - Ectromelia virus/*growth & development/*isolation & purification
MH  - Mice
MH  - Viral Load/*methods
MH  - Viral Plaque Assay/*methods
MH  - Virus Cultivation/*methods
OTO - NOTNLM
OT  - *ectromelia virus
OT  - *orthopoxvirus
OT  - *poxvirus
OT  - *virus plaque assay
OT  - *virus purification
EDAT- 2018/10/04 06:00
MHDA- 2019/06/04 06:00
CRDT- 2018/10/04 06:00
PHST- 2018/10/04 06:00 [pubmed]
PHST- 2019/06/04 06:00 [medline]
PHST- 2018/10/04 06:00 [entrez]
AID - 10.1002/cpmc.65 [doi]
PST - ppublish
SO  - Curr Protoc Microbiol. 2018 Nov;51(1):e65. doi: 10.1002/cpmc.65. Epub 2018 Oct 3.

PMID- 30279170
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20190315
LR  - 20190315
IS  - 1756-1833 (Electronic)
IS  - 0959-8138 (Linking)
VI  - 363
DP  - 2018 Oct 2
TI  - Sixty seconds on . . . monkeypox.
PG  - k4132
LID - 10.1136/bmj.k4132 [doi]
FAU - Rimmer, Abi
AU  - Rimmer A
AD  - The BMJ.
LA  - eng
PT  - Journal Article
DEP - 20181002
PL  - England
TA  - BMJ
JT  - BMJ (Clinical research ed.)
JID - 8900488
EDAT- 2018/10/04 06:00
MHDA- 2018/10/04 06:01
CRDT- 2018/10/04 06:00
PHST- 2018/10/04 06:00 [entrez]
PHST- 2018/10/04 06:00 [pubmed]
PHST- 2018/10/04 06:01 [medline]
AID - 10.1136/bmj.k4132 [doi]
PST - epublish
SO  - BMJ. 2018 Oct 2;363:k4132. doi: 10.1136/bmj.k4132.

PMID- 30264710
OWN - NLM
STAT- MEDLINE
DCOM- 20181102
LR  - 20181102
IS  - 1474-547X (Electronic)
IS  - 0140-6736 (Linking)
VI  - 392
IP  - 10152
DP  - 2018 Sep 22
TI  - Monkeypox contacts: a puzzling problem.
PG  - 986
LID - S0140-6736(18)32254-2 [pii]
LID - 10.1016/S0140-6736(18)32254-2 [doi]
FAU - The Lancet
AU  - The Lancet
LA  - eng
PT  - Editorial
DEP - 20180920
PL  - England
TA  - Lancet
JT  - Lancet (London, England)
JID - 2985213R
SB  - IM
MH  - Air Travel/statistics & numerical data
MH  - Communicable Diseases, Imported/epidemiology/*transmission
MH  - Disease Outbreaks
MH  - England/epidemiology
MH  - Global Health
MH  - Humans
MH  - Monkeypox/epidemiology/*transmission
MH  - Nigeria/epidemiology
EDAT- 2018/09/29 06:00
MHDA- 2018/11/06 06:00
CRDT- 2018/09/29 06:00
PHST- 2018/09/29 06:00 [entrez]
PHST- 2018/09/29 06:00 [pubmed]
PHST- 2018/11/06 06:00 [medline]
AID - S0140-6736(18)32254-2 [pii]
AID - 10.1016/S0140-6736(18)32254-2 [doi]
PST - ppublish
SO  - Lancet. 2018 Sep 22;392(10152):986. doi: 10.1016/S0140-6736(18)32254-2. Epub 2018Sep 20.

PMID- 30255836
OWN - NLM
STAT- MEDLINE
DCOM- 20191007
LR  - 20191007
IS  - 1560-7917 (Electronic)
IS  - 1025-496X (Linking)
VI  - 23
IP  - 38
DP  - 2018 Sep
TI  - Two cases of monkeypox imported to the United Kingdom, September 2018.
LID - 10.2807/1560-7917.ES.2018.23.38.1800509 [doi]
AB  - In early September 2018, two cases of monkeypox were reported in the UnitedKingdom (UK), diagnosed on 7 September in Cornwall (South West England) and 11September in Blackpool (North West England). The cases were epidemiologicallyunconnected and had recently travelled to the UK from Nigeria, where monkeypox iscurrently circulating. We describe the epidemiology and the public healthresponse for the first diagnosed cases outside the African continent since 2003.
FAU - Vaughan, Aisling
AU  - Vaughan A
AD  - NIHR Health Protection Research Unit in Emerging and Zoonotic Infections,University of Liverpool, Liverpool, United Kingdom.
AD  - Emerging Infections and Zoonoses Section, National Infection Service, PublicHealth England, Colindale, London, United Kingdom.
FAU - Aarons, Emma
AU  - Aarons E
AD  - Rare and Imported Pathogens Laboratory, Public Health England, Porton, Salisbury,United Kingdom.
FAU - Astbury, John
AU  - Astbury J
AD  - Field Service, National Infection Service, Public Health England, United Kingdom.
FAU - Balasegaram, Sooria
AU  - Balasegaram S
AD  - Field Service, National Infection Service, Public Health England, United Kingdom.
FAU - Beadsworth, Mike
AU  - Beadsworth M
AD  - University of Liverpool, Liverpool, United Kingdom, Liverpool, United Kingdom.
AD  - Tropical and Infectious Disease Unit, Royal Liverpool University Hospital,Liverpool, United Kingdom.
FAU - Beck, Charles R
AU  - Beck CR
AD  - Population Health Sciences, Bristol Medical School, University of Bristol,Bristol, United Kingdom.
AD  - Field Service, National Infection Service, Public Health England, United Kingdom.
FAU - Chand, Meera
AU  - Chand M
AD  - NIHR Health Protection Research Unit in Respiratory Infections, Imperial College London, London, United Kingdom.
AD  - Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
AD  - National Infection Service, Public Health England, Colindale, London, UnitedKingdom.
FAU - O'Connor, Catherine
AU  - O'Connor C
AD  - Emerging Infections and Zoonoses Section, National Infection Service, PublicHealth England, Colindale, London, United Kingdom.
FAU - Dunning, Jake
AU  - Dunning J
AD  - Department of Infection, Royal Free London NHS Foundation Trust, London, UnitedKingdom.
AD  - National Infection Service, Public Health England, Colindale, London, UnitedKingdom.
FAU - Ghebrehewet, Sam
AU  - Ghebrehewet S
AD  - Field Service, National Infection Service, Public Health England, United Kingdom.
FAU - Harper, Nick
AU  - Harper N
AD  - Blackpool Teaching Hospitals NHS Foundation Trust, Blackpool, United Kingdom.
FAU - Howlett-Shipley, Ruth
AU  - Howlett-Shipley R
AD  - Defence Medical Services, Ministry of Defence (MOD), United Kingdom.
FAU - Ihekweazu, Chikwe
AU  - Ihekweazu C
AD  - Nigeria Centre for Disease Control (NCDC), Abuja, Nigeria.
FAU - Jacobs, Michael
AU  - Jacobs M
AD  - Department of Infection, Royal Free London NHS Foundation Trust, London, UnitedKingdom.
FAU - Kaindama, Lukeki
AU  - Kaindama L
AD  - Travel and Migrant Health Section, National Infection Service, Public HealthEngland, Colindale, London, United Kingdom.
FAU - Katwa, Parisha
AU  - Katwa P
AD  - Travel and Migrant Health Section, National Infection Service, Public HealthEngland, Colindale, London, United Kingdom.
FAU - Khoo, Saye
AU  - Khoo S
AD  - University of Liverpool, Liverpool, United Kingdom, Liverpool, United Kingdom.
AD  - Tropical and Infectious Disease Unit, Royal Liverpool University Hospital,Liverpool, United Kingdom.
FAU - Lamb, Lucy
AU  - Lamb L
AD  - Defence Medical Services, Ministry of Defence (MOD), United Kingdom.
AD  - Department of Infection, Royal Free London NHS Foundation Trust, London, UnitedKingdom.
FAU - Mawdsley, Sharon
AU  - Mawdsley S
AD  - Blackpool Teaching Hospitals NHS Foundation Trust, Blackpool, United Kingdom.
FAU - Morgan, Dilys
AU  - Morgan D
AD  - Emerging Infections and Zoonoses Section, National Infection Service, PublicHealth England, Colindale, London, United Kingdom.
FAU - Palmer, Ruth
AU  - Palmer R
AD  - Blackpool Teaching Hospitals NHS Foundation Trust, Blackpool, United Kingdom.
FAU - Phin, Nick
AU  - Phin N
AD  - National Infection Service, Public Health England, Colindale, London, UnitedKingdom.
FAU - Russell, Katherine
AU  - Russell K
AD  - Emerging Infections and Zoonoses Section, National Infection Service, PublicHealth England, Colindale, London, United Kingdom.
FAU - Said, Bengu
AU  - Said B
AD  - Emerging Infections and Zoonoses Section, National Infection Service, PublicHealth England, Colindale, London, United Kingdom.
FAU - Simpson, Andrew
AU  - Simpson A
AD  - Rare and Imported Pathogens Laboratory, Public Health England, Porton, Salisbury,United Kingdom.
FAU - Vivancos, Roberto
AU  - Vivancos R
AD  - NIHR Health Protection Research Unit in Gastrointestinal Infections, Universityof Liverpool, Liverpool, United Kingdom.
AD  - NIHR Health Protection Research Unit in Emerging and Zoonotic Infections,University of Liverpool, Liverpool, United Kingdom.
AD  - Field Service, National Infection Service, Public Health England, United Kingdom.
FAU - Wade, Michael
AU  - Wade M
AD  - Field Service, National Infection Service, Public Health England, United Kingdom.
FAU - Walsh, Amanda
AU  - Walsh A
AD  - Emerging Infections and Zoonoses Section, National Infection Service, PublicHealth England, Colindale, London, United Kingdom.
FAU - Wilburn, Jennifer
AU  - Wilburn J
AD  - Emerging Infections and Zoonoses Section, National Infection Service, PublicHealth England, Colindale, London, United Kingdom.
LA  - eng
PT  - Journal Article
PL  - Sweden
TA  - Euro Surveill
JT  - Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
JID - 100887452
SB  - IM
MH  - Animals
MH  - Communicable Diseases, Emerging/diagnosis/epidemiology/transmission/*virology
MH  - Contact Tracing
MH  - Humans
MH  - Monkeypox/*diagnosis/virology
MH  - Monkeypox virus/*isolation & purification
MH  - Nigeria/epidemiology
MH  - Poxviridae Infections/microbiology/transmission
MH  - Public Health
MH  - Risk Assessment
MH  - *Travel
MH  - United Kingdom
PMC - PMC6157091
OTO - NOTNLM
OT  - *England
OT  - *Monkeypox
OT  - *Nigeria
OT  - *Poxvirus
OT  - *United Kingdom
EDAT- 2018/09/27 06:00
MHDA- 2019/10/08 06:00
CRDT- 2018/09/27 06:00
PHST- 2018/09/27 06:00 [entrez]
PHST- 2018/09/27 06:00 [pubmed]
PHST- 2019/10/08 06:00 [medline]
AID - 10.2807/1560-7917.ES.2018.23.38.1800509 [doi]
PST - ppublish
SO  - Euro Surveill. 2018 Sep;23(38). doi: 10.2807/1560-7917.ES.2018.23.38.1800509.

PMID- 30235181
OWN - NLM
STAT- MEDLINE
DCOM- 20181214
LR  - 20181214
IS  - 1545-861X (Electronic)
IS  - 0149-2195 (Linking)
VI  - 67
IP  - 37
DP  - 2018 Sep 21
TI  - Notes from the Field: Responding to an Outbreak of Monkeypox Using the One HealthApproach - Nigeria, 2017-2018.
PG  - 1040-1041
LID - 10.15585/mmwr.mm6737a5 [doi]
FAU - Eteng, Womi-Eteng
AU  - Eteng WE
FAU - Mandra, Anna
AU  - Mandra A
FAU - Doty, Jeff
AU  - Doty J
FAU - Yinka-Ogunleye, Adesola
AU  - Yinka-Ogunleye A
FAU - Aruna, Sola
AU  - Aruna S
FAU - Reynolds, Mary G
AU  - Reynolds MG
FAU - McCollum, Andrea M
AU  - McCollum AM
FAU - Davidson, Whitni
AU  - Davidson W
FAU - Wilkins, Kimberly
AU  - Wilkins K
FAU - Saleh, Muhammad
AU  - Saleh M
FAU - Ipadeola, Oladipupo
AU  - Ipadeola O
FAU - Manneh, Lamin
AU  - Manneh L
FAU - Anebonam, Uchenna
AU  - Anebonam U
FAU - Abdulkareem, Zainab
AU  - Abdulkareem Z
FAU - Okoli, Nma
AU  - Okoli N
FAU - Agenyi, Jeremiah
AU  - Agenyi J
FAU - Dan-Nwafor, Chioma
AU  - Dan-Nwafor C
FAU - Mahmodu, Ibrahim
AU  - Mahmodu I
FAU - Ihekweazu, Chikwe
AU  - Ihekweazu C
LA  - eng
PT  - Journal Article
DEP - 20180921
PL  - United States
TA  - MMWR Morb Mortal Wkly Rep
JT  - MMWR. Morbidity and mortality weekly report
JID - 7802429
SB  - IM
MH  - Animals
MH  - Disease Outbreaks/*prevention & control
MH  - Humans
MH  - Monkeypox/epidemiology/*prevention & control
MH  - Nigeria/epidemiology
MH  - *One Health
PMC - PMC6147416
COIS- All authors have completed and submitted the ICMJE form for disclosure ofpotential conflicts of interest. No potential conflicts of interest weredisclosed.
EDAT- 2018/09/21 06:00
MHDA- 2018/12/15 06:00
CRDT- 2018/09/21 06:00
PHST- 2018/09/21 06:00 [entrez]
PHST- 2018/09/21 06:00 [pubmed]
PHST- 2018/12/15 06:00 [medline]
AID - 10.15585/mmwr.mm6737a5 [doi]
PST - epublish
SO  - MMWR Morb Mortal Wkly Rep. 2018 Sep 21;67(37):1040-1041. doi:10.15585/mmwr.mm6737a5.

PMID- 30234087
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20201001
IS  - 2296-2565 (Print)
IS  - 2296-2565 (Linking)
VI  - 6
DP  - 2018
TI  - Emergence of Monkeypox as the Most Important Orthopoxvirus Infection in Humans.
PG  - 241
LID - 10.3389/fpubh.2018.00241 [doi]
AB  - Monkeypox is an emerging zoonotic disease recognized as the most importantorthopoxvirus infection in humans in the smallpox post-eradication era. Theclinical presentation of monkeypox is similar to the one of smallpox. The casefatality rate of monkeypox (10%) lies between the case fatality rate of variolamajor (30%) and variola minor (1%). The disease is endemic in the DemocraticRepublic of the Congo, but other countries of Central and West Africa eitherreported cases of monkeypox in humans or circulation in wildlife. The disease wasalso imported once into the USA. The disease has always been considered rare and self-limiting, however recent sporadic reports suggest otherwise. Unfortunately, the collected data is limited, dispersed and often incomplete. Therefore, theobjective of this review is to trace all reported human monkeypox outbreaks andrelevant epidemiological information. The frequency and geographical spread ofhuman monkeypox cases have increased in recent years, and there are huge gaps in our understanding of the disease's emergence, epidemiology, and ecology. Themonkeypox virus is considered a high threat pathogen causing a disease of public health importance. Therefore, there is an urgent need to focus on buildingsurveillance capacities which will provide valuable information for designingappropriate prevention, preparedness and response activities.
FAU - Sklenovska, Nikola
AU  - Sklenovska N
AD  - Laboratory of Clinical Virology, Department of Microbiology & Immunology, RegaInstitute for Medical Research, KU Leuven, Leuven, Belgium.
FAU - Van Ranst, Marc
AU  - Van Ranst M
AD  - Laboratory of Clinical Virology, Department of Microbiology & Immunology, RegaInstitute for Medical Research, KU Leuven, Leuven, Belgium.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20180904
PL  - Switzerland
TA  - Front Public Health
JT  - Frontiers in public health
JID - 101616579
PMC - PMC6131633
OTO - NOTNLM
OT  - disease outbreaks
OT  - emerging infectious diseases
OT  - monkeypox
OT  - one health
OT  - orthopoxvirus
OT  - zoonosis
EDAT- 2018/09/21 06:00
MHDA- 2018/09/21 06:01
CRDT- 2018/09/21 06:00
PHST- 2018/04/10 00:00 [received]
PHST- 2018/08/10 00:00 [accepted]
PHST- 2018/09/21 06:00 [entrez]
PHST- 2018/09/21 06:00 [pubmed]
PHST- 2018/09/21 06:01 [medline]
AID - 10.3389/fpubh.2018.00241 [doi]
PST - epublish
SO  - Front Public Health. 2018 Sep 4;6:241. doi: 10.3389/fpubh.2018.00241. eCollection2018.

PMID- 30120818
OWN - NLM
STAT- MEDLINE
DCOM- 20190506
LR  - 20210109
IS  - 1750-2659 (Electronic)
IS  - 1750-2640 (Linking)
VI  - 12
IP  - 6
DP  - 2018 Nov
TI  - The national and provincial burden of medically attended influenza-associatedinfluenza-like illness and severe acute respiratory illness in the DemocraticRepublic of Congo, 2013-2015.
PG  - 695-705
LID - 10.1111/irv.12601 [doi]
AB  - BACKGROUND: Estimates of influenza-associated outpatient consultations andhospitalizations are severely limited in low- and middle-income countries,especially in Africa. METHODS: We conducted active prospective surveillance forinfluenza-like illness (ILI) and severe acute respiratory illness (SARI) at 5healthcare facilities situated in Kinshasa Province during 2013-2015. We testedupper respiratory tract samples for influenza viruses using a reversetranscription-polymerase chain reaction assay. We estimated age-specific numbers and rates of influenza-associated ILI outpatient consultations and SARIhospitalizations for Kinshasa Province using a combination of administrative and influenza surveillance data. These estimates were extrapolated to each of theremaining 10 provinces accounting for provincial differences in prevalence ofrisk factors for pneumonia and healthcare-seeking behavior. Rates were reportedper 100 000 population. RESULTS: During 2013-2015, the mean annual nationalnumber of influenza-associated ILI outpatient consultations was 1 003 212 (95%Confidence Incidence [CI]: 719 335-1 338 050 - Rate: 1205.3; 95% CI:864.2-1607.5); 199 839 (95% CI: 153 563-254 759 - Rate: 1464.0; 95% CI:1125.0-1866.3) among children aged <5 years and 803 374 (95% CI: 567 772-1 083291 - Rate: 1154.5; 95% CI: 813.1-1556.8) among individuals aged >/=5 years. The mean annual national number of influenza-associated SARI hospitalizations was 40 361 (95% CI: 24 014-60 514 - Rate: 48.5; 95% CI: 28.9-72.7); 25 452 (95% CI: 19146-32 944 - Rate: 186.5; 95% CI: 140.3-241.3) among children aged <5 years and14 909 (95% CI: 4868-27 570 - Rate: 21.4; 95% CI: 28.9-72.7) among individualsaged >/=5 years. CONCLUSIONS: The burden of influenza-associated ILI outpatientconsultations and SARI hospitalizations was substantial and was highest amonghospitalized children aged <5 years.
CI  - (c) 2018 The Authors. Influenza and Other Respiratory Viruses Published by JohnWiley & Sons Ltd.
FAU - Babakazo, Pelagie
AU  - Babakazo P
AD  - Kinshasa School of Public Health, University of Kinshasa, Kinshasa, DemocraticRepublic of Congo.
FAU - Lubula, Leopold
AU  - Lubula L
AD  - Division de Lutte Contre la Maladie, Ministry of Health, Kinshasa, DemocraticRepublic of Congo.
FAU - Disasuani, Wally
AU  - Disasuani W
AD  - Kinshasa School of Public Health, University of Kinshasa, Kinshasa, DemocraticRepublic of Congo.
FAU - Manya, Leonie Kitoko
AU  - Manya LK
AD  - Division de Lutte Contre la Maladie, Ministry of Health, Kinshasa, DemocraticRepublic of Congo.
FAU - Nkwembe, Edith
AU  - Nkwembe E
AD  - Institut National de Recherche Biomedicale, Ministry of Health, Kinshasa,Democratic Republic of Congo.
FAU - Mitongo, Naomi
AU  - Mitongo N
AD  - Institut National de Recherche Biomedicale, Ministry of Health, Kinshasa,Democratic Republic of Congo.
FAU - Kavunga-Membo, Hugo
AU  - Kavunga-Membo H
AD  - Institut National de Recherche Biomedicale, Ministry of Health, Kinshasa,Democratic Republic of Congo.
FAU - Changachanga, Jean-Claude
AU  - Changachanga JC
AD  - Institut National de Recherche Biomedicale, Ministry of Health, Kinshasa,Democratic Republic of Congo.
FAU - Muhemedi, Saleh
AU  - Muhemedi S
AD  - Kinshasa School of Public Health, University of Kinshasa, Kinshasa, DemocraticRepublic of Congo.
FAU - Ilunga, Benoit Kebela
AU  - Ilunga BK
AD  - Division de Lutte Contre la Maladie, Ministry of Health, Kinshasa, DemocraticRepublic of Congo.
FAU - Wemakoy, Emile Okitolonda
AU  - Wemakoy EO
AD  - Kinshasa School of Public Health, University of Kinshasa, Kinshasa, DemocraticRepublic of Congo.
FAU - Tamfum, Jean-Jacques Muyembe
AU  - Tamfum JM
AD  - Institut National de Recherche Biomedicale, Ministry of Health, Kinshasa,Democratic Republic of Congo.
FAU - Kabamba-Tshilobo, Joelle
AU  - Kabamba-Tshilobo J
AD  - Influenza and Monkeypox Program, Centers for Disease Control and Prevention,Kinshasa, Democratic Republic of Congo.
FAU - Tempia, Stefano
AU  - Tempia S
AUID- ORCID: 0000-0003-4395-347X
AD  - Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
AD  - Influenza Program, Centers for Disease Control and Prevention, Pretoria, SouthAfrica.
AD  - Centre for Respiratory Diseases and Meningitis, National Institute forCommunicable Diseases of the National Health Laboratory Service, Johannesburg,South Africa.
AD  - MassGenics, Duluth, Georgia.
LA  - eng
GR  - U51IP000602/US Centers for Disease Control and Prevention/International
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, P.H.S.
DEP - 20180906
PL  - England
TA  - Influenza Other Respir Viruses
JT  - Influenza and other respiratory viruses
JID - 101304007
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Ambulatory Care/*statistics & numerical data
MH  - Child
MH  - Child, Preschool
MH  - Democratic Republic of the Congo/epidemiology
MH  - Facilities and Services Utilization
MH  - Female
MH  - Hospitalization/*statistics & numerical data
MH  - Humans
MH  - Infant
MH  - Infant, Newborn
MH  - Male
MH  - Middle Aged
MH  - Prevalence
MH  - Prospective Studies
MH  - Respiratory Tract Infections/*epidemiology
MH  - Risk Factors
MH  - Young Adult
PMC - PMC6185889
OTO - NOTNLM
OT  - *Democratic Republic of Congo
OT  - *burden
OT  - *influenza
OT  - *influenza-like illness
OT  - *severe acute respiratory illness
EDAT- 2018/08/19 06:00
MHDA- 2019/05/07 06:00
CRDT- 2018/08/19 06:00
PHST- 2018/06/01 00:00 [received]
PHST- 2018/08/01 00:00 [revised]
PHST- 2018/08/08 00:00 [accepted]
PHST- 2018/08/19 06:00 [pubmed]
PHST- 2019/05/07 06:00 [medline]
PHST- 2018/08/19 06:00 [entrez]
AID - 10.1111/irv.12601 [doi]
PST - ppublish
SO  - Influenza Other Respir Viruses. 2018 Nov;12(6):695-705. doi: 10.1111/irv.12601.Epub 2018 Sep 6.

PMID- 30000158
STAT- Publisher
DA  - 20180713
PB  - National Library of Medicine (US)
DP  - 2006
TI  - Smallpox Vaccine
BTI - Drugs and Lactation Database (LactMed)
AB  - The Centers for Disease Control and Prevention recommends that nursing mothersnot receive the smallpox vaccine, even if they are pumping their milk and feedingit to their infant by bottle feeding. If a woman received smallpox vaccine duringpregnancy or breastfeeding, she should avoid breastfeeding and handling any baby for at least 3 to 4 weeks until the vaccination scab has separated from thevaccination site. The breasts can be pumped to maintain the milk supply, but the milk should be discarded.[1-3] The newer smallpox and monkeypox vaccine is alive, non-replicating vaccine and is not likely to have these problems duringbreastfeeding. If a close contact of the nursing mother receives the smallpoxvaccine should wash their hands with soap and warm water after direct contactwith the vaccination site, or anything that has touched the vaccination site(bandages, clothing, towels, bedding, etc.). This is will help prevent the spreadof vaccinia virus to contacts, including young babies. If a breastfeeding mother who has had close contact with a person recently vaccinated against smallpoxdevelops a rash, she should check with her healthcare provider to determine ifthe rash is related to the smallpox vaccine. If she has a vaccine-related rash,breastfeeding should not take place until all scabs from the rash have fallenoff.[2]
LA  - eng
PT  - Review
PT  - Book Chapter
PL  - Bethesda (MD)
OTO - NLM
OT  - Dryvax
OT  - Jynneos
EDAT- 2018/07/13 06:01
MHDA- 2018/07/13 06:01
CDAT- 2018/07/13 06:01
AID - NBK501099 [bookaccession]

PMID- 29982575
OWN - NLM
STAT- MEDLINE
DCOM- 20190917
LR  - 20191210
IS  - 1537-6613 (Electronic)
IS  - 0022-1899 (Linking)
VI  - 218
IP  - 9
DP  - 2018 Sep 22
TI  - Effects of Treatment Delay on Efficacy of Tecovirimat Following Lethal AerosolMonkeypox Virus Challenge in Cynomolgus Macaques.
PG  - 1490-1499
LID - 10.1093/infdis/jiy326 [doi]
AB  - Background: Tecovirimat (ST-246) is being developed as an antiviral therapeuticfor smallpox for use in the event of an accidental or intentional release. Thelast reported case of smallpox was 1978 but the potential for use of variolavirus for biowarfare has renewed interest in smallpox antiviral therapeutics.Methods: Cynomolgus macaques were challenged with a lethal dose of monkeypoxvirus (MPXV) by aerosol as a model for human smallpox and treated orally with 10 mg/kg tecovirimat once daily starting up to 8 days following challenge. Monkeyswere monitored for survival, lesions, and clinical signs of disease. Samples werecollected for measurement of viremia by quantitative real-time polymerase chainreaction, and for white blood cell counts. Results: Survival in animalsinitiating treatment up to 5 days postchallenge was 100%. In animals treatedstarting 6, 7, or 8 days following challenge, survival was 67%, 100%, and 50%,respectively. Treatment initiation up to 4 days following challenge reducedseverity of clinical manifestations of infection. Conclusions: Tecovirimattreatment initiated up to 8 days following a lethal aerosol MPXV challengeimproves survival and, when initiated earlier than 5 days after challenge,provides protection from clinical effects of disease, supporting the conclusionthat it is a promising smallpox antiviral therapeutic candidate.
FAU - Russo, Andrew T
AU  - Russo AT
AD  - Lovelace Respiratory Research Institute, Albuquerque, New Mexico.
AD  - Poxvirus Research Group, SIGA Technologies, Inc, Corvallis, Oregon.
FAU - Grosenbach, Douglas W
AU  - Grosenbach DW
AD  - Poxvirus Research Group, SIGA Technologies, Inc, Corvallis, Oregon.
FAU - Brasel, Trevor L
AU  - Brasel TL
AD  - Lovelace Respiratory Research Institute, Albuquerque, New Mexico.
AD  - Sealy Center for Vaccine Development, University of Texas Medical Branch,Galveston.
FAU - Baker, Robert O
AU  - Baker RO
AD  - Lovelace Respiratory Research Institute, Albuquerque, New Mexico.
AD  - Microbiology and Molecular Biology Division, Illinois Institute of TechnologyResearch Institute, Chicago.
FAU - Cawthon, Andrew G
AU  - Cawthon AG
AD  - Lovelace Respiratory Research Institute, Albuquerque, New Mexico.
AD  - Bacteriology, Virology and In Vitro Operations, Battelle Memorial Institute,Columbus, Ohio.
FAU - Reynolds, Erin
AU  - Reynolds E
AD  - Lovelace Respiratory Research Institute, Albuquerque, New Mexico.
AD  - Department of Pathology, University of Texas Medical Branch, Galveston.
FAU - Bailey, Tara
AU  - Bailey T
AD  - Lovelace Respiratory Research Institute, Albuquerque, New Mexico.
AD  - Covance Laboratories, Madison, Wisconsin.
FAU - Kuehl, Philip J
AU  - Kuehl PJ
AD  - Lovelace Respiratory Research Institute, Albuquerque, New Mexico.
FAU - Sugita, Victoria
AU  - Sugita V
AD  - Lovelace Respiratory Research Institute, Albuquerque, New Mexico.
AD  - University of New Mexico, Albuquerque.
FAU - Agans, Krystle
AU  - Agans K
AD  - Lovelace Respiratory Research Institute, Albuquerque, New Mexico.
AD  - Department of Microbiology and Immunology, University of Texas Medical Branch,Galveston.
FAU - Hruby, Dennis E
AU  - Hruby DE
AD  - SIGA Technologies, Inc, Corvallis, Oregon.
LA  - eng
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PL  - United States
TA  - J Infect Dis
JT  - The Journal of infectious diseases
JID - 0413675
RN  - 0 (Aerosols)
RN  - 0 (Benzamides)
RN  - 0 (Isoindoles)
RN  - F925RR824R (Tecovirimat)
SB  - IM
MH  - Aerosols/*adverse effects
MH  - Animals
MH  - Benzamides/*therapeutic use
MH  - Female
MH  - Isoindoles/*therapeutic use
MH  - Macaca fascicularis
MH  - Male
MH  - Monkeypox/*drug therapy
MH  - Monkeypox virus/*drug effects
MH  - Time-to-Treatment
PMC - PMC6151088
EDAT- 2018/07/10 06:00
MHDA- 2019/09/19 06:00
CRDT- 2018/07/09 06:00
PHST- 2018/04/02 00:00 [received]
PHST- 2018/06/15 00:00 [accepted]
PHST- 2018/07/10 06:00 [pubmed]
PHST- 2019/09/19 06:00 [medline]
PHST- 2018/07/09 06:00 [entrez]
AID - 5049262 [pii]
AID - 10.1093/infdis/jiy326 [doi]
PST - ppublish
SO  - J Infect Dis. 2018 Sep 22;218(9):1490-1499. doi: 10.1093/infdis/jiy326.

PMID- 29972742
OWN - NLM
STAT- MEDLINE
DCOM- 20180713
LR  - 20191210
IS  - 1533-4406 (Electronic)
IS  - 0028-4793 (Linking)
VI  - 379
IP  - 1
DP  - 2018 Jul 5
TI  - Oral Tecovirimat for the Treatment of Smallpox.
PG  - 44-53
LID - 10.1056/NEJMoa1705688 [doi]
AB  - BACKGROUND: Smallpox was declared eradicated in 1980, but variola virus (VARV),which causes smallpox, still exists. There is no known effective treatment forsmallpox; therefore, tecovirimat is being developed as an oral smallpox therapy. Because clinical trials in a context of natural disease are not possible, analternative developmental path to evaluate efficacy and safety was needed.METHODS: We investigated the efficacy of tecovirimat in nonhuman primate(monkeypox) and rabbit (rabbitpox) models in accordance with the Food and DrugAdministration (FDA) Animal Efficacy Rule, which was interpreted for smallpoxtherapeutics by an expert advisory committee. We also conducted aplacebo-controlled pharmacokinetic and safety trial involving 449 adultvolunteers. RESULTS: The minimum dose of tecovirimat required in order to achievemore than 90% survival in the monkeypox model was 10 mg per kilogram of bodyweight for 14 days, and a dose of 40 mg per kilogram for 14 days was similarlyefficacious in the rabbitpox model. Although the effective dose per kilogram was higher in rabbits, exposure was lower, with a mean steady-state maximum, minimum,and average (mean) concentration (Cmax, Cmin, and Cavg, respectively) of 374, 25,and 138 ng per milliliter, respectively, in rabbits and 1444, 169, and 598 ng permilliliter in nonhuman primates, as well as an area under the concentration-time curve over 24 hours (AUC0-24hr) of 3318 ngxhours per milliliter in rabbits and14,352 ngxhours per milliliter in nonhuman primates. These findings suggestedthat the nonhuman primate was the more conservative model for the estimation ofthe required drug exposure in humans. A dose of 600 mg twice daily for 14 dayswas selected for testing in humans and provided exposures in excess of those innonhuman primates (mean steady-state Cmax, Cmin, and Cavg of 2209, 690, and 1270 ng per milliliter and AUC0-24hr of 30,632 ngxhours per milliliter). No pattern oftroubling adverse events was observed. CONCLUSIONS: On the basis of its efficacy in two animal models and pharmacokinetic and safety data in humans, tecovirimatis being advanced as a therapy for smallpox in accordance with the FDA AnimalRule. (Funded by the National Institutes of Health and the Biomedical AdvancedResearch and Development Authority; ClinicalTrials.gov number, NCT02474589 .).
FAU - Grosenbach, Douglas W
AU  - Grosenbach DW
AD  - From SIGA Technologies, Corvallis, OR.
FAU - Honeychurch, Kady
AU  - Honeychurch K
AD  - From SIGA Technologies, Corvallis, OR.
FAU - Rose, Eric A
AU  - Rose EA
AD  - From SIGA Technologies, Corvallis, OR.
FAU - Chinsangaram, Jarasvech
AU  - Chinsangaram J
AD  - From SIGA Technologies, Corvallis, OR.
FAU - Frimm, Annie
AU  - Frimm A
AD  - From SIGA Technologies, Corvallis, OR.
FAU - Maiti, Biswajit
AU  - Maiti B
AD  - From SIGA Technologies, Corvallis, OR.
FAU - Lovejoy, Candace
AU  - Lovejoy C
AD  - From SIGA Technologies, Corvallis, OR.
FAU - Meara, Ingrid
AU  - Meara I
AD  - From SIGA Technologies, Corvallis, OR.
FAU - Long, Paul
AU  - Long P
AD  - From SIGA Technologies, Corvallis, OR.
FAU - Hruby, Dennis E
AU  - Hruby DE
AD  - From SIGA Technologies, Corvallis, OR.
LA  - eng
SI  - ClinicalTrials.gov/NCT02474589
GR  - HHSN266200600014C/AI/NIAID NIH HHS/United States
PT  - Journal Article
PT  - Randomized Controlled Trial
PT  - Research Support, N.I.H., Extramural
PL  - United States
TA  - N Engl J Med
JT  - The New England journal of medicine
JID - 0255562
RN  - 0 (Antiviral Agents)
RN  - 0 (Benzamides)
RN  - 0 (Isoindoles)
RN  - F925RR824R (Tecovirimat)
SB  - IM
CIN - N Engl J Med. 2018 Nov 22;379(21):2084-2085. PMID: 30462945
MH  - Administration, Oral
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Animals
MH  - Antiviral Agents/*administration & dosage/adverse effects/pharmacokinetics
MH  - Benzamides/*administration & dosage/adverse effects/pharmacokinetics
MH  - Disease Models, Animal
MH  - Dose-Response Relationship, Drug
MH  - Double-Blind Method
MH  - Female
MH  - Healthy Volunteers
MH  - Humans
MH  - Isoindoles/*administration & dosage/adverse effects/pharmacokinetics
MH  - Macaca fascicularis
MH  - Male
MH  - Middle Aged
MH  - Monkeypox/*drug therapy/mortality
MH  - Monkeypox virus
MH  - Poxviridae Infections/*drug therapy/mortality
MH  - Rabbits
MH  - Vaccinia virus
MH  - Young Adult
PMC - PMC6086581
MID - NIHMS980030
EDAT- 2018/07/05 06:00
MHDA- 2018/07/14 06:00
CRDT- 2018/07/05 06:00
PHST- 2018/07/05 06:00 [entrez]
PHST- 2018/07/05 06:00 [pubmed]
PHST- 2018/07/14 06:00 [medline]
AID - 10.1056/NEJMoa1705688 [doi]
PST - ppublish
SO  - N Engl J Med. 2018 Jul 5;379(1):44-53. doi: 10.1056/NEJMoa1705688.

PMID- 29934850
OWN - NLM
STAT- MEDLINE
DCOM- 20180905
LR  - 20180905
IS  - 1618-2650 (Electronic)
IS  - 1618-2642 (Linking)
VI  - 410
IP  - 23
DP  - 2018 Sep
TI  - A many probes-one spot hybridization oligonucleotide microarray.
PG  - 5817-5823
LID - 10.1007/s00216-018-1190-8 [doi]
AB  - A variant of the hybridization oligonucleotide microarray, utilizing theprinciple of many probes-one spot (MPOS-microarrays), is proposed. A case studybased on Orthopoxviruses (Variola, Monkeypox, and Ectromelia viruses)demonstrates a considerable increase in the fluorescence signal (up to 100-fold) when several oligonucleotide probes are printed to one spot. Moreover, thespecificity of detection also increases (almost 1000-fold), allowing the use ofprobes that individually lack such high specificity. The optimal probes have a Tmof 32-37 degrees C and length of 13-15 bases. We suggest that the highspecificity and sensitivity of the MPOS-microarray is a result of cooperativityof DNA binding with all probes immobilized in the spot. This variant of DNAdetection can be useful for designing biosensors, tools for point-of-care (POC)diagnostics, microbial ecology, analysis of clustered regularly interspaced shortpalindromic repeats (CRISPR), and others. Graphical abstract .
FAU - Kostina, Elena V
AU  - Kostina EV
AD  - Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences, pr. Lavrentieva 8, Novosibirsk, 630090, Russia.
FAU - Sinyakov, Alexander N
AU  - Sinyakov AN
AD  - Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences, pr. Lavrentieva 8, Novosibirsk, 630090, Russia.
FAU - Ryabinin, Vladimir A
AU  - Ryabinin VA
AD  - Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences, pr. Lavrentieva 8, Novosibirsk, 630090, Russia.ryabinin@niboch.nsc.ru.
LA  - eng
PT  - Journal Article
DEP - 20180622
PL  - Germany
TA  - Anal Bioanal Chem
JT  - Analytical and bioanalytical chemistry
JID - 101134327
RN  - 0 (DNA, Viral)
RN  - 0 (Immobilized Nucleic Acids)
RN  - 0 (Oligonucleotide Probes)
SB  - IM
MH  - Base Sequence
MH  - DNA, Viral/*analysis/genetics
MH  - Equipment Design
MH  - Immobilized Nucleic Acids/chemistry/genetics
MH  - *Nucleic Acid Hybridization
MH  - Oligonucleotide Array Sequence Analysis/*instrumentation
MH  - Oligonucleotide Probes/chemistry/genetics
MH  - Orthopoxvirus/chemistry/*genetics
MH  - Poxviridae Infections/virology
OTO - NOTNLM
OT  - Diagnostics
OT  - Hybridization
OT  - MPOS-microarray
OT  - Orthopoxviruses
EDAT- 2018/06/24 06:00
MHDA- 2018/09/06 06:00
CRDT- 2018/06/24 06:00
PHST- 2018/04/20 00:00 [received]
PHST- 2018/06/11 00:00 [accepted]
PHST- 2018/05/30 00:00 [revised]
PHST- 2018/06/24 06:00 [pubmed]
PHST- 2018/09/06 06:00 [medline]
PHST- 2018/06/24 06:00 [entrez]
AID - 10.1007/s00216-018-1190-8 [doi]
AID - 10.1007/s00216-018-1190-8 [pii]
PST - ppublish
SO  - Anal Bioanal Chem. 2018 Sep;410(23):5817-5823. doi: 10.1007/s00216-018-1190-8.Epub 2018 Jun 22.

PMID- 29927927
OWN - NLM
STAT- MEDLINE
DCOM- 20180813
LR  - 20181114
IS  - 1935-2735 (Electronic)
IS  - 1935-2727 (Linking)
VI  - 12
IP  - 6
DP  - 2018 Jun
TI  - Intranasal monkeypox marmoset model: Prophylactic antibody treatment providesbenefit against severe monkeypox virus disease.
PG  - e0006581
LID - 10.1371/journal.pntd.0006581 [doi]
AB  - Concerns regarding outbreaks of human monkeypox or the potential reintroductionof smallpox into an immunological naive population have prompted the development of animal models and countermeasures. Here we present a marmoset model ofmonkeypox and smallpox disease utilizing a relevant poxvirus via a naturalexposure route. We found that 1000 plaque forming units (PFU) of Monkeypox virus was sufficient to recapitulate smallpox disease, to include an incubation period of approximately 13 days, followed by the onset of rash, and death between 15 and17 days. Temporally accurate manifestation of viremia and oral shedding were alsofeatures. The number of lesions ranged from no lesions to 299, the most reported in a marmoset exposed to a poxvirus. To both evaluate the efficacy of ourantibodies and the applicability of the model system, marmosets wereprophylactically treated with two monoclonal antibodies, c7D11 and c8A. Of three marmosets, two were completely free of disease and a single marmoset died 8 days after the mock (n = 1) or PBS control(s) (n = 2). Evaluation of the serum levels of the three animals provided a possible explanation to the animal succumbing to disease. Interestingly, more females had lesions (and a greater number oflesions) and lower viral burden (viremia and oral shedding) than males in ourstudies, suggesting a possible gender effect.
FAU - Mucker, Eric M
AU  - Mucker EM
AUID- ORCID: 0000-0002-4656-5379
AD  - United States Army Medical Research Institute of Infectious Diseases, VirologyDivision, Fort Detrick Maryland, United States of America.
FAU - Wollen-Roberts, Suzanne E
AU  - Wollen-Roberts SE
AUID- ORCID: 0000-0002-9409-2756
AD  - United States Army Medical Research Institute of Infectious Diseases, VirologyDivision, Fort Detrick Maryland, United States of America.
FAU - Kimmel, Adrienne
AU  - Kimmel A
AD  - United States Army Medical Research Institute of Infectious Diseases, VirologyDivision, Fort Detrick Maryland, United States of America.
FAU - Shamblin, Josh
AU  - Shamblin J
AD  - United States Army Medical Research Institute of Infectious Diseases, VirologyDivision, Fort Detrick Maryland, United States of America.
FAU - Sampey, Darryl
AU  - Sampey D
AD  - BioFactura, Inc, Frederick, Maryland, United States of America.
FAU - Hooper, Jay W
AU  - Hooper JW
AD  - United States Army Medical Research Institute of Infectious Diseases, VirologyDivision, Fort Detrick Maryland, United States of America.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20180621
PL  - United States
TA  - PLoS Negl Trop Dis
JT  - PLoS neglected tropical diseases
JID - 101291488
RN  - 0 (Antibodies, Monoclonal)
RN  - 0 (Antibodies, Viral)
SB  - IM
MH  - Animals
MH  - Antibodies, Monoclonal/therapeutic use
MH  - Antibodies, Viral/*therapeutic use
MH  - Callithrix/*virology
MH  - *Disease Models, Animal
MH  - Female
MH  - Humans
MH  - Male
MH  - Monkeypox/*prevention & control/virology
MH  - Monkeypox virus/*immunology
MH  - Viral Load
PMC - PMC6029809
COIS- JWH is an inventor on a patent related to monoclonal antibody c7d11. DS isemployed by Biofactura Inc., a company that has licensing rights related to themonoclonal antibodies used in this study. No other competing interests exist.
EDAT- 2018/06/22 06:00
MHDA- 2018/08/14 06:00
CRDT- 2018/06/22 06:00
PHST- 2018/02/24 00:00 [received]
PHST- 2018/06/04 00:00 [accepted]
PHST- 2018/07/03 00:00 [revised]
PHST- 2018/06/22 06:00 [pubmed]
PHST- 2018/08/14 06:00 [medline]
PHST- 2018/06/22 06:00 [entrez]
AID - 10.1371/journal.pntd.0006581 [doi]
AID - PNTD-D-18-00419 [pii]
PST - epublish
SO  - PLoS Negl Trop Dis. 2018 Jun 21;12(6):e0006581. doi:10.1371/journal.pntd.0006581. eCollection 2018 Jun.

PMID- 29774865
OWN - NLM
STAT- MEDLINE
DCOM- 20190401
LR  - 20190401
IS  - 1080-6059 (Electronic)
IS  - 1080-6040 (Linking)
VI  - 24
IP  - 6
DP  - 2018 Jun
TI  - Strengthening of Surveillance during Monkeypox Outbreak, Republic of the Congo,2017.
PG  - 1158-1160
LID - 10.3201/eid2406.180248 [doi]
AB  - Reports of 10 suspected cases of monkeypox in Likouala Department, Republic ofthe Congo, triggered an investigation and response in March 2017 that includedcommunity education and surveillance strengthening. Increasing numbers ofoutbreaks suggest that monkeypox virus is becoming a more prevalent humanpathogen. Diverse approaches are necessary for disease control and prevention.
FAU - Doshi, Reena H
AU  - Doshi RH
FAU - Guagliardo, Sarah Anne J
AU  - Guagliardo SAJ
FAU - Dzabatou-Babeaux, Angelie
AU  - Dzabatou-Babeaux A
FAU - Likouayoulou, Camille
AU  - Likouayoulou C
FAU - Ndakala, Nestor
AU  - Ndakala N
FAU - Moses, Cynthia
AU  - Moses C
FAU - Olson, Victoria
AU  - Olson V
FAU - McCollum, Andrea M
AU  - McCollum AM
FAU - Petersen, Brett W
AU  - Petersen BW
LA  - eng
PT  - Letter
PL  - United States
TA  - Emerg Infect Dis
JT  - Emerging infectious diseases
JID - 9508155
SB  - IM
MH  - Animals
MH  - Congo/epidemiology
MH  - *Disease Outbreaks
MH  - Humans
MH  - Monkeypox/diagnosis/*epidemiology/*virology
MH  - *Monkeypox virus
MH  - Population Surveillance
PMC - PMC6004878
OTO - NOTNLM
OT  - *Likouala Department
OT  - *Republic of the Congo
OT  - *community members
OT  - *epidemiology
OT  - *healthcare workers
OT  - *monkeypox
OT  - *monkeypox virus
OT  - *outbreak
OT  - *surveillance
OT  - *viruses
OT  - *zoonoses
EDAT- 2018/05/19 06:00
MHDA- 2019/04/02 06:00
CRDT- 2018/05/19 06:00
PHST- 2018/05/19 06:00 [entrez]
PHST- 2018/05/19 06:00 [pubmed]
PHST- 2019/04/02 06:00 [medline]
AID - 10.3201/eid2406.180248 [doi]
PST - ppublish
SO  - Emerg Infect Dis. 2018 Jun;24(6):1158-1160. doi: 10.3201/eid2406.180248.

PMID- 29757202
OWN - NLM
STAT- MEDLINE
DCOM- 20190306
LR  - 20190306
IS  - 1999-4915 (Electronic)
IS  - 1999-4915 (Linking)
VI  - 10
IP  - 5
DP  - 2018 May 12
TI  - Genome Sequences of Akhmeta Virus, an Early Divergent Old World Orthopoxvirus.
LID - E252 [pii]
LID - 10.3390/v10050252 [doi]
AB  - Annotated whole genome sequences of three isolates of the Akhmeta virus (AKMV), anovel species of orthopoxvirus (OPXV), isolated from the Akhmeta and Vani regionsof the country Georgia, are presented and discussed. The AKMV genome is similarin genomic content and structure to that of the cowpox virus (CPXV), but a lower sequence identity was found between AKMV and Old World OPXVs than between otherknown species of Old World OPXVs. Phylogenetic analysis showed that AKMV divergedprior to other Old World OPXV. AKMV isolates formed a monophyletic clade in theOPXV phylogeny, yet the sequence variability between AKMV isolates was higherthan between the monkeypox virus strains in the Congo basin and West Africa. AnAKMV isolate from Vani contained approximately six kb sequence in the leftterminal region that shared a higher similarity with CPXV than with other AKMVisolates, whereas the rest of the genome was most similar to AKMV, suggestingrecombination between AKMV and CPXV in a region containing several host range andvirulence genes.
FAU - Gao, Jinxin
AU  - Gao J
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,National Center for Emerging and Zoonotic Infectious Diseases, Centers of DiseaseControl and Prevention, 1600 Clifton Road NE, Atlanta, GA 30333, USA.jgao2@cdc.gov.
FAU - Gigante, Crystal
AU  - Gigante C
AUID- ORCID: 0000-0002-2169-7156
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,National Center for Emerging and Zoonotic Infectious Diseases, Centers of DiseaseControl and Prevention, 1600 Clifton Road NE, Atlanta, GA 30333, USA.lzu1@cdc.gov.
FAU - Khmaladze, Ekaterine
AU  - Khmaladze E
AD  - Laboratory of Molecular Epidemiology, National Center for Disease Control andPublic Health of Georgia, 9 M. Asatiani Street, Tbilisi 0177, Georgia.e.khmaladze@ncdc.ge.
FAU - Liu, Pengbo
AU  - Liu P
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,National Center for Emerging and Zoonotic Infectious Diseases, Centers of DiseaseControl and Prevention, 1600 Clifton Road NE, Atlanta, GA 30333, USA.pliu0628@gmail.com.
FAU - Tang, Shiyuyun
AU  - Tang S
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,National Center for Emerging and Zoonotic Infectious Diseases, Centers of DiseaseControl and Prevention, 1600 Clifton Road NE, Atlanta, GA 30333, USA.Tangshi06@gmail.com.
FAU - Wilkins, Kimberly
AU  - Wilkins K
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,National Center for Emerging and Zoonotic Infectious Diseases, Centers of DiseaseControl and Prevention, 1600 Clifton Road NE, Atlanta, GA 30333, USA.ibx4@cdc.gov.
FAU - Zhao, Kun
AU  - Zhao K
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,National Center for Emerging and Zoonotic Infectious Diseases, Centers of DiseaseControl and Prevention, 1600 Clifton Road NE, Atlanta, GA 30333, USA.vzt5@cdc.gov.
FAU - Davidson, Whitni
AU  - Davidson W
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,National Center for Emerging and Zoonotic Infectious Diseases, Centers of DiseaseControl and Prevention, 1600 Clifton Road NE, Atlanta, GA 30333, USA.wfd6@cdc.gov.
FAU - Nakazawa, Yoshinori
AU  - Nakazawa Y
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,National Center for Emerging and Zoonotic Infectious Diseases, Centers of DiseaseControl and Prevention, 1600 Clifton Road NE, Atlanta, GA 30333, USA.inp7@cdc.gov.
FAU - Maghlakelidze, Giorgi
AU  - Maghlakelidze G
AD  - Division of Global Health Protection (DGHP), Center for Global Health, Centersfor Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30333, USA.kuo9@cdc.gov.
FAU - Geleishvili, Marika
AU  - Geleishvili M
AD  - Division of Global Health Protection (DGHP), Center for Global Health, Centersfor Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30333, USA.ivu9@cdc.gov.
FAU - Kokhreidze, Maka
AU  - Kokhreidze M
AD  - Laboratory of the Ministry of Agriculture of Georgia (LMA), Animal DiseaseDiagnostic Department, 49 Vaso Godziashvilis Street, Tbilisi 0159, Georgia.maka.kokhreidze@lma.gov.ge.
FAU - Carroll, Darin S
AU  - Carroll DS
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,National Center for Emerging and Zoonotic Infectious Diseases, Centers of DiseaseControl and Prevention, 1600 Clifton Road NE, Atlanta, GA 30333, USA.DCarroll@cdc.gov.
FAU - Emerson, Ginny
AU  - Emerson G
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,National Center for Emerging and Zoonotic Infectious Diseases, Centers of DiseaseControl and Prevention, 1600 Clifton Road NE, Atlanta, GA 30333, USA.GEmerson@cdc.gov.
FAU - Li, Yu
AU  - Li Y
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,National Center for Emerging and Zoonotic Infectious Diseases, Centers of DiseaseControl and Prevention, 1600 Clifton Road NE, Atlanta, GA 30333, USA.YuLi@cdc.gov.
LA  - eng
PT  - Journal Article
PT  - Research Support, U.S. Gov't, Non-P.H.S.
PT  - Research Support, U.S. Gov't, P.H.S.
DEP - 20180512
PL  - Switzerland
TA  - Viruses
JT  - Viruses
JID - 101509722
RN  - 0 (DNA, Viral)
SB  - IM
MH  - Africa, Western
MH  - Congo
MH  - Cowpox virus/genetics
MH  - DNA, Viral/genetics
MH  - *Genome, Viral
MH  - Monkeypox virus/genetics
MH  - Orthopoxvirus/*classification/*genetics
MH  - Phenotype
MH  - Phylogeny
MH  - Recombination, Genetic
MH  - Sequence Analysis, DNA
MH  - Variola virus/genetics
MH  - Whole Genome Sequencing
PMC - PMC5977245
OTO - NOTNLM
OT  - *Akhmeta virus
OT  - *cowpox virus
OT  - *orthopoxvirus
OT  - *recombination
EDAT- 2018/05/15 06:00
MHDA- 2019/03/07 06:00
CRDT- 2018/05/15 06:00
PHST- 2018/04/18 00:00 [received]
PHST- 2018/05/08 00:00 [revised]
PHST- 2018/05/11 00:00 [accepted]
PHST- 2018/05/15 06:00 [entrez]
PHST- 2018/05/15 06:00 [pubmed]
PHST- 2019/03/07 06:00 [medline]
AID - v10050252 [pii]
AID - 10.3390/v10050252 [doi]
PST - epublish
SO  - Viruses. 2018 May 12;10(5). pii: v10050252. doi: 10.3390/v10050252.

PMID- 29747868
OWN - NLM
STAT- MEDLINE
DCOM- 20191010
LR  - 20191010
IS  - 1578-8989 (Electronic)
IS  - 0025-7753 (Linking)
VI  - 151
IP  - 8
DP  - 2018 Oct 23
TI  - Should we be already worried about Monkeypox?
PG  - 320-322
LID - S0025-7753(18)30225-2 [pii]
LID - 10.1016/j.medcli.2018.03.025 [doi]
FAU - Reina, Jordi
AU  - Reina J
AD  - Unidad de Virologia, Servicio de Microbiologia, Hospital Universitario SonEspases, Palma de Mallorca, Espana. Electronic address: jorge.reina@ssib.es.
FAU - Reina, Nuria
AU  - Reina N
AD  - Facultad de Medicina, Universitat de Girona, Girona, Espana.
LA  - eng
LA  - spa
PT  - Editorial
TT  - inverted question markDeberiamos empezar a preocuparnos por la viruela de losmonos?
DEP - 20180507
PL  - Spain
TA  - Med Clin (Barc)
JT  - Medicina clinica
JID - 0376377
RN  - 0 (Antiviral Agents)
SB  - IM
MH  - Animals
MH  - Antiviral Agents/therapeutic use
MH  - Communicable Diseases, Emerging/drug therapy/prevention &control/transmission/virology
MH  - Disease Outbreaks/prevention & control/statistics & numerical data
MH  - Humans
MH  - *Monkeypox/drug therapy/epidemiology/prevention & control/transmission
MH  - Monkeypox virus/genetics
MH  - Population Surveillance
MH  - Vaccination
EDAT- 2018/05/12 06:00
MHDA- 2019/10/11 06:00
CRDT- 2018/05/12 06:00
PHST- 2018/01/08 00:00 [received]
PHST- 2018/03/27 00:00 [revised]
PHST- 2018/03/30 00:00 [accepted]
PHST- 2018/05/12 06:00 [pubmed]
PHST- 2019/10/11 06:00 [medline]
PHST- 2018/05/12 06:00 [entrez]
AID - S0025-7753(18)30225-2 [pii]
AID - 10.1016/j.medcli.2018.03.025 [doi]
PST - ppublish
SO  - Med Clin (Barc). 2018 Oct 23;151(8):320-322. doi: 10.1016/j.medcli.2018.03.025.Epub 2018 May 7.

PMID- 29732376
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220129
IS  - 2328-8957 (Print)
IS  - 2328-8957 (Linking)
VI  - 4
IP  - 4
DP  - 2017 Fall
TI  - A Nosocomial Outbreak of Human Monkeypox in the Central African Republic.
PG  - ofx168
LID - 10.1093/ofid/ofx168 [doi]
AB  - An outbreak of familial monkeypox occurred in the Central African Republic in2015/2016 by 3 transmission modes: familial, health care-related, andtransport-related. Ten people (3 children and 7 adults) were infected. Mostpresented with cutaneous lesions and fever, and 2 children died. The viral strainresponsible was a Zaire genotype strain.
FAU - Nakoune, Emmanuel
AU  - Nakoune E
AD  - Virology Department, Institut Pasteur de Bangui, Bangui, Central AfricanRepublic.
FAU - Lampaert, Emmanuel
AU  - Lampaert E
AD  - Medecins Sans Frontiere (MSF) Belgique, Bangui, Central African Republic.
FAU - Ndjapou, Severin Gervais
AU  - Ndjapou SG
AD  - Ministere de la Sante, de l'Hygiene Publique et de la Population, Bangui, CentralAfrican Republic.
FAU - Janssens, Carole
AU  - Janssens C
AD  - Medecins Sans Frontiere (MSF) Belgique, Bangui, Central African Republic.
FAU - Zuniga, Isabel
AU  - Zuniga I
AD  - Medecins Sans Frontiere (MSF) Belgique, Bangui, Central African Republic.
FAU - Van Herp, Michel
AU  - Van Herp M
AD  - Medecins Sans Frontiere (MSF) Belgique, Bangui, Central African Republic.
FAU - Fongbia, Jean Paul
AU  - Fongbia JP
AD  - Ministere de la Sante, de l'Hygiene Publique et de la Population, Bangui, CentralAfrican Republic.
FAU - Koyazegbe, Thomas Daquin
AU  - Koyazegbe TD
AD  - World Health Organization, Bangui, Central African Republic.
FAU - Selekon, Benjamin
AU  - Selekon B
AD  - Virology Department, Institut Pasteur de Bangui, Bangui, Central AfricanRepublic.
FAU - Komoyo, Giscard Francis
AU  - Komoyo GF
AD  - Virology Department, Institut Pasteur de Bangui, Bangui, Central AfricanRepublic.
FAU - Garba-Ouangole, Sandra Miriella
AU  - Garba-Ouangole SM
AD  - Virology Department, Institut Pasteur de Bangui, Bangui, Central AfricanRepublic.
FAU - Manengu, Casimir
AU  - Manengu C
AD  - World Health Organization, Bangui, Central African Republic.
FAU - Manuguerra, Jean-Claude
AU  - Manuguerra JC
AD  - Unite Environnement et Risques Infectieux, Cellule d'Intervention Biologiqued'Urgence.
FAU - Kazanji, Mirdad
AU  - Kazanji M
AD  - Virology Department, Institut Pasteur de Bangui, Bangui, Central AfricanRepublic.
FAU - Gessain, Antoine
AU  - Gessain A
AD  - Epidemiology and Physiopathology of Oncogenic Viruses, Institut Pasteur, Paris,France.
AD  - Centre National de la Recherche Scientifique (CNRS), UMR3569, Paris, France.
FAU - Berthet, Nicolas
AU  - Berthet N
AD  - Unite Environnement et Risques Infectieux, Cellule d'Intervention Biologiqued'Urgence.
AD  - Centre National de la Recherche Scientifique (CNRS), UMR3569, Paris, France.
AD  - Department of Zoonosis and Emerging Diseases, Centre International de Recherches Medicales de Franceville (CIRMF), Franceville, Gabon.
LA  - eng
GR  - 001/WHO_/World Health Organization/International
PT  - Journal Article
DEP - 20171103
PL  - United States
TA  - Open Forum Infect Dis
JT  - Open forum infectious diseases
JID - 101637045
PMC - PMC5920348
OTO - NOTNLM
OT  - Central African Republic
OT  - monkeypox
OT  - nosocomial outbreak
EDAT- 2018/05/08 06:00
MHDA- 2018/05/08 06:01
CRDT- 2018/05/08 06:00
PHST- 2016/11/17 00:00 [received]
PHST- 2017/10/10 00:00 [accepted]
PHST- 2018/05/08 06:00 [entrez]
PHST- 2018/05/08 06:00 [pubmed]
PHST- 2018/05/08 06:01 [medline]
AID - 10.1093/ofid/ofx168 [doi]
AID - ofx168 [pii]
PST - epublish
SO  - Open Forum Infect Dis. 2017 Nov 3;4(4):ofx168. doi: 10.1093/ofid/ofx168.eCollection 2017 Fall.

PMID- 29676720
OWN - NLM
STAT- MEDLINE
DCOM- 20190328
LR  - 20191209
IS  - 1465-2099 (Electronic)
IS  - 0022-1317 (Linking)
VI  - 99
IP  - 6
DP  - 2018 Jun
TI  - Mutagenic repair of double-stranded DNA breaks in vaccinia virus genomes requirescellular DNA ligase IV activity in the cytosol.
PG  - 790-804
LID - 10.1099/jgv.0.001034 [doi]
AB  - Poxviruses comprise a group of large dsDNA viruses that include members relevant to human and animal health, such as variola virus, monkeypox virus, cowpox virus and vaccinia virus (VACV). Poxviruses are remarkable for their unique replicationcycle, which is restricted to the cytoplasm of infected cells. The independencefrom the host nucleus requires poxviruses to encode most of the enzymes involved in DNA replication, transcription and processing. Here, we use the CRISPR/Cas9genome engineering system to induce DNA damage to VACV (strain Western Reserve)genomes. We show that targeting CRISPR/Cas9 to essential viral genes limits virusreplication efficiently. Although VACV is a strictly cytoplasmic pathogen, weobserved extensive viral genome editing at the target site; this is reminiscentof a non-homologous end-joining DNA repair mechanism. This pathway was notdependent on the viral DNA ligase, but critically involved the cellular DNAligase IV. Our data show that DNA ligase IV can act outside of the nucleus toallow repair of dsDNA breaks in poxvirus genomes. This pathway might contributeto the introduction of mutations within the genome of poxviruses and may thereby promote the evolution of these viruses.
FAU - Luteijn, Rutger David
AU  - Luteijn RD
AD  - Department of Medical Microbiology, University Medical Center Utrecht, Utrecht,The Netherlands.
AD  - Present address: Department of Molecular and Cell Biology, University ofCalifornia, Berkeley, USA.
FAU - Drexler, Ingo
AU  - Drexler I
AD  - Institute for Virology, University Hospital Dusseldorf, Dusseldorf, Germany.
FAU - Smith, Geoffrey L
AU  - Smith GL
AD  - Department of Pathology, University of Cambridge, Cambridge, UK.
FAU - Lebbink, Robert Jan
AU  - Lebbink RJ
AD  - Department of Medical Microbiology, University Medical Center Utrecht, Utrecht,The Netherlands.
FAU - Wiertz, Emmanuel J H J
AU  - Wiertz EJHJ
AD  - Department of Medical Microbiology, University Medical Center Utrecht, Utrecht,The Netherlands.
LA  - eng
GR  - Wellcome Trust/United Kingdom
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20180420
PL  - England
TA  - J Gen Virol
JT  - The Journal of general virology
JID - 0077340
RN  - 0 (DNA, Viral)
RN  - 0 (LIG4 protein, human)
RN  - EC 6.5.1.1 (DNA Ligase ATP)
SB  - IM
MH  - CRISPR-Cas Systems
MH  - Cell Line, Tumor
MH  - Cytosol/metabolism/virology
MH  - *DNA Breaks, Double-Stranded
MH  - DNA Ligase ATP/genetics/*metabolism
MH  - *DNA Repair
MH  - DNA Replication
MH  - DNA, Viral/genetics
MH  - *Genome, Viral
MH  - HEK293 Cells
MH  - Host Microbial Interactions/*genetics
MH  - Humans
MH  - Mutagenesis
MH  - Vaccinia virus/*genetics/physiology
MH  - Virus Replication/genetics
OTO - NOTNLM
OT  - *CRISPR/Cas9
OT  - *DNA ligase IV
OT  - *Poxvirus
OT  - *genome editing
OT  - *mutagenesis
OT  - *viral genome repair
EDAT- 2018/04/21 06:00
MHDA- 2019/03/29 06:00
CRDT- 2018/04/21 06:00
PHST- 2018/04/21 06:00 [pubmed]
PHST- 2019/03/29 06:00 [medline]
PHST- 2018/04/21 06:00 [entrez]
AID - 10.1099/jgv.0.001034 [doi]
PST - ppublish
SO  - J Gen Virol. 2018 Jun;99(6):790-804. doi: 10.1099/jgv.0.001034. Epub 2018 Apr 20.

PMID- 29619921
OWN - NLM
STAT- MEDLINE
DCOM- 20190401
LR  - 20190401
IS  - 1080-6059 (Electronic)
IS  - 1080-6040 (Linking)
VI  - 24
IP  - 6
DP  - 2018 Jun
TI  - Reemergence of Human Monkeypox in Nigeria, 2017.
PG  - 1149-1151
LID - 10.3201/eid2406.180017 [doi]
AB  - In Nigeria, before 2017 the most recent case of human monkeypox had been reportedin 1978. By mid-November 2017, a large outbreak caused by the West African clade resulted in 146 suspected cases and 42 laboratory-confirmed cases from 14 states.Although the source is unknown, multiple sources are suspected.
FAU - Yinka-Ogunleye, Adesola
AU  - Yinka-Ogunleye A
FAU - Aruna, Olusola
AU  - Aruna O
FAU - Ogoina, Dimie
AU  - Ogoina D
FAU - Aworabhi, Neni
AU  - Aworabhi N
FAU - Eteng, Womi
AU  - Eteng W
FAU - Badaru, Sikiru
AU  - Badaru S
FAU - Mohammed, Amina
AU  - Mohammed A
FAU - Agenyi, Jeremiah
AU  - Agenyi J
FAU - Etebu, E N
AU  - Etebu EN
FAU - Numbere, Tamuno-Wari
AU  - Numbere TW
FAU - Ndoreraho, Adolphe
AU  - Ndoreraho A
FAU - Nkunzimana, Eduard
AU  - Nkunzimana E
FAU - Disu, Yahyah
AU  - Disu Y
FAU - Dalhat, Mahmood
AU  - Dalhat M
FAU - Nguku, Patrick
AU  - Nguku P
FAU - Mohammed, Abdulaziz
AU  - Mohammed A
FAU - Saleh, Muhammad
AU  - Saleh M
FAU - McCollum, Andrea
AU  - McCollum A
FAU - Wilkins, Kimberly
AU  - Wilkins K
FAU - Faye, Ousmane
AU  - Faye O
FAU - Sall, Amadou
AU  - Sall A
FAU - Happi, Christian
AU  - Happi C
FAU - Mba, Nwando
AU  - Mba N
FAU - Ojo, Olubumi
AU  - Ojo O
FAU - Ihekweazu, Chikwe
AU  - Ihekweazu C
LA  - eng
PT  - Case Reports
PT  - Letter
DEP - 20180617
PL  - United States
TA  - Emerg Infect Dis
JT  - Emerging infectious diseases
JID - 9508155
SB  - IM
MH  - Animals
MH  - Child
MH  - Communicable Diseases, Emerging/diagnosis/*epidemiology/transmission/*virology
MH  - *Disease Outbreaks
MH  - Exanthema/pathology/virology
MH  - Humans
MH  - Male
MH  - Monkeypox/*epidemiology/*virology
MH  - *Monkeypox virus/classification/genetics
MH  - Nigeria/epidemiology
MH  - Population Surveillance
MH  - *Zoonoses
PMC - PMC6004876
OTO - NOTNLM
OT  - * Human monkeypox
OT  - * Nigeria
OT  - * disease
OT  - * reemergence
OT  - * viruses
OT  - * zoonoses
EDAT- 2018/04/06 06:00
MHDA- 2019/04/02 06:00
CRDT- 2018/04/06 06:00
PHST- 2018/04/06 06:00 [pubmed]
PHST- 2019/04/02 06:00 [medline]
PHST- 2018/04/06 06:00 [entrez]
AID - 10.3201/eid2406.180017 [doi]
PST - ppublish
SO  - Emerg Infect Dis. 2018 Jun;24(6):1149-1151. doi: 10.3201/eid2406.180017. Epub2018 Jun 17.

PMID- 29573840
OWN - NLM
STAT- MEDLINE
DCOM- 20190617
LR  - 20220129
IS  - 1769-6690 (Electronic)
IS  - 0399-077X (Linking)
VI  - 48
IP  - 4
DP  - 2018 Jun
TI  - Investigation of an outbreak of monkeypox in an area occupied by armed groups,Central African Republic.
PG  - 263-268
LID - S0399-077X(17)30026-4 [pii]
LID - 10.1016/j.medmal.2018.02.010 [doi]
AB  - BACKGROUND: Monkeypox is a zoonosis caused by an Orthopoxvirus of the Poxviridae family. Human infections are often severe and are a public health problem.PATIENTS AND METHOD: We conducted a monkeypox outbreak investigation of suspectedcase patients in five villages of the Alindao-Mingala Health District followingblood sample confirmation of the virus by the Institut Pasteur in Bangui. Weaimed to determine disease characteristics, to describe the context and the risk factors, and to measure the incidence and case fatality. Patients were reportedin the villages of Rehou 4, 5, Dalakere 1, Kongbo, and Pavika from August toOctober 2016. Data was collected on individual records when interviewing patientsor parents. RESULTS: A total of 26 patients were identified. The<10 years and21-30 years age groups were the most affected. The overall attack rate was 5 per 1000 inhabitants and the case fatality was 7.7%. Young age and the absence ofsmallpox vaccination were associated with severe presentations in 87.5% of cases.CONCLUSION: The annual number of monkeypox outbreaks increases in the CentralAfrican Republic with severe presentations and a high case fatality especially inchildren. Reinforcing the surveillance and characterization of circulatingstrains will provide information on the need for vaccine production.
CI  - Copyright (c) 2018 Elsevier Masson SAS. All rights reserved.
FAU - Kalthan, E
AU  - Kalthan E
AD  - Direction de la region sanitaire N(o)6, Central African Republic. Electronicaddress: kalthanernest@yahoo.fr.
FAU - Tenguere, J
AU  - Tenguere J
AD  - Centre d'operation d'urgence en sante publique (RCA), Central African Republic.
FAU - Ndjapou, S G
AU  - Ndjapou SG
AD  - Service de la surveillance epidemiologique integree, de gestion des epidemies et des situations d'urgence (RCA), Central African Republic.
FAU - Koyazengbe, T A
AU  - Koyazengbe TA
AD  - Organisation Mondiale de la Sante (Bangui), Central African Republic.
FAU - Mbomba, J
AU  - Mbomba J
AD  - District d'Alindao-Mingala, Central African Republic.
FAU - Marada, R M
AU  - Marada RM
AD  - Cordaid Alindao, Central African Republic.
FAU - Rombebe, P
AU  - Rombebe P
AD  - Centre d'operation d'urgence en sante publique (RCA), Central African Republic.
FAU - Yangueme, P
AU  - Yangueme P
AD  - Hopital de l'Amitie, Central African Republic.
FAU - Babamingui, M
AU  - Babamingui M
AD  - District d'Alindao-Mingala, Central African Republic.
FAU - Sambella, A
AU  - Sambella A
AD  - International Medical Corps (BRIA), Central African Republic.
FAU - Nakoune, E R
AU  - Nakoune ER
AD  - Institut Pasteur de Bangui, Central African Republic.
LA  - eng
GR  - 001/WHO_/World Health Organization/International
PT  - Journal Article
DEP - 20180321
PL  - France
TA  - Med Mal Infect
JT  - Medecine et maladies infectieuses
JID - 0311416
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Armed Conflicts
MH  - Central African Republic/epidemiology
MH  - Child
MH  - Child, Preschool
MH  - *Disease Outbreaks
MH  - Female
MH  - Humans
MH  - Infant
MH  - Male
MH  - Middle Aged
MH  - Monkeypox/*epidemiology
MH  - Young Adult
OTO - NOTNLM
OT  - Monkeypox
OT  - Outbreak
OT  - Zoonose
OT  - Zoonoses
OT  - Epidemie
EDAT- 2018/03/27 06:00
MHDA- 2019/06/18 06:00
CRDT- 2018/03/26 06:00
PHST- 2017/01/20 00:00 [received]
PHST- 2017/06/01 00:00 [revised]
PHST- 2018/02/27 00:00 [accepted]
PHST- 2018/03/27 06:00 [pubmed]
PHST- 2019/06/18 06:00 [medline]
PHST- 2018/03/26 06:00 [entrez]
AID - S0399-077X(17)30026-4 [pii]
AID - 10.1016/j.medmal.2018.02.010 [doi]
PST - ppublish
SO  - Med Mal Infect. 2018 Jun;48(4):263-268. doi: 10.1016/j.medmal.2018.02.010. Epub2018 Mar 21.

PMID- 29551886
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20201001
IS  - 1176-9343 (Print)
IS  - 1176-9343 (Linking)
VI  - 14
DP  - 2018
TI  - Evolution of Synonymous Codon Usage Bias in West African and Central AfricanStrains of Monkeypox Virus.
PG  - 1176934318761368
LID - 10.1177/1176934318761368 [doi]
AB  - The evolution of bias in synonymous codon usage in chosen monkeypox viral genomesand the factors influencing its diversification have not been reported so far. Inthis study, various trends associated with synonymous codon usage in chosenmonkeypox viral genomes were investigated, and the results are reported.Identification of factors that influence codon usage in chosen monkeypox viralgenomes was done using various codon usage indices, such as the relativesynonymous codon usage, the effective number of codons, and the codon adaptation index. The Spearman rank correlation analysis and a correspondence analysis were used for correlating various factors with codon usage. The results revealed that mutational pressure due to compositional constraints, gene expression level, and selection at the codon level for utilization of putative optimal codons are majorfactors influencing synonymous codon usage bias in monkeypox viral genomes. Acluster analysis of relative synonymous codon usage values revealed a grouping ofmore virulent strains as one major cluster (Central African strains) and agrouping of less virulent strains (West African strains) as another majorcluster, indicating a relationship between virulence and synonymous codon usagebias. This study concluded that a balance between the mutational pressure acting at the base composition level and the selection pressure acting at the amino acidlevel frames synonymous codon usage bias in the chosen monkeypox viruses. Thenatural selection from the host does not seem to have influenced the synonymouscodon usage bias in the analyzed monkeypox viral genomes.
FAU - Karumathil, Sudeesh
AU  - Karumathil S
AD  - Centre for Evolutionary Ecology, Aushmath Biosciences, Coimbatore, India.
FAU - Raveendran, Nimal T
AU  - Raveendran NT
AD  - Amrita Centre for Nanosciences, Amrita Vishwa Vidyapeetham, Kochi, India.
FAU - Ganesh, Doss
AU  - Ganesh D
AD  - Department of Plant Biotechnology, School of Biotechnology, Madurai KamarajUniversity, Madurai, India.
FAU - Kumar Ns, Sampath
AU  - Kumar Ns S
AD  - Department of Biotechnology, Vignan's University, Guntur, India.
FAU - Nair, Rahul R
AU  - Nair RR
AD  - Centre for Evolutionary Ecology, Aushmath Biosciences, Coimbatore, India.
FAU - Dirisala, Vijaya R
AU  - Dirisala VR
AD  - Department of Biotechnology, Vignan's University, Guntur, India.
LA  - eng
PT  - Journal Article
DEP - 20180309
PL  - United States
TA  - Evol Bioinform Online
JT  - Evolutionary bioinformatics online
JID - 101256319
PMC - PMC5846927
OTO - NOTNLM
OT  - Monkeypox viruses (MPXV)
OT  - mutational pressure
OT  - selection pressure
OT  - synonymous codon usage bias (SCUB)
COIS- Declaration of conflicting interests:The author(s) declared no potentialconflicts of interest with respect to the research, authorship, and/orpublication of this article.
EDAT- 2018/03/20 06:00
MHDA- 2018/03/20 06:01
CRDT- 2018/03/20 06:00
PHST- 2017/08/17 00:00 [received]
PHST- 2018/02/01 00:00 [accepted]
PHST- 2018/03/20 06:00 [entrez]
PHST- 2018/03/20 06:00 [pubmed]
PHST- 2018/03/20 06:01 [medline]
AID - 10.1177/1176934318761368 [doi]
AID - 10.1177_1176934318761368 [pii]
PST - epublish
SO  - Evol Bioinform Online. 2018 Mar 9;14:1176934318761368. doi:10.1177/1176934318761368. eCollection 2018.

PMID- 29546750
OWN - NLM
STAT- MEDLINE
DCOM- 20180322
LR  - 20180417
IS  - 0049-8114 (Print)
IS  - 0049-8114 (Linking)
VI  - 93
IP  - 11
DP  - 2018 Mar 16
TI  - Emergence of monkeypox in West Africa and Central Africa, 1970-2017.
PG  - 125-32
LA  - eng
LA  - fre
GR  - U01 CK000539/CK/NCEZID CDC HHS/United States
PT  - Journal Article
TT  - Emergence de l'orthopoxvirose simienne en Afrique de l'Ouest et en Afriquecentrale, 1970-2017.
DEP - 20180316
PL  - Switzerland
TA  - Wkly Epidemiol Rec
JT  - Releve epidemiologique hebdomadaire
JID - 0240017
RN  - 0 (Smallpox Vaccine)
SB  - IM
MH  - Africa, Central/epidemiology
MH  - Africa, Western/epidemiology
MH  - Animals
MH  - Communicable Diseases, Emerging/*epidemiology/immunology/prevention &control/virology
MH  - Humans
MH  - Monkeypox/*epidemiology/immunology/prevention & control
MH  - Smallpox Vaccine/immunology
MH  - Zoonoses/*epidemiology/virology
EDAT- 2018/03/17 06:00
MHDA- 2018/03/23 06:00
CRDT- 2018/03/17 06:00
PHST- 2018/03/17 06:00 [entrez]
PHST- 2018/03/17 06:00 [pubmed]
PHST- 2018/03/23 06:00 [medline]
PST - epublish
SO  - Wkly Epidemiol Rec. 2018 Mar 16;93(11):125-32.

PMID- 29543790
OWN - NLM
STAT- MEDLINE
DCOM- 20180316
LR  - 20181114
IS  - 1545-861X (Electronic)
IS  - 0149-2195 (Linking)
VI  - 67
IP  - 10
DP  - 2018 Mar 16
TI  - Emergence of Monkeypox - West and Central Africa, 1970-2017.
PG  - 306-310
LID - 10.15585/mmwr.mm6710a5 [doi]
AB  - The recent apparent increase in human monkeypox cases across a wide geographicarea, the potential for further spread, and the lack of reliable surveillancehave raised the level of concern for this emerging zoonosis. In November 2017,the World Health Organization (WHO), in collaboration with CDC, hosted aninformal consultation on monkeypox with researchers, global health partners,ministries of health, and orthopoxvirus experts to review and discuss humanmonkeypox in African countries where cases have been recently detected and alsoidentify components of surveillance and response that need improvement. Endemichuman monkeypox has been reported from more countries in the past decade thanduring the previous 40 years. Since 2016, confirmed cases of monkeypox haveoccurred in Central African Republic, Democratic Republic of the Congo, Liberia, Nigeria, Republic of the Congo, and Sierra Leone and in captive chimpanzees inCameroon. Many countries with endemic monkeypox lack recent experience andspecific knowledge about the disease to detect cases, treat patients, and preventfurther spread of the virus. Specific improvements in surveillance capacity,laboratory diagnostics, and infection control measures are needed to launch anefficient response. Further, gaps in knowledge about the epidemiology and ecologyof the virus need to be addressed to design, recommend, and implement neededprevention and control measures.
FAU - Durski, Kara N
AU  - Durski KN
FAU - McCollum, Andrea M
AU  - McCollum AM
FAU - Nakazawa, Yoshinori
AU  - Nakazawa Y
FAU - Petersen, Brett W
AU  - Petersen BW
FAU - Reynolds, Mary G
AU  - Reynolds MG
FAU - Briand, Sylvie
AU  - Briand S
FAU - Djingarey, Mamoudou Harouna
AU  - Djingarey MH
FAU - Olson, Victoria
AU  - Olson V
FAU - Damon, Inger K
AU  - Damon IK
FAU - Khalakdina, Asheena
AU  - Khalakdina A
LA  - eng
GR  - U01 CK000539/CK/NCEZID CDC HHS/United States
PT  - Journal Article
DEP - 20180316
PL  - United States
TA  - MMWR Morb Mortal Wkly Rep
JT  - MMWR. Morbidity and mortality weekly report
JID - 7802429
SB  - IM
EIN - MMWR Morb Mortal Wkly Rep. 2018 Apr 27;67(16):479. PMID: 29698383
MH  - Africa, Central/epidemiology
MH  - Africa, Western/epidemiology
MH  - *Communicable Diseases, Emerging
MH  - Humans
MH  - Monkeypox/*epidemiology
PMC - PMC5857192
COIS- No conflicts of interest were reported.
EDAT- 2018/03/16 06:00
MHDA- 2018/03/17 06:00
CRDT- 2018/03/16 06:00
PHST- 2018/03/16 06:00 [entrez]
PHST- 2018/03/16 06:00 [pubmed]
PHST- 2018/03/17 06:00 [medline]
AID - 10.15585/mmwr.mm6710a5 [doi]
PST - epublish
SO  - MMWR Morb Mortal Wkly Rep. 2018 Mar 16;67(10):306-310. doi:10.15585/mmwr.mm6710a5.

PMID- 29510577
OWN - NLM
STAT- MEDLINE
DCOM- 20180918
LR  - 20191210
IS  - 1999-4915 (Electronic)
IS  - 1999-4915 (Linking)
VI  - 10
IP  - 3
DP  - 2018 Mar 5
TI  - Loss of Actin-Based Motility Impairs Ectromelia Virus Release In Vitro but Is NotCritical to Spread In Vivo.
LID - E111 [pii]
LID - 10.3390/v10030111 [doi]
AB  - Ectromelia virus (ECTV) is an orthopoxvirus and the causative agent of mousepox. Like other poxviruses such as variola virus (agent of smallpox), monkeypox virus and vaccinia virus (the live vaccine for smallpox), ECTV promotesactin-nucleation at the surface of infected cells during virus release. Homologs of the viral protein A36 mediate this function through phosphorylation of one or two tyrosine residues that ultimately recruit the cellular Arp2/3actin-nucleating complex. A36 also functions in the intracellular trafficking of virus mediated by kinesin-1. Here, we describe the generation of a recombinantECTV that is specifically disrupted in actin-based motility allowing us toexamine the role of this transport step in vivo for the first time. We show that actin-based motility has a critical role in promoting the release of virus frominfected cells in vitro but plays a minor role in virus spread in vivo. It islikely that loss of microtubule-dependent transport is a major factor for theattenuation observed when A36R is deleted.
FAU - Duncan, Melanie Laura
AU  - Duncan ML
AD  - School of Life and Environmental Sciences, The University of Sydney, Sydney, NSW 2006, Australia. melanie.duncan@sydney.edu.au.
FAU - Horsington, Jacquelyn
AU  - Horsington J
AD  - School of Life and Environmental Sciences, The University of Sydney, Sydney, NSW 2006, Australia. jacquelynjh@gmail.com.
FAU - Eldi, Preethi
AU  - Eldi P
AD  - School of Medicine, College of Health and Medicine, The University of Tasmania,Hobart, TAS 7005, Australia. preethi.eldi@gmail.com.
AD  - The John Curtin School of Medical Research, Australian National University,Canberra, ACT 2601, Australia. preethi.eldi@gmail.com.
FAU - Al Rumaih, Zahrah
AU  - Al Rumaih Z
AD  - School of Medicine, College of Health and Medicine, The University of Tasmania,Hobart, TAS 7005, Australia. rumaihxj@gmail.com.
AD  - The John Curtin School of Medical Research, Australian National University,Canberra, ACT 2601, Australia. rumaihxj@gmail.com.
FAU - Karupiah, Gunasegaran
AU  - Karupiah G
AD  - School of Medicine, College of Health and Medicine, The University of Tasmania,Hobart, TAS 7005, Australia. guna.karupiah@utas.edu.au.
AD  - The John Curtin School of Medical Research, Australian National University,Canberra, ACT 2601, Australia. guna.karupiah@utas.edu.au.
FAU - Newsome, Timothy P
AU  - Newsome TP
AUID- ORCID: 0000-0002-2193-596X
AD  - School of Life and Environmental Sciences, The University of Sydney, Sydney, NSW 2006, Australia. tim.newsome@sydney.edu.au.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20180305
PL  - Switzerland
TA  - Viruses
JT  - Viruses
JID - 101509722
RN  - 0 (Actins)
RN  - 0 (Viral Proteins)
SB  - IM
MH  - Actins/*metabolism
MH  - Animals
MH  - Biological Transport
MH  - Cell Line
MH  - Chlorocebus aethiops
MH  - Ectromelia virus/*physiology
MH  - Ectromelia, Infectious/*metabolism/*virology
MH  - Gene Expression
MH  - Humans
MH  - Mice
MH  - Mice, Knockout
MH  - Mutation
MH  - Protein Binding
MH  - Viral Proteins/chemistry/genetics/metabolism
MH  - *Virus Release
PMC - PMC5869504
OTO - NOTNLM
OT  - *A36
OT  - *Arp2/3 complex
OT  - *actin-based motility
OT  - *viral release
OT  - *virus transport
COIS- The authors declare no conflict of interest.
EDAT- 2018/03/08 06:00
MHDA- 2018/09/19 06:00
CRDT- 2018/03/08 06:00
PHST- 2018/02/15 00:00 [received]
PHST- 2018/03/01 00:00 [revised]
PHST- 2018/03/01 00:00 [accepted]
PHST- 2018/03/08 06:00 [entrez]
PHST- 2018/03/08 06:00 [pubmed]
PHST- 2018/09/19 06:00 [medline]
AID - v10030111 [pii]
AID - 10.3390/v10030111 [doi]
PST - epublish
SO  - Viruses. 2018 Mar 5;10(3). pii: v10030111. doi: 10.3390/v10030111.

PMID- 29495547
OWN - NLM
STAT- MEDLINE
DCOM- 20180918
LR  - 20181114
IS  - 1999-4915 (Electronic)
IS  - 1999-4915 (Linking)
VI  - 10
IP  - 3
DP  - 2018 Feb 28
TI  - Modulating Vaccinia Virus Immunomodulators to Improve Immunological Memory.
LID - E101 [pii]
LID - 10.3390/v10030101 [doi]
AB  - The increasing frequency of monkeypox virus infections, new outbreaks of otherzoonotic orthopoxviruses and concern about the re-emergence of smallpox haveprompted research into developing antiviral drugs and better vaccines againstthese viruses. This article considers the genetic engineering of vaccinia virus(VACV) to enhance vaccine immunogenicity and safety. The virulence,immunogenicity and protective efficacy of VACV strains engineered to lackspecific immunomodulatory or host range proteins are described. The ultimate goalis to develop safer and more immunogenic VACV vaccines that induce long-lastingimmunological memory.
FAU - Albarnaz, Jonas D
AU  - Albarnaz JD
AUID- ORCID: 0000-0002-8792-813X
AD  - Department of Pathology, University of Cambridge, Tennis Court Road, CambridgeCB2 1QP, UK. jd732@cam.ac.uk.
FAU - Torres, Alice A
AU  - Torres AA
AD  - Department of Pathology, University of Cambridge, Tennis Court Road, CambridgeCB2 1QP, UK. at678@cam.ac.uk.
FAU - Smith, Geoffrey L
AU  - Smith GL
AD  - Department of Pathology, University of Cambridge, Tennis Court Road, CambridgeCB2 1QP, UK. gls37@cam.ac.uk.
LA  - eng
GR  - Wellcome Trust/United Kingdom
GR  - Medical Research Council/United Kingdom
GR  - Biotechnology and Biological Sciences Research Council/United Kingdom
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Review
DEP - 20180228
PL  - Switzerland
TA  - Viruses
JT  - Viruses
JID - 101509722
RN  - 0 (Cytokines)
RN  - 0 (Inflammation Mediators)
RN  - 0 (Smallpox Vaccine)
RN  - 0 (Viral Vaccines)
SB  - IM
MH  - Animals
MH  - Communicable Diseases, Emerging/immunology/metabolism/prevention & control
MH  - Cytokines/metabolism
MH  - *Genetic Engineering
MH  - Humans
MH  - Immunity
MH  - Immunogenicity, Vaccine
MH  - *Immunologic Memory
MH  - *Immunomodulation
MH  - Inflammation Mediators/metabolism
MH  - Smallpox/drug therapy/immunology/metabolism/prevention & control
MH  - Smallpox Vaccine/immunology
MH  - Vaccinia virus/*genetics/immunology
MH  - Viral Vaccines/genetics/*immunology
MH  - Zoonoses
PMC - PMC5869494
OTO - NOTNLM
OT  - *genetic engineering
OT  - *immune evasion
OT  - *immunological memory
OT  - *orthopoxviruses
OT  - *smallpox
OT  - *vaccine
OT  - *vaccinia virus
COIS- The authors declare no conflict of interest.
EDAT- 2018/03/03 06:00
MHDA- 2018/09/19 06:00
CRDT- 2018/03/03 06:00
PHST- 2018/02/07 00:00 [received]
PHST- 2018/02/21 00:00 [revised]
PHST- 2018/02/22 00:00 [accepted]
PHST- 2018/03/03 06:00 [entrez]
PHST- 2018/03/03 06:00 [pubmed]
PHST- 2018/09/19 06:00 [medline]
AID - v10030101 [pii]
AID - 10.3390/v10030101 [doi]
PST - epublish
SO  - Viruses. 2018 Feb 28;10(3). pii: v10030101. doi: 10.3390/v10030101.

PMID- 29446492
OWN - NLM
STAT- MEDLINE
DCOM- 20190415
LR  - 20190415
IS  - 1096-9071 (Electronic)
IS  - 0146-6615 (Linking)
VI  - 90
IP  - 6
DP  - 2018 Jun
TI  - Bayesian reconstruction of the evolutionary history and cross-species transition of variola virus and orthopoxviruses.
PG  - 1134-1141
LID - 10.1002/jmv.25055 [doi]
AB  - Variola virus (VARV), the causative agent of smallpox, is an exclusively humanvirus belonging to the genus Orthopoxvirus, which includes many other viralspecies covering a wide range of mammal hosts, such as vaccinia, cowpox,camelpox, taterapox, ectromelia, and monkeypox virus. The tempo and mode ofevolution of Orthopoxviruses were reconstructed using a Bayesian phylodynamicframework by analysing 80 hemagglutinin sequences retrieved from publicdatabases. Bayesian phylogeography was used to estimate their putative ancestral hosts. In order to estimate the substitution rate, the tree including all of the available Orthopoxviruses was calibrated using historical references dating theSouth American variola minor clade (alastrim) to between the XVI and XIX century.The mean substitution rate determined by the analysis was 6.5 x 10(-6)substitutions/site/year. Based on this evolutionary estimate, the time of themost recent common ancestor of the genus Orthopoxvirus was placed at about 10 000years before the present. Cowpox virus was the species closest to the root of thephylogenetic tree. The root of VARV circulating in the XX century was estimatedto be about 700 years ago, corresponding to about 1300 AD. The divergence betweenWest African and South American VARV went back about 500 years ago (fallingapproximately in the XVI century). A rodent species is the most probableancestral host from which the ancestors of all the known Orthopoxviruses weretransmitted to the other mammal host species, and each of these speciesrepresented a dead-end for each new poxvirus species, without any furtherinter-specific spread.
CI  - (c) 2018 Wiley Periodicals, Inc.
FAU - Zehender, Gianguglielmo
AU  - Zehender G
AUID- ORCID: 0000-0002-1886-2915
AD  - Department of Biomedical and Clinical Sciences "Luigi Sacco", University ofMilan, Milan, Italy.
AD  - Coordinated Research Center "EpiSoMI", University of Milan, Milano, Italy.
FAU - Lai, Alessia
AU  - Lai A
AUID- ORCID: 0000-0002-3174-5721
AD  - Department of Biomedical and Clinical Sciences "Luigi Sacco", University ofMilan, Milan, Italy.
FAU - Veo, Carla
AU  - Veo C
AD  - Department of Biomedical and Clinical Sciences "Luigi Sacco", University ofMilan, Milan, Italy.
FAU - Bergna, Annalisa
AU  - Bergna A
AD  - Department of Biomedical and Clinical Sciences "Luigi Sacco", University ofMilan, Milan, Italy.
FAU - Ciccozzi, Massimo
AU  - Ciccozzi M
AUID- ORCID: 0000-0003-3866-9239
AD  - Unit of Clinical Pathology and Microbiology, University Campus Bio-Medico ofRome, Rome, Italy.
FAU - Galli, Massimo
AU  - Galli M
AD  - Department of Biomedical and Clinical Sciences "Luigi Sacco", University ofMilan, Milan, Italy.
LA  - eng
PT  - Journal Article
DEP - 20180312
PL  - United States
TA  - J Med Virol
JT  - Journal of medical virology
JID - 7705876
SB  - IM
MH  - Animals
MH  - Bayes Theorem
MH  - Computational Biology
MH  - *Evolution, Molecular
MH  - Humans
MH  - Mutation Rate
MH  - Orthopoxvirus/*genetics
MH  - *Phylogeography
EDAT- 2018/02/16 06:00
MHDA- 2019/04/16 06:00
CRDT- 2018/02/16 06:00
PHST- 2017/11/10 00:00 [received]
PHST- 2018/02/03 00:00 [accepted]
PHST- 2018/02/16 06:00 [pubmed]
PHST- 2019/04/16 06:00 [medline]
PHST- 2018/02/16 06:00 [entrez]
AID - 10.1002/jmv.25055 [doi]
PST - ppublish
SO  - J Med Virol. 2018 Jun;90(6):1134-1141. doi: 10.1002/jmv.25055. Epub 2018 Mar 12.

PMID- 29410823
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20200929
IS  - 2054-5703 (Print)
IS  - 2054-5703 (Linking)
VI  - 5
IP  - 1
DP  - 2018 Jan
TI  - Ghosts of infections past: using archival samples to understand a century ofmonkeypox virus prevalence among host communities across space and time.
PG  - 171089
LID - 10.1098/rsos.171089 [doi]
AB  - Infectious diseases that originate from multiple wildlife hosts can be complexand problematic to manage. A full understanding is further limited by largetemporal and spatial gaps in sampling. However, these limitations can beovercome, in part, by using historical samples, such as those derived from museumcollections. Here, we screened over 1000 museum specimens collected over the past120 years to examine the historical distribution and prevalence of monkeypoxvirus (MPXV) in five species of African rope squirrel (Funisciurus sp.) collectedacross Central Africa. We found evidence of MPXV infections in host species asearly as 1899, half a century earlier than the first recognized case of MPXV in1958, supporting the suggestion that historic pox-like outbreaks in humans andnon-human primates may have been caused by MPXV rather than smallpox asoriginally thought. MPX viral DNA was found in 93 of 1038 (9.0%) specimens fromfive Funisciurus species (F. anerythrus, F. carruthersi, F. congicus, F.lemniscatus and F. pyrropus), of which F. carruthersi and pyrropus had notpreviously been identified as potential MPXV hosts. We additionally documentedrelative prevalence rates of infection in museum specimens of Funisciurus andexamined the spatial and temporal distribution of MPXV in these potential hostspecies across nearly a hundred years (1899-1993).
FAU - Tiee, Madeline S
AU  - Tiee MS
AUID- ORCID: 0000-0002-8948-0826
AD  - Department of Ecology and Evolutionary Biology, Institute of the Environment and Sustainability, University of California, Los Angeles, CA, USA.
AD  - Center for Tropical Research, Institute of the Environment and Sustainability,University of California, Los Angeles, CA, USA.
FAU - Harrigan, Ryan J
AU  - Harrigan RJ
AD  - Center for Tropical Research, Institute of the Environment and Sustainability,University of California, Los Angeles, CA, USA.
FAU - Thomassen, Henri A
AU  - Thomassen HA
AD  - Center for Tropical Research, Institute of the Environment and Sustainability,University of California, Los Angeles, CA, USA.
AD  - Institute of Evolution and Ecology, University of Tubingen, Tubingen, Germany.
FAU - Smith, Thomas B
AU  - Smith TB
AD  - Department of Ecology and Evolutionary Biology, Institute of the Environment and Sustainability, University of California, Los Angeles, CA, USA.
AD  - Center for Tropical Research, Institute of the Environment and Sustainability,University of California, Los Angeles, CA, USA.
LA  - eng
SI  - figshare/10.6084/m9.figshare.c.3973995
PT  - Journal Article
DEP - 20180131
PL  - England
TA  - R Soc Open Sci
JT  - Royal Society open science
JID - 101647528
PMC - PMC5792900
OTO - NOTNLM
OT  - Funisciurus
OT  - ancient DNA
OT  - host community
OT  - monkeypox
OT  - museum specimens
OT  - zoonotic diseases
COIS- We have no competing interests.
EDAT- 2018/02/08 06:00
MHDA- 2018/02/08 06:01
CRDT- 2018/02/08 06:00
PHST- 2017/08/08 00:00 [received]
PHST- 2017/12/15 00:00 [accepted]
PHST- 2018/02/08 06:00 [entrez]
PHST- 2018/02/08 06:00 [pubmed]
PHST- 2018/02/08 06:01 [medline]
AID - 10.1098/rsos.171089 [doi]
AID - rsos171089 [pii]
PST - epublish
SO  - R Soc Open Sci. 2018 Jan 31;5(1):171089. doi: 10.1098/rsos.171089. eCollection2018 Jan.

PMID- 29401327
OWN - NLM
STAT- MEDLINE
DCOM- 20190322
LR  - 20190322
IS  - 1930-613X (Electronic)
IS  - 0026-4075 (Linking)
VI  - 183
IP  - 1-2
DP  - 2018 Jan 1
TI  - Beyond the Dirty Dozen: A Proposed Methodology for Assessing Future BioweaponThreats.
PG  - e59-e65
LID - 10.1093/milmed/usx004 [doi]
AB  - Background: Defense policy planners and countermeasure developers are often facedwith vexing problems involving the prioritization of resources and efforts. This is especially true in the area of Biodefense, where each new emerging infectious disease outbreak brings with it questions regarding the causative agent'spotential for weaponization. Recent experience with West Nile Virus, Severe AcuteRespiratory Syndrome, Monkeypox, and H1N1 Influenza highlights this problem.Appropriately, in each of these cases, the possibility of bioterrorism wasraised, although each outbreak ultimately proved to have a natural origin. Infact, determining whether an outbreak has an unnatural origin can be quitedifficult. Thus, the questions remain: could the causative agents of these andother emerging infectious disease outbreaks pose a future weaponization threat?And how great is that threat? Should precious resources be diverted from otherdefense efforts in order to prepare for possible hostile employment of noveldiseases by belligerents? Answering such critical questions requires some form ofsystematic threat assessment. Methods: Through extensive collaborative workconducted within NATO's Biomedical Advisory Council, we developed a scoringmatrix for evaluating the weaponization potential of the causative agents of suchdiseases and attempted to validate our matrix by examining the reproducibility ofdata using known threat agents. Our matrix included 12 attributes of a potential weapon and was provided, along with detailed scoring instructions, to 12 groupsof biodefense experts in 6 NATO nations. Study participants were asked to scoreeach of these 12 attributes on a scale of 0-3: Infectivity, Infection-to-Disease Ratio (Reliability), Predictability (& Incubation Period), Morbidity & Mortality (Virulence), Ease of Large-Scale Production & Storage, Aerosol Stability,Atmospheric Stability, Ease of Dispersal, Communicability, ProphylacticCountermeasure Availability, Therapeutic Countermeasure Availability, and Ease ofDetection. Reproducibility of scoring data was assessed by examining the standarddeviations (SD) of mean scores. Results: Our results were unexpected. Severalfamiliar biothreat diseases such as anthrax and tularemia were judged, by ourexperts, to be less threatening than many others owing to a number of factorsincluding ease of detection, lack of communicability, and the ready availability of countermeasures. Conversely, several toxins were judged by experts to havevery high potential as threat agents owing, in part, to their reliability,virulence, and a lack of available countermeasures. Agreement among experts, asdetermined by lower SD about a mean score, was greater for more familiar threats.Discussion: Our study was designed to provide a concise and east-to-apply set of criteria that could be used by NATO nations to evaluate emerging infectiousdisease threats with respect to their weaponization potential. Our results wereunexpected. We believe that a lack of appropriate weighting factors may explainthese results and suggest that future studies weigh each of the 12 proposedcriteria based on the intended use of the assessment data and other situationalfactors. We believe that the greatest value of our study lies in a codificationof the attributes of a biological weapon.
CI  - (c) Association of Military Surgeons of the United States 2017. All rightsreserved. For permissions, please e-mail: journals.permissions@oup.com
FAU - Cieslak, Theodore J
AU  - Cieslak TJ
AD  - Department of Epidemiology, College of Public Health, University of NebraskaMedical Center, Omaha, NE 68198.
FAU - Kortepeter, Mark G
AU  - Kortepeter MG
AD  - Office of the Dean, School of Medicine, Uniformed Services University of theHealth Sciences, Bethesda, MD 20814.
FAU - Wojtyk, Ronald J
AU  - Wojtyk RJ
AD  - Operational Medicine Division, Directorate of Health Services Operations,Canadian Forces Health Services Group Headquarters, Ottawa, Canada ON K1A 0K6.
FAU - Jansen, Hugo-Jan
AU  - Jansen HJ
AD  - Expert Centre Force Health Protection, Support Command, Netherlands Ministry ofDefence, Doorn l MPC 56A, Netherlands.
FAU - Reyes, Ricardo A
AU  - Reyes RA
AD  - Health Physics Office, Walter Reed National Military Medical Center, Bethesda, MD20889.
FAU - Smith, James O
AU  - Smith JO
AD  - CBRN Program Office, Office of the U.S. Army Surgeon General, Falls Church, VA22041.
CN  - NATO Biological Medical Advisory Panel
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
PL  - England
TA  - Mil Med
JT  - Military medicine
JID - 2984771R
RN  - 0 (Biological Warfare Agents)
RN  - 0 (Toxins, Biological)
SB  - IM
MH  - Biological Warfare Agents/*classification/statistics & numerical data
MH  - Disease Outbreaks/prevention & control
MH  - Forecasting/*methods
MH  - Humans
MH  - Reproducibility of Results
MH  - Research Design/*standards
MH  - Risk Assessment/*methods/standards
MH  - Toxins, Biological/analysis
EDAT- 2018/02/06 06:00
MHDA- 2019/03/23 06:00
CRDT- 2018/02/06 06:00
PHST- 2016/08/22 00:00 [received]
PHST- 2017/10/23 00:00 [accepted]
PHST- 2018/02/06 06:00 [entrez]
PHST- 2018/02/06 06:00 [pubmed]
PHST- 2019/03/23 06:00 [medline]
AID - 4644219 [pii]
AID - 10.1093/milmed/usx004 [doi]
PST - ppublish
SO  - Mil Med. 2018 Jan 1;183(1-2):e59-e65. doi: 10.1093/milmed/usx004.

PMID- 29361427
OWN - NLM
STAT- MEDLINE
DCOM- 20190212
LR  - 20190215
IS  - 1474-4457 (Electronic)
IS  - 1473-3099 (Linking)
VI  - 18
IP  - 3
DP  - 2018 Mar
TI  - Genomic characterisation of human monkeypox virus in Nigeria.
PG  - 246
LID - S1473-3099(18)30043-4 [pii]
LID - 10.1016/S1473-3099(18)30043-4 [doi]
FAU - Faye, Ousmane
AU  - Faye O
AD  - Institute Pasteur, Dakar, Senegal.
FAU - Pratt, Catherine B
AU  - Pratt CB
AD  - Center for Genome Sciences, US Army Medical Research Institute of InfectiousDisease, Frederick, MD 21702, USA; College of Public Health, University ofNebraska Medical Center, Omaha, NE, USA.
FAU - Faye, Martin
AU  - Faye M
AD  - Institute Pasteur, Dakar, Senegal.
FAU - Fall, Gamou
AU  - Fall G
AD  - Institute Pasteur, Dakar, Senegal.
FAU - Chitty, Joseph A
AU  - Chitty JA
AD  - Center for Genome Sciences, US Army Medical Research Institute of InfectiousDisease, Frederick, MD 21702, USA.
FAU - Diagne, Moussa M
AU  - Diagne MM
AD  - Institute Pasteur, Dakar, Senegal.
FAU - Wiley, Michael R
AU  - Wiley MR
AD  - Center for Genome Sciences, US Army Medical Research Institute of InfectiousDisease, Frederick, MD 21702, USA; College of Public Health, University ofNebraska Medical Center, Omaha, NE, USA.
FAU - Yinka-Ogunleye, Adesola F
AU  - Yinka-Ogunleye AF
AD  - Nigeria Centre for Disease Control, Abuja, Nigeria.
FAU - Aruna, Sola
AU  - Aruna S
AD  - Nigeria Centre for Disease Control, Abuja, Nigeria; Measure Evaluation, Abuja,Nigeria.
FAU - Etebu, Ebitimitula N
AU  - Etebu EN
AD  - Bayelsa State Ministry of Health, Yenagoa, Nigeria.
FAU - Aworabhi, Neni
AU  - Aworabhi N
AD  - Bayelsa State Ministry of Health, Yenagoa, Nigeria.
FAU - Ogoina, Dimie
AU  - Ogoina D
AD  - Niger Delta University Teaching Hospital/Niger Delta University, Yenagoa,Nigeria.
FAU - Numbere, Wari
AU  - Numbere W
AD  - Nigeria Field Epidemiology and Laboratory Training Program, Ibadan, Nigeria.
FAU - Mba, Nwando
AU  - Mba N
AD  - Nigeria Centre for Disease Control, Abuja, Nigeria.
FAU - Palacios, Gustavo
AU  - Palacios G
AD  - Center for Genome Sciences, US Army Medical Research Institute of InfectiousDisease, Frederick, MD 21702, USA. Electronic address:gustavo.f.palacios.ctr@mail.mil.
FAU - Sall, Amadou A
AU  - Sall AA
AD  - Institute Pasteur, Dakar, Senegal.
FAU - Ihekweazu, Chikwe
AU  - Ihekweazu C
AD  - Nigeria Centre for Disease Control, Abuja, Nigeria.
LA  - eng
PT  - Letter
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20180118
PL  - United States
TA  - Lancet Infect Dis
JT  - The Lancet. Infectious diseases
JID - 101130150
SB  - IM
EIN - Lancet Infect Dis. 2018 Mar;18(3):244. PMID: 29485083
MH  - *Disease Outbreaks
MH  - *Genome, Viral
MH  - *Genomics
MH  - Humans
MH  - Monkeypox/*epidemiology/*virology
MH  - Monkeypox virus/*genetics
MH  - Nigeria/epidemiology
EDAT- 2018/01/24 06:00
MHDA- 2019/02/13 06:00
CRDT- 2018/01/24 06:00
PHST- 2017/12/12 00:00 [received]
PHST- 2017/12/28 00:00 [accepted]
PHST- 2018/01/24 06:00 [pubmed]
PHST- 2019/02/13 06:00 [medline]
PHST- 2018/01/24 06:00 [entrez]
AID - S1473-3099(18)30043-4 [pii]
AID - 10.1016/S1473-3099(18)30043-4 [doi]
PST - ppublish
SO  - Lancet Infect Dis. 2018 Mar;18(3):246. doi: 10.1016/S1473-3099(18)30043-4. Epub2018 Jan 18.

PMID- 29231870
OWN - NLM
STAT- MEDLINE
DCOM- 20180716
LR  - 20181113
IS  - 1999-4915 (Electronic)
IS  - 1999-4915 (Linking)
VI  - 9
IP  - 12
DP  - 2017 Dec 12
TI  - Improving the Care and Treatment of Monkeypox Patients in Low-Resource Settings: Applying Evidence from Contemporary Biomedical and Smallpox Biodefense Research.
LID - E380 [pii]
LID - 10.3390/v9120380 [doi]
AB  - Monkeypox is a smallpox-like illness that can be accompanied by a range ofsignificant medical complications. To date there are no standard or optimizedguidelines for the clinical management of monkeypox (MPX) patients, particularly in low-resource settings. Consequently, patients can experience protractedillness and poor outcomes. Improving care necessitates developing a betterunderstanding of the range of clinical manifestations-including complications andsequelae-as well as of features of illness that may be predictive of illnessseverity and poor outcomes. Experimental and natural infection of non-humanprimates with monkeypox virus can inform the approach to improving patient care, and may suggest options for pharmaceutical intervention. These studies havetraditionally been performed to address the threat of smallpox bioterrorism andwere designed with the intent of using MPX as a disease surrogate for smallpox.In many cases this necessitated employing high-dose, inhalational or intravenous challenge to recapitulate the severe manifestations of illness seen withsmallpox. Overall, these data-and data from biomedical research involving burns, superficial wounds, herpes, eczema vaccinatum, and so forth-suggest that MPXpatients could benefit from clinical support to mitigate the consequences ofcompromised skin and mucosa. This should include prevention and treatment ofsecondary bacterial infections (and other complications), ensuring adequatehydration and nutrition, and protecting vulnerable anatomical locations such asthe eyes and genitals. A standard of care that considers these factors should be developed and assessed in different settings, using clinical metrics specific forMPX alongside consideration of antiviral therapies.
FAU - Reynolds, Mary G
AU  - Reynolds MG
AD  - US Centers for Disease Control and Prevention, Poxvirus and Rabies Branch,Atlanta, GA 30329, USA. nzr6@cdc.gov.
FAU - McCollum, Andrea M
AU  - McCollum AM
AD  - US Centers for Disease Control and Prevention, Poxvirus and Rabies Branch,Atlanta, GA 30329, USA. azv4@cdc.gov.
FAU - Nguete, Beatrice
AU  - Nguete B
AD  - Kinshasa School of Public Health, Kinshasa 11850, Congo. beatanguete13@gmail.com.
FAU - Shongo Lushima, Robert
AU  - Shongo Lushima R
AD  - Ministry of Health, Kinshasa 11842, Congo. robert_shongo@yahoo.fr.
FAU - Petersen, Brett W
AU  - Petersen BW
AD  - US Centers for Disease Control and Prevention, Poxvirus and Rabies Branch,Atlanta, GA 30329, USA. ige3@cdc.gov.
LA  - eng
GR  - U01 CK000539/CK/NCEZID CDC HHS/United States
PT  - Journal Article
PT  - Review
DEP - 20171212
PL  - Switzerland
TA  - Viruses
JT  - Viruses
JID - 101509722
SB  - IM
MH  - Animals
MH  - Bacterial Infections/prevention & control
MH  - Biomedical Research/methods
MH  - *Disease Management
MH  - Disease Models, Animal
MH  - Eye/pathology
MH  - Humans
MH  - Monkeypox/*diagnosis/*therapy
MH  - Mucous Membrane/pathology
MH  - Skin/pathology
MH  - *Standard of Care
PMC - PMC5744154
OTO - NOTNLM
OT  - *Orthopoxvirus
OT  - *animal model
OT  - *clinical syndrome
OT  - *monkeypox
OT  - *standard of care
COIS- The authors declare no conflict of interest.
EDAT- 2017/12/13 06:00
MHDA- 2018/07/17 06:00
CRDT- 2017/12/13 06:00
PHST- 2017/10/06 00:00 [received]
PHST- 2017/11/16 00:00 [revised]
PHST- 2017/12/07 00:00 [accepted]
PHST- 2017/12/13 06:00 [entrez]
PHST- 2017/12/13 06:00 [pubmed]
PHST- 2018/07/17 06:00 [medline]
AID - v9120380 [pii]
AID - 10.3390/v9120380 [doi]
PST - epublish
SO  - Viruses. 2017 Dec 12;9(12). pii: v9120380. doi: 10.3390/v9120380.

PMID- 29204136
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20201001
IS  - 1664-302X (Print)
IS  - 1664-302X (Linking)
VI  - 8
DP  - 2017
TI  - Suppression of Poxvirus Replication by Resveratrol.
PG  - 2196
LID - 10.3389/fmicb.2017.02196 [doi]
AB  - Poxviruses continue to cause serious diseases even after eradication of thehistorically deadly infectious human disease, smallpox. Poxviruses are currently being developed as vaccine vectors and cancer therapeutic agents. Resveratrol is a natural polyphenol stilbenoid found in plants that has been shown to inhibit orenhance replication of a number of viruses, but the effect of resveratrol onpoxvirus replication is unknown. In the present study, we found that resveratrol dramatically suppressed the replication of vaccinia virus (VACV), the prototypic member of poxviruses, in various cell types. Resveratrol also significantlyreduced the replication of monkeypox virus, a zoonotic virus that is endemic inWestern and Central Africa and causes human mortality. The inhibitory effect ofresveratrol on poxviruses is independent of VACV N1 protein, a potentialresveratrol binding target. Further experiments demonstrated that resveratrol hadlittle effect on VACV early gene expression, while it suppressed VACV DNAsynthesis, and subsequently post-replicative gene expression.
FAU - Cao, Shuai
AU  - Cao S
AD  - Division of Biology, Kansas State University, Manhattan, KS, United States.
FAU - Realegeno, Susan
AU  - Realegeno S
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,National Center for Emerging and Zoonotic Infectious Diseases, Centers forDisease Control and Prevention, Atlanta, GA, United States.
FAU - Pant, Anil
AU  - Pant A
AD  - Division of Biology, Kansas State University, Manhattan, KS, United States.
FAU - Satheshkumar, Panayampalli S
AU  - Satheshkumar PS
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,National Center for Emerging and Zoonotic Infectious Diseases, Centers forDisease Control and Prevention, Atlanta, GA, United States.
FAU - Yang, Zhilong
AU  - Yang Z
AD  - Division of Biology, Kansas State University, Manhattan, KS, United States.
LA  - eng
GR  - P20 GM113117/GM/NIGMS NIH HHS/United States
PT  - Journal Article
DEP - 20171117
PL  - Switzerland
TA  - Front Microbiol
JT  - Frontiers in microbiology
JID - 101548977
PMC - PMC5698801
OTO - NOTNLM
OT  - DNA synthesis
OT  - antiviral
OT  - gene expression
OT  - monkeypox
OT  - poxvirus
OT  - resveratrol
OT  - vaccinia virus
EDAT- 2017/12/06 06:00
MHDA- 2017/12/06 06:01
CRDT- 2017/12/06 06:00
PHST- 2017/08/31 00:00 [received]
PHST- 2017/10/26 00:00 [accepted]
PHST- 2017/12/06 06:00 [entrez]
PHST- 2017/12/06 06:00 [pubmed]
PHST- 2017/12/06 06:01 [medline]
AID - 10.3389/fmicb.2017.02196 [doi]
PST - epublish
SO  - Front Microbiol. 2017 Nov 17;8:2196. doi: 10.3389/fmicb.2017.02196. eCollection2017.

PMID- 29155663
OWN - NLM
STAT- MEDLINE
DCOM- 20180627
LR  - 20181113
IS  - 1080-6059 (Electronic)
IS  - 1080-6040 (Linking)
VI  - 23
IP  - 13
DP  - 2017 Dec
TI  - Frameworks for Preventing, Detecting, and Controlling Zoonotic Diseases.
LID - 10.3201/eid2313.170601 [doi]
AB  - Preventing zoonotic diseases requires coordinated actions by governmentauthorities responsible for human and animal health. Constructing the frameworks needed to foster intersectoral collaboration can be approached in many ways. Wehighlight 3 examples of approaches to implement zoonotic disease prevention andcontrol programs. The first, rabies control in Ethiopia, was implemented using anumbrella approach: a comprehensive program designed for accelerated impact. Thesecond, a monkeypox program in Democratic Republic of the Congo, was implemented in a stepwise manner, whereby incremental improvements and activities wereincorporated into the program. The third approach, a pathogen discovery program, applied in the country of Georgia, was designed to characterize and understandthe ecology, epidemiology, and pathogenesis of a new zoonotic pathogen. No oneapproach is superior, but various factors should be taken into account duringdesign, planning, and implementation.
FAU - Shiferaw, Miriam L
AU  - Shiferaw ML
FAU - Doty, Jeffrey B
AU  - Doty JB
FAU - Maghlakelidze, Giorgi
AU  - Maghlakelidze G
FAU - Morgan, Juliette
AU  - Morgan J
FAU - Khmaladze, Ekaterine
AU  - Khmaladze E
FAU - Parkadze, Otar
AU  - Parkadze O
FAU - Donduashvili, Marina
AU  - Donduashvili M
FAU - Wemakoy, Emile Okitolonda
AU  - Wemakoy EO
FAU - Muyembe, Jean-Jacques
AU  - Muyembe JJ
FAU - Mulumba, Leopold
AU  - Mulumba L
FAU - Malekani, Jean
AU  - Malekani J
FAU - Kabamba, Joelle
AU  - Kabamba J
FAU - Kanter, Theresa
AU  - Kanter T
FAU - Boulanger, Linda Lucy
AU  - Boulanger LL
FAU - Haile, Abraham
AU  - Haile A
FAU - Bekele, Abyot
AU  - Bekele A
FAU - Bekele, Meseret
AU  - Bekele M
FAU - Tafese, Kasahun
AU  - Tafese K
FAU - McCollum, Andrea A
AU  - McCollum AA
FAU - Reynolds, Mary G
AU  - Reynolds MG
LA  - eng
PT  - Journal Article
PT  - Research Support, U.S. Gov't, P.H.S.
PT  - Research Support, U.S. Gov't, Non-P.H.S.
PL  - United States
TA  - Emerg Infect Dis
JT  - Emerging infectious diseases
JID - 9508155
SB  - IM
MH  - Animals
MH  - Capacity Building
MH  - Congo/epidemiology
MH  - Ethiopia/epidemiology
MH  - Georgia/epidemiology
MH  - Health Plan Implementation
MH  - Humans
MH  - *National Health Programs
MH  - *Public Health Surveillance/methods
MH  - Zoonoses/diagnosis/*epidemiology/*prevention & control
PMC - PMC5711328
OTO - NOTNLM
OT  - *Democratic Republic of the Congo
OT  - *Ethiopia
OT  - *Republic of Georgia
OT  - *United States
OT  - *global health security
OT  - *prevention and control
OT  - *program design
OT  - *public health program implementation
OT  - *zoonoses
EDAT- 2017/11/21 06:00
MHDA- 2018/06/28 06:00
CRDT- 2017/11/21 06:00
PHST- 2017/11/21 06:00 [entrez]
PHST- 2017/11/21 06:00 [pubmed]
PHST- 2018/06/28 06:00 [medline]
AID - 10.3201/eid2313.170601 [doi]
PST - ppublish
SO  - Emerg Infect Dis. 2017 Dec;23(13). doi: 10.3201/eid2313.170601.

PMID- 29100534
OWN - NLM
STAT- MEDLINE
DCOM- 20180709
LR  - 20191210
IS  - 1743-422X (Electronic)
IS  - 1743-422X (Linking)
VI  - 14
IP  - 1
DP  - 2017 Nov 3
TI  - Validation of a pan-orthopox real-time PCR assay for the detection andquantification of viral genomes from nonhuman primate blood.
PG  - 210
LID - 10.1186/s12985-017-0880-8 [doi]
AB  - BACKGROUND: In 1980, smallpox disease was eradicated from nature and Variolavirus, the etiological agent of smallpox, was confined to two laboratories, onelocated in Russia (Moscow) later moved to VECTOR (Novosibirsk, Siberia) and onein the United States (CDC Atlanta). Vaccinations among the general public ceased shortly after the successful eradication campaign, resulting in an increasinglyimmunologically susceptible population. Because of the possibility of intentionalreintroduction of Variola virus and the emergence of other pathogenic poxviruses,there is a great need for the development of medical countermeasures to treatpoxvirus disease. It is highly likely that the U.S. FDA "animal rule" will benecessary for regulatory approval of these interventions. Therefore, relevantanimal models and the associated supporting assays will require development tostand up to regulatory scrutiny. METHODS: An optimized real time PCR assay forthe detection of orthopoxviruses has been developed by researchers at the United States Army Research Institute of Infectious Diseases (USAMRIID). To supportanimal studies that will be used to support approval of medical countermeasuresby the U.S. FDA, the assay was designed to quantitate poxvirus genomic DNA in anonhuman primate (cynomolgus macaque) blood matrix as a measurement of viremia.This manuscript describes the validation of the process, including DNA extractionfrom whole blood anticoagulated with EDTA, for obtaining and quantitatingmonkeypox genomes by evaluating precision, accuracy, the standard curve,specificity, robustness and stability of the assay and/or components of theassay. RESULTS: The assay had a lower limit of quantitation of 50 genome copies/5uL sample, upper limit of quantitation of 5 x 10(7) GC/5uL sample and a limit of detection of 2.5 genome copies /5uL sample. The assay was specific fororthopoxvirus. Matrix effects were detected and suggest the presence of PCRinhibitor(s) that was co-extracted with the target DNA. CONCLUSIONS: The assayhas been validated for the purpose of quantitating monkeypox viral load in blood from cynomolgus macaques. This assay has and will continue to support submissionsto the FDA for approval of antiviral therapeutics for smallpox.
FAU - Mucker, Eric M
AU  - Mucker EM
AD  - Virology Division, U.S. Army Medical Research Institute of Infectious Diseases,1425 Porter Street, Fort Detrick, Frederick, MD, 21702-5011, USA.eric.m.mucker.ctr@mail.mil.
FAU - Hartmann, Christopher
AU  - Hartmann C
AD  - Virology Division, U.S. Army Medical Research Institute of Infectious Diseases,1425 Porter Street, Fort Detrick, Frederick, MD, 21702-5011, USA.
FAU - Hering, Donna
AU  - Hering D
AD  - Quality Assurance & Regulatory Compliance Office, U.S. Army Medical ResearchInstitute of Infectious Diseases, 1425 Porter Street, Fort Detrick, Frederick,MD, 21702-5011, USA.
FAU - Giles, Wendy
AU  - Giles W
AD  - Office of Regulated Studies, U.S. Army Medical Research Institute of InfectiousDiseases, 1425 Porter Street, Fort Detrick, Frederick, MD, 21702-5011, USA.
FAU - Miller, David
AU  - Miller D
AD  - Virology Division, U.S. Army Medical Research Institute of Infectious Diseases,1425 Porter Street, Fort Detrick, Frederick, MD, 21702-5011, USA.
FAU - Fisher, Robert
AU  - Fisher R
AD  - Virology Division, U.S. Army Medical Research Institute of Infectious Diseases,1425 Porter Street, Fort Detrick, Frederick, MD, 21702-5011, USA.
FAU - Huggins, John
AU  - Huggins J
AD  - Division of Medicine, U.S. Army Medical Research Institute of InfectiousDiseases, 1425 Porter Street, Fort Detrick, Frederick, MD, 21702-5011, USA.
LA  - eng
PT  - Journal Article
PT  - Validation Study
DEP - 20171103
PL  - England
TA  - Virol J
JT  - Virology journal
JID - 101231645
RN  - 0 (DNA, Viral)
SB  - IM
MH  - Animals
MH  - DNA, Viral/blood/isolation & purification
MH  - *Genome, Viral
MH  - Macaca fascicularis/*blood
MH  - Monkeypox virus/genetics/*isolation & purification
MH  - Real-Time Polymerase Chain Reaction/*methods
MH  - Sensitivity and Specificity
MH  - United States
MH  - United States Food and Drug Administration
MH  - Viremia/blood
PMC - PMC5670720
EDAT- 2017/11/05 06:00
MHDA- 2018/07/10 06:00
CRDT- 2017/11/05 06:00
PHST- 2017/08/24 00:00 [received]
PHST- 2017/10/27 00:00 [accepted]
PHST- 2017/11/05 06:00 [entrez]
PHST- 2017/11/05 06:00 [pubmed]
PHST- 2018/07/10 06:00 [medline]
AID - 10.1186/s12985-017-0880-8 [doi]
AID - 10.1186/s12985-017-0880-8 [pii]
PST - epublish
SO  - Virol J. 2017 Nov 3;14(1):210. doi: 10.1186/s12985-017-0880-8.

PMID- 29029238
OWN - NLM
STAT- MEDLINE
DCOM- 20181217
LR  - 20181217
IS  - 1537-6613 (Electronic)
IS  - 0022-1899 (Linking)
VI  - 216
IP  - 7
DP  - 2017 Oct 17
TI  - Toward Understanding the Outcomes of Monkeypox Infection in Human Pregnancy.
PG  - 795-797
LID - 10.1093/infdis/jix342 [doi]
FAU - Kisalu, Neville K
AU  - Kisalu NK
AD  - Vaccine Research Center, National Institute of Allergy and Infectious Diseases,National Institutes of Health, Bethesda, Maryland.
FAU - Mokili, John L
AU  - Mokili JL
AD  - Donald P. Shiley BioScience Center.
AD  - Viral Information Institute.
AD  - Biology Department, San Diego State University, California.
LA  - eng
PT  - Journal Article
PT  - Comment
PL  - United States
TA  - J Infect Dis
JT  - The Journal of infectious diseases
JID - 0413675
SB  - IM
CON - J Infect Dis. 2017 Oct 17;216(7):824-828. PMID: 29029147
MH  - Animals
MH  - Congo
MH  - Democratic Republic of the Congo
MH  - Family
MH  - Female
MH  - *Fetus
MH  - Humans
MH  - *Monkeypox
MH  - Pregnancy
PMC - PMC6279131
OTO - NOTNLM
OT  - *Monkeypox virus
OT  - *mother-to-child transmission
OT  - *orthopoxvirus
OT  - *pregnancy
OT  - *vertical transmission
EDAT- 2017/10/14 06:00
MHDA- 2018/12/18 06:00
CRDT- 2017/10/14 06:00
PHST- 2017/07/17 00:00 [received]
PHST- 2017/07/18 00:00 [accepted]
PHST- 2017/10/14 06:00 [pubmed]
PHST- 2018/12/18 06:00 [medline]
PHST- 2017/10/14 06:00 [entrez]
AID - 4348690 [pii]
AID - 10.1093/infdis/jix342 [doi]
PST - ppublish
SO  - J Infect Dis. 2017 Oct 17;216(7):795-797. doi: 10.1093/infdis/jix342.

PMID- 29029147
OWN - NLM
STAT- MEDLINE
DCOM- 20171116
LR  - 20181215
IS  - 1537-6613 (Electronic)
IS  - 0022-1899 (Linking)
VI  - 216
IP  - 7
DP  - 2017 Oct 17
TI  - Maternal and Fetal Outcomes Among Pregnant Women With Human Monkeypox Infectionin the Democratic Republic of Congo.
PG  - 824-828
LID - 10.1093/infdis/jix260 [doi]
AB  - Human monkeypox is an endemic disease in rain-forested regions of centralDemocratic Republic of Congo. We report fetal outcomes for 1 of 4 pregnant women who participated in an observational study at the General Hospital of Kole(Sankuru Province), where 222 symptomatic subjects were followed between 2007 and2011. Of the 4 pregnant women, 1 gave birth to a healthy infant, 2 hadmiscarriages in the first trimester, and 1 had fetal death, with the maceratedstillborn showing diffuse cutaneous maculopapillary skin lesions involving thehead, trunk and extremities, including palms of hands and soles of feet.
CI  - (c) The Author 2017. Published by Oxford University Press for the InfectiousDiseases Society of America. All rights reserved. For permissions, e-mail:journals.permissions@oup.com.
FAU - Mbala, Placide K
AU  - Mbala PK
AD  - L'Institut National de Recherche Biomedicale.
AD  - Metabiota, Kinshasa.
FAU - Huggins, John W
AU  - Huggins JW
AD  - Divisions of Medicine, US Army Medical Institute of Infectious Diseases, FortDetrick, Maryland.
FAU - Riu-Rovira, Therese
AU  - Riu-Rovira T
AD  - L'Hopital General de Reference de Kole, Kole-sur-Lukenie, Democratic Republic of Congo.
FAU - Ahuka, Steve M
AU  - Ahuka SM
AD  - L'Institut National de Recherche Biomedicale.
FAU - Mulembakani, Prime
AU  - Mulembakani P
AD  - Metabiota, Kinshasa.
FAU - Rimoin, Anne W
AU  - Rimoin AW
AD  - Department of Epidemiology, Jonathan and Karin Fielding School of Public Health, University of California-Los Angeles.
FAU - Martin, James W
AU  - Martin JW
AD  - Regional Health Command-Atlantic, Ft Belvoir, Virginia.
FAU - Muyembe, Jean-Jacques T
AU  - Muyembe JT
AD  - L'Institut National de Recherche Biomedicale.
LA  - eng
PT  - Case Reports
PT  - Journal Article
PT  - Research Support, U.S. Gov't, Non-P.H.S.
PL  - United States
TA  - J Infect Dis
JT  - The Journal of infectious diseases
JID - 0413675
SB  - IM
CIN - J Infect Dis. 2017 Oct 17;216(7):795-797. PMID: 29029238
MH  - Abortion, Spontaneous/virology
MH  - Adult
MH  - Democratic Republic of the Congo/epidemiology
MH  - Female
MH  - Humans
MH  - Monkeypox/*epidemiology/*pathology
MH  - Monkeypox virus/*isolation & purification
MH  - Pregnancy
MH  - Pregnancy Complications, Infectious/*epidemiology/*virology
MH  - *Pregnancy Outcome
MH  - Viral Load
MH  - Young Adult
OTO - NOTNLM
OT  - *Democratic Republic of Congo
OT  - *Monkeypox
OT  - *abortion
OT  - *maternal-fetal infection
OT  - *orthopoxvirus
OT  - *pregnancy
EDAT- 2017/10/14 06:00
MHDA- 2017/11/29 06:00
CRDT- 2017/10/14 06:00
PHST- 2017/02/07 00:00 [received]
PHST- 2017/05/25 00:00 [accepted]
PHST- 2017/10/14 06:00 [pubmed]
PHST- 2017/11/29 06:00 [medline]
PHST- 2017/10/14 06:00 [entrez]
AID - 4348689 [pii]
AID - 10.1093/infdis/jix260 [doi]
PST - ppublish
SO  - J Infect Dis. 2017 Oct 17;216(7):824-828. doi: 10.1093/infdis/jix260.

PMID- 28972544
OWN - NLM
STAT- MEDLINE
DCOM- 20180524
LR  - 20181113
IS  - 1999-4915 (Electronic)
IS  - 1999-4915 (Linking)
VI  - 9
IP  - 10
DP  - 2017 Oct 3
TI  - Assessing Monkeypox Virus Prevalence in Small Mammals at the Human-AnimalInterface in the Democratic Republic of the Congo.
LID - E283 [pii]
LID - 10.3390/v9100283 [doi]
AB  - During 2012, 2013 and 2015, we collected small mammals within 25 km of the townof Boende in Tshuapa Province, the Democratic Republic of the Congo. Theprevalence of monkeypox virus (MPXV) in this area is unknown; however, cases ofhuman infection were previously confirmed near these collection sites. Sampleswere collected from 353 mammals (rodents, shrews, pangolins, elephant shrews, apotamogale, and a hyrax). Some rodents and shrews were captured from houses wherehuman monkeypox cases have recently been identified, but most were trapped inforests and agricultural areas near villages. Real-time PCR and ELISA were usedto assess evidence of MPXV infection and other Orthopoxvirus (OPXV) infections inthese small mammals. Seven (2.0%) of these animal samples were found to beanti-orthopoxvirus immunoglobulin G (IgG) antibody positive (six rodents: twoFunisciurus spp.; one Graphiurus lorraineus; one Cricetomys emini; oneHeliosciurus sp.; one Oenomys hypoxanthus, and one elephant shrew Petrodromustetradactylus); no individuals were found positive in PCR-based assays. Theseresults suggest that a variety of animals can be infected with OPXVs, and thatepidemiology studies and educational campaigns should focus on animals thatpeople are regularly contacting, including larger rodents used as proteinsources.
FAU - Doty, Jeffrey B
AU  - Doty JB
AD  - U.S. Centers for Disease Control and Prevention, Poxvirus and Rabies Branch, 1600Clifton Rd. NE, Atlanta, GA 30333, USA. jdoty@cdc.gov.
FAU - Malekani, Jean M
AU  - Malekani JM
AD  - University of Kinshasa, Department of Biology, P.O. Box 218 Kinshasa XI,Democratic Republic of the Congo. jean.malekani@unikin.ac.cd.
FAU - Kalemba, Lem's N
AU  - Kalemba LN
AD  - University of Kinshasa, Department of Biology, P.O. Box 218 Kinshasa XI,Democratic Republic of the Congo. lemskalemba@yahoo.com.
FAU - Stanley, William T
AU  - Stanley WT
AD  - Field Museum of Natural History, 1400 S. Lake Shore Dr., Chicago, IL 60605, USA. wstanley@fieldmuseum.org.
FAU - Monroe, Benjamin P
AU  - Monroe BP
AD  - U.S. Centers for Disease Control and Prevention, Poxvirus and Rabies Branch, 1600Clifton Rd. NE, Atlanta, GA 30333, USA. bmonroe@cdc.gov.
FAU - Nakazawa, Yoshinori U
AU  - Nakazawa YU
AD  - U.S. Centers for Disease Control and Prevention, Poxvirus and Rabies Branch, 1600Clifton Rd. NE, Atlanta, GA 30333, USA. ynakazawa@cdc.gov.
FAU - Mauldin, Matthew R
AU  - Mauldin MR
AUID- ORCID: 0000-0002-3807-2339
AD  - U.S. Centers for Disease Control and Prevention, Poxvirus and Rabies Branch, 1600Clifton Rd. NE, Atlanta, GA 30333, USA. mmauldin@cdc.gov.
FAU - Bakambana, Tresor L
AU  - Bakambana TL
AD  - University of Kinshasa, Department of Biology, P.O. Box 218 Kinshasa XI,Democratic Republic of the Congo. tresluemba@yahoo.fr.
FAU - Liyandja Dja Liyandja, Tobit
AU  - Liyandja Dja Liyandja T
AD  - University of Kinshasa, Department of Biology, P.O. Box 218 Kinshasa XI,Democratic Republic of the Congo. tobitliyandja@yahoo.fr.
FAU - Braden, Zachary H
AU  - Braden ZH
AD  - U.S. Centers for Disease Control and Prevention, Poxvirus and Rabies Branch, 1600Clifton Rd. NE, Atlanta, GA 30333, USA. zbraden@cdc.gov.
FAU - Wallace, Ryan M
AU  - Wallace RM
AD  - U.S. Centers for Disease Control and Prevention, Poxvirus and Rabies Branch, 1600Clifton Rd. NE, Atlanta, GA 30333, USA. euk5@cdc.gov.
FAU - Malekani, Divin V
AU  - Malekani DV
AD  - University of Kinshasa, Department of Biology, P.O. Box 218 Kinshasa XI,Democratic Republic of the Congo. divin.malekani@unikin.ac.cd.
FAU - McCollum, Andrea M
AU  - McCollum AM
AD  - U.S. Centers for Disease Control and Prevention, Poxvirus and Rabies Branch, 1600Clifton Rd. NE, Atlanta, GA 30333, USA. azv4@cdc.gov.
FAU - Gallardo-Romero, Nadia
AU  - Gallardo-Romero N
AD  - U.S. Centers for Disease Control and Prevention, Poxvirus and Rabies Branch, 1600Clifton Rd. NE, Atlanta, GA 30333, USA. hfa5@cdc.gov.
FAU - Kondas, Ashley
AU  - Kondas A
AD  - U.S. Centers for Disease Control and Prevention, Poxvirus and Rabies Branch, 1600Clifton Rd. NE, Atlanta, GA 30333, USA. akondas@cdc.gov.
FAU - Peterson, A Townsend
AU  - Peterson AT
AUID- ORCID: 0000-0003-0243-2379
AD  - Biodiversity Institute, University of Kansas, 1345 Jayhawk Blvd., Lawrence, KS66045, USA. town@ku.edu.
FAU - Osorio, Jorge E
AU  - Osorio JE
AD  - University of Wisconsin, School of Veterinary Medicine, 2015 Linden Dr., Madison,WI 53706, USA. osorio@svm.vetmed.wisc.edu.
FAU - Rocke, Tonie E
AU  - Rocke TE
AD  - U.S. Geological Survey, National Wildlife Health Center, 6006 Schroeder Rd.,Madison, WI 53711, USA. trocke@usgs.gov.
FAU - Karem, Kevin L
AU  - Karem KL
AD  - U.S. Centers for Disease Control and Prevention, Poxvirus and Rabies Branch, 1600Clifton Rd. NE, Atlanta, GA 30333, USA. kkarem@cdc.gov.
FAU - Emerson, Ginny L
AU  - Emerson GL
AD  - U.S. Centers for Disease Control and Prevention, Poxvirus and Rabies Branch, 1600Clifton Rd. NE, Atlanta, GA 30333, USA. gemerson@cdc.gov.
FAU - Carroll, Darin S
AU  - Carroll DS
AD  - U.S. Centers for Disease Control and Prevention, Poxvirus and Rabies Branch, 1600Clifton Rd. NE, Atlanta, GA 30333, USA. dcarroll@cdc.gov.
LA  - eng
GR  - U01 CK000539/CK/NCEZID CDC HHS/United States
PT  - Journal Article
DEP - 20171003
PL  - Switzerland
TA  - Viruses
JT  - Viruses
JID - 101509722
RN  - 0 (Antibodies, Viral)
RN  - 0 (Immunoglobulin G)
SB  - IM
MH  - Animals
MH  - Animals, Wild/*virology
MH  - Antibodies, Viral/blood
MH  - Democratic Republic of the Congo/epidemiology
MH  - Enzyme-Linked Immunosorbent Assay
MH  - Humans
MH  - Immunoglobulin G/blood
MH  - Mammals/virology
MH  - Monkeypox/epidemiology/transmission/*veterinary/virology
MH  - Monkeypox virus/genetics/immunology/*isolation & purification/pathogenicity
MH  - Poxviridae Infections/epidemiology/immunology/veterinary/virology
MH  - Prevalence
MH  - Real-Time Polymerase Chain Reaction
MH  - Risk Factors
MH  - Sciuridae/virology
MH  - Shrews/virology
PMC - PMC5691634
OTO - NOTNLM
OT  - *habitat analysis
OT  - *human-animal interface
OT  - *monkeypox
OT  - *orthopoxviruses
OT  - *serology
OT  - *small mammals
OT  - *wildlife
COIS- The authors declare no conflict of interest. This research was supported by theNational Institutes of Health grant 1R01TW008859-01 ("Sylvatic Reservoirs ofHuman Monkeypox"). Use of trade, firm, or product names is for descriptivepurposes only and does not imply endorsement by the United States Government. Thefindings and conclusions in this report are those of the authors and do notnecessarily represent the views of the Centers for Disease Control andPrevention. The funders had no role in study design, data collection andanalysis, decision to publish, or preparation of the manuscript.
EDAT- 2017/10/04 06:00
MHDA- 2018/05/25 06:00
CRDT- 2017/10/04 06:00
PHST- 2017/08/07 00:00 [received]
PHST- 2017/09/15 00:00 [revised]
PHST- 2017/09/19 00:00 [accepted]
PHST- 2017/10/04 06:00 [entrez]
PHST- 2017/10/04 06:00 [pubmed]
PHST- 2018/05/25 06:00 [medline]
AID - v9100283 [pii]
AID - 10.3390/v9100283 [doi]
PST - epublish
SO  - Viruses. 2017 Oct 3;9(10). pii: v9100283. doi: 10.3390/v9100283.

PMID- 28894977
OWN - NLM
STAT- MEDLINE
DCOM- 20180619
LR  - 20220728
IS  - 1612-9210 (Electronic)
IS  - 1612-9202 (Linking)
VI  - 14
IP  - 3
DP  - 2017 Sep
TI  - Varicella Coinfection in Patients with Active Monkeypox in the DemocraticRepublic of the Congo.
PG  - 564-574
LID - 10.1007/s10393-017-1266-5 [doi]
AB  - From 2006 to 2007, an active surveillance program for human monkeypox (MPX) inthe Democratic Republic of the Congo identified 151 cases of coinfection withmonkeypox virus and varicella zoster virus from 1158 suspected cases of human MPX(13%). Using clinical and socio-demographic data collected with standardizedinstruments by trained, local nurse supervisors, we examined a variety ofhypotheses to explain the unexpectedly high proportion of coinfections among the sample, including the hypothesis that the two viruses occur independently. Theprobabilities of disease incidence and selection necessary to yield the observed sample proportion of coinfections under an assumption of independence areplausible given what is known and assumed about human MPX incidence. Cases ofhuman MPX are expected to be underreported, and more coinfections are expectedwith improved surveillance.
FAU - Hoff, Nicole A
AU  - Hoff NA
AD  - UCLA Fielding School of Public Health, 41-275 CHS, 650 Charles E. Young Dr.South, Los Angeles, CA, 90095, USA. nhoff84@ucla.edu.
FAU - Morier, Douglas S
AU  - Morier DS
AD  - UCLA Fielding School of Public Health, 41-275 CHS, 650 Charles E. Young Dr.South, Los Angeles, CA, 90095, USA.
FAU - Kisalu, Neville K
AU  - Kisalu NK
AD  - National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
FAU - Johnston, Sara C
AU  - Johnston SC
AD  - Vaccine Research Center, National Institute of Allergy and Infectious Diseases,Bethesda, MD, USA.
AD  - United States Army Medical Research Institute of Infectious Diseases, FortDetrick, Frederick, MD, USA.
FAU - Doshi, Reena H
AU  - Doshi RH
AD  - UCLA Fielding School of Public Health, 41-275 CHS, 650 Charles E. Young Dr.South, Los Angeles, CA, 90095, USA.
FAU - Hensley, Lisa E
AU  - Hensley LE
AD  - National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
FAU - Okitolonda-Wemakoy, Emile
AU  - Okitolonda-Wemakoy E
AD  - Kinshasa School of Public Health, Kinshasa, Democratic Republic of the Congo.
FAU - Muyembe-Tamfum, Jean Jacques
AU  - Muyembe-Tamfum JJ
AD  - Institut National de Recherche Biomedicale, Kinshasa, Democratic Republic of the Congo.
FAU - Lloyd-Smith, James O
AU  - Lloyd-Smith JO
AD  - UCLA Fielding School of Public Health, 41-275 CHS, 650 Charles E. Young Dr.South, Los Angeles, CA, 90095, USA.
FAU - Rimoin, Anne W
AU  - Rimoin AW
AD  - UCLA Fielding School of Public Health, 41-275 CHS, 650 Charles E. Young Dr.South, Los Angeles, CA, 90095, USA. arimoin@g.ucla.edu.
LA  - eng
PT  - Journal Article
DEP - 20170911
PL  - United States
TA  - Ecohealth
JT  - EcoHealth
JID - 101222144
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Animals
MH  - Chickenpox/*epidemiology
MH  - Child
MH  - Child, Preschool
MH  - Coinfection
MH  - Democratic Republic of the Congo/epidemiology
MH  - *Epidemiological Monitoring
MH  - Female
MH  - Herpesvirus 3, Human/*isolation & purification
MH  - Humans
MH  - Incidence
MH  - Infant
MH  - Infant, Newborn
MH  - Male
MH  - Middle Aged
MH  - Monkeypox/*epidemiology
MH  - Monkeypox virus/*isolation & purification
MH  - Prevalence
MH  - Young Adult
OTO - NOTNLM
OT  - *Emerging infectious disease
OT  - *Monkeypox
OT  - *Selection bias
OT  - *Surveillance
OT  - *Varicella zoster virus
EDAT- 2017/09/13 06:00
MHDA- 2018/06/21 06:00
CRDT- 2017/09/13 06:00
PHST- 2016/09/23 00:00 [received]
PHST- 2017/06/30 00:00 [accepted]
PHST- 2017/06/26 00:00 [revised]
PHST- 2017/09/13 06:00 [pubmed]
PHST- 2018/06/21 06:00 [medline]
PHST- 2017/09/13 06:00 [entrez]
AID - 10.1007/s10393-017-1266-5 [doi]
AID - 10.1007/s10393-017-1266-5 [pii]
PST - ppublish
SO  - Ecohealth. 2017 Sep;14(3):564-574. doi: 10.1007/s10393-017-1266-5. Epub 2017 Sep 11.

PMID- 28892474
OWN - NLM
STAT- MEDLINE
DCOM- 20170915
LR  - 20191210
IS  - 1935-2735 (Electronic)
IS  - 1935-2727 (Linking)
VI  - 11
IP  - 9
DP  - 2017 Sep
TI  - Enhancing case definitions for surveillance of human monkeypox in the Democratic Republic of Congo.
PG  - e0005857
LID - 10.1371/journal.pntd.0005857 [doi]
AB  - BACKGROUND: Human monkeypox (MPX) occurs at appreciable rates in the DemocraticRepublic of Congo (DRC). Infection with varicella zoster virus (VZV) has asimilar presentation to that of MPX, and in areas where MPX is endemic these two illnesses are commonly mistaken. This study evaluated the diagnostic utility oftwo surveillance case definitions for MPX and specific clinical characteristicsassociated with laboratory-confirmed MPX cases. METHODOLOGY/PRINCIPAL FINDINGS:Data from a cohort of suspect MPX cases (identified by surveillance over thecourse of a 42 month period during 2009-2014) from DRC were used; real-time PCRdiagnostic test results were used to establish MPX and VZV diagnoses. A total of 333 laboratory-confirmed MPX cases, 383 laboratory-confirmed VZV cases, and 36cases that were determined to not be either MPX or VZV were included in theanalyses. Significant (p<0.05) differences between laboratory-confirmed MPX andVZV cases were noted for several signs/symptoms including key rashcharacteristics. Both surveillance case definitions had high sensitivity and low specificities for individuals that had suspected MPX virus infections. Using 12signs/symptoms with high sensitivity and/or specificity values, a receiveroperator characteristic analysis showed that models for MPX cases that had thepresence of 'fever before rash' plus at least 7 or 8 of the 12 signs/symptomsdemonstrated a more balanced performance between sensitivity and specificity.CONCLUSIONS: Laboratory-confirmed MPX and VZV cases presented with many of thesame signs and symptoms, and the analysis here emphasized the utility ofincluding 12 specific signs/symptoms when investigating MPX cases. In order todocument and detect endemic human MPX cases, a surveillance case definition with more specificity is needed for accurate case detection. In the absence of a more specific case definition, continued emphasis on confirmatory laboratory-baseddiagnostics is warranted.
FAU - Osadebe, Lynda
AU  - Osadebe L
AD  - Epidemic Intelligence Service, Scientific Education and Professional Development Program Office, U.S. Centers for Disease Control and Prevention, Atlanta,Georgia, United States of America.
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,National Center for Emerging and Zoonotic Infectious Diseases, U.S. Centers forDisease Control and Prevention, Atlanta, Georgia, United States of America.
FAU - Hughes, Christine M
AU  - Hughes CM
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,National Center for Emerging and Zoonotic Infectious Diseases, U.S. Centers forDisease Control and Prevention, Atlanta, Georgia, United States of America.
FAU - Shongo Lushima, Robert
AU  - Shongo Lushima R
AD  - Ministry of Health, Kinshasa, Democratic Republic of Congo.
FAU - Kabamba, Joelle
AU  - Kabamba J
AD  - U.S. Centers for Disease Control and Prevention, Kinshasa, Democratic Republic ofCongo.
FAU - Nguete, Beatrice
AU  - Nguete B
AD  - Kinshasa School of Public Health, Kinshasa, Democratic Republic of Congo.
FAU - Malekani, Jean
AU  - Malekani J
AD  - University of Kinshasa, Kinshasa, Democratic Republic of Congo.
FAU - Pukuta, Elisabeth
AU  - Pukuta E
AD  - Institut National de Recherche Biomedicale, Kinshasa, Democratic Republic ofCongo.
FAU - Karhemere, Stomy
AU  - Karhemere S
AD  - Institut National de Recherche Biomedicale, Kinshasa, Democratic Republic ofCongo.
FAU - Muyembe Tamfum, Jean-Jacques
AU  - Muyembe Tamfum JJ
AD  - Institut National de Recherche Biomedicale, Kinshasa, Democratic Republic ofCongo.
FAU - Wemakoy Okitolonda, Emile
AU  - Wemakoy Okitolonda E
AD  - Kinshasa School of Public Health, Kinshasa, Democratic Republic of Congo.
FAU - Reynolds, Mary G
AU  - Reynolds MG
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,National Center for Emerging and Zoonotic Infectious Diseases, U.S. Centers forDisease Control and Prevention, Atlanta, Georgia, United States of America.
FAU - McCollum, Andrea M
AU  - McCollum AM
AUID- ORCID: http://orcid.org/0000-0002-9136-818X
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,National Center for Emerging and Zoonotic Infectious Diseases, U.S. Centers forDisease Control and Prevention, Atlanta, Georgia, United States of America.
LA  - eng
GR  - U01 CK000539/CK/NCEZID CDC HHS/United States
PT  - Evaluation Study
PT  - Journal Article
DEP - 20170911
PL  - United States
TA  - PLoS Negl Trop Dis
JT  - PLoS neglected tropical diseases
JID - 101291488
SB  - IM
MH  - *Decision Support Techniques
MH  - Democratic Republic of the Congo/epidemiology
MH  - *Epidemiological Monitoring
MH  - Humans
MH  - Monkeypox/*diagnosis/*epidemiology/pathology
MH  - Sensitivity and Specificity
PMC - PMC5593177
EDAT- 2017/09/12 06:00
MHDA- 2017/09/16 06:00
CRDT- 2017/09/12 06:00
PHST- 2017/04/15 00:00 [received]
PHST- 2017/08/05 00:00 [accepted]
PHST- 2017/09/12 06:00 [entrez]
PHST- 2017/09/12 06:00 [pubmed]
PHST- 2017/09/16 06:00 [medline]
AID - 10.1371/journal.pntd.0005857 [doi]
AID - PNTD-D-17-00482 [pii]
PST - epublish
SO  - PLoS Negl Trop Dis. 2017 Sep 11;11(9):e0005857. doi:10.1371/journal.pntd.0005857. eCollection 2017 Sep.

PMID- 28827792
OWN - NLM
STAT- MEDLINE
DCOM- 20170907
LR  - 20201214
IS  - 1935-2735 (Electronic)
IS  - 1935-2727 (Linking)
VI  - 11
IP  - 8
DP  - 2017 Aug
TI  - Characterization of Monkeypox virus infection in African rope squirrels(Funisciurus sp.).
PG  - e0005809
LID - 10.1371/journal.pntd.0005809 [doi]
AB  - Monkeypox (MPX) is a zoonotic disease endemic in Central and West Africa and iscaused by Monkeypox virus (MPXV), the most virulent Orthopoxvirus affectinghumans since the eradication of Variola virus (VARV). Many aspects of the MPXVtransmission cycle, including the natural host of the virus, remain unknown.African rope squirrels (Funisciurus spp.) are considered potential reservoirs of MPXV, as serosurveillance data in Central Africa has confirmed the circulation ofthe virus in these rodent species [1,2]. In order to understand the tissuetropism and clinical signs associated with infection with MPXV in these species, wild-caught rope squirrels were experimentally infected via intranasal andintradermal exposure with a recombinant MPXV strain from Central Africaengineered to express the luciferase gene. After infection, we monitored viralreplication and shedding via in vivo bioluminescent imaging, viral culture andreal time PCR. MPXV infection in African rope squirrels caused mortality andmoderate to severe morbidity, with clinical signs including pox lesions in theskin, eyes, mouth and nose, dyspnea, and profuse nasal discharge. Both intranasaland intradermal exposures induced high levels of viremia, fast systemic spread,and long periods of viral shedding. Shedding and luminescence peaked at day 6post infection and was still detectable after 15 days. Interestingly, onesentinel animal, housed in the same room but in a separate cage, also developedsevere MPX disease and was euthanized. This study indicates that MPXV causessignificant pathology in African rope squirrels and infected rope squirrels shed large quantities of virus, supporting their role as a potential source of MPXVtransmission to humans and other animals in endemic MPX regions.
FAU - Falendysz, Elizabeth A
AU  - Falendysz EA
AUID- ORCID: http://orcid.org/0000-0003-2895-8918
AD  - US Geological Survey, National Wildlife Health Center, Madison, Wisconsin, UnitedStates of America.
FAU - Lopera, Juan G
AU  - Lopera JG
AD  - Department of Pathobiological Sciences, School of Veterinary Medicine, Universityof Wisconsin, Madison, Wisconsin, United States of America.
FAU - Doty, Jeffrey B
AU  - Doty JB
AD  - Centers for Disease Control and Prevention, Atlanta, Georgia, United States ofAmerica.
FAU - Nakazawa, Yoshinori
AU  - Nakazawa Y
AD  - Centers for Disease Control and Prevention, Atlanta, Georgia, United States ofAmerica.
FAU - Crill, Colleen
AU  - Crill C
AD  - US Geological Survey, National Wildlife Health Center, Madison, Wisconsin, UnitedStates of America.
FAU - Lorenzsonn, Faye
AU  - Lorenzsonn F
AD  - US Geological Survey, National Wildlife Health Center, Madison, Wisconsin, UnitedStates of America.
FAU - Kalemba, Lem's N
AU  - Kalemba LN
AD  - University of Kinshasa, Kinshasa, Democratic Republic of Congo.
FAU - Ronderos, Monica D
AU  - Ronderos MD
AD  - Department of Pathobiological Sciences, School of Veterinary Medicine, Universityof Wisconsin, Madison, Wisconsin, United States of America.
FAU - Mejia, Andres
AU  - Mejia A
AD  - Animal Services (Pathology), Wisconsin National Primate Research Center,University of Wisconsin, Madison, Wisconsin, United States of America.
FAU - Malekani, Jean M
AU  - Malekani JM
AD  - University of Kinshasa, Kinshasa, Democratic Republic of Congo.
FAU - Karem, Kevin
AU  - Karem K
AD  - Centers for Disease Control and Prevention, Atlanta, Georgia, United States ofAmerica.
FAU - Carroll, Darin S
AU  - Carroll DS
AD  - Centers for Disease Control and Prevention, Atlanta, Georgia, United States ofAmerica.
FAU - Osorio, Jorge E
AU  - Osorio JE
AD  - Department of Pathobiological Sciences, School of Veterinary Medicine, Universityof Wisconsin, Madison, Wisconsin, United States of America.
FAU - Rocke, Tonie E
AU  - Rocke TE
AD  - US Geological Survey, National Wildlife Health Center, Madison, Wisconsin, UnitedStates of America.
LA  - eng
GR  - R01 TW008859/TW/FIC NIH HHS/United States
PT  - Journal Article
DEP - 20170821
PL  - United States
TA  - PLoS Negl Trop Dis
JT  - PLoS neglected tropical diseases
JID - 101291488
RN  - 0 (Antibodies, Viral)
RN  - 0 (DNA, Viral)
SB  - IM
MH  - Africa, Central
MH  - Africa, Western
MH  - Animals
MH  - Antibodies, Viral/blood
MH  - DNA, Viral/blood
MH  - Humans
MH  - Monkeypox/*veterinary
MH  - Monkeypox virus/*physiology
MH  - Sciuridae/immunology/*virology
MH  - Virus Replication
MH  - Virus Shedding
PMC - PMC5578676
EDAT- 2017/08/23 06:00
MHDA- 2017/09/08 06:00
CRDT- 2017/08/23 06:00
PHST- 2017/03/02 00:00 [received]
PHST- 2017/07/17 00:00 [accepted]
PHST- 2017/08/31 00:00 [revised]
PHST- 2017/08/23 06:00 [pubmed]
PHST- 2017/09/08 06:00 [medline]
PHST- 2017/08/23 06:00 [entrez]
AID - 10.1371/journal.pntd.0005809 [doi]
AID - PNTD-D-17-00305 [pii]
PST - epublish
SO  - PLoS Negl Trop Dis. 2017 Aug 21;11(8):e0005809. doi:10.1371/journal.pntd.0005809. eCollection 2017 Aug.

PMID- 28814515
OWN - NLM
STAT- MEDLINE
DCOM- 20171109
LR  - 20201119
IS  - 1098-5514 (Electronic)
IS  - 0022-538X (Linking)
VI  - 91
IP  - 21
DP  - 2017 Nov 1
TI  - [(18)F]-Fluorodeoxyglucose Uptake in Lymphoid Tissue Serves as a Predictor ofDisease Outcome in the Nonhuman Primate Model of Monkeypox Virus Infection.
LID - e00897-17 [pii]
LID - 10.1128/JVI.00897-17 [doi]
AB  - Real-time bioimaging of infectious disease processes may aid countermeasuredevelopment and lead to an improved understanding of pathogenesis. However, fewstudies have identified biomarkers for monitoring infections using in vivoimaging. Previously, we demonstrated that positron emission tomography/computedtomography (PET/CT) imaging with [(18)F]-fluorodeoxyglucose (FDG) can monitormonkeypox disease progression in vivo in nonhuman primates (NHPs). In this study,we investigated [(18)F]-FDG-PET/CT imaging of immune processes in lymphoidtissues to identify patterns of inflammation in the monkepox NHP model and todetermine the value of [(18)F]-FDG-PET/CT as a biomarker for disease andtreatment outcomes. Quantitative analysis of [(18)F]-FDG-PET/CT images revealeddifferences between moribund and surviving animals at two sites vital to theimmune response to viral infections, bone marrow and lymph nodes (LNs). Moribund NHPs demonstrated increased [(18)F]-FDG uptake in bone marrow 4 dayspostinfection compared to surviving NHPs. In surviving, treated NHPs, increase inLN volume correlated with [(18)F]-FDG uptake and peaked 10 days postinfection,while minimal lymphadenopathy and higher glycolytic activity were observed inmoribund NHPs early in infection. Imaging data were supported by standardvirology, pathology, and immunology findings. Even with the limited number ofsubjects, imaging was able to differentiate the difference between diseaseoutcomes, warranting additional studies to demonstrate whether [(18)F]-FDG-PET/CTcan identify other, subtler effects. Visualizing altered metabolic activity atsites involved in the immune response by [(18)F]-FDG-PET/CT imaging is a powerfultool for identifying key disease-specific time points and locations that are mostrelevant for pathogenesis and treatment.IMPORTANCE Positron emission tomographyand computed tomography (PET/CT) imaging is a universal tool in oncology andneuroscience. The application of this technology to infectious diseases is farless developed. We used PET/CT imaging with [(18)F]-labeled fluorodeoxyglucose([(18)F]-FDG) in monkeys after monkeypox virus exposure to monitor the immuneresponse in lymphoid tissues. In lymph nodes of surviving monkeys, changes in[(18)F]-FDG uptake positively correlated with enlargement of the lymph nodes and peaked on day 10 postinfection. In contrast, the bone marrow and lymph nodes ofnonsurvivors showed increased [(18)F]-FDG uptake by day 4 postinfection withminimal lymph node enlargement, indicating that elevated cell metabolic activity early after infection is predictive of disease outcome. [(18)F]-FDG-PET/CTimaging can provide real-time snapshots of metabolic activity changes in responseto viral infections and identify key time points and locations most relevant for monitoring the development of pathogenesis and for potential treatment to beeffective.
CI  - Copyright (c) 2017 American Society for Microbiology.
FAU - Dyall, Julie
AU  - Dyall J
AD  - Integrated Research Facility, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, Frederick, Maryland, USAdyallj@niaid.nih.gov.
FAU - Johnson, Reed F
AU  - Johnson RF
AD  - Emerging Viral Pathogens Section, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, Frederick, Maryland, USA.
FAU - Chefer, Svetlana
AU  - Chefer S
AD  - Integrated Research Facility, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, Frederick, Maryland, USA.
FAU - Leyson, Christopher
AU  - Leyson C
AD  - Integrated Research Facility, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, Frederick, Maryland, USA.
FAU - Thomasson, David
AU  - Thomasson D
AD  - Integrated Research Facility, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, Frederick, Maryland, USA.
FAU - Seidel, Jurgen
AU  - Seidel J
AD  - Integrated Research Facility, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, Frederick, Maryland, USA.
FAU - Ragland, Dan R
AU  - Ragland DR
AD  - Integrated Research Facility, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, Frederick, Maryland, USA.
FAU - Byrum, Russell
AU  - Byrum R
AD  - Integrated Research Facility, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, Frederick, Maryland, USA.
FAU - Jett, Catherine
AU  - Jett C
AD  - Integrated Research Facility, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, Frederick, Maryland, USA.
FAU - Cann, Jennifer A
AU  - Cann JA
AD  - Integrated Research Facility, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, Frederick, Maryland, USA.
FAU - St Claire, Marisa
AU  - St Claire M
AD  - Integrated Research Facility, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, Frederick, Maryland, USA.
FAU - Jagoda, Elaine
AU  - Jagoda E
AD  - Molecular Imaging Program, National Cancer Institute, National Institutes ofHealth, Bethesda, Maryland, USA.
FAU - Reba, Richard C
AU  - Reba RC
AD  - Integrated Research Facility, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, Frederick, Maryland, USA.
AD  - Center for Infectious Disease Imaging, Radiology and Imaging Sciences, ClinicalCenter, National Institutes of Health, Bethesda, Maryland, USA.
FAU - Hammoud, Dima
AU  - Hammoud D
AD  - Integrated Research Facility, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, Frederick, Maryland, USA.
AD  - Center for Infectious Disease Imaging, Radiology and Imaging Sciences, ClinicalCenter, National Institutes of Health, Bethesda, Maryland, USA.
FAU - Blaney, Joseph E
AU  - Blaney JE
AD  - Emerging Viral Pathogens Section, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, Frederick, Maryland, USA.
AD  - Molecular Imaging Program, National Cancer Institute, National Institutes ofHealth, Bethesda, Maryland, USA.
FAU - Jahrling, Peter B
AU  - Jahrling PB
AD  - Integrated Research Facility, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, Frederick, Maryland, USA.
AD  - Emerging Viral Pathogens Section, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, Frederick, Maryland, USA.
LA  - eng
GR  - HHSN272200700016I/AI/NIAID NIH HHS/United States
PT  - Journal Article
DEP - 20171013
PL  - United States
TA  - J Virol
JT  - Journal of virology
JID - 0113724
RN  - 0 (Antiviral Agents)
RN  - 0 (Organophosphonates)
RN  - 0 (Radiopharmaceuticals)
RN  - 0Z5B2CJX4D (Fluorodeoxyglucose F18)
RN  - 8J337D1HZY (Cytosine)
RN  - JIL713Q00N (Cidofovir)
SB  - IM
MH  - Animals
MH  - Antiviral Agents/pharmacology
MH  - Bone Marrow/diagnostic imaging/drug effects/pathology
MH  - Cidofovir
MH  - Cytosine/*analogs & derivatives/pharmacology
MH  - Fluorodeoxyglucose F18/*metabolism
MH  - Lymphadenopathy/diagnostic imaging/*pathology
MH  - Lymphoid Tissue/diagnostic imaging/drug effects/*pathology
MH  - Macaca mulatta/virology
MH  - Male
MH  - Monkeypox/diagnostic imaging/drug therapy/*pathology/virology
MH  - Monkeypox virus/*pathogenicity
MH  - Organophosphonates/*pharmacology
MH  - Positron Emission Tomography Computed Tomography/*methods
MH  - Prognosis
MH  - Radiopharmaceuticals/metabolism
MH  - Survival Rate
PMC - PMC5640857
OTO - NOTNLM
OT  - *PET/CT
OT  - *cidofovir
OT  - *imaging
OT  - *monkeypox virus
OT  - *nonhuman primate
OT  - *orthopoxvirus
OT  - *virus
EDAT- 2017/08/18 06:00
MHDA- 2017/11/10 06:00
CRDT- 2017/08/18 06:00
PHST- 2017/05/31 00:00 [received]
PHST- 2017/07/14 00:00 [accepted]
PHST- 2017/08/18 06:00 [pubmed]
PHST- 2017/11/10 06:00 [medline]
PHST- 2017/08/18 06:00 [entrez]
AID - JVI.00897-17 [pii]
AID - 10.1128/JVI.00897-17 [doi]
PST - epublish
SO  - J Virol. 2017 Oct 13;91(21). pii: JVI.00897-17. doi: 10.1128/JVI.00897-17. Print 2017 Nov 1.

PMID- 28763036
OWN - NLM
STAT- MEDLINE
DCOM- 20180403
LR  - 20181113
IS  - 1999-4915 (Electronic)
IS  - 1999-4915 (Linking)
VI  - 9
IP  - 8
DP  - 2017 Aug 1
TI  - Evaluation of Taterapox Virus in Small Animals.
LID - E203 [pii]
LID - 10.3390/v9080203 [doi]
AB  - Taterapox virus (TATV), which was isolated from an African gerbil (Tatera kempi) in 1975, is the most closely related virus to variola; however, only the originalreport has examined its virology. We have evaluated the tropism of TATV in vivoin small animals. We found that TATV does not infect Graphiurus kelleni, aspecies of African dormouse, but does induce seroconversion in the Mongoliangerbil (Meriones unguiculatus) and in mice; however, in wild-type mice andgerbils, the virus produces an unapparent infection. Following intranasal andfootpad inoculations with 1 x 10(6) plaque forming units (PFU) of TATV,immunocompromised stat1(-/-) mice showed signs of disease but did not die;however, SCID mice were susceptible to intranasal and footpad infections with100% mortality observed by Day 35 and Day 54, respectively. We show that death isunlikely to be a result of the virus mutating to have increased virulence andthat SCID mice are capable of transmitting TATV to C57BL/6 and C57BL/6 stat1(-/-)animals; however, transmission did not occur from TATV inoculated wild-type orstat1(-/-) mice. Comparisons with ectromelia (the etiological agent of mousepox) suggest that TATV behaves differently both at the site of inoculation and in the immune response that it triggers.
FAU - Parker, Scott
AU  - Parker S
AD  - Department of Molecular Microbiology and Immunology, Saint Louis UniversitySchool of Medicine, 1100 South Grand Boulevard, St. Louis, MO 63104, USA.scott9379@gmail.com.
FAU - Crump, Ryan
AU  - Crump R
AD  - Department of Molecular Microbiology and Immunology, Saint Louis UniversitySchool of Medicine, 1100 South Grand Boulevard, St. Louis, MO 63104, USA.rcrump1313@gmail.com.
FAU - Hartzler, Hollyce
AU  - Hartzler H
AD  - Department of Molecular Microbiology and Immunology, Saint Louis UniversitySchool of Medicine, 1100 South Grand Boulevard, St. Louis, MO 63104, USA.hollyce@gmail.com.
FAU - Buller, R Mark
AU  - Buller RM
AD  - Department of Molecular Microbiology and Immunology, Saint Louis UniversitySchool of Medicine, 1100 South Grand Boulevard, St. Louis, MO 63104, USA.mark.buller@gmail.com.
LA  - eng
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20170801
PL  - Switzerland
TA  - Viruses
JT  - Viruses
JID - 101509722
RN  - 0 (Antiviral Agents)
RN  - 0 (STAT1 Transcription Factor)
RN  - 0 (Stat1 protein, mouse)
SB  - IM
MH  - Animals
MH  - Antiviral Agents/therapeutic use
MH  - Disease Models, Animal
MH  - Ectromelia virus/genetics/physiology
MH  - Ectromelia, Infectious/virology
MH  - Host Specificity
MH  - Mice
MH  - Mice, Inbred C57BL
MH  - Mice, SCID
MH  - Orthopoxvirus/genetics/immunology/isolation & purification/*physiology
MH  - Poxviridae Infections/drug therapy/immunology/transmission/*virology
MH  - STAT1 Transcription Factor/deficiency/genetics
MH  - *Viral Tropism
PMC - PMC5580460
OTO - NOTNLM
OT  - *SCID
OT  - *footpad
OT  - *intranasal
OT  - *monkeypox
OT  - *orthopoxvirus
OT  - *smallpox
OT  - *taterapox
OT  - *variola
COIS- The authors declare no conflict of interest.
EDAT- 2017/08/02 06:00
MHDA- 2018/04/04 06:00
CRDT- 2017/08/02 06:00
PHST- 2017/07/08 00:00 [received]
PHST- 2017/07/20 00:00 [revised]
PHST- 2017/07/24 00:00 [accepted]
PHST- 2017/08/02 06:00 [entrez]
PHST- 2017/08/02 06:00 [pubmed]
PHST- 2018/04/04 06:00 [medline]
AID - v9080203 [pii]
AID - 10.3390/v9080203 [doi]
PST - epublish
SO  - Viruses. 2017 Aug 1;9(8). pii: v9080203. doi: 10.3390/v9080203.

PMID- 28747505
OWN - NLM
STAT- MEDLINE
DCOM- 20170926
LR  - 20191210
IS  - 1098-5514 (Electronic)
IS  - 0022-538X (Linking)
VI  - 91
IP  - 19
DP  - 2017 Oct 1
TI  - Insufficient Innate Immunity Contributes to the Susceptibility of the Castaneous Mouse to Orthopoxvirus Infection.
LID - e01042-17 [pii]
LID - 10.1128/JVI.01042-17 [doi]
AB  - The castaneous (CAST) mouse, a wild-derived inbred strain, is highly susceptible to orthopoxvirus infection by intranasal and systemic routes. The 50% lethalintraperitoneal dose of vaccinia virus (VACV) was 3 PFU for CAST mice, whereasBALB/c mice survived 10(6) PFU. At all times and in all organs analyzed, virustiters were higher in CAST than in BALB/c mice. In individual CAST mice,luciferase-expressing VACV was seen to replicate rapidly leading to death,whereas virus levels increased for a few days and then declined in BALB/c mice.Increases in gamma interferon (IFN-gamma) and tumor necrosis factor alpha(TNF-alpha) were delayed and low in CAST mice compared to BALB/c mice followingVACV infection or poly(I-C) inoculation, consistent with differences in innateimmune responses. In addition, naive CAST mice had considerably lower numbers of NK and T cells than BALB/c mice. The percentage of IFN-gamma-producing CD4(+) andCD8(+) T cells increased following infection of CAST mice only after considerablevirus spread, and the absolute cell numbers remained low. Administration ofexogenous IFN-gamma or -alpha to CAST mice before or during the first days ofinfection suppressed virus replication and prolonged survival, allowing the mice to make adaptive CD4(+) and CD8(+) T cell responses that were necessary to clear the virus after cessation of interferon treatment. Thus, insufficient innatecytokine and cellular immune responses contribute to the unique susceptibility ofCAST mice to VACV, whereas the adaptive immune response can be protective only ifvirus replication is suppressed during the first several days ofinfection.IMPORTANCE Most inbred mouse strains are relatively resistant toorthopoxviruses. The castaneous (CAST) mouse is a notable exception, exhibitingextreme vulnerability to monkeypox virus, cowpox virus, and vaccinia virus andthus providing a unique model for studying pathogenicity, immunity, vaccines, andantiviral drugs. To fully utilize the CAST mouse for such purposes, it isnecessary to understand the basis for virus susceptibility. We showed that naive CAST mice make low IFN-gamma and TNF-alpha responses and have low levels of NKcells and CD4(+) and CD8(+) T cells compared to a resistant classical inbredmouse strain. Attenuating virus replication with one or more doses of exogenousIFN-alpha or -gamma before or during the first few days of infection enabled the development of adaptive cellular immunity and clearance of virus. Further geneticstudies may reveal the basis for the low innate immunity.
CI  - Copyright (c) 2017 American Society for Microbiology.
FAU - Earl, Patricia L
AU  - Earl PL
AD  - Laboratory of Viral Diseases, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, Bethesda, Maryland, USA.
FAU - Americo, Jeffrey L
AU  - Americo JL
AD  - Laboratory of Viral Diseases, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, Bethesda, Maryland, USA.
FAU - Moss, Bernard
AU  - Moss B
AUID- ORCID: http://orcid.org/0000-0002-2154-8564
AD  - Laboratory of Viral Diseases, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, Bethesda, Maryland, USA bmoss@nih.gov.
LA  - eng
PT  - Journal Article
DEP - 20170912
PL  - United States
TA  - J Virol
JT  - Journal of virology
JID - 0113724
RN  - 0 (Tumor Necrosis Factor-alpha)
RN  - 82115-62-6 (Interferon-gamma)
SB  - IM
MH  - Animals
MH  - CD4-Positive T-Lymphocytes/immunology
MH  - CD8-Positive T-Lymphocytes/immunology
MH  - Cell Line
MH  - Chlorocebus aethiops
MH  - Female
MH  - Immunity, Innate/*immunology
MH  - Interferon-gamma/*metabolism/therapeutic use
MH  - Killer Cells, Natural/*immunology
MH  - Lymphocyte Count
MH  - Mice
MH  - Mice, Inbred BALB C
MH  - Poxviridae Infections/*immunology/virology
MH  - Tumor Necrosis Factor-alpha/*metabolism/therapeutic use
MH  - Vaccinia virus/*immunology
MH  - Virus Replication/immunology
PMC - PMC5599762
OTO - NOTNLM
OT  - *NK cells
OT  - *T cells
OT  - *adaptive immunity
OT  - *immune deficiency
OT  - *innate immunity
OT  - *interferons
OT  - *poxvirus
OT  - *vaccinia virus
EDAT- 2017/07/28 06:00
MHDA- 2017/09/28 06:00
CRDT- 2017/07/28 06:00
PHST- 2017/06/21 00:00 [received]
PHST- 2017/07/19 00:00 [accepted]
PHST- 2017/07/28 06:00 [pubmed]
PHST- 2017/09/28 06:00 [medline]
PHST- 2017/07/28 06:00 [entrez]
AID - JVI.01042-17 [pii]
AID - 10.1128/JVI.01042-17 [doi]
PST - epublish
SO  - J Virol. 2017 Sep 12;91(19). pii: JVI.01042-17. doi: 10.1128/JVI.01042-17. Print 2017 Oct 1.

PMID- 28727764
OWN - NLM
STAT- MEDLINE
DCOM- 20170925
LR  - 20191210
IS  - 1932-6203 (Electronic)
IS  - 1932-6203 (Linking)
VI  - 12
IP  - 7
DP  - 2017
TI  - Vaccinia virus and Cowpox virus are not susceptible to the interferon-inducedantiviral protein MxA.
PG  - e0181459
LID - 10.1371/journal.pone.0181459 [doi]
AB  - MxA protein is expressed in response to type I and type III Interferon andconstitute an important antiviral factor with broad antiviral activity to diverseRNA viruses. In addition, some studies expand the range of MxA antiviral activityto include particular DNA viruses like Monkeypox virus (MPXV) and African SwineFever virus (ASFV). However, a broad profile of activity of MxA to large DNAviruses has not been established to date. Here, we investigated if some wellcharacterized DNA viruses belonging to the Poxviridae family are sensitive tohuman MxA. A cell line inducibly expressing MxA to inhibitory levels showed noanti-Vaccinia virus (VACV) virus activity, indicating either lack ofsusceptibility of the virus, or the existence of viral factors capable ofcounteracting MxA inhibition. To determine if VACV resistance to MxA was due to avirus-encoded anti-MxA activity, we performed coinfections of VACV and theMxA-sensitive Vesicular Stomatitis virus (VSV), and show that VACV does notprotect VSV from MxA inhibition in trans. Those results were extended to several VACV strains and two CPXV strains, thus confirming that those Orthopoxviruses do not block MxA action. Overall, these results point to a lack of susceptibility ofthe Poxviridae to MxA antiviral activity.
FAU - Lorenzo, Maria M
AU  - Lorenzo MM
AD  - Departamento de Biotecnologia, Instituto Nacional de Investigacion y TecnologiaAgraria y Alimentaria (I.N.I.A.), Madrid, Spain.
FAU - Sanchez-Puig, Juana M
AU  - Sanchez-Puig JM
AD  - Departamento de Biotecnologia, Instituto Nacional de Investigacion y TecnologiaAgraria y Alimentaria (I.N.I.A.), Madrid, Spain.
FAU - Blasco, Rafael
AU  - Blasco R
AUID- ORCID: http://orcid.org/0000-0002-8819-5767
AD  - Departamento de Biotecnologia, Instituto Nacional de Investigacion y TecnologiaAgraria y Alimentaria (I.N.I.A.), Madrid, Spain.
LA  - eng
PT  - Journal Article
DEP - 20170720
PL  - United States
TA  - PLoS One
JT  - PloS one
JID - 101285081
RN  - 0 (MX1 protein, human)
RN  - 0 (Myxovirus Resistance Proteins)
SB  - IM
MH  - Animals
MH  - Blotting, Western
MH  - Cell Line
MH  - Chlorocebus aethiops
MH  - Coinfection
MH  - Cowpox/metabolism
MH  - Cowpox virus/*physiology
MH  - Flow Cytometry
MH  - Fluorescent Antibody Technique
MH  - Humans
MH  - Microscopy, Fluorescence
MH  - Myxovirus Resistance Proteins/*metabolism
MH  - Vaccinia/metabolism
MH  - Vaccinia virus/*physiology
MH  - Vesicular Stomatitis/metabolism
MH  - Vesiculovirus
MH  - Virus Replication
PMC - PMC5519081
EDAT- 2017/07/21 06:00
MHDA- 2017/09/26 06:00
CRDT- 2017/07/21 06:00
PHST- 2017/04/27 00:00 [received]
PHST- 2017/06/19 00:00 [accepted]
PHST- 2017/07/21 06:00 [entrez]
PHST- 2017/07/21 06:00 [pubmed]
PHST- 2017/09/26 06:00 [medline]
AID - 10.1371/journal.pone.0181459 [doi]
AID - PONE-D-17-16267 [pii]
PST - epublish
SO  - PLoS One. 2017 Jul 20;12(7):e0181459. doi: 10.1371/journal.pone.0181459.eCollection 2017.

PMID- 28606813
OWN - NLM
STAT- MEDLINE
DCOM- 20180312
LR  - 20180402
IS  - 1873-2518 (Electronic)
IS  - 0264-410X (Linking)
VI  - 35
IP  - 31
DP  - 2017 Jul 5
TI  - Comparative Efficacy of Intramuscular and Scarification Routes of Administration of Live Smallpox Vaccine in a Murine Challenge Model.
PG  - 3889-3896
LID - S0264-410X(17)30706-5 [pii]
LID - 10.1016/j.vaccine.2017.05.058 [doi]
AB  - In recent years concern has mounted regarding the possibility of a re-emergenceof smallpox through biowarfare or bioterrorism. There is also concern over theincidence of human monkeypox in endemic areas and the potential for monkeypox to be accidentally transported to non-endemic areas. In the event of re-emergence ofsmallpox or emergence of monkeypox, the accepted route of administration for livereplicating smallpox vaccine is dermal scarification, which generates avirus-shedding lesion that persists for several days at the vaccination site. Thelesion is a potential source of contact transmission of vaccine to individualswho may be contra-indicated for receipt of the live vaccine. In this study, wecompare dermal scarification with intramuscular vaccination for replicatingsmallpox vaccine in a mouse lethal challenge model. Comparisons are made overmultiple vaccine and challenge doses and data recorded for lethality, diseaseseverity, and antibody responses. Qualitative and quantitative differencesbetween the two routes are observed, and for the intramuscular route the febrile response is not suppressed after subsequent virulent vaccinia virus challenge.However both routes generate an immune response and protect from severe diseaseand death. Although dermal scarification is the preferred route of vaccinationfor the general population, intramuscular vaccination may be an option for peoplewho are not contraindicated for the live vaccine, but who are close contacts ofpeople who are contraindicated for the live vaccine, in an emergency situation.
CI  - Crown Copyright (c) 2017. Published by Elsevier Ltd. All rights reserved.
FAU - Phelps, A
AU  - Phelps A
AD  - CBR Division, Dstl Porton Down, Salisbury SP4 0JQ, UK.
FAU - Gates, A J
AU  - Gates AJ
AD  - CBR Division, Dstl Porton Down, Salisbury SP4 0JQ, UK.
FAU - Eastaugh, L
AU  - Eastaugh L
AD  - CBR Division, Dstl Porton Down, Salisbury SP4 0JQ, UK.
FAU - Hillier, M
AU  - Hillier M
AD  - CBR Division, Dstl Porton Down, Salisbury SP4 0JQ, UK.
FAU - Ulaeto, D O
AU  - Ulaeto DO
AD  - CBR Division, Dstl Porton Down, Salisbury SP4 0JQ, UK; The Pirbright Institute,Ash Road, Woking GU24 0NF, UK. Electronic address: dulaeto@dstl.gov.uk.
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20170609
PL  - Netherlands
TA  - Vaccine
JT  - Vaccine
JID - 8406899
RN  - 0 (Smallpox Vaccine)
RN  - 0 (Vaccines, Attenuated)
SB  - IM
MH  - Administration, Cutaneous
MH  - Animals
MH  - Disease Models, Animal
MH  - Female
MH  - Injections, Intramuscular
MH  - Mice, Inbred BALB C
MH  - Smallpox Vaccine/*administration & dosage/*immunology
MH  - Survival Analysis
MH  - Treatment Outcome
MH  - Vaccines, Attenuated/administration & dosage/immunology
MH  - Vaccinia/*prevention & control
MH  - Vaccinia virus/*immunology
OTO - NOTNLM
OT  - *Febrile response
OT  - *Intramuscular vaccination
OT  - *Monkeypox
OT  - *Smallpox
OT  - *Vaccinia
EDAT- 2017/06/14 06:00
MHDA- 2018/03/13 06:00
CRDT- 2017/06/14 06:00
PHST- 2017/02/06 00:00 [received]
PHST- 2017/05/17 00:00 [revised]
PHST- 2017/05/20 00:00 [accepted]
PHST- 2017/06/14 06:00 [pubmed]
PHST- 2018/03/13 06:00 [medline]
PHST- 2017/06/14 06:00 [entrez]
AID - S0264-410X(17)30706-5 [pii]
AID - 10.1016/j.vaccine.2017.05.058 [doi]
PST - ppublish
SO  - Vaccine. 2017 Jul 5;35(31):3889-3896. doi: 10.1016/j.vaccine.2017.05.058. Epub2017 Jun 9.

PMID- 28406414
OWN - NLM
STAT- MEDLINE
DCOM- 20180417
LR  - 20180417
IS  - 2261-2211 (Electronic)
IS  - 2261-3684 (Linking)
VI  - 27
IP  - 1
DP  - 2017 Feb 1
TI  - Review of poxvirus: emergence of monkeypox.
PG  - 29-39
LID - 10.1684/mst.2017.0653 [doi]
AB  - This article reviews the different types of poxvirus infections. Smallpox,although eradicated, must continue to be monitored because of the potential risk of accidental or voluntary (by bioterrorism) reintroduction. Monkeypox and cowpoxviruses are considered to be emergent today ; their high risk of dissemination isdue to the increase in international transport as well as trends for new animals as pets and the loss of vaccinal protection against smallpox. Molluscumcontagiosum (molluscipoxvirus) causes mild infections, is particularly frequentin children ; in adults it is a marker of the risk of sexually transmittedinfections and can, in cases with profuse lesions, reveal AIDS.
FAU - Morand, A
AU  - Morand A
AD  - Service de pediatrie, CHU Timone, Marseille, France.
FAU - Delaigue, S
AU  - Delaigue S
AD  - Medecins sans Frontieres Teleexpertise, Toronto, Canada.
FAU - Morand, J J
AU  - Morand JJ
AD  - Service de dermatologie, HIA Sainte-Anne, Toulon, France.
LA  - eng
PT  - Journal Article
PT  - Review
TT  - Panorama des poxvirus : emergence du monkeypox.
PL  - France
TA  - Med Sante Trop
JT  - Medecine et sante tropicales
JID - 101581406
SB  - IM
MH  - Humans
MH  - Monkeypox/diagnosis/therapy
MH  - *Poxviridae Infections/diagnosis/therapy
OTO - NOTNLM
OT  - cowpox
OT  - molluscum contagiosum
OT  - monkeypox
OT  - orf
OT  - poxvirus
OT  - smallpox
OT  - vaccinia
EDAT- 2017/04/14 06:00
MHDA- 2018/04/18 06:00
CRDT- 2017/04/14 06:00
PHST- 2017/04/14 06:00 [entrez]
PHST- 2017/04/14 06:00 [pubmed]
PHST- 2018/04/18 06:00 [medline]
AID - mst.2017.0653 [pii]
AID - 10.1684/mst.2017.0653 [doi]
PST - ppublish
SO  - Med Sante Trop. 2017 Feb 1;27(1):29-39. doi: 10.1684/mst.2017.0653.

PMID- 28331092
OWN - NLM
STAT- MEDLINE
DCOM- 20170727
LR  - 20191210
IS  - 1098-5514 (Electronic)
IS  - 0022-538X (Linking)
VI  - 91
IP  - 11
DP  - 2017 Jun 1
TI  - Monkeypox Virus Host Factor Screen Using Haploid Cells Identifies Essential Role of GARP Complex in Extracellular Virus Formation.
LID - e00011-17 [pii]
LID - 10.1128/JVI.00011-17 [doi]
AB  - Monkeypox virus (MPXV) is a human pathogen that is a member of the Orthopoxvirus genus, which includes Vaccinia virus and Variola virus (the causative agent ofsmallpox). Human monkeypox is considered an emerging zoonotic infectious disease.To identify host factors required for MPXV infection, we performed a genome-wide insertional mutagenesis screen in human haploid cells. The screen revealedseveral candidate genes, including those involved in Golgi trafficking,glycosaminoglycan biosynthesis, and glycosylphosphatidylinositol (GPI)-anchorbiosynthesis. We validated the role of a set of vacuolar protein sorting (VPS)genes during infection, VPS51 to VPS54 (VPS51-54), which comprise theGolgi-associated retrograde protein (GARP) complex. The GARP complex is atethering complex involved in retrograde transport of endosomes to thetrans-Golgi apparatus. Our data demonstrate that VPS52 and VPS54 were dispensablefor mature virion (MV) production but were required for extracellular virus (EV) formation. For comparison, a known antiviral compound, ST-246, was used in ourexperiments, demonstrating that EV titers in VPS52 and VPS54 knockout (KO) cells were comparable to levels exhibited by ST-246-treated wild-type cells. Confocalmicroscopy was used to examine actin tail formation, one of the viral egressmechanisms for cell-to-cell dissemination, and revealed an absence of actin tailsin VPS52KO- or VPS54KO-infected cells. Further evaluation of these cells byelectron microscopy demonstrated a decrease in levels of wrapped viruses (WVs)compared to those seen with the wild-type control. Collectively, our datademonstrate the role of GARP complex genes in double-membrane wrapping of MVsnecessary for EV formation, implicating the host endosomal trafficking pathway inorthopoxvirus infection.IMPORTANCE Human monkeypox is an emerging zoonoticinfectious disease caused by Monkeypox virus (MPXV). Of the two MPXV clades, the Congo Basin strain is associated with severe disease, increased mortality, andincreased human-to-human transmission relative to the West African strain.Monkeypox is endemic in regions of western and central Africa but was introduced into the United States in 2003 from the importation of infected animals. Thethreat of MPXV and other orthopoxviruses is increasing due to the absence ofroutine smallpox vaccination leading to a higher proportion of naive populations.In this study, we have identified and validated candidate genes that are requiredfor MPXV infection, specifically, those associated with the Golgi-associatedretrograde protein (GARP) complex. Identifying host targets required forinfection that prevents extracellular virus formation such as the GARP complex orthe retrograde pathway can provide a potential target for antiviral therapy.
CI  - Copyright (c) 2017 American Society for Microbiology.
FAU - Realegeno, Susan
AU  - Realegeno S
AD  - Poxvirus and Rabies Branch, Division of High Consequence Pathogens and Pathology,Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
FAU - Puschnik, Andreas S
AU  - Puschnik AS
AD  - Department of Microbiology and Immunology, Stanford University School ofMedicine, Stanford, California, USA.
FAU - Kumar, Amrita
AU  - Kumar A
AD  - Immunology and Pathogenesis Branch, Influenza Division, National Center forImmunization and Respiratory Diseases, Centers for Disease Control andPrevention, Atlanta, Georgia, USA.
FAU - Goldsmith, Cynthia
AU  - Goldsmith C
AD  - Infectious Disease Pathology Branch, Division of High Consequence Pathogens andPathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
FAU - Burgado, Jillybeth
AU  - Burgado J
AD  - Poxvirus and Rabies Branch, Division of High Consequence Pathogens and Pathology,Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
FAU - Sambhara, Suryaprakash
AU  - Sambhara S
AD  - Immunology and Pathogenesis Branch, Influenza Division, National Center forImmunization and Respiratory Diseases, Centers for Disease Control andPrevention, Atlanta, Georgia, USA.
FAU - Olson, Victoria A
AU  - Olson VA
AD  - Poxvirus and Rabies Branch, Division of High Consequence Pathogens and Pathology,Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
FAU - Carroll, Darin
AU  - Carroll D
AD  - Poxvirus and Rabies Branch, Division of High Consequence Pathogens and Pathology,Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
FAU - Damon, Inger
AU  - Damon I
AD  - Poxvirus and Rabies Branch, Division of High Consequence Pathogens and Pathology,Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
FAU - Hirata, Tetsuya
AU  - Hirata T
AD  - Department of Immunoregulation, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
FAU - Kinoshita, Taroh
AU  - Kinoshita T
AD  - Department of Immunoregulation, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
FAU - Carette, Jan E
AU  - Carette JE
AD  - Department of Microbiology and Immunology, Stanford University School ofMedicine, Stanford, California, USA carette@stanford.edu spanayampalli@cdc.gov.
FAU - Satheshkumar, Panayampalli Subbian
AU  - Satheshkumar PS
AD  - Poxvirus and Rabies Branch, Division of High Consequence Pathogens and Pathology,Centers for Disease Control and Prevention, Atlanta, Georgia, USAcarette@stanford.edu spanayampalli@cdc.gov.
LA  - eng
GR  - U19 AI109662/AI/NIAID NIH HHS/United States
PT  - Journal Article
DEP - 20170512
PL  - United States
TA  - J Virol
JT  - Journal of virology
JID - 0113724
RN  - 0 (Actins)
RN  - 0 (Benzamides)
RN  - 0 (Glycosaminoglycans)
RN  - 0 (Glycosylphosphatidylinositols)
RN  - 0 (Isoindoles)
RN  - 0 (LRRC32 protein, human)
RN  - 0 (Membrane Proteins)
RN  - 0 (VPS53 protein, human)
RN  - 0 (Vesicular Transport Proteins)
RN  - F925RR824R (Tecovirimat)
SB  - IM
MH  - Actins/drug effects/metabolism
MH  - Animals
MH  - Benzamides/pharmacology
MH  - Biological Transport
MH  - Cell Line
MH  - Endosomes/*metabolism
MH  - Genome, Human
MH  - Glycosaminoglycans/biosynthesis/genetics
MH  - Glycosylphosphatidylinositols/biosynthesis
MH  - Golgi Apparatus/genetics/metabolism
MH  - Haploidy
MH  - *Host-Pathogen Interactions
MH  - Humans
MH  - Isoindoles/pharmacology
MH  - Membrane Proteins/*genetics/metabolism
MH  - Monkeypox/virology
MH  - Monkeypox virus/*physiology
MH  - Mutagenesis, Insertional
MH  - Vesicular Transport Proteins/genetics/*metabolism
MH  - Viral Load
MH  - Virus Replication
PMC - PMC5432867
OTO - NOTNLM
OT  - *GARP complex
OT  - *HAP1 screen
OT  - *poxviruses
OT  - *retrograde transport
EDAT- 2017/03/24 06:00
MHDA- 2017/07/28 06:00
CRDT- 2017/03/24 06:00
PHST- 2017/01/27 00:00 [received]
PHST- 2017/03/14 00:00 [accepted]
PHST- 2017/03/24 06:00 [pubmed]
PHST- 2017/07/28 06:00 [medline]
PHST- 2017/03/24 06:00 [entrez]
AID - JVI.00011-17 [pii]
AID - 10.1128/JVI.00011-17 [doi]
PST - epublish
SO  - J Virol. 2017 May 12;91(11). pii: JVI.00011-17. doi: 10.1128/JVI.00011-17. Print 2017 Jun 1.

PMID- 28192435
OWN - NLM
STAT- MEDLINE
DCOM- 20170824
LR  - 20190208
IS  - 1932-6203 (Electronic)
IS  - 1932-6203 (Linking)
VI  - 12
IP  - 2
DP  - 2017
TI  - Presumptive risk factors for monkeypox in rural communities in the DemocraticRepublic of the Congo.
PG  - e0168664
LID - 10.1371/journal.pone.0168664 [doi]
AB  - Monkeypox virus (MPXV), a close relative of Variola virus, is a zoonotic viruswith an unknown reservoir. Interaction with infected wildlife, bites fromperi-domestic animals, and bushmeat hunting are hypothesized routes of infection from wildlife to humans. Using a Risk Questionnaire, performed inmonkeypox-affected areas of rural Democratic Republic of the Congo, we describethe lifestyles and demographics associated with presumptive risk factors for MPXVinfection. We generated two indices to assess risk: Household Materials Index(HMI), a proxy for socioeconomic status of households and Risk Activity Index(RAI), which describes presumptive risk for animal-to-human transmission of MPXV.Based on participant self-reported activity patterns, we found that people inthis population are more likely to visit the forest than a market to fulfillmaterial needs, and that the reported occupation is limited in describingbehavior of individuals may participate. Being bitten by rodents in the home was commonly reported, and this was significantly associated with a low HMI. Thehighest scoring RAI sub-groups were 'hunters' and males aged >/= 18 years;however, several activities involving MPXV-implicated animals were distributedacross all sub-groups. The current analysis may be useful in identifying at-risk groups and help to direct education, outreach and prevention efforts moreefficiently.
FAU - Quiner, Claire A
AU  - Quiner CA
AUID- ORCID: http://orcid.org/0000-0003-4419-1542
AD  - Division of Epidemiology and Biostatistics, School of Public Health, Universityof California, Berkeley, California, United States of America.
AD  - US Centers for Disease Control and Prevention, Poxvirus and Rabies Branch,Atlanta, Georgia, United States of America.
FAU - Moses, Cynthia
AU  - Moses C
AD  - International Conservation Education Fund, Washington, D.C., United States ofAmerica.
FAU - Monroe, Benjamin P
AU  - Monroe BP
AD  - US Centers for Disease Control and Prevention, Poxvirus and Rabies Branch,Atlanta, Georgia, United States of America.
FAU - Nakazawa, Yoshinori
AU  - Nakazawa Y
AD  - US Centers for Disease Control and Prevention, Poxvirus and Rabies Branch,Atlanta, Georgia, United States of America.
FAU - Doty, Jeffrey B
AU  - Doty JB
AD  - US Centers for Disease Control and Prevention, Poxvirus and Rabies Branch,Atlanta, Georgia, United States of America.
FAU - Hughes, Christine M
AU  - Hughes CM
AD  - US Centers for Disease Control and Prevention, Poxvirus and Rabies Branch,Atlanta, Georgia, United States of America.
FAU - McCollum, Andrea M
AU  - McCollum AM
AD  - US Centers for Disease Control and Prevention, Poxvirus and Rabies Branch,Atlanta, Georgia, United States of America.
FAU - Ibata, Saturnin
AU  - Ibata S
AD  - International Conservation Education Fund, Washington, D.C., United States ofAmerica.
FAU - Malekani, Jean
AU  - Malekani J
AD  - University of Kinshasa, Department of Biology, Kinshasa, Democratic Republic ofCongo.
FAU - Okitolonda, Emile
AU  - Okitolonda E
AD  - Kinshasa School of Public Health, Kinshasa, Democratic Republic of Congo.
FAU - Carroll, Darin S
AU  - Carroll DS
AD  - International Conservation Education Fund, Washington, D.C., United States ofAmerica.
FAU - Reynolds, Mary G
AU  - Reynolds MG
AD  - US Centers for Disease Control and Prevention, Poxvirus and Rabies Branch,Atlanta, Georgia, United States of America.
LA  - eng
GR  - U01 CK000539/CK/NCEZID CDC HHS/United States
PT  - Journal Article
DEP - 20170213
PL  - United States
TA  - PLoS One
JT  - PloS one
JID - 101285081
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Animals
MH  - Animals, Wild/virology
MH  - Democratic Republic of the Congo/epidemiology
MH  - Family Characteristics
MH  - Female
MH  - Host-Pathogen Interactions
MH  - Humans
MH  - Life Style
MH  - Male
MH  - Monkeypox/epidemiology/*transmission/virology
MH  - Monkeypox virus/physiology
MH  - Occupations
MH  - Risk Assessment
MH  - Risk Factors
MH  - Rodentia/virology
MH  - Rural Health/*statistics & numerical data
MH  - Rural Population/*statistics & numerical data
MH  - Socioeconomic Factors
MH  - Surveys and Questionnaires
MH  - Young Adult
PMC - PMC5305065
COIS- The authors declare that they have no competing interests regarding real orperceived conflicts of interest.
EDAT- 2017/02/14 06:00
MHDA- 2017/08/25 06:00
CRDT- 2017/02/14 06:00
PHST- 2016/03/08 00:00 [received]
PHST- 2016/12/05 00:00 [accepted]
PHST- 2017/02/14 06:00 [entrez]
PHST- 2017/02/14 06:00 [pubmed]
PHST- 2017/08/25 06:00 [medline]
AID - 10.1371/journal.pone.0168664 [doi]
AID - PONE-D-16-08026 [pii]
PST - epublish
SO  - PLoS One. 2017 Feb 13;12(2):e0168664. doi: 10.1371/journal.pone.0168664.eCollection 2017.

PMID- 28131867
OWN - NLM
STAT- MEDLINE
DCOM- 20171002
LR  - 20171226
IS  - 1879-0984 (Electronic)
IS  - 0166-0934 (Linking)
VI  - 243
DP  - 2017 May
TI  - A rapid Orthopoxvirus purification protocol suitable for high-containmentlaboratories.
PG  - 68-73
LID - S0166-0934(16)30485-2 [pii]
LID - 10.1016/j.jviromet.2017.01.018 [doi]
AB  - Virus purification in a high-containment setting provides unique challenges dueto barrier precautions and operational safety approaches that are not necessaryin lower biosafety level (BSL) 2 environments. The need for high risk grouppathogen diagnostic assay development, anti-viral research, pathogenesis andvaccine efficacy research necessitates work in BSL-3 and BSL-4 labs withinfectious agents. When this work is performed in accordance with BSL-4practices, modifications are often required in standard protocols. Classicalvirus purification techniques are difficult to execute in a BSL-3 or BSL-4laboratory because of the work practices used in these environments.Orthopoxviruses are a family of viruses that, in some cases, requires work in ahigh-containment laboratory and due to size do not lend themselves to simplerpurification methods. Current CDC purification techniques of orthopoxviruses uses1,1,2-trichlorotrifluoroethane, commonly known as Genetron((R)). Genetron((R)) isa chlorofluorocarbon (CFC) that has been shown to be detrimental to the ozone andhas been phased out and the limited amount of product makes it no longer afeasible option for poxvirus purification purposes. Here we demonstrate a newOrthopoxvirus purification method that is suitable for high-containmentlaboratories and produces virus that is not only comparable to previouspurification methods, but improves on purity and yield.
CI  - Published by Elsevier B.V.
FAU - Hughes, Laura
AU  - Hughes L
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,National Center for Emerging Zoonotic Infectious Diseases, Centers for DiseaseControl and Prevention, Atlanta, GA 30329, USA. Electronic address: bkz2@cdc.gov.
FAU - Wilkins, Kimberly
AU  - Wilkins K
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,National Center for Emerging Zoonotic Infectious Diseases, Centers for DiseaseControl and Prevention, Atlanta, GA 30329, USA.
FAU - Goldsmith, Cynthia S
AU  - Goldsmith CS
AD  - Infectious Diseases Pathology Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging Zoonotic Infectious Diseases, Centers forDisease Control and Prevention, Atlanta, GA 30329, USA.
FAU - Smith, Scott
AU  - Smith S
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,National Center for Emerging Zoonotic Infectious Diseases, Centers for DiseaseControl and Prevention, Atlanta, GA 30329, USA.
FAU - Hudson, Paul
AU  - Hudson P
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,National Center for Emerging Zoonotic Infectious Diseases, Centers for DiseaseControl and Prevention, Atlanta, GA 30329, USA.
FAU - Patel, Nishi
AU  - Patel N
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,National Center for Emerging Zoonotic Infectious Diseases, Centers for DiseaseControl and Prevention, Atlanta, GA 30329, USA.
FAU - Karem, Kevin
AU  - Karem K
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,National Center for Emerging Zoonotic Infectious Diseases, Centers for DiseaseControl and Prevention, Atlanta, GA 30329, USA.
FAU - Damon, Inger
AU  - Damon I
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,National Center for Emerging Zoonotic Infectious Diseases, Centers for DiseaseControl and Prevention, Atlanta, GA 30329, USA.
FAU - Li, Yu
AU  - Li Y
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,National Center for Emerging Zoonotic Infectious Diseases, Centers for DiseaseControl and Prevention, Atlanta, GA 30329, USA.
FAU - Olson, Victoria A
AU  - Olson VA
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,National Center for Emerging Zoonotic Infectious Diseases, Centers for DiseaseControl and Prevention, Atlanta, GA 30329, USA.
FAU - Satheshkumar, P S
AU  - Satheshkumar PS
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,National Center for Emerging Zoonotic Infectious Diseases, Centers for DiseaseControl and Prevention, Atlanta, GA 30329, USA.
LA  - eng
PT  - Journal Article
PT  - Research Support, U.S. Gov't, Non-P.H.S.
PT  - Research Support, U.S. Gov't, P.H.S.
DEP - 20170126
PL  - Netherlands
TA  - J Virol Methods
JT  - Journal of virological methods
JID - 8005839
SB  - IM
MH  - Animals
MH  - Containment of Biohazards
MH  - Humans
MH  - Laboratories
MH  - Orthopoxvirus/*isolation & purification
MH  - Time Factors
MH  - Virology/*methods
OTO - NOTNLM
OT  - *High-containment
OT  - *Monkeypox
OT  - *Orthopoxvirus
OT  - *Purification
OT  - *Variola
EDAT- 2017/01/31 06:00
MHDA- 2017/10/03 06:00
CRDT- 2017/01/30 06:00
PHST- 2016/09/26 00:00 [received]
PHST- 2017/01/19 00:00 [revised]
PHST- 2017/01/20 00:00 [accepted]
PHST- 2017/01/31 06:00 [pubmed]
PHST- 2017/10/03 06:00 [medline]
PHST- 2017/01/30 06:00 [entrez]
AID - S0166-0934(16)30485-2 [pii]
AID - 10.1016/j.jviromet.2017.01.018 [doi]
PST - ppublish
SO  - J Virol Methods. 2017 May;243:68-73. doi: 10.1016/j.jviromet.2017.01.018. Epub2017 Jan 26.

PMID- 28039021
OWN - NLM
STAT- MEDLINE
DCOM- 20171227
LR  - 20200316
IS  - 1872-9096 (Electronic)
IS  - 0166-3542 (Linking)
VI  - 139
DP  - 2017 Mar
TI  - Buccal viral DNA as a trigger for brincidofovir therapy in the mousepox model of smallpox.
PG  - 112-116
LID - S0166-3542(16)30337-0 [pii]
LID - 10.1016/j.antiviral.2016.12.015 [doi]
AB  - Orthopoxviruses continue to pose a significant threat to the population aspotential agents of bioterrorism. An intentional release of natural or engineeredvariola virus (VARV) or monkeypox viruses would cause mortality and morbidity in the target population. To address this, antivirals have been developed andevaluated in animal models of smallpox and monkeypox. One such antiviral,brincidofovir (BCV, previously CMX001), has demonstrated high levels of efficacy against orthopoxviruses in animal models and is currently under clinicalevaluation for prevention and treatment of diseases caused by cytomegalovirusesand adenoviruses. In this study we use the mousepox model of smallpox to evaluatethe relationship between the magnitude of the infectious virus dose and anefficacious BCV therapy outcome when treatment is initiated concomitant withdetection of ectromelia virus viral DNA (vDNA) in mouse buccal swabs. We foundthat vDNA could be detected in buccal swabs of some, but not all infected miceover a range of challenge doses by day 3 or 4 postexposure, when initiation ofBCV treatment was efficacious, suggesting that detection of vDNA in buccal swabs could be used as a trigger to initiate BCV treatment of an entire potentiallyexposed population. However, buccal swabs of some mice did not become positiveuntil 5 days postexposure, when initiation of BCV therapy failed to protect mice that received high doses of virus. And finally, the data suggest that thetherapeutic window for efficacious BCV treatment decreases as the virusinfectious dose increases. Extrapolating these findings to VARV, the data suggestthat treatment should be initiated as soon as possible after exposure and notrely on a diagnostic tool such as the measurement of vDNA in buccal cavity swabs;however, consideration should be given to the fact that thebehavior/disease-course of VARV in humans is different from that of ectromeliavirus in the mouse.
CI  - Copyright (c) 2016 Elsevier B.V. All rights reserved.
FAU - Crump, Ryan
AU  - Crump R
AD  - Saint Louis University School of Medicine, 1100 S. Grand Blvd, St. Louis, MO63104, USA.
FAU - Korom, Maria
AU  - Korom M
AD  - The George Washington University, School of Medicine and Health Sciences,Department of Microbiology, Immunology and Tropical Medicine, 2300 Eye Street, NWWashington, DC 20037, USA.
FAU - Buller, R Mark
AU  - Buller RM
AD  - Saint Louis University School of Medicine, 1100 S. Grand Blvd, St. Louis, MO63104, USA.
FAU - Parker, Scott
AU  - Parker S
AD  - Saint Louis University School of Medicine, 1100 S. Grand Blvd, St. Louis, MO63104, USA. Electronic address: scott9379@gmail.com.
LA  - eng
GR  - HHSN272201000021C/AI/NIAID NIH HHS/United States
GR  - HHSN272201000021I/AI/NIAID NIH HHS/United States
GR  - N01 AI015436/AI/NIAID NIH HHS/United States
PT  - Journal Article
DEP - 20161227
PL  - Netherlands
TA  - Antiviral Res
JT  - Antiviral research
JID - 8109699
RN  - 0 (Antiviral Agents)
RN  - 0 (DNA, Viral)
RN  - 0 (Organophosphonates)
RN  - 6794O900AX (brincidofovir)
RN  - 8J337D1HZY (Cytosine)
SB  - IM
MH  - Animals
MH  - Antiviral Agents/administration & dosage/*therapeutic use
MH  - Cytosine/administration & dosage/*analogs & derivatives/therapeutic use
MH  - DNA, Viral/*drug effects/isolation & purification
MH  - Disease Models, Animal
MH  - Ectromelia virus/*drug effects
MH  - Ectromelia, Infectious/*drug therapy/virology
MH  - Mice
MH  - Mouth Mucosa/*virology
MH  - Organophosphonates/administration & dosage/*therapeutic use
MH  - Orthopoxvirus/drug effects
MH  - Smallpox/drug therapy/virology
PMC - PMC5291782
MID - NIHMS841785
OTO - NOTNLM
OT  - Antiviral
OT  - Brincidofovir
OT  - CMX001
OT  - Ectromelia
OT  - Variola virus
OT  - Viral DNA
EDAT- 2017/01/01 06:00
MHDA- 2017/12/28 06:00
CRDT- 2017/01/01 06:00
PHST- 2016/06/14 00:00 [received]
PHST- 2016/12/16 00:00 [revised]
PHST- 2016/12/22 00:00 [accepted]
PHST- 2017/01/01 06:00 [pubmed]
PHST- 2017/12/28 06:00 [medline]
PHST- 2017/01/01 06:00 [entrez]
AID - S0166-3542(16)30337-0 [pii]
AID - 10.1016/j.antiviral.2016.12.015 [doi]
PST - ppublish
SO  - Antiviral Res. 2017 Mar;139:112-116. doi: 10.1016/j.antiviral.2016.12.015. Epub2016 Dec 27.

PMID- 30123790
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220318
IS  - 2278-1005 (Print)
IS  - 2278-1005 (Linking)
VI  - 25
IP  - 2
DP  - 2017
TI  - Evolution of a Disease Surveillance System: An Increase in Reporting of HumanMonkeypox Disease in the Democratic Republic of the Congo, 2001-2013.
LID - IJTDH.35885 [pii]
LID - 10.9734/IJTDH/2017/35885 [doi]
AB  - OBJECTIVE: Evaluating the effectiveness of a surveillance system, and how itimproves over time has significant implications for disease control andprevention. In the Democratic Republic of Congo (DRC), the Integrated DiseaseSurveillance and Response (IDSR) was implemented to estimate the burden ofdisease, monitor changes in disease occurrence, and inform resource allocation.For this effort we utilized national passive surveillance data from DRC's IDSR toexplore reporting trends of human monkeypox (MPX) from 2001 to 2013. METHODS: We obtained surveillance data on MPX cases occurring between January 2001 andDecember 2013 from the DRC Ministry of Health (MoH). Phases of the surveillancesystem, yearly trends in reporting and estimated incidence for MPX were analyzed using SAS v9.2 and Health Mapper. RESULTS: Between 2001 and 2013, three discrete surveillance phases were identified that described the evolution of thesurveillance system. Overall, an increase in suspected MPX cases was reported,beyond what would be expected from simply an improved reporting system. Whenrestricting the analysis to the "stable phase," national estimated incidenceincreased from 2.13 per 100,000 in 2008 to 2.84 per 100,000 in 2013. CONCLUSIONS:The reported increase in MPX, based on an evolving surveillance system, is likelyto be a true increase in disease occurrence rather than simply improvements tothe surveillance system. Further analyses should provide critical information forimproved prevention and control strategies and highlight areas of improvement forfuture data collection efforts.
FAU - Hoff, Nicole A
AU  - Hoff NA
AD  - Fielding School of Public Health, University of California, Los Angeles, CA, USA.
FAU - Doshi, Reena H
AU  - Doshi RH
AD  - Fielding School of Public Health, University of California, Los Angeles, CA, USA.
FAU - Colwell, Brian
AU  - Colwell B
AD  - Health Promotion and Community Health Sciences, Texas A&M School of PublicHealth, College Station, TX, USA.
FAU - Kebela-Illunga, Benoit
AU  - Kebela-Illunga B
AD  - Ministry of Public Health, Direction for Disease Control, Democratic Republic of the Congo.
FAU - Mukadi, Patrick
AU  - Mukadi P
AD  - National Institute for Biomedical Research, Democratic Republic of the Congo.
FAU - Mossoko, Mathias
AU  - Mossoko M
AD  - Ministry of Public Health, Direction for Disease Control, Democratic Republic of the Congo.
FAU - Spencer, D'Andre
AU  - Spencer D
AD  - Fielding School of Public Health, University of California, Los Angeles, CA, USA.
FAU - Muyembe-Tamfum, Jean-Jacque
AU  - Muyembe-Tamfum JJ
AD  - National Institute for Biomedical Research, Democratic Republic of the Congo.
FAU - Okitolonda-Wemakoy, Emile
AU  - Okitolonda-Wemakoy E
AD  - Kinshasa School of Public Health, University of Kinshasa, Democratic Republic of the Congo.
FAU - Lloyd-Smith, Jamie
AU  - Lloyd-Smith J
AD  - University of California, Los Angeles, CA, USA.
FAU - Rimoin, Anne W
AU  - Rimoin AW
AD  - Fielding School of Public Health, University of California, Los Angeles, CA, USA.
LA  - eng
GR  - K01 AI074810/AI/NIAID NIH HHS/United States
PT  - Journal Article
DEP - 20170828
PL  - India
TA  - Int J Trop Dis Health
JT  - International journal of tropical disease & health
JID - 101632866
PMC - PMC6095679
MID - NIHMS983419
OTO - NOTNLM
OT  - Democratic Republic of Congo
OT  - Monkeypox
OT  - disease trends
OT  - passive surveillance
COIS- COMPETING INTERESTS Authors have declared that no competing interests exist.
EDAT- 2017/01/01 00:00
MHDA- 2017/01/01 00:01
CRDT- 2018/08/21 06:00
PHST- 2018/08/21 06:00 [entrez]
PHST- 2017/01/01 00:00 [pubmed]
PHST- 2017/01/01 00:01 [medline]
AID - 10.9734/IJTDH/2017/35885 [doi]
PST - ppublish
SO  - Int J Trop Dis Health. 2017;25(2). doi: 10.9734/IJTDH/2017/35885. Epub 2017 Aug28.

PMID- 28003603
OWN - NLM
STAT- MEDLINE
DCOM- 20180327
LR  - 20180327
IS  - 1884-2836 (Electronic)
IS  - 1344-6304 (Linking)
VI  - 70
IP  - 4
DP  - 2017 Jul 24
TI  - A Single Vaccination of Nonhuman Primates with Highly Attenuated SmallpoxVaccine, LC16m8, Provides Long-term Protection against Monkeypox.
PG  - 408-415
LID - 10.7883/yoken.JJID.2016.417 [doi]
AB  - Monkeypox virus (MPXV) causes human monkeypox (human MPX), which is a similardisease to smallpox in humans. A previous study showed that a single vaccination of monkeys with LC16m8, a highly attenuated smallpox vaccine, protected them fromMPX from 4-5 weeks post-vaccination. In this study, we evaluated the long-termefficacy of a single vaccination with LC16m8 in a nonhuman primate model of MPXV infection. The monkeys were inoculated with either LC16m8, Lister (parentalstrain of LC16m8), or a mock-up vaccine, and then challenged with MPXV via asubcutaneous route, at 6 and 12 months after vaccination, which we compared with either Lister or the mock-up vaccination. The LC16m8 monkeys exhibited almost no MPX-associated symptoms, whereas most of the naive monkeys died. LC16m8 generatedthe protective memory immune response against MPXV, as suggested by the immediateviremia reduction and the response of the IgG antibody. The results demonstrated that the vaccination of monkeys with a single dose of LC16m8 provided durableprotection against MPXV for longer than one year after immunization. The results suggest that the vaccination of humans with LC16m8 could induce long-termprotection against MPXV infection.
FAU - Iizuka, Itoe
AU  - Iizuka I
AD  - Laboratory of Special Pathogens, Department of Virology 1, National Institute of Infectious Diseases.
AD  - Department of Developmental Medical Sciences, Graduate School of Medicine, TheUniversity of Tokyo.
FAU - Ami, Yasushi
AU  - Ami Y
AD  - Department of Experimental Animals Research, National Institute of InfectiousDiseases.
FAU - Suzaki, Yuriko
AU  - Suzaki Y
AD  - Department of Experimental Animals Research, National Institute of InfectiousDiseases.
FAU - Nagata, Noriyo
AU  - Nagata N
AD  - Department of Pathology, National Institute of Infectious Diseases.
FAU - Fukushi, Shuetsu
AU  - Fukushi S
AD  - Laboratory of Special Pathogens, Department of Virology 1, National Institute of Infectious Diseases.
FAU - Ogata, Momoko
AU  - Ogata M
AD  - Laboratory of Special Pathogens, Department of Virology 1, National Institute of Infectious Diseases.
FAU - Morikawa, Shigeru
AU  - Morikawa S
AD  - Department of Veterinary Science, National Institute of Infectious Diseases.
FAU - Hasegawa, Hideki
AU  - Hasegawa H
AD  - Department of Pathology, National Institute of Infectious Diseases.
FAU - Mizuguchi, Masashi
AU  - Mizuguchi M
AD  - Department of Developmental Medical Sciences, Graduate School of Medicine, TheUniversity of Tokyo.
FAU - Kurane, Ichiro
AU  - Kurane I
AD  - National Institute of Infectious Diseases.
FAU - Saijo, Masayuki
AU  - Saijo M
AD  - Laboratory of Special Pathogens, Department of Virology 1, National Institute of Infectious Diseases.
AD  - Department of Developmental Medical Sciences, Graduate School of Medicine, TheUniversity of Tokyo.
LA  - eng
PT  - Journal Article
DEP - 20161222
PL  - Japan
TA  - Jpn J Infect Dis
JT  - Japanese journal of infectious diseases
JID - 100893704
RN  - 0 (Smallpox Vaccine)
RN  - 0 (Vaccines, Attenuated)
SB  - IM
MH  - Animals
MH  - Disease Models, Animal
MH  - Female
MH  - Macaca fascicularis
MH  - Male
MH  - Monkeypox/*prevention & control
MH  - Smallpox Vaccine/*administration & dosage/*immunology
MH  - Survival Analysis
MH  - Treatment Outcome
MH  - Vaccines, Attenuated/administration & dosage/immunology
OTO - NOTNLM
OT  - LC16m8
OT  - monkeypox
OT  - monkeypox virus
OT  - smallpox vaccine
OT  - vaccinia virus
EDAT- 2016/12/23 06:00
MHDA- 2018/03/28 06:00
CRDT- 2016/12/23 06:00
PHST- 2016/12/23 06:00 [pubmed]
PHST- 2018/03/28 06:00 [medline]
PHST- 2016/12/23 06:00 [entrez]
AID - 10.7883/yoken.JJID.2016.417 [doi]
PST - ppublish
SO  - Jpn J Infect Dis. 2017 Jul 24;70(4):408-415. doi: 10.7883/yoken.JJID.2016.417.Epub 2016 Dec 22.

PMID- 27994107
OWN - NLM
STAT- MEDLINE
DCOM- 20170531
LR  - 20190309
IS  - 1476-1645 (Electronic)
IS  - 0002-9637 (Linking)
VI  - 96
IP  - 2
DP  - 2017 Feb 8
TI  - Evaluation of the GeneXpert for Human Monkeypox Diagnosis.
PG  - 405-410
LID - 10.4269/ajtmh.16-0567 [doi]
AB  - Monkeypox virus (MPXV), a zoonotic orthopoxvirus (OPX), is endemic in theDemocratic Republic of Congo (DRC). Currently, diagnostic assays for humanmonkeypox (MPX) focus on real-time quantitative polymerase chain reaction (PCR)assays, which are typically performed in sophisticated laboratory settings.Herein, we evaluated the accuracy and utility of a multiplex MPX assay using the GeneXpert platform, a portable rapid diagnostic device that may serve as apoint-of-care test to diagnose infections in endemic areas. The multiplex MPX/OPXassay includes a MPX-specific PCR test, OPX-generic PCR test, and an internalcontrol PCR test. In total, 164 diagnostic specimens (50 crusts and 114 vesicularswabs) were collected from suspected MPX cases in Tshuapa Province, DRC, undernational surveillance guidelines. The specimens were tested with the GeneXpertMPX/OPX assay and an OPX PCR assay at the Institut National de RechercheBiomedicale (INRB) in Kinshasa. Aliquots of each specimen were tested in parallelwith a MPX-specific PCR assay at the Centers for Disease Control and Prevention. The results of the MPX PCR were used as the gold standard for all analyses. TheGeneXpert MPX/OPX assay performed at INRB had a sensitivity of 98.8% andspecificity of 100%. The GeneXpert assay performed well with both crust andvesicle samples. The GeneXpert MPX/OPX test incorporates a simple methodologythat performs well in both laboratory and field conditions, suggesting itsviability as a diagnostic platform that may expand and expedite current MPXdetection capabilities.
CI  - (c) The American Society of Tropical Medicine and Hygiene.
FAU - Li, Daniel
AU  - Li D
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,National Center for Enteric and Zoonotic Infectious Diseases, Centers for DiseaseControl and Prevention, Atlanta, Georgia.
FAU - Wilkins, Kimberly
AU  - Wilkins K
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,National Center for Enteric and Zoonotic Infectious Diseases, Centers for DiseaseControl and Prevention, Atlanta, Georgia.
FAU - McCollum, Andrea M
AU  - McCollum AM
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,National Center for Enteric and Zoonotic Infectious Diseases, Centers for DiseaseControl and Prevention, Atlanta, Georgia.
FAU - Osadebe, Lynda
AU  - Osadebe L
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,National Center for Enteric and Zoonotic Infectious Diseases, Centers for DiseaseControl and Prevention, Atlanta, Georgia.
FAU - Kabamba, Joelle
AU  - Kabamba J
AD  - Centers for Disease Control and Prevention, Kinshasa, Democratic Republic ofCongo.
FAU - Nguete, Beatrice
AU  - Nguete B
AD  - Kinshasa School of Public Health, Kinshasa, Democratic Republic of Congo.
FAU - Likafi, Toutou
AU  - Likafi T
AD  - Kinshasa School of Public Health, Kinshasa, Democratic Republic of Congo.
FAU - Balilo, Marcel Pie
AU  - Balilo MP
AD  - Kinshasa School of Public Health, Kinshasa, Democratic Republic of Congo.
FAU - Lushima, Robert Shongo
AU  - Lushima RS
AD  - Ministry of Health, Kinshasa, Democratic Republic of Congo.
FAU - Malekani, Jean
AU  - Malekani J
AD  - University of Kinshasa, Kinshasa, Democratic Republic of Congo.
FAU - Damon, Inger K
AU  - Damon IK
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,National Center for Enteric and Zoonotic Infectious Diseases, Centers for DiseaseControl and Prevention, Atlanta, Georgia.
FAU - Vickery, Michael C L
AU  - Vickery MCL
AD  - BioGX, Birmingham, Alabama.
FAU - Pukuta, Elisabeth
AU  - Pukuta E
AD  - Institut National de Recherche Biomedicale, Ministry of Health, Kinshasa,Democratic Republic of Congo.
FAU - Nkawa, Frida
AU  - Nkawa F
AD  - Institut National de Recherche Biomedicale, Ministry of Health, Kinshasa,Democratic Republic of Congo.
FAU - Karhemere, Stomy
AU  - Karhemere S
AD  - Institut National de Recherche Biomedicale, Ministry of Health, Kinshasa,Democratic Republic of Congo.
FAU - Tamfum, Jean-Jacques Muyembe
AU  - Tamfum JM
AD  - Institut National de Recherche Biomedicale, Ministry of Health, Kinshasa,Democratic Republic of Congo.
FAU - Okitolonda, Emile Wemakoy
AU  - Okitolonda EW
AD  - Kinshasa School of Public Health, Kinshasa, Democratic Republic of Congo.
FAU - Li, Yu
AU  - Li Y
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,National Center for Enteric and Zoonotic Infectious Diseases, Centers for DiseaseControl and Prevention, Atlanta, Georgia.
FAU - Reynolds, Mary G
AU  - Reynolds MG
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,National Center for Enteric and Zoonotic Infectious Diseases, Centers for DiseaseControl and Prevention, Atlanta, Georgia.
LA  - eng
GR  - U01 CK000539/CK/NCEZID CDC HHS/United States
PT  - Journal Article
DEP - 20161219
PL  - United States
TA  - Am J Trop Med Hyg
JT  - The American journal of tropical medicine and hygiene
JID - 0370507
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Child
MH  - Child, Preschool
MH  - Democratic Republic of the Congo/epidemiology
MH  - Female
MH  - Humans
MH  - Infant
MH  - Infant, Newborn
MH  - Male
MH  - Middle Aged
MH  - Monkeypox/*diagnosis/epidemiology/*genetics
MH  - Monkeypox virus/*genetics
MH  - Point-of-Care Systems
MH  - Polymerase Chain Reaction/*methods
MH  - Sensitivity and Specificity
MH  - Young Adult
PMC - PMC5303045
COIS- M. C. L. Vickery works for a company whose product is represented in thisarticle.
EDAT- 2016/12/21 06:00
MHDA- 2017/06/01 06:00
CRDT- 2016/12/21 06:00
PHST- 2016/07/11 00:00 [received]
PHST- 2016/10/27 00:00 [accepted]
PHST- 2016/12/21 06:00 [pubmed]
PHST- 2017/06/01 06:00 [medline]
PHST- 2016/12/21 06:00 [entrez]
AID - 10.4269/ajtmh.16-0567 [doi]
PST - ppublish
SO  - Am J Trop Med Hyg. 2017 Feb 8;96(2):405-410. doi: 10.4269/ajtmh.16-0567. Epub2016 Dec 19.

PMID- 30270859
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20201001
IS  - 2414-6366 (Electronic)
IS  - 2414-6366 (Linking)
VI  - 1
IP  - 1
DP  - 2016 Dec 20
TI  - Human Monkeypox: Current State of Knowledge and Implications for the Future.
LID - E8 [pii]
LID - 10.3390/tropicalmed1010008 [doi]
AB  - The zoonosis human monkeypox (MPX) was discovered in 1970, twelve years after thediscovery of monkeypox virus (MPXV) in a Danish laboratory in 1958. Historically confined to West Africa (WA) and the Congo basin (CB), new epidemics in Sudan andthe United States of America (USA) have fuelled new research highlightingenvironmental factors contributing to the expanded geographical spread ofmonkeypox virus (MPXV). A systematic literature review was conducted inMEDLINE((R)) (Ovid), MEDLINE((R)) (PubMed) and Google Scholar databases using thesearch terms: monkeypox, MPXV and "human monkeypox". The literature revealed MPX has classic prodromal symptoms followed by a total body rash. The soledistinguishing clinical characteristic from other pox-like illnesses is theprofound lymphadenopathy. Laboratory diagnosis of MPX is essential, a suitabletest for endemic areas is under development but not yet available. For the timebeing anti-poxvirus antibodies in an unvaccinated individual with a history ofsevere illness and rash can suggest MPX infection. The reservoir host remainselusive yet the rope squirrel and Gambian pouched rat appear to be the mostlikely candidates. Transmission includes fomite, droplet, direct contact withinfected humans or animals and consumption of infected meat. Though smallpoxvaccination is protective against MPXV, new non-immune generations contribute to increasing incidence. Environmental factors are increasing the frequency ofcontact with potential hosts, thus increasing the risk of animal-to-humantransmission. Increased risk of transmission through globalisation, conflict and environmental influences makes MPX a more realistic threat to previouslyunaffected countries. Health worker training and further development andaccessibility of suitable diagnostic tests, vaccinations and anti-viral treatmentis becoming increasingly necessary.
FAU - Brown, Katy
AU  - Brown K
AD  - College of Public Health, Medical and Veterinary Sciences, James Cook University,Townsville QLD 4811, Australia. katy.brown@my.jcu.edu.au.
AD  - Medecins Sans Frontieres, Geneva 1202, Switzerland. katy.brown@my.jcu.edu.au.
FAU - Leggat, Peter A
AU  - Leggat PA
AD  - College of Public Health, Medical and Veterinary Sciences, James Cook University,Townsville QLD 4811, Australia. peter.leggat@jcu.edu.au.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20161220
PL  - Switzerland
TA  - Trop Med Infect Dis
JT  - Tropical medicine and infectious disease
JID - 101709042
PMC - PMC6082047
OTO - NOTNLM
OT  - MPX
OT  - MPXV
OT  - human monkeypox
OT  - monkeypox
EDAT- 2016/12/20 00:00
MHDA- 2016/12/20 00:01
CRDT- 2018/10/02 06:00
PHST- 2016/09/30 00:00 [received]
PHST- 2016/12/11 00:00 [revised]
PHST- 2016/12/13 00:00 [accepted]
PHST- 2018/10/02 06:00 [entrez]
PHST- 2016/12/20 00:00 [pubmed]
PHST- 2016/12/20 00:01 [medline]
AID - tropicalmed1010008 [pii]
AID - 10.3390/tropicalmed1010008 [doi]
PST - epublish
SO  - Trop Med Infect Dis. 2016 Dec 20;1(1). pii: tropicalmed1010008. doi:10.3390/tropicalmed1010008.

PMID- 27938377
OWN - NLM
STAT- MEDLINE
DCOM- 20170821
LR  - 20191210
IS  - 1743-422X (Electronic)
IS  - 1743-422X (Linking)
VI  - 13
IP  - 1
DP  - 2016 Dec 9
TI  - Rapid and sensitive point-of-care detection of Orthopoxviruses by ABICAPimmunofiltration.
PG  - 207
AB  - BACKGROUND: The rapid and reliable detection of infectious agents is one of themost challenging tasks in scenarios lacking well-equipped laboratoryinfrastructure, like diagnostics in rural areas of developing countries.Commercially available point-of-care diagnostic tests for emerging and rarediseases are particularly scarce. RESULTS: In this work we present apoint-of-care test for the detection of Orthopoxviruses (OPV). The OPV ABICAPassay detects down to 1 x 10(4) plaque forming units/mL of OPV particles within45 min. It can be applied to clinical material like skin crusts and detects allzoonotic OPV infecting humans, including Vaccinia, Cowpox, Monkeypox, and mostimportantly Variola virus. CONCLUSIONS: Given the high sensitivity and the easeof handling, the novel assay could be highly useful for on-site diagnostics ofsuspected Monkeypox virus infections in areas lacking proper laboratoryinfrastructure as well as rapid on-site testing of suspected bioterrorismsamples.
FAU - Stern, Daniel
AU  - Stern D
AUID- ORCID: 0000-0001-9057-4283
AD  - Centre for Biological Threats and Special Pathogens (ZBS), Robert Koch Institute,Seestrasse 10, 13353, Berlin, Germany. SternD@rki.de.
FAU - Olson, Victoria A
AU  - Olson VA
AD  - Division of High-Consequence Pathogens and Pathology, Poxvirus and Rabies Branch,Centers for Disease Control and Prevention, Atlanta, GA, USA.
FAU - Smith, Scott K
AU  - Smith SK
AD  - Division of High-Consequence Pathogens and Pathology, Poxvirus and Rabies Branch,Centers for Disease Control and Prevention, Atlanta, GA, USA.
FAU - Pietraszczyk, Marko
AU  - Pietraszczyk M
AD  - Senova GmbH, Weimar, Germany.
FAU - Miller, Lilija
AU  - Miller L
AD  - Centre for Biological Threats and Special Pathogens (ZBS), Robert Koch Institute,Seestrasse 10, 13353, Berlin, Germany.
AD  - Novel Vaccination Strategies and Early Immune Responses, Paul-Ehrlich-Institut,Langen, Germany.
FAU - Miethe, Peter
AU  - Miethe P
AD  - FZMB GmbH, Bad Langensalza, Germany.
FAU - Dorner, Brigitte G
AU  - Dorner BG
AD  - Centre for Biological Threats and Special Pathogens (ZBS), Robert Koch Institute,Seestrasse 10, 13353, Berlin, Germany.
FAU - Nitsche, Andreas
AU  - Nitsche A
AD  - Centre for Biological Threats and Special Pathogens (ZBS), Robert Koch Institute,Seestrasse 10, 13353, Berlin, Germany.
LA  - eng
PT  - Evaluation Study
PT  - Journal Article
DEP - 20161209
PL  - England
TA  - Virol J
JT  - Virology journal
JID - 101231645
SB  - IM
MH  - Animals
MH  - Filtration/*methods
MH  - Humans
MH  - Immunoassay/*methods
MH  - Orthopoxvirus/*isolation & purification
MH  - *Point-of-Care Systems
MH  - Poxviridae Infections/*diagnosis/*veterinary
MH  - Sensitivity and Specificity
MH  - Time Factors
MH  - Virology/*methods
PMC - PMC5148848
OTO - NOTNLM
OT  - *ABICAP
OT  - *Cowpox virus
OT  - *Monkeypox virus
OT  - *Orthopoxvirus
OT  - *Point-of-care
OT  - *Rapid detection
OT  - *Vaccinia virus
OT  - *Variola virus
OT  - *Zoonosis
OT  - *bioterrorism
EDAT- 2016/12/13 06:00
MHDA- 2017/08/22 06:00
CRDT- 2016/12/13 06:00
PHST- 2016/07/01 00:00 [received]
PHST- 2016/12/02 00:00 [accepted]
PHST- 2016/12/13 06:00 [entrez]
PHST- 2016/12/13 06:00 [pubmed]
PHST- 2017/08/22 06:00 [medline]
AID - 10.1186/s12985-016-0665-5 [doi]
AID - 10.1186/s12985-016-0665-5 [pii]
PST - epublish
SO  - Virol J. 2016 Dec 9;13(1):207. doi: 10.1186/s12985-016-0665-5.

PMID- 27933782
OWN - NLM
STAT- MEDLINE
DCOM- 20180131
LR  - 20191008
IS  - 2373-8227 (Electronic)
IS  - 2373-8227 (Linking)
VI  - 2
IP  - 11
DP  - 2016 Nov 11
TI  - Integration of Global Analyses of Host Molecular Responses with Clinical Data To Evaluate Pathogenesis and Advance Therapies for Emerging and Re-emerging ViralInfections.
PG  - 787-799
AB  - Outbreaks associated with emerging and re-emerging viral pathogens continue toincrease in frequency and are associated with an increasing burden to globalhealth. In light of this, there is a need to integrate basic and clinicalresearch for investigating the connections between molecular and clinicalpathogenesis and for therapeutic development strategies. Here, we will discussthis approach with a focus on the emerging viral pathogens Middle Eastrespiratory syndrome coronavirus (MERS-CoV), Ebola virus (EBOV), and monkeypoxvirus (MPXV) from the context of clinical presentation, immunological andmolecular features of the diseases, and OMICS-based analyses of pathogenesis.Furthermore, we will highlight the role of global investigations of host kinases,the kinome, for investigating emerging and re-emerging viral pathogens from thecontext of characterizing cellular responses and identifying novel therapeutictargets. Lastly, we will address how increased integration of clinical and basic research will assist treatment and prevention efforts for emerging pathogens.
FAU - Falcinelli, Shane D
AU  - Falcinelli SD
AD  - Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland 20814, United States.
FAU - Chertow, Daniel S
AU  - Chertow DS
AD  - Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland 20814, United States.
FAU - Kindrachuk, Jason
AU  - Kindrachuk J
AD  - Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland 20814, United States.
LA  - eng
GR  - Z99 CL999999/Intramural NIH HHS/United States
PT  - Journal Article
PT  - Review
PT  - Research Support, N.I.H., Intramural
DEP - 20160805
PL  - United States
TA  - ACS Infect Dis
JT  - ACS infectious diseases
JID - 101654580
RN  - 0 (Antiviral Agents)
SB  - IM
MH  - Animals
MH  - Antiviral Agents/pharmacology
MH  - Humans
MH  - Virus Diseases/drug therapy/*genetics/metabolism/*virology
MH  - *Virus Physiological Phenomena
MH  - Viruses/drug effects/genetics/pathogenicity
PMC - PMC6131701
MID - NIHMS987446
OTO - NOTNLM
OT  - *cell signaling
OT  - *emerging pathogens
OT  - *high-consequence pathogens
OT  - *kinases
OT  - *kinomics
OT  - *virology
EDAT- 2016/12/10 06:00
MHDA- 2018/02/01 06:00
CRDT- 2016/12/10 06:00
PHST- 2016/12/10 06:00 [entrez]
PHST- 2016/12/10 06:00 [pubmed]
PHST- 2018/02/01 06:00 [medline]
AID - 10.1021/acsinfecdis.6b00104 [doi]
PST - ppublish
SO  - ACS Infect Dis. 2016 Nov 11;2(11):787-799. doi: 10.1021/acsinfecdis.6b00104. Epub2016 Aug 5.

PMID- 27783372
OWN - NLM
STAT- MEDLINE
DCOM- 20170303
LR  - 20170303
IS  - 1961-9049 (Electronic)
IS  - 0037-9085 (Linking)
VI  - 109
IP  - 5
DP  - 2016 Dec
TI  - [Twelve cases of monkeypox virus outbreak in Bangassou District (Central African Republic) in December 2015].
PG  - 358-363
LID - 10.1007/s13149-016-0516-z [doi]
AB  - An outbreak of monkeypox occurred in the district of Bangassou in 2015. Themonkeypox is a re-emerging zoonosis of viral origin highly contagious. It is aneruptive fever which evolves in an epidemic manner. An investigation was heldDecember 10, 2015, to February 10, 2016 in the focus of the epidemic. Itsobjective was to describe the epidemic according to the time, places and peopleand to determine the incidence and lethality of the disease. This was adescriptive study. The data collection was made by interview and using a linearplug composed of several sections. All suspected cases were taken into account.The interview was done with patients or the parents of sick children. The bloodand the contents of the lesions were collected and sent to the laboratory of the Institut Pasteur in Bangui for confirmation. Our data were analyzed with Epiinfo7. In total 12 patients had been registered including 9 secondary cases.Patients aged 31 to 40 years and less than 10 years were most affected. Inaddition, adults were most affected by the disease (8/12). The average age was 25years with extremes at 15 months and 41 years. The sex male/female ratio was 1.The overall attack rate of disease and lethality were 0.2 per 1000 inhabitantsand 25% respectively. The fatality was 67% among children less than 10 years.Fever and rash were the main symptoms of the disease. Lymphadenopathy was presentin 54.5%. Ten of the 12 patients were hospitalized (83%). The average duration ofhospitalization was 13 days with the extremes 6 and 28 days. The monkeypox likesmallpox remains a serious and fatal disease in children. A survey of animalreservoirs complained to identify strains of the virus is essential. During anoutbreak, good communication and isolation of patients may break the chain oftransmission. Other measures to limit their contact with the forest or virusreservoirs are to be encouraged.
FAU - Kalthan, E
AU  - Kalthan E
AD  - Direction de la region sanitaire No6, Bangui, Republique centrafricaine.kalthanernest@yahoo.fr.
FAU - Dondo-Fongbia, J P
AU  - Dondo-Fongbia JP
AD  - Hopital regional universitaire de Bangassou, Bangassou, Republiquecentrafricaine.
FAU - Yambele, S
AU  - Yambele S
AD  - District sanitaire de Bangassou, Bangassou, Republique centrafricaine.
FAU - Dieu-Creer, L R
AU  - Dieu-Creer LR
AD  - Direction de la region sanitaire No6, Bangui, Republique centrafricaine.
FAU - Zepio, R
AU  - Zepio R
AD  - District sanitaire de Bangassou, Bangassou, Republique centrafricaine.
FAU - Pamatika, C M
AU  - Pamatika CM
AD  - Unite des mycobacteries, Service de laboratoire, Hopital de l'Amitie, Bangui,Republique centrafricaine.
LA  - fre
PT  - Journal Article
TT  - Epidemie de 12 cas de maladie a virus monkeypox dans le district de Bangassou en Republique Centrafricaine en decembre 2015.
DEP - 20161025
PL  - France
TA  - Bull Soc Pathol Exot
JT  - Bulletin de la Societe de pathologie exotique (1990)
JID - 9212564
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Animals
MH  - Central African Republic
MH  - Child
MH  - Child, Preschool
MH  - *Disease Outbreaks
MH  - Epidemics
MH  - Female
MH  - Humans
MH  - Infant
MH  - Male
MH  - Monkeypox/diagnosis/*epidemiology
MH  - Monkeypox virus/isolation & purification
MH  - Young Adult
MH  - Zoonoses/*epidemiology/virology
OTO - NOTNLM
OT  - *Bakouma
OT  - *Bandoufou
OT  - *Bangassou
OT  - *Central African Republic
OT  - *Epidemic
OT  - *Fadama
OT  - *Investigation
OT  - *Lingo
OT  - *Madigui
OT  - *Monkeypox
OT  - *Sub-Saharan Africa
OT  - *Zoonosis
EDAT- 2016/10/27 06:00
MHDA- 2017/03/04 06:00
CRDT- 2016/10/27 06:00
PHST- 2016/03/26 00:00 [received]
PHST- 2016/06/02 00:00 [accepted]
PHST- 2016/10/27 06:00 [pubmed]
PHST- 2017/03/04 06:00 [medline]
PHST- 2016/10/27 06:00 [entrez]
AID - 10.1007/s13149-016-0516-z [doi]
AID - 10.1007/s13149-016-0516-z [pii]
PST - ppublish
SO  - Bull Soc Pathol Exot. 2016 Dec;109(5):358-363. doi: 10.1007/s13149-016-0516-z.Epub 2016 Oct 25.

PMID- 27768891
OWN - NLM
STAT- MEDLINE
DCOM- 20161216
LR  - 20190610
IS  - 1097-4172 (Electronic)
IS  - 0092-8674 (Linking)
VI  - 167
IP  - 3
DP  - 2016 Oct 20
TI  - Cross-Neutralizing and Protective Human Antibody Specificities to PoxvirusInfections.
PG  - 684-694.e9
LID - S0092-8674(16)31334-4 [pii]
LID - 10.1016/j.cell.2016.09.049 [doi]
AB  - Monkeypox (MPXV) and cowpox (CPXV) are emerging agents that cause severe humaninfections on an intermittent basis, and variola virus (VARV) has potential foruse as an agent of bioterror. Vaccinia immune globulin (VIG) has been usedtherapeutically to treat severe orthopoxvirus infections but is in short supply. We generated a large panel of orthopoxvirus-specific human monoclonal antibodies (Abs) from immune subjects to investigate the molecular basis of broadlyneutralizing antibody responses for diverse orthopoxviruses. Detailed analysisrevealed the principal neutralizing antibody specificities that arecross-reactive for VACV, CPXV, MPXV, and VARV and that are determinants ofprotection in murine challenge models. Optimal protection following respiratoryor systemic infection required a mixture of Abs that targeted several membraneproteins, including proteins on enveloped and mature virion forms of virus. This work reveals orthopoxvirus targets for human Abs that mediate cross-protectiveimmunity and identifies new candidate Ab therapeutic mixtures to replace VIG.
CI  - Copyright (c) 2016 Elsevier Inc. All rights reserved.
FAU - Gilchuk, Iuliia
AU  - Gilchuk I
AD  - The Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville,TN 37232, USA.
FAU - Gilchuk, Pavlo
AU  - Gilchuk P
AD  - Department of Pathology, Microbiology and Immunology, Vanderbilt UniversityMedical Center, Nashville, TN 37232, USA; Veterans Administration TennesseeValley Healthcare System, Nashville, TN 37332, USA.
FAU - Sapparapu, Gopal
AU  - Sapparapu G
AD  - The Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville,TN 37232, USA; Department of Pediatrics, Vanderbilt University Medical Center,Nashville, TN 37232, USA.
FAU - Lampley, Rebecca
AU  - Lampley R
AD  - The Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville,TN 37232, USA.
FAU - Singh, Vidisha
AU  - Singh V
AD  - The Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville,TN 37232, USA.
FAU - Kose, Nurgun
AU  - Kose N
AD  - The Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville,TN 37232, USA.
FAU - Blum, David L
AU  - Blum DL
AD  - The Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville,TN 37232, USA.
FAU - Hughes, Laura J
AU  - Hughes LJ
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.
FAU - Satheshkumar, Panayampalli S
AU  - Satheshkumar PS
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.
FAU - Townsend, Michael B
AU  - Townsend MB
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.
FAU - Kondas, Ashley V
AU  - Kondas AV
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.
FAU - Reed, Zachary
AU  - Reed Z
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA; Laboratory Leadership Service, Centers for Disease Control andPrevention, Atlanta, GA 30329, USA.
FAU - Weiner, Zachary
AU  - Weiner Z
AD  - Laboratory Leadership Service, Centers for Disease Control and Prevention,Atlanta, GA 30329, USA.
FAU - Olson, Victoria A
AU  - Olson VA
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.
FAU - Hammarlund, Erika
AU  - Hammarlund E
AD  - Division of Neuroscience, Oregon National Primate Research Center, Beaverton, OR 97006, USA.
FAU - Raue, Hans-Peter
AU  - Raue HP
AD  - Division of Neuroscience, Oregon National Primate Research Center, Beaverton, OR 97006, USA.
FAU - Slifka, Mark K
AU  - Slifka MK
AD  - Division of Neuroscience, Oregon National Primate Research Center, Beaverton, OR 97006, USA.
FAU - Slaughter, James C
AU  - Slaughter JC
AD  - Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
FAU - Graham, Barney S
AU  - Graham BS
AD  - Vaccine Research Center, National Institute of Allergy and Infectious Diseases,Bethesda, MD 20892, USA.
FAU - Edwards, Kathryn M
AU  - Edwards KM
AD  - Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN37232, USA.
FAU - Eisenberg, Roselyn J
AU  - Eisenberg RJ
AD  - Department of Pathobiology, School of Veterinary Medicine, University ofPennsylvania, Philadelphia, PA 19104, USA.
FAU - Cohen, Gary H
AU  - Cohen GH
AD  - Department of Microbiology, School of Dental Medicine, University ofPennsylvania, Philadelphia, PA 19104, USA.
FAU - Joyce, Sebastian
AU  - Joyce S
AD  - Department of Pathology, Microbiology and Immunology, Vanderbilt UniversityMedical Center, Nashville, TN 37232, USA; Veterans Administration TennesseeValley Healthcare System, Nashville, TN 37332, USA.
FAU - Crowe, James E Jr
AU  - Crowe JE Jr
AD  - The Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville,TN 37232, USA; Department of Pathology, Microbiology and Immunology, VanderbiltUniversity Medical Center, Nashville, TN 37232, USA; Department of Pediatrics,Vanderbilt University Medical Center, Nashville, TN 37232, USA. Electronicaddress: james.crowe@vanderbilt.edu.
LA  - eng
GR  - P51 OD011092/OD/NIH HHS/United States
GR  - UL1 TR000445/TR/NCATS NIH HHS/United States
GR  - I01 BX001444/BX/BLRD VA/United States
GR  - P30 DK058404/DK/NIDDK NIH HHS/United States
GR  - U01 AI48512/AI/NIAID NIH HHS/United States
GR  - U19 AI109948/AI/NIAID NIH HHS/United States
GR  - P30 CA068485/CA/NCI NIH HHS/United States
GR  - UL1 RR024975/RR/NCRR NIH HHS/United States
GR  - HHSN272200900047C/AI/NIAID NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, N.I.H., Intramural
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Cell
JT  - Cell
JID - 0413066
RN  - 0 (Antibodies, Monoclonal)
RN  - 0 (Antibodies, Neutralizing)
RN  - 0 (Antibodies, Viral)
SB  - IM
MH  - Antibodies, Monoclonal/*immunology
MH  - Antibodies, Neutralizing/*immunology
MH  - Antibodies, Viral/*immunology
MH  - *Antibody Specificity
MH  - Cowpox/immunology
MH  - Cowpox virus/immunology
MH  - Cross Reactions
MH  - Humans
MH  - Leukocytes, Mononuclear/immunology
MH  - Monkeypox/immunology
MH  - Monkeypox virus/immunology
MH  - Poxviridae Infections/*immunology
MH  - Smallpox/immunology
MH  - Vaccinia/immunology
MH  - Vaccinia virus/immunology
MH  - Variola virus/immunology
PMC - PMC5093772
MID - NIHMS820462
OTO - NOTNLM
OT  - antigen specificity
OT  - cross-neutralization
OT  - human monoclonal antibodies
OT  - poxvirus infections
OT  - protective immunity
OT  - smallpox vaccine
EDAT- 2016/10/22 06:00
MHDA- 2016/12/17 06:00
CRDT- 2016/10/22 06:00
PHST- 2016/06/24 00:00 [received]
PHST- 2016/09/02 00:00 [revised]
PHST- 2016/09/27 00:00 [accepted]
PHST- 2016/10/22 06:00 [pubmed]
PHST- 2016/12/17 06:00 [medline]
PHST- 2016/10/22 06:00 [entrez]
AID - S0092-8674(16)31334-4 [pii]
AID - 10.1016/j.cell.2016.09.049 [doi]
PST - ppublish
SO  - Cell. 2016 Oct 20;167(3):684-694.e9. doi: 10.1016/j.cell.2016.09.049.

PMID- 27637905
OWN - NLM
STAT- MEDLINE
DCOM- 20171116
LR  - 20180212
IS  - 1872-9096 (Electronic)
IS  - 0166-3542 (Linking)
VI  - 134
DP  - 2016 Oct
TI  - Protection of mice against the highly pathogenic VVIHD-J by DNA and fowlpoxrecombinant vaccines, administered by electroporation and intranasal routes,correlates with serum neutralizing activity.
PG  - 182-191
LID - S0166-3542(16)30370-9 [pii]
LID - 10.1016/j.antiviral.2016.09.002 [doi]
AB  - The control of smallpox was achieved using live vaccinia virus (VV) vaccine,which successfully eradicated the disease worldwide. As the variola virus nolonger exists as a natural infection agent, mass vaccination was discontinuedafter 1980. However, emergence of smallpox outbreaks caused by accidental ordeliberate release of variola virus has stimulated new research forsecond-generation vaccine development based on attenuated VV strains. Consideringthe closely related animal poxviruses that also arise as zoonoses, and theincreasing number of unvaccinated or immunocompromised people, a safer and moreeffective vaccine is still required. With this aim, new vectors based on avianpoxviruses that cannot replicate in mammals should improve the safety ofconventional vaccines, and protect from zoonotic orthopoxvirus diseases, such as cowpox and monkeypox. In this study, DNA and fowlpox (FP) recombinants thatexpressed the VV L1R, A27L, A33R, and B5R genes were generated (4DNAmix, 4FPmix, respectively) and tested in mice using novel administration routes. Mice wereprimed with 4DNAmix by electroporation, and boosted with 4FPmix appliedintranasally. The lethal VVIHD-J strain was then administered by intranasalchallenge. All of the mice receiving 4DNAmix followed by 4FPmix, and 20% of themice immunized only with 4FPmix, were protected. The induction of specifichumoral and cellular immune responses directly correlated with this protection.In particular, higher anti-A27 antibodies and IFNgamma-producing T lymphocyteswere measured in the blood and spleen of the protected mice, as compared tocontrols. VVIHD-J neutralizing antibodies in sera from the protected mice suggestthat the prime/boost vaccination regimen with 4DNAmix plus 4FPmix may be aneffective and safe mode to induce protection against smallpox and poxviruszoonotic infections. The electroporation/intranasal administration routescontributed to effective immune responses and mouse survival.
CI  - Copyright (c) 2016 Elsevier B.V. All rights reserved.
FAU - Bissa, Massimiliano
AU  - Bissa M
AD  - Department of Pharmacological and Biomolecular Sciences, University of Milan, ViaBalzaretti, 9, 20133 Milano, Italy. Electronic address:massimiliano.bissa@nih.gov.
FAU - Quaglino, Elena
AU  - Quaglino E
AD  - Department of Molecular Biotechnology and Health Sciences, MolecularBiotechnology Center, University of Turin, Via Nizza 52, 10126 Torino, Italy.Electronic address: elena.quaglino@unito.it.
FAU - Zanotto, Carlo
AU  - Zanotto C
AD  - Department of Medical Biotechnologies and Translational Medicine, University ofMilan, Via Vanvitelli, 32, 20129 Milano, Italy. Electronic address:carlo.zanotto@unimi.it.
FAU - Illiano, Elena
AU  - Illiano E
AD  - Department of Pharmacological and Biomolecular Sciences, University of Milan, ViaBalzaretti, 9, 20133 Milano, Italy. Electronic address: elena.illiano@unimi.it.
FAU - Rolih, Valeria
AU  - Rolih V
AD  - Department of Molecular Biotechnology and Health Sciences, MolecularBiotechnology Center, University of Turin, Via Nizza 52, 10126 Torino, Italy.Electronic address: valeria.rolih@unito.it.
FAU - Pacchioni, Sole
AU  - Pacchioni S
AD  - Department of Pharmacological and Biomolecular Sciences, University of Milan, ViaBalzaretti, 9, 20133 Milano, Italy. Electronic address: sol83@libero.it.
FAU - Cavallo, Federica
AU  - Cavallo F
AD  - Department of Molecular Biotechnology and Health Sciences, MolecularBiotechnology Center, University of Turin, Via Nizza 52, 10126 Torino, Italy.Electronic address: federica.cavallo@unito.it.
FAU - De Giuli Morghen, Carlo
AU  - De Giuli Morghen C
AD  - Department of Medical Biotechnologies and Translational Medicine, University ofMilan, Via Vanvitelli, 32, 20129 Milano, Italy; Catholic University "Our Lady of Good Counsel", Rr. Dritan Hoxha, Tirana, Albania. Electronic address:carlo.degiulimorghen@unimi.it.
FAU - Radaelli, Antonia
AU  - Radaelli A
AD  - Department of Pharmacological and Biomolecular Sciences, University of Milan, ViaBalzaretti, 9, 20133 Milano, Italy; Cellular and Molecular Pharmacology Section, National Research Council (CNR), Institute of Neurosciences, University of Milan,Via Vanvitelli, 32, 20129 Milano, Italy. Electronic address:antonia.radaelli@unimi.it.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20160913
PL  - Netherlands
TA  - Antiviral Res
JT  - Antiviral research
JID - 8109699
RN  - 0 (Antibodies, Neutralizing)
RN  - 0 (Smallpox Vaccine)
RN  - 0 (Vaccines, Synthetic)
RN  - 0 (Viral Vaccines)
RN  - 82115-62-6 (Interferon-gamma)
SB  - IM
MH  - Animals
MH  - Antibodies, Neutralizing/*blood
MH  - *Electroporation
MH  - Fowlpox/*genetics
MH  - Immunity, Cellular
MH  - Immunity, Humoral
MH  - Interferon-gamma/blood/immunology
MH  - Mice
MH  - Monkeypox/prevention & control
MH  - Neutralization Tests
MH  - Smallpox/prevention & control
MH  - Smallpox Vaccine/*administration & dosage/genetics/immunology
MH  - Vaccination/*methods
MH  - Vaccines, Synthetic/administration & dosage/genetics/immunology
MH  - Vaccinia virus/*genetics/pathogenicity
MH  - Viral Vaccines/administration & dosage/genetics/immunology
OTO - NOTNLM
OT  - *Fowlpox virus
OT  - *Intranasal mucosal vaccination
OT  - *L1R, A27L, A33R, B5R VV genes
OT  - *OPXV vaccine
OT  - *Prime/boost
OT  - *Recombinant vaccines
EDAT- 2016/09/18 06:00
MHDA- 2017/11/29 06:00
CRDT- 2016/09/18 06:00
PHST- 2016/07/12 00:00 [received]
PHST- 2016/09/05 00:00 [revised]
PHST- 2016/09/09 00:00 [accepted]
PHST- 2016/09/18 06:00 [pubmed]
PHST- 2017/11/29 06:00 [medline]
PHST- 2016/09/18 06:00 [entrez]
AID - S0166-3542(16)30370-9 [pii]
AID - 10.1016/j.antiviral.2016.09.002 [doi]
PST - ppublish
SO  - Antiviral Res. 2016 Oct;134:182-191. doi: 10.1016/j.antiviral.2016.09.002. Epub2016 Sep 13.

PMID- 27585810
OWN - NLM
STAT- MEDLINE
DCOM- 20170911
LR  - 20191210
IS  - 1471-2164 (Electronic)
IS  - 1471-2164 (Linking)
VI  - 17 Suppl 5
DP  - 2016 Aug 31
TI  - Finishing monkeypox genomes from short reads: assembly analysis and a neuralnetwork method.
PG  - 497
LID - 10.1186/s12864-016-2826-8 [doi]
AB  - BACKGROUND: Poxviruses constitute one of the largest and most complex animalvirus families known. The notorious smallpox disease has been eradicated and the virus contained, but its simian sister, monkeypox is an emerging, untreatableinfectious disease, killing 1 to 10 % of its human victims. In the case ofpoxviruses, the emergence of monkeypox outbreaks in humans and the need tomonitor potential malicious release of smallpox virus requires development ofmethods for rapid virus identification. Whole-genome sequencing (WGS) is anemergent technology with increasing application to the diagnosis of diseases and the identification of outbreak pathogens. But "finishing" such a genome is alaborious and time-consuming process, not easily automated. To date the large,complete poxvirus genomes have not been studied comprehensively in terms ofapplying WGS techniques and evaluating genome assembly algorithms. RESULTS: Toexplore the limitations to finishing a poxvirus genome from short reads, we firstanalyze the repetitive regions in a monkeypox genome and evaluate genome assemblyon the simulated reads. We also report on procedures and insights relevant to theassembly (from realistically short reads) of genomes. Finally, we propose aneural network method (namely Neural-KSP) to "finish" the process by closing gapsremaining after conventional assembly, as the final stage in a protocol toelucidate clinical poxvirus genomic sequences. CONCLUSIONS: The protocol mayprove useful in any clinical viral isolate (regardless if a reference-strainsequence is available) and especially useful in genomes confounded by many globaland local repetitive sequences embedded in them. This work highlights thefeasibility of finishing real, complex genomes by systematically analyzinggenetic characteristics, thus remedying existing assembly shortcomings with aneural network method. Such finished sequences may enable clinicians to trackgenetic distance between viral isolates that provides a powerful epidemiological tool.
FAU - Zhao, Kun
AU  - Zhao K
AD  - Office of Infectious Diseases, Centers for Disease Control and Prevention,Atlanta, 30333, USA. vzt5@cdc.gov.
FAU - Wohlhueter, Robert M
AU  - Wohlhueter RM
AD  - Department of Chemistry, Georgia State University, Atlanta, 30303, USA.
FAU - Li, Yu
AU  - Li Y
AD  - Poxvirus and Rabies Branch, Division of High Consequence Pathogens and Pathology,National Center for Emerging and Zoonotic Infectious Diseases, Centers forDisease Control and Prevention, Atlanta, 30333, USA.
LA  - eng
PT  - Journal Article
DEP - 20160831
PL  - England
TA  - BMC Genomics
JT  - BMC genomics
JID - 100965258
SB  - IM
MH  - *Genome, Viral
MH  - High-Throughput Nucleotide Sequencing
MH  - Humans
MH  - Monkeypox/virology
MH  - Monkeypox virus/*genetics
MH  - Neural Networks, Computer
MH  - Sequence Analysis, DNA
PMC - PMC5009526
OTO - NOTNLM
OT  - *Gap filling
OT  - *Graph
OT  - *Neural Network
OT  - *Poxvirus
OT  - *Public health
OT  - *Repetitive sequence
OT  - *Whole-genome sequencing
OT  - *de novo Assembly
EDAT- 2016/09/03 06:00
MHDA- 2017/09/12 06:00
CRDT- 2016/09/03 06:00
PHST- 2016/09/03 06:00 [entrez]
PHST- 2016/09/03 06:00 [pubmed]
PHST- 2017/09/12 06:00 [medline]
AID - 10.1186/s12864-016-2826-8 [doi]
AID - 10.1186/s12864-016-2826-8 [pii]
PST - epublish
SO  - BMC Genomics. 2016 Aug 31;17 Suppl 5:497. doi: 10.1186/s12864-016-2826-8.

PMID- 27477914
OWN - NLM
STAT- MEDLINE
DCOM- 20171004
LR  - 20191210
IS  - 1879-0984 (Electronic)
IS  - 0166-0934 (Linking)
VI  - 236
DP  - 2016 Oct
TI  - Species-specific differentiation of variola, monkeypox, and varicella-zosterviruses by multiplex real-time PCR assay.
PG  - 215-220
LID - S0166-0934(16)30067-2 [pii]
LID - 10.1016/j.jviromet.2016.07.024 [doi]
AB  - A method of one-stage rapid detection and differentiation of epidemiologicallyimportant variola virus (VARV), monkeypox virus (MPXV), and varicella-zostervirus (VZV) utilizing multiplex real-time TaqMan PCR assay was developed. Fourhybridization probes with various fluorescent dyes and the correspondingfluorescence quenchers were simultaneously used for the assay. The hybridization probes specific for the VARV sequence contained FAM/BHQ1 as a dye/quencher pair; MPXV-specific, JOE/BHQ1; VZV-specific, TAMRA/BHQ2; and internal control-specific,Cy5/BHQ3. The specificity and sensitivity of the developed method were assessedby analyzing DNA of 32 strains belonging to orthopoxvirus and herpesvirusspecies.
CI  - Copyright (c) 2016 Elsevier B.V. All rights reserved.
FAU - Maksyutov, Rinat A
AU  - Maksyutov RA
AD  - State Research Center of Virology and Biotechnology "VECTOR", Koltsovo,Novosibirsk Region, 630559, Russia. Electronic address: maksrinat@yandex.ru.
FAU - Gavrilova, Elena V
AU  - Gavrilova EV
AD  - State Research Center of Virology and Biotechnology "VECTOR", Koltsovo,Novosibirsk Region, 630559, Russia. Electronic address: lgavrilova@yandex.ru.
FAU - Shchelkunov, Sergei N
AU  - Shchelkunov SN
AD  - State Research Center of Virology and Biotechnology "VECTOR", Koltsovo,Novosibirsk Region, 630559, Russia. Electronic address: snshchel@vector.nsc.ru.
LA  - eng
PT  - Evaluation Study
PT  - Journal Article
DEP - 20160728
PL  - Netherlands
TA  - J Virol Methods
JT  - Journal of virological methods
JID - 8005839
SB  - IM
MH  - Herpesvirus 3, Human/classification/genetics/*isolation & purification
MH  - Monkeypox virus/classification/genetics/*isolation & purification
MH  - Multiplex Polymerase Chain Reaction/*methods
MH  - Real-Time Polymerase Chain Reaction/*methods
MH  - Sensitivity and Specificity
MH  - Variola virus/classification/genetics/*isolation & purification
MH  - Virology/*methods
OTO - NOTNLM
OT  - *Monkeypox virus
OT  - *Real-time PCR
OT  - *Varicella-zoster virus
OT  - *Variola virus
EDAT- 2016/08/02 06:00
MHDA- 2017/10/05 06:00
CRDT- 2016/08/02 06:00
PHST- 2016/02/09 00:00 [received]
PHST- 2016/07/23 00:00 [revised]
PHST- 2016/07/25 00:00 [accepted]
PHST- 2016/08/02 06:00 [entrez]
PHST- 2016/08/02 06:00 [pubmed]
PHST- 2017/10/05 06:00 [medline]
AID - S0166-0934(16)30067-2 [pii]
AID - 10.1016/j.jviromet.2016.07.024 [doi]
PST - ppublish
SO  - J Virol Methods. 2016 Oct;236:215-220. doi: 10.1016/j.jviromet.2016.07.024. Epub 2016 Jul 28.

PMID- 27467578
OWN - NLM
STAT- MEDLINE
DCOM- 20170504
LR  - 20181113
IS  - 1096-0341 (Electronic)
IS  - 0042-6822 (Linking)
VI  - 497
DP  - 2016 Oct
TI  - Monkeypox virus induces the synthesis of less dsRNA than vaccinia virus, and ismore resistant to the anti-poxvirus drug, IBT, than vaccinia virus.
PG  - 125-135
LID - S0042-6822(16)30183-0 [pii]
LID - 10.1016/j.virol.2016.07.016 [doi]
AB  - Monkeypox virus (MPXV) infection fails to activate the host anti-viral protein,PKR, despite lacking a full-length homologue of the vaccinia virus (VACV) PKRinhibitor, E3. Since PKR can be activated by dsRNA produced during a viralinfection, we have analyzed the accumulation of dsRNA in MPXV-infected cells.MPXV infection led to less accumulation of dsRNA than VACV infection. Because in VACV infections accumulation of abnormally low amounts of dsRNA is associatedwith mutations that lead to resistance to the anti-poxvirus drug isatinbeta-thiosemicarbazone (IBT), we investigated the effects of treatment ofMPXV-infected cells with IBT. MPXV infection was eight-fold more resistant to IBTthan wild-type vaccinia virus (wtVACV). These results demonstrate that MPXVinfection leads to the accumulation of less dsRNA than wtVACV, which in turnlikely leads to a decreased capacity for activation of the dsRNA-dependent hostenzyme, PKR.
CI  - Copyright (c) 2016 Elsevier Inc. All rights reserved.
FAU - Arndt, William D
AU  - Arndt WD
AD  - School of Life Sciences, Arizona State University, MC5401, Tempe, AZ 85287-5401, USA; The Biodesign Institute, Center for Infectious Diseases and Vaccinology,Arizona State University, MC5401, Tempe, AZ 85287-5401, USA. Electronic address: wdarndt@sandia.gov.
FAU - White, Stacy D
AU  - White SD
AD  - School of Life Sciences, Arizona State University, MC5401, Tempe, AZ 85287-5401, USA; The Biodesign Institute, Center for Infectious Diseases and Vaccinology,Arizona State University, MC5401, Tempe, AZ 85287-5401, USA. Electronic address: Stacy.White@azdhs.gov.
FAU - Johnson, Brian P
AU  - Johnson BP
AD  - The Biodesign Institute, Center for Infectious Diseases and Vaccinology, Arizona State University, MC5401, Tempe, AZ 85287-5401, USA. Electronic address:brian.p.johnson@asu.edu.
FAU - Huynh, Trung
AU  - Huynh T
AD  - School of Life Sciences, Arizona State University, MC5401, Tempe, AZ 85287-5401, USA; The Biodesign Institute, Center for Infectious Diseases and Vaccinology,Arizona State University, MC5401, Tempe, AZ 85287-5401, USA. Electronic address: trung.huynh@asu.edu.
FAU - Liao, Jeffrey
AU  - Liao J
AD  - School of Life Sciences, Arizona State University, MC5401, Tempe, AZ 85287-5401, USA; The Biodesign Institute, Center for Infectious Diseases and Vaccinology,Arizona State University, MC5401, Tempe, AZ 85287-5401, USA. Electronic address: Jeffrey.liao@asu.edu.
FAU - Harrington, Heather
AU  - Harrington H
AD  - School of Life Sciences, Arizona State University, MC5401, Tempe, AZ 85287-5401, USA; The Biodesign Institute, Center for Infectious Diseases and Vaccinology,Arizona State University, MC5401, Tempe, AZ 85287-5401, USA. Electronic address: heather.harrington@asu.edu.
FAU - Cotsmire, Samantha
AU  - Cotsmire S
AD  - The Biodesign Institute, Center for Infectious Diseases and Vaccinology, Arizona State University, MC5401, Tempe, AZ 85287-5401, USA. Electronic address:Samantha.cotsmire@asu.edu.
FAU - Kibler, Karen V
AU  - Kibler KV
AD  - The Biodesign Institute, Center for Infectious Diseases and Vaccinology, Arizona State University, MC5401, Tempe, AZ 85287-5401, USA. Electronic address:Karen.kibler@asu.edu.
FAU - Langland, Jeffrey
AU  - Langland J
AD  - The Biodesign Institute, Center for Infectious Diseases and Vaccinology, Arizona State University, MC5401, Tempe, AZ 85287-5401, USA. Electronic address:jeffrey.langland@asu.edu.
FAU - Jacobs, Bertram L
AU  - Jacobs BL
AD  - School of Life Sciences, Arizona State University, MC5401, Tempe, AZ 85287-5401, USA; The Biodesign Institute, Center for Infectious Diseases and Vaccinology,Arizona State University, MC5401, Tempe, AZ 85287-5401, USA. Electronic address: bjacobs@asu.edu.
LA  - eng
GR  - R01 AI095394/AI/NIAID NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20160726
PL  - United States
TA  - Virology
JT  - Virology
JID - 0110674
RN  - 0 (Antiviral Agents)
RN  - 0 (DNA, Viral)
RN  - 0 (RNA, Double-Stranded)
RN  - 0 (Viral Proteins)
SB  - IM
MH  - Antiviral Agents/*pharmacology
MH  - Cell Line
MH  - DNA, Viral
MH  - *Drug Resistance, Viral
MH  - HeLa Cells
MH  - Humans
MH  - Monkeypox virus/*drug effects/*physiology
MH  - Open Reading Frames
MH  - RNA, Double-Stranded/*biosynthesis
MH  - Transcription, Genetic
MH  - Vaccinia virus/*drug effects/*physiology
MH  - Viral Proteins/genetics
MH  - Virulence/genetics
MH  - Virus Replication
PMC - PMC5026613
MID - NIHMS805941
OTO - NOTNLM
OT  - *E3 gene
OT  - *F3 gene
OT  - *IBT resistance
OT  - *Innate immune evasion
OT  - *Monkeypox virus
OT  - *Poxvirus pathogenesis
OT  - *Poxvirus transcription
OT  - *Vaccinia virus
OT  - *Virulence
OT  - *dsRNA
EDAT- 2016/07/29 06:00
MHDA- 2017/05/05 06:00
CRDT- 2016/07/29 06:00
PHST- 2016/04/13 00:00 [received]
PHST- 2016/07/16 00:00 [revised]
PHST- 2016/07/18 00:00 [accepted]
PHST- 2016/07/29 06:00 [entrez]
PHST- 2016/07/29 06:00 [pubmed]
PHST- 2017/05/05 06:00 [medline]
AID - S0042-6822(16)30183-0 [pii]
AID - 10.1016/j.virol.2016.07.016 [doi]
PST - ppublish
SO  - Virology. 2016 Oct;497:125-135. doi: 10.1016/j.virol.2016.07.016. Epub 2016 Jul26.

PMID- 27466413
OWN - NLM
STAT- MEDLINE
DCOM- 20170509
LR  - 20181113
IS  - 1098-5514 (Electronic)
IS  - 0022-538X (Linking)
VI  - 90
IP  - 19
DP  - 2016 Oct 1
TI  - Retrograde Transport from Early Endosomes to the trans-Golgi Network EnablesMembrane Wrapping and Egress of Vaccinia Virus Virions.
PG  - 8891-905
LID - 10.1128/JVI.01114-16 [doi]
AB  - UNLABELLED: The anterograde pathway, from the endoplasmic reticulum through thetrans-Golgi network to the cell surface, is utilized by trans-membrane andsecretory proteins. The retrograde pathway, which directs traffic in the oppositedirection, is used following endocytosis of exogenous molecules and recycling of membrane proteins. Microbes exploit both routes: viruses typically use theanterograde pathway for envelope formation prior to exiting the cell, whereasricin and Shiga-like toxins and some nonenveloped viruses use the retrogradepathway for cell entry. Mining a human genome-wide RNA interference (RNAi) screenrevealed a need for multiple retrograde pathway components for cell-to-cellspread of vaccinia virus. We confirmed and extended these results whilediscovering that retrograde trafficking was required for virus egress rather thanentry. Retro-2, a specific retrograde trafficking inhibitor of protein toxins,potently prevented spread of vaccinia virus as well as monkeypox virus, a humanpathogen. Electron and confocal microscopy studies revealed that Retro-2prevented wrapping of virions with an additional double-membrane envelope thatenables microtubular transport, exocytosis, and actin polymerization. The viralB5 and F13 protein components of this membrane, which are required for wrapping, normally colocalize in the trans-Golgi network. However, only B5 traffics throughthe secretory pathway, suggesting that F13 uses another route to the trans-Golgi network. The retrograde route was demonstrated by finding that F13 was largelyconfined to early endosomes and failed to colocalize with B5 in the presence ofRetro-2. Thus, vaccinia virus makes novel use of the retrograde transport system for formation of the viral wrapping membrane. IMPORTANCE: Efficient cell-to-cell spread of vaccinia virus and other orthopoxviruses depends on the wrapping ofinfectious particles with a double membrane that enables microtubular transport, exocytosis, and actin polymerization. Interference with wrapping or subsequentsteps results in severe attenuation of the virus. Some previous studies hadsuggested that the wrapping membrane arises from the trans-Golgi network, whereasothers suggested an origin from early endosomes. Some nonenveloped viruses useretrograde trafficking for entry into the cell. In contrast, we provided evidencethat retrograde transport from early endosomes to the trans-Golgi network isrequired for the membrane-wrapping step in morphogenesis of vaccinia virus andegress from the cell. The potent in vitro inhibition of this step by the drugRetro-2 suggests that derivatives with enhanced pharmacological properties might serve as useful antipoxviral agents.
CI  - Copyright (c) 2016, American Society for Microbiology. All Rights Reserved.
FAU - Sivan, Gilad
AU  - Sivan G
AD  - Laboratory of Viral Diseases, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, Bethesda, Maryland, USA.
FAU - Weisberg, Andrea S
AU  - Weisberg AS
AD  - Laboratory of Viral Diseases, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, Bethesda, Maryland, USA.
FAU - Americo, Jeffrey L
AU  - Americo JL
AD  - Laboratory of Viral Diseases, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, Bethesda, Maryland, USA.
FAU - Moss, Bernard
AU  - Moss B
AUID- ORCID: 0000-0002-2154-8564
AD  - Laboratory of Viral Diseases, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, Bethesda, Maryland, USA bmoss@nih.gov.
LA  - eng
GR  - ZIA AI001074/AI/NIAID NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Intramural
DEP - 20160912
PL  - United States
TA  - J Virol
JT  - Journal of virology
JID - 0113724
SB  - IM
MH  - Biological Transport
MH  - Cell Membrane
MH  - Endosomes/*metabolism
MH  - Exocytosis
MH  - HeLa Cells
MH  - Humans
MH  - Microscopy, Confocal
MH  - Microscopy, Electron
MH  - Monkeypox virus/metabolism/physiology
MH  - Vaccinia virus/metabolism/*physiology
MH  - Virion/*metabolism
MH  - *Virus Release
MH  - trans-Golgi Network/*metabolism
PMC - PMC5021392
EDAT- 2016/07/29 06:00
MHDA- 2017/05/10 06:00
CRDT- 2016/07/29 06:00
PHST- 2016/06/09 00:00 [received]
PHST- 2016/07/18 00:00 [accepted]
PHST- 2016/07/29 06:00 [entrez]
PHST- 2016/07/29 06:00 [pubmed]
PHST- 2017/05/10 06:00 [medline]
AID - JVI.01114-16 [pii]
AID - 10.1128/JVI.01114-16 [doi]
PST - epublish
SO  - J Virol. 2016 Sep 12;90(19):8891-905. doi: 10.1128/JVI.01114-16. Print 2016 Oct1.

PMID- 27404372
OWN - NLM
STAT- MEDLINE
DCOM- 20170206
LR  - 20170206
IS  - 1469-0691 (Electronic)
IS  - 1198-743X (Linking)
VI  - 22
IP  - 8
DP  - 2016 Aug
TI  - Emerging diseases-the monkeypox epidemic in the Democratic Republic of the Congo.
PG  - 658-9
LID - 10.1016/j.cmi.2016.07.004 [doi]
LID - S1198-743X(16)30228-2 [pii]
FAU - Kantele, A
AU  - Kantele A
AD  - Infectious Diseases, University of Helsinki and Helsinki University Hospital,Helsinki, Finland; Unit of Infectious Diseases, Solna, Karolinska Institutet,Stockholm, Sweden. Electronic address: anu.kantele@hus.fi.
FAU - Chickering, K
AU  - Chickering K
AD  - Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles,CA, USA.
FAU - Vapalahti, O
AU  - Vapalahti O
AD  - Departments of Virology and Veterinary Biosciences, University of Helsinki,Finland; Department of Virology and Immunology, University of Helsinki andHelsinki University Hospital, Helsinki, Finland.
FAU - Rimoin, A W
AU  - Rimoin AW
AD  - Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles,CA, USA.
LA  - eng
PT  - Editorial
PT  - Historical Article
DEP - 20160709
PL  - England
TA  - Clin Microbiol Infect
JT  - Clinical microbiology and infection : the official publication of the EuropeanSociety of Clinical Microbiology and Infectious Diseases
JID - 9516420
SB  - IM
MH  - Animals
MH  - Communicable Diseases, Emerging/*epidemiology/history/transmission
MH  - Democratic Republic of the Congo/epidemiology
MH  - History, 20th Century
MH  - History, 21st Century
MH  - Humans
MH  - Monkeypox/*epidemiology/history/transmission
MH  - Population Surveillance
EDAT- 2016/07/13 06:00
MHDA- 2017/02/07 06:00
CRDT- 2016/07/13 06:00
PHST- 2016/05/31 00:00 [received]
PHST- 2016/06/30 00:00 [revised]
PHST- 2016/07/01 00:00 [accepted]
PHST- 2016/07/13 06:00 [entrez]
PHST- 2016/07/13 06:00 [pubmed]
PHST- 2017/02/07 06:00 [medline]
AID - S1198-743X(16)30228-2 [pii]
AID - 10.1016/j.cmi.2016.07.004 [doi]
PST - ppublish
SO  - Clin Microbiol Infect. 2016 Aug;22(8):658-9. doi: 10.1016/j.cmi.2016.07.004. Epub2016 Jul 9.

PMID- 27191380
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20180112
LR  - 20181113
IS  - 1080-6059 (Electronic)
IS  - 1080-6040 (Linking)
VI  - 22
IP  - 6
DP  - 2016 Jun
TI  - Extended Human-to-Human Transmission during a Monkeypox Outbreak in theDemocratic Republic of the Congo.
PG  - 1014-21
LID - 10.3201/eid2206.150579 [doi]
AB  - A >600% increase in monkeypox cases occurred in the Bokungu Health Zone of theDemocratic Republic of the Congo during the second half of 2013; this increaseprompted an outbreak investigation. A total of 104 possible cases were reportedfrom this health zone; among 60 suspected cases that were tested, 50 (48.1%)cases were confirmed by laboratory testing, and 10 (9.6%) tested negative formonkeypox virus (MPXV) infection. The household attack rate (i.e., rate ofpersons living with an infected person that develop symptoms of MPXV infection)was 50%. Nine families showed >1 transmission event, and >6 transmission eventsoccurred within this health zone. Mean incubation period was 8 days (range 4-14days). The high attack rate and transmission observed in this study reinforce theimportance of surveillance and rapid identification of monkeypox cases. Communityeducation and training are needed to prevent transmission of MPXV infectionduring outbreaks.
FAU - Nolen, Leisha Diane
AU  - Nolen LD
FAU - Osadebe, Lynda
AU  - Osadebe L
FAU - Katomba, Jacques
AU  - Katomba J
FAU - Likofata, Jacques
AU  - Likofata J
FAU - Mukadi, Daniel
AU  - Mukadi D
FAU - Monroe, Benjamin
AU  - Monroe B
FAU - Doty, Jeffrey
AU  - Doty J
FAU - Hughes, Christine Marie
AU  - Hughes CM
FAU - Kabamba, Joelle
AU  - Kabamba J
FAU - Malekani, Jean
AU  - Malekani J
FAU - Bomponda, Pierre Lokwa
AU  - Bomponda PL
FAU - Lokota, Jules Inonga
AU  - Lokota JI
FAU - Balilo, Marcel Pie
AU  - Balilo MP
FAU - Likafi, Toutou
AU  - Likafi T
FAU - Lushima, Robert Shongo
AU  - Lushima RS
FAU - Ilunga, Benoit Kebela
AU  - Ilunga BK
FAU - Nkawa, Frida
AU  - Nkawa F
FAU - Pukuta, Elisabeth
AU  - Pukuta E
FAU - Karhemere, Stomy
AU  - Karhemere S
FAU - Tamfum, Jean-Jacques Muyembe
AU  - Tamfum JJ
FAU - Nguete, Beatrice
AU  - Nguete B
FAU - Wemakoy, Emile Okitolonda
AU  - Wemakoy EO
FAU - McCollum, Andrea M
AU  - McCollum AM
FAU - Reynolds, Mary G
AU  - Reynolds MG
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Emerg Infect Dis
JT  - Emerging infectious diseases
JID - 9508155
EIN - Emerg Infect Dis. 2016 Oct;22(10 ):. PMID: 27598564
PMC - PMC4880088
OTO - NOTNLM
OT  - *Africa
OT  - *Democratic Republic of the Congo
OT  - *animal diseases
OT  - *incubation
OT  - *monkeypox
OT  - *monkeypox virus
OT  - *orthopoxvirus
OT  - *transmission
OT  - *viruses
OT  - *zoonosis
EDAT- 2016/05/19 06:00
MHDA- 2016/05/19 06:01
CRDT- 2016/05/19 06:00
PHST- 2016/05/19 06:00 [entrez]
PHST- 2016/05/19 06:00 [pubmed]
PHST- 2016/05/19 06:01 [medline]
AID - 10.3201/eid2206.150579 [doi]
PST - ppublish
SO  - Emerg Infect Dis. 2016 Jun;22(6):1014-21. doi: 10.3201/eid2206.150579.

PMID- 26985679
OWN - NLM
STAT- MEDLINE
DCOM- 20160722
LR  - 20191210
IS  - 1545-861X (Electronic)
IS  - 0149-2195 (Linking)
VI  - 65
IP  - 10
DP  - 2016 Mar 18
TI  - Use of Vaccinia Virus Smallpox Vaccine in Laboratory and Health Care Personnel atRisk for Occupational Exposure to Orthopoxviruses - Recommendations of theAdvisory Committee on Immunization Practices (ACIP), 2015.
PG  - 257-62
LID - 10.15585/mmwr.mm6510a2 [doi]
AB  - On June 25, 2015, the Advisory Committee on Immunization Practices (ACIP)recommended routine vaccination with live smallpox (vaccinia) vaccine (ACAM2000) for laboratory personnel who directly handle 1) cultures or 2) animalscontaminated or infected with replication-competent vaccinia virus, recombinantvaccinia viruses derived from replication-competent vaccinia strains (i.e., thosethat are capable of causing clinical infection and producing infectious virus in humans), or other orthopoxviruses that infect humans (e.g., monkeypox, cowpox,and variola) (recommendation category: A, evidence type 2 [Box]). Health carepersonnel (e.g., physicians and nurses) who currently treat or anticipatetreating patients with vaccinia virus infections and whose contact withreplication-competent vaccinia viruses is limited to contaminated materials(e.g., dressings) and persons administering ACAM2000 smallpox vaccine who adhere to appropriate infection prevention measures can be offered vaccination withACAM2000 (recommendation category: B, evidence type 2 [Box]). These revisedrecommendations update the previous ACIP recommendations for nonemergency use of vaccinia virus smallpox vaccine for laboratory and health care personnel at risk for occupational exposure to orthopoxviruses (1). Since 2001, when the previousACIP recommendations were developed, ACAM2000 has replaced Dryvax as the onlysmallpox vaccine licensed by the U.S. Food and Drug Administration (FDA) andavailable for use in the United States (2). These recommendations containinformation on ACAM2000 and its use in laboratory and health care personnel atrisk for occupational exposure to orthopoxviruses.
FAU - Petersen, Brett W
AU  - Petersen BW
FAU - Harms, Tiara J
AU  - Harms TJ
FAU - Reynolds, Mary G
AU  - Reynolds MG
FAU - Harrison, Lee H
AU  - Harrison LH
LA  - eng
PT  - Journal Article
DEP - 20160318
PL  - United States
TA  - MMWR Morb Mortal Wkly Rep
JT  - MMWR. Morbidity and mortality weekly report
JID - 7802429
RN  - 0 (Smallpox Vaccine)
SB  - IM
MH  - Advisory Committees
MH  - Centers for Disease Control and Prevention, U.S.
MH  - *Health Personnel
MH  - Humans
MH  - Immunization/standards
MH  - *Laboratories
MH  - Occupational Exposure/*statistics & numerical data
MH  - *Orthopoxvirus
MH  - Practice Guidelines as Topic
MH  - Risk Assessment
MH  - Smallpox/prevention & control
MH  - Smallpox Vaccine/*administration & dosage
MH  - United States
MH  - Vaccinia virus
EDAT- 2016/03/18 06:00
MHDA- 2016/07/23 06:00
CRDT- 2016/03/18 06:00
PHST- 2016/03/18 06:00 [entrez]
PHST- 2016/03/18 06:00 [pubmed]
PHST- 2016/07/23 06:00 [medline]
AID - 10.15585/mmwr.mm6510a2 [doi]
PST - epublish
SO  - MMWR Morb Mortal Wkly Rep. 2016 Mar 18;65(10):257-62. doi:10.15585/mmwr.mm6510a2.

PMID- 26930499
OWN - NLM
STAT- MEDLINE
DCOM- 20160726
LR  - 20181113
IS  - 1932-6203 (Electronic)
IS  - 1932-6203 (Linking)
VI  - 11
IP  - 3
DP  - 2016
TI  - Development of a Genus-Specific Antigen Capture ELISA for Orthopoxviruses -Target Selection and Optimized Screening.
PG  - e0150110
LID - 10.1371/journal.pone.0150110 [doi]
AB  - Orthopoxvirus species like cowpox, vaccinia and monkeypox virus cause zoonoticinfections in humans worldwide. Infections often occur in rural areas lackingproper diagnostic infrastructure as exemplified by monkeypox, which is endemic inWestern and Central Africa. While PCR detection requires demanding equipment and is restricted to genome detection, the evidence of virus particles can complementor replace PCR. Therefore, an easily distributable and manageable antigen captureenzyme-linked immunosorbent assay (ELISA) for the detection of orthopoxviruseswas developed to facilitate particle detection. By comparing the virus particlebinding properties of polyclonal antibodies developed against surface-exposedattachment or fusion proteins, the surface protein A27 was found to be awell-bound, highly immunogenic and exposed target for antibodies aiming at virus particle detection. Subsequently, eight monoclonal anti-A27 antibodies weregenerated and characterized by peptide epitope mapping and surface plasmonresonance measurements. All antibodies were found to bind with high affinity totwo epitopes at the heparin binding site of A27, toward either the N- orC-terminal of the crucial KKEP-segment of A27. Two antibodies recognizingdifferent epitopes were implemented in an antigen capture ELISA. Validationshowed robust detection of virus particles from 11 different orthopoxvirusisolates pathogenic to humans, with the exception of MVA, which is apathogenic tohumans. Most orthopoxviruses could be detected reliably for viral loads above 1 x103 PFU/mL. To our knowledge, this is the first solely monoclonal and thereforereproducible antibody-based antigen capture ELISA able to detect all humanpathogenic orthopoxviruses including monkeypox virus, except variola virus which was not included. Therefore, the newly developed antibody-based assay represents important progress towards feasible particle detection of this important genus ofviruses.
FAU - Stern, Daniel
AU  - Stern D
AD  - Highly Pathogenic Viruses (ZBS 1), Centre for Biological Threats and SpecialPathogens, Robert Koch Institute, Berlin, Germany.
FAU - Pauly, Diana
AU  - Pauly D
AD  - Biological Toxins (ZBS 3), Centre for Biological Threats and Special Pathogens,Robert Koch Institute, Berlin, Germany.
FAU - Zydek, Martin
AU  - Zydek M
AD  - Biosystems Technology, Institute of Applied Life Sciences, Technical Universityof Applied Sciences, Wildau, Germany.
FAU - Miller, Lilija
AU  - Miller L
AD  - Highly Pathogenic Viruses (ZBS 1), Centre for Biological Threats and SpecialPathogens, Robert Koch Institute, Berlin, Germany.
FAU - Piesker, Janett
AU  - Piesker J
AD  - Advanced Light and Electron Microscopy (ZBS 4), Centre for Biological Threats andSpecial Pathogens, Robert Koch Institute, Berlin, Germany.
FAU - Laue, Michael
AU  - Laue M
AD  - Advanced Light and Electron Microscopy (ZBS 4), Centre for Biological Threats andSpecial Pathogens, Robert Koch Institute, Berlin, Germany.
FAU - Lisdat, Fred
AU  - Lisdat F
AD  - Biosystems Technology, Institute of Applied Life Sciences, Technical Universityof Applied Sciences, Wildau, Germany.
FAU - Dorner, Martin B
AU  - Dorner MB
AD  - Biological Toxins (ZBS 3), Centre for Biological Threats and Special Pathogens,Robert Koch Institute, Berlin, Germany.
FAU - Dorner, Brigitte G
AU  - Dorner BG
AD  - Biological Toxins (ZBS 3), Centre for Biological Threats and Special Pathogens,Robert Koch Institute, Berlin, Germany.
FAU - Nitsche, Andreas
AU  - Nitsche A
AD  - Highly Pathogenic Viruses (ZBS 1), Centre for Biological Threats and SpecialPathogens, Robert Koch Institute, Berlin, Germany.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20160301
PL  - United States
TA  - PLoS One
JT  - PloS one
JID - 101285081
RN  - 0 (Antibodies, Monoclonal)
RN  - 0 (Antibodies, Viral)
RN  - 0 (Epitopes)
SB  - IM
MH  - Antibodies, Monoclonal/immunology
MH  - Antibodies, Viral/immunology
MH  - Enzyme-Linked Immunosorbent Assay/*methods
MH  - Epitopes/*immunology
MH  - Orthopoxvirus/genetics/*immunology/metabolism
PMC - PMC4773239
EDAT- 2016/03/02 06:00
MHDA- 2016/07/28 06:00
CRDT- 2016/03/02 06:00
PHST- 2015/11/17 00:00 [received]
PHST- 2016/02/09 00:00 [accepted]
PHST- 2016/03/02 06:00 [entrez]
PHST- 2016/03/02 06:00 [pubmed]
PHST- 2016/07/28 06:00 [medline]
AID - 10.1371/journal.pone.0150110 [doi]
AID - PONE-D-15-49143 [pii]
PST - epublish
SO  - PLoS One. 2016 Mar 1;11(3):e0150110. doi: 10.1371/journal.pone.0150110.eCollection 2016.

PMID- 26861777
OWN - NLM
STAT- MEDLINE
DCOM- 20170505
LR  - 20191210
IS  - 1465-2099 (Electronic)
IS  - 0022-1317 (Linking)
VI  - 97
IP  - 5
DP  - 2016 May
TI  - New effective chemically synthesized anti-smallpox compound NIOCH-14.
PG  - 1229-1239
LID - 10.1099/jgv.0.000422 [doi]
AB  - Antiviral activity of the new chemically synthesized compound NIOCH-14 (aderivative of tricyclodicarboxylic acid) in comparison with ST-246 (the condensedderivative of pyrroledione) was observed in experiments in vitro and in vivousing orthopoxviruses including highly pathogenic ones. After oral administrationof NIOCH-14 to outbred ICR mice infected intranasally with 100 % lethal dose ofectromelia virus, it was shown that 50 % effective doses of NIOCH-14 and ST-246did not significantly differ. The 'therapeutic window' varied from 1 day beforeinfection to 6 days post-infection (p.i.) to achieve 100-60 % survival rate. The administration of NIOCH-14 and ST-246 to mice resulted in a significant reductionof ectromelia virus titres in organs examined as compared with the control andalso reduced pathological changes in the lungs 6 days p.i. Oral administration ofNIOCH-14 and ST-246 to ICR mice and marmots challenged with monkeypox virus ascompared with the control resulted in a significant reduction of virus productionin the lungs and the proportion of infected mice 7 days p.i. as well as theabsence of disease in marmots. Significantly lower proportions of infected miceand virus production levels in the lungs as compared with the control weredemonstrated in experiments after oral administration of NIOCH-14 and ST-246 toICR mice and immunodeficient SCID mice challenged with variola virus 3 and 4 daysp.i., respectively. The results obtained suggest good prospects for further studyof the chemical compound NIOCH-14 to create a new smallpox drug on its basis.
FAU - Mazurkov, Oleg Yu
AU  - Mazurkov OY
AD  - State Research Center of Virology and Biotechnology Vector (SRC VBVector),Koltsovo, Novosibirsk region,Russian Federation.
FAU - Kabanov, Alexey S
AU  - Kabanov AS
AD  - State Research Center of Virology and Biotechnology Vector (SRC VBVector),Koltsovo, Novosibirsk region,Russian Federation.
FAU - Shishkina, Larisa N
AU  - Shishkina LN
AD  - State Research Center of Virology and Biotechnology Vector (SRC VBVector),Koltsovo, Novosibirsk region,Russian Federation.
FAU - Sergeev, Alexander A
AU  - Sergeev AA
AD  - State Research Center of Virology and Biotechnology Vector (SRC VBVector),Koltsovo, Novosibirsk region,Russian Federation.
FAU - Skarnovich, Maksim O
AU  - Skarnovich MO
AD  - State Research Center of Virology and Biotechnology Vector (SRC VBVector),Koltsovo, Novosibirsk region,Russian Federation.
FAU - Bormotov, Nikolay I
AU  - Bormotov NI
AD  - State Research Center of Virology and Biotechnology Vector (SRC VBVector),Koltsovo, Novosibirsk region,Russian Federation.
FAU - Skarnovich, Maria A
AU  - Skarnovich MA
AD  - State Research Center of Virology and Biotechnology Vector (SRC VBVector),Koltsovo, Novosibirsk region,Russian Federation.
FAU - Ovchinnikova, Alena S
AU  - Ovchinnikova AS
AD  - State Research Center of Virology and Biotechnology Vector (SRC VBVector),Koltsovo, Novosibirsk region,Russian Federation.
FAU - Titova, Ksenya A
AU  - Titova KA
AD  - State Research Center of Virology and Biotechnology Vector (SRC VBVector),Koltsovo, Novosibirsk region,Russian Federation.
FAU - Galahova, Darya O
AU  - Galahova DO
AD  - State Research Center of Virology and Biotechnology Vector (SRC VBVector),Koltsovo, Novosibirsk region,Russian Federation.
FAU - Bulychev, Leonid E
AU  - Bulychev LE
AD  - State Research Center of Virology and Biotechnology Vector (SRC VBVector),Koltsovo, Novosibirsk region,Russian Federation.
FAU - Sergeev, Artemiy A
AU  - Sergeev AA
AD  - State Research Center of Virology and Biotechnology Vector (SRC VBVector),Koltsovo, Novosibirsk region,Russian Federation.
FAU - Taranov, Oleg S
AU  - Taranov OS
AD  - State Research Center of Virology and Biotechnology Vector (SRC VBVector),Koltsovo, Novosibirsk region,Russian Federation.
FAU - Selivanov, Boris A
AU  - Selivanov BA
AD  - N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry(NIOCH),Novosibirsk,Russian Federation.
FAU - Tikhonov, Alexey Ya
AU  - Tikhonov AY
AD  - N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry(NIOCH),Novosibirsk,Russian Federation.
FAU - Zavjalov, Evgenii L
AU  - Zavjalov EL
AD  - Institute of Cytology and Genetics (ICG),Novosibirsk,Russian Federation.
FAU - Agafonov, Alexander P
AU  - Agafonov AP
AD  - State Research Center of Virology and Biotechnology Vector (SRC VBVector),Koltsovo, Novosibirsk region,Russian Federation.
FAU - Sergeev, Alexander N
AU  - Sergeev AN
AD  - State Research Center of Virology and Biotechnology Vector (SRC VBVector),Koltsovo, Novosibirsk region,Russian Federation.
LA  - eng
PT  - Journal Article
DEP - 20160208
PL  - England
TA  - J Gen Virol
JT  - The Journal of general virology
JID - 0077340
RN  - 0 (Antiviral Agents)
RN  - 0 (Benzamides)
RN  - 0 (Dicarboxylic Acids)
RN  - 0 (Isoindoles)
RN  - 0 (NIOCH-14)
RN  - F925RR824R (Tecovirimat)
SB  - IM
MH  - Animals
MH  - Antiviral Agents/*chemistry/*pharmacology
MH  - Benzamides/chemical synthesis/pharmacology
MH  - Chlorocebus aethiops
MH  - Dicarboxylic Acids/*chemistry/*pharmacology
MH  - Female
MH  - Isoindoles/chemical synthesis/pharmacology
MH  - Male
MH  - Marmota
MH  - Mice
MH  - Mice, Inbred ICR
MH  - Mice, SCID
MH  - Molecular Structure
MH  - Monkeypox/*drug therapy
MH  - Monkeypox virus
MH  - Smallpox/*drug therapy
MH  - Variola virus
MH  - Vero Cells
EDAT- 2016/02/11 06:00
MHDA- 2017/05/06 06:00
CRDT- 2016/02/11 06:00
PHST- 2016/02/11 06:00 [entrez]
PHST- 2016/02/11 06:00 [pubmed]
PHST- 2017/05/06 06:00 [medline]
AID - 10.1099/jgv.0.000422 [doi]
PST - ppublish
SO  - J Gen Virol. 2016 May;97(5):1229-1239. doi: 10.1099/jgv.0.000422. Epub 2016 Feb8.

PMID- 26700306
OWN - NLM
STAT- MEDLINE
DCOM- 20160419
LR  - 20211203
IS  - 1553-7374 (Electronic)
IS  - 1553-7366 (Linking)
VI  - 11
IP  - 12
DP  - 2015 Dec
TI  - Evidence for Persistence of Ectromelia Virus in Inbred Mice, RecrudescenceFollowing Immunosuppression and Transmission to Naive Mice.
PG  - e1005342
LID - 10.1371/journal.ppat.1005342 [doi]
AB  - Orthopoxviruses (OPV), including variola, vaccinia, monkeypox, cowpox andectromelia viruses cause acute infections in their hosts. With the exception ofvariola virus (VARV), the etiological agent of smallpox, other OPV have beenreported to persist in a variety of animal species following natural orexperimental infection. Despite the implications and significance for the ecologyand epidemiology of diseases these viruses cause, those reports have never beenthoroughly investigated. We used the mouse pathogen ectromelia virus (ECTV), the agent of mousepox and a close relative of VARV to investigate virus persistencein inbred mice. We provide evidence that ECTV causes a persistent infection insome susceptible strains of mice in which low levels of virus genomes weredetected in various tissues late in infection. The bone marrow (BM) and bloodappeared to be key sites of persistence. Contemporaneous with virus persistence, antiviral CD8 T cell responses were demonstrable over the entire 25-week studyperiod, with a change in the immunodominance hierarchy evident during the first 3weeks. Some virus-encoded host response modifiers were found to modulate viruspersistence whereas host genes encoded by the NKC and MHC class I reduced thepotential for persistence. When susceptible strains of mice that had apparentlyrecovered from infection were subjected to sustained immunosuppression withcyclophosphamide (CTX), animals succumbed to mousepox with high titers ofinfectious virus in various organs. CTX treated index mice transmitted virus to, and caused disease in, co-housed naive mice. The most surprising but significant finding was that immunosuppression of disease-resistant C57BL/6 mice severalweeks after recovery from primary infection generated high titers of virus inmultiple tissues. Resistant mice showed no evidence of a persistent infection.This is the strongest evidence that ECTV can persist in inbred mice, regardlessof their resistance status.
FAU - Sakala, Isaac G
AU  - Sakala IG
AD  - Department of Immunology and Infectious Disease, John Curtin School of MedicalResearch, Australian National University, Canberra, Australia.
FAU - Chaudhri, Geeta
AU  - Chaudhri G
AD  - Department of Immunology and Infectious Disease, John Curtin School of MedicalResearch, Australian National University, Canberra, Australia.
FAU - Scalzo, Anthony A
AU  - Scalzo AA
AD  - Immunology and Virology Program, Centre for Ophthalmology & Visual Science, TheLions Eye Institute, University of Western Australia, Perth, Western Australia,Australia.
FAU - Eldi, Preethi
AU  - Eldi P
AD  - Department of Immunology and Infectious Disease, John Curtin School of MedicalResearch, Australian National University, Canberra, Australia.
FAU - Newsome, Timothy P
AU  - Newsome TP
AD  - School of Molecular Bioscience, University of Sydney, Sydney, Australia.
FAU - Buller, Robert M
AU  - Buller RM
AD  - Saint Louis University Health Sciences Center, Department of MolecularMicrobiology and Immunology, St Louis, Missouri, United States of America.
FAU - Karupiah, Gunasegaran
AU  - Karupiah G
AD  - Department of Immunology and Infectious Disease, John Curtin School of MedicalResearch, Australian National University, Canberra, Australia.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20151223
PL  - United States
TA  - PLoS Pathog
JT  - PLoS pathogens
JID - 101238921
RN  - 0 (Immunosuppressive Agents)
SB  - IM
MH  - Animals
MH  - Ectromelia virus/*immunology
MH  - Ectromelia, Infectious/*immunology/*transmission
MH  - Immunosuppression Therapy
MH  - Immunosuppressive Agents/pharmacology
MH  - Mice
MH  - Mice, Inbred BALB C
MH  - Mice, Inbred C57BL
MH  - Recurrence
PMC - PMC4689526
EDAT- 2015/12/25 06:00
MHDA- 2016/04/20 06:00
CRDT- 2015/12/25 06:00
PHST- 2015/08/03 00:00 [received]
PHST- 2015/11/24 00:00 [accepted]
PHST- 2015/12/25 06:00 [entrez]
PHST- 2015/12/25 06:00 [pubmed]
PHST- 2016/04/20 06:00 [medline]
AID - 10.1371/journal.ppat.1005342 [doi]
AID - PPATHOGENS-D-15-01811 [pii]
PST - epublish
SO  - PLoS Pathog. 2015 Dec 23;11(12):e1005342. doi: 10.1371/journal.ppat.1005342.eCollection 2015 Dec.

PMID- 26664524
OWN - NLM
STAT- MEDLINE
DCOM- 20160916
LR  - 20181113
IS  - 1937-8688 (Electronic)
VI  - 22
DP  - 2015
TI  - Pox-like lesions and haemorrhagic fever in two concurrent cases in the CentralAfrican Republic: case investigation and management in difficult circumstances.
PG  - 23
LID - 10.11604/pamj.2015.22.23.6620 [doi]
AB  - Cases of monkeypox in humans are frequently reported from the Democratic Republicof Congo. The few reports from the Central African Republic have been limited to cases in the far South closely bordering the Congos. Team members of aninternational medical organisation have suspected clinically two human cases ofMPX, associated with clinical signs of coagulopathy and haemorrhage in the North of the country. Key findings were history of a squirrel, fever and vesiculardermal eruptions. Subsequently patients developed profuse epistaxis andhematemesis, associated with clinical signs of shock. Both patients were isolatedand treated symptomatically. Samples were sent to a regional referencelaboratory, who initially issued a confirmation of the suspected diagnosis of MPXin both cases. The result was later revised, and additional analyses of samplescould not confirm the diagnosis.
FAU - Froeschl, Guenter
AU  - Froeschl G
AD  - Hopital Prefectoral de Batangafo, Central African Republic ;Ludwig-Maximilians-Universitat, Munich, Germany.
FAU - Kayembe, Pitchou Kasongo
AU  - Kayembe PK
AD  - Hopital Prefectoral de Batangafo, Central African Republic.
LA  - eng
PT  - Case Reports
PT  - Journal Article
DEP - 20150910
PL  - Uganda
TA  - Pan Afr Med J
JT  - The Pan African medical journal
JID - 101517926
SB  - IM
MH  - Adult
MH  - Central African Republic
MH  - Hemorrhagic Fevers, Viral/*diagnosis
MH  - Humans
MH  - Male
MH  - Monkeypox/*diagnosis/virology
MH  - Monkeypox virus/*isolation & purification
PMC - PMC4662510
OTO - NOTNLM
OT  - Central African Republic
OT  - Pox-like lesions
OT  - fever
OT  - haemorrhage
OT  - monkeypox
EDAT- 2015/12/15 06:00
MHDA- 2016/09/17 06:00
CRDT- 2015/12/15 06:00
PHST- 2015/03/19 00:00 [received]
PHST- 2015/03/29 00:00 [accepted]
PHST- 2015/12/15 06:00 [entrez]
PHST- 2015/12/15 06:00 [pubmed]
PHST- 2016/09/17 06:00 [medline]
AID - 10.11604/pamj.2015.22.23.6620 [doi]
AID - PAMJ-22-23 [pii]
PST - epublish
SO  - Pan Afr Med J. 2015 Sep 10;22:23. doi: 10.11604/pamj.2015.22.23.6620. eCollection2015.

PMID- 26612372
OWN - NLM
STAT- MEDLINE
DCOM- 20160914
LR  - 20151127
IS  - 1558-299X (Electronic)
IS  - 0095-4543 (Linking)
VI  - 42
IP  - 4
DP  - 2015 Dec
TI  - Viral Skin Diseases.
PG  - 517-67
LID - 10.1016/j.pop.2015.08.006 [doi]
LID - S0095-4543(15)00075-5 [pii]
AB  - In the vast world of skin diseases, viral skin disorders account for asignificant percentage. Most viral skin diseases present with an exanthem (skinrash) and, oftentimes, an accompanying enanthem (lesions involving the mucosalmembrane). In this article, the various viral skin diseases are explored,including viral childhood exanthems (measles, rubella, erythema infectiosum, and roseola), herpes viruses (herpes simplex virus, varicella zoster virus, Kaposisarcoma herpes virus, viral zoonotic infections [orf, monkeypox, ebola,smallpox]), and several other viral skin diseases, such as human papilloma virus,hand, foot, and mouth disease, molluscum contagiosum, and Gianotti-Crostisyndrome.
CI  - Copyright (c) 2015 Elsevier Inc. All rights reserved.
FAU - Ramdass, Priya
AU  - Ramdass P
AD  - Department of Family and Community Medicine, Mount Sinai Medical Center, 1500South California Avenue, 10th Floor, Chicago, IL 60608, USA.
FAU - Mullick, Sahil
AU  - Mullick S
AD  - Department of Family Medicine, Creighton University Medical Center, 601 North30th Street, Suite 6720, Omaha, NE 68131, USA. Electronic address:Sahilmullick@creighton.edu.
FAU - Farber, Harold F
AU  - Farber HF
AD  - Center for Dermatology, Laser, and Cosmetic Surgery, Psoriasis Infusion andTreatment Center, 9892 Bustleton Avenue, Suite 204, Philadelphia, PA 19115, USA.
LA  - eng
PT  - Journal Article
PT  - Review
PL  - United States
TA  - Prim Care
JT  - Primary care
JID - 0430463
RN  - 0 (Anti-Inflammatory Agents, Non-Steroidal)
RN  - 0 (Antipyretics)
RN  - 0 (Antiviral Agents)
SB  - IM
MH  - Anti-Inflammatory Agents, Non-Steroidal/therapeutic use
MH  - Antipyretics/therapeutic use
MH  - Antiviral Agents/therapeutic use
MH  - Comorbidity
MH  - Diagnosis, Differential
MH  - Exanthema
MH  - Humans
MH  - Immunization
MH  - Immunocompromised Host
MH  - *Primary Health Care
MH  - Skin Diseases, Viral/*diagnosis/physiopathology/*therapy
OTO - NOTNLM
OT  - Enanthem
OT  - Exanthem
OT  - Latency
OT  - Self-limited
OT  - Vaccination
OT  - Viral shedding
EDAT- 2015/11/28 06:00
MHDA- 2016/09/15 06:00
CRDT- 2015/11/28 06:00
PHST- 2015/11/28 06:00 [entrez]
PHST- 2015/11/28 06:00 [pubmed]
PHST- 2016/09/15 06:00 [medline]
AID - S0095-4543(15)00075-5 [pii]
AID - 10.1016/j.pop.2015.08.006 [doi]
PST - ppublish
SO  - Prim Care. 2015 Dec;42(4):517-67. doi: 10.1016/j.pop.2015.08.006.

PMID- 26605344
OWN - NLM
STAT- MEDLINE
DCOM- 20160819
LR  - 20181113
IS  - 2314-7156 (Electronic)
IS  - 2314-7156 (Linking)
VI  - 2015
DP  - 2015
TI  - EPIPOX: Immunoinformatic Characterization of the Shared T-Cell Epitome betweenVariola Virus and Related Pathogenic Orthopoxviruses.
PG  - 738020
LID - 10.1155/2015/738020 [doi]
AB  - Concerns that variola viruses might be used as bioweapons have renewed theinterest in developing new and safer smallpox vaccines. Variola virus genomes arenow widely available, allowing computational characterization of the entireT-cell epitome and the use of such information to develop safe and yet effective vaccines. To this end, we identified 124 proteins shared between various species of pathogenic orthopoxviruses including variola minor and major, monkeypox,cowpox, and vaccinia viruses, and we targeted them for T-cell epitope prediction.We recognized 8,106, and 8,483 unique class I and class II MHC-restricted T-cell epitopes that are shared by all mentioned orthopoxviruses. Subsequently, wedeveloped an immunological resource, EPIPOX, upon the predicted T-cell epitome.EPIPOX is freely available online and it has been designed to facilitate reverse vaccinology. Thus, EPIPOX includes key epitope-focused protein annotations: time point expression, presence of leader and transmembrane signals, and knownlocation on outer membrane structures of the infective viruses. These featurescan be used to select specific T-cell epitopes suitable for experimentalvalidation restricted by single MHC alleles, as combinations thereof, or by MHCsupertypes.
FAU - Molero-Abraham, Magdalena
AU  - Molero-Abraham M
AD  - School of Medicine, Unit of Immunology, Complutense University of Madrid, Pza.Ramon y Cajal, s/n, 28040 Madrid, Spain.
FAU - Glutting, John-Paul
AU  - Glutting JP
AD  - School of Medicine, Unit of Immunology, Complutense University of Madrid, Pza.Ramon y Cajal, s/n, 28040 Madrid, Spain.
FAU - Flower, Darren R
AU  - Flower DR
AD  - School of Life and Health Sciences, University of Aston, Aston Triangle,Birmingham B4 7ET, UK.
FAU - Lafuente, Esther M
AU  - Lafuente EM
AD  - School of Medicine, Unit of Immunology, Complutense University of Madrid, Pza.Ramon y Cajal, s/n, 28040 Madrid, Spain.
FAU - Reche, Pedro A
AU  - Reche PA
AD  - School of Medicine, Unit of Immunology, Complutense University of Madrid, Pza.Ramon y Cajal, s/n, 28040 Madrid, Spain.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20151028
PL  - Egypt
TA  - J Immunol Res
JT  - Journal of immunology research
JID - 101627166
RN  - 0 (Antigens, Viral)
RN  - 0 (Epitopes, T-Lymphocyte)
RN  - 0 (Viral Vaccines)
SB  - IM
MH  - Amino Acid Sequence
MH  - Antigens, Viral/chemistry/*immunology
MH  - Computational Biology/*methods
MH  - Cross-Priming/immunology
MH  - Databases, Protein
MH  - Epitopes, T-Lymphocyte/chemistry/*immunology
MH  - Humans
MH  - Orthopoxvirus/*immunology
MH  - *Software
MH  - T-Lymphocytes/*immunology
MH  - Variola virus/*immunology
MH  - Viral Vaccines/immunology
MH  - Web Browser
PMC - PMC4641182
EDAT- 2015/11/26 06:00
MHDA- 2016/08/20 06:00
CRDT- 2015/11/26 06:00
PHST- 2015/06/26 00:00 [received]
PHST- 2015/09/08 00:00 [revised]
PHST- 2015/10/01 00:00 [accepted]
PHST- 2015/11/26 06:00 [entrez]
PHST- 2015/11/26 06:00 [pubmed]
PHST- 2016/08/20 06:00 [medline]
AID - 10.1155/2015/738020 [doi]
PST - ppublish
SO  - J Immunol Res. 2015;2015:738020. doi: 10.1155/2015/738020. Epub 2015 Oct 28.

PMID- 26556597
OWN - NLM
STAT- MEDLINE
DCOM- 20160626
LR  - 20181113
IS  - 1932-6203 (Electronic)
IS  - 1932-6203 (Linking)
VI  - 10
IP  - 11
DP  - 2015
TI  - Comparison of the Cowpox Virus and Vaccinia Virus Mature Virion Proteome:Analysis of the Species- and Strain-Specific Proteome.
PG  - e0141527
LID - 10.1371/journal.pone.0141527 [doi]
AB  - Cowpox virus (CPXV) causes most zoonotic orthopoxvirus (OPV) infections in Europeand Northern as well as Central Asia. The virus has the broadest host range ofOPV and is transmitted to humans from rodents and other wild or domestic animals.Increasing numbers of human CPXV infections in a population with decliningimmunity have raised concerns about the virus' zoonotic potential. While therehave been reports on the proteome of other human-pathogenic OPV, namely vaccinia virus (VACV) and monkeypox virus (MPXV), the protein composition of the CPXVmature virion (MV) is unknown. This study focused on the comparative analysis of the VACV and CPXV MV proteome by label-free single-run proteomics using nanoliquid chromatography and high-resolution tandem mass spectrometry (nLC-MS/MS).The presented data reveal that the common VACV and CPXV MV proteome contains mostof the known conserved and essential OPV proteins and is associated with cellularproteins known to be essential for viral replication. While the species-specific proteome could be linked mainly to less genetically-conserved gene products, the strain-specific protein abundance was found to be of high variance in proteinsassociated with entry, host-virus interaction and protein processing.
FAU - Doellinger, Joerg
AU  - Doellinger J
AD  - Centre for Biological Threats and Special Pathogens, Highly Pathogenic Viruses(ZBS1), Robert Koch Institute, Berlin, Germany.
FAU - Schaade, Lars
AU  - Schaade L
AD  - Centre for Biological Threats and Special Pathogens, Highly Pathogenic Viruses(ZBS1), Robert Koch Institute, Berlin, Germany.
FAU - Nitsche, Andreas
AU  - Nitsche A
AD  - Centre for Biological Threats and Special Pathogens, Highly Pathogenic Viruses(ZBS1), Robert Koch Institute, Berlin, Germany.
LA  - eng
PT  - Comparative Study
PT  - Journal Article
DEP - 20151110
PL  - United States
TA  - PLoS One
JT  - PloS one
JID - 101285081
RN  - 0 (Capsid Proteins)
RN  - 0 (DNA, Viral)
RN  - 0 (Proteome)
RN  - 0 (Viral Proteins)
SB  - IM
MH  - Capsid Proteins/analysis/genetics
MH  - Chromatography, Liquid/methods
MH  - Cowpox virus/*chemistry/genetics/physiology
MH  - DNA, Viral/genetics
MH  - Genes, Viral
MH  - Nanotechnology/methods
MH  - *Proteome
MH  - Species Specificity
MH  - Tandem Mass Spectrometry/methods
MH  - Vaccinia virus/*chemistry/genetics/physiology
MH  - Viral Plaque Assay
MH  - Viral Proteins/*analysis/genetics
MH  - Virion/*chemistry/isolation & purification
MH  - Virus Replication
PMC - PMC4640714
EDAT- 2015/11/12 06:00
MHDA- 2016/06/28 06:00
CRDT- 2015/11/12 06:00
PHST- 2014/10/14 00:00 [received]
PHST- 2015/10/09 00:00 [accepted]
PHST- 2015/11/12 06:00 [entrez]
PHST- 2015/11/12 06:00 [pubmed]
PHST- 2016/06/28 06:00 [medline]
AID - 10.1371/journal.pone.0141527 [doi]
AID - PONE-D-14-46043 [pii]
PST - epublish
SO  - PLoS One. 2015 Nov 10;10(11):e0141527. doi: 10.1371/journal.pone.0141527.eCollection 2015.

PMID- 26517839
OWN - NLM
STAT- MEDLINE
DCOM- 20160328
LR  - 20201215
IS  - 1935-2735 (Electronic)
IS  - 1935-2727 (Linking)
VI  - 9
IP  - 10
DP  - 2015
TI  - Further Assessment of Monkeypox Virus Infection in Gambian Pouched Rats(Cricetomys gambianus) Using In Vivo Bioluminescent Imaging.
PG  - e0004130
LID - 10.1371/journal.pntd.0004130 [doi]
AB  - Monkeypox is a zoonosis clinically similar to smallpox in humans. Recent evidencehas shown a potential risk of increased incidence in central Africa. Despiteattempts to isolate the virus from wild rodents and other small mammals, noreservoir host has been identified. In 2003, Monkeypox virus (MPXV) wasaccidentally introduced into the U.S. via the pet trade and was associated withthe Gambian pouched rat (Cricetomys gambianus). Therefore, we investigated thepotential reservoir competence of the Gambian pouched rat for MPXV by utilizing acombination of in vivo and in vitro methods. We inoculated three animals by theintradermal route and three animals by the intranasal route, with onemock-infected control for each route. Bioluminescent imaging (BLI) was used totrack replicating virus in infected animals and virological assays (e.g. realtime PCR, cell culture) were used to determine viral load in blood, urine,ocular, nasal, oral, and rectal swabs. Intradermal inoculation resulted inclinical signs of monkeypox infection in two of three animals. One severely illanimal was euthanized and the other affected animal recovered. In contrast,intranasal inoculation resulted in subclinical infection in all three animals.All animals, regardless of apparent or inapparent infection, shed virus in oraland nasal secretions. Additionally, BLI identified viral replication in the skin without grossly visible lesions. These results suggest that Gambian pouched rats may play an important role in transmission of the virus to humans, as they arehunted for consumption and it is possible for MPXV-infected pouched rats to shed infectious virus without displaying overt clinical signs.
FAU - Falendysz, Elizabeth A
AU  - Falendysz EA
AD  - U.S. Geological Survey-National Wildlife Health Center, Madison, Wisconsin,United States of America.
FAU - Lopera, Juan G
AU  - Lopera JG
AD  - Department of Pathobiological Science, School of Veterinary Medicine, University of Wisconsin, Madison, Wisconsin, United States of America.
FAU - Lorenzsonn, Faye
AU  - Lorenzsonn F
AD  - Department of Pathobiological Science, School of Veterinary Medicine, University of Wisconsin, Madison, Wisconsin, United States of America.
FAU - Salzer, Johanna S
AU  - Salzer JS
AD  - Centers for Disease Control and Prevention, National Centers for Zoonotic andVector-Borne and Enteric Diseases, Division of High Consequence Pathogens andPathology, Poxvirus and Rabies Branch, Atlanta, Georgia, United States ofAmerica.
FAU - Hutson, Christina L
AU  - Hutson CL
AD  - Centers for Disease Control and Prevention, National Centers for Zoonotic andVector-Borne and Enteric Diseases, Division of High Consequence Pathogens andPathology, Poxvirus and Rabies Branch, Atlanta, Georgia, United States ofAmerica.
FAU - Doty, Jeffrey
AU  - Doty J
AD  - Centers for Disease Control and Prevention, National Centers for Zoonotic andVector-Borne and Enteric Diseases, Division of High Consequence Pathogens andPathology, Poxvirus and Rabies Branch, Atlanta, Georgia, United States ofAmerica.
FAU - Gallardo-Romero, Nadia
AU  - Gallardo-Romero N
AD  - Centers for Disease Control and Prevention, National Centers for Zoonotic andVector-Borne and Enteric Diseases, Division of High Consequence Pathogens andPathology, Poxvirus and Rabies Branch, Atlanta, Georgia, United States ofAmerica.
FAU - Carroll, Darin S
AU  - Carroll DS
AD  - Centers for Disease Control and Prevention, National Centers for Zoonotic andVector-Borne and Enteric Diseases, Division of High Consequence Pathogens andPathology, Poxvirus and Rabies Branch, Atlanta, Georgia, United States ofAmerica.
FAU - Osorio, Jorge E
AU  - Osorio JE
AD  - Department of Pathobiological Science, School of Veterinary Medicine, University of Wisconsin, Madison, Wisconsin, United States of America.
FAU - Rocke, Tonie E
AU  - Rocke TE
AD  - U.S. Geological Survey-National Wildlife Health Center, Madison, Wisconsin,United States of America.
LA  - eng
GR  - R01 TW008859/TW/FIC NIH HHS/United States
GR  - R01 TW 88593/TW/FIC NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20151030
PL  - United States
TA  - PLoS Negl Trop Dis
JT  - PLoS neglected tropical diseases
JID - 101291488
SB  - IM
MH  - Animal Structures/virology
MH  - Animals
MH  - Body Fluids/virology
MH  - Disease Reservoirs
MH  - Female
MH  - Luminescent Measurements
MH  - Male
MH  - Models, Theoretical
MH  - Monkeypox/*pathology/*virology
MH  - Monkeypox virus/*growth & development
MH  - Polymerase Chain Reaction
MH  - Rats
MH  - Rodent Diseases/*pathology/*virology
MH  - Rodentia/*virology
MH  - Virus Cultivation
MH  - Virus Shedding
MH  - Whole Body Imaging
PMC - PMC4627722
EDAT- 2015/10/31 06:00
MHDA- 2016/03/29 06:00
CRDT- 2015/10/31 06:00
PHST- 2015/02/24 00:00 [received]
PHST- 2015/09/09 00:00 [accepted]
PHST- 2015/10/31 06:00 [entrez]
PHST- 2015/10/31 06:00 [pubmed]
PHST- 2016/03/29 06:00 [medline]
AID - 10.1371/journal.pntd.0004130 [doi]
AID - PNTD-D-15-00303 [pii]
PST - epublish
SO  - PLoS Negl Trop Dis. 2015 Oct 30;9(10):e0004130. doi:10.1371/journal.pntd.0004130. eCollection 2015.

PMID- 26517724
OWN - NLM
STAT- MEDLINE
DCOM- 20160328
LR  - 20201215
IS  - 1935-2735 (Electronic)
IS  - 1935-2727 (Linking)
VI  - 9
IP  - 10
DP  - 2015
TI  - Laboratory Investigations of African Pouched Rats (Cricetomys gambianus) as aPotential Reservoir Host Species for Monkeypox Virus.
PG  - e0004013
LID - 10.1371/journal.pntd.0004013 [doi]
AB  - Monkeypox is a zoonotic disease endemic to central and western Africa, where itis a major public health concern. Although Monkeypox virus (MPXV) and monkeypoxdisease in humans have been well characterized, little is known about its naturalhistory, or its maintenance in animal populations of sylvatic reservoir(s). In2003, several species of rodents imported from Ghana were involved in a monkeypoxoutbreak in the United States with individuals of three African rodent genera(Cricetomys, Graphiurus, Funisciurus) shown to be infected with MPXV. Here, weexamine the course of MPXV infection in Cricetomys gambianus (pouched Gambianrats) and this rodent species' competence as a host for the virus. We obtainedten Gambian rats from an introduced colony in Grassy Key, Florida and infectedeight of these via scarification with a challenge dose of 4X104 plaque formingunits (pfu) from either of the two primary clades of MPXV: Congo Basin (C-MPXV: n= 4) or West African (W-MPXV: n = 4); an additional 2 animals served as PBScontrols. Viral shedding and the effect of infection on activity andphysiological aspects of the animals were measured. MPXV challenged animals hadsignificantly higher core body temperatures, reduced activity and increasedweight loss than PBS controls. Viable virus was found in samples taken fromanimals in both experimental groups (C-MPXV and W-MPXV) between 3 and 27 dayspost infection (p.i.) (up to 1X108 pfu/ml), with viral DNA found until day 56p.i. The results from this work show that Cricetomys gambianus (and by inference,probably the closely related species, Cricetomys emini) can be infected with MPXVand shed viable virus particles; thus suggesting that these animals may beinvolved in the maintenance of MPXV in wildlife mammalian populations. Moreresearch is needed to elucidate the epidemiology of MPXV and the role of Gambian rats and other species.
FAU - Hutson, Christina L
AU  - Hutson CL
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
FAU - Nakazawa, Yoshinori J
AU  - Nakazawa YJ
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
FAU - Self, Joshua
AU  - Self J
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
FAU - Olson, Victoria A
AU  - Olson VA
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
FAU - Regnery, Russell L
AU  - Regnery RL
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
FAU - Braden, Zachary
AU  - Braden Z
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
FAU - Weiss, Sonja
AU  - Weiss S
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
FAU - Malekani, Jean
AU  - Malekani J
AD  - Department of Biology, University of Kinshasa, Kinshasa, Democratic Republic ofCongo.
FAU - Jackson, Eddie
AU  - Jackson E
AD  - Animal Resources Branch, Centers for Disease Control and Prevention, Atlanta,Georgia, United States of America.
FAU - Tate, Mallory
AU  - Tate M
AD  - Animal Resources Branch, Centers for Disease Control and Prevention, Atlanta,Georgia, United States of America.
FAU - Karem, Kevin L
AU  - Karem KL
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
FAU - Rocke, Tonie E
AU  - Rocke TE
AD  - U.S. Geological Survey-National Wildlife Health Center, Madison, Wisconsin,United States of America.
FAU - Osorio, Jorge E
AU  - Osorio JE
AD  - Department of Pathobiological Science, School of Veterinary Medicine, University of Wisconsin, Madison, Wisconsin, United States of America.
FAU - Damon, Inger K
AU  - Damon IK
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
FAU - Carroll, Darin S
AU  - Carroll DS
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
LA  - eng
GR  - R01 TW008859/TW/FIC NIH HHS/United States
GR  - 1R01TW008859-01/TW/FIC NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20151030
PL  - United States
TA  - PLoS Negl Trop Dis
JT  - PLoS neglected tropical diseases
JID - 101291488
SB  - IM
MH  - Animals
MH  - Body Temperature
MH  - Body Weight
MH  - *Disease Reservoirs
MH  - Locomotion
MH  - Models, Theoretical
MH  - Monkeypox/pathology/*veterinary/virology
MH  - Monkeypox virus/*isolation & purification
MH  - Rodent Diseases/*pathology/*virology
MH  - Rodentia/*virology
MH  - Virus Shedding
PMC - PMC4627651
EDAT- 2015/10/31 06:00
MHDA- 2016/03/29 06:00
CRDT- 2015/10/31 06:00
PHST- 2015/02/24 00:00 [received]
PHST- 2015/07/28 00:00 [accepted]
PHST- 2015/10/31 06:00 [entrez]
PHST- 2015/10/31 06:00 [pubmed]
PHST- 2016/03/29 06:00 [medline]
AID - 10.1371/journal.pntd.0004013 [doi]
AID - PNTD-D-15-00304 [pii]
PST - epublish
SO  - PLoS Negl Trop Dis. 2015 Oct 30;9(10):e0004013. doi:10.1371/journal.pntd.0004013. eCollection 2015.

PMID- 26426117
OWN - NLM
STAT- MEDLINE
DCOM- 20160603
LR  - 20191210
IS  - 1932-6203 (Electronic)
IS  - 1932-6203 (Linking)
VI  - 10
IP  - 10
DP  - 2015
TI  - Development of a High-Content Orthopoxvirus Infectivity and NeutralizationAssays.
PG  - e0138836
LID - 10.1371/journal.pone.0138836 [doi]
AB  - Currently, a number of assays measure Orthopoxvirus neutralization with serumfrom individuals, vaccinated against smallpox. In addition to the traditionalplaque reduction neutralization test (PRNT), newer higher throughput assays arebased on neutralization of recombinant vaccinia virus, expressing reporter genes such as beta-galactosidase or green fluorescent protein. These methods could not be used to evaluate neutralization of variola virus, since genetic manipulations of this virus are prohibited by international agreements. Currently, PRNT is the assay of choice to measure neutralization of variola virus. However, PRNT assays are time consuming, labor intensive, and require considerable volume of serumsample for testing. Here, we describe the development of a high-throughput,cell-based imaging assay that can be used to measure neutralization, andcharacterize replication kinetics of various Orthopoxviruses, including variola, vaccinia, monkeypox, and cowpox.
FAU - Gates, Irina
AU  - Gates I
AD  - Atlanta Research and Education Foundation, Decatur, Georgia, United States ofAmerica.
FAU - Olson, Victoria
AU  - Olson V
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology (DHCPP), National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention, Atlanta, Georgia, Unites States ofAmerica.
FAU - Smith, Scott
AU  - Smith S
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology (DHCPP), National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention, Atlanta, Georgia, Unites States ofAmerica.
FAU - Patel, Nishi
AU  - Patel N
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology (DHCPP), National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention, Atlanta, Georgia, Unites States ofAmerica.
FAU - Damon, Inger
AU  - Damon I
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology (DHCPP), National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention, Atlanta, Georgia, Unites States ofAmerica.
FAU - Karem, Kevin
AU  - Karem K
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology (DHCPP), National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention, Atlanta, Georgia, Unites States ofAmerica.
LA  - eng
PT  - Journal Article
PT  - Research Support, U.S. Gov't, P.H.S.
DEP - 20151001
PL  - United States
TA  - PLoS One
JT  - PloS one
JID - 101285081
RN  - 147336-22-9 (Green Fluorescent Proteins)
SB  - IM
MH  - Animals
MH  - Chlorocebus aethiops
MH  - Green Fluorescent Proteins/genetics
MH  - Humans
MH  - Immunization
MH  - Neutralization Tests/*methods
MH  - Orthopoxvirus/genetics/growth & development/*immunology/*pathogenicity
MH  - Sciuridae
MH  - Vero Cells
MH  - Viral Plaque Assay
PMC - PMC4591290
EDAT- 2015/10/02 06:00
MHDA- 2016/06/04 06:00
CRDT- 2015/10/02 06:00
PHST- 2015/07/13 00:00 [received]
PHST- 2015/09/03 00:00 [accepted]
PHST- 2015/10/02 06:00 [entrez]
PHST- 2015/10/02 06:00 [pubmed]
PHST- 2016/06/04 06:00 [medline]
AID - 10.1371/journal.pone.0138836 [doi]
AID - PONE-D-15-29592 [pii]
PST - epublish
SO  - PLoS One. 2015 Oct 1;10(10):e0138836. doi: 10.1371/journal.pone.0138836.eCollection 2015.

PMID- 26381398
OWN - NLM
STAT- MEDLINE
DCOM- 20160524
LR  - 20201215
IS  - 1932-6203 (Electronic)
IS  - 1932-6203 (Linking)
VI  - 10
IP  - 9
DP  - 2015
TI  - A Multiplex PCR/LDR Assay for the Simultaneous Identification of Category AInfectious Pathogens: Agents of Viral Hemorrhagic Fever and Variola Virus.
PG  - e0138484
LID - 10.1371/journal.pone.0138484 [doi]
AB  - CDC designated category A infectious agents pose a major risk to nationalsecurity and require special action for public health preparedness. They include viruses that cause viral hemorrhagic fever (VHF) syndrome as well as variolavirus, the agent of smallpox. VHF is characterized by hemorrhage and fever withmulti-organ failure leading to high morbidity and mortality. Smallpox, a priorscourge, has been eradicated for decades, making it a particularly serious threatif released nefariously in the essentially non-immune world population. Earlydetection of the causative agents, and the ability to distinguish them from otherpathogens, is essential to contain outbreaks, implement proper control measures, and prevent morbidity and mortality. We have developed a multiplex detectionassay that uses several species-specific PCR primers to generate amplicons frommultiple pathogens; these are then targeted in a ligase detection reaction (LDR).The resultant fluorescently-labeled ligation products are detected on a universalarray enabling simultaneous identification of the pathogens. The assay wasevaluated on 32 different isolates associated with VHF (ebolavirus, marburgvirus,Crimean Congo hemorrhagic fever virus, Lassa fever virus, Rift Valley fevervirus, Dengue virus, and Yellow fever virus) as well as variola virus andvaccinia virus (the agent of smallpox and its vaccine strain, respectively). The assay was able to detect all viruses tested, including 8 sequences representativeof different variola virus strains from the CDC repository. It does not crossreact with other emerging zoonoses such as monkeypox virus or cowpox virus, orsix flaviviruses tested (St. Louis encephalitis virus, Murray Valley encephalitisvirus, Powassan virus, Tick-borne encephalitis virus, West Nile virus andJapanese encephalitis virus).
FAU - Das, Sanchita
AU  - Das S
AD  - Department of Medicine, Division of Infectious Diseases, Weill Medical College ofCornell University, New York, New York, United States of America.
FAU - Rundell, Mark S
AU  - Rundell MS
AD  - Department of Microbiology and Immunology, Weill Medical College of CornellUniversity, New York, New York, United States of America.
FAU - Mirza, Aashiq H
AU  - Mirza AH
AD  - Department of Microbiology and Immunology, Weill Medical College of CornellUniversity, New York, New York, United States of America.
FAU - Pingle, Maneesh R
AU  - Pingle MR
AD  - Department of Microbiology and Immunology, Weill Medical College of CornellUniversity, New York, New York, United States of America.
FAU - Shigyo, Kristi
AU  - Shigyo K
AD  - Department of Medicine, Division of Infectious Diseases, Weill Medical College ofCornell University, New York, New York, United States of America.
FAU - Garrison, Aura R
AU  - Garrison AR
AD  - United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America.
FAU - Paragas, Jason
AU  - Paragas J
AD  - Integrated Research Facility, Division of Clinical Research, NIAID, NIH, FortDetrick, Maryland, United States of America.
FAU - Smith, Scott K
AU  - Smith SK
AD  - Poxvirus Team, Poxvirus and Rabies Branch, Division of High Consequence Pathogensand Pathology, National Center of Emerging Zoonotic and Infectious Diseases,Centers for Disease Control and Prevention, Atlanta, Georgia, United States ofAmerica.
FAU - Olson, Victoria A
AU  - Olson VA
AD  - Poxvirus Team, Poxvirus and Rabies Branch, Division of High Consequence Pathogensand Pathology, National Center of Emerging Zoonotic and Infectious Diseases,Centers for Disease Control and Prevention, Atlanta, Georgia, United States ofAmerica.
FAU - Larone, Davise H
AU  - Larone DH
AD  - Department of Microbiology and Immunology, Weill Medical College of CornellUniversity, New York, New York, United States of America; Department of Pathologyand Laboratory Medicine, Weill Medical College of Cornell University, New York,NY, United States of America.
FAU - Spitzer, Eric D
AU  - Spitzer ED
AD  - Department of Pathology, Stony Brook University Medical Center, Stony Brook, New York, United States of America.
FAU - Barany, Francis
AU  - Barany F
AD  - Department of Microbiology and Immunology, Weill Medical College of CornellUniversity, New York, New York, United States of America.
FAU - Golightly, Linnie M
AU  - Golightly LM
AD  - Department of Medicine, Division of Infectious Diseases, Weill Medical College ofCornell University, New York, New York, United States of America; Department ofMicrobiology and Immunology, Weill Medical College of Cornell University, NewYork, New York, United States of America.
LA  - eng
GR  - K24 AI110732/AI/NIAID NIH HHS/United States
GR  - UC1 AI062579/AI/NIAID NIH HHS/United States
GR  - UC1-AI062579/AI/NIAID NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20150918
PL  - United States
TA  - PLoS One
JT  - PloS one
JID - 101285081
SB  - IM
MH  - Hemorrhagic Fevers, Viral/*diagnosis/virology
MH  - Humans
MH  - Multiplex Polymerase Chain Reaction/*methods
MH  - Smallpox/*diagnosis/virology
MH  - Variola virus/*isolation & purification
MH  - Viruses/*isolation & purification
PMC - PMC4575071
EDAT- 2015/09/19 06:00
MHDA- 2016/05/25 06:00
CRDT- 2015/09/19 06:00
PHST- 2014/11/08 00:00 [received]
PHST- 2015/08/30 00:00 [accepted]
PHST- 2015/09/19 06:00 [entrez]
PHST- 2015/09/19 06:00 [pubmed]
PHST- 2016/05/25 06:00 [medline]
AID - 10.1371/journal.pone.0138484 [doi]
AID - PONE-D-14-50344 [pii]
PST - epublish
SO  - PLoS One. 2015 Sep 18;10(9):e0138484. doi: 10.1371/journal.pone.0138484.eCollection 2015.

PMID- 26380309
OWN - NLM
STAT- MEDLINE
DCOM- 20160620
LR  - 20181113
IS  - 2314-6141 (Electronic)
VI  - 2015
DP  - 2015
TI  - Comparison of Monkeypox Virus Clade Kinetics and Pathology within the Prairie DogAnimal Model Using a Serial Sacrifice Study Design.
PG  - 965710
LID - 10.1155/2015/965710 [doi]
AB  - Monkeypox virus (MPXV) infection of the prairie dog is valuable to studyingsystemic orthopoxvirus disease. To further characterize differences in MPXV cladepathogenesis, groups of prairie dogs were intranasally infected (8 x 10(3)p.f.u.) with Congo Basin (CB) or West African (WA) MPXV, and 28 tissues wereharvested on days 2, 4, 6, 9, 12, 17, and 24 postinfection. Samples wereevaluated for the presence of virus and gross and microscopic lesions. Virus was recovered from nasal mucosa, oropharyngeal lymph nodes, and spleen earlier in CB challenged animals (day 4) than WA challenged animals (day 6). For both groups,primary viremia (indicated by viral DNA) was seen on days 6-9 through day 17. CB MPXV spread more rapidly, accumulated to greater levels, and caused greatermorbidity in animals compared to WA MPXV. Histopathology and immunohistochemistry(IHC) findings, however, were similar. Two animals that succumbed to diseasedemonstrated abundant viral antigen in all organs tested, except for brain.Dual-IHC staining of select liver and spleen sections showed that apoptotic cells(identified by TUNEL) tended to colocalize with poxvirus antigen. Interestinglysplenocytes were labelled positive for apoptosis more often than hepatocytes inboth MPXV groups. These findings allow for further characterization ofdifferences between MPXV clade pathogenesis, including identifying sites that areimportant during early viral replication and cellular response to viralinfection.
FAU - Hutson, Christina L
AU  - Hutson CL
AD  - Centers for Disease Control and Prevention, Poxvirus and Rabies Branch, Atlanta, GA 30333, USA ; Department of Pathology, College of Veterinary Medicine, TheUniversity of Georgia, Athens, GA 30602, USA.
FAU - Carroll, Darin S
AU  - Carroll DS
AD  - Centers for Disease Control and Prevention, Poxvirus and Rabies Branch, Atlanta, GA 30333, USA.
FAU - Gallardo-Romero, Nadia
AU  - Gallardo-Romero N
AD  - Centers for Disease Control and Prevention, Poxvirus and Rabies Branch, Atlanta, GA 30333, USA.
FAU - Drew, Clifton
AU  - Drew C
AD  - Centers for Disease Control and Prevention, Poxvirus and Rabies Branch, Atlanta, GA 30333, USA.
FAU - Zaki, Sherif R
AU  - Zaki SR
AD  - Centers for Disease Control and Prevention, Poxvirus and Rabies Branch, Atlanta, GA 30333, USA.
FAU - Nagy, Tamas
AU  - Nagy T
AD  - Department of Pathology, College of Veterinary Medicine, The University ofGeorgia, Athens, GA 30602, USA.
FAU - Hughes, Christine
AU  - Hughes C
AD  - Centers for Disease Control and Prevention, Poxvirus and Rabies Branch, Atlanta, GA 30333, USA.
FAU - Olson, Victoria A
AU  - Olson VA
AD  - Centers for Disease Control and Prevention, Poxvirus and Rabies Branch, Atlanta, GA 30333, USA.
FAU - Sanders, Jeanine
AU  - Sanders J
AD  - Centers for Disease Control and Prevention, Poxvirus and Rabies Branch, Atlanta, GA 30333, USA.
FAU - Patel, Nishi
AU  - Patel N
AD  - Centers for Disease Control and Prevention, Poxvirus and Rabies Branch, Atlanta, GA 30333, USA.
FAU - Smith, Scott K
AU  - Smith SK
AD  - Centers for Disease Control and Prevention, Poxvirus and Rabies Branch, Atlanta, GA 30333, USA.
FAU - Keckler, M Shannon
AU  - Keckler MS
AD  - Centers for Disease Control and Prevention, Poxvirus and Rabies Branch, Atlanta, GA 30333, USA.
FAU - Karem, Kevin
AU  - Karem K
AD  - Centers for Disease Control and Prevention, Poxvirus and Rabies Branch, Atlanta, GA 30333, USA.
FAU - Damon, Inger K
AU  - Damon IK
AD  - Centers for Disease Control and Prevention, Poxvirus and Rabies Branch, Atlanta, GA 30333, USA.
LA  - eng
PT  - Journal Article
DEP - 20150824
PL  - United States
TA  - Biomed Res Int
JT  - BioMed research international
JID - 101600173
RN  - 0 (DNA, Viral)
SB  - IM
MH  - Animals
MH  - DNA, Viral/blood/*genetics
MH  - Disease Models, Animal
MH  - Kinetics
MH  - Liver/virology
MH  - Lymph Nodes/virology
MH  - Monkeypox/blood/genetics/pathology/*virology
MH  - Monkeypox virus/*genetics/pathogenicity
MH  - Nasal Mucosa/virology
MH  - Phylogeny
MH  - Sciuridae/blood/genetics/virology
MH  - Spleen/virology
MH  - Virus Replication/*genetics
PMC - PMC4561332
EDAT- 2015/09/18 06:00
MHDA- 2016/06/21 06:00
CRDT- 2015/09/18 06:00
PHST- 2015/02/11 00:00 [received]
PHST- 2015/06/18 00:00 [accepted]
PHST- 2015/09/18 06:00 [entrez]
PHST- 2015/09/18 06:00 [pubmed]
PHST- 2016/06/21 06:00 [medline]
AID - 10.1155/2015/965710 [doi]
PST - ppublish
SO  - Biomed Res Int. 2015;2015:965710. doi: 10.1155/2015/965710. Epub 2015 Aug 24.

PMID- 26325270
OWN - NLM
STAT- MEDLINE
DCOM- 20160404
LR  - 20210109
IS  - 1553-7374 (Electronic)
IS  - 1553-7366 (Linking)
VI  - 11
IP  - 9
DP  - 2015 Sep
TI  - Structural and Functional Characterization of Anti-A33 Antibodies Reveal a PotentCross-Species Orthopoxviruses Neutralizer.
PG  - e1005148
LID - 10.1371/journal.ppat.1005148 [doi]
AB  - Vaccinia virus A33 is an extracellular enveloped virus (EEV)-specific type IImembrane glycoprotein that is essential for efficient EEV formation andlong-range viral spread within the host. A33 is a target for neutralizingantibody responses against EEV. In this study, we produced seven murine anti-A33 monoclonal antibodies (MAbs) by immunizing mice with live VACV, followed byboosting with the soluble A33 homodimeric ectodomain. Five A33 specific MAbs werecapable of neutralizing EEV in the presence of complement. All MAbs bind toconformational epitopes on A33 but not to linear peptides. To identify theepitopes, we have adetermined the crystal structures of three representativeneutralizing MAbs in complex with A33. We have further determined the bindingkinetics for each of the three antibodies to wild-type A33, as well as toengineered A33 that contained single alanine substitutions within the epitopes ofthe three crystallized antibodies. While the Fab of both MAbs A2C7 and A20G2binds to a single A33 subunit, the Fab from MAb A27D7 binds to both A33 subunits simultaneously. A27D7 binding is resistant to single alanine substitutions withinthe A33 epitope. A27D7 also demonstrated high-affinity binding with recombinantA33 protein that mimics other orthopoxvirus strains in the A27D7 epitope, such asectromelia, monkeypox, and cowpox virus, suggesting that A27D7 is a potentcross-neutralizer. Finally, we confirmed that A27D7 protects mice against alethal challenge with ectromelia virus.
FAU - Matho, Michael H
AU  - Matho MH
AD  - Division of Cell Biology, La Jolla Institute for Allergy and Immunology, LaJolla, California, United States of America.
FAU - Schlossman, Andrew
AU  - Schlossman A
AD  - Division of Cell Biology, La Jolla Institute for Allergy and Immunology, LaJolla, California, United States of America.
FAU - Meng, Xiangzhi
AU  - Meng X
AD  - Department of Microbiology and Immunology, University of Texas Health ScienceCenter, San Antonio, Texas, United States of America.
FAU - Benhnia, Mohammed Rafii-El-Idrissi
AU  - Benhnia MR
AD  - Department of Medical Biochemistry, Molecular Biology, and Immunology, School of Medicine, University of Seville; and Laboratory of Immunovirology, Unit 211,Biomedicine Institute of Seville (IBIS), Seville, Spain.
FAU - Kaever, Thomas
AU  - Kaever T
AD  - Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, California, United States of America.
FAU - Buller, Mark
AU  - Buller M
AD  - Saint Louis University School of Medicine, St. Louis, Missouri, United States of America.
FAU - Doronin, Konstantin
AU  - Doronin K
AD  - Saint Louis University School of Medicine, St. Louis, Missouri, United States of America.
FAU - Parker, Scott
AU  - Parker S
AD  - Saint Louis University School of Medicine, St. Louis, Missouri, United States of America.
FAU - Peters, Bjoern
AU  - Peters B
AD  - Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, California, United States of America.
FAU - Crotty, Shane
AU  - Crotty S
AD  - Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, California, United States of America.
FAU - Xiang, Yan
AU  - Xiang Y
AD  - Department of Microbiology and Immunology, University of Texas Health ScienceCenter, San Antonio, Texas, United States of America.
FAU - Zajonc, Dirk M
AU  - Zajonc DM
AD  - Division of Cell Biology, La Jolla Institute for Allergy and Immunology, LaJolla, California, United States of America.
LA  - eng
SI  - PDB/4LQF
SI  - PDB/4LU5
SI  - PDB/4M1G
GR  - HHSN272201000021C/AI/NIAID NIH HHS/United States
GR  - P41RR001209/RR/NCRR NIH HHS/United States
GR  - P41 RR001209/RR/NCRR NIH HHS/United States
GR  - P41GM103393/GM/NIGMS NIH HHS/United States
GR  - HHSN272201000021I/AI/NIAID NIH HHS/United States
GR  - HHSN272200900048C/AI/NIAID NIH HHS/United States
GR  - P41 GM103393/GM/NIGMS NIH HHS/United States
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20150901
PL  - United States
TA  - PLoS Pathog
JT  - PLoS pathogens
JID - 101238921
RN  - 0 (Antibodies, Monoclonal)
RN  - 0 (Antibodies, Neutralizing)
RN  - 0 (Antigen-Antibody Complex)
RN  - 0 (Immunoglobulin Fab Fragments)
RN  - 0 (Membrane Glycoproteins)
RN  - 0 (Recombinant Proteins)
RN  - 0 (Vaccines, Synthetic)
RN  - 0 (Viral Envelope Proteins)
RN  - 0 (Viral Vaccines)
SB  - IM
MH  - Animals
MH  - Antibodies, Monoclonal/chemistry/genetics/metabolism/therapeutic use
MH  - Antibodies, Neutralizing/chemistry/genetics/*metabolism/therapeutic use
MH  - Antibody Affinity
MH  - Antibody Specificity
MH  - Antigen-Antibody Complex/chemistry/genetics/metabolism
MH  - Chlorocebus aethiops
MH  - Female
MH  - Immunoglobulin Fab Fragments/chemistry/genetics/metabolism
MH  - Membrane Glycoproteins/*antagonists & inhibitors/genetics/metabolism
MH  - Mice, Inbred BALB C
MH  - *Models, Molecular
MH  - Mutation
MH  - Orthopoxvirus/immunology/*physiology
MH  - Poxviridae Infections/immunology/prevention & control/*virology
MH  - Protein Conformation
MH  - Recombinant Proteins/chemistry/metabolism/therapeutic use
MH  - Vaccines, Synthetic/chemistry/genetics/metabolism/therapeutic use
MH  - Vero Cells
MH  - Viral Envelope Proteins/*antagonists & inhibitors/genetics/metabolism
MH  - *Viral Tropism
MH  - Viral Vaccines/chemistry/genetics/metabolism/therapeutic use
PMC - PMC4556652
EDAT- 2015/09/02 06:00
MHDA- 2016/04/05 06:00
CRDT- 2015/09/02 06:00
PHST- 2015/04/20 00:00 [received]
PHST- 2015/08/13 00:00 [accepted]
PHST- 2015/09/02 06:00 [entrez]
PHST- 2015/09/02 06:00 [pubmed]
PHST- 2016/04/05 06:00 [medline]
AID - 10.1371/journal.ppat.1005148 [doi]
AID - PPATHOGENS-D-15-00942 [pii]
PST - epublish
SO  - PLoS Pathog. 2015 Sep 1;11(9):e1005148. doi: 10.1371/journal.ppat.1005148.eCollection 2015 Sep.

PMID- 26319072
OWN - NLM
STAT- MEDLINE
DCOM- 20160817
LR  - 20151109
IS  - 1873-2518 (Electronic)
IS  - 0264-410X (Linking)
VI  - 33
IP  - 45
DP  - 2015 Nov 9
TI  - Recent advances in the study of live attenuated cell-cultured smallpox vaccineLC16m8.
PG  - 6106-11
LID - 10.1016/j.vaccine.2015.07.111 [doi]
LID - S0264-410X(15)01179-2 [pii]
AB  - LC16m8 is a live, attenuated, cell-cultured smallpox vaccine that was developedand licensed in Japan in the 1970s, but was not used in the campaign to eradicatesmallpox. In the early 2000s, the potential threat of bioterrorism led toreconsideration of the need for a smallpox vaccine. Subsequently, LC16m8production was restarted in Japan in 2002, requiring re-evaluation of its safety and efficacy. Approximately 50,000 children in the 1970s and about 3500 healthyadults in the 2000s were vaccinated with LC16m8 in Japan, and 153 adults havebeen vaccinated with LC16m8 or Dryvax in phase I/II clinical trials in the USA.These studies confirmed the safety and efficacy of LC16m8, while several studies in animal models have shown that LC16m8 protects the host against viralchallenge. The World Health Organization Strategic Advisory Group of Experts onImmunization recommended LC16m8, together with ACAM2000, as a stockpile vaccinein 2013. In addition, LC16m8 is expected to be a viable alternative tofirst-generation smallpox vaccines to prevent human monkeypox.
CI  - Copyright (c) 2015 Elsevier Ltd. All rights reserved.
FAU - Eto, Akiko
AU  - Eto A
AD  - Department of Health Crisis Management, National Institute of Public Health,2-3-6 Minami, Wako-shi, 351-0197, Saitama, Japan.
FAU - Saito, Tomoya
AU  - Saito T
AD  - Department of Health Crisis Management, National Institute of Public Health,2-3-6 Minami, Wako-shi, 351-0197, Saitama, Japan.
FAU - Yokote, Hiroyuki
AU  - Yokote H
AD  - Chemo-Sero-Therapeutic Research Institute (Kaketsuken), 1-6-1 Okubo, Kita-ku,Kumamoto-shi, 860-8568, Kumamoto, Japan.
FAU - Kurane, Ichiro
AU  - Kurane I
AD  - National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, 162-8640, Tokyo, Japan.
FAU - Kanatani, Yasuhiro
AU  - Kanatani Y
AD  - Department of Health Crisis Management, National Institute of Public Health,2-3-6 Minami, Wako-shi, 351-0197, Saitama, Japan. Electronic address:ykanatani@niph.go.jp.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Review
DEP - 20150828
PL  - Netherlands
TA  - Vaccine
JT  - Vaccine
JID - 8406899
RN  - 0 (Antibodies, Viral)
RN  - 0 (DryVax vaccine)
RN  - 0 (Smallpox Vaccine)
RN  - 0 (Vaccines, Attenuated)
RN  - 0 (smallpox vaccine LC16m8)
SB  - IM
MH  - Adult
MH  - Animals
MH  - Antibodies, Viral/blood
MH  - Bioterrorism
MH  - Cell Culture Techniques
MH  - Clinical Trials as Topic
MH  - Disease Models, Animal
MH  - Humans
MH  - Japan
MH  - Mice
MH  - Monkeypox/*prevention & control
MH  - Smallpox/*prevention & control
MH  - Smallpox Vaccine/adverse effects/*immunology
MH  - Strategic Stockpile
MH  - Vaccines, Attenuated/administration & dosage/adverse effects/immunology
MH  - Vaccinia virus/immunology
OTO - NOTNLM
OT  - Anti-terrorism
OT  - LC16m8
OT  - Monkeypox
OT  - Smallpox vaccine
EDAT- 2015/09/01 06:00
MHDA- 2016/08/18 06:00
CRDT- 2015/08/31 06:00
PHST- 2015/05/08 00:00 [received]
PHST- 2015/07/20 00:00 [revised]
PHST- 2015/07/29 00:00 [accepted]
PHST- 2015/08/31 06:00 [entrez]
PHST- 2015/09/01 06:00 [pubmed]
PHST- 2016/08/18 06:00 [medline]
AID - S0264-410X(15)01179-2 [pii]
AID - 10.1016/j.vaccine.2015.07.111 [doi]
PST - ppublish
SO  - Vaccine. 2015 Nov 9;33(45):6106-11. doi: 10.1016/j.vaccine.2015.07.111. Epub 2015Aug 28.

PMID- 26283752
OWN - NLM
STAT- MEDLINE
DCOM- 20160202
LR  - 20220318
IS  - 1476-1645 (Electronic)
IS  - 0002-9637 (Linking)
VI  - 93
IP  - 4
DP  - 2015 Oct
TI  - Human Monkeypox in the Kivus, a Conflict Region of the Democratic Republic of theCongo.
PG  - 718-21
LID - 10.4269/ajtmh.15-0095 [doi]
AB  - Monkeypox (MPX) is a zoonotic Orthopoxvirus infection endemic in central andwestern Africa. Human MPX cases occur in the central and northern regions of the Democratic Republic of the Congo (DRC), and this is the first report of confirmedMPX cases in the forested areas of North and South Kivu Provinces, with adetailed epidemiological investigation for one case. The location of each case iswithin areas predicted to be suitable for MPX virus transmission based on anecological niche model. Phylogenetic analysis places these viruses in the CongoBasin clade.
CI  - (c) The American Society of Tropical Medicine and Hygiene.
FAU - McCollum, Andrea M
AU  - McCollum AM
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,U.S. Centers for Disease Control and Prevention, Atlanta, Georgia; DivisionProvinciale de la Sante, Ministere de la Sante Publique, Goma, Nord-Kivu,Democratic Republic of the Congo; Institut National de Recherche Biomedicale,Kinshasa, Democratic Republic of the Congo; Ministere de la Sante Publique,Kinshasa, Democratic Republic of the Congo; U.S. Centers for Disease Control and Prevention, Kinshasa, Democratic Republic of the Congo; University of Kinshasa,Kinshasa, Democratic Republic of the Congo azv4@cdc.gov.
FAU - Nakazawa, Yoshinori
AU  - Nakazawa Y
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,U.S. Centers for Disease Control and Prevention, Atlanta, Georgia; DivisionProvinciale de la Sante, Ministere de la Sante Publique, Goma, Nord-Kivu,Democratic Republic of the Congo; Institut National de Recherche Biomedicale,Kinshasa, Democratic Republic of the Congo; Ministere de la Sante Publique,Kinshasa, Democratic Republic of the Congo; U.S. Centers for Disease Control and Prevention, Kinshasa, Democratic Republic of the Congo; University of Kinshasa,Kinshasa, Democratic Republic of the Congo.
FAU - Ndongala, Guy Mutombo
AU  - Ndongala GM
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,U.S. Centers for Disease Control and Prevention, Atlanta, Georgia; DivisionProvinciale de la Sante, Ministere de la Sante Publique, Goma, Nord-Kivu,Democratic Republic of the Congo; Institut National de Recherche Biomedicale,Kinshasa, Democratic Republic of the Congo; Ministere de la Sante Publique,Kinshasa, Democratic Republic of the Congo; U.S. Centers for Disease Control and Prevention, Kinshasa, Democratic Republic of the Congo; University of Kinshasa,Kinshasa, Democratic Republic of the Congo.
FAU - Pukuta, Elisabeth
AU  - Pukuta E
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,U.S. Centers for Disease Control and Prevention, Atlanta, Georgia; DivisionProvinciale de la Sante, Ministere de la Sante Publique, Goma, Nord-Kivu,Democratic Republic of the Congo; Institut National de Recherche Biomedicale,Kinshasa, Democratic Republic of the Congo; Ministere de la Sante Publique,Kinshasa, Democratic Republic of the Congo; U.S. Centers for Disease Control and Prevention, Kinshasa, Democratic Republic of the Congo; University of Kinshasa,Kinshasa, Democratic Republic of the Congo.
FAU - Karhemere, Stomy
AU  - Karhemere S
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,U.S. Centers for Disease Control and Prevention, Atlanta, Georgia; DivisionProvinciale de la Sante, Ministere de la Sante Publique, Goma, Nord-Kivu,Democratic Republic of the Congo; Institut National de Recherche Biomedicale,Kinshasa, Democratic Republic of the Congo; Ministere de la Sante Publique,Kinshasa, Democratic Republic of the Congo; U.S. Centers for Disease Control and Prevention, Kinshasa, Democratic Republic of the Congo; University of Kinshasa,Kinshasa, Democratic Republic of the Congo.
FAU - Lushima, Robert Shongo
AU  - Lushima RS
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,U.S. Centers for Disease Control and Prevention, Atlanta, Georgia; DivisionProvinciale de la Sante, Ministere de la Sante Publique, Goma, Nord-Kivu,Democratic Republic of the Congo; Institut National de Recherche Biomedicale,Kinshasa, Democratic Republic of the Congo; Ministere de la Sante Publique,Kinshasa, Democratic Republic of the Congo; U.S. Centers for Disease Control and Prevention, Kinshasa, Democratic Republic of the Congo; University of Kinshasa,Kinshasa, Democratic Republic of the Congo.
FAU - Ilunga, Benoit Kebela
AU  - Ilunga BK
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,U.S. Centers for Disease Control and Prevention, Atlanta, Georgia; DivisionProvinciale de la Sante, Ministere de la Sante Publique, Goma, Nord-Kivu,Democratic Republic of the Congo; Institut National de Recherche Biomedicale,Kinshasa, Democratic Republic of the Congo; Ministere de la Sante Publique,Kinshasa, Democratic Republic of the Congo; U.S. Centers for Disease Control and Prevention, Kinshasa, Democratic Republic of the Congo; University of Kinshasa,Kinshasa, Democratic Republic of the Congo.
FAU - Kabamba, Joelle
AU  - Kabamba J
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,U.S. Centers for Disease Control and Prevention, Atlanta, Georgia; DivisionProvinciale de la Sante, Ministere de la Sante Publique, Goma, Nord-Kivu,Democratic Republic of the Congo; Institut National de Recherche Biomedicale,Kinshasa, Democratic Republic of the Congo; Ministere de la Sante Publique,Kinshasa, Democratic Republic of the Congo; U.S. Centers for Disease Control and Prevention, Kinshasa, Democratic Republic of the Congo; University of Kinshasa,Kinshasa, Democratic Republic of the Congo.
FAU - Wilkins, Kimberly
AU  - Wilkins K
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,U.S. Centers for Disease Control and Prevention, Atlanta, Georgia; DivisionProvinciale de la Sante, Ministere de la Sante Publique, Goma, Nord-Kivu,Democratic Republic of the Congo; Institut National de Recherche Biomedicale,Kinshasa, Democratic Republic of the Congo; Ministere de la Sante Publique,Kinshasa, Democratic Republic of the Congo; U.S. Centers for Disease Control and Prevention, Kinshasa, Democratic Republic of the Congo; University of Kinshasa,Kinshasa, Democratic Republic of the Congo.
FAU - Gao, Jinxin
AU  - Gao J
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,U.S. Centers for Disease Control and Prevention, Atlanta, Georgia; DivisionProvinciale de la Sante, Ministere de la Sante Publique, Goma, Nord-Kivu,Democratic Republic of the Congo; Institut National de Recherche Biomedicale,Kinshasa, Democratic Republic of the Congo; Ministere de la Sante Publique,Kinshasa, Democratic Republic of the Congo; U.S. Centers for Disease Control and Prevention, Kinshasa, Democratic Republic of the Congo; University of Kinshasa,Kinshasa, Democratic Republic of the Congo.
FAU - Li, Yu
AU  - Li Y
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,U.S. Centers for Disease Control and Prevention, Atlanta, Georgia; DivisionProvinciale de la Sante, Ministere de la Sante Publique, Goma, Nord-Kivu,Democratic Republic of the Congo; Institut National de Recherche Biomedicale,Kinshasa, Democratic Republic of the Congo; Ministere de la Sante Publique,Kinshasa, Democratic Republic of the Congo; U.S. Centers for Disease Control and Prevention, Kinshasa, Democratic Republic of the Congo; University of Kinshasa,Kinshasa, Democratic Republic of the Congo.
FAU - Emerson, Ginny
AU  - Emerson G
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,U.S. Centers for Disease Control and Prevention, Atlanta, Georgia; DivisionProvinciale de la Sante, Ministere de la Sante Publique, Goma, Nord-Kivu,Democratic Republic of the Congo; Institut National de Recherche Biomedicale,Kinshasa, Democratic Republic of the Congo; Ministere de la Sante Publique,Kinshasa, Democratic Republic of the Congo; U.S. Centers for Disease Control and Prevention, Kinshasa, Democratic Republic of the Congo; University of Kinshasa,Kinshasa, Democratic Republic of the Congo.
FAU - Damon, Inger K
AU  - Damon IK
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,U.S. Centers for Disease Control and Prevention, Atlanta, Georgia; DivisionProvinciale de la Sante, Ministere de la Sante Publique, Goma, Nord-Kivu,Democratic Republic of the Congo; Institut National de Recherche Biomedicale,Kinshasa, Democratic Republic of the Congo; Ministere de la Sante Publique,Kinshasa, Democratic Republic of the Congo; U.S. Centers for Disease Control and Prevention, Kinshasa, Democratic Republic of the Congo; University of Kinshasa,Kinshasa, Democratic Republic of the Congo.
FAU - Carroll, Darin S
AU  - Carroll DS
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,U.S. Centers for Disease Control and Prevention, Atlanta, Georgia; DivisionProvinciale de la Sante, Ministere de la Sante Publique, Goma, Nord-Kivu,Democratic Republic of the Congo; Institut National de Recherche Biomedicale,Kinshasa, Democratic Republic of the Congo; Ministere de la Sante Publique,Kinshasa, Democratic Republic of the Congo; U.S. Centers for Disease Control and Prevention, Kinshasa, Democratic Republic of the Congo; University of Kinshasa,Kinshasa, Democratic Republic of the Congo.
FAU - Reynolds, Mary G
AU  - Reynolds MG
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,U.S. Centers for Disease Control and Prevention, Atlanta, Georgia; DivisionProvinciale de la Sante, Ministere de la Sante Publique, Goma, Nord-Kivu,Democratic Republic of the Congo; Institut National de Recherche Biomedicale,Kinshasa, Democratic Republic of the Congo; Ministere de la Sante Publique,Kinshasa, Democratic Republic of the Congo; U.S. Centers for Disease Control and Prevention, Kinshasa, Democratic Republic of the Congo; University of Kinshasa,Kinshasa, Democratic Republic of the Congo.
FAU - Malekani, Jean
AU  - Malekani J
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,U.S. Centers for Disease Control and Prevention, Atlanta, Georgia; DivisionProvinciale de la Sante, Ministere de la Sante Publique, Goma, Nord-Kivu,Democratic Republic of the Congo; Institut National de Recherche Biomedicale,Kinshasa, Democratic Republic of the Congo; Ministere de la Sante Publique,Kinshasa, Democratic Republic of the Congo; U.S. Centers for Disease Control and Prevention, Kinshasa, Democratic Republic of the Congo; University of Kinshasa,Kinshasa, Democratic Republic of the Congo.
FAU - Tamfum, Jean-Jacques Muyembe
AU  - Tamfum JJ
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,U.S. Centers for Disease Control and Prevention, Atlanta, Georgia; DivisionProvinciale de la Sante, Ministere de la Sante Publique, Goma, Nord-Kivu,Democratic Republic of the Congo; Institut National de Recherche Biomedicale,Kinshasa, Democratic Republic of the Congo; Ministere de la Sante Publique,Kinshasa, Democratic Republic of the Congo; U.S. Centers for Disease Control and Prevention, Kinshasa, Democratic Republic of the Congo; University of Kinshasa,Kinshasa, Democratic Republic of the Congo.
LA  - eng
PT  - Journal Article
DEP - 20150817
PL  - United States
TA  - Am J Trop Med Hyg
JT  - The American journal of tropical medicine and hygiene
JID - 0370507
SB  - IM
MH  - Adult
MH  - Child
MH  - Democratic Republic of the Congo/epidemiology
MH  - Female
MH  - Humans
MH  - Infant
MH  - Male
MH  - Monkeypox/*epidemiology
MH  - *Monkeypox virus/genetics
MH  - Phylogeny
MH  - Warfare
MH  - Young Adult
PMC - PMC4596588
EDAT- 2015/08/19 06:00
MHDA- 2016/02/03 06:00
CRDT- 2015/08/19 06:00
PHST- 2015/02/02 00:00 [received]
PHST- 2015/03/31 00:00 [accepted]
PHST- 2015/08/19 06:00 [entrez]
PHST- 2015/08/19 06:00 [pubmed]
PHST- 2016/02/03 06:00 [medline]
AID - ajtmh.15-0095 [pii]
AID - 10.4269/ajtmh.15-0095 [doi]
PST - ppublish
SO  - Am J Trop Med Hyg. 2015 Oct;93(4):718-21. doi: 10.4269/ajtmh.15-0095. Epub 2015Aug 17.

PMID- 26246580
OWN - NLM
STAT- MEDLINE
DCOM- 20151215
LR  - 20191210
IS  - 1098-5514 (Electronic)
IS  - 0022-538X (Linking)
VI  - 89
IP  - 20
DP  - 2015 Oct
TI  - Evasion of the Innate Immune Type I Interferon System by Monkeypox Virus.
PG  - 10489-99
LID - 10.1128/JVI.00304-15 [doi]
AB  - UNLABELLED: The vaccinia virus (VACV) E3 protein has been shown to be importantfor blocking activation of the cellular innate immune system and allowing viralreplication to occur unhindered. Mutation or deletion of E3L severely affectsviral host range and pathogenesis. While the monkeypox virus (MPXV) genomeencodes a homologue of the VACV E3 protein, encoded by the F3L gene, the MPXVgene is predicted to encode a protein with a truncation of 37 N-terminal aminoacids. VACV with a genome encoding a similarly truncated E3L protein(VACV-E3LDelta37N) has been shown to be attenuated in mouse models, and infectionwith VACV-E3LDelta37N has been shown to lead to activation of the host antiviral protein kinase R pathway. In this report, we present data demonstrating that,despite containing a truncated E3 homologue, MPXV phenotypically resembles awild-type (wt) VACV rather than VACV-E3LDelta37N. Thus, MPXV appears to contain agene or genes that can suppress the phenotypes associated with an N-terminaltruncation in E3. The suppression maps to sequences outside F3L, suggesting that the suppression is extragenic in nature. Thus, MPXV appears to have evolvedmechanisms to minimize the effects of partial inactivation of its E3 homologue.IMPORTANCE: Poxviruses have evolved to have many mechanisms to evade hostantiviral innate immunity; these mechanisms may allow these viruses to causedisease. Within the family of poxviruses, variola virus (which causes smallpox)is the most pathogenic, while monkeypox virus is intermediate in pathogenicitybetween vaccinia virus and variola virus. Understanding the mechanisms ofmonkeypox virus innate immune evasion will help us to understand the evolution ofpoxvirus innate immune evasion capabilities, providing a better understanding of how poxviruses cause disease.
CI  - Copyright (c) 2015, American Society for Microbiology. All Rights Reserved.
FAU - Arndt, William D
AU  - Arndt WD
AD  - School of Life Sciences, Center for Infectious Diseases and Vaccinology, Arizona State University, Tempe, Arizona, USA The Biodesign Institute, Center forInfectious Diseases and Vaccinology, Arizona State University, Tempe, Arizona,USA.
FAU - Cotsmire, Samantha
AU  - Cotsmire S
AD  - The Biodesign Institute, Center for Infectious Diseases and Vaccinology, Arizona State University, Tempe, Arizona, USA.
FAU - Trainor, Kelly
AU  - Trainor K
AD  - School of Life Sciences, Center for Infectious Diseases and Vaccinology, Arizona State University, Tempe, Arizona, USA The Biodesign Institute, Center forInfectious Diseases and Vaccinology, Arizona State University, Tempe, Arizona,USA.
FAU - Harrington, Heather
AU  - Harrington H
AD  - School of Life Sciences, Center for Infectious Diseases and Vaccinology, Arizona State University, Tempe, Arizona, USA The Biodesign Institute, Center forInfectious Diseases and Vaccinology, Arizona State University, Tempe, Arizona,USA.
FAU - Hauns, Kevin
AU  - Hauns K
AD  - School of Life Sciences, Center for Infectious Diseases and Vaccinology, Arizona State University, Tempe, Arizona, USA The Biodesign Institute, Center forInfectious Diseases and Vaccinology, Arizona State University, Tempe, Arizona,USA.
FAU - Kibler, Karen V
AU  - Kibler KV
AD  - The Biodesign Institute, Center for Infectious Diseases and Vaccinology, Arizona State University, Tempe, Arizona, USA.
FAU - Huynh, Trung P
AU  - Huynh TP
AD  - School of Life Sciences, Center for Infectious Diseases and Vaccinology, Arizona State University, Tempe, Arizona, USA The Biodesign Institute, Center forInfectious Diseases and Vaccinology, Arizona State University, Tempe, Arizona,USA.
FAU - Jacobs, Bertram L
AU  - Jacobs BL
AD  - School of Life Sciences, Center for Infectious Diseases and Vaccinology, Arizona State University, Tempe, Arizona, USA The Biodesign Institute, Center forInfectious Diseases and Vaccinology, Arizona State University, Tempe, Arizona,USA bjacobs@asu.edu.
LA  - eng
GR  - R01 AI095394/AI/NIAID NIH HHS/United States
GR  - R01AI095394/AI/NIAID NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20150805
PL  - United States
TA  - J Virol
JT  - Journal of virology
JID - 0113724
RN  - 0 (E3L protein, Vaccinia virus)
RN  - 0 (Interferon Type I)
RN  - 0 (RNA-Binding Proteins)
RN  - 0 (Viral Proteins)
SB  - IM
MH  - Amino Acid Sequence
MH  - Animals
MH  - Biological Evolution
MH  - Cell Line
MH  - Chlorocebus aethiops
MH  - Cricetulus
MH  - Epithelial Cells/immunology/virology
MH  - Gene Expression
MH  - HeLa Cells
MH  - Host Specificity
MH  - Host-Pathogen Interactions
MH  - Humans
MH  - *Immune Evasion
MH  - *Immunity, Innate
MH  - Interferon Type I/genetics/*immunology
MH  - Molecular Sequence Data
MH  - Monkeypox virus/*genetics/immunology/pathogenicity
MH  - RNA-Binding Proteins/chemistry/*genetics/immunology
MH  - Rabbits
MH  - Sequence Alignment
MH  - Signal Transduction
MH  - Vaccinia virus/*genetics/immunology/pathogenicity
MH  - Vero Cells
MH  - Viral Proteins/chemistry/*genetics/immunology
MH  - Virus Replication
PMC - PMC4580173
EDAT- 2015/08/08 06:00
MHDA- 2015/12/17 06:00
CRDT- 2015/08/07 06:00
PHST- 2015/06/02 00:00 [received]
PHST- 2015/08/01 00:00 [accepted]
PHST- 2015/08/07 06:00 [entrez]
PHST- 2015/08/08 06:00 [pubmed]
PHST- 2015/12/17 06:00 [medline]
AID - JVI.00304-15 [pii]
AID - 10.1128/JVI.00304-15 [doi]
PST - ppublish
SO  - J Virol. 2015 Oct;89(20):10489-99. doi: 10.1128/JVI.00304-15. Epub 2015 Aug 5.

PMID- 26147658
OWN - NLM
STAT- MEDLINE
DCOM- 20160419
LR  - 20191210
IS  - 1932-6203 (Electronic)
IS  - 1932-6203 (Linking)
VI  - 10
IP  - 7
DP  - 2015
TI  - Susceptibility of Marmosets (Callithrix jacchus) to Monkeypox Virus: A Low DoseProspective Model for Monkeypox and Smallpox Disease.
PG  - e0131742
LID - 10.1371/journal.pone.0131742 [doi]
AB  - Although current nonhuman primate models of monkeypox and smallpox diseasesprovide some insight into disease pathogenesis, they require a high titerinoculum, use an unnatural route of infection, and/or do not accurately representthe entire disease course. This is a concern when developing smallpox and/ormonkeypox countermeasures or trying to understand host pathogen relationships. Inour studies, we altered half of the test system by using a New World nonhumanprimate host, the common marmoset. Based on dose finding studies, we found thatmarmosets are susceptible to monkeypox virus infection, produce a high viremia,and have pathological features consistent with smallpox and monkeypox in humans. The low dose (48 plaque forming units) required to elicit a uniformly lethaldisease and the extended incubation (preclinical signs) are unique features amongnonhuman primate models utilizing monkeypox virus. The uniform lethality,hemorrhagic rash, high viremia, decrease in platelets, pathology, and abbreviatedacute phase are reflective of early-type hemorrhagic smallpox.
FAU - Mucker, Eric M
AU  - Mucker EM
AD  - Virology Division, United States Army Medical Research Institute of InfectiousDiseases, Fort Detrick, Maryland, United States of America; Tulane UniversitySchool of Medicine, New Orleans, Louisianna, United States of America.
FAU - Chapman, Jennifer
AU  - Chapman J
AD  - Joint Pathology Center, Silver Spring, Maryland, United States of America.
FAU - Huzella, Louis M
AU  - Huzella LM
AD  - Integrated Research Facility, National Institute of Allergy and InfectiousDiseases, Fort Detrick, Maryland, United States of America.
FAU - Huggins, John W
AU  - Huggins JW
AD  - Virology Division, United States Army Medical Research Institute of InfectiousDiseases, Fort Detrick, Maryland, United States of America.
FAU - Shamblin, Joshua
AU  - Shamblin J
AD  - Virology Division, United States Army Medical Research Institute of InfectiousDiseases, Fort Detrick, Maryland, United States of America.
FAU - Robinson, Camenzind G
AU  - Robinson CG
AD  - Pathology Division, United States Army Medical Research Institute of InfectiousDiseases, Fort Detrick, Maryland, United States of America.
FAU - Hensley, Lisa E
AU  - Hensley LE
AD  - Integrated Research Facility, National Institute of Allergy and InfectiousDiseases, Fort Detrick, Maryland, United States of America.
LA  - eng
PT  - Journal Article
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20150706
PL  - United States
TA  - PLoS One
JT  - PloS one
JID - 101285081
SB  - IM
MH  - Animals
MH  - Callithrix
MH  - Chlorocebus aethiops
MH  - *Disease Susceptibility
MH  - Male
MH  - *Models, Biological
MH  - Monkeypox/*physiopathology
MH  - Monkeypox virus/isolation & purification/*pathogenicity
MH  - Prospective Studies
MH  - Variola virus/isolation & purification/*pathogenicity
MH  - Vero Cells
MH  - Viral Load
PMC - PMC4492619
EDAT- 2015/07/07 06:00
MHDA- 2016/04/20 06:00
CRDT- 2015/07/07 06:00
PHST- 2015/02/09 00:00 [received]
PHST- 2015/06/05 00:00 [accepted]
PHST- 2015/07/07 06:00 [entrez]
PHST- 2015/07/07 06:00 [pubmed]
PHST- 2016/04/20 06:00 [medline]
AID - 10.1371/journal.pone.0131742 [doi]
AID - PONE-D-15-02637 [pii]
PST - epublish
SO  - PLoS One. 2015 Jul 6;10(7):e0131742. doi: 10.1371/journal.pone.0131742.eCollection 2015.

PMID- 26116113
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20150627
LR  - 20201119
IS  - 2191-219X (Print)
IS  - 2191-219X (Linking)
VI  - 4
IP  - 1
DP  - 2014 Dec
TI  - The effect of volume of interest definition on quantification of lymph nodeimmune response to a monkeypox virus infection assessed by (18)F-FDG-PET.
PG  - 49
LID - 10.1186/s13550-014-0049-z [doi]
AB  - BACKGROUND: 2-deoxy-2-[(18)F]fluoro-D-glucose-positron emission tomography((18)F-FDG-PET) is applied in the clinic for infection assessment and is underconsideration for investigating the inflammatory/immune response in lymphoidtissue in animal models of viral infection. Assessing changes in (18)F-FDG uptakeof lymph nodes (LNs), primary lymphoid tissues targeted during viral infection,requires suitable methods for image analysis. Similar to tumor evaluation,reliable quantitation of the LN function via multiple (18)F-FDG-PET sessions willdepend how the volume of interest is defined. Volume of interest definition has adirect effect on statistical outcome. The current study objective is to comparefor the first time agreement between conventional and modified VOI metrics todetermine which method(s) provide(s) reproducible standardized uptake values(SUVs) for (18)F-FDG uptake in the LN of rhesus macaques. METHODS: Multiple(18)F-FDG-PET images of LNs in macaques were acquired prior to and aftermonkeypox virus intravenous inoculation. We compared five image analysisapproaches, SUVmax, SUVmean, SUVthreshold, modified SUVthreshold, and SUVfixedvolume, to investigate the impact of these approaches on quantification of thechanges in LN metabolic activity denoting the immune response during viralinfection progression. RESULTS: The lowest data repeatability was observed withSUVmax. The best correspondence was between SUVfixed volume and conventional and modified SUVthreshold. A statistically significant difference in the LN (18)F-FDGuptake between surviving and moribund animals was shown using modifiedSUVthreshold and SUVfixed volume (adjusted p = 0.0037 and p = 0.0001,respectively). CONCLUSIONS: Quantification of the LN (18)F-FDG uptake is highlysensitive to the method applied for PET image analysis. SUVfixed volume andmodified SUVthreshold demonstrate better reproducibility for SUV estimates thanSUVmax, SUVmean, and SUVthreshold. SUVfixed volume and modified SUVthreshold are capable of distinguishing between groups with different disease outcomes.Therefore, these methods are the preferred approaches for evaluating the LNfunction during viral infection by (18)F-FDG-PET. Validation of multipleapproaches is necessary to choose a suitable method to monitor changes in LNmetabolic activity during progression of viral infection.
FAU - Chefer, Svetlana
AU  - Chefer S
AD  - Division of Clinical Research, Integrated Research Facility, National Instituteof Allergy and Infectious Diseases, National Institutes of Health, 8200 Research Plaza, Frederick, MD, 21702, USA, schefer@mail.nih.gov.
FAU - Reba, Richard C
AU  - Reba RC
FAU - Leyson, Christopher Z
AU  - Leyson CZ
FAU - Seidel, Jurgen
AU  - Seidel J
FAU - Johnson, Reed F
AU  - Johnson RF
FAU - Blaney, Joseph E
AU  - Blaney JE
FAU - Jahrling, Peter B
AU  - Jahrling PB
FAU - Dyall, Julie
AU  - Dyall J
LA  - eng
GR  - HHSN272200700016I/AI/NIAID NIH HHS/United States
PT  - Journal Article
DEP - 20140916
PL  - Germany
TA  - EJNMMI Res
JT  - EJNMMI research
JID - 101560946
PMC - PMC4452685
EDAT- 2015/06/28 06:00
MHDA- 2015/06/28 06:01
CRDT- 2015/06/28 06:00
PHST- 2014/05/22 00:00 [received]
PHST- 2014/09/04 00:00 [accepted]
PHST- 2015/06/28 06:00 [entrez]
PHST- 2015/06/28 06:00 [pubmed]
PHST- 2015/06/28 06:01 [medline]
AID - 10.1186/s13550-014-0049-z [doi]
PST - ppublish
SO  - EJNMMI Res. 2014 Dec;4(1):49. doi: 10.1186/s13550-014-0049-z. Epub 2014 Sep 16.

PMID- 26086739
OWN - NLM
STAT- MEDLINE
DCOM- 20160209
LR  - 20210109
IS  - 1935-2735 (Electronic)
IS  - 1935-2727 (Linking)
VI  - 9
IP  - 6
DP  - 2015 Jun
TI  - BoHV-4-Based Vector Single Heterologous Antigen Delivery Protects STAT1(-/-) Micefrom Monkeypoxvirus Lethal Challenge.
PG  - e0003850
LID - 10.1371/journal.pntd.0003850 [doi]
AB  - Monkeypox virus (MPXV) is the etiological agent of human (MPX). It is an emergingorthopoxvirus zoonosis in the tropical rain forest of Africa and is endemic inthe Congo-basin and sporadic in West Africa; it remains a tropical neglecteddisease of persons in impoverished rural areas. Interaction of the humanpopulation with wildlife increases human infection with MPX virus (MPXV), andinfection from human to human is possible. Smallpox vaccination provides goodcross-protection against MPX; however, the vaccination campaign ended in Africain 1980, meaning that a large proportion of the population is currentlyunprotected against MPXV infection. Disease control hinges on deterring zoonotic exposure to the virus and, barring that, interrupting person-to-person spread.However, there are no FDA-approved therapies against MPX, and current vaccinesare limited due to safety concerns. For this reason, new studies on pathogenesis,prophylaxis and therapeutics are still of great interest, not only for thescientific community but also for the governments concerned that MPXV could beused as a bioterror agent. In the present study, a new vaccination strategyapproach based on three recombinant bovine herpesvirus 4 (BoHV-4) vectors, eachexpressing different MPXV glycoproteins, A29L, M1R and B6R were investigated interms of protection from a lethal MPXV challenge in STAT1 knockout mice.BoHV-4-A-CMV-A29LgD106DeltaTK, BoHV-4-A-EF1alpha-M1RgD106DeltaTK andBoHV-4-A-EF1alpha-B6RgD106DeltaTK were successfully constructed byrecombineering, and their capacity to express their transgene was demonstrated. Asmall challenge study was performed, and all three recombinant BoHV-4 appearedsafe (no weight-loss or obvious adverse events) following intraperitonealadministration. Further, BoHV-4-A-EF1alpha-M1RgD106DeltaTK alone or incombination with BoHV-4-A-CMV-A29LgD106DeltaTK andBoHV-4-A-EF1alpha-B6RgD106DeltaTK, was shown to be able to protect, 100% aloneand 80% in combination, STAT1(-/-) mice against mortality and morbidity. Thiswork demonstrated the efficacy of BoHV-4 based vectors and the use of BoHV-4 as avaccine-vector platform.
FAU - Franceschi, Valentina
AU  - Franceschi V
AD  - Department of Medical-Veterinary Science, University of Parma, Parma, Italy.
FAU - Parker, Scott
AU  - Parker S
AD  - Molecular Microbiology and Immunology, Saint Louis University School of Medicine,St. Louis, Missouri, United States of America.
FAU - Jacca, Sarah
AU  - Jacca S
AD  - Department of Medical-Veterinary Science, University of Parma, Parma, Italy.
FAU - Crump, Ryan W
AU  - Crump RW
AD  - Molecular Microbiology and Immunology, Saint Louis University School of Medicine,St. Louis, Missouri, United States of America.
FAU - Doronin, Konstantin
AU  - Doronin K
AD  - Molecular Microbiology and Immunology, Saint Louis University School of Medicine,St. Louis, Missouri, United States of America.
FAU - Hembrador, Edguardo
AU  - Hembrador E
AD  - Molecular Microbiology and Immunology, Saint Louis University School of Medicine,St. Louis, Missouri, United States of America.
FAU - Pompilio, Daniela
AU  - Pompilio D
AD  - Department of Medical-Veterinary Science, University of Parma, Parma, Italy.
FAU - Tebaldi, Giulia
AU  - Tebaldi G
AD  - Department of Medical-Veterinary Science, University of Parma, Parma, Italy.
FAU - Estep, Ryan D
AU  - Estep RD
AD  - Vaccine and Gene Therapy Institute, Oregon Health and Science University,Beaverton, Oregon, United States of America.
FAU - Wong, Scott W
AU  - Wong SW
AD  - Vaccine and Gene Therapy Institute, Oregon Health and Science University,Beaverton, Oregon, United States of America.
FAU - Buller, Mark R
AU  - Buller MR
AD  - Molecular Microbiology and Immunology, Saint Louis University School of Medicine,St. Louis, Missouri, United States of America.
FAU - Donofrio, Gaetano
AU  - Donofrio G
AD  - Department of Medical-Veterinary Science, University of Parma, Parma, Italy.
LA  - eng
GR  - HHSN272201000021C/AI/NIAID NIH HHS/United States
GR  - HHSN272201000021I/AI/NIAID NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20150618
PL  - United States
TA  - PLoS Negl Trop Dis
JT  - PLoS neglected tropical diseases
JID - 101291488
RN  - 0 (Antigens, Viral)
RN  - 0 (STAT1 Transcription Factor)
RN  - 0 (Stat1 protein, mouse)
RN  - 0 (Viral Vaccines)
SB  - IM
MH  - Amino Acid Sequence
MH  - Animals
MH  - Antigens, Viral/*immunology
MH  - Base Sequence
MH  - Cattle
MH  - Cell Line
MH  - Gene Expression Regulation
MH  - Genetic Vectors
MH  - Herpesvirus 4, Bovine/immunology/*physiology
MH  - Humans
MH  - Mice
MH  - Mice, Knockout
MH  - Molecular Sequence Data
MH  - Monkeypox/*prevention & control
MH  - Monkeypox virus/*immunology
MH  - STAT1 Transcription Factor/genetics/*metabolism
MH  - Transfection
MH  - Viral Vaccines/genetics/*immunology
PMC - PMC4473039
EDAT- 2015/06/19 06:00
MHDA- 2016/02/10 06:00
CRDT- 2015/06/19 06:00
PHST- 2014/12/30 00:00 [received]
PHST- 2015/05/27 00:00 [accepted]
PHST- 2015/06/19 06:00 [entrez]
PHST- 2015/06/19 06:00 [pubmed]
PHST- 2016/02/10 06:00 [medline]
AID - 10.1371/journal.pntd.0003850 [doi]
AID - PNTD-D-14-02243 [pii]
PST - epublish
SO  - PLoS Negl Trop Dis. 2015 Jun 18;9(6):e0003850. doi: 10.1371/journal.pntd.0003850.eCollection 2015 Jun.

PMID- 26060872
OWN - NLM
STAT- MEDLINE
DCOM- 20151215
LR  - 20191113
IS  - 1938-744X (Electronic)
IS  - 1935-7893 (Linking)
VI  - 9
IP  - 2
DP  - 2015 Apr
TI  - Poxvirus countermeasures during an emergency in the United States.
PG  - 121-6
AB  - Although smallpox was eradicated worldwide by 1980, national security expertsremain concerned that it could be used in a deliberate attack. The United States and other governments have given priority to developing and stockpiling vaccines and antivirals to protect their populations from the potential reintroduction of this deadly disease. Public health officials are also concerned about the spread of related zoonotic orthopoxviruses such as monkeypox and cowpox, against whichsmallpox vaccine provides protection. This report analyzes how medicalcountermeasures available in the US Strategic National Stockpile will be givenpriority and used in the event of an intentional or accidental release ofsmallpox in the United States.
FAU - Bice, Steve
AU  - Bice S
FAU - Yeskey, Kevin
AU  - Yeskey K
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Disaster Med Public Health Prep
JT  - Disaster medicine and public health preparedness
JID - 101297401
RN  - 0 (Smallpox Vaccine)
SB  - IM
MH  - Bioterrorism/*legislation & jurisprudence
MH  - Disaster Planning/legislation & jurisprudence/*methods/organization &administration
MH  - Humans
MH  - Mass Vaccination/*methods/organization & administration
MH  - Smallpox/*prevention & control/transmission
MH  - Smallpox Vaccine/administration & dosage/*supply & distribution
MH  - Strategic Stockpile
MH  - United States/epidemiology
EDAT- 2015/06/11 06:00
MHDA- 2015/12/17 06:00
CRDT- 2015/06/11 06:00
PHST- 2015/06/11 06:00 [entrez]
PHST- 2015/06/11 06:00 [pubmed]
PHST- 2015/12/17 06:00 [medline]
AID - 10.1017/dmp.2014.100 [doi]
PST - ppublish
SO  - Disaster Med Public Health Prep. 2015 Apr;9(2):121-6. doi: 10.1017/dmp.2014.100.

PMID- 26013374
OWN - NLM
STAT- MEDLINE
DCOM- 20151027
LR  - 20220316
IS  - 1476-1645 (Electronic)
IS  - 0002-9637 (Linking)
VI  - 93
IP  - 2
DP  - 2015 Aug
TI  - Introduction of Monkeypox into a Community and Household: Risk Factors andZoonotic Reservoirs in the Democratic Republic of the Congo.
PG  - 410-5
LID - 10.4269/ajtmh.15-0168 [doi]
AB  - An increased incidence of monkeypox (MPX) infections in the Democratic Republicof the Congo was noted by the regional surveillance system in October 2013.Little information exists regarding how MPX is introduced into the community and the factors associated with transmission within the household. Sixty-eight wildanimals were collected and tested for Orthopoxvirus. Two of three rope squirrels (Funisciurus sp.) were positive for antibodies to Orthopoxviruses; however, noincreased risk was associated with the consumption or preparation of ropesquirrels. A retrospective cohort investigation and a case-control investigation were performed to identify risk factors affecting the introduction of monkeypoxvirus (MPXV) into the community and transmission within the home. School-agemales were the individuals most frequently identified as the first personinfected in the household and were the group most frequently affected overall.Risk factors of acquiring MPXV in a household included sleeping in the same room or bed, or using the same plate or cup as the primary case. There was nosignificant risk associated with eating or processing of wild animals. Activitiesassociated with an increased risk of MPXV transmission all have potential forvirus exposure to the mucosa.
CI  - (c) The American Society of Tropical Medicine and Hygiene.
FAU - Nolen, Leisha Diane
AU  - Nolen LD
AD  - U.S. Centers for Disease Control and Prevention, Bacterial Special PathogensBranch, Atlanta, Georgia; U.S. Centers for Disease Control and Prevention,Epidemic Intelligence Service, Atlanta, Georgia; U.S. Centers for Disease Controland Prevention, Poxvirus and Rabies Branch, Atlanta, Georgia; Minstere de laSante, Kinshasa, The Democratic Republic of Congo; U.S. Centers for DiseaseControl and Prevention, Field Epidemiology Training Program, Kinshasa, TheDemocratic Republic of Congo; National Institute for Biomedical Research,Kinshasa, The Democratic Republic of Congo; U.S. Centers for Disease Control and Prevention Kinshasa, The Democratic Republic of Congo; University of Kinshasa,Department of Biology, Kinshasa, The Democratic Republic of Congo; Minstere de laSante, Tshuapa Health District, The Democratic Republic of Congo; Kinshasa Schoolof Public Health, The Democratic Republic of Congo xdf8@cdc.gov.
FAU - Osadebe, Lynda
AU  - Osadebe L
AD  - U.S. Centers for Disease Control and Prevention, Bacterial Special PathogensBranch, Atlanta, Georgia; U.S. Centers for Disease Control and Prevention,Epidemic Intelligence Service, Atlanta, Georgia; U.S. Centers for Disease Controland Prevention, Poxvirus and Rabies Branch, Atlanta, Georgia; Minstere de laSante, Kinshasa, The Democratic Republic of Congo; U.S. Centers for DiseaseControl and Prevention, Field Epidemiology Training Program, Kinshasa, TheDemocratic Republic of Congo; National Institute for Biomedical Research,Kinshasa, The Democratic Republic of Congo; U.S. Centers for Disease Control and Prevention Kinshasa, The Democratic Republic of Congo; University of Kinshasa,Department of Biology, Kinshasa, The Democratic Republic of Congo; Minstere de laSante, Tshuapa Health District, The Democratic Republic of Congo; Kinshasa Schoolof Public Health, The Democratic Republic of Congo.
FAU - Katomba, Jacques
AU  - Katomba J
AD  - U.S. Centers for Disease Control and Prevention, Bacterial Special PathogensBranch, Atlanta, Georgia; U.S. Centers for Disease Control and Prevention,Epidemic Intelligence Service, Atlanta, Georgia; U.S. Centers for Disease Controland Prevention, Poxvirus and Rabies Branch, Atlanta, Georgia; Minstere de laSante, Kinshasa, The Democratic Republic of Congo; U.S. Centers for DiseaseControl and Prevention, Field Epidemiology Training Program, Kinshasa, TheDemocratic Republic of Congo; National Institute for Biomedical Research,Kinshasa, The Democratic Republic of Congo; U.S. Centers for Disease Control and Prevention Kinshasa, The Democratic Republic of Congo; University of Kinshasa,Department of Biology, Kinshasa, The Democratic Republic of Congo; Minstere de laSante, Tshuapa Health District, The Democratic Republic of Congo; Kinshasa Schoolof Public Health, The Democratic Republic of Congo.
FAU - Likofata, Jacques
AU  - Likofata J
AD  - U.S. Centers for Disease Control and Prevention, Bacterial Special PathogensBranch, Atlanta, Georgia; U.S. Centers for Disease Control and Prevention,Epidemic Intelligence Service, Atlanta, Georgia; U.S. Centers for Disease Controland Prevention, Poxvirus and Rabies Branch, Atlanta, Georgia; Minstere de laSante, Kinshasa, The Democratic Republic of Congo; U.S. Centers for DiseaseControl and Prevention, Field Epidemiology Training Program, Kinshasa, TheDemocratic Republic of Congo; National Institute for Biomedical Research,Kinshasa, The Democratic Republic of Congo; U.S. Centers for Disease Control and Prevention Kinshasa, The Democratic Republic of Congo; University of Kinshasa,Department of Biology, Kinshasa, The Democratic Republic of Congo; Minstere de laSante, Tshuapa Health District, The Democratic Republic of Congo; Kinshasa Schoolof Public Health, The Democratic Republic of Congo.
FAU - Mukadi, Daniel
AU  - Mukadi D
AD  - U.S. Centers for Disease Control and Prevention, Bacterial Special PathogensBranch, Atlanta, Georgia; U.S. Centers for Disease Control and Prevention,Epidemic Intelligence Service, Atlanta, Georgia; U.S. Centers for Disease Controland Prevention, Poxvirus and Rabies Branch, Atlanta, Georgia; Minstere de laSante, Kinshasa, The Democratic Republic of Congo; U.S. Centers for DiseaseControl and Prevention, Field Epidemiology Training Program, Kinshasa, TheDemocratic Republic of Congo; National Institute for Biomedical Research,Kinshasa, The Democratic Republic of Congo; U.S. Centers for Disease Control and Prevention Kinshasa, The Democratic Republic of Congo; University of Kinshasa,Department of Biology, Kinshasa, The Democratic Republic of Congo; Minstere de laSante, Tshuapa Health District, The Democratic Republic of Congo; Kinshasa Schoolof Public Health, The Democratic Republic of Congo.
FAU - Monroe, Benjamin
AU  - Monroe B
AD  - U.S. Centers for Disease Control and Prevention, Bacterial Special PathogensBranch, Atlanta, Georgia; U.S. Centers for Disease Control and Prevention,Epidemic Intelligence Service, Atlanta, Georgia; U.S. Centers for Disease Controland Prevention, Poxvirus and Rabies Branch, Atlanta, Georgia; Minstere de laSante, Kinshasa, The Democratic Republic of Congo; U.S. Centers for DiseaseControl and Prevention, Field Epidemiology Training Program, Kinshasa, TheDemocratic Republic of Congo; National Institute for Biomedical Research,Kinshasa, The Democratic Republic of Congo; U.S. Centers for Disease Control and Prevention Kinshasa, The Democratic Republic of Congo; University of Kinshasa,Department of Biology, Kinshasa, The Democratic Republic of Congo; Minstere de laSante, Tshuapa Health District, The Democratic Republic of Congo; Kinshasa Schoolof Public Health, The Democratic Republic of Congo.
FAU - Doty, Jeffrey
AU  - Doty J
AD  - U.S. Centers for Disease Control and Prevention, Bacterial Special PathogensBranch, Atlanta, Georgia; U.S. Centers for Disease Control and Prevention,Epidemic Intelligence Service, Atlanta, Georgia; U.S. Centers for Disease Controland Prevention, Poxvirus and Rabies Branch, Atlanta, Georgia; Minstere de laSante, Kinshasa, The Democratic Republic of Congo; U.S. Centers for DiseaseControl and Prevention, Field Epidemiology Training Program, Kinshasa, TheDemocratic Republic of Congo; National Institute for Biomedical Research,Kinshasa, The Democratic Republic of Congo; U.S. Centers for Disease Control and Prevention Kinshasa, The Democratic Republic of Congo; University of Kinshasa,Department of Biology, Kinshasa, The Democratic Republic of Congo; Minstere de laSante, Tshuapa Health District, The Democratic Republic of Congo; Kinshasa Schoolof Public Health, The Democratic Republic of Congo.
FAU - Kalemba, Lem's
AU  - Kalemba L
AD  - U.S. Centers for Disease Control and Prevention, Bacterial Special PathogensBranch, Atlanta, Georgia; U.S. Centers for Disease Control and Prevention,Epidemic Intelligence Service, Atlanta, Georgia; U.S. Centers for Disease Controland Prevention, Poxvirus and Rabies Branch, Atlanta, Georgia; Minstere de laSante, Kinshasa, The Democratic Republic of Congo; U.S. Centers for DiseaseControl and Prevention, Field Epidemiology Training Program, Kinshasa, TheDemocratic Republic of Congo; National Institute for Biomedical Research,Kinshasa, The Democratic Republic of Congo; U.S. Centers for Disease Control and Prevention Kinshasa, The Democratic Republic of Congo; University of Kinshasa,Department of Biology, Kinshasa, The Democratic Republic of Congo; Minstere de laSante, Tshuapa Health District, The Democratic Republic of Congo; Kinshasa Schoolof Public Health, The Democratic Republic of Congo.
FAU - Malekani, Jean
AU  - Malekani J
AD  - U.S. Centers for Disease Control and Prevention, Bacterial Special PathogensBranch, Atlanta, Georgia; U.S. Centers for Disease Control and Prevention,Epidemic Intelligence Service, Atlanta, Georgia; U.S. Centers for Disease Controland Prevention, Poxvirus and Rabies Branch, Atlanta, Georgia; Minstere de laSante, Kinshasa, The Democratic Republic of Congo; U.S. Centers for DiseaseControl and Prevention, Field Epidemiology Training Program, Kinshasa, TheDemocratic Republic of Congo; National Institute for Biomedical Research,Kinshasa, The Democratic Republic of Congo; U.S. Centers for Disease Control and Prevention Kinshasa, The Democratic Republic of Congo; University of Kinshasa,Department of Biology, Kinshasa, The Democratic Republic of Congo; Minstere de laSante, Tshuapa Health District, The Democratic Republic of Congo; Kinshasa Schoolof Public Health, The Democratic Republic of Congo.
FAU - Kabamba, Joelle
AU  - Kabamba J
AD  - U.S. Centers for Disease Control and Prevention, Bacterial Special PathogensBranch, Atlanta, Georgia; U.S. Centers for Disease Control and Prevention,Epidemic Intelligence Service, Atlanta, Georgia; U.S. Centers for Disease Controland Prevention, Poxvirus and Rabies Branch, Atlanta, Georgia; Minstere de laSante, Kinshasa, The Democratic Republic of Congo; U.S. Centers for DiseaseControl and Prevention, Field Epidemiology Training Program, Kinshasa, TheDemocratic Republic of Congo; National Institute for Biomedical Research,Kinshasa, The Democratic Republic of Congo; U.S. Centers for Disease Control and Prevention Kinshasa, The Democratic Republic of Congo; University of Kinshasa,Department of Biology, Kinshasa, The Democratic Republic of Congo; Minstere de laSante, Tshuapa Health District, The Democratic Republic of Congo; Kinshasa Schoolof Public Health, The Democratic Republic of Congo.
FAU - Bomponda, Pierre Lokwa
AU  - Bomponda PL
AD  - U.S. Centers for Disease Control and Prevention, Bacterial Special PathogensBranch, Atlanta, Georgia; U.S. Centers for Disease Control and Prevention,Epidemic Intelligence Service, Atlanta, Georgia; U.S. Centers for Disease Controland Prevention, Poxvirus and Rabies Branch, Atlanta, Georgia; Minstere de laSante, Kinshasa, The Democratic Republic of Congo; U.S. Centers for DiseaseControl and Prevention, Field Epidemiology Training Program, Kinshasa, TheDemocratic Republic of Congo; National Institute for Biomedical Research,Kinshasa, The Democratic Republic of Congo; U.S. Centers for Disease Control and Prevention Kinshasa, The Democratic Republic of Congo; University of Kinshasa,Department of Biology, Kinshasa, The Democratic Republic of Congo; Minstere de laSante, Tshuapa Health District, The Democratic Republic of Congo; Kinshasa Schoolof Public Health, The Democratic Republic of Congo.
FAU - Lokota, Jules Inonga
AU  - Lokota JI
AD  - U.S. Centers for Disease Control and Prevention, Bacterial Special PathogensBranch, Atlanta, Georgia; U.S. Centers for Disease Control and Prevention,Epidemic Intelligence Service, Atlanta, Georgia; U.S. Centers for Disease Controland Prevention, Poxvirus and Rabies Branch, Atlanta, Georgia; Minstere de laSante, Kinshasa, The Democratic Republic of Congo; U.S. Centers for DiseaseControl and Prevention, Field Epidemiology Training Program, Kinshasa, TheDemocratic Republic of Congo; National Institute for Biomedical Research,Kinshasa, The Democratic Republic of Congo; U.S. Centers for Disease Control and Prevention Kinshasa, The Democratic Republic of Congo; University of Kinshasa,Department of Biology, Kinshasa, The Democratic Republic of Congo; Minstere de laSante, Tshuapa Health District, The Democratic Republic of Congo; Kinshasa Schoolof Public Health, The Democratic Republic of Congo.
FAU - Balilo, Marcel Pie
AU  - Balilo MP
AD  - U.S. Centers for Disease Control and Prevention, Bacterial Special PathogensBranch, Atlanta, Georgia; U.S. Centers for Disease Control and Prevention,Epidemic Intelligence Service, Atlanta, Georgia; U.S. Centers for Disease Controland Prevention, Poxvirus and Rabies Branch, Atlanta, Georgia; Minstere de laSante, Kinshasa, The Democratic Republic of Congo; U.S. Centers for DiseaseControl and Prevention, Field Epidemiology Training Program, Kinshasa, TheDemocratic Republic of Congo; National Institute for Biomedical Research,Kinshasa, The Democratic Republic of Congo; U.S. Centers for Disease Control and Prevention Kinshasa, The Democratic Republic of Congo; University of Kinshasa,Department of Biology, Kinshasa, The Democratic Republic of Congo; Minstere de laSante, Tshuapa Health District, The Democratic Republic of Congo; Kinshasa Schoolof Public Health, The Democratic Republic of Congo.
FAU - Likafi, Toutou
AU  - Likafi T
AD  - U.S. Centers for Disease Control and Prevention, Bacterial Special PathogensBranch, Atlanta, Georgia; U.S. Centers for Disease Control and Prevention,Epidemic Intelligence Service, Atlanta, Georgia; U.S. Centers for Disease Controland Prevention, Poxvirus and Rabies Branch, Atlanta, Georgia; Minstere de laSante, Kinshasa, The Democratic Republic of Congo; U.S. Centers for DiseaseControl and Prevention, Field Epidemiology Training Program, Kinshasa, TheDemocratic Republic of Congo; National Institute for Biomedical Research,Kinshasa, The Democratic Republic of Congo; U.S. Centers for Disease Control and Prevention Kinshasa, The Democratic Republic of Congo; University of Kinshasa,Department of Biology, Kinshasa, The Democratic Republic of Congo; Minstere de laSante, Tshuapa Health District, The Democratic Republic of Congo; Kinshasa Schoolof Public Health, The Democratic Republic of Congo.
FAU - Lushima, Robert Shongo
AU  - Lushima RS
AD  - U.S. Centers for Disease Control and Prevention, Bacterial Special PathogensBranch, Atlanta, Georgia; U.S. Centers for Disease Control and Prevention,Epidemic Intelligence Service, Atlanta, Georgia; U.S. Centers for Disease Controland Prevention, Poxvirus and Rabies Branch, Atlanta, Georgia; Minstere de laSante, Kinshasa, The Democratic Republic of Congo; U.S. Centers for DiseaseControl and Prevention, Field Epidemiology Training Program, Kinshasa, TheDemocratic Republic of Congo; National Institute for Biomedical Research,Kinshasa, The Democratic Republic of Congo; U.S. Centers for Disease Control and Prevention Kinshasa, The Democratic Republic of Congo; University of Kinshasa,Department of Biology, Kinshasa, The Democratic Republic of Congo; Minstere de laSante, Tshuapa Health District, The Democratic Republic of Congo; Kinshasa Schoolof Public Health, The Democratic Republic of Congo.
FAU - Tamfum, Jean-Jacques Muyembe
AU  - Tamfum JJ
AD  - U.S. Centers for Disease Control and Prevention, Bacterial Special PathogensBranch, Atlanta, Georgia; U.S. Centers for Disease Control and Prevention,Epidemic Intelligence Service, Atlanta, Georgia; U.S. Centers for Disease Controland Prevention, Poxvirus and Rabies Branch, Atlanta, Georgia; Minstere de laSante, Kinshasa, The Democratic Republic of Congo; U.S. Centers for DiseaseControl and Prevention, Field Epidemiology Training Program, Kinshasa, TheDemocratic Republic of Congo; National Institute for Biomedical Research,Kinshasa, The Democratic Republic of Congo; U.S. Centers for Disease Control and Prevention Kinshasa, The Democratic Republic of Congo; University of Kinshasa,Department of Biology, Kinshasa, The Democratic Republic of Congo; Minstere de laSante, Tshuapa Health District, The Democratic Republic of Congo; Kinshasa Schoolof Public Health, The Democratic Republic of Congo.
FAU - Okitolonda, Emile Wemakoy
AU  - Okitolonda EW
AD  - U.S. Centers for Disease Control and Prevention, Bacterial Special PathogensBranch, Atlanta, Georgia; U.S. Centers for Disease Control and Prevention,Epidemic Intelligence Service, Atlanta, Georgia; U.S. Centers for Disease Controland Prevention, Poxvirus and Rabies Branch, Atlanta, Georgia; Minstere de laSante, Kinshasa, The Democratic Republic of Congo; U.S. Centers for DiseaseControl and Prevention, Field Epidemiology Training Program, Kinshasa, TheDemocratic Republic of Congo; National Institute for Biomedical Research,Kinshasa, The Democratic Republic of Congo; U.S. Centers for Disease Control and Prevention Kinshasa, The Democratic Republic of Congo; University of Kinshasa,Department of Biology, Kinshasa, The Democratic Republic of Congo; Minstere de laSante, Tshuapa Health District, The Democratic Republic of Congo; Kinshasa Schoolof Public Health, The Democratic Republic of Congo.
FAU - McCollum, Andrea M
AU  - McCollum AM
AD  - U.S. Centers for Disease Control and Prevention, Bacterial Special PathogensBranch, Atlanta, Georgia; U.S. Centers for Disease Control and Prevention,Epidemic Intelligence Service, Atlanta, Georgia; U.S. Centers for Disease Controland Prevention, Poxvirus and Rabies Branch, Atlanta, Georgia; Minstere de laSante, Kinshasa, The Democratic Republic of Congo; U.S. Centers for DiseaseControl and Prevention, Field Epidemiology Training Program, Kinshasa, TheDemocratic Republic of Congo; National Institute for Biomedical Research,Kinshasa, The Democratic Republic of Congo; U.S. Centers for Disease Control and Prevention Kinshasa, The Democratic Republic of Congo; University of Kinshasa,Department of Biology, Kinshasa, The Democratic Republic of Congo; Minstere de laSante, Tshuapa Health District, The Democratic Republic of Congo; Kinshasa Schoolof Public Health, The Democratic Republic of Congo.
FAU - Reynolds, Mary G
AU  - Reynolds MG
AD  - U.S. Centers for Disease Control and Prevention, Bacterial Special PathogensBranch, Atlanta, Georgia; U.S. Centers for Disease Control and Prevention,Epidemic Intelligence Service, Atlanta, Georgia; U.S. Centers for Disease Controland Prevention, Poxvirus and Rabies Branch, Atlanta, Georgia; Minstere de laSante, Kinshasa, The Democratic Republic of Congo; U.S. Centers for DiseaseControl and Prevention, Field Epidemiology Training Program, Kinshasa, TheDemocratic Republic of Congo; National Institute for Biomedical Research,Kinshasa, The Democratic Republic of Congo; U.S. Centers for Disease Control and Prevention Kinshasa, The Democratic Republic of Congo; University of Kinshasa,Department of Biology, Kinshasa, The Democratic Republic of Congo; Minstere de laSante, Tshuapa Health District, The Democratic Republic of Congo; Kinshasa Schoolof Public Health, The Democratic Republic of Congo.
LA  - eng
PT  - Journal Article
DEP - 20150526
PL  - United States
TA  - Am J Trop Med Hyg
JT  - The American journal of tropical medicine and hygiene
JID - 0370507
RN  - 0 (Antibodies, Viral)
SB  - IM
MH  - Animals
MH  - Animals, Wild/virology
MH  - Antibodies, Viral/blood
MH  - Case-Control Studies
MH  - Child
MH  - Child, Preschool
MH  - Democratic Republic of the Congo/epidemiology
MH  - Family Characteristics
MH  - Female
MH  - Humans
MH  - Male
MH  - Monkeypox/diagnosis/*epidemiology/*transmission/veterinary
MH  - Monkeypox virus/isolation & purification
MH  - Retrospective Studies
MH  - Risk Factors
MH  - Sciuridae/virology
PMC - PMC4530773
EDAT- 2015/05/28 06:00
MHDA- 2015/10/28 06:00
CRDT- 2015/05/28 06:00
PHST- 2015/02/27 00:00 [received]
PHST- 2015/04/02 00:00 [accepted]
PHST- 2015/05/28 06:00 [entrez]
PHST- 2015/05/28 06:00 [pubmed]
PHST- 2015/10/28 06:00 [medline]
AID - ajtmh.15-0168 [pii]
AID - 10.4269/ajtmh.15-0168 [doi]
PST - ppublish
SO  - Am J Trop Med Hyg. 2015 Aug;93(2):410-5. doi: 10.4269/ajtmh.15-0168. Epub 2015May 26.

PMID- 25997608
OWN - NLM
STAT- MEDLINE
DCOM- 20161114
LR  - 20200325
IS  - 1437-1588 (Electronic)
IS  - 1436-9990 (Linking)
VI  - 58
IP  - 7
DP  - 2015 Jul
TI  - [Epidemiology of Ebola virus disease and of other highly contagious,life-threatening diseases with low incidence in Germany].
PG  - 705-13
LID - 10.1007/s00103-015-2165-y [doi]
AB  - Apart from sporadic exported cases, the occurrence of Ebola, Marburg and Lassavirus diseases is limited to the African continent. Crimean-Congo HemorrhagicFever occurs in Southeastern Europe but, so far, not in Germany. Otherhemorrhagic fever disease-viruses occur in distinct regions in South America.Pulmonary plague is the bacterial infectious disease with the most contagious andlethal course and it is endemic to Madagascar and East Africa, but also occurs inother countries (e.g. India, USA). Monkey pox epidemics have occurred in remoteareas of the Congo Basin. Such outbreaks could potentially become more commonwith the discontinuation of the cross-protective smallpox vaccination. The SevereAcute Respiratory Syndrome (SARS) that emerged in 2002/2003 is another pathogenwith significant epidemic potential. Typical for these diseases is a naturalcirculation between reservoir animals in remote areas. Sporadic transmission tohumans can occur through contact with an infected animal. Subsequenthuman-to-human transmission can lead to epidemics, such as the current outbreakof Ebola virus disease in West Africa.
FAU - Ehlkes, L
AU  - Ehlkes L
AD  - Arbeitsgruppe Infektionsepidemiologie, Bernhard-Nocht-Institut fur Tropenmedizin (BNITM), Bernhard-Nocht-Str. 74, 20359, Hamburg, Deutschland.
FAU - Kreuels, B
AU  - Kreuels B
FAU - Schwarz, N G
AU  - Schwarz NG
FAU - May, Jurgen
AU  - May J
LA  - ger
PT  - Journal Article
TT  - Epidemiologie des Ebolafiebers und anderer, in Deutschland seltenerhochkontagioser, lebensbedrohlicher Erkrankungen.
PL  - Germany
TA  - Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
JT  - Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
JID - 101181368
SB  - IM
EIN - Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015Jul;58(7):760. PMID: 26099225
MH  - Communicable Diseases/*epidemiology
MH  - Disease Reservoirs/*statistics & numerical data
MH  - Female
MH  - Germany/epidemiology
MH  - Hemorrhagic Fever, Ebola/*epidemiology
MH  - Humans
MH  - Incidence
MH  - Male
MH  - Pandemics/*statistics & numerical data
MH  - Population Surveillance/*methods
MH  - Risk Factors
PMC - PMC7080030
EDAT- 2015/05/23 06:00
MHDA- 2016/11/15 06:00
CRDT- 2015/05/23 06:00
PHST- 2015/05/23 06:00 [entrez]
PHST- 2015/05/23 06:00 [pubmed]
PHST- 2016/11/15 06:00 [medline]
AID - 10.1007/s00103-015-2165-y [doi]
PST - ppublish
SO  - Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015Jul;58(7):705-13. doi: 10.1007/s00103-015-2165-y.

PMID- 25944444
OWN - NLM
STAT- MEDLINE
DCOM- 20170215
LR  - 20181202
IS  - 1865-1682 (Electronic)
IS  - 1865-1674 (Linking)
VI  - 64
IP  - 1
DP  - 2017 Feb
TI  - Using the Ground Squirrel (Marmota bobak) as an Animal Model to Assess Monkeypox Drug Efficacy.
PG  - 226-236
LID - 10.1111/tbed.12364 [doi]
AB  - In experiments to study the sensitivity of ground squirrels (Marmota bobak) tomonkeypox virus (MPXV) at intranasal challenge, expressed pox-like clinicalsymptoms (hyperthermia, lymphadenitis, skin rash all over the body and mucousmembranes and others) were observed 7-9 days post-infection. The 50% infectivedose (ID50 ) of MPXV for these marmots determined by the presence of clinicalsigns of the disease was 2.2 log10 PFU. Some diseased marmots (about 40%) died13-22 days post-infection, and the mortality rate was weakly dependent on MPXVinfective dose. Lungs with trachea were primary target organs of marmotschallenged intranasally (with ~30 ID50 ). The pathogen got to secondary targetorgans of the animals mainly via the lymphatic way (with replication inbifurcation lymph nodes). Lungs with trachea, nasal mucosa and skin were theorgans where the maximum MPXV amounts accumulated in these animals. Evidences of the pathogen presence and replication were revealed in these and subcutaneouslyinfected marmots in the traditional primary target cells for MPXV (macrophagesand respiratory tract epitheliocytes), as well as in some other cells(endotheliocytes, plasmocytes, fibroblasts, reticular and smooth muscle cells).Our use of this animal species to assess the antiviral efficacy of some drugsdemonstrated the agreement of the obtained results with those described inscientific literature, which opens up the prospects of using marmots as animalmodels for monkeypox to develop therapeutic and preventive anti-smallpox drugs.
CI  - (c) 2015 Blackwell Verlag GmbH.
FAU - Sergeev, A A
AU  - Sergeev AA
AD  - Federal Budgetary Research Institution - State Research Center of Virology andBiotechnology VECTOR, Federal Service for Surveillance on Consumer RightsProtection and Human Well-being, Koltsovo, Russia.
FAU - Kabanov, A S
AU  - Kabanov AS
AD  - Federal Budgetary Research Institution - State Research Center of Virology andBiotechnology VECTOR, Federal Service for Surveillance on Consumer RightsProtection and Human Well-being, Koltsovo, Russia.
FAU - Bulychev, L E
AU  - Bulychev LE
AD  - Federal Budgetary Research Institution - State Research Center of Virology andBiotechnology VECTOR, Federal Service for Surveillance on Consumer RightsProtection and Human Well-being, Koltsovo, Russia.
FAU - Sergeev, A A
AU  - Sergeev AA
AD  - Federal Budgetary Research Institution - State Research Center of Virology andBiotechnology VECTOR, Federal Service for Surveillance on Consumer RightsProtection and Human Well-being, Koltsovo, Russia.
FAU - Pyankov, O V
AU  - Pyankov OV
AD  - Federal Budgetary Research Institution - State Research Center of Virology andBiotechnology VECTOR, Federal Service for Surveillance on Consumer RightsProtection and Human Well-being, Koltsovo, Russia.
FAU - Bodnev, S A
AU  - Bodnev SA
AD  - Federal Budgetary Research Institution - State Research Center of Virology andBiotechnology VECTOR, Federal Service for Surveillance on Consumer RightsProtection and Human Well-being, Koltsovo, Russia.
FAU - Galahova, D O
AU  - Galahova DO
AD  - Federal Budgetary Research Institution - State Research Center of Virology andBiotechnology VECTOR, Federal Service for Surveillance on Consumer RightsProtection and Human Well-being, Koltsovo, Russia.
FAU - Zamedyanskaya, A S
AU  - Zamedyanskaya AS
AD  - Federal Budgetary Research Institution - State Research Center of Virology andBiotechnology VECTOR, Federal Service for Surveillance on Consumer RightsProtection and Human Well-being, Koltsovo, Russia.
FAU - Titova, K A
AU  - Titova KA
AD  - Federal Budgetary Research Institution - State Research Center of Virology andBiotechnology VECTOR, Federal Service for Surveillance on Consumer RightsProtection and Human Well-being, Koltsovo, Russia.
FAU - Glotova, T I
AU  - Glotova TI
AD  - State Scientific Establishment - Institute of Experimental Veterinary Science of Siberia and the Far East Russian Academy of Agricultural Sciences, Krasnoobsk,Russia.
FAU - Taranov, O S
AU  - Taranov OS
AD  - Federal Budgetary Research Institution - State Research Center of Virology andBiotechnology VECTOR, Federal Service for Surveillance on Consumer RightsProtection and Human Well-being, Koltsovo, Russia.
FAU - Omigov, V V
AU  - Omigov VV
AD  - Federal Budgetary Research Institution - State Research Center of Virology andBiotechnology VECTOR, Federal Service for Surveillance on Consumer RightsProtection and Human Well-being, Koltsovo, Russia.
FAU - Shishkina, L N
AU  - Shishkina LN
AD  - Federal Budgetary Research Institution - State Research Center of Virology andBiotechnology VECTOR, Federal Service for Surveillance on Consumer RightsProtection and Human Well-being, Koltsovo, Russia.
FAU - Agafonov, A P
AU  - Agafonov AP
AD  - Federal Budgetary Research Institution - State Research Center of Virology andBiotechnology VECTOR, Federal Service for Surveillance on Consumer RightsProtection and Human Well-being, Koltsovo, Russia.
FAU - Sergeev, A N
AU  - Sergeev AN
AD  - Federal Budgetary Research Institution - State Research Center of Virology andBiotechnology VECTOR, Federal Service for Surveillance on Consumer RightsProtection and Human Well-being, Koltsovo, Russia.
LA  - eng
PT  - Journal Article
DEP - 20150505
PL  - Germany
TA  - Transbound Emerg Dis
JT  - Transboundary and emerging diseases
JID - 101319538
RN  - 0 (Antiviral Agents)
SB  - IM
MH  - Administration, Intranasal/veterinary
MH  - Animals
MH  - Antiviral Agents/*adverse effects
MH  - Disease Models, Animal
MH  - Female
MH  - Male
MH  - *Marmota
MH  - Monkeypox/drug therapy/*veterinary
MH  - Monkeypox virus/*drug effects
OTO - NOTNLM
OT  - Marmota bobak
OT  - animal model
OT  - anti-monkeypox efficacy
OT  - drug
OT  - ground squirrel
OT  - intranasal challenge
OT  - monkeypox virus
EDAT- 2015/05/07 06:00
MHDA- 2017/02/16 06:00
CRDT- 2015/05/07 06:00
PHST- 2015/01/25 00:00 [received]
PHST- 2015/05/07 06:00 [pubmed]
PHST- 2017/02/16 06:00 [medline]
PHST- 2015/05/07 06:00 [entrez]
AID - 10.1111/tbed.12364 [doi]
PST - ppublish
SO  - Transbound Emerg Dis. 2017 Feb;64(1):226-236. doi: 10.1111/tbed.12364. Epub 2015 May 5.

PMID- 25932665
OWN - NLM
STAT- MEDLINE
DCOM- 20160422
LR  - 20150711
IS  - 1943-3700 (Electronic)
IS  - 0090-3558 (Linking)
VI  - 51
IP  - 3
DP  - 2015 Jul
TI  - Collection and Utilization of Animal Carcasses Associated with zoonotic Diseasein Tshuapa District, the Democratic Republic of the Congo, 2012.
PG  - 734-8
LID - 10.7589/2014-05-140 [doi]
AB  - The collection and consumption of animal carcasses is a common activity inforested areas of the Congo River basin and creates sustainability, conservation,and health concerns. Residents of the Tshuapa District reported collecting theremains of 5,878 animals from >30 species when surveyed about their wildlifeconsumption habits. Carcasses were discovered in varying degrees of decompositionand were often consumed at home or sold in local markets. The most commonlycollected animals were Cricetomys gambianus (Northern giant pouched rat),Cercopithecus ascanius (red-tailed monkey), and Heliosciurus rufobrachium(red-legged sun squirrel). Many of the species recorded may be hosts of zoonotic pathogens, creating concern for spillover events.
FAU - Monroe, Benjamin P
AU  - Monroe BP
AD  - 1 Poxvirus and Rabies Program, Division of High-Consequence Pathogens andPathology, Centers for Disease Control and Prevention, Mailstop A-30, 1600Clifton Road, Atlanta Georgia, USA.
FAU - Doty, Jeffrey B
AU  - Doty JB
AD  - 1 Poxvirus and Rabies Program, Division of High-Consequence Pathogens andPathology, Centers for Disease Control and Prevention, Mailstop A-30, 1600Clifton Road, Atlanta Georgia, USA.
FAU - Moses, Cynthia
AU  - Moses C
AD  - 2 International Conservation and Education Fund, 236 11th Street SE, Washington, DC 20003-2124, USA.
FAU - Ibata, Saturnin
AU  - Ibata S
AD  - 2 International Conservation and Education Fund, 236 11th Street SE, Washington, DC 20003-2124, USA.
FAU - Reynolds, Mary
AU  - Reynolds M
AD  - 1 Poxvirus and Rabies Program, Division of High-Consequence Pathogens andPathology, Centers for Disease Control and Prevention, Mailstop A-30, 1600Clifton Road, Atlanta Georgia, USA.
FAU - Carroll, Darin
AU  - Carroll D
AD  - 1 Poxvirus and Rabies Program, Division of High-Consequence Pathogens andPathology, Centers for Disease Control and Prevention, Mailstop A-30, 1600Clifton Road, Atlanta Georgia, USA.
LA  - eng
PT  - Journal Article
DEP - 20150501
PL  - United States
TA  - J Wildl Dis
JT  - Journal of wildlife diseases
JID - 0244160
SB  - IM
MH  - Animals
MH  - *Animals, Wild/virology
MH  - Cercopithecus/virology
MH  - Conservation of Natural Resources
MH  - Democratic Republic of the Congo/epidemiology
MH  - Rats/virology
MH  - Sciuridae/virology
MH  - Zoonoses/*epidemiology
OTO - NOTNLM
OT  - Bushmeat
OT  - Ebola
OT  - carcass
OT  - monkeypox
OT  - primate
OT  - rodent
OT  - spillover
EDAT- 2015/05/02 06:00
MHDA- 2016/04/23 06:00
CRDT- 2015/05/02 06:00
PHST- 2015/05/02 06:00 [entrez]
PHST- 2015/05/02 06:00 [pubmed]
PHST- 2016/04/23 06:00 [medline]
AID - 10.7589/2014-05-140 [doi]
PST - ppublish
SO  - J Wildl Dis. 2015 Jul;51(3):734-8. doi: 10.7589/2014-05-140. Epub 2015 May 1.

PMID- 25912718
OWN - NLM
STAT- MEDLINE
DCOM- 20151217
LR  - 20190108
IS  - 1999-4915 (Electronic)
IS  - 1999-4915 (Linking)
VI  - 7
IP  - 4
DP  - 2015 Apr 22
TI  - A phylogeographic investigation of African monkeypox.
PG  - 2168-84
LID - 10.3390/v7042168 [doi]
AB  - Monkeypox is a zoonotic disease caused by a virus member of the genusOrthopoxvirus and is endemic to Central and Western African countries. Previouswork has identified two geographically disjuct clades of monkeypox virus based onthe analysis of a few genomes coupled with epidemiological and clinical analyses;however, environmental and geographic causes of this differentiation have notbeen explored. Here, we expand previous phylogenetic studies by analyzing alarger set of monkeypox virus genomes originating throughout Sub-Saharan Africato identify possible biogeographic barriers associated with geneticdifferentiation; and projected ecological niche models onto environmentalconditions at three periods in the past to explore the potential role of climate oscillations in the evolution of the two primary clades. Analyses supported theseparation of the Congo Basin and West Africa clades; the Congo Basin clade showsmuch shorter branches, which likely indicate a more recent diversification ofisolates within this clade. The area between the Sanaga and Cross Rivers divides the two clades and the Dahomey Gap seems to have also served as a barrier within the West African clade. Contraction of areas with suitable environments formonkeypox virus during the Last Glacial Maximum, suggests that the Congo Basinclade of monkeypox virus experienced a severe bottleneck and has since expandedits geographic range.
FAU - Nakazawa, Yoshinori
AU  - Nakazawa Y
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, 1600Clifton Rd NE, Atlanta, GA 30333, USA. ynakazawa@cdc.gov.
FAU - Mauldin, Matthew R
AU  - Mauldin MR
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, 1600Clifton Rd NE, Atlanta, GA 30333, USA. mmauldin@cdc.gov.
AD  - Oak Ridge Institute for Science and Education (ORISE) CDC Fellowship Program, OakRidge, TN 37831, USA. mmauldin@cdc.gov.
FAU - Emerson, Ginny L
AU  - Emerson GL
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, 1600Clifton Rd NE, Atlanta, GA 30333, USA. gemerson@cdc.gov.
FAU - Reynolds, Mary G
AU  - Reynolds MG
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, 1600Clifton Rd NE, Atlanta, GA 30333, USA. mreynolds3@cdc.gov.
FAU - Lash, R Ryan
AU  - Lash RR
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, 1600Clifton Rd NE, Atlanta, GA 30333, USA. rlash@cdc.gov.
FAU - Gao, Jinxin
AU  - Gao J
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, 1600Clifton Rd NE, Atlanta, GA 30333, USA. jgao2@cdc.gov.
FAU - Zhao, Hui
AU  - Zhao H
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, 1600Clifton Rd NE, Atlanta, GA 30333, USA. hzhao1@cdc.gov.
FAU - Li, Yu
AU  - Li Y
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, 1600Clifton Rd NE, Atlanta, GA 30333, USA. yuli@cdc.gov.
FAU - Muyembe, Jean-Jacques
AU  - Muyembe JJ
AD  - INRB Laboratory, Avenue de la Democratie. Kinshasa-Gombe B.P. 1197 Kinshasa 1,Democratic Republic of the Congo. muyembejj@gmail.com.
FAU - Kingebeni, Placide Mbala
AU  - Kingebeni PM
AD  - INRB Laboratory, Avenue de la Democratie. Kinshasa-Gombe B.P. 1197 Kinshasa 1,Democratic Republic of the Congo. mbalaplacide@gmail.com.
FAU - Wemakoy, Okito
AU  - Wemakoy O
AD  - Kinshasa School of Public Health, University of Kinshasa, 11850 Kinshasa,Democratic Republic of the Congo. okitow@yahoo.fr.
FAU - Malekani, Jean
AU  - Malekani J
AD  - Biology Department, University of Kinshasa, P.O. Box 218 Kinshasa XI, Democratic Republic of the Congo. jean.malekani@unikin.ac.cd.
FAU - Karem, Kevin L
AU  - Karem KL
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, 1600Clifton Rd NE, Atlanta, GA 30333, USA. kkarem@cdc.gov.
FAU - Damon, Inger K
AU  - Damon IK
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, 1600Clifton Rd NE, Atlanta, GA 30333, USA. idamon@cdc.gov.
FAU - Carroll, Darin S
AU  - Carroll DS
AD  - Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, 1600Clifton Rd NE, Atlanta, GA 30333, USA. dcarroll@cdc.gov.
LA  - eng
SI  - GENBANK/KJ642612
SI  - GENBANK/KJ642613
SI  - GENBANK/KJ642614
SI  - GENBANK/KJ642615
SI  - GENBANK/KJ642616
SI  - GENBANK/KJ642617
SI  - GENBANK/KJ642618
SI  - GENBANK/KJ642619
SI  - GENBANK/KP849469
SI  - GENBANK/KP849470
SI  - GENBANK/KP849471
PT  - Journal Article
PT  - Research Support, U.S. Gov't, Non-P.H.S.
PT  - Research Support, U.S. Gov't, P.H.S.
DEP - 20150422
PL  - Switzerland
TA  - Viruses
JT  - Viruses
JID - 101509722
RN  - 0 (DNA, Viral)
SB  - IM
MH  - Africa South of the Sahara/epidemiology
MH  - Animals
MH  - Cluster Analysis
MH  - DNA, Viral/chemistry/genetics
MH  - Ecosystem
MH  - Humans
MH  - Molecular Sequence Data
MH  - Monkeypox/*epidemiology/*virology
MH  - Monkeypox virus/*classification/*genetics/isolation & purification
MH  - *Phylogeography
MH  - Sequence Analysis, DNA
MH  - Sequence Homology
PMC - PMC4411695
EDAT- 2015/04/29 06:00
MHDA- 2015/12/19 06:00
CRDT- 2015/04/28 06:00
PHST- 2015/02/13 00:00 [received]
PHST- 2015/04/15 00:00 [revised]
PHST- 2015/04/20 00:00 [accepted]
PHST- 2015/04/28 06:00 [entrez]
PHST- 2015/04/29 06:00 [pubmed]
PHST- 2015/12/19 06:00 [medline]
AID - v7042168 [pii]
AID - 10.3390/v7042168 [doi]
PST - epublish
SO  - Viruses. 2015 Apr 22;7(4):2168-84. doi: 10.3390/v7042168.

PMID- 25896687
OWN - NLM
STAT- MEDLINE
DCOM- 20160315
LR  - 20191210
IS  - 1098-6596 (Electronic)
IS  - 0066-4804 (Linking)
VI  - 59
IP  - 7
DP  - 2015 Jul
TI  - Treatment with the smallpox antiviral tecovirimat (ST-246) alone or incombination with ACAM2000 vaccination is effective as a postsymptomatic therapyfor monkeypox virus infection.
PG  - 4296-300
LID - 10.1128/AAC.00208-15 [doi]
AB  - The therapeutic efficacies of smallpox vaccine ACAM2000 and antiviral tecovirimatgiven alone or in combination starting on day 3 postinfection were compared in a cynomolgus macaque model of lethal monkeypox virus infection. Postexposureadministration of ACAM2000 alone did not provide any protection against severemonkeypox disease or mortality. In contrast, postexposure treatment withtecovirimat alone or in combination with ACAM2000 provided full protection.Additionally, tecovirimat treatment delayed until day 4, 5, or 6 postinfectionwas 83% (days 4 and 5) or 50% (day 6) effective.
CI  - Copyright (c) 2015, American Society for Microbiology. All Rights Reserved.
FAU - Berhanu, Aklile
AU  - Berhanu A
AD  - SIGA Technologies, Inc., Corvallis, Oregon, USA aberhanu@Siga.com.
FAU - Prigge, Jonathan T
AU  - Prigge JT
AD  - Southern Research Institute, Frederick, Maryland, USA.
FAU - Silvera, Peter M
AU  - Silvera PM
AD  - Southern Research Institute, Frederick, Maryland, USA.
FAU - Honeychurch, Kady M
AU  - Honeychurch KM
AD  - SIGA Technologies, Inc., Corvallis, Oregon, USA.
FAU - Hruby, Dennis E
AU  - Hruby DE
AD  - SIGA Technologies, Inc., Corvallis, Oregon, USA.
FAU - Grosenbach, Douglas W
AU  - Grosenbach DW
AD  - SIGA Technologies, Inc., Corvallis, Oregon, USA.
LA  - eng
GR  - HHSN272200800041C/AI/NIAID NIH HHS/United States
GR  - R03 NR009349/NR/NINR NIH HHS/United States
GR  - HHSN272200800041C/PHS HHS/United States
GR  - HHSO100201100023C/PHS HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20150420
PL  - United States
TA  - Antimicrob Agents Chemother
JT  - Antimicrobial agents and chemotherapy
JID - 0315061
RN  - 0 (ACAM2000)
RN  - 0 (Antiviral Agents)
RN  - 0 (Benzamides)
RN  - 0 (Isoindoles)
RN  - 0 (Smallpox Vaccine)
RN  - 0 (Viral Vaccines)
RN  - F925RR824R (Tecovirimat)
SB  - IM
MH  - Animals
MH  - Antiviral Agents/*therapeutic use
MH  - Benzamides/*therapeutic use
MH  - Body Weight/drug effects
MH  - Combined Modality Therapy
MH  - Isoindoles/*therapeutic use
MH  - Leukocyte Count
MH  - Macaca fascicularis
MH  - Monkeypox/*drug therapy/mortality/virology
MH  - *Monkeypox virus/immunology
MH  - Smallpox/*drug therapy
MH  - Smallpox Vaccine/*therapeutic use
MH  - Vaccination
MH  - Viral Load/drug effects
MH  - Viral Vaccines/*therapeutic use
PMC - PMC4468657
EDAT- 2015/04/22 06:00
MHDA- 2016/03/16 06:00
CRDT- 2015/04/22 06:00
PHST- 2015/01/27 00:00 [received]
PHST- 2015/04/08 00:00 [accepted]
PHST- 2015/04/22 06:00 [entrez]
PHST- 2015/04/22 06:00 [pubmed]
PHST- 2016/03/16 06:00 [medline]
AID - AAC.00208-15 [pii]
AID - 10.1128/AAC.00208-15 [doi]
PST - ppublish
SO  - Antimicrob Agents Chemother. 2015 Jul;59(7):4296-300. doi: 10.1128/AAC.00208-15. Epub 2015 Apr 20.

PMID- 25860289
OWN - NLM
STAT- MEDLINE
DCOM- 20160406
LR  - 20220410
IS  - 1553-7358 (Electronic)
IS  - 1553-734X (Linking)
VI  - 11
IP  - 4
DP  - 2015 Apr
TI  - Characterizing the transmission potential of zoonotic infections from minoroutbreaks.
PG  - e1004154
LID - 10.1371/journal.pcbi.1004154 [doi]
AB  - The transmission potential of a novel infection depends on both the inherenttransmissibility of a pathogen, and the level of susceptibility in the hostpopulation. However, distinguishing between these pathogen- andpopulation-specific properties typically requires detailed serological studies,which are rarely available in the early stages of an outbreak. Using a simpletransmission model that incorporates age-stratified social mixing patterns, wepresent a novel method for characterizing the transmission potential ofsubcritical infections, which have effective reproduction number R<1, fromreadily available data on the size of outbreaks. We show that the model canidentify the extent to which outbreaks are driven by inherent pathogentransmissibility and pre-existing population immunity, and can generate unbiased estimates of the effective reproduction number. Applying the method to real-life infections, we obtained accurate estimates for the degree of age-specificimmunity against monkeypox, influenza A(H5N1) and A(H7N9), and refined existingestimates of the reproduction number. Our results also suggest minimalpre-existing immunity to MERS-CoV in humans. The approach we describe cantherefore provide crucial information about novel infections before serologicalsurveys and other detailed analyses are available. The methods would also beapplicable to data stratified by factors such as profession or location, whichwould make it possible to measure the transmission potential of emerginginfections in a wide range of settings.
FAU - Kucharski, Adam J
AU  - Kucharski AJ
AD  - Centre for the Mathematical Modelling of Infectious Diseases, London School ofHygiene & Tropical Medicine, London, United Kingdom; Fogarty InternationalCenter, National Institutes of Health, Bethesda, Maryland, United States.
FAU - Edmunds, W John
AU  - Edmunds WJ
AD  - Centre for the Mathematical Modelling of Infectious Diseases, London School ofHygiene & Tropical Medicine, London, United Kingdom.
LA  - eng
GR  - MR/K021524/1/Medical Research Council/United Kingdom
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20150410
PL  - United States
TA  - PLoS Comput Biol
JT  - PLoS computational biology
JID - 101238922
SB  - IM
MH  - Age Distribution
MH  - Animals
MH  - Communicable Diseases, Emerging/*epidemiology/*transmission
MH  - Computer Simulation
MH  - Disease Outbreaks/*statistics & numerical data
MH  - Disease Susceptibility/epidemiology
MH  - Humans
MH  - Incidence
MH  - *Models, Statistical
MH  - Risk Assessment/methods
MH  - Zoonoses/*epidemiology/*transmission
PMC - PMC4393285
EDAT- 2015/04/11 06:00
MHDA- 2016/04/07 06:00
CRDT- 2015/04/11 06:00
PHST- 2014/10/20 00:00 [received]
PHST- 2015/01/23 00:00 [accepted]
PHST- 2015/04/11 06:00 [entrez]
PHST- 2015/04/11 06:00 [pubmed]
PHST- 2016/04/07 06:00 [medline]
AID - 10.1371/journal.pcbi.1004154 [doi]
AID - PCOMPBIOL-D-14-01912 [pii]
PST - epublish
SO  - PLoS Comput Biol. 2015 Apr 10;11(4):e1004154. doi: 10.1371/journal.pcbi.1004154. eCollection 2015 Apr.

PMID- 25791934
OWN - NLM
STAT- MEDLINE
DCOM- 20150803
LR  - 20191008
IS  - 1096-0341 (Electronic)
IS  - 0042-6822 (Linking)
VI  - 481
DP  - 2015 Jul
TI  - Genetic studies of the susceptibility of classical and wild-derived inbred mouse strains to monkeypox virus.
PG  - 161-5
LID - 10.1016/j.virol.2015.02.048 [doi]
LID - S0042-6822(15)00113-0 [pii]
AB  - Previously, we screened 38 inbred mouse strains for susceptibility to monkeypoxvirus (MPXV) and focused on wild-derived CAST mice because of their extremevulnerability. Here, we provide further analysis of inbred mouse strains. NZW/Lacand C58 mice exhibited more weight loss than other classical inbred strains butall survived intranasal challenges with 10(4) to 10(6)PFU of MPXV. Mice fromthree wild derived strains, in addition to CAST, exhibited severe weight loss anddied or were euthanized. LD50 values for CASA, MOLF and PERA were 100, 6800 and>10(5)PFU, respectively. CASA was inbred independently from the same founders as CAST, whereas MOLF and PERA are genetically and geographically distinct. The MPXVsusceptibility of the F1 progeny of CAST and either C57BL/6 or BALB/c indicatedthat resistance is dominant. Back-crossing the F1 progeny of C57BL/6 and CAST to CAST suggested more than one independent resistant locus.
CI  - Published by Elsevier Inc.
FAU - Earl, Patricia L
AU  - Earl PL
AD  - Laboratory of Viral Diseases, 33 North Drive, National Institute of Allergy andInfectious Diseases, National Institutes of Health, Bethesda, MD 20892, UnitesStates.
FAU - Americo, Jeffrey L
AU  - Americo JL
AD  - Laboratory of Viral Diseases, 33 North Drive, National Institute of Allergy andInfectious Diseases, National Institutes of Health, Bethesda, MD 20892, UnitesStates.
FAU - Moss, Bernard
AU  - Moss B
AD  - Laboratory of Viral Diseases, 33 North Drive, National Institute of Allergy andInfectious Diseases, National Institutes of Health, Bethesda, MD 20892, UnitesStates. Electronic address: bmoss@nih.gov.
LA  - eng
GR  - ZIA AI000979-08/Intramural NIH HHS/United States
GR  - 1ZIAAI00097909/PHS HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Intramural
DEP - 20150317
PL  - United States
TA  - Virology
JT  - Virology
JID - 0110674
SB  - IM
MH  - Animals
MH  - Disease Models, Animal
MH  - Female
MH  - *Genetic Predisposition to Disease
MH  - Humans
MH  - Male
MH  - *Mice/genetics
MH  - Mice, Inbred BALB C
MH  - Mice, Inbred C57BL
MH  - Mice, Inbred Strains
MH  - Monkeypox/*genetics/virology
MH  - Monkeypox virus/pathogenicity/*physiology
MH  - Virulence
PMC - PMC4437815
MID - NIHMS673178
OTO - NOTNLM
OT  - Pathogenesis
OT  - Poxvirus
OT  - Select agent
OT  - Virulence
EDAT- 2015/03/21 06:00
MHDA- 2015/08/04 06:00
CRDT- 2015/03/21 06:00
PHST- 2015/01/30 00:00 [received]
PHST- 2015/02/18 00:00 [revised]
PHST- 2015/02/21 00:00 [accepted]
PHST- 2015/03/21 06:00 [entrez]
PHST- 2015/03/21 06:00 [pubmed]
PHST- 2015/08/04 06:00 [medline]
AID - S0042-6822(15)00113-0 [pii]
AID - 10.1016/j.virol.2015.02.048 [doi]
PST - ppublish
SO  - Virology. 2015 Jul;481:161-5. doi: 10.1016/j.virol.2015.02.048. Epub 2015 Mar 17.

PMID- 25653439
OWN - NLM
STAT- MEDLINE
DCOM- 20150528
LR  - 20181113
IS  - 1098-5514 (Electronic)
IS  - 0022-538X (Linking)
VI  - 89
IP  - 8
DP  - 2015 Apr
TI  - Sequence of pathogenic events in cynomolgus macaques infected with aerosolizedmonkeypox virus.
PG  - 4335-44
LID - 10.1128/JVI.03029-14 [doi]
AB  - UNLABELLED: To evaluate new vaccines when human efficacy studies are notpossible, the FDA's "Animal Rule" requires well-characterized models ofinfection. Thus, in the present study, the early pathogenic events of monkeypoxinfection in nonhuman primates, a surrogate for variola virus infection, werecharacterized. Cynomolgus macaques were exposed to aerosolized monkeypox virus(10(5) PFU). Clinical observations, viral loads, immune responses, andpathological changes were examined on days 2, 4, 6, 8, 10, and 12 postchallenge. Viral DNA (vDNA) was detected in the lungs on day 2 postchallenge, and viralantigen was detected, by immunostaining, in the epithelium of bronchi,bronchioles, and alveolar walls. Lesions comprised rare foci of dysplastic andsloughed cells in respiratory bronchioles. By day 4, vDNA was detected in thethroat, tonsil, and spleen, and monkeypox antigen was detected in the lung, hilarand submandibular lymph nodes, spleen, and colon. Lung lesions comprised focalepithelial necrosis and inflammation. Body temperature peaked on day 6, poxlesions appeared on the skin, and lesions, with positive immunostaining, werepresent in the lung, tonsil, spleen, lymph nodes, and colon. By day 8, vDNA waspresent in 9/13 tissues. Blood concentrations of interleukin 1ra (IL-1ra), IL-6, and gamma interferon (IFN-gamma) increased markedly. By day 10, circulating IgGantibody concentrations increased, and on day 12, animals showed early signs ofrecovery. These results define early events occurring in an inhalational macaque monkeypox infection model, supporting its use as a surrogate model for humansmallpox. IMPORTANCE: Bioterrorism poses a major threat to public health, as the deliberate release of infectious agents, such smallpox or a related virus,monkeypox, would have catastrophic consequences. The development and testing ofnew medical countermeasures, e.g., vaccines, are thus priorities; however, tests for efficacy in humans cannot be performed because it would be unethical andfield trials are not feasible. To overcome this, the FDA may grant marketingapproval of a new product based upon the "Animal Rule," in which interventionsare tested for efficacy in well-characterized animal models. Monkeypox virusinfection of nonhuman primates (NHPs) presents a potential surrogate diseasemodel for smallpox. Previously, the later stages of monkeypox infection weredefined, but the early course of infection remains unstudied. Here, the earlypathogenic events of inhalational monkeypox infection in NHPs were characterized,and the results support the use of this surrogate model for testing humansmallpox interventions.
CI  - Copyright (c) 2015, American Society for Microbiology. All Rights Reserved.
FAU - Tree, J A
AU  - Tree JA
AD  - Microbiological Services, Public Health England, Porton Down, Salisbury,Wiltshire, United Kingdom julia.tree@phe.gov.uk.
FAU - Hall, G
AU  - Hall G
AD  - Microbiological Services, Public Health England, Porton Down, Salisbury,Wiltshire, United Kingdom.
FAU - Pearson, G
AU  - Pearson G
AD  - Microbiological Services, Public Health England, Porton Down, Salisbury,Wiltshire, United Kingdom.
FAU - Rayner, E
AU  - Rayner E
AD  - Microbiological Services, Public Health England, Porton Down, Salisbury,Wiltshire, United Kingdom.
FAU - Graham, V A
AU  - Graham VA
AD  - Microbiological Services, Public Health England, Porton Down, Salisbury,Wiltshire, United Kingdom.
FAU - Steeds, K
AU  - Steeds K
AD  - Microbiological Services, Public Health England, Porton Down, Salisbury,Wiltshire, United Kingdom.
FAU - Bewley, K R
AU  - Bewley KR
AD  - Microbiological Services, Public Health England, Porton Down, Salisbury,Wiltshire, United Kingdom.
FAU - Hatch, G J
AU  - Hatch GJ
AD  - Microbiological Services, Public Health England, Porton Down, Salisbury,Wiltshire, United Kingdom.
FAU - Dennis, M
AU  - Dennis M
AD  - Microbiological Services, Public Health England, Porton Down, Salisbury,Wiltshire, United Kingdom.
FAU - Taylor, I
AU  - Taylor I
AD  - Microbiological Services, Public Health England, Porton Down, Salisbury,Wiltshire, United Kingdom.
FAU - Roberts, A D
AU  - Roberts AD
AD  - Microbiological Services, Public Health England, Porton Down, Salisbury,Wiltshire, United Kingdom.
FAU - Funnell, S G P
AU  - Funnell SG
AD  - Microbiological Services, Public Health England, Porton Down, Salisbury,Wiltshire, United Kingdom.
FAU - Vipond, J
AU  - Vipond J
AD  - Microbiological Services, Public Health England, Porton Down, Salisbury,Wiltshire, United Kingdom.
LA  - eng
GR  - N01AI30062/AI/NIAID NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20150204
PL  - United States
TA  - J Virol
JT  - Journal of virology
JID - 0113724
RN  - 0 (Aerosols)
RN  - 0 (Antigens, Viral)
RN  - 0 (Cytokines)
RN  - 0 (DNA, Viral)
SB  - IM
MH  - Aerosols/administration & dosage
MH  - Animals
MH  - Antigens, Viral/metabolism
MH  - Cytokines/blood
MH  - DNA, Viral/metabolism
MH  - *Disease Models, Animal
MH  - Enzyme-Linked Immunosorbent Assay
MH  - Flow Cytometry
MH  - Lung/virology
MH  - *Macaca fascicularis
MH  - Male
MH  - Monkeypox/*immunology/*physiopathology
MH  - *Monkeypox virus
MH  - Real-Time Polymerase Chain Reaction
MH  - Time Factors
MH  - Viral Load
MH  - Viral Plaque Assay
PMC - PMC4442344
EDAT- 2015/02/06 06:00
MHDA- 2015/05/29 06:00
CRDT- 2015/02/06 06:00
PHST- 2015/02/06 06:00 [entrez]
PHST- 2015/02/06 06:00 [pubmed]
PHST- 2015/05/29 06:00 [medline]
AID - JVI.03029-14 [pii]
AID - 10.1128/JVI.03029-14 [doi]
PST - ppublish
SO  - J Virol. 2015 Apr;89(8):4335-44. doi: 10.1128/JVI.03029-14. Epub 2015 Feb 4.

PMID- 25646658
OWN - NLM
STAT- MEDLINE
DCOM- 20151117
LR  - 20181113
IS  - 1557-8127 (Electronic)
IS  - 1540-658X (Linking)
VI  - 13
IP  - 1
DP  - 2015 Jan-Feb
TI  - Probing the virus host interaction in high containment: an approach using pooled short hairpin RNA.
PG  - 34-43
LID - 10.1089/adt.2014.613 [doi]
AB  - The study of viruses in high containment offers unique challenges fortechnology-intense approaches. These approaches include high-throughput screeningfor small-molecule antivirals and genetic perturbation-based screens for hostfactors required for viral replication. Here, we describe the use of whole-genomescale pooled short hairpin RNA (shRNA) libraries to screen for host factorsnecessary for viral infection at BSL2, and the transition of this technique into the BSL4 environment. Pooled screening provides a unique way to circumvent manyof the technological challenges associated with other high-throughput screeningapproaches in high containment. Our pooled screening approach identified hostfactors involved in the replication of orthopoxviruses (Vaccinia and Monkeypox)and filoviruses (Ebola and Marburg) under conditions that enable straightforward screen-to-follow-up approaches.
FAU - Filone, Claire Marie
AU  - Filone CM
AD  - 1 National Emerging Infectious Diseases Laboratory, Boston University School ofMedicine , Boston, Massachusetts.
FAU - Dower, Ken
AU  - Dower K
FAU - Cowley, Glenn S
AU  - Cowley GS
FAU - Hensley, Lisa E
AU  - Hensley LE
FAU - Connor, John H
AU  - Connor JH
LA  - eng
GR  - 5T32AI089673-04/AI/NIAID NIH HHS/United States
GR  - R03MH094169/MH/NIMH NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20150203
PL  - United States
TA  - Assay Drug Dev Technol
JT  - Assay and drug development technologies
JID - 101151468
RN  - 0 (RNA, Small Interfering)
SB  - IM
MH  - Biological Assay/methods
MH  - Containment of Biohazards
MH  - *Genomic Library
MH  - High-Throughput Nucleotide Sequencing/*methods
MH  - Host-Pathogen Interactions/*genetics
MH  - Humans
MH  - RNA, Small Interfering/*genetics
MH  - Vaccinia/*virology
MH  - Vaccinia virus/*physiology
MH  - Virus Integration/physiology
PMC - PMC4340469
EDAT- 2015/02/04 06:00
MHDA- 2015/11/18 06:00
CRDT- 2015/02/04 06:00
PHST- 2015/02/04 06:00 [entrez]
PHST- 2015/02/04 06:00 [pubmed]
PHST- 2015/11/18 06:00 [medline]
AID - 10.1089/adt.2014.613 [doi]
PST - ppublish
SO  - Assay Drug Dev Technol. 2015 Jan-Feb;13(1):34-43. doi: 10.1089/adt.2014.613. Epub2015 Feb 3.

PMID- 25600603
OWN - NLM
STAT- MEDLINE
DCOM- 20160223
LR  - 20210304
IS  - 1873-5967 (Electronic)
IS  - 1386-6532 (Linking)
VI  - 63
DP  - 2015 Feb
TI  - Cytokine modulation correlates with severity of monkeypox disease in humans.
PG  - 42-5
LID - 10.1016/j.jcv.2014.12.001 [doi]
LID - S1386-6532(14)00463-6 [pii]
AB  - BACKGROUND: Human monkeypox is a zoonotic disease endemic to parts of Africa.Similar to other orthopoxviruses, virus and host have considerable interactionsthrough immunomodulation. These interactions likely drive the establishment of a productive infection and disease progression, resulting in the range of diseasepresentations and case fatality rates observed for members of the Orthopoxvirusgenus. OBJECTIVES: Much of our understanding about the immune response toorthopoxvirus infection comes from either in vitro or in vivo studies performedin small animals or non-human primates. Here, we conducted a detailed assessment of cytokine responses to monkeypox virus using serum from acutely ill humanscollected during monkeypox active disease surveillance (2005-2007) in theDemocratic Republic of the Congo. STUDY DESIGN: Nineteen serum samples that were from patients with confirmed monkeypox virus infections were selected forcytokine profiling. Cytokine profiling was performed on the Bio-Rad Bioplex 100system using a 30-plex human cytokine panel. RESULTS: Cytokine profiling revealedelevated cytokine concentrations in all samples. Overproduction of certaincytokines (interleukin [IL]-2R, IL-10, and granulocyte macrophage-colonystimulating factor were observed in patients with serious disease (defined as>250 lesions based on the World Health Organization scoring system). CONCLUSIONS:The data suggest that cytokine modulation affects monkeypox disease severity inhumans.
CI  - Copyright (c) 2014 Elsevier B.V. All rights reserved.
FAU - Johnston, Sara C
AU  - Johnston SC
AD  - Virology Division, United States Army Medical Research Institute of InfectiousDiseases, 1425 Porter Street, Fort Detrick, MD 21702, USA.
FAU - Johnson, Joshua C
AU  - Johnson JC
AD  - Virology Division, United States Army Medical Research Institute of InfectiousDiseases, 1425 Porter Street, Fort Detrick, MD 21702, USA.
FAU - Stonier, Spencer W
AU  - Stonier SW
AD  - Virology Division, United States Army Medical Research Institute of InfectiousDiseases, 1425 Porter Street, Fort Detrick, MD 21702, USA.
FAU - Lin, Kenny L
AU  - Lin KL
AD  - Virology Division, United States Army Medical Research Institute of InfectiousDiseases, 1425 Porter Street, Fort Detrick, MD 21702, USA.
FAU - Kisalu, Neville K
AU  - Kisalu NK
AD  - Department of Microbiology, Immunology, and Molecular Genetics, UCLA, 609 CharlesE. Young Dr. East, 1602 Molecular Science Building, Los Angeles, CA 90095, USA.
FAU - Hensley, Lisa E
AU  - Hensley LE
AD  - Virology Division, United States Army Medical Research Institute of InfectiousDiseases, 1425 Porter Street, Fort Detrick, MD 21702, USA.
FAU - Rimoin, Anne W
AU  - Rimoin AW
AD  - Department of Epidemiology, UCLA School of Public Health, 650 Charles E. YoungDr. South, Los Angeles, CA 90024, USA. Electronic address: arimoin@ucla.edu.
LA  - eng
GR  - K01 AI074810/AI/NIAID NIH HHS/United States
PT  - Journal Article
DEP - 20141204
PL  - Netherlands
TA  - J Clin Virol
JT  - Journal of clinical virology : the official publication of the Pan AmericanSociety for Clinical Virology
JID - 9815671
RN  - 0 (Cytokines)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Animals
MH  - Child
MH  - Child, Preschool
MH  - Cytokines/*blood
MH  - Democratic Republic of the Congo
MH  - Female
MH  - Humans
MH  - Infant
MH  - Male
MH  - Monkeypox/*immunology/*pathology
MH  - Monkeypox virus/*immunology
MH  - *Severity of Illness Index
MH  - Young Adult
OTO - NOTNLM
OT  - Cytokine
OT  - Cytokine storm
OT  - Monkeypox
OT  - Orthopoxvirus
OT  - Regulatory T cell
EDAT- 2015/01/21 06:00
MHDA- 2016/02/26 06:00
CRDT- 2015/01/21 06:00
PHST- 2014/09/24 00:00 [received]
PHST- 2014/12/01 00:00 [revised]
PHST- 2014/12/02 00:00 [accepted]
PHST- 2015/01/21 06:00 [entrez]
PHST- 2015/01/21 06:00 [pubmed]
PHST- 2016/02/26 06:00 [medline]
AID - S1386-6532(14)00463-6 [pii]
AID - 10.1016/j.jcv.2014.12.001 [doi]
PST - ppublish
SO  - J Clin Virol. 2015 Feb;63:42-5. doi: 10.1016/j.jcv.2014.12.001. Epub 2014 Dec 4.

PMID- 25597343
OWN - NLM
STAT- MEDLINE
DCOM- 20170119
LR  - 20181202
IS  - 1865-1682 (Electronic)
IS  - 1865-1674 (Linking)
VI  - 63
IP  - 5
DP  - 2016 Oct
TI  - The Possibility of Using the ICR Mouse as an Animal Model to Assess AntimonkeypoxDrug Efficacy.
PG  - e419-30
LID - 10.1111/tbed.12323 [doi]
AB  - As a result of the conducted experimental studies on intranasal challenge of ICR mice, rabbits and miniature pigs (even in the maximum variant) with the doses of 4.0-5.5 lg PFU of monkeypox virus (MPXV), some clinical signs such as purulentconjunctivitis, blepharitis and ruffled fur were found only in mice. The 50%infective dose (C ID50 ) of MPXV for these animals estimated by the presence ofexternal clinical signs was 4.8 lg PFU, and L ID50 estimated by the viruspresence in the lungs of mice 7 days post-infection taking into account its 10%application in the animal respiratory tract was 1.4 lg PFU. When studying thedynamics of MPXV propagation in mice challenged intranasally with 25 L ID50 ofMPXV, the maximum pathogen accumulation was revealed in nasal cavity, lungs andbrain: 5.7 +/- 0.1, 5.5 +/- 0.1 and 5.3 +/- 0.3 lg PFU/ml, respectively. Thepathomorphological examination of these animals revealed the presence andreplication of the pathogen in the traditional primary target cells for MPXV(mononuclear phagocyte system cells and respiratory tract epitheliocytes) as wellas in some other types of cells (endothelial cells, reticular cells, connectivetissue cells). Our use of these animals to assess the antiviral efficacy of some drugs demonstrated the agreement of the results (a significant positive effect ofNIOCH-14 and ST-246) with those described in scientific literature, which opensup the prospects of using ICR mice as animal models for monkeypox to developpreventive antismallpox drugs.
CI  - (c) 2015 Blackwell Verlag GmbH.
FAU - Sergeev, Al A
AU  - Sergeev AA
AD  - Federal Budgetary Research Institution - State Research Center of Virology andBiotechnology Vector, Federal Service for Surveillance on Consumer RightsProtection and Human Well-being, Koltsovo, Russia.
FAU - Kabanov, A S
AU  - Kabanov AS
AD  - Federal Budgetary Research Institution - State Research Center of Virology andBiotechnology Vector, Federal Service for Surveillance on Consumer RightsProtection and Human Well-being, Koltsovo, Russia.
FAU - Bulychev, L E
AU  - Bulychev LE
AD  - Federal Budgetary Research Institution - State Research Center of Virology andBiotechnology Vector, Federal Service for Surveillance on Consumer RightsProtection and Human Well-being, Koltsovo, Russia.
FAU - Sergeev, Ar A
AU  - Sergeev AA
AD  - Federal Budgetary Research Institution - State Research Center of Virology andBiotechnology Vector, Federal Service for Surveillance on Consumer RightsProtection and Human Well-being, Koltsovo, Russia.
FAU - Pyankov, O V
AU  - Pyankov OV
AD  - Federal Budgetary Research Institution - State Research Center of Virology andBiotechnology Vector, Federal Service for Surveillance on Consumer RightsProtection and Human Well-being, Koltsovo, Russia.
FAU - Bodnev, S A
AU  - Bodnev SA
AD  - Federal Budgetary Research Institution - State Research Center of Virology andBiotechnology Vector, Federal Service for Surveillance on Consumer RightsProtection and Human Well-being, Koltsovo, Russia.
FAU - Galahova, D O
AU  - Galahova DO
AD  - Federal Budgetary Research Institution - State Research Center of Virology andBiotechnology Vector, Federal Service for Surveillance on Consumer RightsProtection and Human Well-being, Koltsovo, Russia.
FAU - Zamedyanskaya, A S
AU  - Zamedyanskaya AS
AD  - Federal Budgetary Research Institution - State Research Center of Virology andBiotechnology Vector, Federal Service for Surveillance on Consumer RightsProtection and Human Well-being, Koltsovo, Russia.
FAU - Titova, K A
AU  - Titova KA
AD  - Federal Budgetary Research Institution - State Research Center of Virology andBiotechnology Vector, Federal Service for Surveillance on Consumer RightsProtection and Human Well-being, Koltsovo, Russia.
FAU - Glotov, A G
AU  - Glotov AG
AD  - State Scientific Establishment - Institute of Experimental Veterinary Science of Siberia and the Far East Russian Academy of Agricultural Sciences, Krasnoobsk,Russia.
FAU - Taranov, O S
AU  - Taranov OS
AD  - Federal Budgetary Research Institution - State Research Center of Virology andBiotechnology Vector, Federal Service for Surveillance on Consumer RightsProtection and Human Well-being, Koltsovo, Russia.
FAU - Omigov, V V
AU  - Omigov VV
AD  - Federal Budgetary Research Institution - State Research Center of Virology andBiotechnology Vector, Federal Service for Surveillance on Consumer RightsProtection and Human Well-being, Koltsovo, Russia.
FAU - Shishkina, L N
AU  - Shishkina LN
AD  - Federal Budgetary Research Institution - State Research Center of Virology andBiotechnology Vector, Federal Service for Surveillance on Consumer RightsProtection and Human Well-being, Koltsovo, Russia.
FAU - Agafonov, A P
AU  - Agafonov AP
AD  - Federal Budgetary Research Institution - State Research Center of Virology andBiotechnology Vector, Federal Service for Surveillance on Consumer RightsProtection and Human Well-being, Koltsovo, Russia.
FAU - Sergeev, A N
AU  - Sergeev AN
AD  - Federal Budgetary Research Institution - State Research Center of Virology andBiotechnology Vector, Federal Service for Surveillance on Consumer RightsProtection and Human Well-being, Koltsovo, Russia.
LA  - eng
PT  - Journal Article
DEP - 20150119
PL  - Germany
TA  - Transbound Emerg Dis
JT  - Transboundary and emerging diseases
JID - 101319538
RN  - 0 (Antiviral Agents)
SB  - IM
MH  - Animals
MH  - Antiviral Agents/pharmacology
MH  - Disease Models, Animal
MH  - Disease Susceptibility/veterinary
MH  - Mice, Inbred ICR/*virology
MH  - Monkeypox/drug therapy/*veterinary
MH  - *Monkeypox virus
OTO - NOTNLM
OT  - ICR mouse
OT  - animal model
OT  - antimonkeypox efficacy
OT  - drug
OT  - intranasal challenge
OT  - monkeypox virus
EDAT- 2015/01/20 06:00
MHDA- 2017/01/20 06:00
CRDT- 2015/01/20 06:00
PHST- 2014/11/03 00:00 [received]
PHST- 2015/01/20 06:00 [entrez]
PHST- 2015/01/20 06:00 [pubmed]
PHST- 2017/01/20 06:00 [medline]
AID - 10.1111/tbed.12323 [doi]
PST - ppublish
SO  - Transbound Emerg Dis. 2016 Oct;63(5):e419-30. doi: 10.1111/tbed.12323. Epub 2015 Jan 19.

PMID- 27024916
OWN - NLM
STAT- MEDLINE
DCOM- 20160408
LR  - 20161109
IS  - 0507-4088 (Print)
IS  - 0507-4088 (Linking)
VI  - 60
IP  - 6
DP  - 2015
TI  - [Development of the disease in marmot at the intranasal infection with themonkeypox virus].
PG  - 37-41
AB  - In experimental study the sensitivity of the Marmota bobak species to themonkeypox virus (MPXV) with the intranasal (i/n) infection was tested. It wasdemonstrated that 50% of the infective dose (ID50) of the MPXV on externalclinical signs of the disease was 2.2 Ig plaque forming units (PFU). Thepercentage of the marmot mortality is slightly dependent on the infecting dose ofthe MPXV, therefore it is not possible to correctly determine the value of 50 %fatal dose (FD50) for these animals. The most pronounced external clinical signs of the disease were obtained in the marmots: pox-like skin rash throughout thesurface of the body and mucous membranes, purulent discharge from the nose,lymphadenitis, discoordination, tremor of the extremities, fever, increasedaggression, and ruffled fur. In the course of experiments intended to determinethe dynamics of the accumulation of the MPXV in various organs, tissues, andblood serum of marmot infected i/n with dose of 3.7 Ig PFU, it was found that thetrachea, lungs, and the bifurcation lymph nodes are the primary target organs.The trachea, lungs, nasal mucosa membrane, and skin are the organs with maximalvirus replication recorded at 5, 7, 9, and 12 days after the infection. Thetransfer of the MPXV into the secondary target organs (nasal mucosa membrane,brain, spleen, duodenum, adrenal glands, and skin) was carried out in marmotswith lymphogenic and hematogenic ways of the dissemination of the infection.
FAU - Sergeev, A A
AU  - Sergeev AA
FAU - Kabanov, A S
AU  - Kabanov AS
FAU - Bulychev, L E
AU  - Bulychev LE
FAU - Sergeev, Ar A
AU  - Sergeev AA
FAU - Pyankov, O V
AU  - Pyankov OV
FAU - Bodnev, S A
AU  - Bodnev SA
FAU - Galakhova, D O
AU  - Galakhova DO
FAU - Zamedyanskaya, A S
AU  - Zamedyanskaya AS
FAU - Titova, K A
AU  - Titova KA
FAU - Shishkina, L N
AU  - Shishkina LN
FAU - Agafonov, A P
AU  - Agafonov AP
FAU - Sergeev, A N
AU  - Sergeev AN
LA  - rus
PT  - English Abstract
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - Russia (Federation)
TA  - Vopr Virusol
JT  - Voprosy virusologii
JID - 0417337
SB  - IM
MH  - Administration, Intranasal
MH  - Animals
MH  - Female
MH  - Lung/pathology/virology
MH  - Lymph Nodes/pathology/virology
MH  - Male
MH  - Marmota
MH  - Monkeypox/mortality/*pathology/*virology
MH  - Monkeypox virus/*pathogenicity/physiology
MH  - Nasal Mucosa/pathology/virology
MH  - Skin/pathology/virology
MH  - Spleen/pathology/virology
MH  - Survival Analysis
MH  - Trachea/pathology/virology
MH  - Virus Replication/*physiology
EDAT- 2015/01/01 00:00
MHDA- 2016/04/09 06:00
CRDT- 2016/03/31 06:00
PHST- 2016/03/31 06:00 [entrez]
PHST- 2015/01/01 00:00 [pubmed]
PHST- 2016/04/09 06:00 [medline]
PST - ppublish
SO  - Vopr Virusol. 2015;60(6):37-41.

PMID- 25476836
OWN - NLM
STAT- MEDLINE
DCOM- 20150305
LR  - 20181113
IS  - 1749-6632 (Electronic)
IS  - 0077-8923 (Linking)
VI  - 1334
DP  - 2014 Dec
TI  - One Medicine One Science: a framework for exploring challenges at theintersection of animals, humans, and the environment.
PG  - 26-44
LID - 10.1111/nyas.12601 [doi]
AB  - Characterizing the health consequences of interactions among animals, humans, andthe environment in the face of climatic change, environmental disturbance, andexpanding human populations is a critical global challenge in today's world.Exchange of interdisciplinary knowledge in basic and applied sciences andmedicine that includes scientists, health professionals, key sponsors, and policyexperts revealed that relevant case studies of monkeypox, influenza A,tuberculosis, and HIV can be used to guide strategies for anticipating andresponding to new disease threats such as the Ebola and Chickungunya viruses, as well as to improve programs to control existing zoonotic diseases, includingtuberculosis. The problem of safely feeding the world while preserving theenvironment and avoiding issues such as antibiotic resistance in animals andhumans requires cooperative scientific problem solving. Food poisoning outbreaks resulting from Salmonella growing in vegetables have demonstrated the need forknowledge of pathogen evolution and adaptation in developing appropriatecountermeasures for prevention and policy development. Similarly, pesticide usefor efficient crop production must take into consideration bee populationdeclines that threaten the availability of the two-thirds of human foods that aredependent on pollination. This report presents and weighs the objective merits ofcompeting health priorities and identifies gaps in knowledge that threaten healthsecurity, to promote discussion of major public policy implications such thatthey may be decided with at least an underlying platform of facts.
CI  - (c) 2014 The Authors. Annals of the New York Academy of Sciences published byWiley Periodicals Inc. on behalf of The New York Academy of Sciences.
FAU - Travis, Dominic A
AU  - Travis DA
AD  - Department of Veterinary Population Medicine, College of Veterinary Medicine,University of Minnesota, St. Paul, Minnesota.
FAU - Sriramarao, P
AU  - Sriramarao P
FAU - Cardona, Carol
AU  - Cardona C
FAU - Steer, Clifford J
AU  - Steer CJ
FAU - Kennedy, Shaun
AU  - Kennedy S
FAU - Sreevatsan, Srinand
AU  - Sreevatsan S
FAU - Murtaugh, Michael P
AU  - Murtaugh MP
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20141204
PL  - United States
TA  - Ann N Y Acad Sci
JT  - Annals of the New York Academy of Sciences
JID - 7506858
SB  - IM
MH  - Agriculture/*legislation & jurisprudence/trends
MH  - Animals
MH  - Communicable Diseases, Emerging/prevention & control
MH  - Congresses as Topic
MH  - Environment
MH  - Food Safety
MH  - *Global Health/legislation & jurisprudence
MH  - Humans
MH  - Population Growth
MH  - Public Health/legislation & jurisprudence
MH  - *Public Policy
PMC - PMC4383647
OTO - NOTNLM
OT  - One Medicine One Science
OT  - emerging infectious disease
OT  - food safety
OT  - food security
OT  - global health
OT  - iCOMOS
OT  - one health
EDAT- 2014/12/06 06:00
MHDA- 2015/03/07 06:00
CRDT- 2014/12/06 06:00
PHST- 2014/12/06 06:00 [entrez]
PHST- 2014/12/06 06:00 [pubmed]
PHST- 2015/03/07 06:00 [medline]
AID - 10.1111/nyas.12601 [doi]
PST - ppublish
SO  - Ann N Y Acad Sci. 2014 Dec;1334:26-44. doi: 10.1111/nyas.12601. Epub 2014 Dec 4.

PMID- 25462355
OWN - NLM
STAT- MEDLINE
DCOM- 20150306
LR  - 20191008
IS  - 1096-0341 (Electronic)
IS  - 0042-6822 (Linking)
VI  - 475
DP  - 2015 Jan 15
TI  - Comparative live bioluminescence imaging of monkeypox virus dissemination in awild-derived inbred mouse (Mus musculus castaneus) and outbred African dormouse(Graphiurus kelleni).
PG  - 150-8
LID - 10.1016/j.virol.2014.11.015 [doi]
LID - S0042-6822(14)00516-9 [pii]
AB  - Monkeypox virus belongs to the orthopoxvirus genus, infects rodents and monkeysin Africa, produces a smallpox-like zoonotic disease in humans, and has thepotential for global spread and exploitation for bioterrorism. Several smallanimal models for studying monkeypox virus pathogenesis have been investigated.The African dormouse is a candidate natural host but is outbred and noimmunological reagents exist. Although not a natural host, the CAST/EiJ mouse is inbred and animals and reagents are commercially available. We compared thedissemination of monkeypox virus by bioluminescence imaging in CAST/EiJ mice and dormice. In CAST/EiJ mice, intense replication occurred at the intranasal site ofinoculation and virus spread rapidly to lungs and abdominal organs, which had alower virus burden. Compared to CAST/EiJ mice, dormice exhibited a greatervariation of virus spread, a slower time course, less replication in the head andchest, and more replication in abdominal organs prior to death.
CI  - Published by Elsevier Inc.
FAU - Earl, Patricia L
AU  - Earl PL
AD  - Laboratory of Viral Diseases, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, Bethesda, MD 20892, United States.
FAU - Americo, Jeffrey L
AU  - Americo JL
AD  - Laboratory of Viral Diseases, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, Bethesda, MD 20892, United States.
FAU - Cotter, Catherine A
AU  - Cotter CA
AD  - Laboratory of Viral Diseases, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, Bethesda, MD 20892, United States.
FAU - Moss, Bernard
AU  - Moss B
AD  - Laboratory of Viral Diseases, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, Bethesda, MD 20892, United States.Electronic address: bmoss@nih.gov.
LA  - eng
GR  - ZIA AI000979-08/Intramural NIH HHS/United States
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, N.I.H., Intramural
DEP - 20141202
PL  - United States
TA  - Virology
JT  - Virology
JID - 0110674
SB  - IM
MH  - Animals
MH  - Female
MH  - Luminescent Measurements
MH  - Male
MH  - Mice
MH  - Mice, Inbred BALB C
MH  - *Mice, Inbred Strains
MH  - Monkeypox/*veterinary/virology
MH  - Monkeypox virus/*pathogenicity/*physiology
MH  - *Myoxidae
MH  - Tissue Distribution
MH  - Virulence
PMC - PMC4280325
MID - NIHMS646772
OTO - NOTNLM
OT  - Animal models
OT  - Monkeypox virus pathogenesis
OT  - Monkeypox virus virulence
OT  - Orthopoxviruses
OT  - Smallpox
EDAT- 2014/12/03 06:00
MHDA- 2015/03/07 06:00
CRDT- 2014/12/03 06:00
PHST- 2014/10/11 00:00 [received]
PHST- 2014/11/13 00:00 [revised]
PHST- 2014/11/14 00:00 [accepted]
PHST- 2014/12/03 06:00 [entrez]
PHST- 2014/12/03 06:00 [pubmed]
PHST- 2015/03/07 06:00 [medline]
AID - S0042-6822(14)00516-9 [pii]
AID - 10.1016/j.virol.2014.11.015 [doi]
PST - ppublish
SO  - Virology. 2015 Jan 15;475:150-8. doi: 10.1016/j.virol.2014.11.015. Epub 2014 Dec 2.

PMID- 25462353
OWN - NLM
STAT- MEDLINE
DCOM- 20150306
LR  - 20181113
IS  - 1096-0341 (Electronic)
IS  - 0042-6822 (Linking)
VI  - 475
DP  - 2015 Jan 15
TI  - Attenuation of monkeypox virus by deletion of genomic regions.
PG  - 129-38
LID - 10.1016/j.virol.2014.11.009 [doi]
LID - S0042-6822(14)00503-0 [pii]
AB  - Monkeypox virus (MPXV) is an emerging pathogen from Africa that causes diseasesimilar to smallpox. Two clades with different geographic distributions andvirulence have been described. Here, we utilized bioinformatic tools to identify genomic regions in MPXV containing multiple virulence genes and explored theirroles in pathogenicity; two selected regions were then deleted singularly or incombination. In vitro and in vivo studies indicated that these regions play asignificant role in MPXV replication, tissue spread, and mortality in mice.Interestingly, while deletion of either region led to decreased virulence inmice, one region had no effect on in vitro replication. Deletion of both regions simultaneously also reduced cell culture replication and significantly increased the attenuation in vivo over either single deletion. Attenuated MPXV with genomicdeletions present a safe and efficacious tool in the study of MPX pathogenesisand in the identification of genetic factors associated with virulence.
CI  - Copyright (c) 2014 Elsevier Inc. All rights reserved.
FAU - Lopera, Juan G
AU  - Lopera JG
AD  - Department of Pathobiological Sciences, School of Veterinary Medicine, Universityof Wisconsin, Madison, WI, USA. Electronic address: loperapena@wisc.edu.
FAU - Falendysz, Elizabeth A
AU  - Falendysz EA
AD  - National Wildlife Health Center, U.S. Geological Survey, Madison, WI, USA.
FAU - Rocke, Tonie E
AU  - Rocke TE
AD  - National Wildlife Health Center, U.S. Geological Survey, Madison, WI, USA.
FAU - Osorio, Jorge E
AU  - Osorio JE
AD  - Department of Pathobiological Sciences, School of Veterinary Medicine, Universityof Wisconsin, Madison, WI, USA. Electronic address: osorio@svm.vetmed.wisc.edu.
LA  - eng
GR  - U54 AI057153/AI/NIAID NIH HHS/United States
GR  - 1-U54-AI-057153/AI/NIAID NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20141201
PL  - United States
TA  - Virology
JT  - Virology
JID - 0110674
RN  - 0 (Antibodies, Viral)
SB  - IM
MH  - Animals
MH  - Antibodies, Viral
MH  - Cell Line
MH  - Female
MH  - Gene Expression Regulation, Viral
MH  - Humans
MH  - Mice
MH  - Mice, Inbred Strains
MH  - Monkeypox/immunology/metabolism/*virology
MH  - Monkeypox virus/*classification/genetics/pathogenicity
MH  - Mutation
MH  - Real-Time Polymerase Chain Reaction
MH  - Reassortant Viruses
MH  - Viral Plaque Assay
MH  - Virulence
MH  - Virus Replication/genetics/physiology
PMC - PMC4720520
MID - NIHMS646163
OTO - NOTNLM
OT  - In vivo bioluminescence imaging
OT  - Monkeypox virus
OT  - Monkeypox virus pathogenesis
OT  - Vaccinia virus
OT  - Variola virus
OT  - Viral replication
OT  - Virulence factors
EDAT- 2014/12/03 06:00
MHDA- 2015/03/07 06:00
CRDT- 2014/12/03 06:00
PHST- 2014/09/11 00:00 [received]
PHST- 2014/10/20 00:00 [revised]
PHST- 2014/11/03 00:00 [accepted]
PHST- 2014/12/03 06:00 [entrez]
PHST- 2014/12/03 06:00 [pubmed]
PHST- 2015/03/07 06:00 [medline]
AID - S0042-6822(14)00503-0 [pii]
AID - 10.1016/j.virol.2014.11.009 [doi]
PST - ppublish
SO  - Virology. 2015 Jan 15;475:129-38. doi: 10.1016/j.virol.2014.11.009. Epub 2014 Dec1.

PMID- 25456389
OWN - NLM
STAT- MEDLINE
DCOM- 20150803
LR  - 20191210
IS  - 1464-3391 (Electronic)
IS  - 0968-0896 (Linking)
VI  - 22
IP  - 24
DP  - 2014 Dec 15
TI  - Synthesis and antiviral activities of 3-deaza-3-fluoroaristeromycin and its 5'analogues.
PG  - 6961-4
LID - 10.1016/j.bmc.2014.10.014 [doi]
LID - S0968-0896(14)00727-5 [pii]
AB  - The naturally occurring adenine based carbocyclic nucleosides aristeromycin andneplanocin A and their 3-deaza analogues have found a prominent place in thesearch for diverse antiviral activity agent scaffolds because of their ability toinhibit S-adenosylhomocysteine (AdoHcy) hydrolase. Following the lead of thesecompounds, their 3-deaza-3-fluoroaristeromycin analogues have been synthesizedand their effect on S-adenosylhomocysteine hydrolase and RNA and DNA virusesdetermined.
CI  - Copyright (c) 2014 Elsevier Ltd. All rights reserved.
FAU - Chen, Qi
AU  - Chen Q
AD  - Molette Laboratory for Drug Discovery, Department of Chemistry and Biochemistry, Auburn University, Auburn, AL 36849-5312, United States.
FAU - Liu, Chong
AU  - Liu C
AD  - Molette Laboratory for Drug Discovery, Department of Chemistry and Biochemistry, Auburn University, Auburn, AL 36849-5312, United States.
FAU - Komazin, Gloria
AU  - Komazin G
AD  - Microbiotix, Inc., One Innovation Drive, Worcester, MA 01605, United States.
FAU - Bowlin, Terry L
AU  - Bowlin TL
AD  - Microbiotix, Inc., One Innovation Drive, Worcester, MA 01605, United States.
FAU - Schneller, Stewart W
AU  - Schneller SW
AD  - Molette Laboratory for Drug Discovery, Department of Chemistry and Biochemistry, Auburn University, Auburn, AL 36849-5312, United States. Electronic address:schnest@auburn.edu.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20141106
PL  - England
TA  - Bioorg Med Chem
JT  - Bioorganic & medicinal chemistry
JID - 9413298
RN  - 0 (Antiviral Agents)
RN  - 0 (Enzyme Inhibitors)
RN  - 979-92-0 (S-Adenosylhomocysteine)
RN  - EC 3.3.1.1 (Adenosylhomocysteinase)
SB  - IM
MH  - Adenosylhomocysteinase/antagonists & inhibitors/metabolism
MH  - Animals
MH  - Antiviral Agents/*chemical synthesis/chemistry/pharmacology
MH  - Cell Line
MH  - Chlorocebus aethiops
MH  - DNA Viruses/drug effects
MH  - Enzyme Inhibitors/chemical synthesis/chemistry
MH  - HEK293 Cells
MH  - Humans
MH  - RNA Viruses/drug effects
MH  - S-Adenosylhomocysteine/*analogs & derivatives/chemical synthesis/pharmacology
MH  - Vero Cells
OTO - NOTNLM
OT  - 3-Deazaaristeromycin
OT  - AdoHcy hydrolase
OT  - Carbocyclic nucleosides
OT  - Measles
OT  - Mitsunobu coupling
OT  - Monkeypox
EDAT- 2014/12/03 06:00
MHDA- 2015/08/04 06:00
CRDT- 2014/12/03 06:00
PHST- 2014/08/21 00:00 [received]
PHST- 2014/10/01 00:00 [revised]
PHST- 2014/10/12 00:00 [accepted]
PHST- 2014/12/03 06:00 [entrez]
PHST- 2014/12/03 06:00 [pubmed]
PHST- 2015/08/04 06:00 [medline]
AID - S0968-0896(14)00727-5 [pii]
AID - 10.1016/j.bmc.2014.10.014 [doi]
PST - ppublish
SO  - Bioorg Med Chem. 2014 Dec 15;22(24):6961-4. doi: 10.1016/j.bmc.2014.10.014. Epub 2014 Nov 6.

PMID- 25356657
OWN - NLM
STAT- MEDLINE
DCOM- 20160426
LR  - 20220129
IS  - 1553-7374 (Electronic)
IS  - 1553-7366 (Linking)
VI  - 10
IP  - 10
DP  - 2014 Oct
TI  - Detecting differential transmissibilities that affect the size of self-limitedoutbreaks.
PG  - e1004452
LID - 10.1371/journal.ppat.1004452 [doi]
AB  - Our ability to respond appropriately to infectious diseases is enhanced byidentifying differences in the potential for transmitting infection betweenindividuals. Here, we identify epidemiological traits of self-limited infections (i.e. infections with an effective reproduction number satisfying [0 < R eff < 1)that correlate with transmissibility. Our analysis is based on a branchingprocess model that permits statistical comparison of both the strength andheterogeneity of transmission for two distinct types of cases. Our approachprovides insight into a variety of scenarios, including the transmission ofMiddle East Respiratory Syndrome Coronavirus (MERS-CoV) in the Arabian peninsula,measles in North America, pre-eradication smallpox in Europe, and human monkeypoxin the Democratic Republic of the Congo. When applied to chain size data forMERS-CoV transmission before 2014, our method indicates that despite an apparent trend towards improved control, there is not enough statistical evidence toindicate that R eff has declined with time. Meanwhile, chain size data formeasles in the United States and Canada reveal statistically significantgeographic variation in R eff, suggesting that the timing and coverage ofnational vaccination programs, as well as contact tracing procedures, may shapethe size distribution of observed infection clusters. Infection source data forsmallpox suggests that primary cases transmitted more than secondary cases, andprovides a quantitative assessment of the effectiveness of control interventions.Human monkeypox, on the other hand, does not show evidence of differentialtransmission between animals in contact with humans, primary cases, or secondary cases, which assuages the concern that social mixing can amplify transmission by secondary cases. Lastly, we evaluate surveillance requirements for detecting achange in the human-to-human transmission of monkeypox since the cessation ofcross-protective smallpox vaccination. Our studies lay the foundation for future investigations regarding how infection source, vaccination status or otherputative transmissibility traits may affect self-limited transmission.
FAU - Blumberg, Seth
AU  - Blumberg S
AD  - Francis I. Proctor Foundation, University of California San Francisco, SanFrancisco, California, United States of America; Fogarty International Center,National Institutes of Health, Bethesda, Maryland, United States of America.
FAU - Funk, Sebastian
AU  - Funk S
AD  - Centre for the Mathematical Modelling of Infectious Diseases, London School ofHygiene & Tropical Medicine, London, United Kingdom; Ecology and EvolutionaryBiology, Princeton University, Princeton, New Jersey, United States of America.
FAU - Pulliam, Juliet R C
AU  - Pulliam JR
AD  - Fogarty International Center, National Institutes of Health, Bethesda, Maryland, United States of America; Department of Biology, University of Florida,Gainesville, Florida, United States of America; Emerging Pathogens Institute,University of Florida, Gainesville, Florida, United States of America.
LA  - eng
GR  - MR/K021680/1/MRC_/Medical Research Council/United Kingdom
GR  - U01 GM087728/GM/NIGMS NIH HHS/United States
GR  - 1-U01-GM087728/GM/NIGMS NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20141030
PL  - United States
TA  - PLoS Pathog
JT  - PLoS pathogens
JID - 101238921
SB  - IM
MH  - Coronavirus Infections/*epidemiology/prevention & control/transmission
MH  - Democratic Republic of the Congo/epidemiology
MH  - *Disease Outbreaks
MH  - Europe/epidemiology
MH  - Humans
MH  - Measles/*epidemiology/prevention & control/transmission
MH  - Middle East/epidemiology
MH  - *Middle East Respiratory Syndrome Coronavirus
MH  - Models, Biological
MH  - Monkeypox/*epidemiology/prevention & control/transmission
MH  - North America/epidemiology
MH  - Smallpox/*epidemiology/prevention & control/transmission
MH  - Stochastic Processes
MH  - Vaccination
PMC - PMC4214794
EDAT- 2014/10/31 06:00
MHDA- 2016/04/27 06:00
CRDT- 2014/10/31 06:00
PHST- 2014/01/26 00:00 [received]
PHST- 2014/09/04 00:00 [accepted]
PHST- 2014/10/31 06:00 [entrez]
PHST- 2014/10/31 06:00 [pubmed]
PHST- 2016/04/27 06:00 [medline]
AID - 10.1371/journal.ppat.1004452 [doi]
AID - PPATHOGENS-D-14-00229 [pii]
PST - epublish
SO  - PLoS Pathog. 2014 Oct 30;10(10):e1004452. doi: 10.1371/journal.ppat.1004452.eCollection 2014 Oct.

PMID- 25319753
OWN - NLM
STAT- MEDLINE
DCOM- 20150330
LR  - 20220316
IS  - 1465-2099 (Electronic)
IS  - 0022-1317 (Linking)
VI  - 96
IP  - Pt 2
DP  - 2015 Feb
TI  - Orthopoxvirus infection among wildlife in Zambia.
PG  - 390-394
LID - 10.1099/vir.0.070219-0 [doi]
AB  - Human monkeypox is a viral zoonosis caused by monkeypox virus, an orthopoxvirus(OPXV). The majority of human monkeypox cases have been reported in moistforested regions in West and Central Africa, particularly in the DemocraticRepublic of the Congo (DRC). In this study we investigated zoonotic OPXVinfection among wild animals in Zambia, which shares a border with DRC, to assessthe geographical distribution of OPXV. We screened for OPXV antibodies in serafrom non-human primates (NHPs), rodents and shrews by ELISA, and performedreal-time PCR to detect OPXV DNA in spleen samples. Serological analysisindicated that 38 of 259 (14.7 %) rodents, 14 of 42 (33.3 %) shrews and 4 of 188 (2.1 %) NHPs had antibodies against OPXV. The OPXV DNA could not be detected inspleens from any animals tested. Our results indicated that wild animals livingin rural human habitation areas of Zambia have been infected with OPXV.
CI  - (c) 2015 The Authors.
FAU - Orba, Yasuko
AU  - Orba Y
AD  - Division of Molecular Pathobiology, Research Center for Zoonosis Control,Hokkaido University, N20, W10, Kita-ku, Sapporo 001-0020, Japan.
FAU - Sasaki, Michihito
AU  - Sasaki M
AD  - Division of Molecular Pathobiology, Research Center for Zoonosis Control,Hokkaido University, N20, W10, Kita-ku, Sapporo 001-0020, Japan.
FAU - Yamaguchi, Hiroki
AU  - Yamaguchi H
AD  - Division of Molecular Pathobiology, Research Center for Zoonosis Control,Hokkaido University, N20, W10, Kita-ku, Sapporo 001-0020, Japan.
FAU - Ishii, Akihiro
AU  - Ishii A
AD  - Hokudai Center for Zoonosis Control in Zambia, PO Box 32379, Lusaka, Zambia.
FAU - Thomas, Yuka
AU  - Thomas Y
AD  - Hokudai Center for Zoonosis Control in Zambia, PO Box 32379, Lusaka, Zambia.
FAU - Ogawa, Hirohito
AU  - Ogawa H
AD  - Hokudai Center for Zoonosis Control in Zambia, PO Box 32379, Lusaka, Zambia.
FAU - Hang'ombe, Bernard M
AU  - Hang'ombe BM
AD  - Department of Paraclinical Studies, School of Veterinary Medicine, University of Zambia, PO Box 32379, Lusaka, Zambia.
FAU - Mweene, Aaron S
AU  - Mweene AS
AD  - Department of Disease Control, School of Veterinary Medicine, University ofZambia, PO Box 32379, Lusaka, Zambia.
FAU - Morikawa, Shigeru
AU  - Morikawa S
AD  - Department of Veterinary Science, National Institute of Infectious Diseases,1-23-1 Toyama, Shinjyuku-ku, Tokyo 162-8640, Japan.
FAU - Saijo, Masayuki
AU  - Saijo M
AD  - Department of Virology I, National Institute of Infectious Diseases, 1-23-1Toyama, Shinjyuku-ku, Tokyo 162-8640, Japan.
FAU - Sawa, Hirofumi
AU  - Sawa H
AD  - Global Institution for Collaborative Research and Education (GI-CoRE), HokkaidoUniversity, N20, W10, Kita-ku, Sapporo 001-0020, Japan.
AD  - Division of Molecular Pathobiology, Research Center for Zoonosis Control,Hokkaido University, N20, W10, Kita-ku, Sapporo 001-0020, Japan.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20141015
PL  - England
TA  - J Gen Virol
JT  - The Journal of general virology
JID - 0077340
RN  - 0 (Antibodies, Viral)
RN  - 0 (DNA, Viral)
SB  - IM
MH  - Animals
MH  - Animals, Wild
MH  - Antibodies, Viral/*blood
MH  - DNA, Viral/genetics/*isolation & purification
MH  - Enzyme-Linked Immunosorbent Assay
MH  - Orthopoxvirus/genetics/immunology/*isolation & purification
MH  - Polymerase Chain Reaction
MH  - Poxviridae Infections/epidemiology/*veterinary/virology
MH  - Primates
MH  - Rodentia
MH  - Seroepidemiologic Studies
MH  - Shrews
MH  - Spleen/virology
MH  - Topography, Medical
MH  - Zambia/epidemiology
MH  - Zoonoses/*epidemiology/virology
EDAT- 2014/10/17 06:00
MHDA- 2015/03/31 06:00
CRDT- 2014/10/17 06:00
PHST- 2014/10/17 06:00 [entrez]
PHST- 2014/10/17 06:00 [pubmed]
PHST- 2015/03/31 06:00 [medline]
AID - 10.1099/vir.0.070219-0 [doi]
PST - ppublish
SO  - J Gen Virol. 2015 Feb;96(Pt 2):390-394. doi: 10.1099/vir.0.070219-0. Epub 2014Oct 15.

PMID- 25311190
OWN - NLM
STAT- MEDLINE
DCOM- 20150701
LR  - 20160512
IS  - 1618-2650 (Electronic)
IS  - 1618-2642 (Linking)
VI  - 406
IP  - 29
DP  - 2014 Nov
TI  - Identification and characterization of a phage display-derived peptide fororthopoxvirus detection.
PG  - 7611-21
LID - 10.1007/s00216-014-8150-8 [doi]
AB  - Fast and reliable diagnostic assays are required for a resilient detection ofclinical infections or biothreat-relevant pathogens. While PCR has proven to bethe gold standard for nucleic acid detection, the identification of pathogenparticles is still challenging and depends on the availability ofwell-characterized, chemically stable, and selective recognition molecules. Here,we report the screening of a phage display random peptide library for vacciniavirus-binding peptides. The identified peptide was extensively characterizedusing peptide-probe ELISA, surface plasmon resonance, nLC-MS/MS, Western Blot,peptide-based immunofluorescence assay, and electron microscopy. Followingidentification, the phage-free, synthetic peptide, designated alphaVACVpep05, wasshown to bind to vaccinia virus and other orthopoxviruses. We can demonstratethat the highly conserved orthopoxvirus surface protein D8 is the interactionpartner of alphaVACVpep05, thus enabling the peptide to bind to otherorthopoxviruses, including cowpox virus and monkeypox virus, viruses that causeclinically relevant zoonotic infections in humans. The process of phagedisplay-mediated peptide identification has been optimized intensively, and weprovide recommendations for the identification of peptides suitable for thedetection of further pathogens. The peptide described here was criticallycharacterized and seems to be a promising reagent for the development ofdiagnostic platforms for orthopoxviruses. We believe that our results will helpto promote the development of alternative, nonantibody-based synthetic detection molecules for further pathogens.
FAU - Miller, Lilija
AU  - Miller L
AD  - Centre for Biological Threats and Special Pathogens, Highly Pathogenic Viruses,Robert Koch-Institut, Nordufer 20, 13353, Berlin, Germany.
FAU - Michel, Janine
AU  - Michel J
FAU - Vogt, Guido
AU  - Vogt G
FAU - Dollinger, Jorg
AU  - Dollinger J
FAU - Stern, Daniel
AU  - Stern D
FAU - Piesker, Janett
AU  - Piesker J
FAU - Nitsche, Andreas
AU  - Nitsche A
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20141014
PL  - Germany
TA  - Anal Bioanal Chem
JT  - Analytical and bioanalytical chemistry
JID - 101134327
RN  - 0 (Peptide Library)
RN  - 0 (Peptides)
RN  - 0 (Viral Proteins)
SB  - IM
MH  - Amino Acid Sequence
MH  - Molecular Sequence Data
MH  - Orthopoxvirus/*isolation & purification/*metabolism
MH  - *Peptide Library
MH  - Peptides/*chemistry/*metabolism
MH  - Protein Interaction Mapping/methods
MH  - Viral Proteins/*chemistry/*metabolism
EDAT- 2014/10/15 06:00
MHDA- 2015/07/02 06:00
CRDT- 2014/10/15 06:00
PHST- 2014/04/29 00:00 [received]
PHST- 2014/09/01 00:00 [accepted]
PHST- 2014/07/17 00:00 [revised]
PHST- 2014/10/15 06:00 [entrez]
PHST- 2014/10/15 06:00 [pubmed]
PHST- 2015/07/02 06:00 [medline]
AID - 10.1007/s00216-014-8150-8 [doi]
PST - ppublish
SO  - Anal Bioanal Chem. 2014 Nov;406(29):7611-21. doi: 10.1007/s00216-014-8150-8. Epub2014 Oct 14.

PMID- 25128688
OWN - NLM
STAT- MEDLINE
DCOM- 20150721
LR  - 20200316
IS  - 1872-9096 (Electronic)
IS  - 0166-3542 (Linking)
VI  - 111
DP  - 2014 Nov
TI  - Co-administration of the broad-spectrum antiviral, brincidofovir (CMX001), withsmallpox vaccine does not compromise vaccine protection in mice challenged withectromelia virus.
PG  - 42-52
LID - 10.1016/j.antiviral.2014.08.003 [doi]
LID - S0166-3542(14)00240-X [pii]
AB  - Natural orthopoxvirus outbreaks such as vaccinia, cowpox, cattlepox andbuffalopox continue to cause morbidity in the human population. Monkeypox virusremains a significant agent of morbidity and mortality in Africa. Furthermore,monkeypox virus's broad host-range and expanding environs make it of particularconcern as an emerging human pathogen. Monkeypox virus and variola virus (theetiological agent of smallpox) are both potential agents of bioterrorism. Thefirst line response to orthopoxvirus disease is through vaccination withfirst-generation and second-generation vaccines, such as Dryvax and ACAM2000.Although these vaccines provide excellent protection, their widespread use isimpeded by the high level of adverse events associated with vaccination usinglive, attenuated virus. It is possible that vaccines could be used in combinationwith antiviral drugs to reduce the incidence and severity of vaccine-associatedadverse events, or as a preventive in individuals with uncertain exposure status or contraindication to vaccination. We have used the intranasal mousepox(ectromelia) model to evaluate the efficacy of vaccination with Dryvax orACAM2000 in conjunction with treatment using the broad spectrum antiviral,brincidofovir (BCV, CMX001). We found that co-treatment with BCV reduced theseverity of vaccination-associated lesion development. Although the immuneresponse to vaccination was quantifiably attenuated, vaccination combined withBCV treatment did not alter the development of full protective immunity, evenwhen administered two days following ectromelia challenge. Studies with anon-replicating vaccine, ACAM3000 (MVA), confirmed that BCV's mechanism ofattenuating the immune response following vaccination with live virus was, asexpected, by limiting viral replication and not through inhibition of the immune system. These studies suggest that, in the setting of post-exposure prophylaxis, co-administration of BCV with vaccination should be considered a first responseto a smallpox emergency in subjects of uncertain exposure status or as a means ofreduction of the incidence and severity of vaccine-associated adverse events.
CI  - Copyright (c) 2014 Elsevier B.V. All rights reserved.
FAU - Parker, Scott
AU  - Parker S
AD  - Saint Louis University School of Medicine, 1100 S. Grand Blvd., St. Louis, MO63104, United States.
FAU - Crump, Ryan
AU  - Crump R
AD  - Saint Louis University School of Medicine, 1100 S. Grand Blvd., St. Louis, MO63104, United States.
FAU - Foster, Scott
AU  - Foster S
AD  - Chimerix Inc., 2505 Meridian Parkway, Suite 340, Durham, NC 27713, United States.
FAU - Hartzler, Hollyce
AU  - Hartzler H
AD  - Saint Louis University School of Medicine, 1100 S. Grand Blvd., St. Louis, MO63104, United States.
FAU - Hembrador, Ed
AU  - Hembrador E
AD  - Saint Louis University School of Medicine, 1100 S. Grand Blvd., St. Louis, MO63104, United States.
FAU - Lanier, E Randall
AU  - Lanier ER
AD  - Chimerix Inc., 2505 Meridian Parkway, Suite 340, Durham, NC 27713, United States.
FAU - Painter, George
AU  - Painter G
AD  - Chimerix Inc., 2505 Meridian Parkway, Suite 340, Durham, NC 27713, United States.
FAU - Schriewer, Jill
AU  - Schriewer J
AD  - Saint Louis University School of Medicine, 1100 S. Grand Blvd., St. Louis, MO63104, United States.
FAU - Trost, Lawrence C
AU  - Trost LC
AD  - Chimerix Inc., 2505 Meridian Parkway, Suite 340, Durham, NC 27713, United States.
FAU - Buller, R Mark
AU  - Buller RM
AD  - Saint Louis University School of Medicine, 1100 S. Grand Blvd., St. Louis, MO63104, United States. Electronic address: mark.buller@gmail.com.
LA  - eng
GR  - N01-AI-15436/AI/NIAID NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20140813
PL  - Netherlands
TA  - Antiviral Res
JT  - Antiviral research
JID - 8109699
RN  - 0 (Antiviral Agents)
RN  - 0 (Organophosphonates)
RN  - 0 (Smallpox Vaccine)
RN  - 6794O900AX (brincidofovir)
RN  - 8J337D1HZY (Cytosine)
SB  - IM
MH  - Animals
MH  - Antiviral Agents/*administration & dosage
MH  - Cytosine/administration & dosage/*analogs & derivatives
MH  - Ectromelia virus/immunology/*physiology
MH  - Ectromelia, Infectious/immunology/*prevention & control/virology
MH  - Female
MH  - Humans
MH  - Immunity
MH  - Mice
MH  - Mice, Inbred C57BL
MH  - Organophosphonates/*administration & dosage
MH  - Smallpox Vaccine/*administration & dosage/immunology
MH  - Vaccination
MH  - Virus Replication
OTO - NOTNLM
OT  - ACAM2000
OT  - ACAM3000
OT  - Cidofovir
OT  - Dryvax
OT  - MVA
OT  - Mousepox
EDAT- 2014/08/17 06:00
MHDA- 2015/07/22 06:00
CRDT- 2014/08/17 06:00
PHST- 2014/06/23 00:00 [received]
PHST- 2014/07/31 00:00 [revised]
PHST- 2014/08/04 00:00 [accepted]
PHST- 2014/08/17 06:00 [entrez]
PHST- 2014/08/17 06:00 [pubmed]
PHST- 2015/07/22 06:00 [medline]
AID - S0166-3542(14)00240-X [pii]
AID - 10.1016/j.antiviral.2014.08.003 [doi]
PST - ppublish
SO  - Antiviral Res. 2014 Nov;111:42-52. doi: 10.1016/j.antiviral.2014.08.003. Epub2014 Aug 13.

PMID- 25120821
OWN - NLM
STAT- MEDLINE
DCOM- 20150514
LR  - 20211021
IS  - 1936-2625 (Electronic)
IS  - 1936-2625 (Linking)
VI  - 7
IP  - 7
DP  - 2014
TI  - Pathogenesis of fulminant monkeypox with bacterial sepsis after experimentalinfection with West African monkeypox virus in a cynomolgus monkey.
PG  - 4359-70
AB  - The pathogenesis of severe human monkeypox, which causes systemic and fulminantinfections, is not clear. This study presents a case repot of fulminant monkeypoxwith bacterial sepsis after experimental infection with monkeypox virus in acynomolgus monkey (Macaca fascicularis). In our previous study (Saijo et al.,2009, J Gen Virol), two cynomolgus monkeys became moribund after experimentalinfection with monkeypox virus Liberia strain, West African strain. One exhibitedtypical monkeypox-related papulovesicular lesions. The other monkey presentedfulminant clinical symptoms with a characteristic flat red rash similar to thatfound in smallpox, which is associated with extremely high fatality rates. Inthis study, we found that the monkey with flat red rash had high levels ofviremia and neutropenia, as well as high plasma levels of pro-inflammatorycytokines and chemokines compared with the other monkey. Monkeypox virusreplicates in epithelial cells and macrophages in various organs. Sepsis due toGram-positive cocci was confirmed histopathologically in the monkey with flat redrash. The lack of inflammatory response in the lesion suggested that the monkeywith sepsis experienced strong immune suppression during the viral infection. Theneutropenia and excessive inflammatory cytokine responses indicate thatneutrophils play key roles in the pathogenesis of systemic and fulminant humanmonkeypox virus infections with sepsis.
FAU - Nagata, Noriyo
AU  - Nagata N
AD  - Department of Pathology, National Institute of Infectious Diseases 4-7-1 Gakuen, Musashimurayama, Tokyo 208-0011, Japan.
FAU - Saijo, Masayuki
AU  - Saijo M
AD  - Department of Virology 1, National Institute of Infectious Diseases 4-7-1 Gakuen,Musashimurayama, Tokyo 208-0011, Japan.
FAU - Kataoka, Michiyo
AU  - Kataoka M
AD  - Department of Pathology, National Institute of Infectious Diseases 4-7-1 Gakuen, Musashimurayama, Tokyo 208-0011, Japan.
FAU - Ami, Yasushi
AU  - Ami Y
AD  - Department of Division of Experimental Animals Research, National Institute ofInfectious Diseases 4-7-1 Gakuen, Musashimurayama, Tokyo 208-0011, Japan.
FAU - Suzaki, Yuriko
AU  - Suzaki Y
AD  - Department of Division of Experimental Animals Research, National Institute ofInfectious Diseases 4-7-1 Gakuen, Musashimurayama, Tokyo 208-0011, Japan.
FAU - Sato, Yuko
AU  - Sato Y
AD  - Department of Pathology, National Institute of Infectious Diseases 4-7-1 Gakuen, Musashimurayama, Tokyo 208-0011, Japan.
FAU - Iwata-Yoshikawa, Naoko
AU  - Iwata-Yoshikawa N
AD  - Department of Pathology, National Institute of Infectious Diseases 4-7-1 Gakuen, Musashimurayama, Tokyo 208-0011, Japan.
FAU - Ogata, Momoko
AU  - Ogata M
AD  - Department of Virology 1, National Institute of Infectious Diseases 4-7-1 Gakuen,Musashimurayama, Tokyo 208-0011, Japan.
FAU - Kurane, Ichiro
AU  - Kurane I
AD  - Department of Virology 1, National Institute of Infectious Diseases 4-7-1 Gakuen,Musashimurayama, Tokyo 208-0011, Japan.
FAU - Morikawa, Shigeru
AU  - Morikawa S
AD  - Department of Veterinary Science, National Institute of Infectious Diseases1-23-1 Toyama, Shinjuku-ku, Tokyo 162-8640, Japan.
FAU - Sata, Tetsutaro
AU  - Sata T
AD  - Department of Pathology, National Institute of Infectious Diseases 4-7-1 Gakuen, Musashimurayama, Tokyo 208-0011, Japan.
FAU - Hasegawa, Hideki
AU  - Hasegawa H
AD  - Department of Pathology, National Institute of Infectious Diseases 4-7-1 Gakuen, Musashimurayama, Tokyo 208-0011, Japan.
LA  - eng
PT  - Case Reports
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20140615
PL  - United States
TA  - Int J Clin Exp Pathol
JT  - International journal of clinical and experimental pathology
JID - 101480565
SB  - IM
MH  - Animals
MH  - Disease Models, Animal
MH  - Gram-Positive Bacterial Infections/*complications/immunology
MH  - Immunohistochemistry
MH  - Macaca fascicularis
MH  - Monkeypox/*immunology/*pathology/*veterinary
MH  - Monkeypox virus/pathogenicity
MH  - Neutropenia/immunology/veterinary/virology
MH  - Sepsis/*complications/immunology
PMC - PMC4129056
OTO - NOTNLM
OT  - Animal model
OT  - cynomolgus monkey
OT  - cytokine
OT  - monkeypox
OT  - neutropenia
EDAT- 2014/08/15 06:00
MHDA- 2015/05/15 06:00
CRDT- 2014/08/15 06:00
PHST- 2014/05/23 00:00 [received]
PHST- 2014/07/01 00:00 [accepted]
PHST- 2014/08/15 06:00 [entrez]
PHST- 2014/08/15 06:00 [pubmed]
PHST- 2015/05/15 06:00 [medline]
PST - epublish
SO  - Int J Clin Exp Pathol. 2014 Jun 15;7(7):4359-70. eCollection 2014.

PMID- 25108113
OWN - NLM
STAT- MEDLINE
DCOM- 20150110
LR  - 20171021
IS  - 1096-0341 (Electronic)
IS  - 0042-6822 (Linking)
VI  - 464-465
DP  - 2014 Sep
TI  - A highly specific monoclonal antibody against monkeypox virus detects the heparinbinding domain of A27.
PG  - 264-273
LID - S0042-6822(14)00322-5 [pii]
LID - 10.1016/j.virol.2014.06.039 [doi]
AB  - The eradication of smallpox and the cessation of global vaccination led to theincreased prevalence of human infections in Central Africa. Serologic andprotein-based diagnostic assay for MPXV detection is difficult due tocross-reactive antibodies that do not differentiate between diverse orthopoxvirus(OPXV) species. A previously characterized monoclonal antibody (mAb 69-126-3-7)against MPXV [1] was retested for cross-reactivity with various OPXVs. The 14.5kDa band protein that reacted with mAb 69-126-3 was identified to be MPXV A29protein (homolog of vaccinia virus Copenhagen A27). Amino acid sequence analysis of the MPXV A29 with other OPXV homologs identified four amino acid changes.Peptides corresponding to these regions were designed and evaluated for bindingto mAb 69-126-3 by ELISA and BioLayer Interferometry (BLI). Further refinementand truncations mapped the specificity of this antibody to a single amino aciddifference in a 30-mer peptide compared to other OPXV homologs. This particularresidue is proposed to be essential for heparin binding by VACV A27 protein.Despite this substitution, MPXV A29 bound to heparin with similar affinity tothat of VACV A27 protein, suggesting flexibility of this motif for heparinbinding. Although binding of mAb 69-126-3-7 to MPXV A29 prevented interactionwith heparin, it did not have any effect on the infectivity of MPXV.Characterization of 69-126-3-7 mAb antibody allows for the possibility of thegeneration of a serological based species-specific detection of OPXVs despitehigh proteomic homology.
CI  - Published by Elsevier Inc.
FAU - Hughes, Laura J
AU  - Hughes LJ
AD  - Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address:bkz2@cdc.gov.
FAU - Goldstein, Jason
AU  - Goldstein J
AD  - Centers for Disease Control and Prevention, Atlanta, GA, USA.
FAU - Pohl, Jan
AU  - Pohl J
AD  - Centers for Disease Control and Prevention, Atlanta, GA, USA.
FAU - Hooper, Jay W
AU  - Hooper JW
AD  - USAMRIID, Frederick, MD, USA.
FAU - Lee Pitts, R
AU  - Lee Pitts R
AD  - Centers for Disease Control and Prevention, Atlanta, GA, USA.
FAU - Townsend, Michael B
AU  - Townsend MB
AD  - Centers for Disease Control and Prevention, Atlanta, GA, USA.
FAU - Bagarozzi, Dennis
AU  - Bagarozzi D
AD  - Centers for Disease Control and Prevention, Atlanta, GA, USA.
FAU - Damon, Inger K
AU  - Damon IK
AD  - Centers for Disease Control and Prevention, Atlanta, GA, USA.
FAU - Karem, Kevin L
AU  - Karem KL
AD  - Centers for Disease Control and Prevention, Atlanta, GA, USA.
LA  - eng
PT  - Journal Article
PT  - Research Support, U.S. Gov't, Non-P.H.S.
PT  - Research Support, U.S. Gov't, P.H.S.
DEP - 20140809
PL  - United States
TA  - Virology
JT  - Virology
JID - 0110674
RN  - 0 (Antibodies, Monoclonal)
RN  - 0 (Antibodies, Viral)
RN  - 0 (Viral Proteins)
RN  - 9005-49-6 (Heparin)
SB  - IM
MH  - Amino Acid Sequence
MH  - Antibodies, Monoclonal/*immunology
MH  - Antibodies, Viral/*immunology
MH  - Cross Reactions
MH  - Heparin/*immunology
MH  - Humans
MH  - Molecular Sequence Data
MH  - Monkeypox/immunology/*virology
MH  - Monkeypox virus/chemistry/*immunology
MH  - Protein Structure, Tertiary
MH  - Sequence Alignment
MH  - Viral Proteins/chemistry/*immunology
OTO - NOTNLM
OT  - Antibody
OT  - Heparin binding
OT  - Monkeypox virus
OT  - Orthopoxvirus
OT  - Vaccinia virus
EDAT- 2014/08/12 06:00
MHDA- 2015/01/13 06:00
CRDT- 2014/08/10 06:00
PHST- 2014/04/22 00:00 [received]
PHST- 2014/06/10 00:00 [revised]
PHST- 2014/06/30 00:00 [accepted]
PHST- 2014/08/10 06:00 [entrez]
PHST- 2014/08/12 06:00 [pubmed]
PHST- 2015/01/13 06:00 [medline]
AID - S0042-6822(14)00322-5 [pii]
AID - 10.1016/j.virol.2014.06.039 [doi]
PST - ppublish
SO  - Virology. 2014 Sep;464-465:264-273. doi: 10.1016/j.virol.2014.06.039. Epub 2014Aug 9.

PMID- 25101435
STAT- Publisher
DA  - 20140808
PB  - National Academies Press (US)
DP  - 1999
BTI - Assessment of Future Scientific Needs for Live Variola Virus
AB  - In 1980, the World Health Organization (WHO) officially declared that smallpoxhad been eradicated. In 1986, WHO's international Ad Hoc Committee on OrthopoxVirus Infections unanimously recommended destruction of the two remainingofficial stocks of variola virus, one at the Centers for Disease Control andPrevention and the other at the VECTOR laboratory in Siberia. In June 1999, WHOdecided to delay the destruction of these stocks. Informing that decision wasAssessment of Future Scientific Needs for Variola Virus, which examines: --Whether the sequenced variola genome, vaccinia, and monkey pox virus are adequatefor future research or whether the live variola virus itself is needed to assist in the development of antiviral therapies. -- What further benefits, if any,would likely be gained through the use of variola in research and developmentefforts related to agent detection, diagnosis, prevention, and treatment. -- Whatunique potential benefits, if any, the study of variola would have in increasing our fundamental understanding of the biology, host-agent interactions,pathogenesis, and immune mechanisms of viral diseases.
CI  - Copyright 1999 by the National Academy of Sciences. All rights reserved.
CN  - Institute of Medicine (US) Committee on the Assessment of Future Scientific Needsfor Live Variola Virus
LA  - eng
PT  - Review
PT  - Book
PL  - Washington (DC)
EDAT- 2014/08/08 06:00
MHDA- 2014/08/08 06:00
CDAT- 2014/08/08 06:00
AID - NBK230919 [bookaccession]
AID - 10.17226/6445 [doi]

PMID- 25100640
OWN - NLM
STAT- MEDLINE
DCOM- 20150707
LR  - 20141107
IS  - 1572-8773 (Electronic)
IS  - 0966-0844 (Linking)
VI  - 27
IP  - 6
DP  - 2014 Dec
TI  - Inactivation of bacterial and viral biothreat agents on metallic copper surfaces.
PG  - 1179-89
LID - 10.1007/s10534-014-9781-0 [doi]
AB  - In recent years several studies in laboratory settings and in hospitalenvironments have demonstrated that surfaces of massive metallic copper haveintrinsic antibacterial and antiviral properties. Microbes are rapidlyinactivated by a quick, sharp shock known as contact killing. The underlyingmechanism is not yet fully understood; however, in this process the cytoplasmicmembrane is severely damaged. Pathogenic bacterial and viral high-consequencespecies able to evade the host immune system are among the most serious lethalmicrobial challenges to human health. Here, we investigated contact-killingmediated by copper surfaces of Gram-negative bacteria (Brucella melitensis,Burkholderia mallei, Burkholderia pseudomallei, Francisella tularensis tularensisand Yersinia pestis) and of Gram-positive endospore-forming Bacillus anthracis.Additionally, we also tested inactivation of monkeypox virus and vaccinia viruson copper. This group of pathogens comprises biothreat species (or their closerelatives) classified by the Center for Disease and Control and Prevention (CDC) as microbial select agents posing severe threats to public health and having the potential to be deliberately released. All agents were rapidly inactivated oncopper between 30 s and 5 min with the exception of B. anthracis endospores. For vegetative bacterial cells prolonged contact to metallic copper resulted in thedestruction of cell structure.
FAU - Bleichert, Pauline
AU  - Bleichert P
AD  - Bundeswehr Institute of Microbiology, Munich, Germany.
FAU - Espirito Santo, Christophe
AU  - Espirito Santo C
FAU - Hanczaruk, Matthias
AU  - Hanczaruk M
FAU - Meyer, Hermann
AU  - Meyer H
FAU - Grass, Gregor
AU  - Grass G
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20140807
PL  - Netherlands
TA  - Biometals
JT  - Biometals : an international journal on the role of metal ions in biology,biochemistry, and medicine
JID - 9208478
RN  - 789U1901C5 (Copper)
SB  - IM
MH  - Bacillus anthracis/drug effects/growth & development
MH  - Bacteriolysis/*drug effects
MH  - *Bioterrorism
MH  - Cell Membrane/drug effects
MH  - Copper/*pharmacology
MH  - Gram-Negative Bacteria/*drug effects
MH  - Gram-Positive Bacteria/*drug effects
MH  - Monkeypox virus/*drug effects
MH  - Spores, Bacterial/drug effects
MH  - Vaccinia virus/*drug effects
MH  - Virulence
MH  - Virus Inactivation/*drug effects
EDAT- 2014/08/08 06:00
MHDA- 2015/07/08 06:00
CRDT- 2014/08/08 06:00
PHST- 2014/07/01 00:00 [received]
PHST- 2014/07/27 00:00 [accepted]
PHST- 2014/08/08 06:00 [entrez]
PHST- 2014/08/08 06:00 [pubmed]
PHST- 2015/07/08 06:00 [medline]
AID - 10.1007/s10534-014-9781-0 [doi]
PST - ppublish
SO  - Biometals. 2014 Dec;27(6):1179-89. doi: 10.1007/s10534-014-9781-0. Epub 2014 Aug 7.

PMID- 24943381
OWN - NLM
STAT- MEDLINE
DCOM- 20150416
LR  - 20211021
IS  - 1556-679X (Electronic)
IS  - 1556-679X (Linking)
VI  - 21
IP  - 8
DP  - 2014 Aug
TI  - Matched longitudinal analysis of biomarkers associated with survival.
PG  - 1145-52
LID - 10.1128/CVI.00252-14 [doi]
AB  - The identification of host or pathogen factors linked to clinical outcome is acommon goal in many animal studies of infectious diseases. When the disease isfatal, statistical analysis of such factors may be biased from missingobservations due to deaths. For example, when observations of a subject arecensored before completing the intended study period, the complete trajectorywill not be observed. Even if the factor is not associated with outcome,comparisons of data from survivors with those from nonsurvivors may lead to thewrong conclusions regarding associations with survival. Comparisons betweensubjects must account for differing observation lengths for those who surviverelative to those who do not. Analyzing data over an interval common to allsubjects provides one solution but requires eliminating data, some of which maybe informative about the differences between groups. Here, we present a novelapproach, matched longitudinal analysis (MLA), for analyzing such data based onmatching biomarker intervals for survivors and nonsurvivors. We describe theresults from simulation studies and from a study of monkeypox virus infection in nonhuman primates. In our application, MLA identified low monocytechemoattractant protein-1 (MCP-1) levels as having a statistically significantassociation with survival, whereas the alternative methods did not identify anassociation. The method has general application to longitudinal studies that seekto find associations of biomarker changes with survival.
CI  - Copyright (c) 2014, American Society for Microbiology. All Rights Reserved.
FAU - Dodd, Lori E
AU  - Dodd LE
AD  - Biostatistics Research Branch, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, Bethesda, Maryland, USAdoddl@mail.nih.gov.
FAU - Johnson, Reed F
AU  - Johnson RF
AD  - Emerging Viral Pathogens Section, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, Bethesda, Maryland, USA.
FAU - Blaney, Joseph E
AU  - Blaney JE
AD  - Emerging Viral Pathogens Section, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, Bethesda, Maryland, USA.
FAU - Follmann, Dean
AU  - Follmann D
AD  - Biostatistics Research Branch, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, Bethesda, Maryland, USA.
LA  - eng
GR  - Intramural NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Intramural
DEP - 20140618
PL  - United States
TA  - Clin Vaccine Immunol
JT  - Clinical and vaccine immunology : CVI
JID - 101252125
RN  - 0 (Biomarkers)
RN  - 0 (Chemokine CCL2)
SB  - IM
MH  - Animals
MH  - Biomarkers
MH  - Chemokine CCL2/*blood
MH  - Host-Pathogen Interactions
MH  - Macaca fascicularis
MH  - Matched-Pair Analysis
MH  - Monkeypox virus/*immunology
MH  - Poxviridae Infections/immunology/*mortality/virology
PMC - PMC4135908
EDAT- 2014/06/20 06:00
MHDA- 2015/04/17 06:00
CRDT- 2014/06/20 06:00
PHST- 2014/06/20 06:00 [entrez]
PHST- 2014/06/20 06:00 [pubmed]
PHST- 2015/04/17 06:00 [medline]
AID - CVI.00252-14 [pii]
AID - 10.1128/CVI.00252-14 [doi]
PST - ppublish
SO  - Clin Vaccine Immunol. 2014 Aug;21(8):1145-52. doi: 10.1128/CVI.00252-14. Epub2014 Jun 18.

PMID- 24894622
OWN - NLM
STAT- MEDLINE
DCOM- 20150330
LR  - 20211021
IS  - 1940-087X (Electronic)
IS  - 1940-087X (Linking)
IP  - 87
DP  - 2014 May 15
TI  - Vaccinia reporter viruses for quantifying viral function at all stages of geneexpression.
LID - 10.3791/51522 [doi]
AB  - Poxviruses are a family of double stranded DNA viruses that include active human pathogens such as monkeypox, molluscum contagiousum, and Contagalo virus. Thefamily also includes the smallpox virus, Variola. Due to the complexity ofpoxvirus replication, many questions still remain regarding their gene expressionstrategy. In this article we describe the conceptualization and usage ofrecombinant vaccinia viruses that enable real-time measurement of single andmultiple stages of viral gene expression in a high-throughput format. This isenabled through the use of spectrally distinct fluorescent proteins as reporters for each of three stages of viral replication. These viruses provide a highsignal-to-noise ratio while retaining stage specific expression patterns,enabling plate-based assays and microscopic observations of virus propagation andreplication. These tools have uses for antiviral discovery, studies of thevirus-host interaction, and evolutionary biology.
FAU - Rozelle, Daniel K
AU  - Rozelle DK
AD  - Department of Microbiology, Boston University School of Medicine.
FAU - Filone, Claire Marie
AU  - Filone CM
AD  - Department of Microbiology, Boston University School of Medicine.
FAU - Dower, Ken
AU  - Dower K
AD  - Department of Microbiology, Boston University School of Medicine.
FAU - Connor, John H
AU  - Connor JH
AD  - Department of Microbiology, Boston University School of Medicine;jhconnor@bu.edu.
LA  - eng
GR  - T32 AI007309/AI/NIAID NIH HHS/United States
GR  - P41 086180/PHS HHS/United States
GR  - R01AI1096159-01/AI/NIAID NIH HHS/United States
GR  - 5T32AI 7309/AI/NIAID NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Video-Audio Media
DEP - 20140515
PL  - United States
TA  - J Vis Exp
JT  - Journal of visualized experiments : JoVE
JID - 101313252
SB  - IM
MH  - Gene Expression
MH  - *Gene Expression Regulation, Viral
MH  - Genes, Reporter
MH  - HeLa Cells
MH  - Humans
MH  - Vaccinia virus/genetics/pathogenicity/*physiology
MH  - Virus Replication
PMC - PMC4188345
EDAT- 2014/06/05 06:00
MHDA- 2015/03/31 06:00
CRDT- 2014/06/05 06:00
PHST- 2014/06/05 06:00 [entrez]
PHST- 2014/06/05 06:00 [pubmed]
PHST- 2015/03/31 06:00 [medline]
AID - 10.3791/51522 [doi]
PST - epublish
SO  - J Vis Exp. 2014 May 15;(87). doi: 10.3791/51522.

PMID- 24857667
OWN - NLM
STAT- MEDLINE
DCOM- 20150106
LR  - 20211021
IS  - 1080-6059 (Electronic)
IS  - 1080-6040 (Linking)
VI  - 20
IP  - 6
DP  - 2014 Jun
TI  - Fatal monkeypox in wild-living sooty mangabey, Cote d'Ivoire, 2012.
PG  - 1009-11
LID - 10.3201/eid2006.13-1329 [doi]
AB  - We isolated a monkeypox virus from a wild-living monkey, a sooty mangabey, found dead in Tai National Park, Cote d'Ivoire, in March 2012. The whole-genomesequence obtained from this isolate and directly from clinical specimens showedits close relationship to monkeypox viruses from Western Africa.
FAU - Radonic, Aleksandar
AU  - Radonic A
FAU - Metzger, Sonja
AU  - Metzger S
FAU - Dabrowski, Piotr Wojtek
AU  - Dabrowski PW
FAU - Couacy-Hymann, Emmanuel
AU  - Couacy-Hymann E
FAU - Schuenadel, Livia
AU  - Schuenadel L
FAU - Kurth, Andreas
AU  - Kurth A
FAU - Matz-Rensing, Kerstin
AU  - Matz-Rensing K
FAU - Boesch, Christophe
AU  - Boesch C
FAU - Leendertz, Fabian H
AU  - Leendertz FH
FAU - Nitsche, Andreas
AU  - Nitsche A
LA  - eng
PT  - Case Reports
PT  - Journal Article
PL  - United States
TA  - Emerg Infect Dis
JT  - Emerging infectious diseases
JID - 9508155
SB  - IM
MH  - Animals
MH  - Animals, Newborn
MH  - Cercocebus atys/*virology
MH  - Cote d'Ivoire
MH  - Fatal Outcome
MH  - *Genome, Viral
MH  - High-Throughput Nucleotide Sequencing
MH  - Monkeypox/*virology
MH  - Monkeypox virus/classification/*genetics/isolation & purification
MH  - *Phylogeny
MH  - Phylogeography
PMC - PMC4036778
OTO - NOTNLM
OT  - Cote d'Ivoire
OT  - Poxvirus
OT  - Tai National Park
OT  - monkeypox virus
OT  - viruses
OT  - zoonoses
EDAT- 2014/05/27 06:00
MHDA- 2015/01/07 06:00
CRDT- 2014/05/27 06:00
PHST- 2014/05/27 06:00 [entrez]
PHST- 2014/05/27 06:00 [pubmed]
PHST- 2015/01/07 06:00 [medline]
AID - 10.3201/eid2006.13-1329 [doi]
PST - ppublish
SO  - Emerg Infect Dis. 2014 Jun;20(6):1009-11. doi: 10.3201/eid2006.13-1329.

PMID- 24841633
OWN - NLM
STAT- MEDLINE
DCOM- 20141231
LR  - 20211021
IS  - 1932-6203 (Electronic)
IS  - 1932-6203 (Linking)
VI  - 9
IP  - 5
DP  - 2014
TI  - Simple technique for in field samples collection in the cases of skin rashillness and subsequent PCR detection of orthopoxviruses and varicella zostervirus.
PG  - e96930
LID - 10.1371/journal.pone.0096930 [doi]
AB  - BACKGROUND: In case of outbreak of rash illness in remote areas, clinicallydiscriminating monkeypox (MPX) from severe form of chickenpox and from smallpoxremains a concern for first responders. OBJECTIVE: The goal of the study wastherefore to use MPX and chickenpox outbreaks in Democratic Republic of Congo(DRC) as a test case for establishing a rapid and specific diagnosis in affected remote areas. METHODS: In 2008 and 2009, successive outbreaks of presumed MPXskin rash were reported in Bena Tshiadi, Yangala and Ndesha healthcare districts of the West Kasai province (DRC). Specimens consisting of liquid vesicle dried onfilter papers or crusted scabs from healing patients were sampled by firstresponders. A field analytical facility was deployed nearby in order to carry outa real-time PCR (qPCR) assay using genus consensus primers, consensusorthopoxvirus (OPV) and smallpox-specific probes spanning over the 14 kD fusionprotein encoding gene. A PCR-restriction fragment length polymorphism was usedon-site as backup method to confirm the presence of monkeypox virus (MPXV) insamples. To complete the differential diagnosis of skin rash, chickenpox wastested in parallel using a commercial qPCR assay. In a post-deployment step, aMPXV-specific pyrosequencing was carried out on all biotinylated ampliconsgenerated on-site in order to confirm the on-site results. RESULTS: Whereas MPXV proved to be the agent causing the rash illness outbreak in the Bena Tshiadi, VZVwas the causative agent of the disease in Yangala and Ndesha districts. Inaddition, each on-site result was later confirmed by MPXV-specific pyrosequencinganalysis without any discrepancy. CONCLUSION: This experience of rapid on-sitedual use DNA-based differential diagnosis of rash illnesses demonstrates thepotential of combining tests specifically identifying bioterrorism agents andagents causing natural outbreaks. This opens the way to rapid on-site DNA-basedidentification of a broad spectrum of causative agents in remote areas.
FAU - Dumont, Catherine
AU  - Dumont C
AD  - Royal Military Academy, Bruxelles, Belgium; Center for Applied MolecularTechnologies, Institut de Recherche Experimentale et Clinique, Universitecatholique de Louvain, Brussels, Belgium.
FAU - Irenge, Leonid M
AU  - Irenge LM
AD  - Defense Laboratories Department, ACOS Ops&Trg, Belgian Armed Forces, Peutie,Belgium; Center for Applied Molecular Technologies, Institut de RechercheExperimentale et Clinique, Universite catholique de Louvain, Brussels, Belgium.
FAU - Magazani, Edmond K
AU  - Magazani EK
AD  - Ministere de la Sante Publique, Gombe, Republique Democratique du Congo.
FAU - Garin, Daniel
AU  - Garin D
AD  - IRBA, Institut de Recherches Biomedicales des Armees, Service de Sante desArmees, Bretigny-sur-Orge, Cedex, France.
FAU - Muyembe, Jean-Jacques T
AU  - Muyembe JJ
AD  - Laboratoire National de Sante Publique, Institut National de RechercheBiomedicale, Kinshasa, Democratic Republic of Congo.
FAU - Bentahir, Mostafa
AU  - Bentahir M
AD  - Defense Laboratories Department, ACOS Ops&Trg, Belgian Armed Forces, Peutie,Belgium; Center for Applied Molecular Technologies, Institut de RechercheExperimentale et Clinique, Universite catholique de Louvain, Brussels, Belgium.
FAU - Gala, Jean-Luc
AU  - Gala JL
AD  - Defense Laboratories Department, ACOS Ops&Trg, Belgian Armed Forces, Peutie,Belgium; Center for Applied Molecular Technologies, Institut de RechercheExperimentale et Clinique, Universite catholique de Louvain, Brussels, Belgium.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20140519
PL  - United States
TA  - PLoS One
JT  - PloS one
JID - 101285081
RN  - 0 (DNA, Viral)
SB  - IM
MH  - Chickenpox/virology
MH  - DNA, Viral/genetics
MH  - Exanthema/*virology
MH  - Herpesvirus 3, Human/*genetics/pathogenicity
MH  - Humans
MH  - Monkeypox virus/*genetics/pathogenicity
MH  - Orthopoxvirus/*genetics/pathogenicity
MH  - Polymerase Chain Reaction/methods
MH  - Variola virus/genetics/pathogenicity
PMC - PMC4026132
EDAT- 2014/05/21 06:00
MHDA- 2015/01/01 06:00
CRDT- 2014/05/21 06:00
PHST- 2013/12/16 00:00 [received]
PHST- 2014/04/13 00:00 [accepted]
PHST- 2014/05/21 06:00 [entrez]
PHST- 2014/05/21 06:00 [pubmed]
PHST- 2015/01/01 06:00 [medline]
AID - 10.1371/journal.pone.0096930 [doi]
AID - PONE-D-13-53021 [pii]
PST - epublish
SO  - PLoS One. 2014 May 19;9(5):e96930. doi: 10.1371/journal.pone.0096930. eCollection2014.

PMID- 24832205
OWN - NLM
STAT- MEDLINE
DCOM- 20150615
LR  - 20211021
IS  - 1553-7374 (Electronic)
IS  - 1553-7366 (Linking)
VI  - 10
IP  - 5
DP  - 2014 May
TI  - T cell inactivation by poxviral B22 family proteins increases viral virulence.
PG  - e1004123
LID - 10.1371/journal.ppat.1004123 [doi]
AB  - Infections with monkeypox, cowpox and weaponized variola virus remain a threat tothe increasingly unvaccinated human population, but little is known about theirmechanisms of virulence and immune evasion. We now demonstrate that B22 proteins,encoded by the largest genes of these viruses, render human T cells unresponsive to stimulation of the T cell receptor by MHC-dependent antigen presentation or byMHC-independent stimulation. In contrast, stimuli that bypass TCR-signaling arenot inhibited. In a non-human primate model of monkeypox, virus lacking the B22R homologue (MPXVDelta197) caused only mild disease with lower viremia andcutaneous pox lesions compared to wild type MPXV which caused high viremia,morbidity and mortality. Since MPXVDelta197-infected animals displayedaccelerated T cell responses and less T cell dysregulation than MPXV US2003, weconclude that B22 family proteins cause viral virulence by suppressing T cellcontrol of viral dissemination.
FAU - Alzhanova, Dina
AU  - Alzhanova D
AD  - Vaccine and Gene Therapy Institute, Oregon National Primate Research Center,Portland, Oregon, United States of America.
FAU - Hammarlund, Erika
AU  - Hammarlund E
AD  - Division of Neuroscience, Oregon National Primate Research Center, Portland,Oregon, United States of America.
FAU - Reed, Jason
AU  - Reed J
AD  - Vaccine and Gene Therapy Institute, Oregon National Primate Research Center,Portland, Oregon, United States of America.
FAU - Meermeier, Erin
AU  - Meermeier E
AD  - Department of Pulmonary and Critical Care Medicine, Oregon Health & ScienceUniversity, Portland, Oregon, United States of America; Portland VeteransAdministration Medical Center, Portland, Oregon, United States of America.
FAU - Rawlings, Stephanie
AU  - Rawlings S
AD  - Vaccine and Gene Therapy Institute, Oregon National Primate Research Center,Portland, Oregon, United States of America.
FAU - Ray, Caroline A
AU  - Ray CA
AD  - Department of Molecular Genetics and Microbiology, Duke University MedicalCenter, Durham, North Carolina, United States of America.
FAU - Edwards, David M
AU  - Edwards DM
AD  - Vaccine and Gene Therapy Institute, Oregon National Primate Research Center,Portland, Oregon, United States of America.
FAU - Bimber, Ben
AU  - Bimber B
AD  - Division of Pathobiology and Immunology, Oregon National Primate Research Center,Portland, Oregon, United States of America.
FAU - Legasse, Alfred
AU  - Legasse A
AD  - Division of Pathobiology and Immunology, Oregon National Primate Research Center,Portland, Oregon, United States of America.
FAU - Planer, Shannon
AU  - Planer S
AD  - Division of Pathobiology and Immunology, Oregon National Primate Research Center,Portland, Oregon, United States of America.
FAU - Sprague, Jerald
AU  - Sprague J
AD  - Vaccine and Gene Therapy Institute, Oregon National Primate Research Center,Portland, Oregon, United States of America.
FAU - Axthelm, Michael K
AU  - Axthelm MK
AD  - Vaccine and Gene Therapy Institute, Oregon National Primate Research Center,Portland, Oregon, United States of America; Division of Pathobiology andImmunology, Oregon National Primate Research Center, Portland, Oregon, UnitedStates of America.
FAU - Pickup, David J
AU  - Pickup DJ
AD  - Department of Molecular Genetics and Microbiology, Duke University MedicalCenter, Durham, North Carolina, United States of America.
FAU - Lewinsohn, David M
AU  - Lewinsohn DM
AD  - Department of Pulmonary and Critical Care Medicine, Oregon Health & ScienceUniversity, Portland, Oregon, United States of America; Portland VeteransAdministration Medical Center, Portland, Oregon, United States of America.
FAU - Gold, Marielle C
AU  - Gold MC
AD  - Department of Pulmonary and Critical Care Medicine, Oregon Health & ScienceUniversity, Portland, Oregon, United States of America; Portland VeteransAdministration Medical Center, Portland, Oregon, United States of America.
FAU - Wong, Scott W
AU  - Wong SW
AD  - Vaccine and Gene Therapy Institute, Oregon National Primate Research Center,Portland, Oregon, United States of America; Division of Pathobiology andImmunology, Oregon National Primate Research Center, Portland, Oregon, UnitedStates of America.
FAU - Sacha, Jonah B
AU  - Sacha JB
AD  - Vaccine and Gene Therapy Institute, Oregon National Primate Research Center,Portland, Oregon, United States of America; Division of Pathobiology andImmunology, Oregon National Primate Research Center, Portland, Oregon, UnitedStates of America.
FAU - Slifka, Mark K
AU  - Slifka MK
AD  - Division of Neuroscience, Oregon National Primate Research Center, Portland,Oregon, United States of America.
FAU - Fruh, Klaus
AU  - Fruh K
AD  - Vaccine and Gene Therapy Institute, Oregon National Primate Research Center,Portland, Oregon, United States of America; Division of Pathobiology andImmunology, Oregon National Primate Research Center, Portland, Oregon, UnitedStates of America.
LA  - eng
GR  - P51 OD011092/OD/NIH HHS/United States
GR  - R01 AI048090/AI/NIAID NIH HHS/United States
GR  - R01 AI078965/AI/NIAID NIH HHS/United States
GR  - U42 OD010426/OD/NIH HHS/United States
GR  - U19AI109948/AI/NIAID NIH HHS/United States
GR  - T32 HL083808/HL/NHLBI NIH HHS/United States
GR  - U19 AI109948/AI/NIAID NIH HHS/United States
GR  - P51OD011092/OD/NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20140515
PL  - United States
TA  - PLoS Pathog
JT  - PLoS pathogens
JID - 101238921
RN  - 0 (Viral Proteins)
SB  - IM
MH  - Animals
MH  - CHO Cells
MH  - Cells, Cultured
MH  - Chlorocebus aethiops
MH  - Cricetinae
MH  - Cricetulus
MH  - Female
MH  - HEK293 Cells
MH  - Humans
MH  - *Immune Evasion/genetics
MH  - Jurkat Cells
MH  - Macaca mulatta
MH  - Mice
MH  - Mice, Inbred BALB C
MH  - Monkeypox/immunology
MH  - Poxviridae/genetics/immunology/*pathogenicity
MH  - Poxviridae Infections/*immunology
MH  - T-Lymphocytes/*immunology/*virology
MH  - Viral Proteins/*physiology
PMC - PMC4022744
EDAT- 2014/05/17 06:00
MHDA- 2015/06/16 06:00
CRDT- 2014/05/17 06:00
PHST- 2013/08/21 00:00 [received]
PHST- 2014/04/02 00:00 [accepted]
PHST- 2014/05/17 06:00 [entrez]
PHST- 2014/05/17 06:00 [pubmed]
PHST- 2015/06/16 06:00 [medline]
AID - 10.1371/journal.ppat.1004123 [doi]
AID - PPATHOGENS-D-13-02238 [pii]
PST - epublish
SO  - PLoS Pathog. 2014 May 15;10(5):e1004123. doi: 10.1371/journal.ppat.1004123.eCollection 2014 May.

PMID- 24779460
OWN - NLM
STAT- MEDLINE
DCOM- 20150302
LR  - 20211021
IS  - 1943-3700 (Electronic)
IS  - 0090-3558 (Linking)
VI  - 50
IP  - 3
DP  - 2014 Jul
TI  - Evaluation of monkeypox virus infection of black-tailed prairie dogs (Cynomysludovicianus) using in vivo bioluminescent imaging.
PG  - 524-36
LID - 10.7589/2013-07-171 [doi]
AB  - Monkeypox (MPX) is a re-emerging zoonotic disease that is endemic in Central and West Africa, where it can cause a smallpox-like disease in humans. Despite manyepidemiologic and field investigations of MPX, no definitive reservoir specieshas been identified. Using recombinant viruses expressing the firefly luciferase (luc) gene, we previously demonstrated the suitability of in vivo bioluminescent imaging (BLI) to study the pathogenesis of MPX in animal models. Here, weevaluated BLI as a novel approach for tracking MPX virus infection inblack-tailed prairie dogs (Cynomys ludovicianus). Prairie dogs were affectedduring a multistate outbreak of MPX in the US in 2003 and have since been used asan animal model of this disease. Our BLI results were compared with PCR and virusisolation from tissues collected postmortem. Virus was easily detected andquantified in skin and superficial tissues by BLI before and during clinicalphases, as well as in subclinical secondary cases, but was not reliably detected in deep tissues such as the lung. Although there are limitations to viraldetection in larger wild rodent species, BLI can enhance the use of prairie dogs as an animal model of MPX and can be used for the study of infection, diseaseprogression, and transmission in potential wild rodent reservoirs.
FAU - Falendysz, Elizabeth A
AU  - Falendysz EA
AD  - 1 US Geological Survey-National Wildlife Health Center, 6006 Schroeder Road,Madison, Wisconsin 53711, USA.
FAU - Londono-Navas, Angela M
AU  - Londono-Navas AM
FAU - Meteyer, Carol U
AU  - Meteyer CU
FAU - Pussini, Nicola
AU  - Pussini N
FAU - Lopera, Juan G
AU  - Lopera JG
FAU - Osorio, Jorge E
AU  - Osorio JE
FAU - Rocke, Tonie E
AU  - Rocke TE
LA  - eng
GR  - R01 TW008859/TW/FIC NIH HHS/United States
GR  - TW8859-3/TW/FIC NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20140429
PL  - United States
TA  - J Wildl Dis
JT  - Journal of wildlife diseases
JID - 0244160
SB  - IM
MH  - Animals
MH  - Female
MH  - Luminescent Measurements/*veterinary
MH  - Male
MH  - Monkeypox/*veterinary/virology
MH  - Monkeypox virus/*physiology
MH  - *Sciuridae
PMC - PMC4636010
MID - NIHMS729409
OTO - NOTNLM
OT  - Bioluminescence
OT  - Monkeypox virus
OT  - Orthopoxvirus
OT  - black-tailed prairie dog
OT  - histopathology
OT  - in vivo imaging
OT  - poxvirus
OT  - real-time PCR
EDAT- 2014/05/02 06:00
MHDA- 2015/03/03 06:00
CRDT- 2014/05/01 06:00
PHST- 2014/05/01 06:00 [entrez]
PHST- 2014/05/02 06:00 [pubmed]
PHST- 2015/03/03 06:00 [medline]
AID - 10.7589/2013-07-171 [doi]
PST - ppublish
SO  - J Wildl Dis. 2014 Jul;50(3):524-36. doi: 10.7589/2013-07-171. Epub 2014 Apr 29.

PMID- 24606683
OWN - NLM
STAT- MEDLINE
DCOM- 20140527
LR  - 20220316
IS  - 1096-0341 (Electronic)
IS  - 0042-6822 (Linking)
VI  - 452-453
DP  - 2014 Mar
TI  - Elimination of A-type inclusion formation enhances cowpox virus replication inmice: implications for orthopoxvirus evolution.
PG  - 59-66
LID - 10.1016/j.virol.2013.12.030 [doi]
LID - S0042-6822(13)00700-9 [pii]
AB  - Some orthopoxviruses including cowpox virus embed virus particles in densebodies, comprised of the A-type inclusion (ATI) protein, which may providelong-term environmental protection. This strategy could be beneficial if the hostpopulation is sparse or spread is inefficient or indirect. However, the formationof ATI may be neutral or disadvantageous for orthopoxviruses that rely on direct respiratory spread. Disrupted ATI open reading frames in orthopoxviruses such as variola virus, the agent of smallpox, and monkeypox virus suggests that loss ofthis feature provided positive selection. To test this hypothesis, we constructedcowpox virus mutants with deletion of the ATI gene or another gene required forembedding virions. The ATI deletion mutant caused greater weight loss and higher replication in the respiratory tract than control viruses, supporting ourhypothesis. Deletion of the gene for embedding virions had a lesser effect,possibly due to known additional functions of the encoded protein.
CI  - Published by Elsevier Inc.
FAU - Kastenmayer, Robin J
AU  - Kastenmayer RJ
AD  - Laboratory of Viral Diseases, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, 33 North Drive, MSC 3210, Bethesda, MD20892-3210, USA.
FAU - Maruri-Avidal, Liliana
AU  - Maruri-Avidal L
AD  - Laboratory of Viral Diseases, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, 33 North Drive, MSC 3210, Bethesda, MD20892-3210, USA.
FAU - Americo, Jeffrey L
AU  - Americo JL
AD  - Laboratory of Viral Diseases, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, 33 North Drive, MSC 3210, Bethesda, MD20892-3210, USA.
FAU - Earl, Patricia L
AU  - Earl PL
AD  - Laboratory of Viral Diseases, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, 33 North Drive, MSC 3210, Bethesda, MD20892-3210, USA.
FAU - Weisberg, Andrea S
AU  - Weisberg AS
AD  - Laboratory of Viral Diseases, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, 33 North Drive, MSC 3210, Bethesda, MD20892-3210, USA.
FAU - Moss, Bernard
AU  - Moss B
AD  - Laboratory of Viral Diseases, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, 33 North Drive, MSC 3210, Bethesda, MD20892-3210, USA. Electronic address: bmoss@nih.gov.
LA  - eng
GR  - ZIA AI000979-08/Intramural NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Intramural
DEP - 20140129
PL  - United States
TA  - Virology
JT  - Virology
JID - 0110674
RN  - 0 (Viral Proteins)
SB  - IM
MH  - Animals
MH  - *Biological Evolution
MH  - Cowpox/*virology
MH  - Cowpox virus/genetics/*physiology
MH  - *Gene Deletion
MH  - Humans
MH  - Inclusion Bodies, Viral/virology
MH  - Mice
MH  - Mice, Inbred BALB C
MH  - Orthopoxvirus/*genetics/physiology
MH  - Viral Proteins/*genetics/metabolism
MH  - *Virus Replication
PMC - PMC3962674
MID - NIHMS562133
OTO - NOTNLM
OT  - Cowpox virus inclusions
OT  - Poxvirus pathogenicity
OT  - Respiratory virus infection
EDAT- 2014/03/13 06:00
MHDA- 2014/05/28 06:00
CRDT- 2014/03/11 06:00
PHST- 2013/09/11 00:00 [received]
PHST- 2013/10/04 00:00 [revised]
PHST- 2013/12/23 00:00 [accepted]
PHST- 2014/03/11 06:00 [entrez]
PHST- 2014/03/13 06:00 [pubmed]
PHST- 2014/05/28 06:00 [medline]
AID - S0042-6822(13)00700-9 [pii]
AID - 10.1016/j.virol.2013.12.030 [doi]
PST - ppublish
SO  - Virology. 2014 Mar;452-453:59-66. doi: 10.1016/j.virol.2013.12.030. Epub 2014 Jan29.

PMID- 24563659
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20211021
IS  - 1746-0794 (Print)
IS  - 1746-0794 (Linking)
VI  - 8
IP  - 9
DP  - 2013 Sep
TI  - Orthopoxvirus inhibitors that are active in animal models: an update from 2008 to2012.
PG  - 891-901
AB  - Antiviral agents are being sought as countermeasures for the potential deliberaterelease of smallpox (variola) and monkeypox viruses, for the treatment ofnaturally acquired monkeypox virus infections, and as therapy for complicationsdue to smallpox (live-attenuated vaccinia virus) vaccination or accidentalinfection after exposure to vaccinated persons. Reviews of the scientificliterature spanning 1950-2008 have documented the progress made in developingsmall-animal models of poxvirus infection and identifying novel antiviral agents.Compounds of considerable interest include cidofovir, CMX001 and ST-246(R)(tecovirimat; SIGA Technologies, NY, USA). New inhibitors have been identifiedsince 2008, most of which do not exhibit the kind of potency and selectivityrequired for drug development. Two promising agents include 4'-thioidoxuridine (anucleoside analog) and mDEF201 (an adenovirus-vectored interferon). Compoundsthat have been effectively used in combination studies include vaccinia immuneglobulin, cidofovir, ST-246 and CMX001. In the future there may be an increase inexperimental work using active compounds in combination.
FAU - Smee, Donald F
AU  - Smee DF
AD  - Institute for Antiviral Research, Department of Animal, Dairy & VeterinarySciences, Utah State University, Logan, UT, 84322-5600, USA, Tel.: +1 435 7972897, , dsmee@cc.usu.edu.
LA  - eng
GR  - HHSN272201000039I/AI/NIAID NIH HHS/United States
PT  - Journal Article
PL  - England
TA  - Future Virol
JT  - Future virology
JID - 101278124
PMC - PMC3929309
MID - NIHMS537960
OTO - NOTNLM
OT  - antiviral
OT  - camelpox
OT  - cowpox
OT  - drug combinations
OT  - ectromelia
OT  - monkeypox
OT  - rabbitpox
OT  - smallpox
OT  - vaccinia
EDAT- 2014/02/25 06:00
MHDA- 2014/02/25 06:01
CRDT- 2014/02/25 06:00
PHST- 2014/02/25 06:00 [entrez]
PHST- 2014/02/25 06:00 [pubmed]
PHST- 2014/02/25 06:01 [medline]
AID - 10.2217/fvl.13.76 [doi]
PST - ppublish
SO  - Future Virol. 2013 Sep;8(9):891-901. doi: 10.2217/fvl.13.76.

PMID- 24516381
OWN - NLM
STAT- MEDLINE
DCOM- 20141003
LR  - 20211021
IS  - 1553-7374 (Electronic)
IS  - 1553-7366 (Linking)
VI  - 10
IP  - 2
DP  - 2014 Feb
TI  - The master regulator of the cellular stress response (HSF1) is critical fororthopoxvirus infection.
PG  - e1003904
LID - 10.1371/journal.ppat.1003904 [doi]
AB  - The genus Orthopoxviridae contains a diverse group of human pathogens includingmonkeypox, smallpox and vaccinia. These viruses are presumed to be less dependenton host functions than other DNA viruses because they have large genomes andreplicate in the cytoplasm, but a detailed understanding of the host factorsrequired by orthopoxviruses is lacking. To address this topic, we performed anunbiased, genome-wide pooled RNAi screen targeting over 17,000 human genes toidentify the host factors that support orthopoxvirus infection. We used secondaryand tertiary assays to validate our screen results. One of the strongest hits washeat shock factor 1 (HSF1), the ancient master regulator of the cytoprotectiveheat-shock response. In investigating the behavior of HSF1 during vacciniainfection, we found that HSF1 was phosphorylated, translocated to the nucleus,and increased transcription of HSF1 target genes. Activation of HSF1 wassupportive for virus replication, as RNAi knockdown and HSF1 small moleculeinhibition prevented orthopoxvirus infection. Consistent with its role as atranscriptional activator, inhibition of several HSF1 targets also blockedvaccinia virus replication. These data show that orthopoxviruses co-opt hosttranscriptional responses for their own benefit, thereby effectively extendingtheir functional genome to include genes residing within the host DNA. Thedependence on HSF1 and its chaperone network offers multiple opportunities forantiviral drug development.
FAU - Filone, Claire Marie
AU  - Filone CM
AD  - Department of Microbiology, Boston University School of Medicine, Boston,Massachusetts, United States of America ; United States Army Medical ResearchInstitute of Infectious Diseases, Virology Division, Fort Detrick, Maryland,United States of America.
FAU - Caballero, Ignacio S
AU  - Caballero IS
AD  - Department of Microbiology, Boston University School of Medicine, Boston,Massachusetts, United States of America.
FAU - Dower, Ken
AU  - Dower K
AD  - Department of Microbiology, Boston University School of Medicine, Boston,Massachusetts, United States of America.
FAU - Mendillo, Marc L
AU  - Mendillo ML
AD  - Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, UnitedStates of America.
FAU - Cowley, Glenn S
AU  - Cowley GS
AD  - The Broad Institute, Cambridge Massachusetts, United States of America.
FAU - Santagata, Sandro
AU  - Santagata S
AD  - Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, UnitedStates of America.
FAU - Rozelle, Daniel K
AU  - Rozelle DK
AD  - Department of Microbiology, Boston University School of Medicine, Boston,Massachusetts, United States of America.
FAU - Yen, Judy
AU  - Yen J
AD  - Department of Microbiology, Boston University School of Medicine, Boston,Massachusetts, United States of America.
FAU - Rubins, Kathleen H
AU  - Rubins KH
AD  - Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, UnitedStates of America.
FAU - Hacohen, Nir
AU  - Hacohen N
AD  - The Broad Institute, Cambridge Massachusetts, United States of America.
FAU - Root, David E
AU  - Root DE
AD  - The Broad Institute, Cambridge Massachusetts, United States of America.
FAU - Hensley, Lisa E
AU  - Hensley LE
AD  - United States Army Medical Research Institute of Infectious Diseases, VirologyDivision, Fort Detrick, Maryland, United States of America.
FAU - Connor, John
AU  - Connor J
AD  - Department of Microbiology, Boston University School of Medicine, Boston,Massachusetts, United States of America.
LA  - eng
GR  - R03 MH094169/MH/NIMH NIH HHS/United States
GR  - R03 MH094169-01/MH/NIMH NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20140206
PL  - United States
TA  - PLoS Pathog
JT  - PLoS pathogens
JID - 101238921
RN  - 0 (DNA-Binding Proteins)
RN  - 0 (HSF1 protein, human)
RN  - 0 (Heat Shock Transcription Factors)
RN  - 0 (Transcription Factors)
SB  - IM
MH  - Cell Line
MH  - DNA-Binding Proteins/*genetics
MH  - Fluorescent Antibody Technique
MH  - Heat Shock Transcription Factors
MH  - Host-Parasite Interactions/*genetics
MH  - Humans
MH  - Immunoblotting
MH  - *Orthopoxvirus
MH  - Poxviridae Infections/*genetics
MH  - Reverse Transcriptase Polymerase Chain Reaction
MH  - Transcription Factors/*genetics
MH  - Virus Replication/*genetics
PMC - PMC3916389
EDAT- 2014/02/12 06:00
MHDA- 2014/10/04 06:00
CRDT- 2014/02/12 06:00
PHST- 2013/06/14 00:00 [received]
PHST- 2013/12/12 00:00 [accepted]
PHST- 2014/02/12 06:00 [entrez]
PHST- 2014/02/12 06:00 [pubmed]
PHST- 2014/10/04 06:00 [medline]
AID - 10.1371/journal.ppat.1003904 [doi]
AID - PPATHOGENS-D-13-01645 [pii]
PST - epublish
SO  - PLoS Pathog. 2014 Feb 6;10(2):e1003904. doi: 10.1371/journal.ppat.1003904.eCollection 2014 Feb.

PMID- 24457084
OWN - NLM
STAT- MEDLINE
DCOM- 20140902
LR  - 20220128
IS  - 1080-6059 (Electronic)
IS  - 1080-6040 (Linking)
VI  - 20
IP  - 2
DP  - 2014 Feb
TI  - Genomic variability of monkeypox virus among humans, Democratic Republic of theCongo.
PG  - 232-9
LID - 10.3201/eid2002.130118 [doi]
AB  - Monkeypox virus is a zoonotic virus endemic to Central Africa. Although activedisease surveillance has assessed monkeypox disease prevalence and geographicrange, information about virus diversity is lacking. We therefore assessed genomediversity of viruses in 60 samples obtained from humans with primary andsecondary cases of infection from 2005 through 2007. We detected 4 distinctlineages and a deletion that resulted in gene loss in 10 (16.7%) samples and thatseemed to correlate with human-to-human transmission (p = 0.0544). The datasuggest a high frequency of spillover events from the pool of viruses in nonhumananimals, active selection through genomic destabilization and gene loss, andincreased disease transmissibility and severity. The potential for acceleratedadaptation to humans should be monitored through improved surveillance.
FAU - Kugelman, Jeffrey R
AU  - Kugelman JR
FAU - Johnston, Sara C
AU  - Johnston SC
FAU - Mulembakani, Prime M
AU  - Mulembakani PM
FAU - Kisalu, Neville
AU  - Kisalu N
FAU - Lee, Michael S
AU  - Lee MS
FAU - Koroleva, Galina
AU  - Koroleva G
FAU - McCarthy, Sarah E
AU  - McCarthy SE
FAU - Gestole, Marie C
AU  - Gestole MC
FAU - Wolfe, Nathan D
AU  - Wolfe ND
FAU - Fair, Joseph N
AU  - Fair JN
FAU - Schneider, Bradley S
AU  - Schneider BS
FAU - Wright, Linda L
AU  - Wright LL
FAU - Huggins, John
AU  - Huggins J
FAU - Whitehouse, Chris A
AU  - Whitehouse CA
FAU - Wemakoy, Emile Okitolonda
AU  - Wemakoy EO
FAU - Muyembe-Tamfum, Jean Jacques
AU  - Muyembe-Tamfum JJ
FAU - Hensley, Lisa E
AU  - Hensley LE
FAU - Palacios, Gustavo F
AU  - Palacios GF
FAU - Rimoin, Anne W
AU  - Rimoin AW
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
PL  - United States
TA  - Emerg Infect Dis
JT  - Emerging infectious diseases
JID - 9508155
SB  - IM
MH  - Adaptation, Biological/genetics
MH  - Amino Acid Sequence
MH  - Animals
MH  - Democratic Republic of the Congo/epidemiology
MH  - Epidemiological Monitoring
MH  - Gene Deletion
MH  - *Genome, Viral
MH  - *Genomic Instability
MH  - Humans
MH  - Molecular Sequence Data
MH  - Monkeypox/epidemiology/virology
MH  - Monkeypox virus/classification/*genetics
MH  - *Phylogeny
MH  - Sequence Analysis, DNA
MH  - Severity of Illness Index
PMC - PMC3901482
OTO - NOTNLM
OT  - Democratic Republic of the Congo
OT  - Monkeypox virus
OT  - emerging infectious disease
OT  - gene loss
OT  - genomic diversity
OT  - genomic reduction
OT  - viruses
EDAT- 2014/01/25 06:00
MHDA- 2014/09/03 06:00
CRDT- 2014/01/25 06:00
PHST- 2014/01/25 06:00 [entrez]
PHST- 2014/01/25 06:00 [pubmed]
PHST- 2014/09/03 06:00 [medline]
AID - 10.3201/eid2002.130118 [doi]
PST - ppublish
SO  - Emerg Infect Dis. 2014 Feb;20(2):232-9. doi: 10.3201/eid2002.130118.

PMID- 24418545
OWN - NLM
STAT- MEDLINE
DCOM- 20140407
LR  - 20211021
IS  - 1096-0341 (Electronic)
IS  - 0042-6822 (Linking)
VI  - 449
DP  - 2014 Jan 20
TI  - Susceptibility of the wild-derived inbred CAST/Ei mouse to infection byorthopoxviruses analyzed by live bioluminescence imaging.
PG  - 120-32
LID - 10.1016/j.virol.2013.11.017 [doi]
LID - S0042-6822(13)00630-2 [pii]
AB  - Classical inbred mice are extensively used for virus research. However, werecently found that some wild-derived inbred mouse strains are more susceptiblethan classical strains to monkeypox virus. Experiments described here indicatedthat the 50% lethal dose of vaccinia virus (VACV) and cowpox virus (CPXV) weretwo logs lower in wild-derived inbred CAST/Ei mice than classical inbred BALB/cmice, whereas there was little difference in the susceptibility of the mousestrains to herpes simplex virus. Live bioluminescence imaging was used to follow spread of pathogenic and attenuated VACV strains and CPXV virus from nasalpassages to organs in the chest and abdomen of CAST/Ei mice. Luminescenceincreased first in the head and then simultaneously in the chest and abdomen in adose-dependent manner. The spreading kinetics was more rapid with VACV than CPXV although the peak photon flux was similar. These data suggest advantages ofCAST/Ei mice for orthopoxvirus studies.
CI  - (c) 2013 Published by Elsevier Inc.
FAU - Americo, Jeffrey L
AU  - Americo JL
AD  - Laboratory of Viral Diseases, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, Bethesda, MD 20892, USA.
FAU - Sood, Cindy L
AU  - Sood CL
AD  - Laboratory of Viral Diseases, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, Bethesda, MD 20892, USA.
FAU - Cotter, Catherine A
AU  - Cotter CA
AD  - Laboratory of Viral Diseases, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, Bethesda, MD 20892, USA.
FAU - Vogel, Jodi L
AU  - Vogel JL
AD  - Laboratory of Viral Diseases, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, Bethesda, MD 20892, USA.
FAU - Kristie, Thomas M
AU  - Kristie TM
AD  - Laboratory of Viral Diseases, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, Bethesda, MD 20892, USA.
FAU - Moss, Bernard
AU  - Moss B
AD  - Laboratory of Viral Diseases, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, Bethesda, MD 20892, USA. Electronicaddress: bmoss@nih.gov.
FAU - Earl, Patricia L
AU  - Earl PL
AD  - Laboratory of Viral Diseases, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, Bethesda, MD 20892, USA. Electronicaddress: pearl@nih.gov.
LA  - eng
GR  - ZIA AI000979-07/Intramural NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Intramural
DEP - 20131128
PL  - United States
TA  - Virology
JT  - Virology
JID - 0110674
SB  - IM
MH  - Animals
MH  - Animals, Wild/*virology
MH  - Cell Line
MH  - Chlorocebus aethiops
MH  - Cowpox/*virology
MH  - Cowpox virus/genetics/*pathogenicity/physiology
MH  - *Disease Models, Animal
MH  - Female
MH  - Humans
MH  - Mice
MH  - Mice, Inbred BALB C
MH  - Mice, Inbred Strains/virology
MH  - Vaccinia/*virology
MH  - Vaccinia virus/genetics/*pathogenicity/physiology
MH  - Virulence
MH  - Whole Body Imaging
PMC - PMC3902144
MID - NIHMS541419
OTO - NOTNLM
OT  - Cowpox virus pathogenesis
OT  - Poxvirus pathogenesis
OT  - Vaccinia virus pathogenesis
OT  - Wild-derived inbred mice
EDAT- 2014/01/15 06:00
MHDA- 2014/04/08 06:00
CRDT- 2014/01/15 06:00
PHST- 2013/09/26 00:00 [received]
PHST- 2013/10/28 00:00 [revised]
PHST- 2013/11/07 00:00 [accepted]
PHST- 2014/01/15 06:00 [entrez]
PHST- 2014/01/15 06:00 [pubmed]
PHST- 2014/04/08 06:00 [medline]
AID - S0042-6822(13)00630-2 [pii]
AID - 10.1016/j.virol.2013.11.017 [doi]
PST - ppublish
SO  - Virology. 2014 Jan 20;449:120-32. doi: 10.1016/j.virol.2013.11.017. Epub 2013 Nov28.

PMID- 24354064
OWN - NLM
STAT- MEDLINE
DCOM- 20140117
LR  - 20191210
IS  - 0507-4088 (Print)
IS  - 0507-4088 (Linking)
VI  - 58
IP  - 4
DP  - 2013 Jul-Aug
TI  - [A comparative study of the antiviral activity of chemical compounds concerningthe orthopoxviruses experiments in vivo].
PG  - 39-43
AB  - In the experiments using intranasal (i/n) infection of mice with the ectromeliavirus (EV) in a dose 10 LD50/head (10 x 50% lethal doselhead) or with themonkaypox virus (MPXV) in a dose 10 ID50/head (10 x 50% infective dose/ head) it was demonstrated that the antiviral efficiency of chemical compounds - thecondensed derivatives of pyrrolidin-2,5-dion, as well as their predecessors andthe nearest analogues, synthesized in Novosibirsk Institute of Organic Chemistry of the Siberian Branch of the Russian Academy of Sciences (NIOCH SB RAS) wasobserved. As a positive control we used the antipoxvirus chemical preparationST-246 available from SIGA Technologies Inc. (USA), synthesized in NIOCH SB RASby the technique suggested by the authors. It was demonstrated that the compound NIOCH-14(7-[N'-(4-Trifluoromethylbenzoil)-hydrazidecarbonil]-tricyclo[3.2.2.02,4]non-8-en-6-carbonic acid) possessed comparable with ST-246 antiviral activity concerning EV and MPXV on all indicators used. Therefore, at infection of mice with EV(strain K-1) and peroral administration of NIOCH-14 and ST-246 in a dose 50 mkg/gof mouse weight (12-14 g) within 10 days the survival rate and average lifeexpectancy of mice authentically exceeded the control levels. EV titers in lungs through 6 days after infection in the same groups were lower than in the control.In addition to that, after 7 days of infection of mice with MPXV (strainV79-1-005) and daily peroral administration of NIOCH-14 and ST-246 in a dose 60mkg/g of mouse weight (9-11 g) authentic decrease in a part of infected animalsand MPXV titers in lungs was observed.
FAU - Kabanov, A S
AU  - Kabanov AS
FAU - Sergeev, Al A
AU  - Sergeev AA
FAU - Shishkina, L N
AU  - Shishkina LN
FAU - Bulychev, L E
AU  - Bulychev LE
FAU - Skarnovich, M O
AU  - Skarnovich MO
FAU - Sergeev, Ar A
AU  - Sergeev AA
FAU - Bormotov, N I
AU  - Bormotov NI
FAU - P'iankov, O V
AU  - P'iankov OV
FAU - Serova, O A
AU  - Serova OA
FAU - Bodnev, S A
AU  - Bodnev SA
FAU - Selivanov, B A
AU  - Selivanov BA
FAU - Tikhonov, A Ia
AU  - Tikhonov AIa
FAU - Agafonov, A P
AU  - Agafonov AP
FAU - Sergeev, A N
AU  - Sergeev AN
LA  - rus
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - Russia (Federation)
TA  - Vopr Virusol
JT  - Voprosy virusologii
JID - 0417337
RN  - 0 (Antiviral Agents)
SB  - IM
MH  - Animals
MH  - *Antiviral Agents/chemical synthesis/chemistry/pharmacology
MH  - Chlorocebus aethiops
MH  - *Ectromelia virus
MH  - Ectromelia, Infectious/*drug therapy/pathology/virology
MH  - Female
MH  - Male
MH  - Mice
MH  - Monkeypox/*drug therapy/pathology/virology
MH  - *Monkeypox virus
MH  - Vero Cells
EDAT- 2013/12/21 06:00
MHDA- 2014/01/18 06:00
CRDT- 2013/12/21 06:00
PHST- 2013/12/21 06:00 [entrez]
PHST- 2013/12/21 06:00 [pubmed]
PHST- 2014/01/18 06:00 [medline]
PST - ppublish
SO  - Vopr Virusol. 2013 Jul-Aug;58(4):39-43.

PMID- 24339772
OWN - NLM
STAT- MEDLINE
DCOM- 20140903
LR  - 20220316
IS  - 1553-7374 (Electronic)
IS  - 1553-7366 (Linking)
VI  - 9
IP  - 12
DP  - 2013
TI  - An increasing danger of zoonotic orthopoxvirus infections.
PG  - e1003756
LID - 10.1371/journal.ppat.1003756 [doi]
AB  - On May 8, 1980, the World Health Assembly at its 33(rd) session solemnly declaredthat the world and all its peoples had won freedom from smallpox and recommended ceasing the vaccination of the population against smallpox. Currently, a largerpart of the world population has no immunity not only against smallpox but alsoagainst other zoonotic orthopoxvirus infections. Recently, recorded outbreaks of orthopoxvirus diseases not only of domestic animals but also of humans havebecome more frequent. All this indicates a new situation in the ecology andevolution of zoonotic orthopoxviruses. Analysis of state-of-the-art data on thephylogenetic relationships, ecology, and host range oforthopoxviruses--etiological agents of smallpox (variola virus, VARV), monkeypox (MPXV), cowpox (CPXV), vaccinia (VACV), and camelpox (CMLV)--as well as thepatterns of their evolution suggests that a VARV-like virus could emerge in thecourse of natural evolution of modern zoonotic orthopoxviruses. Thus, there is aninsistent need for organization of the international control over the outbreaksof zoonotic orthopoxvirus infections in various countries to provide a rapidresponse and prevent them from developing into epidemics.
FAU - Shchelkunov, Sergei N
AU  - Shchelkunov SN
AD  - State Research Center of Virology and Biotechnology VECTOR, Koltsovo, NovosibirskOblast, Russia ; Novosibirsk State University, Novosibirsk, Russia.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20131205
PL  - United States
TA  - PLoS Pathog
JT  - PLoS pathogens
JID - 101238921
SB  - IM
MH  - Animals
MH  - Disease Outbreaks
MH  - Disease Reservoirs/statistics & numerical data
MH  - Evolution, Molecular
MH  - Humans
MH  - Infection Control
MH  - Mass Vaccination
MH  - Orthopoxvirus/genetics/pathogenicity
MH  - Poxviridae Infections/*epidemiology/prevention & control
MH  - Vaccinia virus/genetics/pathogenicity
MH  - Variola virus/genetics/pathogenicity
MH  - Zoonoses/*epidemiology
PMC - PMC3855571
EDAT- 2013/12/18 06:00
MHDA- 2014/09/04 06:00
CRDT- 2013/12/17 06:00
PHST- 2013/12/17 06:00 [entrez]
PHST- 2013/12/18 06:00 [pubmed]
PHST- 2014/09/04 06:00 [medline]
AID - 10.1371/journal.ppat.1003756 [doi]
AID - PPATHOGENS-D-13-01729 [pii]
PST - ppublish
SO  - PLoS Pathog. 2013;9(12):e1003756. doi: 10.1371/journal.ppat.1003756. Epub 2013Dec 5.

PMID- 24312452
OWN - NLM
STAT- MEDLINE
DCOM- 20140818
LR  - 20220408
IS  - 1932-6203 (Electronic)
IS  - 1932-6203 (Linking)
VI  - 8
IP  - 12
DP  - 2013
TI  - Genome-wide comparison of cowpox viruses reveals a new clade related to Variolavirus.
PG  - e79953
LID - 10.1371/journal.pone.0079953 [doi]
AB  - Zoonotic infections caused by several orthopoxviruses (OPV) like monkeypox virus or vaccinia virus have a significant impact on human health. In Europe, thenumber of diagnosed infections with cowpox viruses (CPXV) is increasing inanimals as well as in humans. CPXV used to be enzootic in cattle; however, suchinfections were not being diagnosed over the last decades. Instead, individualcases of cowpox are being found in cats or exotic zoo animals that transmit theinfection to humans. Both animals and humans reveal local exanthema on arms andlegs or on the face. Although cowpox is generally regarded as a self-limitingdisease, immunosuppressed patients can develop a lethal systemic diseaseresembling smallpox. To date, only limited information on the complex and,compared to other OPV, sparsely conserved CPXV genomes is available. Since CPXVdisplays the widest host range of all OPV known, it seems important to comprehendthe genetic repertoire of CPXV which in turn may help elucidate specificmechanisms of CPXV pathogenesis and origin. Therefore, 22 genomes of independent CPXV strains from clinical cases, involving ten humans, four rats, two cats, two jaguarundis, one beaver, one elephant, one marah and one mongoose, were sequencedby using massive parallel pyrosequencing. The extensive phylogenetic analysisshowed that the CPXV strains sequenced clearly cluster into several distinctclades, some of which are closely related to Vaccinia viruses while othersrepresent different clades in a CPXV cluster. Particularly one CPXV clade is moreclosely related to Camelpox virus, Taterapox virus and Variola virus than to any other known OPV. These results support and extend recent data from other groupswho postulate that CPXV does not form a monophyletic clade and should be divided into multiple lineages.
FAU - Dabrowski, Piotr Wojtek
AU  - Dabrowski PW
AD  - Centre for Biological Threats and Special Pathogens, Robert Koch Institute,Berlin, Germany.
FAU - Radonic, Aleksandar
AU  - Radonic A
FAU - Kurth, Andreas
AU  - Kurth A
FAU - Nitsche, Andreas
AU  - Nitsche A
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20131203
PL  - United States
TA  - PLoS One
JT  - PloS one
JID - 101285081
SB  - IM
MH  - Animals
MH  - Cats
MH  - Cattle
MH  - Cowpox virus/*classification/*genetics
MH  - Genome, Viral/*physiology
MH  - *Genome-Wide Association Study
MH  - Humans
MH  - Rats
MH  - Variola virus/*classification/*genetics
PMC - PMC3848979
EDAT- 2013/12/07 06:00
MHDA- 2014/08/19 06:00
CRDT- 2013/12/07 06:00
PHST- 2013/04/18 00:00 [received]
PHST- 2013/09/27 00:00 [accepted]
PHST- 2013/12/07 06:00 [entrez]
PHST- 2013/12/07 06:00 [pubmed]
PHST- 2014/08/19 06:00 [medline]
AID - 10.1371/journal.pone.0079953 [doi]
AID - PONE-D-13-16365 [pii]
PST - epublish
SO  - PLoS One. 2013 Dec 3;8(12):e79953. doi: 10.1371/journal.pone.0079953. eCollection2013.

PMID- 26137813
OWN - NLM
STAT- MEDLINE
DCOM- 20150814
LR  - 20150703
IS  - 0001-4079 (Print)
IS  - 0001-4079 (Linking)
VI  - 197
IP  - 9
DP  - 2013 Dec
TI  - [Resequencing microarrays: a rapid tool for better identification andunderstanding of viral and bacterial emergence].
PG  - 1669-82
AB  - The introduction of microarray technologies in microbiology has transformed thedetection and characterization of microbial pathogens. Microarray-based platformscan be classified into different families according to their characteristics and applications. Resequencing microarrays have several advantages over othertechnologies for pathogen detection and characterization.
FAU - Berthet, Nicolas
AU  - Berthet N
AD  - Centre International de Recherches Medicales de Franceville (CIRMF), Departement Zoonose et Maladies Emergentes, BP 769 - Franceville, Gabon, CNRS, UMR 3569, 25rue du docteur Roux - 75724 Paris. nicolas.berthet@ird.fr
LA  - fre
GR  - UC1 AI062613/AI/NIAID NIH HHS/United States
PT  - English Abstract
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PT  - Review
TT  - La puce a ADN de resequencage: un outil rapide pour mieux identifier etcomprendre une emergence virale et bacterienne.
PL  - Netherlands
TA  - Bull Acad Natl Med
JT  - Bulletin de l'Academie nationale de medecine
JID - 7503383
RN  - 0 (Bacterial Toxins)
RN  - 0 (DNA, Bacterial)
RN  - 0 (DNA, Viral)
SB  - IM
MH  - Animals
MH  - Bacterial Infections/epidemiology/*microbiology
MH  - Bacterial Toxins/genetics
MH  - Birds/virology
MH  - Clostridium/genetics/isolation & purification
MH  - Clostridium Infections/microbiology
MH  - Communicable Diseases, Emerging/*microbiology/*virology
MH  - DNA, Bacterial/*genetics
MH  - DNA, Viral/*genetics
MH  - Genes, Bacterial
MH  - Genes, Viral
MH  - Humans
MH  - Influenza A Virus, H1N1 Subtype/classification/genetics/isolation & purification
MH  - Influenza A virus/classification/genetics
MH  - Influenza in Birds/virology
MH  - Influenza, Human/virology
MH  - Monkeypox/virology
MH  - Monkeypox virus/genetics/isolation & purification
MH  - Oligonucleotide Array Sequence Analysis/classification/*methods
MH  - Orthomyxoviridae Infections/veterinary/virology
MH  - Phylogeny
MH  - Sequence Analysis, DNA/classification/*methods
MH  - Sequence Homology, Nucleic Acid
MH  - Swine/virology
MH  - Swine Diseases/virology
MH  - Virus Diseases/epidemiology/*virology
EDAT- 2013/12/01 00:00
MHDA- 2015/08/15 06:00
CRDT- 2015/07/04 06:00
PHST- 2015/07/04 06:00 [entrez]
PHST- 2013/12/01 00:00 [pubmed]
PHST- 2015/08/15 06:00 [medline]
PST - ppublish
SO  - Bull Acad Natl Med. 2013 Dec;197(9):1669-82.

PMID- 26137812
OWN - NLM
STAT- MEDLINE
DCOM- 20150814
LR  - 20211203
IS  - 0001-4079 (Print)
IS  - 0001-4079 (Linking)
VI  - 197
IP  - 9
DP  - 2013 Dec
TI  - [Mechanisms of viral emergence and interspecies transmission: the exemple ofsimian foamy viruses in Central Africa].
PG  - 1655-67; discussion 1667-8
AB  - A large proportion of viral pathogens that have emerged during the last decadesin humans are considered to have originated from various animal species. This is well exemplified by several recent epidemics such as those of Nipah, Severe AcuteRespiratory Syndrome, Avian flu, Ebola, Monkeypox, and Hantaviruses. After theinitial interspecies transmission per se, the viruses can disseminate into thehuman population through various and distinct mechanisms. Some of them are wellcharacterized and understood, thus allowing a certain level of risk control andprevention. Surprisingly and in contrast, the initial steps that lead to theemergence of several viruses, and of their associated diseases, remain stillpoorly understood. Epidemiological field studies conducted in certain specifichigh-risk populations are thus necessary to obtain new insights into the earlyevents of this emergence process. Human infections by simian viruses representincreasing public health concerns. Indeed, by virtue of their geneticandphysiological similarities, non-human primates (NHPs) are considered to belikely the sources of viruses that can infect humans and thus may pose asignificant threat to human population. This is well illustrated by retroviruses,which have the ability to cross species, adapt to a new host and sometimes spreadwithin these new species. Sequence comparison and phylogenetic studies have thus clearly showed that the emergence of human immunodeficiency virus type 1 (HIV-1) and HIV-2 in humans have resulted from several independent interspeciestransmissions of different SIV types from Chimpanzees and African monkeys(including sooty mangabeys), respectively, probably during the first part of the last century. The situation for Human T cell Lymphotropic virus type 1 (HTLV-1)is, for certain aspects, quite comparable. Indeed, the origin of most HTLV-1subtypes appears to be linked to interspecies transmission betweenSTLV-1-infected monkeys and humans, followed by variable periods of evolution in the human host. In this review, after an introduction on emerging viruses, wewill briefly present the results of a large epidemiological study performed ingroups of Bantus and Pygmies living in villages and settlements located in therain forest of the South region of Cameroon. These populations are living nearby the habitats of several monkeys and apes, often naturally infected by differentretroviruses including SIV, STLV and simianfoamy virus. Most of the personsincluded in this study were hunters of such NHPs, thus at high risk of contactwith infected body fluids (blood, saliva,...) during hunting activities. Afterreviewing the current available data on the discovery, cross-species transmissionfrom monkeys and apes to humans of the simian foamy retroviruses, we will report the results of our study. Such infection is a unique natural model to study thedifferent mechanisms of restriction of retroviral emergence in Humans.
FAU - Gessain, Antoine
AU  - Gessain A
AD  - Institut Pasteur, Unite d'Epidemiologie et Physiopathologie des Virus Oncogenes, Departement de Virologie - F-75015 Paris, France. agessain@pasteur.fr
LA  - fre
PT  - Journal Article
PT  - Review
TT  - Mecanismes d'emergence virale et transmission interespeces: l'exemple desretrovirus Foamy simiens chez l'Homme en Afrique Centrale.
PL  - Netherlands
TA  - Bull Acad Natl Med
JT  - Bulletin de l'Academie nationale de medecine
JID - 7503383
SB  - IM
MH  - Abattoirs
MH  - Adaptation, Physiological/genetics
MH  - Adult
MH  - Africa, Central/epidemiology
MH  - Age Distribution
MH  - Animals
MH  - Bites and Stings/virology
MH  - Cameroon/epidemiology
MH  - Communicable Diseases, Emerging/epidemiology/*transmission/veterinary/virology
MH  - Ethnicity
MH  - Female
MH  - Food Handling
MH  - Haplorhini/virology
MH  - Hominidae/virology
MH  - Host Specificity/genetics/*physiology
MH  - Humans
MH  - Male
MH  - Meat/adverse effects/virology
MH  - Occupational Exposure
MH  - Primate Diseases/epidemiology/*virology
MH  - Retroviridae Infections/epidemiology/*transmission/veterinary/virology
MH  - Saliva/virology
MH  - Sex Distribution
MH  - Simian foamy virus/genetics/pathogenicity/*physiology
MH  - Species Specificity
MH  - Young Adult
MH  - Zoonoses/epidemiology/*transmission/virology
PMC - PMC7111110
EDAT- 2013/12/01 00:00
MHDA- 2015/08/15 06:00
CRDT- 2015/07/04 06:00
PHST- 2015/07/04 06:00 [entrez]
PHST- 2013/12/01 00:00 [pubmed]
PHST- 2015/08/15 06:00 [medline]
PST - ppublish
SO  - Bull Acad Natl Med. 2013 Dec;197(9):1655-67; discussion 1667-8.

PMID- 24246742
OWN - NLM
STAT- MEDLINE
DCOM- 20140818
LR  - 20220318
IS  - 1876-3405 (Electronic)
IS  - 1876-3405 (Linking)
VI  - 5
IP  - 4
DP  - 2013 Dec
TI  - Enhancing health care worker ability to detect and care for patients withmonkeypox in the Democratic Republic of the Congo.
PG  - 237-43
LID - 10.1093/inthealth/iht029 [doi]
AB  - BACKGROUND: Monkeypox (MPX) is an endemic disease of public health importance in the Democratic Republic of the Congo (DRC). In 2010, the DRC Ministry of Healthjoined with external partners to improve MPX surveillance in the Tshuapa HealthDistrict of DRC. A pivotal component of the program is training of health zonepersonnel in surveillance methods and patient care. In this report we evaluateoutcomes of the training program. METHODS: Health care worker knowledge of keyconcepts in the MPX training curriculum was assessed using an anonymousself-administered survey. Additionally, evaluators collected feedback about thecapacity of participants to perform the surveillance tasks. Training impacts weredetermined by assessing various surveillance performance metrics. RESULTS:Correct trainee responses to questions about MPX symptoms and patient careincreased significantly upon completion of training events. During the 12 months after the initial training, the proportion of suspected cases investigatedincreased significantly (from 6.7 to 37.3%), as compared to the 5 months prior.However, the proportion of reported cases that were ultimately confirmed remainedunchanged, 20.1% (5/24) vs 23.3% (60/257). CONCLUSIONS: We have demonstrated thatthe MPX curriculum developed for this initiative was effective in transferringknowledge and was associated with improved detection of human MPX cases.
FAU - Bass, Jennifer
AU  - Bass J
AD  - US Centers for Disease Control and Prevention, Poxvirus and Rabies Branch,Atlanta, GA USA.
FAU - Tack, Danielle M
AU  - Tack DM
FAU - McCollum, Andrea M
AU  - McCollum AM
FAU - Kabamba, Joelle
AU  - Kabamba J
FAU - Pakuta, Elisabeth
AU  - Pakuta E
FAU - Malekani, Jean
AU  - Malekani J
FAU - Nguete, Beatrice
AU  - Nguete B
FAU - Monroe, Benjamin P
AU  - Monroe BP
FAU - Doty, Jeffrey B
AU  - Doty JB
FAU - Karhemere, Stomy
AU  - Karhemere S
FAU - Damon, Inger K
AU  - Damon IK
FAU - Balilo, Marcel
AU  - Balilo M
FAU - Okitolonda, Emile
AU  - Okitolonda E
FAU - Shongo, Robert L
AU  - Shongo RL
FAU - Reynolds, Mary G
AU  - Reynolds MG
LA  - eng
GR  - CC999999/Intramural CDC HHS/United States
PT  - Journal Article
PT  - Research Support, U.S. Gov't, P.H.S.
DEP - 20131117
PL  - England
TA  - Int Health
JT  - International health
JID - 101517095
SB  - IM
MH  - Adult
MH  - Democratic Republic of the Congo/epidemiology
MH  - Endemic Diseases/statistics & numerical data
MH  - Female
MH  - Follow-Up Studies
MH  - Health Personnel/*education
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Monkeypox/*diagnosis/epidemiology/*therapy
MH  - Population Surveillance/methods
MH  - Program Evaluation/methods
MH  - Public Health/methods/statistics & numerical data
PMC - PMC5688513
MID - NIHMS913457
OTO - NOTNLM
OT  - Monkeypox
OT  - PCR
OT  - Surveillance
OT  - Training evaluation
OT  - Zoonosis
EDAT- 2013/11/20 06:00
MHDA- 2014/08/19 06:00
CRDT- 2013/11/20 06:00
PHST- 2013/11/20 06:00 [entrez]
PHST- 2013/11/20 06:00 [pubmed]
PHST- 2014/08/19 06:00 [medline]
AID - iht029 [pii]
AID - 10.1093/inthealth/iht029 [doi]
PST - ppublish
SO  - Int Health. 2013 Dec;5(4):237-43. doi: 10.1093/inthealth/iht029. Epub 2013 Nov17.

PMID- 24210113
OWN - NLM
STAT- MEDLINE
DCOM- 20140102
LR  - 20211021
IS  - 1096-0341 (Electronic)
IS  - 0042-6822 (Linking)
VI  - 447
IP  - 1-2
DP  - 2013 Dec
TI  - Characterizing monkeypox virus specific CD8+ T cell epitopes in rhesus macaques.
PG  - 181-6
LID - 10.1016/j.virol.2013.09.003 [doi]
LID - S0042-6822(13)00512-6 [pii]
AB  - To characterize T cell epitopes in monkeypox virus (MPXV) infected rhesusmacaques, we utilized IFNgamma Elispot assay to screen 400 predicted peptidesfrom 20MPXV proteins. Two peptides from the F8L protein, an analog of E9L proteinin vaccinia, were found to elicit CD8+ T cell responses. Prediction and in vitro MHC binding analyses suggest that one is restricted by Mamu-A1()001 and anotherby Mamu-A1()002. The Mamu-A1()002 epitope is completely identical in all reportedsequences for variola, vaccinia, cowpox and MPXV. The Mamu-A1()001 epitope isconserved in MPXV and vaccinia, and has one residue substitution (V6>I) in somecowpox sequences and all variola sequences. Given CD8+ T-cell epitopes from E9Lwere also identified in humans and mice, our data suggested that F8L/E9L may be adominant pox viral protein for CD8+ T cell responses, and may be considered as a target when designing vaccines that target pox-specific T cell responses.
CI  - (c) 2013 Elsevier Inc. All rights reserved.
FAU - Song, Haifeng
AU  - Song H
AD  - Integrated Research Facility, NIAID/NIH, Frederick, MD 21702, USA. Electronicaddress: songhai@mail.nih.gov.
FAU - Sidney, John
AU  - Sidney J
FAU - Wiseman, Roger W
AU  - Wiseman RW
FAU - Josleyn, Nicole
AU  - Josleyn N
FAU - Cohen, Melanie
AU  - Cohen M
FAU - Blaney, Joseph E
AU  - Blaney JE
FAU - Jahrling, Peter B
AU  - Jahrling PB
FAU - Sette, Alessandro
AU  - Sette A
LA  - eng
GR  - HHSN272200700016I/AI/NIAID NIH HHS/United States
GR  - Z99 AI999999/Intramural NIH HHS/United States
PT  - Journal Article
DEP - 20130928
PL  - United States
TA  - Virology
JT  - Virology
JID - 0110674
RN  - 0 (Epitopes, T-Lymphocyte)
RN  - 0 (Histocompatibility Antigens Class I)
RN  - 0 (Mamu-A 01 antigen)
RN  - 0 (Mamu-A 02 antigen)
RN  - 82115-62-6 (Interferon-gamma)
SB  - IM
MH  - Animals
MH  - CD8-Positive T-Lymphocytes/*immunology
MH  - Enzyme-Linked Immunospot Assay
MH  - Epitopes, T-Lymphocyte/*immunology
MH  - Histocompatibility Antigens Class I/metabolism
MH  - Interferon-gamma/metabolism
MH  - Macaca mulatta
MH  - Monkeypox virus/*immunology
MH  - Protein Binding
PMC - PMC4771384
MID - NIHMS524043
OTO - NOTNLM
OT  - Bioinformatics analysis
OT  - CD8+ T cells
OT  - Elispot
OT  - Monkeypox virus
OT  - Peptides
OT  - Rhesus
OT  - T cell epitopes
EDAT- 2013/11/12 06:00
MHDA- 2014/01/03 06:00
CRDT- 2013/11/12 06:00
PHST- 2013/07/08 00:00 [received]
PHST- 2013/08/13 00:00 [revised]
PHST- 2013/09/03 00:00 [accepted]
PHST- 2013/11/12 06:00 [entrez]
PHST- 2013/11/12 06:00 [pubmed]
PHST- 2014/01/03 06:00 [medline]
AID - S0042-6822(13)00512-6 [pii]
AID - 10.1016/j.virol.2013.09.003 [doi]
PST - ppublish
SO  - Virology. 2013 Dec;447(1-2):181-6. doi: 10.1016/j.virol.2013.09.003. Epub 2013Sep 28.

PMID- 24158414
OWN - NLM
STAT- MEDLINE
DCOM- 20140820
LR  - 20220316
IS  - 1537-6591 (Electronic)
IS  - 1058-4838 (Linking)
VI  - 58
IP  - 2
DP  - 2014 Jan
TI  - Human monkeypox.
PG  - 260-7
LID - 10.1093/cid/cit703 [doi]
AB  - Human monkeypox is a zoonotic Orthopoxvirus with a presentation similar tosmallpox. Clinical differentiation of the disease from smallpox and varicella is difficult. Laboratory diagnostics are principal components to identification and surveillance of disease, and new tests are needed for a more precise and rapiddiagnosis. The majority of human infections occur in Central Africa, wheresurveillance in rural areas with poor infrastructure is difficult but can beaccomplished with evidence-guided tools and educational materials to informpublic health workers of important principles. Contemporary epidemiologicalstudies are needed now that populations do not receive routine smallpoxvaccination. New therapeutics and vaccines offer hope for the treatment andprevention of monkeypox; however, more research must be done before they areready to be deployed in an endemic setting. There is a need for more research in the epidemiology, ecology, and biology of the virus in endemic areas to betterunderstand and prevent human infections.
FAU - McCollum, Andrea M
AU  - McCollum AM
AD  - Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology,National Center for Emerging and Zoonotic Infectious Diseases, Centers forDisease Control and Prevention, Atlanta, Georgia.
FAU - Damon, Inger K
AU  - Damon IK
LA  - eng
PT  - Journal Article
PT  - Research Support, U.S. Gov't, P.H.S.
PT  - Review
DEP - 20131024
PL  - United States
TA  - Clin Infect Dis
JT  - Clinical infectious diseases : an official publication of the Infectious DiseasesSociety of America
JID - 9203213
SB  - IM
EIN - Clin Infect Dis. 2014 Jun;58(12):1792
MH  - Africa, Central/epidemiology
MH  - Animals
MH  - Communicable Diseases, Emerging/diagnosis/*epidemiology/virology
MH  - Endemic Diseases
MH  - Humans
MH  - Monkeypox/diagnosis/*epidemiology/virology
MH  - Orthopoxvirus/*isolation & purification
MH  - Rural Population
MH  - Zoonoses/diagnosis/*epidemiology/virology
OTO - NOTNLM
OT  - Orthopoxvirus
OT  - monkeypox
OT  - smallpox
EDAT- 2013/10/26 06:00
MHDA- 2014/08/21 06:00
CRDT- 2013/10/26 06:00
PHST- 2013/10/26 06:00 [entrez]
PHST- 2013/10/26 06:00 [pubmed]
PHST- 2014/08/21 06:00 [medline]
AID - cit703 [pii]
AID - 10.1093/cid/cit703 [doi]
PST - ppublish
SO  - Clin Infect Dis. 2014 Jan;58(2):260-7. doi: 10.1093/cid/cit703. Epub 2013 Oct 24.

PMID- 24147080
OWN - NLM
STAT- MEDLINE
DCOM- 20140605
LR  - 20211021
IS  - 1932-6203 (Electronic)
IS  - 1932-6203 (Linking)
VI  - 8
IP  - 10
DP  - 2013
TI  - Monkeypox virus infection of rhesus macaques induces massive expansion of naturalkiller cells but suppresses natural killer cell functions.
PG  - e77804
LID - 10.1371/journal.pone.0077804 [doi]
AB  - Natural killer (NK) cells play critical roles in innate immunity and in bridging innate and adaptive immune responses against viral infection. However, theresponse of NK cells to monkeypox virus (MPXV) infection is not wellcharacterized. In this intravenous challenge study of MPXV infection in rhesusmacaques (Macaca mulatta), we analyzed blood and lymph node NK cell changes inabsolute cell numbers, cell proliferation, chemokine receptor expression, andcellular functions. Our results showed that the absolute number of total NK cellsin the blood increased in response to MPXV infection at a magnitude of 23-fold,manifested by increases in CD56+, CD16+, CD16-CD56- double negative, andCD16+CD56+ double positive NK cell subsets. Similarly, the frequency and NK cell numbers in the lymph nodes also largely increased with the total NK cell numberincreasing 46.1-fold. NK cells both in the blood and lymph nodes massivelyproliferated in response to MPXV infection as measured by Ki67 expression.Chemokine receptor analysis revealed reduced expression of CXCR3, CCR7, and CCR6 on NK cells at early time points (days 2 and 4 after virus inoculation), followedby an increased expression of CXCR3 and CCR5 at later time points (days 7-8) ofinfection. In addition, MPXV infection impaired NK cell degranulation and ablatedsecretion of interferon-gamma and tumor necrosis factor-alpha. Our data suggest adynamic model by which NK cells respond to MPXV infection of rhesus macaques.Upon virus infection, NK cells proliferated robustly, resulting in massiveincreases in NK cell numbers. However, the migrating capacity of NK cells totissues at early time points might be reduced, and the functions of cytotoxicity and cytokine secretion were largely compromised. Collectively, the data mayexplain, at least partially, the pathogenesis of MPXV infection in rhesusmacaques.
FAU - Song, Haifeng
AU  - Song H
AD  - Integrated Research Facility, National Institute of Allergy and InfectiousDiseases, National Institutes of Health, Frederick, Maryland, United States ofAmerica.
FAU - Josleyn, Nicole
AU  - Josleyn N
FAU - Janosko, Krisztina
AU  - Janosko K
FAU - Skinner, Jeff
AU  - Skinner J
FAU - Reeves, R Keith
AU  - Reeves RK
FAU - Cohen, Melanie
AU  - Cohen M
FAU - Jett, Catherine
AU  - Jett C
FAU - Johnson, Reed
AU  - Johnson R
FAU - Blaney, Joseph E
AU  - Blaney JE
FAU - Bollinger, Laura
AU  - Bollinger L
FAU - Jennings, Gerald
AU  - Jennings G
FAU - Jahrling, Peter B
AU  - Jahrling PB
LA  - eng
GR  - HHSN272200200016I/PHS HHS/United States
GR  - Intramural NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, N.I.H., Intramural
DEP - 20131017
PL  - United States
TA  - PLoS One
JT  - PloS one
JID - 101285081
RN  - 0 (CD56 Antigen)
RN  - 0 (Receptors, CCR6)
RN  - 0 (Receptors, CCR7)
RN  - 0 (Receptors, CXCR3)
RN  - 0 (Receptors, IgG)
SB  - IM
MH  - Animals
MH  - CD56 Antigen/metabolism
MH  - Killer Cells, Natural/*cytology/*metabolism
MH  - Macaca mulatta/*immunology/*virology
MH  - Monkeypox virus/*immunology/*pathogenicity
MH  - Poxviridae Infections/*immunology/metabolism
MH  - Receptors, CCR6/metabolism
MH  - Receptors, CCR7/metabolism
MH  - Receptors, CXCR3/metabolism
MH  - Receptors, IgG/metabolism
PMC - PMC3798392
EDAT- 2013/10/23 06:00
MHDA- 2014/06/06 06:00
CRDT- 2013/10/23 06:00
PHST- 2013/04/15 00:00 [received]
PHST- 2013/09/05 00:00 [accepted]
PHST- 2013/10/23 06:00 [entrez]
PHST- 2013/10/23 06:00 [pubmed]
PHST- 2014/06/06 06:00 [medline]
AID - 10.1371/journal.pone.0077804 [doi]
AID - PONE-D-13-16728 [pii]
PST - epublish
SO  - PLoS One. 2013 Oct 17;8(10):e77804. doi: 10.1371/journal.pone.0077804.eCollection 2013.

PMID- 24050999
OWN - NLM
STAT- MEDLINE
DCOM- 20140707
LR  - 20181202
IS  - 1872-7492 (Electronic)
IS  - 0168-1702 (Linking)
VI  - 178
IP  - 2
DP  - 2013 Dec 26
TI  - Systemically administered DNA and fowlpox recombinants expressing four vacciniavirus genes although immunogenic do not protect mice against the highlypathogenic IHD-J vaccinia strain.
PG  - 374-82
LID - 10.1016/j.virusres.2013.09.016 [doi]
LID - S0168-1702(13)00308-0 [pii]
AB  - The first-generation smallpox vaccine was based on live vaccinia virus (VV) andit successfully eradicated the disease worldwide. Therefore, it was notadministered any more after 1980, as smallpox no longer existed as a naturalinfection. However, emerging threats by terrorist organisations has prompted new programmes for second-generation vaccine development based on attenuated VVstrains, which have been shown to cause rare but serious adverse events inimmunocompromised patients. Considering the closely related animal poxvirusesthat might also be used as bioweapons, and the increasing number of unvaccinated young people and AIDS-affected immunocompromised subjects, a safer and moreeffective smallpox vaccine is still required. New avipoxvirus-based vectorsshould improve the safety of conventional vaccines, and protect from newlyemerging zoonotic orthopoxvirus diseases and from the threat of deliberaterelease of variola or monkeypox virus in a bioterrorist attack. In this study,DNA and fowlpox recombinants expressing the L1R, A27L, A33R and B5R genes wereconstructed and evaluated in a pre-clinical trial in mouse, following sixprime/boost immunisation regimens, to compare their immunogenicity and protectiveefficacy against a challenge with the lethal VV IHD-J strain. Although highernumbers of VV-specific IFNgamma-producing T lymphocytes were observed in theprotected mice, the cytotoxic T-lymphocyte response and the presence ofneutralising antibodies did not always correlate with protection. In spite ofprevious successful results in mice, rabbits and monkeys, where SIV/HIVtransgenes were expressed by the fowlpox vector, the immune response elicited by these recombinants was low, and most of the mice were not protected.
CI  - Copyright (c) 2013 Elsevier B.V. All rights reserved.
FAU - Bissa, Massimiliano
AU  - Bissa M
AD  - Department of Medical Biotechnologies and Translational Medicine, University ofMilan, via Vanvitelli, 32, 20129 Milan, Italy. Electronic address:massimiliano.bissa@unimi.it.
FAU - Pacchioni, Sole Maria
AU  - Pacchioni SM
FAU - Zanotto, Carlo
AU  - Zanotto C
FAU - De Giuli Morghen, Carlo
AU  - De Giuli Morghen C
FAU - Illiano, Elena
AU  - Illiano E
FAU - Granucci, Francesca
AU  - Granucci F
FAU - Zanoni, Ivan
AU  - Zanoni I
FAU - Broggi, Achille
AU  - Broggi A
FAU - Radaelli, Antonia
AU  - Radaelli A
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20130916
PL  - Netherlands
TA  - Virus Res
JT  - Virus research
JID - 8410979
RN  - 0 (Antibodies, Neutralizing)
RN  - 0 (Antibodies, Viral)
RN  - 0 (Smallpox Vaccine)
RN  - 0 (Vaccines, DNA)
RN  - 0 (Viral Proteins)
RN  - 82115-62-6 (Interferon-gamma)
SB  - IM
MH  - Animals
MH  - Antibodies, Neutralizing/blood
MH  - Antibodies, Viral/blood
MH  - Cytotoxicity, Immunologic
MH  - Female
MH  - Fowlpox virus/*genetics
MH  - Genetic Vectors
MH  - Interferon-gamma/metabolism
MH  - Mice
MH  - Mice, Inbred BALB C
MH  - Monkeypox/immunology/*prevention & control
MH  - Smallpox Vaccine/administration & dosage/genetics/*immunology
MH  - T-Lymphocytes/immunology
MH  - Vaccines, DNA/administration & dosage/genetics/*immunology
MH  - Vaccinia virus/genetics/*immunology
MH  - Viral Proteins/genetics/*immunology
OTO - NOTNLM
OT  - Fowlpox virus
OT  - L1R, A27L, A33R and B5R VV genes
OT  - OPXV vaccine
OT  - Prime/boost
OT  - Recombinant vaccine
EDAT- 2013/09/21 06:00
MHDA- 2014/07/08 06:00
CRDT- 2013/09/21 06:00
PHST- 2013/07/03 00:00 [received]
PHST- 2013/09/05 00:00 [revised]
PHST- 2013/09/09 00:00 [accepted]
PHST- 2013/09/21 06:00 [entrez]
PHST- 2013/09/21 06:00 [pubmed]
PHST- 2014/07/08 06:00 [medline]
AID - S0168-1702(13)00308-0 [pii]
AID - 10.1016/j.virusres.2013.09.016 [doi]
PST - ppublish
SO  - Virus Res. 2013 Dec 26;178(2):374-82. doi: 10.1016/j.virusres.2013.09.016. Epub2013 Sep 16.

PMID- 24040344
OWN - NLM
STAT- MEDLINE
DCOM- 20140701
LR  - 20211021
IS  - 1932-6203 (Electronic)
IS  - 1932-6203 (Linking)
VI  - 8
IP  - 9
DP  - 2013
TI  - Mapping monkeypox transmission risk through time and space in the Congo Basin.
PG  - e74816
LID - 10.1371/journal.pone.0074816 [doi]
AB  - Monkeypox is a major public health concern in the Congo Basin area, with changingpatterns of human case occurrences reported in recent years. Whether this trendresults from better surveillance and detection methods, reduced proportions ofvaccinated vs. non-vaccinated human populations, or changing environmentalconditions remains unclear. Our objective is to examine potential correlationsbetween environment and transmission of monkeypox events in the Congo Basin. Wecreated ecological niche models based on human cases reported in the Congo Basin by the World Health Organization at the end of the smallpox eradication campaign,in relation to remotely-sensed Normalized Difference Vegetation Index datasetsfrom the same time period. These models predicted independent spatial subsets of monkeypox occurrences with high confidence; models were then projected ontoparallel environmental datasets for the 2000s to create present-day monkeypoxsuitability maps. Recent trends in human monkeypox infection are associated with broad environmental changes across the Congo Basin. Our results demonstrate that ecological niche models provide useful tools for identification of areas suitablefor transmission, even for poorly-known diseases like monkeypox.
FAU - Nakazawa, Yoshinori
AU  - Nakazawa Y
AD  - Centers for Disease Control and Prevention, Atlanta, Georgia, United States ofAmerica ; Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee,United States of America.
FAU - Lash, R Ryan
AU  - Lash RR
FAU - Carroll, Darin S
AU  - Carroll DS
FAU - Damon, Inger K
AU  - Damon IK
FAU - Karem, Kevin L
AU  - Karem KL
FAU - Reynolds, Mary G
AU  - Reynolds MG
FAU - Osorio, Jorge E
AU  - Osorio JE
FAU - Rocke, Tonie E
AU  - Rocke TE
FAU - Malekani, Jean M
AU  - Malekani JM
FAU - Muyembe, Jean-Jacques
AU  - Muyembe JJ
FAU - Formenty, Pierre
AU  - Formenty P
FAU - Peterson, A Townsend
AU  - Peterson AT
LA  - eng
GR  - R01 TW008859/TW/FIC NIH HHS/United States
GR  - 1R01TW008859-01/TW/FIC NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20130905
PL  - United States
TA  - PLoS One
JT  - PloS one
JID - 101285081
SB  - IM
MH  - Algorithms
MH  - Animals
MH  - Area Under Curve
MH  - Cameroon/epidemiology
MH  - Central African Republic/epidemiology
MH  - Congo/epidemiology
MH  - Democratic Republic of the Congo/epidemiology
MH  - Environment
MH  - Epidemiological Monitoring
MH  - Gabon/epidemiology
MH  - Geographic Information Systems
MH  - *Geographic Mapping
MH  - Geography
MH  - Humans
MH  - Macaca fascicularis
MH  - *Models, Biological
MH  - Monkeypox/*transmission
MH  - ROC Curve
MH  - Risk
MH  - Spatio-Temporal Analysis
PMC - PMC3764067
EDAT- 2013/09/17 06:00
MHDA- 2014/07/02 06:00
CRDT- 2013/09/17 06:00
PHST- 2012/08/07 00:00 [received]
PHST- 2013/08/09 00:00 [accepted]
PHST- 2013/09/17 06:00 [entrez]
PHST- 2013/09/17 06:00 [pubmed]
PHST- 2014/07/02 06:00 [medline]
AID - 10.1371/journal.pone.0074816 [doi]
AID - PONE-D-12-23863 [pii]
PST - epublish
SO  - PLoS One. 2013 Sep 5;8(9):e74816. doi: 10.1371/journal.pone.0074816. eCollection 2013.

PMID- 23994378
OWN - NLM
STAT- MEDLINE
DCOM- 20140602
LR  - 20211021
IS  - 1873-2518 (Electronic)
IS  - 0264-410X (Linking)
VI  - 31
IP  - 45
DP  - 2013 Oct 25
TI  - The effects of post-exposure smallpox vaccination on clinical diseasepresentation: addressing the data gaps between historical epidemiology and modernsurrogate model data.
PG  - 5192-201
LID - 10.1016/j.vaccine.2013.08.039 [doi]
LID - S0264-410X(13)01130-4 [pii]
AB  - Decades after public health interventions - including pre- and post-exposurevaccination - were used to eradicate smallpox, zoonotic orthopoxvirus outbreaksand the potential threat of a release of variola virus remain public healthconcerns. Routine prophylactic smallpox vaccination of the public ceasedworldwide in 1980, and the adverse event rate associated with the currentlylicensed live vaccinia virus vaccine makes reinstatement of policies recommendingroutine pre-exposure vaccination unlikely in the absence of an orthopoxvirusoutbreak. Consequently, licensing of safer vaccines and therapeutics that can be used post-orthopoxvirus exposure is necessary to protect the global populationfrom these threats. Variola virus is a solely human pathogen that does notnaturally infect any other known animal species. Therefore, the use of surrogate viruses in animal models of orthopoxvirus infection is important for thedevelopment of novel vaccines and therapeutics. Major complications involved withthe use of surrogate models include both the absence of a model that accuratelymimics all aspects of human smallpox disease and a lack of reproducibility acrossmodel species. These complications limit our ability to model post-exposurevaccination with newer vaccines for application to human orthopoxvirus outbreaks.This review seeks to (1) summarize conclusions about the efficacy ofpost-exposure smallpox vaccination from historic epidemiological reports andmodern animal studies; (2) identify data gaps in these studies; and (3) summarizethe clinical features of orthopoxvirus-associated infections in various animalmodels to identify those models that are most useful for post-exposurevaccination studies. The ultimate purpose of this review is to provideobservations and comments regarding available model systems and data gaps for usein improving post-exposure medical countermeasures against orthopoxviruses.
CI  - Copyright (c) 2013 Elsevier Ltd. All rights reserved.
FAU - Keckler, M Shannon
AU  - Keckler MS
AD  - Centers for Disease Control and Prevention, Division of High-ConsequencePathogens and Pathology, Poxvirus and Rabies Branch, United States. Electronicaddress: hbq0@cdc.gov.
FAU - Reynolds, Mary G
AU  - Reynolds MG
FAU - Damon, Inger K
AU  - Damon IK
FAU - Karem, Kevin L
AU  - Karem KL
LA  - eng
GR  - CC999999/Intramural CDC HHS/United States
PT  - Journal Article
PT  - Review
DEP - 20130827
PL  - Netherlands
TA  - Vaccine
JT  - Vaccine
JID - 8406899
RN  - 0 (Smallpox Vaccine)
SB  - IM
MH  - Animals
MH  - Disease Models, Animal
MH  - Humans
MH  - Post-Exposure Prophylaxis/*methods
MH  - Smallpox/*pathology/*prevention & control
MH  - Smallpox Vaccine/*administration & dosage
MH  - Vaccination/*methods
PMC - PMC4623313
MID - NIHMS729224
OID - NLM: HHSPA729224
OTO - NOTNLM
OT  - Animal models
OT  - Epidemiology
OT  - Monkeypox
OT  - Orthopoxviruses
OT  - Post-exposure vaccination
OT  - Prophylactic vaccination
OT  - Smallpox
OT  - Smallpox vaccination
OT  - Vaccinia
OT  - Variola virus
EDAT- 2013/09/03 06:00
MHDA- 2014/06/03 06:00
CRDT- 2013/09/03 06:00
PHST- 2013/04/14 00:00 [received]
PHST- 2013/08/05 00:00 [revised]
PHST- 2013/08/13 00:00 [accepted]
PHST- 2013/09/03 06:00 [entrez]
PHST- 2013/09/03 06:00 [pubmed]
PHST- 2014/06/03 06:00 [medline]
AID - S0264-410X(13)01130-4 [pii]
AID - 10.1016/j.vaccine.2013.08.039 [doi]
PST - ppublish
SO  - Vaccine. 2013 Oct 25;31(45):5192-201. doi: 10.1016/j.vaccine.2013.08.039. Epub2013 Aug 27.

PMID- 23935820
OWN - NLM
STAT- MEDLINE
DCOM- 20140421
LR  - 20211021
IS  - 1932-6203 (Electronic)
IS  - 1932-6203 (Linking)
VI  - 8
IP  - 7
DP  - 2013
TI  - Pathogen-host associations and predicted range shifts of human monkeypox inresponse to climate change in central Africa.
PG  - e66071
LID - 10.1371/journal.pone.0066071 [doi]
AB  - Climate change is predicted to result in changes in the geographic ranges andlocal prevalence of infectious diseases, either through direct effects on thepathogen, or indirectly through range shifts in vector and reservoir species. To better understand the occurrence of monkeypox virus (MPXV), an emergingOrthopoxvirus in humans, under contemporary and future climate conditions, weused ecological niche modeling techniques in conjunction with climate andremote-sensing variables. We first created spatially explicit probabilitydistributions of its candidate reservoir species in Africa's Congo Basin.Reservoir species distributions were subsequently used to model current andprojected future distributions of human monkeypox (MPX). Results indicate thatforest clearing and climate are significant driving factors of the transmissionof MPX from wildlife to humans under current climate conditions. Models undercontemporary climate conditions performed well, as indicated by high values forthe area under the receiver operator curve (AUC), and tests on spatially randomlyand non-randomly omitted test data. Future projections were made on IPCC 4(th)Assessment climate change scenarios for 2050 and 2080, ranging from moreconservative to more aggressive, and representing the potential variation within which range shifts can be expected to occur. Future projections showed rangeshifts into regions where MPX has not been recorded previously. Increasedsuitability for MPX was predicted in eastern Democratic Republic of Congo. Modelsdeveloped here are useful for identifying areas where environmental conditionsmay become more suitable for human MPX; targeting candidate reservoir species forfuture screening efforts; and prioritizing regions for future MPX surveillanceefforts.
FAU - Thomassen, Henri A
AU  - Thomassen HA
AD  - Center for Tropical Research, University of California Los Angeles, Los Angeles, California, USA.
FAU - Fuller, Trevon
AU  - Fuller T
FAU - Asefi-Najafabady, Salvi
AU  - Asefi-Najafabady S
FAU - Shiplacoff, Julia A G
AU  - Shiplacoff JA
FAU - Mulembakani, Prime M
AU  - Mulembakani PM
FAU - Blumberg, Seth
AU  - Blumberg S
FAU - Johnston, Sara C
AU  - Johnston SC
FAU - Kisalu, Neville K
AU  - Kisalu NK
FAU - Kinkela, Timothee L
AU  - Kinkela TL
FAU - Fair, Joseph N
AU  - Fair JN
FAU - Wolfe, Nathan D
AU  - Wolfe ND
FAU - Shongo, Robert L
AU  - Shongo RL
FAU - LeBreton, Matthew
AU  - LeBreton M
FAU - Meyer, Hermann
AU  - Meyer H
FAU - Wright, Linda L
AU  - Wright LL
FAU - Muyembe, Jean-Jacques
AU  - Muyembe JJ
FAU - Buermann, Wolfgang
AU  - Buermann W
FAU - Okitolonda, Emile
AU  - Okitolonda E
FAU - Hensley, Lisa E
AU  - Hensley LE
FAU - Lloyd-Smith, James O
AU  - Lloyd-Smith JO
FAU - Smith, Thomas B
AU  - Smith TB
FAU - Rimoin, Anne W
AU  - Rimoin AW
LA  - eng
GR  - DP1 OD000370/OD/NIH HHS/United States
GR  - R01 AI074059/AI/NIAID NIH HHS/United States
GR  - -1R01AI074059-01/AI/NIAID NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20130731
PL  - United States
TA  - PLoS One
JT  - PloS one
JID - 101285081
SB  - IM
MH  - Animals
MH  - Cercopithecus/virology
MH  - *Climate Change
MH  - Democratic Republic of the Congo
MH  - Disease Reservoirs/*virology
MH  - Ecosystem
MH  - Geography
MH  - Host-Pathogen Interactions
MH  - Humans
MH  - Models, Theoretical
MH  - Monkeypox/transmission/*virology
MH  - Monkeypox virus/*physiology
MH  - Sciuridae/virology
MH  - Trees/growth & development
PMC - PMC3729955
EDAT- 2013/08/13 06:00
MHDA- 2014/04/22 06:00
CRDT- 2013/08/13 06:00
PHST- 2012/06/03 00:00 [received]
PHST- 2013/05/05 00:00 [accepted]
PHST- 2013/08/13 06:00 [entrez]
PHST- 2013/08/13 06:00 [pubmed]
PHST- 2014/04/22 06:00 [medline]
AID - 10.1371/journal.pone.0066071 [doi]
AID - PONE-D-12-17252 [pii]
PST - epublish
SO  - PLoS One. 2013 Jul 31;8(7):e66071. doi: 10.1371/journal.pone.0066071. Print 2013.

PMID- 23809939
OWN - NLM
STAT- MEDLINE
DCOM- 20130930
LR  - 20191210
IS  - 1096-0341 (Electronic)
IS  - 0042-6822 (Linking)
VI  - 443
IP  - 2
DP  - 2013 Sep 1
TI  - Orthopoxvirus variola infection of Cynomys ludovicianus (North American blacktailed prairie dog).
PG  - 358-62
LID - 10.1016/j.virol.2013.05.029 [doi]
LID - S0042-6822(13)00310-3 [pii]
AB  - Since the eradication of Smallpox, researchers have attempted to studyOrthopoxvirus pathogenesis and immunity in animal models in order to correlateresults human smallpox. A solely human pathogen, Orthopoxvirus variola fails toproduce authentic smallpox illness in any other animal species tested to date. In2003, an outbreak in the USA of Orthopoxvirus monkeypox, revealed thesusceptibility of the North American black-tailed prairie dog (Cynomysludovicianus) to infection and fulminate disease. Prairie dogs infected withOrthopoxvirus monkeypox present with a clinical scenario similar to ordinarysmallpox, including prodrome, rash, and high mortality. This study examines ifBlack-tailed prairie dogs can become infected with O. variola and serve as asurrogate model for the study of human smallpox disease. Substantive evidence of infection is found in immunological seroconversion of animals to eitherintranasal or intradermal challenges with O. variola, but in the absence of overtillness.
CI  - Published by Elsevier Inc.
FAU - Carroll, Darin S
AU  - Carroll DS
AD  - Centers for Disease Control and Prevention, National Centers for Zoonotic andVector-Borne and Enteric Diseases, Division of High Consequence Pathogens andPathology, Poxvirus Program, Atlanta, GA, USA.
FAU - Olson, Victoria A
AU  - Olson VA
FAU - Smith, Scott K
AU  - Smith SK
FAU - Braden, Zach H
AU  - Braden ZH
FAU - Patel, Nishi
AU  - Patel N
FAU - Abel, Jason
AU  - Abel J
FAU - Li, Yu
AU  - Li Y
FAU - Damon, Inger K
AU  - Damon IK
FAU - Karem, Kevin L
AU  - Karem KL
LA  - eng
PT  - Evaluation Study
PT  - Journal Article
PT  - Research Support, U.S. Gov't, P.H.S.
DEP - 20130627
PL  - United States
TA  - Virology
JT  - Virology
JID - 0110674
RN  - 0 (Antibodies, Viral)
SB  - IM
MH  - Animals
MH  - Antibodies, Viral/blood
MH  - *Disease Models, Animal
MH  - Female
MH  - Humans
MH  - Immunity
MH  - Male
MH  - Orthopoxvirus/genetics/immunology/*pathogenicity
MH  - Poxviridae Infections/immunology/pathology
MH  - Sciuridae/*virology
MH  - Smallpox/immunology/*pathology/virology
OTO - NOTNLM
OT  - Animal model
OT  - Immunity
OT  - Infection
OT  - Orthopoxvirus
OT  - Prairie dog
OT  - Smallpox
OT  - Variola
EDAT- 2013/07/03 06:00
MHDA- 2013/10/01 06:00
CRDT- 2013/07/02 06:00
PHST- 2013/03/27 00:00 [received]
PHST- 2013/05/02 00:00 [revised]
PHST- 2013/05/20 00:00 [accepted]
PHST- 2013/07/02 06:00 [entrez]
PHST- 2013/07/03 06:00 [pubmed]
PHST- 2013/10/01 06:00 [medline]
AID - S0042-6822(13)00310-3 [pii]
AID - 10.1016/j.virol.2013.05.029 [doi]
PST - ppublish
SO  - Virology. 2013 Sep 1;443(2):358-62. doi: 10.1016/j.virol.2013.05.029. Epub 2013Jun 27.

PMID- 23798698
OWN - NLM
STAT- MEDLINE
DCOM- 20140203
LR  - 20211021
IS  - 1471-2970 (Electronic)
IS  - 0962-8436 (Linking)
VI  - 368
IP  - 1623
DP  - 2013 Aug 5
TI  - Vacated niches, competitive release and the community ecology of pathogeneradication.
PG  - 20120150
LID - 10.1098/rstb.2012.0150 [doi]
AB  - A recurring theme in the epidemiological literature on disease eradication isthat each pathogen occupies an ecological niche, and eradication of one pathogen leaves a vacant niche that favours the emergence of new pathogens to replace it. However, eminent figures have rejected this view unequivocally, stating thatthere is no basis to fear pathogen replacement and even that pathogen niches donot exist. After exploring the roots of this controversy, I propose resolutionsto disputed issues by drawing on broader ecological theory, and advance a newconsensus based on robust mechanistic principles. I argue that pathogeneradication (and cessation of vaccination) leads to a 'vacated niche', whichcould be re-invaded by the original pathogen if introduced. Consequences forother pathogens will vary, with the crucial mechanisms being competitive release,whereby the decline of one species allows its competitors to perform better, and evolutionary adaptation. Hence, eradication can cause a quantitative rise in the incidence of another infection, but whether this leads to emergence as an endemicpathogen depends on additional factors. I focus on the case study of humanmonkeypox and its rise following smallpox eradication, but also survey how these ideas apply to other pathogens and discuss implications for eradication policy.
FAU - Lloyd-Smith, James O
AU  - Lloyd-Smith JO
AD  - Department of Ecology and Evolutionary Biology, University of California, LosAngeles, 610 Charles E. Young Drive South, Los Angeles, CA 90095, USA.jlloydsmith@ucla.edu
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20130624
PL  - England
TA  - Philos Trans R Soc Lond B Biol Sci
JT  - Philosophical transactions of the Royal Society of London. Series B, Biologicalsciences
JID - 7503623
SB  - IM
MH  - Adaptation, Biological/*physiology
MH  - Animals
MH  - Disease Eradication/*methods
MH  - Ecology/*methods
MH  - Humans
MH  - *Models, Biological
MH  - Monkeypox/epidemiology
MH  - Population Dynamics
MH  - Smallpox/epidemiology
MH  - Species Specificity
MH  - Zoonoses/*transmission
PMC - PMC3720048
OTO - NOTNLM
OT  - competitive release
OT  - ecological niche
OT  - emerging infectious disease
OT  - monkeypox
OT  - pathogen eradication
OT  - zoonosis
EDAT- 2013/06/27 06:00
MHDA- 2014/02/04 06:00
CRDT- 2013/06/27 06:00
PHST- 2013/06/27 06:00 [entrez]
PHST- 2013/06/27 06:00 [pubmed]
PHST- 2014/02/04 06:00 [medline]
AID - rstb.2012.0150 [pii]
AID - 10.1098/rstb.2012.0150 [doi]
PST - epublish
SO  - Philos Trans R Soc Lond B Biol Sci. 2013 Jun 24;368(1623):20120150. doi:10.1098/rstb.2012.0150. Print 2013 Aug 5.

PMID- 23760373
OWN - NLM
STAT- MEDLINE
DCOM- 20131231
LR  - 20220409
IS  - 0971-5916 (Print)
IS  - 0971-5916 (Linking)
VI  - 137
IP  - 5
DP  - 2013 May
TI  - Smallpox: can we still learn from the journey to eradication?
PG  - 895-9
AB  - One of the most celebrated achievements of immunology and modern medicine is the eradication of the dreaded plague smallpox. From the introduction of smallpoxvaccination by Edward Jenner, to its popularization by Louis Pasteur, to theeradication effort led by Donald Henderson, this story has many lessons for ustoday, including the characteristics of the disease and vaccine that permittedits eradication, and the obviousness of the vaccine as a vector for otherintractable Infectious diseases. The disease itself, interpreted in the light of modern molecular immunology, is an obvious immunopathological disease, whichoccurs after a latent interval of 1-2 weeks, and manifests as a systemiccell-mediated delayed type hypersensitivity (DTH) syndrome. The vaccine thatslayed this dragon was given the name vaccinia, and was thought to have evolvedfrom cowpox virus, but is now known to be most closely related to a poxvirusisolated from a horse. Of interest is the fact that of the various isolates oforthopox viruses, only variola, vaccinia and monkeypox viruses can infect humans.In contrast to the systemic disease of variola, vaccinia only replicates locally at the site of inoculation, and causes a localized DTH response that usuallypeaks after 7-10 days. This difference in the pathogenicity of variola vs.vaccinia is thought to be due to the capacity of variola to circumvent innateimmunity, which allows it to disseminate widely before the adaptive immuneresponse occurs. Thus, the fact that vaccinia virus is attenuated compared tovariola, but is still replication competent, makes for its remarkable efficacy asa vaccine, as the localized infection activates all of the cells and molecules ofboth innate and adaptive immunity. Accordingly vaccinia itself, and not modified replication incompetent vaccina, is the hope for use as a vector in theeradication of additional pathogenic microbes from the globe.
FAU - Smith, Kendall A
AU  - Smith KA
AD  - The Division of Immunology, Department of Medicine, Weill Medical College,Cornell University, New York, USA. kasmith@med.cornell.edu
LA  - eng
PT  - Historical Article
PT  - Journal Article
PT  - Review
PL  - India
TA  - Indian J Med Res
JT  - The Indian journal of medical research
JID - 0374701
SB  - IM
MH  - Adaptive Immunity
MH  - Animals
MH  - *Disease Eradication
MH  - History, 19th Century
MH  - History, 20th Century
MH  - Humans
MH  - Monkeypox virus
MH  - Smallpox/*epidemiology/history/*pathology
MH  - Vaccination
MH  - Variola virus/genetics/*pathogenicity
PMC - PMC3734679
EDAT- 2013/06/14 06:00
MHDA- 2014/01/01 06:00
CRDT- 2013/06/14 06:00
PHST- 2013/06/14 06:00 [entrez]
PHST- 2013/06/14 06:00 [pubmed]
PHST- 2014/01/01 06:00 [medline]
AID - IndianJMedRes_2013_137_5_895_113002 [pii]
PST - ppublish
SO  - Indian J Med Res. 2013 May;137(5):895-9.

PMID- 23658504
OWN - NLM
STAT- MEDLINE
DCOM- 20140311
LR  - 20211021
IS  - 1553-7358 (Electronic)
IS  - 1553-734X (Linking)
VI  - 9
IP  - 5
DP  - 2013
TI  - Inference of R(0) and transmission heterogeneity from the size distribution ofstuttering chains.
PG  - e1002993
LID - 10.1371/journal.pcbi.1002993 [doi]
AB  - For many infectious disease processes such as emerging zoonoses andvaccine-preventable diseases, [Formula: see text] and infections occur asself-limited stuttering transmission chains. A mechanistic understanding oftransmission is essential for characterizing the risk of emerging diseases andmonitoring spatio-temporal dynamics. Thus methods for inferring [Formula: seetext] and the degree of heterogeneity in transmission from stuttering chain data have important applications in disease surveillance and management. Previousresearchers have used chain size distributions to infer [Formula: see text], but estimation of the degree of individual-level variation in infectiousness (asquantified by the dispersion parameter, [Formula: see text]) has typicallyrequired contact tracing data. Utilizing branching process theory along with anegative binomial offspring distribution, we demonstrate how maximum likelihoodestimation can be applied to chain size data to infer both [Formula: see text]and the dispersion parameter that characterizes heterogeneity. While the maximum likelihood value for [Formula: see text] is a simple function of the averagechain size, the associated confidence intervals are dependent on the inferreddegree of transmission heterogeneity. As demonstrated for monkeypox data from theDemocratic Republic of Congo, this impacts when a statistically significantchange in [Formula: see text] is detectable. In addition, by allowing forsuperspreading events, inference of [Formula: see text] shifts the thresholdabove which a transmission chain should be considered anomalously large for agiven value of [Formula: see text] (thus reducing the probability of false alarmsabout pathogen adaptation). Our analysis of monkeypox also clarifies the various ways that imperfect observation can impact inference of transmission parameters, and highlights the need to quantitatively evaluate whether observation is likely to significantly bias results.
FAU - Blumberg, Seth
AU  - Blumberg S
AD  - Fogarty International Center, National Institute of Health, Bethesda, Maryland,USA. seth.blumberg@ucsf.edu
FAU - Lloyd-Smith, James O
AU  - Lloyd-Smith JO
LA  - eng
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20130502
PL  - United States
TA  - PLoS Comput Biol
JT  - PLoS computational biology
JID - 101238922
SB  - IM
MH  - Animals
MH  - Cluster Analysis
MH  - Computer Simulation
MH  - *Contact Tracing
MH  - Democratic Republic of the Congo
MH  - *Disease Transmission, Infectious
MH  - Humans
MH  - *Models, Biological
MH  - *Models, Statistical
MH  - Monkeypox/transmission
MH  - Zoonoses/transmission
PMC - PMC3642075
EDAT- 2013/05/10 06:00
MHDA- 2014/03/13 06:00
CRDT- 2013/05/10 06:00
PHST- 2012/08/21 00:00 [received]
PHST- 2013/02/04 00:00 [accepted]
PHST- 2013/05/10 06:00 [entrez]
PHST- 2013/05/10 06:00 [pubmed]
PHST- 2014/03/13 06:00 [medline]
AID - 10.1371/journal.pcbi.1002993 [doi]
AID - PCOMPBIOL-D-12-01328 [pii]
PST - ppublish
SO  - PLoS Comput Biol. 2013;9(5):e1002993. doi: 10.1371/journal.pcbi.1002993. Epub2013 May 2.

PMID- 23658452
OWN - NLM
STAT- MEDLINE
DCOM- 20130904
LR  - 20211021
IS  - 1098-5514 (Electronic)
IS  - 0022-538X (Linking)
VI  - 87
IP  - 14
DP  - 2013 Jul
TI  - Assessment of the protective effect of Imvamune and Acam2000 vaccines againstaerosolized monkeypox virus in cynomolgus macaques.
PG  - 7805-15
LID - 10.1128/JVI.03481-12 [doi]
AB  - To support the licensure of a new and safer vaccine to protect people againstsmallpox, a monkeypox model of infection in cynomolgus macaques, which simulates smallpox in humans, was used to evaluate two vaccines, Acam2000 and Imvamune, forprotection against disease. Animals vaccinated with a single immunization ofImvamune were not protected completely from severe and/or lethal infection,whereas those receiving either a prime and boost of Imvamune or a singleimmunization with Acam2000 were protected completely. Additional parameters,including clinical observations, radiographs, viral load in blood, throat swabs, and selected tissues, vaccinia virus-specific antibody responses,immunophenotyping, extracellular cytokine levels, and histopathology wereassessed. There was no significant difference (P > 0.05) between the levels ofneutralizing antibody in animals vaccinated with a single immunization ofAcam2000 (132 U/ml) and the prime-boost Imvamune regime (69 U/ml) prior tochallenge with monkeypox virus. After challenge, there was evidence of viralexcretion from the throats of 2 of 6 animals in the prime-boost Imvamune group,whereas there was no confirmation of excreted live virus in the Acam2000 group.This evaluation of different human smallpox vaccines in cynomolgus macaques helpsto provide information about optimal vaccine strategies in the absence of humanchallenge studies.
FAU - Hatch, Graham J
AU  - Hatch GJ
AD  - Microbiological Services, Public Health England, Salisbury, Wiltshire, UnitedKingdom. graham.hatch@phe.gov.uk
FAU - Graham, Victoria A
AU  - Graham VA
FAU - Bewley, Kevin R
AU  - Bewley KR
FAU - Tree, Julia A
AU  - Tree JA
FAU - Dennis, Mike
AU  - Dennis M
FAU - Taylor, Irene
AU  - Taylor I
FAU - Funnell, Simon G P
AU  - Funnell SG
FAU - Bate, Simon R
AU  - Bate SR
FAU - Steeds, Kimberley
AU  - Steeds K
FAU - Tipton, Thomas
AU  - Tipton T
FAU - Bean, Thomas
AU  - Bean T
FAU - Hudson, Laura
AU  - Hudson L
FAU - Atkinson, Deborah J
AU  - Atkinson DJ
FAU - McLuckie, Gemma
AU  - McLuckie G
FAU - Charlwood, Melanie
AU  - Charlwood M
FAU - Roberts, Allen D G
AU  - Roberts AD
FAU - Vipond, Julia
AU  - Vipond J
LA  - eng
PT  - Comparative Study
PT  - Evaluation Study
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20130508
PL  - United States
TA  - J Virol
JT  - Journal of virology
JID - 0113724
RN  - 0 (Antibodies, Neutralizing)
RN  - 0 (Smallpox Vaccine)
RN  - 0 (Vaccines, Attenuated)
RN  - TU8J357395 (imvamune)
SB  - IM
MH  - Animals
MH  - Antibodies, Neutralizing/immunology
MH  - Enzyme-Linked Immunosorbent Assay
MH  - Female
MH  - Flow Cytometry
MH  - Immunization/*methods
MH  - Macaca fascicularis
MH  - Male
MH  - Orthopoxvirus/*immunology
MH  - Poxviridae Infections/*prevention & control
MH  - Real-Time Polymerase Chain Reaction
MH  - Smallpox Vaccine/*pharmacology
MH  - Vaccines, Attenuated/pharmacology
MH  - Virus Shedding/immunology
PMC - PMC3700201
EDAT- 2013/05/10 06:00
MHDA- 2013/09/05 06:00
CRDT- 2013/05/10 06:00
PHST- 2013/05/10 06:00 [entrez]
PHST- 2013/05/10 06:00 [pubmed]
PHST- 2013/09/05 06:00 [medline]
AID - JVI.03481-12 [pii]
AID - 10.1128/JVI.03481-12 [doi]
PST - ppublish
SO  - J Virol. 2013 Jul;87(14):7805-15. doi: 10.1128/JVI.03481-12. Epub 2013 May 8.

PMID- 23626656
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20211021
IS  - 1746-0794 (Print)
IS  - 1746-0794 (Linking)
VI  - 8
IP  - 2
DP  - 2013 Feb 1
TI  - A review of experimental and natural infections of animals with monkeypox virusbetween 1958 and 2012.
PG  - 129-157
AB  - Monkeypox virus (MPXV) was discovered in 1958 during an outbreak in an animalfacility in Copenhagen, Denmark. Since its discovery, MPXV has revealed apropensity to infect and induce disease in a large number of animals within themammalia class from pan-geographical locations. This finding has impeded theelucidation of the natural host, although the strongest candidates are Africansquirrels and/or other rodents. Experimentally, MPXV can infect animals via avariety of multiple different inoculation routes; however, the natural route oftransmission is unknown and is likely to be somewhat species specific. In thisreview we have attempted to compile and discuss all published articles thatdescribe experimental or natural infections with MPXV, dating from the initialdiscovery of the virus through to the year 2012. We further discuss thecomparative disease courses and pathologies of the host species.
FAU - Parker, Scott
AU  - Parker S
AD  - Department of Molecular Microbiology & Immunology, Saint Louis University School of Medicine, 1100 S. Grand Blvd, Saint Louis, MO 63104, USA.
FAU - Buller, R Mark
AU  - Buller RM
LA  - eng
GR  - N01 AI015436/AI/NIAID NIH HHS/United States
PT  - Journal Article
PL  - England
TA  - Future Virol
JT  - Future virology
JID - 101278124
PMC - PMC3635111
MID - NIHMS456531
OTO - NOTNLM
OT  - aerosol
OT  - animals
OT  - infection
OT  - intrabronchial
OT  - intradermal
OT  - intramuscular
OT  - intranasal
OT  - intratracheal
OT  - intravenous
OT  - outbreak
OT  - primates
OT  - subcutaneous
EDAT- 2013/04/30 06:00
MHDA- 2013/04/30 06:01
CRDT- 2013/04/30 06:00
PHST- 2013/04/30 06:00 [entrez]
PHST- 2013/04/30 06:00 [pubmed]
PHST- 2013/04/30 06:01 [medline]
AID - 10.2217/fvl.12.130 [doi]
PST - ppublish
SO  - Future Virol. 2013 Feb 1;8(2):129-157. doi: 10.2217/fvl.12.130.
